Citrus Sinensis ID: 002409
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 927 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGI2 | 929 | Probable LRR receptor-lik | no | no | 0.929 | 0.927 | 0.494 | 0.0 | |
| Q9FZB8 | 871 | Probable LRR receptor-lik | no | no | 0.889 | 0.947 | 0.347 | 1e-136 | |
| Q9FZB1 | 872 | Probable LRR receptor-lik | no | no | 0.869 | 0.924 | 0.343 | 1e-132 | |
| C0LGG4 | 890 | Probable LRR receptor-lik | no | no | 0.893 | 0.930 | 0.341 | 1e-130 | |
| Q9ZQR3 | 868 | Leucine-rich repeat recep | no | no | 0.867 | 0.926 | 0.357 | 1e-130 | |
| Q9ZQQ7 | 886 | Putative leucine-rich rep | no | no | 0.912 | 0.954 | 0.350 | 1e-129 | |
| Q9LIG2 | 899 | Receptor-like protein kin | no | no | 0.877 | 0.904 | 0.347 | 1e-129 | |
| O64556 | 877 | Putative leucine-rich rep | no | no | 0.872 | 0.922 | 0.339 | 1e-127 | |
| O65924 | 881 | Putative leucine-rich rep | no | no | 0.886 | 0.933 | 0.328 | 1e-125 | |
| C0LGG6 | 876 | Probable LRR receptor-lik | no | no | 0.867 | 0.917 | 0.336 | 1e-125 |
| >sp|C0LGI2|Y1677_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g67720 OS=Arabidopsis thaliana GN=At1g67720 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 862 bits (2226), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 436/881 (49%), Positives = 584/881 (66%), Gaps = 19/881 (2%)
Query: 15 SVLILLLLDSSSAQMPGFVSLNCGGNENFTD-EIGLQWIADDHLI-YGEISNISVANETR 72
+V L L+ +Q+ FVS++CG + N+TD GL W++D +I G+ ++ N
Sbjct: 9 AVTCLFLVPFVLSQVTEFVSIDCGCSSNYTDPRTGLGWVSDSEIIKQGKPVTLANTNWNS 68
Query: 73 KQYMTLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTI 132
QY R FP D++KYCY+L R RY++R TFLYG + YPKF + L T W+T+
Sbjct: 69 MQYRRRRDFPTDNKKYCYRLSTKERRRYIVRTTFLYGGLGSEEAYPKFQLYLDATKWATV 128
Query: 133 VISDAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLS 192
I + + + V ELI A+S +DVC+ A TG PF+STLELR N S+Y T +ED ++L
Sbjct: 129 TIQEVSRVYVEELIVRATSSYVDVCVCCAITGSPFMSTLELRPLNLSMYATDYEDNFFLK 188
Query: 193 VSARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDEL 252
V+AR+NFGA + +RYPDDP+DRIWESD K+ NYLV VA GT +++T I+ + E
Sbjct: 189 VAARVNFGAPNMDALRYPDDPYDRIWESDINKRPNYLVGVAPGTTRINTSKTINTLTREY 248
Query: 253 PPQKVMQTAVVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDV 312
PP KVMQTAVVGT G ++YRLNL+ FP A YFAEIE+L +E+RKF+LV P PD
Sbjct: 249 PPMKVMQTAVVGTQGLISYRLNLEDFPANARAYAYFAEIEELGANETRKFKLVQPYFPDY 308
Query: 313 SKAIVNIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYL---- 368
S A+VNI ENA G Y +YEP Y N++L FVL+F FGKT DS++GPLLNA+EI+KYL
Sbjct: 309 SNAVVNIAENANGSYTLYEPSYMNVTLDFVLTFSFGKTKDSTQGPLLNAIEISKYLPISV 368
Query: 369 --ERNDGSIDAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNL 426
+R+D S+ + ++ S+ +DWA EGGDPC+PV WSW+ C+S P +T I LS KNL
Sbjct: 369 KTDRSDVSV--LDAIRSMSPDSDWASEGGDPCIPVLWSWVNCSSTSPPRVTKIALSRKNL 426
Query: 427 TGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPN 486
G IP + + +L ELWLD N LTG +PD S +L+I+HLE+NQL+G LP L +LPN
Sbjct: 427 RGEIPPGINYMEALTELWLDDNELTGTLPDMSKLVNLKIMHLENNQLSGSLPPYLAHLPN 486
Query: 487 LRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVL--- 543
L+EL ++NN G +PS+LL V+ Y N L + KH I+G S+ A +
Sbjct: 487 LQELSIENNSFKGKIPSALLKGKVLFKYNNNPELQNEAQ-RKHFWQILGISIAAVAILLL 545
Query: 544 --LLATVVSCLFMHKGKKNNYDK-EQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDAT 600
+ V+ C + + D E + L V + A+ +L +E+AT
Sbjct: 546 LVGGSLVLLCALRKTKRADKGDSTETKKKGLVAYSAVRGGHLLDEGVAYFISLPVLEEAT 605
Query: 601 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQF 660
KK+G G FG VYYG++KDGKE+AVK+ S R+F EV LLSRIHHRNLV
Sbjct: 606 DNFSKKVGRGSFGSVYYGRMKDGKEVAVKITADPSSHLNRQFVTEVALLSRIHHRNLVPL 665
Query: 661 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 720
+GYC+E R +LVYE+MHNG+L +HL+G+ ++ ++W+ RL+IA+DAAKG+EYLHTGC
Sbjct: 666 IGYCEEADRRILVYEYMHNGSLGDHLHGSSDYKP-LDWLTRLQIAQDAAKGLEYLHTGCN 724
Query: 721 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 780
P+IIHRD+KSSNILLD +MRAKVSDFGLS+ + +HVSS+ +GTVGYLDPEYY SQQL
Sbjct: 725 PSIIHRDVKSSNILLDINMRAKVSDFGLSRQTEEDLTHVSSVAKGTVGYLDPEYYASQQL 784
Query: 781 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 840
T+KSDVYSFGV+L EL+SG++ +S E FG NIV WA+ I GD+ GIIDP +
Sbjct: 785 TEKSDVYSFGVVLFELLSGKKPVSAEDFGPEL-NIVHWARSLIRKGDVCGIIDPCIASNV 843
Query: 841 DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIER 881
I+S+W++ E A CV GH RP + EV+ IQDAI IER
Sbjct: 844 KIESVWRVAEVANQCVEQRGHNRPRMQEVIVAIQDAIRIER 884
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FZB8|Y5181_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51810 OS=Arabidopsis thaliana GN=At1g51810 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 485 bits (1248), Expect = e-136, Method: Compositional matrix adjust.
Identities = 327/942 (34%), Positives = 505/942 (53%), Gaps = 117/942 (12%)
Query: 1 MERRRRLLLPFSVASVLILLLLDSSSAQMP-GFVSLNCG----GNENFTDEIGLQWIADD 55
MER + FS L+L AQ P GF++L+CG G+ GL + +DD
Sbjct: 1 MERHCLFFVIFS-------LILHLVQAQDPIGFINLDCGLSIQGSPYKESSTGLTYTSDD 53
Query: 56 HLIY-GEISNISVANET--RKQYMTLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFD 112
+ G+I I+ E+ +K TLR+FP D + C+ L+V T+YLI+ TFLYGN+D
Sbjct: 54 GFVQSGKIGKITKELESLYKKPERTLRYFP-DGVRNCFSLNVTRGTKYLIKPTFLYGNYD 112
Query: 113 NNNVYPKFDISLGPTHWSTIVISDAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLE 172
NV P FD+ +GP W T+ + ++E++ ++ S + VCL T P+I+TLE
Sbjct: 113 GRNVIPDFDLYIGPNMWITVNTDNT----IKEILHVSKSNTLQVCLVKTGTSIPYINTLE 168
Query: 173 LRQFNGSVYLTPFEDRYYLSVSARINF-----GADSEAPVRYPDDPFDRIWESDSLKKAN 227
LR P D Y + S +N+ ++ + + YPDD DRIW+ L +
Sbjct: 169 LR---------PLADDIYTNESGSLNYLFRVYYSNLKGYIEYPDDVHDRIWK-QILPYQD 218
Query: 228 YLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGTNGSLT---YRLNLDGFPGFGWA 284
+ + ++T L I++ +D PQ+VM+TAV S T + NL+ +
Sbjct: 219 WQI--------LTTNLQINVSNDYDLPQRVMKTAVTPIKASTTTMEFPWNLEPPTSQFYL 270
Query: 285 VTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKYRVYEPGYTNLSLPFVLS 344
+FAE++ L +E+R+F +VL N ++ Y P + + + +
Sbjct: 271 FLHFAELQSLQANETREFNVVL---------------NGNVTFKSYSPKFLEMQTVYSTA 315
Query: 345 ----------FKFGKTYDSSRGPLLNAMEINKYL-----ERNDGSIDAIVSVISLY--SS 387
+ KT S+ PL+NAME L E N + AI ++ S Y S
Sbjct: 316 PKQCDGGKCLLQLVKTSRSTLPPLINAMEAYTVLDFPQIETNVDEVIAIKNIQSTYGLSK 375
Query: 388 ADWAQEGGDPCLPVPWSW--LQCN----SDPQPSITVIHLSSKNLTGNIPSDLTKLSSLV 441
W GDPC+P + W L CN S P P IT ++LSS LTG I + L++L
Sbjct: 376 TTWQ---GDPCVPKKFLWDGLNCNNSDDSTP-PIITSLNLSSSGLTGIIVLTIQNLANLQ 431
Query: 442 ELWLDGNSLTGPIPDF-SGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGT 500
EL L N+L+G +P+F + L +I+L N L+G +P L+ L+ N L+ T
Sbjct: 432 ELDLSNNNLSGGVPEFLADMKSLLVINLSGNNLSGVVPQKLIEKKMLKLNIEGNPKLNCT 491
Query: 501 VPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAV-LLLATVVSCLFMHKGKK 559
V S ++K+ EGGR K + I I +S+G+ V +A ++ C+ +K
Sbjct: 492 V-ESCVNKD-----------EEGGRQIKSMTIPIVASIGSVVAFTVALMIFCVV----RK 535
Query: 560 NNYDKEQHRHSLPVQRPVSSLNDAPAEAAHC--FTLSDIEDATKMLEKKIGSGGFGVVYY 617
NN ++ S P S + P FT +++ T +K +G GGFG+VYY
Sbjct: 536 NNPSNDEAPTS--CMLPADSRSSEPTIVTKNKKFTYAEVLTMTNNFQKILGKGGFGIVYY 593
Query: 618 GKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677
G + +++AVK+L+ +S QG ++F EV LL R+HH+NLV +GYC+E + L+YE+M
Sbjct: 594 GSVNGTEQVAVKMLSHSSAQGYKQFKAEVELLLRVHHKNLVGLVGYCEEGDKLALIYEYM 653
Query: 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK 737
NG L EH+ G +NW RL+IA +AA+G+EYLH GC P ++HRD+K++NILL++
Sbjct: 654 ANGDLDEHMSGK-RGGSILNWGTRLKIALEAAQGLEYLHNGCKPLMVHRDVKTTNILLNE 712
Query: 738 HMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLEL 796
H K++DFGLS+ F ++G +HVS++V GT+GYLDPEYY + LT+KSDVYSFGV+LL +
Sbjct: 713 HFDTKLADFGLSRSFPIEGETHVSTVVAGTIGYLDPEYYRTNWLTEKSDVYSFGVVLLVM 772
Query: 797 ISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCV 856
I+ Q I + R+I +W + GDI+ I DP+LL +Y+ S+WK E A+ C+
Sbjct: 773 ITNQPVIDQNR---EKRHIAEWVGGMLTKGDIKSITDPNLLGDYNSGSVWKAVELAMSCM 829
Query: 857 LPHGHMRPSISEVLKDIQDAIVIE--REAAAARDGNSDDMSR 896
P RP++S+V+ ++++ + E RE + M+R
Sbjct: 830 NPSSMTRPTMSQVVFELKECLASESSREVSMTFGTEVAPMAR 871
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FZB1|Y5188_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51880 OS=Arabidopsis thaliana GN=At1g51880 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 472 bits (1214), Expect = e-132, Method: Compositional matrix adjust.
Identities = 315/916 (34%), Positives = 482/916 (52%), Gaps = 110/916 (12%)
Query: 20 LLLDSSSAQ-MPGFVSLNCG---GNENFTDEI-GLQWIADDHLI-YGEISNISV--ANET 71
++L+S AQ GF+SL+CG N +T++ + + +D + I G + IS +
Sbjct: 16 VILESVQAQDQLGFISLDCGLVPKNATYTEKTTNITYKSDANYIDSGLVGRISAEYKAQL 75
Query: 72 RKQYMTLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWST 131
++Q T+R FP R CY ++ ++RYLIRATF YGN+D PKFDI +GP+ W++
Sbjct: 76 QQQTWTVRSFPEGERN-CYNFNLTAKSRYLIRATFTYGNYDGLRQVPKFDIHIGPSKWTS 134
Query: 132 IVISDAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYL 191
+ + V E+I + + ++ +CL G PFIS+LELR N + YLT L
Sbjct: 135 VKLDGVGNGAVLEMIHVLTQDRLQICLVKTGKGIPFISSLELRPLNNNTYLTQSGS---L 191
Query: 192 SVSARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDE 251
AR+ F A + +RY +D DR+W + G + +ST L +D +
Sbjct: 192 IGFARVFFSA-TPTFIRYDEDIHDRVW----------VRQFGNGLKSISTDLLVDTSNPY 240
Query: 252 LPPQKVMQTAVVGTNGS--LTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQ 309
PQ V +TA V +N S L + LD + +FAEI+ L ++ R+F + G
Sbjct: 241 DVPQAVAKTACVPSNASQPLIFDWTLDNITSQSYVYMHFAEIQTLKDNDIREFNITYNG- 299
Query: 310 PDVSKAIVNIQENAQGKYRVYEPGYTNLSLPF----------VLSFKFGKTYDSSRGPLL 359
Q Y P +S F S F KT +S+ PL+
Sbjct: 300 -------------GQNVYSYLRPEKFEISTLFDSKPLSSPDGSFSLSFTKTGNSTLPPLI 346
Query: 360 NAMEINKY-----LERNDGSIDAIVSVISLYSSADWAQEGGDPCLPVPWSW--LQC---N 409
N +EI K LE + + A++++ + Y + GDPC P + W L C N
Sbjct: 347 NGLEIYKVLDLLELETDQDEVSAMINIKATYDLSKKVSWQGDPCAPKSYQWEGLNCSYPN 406
Query: 410 SDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHL 468
SD QP I ++L+ LTG I +++KL+ L+EL L N L+G IP+ F+ L++I+L
Sbjct: 407 SD-QPRIISLNLAENKLTGTITPEISKLTQLIELDLSKNDLSGEIPEFFADMKLLKLINL 465
Query: 469 EDN-QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGA 527
N L +P S+ + + L + +LS TV +K V L G+
Sbjct: 466 SGNLGLNSTIPDSIQQRLDSKSLIL---ILSKTV-----TKTVTLK----------GKSK 507
Query: 528 KHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEA 587
K I I +SV A V L +++ F+ + K +K + + +R +
Sbjct: 508 KVPMIPIVASV-AGVFALLVILAIFFVVRRKNGESNKGTNPSIITKERRI---------- 556
Query: 588 AHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVT 647
T ++ T E+ +G GGFG VY+G L+D ++AVK+L+ +S QG +EF EV
Sbjct: 557 ----TYPEVLKMTNNFERVLGKGGFGTVYHGNLED-TQVAVKMLSHSSAQGYKEFKAEVE 611
Query: 648 LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED 707
LL R+HHRNLV +GYC + L+YE+M NG LKE++ G + W R++IA +
Sbjct: 612 LLLRVHHRNLVGLVGYCDDGDNLALIYEYMANGDLKENMSGK-RGGNVLTWENRMQIAVE 670
Query: 708 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGT 766
AA+G+EYLH GC P ++HRD+K++NILL++ AK++DFGLS+ F VDG SHVS++V GT
Sbjct: 671 AAQGLEYLHNGCTPPMVHRDVKTTNILLNERYGAKLADFGLSRSFPVDGESHVSTVVAGT 730
Query: 767 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG 826
GYLDPEYY + L++KSDVYSFGV+LLE+++ Q + +I +W + G
Sbjct: 731 PGYLDPEYYRTNWLSEKSDVYSFGVVLLEIVTNQPVTDKTR---ERTHINEWVGSMLTKG 787
Query: 827 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIEREAAAA 886
DI+ I+DP L+ +YD WKI E AL CV P + RP+++ V+ ++ + + +E A
Sbjct: 788 DIKSILDPKLMGDYDTNGAWKIVELALACVNPSSNRRPTMAHVVTELNECVALEN---AR 844
Query: 887 RDGNSDDMSRNSLHSS 902
R G R +H+S
Sbjct: 845 RQG------REEMHTS 854
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG4|Y1518_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51860 OS=Arabidopsis thaliana GN=At1g51860 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 468 bits (1204), Expect = e-130, Method: Compositional matrix adjust.
Identities = 320/936 (34%), Positives = 490/936 (52%), Gaps = 108/936 (11%)
Query: 16 VLILLLLDSSSAQ-MPGFVSLNCG---GNENFTDE-IGLQWIAD-DHLIYGEISNISVAN 69
++ +L S AQ GF+SL+CG +T++ + + +D D++ G + I+ A
Sbjct: 12 IIAFTVLRSVEAQNQAGFISLDCGLVPKETTYTEKSTNITYKSDVDYIDSGLVGKINDAY 71
Query: 70 ETR--KQYMTLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPT 127
+T+ +Q +R FP R CY +++ +YLIR TF+YGN+D N +P FD+ +GP
Sbjct: 72 KTQFQQQVWAVRSFPVGQRN-CYNVNLTANNKYLIRGTFVYGNYDGLNQFPSFDLHIGPN 130
Query: 128 HWSTIVISDAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFED 187
WS++ I + E+I + ++VCL PFIS+LE+R N YLT
Sbjct: 131 KWSSVKILGVTNTSMHEIIHVVPQDSLEVCLVKTGPTTPFISSLEVRPLNNESYLT---Q 187
Query: 188 RYYLSVSARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDL 247
L + AR+ F + S + +RY +D DR+W S + + T +ST LPID
Sbjct: 188 SGSLMLFARVYFPSSSSSFIRYDEDIHDRVWNSFTDDE----------TVWISTDLPIDT 237
Query: 248 RSDELPPQKVMQTAVVGTNGSLTYRL--NLDGFPGFGWAVTYFAEIEDLDPDESRKFRLV 305
+ PQ VM+TA V N S + L LD + +FAE+++L +E+R+F
Sbjct: 238 SNSYDMPQSVMKTAAVPKNASEPWLLWWTLDENTAQSYVYMHFAEVQNLTANETREF--- 294
Query: 306 LPGQPDVSKAIVNIQENAQGKYRVY-EPGYTNLSLPF----------VLSFKFGKTYDSS 354
NI N ++ Y P ++S F + +F F T +S+
Sbjct: 295 ------------NITYNGGLRWFSYLRPPNLSISTIFNPRAVSSSNGIFNFTFAMTGNST 342
Query: 355 RGPLLNAMEINKY-----LERNDGSIDAIVSVISLYSSADWAQEGGDPCLPVPWSW--LQ 407
PLLNA+EI LE N + A++++ Y + GDPC P + W L
Sbjct: 343 LPPLLNALEIYTVVDILQLETNKDEVSAMMNIKETYGLSKKISWQGDPCAPQLYRWEGLN 402
Query: 408 CN-SDPQPS-ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLR 464
C+ D + S I ++L+ LTG+I SD++KL+ L L L N L+G IP F+ L+
Sbjct: 403 CSYPDSEGSRIISLNLNGSELTGSITSDISKLTLLTVLDLSNNDLSGDIPTFFAEMKSLK 462
Query: 465 IIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL----SKNVVLNYAGNINL 520
+I+L N PNL N+ + +P SL SK++ L N+ L
Sbjct: 463 LINLSGN-------------PNL-------NLTA--IPDSLQQRVNSKSLTLILGENLTL 500
Query: 521 HEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQHRHSLP-------- 572
K + I +SV A V L +++ F+ K K + + H+ P
Sbjct: 501 TPKKESKKVPMVAIAASV-AGVFALLVILAIFFVIKRK----NVKAHKSPGPPPLVTPGI 555
Query: 573 VQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLT 632
V+ S N + T ++ T E+ +G GGFG VY+G L DG E+AVK+L+
Sbjct: 556 VKSETRSSNPSIITRERKITYPEVLKMTNNFERVLGKGGFGTVYHGNL-DGAEVAVKMLS 614
Query: 633 SNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH 692
+S QG +EF EV LL R+HHR+LV +GYC + L+YE+M NG L+E++ G
Sbjct: 615 HSSAQGYKEFKAEVELLLRVHHRHLVGLVGYCDDGDNLALIYEYMANGDLRENMSGK-RG 673
Query: 693 EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-F 751
+ W R++IA +AA+G+EYLH GC P ++HRD+K++NILL++ AK++DFGLS+ F
Sbjct: 674 GNVLTWENRMQIAVEAAQGLEYLHNGCRPPMVHRDVKTTNILLNERCGAKLADFGLSRSF 733
Query: 752 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGAN 811
+DG HVS++V GT GYLDPEYY + L++KSDVYSFGV+LLE+++ Q I +
Sbjct: 734 PIDGECHVSTVVAGTPGYLDPEYYRTNWLSEKSDVYSFGVVLLEIVTNQPVIDKTR---E 790
Query: 812 CRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 871
+I W + GDI+ I+DP L+ +YD WKI E AL CV P + RP+++ V+
Sbjct: 791 RPHINDWVGFMLTKGDIKSIVDPKLMGDYDTNGAWKIVELALACVNPSSNRRPTMAHVVM 850
Query: 872 DIQDAIVIEREAAAARDGNSDDMSRNSLHSSLNVGS 907
++ D + +E A R G+ + S S+ SL+ S
Sbjct: 851 ELNDCVALEN---ARRQGSEEMYSMGSVDYSLSSTS 883
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZQR3|Y2451_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At2g14510 OS=Arabidopsis thaliana GN=At2g14510 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 468 bits (1204), Expect = e-130, Method: Compositional matrix adjust.
Identities = 326/912 (35%), Positives = 484/912 (53%), Gaps = 108/912 (11%)
Query: 1 MERRRRLLLPFSVASVLILLLLDSSSAQMPGFVSLNCG--GNENFTD-EIGLQWIADDHL 57
ME R + +L + A+ I+ L+ S + Q GF+SL+CG E++ + L +I+D +
Sbjct: 1 METRNKFML-LACATFSIMSLVKSQNQQ--GFISLDCGLPSKESYIEPSSNLTFISDVNF 57
Query: 58 I----YGEISNISVANETRKQYMTLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDN 113
I G I N S N K + LR+FP D + CY L V T+YLIR F YGN+D
Sbjct: 58 IRGGKTGNIQNNSRTNFIFKPFKVLRYFP-DGIRNCYSLSVKQGTKYLIRTLFYYGNYDG 116
Query: 114 NNVYPKFDISLGPTHWSTI--VISDAATIEVRELIFLASSPKIDVCLSNATTGQPFISTL 171
N P+FD+ LGP W+++ +I+D V E++ + S +D+CL T P IS +
Sbjct: 117 LNTSPRFDLFLGPNIWTSVDVLIADVGDGVVEEIVHVTRSNILDICLVKTGTSTPMISAI 176
Query: 172 ELRQFNGSVYLTPFEDRYYLSVSARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVD 231
ELR Y L A F EA +RYP+D +DR+W S +
Sbjct: 177 ELRPLRYDTYTARTGS---LKSMAHFYFTNSDEA-IRYPEDVYDRVWMPYSQPEWT---- 228
Query: 232 VAAGTEKVSTKLPIDLRSDEL-PPQKVMQTAVVGTNGS--LTYRLNLDGFPGFGWAVTYF 288
+++T + SD PPQ V+QTA + TNGS LT+ NL+ +A +F
Sbjct: 229 ------QINTTRNVSGFSDGYNPPQGVIQTASIPTNGSEPLTFTWNLESSDDETYAYLFF 282
Query: 289 AEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKYRVYEPGYTNLSLPF------- 341
AEI+ L +E+R+F+++ G + Y ++ LS P
Sbjct: 283 AEIQQLKVNETREFKILANGVDYID-------------YTPWKFEARTLSNPAPLKCEGG 329
Query: 342 VLSFKFGKTYDSSRGPLLNAMEINKYLE--RNDGSIDAIVSVISLYSSADWAQEG--GDP 397
V + KT S+ PL+NA+EI ++ ++D + D ++++ + S+ ++ GDP
Sbjct: 330 VCRVQLSKTPKSTLPPLMNAIEIFSVIQFPQSDTNTDEVIAIKKIQSTYQLSRISWQGDP 389
Query: 398 CLPVPWSWL--QCN----SDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLT 451
C+P +SW+ CN S P P I + LS LTG I + L+ L EL L N+LT
Sbjct: 390 CVPKQFSWMGVSCNVIDISTP-PRIISLDLSLSGLTGVISPSIQNLTMLRELDLSNNNLT 448
Query: 452 GPIPDF-SGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNV 510
G +P+F + L +IHL N L G +P +L + RE KN
Sbjct: 449 GEVPEFLATIKPLLVIHLRGNNLRGSVPQALQD----RE------------------KND 486
Query: 511 VLNYAGNINLHEGGRGAKH--LNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQHR 568
L + N+ G+ L I+ S AV ++ V+ +F+ + +K++ K
Sbjct: 487 GLKLFVDPNITRRGKHQPKSWLVAIVASISCVAVTIIVLVL--IFIFRRRKSSTRK---- 540
Query: 569 HSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAV 628
V RP + + F S++++ T E +G GGFGVVY+G L + +++AV
Sbjct: 541 ----VIRPSLEMKN------RRFKYSEVKEMTNNFEVVLGKGGFGVVYHGFL-NNEQVAV 589
Query: 629 KVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG 688
KVL+ +S QG +EF EV LL R+HH NLV +GYC E L+YEFM NG LKEHL G
Sbjct: 590 KVLSQSSTQGYKEFKTEVELLLRVHHVNLVSLVGYCDEGIDLALIYEFMENGNLKEHLSG 649
Query: 689 TLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 748
+NW RL+IA ++A GIEYLH GC P ++HRD+KS+NILL AK++DFGL
Sbjct: 650 K-RGGSVLNWSSRLKIAIESALGIEYLHIGCQPPMVHRDVKSTNILLGLRFEAKLADFGL 708
Query: 749 SK-FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 807
S+ F V +HVS+ V GT+GYLDPEYY+ LT+KSDVYSFG++LLE I+GQ I +
Sbjct: 709 SRSFLVGSQAHVSTNVAGTLGYLDPEYYLKNWLTEKSDVYSFGIVLLESITGQPVIEQSR 768
Query: 808 FGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSIS 867
+ IV+WAK + +GDI+ I+DP+L +YD S WK E A++C+ P RP+++
Sbjct: 769 ---DKSYIVEWAKSMLANGDIESIMDPNLHQDYDSSSSWKALELAMLCINPSSTQRPNMT 825
Query: 868 EVLKDIQDAIVI 879
V ++ + + I
Sbjct: 826 RVAHELNECLEI 837
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZQQ7|Y2144_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g14440 OS=Arabidopsis thaliana GN=At2g14440 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 464 bits (1195), Expect = e-129, Method: Compositional matrix adjust.
Identities = 326/930 (35%), Positives = 497/930 (53%), Gaps = 84/930 (9%)
Query: 1 MERRRRLLLPFSVASVLILLLLDSSSAQMPGFVSLNCGGNENFTDEI----GLQWIADDH 56
ME R +L+L + A+ I+ L+ S + Q GF+SL CG N + I L +I+D +
Sbjct: 1 METRSKLML-LACATFSIISLVKSQNQQ--GFISLYCGLPSNESPYIEPLTNLTYISDVN 57
Query: 57 LI----YGEISNISVANETRKQYMTLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFD 112
+ G I N S + T + Y LR+FP R CY L V T+YLIR F YGN+D
Sbjct: 58 FVRGGKTGNIKNNSDIDFTSRPYKVLRYFPEGIRN-CYSLSVKQGTKYLIRTLFFYGNYD 116
Query: 113 NNNVYPKFDISLGPTHWSTIVIS--DAATIEVRELIFLASSPKIDVCLSNATTGQPFIST 170
N P+FD+ LGP W+++ + D + E+I + +D+CL T P IS
Sbjct: 117 GLNTSPRFDLFLGPNIWTSVDVQKVDGGDGVIEEIIHVTRCNILDICLVKTGTTTPMISA 176
Query: 171 LELRQFNGSVYLTPFEDRYYLSVSARINF-GADSEAPVRYPDDPFDRIWESDSLKKANYL 229
+ELR Y S+ ++F +S VRYP+D +DR+W S +
Sbjct: 177 IELRPLRYDTYTARTG-----SLKKILHFYFTNSGKEVRYPEDVYDRVWIPHSQPEWT-- 229
Query: 230 VDVAAGTEKVSTKLPIDLRSDEL-PPQKVMQTAVVGTNGS--LTYRLNLDGFPGFGWAVT 286
+++T + SD PPQ V++TA + TN S LT+ + +A
Sbjct: 230 --------QINTTRNVSGFSDGYNPPQDVIKTASIPTNVSEPLTFTWMSESSDDETYAYL 281
Query: 287 YFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKYRVYEPGYTNLSLPF---VL 343
YFAEI+ L +E+R+F++++ G V + K+ E T +L V
Sbjct: 282 YFAEIQQLKANETRQFKILVNG--------VYYIDYIPRKFEA-ETLITPAALKCGGGVC 332
Query: 344 SFKFGKTYDSSRGPLLNAMEINKYLE--RNDGSIDAIVSVISLYSSADWAQEG--GDPCL 399
+ KT S+ P +NA+EI ++ ++D + D ++++ ++ S+ ++ GDPC+
Sbjct: 333 RVQLSKTPKSTLPPQMNAIEIFSVIQFPQSDTNTDEVIAIKNIQSTYKVSRISWQGDPCV 392
Query: 400 PVPWSWL--QCN----SDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGP 453
P+ +SW+ CN S P P I + LSS LTG I + L+ L EL L N+LTG
Sbjct: 393 PIQFSWMGVSCNVIDISTP-PRIISLDLSSSGLTGVITPSIQNLTMLRELDLSNNNLTGV 451
Query: 454 IP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVL 512
IP LR + L +N LTG +P L + L ++++ N L G+VP +L +
Sbjct: 452 IPPSLQNLTMLRELDLSNNNLTGEVPEFLATIKPLLVIHLRGNNLRGSVPQALQDRE--- 508
Query: 513 NYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQHRHSLP 572
N G + L G K + I +S+ + + +V +F+ + +K++ K
Sbjct: 509 NNDG-LKLLRGKHQPKSWLVAIVASISCVAVTIIVLV-LIFIFRRRKSSTRK-------- 558
Query: 573 VQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLT 632
V RP + + F S++++ T E +G GGFGVVY+G L + +++AVKVL+
Sbjct: 559 VIRPSLEMKN------RRFKYSEVKEMTNNFEVVLGKGGFGVVYHGFL-NNEQVAVKVLS 611
Query: 633 SNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH 692
+S QG +EF EV LL R+HH NLV +GYC + L+YEFM NG LKEHL G
Sbjct: 612 QSSTQGYKEFKTEVELLLRVHHVNLVSLVGYCDKGNDLALIYEFMENGNLKEHLSGK-RG 670
Query: 693 EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-F 751
+NW RL+IA ++A GIEYLH GC P ++HRD+KS+NILL AK++DFGLS+ F
Sbjct: 671 GPVLNWPGRLKIAIESALGIEYLHIGCKPPMVHRDVKSTNILLGLRFEAKLADFGLSRSF 730
Query: 752 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGAN 811
V +HVS+ V GT+GYLDPEYY LT+KSDVYSFG++LLE+I+GQ I + +
Sbjct: 731 LVGSQTHVSTNVAGTLGYLDPEYYQKNWLTEKSDVYSFGIVLLEIITGQPVIEQSR---D 787
Query: 812 CRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 871
IV+WAK + +GDI+ I+D +L +YD S WK E A++C+ P +RP+++ V
Sbjct: 788 KSYIVEWAKSMLANGDIESIMDRNLHQDYDTSSSWKALELAMLCINPSSTLRPNMTRVAH 847
Query: 872 DIQDAIVIEREAAAARDGNSDDMSRNSLHS 901
++ + + I R + S++S H+
Sbjct: 848 ELNECLEIYN--LTKRRSQDQNSSKSSGHT 875
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LIG2|RLK6_ARATH Receptor-like protein kinase At3g21340 OS=Arabidopsis thaliana GN=At3g21340 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 462 bits (1190), Expect = e-129, Method: Compositional matrix adjust.
Identities = 319/919 (34%), Positives = 474/919 (51%), Gaps = 106/919 (11%)
Query: 31 GFVSLNCGGNEN---FTD-EIGLQWIADDHLIY-GEISNISVANET--RKQYMTLRHFPA 83
GF+SL+CG N + D GL + DD + G+ I A E+ K + LR+FP
Sbjct: 32 GFISLDCGSLPNEPPYNDPSTGLTYSTDDGFVQSGKTGRIQKAFESIFSKPSLKLRYFP- 90
Query: 84 DSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAATIEVR 143
D + CY L+V T YLI+A F+YGN+D N P FD+ LGP W T+ ++ ++
Sbjct: 91 DGFRNCYTLNVTQDTNYLIKAVFVYGNYDGLNNPPSFDLYLGPNLWVTVDMNGRTNGTIQ 150
Query: 144 ELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLT-----PFEDRYYLSVSARIN 198
E+I S + VCL T P I+TLELR + Y T + RYY S S +
Sbjct: 151 EIIHKTISKSLQVCLVKTGTSSPMINTLELRPLKNNTYNTQSGSLKYFFRYYFSGSGQ-- 208
Query: 199 FGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVM 258
+RYPDD DR W D TE ++T L I+ + PP+ VM
Sbjct: 209 -------NIRYPDDVNDRKWYP--------FFDAKEWTE-LTTNLNINSSNGYAPPEVVM 252
Query: 259 QTAV--VGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAI 316
+A + T G+ + L + +FAEI+ L ++R+F++ L
Sbjct: 253 ASASTPISTFGTWNFSWLLPSSTTQFYVYMHFAEIQTLRSLDTREFKVTL---------- 302
Query: 317 VNIQENAQGKYRVYEPGYTNLSLPFVLS----------FKFGKTYDSSRGPLLNAMEINK 366
N + Y Y P F + + KT S+ PL+NA+E+
Sbjct: 303 -----NGKLAYERYSPKTLATETIFYSTPQQCEDGTCLLELTKTPKSTLPPLMNALEVFT 357
Query: 367 Y-----LERNDGSIDAIVSVISLY--SSADWAQEGGDPCLPVPWSW--LQCN----SDPQ 413
+E N + AI S+ S Y S W GDPC+P + W L CN S P
Sbjct: 358 VIDFPQMETNPDDVAAIKSIQSTYGLSKISWQ---GDPCVPKQFLWEGLNCNNLDNSTP- 413
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF-SGCPDLRIIHLEDNQ 472
P +T ++LSS +LTG I + L+ L EL L N+LTG IP+F + L +I+L N
Sbjct: 414 PIVTSLNLSSSHLTGIIAQGIQNLTHLQELDLSNNNLTGGIPEFLADIKSLLVINLSGNN 473
Query: 473 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNI 532
G +P L+ L+ + N L + + +N AGN GAK +N+
Sbjct: 474 FNGSIPQILLQKKGLKLILEGNANL-------ICPDGLCVNKAGN-------GGAKKMNV 519
Query: 533 IIG--SSVGAAVLL---LATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEA 587
+I +SV V+L LA + + V R + S A
Sbjct: 520 VIPIVASVAFVVVLGSALAFFFIFKKKKTSNSQDLGPSSYTQVSEV-RTIRSSESAIMTK 578
Query: 588 AHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVT 647
FT S++ T E+ +G GGFG+VY+G + + +++AVK+L+ +S QG +EF EV
Sbjct: 579 NRRFTYSEVVTMTNNFERVLGKGGFGMVYHGTVNNTEQVAVKMLSHSSSQGYKEFKAEVE 638
Query: 648 LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED 707
LL R+HH+NLV +GYC E L+YE+M NG L+EH+ G +NW RL+I +
Sbjct: 639 LLLRVHHKNLVGLVGYCDEGENLALIYEYMANGDLREHMSGK-RGGSILNWETRLKIVVE 697
Query: 708 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGT 766
+A+G+EYLH GC P ++HRD+K++NILL++H+ AK++DFGLS+ F ++G +HVS++V GT
Sbjct: 698 SAQGLEYLHNGCKPPMVHRDVKTTNILLNEHLHAKLADFGLSRSFPIEGETHVSTVVAGT 757
Query: 767 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG 826
GYLDPEYY + L +KSDVYSFG++LLE+I+ Q I+ + +I +W L + G
Sbjct: 758 PGYLDPEYYRTNWLNEKSDVYSFGIVLLEIITNQLVINQSR---EKPHIAEWVGLMLTKG 814
Query: 827 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIEREAAAA 886
DIQ I+DP L +YD S+W+ E A+ C+ P RP++S+V+ ++ + + E A
Sbjct: 815 DIQNIMDPKLYGDYDSGSVWRAVELAMSCLNPSSARRPTMSQVVIELNECLSYEN----A 870
Query: 887 RDGNSDDM-SRNSLHSSLN 904
R G S +M S +S+ S+N
Sbjct: 871 RGGTSQNMNSESSIEVSMN 889
|
Probable receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64556|Y2923_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g19230 OS=Arabidopsis thaliana GN=At2g19230 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 456 bits (1174), Expect = e-127, Method: Compositional matrix adjust.
Identities = 315/929 (33%), Positives = 497/929 (53%), Gaps = 120/929 (12%)
Query: 8 LLPF-SVASVLILLLLDSSSAQMPGFVSLNCGGNEN---FTDEIGLQWIADDHLI-YGEI 62
LP S AS +++L+L + Q GFVS++CG E+ + ++ +++I+D + G I
Sbjct: 6 FLPLVSFASFVVVLVLVCAQDQ-SGFVSIDCGIPEDSSYYDEKTDIKYISDAAFVESGTI 64
Query: 63 SNISVANETR---KQYMTLRHFPADSRKYCYKLDVITRT--RYLIRATFLYGNFDNNNVY 117
+I + + KQ+ +R FP + +K CY + +YLIR F+YGN+DN
Sbjct: 65 HSIDSKFQKKNLEKQFQKVRSFP-EGKKNCYDVQPPQGKGFKYLIRTRFMYGNYDNLGKA 123
Query: 118 PKFDISLGPTHWSTIVISDAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFN 177
P FD+ LG W ++ + ++ TI +E+I+ S K+ VCL + G PF+S LELR
Sbjct: 124 PDFDLYLGVNLWDSVTLENSTTIVTKEIIYTLRSDKVHVCLVDKERGTPFLSVLELRLLK 183
Query: 178 GSVYLTPFEDRYYLSVSARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTE 237
++Y T + L + R + GA + P RY DD FDR W L N+L+
Sbjct: 184 NNIYETASDS---LMLYRRWDLGATGDLPARYKDDIFDRFWMP--LMFPNFLI------- 231
Query: 238 KVSTKLPIDLRSDE--LPPQKVMQTAVVGTNGS----LTYRLNLDGFPGFGWAV-TYFAE 290
++T L ID S LPP VM TAV N S + Y D P + + + +FAE
Sbjct: 232 -LNTSLMIDPTSSNGFLPPSVVMSTAVAPMNSSIEQIMVYWEPRD--PNWKFYIYIHFAE 288
Query: 291 IEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKYRVYEPGYTN--LSLPFVLSFKFG 348
+E L +E+R+F + L +K ++ + Y + Y +S PF L F
Sbjct: 289 VEKLPSNETREFSVFL------NKEQIDTTSVFRPSYLYTDTLYVQNPVSGPF-LEFVLR 341
Query: 349 KTYDSSRGPLLNAMEI---NKYLE--RNDGSIDAIVSVISLYSSA-DWAQEGGDPCLPV- 401
+ S+R P++NA+E N++L+ + +DAI+ + + Y +W GDPC P
Sbjct: 342 QGVKSTRPPIMNAIETYRTNEFLDLPTDQNDVDAIMKIKTKYKVKKNWL---GDPCAPFG 398
Query: 402 -PWSWLQCN--SDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFS 458
PW + C+ ++ P I ++LS LTG I P F
Sbjct: 399 YPWQGINCSYTANNPPRIISVNLSFSGLTGQID-----------------------PVFI 435
Query: 459 GCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN----VVLNY 514
L+ + L +N+LTG +P L NLP+L EL ++ N L+G +P LL ++ + L
Sbjct: 436 TLTPLQKLDLSNNRLTGTVPDFLANLPDLTELNLEENKLTGILPEKLLERSKDGSLSLRV 495
Query: 515 AGNINL--HEGGRGAK-----HLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQH 567
GN +L + R K ++ + S G LLLA + F + +
Sbjct: 496 GGNPDLCVSDSCRNKKTERKEYIIPSVASVTGLFFLLLALISFWQFKKRQQ--------- 546
Query: 568 RHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIA 627
S+ P + + S+I + T E+ +G GGFG VYYG L+ G+++A
Sbjct: 547 -----------SVKTGPLDTKRYYKYSEIVEITNNFERVLGQGGFGKVYYGVLR-GEQVA 594
Query: 628 VKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY 687
+K+L+ +S QG +EF EV LL R+HH+NL+ +GYC E + L+YE++ NGTL ++L
Sbjct: 595 IKMLSKSSAQGYKEFRAEVELLLRVHHKNLIALIGYCHEGDQMALIYEYIGNGTLGDYLS 654
Query: 688 GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG 747
G + ++W +RL+I+ DAA+G+EYLH GC P I+HRD+K +NIL+++ ++AK++DFG
Sbjct: 655 GK--NSSILSWEERLQISLDAAQGLEYLHNGCKPPIVHRDVKPTNILINEKLQAKIADFG 712
Query: 748 LSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 806
LS+ F ++G S VS+ V GT+GYLDPE+Y QQ ++KSDVYSFGV+LLE+I+GQ IS
Sbjct: 713 LSRSFTLEGDSQVSTEVAGTIGYLDPEHYSMQQFSEKSDVYSFGVVLLEVITGQPVISRS 772
Query: 807 KFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSI 866
+ N R+I L + GDI+ I+DP L + ++ WKI E AL C R ++
Sbjct: 773 RTEEN-RHISDRVSLMLSKGDIKSIVDPKLGERFNAGLAWKITEVALACASESTKTRLTM 831
Query: 867 SEVLKDIQDAIVIEREAAAARDGNSDDMS 895
S+V+ ++++++ R + G+S D+S
Sbjct: 832 SQVVAELKESLCRARTS-----GDSGDIS 855
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65924|Y2921_ARATH Putative leucine-rich repeat receptor-like protein kinase At2g19210 OS=Arabidopsis thaliana GN=At2g19210 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 451 bits (1160), Expect = e-125, Method: Compositional matrix adjust.
Identities = 309/942 (32%), Positives = 496/942 (52%), Gaps = 120/942 (12%)
Query: 8 LLPFSVASVLILLLLDSSSAQMPGFVSLNCGGNEN--FTDEI-GLQWIADDHLI-YGEIS 63
L+ F+ + +LL+ + GFVS++CG E+ + DE +++++D + G I
Sbjct: 9 LIIFACFFAVFVLLV--RAQDQSGFVSIDCGIPEDSSYNDETTDIKYVSDAAFVESGTIH 66
Query: 64 NISVANET---RKQYMTLRHFPADSRKYCYKLDVITRT--RYLIRATFLYGNFDNNNVYP 118
+I +T KQ+ +R FP +R CY + +YLIR F+YGN+DN P
Sbjct: 67 SIDPEFQTSSLEKQFQNVRSFPEGNRN-CYDVKPPQGKGFKYLIRTRFMYGNYDNLGKAP 125
Query: 119 KFDISLGPTHWSTIVISDAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNG 178
FD+ LG W ++ I +A TI +E+I S + VCL + G PF+S LE+R
Sbjct: 126 DFDLYLGFNIWDSVTIDNATTIVTKEIIHTLRSDHVHVCLVDKNRGTPFLSALEIRLLKS 185
Query: 179 SVYLTPFEDRYYLSVSARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEK 238
+ Y TP++ L + R + G PVRY DD FDRIW L+ Y +
Sbjct: 186 NTYETPYDS---LILFKRWDLGGLGALPVRYKDDVFDRIWIP--LRFPKYTI-------- 232
Query: 239 VSTKLPIDLRSDE--LPPQKVMQTAVVGTNGSLTYRLNLD-GFPGFGWAV-TYFAEIEDL 294
+ L ID ++E P + VM TA + S + + P + + V +FAE+ +L
Sbjct: 233 FNASLTIDSNNNEGFQPARFVMNTATSPEDLSQDIIFSWEPKDPTWKYFVYMHFAEVVEL 292
Query: 295 DPDESRKFRLVLPGQPDVSKAIVNIQENAQGKYRVYEPGYTNLSLPFV--------LSFK 346
+E+R+F+++L ++ +N+ + P Y FV L F+
Sbjct: 293 PSNETREFKVLL------NEKEINMSS--------FSPRYLYTDTLFVQNPVSGPKLEFR 338
Query: 347 FGKTYDSSRGPLLNAME---INKYLER--NDGSIDAIVSVISLYS-SADWAQEGGDPCLP 400
+T S+ P++NA+E +N++L+ + +DAI+ + S Y W GDPC P
Sbjct: 339 LQQTPRSTLPPIINAIETYRVNEFLQSPTDQQDVDAIMRIKSKYGVKKSWL---GDPCAP 395
Query: 401 V--PWSWLQCN--SDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD 456
V PW + C+ + P I ++LSS LTG I + + L+ L
Sbjct: 396 VKYPWKDINCSYVDNESPRIISVNLSSSGLTGEIDAAFSNLTLL---------------- 439
Query: 457 FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN----VVL 512
I+ L +N LTG +P L NL NL EL ++ N LSG +P LL ++ ++L
Sbjct: 440 -------HILDLSNNSLTGKIPDFLGNLHNLTELNLEGNKLSGAIPVKLLERSNKKLILL 492
Query: 513 NYAGNINLHEGG-------RGAKHLNII--IGSSVGAAVLLLATVVSCLFMHKGKKNNYD 563
GN +L + K++ II + S VG L+LA + L+
Sbjct: 493 RIDGNPDLCVSASCQISDEKTKKNVYIIPLVASVVGVLGLVLAIALFLLY---------- 542
Query: 564 KEQHRHSLPVQRPVSSLNDAPAEAA-HCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD 622
K++HR + P + + S++ T E+ +G GGFG VY+G L D
Sbjct: 543 KKRHRRG-----GSGGVRAGPLDTTKRYYKYSEVVKVTNNFERVLGQGGFGKVYHGVLND 597
Query: 623 GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 682
++AVK+L+ +S QG +EF EV LL R+HH+NL +GYC E + L+YEFM NGTL
Sbjct: 598 -DQVAVKILSESSAQGYKEFRAEVELLLRVHHKNLTALIGYCHEGKKMALIYEFMANGTL 656
Query: 683 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAK 742
++L G ++ ++W +RL+I+ DAA+G+EYLH GC P I+ RD+K +NIL+++ ++AK
Sbjct: 657 GDYLSGEKSYV--LSWEERLQISLDAAQGLEYLHNGCKPPIVQRDVKPANILINEKLQAK 714
Query: 743 VSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE 801
++DFGLS+ A+DG + ++ V GT+GYLDPEY+++Q+L++KSD+YSFGV+LLE++SGQ
Sbjct: 715 IADFGLSRSVALDGNNQDTTAVAGTIGYLDPEYHLTQKLSEKSDIYSFGVVLLEVVSGQP 774
Query: 802 AISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGH 861
I+ + A +I L + +GDI+GI+DP L + +D S WKI E A+ C
Sbjct: 775 VIARSRTTAENIHITDRVDLMLSTGDIRGIVDPKLGERFDAGSAWKITEVAMACASSSSK 834
Query: 862 MRPSISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSL 903
RP++S V+ ++++++ R + + D + + S +
Sbjct: 835 NRPTMSHVVAELKESVSRARAGGGSGASSVTDPAMTNFDSGM 876
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG6|Y5189_ARATH Probable LRR receptor-like protein kinase At1g51890 OS=Arabidopsis thaliana GN=At1g51890 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 451 bits (1160), Expect = e-125, Method: Compositional matrix adjust.
Identities = 304/903 (33%), Positives = 476/903 (52%), Gaps = 99/903 (10%)
Query: 16 VLILLLLDSSSAQ-MPGFVSLNCG----------GNENFTDEIGLQWIADDHLIYGEISN 64
+ + +L AQ GF+SL+CG + N T +I D + G+I+
Sbjct: 8 IFVFAVLGLVQAQDQSGFISLDCGLVPTEITYVEKSTNITYRSDATYI--DSGVPGKINE 65
Query: 65 ISVANETRKQYMTLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISL 124
+ + ++Q LR FP R CY + + +YLIR TF+YGN+D N P FD+ +
Sbjct: 66 V-YRTQFQQQIWALRSFPEGQRN-CYNFSLTAKRKYLIRGTFIYGNYDGLNQLPSFDLYI 123
Query: 125 GPTHWSTIVISDAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTP 184
GP W+++ I V E+I + + +CL PFIS+LELR N + Y+T
Sbjct: 124 GPNKWTSVSIPGVRNGSVSEMIHVLRQDHLQICLVKTGETTPFISSLELRPLNNNTYVTK 183
Query: 185 FEDRYYLSVSARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLP 244
L V AR+ F + + +RY +D DRIW L N L +ST+L
Sbjct: 184 SGS---LIVVARLYF-SPTPPFLRYDEDVHDRIW-IPFLDNKNSL---------LSTELS 229
Query: 245 IDLRSDELPPQKVMQTAVVGTNGSLTYRLN--LDGFPGFGWAVTYFAEIEDLDPDESRKF 302
+D + PQ V +TA V N + ++N LD + +FAEIE+L+ +E+R+F
Sbjct: 230 VDTSNFYNVPQTVAKTAAVPLNATQPLKINWSLDDITSQSYIYMHFAEIENLEANETREF 289
Query: 303 RLVLPGQPDVSKAIVNIQENAQGKYR--------VYEPGYTNLSLPFVLSFKFGKTYDSS 354
+ G EN +R VY P + SL +F F T +S+
Sbjct: 290 NITYNG-----------GENWFSYFRPPKFRITTVYNPAAVS-SLDGNFNFTFSMTGNST 337
Query: 355 RGPLLNAMEINKYLE-----RNDGSIDAIVSVISLYSSADWAQEGGDPCLPVPWSW--LQ 407
PL+N +EI + LE + A++++ ++Y + + GDPC P + W L
Sbjct: 338 HPPLINGLEIYQVLELPQLDTYQDEVSAMMNIKTIYGLSKRSSWQGDPCAPELYRWEGLN 397
Query: 408 C---NSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDL 463
C N P P I ++LS NL+G I SD++KL+ L EL L N L+G IP FS +L
Sbjct: 398 CSYPNFAP-PQIISLNLSGSNLSGTITSDISKLTHLRELDLSNNDLSGDIPFVFSDMKNL 456
Query: 464 RIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEG 523
+I+L N+ L+ +VP +L + + N + + E
Sbjct: 457 TLINLSGNK-----------------------NLNRSVPETLQKR--IDNKSLTLIRDET 491
Query: 524 GRGAKHLNIIIGSSVGA--AVLLLATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLN 581
G+ + ++ + I +SV + AVL++ +V + K + N + + V+ S +
Sbjct: 492 GKNSTNV-VAIAASVASVFAVLVILAIVFVVIRKKQRTNEASGPRSFTTGTVKSDARSSS 550
Query: 582 DAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKRE 641
+ FT S++ TK E+ +G GGFG VY+G L D ++AVK+L+ +S QG +E
Sbjct: 551 SSIITKERKFTYSEVLKMTKNFERVLGKGGFGTVYHGNLDD-TQVAVKMLSHSSAQGYKE 609
Query: 642 FTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI-NWIK 700
F EV LL R+HHR+LV +GYC + L+YE+M G L+E++ G H + +W
Sbjct: 610 FKAEVELLLRVHHRHLVGLVGYCDDGDNLALIYEYMEKGDLRENMSG--KHSVNVLSWET 667
Query: 701 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHV 759
R++IA +AA+G+EYLH GC P ++HRD+K +NILL++ +AK++DFGLS+ F VDG SHV
Sbjct: 668 RMQIAVEAAQGLEYLHNGCRPPMVHRDVKPTNILLNERSQAKLADFGLSRSFPVDGESHV 727
Query: 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA 819
++V GT GYLDPEYY + L++KSDVYSFGV+LLE+++ Q ++ + +I +W
Sbjct: 728 MTVVAGTPGYLDPEYYRTNWLSEKSDVYSFGVVLLEIVTNQPVMNKNR---ERPHINEWV 784
Query: 820 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 879
+ +GDI+ I+DP L ++YD +WK+ E AL CV P RP++ V+ ++ + + +
Sbjct: 785 MFMLTNGDIKSIVDPKLNEDYDTNGVWKVVELALACVNPSSSRRPTMPHVVMELNECLAL 844
Query: 880 ERE 882
E E
Sbjct: 845 EIE 847
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 927 | ||||||
| 224068652 | 924 | predicted protein [Populus trichocarpa] | 0.973 | 0.976 | 0.811 | 0.0 | |
| 356570730 | 936 | PREDICTED: probable LRR receptor-like se | 0.967 | 0.958 | 0.803 | 0.0 | |
| 224138590 | 921 | predicted protein [Populus trichocarpa] | 0.971 | 0.978 | 0.809 | 0.0 | |
| 356503698 | 937 | PREDICTED: probable LRR receptor-like se | 0.987 | 0.976 | 0.784 | 0.0 | |
| 255568426 | 900 | Nodulation receptor kinase precursor, pu | 0.946 | 0.974 | 0.807 | 0.0 | |
| 297741494 | 924 | unnamed protein product [Vitis vinifera] | 0.990 | 0.993 | 0.789 | 0.0 | |
| 225439769 | 927 | PREDICTED: probable LRR receptor-like se | 0.976 | 0.976 | 0.792 | 0.0 | |
| 357510569 | 932 | Leucine-rich repeat receptor-like protei | 0.969 | 0.964 | 0.781 | 0.0 | |
| 449440057 | 897 | PREDICTED: probable LRR receptor-like se | 0.947 | 0.978 | 0.758 | 0.0 | |
| 356545961 | 902 | PREDICTED: probable LRR receptor-like se | 0.939 | 0.965 | 0.775 | 0.0 |
| >gi|224068652|ref|XP_002326166.1| predicted protein [Populus trichocarpa] gi|222833359|gb|EEE71836.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1534 bits (3971), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 737/908 (81%), Positives = 821/908 (90%), Gaps = 6/908 (0%)
Query: 24 SSSAQMPGFVSLNCGGNENFTDEIGLQWIADDHLIYGEISNISVANETRKQYMTLRHFPA 83
+SSAQ PGF+SL+CGG NFTD++GL W +D + YG ++ISVANETRKQY T+RHFPA
Sbjct: 19 ASSAQ-PGFLSLDCGGPVNFTDDLGLSWTSDFNFSYGAAASISVANETRKQYTTVRHFPA 77
Query: 84 DSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAATIEVR 143
DSRKYCY+LDV +RTRYL+RATFLYGNFD+NNVYPKFDIS+GPTHWSTIVISDA TIE
Sbjct: 78 DSRKYCYRLDVTSRTRYLLRATFLYGNFDSNNVYPKFDISVGPTHWSTIVISDANTIEST 137
Query: 144 ELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARINFGADS 203
ELIFLASS + VCLSNATTGQPFISTLELRQFNGSVY T FE+++YLS+SARINFGAD+
Sbjct: 138 ELIFLASSSSMSVCLSNATTGQPFISTLELRQFNGSVYYTEFENQFYLSMSARINFGADN 197
Query: 204 EAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVV 263
EAP+RYPDDP+DRIWESDS+KKANYLVDVAAGT+KVST +PID+ DE PP++VMQTAVV
Sbjct: 198 EAPIRYPDDPYDRIWESDSVKKANYLVDVAAGTKKVSTDMPIDVNIDERPPERVMQTAVV 257
Query: 264 GTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENA 323
GTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDP+ESRKFRLVLPG PD+SKAIVNI+ENA
Sbjct: 258 GTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPEESRKFRLVLPGYPDMSKAIVNIEENA 317
Query: 324 QGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDAIV--SV 381
QGKYR+YEPGYTNLSLPFVLSF+FGKT DSSRGPL+NAMEI+KYLE+NDG++D V V
Sbjct: 318 QGKYRLYEPGYTNLSLPFVLSFRFGKTSDSSRGPLVNAMEIHKYLEKNDGTLDGYVISRV 377
Query: 382 ISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLV 441
I +S+ DWAQEGGDPCLPVPWSW+QCNSD +P I + LSSKNL+GN+PS LT L+ LV
Sbjct: 378 ILSHSTEDWAQEGGDPCLPVPWSWVQCNSDARPRIVKLSLSSKNLSGNVPSGLTMLTGLV 437
Query: 442 ELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTV 501
ELWLDGNSLTGPIPDF+GC L IIHLE+NQLTG LPSSL+NLPNLRELYVQNN+LSGT+
Sbjct: 438 ELWLDGNSLTGPIPDFTGCTGLEIIHLENNQLTGELPSSLLNLPNLRELYVQNNLLSGTI 497
Query: 502 PSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNN 561
PS L S+ V LNY+GNINL EG R +H++IIIGSSVGAAVLL+AT+VSCLFMHKGKK +
Sbjct: 498 PSGL-SRKVALNYSGNINLREGARRGRHMDIIIGSSVGAAVLLIATIVSCLFMHKGKKRH 556
Query: 562 YDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK 621
D+EQ R SLP+Q VSSL +AP EAAHCFT +IEDATK EKKIGSGGFGVVYYGK+K
Sbjct: 557 PDQEQLRDSLPMQMVVSSLRNAPGEAAHCFTTFEIEDATKKFEKKIGSGGFGVVYYGKMK 616
Query: 622 DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 681
DG+EIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE+G+S+LVYEFMHNGT
Sbjct: 617 DGREIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEDGKSMLVYEFMHNGT 676
Query: 682 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRA 741
LKEHLYG L + INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL+DK+MRA
Sbjct: 677 LKEHLYGPLKRGKSINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILVDKNMRA 736
Query: 742 KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE 801
KV+DFGLSK AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLEL+SGQE
Sbjct: 737 KVADFGLSKLAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELMSGQE 796
Query: 802 AISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGH 861
AISNE FG NCRNIVQWAKLHIESGDIQGIIDPSL EYDIQSMWKI EKALMCV PHGH
Sbjct: 797 AISNESFGVNCRNIVQWAKLHIESGDIQGIIDPSLCGEYDIQSMWKIAEKALMCVQPHGH 856
Query: 862 MRPSISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSLNVGS--FGGTENFLSLDE 919
MRPSISEVLK+IQDAI+IERE AAR+ SD+MSRNS+HSSLN+GS GG EN+L+LDE
Sbjct: 857 MRPSISEVLKEIQDAILIEREVTAAREDISDEMSRNSVHSSLNLGSLDLGGAENYLALDE 916
Query: 920 SIVRPSAR 927
SI +P+AR
Sbjct: 917 SIAQPTAR 924
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356570730|ref|XP_003553538.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1529 bits (3959), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 730/909 (80%), Positives = 809/909 (88%), Gaps = 12/909 (1%)
Query: 29 MPGFVSLNCGGNENFTDEIGLQWIADDHLIYGEISNISVANETRKQYMTLRHFPADSRKY 88
M GFVSL+CGG E FTDE+GL W DD L YG+IS ISVANETRKQY TLRHFPADSRKY
Sbjct: 30 MQGFVSLDCGGTEKFTDELGLHWTPDDKLTYGQISTISVANETRKQYTTLRHFPADSRKY 89
Query: 89 CYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAATIEVRELIFL 148
CY L+V++RTRYL+RA+FLYGNFDNNNVYPKFDIS+G THWSTIVISDA +IE+RELIFL
Sbjct: 90 CYTLEVVSRTRYLLRASFLYGNFDNNNVYPKFDISVGATHWSTIVISDANSIEMRELIFL 149
Query: 149 ASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARINFGADSEAPVR 208
ASSP + VCLSNATTGQPFISTLELRQFNGSVY T FE +YLSVSARINFGA+S+AP+R
Sbjct: 150 ASSPTVSVCLSNATTGQPFISTLELRQFNGSVYYTQFEQHFYLSVSARINFGAESDAPIR 209
Query: 209 YPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGTNGS 268
YPDDPFDRIWESDS+KKANYLVDVAAGTEK+ST +PID+ DE+PP KVMQTAVVGTNGS
Sbjct: 210 YPDDPFDRIWESDSVKKANYLVDVAAGTEKISTTVPIDVNRDEMPPVKVMQTAVVGTNGS 269
Query: 269 LTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKYR 328
LTYRLNLDGFPG GWA TYFAEIEDLDPDESRKFRLVLPGQPD+SKA+VNI+ENAQGKYR
Sbjct: 270 LTYRLNLDGFPGTGWAFTYFAEIEDLDPDESRKFRLVLPGQPDISKAVVNIEENAQGKYR 329
Query: 329 VYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDA--IVSVISLYS 386
+YEPG+TN+SLPFVLSF+FGKTYDSSRGPLLNAMEIN YLE+NDGS+D I +++S YS
Sbjct: 330 LYEPGFTNISLPFVLSFRFGKTYDSSRGPLLNAMEINMYLEKNDGSLDGATISNILSHYS 389
Query: 387 SADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLD 446
+ADW QEGGDPCLPVPWSW++CNSDPQP I I LS+KNLTGNIP D+TKL LVELWLD
Sbjct: 390 AADWLQEGGDPCLPVPWSWVRCNSDPQPRIVSILLSNKNLTGNIPLDITKLVGLVELWLD 449
Query: 447 GNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL 506
GN LTGP PDF+GC DL+IIHLE+NQLTG LP+SL NLP+LRELYVQNNMLSGT+PS LL
Sbjct: 450 GNMLTGPFPDFTGCMDLKIIHLENNQLTGVLPTSLTNLPSLRELYVQNNMLSGTIPSELL 509
Query: 507 SKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQ 566
SK++VLNY+GNINLH R H+ +IIGSSVGA+VLLLAT++SCL+MHKGK+ + EQ
Sbjct: 510 SKDLVLNYSGNINLHRESRIKGHMYVIIGSSVGASVLLLATIISCLYMHKGKRRYH--EQ 567
Query: 567 HR------HSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKL 620
R SLP QR S +D PAEAAHCF+ S+IE+AT EKKIGSGGFGVVYYGKL
Sbjct: 568 GRILNSCIDSLPTQRLASWKSDDPAEAAHCFSYSEIENATNNFEKKIGSGGFGVVYYGKL 627
Query: 621 KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 680
KDGKEIAVKVLTSNSYQGKREF+NEVTLLSRIHHRNLVQ LGYC++E S+LVYEFMHNG
Sbjct: 628 KDGKEIAVKVLTSNSYQGKREFSNEVTLLSRIHHRNLVQLLGYCRDEENSMLVYEFMHNG 687
Query: 681 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR 740
TLKEHLYG L H + INWIKRLEIAEDAAKGIEYLHTGCVP +IHRDLKSSNILLDKHMR
Sbjct: 688 TLKEHLYGPLVHGRSINWIKRLEIAEDAAKGIEYLHTGCVPVVIHRDLKSSNILLDKHMR 747
Query: 741 AKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 800
AKVSDFGLSK AVDG SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ
Sbjct: 748 AKVSDFGLSKLAVDGVSHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 807
Query: 801 EAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHG 860
EAISNE FG NCRNIVQWAKLHIESGDIQGIIDP L ++YD+QSMWKI EKALMCV PHG
Sbjct: 808 EAISNESFGVNCRNIVQWAKLHIESGDIQGIIDPLLRNDYDLQSMWKIAEKALMCVQPHG 867
Query: 861 HMRPSISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSLNVGS--FGGTENFLSLD 918
HMRPSISE LK+IQDAI IER+A A R+GNSDDMS+NS HSS+N+GS GG E++LS+D
Sbjct: 868 HMRPSISEALKEIQDAISIERQAEALREGNSDDMSKNSFHSSMNMGSMDLGGAESYLSID 927
Query: 919 ESIVRPSAR 927
ESI +P+AR
Sbjct: 928 ESIAQPTAR 936
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224138590|ref|XP_002322852.1| predicted protein [Populus trichocarpa] gi|222867482|gb|EEF04613.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1524 bits (3946), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 735/908 (80%), Positives = 819/908 (90%), Gaps = 7/908 (0%)
Query: 24 SSSAQMPGFVSLNCGGNENFTDEIGLQWIADDHLIYGEISNISVANETRKQYMTLRHFPA 83
+SSAQ PGF+SL+CGG NFTD +GL W +D + IYGE ++ISVANETRKQY T+RHFPA
Sbjct: 17 ASSAQ-PGFLSLDCGGPANFTDALGLSWTSDVNFIYGEAASISVANETRKQYTTVRHFPA 75
Query: 84 DSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAATIEVR 143
D+RKYCY+LDV +RTRYL+RATFLYG+FDNNNVYPKFDIS+GPTHWSTIVISDA TIE
Sbjct: 76 DTRKYCYRLDVTSRTRYLLRATFLYGDFDNNNVYPKFDISVGPTHWSTIVISDANTIESI 135
Query: 144 ELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARINFGADS 203
ELIFLASS I VCLSNATTGQPFISTLELRQFNGSVY T FE++++LSVSARINFGADS
Sbjct: 136 ELIFLASSSSISVCLSNATTGQPFISTLELRQFNGSVYFTAFENQFFLSVSARINFGADS 195
Query: 204 EAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVV 263
PVRYPDDP+DRIWESDS+KKANYLVDVAAGT+KVST +PI++ DE PP+KVMQTAVV
Sbjct: 196 VDPVRYPDDPYDRIWESDSVKKANYLVDVAAGTKKVSTDMPINVNIDERPPEKVMQTAVV 255
Query: 264 GTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENA 323
GTNGSLTYRLNLDGFPGFGWA TYFAEIEDLDP ESRKFRLVLPG PD+SKA+VNI+ENA
Sbjct: 256 GTNGSLTYRLNLDGFPGFGWACTYFAEIEDLDPTESRKFRLVLPGNPDMSKAVVNIEENA 315
Query: 324 QGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDA--IVSV 381
QGKYR+YEPGYTNLSLPFVLSF+FGKT DSSRGPLLNAMEINKYLE+NDGS+D I V
Sbjct: 316 QGKYRLYEPGYTNLSLPFVLSFRFGKTSDSSRGPLLNAMEINKYLEKNDGSLDGDVISGV 375
Query: 382 ISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLV 441
I LYS+ADWAQEGGDPC+PVPWSW+QCNS+ +P I + LSSKNL+G++PSDLTKL+ LV
Sbjct: 376 ILLYSTADWAQEGGDPCMPVPWSWVQCNSEARPRIVKLSLSSKNLSGSVPSDLTKLTGLV 435
Query: 442 ELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTV 501
ELWLDGNSLTGPIPDF+GC DL IIHLE+NQLTG LPSSL+NLPNLRELYVQNNMLSGT+
Sbjct: 436 ELWLDGNSLTGPIPDFTGCTDLEIIHLENNQLTGELPSSLLNLPNLRELYVQNNMLSGTI 495
Query: 502 PSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNN 561
PS L + VVLNY+GNINLHEG R +H+ IIIGSSVGAAVLL+ T+VSC+FM KGKK +
Sbjct: 496 PSGL-GRKVVLNYSGNINLHEGARRGRHMGIIIGSSVGAAVLLITTLVSCMFMQKGKKRH 554
Query: 562 YDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK 621
D+EQ R SLPVQR VS+L++AP EAAH FT +IEDATK EKKIGSGGFGVVYYGK+K
Sbjct: 555 PDQEQLRDSLPVQRVVSTLSNAPGEAAHRFTSFEIEDATKKFEKKIGSGGFGVVYYGKMK 614
Query: 622 DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 681
DG+EIAVKVLTSNS+QGKREF+NEV+LLSRIHHRNLVQFLG+CQE G+S+LVYEFMHNGT
Sbjct: 615 DGREIAVKVLTSNSFQGKREFSNEVSLLSRIHHRNLVQFLGFCQEVGKSMLVYEFMHNGT 674
Query: 682 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRA 741
LKEHLYG L + I+WIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLK+SNILLDK+MRA
Sbjct: 675 LKEHLYGPLKQGRSISWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKTSNILLDKNMRA 734
Query: 742 KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE 801
KV+DFGLSK AVDGASHVSSIVRGTVGYLDPEYYISQQLT+KSDVYSFGVILLEL+SGQE
Sbjct: 735 KVADFGLSKLAVDGASHVSSIVRGTVGYLDPEYYISQQLTNKSDVYSFGVILLELMSGQE 794
Query: 802 AISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGH 861
AISNE FG NCRNIVQWAKLHIESGDIQGIIDPSL +E+DIQSMWKI EKAL CV PHGH
Sbjct: 795 AISNESFGVNCRNIVQWAKLHIESGDIQGIIDPSLCNEFDIQSMWKIAEKALTCVQPHGH 854
Query: 862 MRPSISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSLNVGS--FGGTENFLSLDE 919
MRPSISEVLK+IQDAI+IERE AAR G SD+MSRNS+ SS N+GS GGTEN L+LDE
Sbjct: 855 MRPSISEVLKEIQDAILIEREVTAAR-GFSDEMSRNSVQSSFNLGSLDLGGTENCLALDE 913
Query: 920 SIVRPSAR 927
SI RP+AR
Sbjct: 914 SIARPTAR 921
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356503698|ref|XP_003520642.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1523 bits (3943), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 727/927 (78%), Positives = 817/927 (88%), Gaps = 12/927 (1%)
Query: 11 FSVASVLILLLLDSSSAQMPGFVSLNCGGNENFTDEIGLQWIADDHLIYGEISNISVANE 70
F+++ LIL SS+ M GFVSL+CGG E F DEIGL W DD L YG+IS ISV NE
Sbjct: 13 FALSLSLILHSPFSSAQIMQGFVSLDCGGTEKFADEIGLHWTPDDKLTYGQISTISVVNE 72
Query: 71 TRKQYMTLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWS 130
TRKQY TLRHFPADSRKYCY L+V++RTRYL+RA+FLYGNFD+NNVYPKFDIS+GPTHWS
Sbjct: 73 TRKQYTTLRHFPADSRKYCYTLEVVSRTRYLLRASFLYGNFDDNNVYPKFDISIGPTHWS 132
Query: 131 TIVISDAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYY 190
TIVISDA +IE+RELIFLASSP + VCLSNATTGQPFISTLELRQFNGSVY T FE+ +Y
Sbjct: 133 TIVISDANSIEMRELIFLASSPTVSVCLSNATTGQPFISTLELRQFNGSVYYTQFEEHFY 192
Query: 191 LSVSARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSD 250
LSVSARINFGA+S+AP+RYPDDPFDRIWESDS+KKANYLVDVAAGTEK+ST +PID+ D
Sbjct: 193 LSVSARINFGAESDAPIRYPDDPFDRIWESDSVKKANYLVDVAAGTEKISTTVPIDVNRD 252
Query: 251 ELPPQKVMQTAVVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQP 310
E+PP KVMQTAVVGTNGSLTYRLNLDGFPG GWA TYFAEIEDLDP+ESRKFRLVLPGQP
Sbjct: 253 EMPPVKVMQTAVVGTNGSLTYRLNLDGFPGTGWAFTYFAEIEDLDPNESRKFRLVLPGQP 312
Query: 311 DVSKAIVNIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLER 370
D+SKA+VNI+ENAQGKYR+YEPG+TN+SLPFVLSF+FGKTYDSSRGPLLNAMEIN YLE+
Sbjct: 313 DISKAVVNIEENAQGKYRLYEPGFTNISLPFVLSFRFGKTYDSSRGPLLNAMEINMYLEK 372
Query: 371 NDGSIDA--IVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTG 428
NDGS+D I +++S YS+ DWAQEGGDPCLPVPWSW++CNSDPQP I I LS+KNLTG
Sbjct: 373 NDGSLDGATISNILSHYSAEDWAQEGGDPCLPVPWSWVRCNSDPQPRIVSILLSNKNLTG 432
Query: 429 NIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 488
NIP D+TKL LVELWLDGN LTGP PDF+GC DL+IIHLE+NQLTG LP+SL NLP+LR
Sbjct: 433 NIPMDITKLVGLVELWLDGNMLTGPFPDFTGCMDLKIIHLENNQLTGVLPTSLTNLPSLR 492
Query: 489 ELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATV 548
ELYVQNNMLSGT+PS LLSK++VLNY+GNINLH R H+ +IIGSSVGA+VLLLAT+
Sbjct: 493 ELYVQNNMLSGTIPSELLSKDLVLNYSGNINLHRESRIKGHMYVIIGSSVGASVLLLATI 552
Query: 549 VSCLFMHKGKKNNYDKEQHR------HSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKM 602
+SCL+M KGK+ + EQ R SLP QR S +D PAEAAHCF+ +IE+AT
Sbjct: 553 ISCLYMRKGKRRYH--EQGRILNNRIDSLPTQRLASWKSDDPAEAAHCFSFPEIENATNN 610
Query: 603 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 662
E KIGSGGFG+VYYGKLKDGKEIAVKVLTSNSYQGKREF+NEVTLLSRIHHRNLVQ LG
Sbjct: 611 FETKIGSGGFGIVYYGKLKDGKEIAVKVLTSNSYQGKREFSNEVTLLSRIHHRNLVQLLG 670
Query: 663 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 722
YC++E S+LVYEFMHNGTLKEHLYG L H + INWIKRLEIAEDAAKGIEYLHTGC+P
Sbjct: 671 YCRDEESSMLVYEFMHNGTLKEHLYGPLVHGRSINWIKRLEIAEDAAKGIEYLHTGCIPV 730
Query: 723 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 782
+IHRDLKSSNILLDKHMRAKVSDFGLSK AVDG SHVSSIVRGTVGYLDPEYYISQQLTD
Sbjct: 731 VIHRDLKSSNILLDKHMRAKVSDFGLSKLAVDGVSHVSSIVRGTVGYLDPEYYISQQLTD 790
Query: 783 KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 842
KSDVYSFGVILLELISGQEAISNE FG NCRNIVQWAKLHIESGDIQGIIDP L ++YD+
Sbjct: 791 KSDVYSFGVILLELISGQEAISNESFGVNCRNIVQWAKLHIESGDIQGIIDPLLRNDYDL 850
Query: 843 QSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSS 902
QSMWKI EKALMCV PHGHMRP+ISEV+K+IQDAI IER+A A R+GNSDDMS++S HSS
Sbjct: 851 QSMWKIAEKALMCVQPHGHMRPTISEVIKEIQDAISIERQAEALREGNSDDMSKHSFHSS 910
Query: 903 LNVGS--FGGTENFLSLDESIVRPSAR 927
+N+GS GG E++LS+DESI +P+AR
Sbjct: 911 MNMGSMDLGGAESYLSIDESIAQPTAR 937
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255568426|ref|XP_002525187.1| Nodulation receptor kinase precursor, putative [Ricinus communis] gi|223535484|gb|EEF37153.1| Nodulation receptor kinase precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1506 bits (3899), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 733/908 (80%), Positives = 802/908 (88%), Gaps = 31/908 (3%)
Query: 25 SSAQMPGFVSLNCGGNENFTDEIGLQWIADDHLIYGEISNISVANETRKQYMTLRHFPAD 84
SSAQMPGFVSLNCGG ENFTDE+GL W +DD LIYGE + ISVANETRKQY TLRHFPAD
Sbjct: 19 SSAQMPGFVSLNCGGKENFTDELGLVWTSDDSLIYGEPATISVANETRKQYKTLRHFPAD 78
Query: 85 SRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAATIEVRE 144
SRKYCY LDVI+RTRYL+RATFLYGNFDNNNVYPKFDIS+G THWSTIVISDA TIE E
Sbjct: 79 SRKYCYTLDVISRTRYLLRATFLYGNFDNNNVYPKFDISVGATHWSTIVISDANTIESIE 138
Query: 145 LIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARINFGADSE 204
LIFLASSP I VCLSNATTGQPFISTLELRQFNGSVY T FE+++YLS+SARINFGADSE
Sbjct: 139 LIFLASSPTISVCLSNATTGQPFISTLELRQFNGSVYYTSFENQFYLSISARINFGADSE 198
Query: 205 APVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVG 264
APVRYPDDPFDRIWESDS+KKANYLVDVAAGTEK+ST + ID+ +DE PP+KVMQTAVVG
Sbjct: 199 APVRYPDDPFDRIWESDSVKKANYLVDVAAGTEKISTNMSIDVSNDERPPEKVMQTAVVG 258
Query: 265 TNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQ 324
TNGSLTYRLNLDGFPGFGWAVTYFAEIEDL PDESRKFRL+LPG PD+SK IVNIQENAQ
Sbjct: 259 TNGSLTYRLNLDGFPGFGWAVTYFAEIEDLAPDESRKFRLILPGFPDMSKPIVNIQENAQ 318
Query: 325 GKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDA--IVSVI 382
GKYR+Y+PGY N+SLPFVLSF+FGKT DSSRGPLLNAMEINKYLE+NDGS+D I SVI
Sbjct: 319 GKYRLYQPGYPNISLPFVLSFRFGKTSDSSRGPLLNAMEINKYLEKNDGSLDGEVIASVI 378
Query: 383 SLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVE 442
SLY+S DWAQEGGDPCLPVPWSWLQCNSD +P I I LSSKNLTGNIPSDL KL L E
Sbjct: 379 SLYTSTDWAQEGGDPCLPVPWSWLQCNSDARPRIIKISLSSKNLTGNIPSDLPKLKGLAE 438
Query: 443 LWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVP 502
L E+NQLTG LPSSLMNLP+LRELYVQNN+LSGTVP
Sbjct: 439 FHL-----------------------ENNQLTGGLPSSLMNLPHLRELYVQNNLLSGTVP 475
Query: 503 SSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNY 562
S LL KN+ LNY+GN+++HEGGR KH IIIGSSVGAAVLL+AT+ SC F+ +GKK+N+
Sbjct: 476 SGLLDKNLFLNYSGNLHVHEGGRREKHTGIIIGSSVGAAVLLIATIASCFFIRRGKKSNH 535
Query: 563 DKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD 622
D E HR PVQR VS+LND PAE A+CFT S+IEDAT+ LEKKIGSGGFG+VYYGKLK+
Sbjct: 536 DYEHHRVPPPVQRLVSTLNDNPAEGAYCFTFSEIEDATRKLEKKIGSGGFGIVYYGKLKN 595
Query: 623 GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 682
GKEIAVKVLT+NS+QGKREF+NEVTLLSRIHHRNLVQFLG+CQE+GRS+LVYE+MHNGTL
Sbjct: 596 GKEIAVKVLTNNSFQGKREFSNEVTLLSRIHHRNLVQFLGFCQEDGRSMLVYEYMHNGTL 655
Query: 683 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAK 742
KEHLYG + + INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLK+SNILLDKHMRAK
Sbjct: 656 KEHLYG--SRGRSINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKTSNILLDKHMRAK 713
Query: 743 VSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEA 802
VSDFGLSK A+DGASHVSS+VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLEL+SG+EA
Sbjct: 714 VSDFGLSKLALDGASHVSSVVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELMSGKEA 773
Query: 803 ISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL-LDEYDIQSMWKIEEKALMCVLPHGH 861
ISNE FG NCRNIVQWAKLHIESGDIQG+ID S DEYDIQSMWKI EKALMCV PHGH
Sbjct: 774 ISNE-FGTNCRNIVQWAKLHIESGDIQGVIDSSFDDDEYDIQSMWKIAEKALMCVQPHGH 832
Query: 862 MRPSISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSLNVGS--FGGTENFLSLDE 919
MRPSISEVLK+IQDAI IERE+ A R+GNSDDMSRNS+HSSLN+GS GGTEN+LSLDE
Sbjct: 833 MRPSISEVLKEIQDAIAIERESVAVREGNSDDMSRNSVHSSLNLGSLELGGTENYLSLDE 892
Query: 920 SIVRPSAR 927
S+ RP+AR
Sbjct: 893 SVARPTAR 900
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297741494|emb|CBI32626.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1506 bits (3898), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 730/925 (78%), Positives = 817/925 (88%), Gaps = 7/925 (0%)
Query: 6 RLLLPFSVASVLILLLLDSSSAQMPGFVSLNCGGNENFTDEIGLQWIADDHLIYGEISNI 65
RLLL F +VL L+D+++AQMPGFVS +CGG+ENFTD++GL W +DD L+YGEI+ I
Sbjct: 4 RLLLLFLSVTVL---LMDAANAQMPGFVSFDCGGSENFTDDLGLWWTSDDQLMYGEIATI 60
Query: 66 SVANETRKQYMTLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLG 125
SVANETRKQY TLRHFPAD+RKYCY LDVI+RTRYL+RATFLYGNFDNN VYPKFDISLG
Sbjct: 61 SVANETRKQYTTLRHFPADNRKYCYTLDVISRTRYLVRATFLYGNFDNNKVYPKFDISLG 120
Query: 126 PTHWSTIVISDAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPF 185
T WSTIVISDA TIE ELIFLAS P I VCLSNATTGQPFISTLELRQFNGS+Y T +
Sbjct: 121 ATPWSTIVISDANTIESSELIFLASDPTISVCLSNATTGQPFISTLELRQFNGSIYYTEY 180
Query: 186 EDRYYLSVSARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPI 245
E+ ++LSVSAR+NFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVA GTEKVST++PI
Sbjct: 181 EEDFFLSVSARVNFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAPGTEKVSTQMPI 240
Query: 246 DLRSDELPPQKVMQTAVVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLV 305
D+ D PP+KVMQTAVVG NG+L+YRLNLDGFPGFGWA TY AEIEDL P+E+RKFRL+
Sbjct: 241 DVNKDSRPPEKVMQTAVVGRNGTLSYRLNLDGFPGFGWAFTYLAEIEDLGPEETRKFRLI 300
Query: 306 LPGQPDVSKAIVNIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEIN 365
LP PD+SK VNIQENAQGKYR+YEPGY N+SLPFVLSFKFGKT DSS+GPLLNAMEIN
Sbjct: 301 LPNMPDLSKPAVNIQENAQGKYRLYEPGYPNISLPFVLSFKFGKTSDSSQGPLLNAMEIN 360
Query: 366 KYLERNDGSID--AIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSS 423
KYLE+ DG +D AI S++ YSS DWA+EGGDPCLPVPWSW+ CNSDPQP I IHLS
Sbjct: 361 KYLEKRDGCLDGSAIASIVLQYSSEDWAKEGGDPCLPVPWSWVACNSDPQPRIVSIHLSG 420
Query: 424 KNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMN 483
KNLTGNIP+DLTKLS LVELWLDGN+L GPIPDF+G +L+ IHLE+NQL+G LPSSL++
Sbjct: 421 KNLTGNIPTDLTKLSGLVELWLDGNALAGPIPDFTGLINLKTIHLENNQLSGELPSSLVD 480
Query: 484 LPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVL 543
L +L+ELYVQNNMLSG VPS LL++N+ NY+GN NLH+G G +H+ IIIGSSVGA VL
Sbjct: 481 LQSLKELYVQNNMLSGKVPSGLLNENLDFNYSGNDNLHKGSTGGRHIGIIIGSSVGAVVL 540
Query: 544 LLATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKML 603
L+AT+ SCLFMHKGKK Y+++Q H LP QR VSSLNDA EAA+CF+LS+IEDAT+
Sbjct: 541 LIATIASCLFMHKGKKRYYEQDQLGHGLPAQRIVSSLNDAATEAANCFSLSEIEDATRKF 600
Query: 604 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 663
EKKIGSGGFGVVYYGK+KDGKEIAVKVL +NSYQG REF+NEVTLLSRIHHRNLVQFLGY
Sbjct: 601 EKKIGSGGFGVVYYGKMKDGKEIAVKVLINNSYQGNREFSNEVTLLSRIHHRNLVQFLGY 660
Query: 664 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 723
CQEEGRS+LVYEFMHNGTLKEHLYG LT E+ I+WIKRLEIAEDAAKGIEYLHTGCVP+I
Sbjct: 661 CQEEGRSMLVYEFMHNGTLKEHLYGPLTRERAISWIKRLEIAEDAAKGIEYLHTGCVPSI 720
Query: 724 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDK 783
IHRDLKSSNILLDK+M+AKVSDFGLSK AVDG+SHVSS+VRGTVGYLDPEYYISQQLTDK
Sbjct: 721 IHRDLKSSNILLDKYMKAKVSDFGLSKLAVDGSSHVSSVVRGTVGYLDPEYYISQQLTDK 780
Query: 784 SDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQ 843
SDVYSFGVILLELISGQEAISNE FG NCRNIVQWAKLHIESGDIQGIIDPSL DEYDIQ
Sbjct: 781 SDVYSFGVILLELISGQEAISNESFGVNCRNIVQWAKLHIESGDIQGIIDPSLRDEYDIQ 840
Query: 844 SMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSL 903
SMWKI EKALMCV PHG MRP ISEV+K+IQ+AI IER A AAR+GNS D SRNS+HSS+
Sbjct: 841 SMWKIAEKALMCVQPHGSMRPPISEVIKEIQEAISIERGAEAAREGNS-DASRNSIHSSI 899
Query: 904 NVG-SFGGTENFLSLDESIVRPSAR 927
N+G G TEN+LS DESI RP+ R
Sbjct: 900 NMGIDVGPTENYLSFDESIARPTPR 924
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225439769|ref|XP_002275389.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1496 bits (3872), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 722/911 (79%), Positives = 808/911 (88%), Gaps = 6/911 (0%)
Query: 22 LDSSSAQMPGFVSLNCGGNENFTDEIGLQWIADDHLIYGEISNISVANETRKQYMTLRHF 81
+D+++AQMPGFVS +CGG+ENFTD++GL W +DD L+YGEI+ ISVANETRKQY TLRHF
Sbjct: 18 MDAANAQMPGFVSFDCGGSENFTDDLGLWWTSDDQLMYGEIATISVANETRKQYTTLRHF 77
Query: 82 PADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAATIE 141
PAD+RKYCY LDVI+RTRYL+RATFLYGNFDNN VYPKFDISLG T WSTIVISDA TIE
Sbjct: 78 PADNRKYCYTLDVISRTRYLVRATFLYGNFDNNKVYPKFDISLGATPWSTIVISDANTIE 137
Query: 142 VRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARINFGA 201
ELIFLAS P I VCLSNATTGQPFISTLELRQFNGS+Y T +E+ ++LSVSAR+NFGA
Sbjct: 138 SSELIFLASDPTISVCLSNATTGQPFISTLELRQFNGSIYYTEYEEDFFLSVSARVNFGA 197
Query: 202 DSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTA 261
DSEAPVRYPDDPFDRIWESDSLKKANYLVDVA GTEKVST++PID+ D PP+KVMQTA
Sbjct: 198 DSEAPVRYPDDPFDRIWESDSLKKANYLVDVAPGTEKVSTQMPIDVNKDSRPPEKVMQTA 257
Query: 262 VVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQE 321
VVG NG+L+YRLNLDGFPGFGWA TY AEIEDL P+E+RKFRL+LP PD+SK VNIQE
Sbjct: 258 VVGRNGTLSYRLNLDGFPGFGWAFTYLAEIEDLGPEETRKFRLILPNMPDLSKPAVNIQE 317
Query: 322 NAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSID--AIV 379
NAQGKYR+YEPGY N+SLPFVLSFKFGKT DSS+GPLLNAMEINKYLE+ DG +D AI
Sbjct: 318 NAQGKYRLYEPGYPNISLPFVLSFKFGKTSDSSQGPLLNAMEINKYLEKRDGCLDGSAIA 377
Query: 380 SVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSS 439
S++ YSS DWA+EGGDPCLPVPWSW+ CNSDPQP I IHLS KNLTGNIP+DLTKLS
Sbjct: 378 SIVLQYSSEDWAKEGGDPCLPVPWSWVACNSDPQPRIVSIHLSGKNLTGNIPTDLTKLSG 437
Query: 440 LVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSG 499
LVELWLDGN+L GPIPDF+G +L+ IHLE+NQL+G LPSSL++L +L+ELYVQNNMLSG
Sbjct: 438 LVELWLDGNALAGPIPDFTGLINLKTIHLENNQLSGELPSSLVDLQSLKELYVQNNMLSG 497
Query: 500 TVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKK 559
VPS LL++N+ NY+GN NLH+G G +H+ IIIGSSVGA VLL+AT+ SCLFMHKGKK
Sbjct: 498 KVPSGLLNENLDFNYSGNDNLHKGSTGGRHIGIIIGSSVGAVVLLIATIASCLFMHKGKK 557
Query: 560 NNYDKEQHR--HSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYY 617
Y++ H+ H LP QR VSSLNDA EAA+CF+LS+IEDAT+ EKKIGSGGFGVVYY
Sbjct: 558 RYYEQGMHQLGHGLPAQRIVSSLNDAATEAANCFSLSEIEDATRKFEKKIGSGGFGVVYY 617
Query: 618 GKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677
GK+KDGKEIAVKVL +NSYQG REF+NEVTLLSRIHHRNLVQFLGYCQEEGRS+LVYEFM
Sbjct: 618 GKMKDGKEIAVKVLINNSYQGNREFSNEVTLLSRIHHRNLVQFLGYCQEEGRSMLVYEFM 677
Query: 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK 737
HNGTLKEHLYG LT E+ I+WIKRLEIAEDAAKGIEYLHTGCVP+IIHRDLKSSNILLDK
Sbjct: 678 HNGTLKEHLYGPLTRERAISWIKRLEIAEDAAKGIEYLHTGCVPSIIHRDLKSSNILLDK 737
Query: 738 HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELI 797
+M+AKVSDFGLSK AVDG+SHVSS+VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELI
Sbjct: 738 YMKAKVSDFGLSKLAVDGSSHVSSVVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELI 797
Query: 798 SGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVL 857
SGQEAISNE FG NCRNIVQWAKLHIESGDIQGIIDPSL DEYDIQSMWKI EKALMCV
Sbjct: 798 SGQEAISNESFGVNCRNIVQWAKLHIESGDIQGIIDPSLRDEYDIQSMWKIAEKALMCVQ 857
Query: 858 PHGHMRPSISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSLNVG-SFGGTENFLS 916
PHG MRP ISEV+K+IQ+AI IER A AAR+GNS D SRNS+HSS+N+G G TEN+LS
Sbjct: 858 PHGSMRPPISEVIKEIQEAISIERGAEAAREGNS-DASRNSIHSSINMGIDVGPTENYLS 916
Query: 917 LDESIVRPSAR 927
DESI RP+ R
Sbjct: 917 FDESIARPTPR 927
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357510569|ref|XP_003625573.1| Leucine-rich repeat receptor-like protein kinase [Medicago truncatula] gi|355500588|gb|AES81791.1| Leucine-rich repeat receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1480 bits (3831), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 706/903 (78%), Positives = 794/903 (87%), Gaps = 4/903 (0%)
Query: 29 MPGFVSLNCGGNENFTDEIGLQWIADDHLIYGEISNISVANETRKQYMTLRHFPADSRKY 88
M GFVSL+CGG+E+FTD+IGL W D+ L YGEIS ISV NETRKQY TLRHFPADSRKY
Sbjct: 30 MQGFVSLDCGGSESFTDDIGLDWTPDNKLTYGEISTISVVNETRKQYTTLRHFPADSRKY 89
Query: 89 CYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAATIEVRELIFL 148
CY LDVI+RTRYL+RA+FLYGNFDNNNVYPKFDIS+G THWSTIVISDA IE+RELIFL
Sbjct: 90 CYTLDVISRTRYLLRASFLYGNFDNNNVYPKFDISVGATHWSTIVISDANIIEMRELIFL 149
Query: 149 ASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARINFGADSEAPVR 208
ASS + VCLSNATTGQPFISTLELRQFNGS+Y T FE ++YLSVSARINFGA+++AP+R
Sbjct: 150 ASSSTVSVCLSNATTGQPFISTLELRQFNGSIYYTQFEQQFYLSVSARINFGAETDAPIR 209
Query: 209 YPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGTNGS 268
YPDDPFDRIWESDS+KKANYLVDVA GTEKVST +PI + D++PP KVMQTAVVGTNGS
Sbjct: 210 YPDDPFDRIWESDSVKKANYLVDVAVGTEKVSTNVPILVNRDDVPPVKVMQTAVVGTNGS 269
Query: 269 LTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKYR 328
LTYRLNLDGFPG WAVTYFAEIEDL P+ESRKFRLVLPGQP++SKAIVNI+ENA GKYR
Sbjct: 270 LTYRLNLDGFPGNAWAVTYFAEIEDLSPNESRKFRLVLPGQPEISKAIVNIEENAFGKYR 329
Query: 329 VYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGS--IDAIVSVISLYS 386
+YEPG+TNLSLPFVLSFKF KT DSS+GPL+NAMEINKYLE+NDGS ++AI V+S YS
Sbjct: 330 LYEPGFTNLSLPFVLSFKFAKTPDSSKGPLVNAMEINKYLEKNDGSPDVEAISGVLSHYS 389
Query: 387 SADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLD 446
SA+W QEGGDPCLPVPWSW++C+SDPQP I I LS KNLTGNIPSD+TKL LVELWLD
Sbjct: 390 SANWTQEGGDPCLPVPWSWIRCSSDPQPRIISILLSGKNLTGNIPSDITKLVGLVELWLD 449
Query: 447 GNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL 506
GN LTGPIPDF+GC DL+IIHLE+NQ G LP+SL NLP+LRELYVQNNMLSG VP LL
Sbjct: 450 GNMLTGPIPDFTGCMDLKIIHLENNQFNGVLPASLANLPSLRELYVQNNMLSGEVPPHLL 509
Query: 507 SKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQ 566
SK+++LNY+GN NLH+ R H+ IIIGS+VGA+VLLLATV+SCL +HKGK+ Y+K+
Sbjct: 510 SKDLILNYSGNTNLHKQSRIKSHMYIIIGSAVGASVLLLATVISCLVIHKGKRRYYEKDH 569
Query: 567 HRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI 626
++P QRP S +D PAEAAHCF+L++IE AT EK+IGSGGFG+VYYGKLK+GKEI
Sbjct: 570 IVSAVPTQRPDSWKSDDPAEAAHCFSLAEIETATNNFEKRIGSGGFGIVYYGKLKEGKEI 629
Query: 627 AVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL 686
AVKVL +NSYQGKREF+NEVTLLSRIHHRNLVQ +GYC+EE S+LVYEFMHNGTLKEHL
Sbjct: 630 AVKVLRNNSYQGKREFSNEVTLLSRIHHRNLVQLIGYCREEENSILVYEFMHNGTLKEHL 689
Query: 687 YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF 746
YGTL H + INWIKRLEIAEDAAKGIEYLHTGCVP +IHRDLK+SNILLD+ MRAKVSDF
Sbjct: 690 YGTLEHGRSINWIKRLEIAEDAAKGIEYLHTGCVPVVIHRDLKTSNILLDRQMRAKVSDF 749
Query: 747 GLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 806
GLSK AVDG SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE
Sbjct: 750 GLSKLAVDGVSHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 809
Query: 807 KFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSI 866
FG +CRNIVQWAKLHIESGDIQGIIDP L YD+QSMWKI EKALMCV PHG MRPSI
Sbjct: 810 SFGLHCRNIVQWAKLHIESGDIQGIIDPLLGSNYDLQSMWKIAEKALMCVQPHGDMRPSI 869
Query: 867 SEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSLNVGS--FGGTENFLSLDESIVRP 924
SEVLK+IQDAI IE+EA R+GNSD+ SRNS SS+N+GS G E+FLS+DESI +P
Sbjct: 870 SEVLKEIQDAISIEKEAETLREGNSDEASRNSFQSSMNIGSMDLGRAESFLSIDESIAQP 929
Query: 925 SAR 927
+AR
Sbjct: 930 TAR 932
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449440057|ref|XP_004137801.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Cucumis sativus] gi|449524194|ref|XP_004169108.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1429 bits (3698), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 690/910 (75%), Positives = 783/910 (86%), Gaps = 32/910 (3%)
Query: 23 DSSSAQMPGFVSLNCGGNENFTDEIGLQWIADDHLIYGEISNISVANETRKQYMTLRHFP 82
D S AQMPGFVSL+CGG E+FTD+IGL+W D + +GE NISVANETRKQYMTLRHFP
Sbjct: 15 DVSFAQMPGFVSLDCGGQESFTDDIGLEWDPDTQVRFGEAVNISVANETRKQYMTLRHFP 74
Query: 83 ADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAATIEV 142
ADSRKYCY L+V +RTRYL+RATFLYGNFDNNNVYPKFDISLG THWSTIVISDA TIEV
Sbjct: 75 ADSRKYCYSLNVTSRTRYLLRATFLYGNFDNNNVYPKFDISLGATHWSTIVISDANTIEV 134
Query: 143 RELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARINFGAD 202
RELIFLAS+P + VCLSNATTGQPFISTLELRQFNGS Y T FED++YLSVSARINFGAD
Sbjct: 135 RELIFLASTPTVSVCLSNATTGQPFISTLELRQFNGSAYYTQFEDQFYLSVSARINFGAD 194
Query: 203 SEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAV 262
SEAPVRYPDDPFDR+WESDS++KANYLVDVAAGTEKVSTKLPID+ DE PPQKVMQTAV
Sbjct: 195 SEAPVRYPDDPFDRMWESDSVRKANYLVDVAAGTEKVSTKLPIDVDRDERPPQKVMQTAV 254
Query: 263 VGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQEN 322
VG NGSLTYRLNLDGFPGFGWAVTYFAEIEDL P ++RKFRLVLPG P++SKA+VNI+EN
Sbjct: 255 VGRNGSLTYRLNLDGFPGFGWAVTYFAEIEDLGPTDTRKFRLVLPGMPEISKAVVNIEEN 314
Query: 323 AQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDAIV--S 380
AQGKYR+YEPG+TN++LPFVLSF+FGKT DSS GPLLNAMEINKYLE++DGS+D V S
Sbjct: 315 AQGKYRLYEPGFTNITLPFVLSFRFGKTQDSSLGPLLNAMEINKYLEKSDGSLDGAVVAS 374
Query: 381 VISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSL 440
VIS + S+DW EGGDPC+PVPWSWLQCNSDPQP I I LS +NL+GNIP+D+ KLS L
Sbjct: 375 VISKFPSSDW-DEGGDPCMPVPWSWLQCNSDPQPRIIKISLSKQNLSGNIPTDIAKLSGL 433
Query: 441 VELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSG 499
VE L+ N LTG +P + P+LR +++++N MLSG
Sbjct: 434 VEFHLENNQLTGELPSSLASLPNLRELYVQNN------------------------MLSG 469
Query: 500 TVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKK 559
TVPS LLSKN+V++Y+GNINLHEGG+ H+ II+GS +GA VLLLATVVSC F+HKG++
Sbjct: 470 TVPSGLLSKNLVVDYSGNINLHEGGK-KNHVYIIVGSVIGAVVLLLATVVSCYFLHKGRR 528
Query: 560 NNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK 619
++++ SL VQR VSS DA E AHCF++++I ATK E+KIGSGGFGVVYYGK
Sbjct: 529 RYHEQDLPEESLAVQRFVSSKGDASKETAHCFSVNEIVQATKDFERKIGSGGFGVVYYGK 588
Query: 620 LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679
L DGKEIAVKVLTSNS+QG+REF NEVTLLSRIHHRNLVQFLGYCQE+ RS+L+YEFMHN
Sbjct: 589 LNDGKEIAVKVLTSNSFQGRREFANEVTLLSRIHHRNLVQFLGYCQEQDRSMLIYEFMHN 648
Query: 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM 739
GTLKEHLYG LT E+ I+WIKRLEIAEDAA+G+EYLHTGC+PAIIHRDLKSSNILLD+HM
Sbjct: 649 GTLKEHLYGPLTREKTISWIKRLEIAEDAARGVEYLHTGCIPAIIHRDLKSSNILLDRHM 708
Query: 740 RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 799
+AKVSDFGLSK AVDG SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG
Sbjct: 709 KAKVSDFGLSKLAVDGVSHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 768
Query: 800 QEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPH 859
QEAISN FGANCRNIVQWAKLHIESGDIQGIIDPSL +EYDIQSMWKI EKALMCV +
Sbjct: 769 QEAISNVNFGANCRNIVQWAKLHIESGDIQGIIDPSLRNEYDIQSMWKIAEKALMCVQAN 828
Query: 860 GHMRPSISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSLNVGSFG--GTENFLSL 917
GH+RPSISEVLK+IQD+I+IERE+ A ++GNSDDMSRNS+H SLN+GS G EN++S
Sbjct: 829 GHLRPSISEVLKEIQDSILIERESTATKEGNSDDMSRNSVH-SLNMGSLDLCGNENYVSF 887
Query: 918 DESIVRPSAR 927
DESI RP+AR
Sbjct: 888 DESIARPTAR 897
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356545961|ref|XP_003541401.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1429 bits (3698), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 702/905 (77%), Positives = 772/905 (85%), Gaps = 34/905 (3%)
Query: 27 AQMPGFVSLNCGGNENFTDEIGLQWIADDHLIYGEISNISVANETRKQYMTLRHFPADSR 86
AQMPGFVSL+CGG ENFTDEIGL W D L YGEISNISVANETRKQY LRHFPADSR
Sbjct: 28 AQMPGFVSLDCGGKENFTDEIGLNWTPDK-LRYGEISNISVANETRKQYTALRHFPADSR 86
Query: 87 KYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAATIEVRELI 146
KYCY LDV++RTRYL+RA+FLYGNFD NNVYPKFDI +G THWSTIVISDA TIE+RELI
Sbjct: 87 KYCYTLDVVSRTRYLLRASFLYGNFDANNVYPKFDIFIGATHWSTIVISDANTIEMRELI 146
Query: 147 FLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARINFGADSEAP 206
FLA SP + VCLSNATTG+PFISTLELRQFNGSVY T E+ +YLSVSARINFGADS+AP
Sbjct: 147 FLALSPTVSVCLSNATTGKPFISTLELRQFNGSVYYTYTEEHFYLSVSARINFGADSDAP 206
Query: 207 VRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGTN 266
+RYPDDPFDRIWESDS+KKANYLVDVAAGT K+ST ID+ SDE+PP KVMQTAVVGTN
Sbjct: 207 IRYPDDPFDRIWESDSVKKANYLVDVAAGTRKISTNKSIDVNSDEMPPMKVMQTAVVGTN 266
Query: 267 GSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGK 326
GSLTYRLNLDGFPGF WA TYFAEIEDL +ESRKFRLVLPG D+SKA+VNI+ENA GK
Sbjct: 267 GSLTYRLNLDGFPGFAWAFTYFAEIEDLAENESRKFRLVLPGHSDISKAVVNIEENAPGK 326
Query: 327 YRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDA--IVSVISL 384
YR+YEPGYTNLSLPFVLSF+FGKT DSSRGPLLNAMEIN+YLE+NDGS D I SV+S
Sbjct: 327 YRLYEPGYTNLSLPFVLSFRFGKTSDSSRGPLLNAMEINEYLEKNDGSPDGEVISSVLSH 386
Query: 385 YSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELW 444
Y SADWAQEGGDPCLPVPWSW++C+SD QP I I LSSKNLTGNIP D+TKL+ LVEL
Sbjct: 387 YFSADWAQEGGDPCLPVPWSWVRCSSDQQPKIISILLSSKNLTGNIPLDITKLTGLVEL- 445
Query: 445 LDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSS 504
HLE+NQLTG L +SL NLPNLRELYVQNNMLSGTVPS
Sbjct: 446 ----------------------HLENNQLTGALSTSLANLPNLRELYVQNNMLSGTVPSD 483
Query: 505 LLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDK 564
LLSK++ LNY GN NLH+G R HL +IIGS+VGAAVLL+AT++SCL M KGK Y++
Sbjct: 484 LLSKDLDLNYTGNTNLHKGSRKKSHLYVIIGSAVGAAVLLVATIISCLVMRKGKTKYYEQ 543
Query: 565 EQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGK 624
S P Q SS + P+E AHCF+ S+IE++T EKKIGSGGFGVVYYGKLKDGK
Sbjct: 544 NS-LVSHPSQSMDSSKSIGPSEVAHCFSFSEIENSTNNFEKKIGSGGFGVVYYGKLKDGK 602
Query: 625 EIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKE 684
EIAVKVLTSNSYQGKREF+NEVTLLSRIHHRNLVQ LGYC+EEG S+L+YEFMHNGTLKE
Sbjct: 603 EIAVKVLTSNSYQGKREFSNEVTLLSRIHHRNLVQLLGYCREEGNSMLIYEFMHNGTLKE 662
Query: 685 HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 744
HLYG LTH + INW+KRLEIAED+AKGIEYLHTGCVPA+IHRDLKSSNILLDKHMRAKVS
Sbjct: 663 HLYGPLTHGRSINWMKRLEIAEDSAKGIEYLHTGCVPAVIHRDLKSSNILLDKHMRAKVS 722
Query: 745 DFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAIS 804
DFGLSK AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSD+YSFGVILLELISGQEAIS
Sbjct: 723 DFGLSKLAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDIYSFGVILLELISGQEAIS 782
Query: 805 NEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP 864
N+ FGANCRNIVQWAKLHIESGDIQGIIDP L + YD+QSMWKI EKALMCV PHGHMRP
Sbjct: 783 NDSFGANCRNIVQWAKLHIESGDIQGIIDPVLQNNYDLQSMWKIAEKALMCVQPHGHMRP 842
Query: 865 SISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSLNVGS--FGGTENFLSLDESIV 922
SISEVLK+IQDAI IEREA +GNSD+ RNS+HSS+N+GS TEN+LS+DESI
Sbjct: 843 SISEVLKEIQDAIAIEREA----EGNSDE-PRNSVHSSINMGSMDLAATENYLSIDESIA 897
Query: 923 RPSAR 927
+P AR
Sbjct: 898 QPIAR 902
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 927 | ||||||
| TAIR|locus:2057991 | 934 | AT2G37050 [Arabidopsis thalian | 0.969 | 0.962 | 0.707 | 0.0 | |
| TAIR|locus:2008565 | 929 | AT1G67720 [Arabidopsis thalian | 0.966 | 0.964 | 0.468 | 8.2e-218 | |
| TAIR|locus:2055165 | 868 | AT2G14510 [Arabidopsis thalian | 0.455 | 0.486 | 0.386 | 1.7e-126 | |
| TAIR|locus:2066158 | 884 | AT2G28990 [Arabidopsis thalian | 0.641 | 0.673 | 0.357 | 6.4e-125 | |
| TAIR|locus:2126540 | 876 | AT4G29990 [Arabidopsis thalian | 0.463 | 0.490 | 0.370 | 5.7e-124 | |
| TAIR|locus:2066163 | 872 | AT2G29000 [Arabidopsis thalian | 0.456 | 0.485 | 0.395 | 1.1e-122 | |
| TAIR|locus:2047675 | 881 | AT2G19210 [Arabidopsis thalian | 0.453 | 0.476 | 0.368 | 2.2e-122 | |
| TAIR|locus:2078171 | 883 | AT3G46400 [Arabidopsis thalian | 0.461 | 0.484 | 0.358 | 1.1e-120 | |
| TAIR|locus:2059093 | 876 | FRK1 "FLG22-induced receptor-l | 0.461 | 0.488 | 0.384 | 1.7e-120 | |
| TAIR|locus:2078191 | 838 | AT3G46420 [Arabidopsis thalian | 0.294 | 0.325 | 0.467 | 5.2e-119 |
| TAIR|locus:2057991 AT2G37050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 3382 (1195.6 bits), Expect = 0., P = 0.
Identities = 645/912 (70%), Positives = 748/912 (82%)
Query: 28 QMPGFVSLNCGGNENFTDEIGLQWIADDHLIYGEISNISVANETRKQYMTLRHFPADSRK 87
Q PGFVSL+CGG E FTDE+GL+W D+HLIYGE +NIS NETR QY TLRHFPADSRK
Sbjct: 24 QAPGFVSLDCGGAEPFTDELGLKWSPDNHLIYGETANISSVNETRTQYTTLRHFPADSRK 83
Query: 88 YCYKLDVITRTRYLIRATFLYGNFDN-NNVYPKFDISLGPTHWSTIVISDAATIEVRELI 146
YCY L+V +R RYLIRATFLYGNFDN NNVYPKFDISLG THW+TIVIS+ IE EL+
Sbjct: 84 YCYTLNVTSRNRYLIRATFLYGNFDNSNNVYPKFDISLGATHWATIVISETYIIETAELV 143
Query: 147 FLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPF-EDRYYLSVSARINFGADSEA 205
FLASSP + VCLSNATTGQPFISTLELRQ +GS+Y + EDR+YLSV+ARINFGA+SEA
Sbjct: 144 FLASSPTVSVCLSNATTGQPFISTLELRQLSGSMYGSMLSEDRFYLSVAARINFGAESEA 203
Query: 206 PVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGT 265
VRYPDDP+DRIWESD KK NYLVDVAAGT +VST LPI+ R D+ PPQKVMQTAVVGT
Sbjct: 204 SVRYPDDPYDRIWESDLQKKPNYLVDVAAGTVRVSTTLPIESRVDDRPPQKVMQTAVVGT 263
Query: 266 NGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQG 325
NGSLTYR+NLDGFPGFGWA TYFAEIEDL DESRKFRLVLP QP+ SK++VNI+EN Q
Sbjct: 264 NGSLTYRMNLDGFPGFGWAFTYFAEIEDLAEDESRKFRLVLPEQPEYSKSVVNIKENTQR 323
Query: 326 KYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDAIV--SVIS 383
YRVY PGY N++LPFVL+F+F KT DSSRGP+LNAMEI+KYL ++DGS+DA V +V S
Sbjct: 324 PYRVYAPGYPNITLPFVLNFRFAKTADSSRGPILNAMEISKYLRKSDGSVDATVMANVAS 383
Query: 384 LYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVEL 443
LYSS +WAQEGGDPC P PWSW+QCNSDPQP + I LSS NLTGNIPSDL KL+ LVEL
Sbjct: 384 LYSSTEWAQEGGDPCSPSPWSWVQCNSDPQPRVVAIKLSSMNLTGNIPSDLVKLTGLVEL 443
Query: 444 WLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGXXXXXXXXXXXXRELYVQNNMLSGTVPS 503
WLDGNS TGPIPDFS CP+L IIHLE+N+LTG +ELY+QNN+L+GT+PS
Sbjct: 444 WLDGNSFTGPIPDFSRCPNLEIIHLENNRLTGKIPSSLTKLPNLKELYLQNNVLTGTIPS 503
Query: 504 SLLSKNVVLNYAGNINLHEGGRGAKHLNIIIXXXXXXXXXXXXXXXXCLFMHKGKKNNY- 562
L +K+V+ N++GN+NL + G K L +II C+ M K KKNN
Sbjct: 504 DL-AKDVISNFSGNLNLEKSGDKGKKLGVIIGASVGAFVLLIATIISCIVMCKSKKNNKL 562
Query: 563 ---DKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK 619
E LP+QR S+L++A +AAHCFTL +IE+ATK EK+IGSGGFG+VYYGK
Sbjct: 563 GKTSAELTNRPLPIQRVSSTLSEAHGDAAHCFTLYEIEEATKKFEKRIGSGGFGIVYYGK 622
Query: 620 LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679
++GKEIAVKVL +NSYQGKREF NEVTLLSRIHHRNLVQFLGYCQEEG+++LVYEFMHN
Sbjct: 623 TREGKEIAVKVLANNSYQGKREFANEVTLLSRIHHRNLVQFLGYCQEEGKNMLVYEFMHN 682
Query: 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM 739
GTLKEHLYG + ++RI+WIKRLEIAEDAA+GIEYLHTGCVPAIIHRDLK+SNILLDKHM
Sbjct: 683 GTLKEHLYGVVPRDRRISWIKRLEIAEDAARGIEYLHTGCVPAIIHRDLKTSNILLDKHM 742
Query: 740 RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 799
RAKVSDFGLSKFAVDG SHVSSIVRGTVGYLDPEYYISQQLT+KSDVYSFGVILLEL+SG
Sbjct: 743 RAKVSDFGLSKFAVDGTSHVSSIVRGTVGYLDPEYYISQQLTEKSDVYSFGVILLELMSG 802
Query: 800 QEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL-DEYDIQSMWKIEEKALMCVLP 858
QEAISNE FG NCRNIVQWAK+HI++GDI+GIIDP+L D+Y +QSMWKI EKAL+CV P
Sbjct: 803 QEAISNESFGVNCRNIVQWAKMHIDNGDIRGIIDPALAEDDYSLQSMWKIAEKALLCVKP 862
Query: 859 HGHMRPSISEVLKDIQXXXXXXXXXXXXXXGNSDDMSRNSLHSS-LNVG--SFGGTENFL 915
HG+MRPS+SEV KDIQ G SD+ SR+S HSS LN+G G+++++
Sbjct: 863 HGNMRPSMSEVQKDIQDAIRIEKEALAARGGISDEFSRSSAHSSSLNMGMLDLAGSQSYV 922
Query: 916 SLDESIVRPSAR 927
S+DES+++P+AR
Sbjct: 923 SIDESVLQPTAR 934
|
|
| TAIR|locus:2008565 AT1G67720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2104 (745.7 bits), Expect = 8.2e-218, P = 8.2e-218
Identities = 427/912 (46%), Positives = 573/912 (62%)
Query: 28 QMPGFVSLNCGGNENFTD-EIGLQWIADDHLI-YGEISNISVANETRKQYMTLRHFPADS 85
Q+ FVS++CG + N+TD GL W++D +I G+ ++ N QY R FP D+
Sbjct: 22 QVTEFVSIDCGCSSNYTDPRTGLGWVSDSEIIKQGKPVTLANTNWNSMQYRRRRDFPTDN 81
Query: 86 RKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAATIEVREL 145
+KYCY+L R RY++R TFLYG + YPKF + L T W+T+ I + + + V EL
Sbjct: 82 KKYCYRLSTKERRRYIVRTTFLYGGLGSEEAYPKFQLYLDATKWATVTIQEVSRVYVEEL 141
Query: 146 IFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARINFGADSEA 205
I A+S +DVC+ A TG PF+STLELR N S+Y T +ED ++L V+AR+NFGA +
Sbjct: 142 IVRATSSYVDVCVCCAITGSPFMSTLELRPLNLSMYATDYEDNFFLKVAARVNFGAPNMD 201
Query: 206 PVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGT 265
+RYPDDP+DRIWESD K+ NYLV VA GT +++T I+ + E PP KVMQTAVVGT
Sbjct: 202 ALRYPDDPYDRIWESDINKRPNYLVGVAPGTTRINTSKTINTLTREYPPMKVMQTAVVGT 261
Query: 266 NGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQG 325
G ++YRLNL+ FP A YFAEIE+L +E+RKF+LV P PD S A+VNI ENA G
Sbjct: 262 QGLISYRLNLEDFPANARAYAYFAEIEELGANETRKFKLVQPYFPDYSNAVVNIAENANG 321
Query: 326 KYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLE---RNDGSIDAIVSVI 382
Y +YEP Y N++L FVL+F FGKT DS++GPLLNA+EI+KYL + D S +++ I
Sbjct: 322 SYTLYEPSYMNVTLDFVLTFSFGKTKDSTQGPLLNAIEISKYLPISVKTDRSDVSVLDAI 381
Query: 383 -SLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLV 441
S+ +DWA EGGDPC+PV WSW+ C+S P +T I LS KNL G IP + + +L
Sbjct: 382 RSMSPDSDWASEGGDPCIPVLWSWVNCSSTSPPRVTKIALSRKNLRGEIPPGINYMEALT 441
Query: 442 ELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGXXXXXXXXXXXXRELYVQNNMLSGTV 501
ELWLD N LTG +PD S +L+I+HLE+NQL+G +EL ++NN G +
Sbjct: 442 ELWLDDNELTGTLPDMSKLVNLKIMHLENNQLSGSLPPYLAHLPNLQELSIENNSFKGKI 501
Query: 502 PSSLLSKNVVLNYAGNINLHEGGRGAKH----LNIIIXXXXXXXXXXXXXXXXCLFMHKG 557
PS+LL V+ Y N L + KH L I I + K
Sbjct: 502 PSALLKGKVLFKYNNNPELQNEAQ-RKHFWQILGISIAAVAILLLLVGGSLVLLCALRKT 560
Query: 558 KK-NNYDK-EQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVV 615
K+ + D E + L V + A+ +L +E+AT KK+G G FG V
Sbjct: 561 KRADKGDSTETKKKGLVAYSAVRGGHLLDEGVAYFISLPVLEEATDNFSKKVGRGSFGSV 620
Query: 616 YYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 675
YYG++KDGKE+AVK+ S R+F EV LLSRIHHRNLV +GYC+E R +LVYE
Sbjct: 621 YYGRMKDGKEVAVKITADPSSHLNRQFVTEVALLSRIHHRNLVPLIGYCEEADRRILVYE 680
Query: 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL 735
+MHNG+L +HL+G+ ++ ++W+ RL+IA+DAAKG+EYLHTGC P+IIHRD+KSSNILL
Sbjct: 681 YMHNGSLGDHLHGSSDYKP-LDWLTRLQIAQDAAKGLEYLHTGCNPSIIHRDVKSSNILL 739
Query: 736 DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLE 795
D +MRAKVSDFGLS+ + +HVSS+ +GTVGYLDPEYY SQQLT+KSDVYSFGV+L E
Sbjct: 740 DINMRAKVSDFGLSRQTEEDLTHVSSVAKGTVGYLDPEYYASQQLTEKSDVYSFGVVLFE 799
Query: 796 LISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMC 855
L+SG++ +S E FG NIV WA+ I GD+ GIIDP + I+S+W++ E A C
Sbjct: 800 LLSGKKPVSAEDFGPEL-NIVHWARSLIRKGDVCGIIDPCIASNVKIESVWRVAEVANQC 858
Query: 856 VLPHGHMRPSISEVLKDIQXXXXXXXXXXXXXXGNSDDMSRNSLHSSLNVGSFGGTENFL 915
V GH RP + EV+ IQ +S S+ + SF E+
Sbjct: 859 VEQRGHNRPRMQEVIVAIQDAIRIERGNENGLKSSSSSSSKAQSSRKTLLTSFLELES-P 917
Query: 916 SLDESIVRPSAR 927
+ + + P+AR
Sbjct: 918 DISRNSLAPAAR 929
|
|
| TAIR|locus:2055165 AT2G14510 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 743 (266.6 bits), Expect = 1.7e-126, Sum P(2) = 1.7e-126
Identities = 172/445 (38%), Positives = 250/445 (56%)
Query: 433 DLTKLSSLVELWLDGNSLTGPI-PDFSGCPDLRIIHLEDNQLTGXXXXXXXXXXXXRELY 491
D++ ++ L L + LTG I P LR + L +N LTG ++
Sbjct: 406 DISTPPRIISLDLSLSGLTGVISPSIQNLTMLRELDLSNNNLTGEVPEFLATIKPLLVIH 465
Query: 492 VQNNMLSGTVPSSLLS--KNVVLNYAGNINLHEGGRGAKHLNIIIXXXXXXXXXXXXXXX 549
++ N L G+VP +L KN L + N+ G+ ++
Sbjct: 466 LRGNNLRGSVPQALQDREKNDGLKLFVDPNITRRGKHQPKSWLVAIVASISCVAVTIIVL 525
Query: 550 XCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGS 609
+F+ + +K++ K V RP + + F S++++ T E +G
Sbjct: 526 VLIFIFRRRKSSTRK--------VIRPSLEMKNRR------FKYSEVKEMTNNFEVVLGK 571
Query: 610 GGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR 669
GGFGVVY+G L + +++AVKVL+ +S QG +EF EV LL R+HH NLV +GYC E
Sbjct: 572 GGFGVVYHGFLNN-EQVAVKVLSQSSTQGYKEFKTEVELLLRVHHVNLVSLVGYCDEGID 630
Query: 670 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLK 729
L+YEFM NG LKEHL G +NW RL+IA ++A GIEYLH GC P ++HRD+K
Sbjct: 631 LALIYEFMENGNLKEHLSGKRGGSV-LNWSSRLKIAIESALGIEYLHIGCQPPMVHRDVK 689
Query: 730 SSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYS 788
S+NILL AK++DFGLS+ F V +HVS+ V GT+GYLDPEYY+ LT+KSDVYS
Sbjct: 690 STNILLGLRFEAKLADFGLSRSFLVGSQAHVSTNVAGTLGYLDPEYYLKNWLTEKSDVYS 749
Query: 789 FGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKI 848
FG++LLE I+GQ I + + IV+WAK + +GDI+ I+DP+L +YD S WK
Sbjct: 750 FGIVLLESITGQPVIEQSR---DKSYIVEWAKSMLANGDIESIMDPNLHQDYDSSSSWKA 806
Query: 849 EEKALMCVLPHGHMRPSISEVLKDI 873
E A++C+ P RP+++ V ++
Sbjct: 807 LELAMLCINPSSTQRPNMTRVAHEL 831
|
|
| TAIR|locus:2066158 AT2G28990 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 897 (320.8 bits), Expect = 6.4e-125, Sum P(2) = 6.4e-125
Identities = 238/665 (35%), Positives = 359/665 (53%)
Query: 239 VSTKLPIDLRSDELPPQKVMQTAVVGTNGSLTYRLNLDGFPGFGWAVTY--FAEIEDLDP 296
++T L I+ + P+ ++QTA + N S + D P Y FAEI+ L+
Sbjct: 224 ITTDLNINNSNAYEIPKNILQTAAIPRNASAPLIITWDPLPINAEVYLYMHFAEIQTLEA 283
Query: 297 DESRKFRLVLPGQPDVSKAIVNIQENAQGKYRVY--EP---GYTNLSLPFVLSFKFGKTY 351
+E+R+F ++L G + S + +Y EP G L V KT
Sbjct: 284 NETRQFDVILRGNFNHS----GFSPTKLKVFTLYTEEPMKCGSEGCYLQLV------KTP 333
Query: 352 DSSRGPLLNAME---INKY--LERNDGSIDAIVSVISLY--SSADWAQEGGDPCLPVPWS 404
+S+ PL+NA+E + ++ LE + +DAI ++ + Y + W GDPCLP S
Sbjct: 334 NSTLPPLINAIEAYSVIEFSQLETSLSDVDAIKNIKNTYKLNKITWQ---GDPCLPQDLS 390
Query: 405 W--LQC---NSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSG 459
W ++C + P+I + LS L G+IP L + L EL L NSLTGP+P F
Sbjct: 391 WESIRCTYVDGSTSPTIISLDLSKSGLNGSIPQILQNFTQLQELDLSNNSLTGPVPIFLA 450
Query: 460 CPDLRIIHLEDNQLTGXXXXXXXXXXXXRELYVQNNMLSGTVPSSLLSKN---VVLNYAG 516
+++ + L + L+G NN LSG+VP +LL K +VL G
Sbjct: 451 --NMKTLSLIN--LSG------------------NN-LSGSVPQALLDKEKEGLVLKLEG 487
Query: 517 NINLHEGG--RGAKHLNIIIXXXXXXXXXXXXXXXXCLFMHKGKKNNYDKEQHRH-SLPV 573
N +L + K ++ LF KK H S+PV
Sbjct: 488 NPDLCKSSFCNTEKKNKFLLPVIASAASLVIVVVVVALFFVFRKKKASPSNLHAPPSMPV 547
Query: 574 QRPV-SSLNDAPAEAAHC-FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVL 631
P +S +++ + FT S++++ T +K +G GGFGVVY+G + +++AVK+L
Sbjct: 548 SNPGHNSQSESSFTSKKIRFTYSEVQEMTNNFDKALGEGGFGVVYHGFVNVIEQVAVKLL 607
Query: 632 TSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLT 691
+ +S QG + F EV LL R+HH NLV +GYC E L+YE+M NG LK+HL G
Sbjct: 608 SQSSSQGYKHFKAEVELLMRVHHINLVSLVGYCDEGEHLALIYEYMPNGDLKQHLSGK-- 665
Query: 692 HEQRI-NWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 750
H + +W RL+I DAA G+EYLHTGCVP ++HRD+K++NILLD+H++AK++DFGLS+
Sbjct: 666 HGGFVLSWESRLKIVLDAALGLEYLHTGCVPPMVHRDIKTTNILLDQHLQAKLADFGLSR 725
Query: 751 -FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG 809
F + +VS++V GT GYLDPEYY + LT+KSD+YSFG++LLE+IS + I +
Sbjct: 726 SFPIGNEKNVSTVVAGTPGYLDPEYYQTNWLTEKSDIYSFGIVLLEIISNRPIIQQSR-- 783
Query: 810 ANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEV 869
+IV+W I GD++ I+DP+L +YDI S+WK E A+ CV RP++S V
Sbjct: 784 -EKPHIVEWVSFMITKGDLRSIMDPNLHQDYDIGSVWKAIELAMSCVSLSSARRPNMSRV 842
Query: 870 LKDIQ 874
+ +++
Sbjct: 843 VNELK 847
|
|
| TAIR|locus:2126540 AT4G29990 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 763 (273.6 bits), Expect = 5.7e-124, Sum P(2) = 5.7e-124
Identities = 168/454 (37%), Positives = 263/454 (57%)
Query: 432 SDLTKLSSLVELWLDGNSLTGPI-PDFSGCPDLRIIHLEDNQLTGXXXXXXXXXXXXREL 490
SD + L L + LTG I P F+ + + L +N LTG EL
Sbjct: 403 SDNNTSPKSIALNLSSSGLTGQIDPAFANLTSINKLDLSNNSLTGKVPDFLASLPNLTEL 462
Query: 491 YVQNNMLSGTVPSSLLSKN----VVLNYAGNINLHEGGR----GAKHLNIIIXXXXXXXX 542
++ N L+G++P+ LL K+ + L + GN +L + K + I+
Sbjct: 463 NLEGNKLTGSIPAKLLEKSKDGSLSLRFGGNPDLCQSPSCQTTTKKKIGYIVPVVASLAG 522
Query: 543 XXXXXXXXCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAA-HCFTLSDIEDATK 601
L H + K R ++ +P+ +N P + A F S++ + T
Sbjct: 523 LLIVLTALALIWH------FKKRSRRGTIS-NKPLG-VNTGPLDTAKRYFIYSEVVNITN 574
Query: 602 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 661
E+ +G GGFG VY+G L +G ++AVK+L+ S QG +EF EV LL R+HH NL +
Sbjct: 575 NFERVLGKGGFGKVYHGFL-NGDQVAVKILSEESTQGYKEFRAEVELLMRVHHTNLTSLI 633
Query: 662 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 721
GYC E+ L+YE+M NG L ++L G + ++W +RL+I+ DAA+G+EYLH GC P
Sbjct: 634 GYCNEDNHMALIYEYMANGNLGDYLSGKSS--LILSWEERLQISLDAAQGLEYLHYGCKP 691
Query: 722 AIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQL 780
I+HRD+K +NILL+++++AK++DFGLS+ F V+G+S VS++V GT+GYLDPEYY ++Q+
Sbjct: 692 PIVHRDVKPANILLNENLQAKIADFGLSRSFPVEGSSQVSTVVAGTIGYLDPEYYATRQM 751
Query: 781 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 840
+KSDVYSFGV+LLE+I+G+ AI + + ++ + +GDI+GI+D L D +
Sbjct: 752 NEKSDVYSFGVVLLEVITGKPAIWHSR--TESVHLSDQVGSMLANGDIKGIVDQRLGDRF 809
Query: 841 DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 874
++ S WKI E AL C RP++S+V+ +++
Sbjct: 810 EVGSAWKITELALACASESSEQRPTMSQVVMELK 843
|
|
| TAIR|locus:2066163 AT2G29000 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 767 (275.1 bits), Expect = 1.1e-122, Sum P(2) = 1.1e-122
Identities = 174/440 (39%), Positives = 243/440 (55%)
Query: 440 LVELWLDGNSLTGPI-PDFSGCPDLRIIHLEDNQLTGXXXXXXXXXXXXRELYVQNNMLS 498
++ L L L G I P L + L N+L+G + + N L
Sbjct: 408 IISLDLSNRGLKGIIEPVLQNLTQLEKLDLSINRLSGEVPEFLANMKSLSNINLSWNNLK 467
Query: 499 GTVPSSLLSKN---VVLNYAGNINLHEGGRGAKHLNIIIXXXXXXXXXXXXXXXXCLFMH 555
G +P +L K + LN GN NL G + + L +
Sbjct: 468 GLIPPALEEKRKNGLKLNTQGNQNLCPGDECKRSIPKFPVTTVVSISAILLTVVVLLIVF 527
Query: 556 KGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVV 615
KK K +HR LP+ + S + FT S++E T E+ IG GGFG+V
Sbjct: 528 IYKKKKTSKVRHR--LPITK--SEILTKKRR----FTYSEVEAVTNKFERVIGEGGFGIV 579
Query: 616 YYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 675
Y+G L D +++AVK+L+ +S QG ++F EV LL R+HH NLV +GYC EE LVYE
Sbjct: 580 YHGHLNDTEQVAVKLLSHSSTQGYKQFKAEVELLLRVHHTNLVNLVGYCNEEDHLALVYE 639
Query: 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL 735
+ NG LK+HL G + +NW RL IA + A+G+EYLH GC P +IHRD+K++NILL
Sbjct: 640 YAANGDLKQHLSGE-SSSAALNWASRLGIATETAQGLEYLHIGCEPPMIHRDVKTTNILL 698
Query: 736 DKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILL 794
D+H AK++DFGLS+ F V SHVS+ V GT GYLDPEYY + LT+KSDVYS G++LL
Sbjct: 699 DEHFHAKLADFGLSRSFPVGVESHVSTNVAGTPGYLDPEYYRTNWLTEKSDVYSMGIVLL 758
Query: 795 ELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALM 854
E+I+ Q I + +I +W L + GDI+ I+DP L EYD S+WK E A+
Sbjct: 759 EIITNQPVIQQVR---EKPHIAEWVGLMLTKGDIKSIMDPKLNGEYDSSSVWKALELAMS 815
Query: 855 CVLPHGHMRPSISEVLKDIQ 874
CV P RP++S+V+ +++
Sbjct: 816 CVNPSSGGRPTMSQVISELK 835
|
|
| TAIR|locus:2047675 AT2G19210 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 723 (259.6 bits), Expect = 2.2e-122, Sum P(2) = 2.2e-122
Identities = 165/448 (36%), Positives = 254/448 (56%)
Query: 440 LVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGXXXXXXXXXXXXRELYVQNNMLS 498
++ + L + LTG I FS L I+ L +N LTG EL ++ N LS
Sbjct: 415 IISVNLSSSGLTGEIDAAFSNLTLLHILDLSNNSLTGKIPDFLGNLHNLTELNLEGNKLS 474
Query: 499 GTVPSSLLSKN----VVLNYAGNINL------HEGGRGAKHLNIIIXXXXXXXXXXXXXX 548
G +P LL ++ ++L GN +L K II
Sbjct: 475 GAIPVKLLERSNKKLILLRIDGNPDLCVSASCQISDEKTKKNVYIIPLVASVVGVLGLVL 534
Query: 549 XXCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAA-HCFTLSDIEDATKMLEKKI 607
LF+ Y K++HR + P + + S++ T E+ +
Sbjct: 535 AIALFLL------Y-KKRHRRG-----GSGGVRAGPLDTTKRYYKYSEVVKVTNNFERVL 582
Query: 608 GSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE 667
G GGFG VY+G L D ++AVK+L+ +S QG +EF EV LL R+HH+NL +GYC E
Sbjct: 583 GQGGFGKVYHGVLNDD-QVAVKILSESSAQGYKEFRAEVELLLRVHHKNLTALIGYCHEG 641
Query: 668 GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRD 727
+ L+YEFM NGTL ++L G ++ ++W +RL+I+ DAA+G+EYLH GC P I+ RD
Sbjct: 642 KKMALIYEFMANGTLGDYLSGEKSYV--LSWEERLQISLDAAQGLEYLHNGCKPPIVQRD 699
Query: 728 LKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDV 786
+K +NIL+++ ++AK++DFGLS+ A+DG + ++ V GT+GYLDPEY+++Q+L++KSD+
Sbjct: 700 VKPANILINEKLQAKIADFGLSRSVALDGNNQDTTAVAGTIGYLDPEYHLTQKLSEKSDI 759
Query: 787 YSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMW 846
YSFGV+LLE++SGQ I+ + A +I L + +GDI+GI+DP L + +D S W
Sbjct: 760 YSFGVVLLEVVSGQPVIARSRTTAENIHITDRVDLMLSTGDIRGIVDPKLGERFDAGSAW 819
Query: 847 KIEEKALMCVLPHGHMRPSISEVLKDIQ 874
KI E A+ C RP++S V+ +++
Sbjct: 820 KITEVAMACASSSSKNRPTMSHVVAELK 847
|
|
| TAIR|locus:2078171 AT3G46400 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 709 (254.6 bits), Expect = 1.1e-120, Sum P(2) = 1.1e-120
Identities = 158/441 (35%), Positives = 242/441 (54%)
Query: 440 LVELWLDGNSLTGPIPDFSGCPDLRIIH---LEDNQLTGXXXXXXXXXXXXRELYVQNNM 496
+ L L + L G IP SG + ++ L +N LTG + ++ N
Sbjct: 413 ITSLNLSSSGLVGTIP--SGIQNFTLLEKLDLSNNNLTGLVPEFLAKMETLLFIDLRKNK 470
Query: 497 LSGTVPSSLLS--KNVVLNYAGNINLHEGGRGAKHLNIIIXXXXXXXXXXXXXXXXCLFM 554
L+G++P++L K + + N ++I +F+
Sbjct: 471 LNGSIPNTLRDREKKGLQIFVDGDNTCLSCVPKNKFPMMIAALAASAIVVAILVLILIFV 530
Query: 555 HKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGV 614
KK + E ++ + S + F S++ + TK EK +G GGFG+
Sbjct: 531 FTKKKWSTHMEVILPTMDIMSKTISEQLIKTKRRR-FAYSEVVEMTKKFEKALGEGGFGI 589
Query: 615 VYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 674
VY+G LK+ +++AVKVL+ +S QG + F EV LL R+HH NLV +GYC E+ L+Y
Sbjct: 590 VYHGYLKNVEQVAVKVLSQSSSQGYKHFKAEVELLLRVHHINLVSLVGYCDEKDHLALIY 649
Query: 675 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL 734
E+M NG LK+HL G + + W RL+IA D A G+EYLH GC P+++HRD+KS+NIL
Sbjct: 650 EYMPNGDLKDHLSGK-QGDSVLEWTTRLQIAVDVALGLEYLHYGCRPSMVHRDVKSTNIL 708
Query: 735 LDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVIL 793
LD AK++DFGLS+ F V S +S++V GT GYLDPEYY + +L + SDVYSFG++L
Sbjct: 709 LDDQFMAKIADFGLSRSFKVGDESEISTVVAGTPGYLDPEYYRTSRLAEMSDVYSFGIVL 768
Query: 794 LELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKAL 853
LE+I+ Q + G +I +W + GDI I+DP+L EY+ +S+W+ E A+
Sbjct: 769 LEIITNQRVFDQAR-GKI--HITEWVAFMLNRGDITRIVDPNLHGEYNSRSVWRAVELAM 825
Query: 854 MCVLPHGHMRPSISEVLKDIQ 874
C P RP++S+V+ +++
Sbjct: 826 SCANPSSEYRPNMSQVVIELK 846
|
|
| TAIR|locus:2059093 FRK1 "FLG22-induced receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 726 (260.6 bits), Expect = 1.7e-120, Sum P(2) = 1.7e-120
Identities = 175/455 (38%), Positives = 259/455 (56%)
Query: 430 IPSDLTKLSSLVELWLDGNSLTGPI-PDFSGCPDLRIIHLEDNQLTGXXXXXXXXXXXXR 488
I SD T +V L + + L G I P FS +R + L N LTG
Sbjct: 406 IQSDNTTNPRVVSLNISFSELRGQIDPAFSNLTSIRKLDLSGNTLTGEIPAFLANLPNLT 465
Query: 489 ELYVQNNMLSGTVPSSL--LSKN--VVLNYAGNINL----HEGGRGAKHLNIIIXXXXXX 540
EL V+ N L+G VP L SKN + L + N +L K+ N I
Sbjct: 466 ELNVEGNKLTGIVPQRLHERSKNGSLSLRFGRNPDLCLSDSCSNTKKKNKNGYIIPLVVV 525
Query: 541 XXXXXXXXXXCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDAT 600
LF + K+Q R +L +R N A F S++ + T
Sbjct: 526 GIIVVLLTALALF------RRFKKKQQRGTLG-ER-----NGPLKTAKRYFKYSEVVNIT 573
Query: 601 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQF 660
E+ IG GGFG VY+G + +G+++AVKVL+ S QG +EF EV LL R+HH NL
Sbjct: 574 NNFERVIGKGGFGKVYHGVI-NGEQVAVKVLSEESAQGYKEFRAEVDLLMRVHHTNLTSL 632
Query: 661 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 720
+GYC E VL+YE+M N L ++L G + ++W +RL+I+ DAA+G+EYLH GC
Sbjct: 633 VGYCNEINHMVLIYEYMANENLGDYLAGKRSFI--LSWEERLKISLDAAQGLEYLHNGCK 690
Query: 721 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 779
P I+HRD+K +NILL++ ++AK++DFGLS+ F+V+G+ +S++V G++GYLDPEYY ++Q
Sbjct: 691 PPIVHRDVKPTNILLNEKLQAKMADFGLSRSFSVEGSGQISTVVAGSIGYLDPEYYSTRQ 750
Query: 780 LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 839
+ +KSDVYS GV+LLE+I+GQ AI++ K +I + + +GDI+GI+D L +
Sbjct: 751 MNEKSDVYSLGVVLLEVITGQPAIASSK--TEKVHISDHVRSILANGDIRGIVDQRLRER 808
Query: 840 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 874
YD+ S WK+ E AL C RP++S+V+ +++
Sbjct: 809 YDVGSAWKMSEIALACTEHTSAQRPTMSQVVMELK 843
|
|
| TAIR|locus:2078191 AT3G46420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 679 (244.1 bits), Expect = 5.2e-119, Sum P(2) = 5.2e-119
Identities = 130/278 (46%), Positives = 186/278 (66%)
Query: 598 DATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL 657
D T ++ +G GGFGVVY+G L +++AVK+L+ +S QG +EF EV LL R+HH NL
Sbjct: 528 DMTNNFQRALGEGGFGVVYHGYLNGSEQVAVKLLSQSSVQGYKEFKAEVELLLRVHHINL 587
Query: 658 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 717
V +GYC + LVYE+M NG LK HL G + ++W RL+IA DAA G+EYLH
Sbjct: 588 VSLVGYCDDRNHLALVYEYMSNGDLKHHLSGR-NNGFVLSWSTRLQIAVDAALGLEYLHI 646
Query: 718 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI 776
GC P+++HRD+KS+NILL + AK++DFGLS+ F + +H+S++V GT GYLDPEYY
Sbjct: 647 GCRPSMVHRDVKSTNILLGEQFTAKMADFGLSRSFQIGDENHISTVVAGTPGYLDPEYYR 706
Query: 777 SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836
+ +L +KSD+YSFG++LLE+I+ Q AI + +I W I GDI IIDP+L
Sbjct: 707 TSRLAEKSDIYSFGIVLLEMITSQHAIDRTRVK---HHITDWVVSLISRGDITRIIDPNL 763
Query: 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 874
Y+ +S+W+ E A+ C P RP++S+V+ D++
Sbjct: 764 QGNYNSRSVWRALELAMSCANPTSEKRPNMSQVVIDLK 801
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | estExt_fgenesh4_pg.C_280116 | hypothetical protein (924 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 927 | |||
| pfam12819 | 335 | pfam12819, Malectin_like, Carbohydrate-binding pro | 4e-89 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-50 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-50 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-48 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-45 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-44 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-44 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-44 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-37 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-35 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-35 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-32 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-32 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-31 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-30 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-30 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-29 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 9e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-28 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-28 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-28 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-27 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-26 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-26 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-26 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-26 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-26 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-26 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-25 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-24 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-24 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-24 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-23 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-23 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-23 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-22 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-22 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-22 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-21 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-21 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-21 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-21 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-21 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-21 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-21 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-21 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 9e-21 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-20 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-20 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-19 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-19 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-19 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-19 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-19 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-19 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-18 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-18 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-18 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-18 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-18 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-18 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-18 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-18 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-18 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-17 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-17 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-17 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-17 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-16 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-16 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-16 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-16 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-16 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-16 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 9e-16 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-15 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-15 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 9e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-14 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-14 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-14 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-14 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 9e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-12 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-12 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-12 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-12 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 9e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-11 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-11 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-11 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-11 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 9e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 8e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 9e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-09 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-08 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 9e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 9e-07 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 1e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 6e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 7e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 9e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 3e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 9e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.002 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.002 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.004 |
| >gnl|CDD|221790 pfam12819, Malectin_like, Carbohydrate-binding protein of the ER | Back alignment and domain information |
|---|
Score = 286 bits (735), Expect = 4e-89
Identities = 126/352 (35%), Positives = 180/352 (51%), Gaps = 36/352 (10%)
Query: 35 LNCG--GNENFTDEI-GLQWIADDHLIY-GEISNISVANETR---KQYMTLRHFPADSRK 87
++CG NE++TD G+ W++D I G+ NIS N + K Y TLR FP D ++
Sbjct: 1 IDCGLPSNESYTDPSTGITWVSDAGFIDTGKSGNISKENSSSFLSKPYKTLRSFP-DGKR 59
Query: 88 YCYKLDVIT--RTRYLIRATFLYGNFDNNN---VYPKFDISLGPTHWSTIVISDAA--TI 140
CY L V T+YLIRATFLYGN+D N P FD+ LG W+T+ +S+ + ++
Sbjct: 60 NCYTLPVTPGKGTKYLIRATFLYGNYDGLNSVSSPPSFDLYLGVNLWTTVNLSNDSGDSV 119
Query: 141 EVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARINFG 200
+I + S + VCL N TG PFIS LELR S+Y + L + AR+NFG
Sbjct: 120 VKEYIIHVTKSDTLSVCLVNTGTGTPFISALELRPLPDSLYPSSGGS-QALKLVARLNFG 178
Query: 201 ADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSD---ELPPQKV 257
+RYPDD +DRIWE + G ++ST L +D+ S+ +PP V
Sbjct: 179 GSEGT-IRYPDDVYDRIWEPFF---------SSPGWSQISTSLSVDISSNNAPYIPPSAV 228
Query: 258 MQTAVVGTNGSLTYRLNLD-GFPGFG-WAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKA 315
+QTAV TN S D P F + +FAEI+ L E+R+F + + G+
Sbjct: 229 LQTAVTPTNASAPLNFTWDLVDPNFEYYVYLHFAEIQSL---ETREFDIYINGKTVYGD- 284
Query: 316 IVNIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKY 367
V+ + +Y N+S +L+ T S+ PLLNA+EI K
Sbjct: 285 -VSPKYLGTDTGALYLDFPVNVSGGGLLNISLVPTSGSTLPPLLNALEIFKV 335
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. The domain is found on a number of plant receptor kinases. Length = 335 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 3e-50
Identities = 73/206 (35%), Positives = 111/206 (53%), Gaps = 13/206 (6%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGK-----EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRN 656
L KK+G G FG VY GKLK E+AVK L + S Q EF E ++ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 657 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 716
+V+ LG C EE +V E+M G L +L + +++ L A A+G+EYL
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYL---RKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 717 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 776
+ IHRDL + N L+ +++ K+SDFGLS+ D + + + ++ PE
Sbjct: 120 SKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLK 176
Query: 777 SQQLTDKSDVYSFGVILLELIS-GQE 801
+ T KSDV+SFGV+L E+ + G++
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFTLGEQ 202
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 176 bits (450), Expect = 6e-50
Identities = 73/206 (35%), Positives = 111/206 (53%), Gaps = 12/206 (5%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGK-----EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRN 656
L KK+G G FG VY G LK E+AVK L + S Q EF E ++ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 657 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 716
+V+ LG C EE ++V E+M G L ++L + ++ L A A+G+EYL
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPKELSLSDLLSFALQIARGMEYLE 120
Query: 717 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 776
+ IHRDL + N L+ +++ K+SDFGLS+ D + + + ++ PE
Sbjct: 121 SKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLK 177
Query: 777 SQQLTDKSDVYSFGVILLELIS-GQE 801
+ T KSDV+SFGV+L E+ + G+E
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEE 203
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 2e-48
Identities = 75/204 (36%), Positives = 117/204 (57%), Gaps = 13/204 (6%)
Query: 607 IGSGGFGVVYYGK-LKDGKEIAVKVLT-SNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 664
+G GGFG VY + K GK++A+K++ +S E E+ +L +++H N+V+ G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 665 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH-TGCVPAI 723
++E LV E+ G+LK+ L +E +++ + L I +G+EYLH G I
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK---ENEGKLSEDEILRILLQILEGLEYLHSNG----I 113
Query: 724 IHRDLKSSNILLDK-HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ-LT 781
IHRDLK NILLD + + K++DFGLSK S + +IV GT Y+ PE + + +
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYS 172
Query: 782 DKSDVYSFGVILLELISGQEAISN 805
+KSD++S GVIL EL ++ I
Sbjct: 173 EKSDIWSLGVILYELPELKDLIRK 196
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 1e-45
Identities = 66/202 (32%), Positives = 112/202 (55%), Gaps = 15/202 (7%)
Query: 603 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 660
+ +K+G G FG VY + K GK +A+KV+ + RE E+ +L ++ H N+V+
Sbjct: 3 ILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRL 62
Query: 661 LGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 718
++E + LV E+ G L + L G L+ ++ +++ +I +EYLH+
Sbjct: 63 YDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLR--QILS----ALEYLHSK 116
Query: 719 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 778
I+HRDLK NILLD+ K++DFGL++ +D +++ V GT Y+ PE + +
Sbjct: 117 G---IVHRDLKPENILLDEDGHVKLADFGLARQ-LDPGEKLTTFV-GTPEYMAPEVLLGK 171
Query: 779 QLTDKSDVYSFGVILLELISGQ 800
D++S GVIL EL++G+
Sbjct: 172 GYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 2e-44
Identities = 73/204 (35%), Positives = 114/204 (55%), Gaps = 16/204 (7%)
Query: 603 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 659
L +K+GSG FG VY K K GK +AVK+L S + + E+ +L R+ H N+V+
Sbjct: 3 LLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVR 62
Query: 660 FLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 717
+ +++ LV E+ G L ++L G L+ ++ ++ +G+EYLH
Sbjct: 63 LIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQI------LRGLEYLH- 115
Query: 718 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 777
IIHRDLK NILLD++ K++DFGL+K + +S +++ V GT Y+ PE +
Sbjct: 116 --SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLG 172
Query: 778 QQL-TDKSDVYSFGVILLELISGQ 800
K DV+S GVIL EL++G+
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 4e-44
Identities = 71/209 (33%), Positives = 107/209 (51%), Gaps = 22/209 (10%)
Query: 605 KKIGSGGFGVVYYGKLKDGK----EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQ 659
KK+G G FG VY GKLK E+AVK L + S + +++F E ++ ++ H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 660 FLGYCQEEGRSVLVYEFMHNGTLKEHL-----YGTLTHEQRINWIKRLEIAEDAAKGIEY 714
LG C EE LV E+M G L ++L + ++ L A AKG+EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 715 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS-----IVRGTVGY 769
L + +HRDL + N L+ + + K+SDFGLS+ D + +R +
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----W 173
Query: 770 LDPEYYISQQLTDKSDVYSFGVILLELIS 798
+ PE T KSDV+SFGV+L E+ +
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 6e-44
Identities = 69/204 (33%), Positives = 108/204 (52%), Gaps = 13/204 (6%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKE-----IAVKVLT-SNSYQGKREFTNEVTLLSRIHHRN 656
L KK+G G FG VY G LK E +AVK L S + + EF E +++ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 657 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 716
+V+ LG C + +V E+M G L + L H +++ L++A AKG+EYL
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFL---RKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 717 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYY 775
+ +HRDL + N L+ +++ K+SDFGLS+ D + + ++ PE
Sbjct: 120 SKN---FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESL 176
Query: 776 ISQQLTDKSDVYSFGVILLELISG 799
+ T KSDV+SFGV+L E+ +
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 3e-37
Identities = 139/485 (28%), Positives = 234/485 (48%), Gaps = 54/485 (11%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 472
+ + LS L+G IP +L+ LV L L N L+G IP FS P L + L NQ
Sbjct: 499 SELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQ 558
Query: 473 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSS--LLSKNVVLNYAGNINLHEGG------ 524
L+G +P +L N+ +L ++ + +N L G++PS+ L+ N AGNI+L G
Sbjct: 559 LSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINAS-AVAGNIDLCGGDTTSGLP 617
Query: 525 -----RGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDK--EQHRHSLPVQRPV 577
R I ++GA L+LA V +G+ N K E + +Q
Sbjct: 618 PCKRVRKTPSWWFYITCTLGA-FLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFD 676
Query: 578 SSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVK-VLTSNS 635
S + + T++DI + K E I G G Y GK +K+G + VK + NS
Sbjct: 677 S-------KVSKSITINDILSSLKE-ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS 728
Query: 636 YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR 695
++E+ + ++ H N+V+ +G C+ E + L++E++ L E L
Sbjct: 729 IP-----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------- 776
Query: 696 INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD--KHMRAKVSDFGLSKFAV 753
++W +R +IA AK + +LH C PA++ +L I++D ++S GL
Sbjct: 777 LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGL--LCT 834
Query: 754 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCR 813
D +SS Y+ PE ++ +T+KSD+Y FG+IL+EL++G+ ++ +FG +
Sbjct: 835 DTKCFISS------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSP-ADAEFGVH-G 886
Query: 814 NIVQWAKLHIESGDIQGIIDPSLLDEYDI--QSMWKIEEKALMCVLPHGHMRPSISEVLK 871
+IV+WA+ + IDPS+ + + + ++ AL C RP ++VLK
Sbjct: 887 SIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLK 946
Query: 872 DIQDA 876
++ A
Sbjct: 947 TLESA 951
|
Length = 968 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 1e-35
Identities = 60/204 (29%), Positives = 106/204 (51%), Gaps = 17/204 (8%)
Query: 605 KKIGSGGFGVVYYGKLKD-GKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 661
+ +G G FG VY KD G+ +AVK L+ +S + E+ +LS + H N+V++
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 662 G-YCQEEGRSVLVY-EFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 717
G EE ++ ++ E++ G+L L +G L I++ +G+ YLH+
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV----IRKY--TRQILEGLAYLHS 119
Query: 718 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA-SHVSSIVRGTVGYLDPEYYI 776
I+HRD+K +NIL+D K++DFG +K D + VRGT ++ PE
Sbjct: 120 NG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 777 SQQLTDKSDVYSFGVILLELISGQ 800
++ +D++S G ++E+ +G+
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 8e-35
Identities = 69/200 (34%), Positives = 111/200 (55%), Gaps = 15/200 (7%)
Query: 605 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 663
+KIG GGFG VY + + GKE+A+KV+ S + K + NE+ +L + H N+V++ G
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 664 CQEEGRSVLVYEFMHNGTLKE---HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 720
++ +V EF G+LK+ TLT E +I ++ + + KG+EYLH+
Sbjct: 66 YLKKDELWIVMEFCSGGSLKDLLKSTNQTLT-ESQIAYVCK-----ELLKGLEYLHSN-- 117
Query: 721 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 780
IIHRD+K++NILL K+ DFGLS D + + + GT ++ PE +
Sbjct: 118 -GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--GTPYWMAPEVINGKPY 174
Query: 781 TDKSDVYSFGVILLELISGQ 800
K+D++S G+ +EL G+
Sbjct: 175 DYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 62/198 (31%), Positives = 107/198 (54%), Gaps = 7/198 (3%)
Query: 602 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 661
K++GSG FGVV+ GK + ++A+K++ + + +F E ++ ++ H NLVQ
Sbjct: 7 TFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLY 65
Query: 662 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 721
G C ++ +V E+M NG L +L + ++ L++ D + +EYL +
Sbjct: 66 GVCTKQRPIFIVTEYMANGCLLNYLR---ERKGKLGTEWLLDMCSDVCEAMEYLESNGF- 121
Query: 722 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 781
IHRDL + N L+ + KVSDFGL+++ +D S + V + PE + + +
Sbjct: 122 --IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFS 179
Query: 782 DKSDVYSFGVILLELISG 799
KSDV+SFGV++ E+ S
Sbjct: 180 SKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 9e-32
Identities = 152/593 (25%), Positives = 250/593 (42%), Gaps = 70/593 (11%)
Query: 13 VASVLILLLLDSSSAQMPGFVSLNCGGNENF-TDEIGLQWIADDHLIYGEISNISVANET 71
+A+ +L +L S ++ P + ++CG N T W D G +N + +
Sbjct: 6 LAASALLAVLASLASPEPFTMRISCGARVNVRTAPTNTLWYKDFAYTGGIPANATRPSFI 65
Query: 72 RKQYMTLRHFP-ADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWS 130
TLR+FP +D + CY ++ + + Y +R F N + P FD+S+ T S
Sbjct: 66 APPLKTLRYFPLSDGPENCYNINRVPKGHYSVRVFFGLVAEPNFDSEPLFDVSVEGTQIS 125
Query: 131 TIVI---SDAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYL--TPF 185
++ S + L+FL +C + G P I ++E+ Q + Y +
Sbjct: 126 SLKSGWSSHDEQVFAEALVFLTDG-SASICFHSTGHGDPAILSIEILQVDDKAYNFGPSW 184
Query: 186 EDRYYLSVSARINFGA-DSEAPVRYPDDPF--DRIWESDSLKKANYLVDVAAGTEKVSTK 242
L + R++ GA S+ Y D + DR W + D A TE V K
Sbjct: 185 GQGVILRTAKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFGSG--SDQAISTENVIKK 242
Query: 243 LPIDLRSDELPPQKVMQTAVVGTNG--SLTYRLNLDGFPGFGWAV-TYFAEIED-LDPDE 298
+ P+ + Q+A+V T+ L+Y +++D P ++V +FAEI++ + +
Sbjct: 243 A---SNAPNFYPESLYQSALVSTDTQPDLSYTMDVD--PNRNYSVWLHFAEIDNSITAEG 297
Query: 299 SRKFRLVLPGQPDVSKAIVNIQENAQGKYRVYEPGYTNLSLP---FVLSFKFGKTYDSSR 355
R F +++ G D + V+I + + +Y T L L V +
Sbjct: 298 KRVFDVLING--DTAFKDVDIVKMSGERY-------TALVLNKTVAVSGRTLTIVLQPKK 348
Query: 356 GP--LLNAMEINKYLERNDGSIDAIVSVI-------SLYSSADWAQEGGDPCLPV--PWS 404
G ++NA+E+ + + ++ VS + L W GDPC+P PWS
Sbjct: 349 GTHAIINAIEVFEIITAESKTLLEEVSALQTLKSSLGLPLRFGW---NGDPCVPQQHPWS 405
Query: 405 WLQCNSDPQPS---ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGC 460
C D I + L ++ L G IP+D++KL L + L GNS+ G IP
Sbjct: 406 GADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSI 465
Query: 461 PDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGN 517
L ++ L N G +P SL L +LR L + N LSG VP++L L N+ N
Sbjct: 466 TSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
Query: 518 INL------HEGGR----GAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKN 560
L G GAK IG + G +V L V+ + K ++N
Sbjct: 526 AGLCGIPGLRACGPHLSVGAK-----IGIAFGVSVAFLFLVICAMCWWKRRQN 573
|
Length = 623 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 1e-31
Identities = 68/195 (34%), Positives = 111/195 (56%), Gaps = 9/195 (4%)
Query: 605 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 664
K++G+G FGVV YGK + ++A+K++ S + EF E ++ ++ H LVQ G C
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 665 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 724
++ +V E+M NG L +L H +R + LE+ +D +G+ YL + I
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYLR---EHGKRFQPSQLLEMCKDVCEGMAYLES---KQFI 122
Query: 725 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI-VRGTVGYLDPEYYISQQLTDK 783
HRDL + N L+D KVSDFGLS++ +D + SS+ + V + PE + + + K
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDD-EYTSSVGSKFPVRWSPPEVLLYSKFSSK 181
Query: 784 SDVYSFGVILLELIS 798
SDV++FGV++ E+ S
Sbjct: 182 SDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 63/204 (30%), Positives = 106/204 (51%), Gaps = 16/204 (7%)
Query: 605 KKIGSGGFGVVYYGKL-----KDGKEIAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLV 658
K++G G FG V + G+++AVK L S Q + +F E+ +L + H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 659 QFLGYCQEEGRSV--LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 716
++ G C++ G L+ E++ +G+L+++L H +IN + L + KG++YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQR---HRDQINLKRLLLFSSQICKGMDYLG 126
Query: 717 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV--DGASHVSSIVRGTVGYLDPEY 774
+ IHRDL + NIL++ K+SDFGL+K +V + + PE
Sbjct: 127 S---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPEC 183
Query: 775 YISQQLTDKSDVYSFGVILLELIS 798
+ + + SDV+SFGV L EL +
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 119 bits (302), Expect = 4e-30
Identities = 78/284 (27%), Positives = 131/284 (46%), Gaps = 48/284 (16%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL-TSNSYQGKREFT-NEVTLLSRIHHRNLVQ 659
+ K+IG G FG VY + DGK +K + SN + +RE NEV +L +++H N+++
Sbjct: 4 IIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK 63
Query: 660 FLGYCQEEGRSVLVYEFMHNGTLKEHL------YGTLTHEQRINWIKRLEIAEDAAKGIE 713
+ +E+G+ +V E+ G L + + EQ ++W +L ++
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL------CLALK 117
Query: 714 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 773
YLH+ I+HRD+K NI L + K+ DFG+SK ++V GT YL PE
Sbjct: 118 YLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPE 173
Query: 774 YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE------SGD 827
++ KSD++S G +L EL + + E I+ K S +
Sbjct: 174 LCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL---KGQYPPIPSQYSSE 230
Query: 828 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 871
++ ++ SLL K E+ RPSI+++L+
Sbjct: 231 LRNLVS-SLL--------QKDPEE-----------RPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 9e-30
Identities = 65/199 (32%), Positives = 108/199 (54%), Gaps = 13/199 (6%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 662
L ++IGSG FG+V+ G + +++A+K + + +F E ++ ++ H LVQ G
Sbjct: 8 LVQEIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66
Query: 663 YCQEEGRSVLVYEFMHNGTLKEHLY---GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 719
C E LV+EFM +G L ++L G + E L + D +G+ YL +
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQE------TLLGMCLDVCEGMAYLESSN 120
Query: 720 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 779
V IHRDL + N L+ ++ KVSDFG+++F +D S+ + V + PE + +
Sbjct: 121 V---IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSK 177
Query: 780 LTDKSDVYSFGVILLELIS 798
+ KSDV+SFGV++ E+ S
Sbjct: 178 YSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 74/202 (36%), Positives = 103/202 (50%), Gaps = 20/202 (9%)
Query: 607 IGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLG 662
+G G FG V + KD GK A+KVL ++E E +LSRI+H +V+ L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK-LH 59
Query: 663 YC-QEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHT-G 718
Y Q E + LV E+ G L HL G + E+R R AE +EYLH+ G
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFS-EERA----RFYAAE-IVLALEYLHSLG 113
Query: 719 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 778
II+RDLK NILLD K++DFGL+K S ++ GT YL PE + +
Sbjct: 114 ----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGK 168
Query: 779 QLTDKSDVYSFGVILLELISGQ 800
D +S GV+L E+++G+
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 9e-29
Identities = 66/192 (34%), Positives = 103/192 (53%), Gaps = 11/192 (5%)
Query: 607 IGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE 666
IG G FG V G + G+++AVK L +S + F E ++++ + H NLVQ LG +
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 667 EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHR 726
+V E+M G+L ++L I ++L A D +G+EYL +HR
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEE---KNFVHR 126
Query: 727 DLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDV 786
DL + N+L+ + + AKVSDFGL+K AS + V + PE ++ + KSDV
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLPVKWTAPEALREKKFSTKSDV 182
Query: 787 YSFGVILLELIS 798
+SFG++L E+ S
Sbjct: 183 WSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 1e-28
Identities = 70/212 (33%), Positives = 110/212 (51%), Gaps = 19/212 (8%)
Query: 602 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVL---TSNSYQGKREFTNEVTLLSRI-HHRNL 657
+ +K+G G FG VY + D K +A+KVL + + F E+ +L+ + H N+
Sbjct: 3 RILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 658 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 717
V+ + Q+EG LV E++ G+L++ L + + ++ + L I +EYLH+
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLED-LLKKIGRKGPLSESEALFILAQILSALEYLHS 119
Query: 718 GCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGASHVS-----SIVRGTVGYLD 771
IIHRD+K NILLD+ K+ DFGL+K D S S S GT GY+
Sbjct: 120 KG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 772 PEYYISQQL---TDKSDVYSFGVILLELISGQ 800
PE + L + SD++S G+ L EL++G
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208
|
Length = 384 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 64/203 (31%), Positives = 103/203 (50%), Gaps = 7/203 (3%)
Query: 595 DIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIH 653
++E ++ K+G G +G VY G K +AVK L ++ + + EF E ++ I
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 60
Query: 654 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 713
H NLVQ LG C E ++ EFM G L ++L + Q +N + L +A + +E
Sbjct: 61 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAME 118
Query: 714 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 773
YL IHRDL + N L+ ++ KV+DFGLS+ + + + + PE
Sbjct: 119 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 175
Query: 774 YYISQQLTDKSDVYSFGVILLEL 796
+ + KSDV++FGV+L E+
Sbjct: 176 SLAYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 61/196 (31%), Positives = 103/196 (52%), Gaps = 6/196 (3%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 662
LE+K+GSG FG V+ G K+ +A+K+L S+ +++F EV L R+ H++L+
Sbjct: 10 LERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFA 69
Query: 663 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 722
C ++ E M G+L L Q + +++A A+G+ YL
Sbjct: 70 VCSVGEPVYIITELMEKGSLLAFLRS--PEGQVLPVASLIDMACQVAEGMAYLEE---QN 124
Query: 723 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 782
IHRDL + NIL+ + + KV+DFGL++ + ++SS + + PE +
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV-YLSSDKKIPYKWTAPEAASHGTFST 183
Query: 783 KSDVYSFGVILLELIS 798
KSDV+SFG++L E+ +
Sbjct: 184 KSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 68/197 (34%), Positives = 105/197 (53%), Gaps = 8/197 (4%)
Query: 605 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLGY 663
+KIG G FG VY G LK E+AVK S KR+F E +L + H N+V+ +G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 664 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 723
C ++ +V E + G+L L + R+ K L+++ DAA G+EYL +
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESKNC--- 114
Query: 724 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT-VGYLDPEYYISQQLTD 782
IHRDL + N L+ ++ K+SDFG+S+ G VS ++ + + PE + T
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 783 KSDVYSFGVILLELISG 799
+SDV+S+G++L E S
Sbjct: 175 ESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 57/204 (27%), Positives = 103/204 (50%), Gaps = 15/204 (7%)
Query: 602 MLEKKIGSGGFGVVYYG-KLKDGKEIAVK--VLTSNSYQGKREFTNEVTLLSRIHHRNLV 658
L IG G FGVVY G L+ G +A+K L + + E+ LL + H N+V
Sbjct: 3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIV 62
Query: 659 QFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLH 716
+++G + ++ E+ NG+L++ + +G ++ ++ +G+ YLH
Sbjct: 63 KYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQV------LQGLAYLH 116
Query: 717 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 776
+IHRD+K++NIL K K++DFG++ ++ S + V GT ++ PE
Sbjct: 117 E---QGVIHRDIKAANILTTKDGVVKLADFGVAT-KLNDVSKDDASVVGTPYWMAPEVIE 172
Query: 777 SQQLTDKSDVYSFGVILLELISGQ 800
+ SD++S G ++EL++G
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 64/203 (31%), Positives = 103/203 (50%), Gaps = 21/203 (10%)
Query: 605 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 663
+KIG G G VY GKE+A+K + Q K NE+ ++ H N+V +
Sbjct: 25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPNIVDYYD- 82
Query: 664 CQEEGRSV-LVYEFMHNGTLKEHLYGTLT--HEQRINWIKRLEIAEDAAKGIEYLHTGCV 720
G + +V E+M G+L + + +E +I ++ R E+ + G+EYLH+
Sbjct: 83 SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCR-EVLQ----GLEYLHSQ-- 135
Query: 721 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD---GASHVSSIVRGTVGYLDPEYYIS 777
+IHRD+KS NILL K K++DFG FA S +S+V GT ++ PE
Sbjct: 136 -NVIHRDIKSDNILLSKDGSVKLADFG---FAAQLTKEKSKRNSVV-GTPYWMAPEVIKR 190
Query: 778 QQLTDKSDVYSFGVILLELISGQ 800
+ K D++S G++ +E+ G+
Sbjct: 191 KDYGPKVDIWSLGIMCIEMAEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 64/197 (32%), Positives = 107/197 (54%), Gaps = 13/197 (6%)
Query: 605 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 664
K++GSG FGVV+ GK + ++A+K + + + +F E ++ ++ H LVQ G C
Sbjct: 10 KELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 665 QEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 721
++ +V EFM NG L +L G L+ + L + +D +G+EYL
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML------LSMCQDVCEGMEYLERN--- 119
Query: 722 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 781
+ IHRDL + N L+ KVSDFG++++ +D SS + V + PE + + +
Sbjct: 120 SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYS 179
Query: 782 DKSDVYSFGVILLELIS 798
KSDV+SFGV++ E+ +
Sbjct: 180 SKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 64/203 (31%), Positives = 107/203 (52%), Gaps = 20/203 (9%)
Query: 607 IGSGGFGVVYYG-KLKDGKEIAVKV--LTSNSYQGK---REFTNEVTLLSRIHHRNLVQF 660
+GSG FG VY G L DG AVK L + G+ ++ E+ LLS++ H N+VQ+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 661 LGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 718
LG +EE + E + G+L + L YG+ + +++ G+EYLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQI------LLGLEYLHDR 121
Query: 719 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 778
+HRD+K +NIL+D + K++DFG++K V+ + S +G+ ++ PE Q
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS--FKGSPYWMAPEVIAQQ 176
Query: 779 QLTD-KSDVYSFGVILLELISGQ 800
+D++S G +LE+ +G+
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 59/205 (28%), Positives = 108/205 (52%), Gaps = 16/205 (7%)
Query: 602 MLEKKIGSGGFGVVYYGKL----KDGKEIAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRN 656
+EK IG G FG V G+L K ++A+K L + S +R +F E +++ + H N
Sbjct: 7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPN 66
Query: 657 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 716
+++ G + +++ E+M NG+L + L ++ + + + + A G++YL
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFLR---ENDGKFTVGQLVGMLRGIASGMKYLS 123
Query: 717 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG---TVGYLDPE 773
+HRDL + NIL++ ++ KVSDFGLS+ S + +G + + PE
Sbjct: 124 EMNY---VHRDLAARNILVNSNLVCKVSDFGLSR--RLEDSEATYTTKGGKIPIRWTAPE 178
Query: 774 YYISQQLTDKSDVYSFGVILLELIS 798
++ T SDV+SFG+++ E++S
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 14/208 (6%)
Query: 595 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH 654
+I+ + L +K+G+G FG V+ G + +AVK L + K +F E ++ ++ H
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRH 60
Query: 655 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG----TLTHEQRINWIKRLEIAEDAAK 710
L+Q C E +V E M G+L E+L G L Q I ++A A
Sbjct: 61 PKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLI------DMAAQVAS 114
Query: 711 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 770
G+ YL IHRDL + N+L+ ++ KV+DFGL++ + + + +
Sbjct: 115 GMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWT 171
Query: 771 DPEYYISQQLTDKSDVYSFGVILLELIS 798
PE + + + KSDV+SFG++L E+++
Sbjct: 172 APEAALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 64/217 (29%), Positives = 111/217 (51%), Gaps = 27/217 (12%)
Query: 603 LEKKIGSGGFGVVYYGKL-----KDGKEI-AVKVLT-SNSYQGKREFTNEVTLLSRIHHR 655
L++++G G FG V+ G+ ++ KE+ AVK L + S +++F E LL+ H
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 656 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL----------YGTLTHEQRINWIKRLEIA 705
N+V+F G C E ++V+E+M +G L + L + + + L+IA
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 706 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG 765
A G+ YL + +HRDL + N L+ + K+ DFG+S+ D + V G
Sbjct: 129 VQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVVKIGDFGMSR---DVYTTDYYRVGG 182
Query: 766 T----VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 798
+ ++ PE + ++ T +SDV+SFGV+L E+ +
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 62/201 (30%), Positives = 102/201 (50%), Gaps = 15/201 (7%)
Query: 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLG 662
K +G G GVVY + K GK A+K + + + +++ E+ L +V+ G
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 663 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL---EIAEDAAKGIEYLHTGC 719
+EG +V E+M G+L + L +++ I IA KG++YLHT
Sbjct: 67 AFYKEGEISIVLEYMDGGSLADLL-------KKVGKIPEPVLAYIARQILKGLDYLHT-- 117
Query: 720 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 779
IIHRD+K SN+L++ K++DFG+SK + ++ V GTV Y+ PE +
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGES 176
Query: 780 LTDKSDVYSFGVILLELISGQ 800
+ +D++S G+ LLE G+
Sbjct: 177 YSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 60/196 (30%), Positives = 103/196 (52%), Gaps = 6/196 (3%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 662
LE+K+G+G FG V+ G ++AVK L + F E ++ ++ H LVQ
Sbjct: 10 LERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS-PEAFLQEAQIMKKLRHDKLVQLYA 68
Query: 663 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 722
C EE +V E+M G+L + L + R+ + +++A A+G+ YL +
Sbjct: 69 VCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLP--QLVDMAAQIAEGMAYLES---RN 123
Query: 723 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 782
IHRDL + NIL+ +++ K++DFGL++ D + + + PE + T
Sbjct: 124 YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTI 183
Query: 783 KSDVYSFGVILLELIS 798
KSDV+SFG++L E+++
Sbjct: 184 KSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 47/219 (21%)
Query: 605 KKIGSGGFGVV---YYGKLKD--GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQ 659
+++G G FG V Y L+D G+ +AVK L ++ + R+F E+ +L + H N+V+
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 660 FLGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 717
+ G C GR LV E++ G+L+++L H +R++ K L A KG+EYL +
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYL---QKHRERLDHRKLLLYASQICKGMEYLGS 126
Query: 718 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 777
+HRDL + NIL++ R K+ DFGL+K V D EYY
Sbjct: 127 ---KRYVHRDLATRNILVESENRVKIGDFGLTK----------------VLPQDKEYYKV 167
Query: 778 QQ-------------LTD-----KSDVYSFGVILLELIS 798
++ LT+ SDV+SFGV+L EL +
Sbjct: 168 REPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 68/227 (29%), Positives = 105/227 (46%), Gaps = 39/227 (17%)
Query: 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREF-TNEVTLLSRI-HHR 655
K IG G F V K K KE A+K+L + K ++ E +L+R+ H
Sbjct: 4 KFGKIIGEGSFSTVVLAKEKETNKEYAIKIL-DKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 656 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIE 713
+++ Q+E V E+ NG L +++ YG+L E+ + AE +E
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLD-EKCTRFY----AAE-ILLALE 116
Query: 714 YLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF----------AVDGASHVSSI 762
YLH+ G IIHRDLK NILLDK M K++DFG +K D + S I
Sbjct: 117 YLHSKG----IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 763 VR---------GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 800
+ GT Y+ PE + SD+++ G I+ ++++G+
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 69/231 (29%), Positives = 111/231 (48%), Gaps = 34/231 (14%)
Query: 591 FTLSDIEDATKMLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLT-SNSYQGKREFT 643
LS + +++G G FG VY G+L +A+K L + + ++EF
Sbjct: 2 IPLSAVR-----FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR 56
Query: 644 NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE---------- 693
E L+S + H N+V LG C +E + +++E++ +G L E L H
Sbjct: 57 QEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDET 116
Query: 694 --QRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 751
++ L IA A G+EYL + +HRDL + N L+ + + K+SDFGLS+
Sbjct: 117 VKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSR- 172
Query: 752 AVDGASH----VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 798
D S V S V ++ PE + + T +SD++SFGV+L E+ S
Sbjct: 173 --DIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 15/217 (6%)
Query: 607 IGSGGFG-VVYYGKLKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 663
+G G FG Y + +D + K LT S + +R+ NE+ +LS + H N++ + +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 664 CQEEGRSVLVYEFMHNGTLKE---HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 720
++ ++ E+ + GTL + G L E+ + W + Y+H
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWY-----LFQIVSAVSYIHKA-- 120
Query: 721 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 780
I+HRD+K+ NI L K K+ DFG+SK S ++V GT Y+ PE +
Sbjct: 121 -GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKY 178
Query: 781 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 817
KSD+++ G +L EL++ + IVQ
Sbjct: 179 NFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 67/200 (33%), Positives = 107/200 (53%), Gaps = 18/200 (9%)
Query: 605 KKIGSGGFGVVYYGKLK-DGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 661
KKIG G FG +Y K K D + +K LT + K EV LL+++ H N+V F
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 662 GYCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRI-NWIKRLEIAEDAAKGIEYLHT 717
QE GR +V E+ G L + + G L E +I +W ++ + G++++H
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GLKHIHD 119
Query: 718 GCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 776
I+HRD+KS NI L K+ M AK+ DFG+++ ++ + ++ GT YL PE
Sbjct: 120 ---RKILHRDIKSQNIFLSKNGMVAKLGDFGIAR-QLNDSMELAYTCVGTPYYLSPEICQ 175
Query: 777 SQQLTDKSDVYSFGVILLEL 796
++ +K+D++S G +L EL
Sbjct: 176 NRPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 66/196 (33%), Positives = 106/196 (54%), Gaps = 13/196 (6%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 662
L + IG G FG V G+ G+++AVK + + + F E +++++HH+NLV+ LG
Sbjct: 10 LGEIIGEGEFGAVLQGEYT-GQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLG 66
Query: 663 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 722
G + V E M G L L ++ I+ L+ + D A+G+EYL +
Sbjct: 67 VILHNGLYI-VMELMSKGNLVNFL--RTRGRALVSVIQLLQFSLDVAEGMEYLES---KK 120
Query: 723 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 782
++HRDL + NIL+ + AKVSDFGL++ G + V+ T PE ++ +
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTA----PEALKHKKFSS 176
Query: 783 KSDVYSFGVILLELIS 798
KSDV+S+GV+L E+ S
Sbjct: 177 KSDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 4e-23
Identities = 64/197 (32%), Positives = 105/197 (53%), Gaps = 13/197 (6%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 662
L + IG G FG V G + G ++AVK + +++ + F E ++++++ H NLVQ LG
Sbjct: 10 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLG 66
Query: 663 YCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 721
EE + +V E+M G+L ++L + L+ + D + +EYL
Sbjct: 67 VIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN--- 121
Query: 722 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 781
+HRDL + N+L+ + AKVSDFGL+K AS + V + PE ++ +
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFS 177
Query: 782 DKSDVYSFGVILLELIS 798
KSDV+SFG++L E+ S
Sbjct: 178 TKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 5e-23
Identities = 67/205 (32%), Positives = 108/205 (52%), Gaps = 21/205 (10%)
Query: 605 KKIGSGGFGVVYYGKLKD-GKEIAVKVLT--SNSYQGKRE---FTNEVTLLSRIHHRNLV 658
K +G G FG VY D G+E+AVK + +S + K+E E+ LL + H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 659 QFLGYCQEEGRSVLVY-EFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYL 715
Q+ G C + ++ ++ E+M G++K+ L YG LT + + +I E G+EYL
Sbjct: 68 QYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR--QILE----GVEYL 120
Query: 716 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI--VRGTVGYLDPE 773
H+ I+HRD+K +NIL D K+ DFG SK S + + V GT ++ PE
Sbjct: 121 HSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177
Query: 774 YYISQQLTDKSDVYSFGVILLELIS 798
+ K+DV+S G ++E+++
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 8e-23
Identities = 67/203 (33%), Positives = 105/203 (51%), Gaps = 19/203 (9%)
Query: 605 KKIGSGGFGVVYYG--KLKDGKEI--AVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQ 659
K++G G FG V G +K GKE+ AVK L GK+EF E ++++++ H +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 660 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 719
+G C+ E +LV E G L ++L + I E+A A G+ YL +
Sbjct: 61 LIGVCKGEP-LMLVMELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLES-- 113
Query: 720 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT--VGYLDPE--YY 775
+HRDL + N+LL +AK+SDFG+S+ G+ + + G + + PE Y
Sbjct: 114 -KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 776 ISQQLTDKSDVYSFGVILLELIS 798
+ + KSDV+S+GV L E S
Sbjct: 173 --GKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 1e-22
Identities = 66/209 (31%), Positives = 114/209 (54%), Gaps = 23/209 (11%)
Query: 603 LEKKIGSGGFGVVYYGKLK-DGKE---IAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNL 657
+E+ IG+G FG V G+LK GK +A+K L S + + +R+F +E +++ + H N+
Sbjct: 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 658 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 717
+ G + +++ EFM NG L L ++ + I+ + + A G++YL
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLR---QNDGQFTVIQLVGMLRGIAAGMKYLSE 124
Query: 718 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS---HVSSI-----VRGTVGY 769
+HRDL + NIL++ ++ KVSDFGLS+F D S + SS+ +R T
Sbjct: 125 ---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA-- 179
Query: 770 LDPEYYISQQLTDKSDVYSFGVILLELIS 798
PE ++ T SDV+S+G+++ E++S
Sbjct: 180 --PEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 3e-22
Identities = 62/210 (29%), Positives = 114/210 (54%), Gaps = 13/210 (6%)
Query: 596 IEDATKMLEKKIGSGGFGVVYYGKLK--DGKEIAVKVLT---SNSYQGKREFTNEVTLLS 650
I+ + +EK IG+G FG V G+LK +EI V + T + + +R+F +E +++
Sbjct: 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMG 60
Query: 651 RIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK 710
+ H N++ G + ++V E+M NG+L L H+ + I+ + + A
Sbjct: 61 QFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLR---KHDGQFTVIQLVGMLRGIAS 117
Query: 711 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG--ASHVSSIVRGTVG 768
G++YL +HRDL + NIL++ ++ KVSDFGLS+ D A++ + + +
Sbjct: 118 GMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 174
Query: 769 YLDPEYYISQQLTDKSDVYSFGVILLELIS 798
+ PE ++ T SDV+S+G+++ E++S
Sbjct: 175 WTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 5e-22
Identities = 62/218 (28%), Positives = 109/218 (50%), Gaps = 9/218 (4%)
Query: 603 LEKKIGSGGFGVVYYGKLK-DGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQ 659
+ KIG G FGVV+ K D + A+K L+ + + + E +E +L+++ +++
Sbjct: 4 ILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIR 63
Query: 660 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 719
+ ++G+ +V E+ NG L + L + + R I G+ +LH+
Sbjct: 64 YYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI--QILLGLAHLHSK- 120
Query: 720 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 779
I+HRD+KS N+ LD + K+ D G++K D + ++IV GT YL PE +
Sbjct: 121 --KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSPELCEDKP 177
Query: 780 LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 817
+KSDV++ GV+L E +G+ GA I++
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 5e-22
Identities = 58/196 (29%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 662
L KK+G+G FG V+ G ++A+K L S F E L+ ++ H LV+
Sbjct: 10 LVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYA 68
Query: 663 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 722
+E ++ E+M NG+L + L + IN K +++A A+G+ ++
Sbjct: 69 VVTQE-PIYIITEYMENGSLVDFLKTPEGIKLTIN--KLIDMAAQIAEGMAFIE---RKN 122
Query: 723 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 782
IHRDL+++NIL+ + + K++DFGL++ D + + + PE T
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 182
Query: 783 KSDVYSFGVILLELIS 798
KSDV+SFG++L E+++
Sbjct: 183 KSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 6e-22
Identities = 77/278 (27%), Positives = 131/278 (47%), Gaps = 37/278 (13%)
Query: 607 IGSGGFGVVYYGKLKDGKEIAVKVL---TSNSYQGKREFTN---EVTLLSRIHHRNLVQF 660
+G G +G VY G G+ IAVK + TSN ++E+ EV LL + H N+VQ+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 661 LGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 718
LG C ++ + EF+ G++ L +G L + K++ G+ YLH
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI------LDGVAYLHNN 121
Query: 719 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSS----IVRGTVGYLDPE 773
CV +HRD+K +N++L + K+ DFG + + A G S + GT ++ PE
Sbjct: 122 CV---VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 774 YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 833
KSD++S G + E+ +G+ +++ A A +I G +G++
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA--------AMFYI--GAHRGLM- 227
Query: 834 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 871
P L D + ++ + C+ H RPS ++L+
Sbjct: 228 PRLPDSFSAAAI----DFVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 7e-22
Identities = 59/196 (30%), Positives = 100/196 (51%), Gaps = 7/196 (3%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 662
LE K+G G FG V+ G +A+K L + F E ++ ++ H LVQ
Sbjct: 10 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA 68
Query: 663 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 722
EE +V E+M G+L + L G + R+ + +++A A G+ Y+
Sbjct: 69 VVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL--VDMAAQIASGMAYVER---MN 122
Query: 723 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 782
+HRDL+++NIL+ +++ KV+DFGL++ D + + + PE + + T
Sbjct: 123 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 783 KSDVYSFGVILLELIS 798
KSDV+SFG++L EL +
Sbjct: 183 KSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 8e-22
Identities = 59/199 (29%), Positives = 97/199 (48%), Gaps = 12/199 (6%)
Query: 606 KIGSGGFGVVYYGKLKDGKEI-AVK-VLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 663
++G G G V +LK+ I A+K + T + +++ E+ + +V++ G
Sbjct: 8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67
Query: 664 CQEEGRSVL--VYEFMHNGTLKEHLYG-TLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 720
+E S + E+ G+L + +Y RI +IAE KG+ YLH+
Sbjct: 68 FLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS--- 123
Query: 721 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 780
IIHRD+K SNILL + + K+ DFG+S V + ++ GT Y+ PE +
Sbjct: 124 RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV---NSLAGTFTGTSFYMAPERIQGKPY 180
Query: 781 TDKSDVYSFGVILLELISG 799
+ SDV+S G+ LLE+
Sbjct: 181 SITSDVWSLGLTLLEVAQN 199
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 73/252 (28%), Positives = 106/252 (42%), Gaps = 40/252 (15%)
Query: 607 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQFLG 662
I G +G V+ K K +I A+KV+ K + E +LS+ +V+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 663 YCQEEGRSVLVYEFMHNGTLKE--HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 720
Q + LV E++ G L G+L + + R+ IAE +EYLH+
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDED-----VARIYIAE-IVLALEYLHSN-- 112
Query: 721 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV--------DGASHVSSIVRGTVGYLDP 772
IIHRDLK NIL+D + K++DFGLSK + D IV GT Y+ P
Sbjct: 113 -GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV-GTPDYIAP 170
Query: 773 EYYISQQLTDKSDVYSFGVILLELISG----QEAISNEKFGANCRNIVQWAKLHIESGDI 828
E + Q + D +S G IL E + G E F +I +G I
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQ------------NILNGKI 218
Query: 829 QGIIDPSLLDEY 840
+ D + DE
Sbjct: 219 EWPEDVEVSDEA 230
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 77/278 (27%), Positives = 125/278 (44%), Gaps = 40/278 (14%)
Query: 605 KKIGSGGFGVVYYGKLKDG------KEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV 658
+ +G G FG+V+ + K K+I V+ +T + + NE +L + H N++
Sbjct: 6 RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLSHPNII 62
Query: 659 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 718
++ E+ ++V E+ GTL E++ ++ + + I + + LH
Sbjct: 63 EYYENFLEDKALMIVMEYAPGGTLAEYI-----QKRCNSLLDEDTILHFFVQILLALHHV 117
Query: 719 CVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 777
I+HRDLK+ NILLDKH M K+ DFG+SK + + + V GT Y+ PE
Sbjct: 118 HTKLILHRDLKTQNILLDKHKMVVKIGDFGISK--ILSSKSKAYTVVGTPCYISPELCEG 175
Query: 778 QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID---P 834
+ KSD+++ G +L EL S + A AN +V L I SG I D P
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKRAFE----AANLPALV----LKIMSGTFAPISDRYSP 227
Query: 835 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872
L I SM + RP +S+++
Sbjct: 228 DL--RQLILSMLNL----------DPSKRPQLSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 20/206 (9%)
Query: 605 KKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQFL 661
KIG G FG VY L G+ +AVK + K +E +E+ +L + H NLV++
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 662 GYCQEEGRSVLVYEFMHNGTLKEHL-YGTLTHEQRIN-WIKRLEIAEDAAKGIEYLHTGC 719
G + + E+ GTL+E L +G + E I + +L +G+ YLH+
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL------LEGLAYLHSH- 118
Query: 720 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG---YLDPEYYI 776
I+HRD+K +NI LD + K+ DFG + + + + V+ G Y+ PE
Sbjct: 119 --GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176
Query: 777 SQQLTDK---SDVYSFGVILLELISG 799
+ +D++S G ++LE+ +G
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATG 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 3e-21
Identities = 68/295 (23%), Positives = 128/295 (43%), Gaps = 58/295 (19%)
Query: 607 IGSGGFGVVYYGKLK----DGKE--IAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQ 659
+G G FG V+ K K +G E + VK L + + EF E+ + ++ H+N+V+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 660 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE-----QRINWIKRLEIAEDAAKGIEY 714
LG C+E ++ E+ G LK+ L T + + ++ +++ + A G+++
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 715 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAVDGASHVSSIVRGTVGYLDP 772
L +HRDL + N L+ KVS LSK + + ++++ + +L P
Sbjct: 133 LSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI--PLRWLAP 187
Query: 773 EYYISQQLTDKSDVYSFGVILLELISGQE----AISNEKFGANCRNIVQWAKLHIESGDI 828
E + KSDV+SFGV++ E+ + E +S+E+ +++G +
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNR-----------LQAGKL 236
Query: 829 QGIIDPSLLDEYDIQSMWKIEEKA------LM--CVLPHGHMRPSISEVLKDIQD 875
+ + E LM C + RPS SE++ + +
Sbjct: 237 E----------------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 3e-21
Identities = 59/202 (29%), Positives = 113/202 (55%), Gaps = 13/202 (6%)
Query: 604 EKKIGSGGFGVVYYGKLK-DGKE---IAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRNLV 658
+K IG+G FG V+ G LK G++ +A+K L + +R +F +E +++ + H N++
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 659 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 718
+ G + ++++ E+M NG L ++L H+ + + + + A G++YL
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLR---DHDGEFSSYQLVGMLRGIAAGMKYLSD- 125
Query: 719 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG--ASHVSSIVRGTVGYLDPEYYI 776
+HRDL + NIL++ ++ KVSDFGLS+ D ++ +S + + + PE
Sbjct: 126 --MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIA 183
Query: 777 SQQLTDKSDVYSFGVILLELIS 798
++ T SDV+SFG+++ E++S
Sbjct: 184 YRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 3e-21
Identities = 68/202 (33%), Positives = 104/202 (51%), Gaps = 17/202 (8%)
Query: 607 IGSGGFGVVYYGKL--KDGKEI--AVKVLTS-NSYQGKREFTNEVTLLSRIHHRNLVQFL 661
IG G FG VY+G L DG++I AVK L + +F E ++ H N++ L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 662 GYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL-EIAEDAAKGIEYLHTGC 719
G C EG ++V +M +G L+ + E +K L AKG+EYL +
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFI----RSETHNPTVKDLIGFGLQVAKGMEYLAS-- 116
Query: 720 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSIVRGTVGYLDPEYYI 776
+HRDL + N +LD+ KV+DFGL++ D + H + + V ++ E
Sbjct: 117 -KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 777 SQQLTDKSDVYSFGVILLELIS 798
+Q+ T KSDV+SFGV+L EL++
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 4e-21
Identities = 58/204 (28%), Positives = 102/204 (50%), Gaps = 20/204 (9%)
Query: 605 KKIGSGGFGVVYYGKLKDGKE-----IAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLV 658
K +GSG FG VY G E +A+KVL S + +E +E +++ + H ++V
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 659 QFLGYCQEEGRSVLVYEFMHNGTLKEHLY---GTLTHEQRINWIKRLEIAEDAAKGIEYL 715
+ LG C + L+ + M G L +++ + + +NW AKG+ YL
Sbjct: 73 RLLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYL 125
Query: 716 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEY 774
++HRDL + N+L+ K++DFGL+K VD + + + + ++ E
Sbjct: 126 EE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 775 YISQQLTDKSDVYSFGVILLELIS 798
+ + T KSDV+S+GV + EL++
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 4e-21
Identities = 61/214 (28%), Positives = 111/214 (51%), Gaps = 21/214 (9%)
Query: 602 MLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR 655
+L++++G G FG V+ + +D +AVK L S +++F E LL+ + H
Sbjct: 8 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHE 67
Query: 656 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY-----GTLTHE----QRINWIKRLEIAE 706
++V+F G C E ++V+E+M +G L + L L E + + L IA+
Sbjct: 68 HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 707 DAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAVDGASHVSSIVR 764
A G+ YL + +HRDL + N L+ +++ K+ DFG+S+ ++ D V
Sbjct: 128 QIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD-YYRVGGHTM 183
Query: 765 GTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 798
+ ++ PE + ++ T +SDV+S GV+L E+ +
Sbjct: 184 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 5e-21
Identities = 64/221 (28%), Positives = 110/221 (49%), Gaps = 26/221 (11%)
Query: 607 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKRE----------FTNEVTLLSRIHHR 655
IG G +G VY + G+ +AVK + + R +E+ L + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 656 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIE 713
N+VQ+LG+ E + E++ G++ L YG EQ + + E +G+
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRF-EEQLVRFF-----TEQVLEGLA 122
Query: 714 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI-VRGTVGYLDP 772
YLH+ I+HRDLK+ N+L+D K+SDFG+SK + D + ++ ++G+V ++ P
Sbjct: 123 YLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179
Query: 773 EYYISQQ--LTDKSDVYSFGVILLELISGQEAISN-EKFGA 810
E S + K D++S G ++LE+ +G+ S+ E A
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA 220
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 5e-21
Identities = 61/197 (30%), Positives = 101/197 (51%), Gaps = 9/197 (4%)
Query: 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLG 662
++IG G FG V+ G+L+ D +AVK K +F E +L + H N+V+ +G
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 663 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 722
C ++ +V E + G L T R+ + +++ E+AA G+EYL +
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLR---TEGPRLKVKELIQMVENAAAGMEYLESKHC-- 115
Query: 723 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT-VGYLDPEYYISQQLT 781
IHRDL + N L+ + K+SDFG+S+ DG + ++ V + PE + +
Sbjct: 116 -IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174
Query: 782 DKSDVYSFGVILLELIS 798
+SDV+SFG++L E S
Sbjct: 175 SESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 5e-21
Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 18/213 (8%)
Query: 605 KKIGSGGFGVVYYGKLK-DGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 661
++G+G GVV + GK +AVK L N K+ E+ +L + + +V F
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQ-ILRELDILHKCNSPYIVGFY 65
Query: 662 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL---EIAEDAAKGIEYLHTG 718
G G + E+M G+L + L ++ I +IA KG+ YLH
Sbjct: 66 GAFYNNGDISICMEYMDGGSLDKIL------KEVQGRIPERILGKIAVAVLKGLTYLHE- 118
Query: 719 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 778
IIHRD+K SNIL++ + K+ DFG+S V+ + GT Y+ PE
Sbjct: 119 -KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV---GTSSYMAPERIQGN 174
Query: 779 QLTDKSDVYSFGVILLELISGQEAISNEKFGAN 811
+ KSD++S G+ L+EL +G+ E +
Sbjct: 175 DYSVKSDIWSLGLSLIELATGRFPYPPENDPPD 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 7e-21
Identities = 62/222 (27%), Positives = 110/222 (49%), Gaps = 34/222 (15%)
Query: 602 MLEKKIGSGGFGVVYYGK------LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR 655
+L++++G G FG V+ + KD +AVK L + +++F E LL+ + H
Sbjct: 8 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHE 67
Query: 656 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG------------TLTHEQRINWIKRLE 703
++V+F G C + ++V+E+M +G L + L + + + L
Sbjct: 68 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 704 IAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-------FAVDGA 756
IA A G+ YL + +HRDL + N L+ ++ K+ DFG+S+ + V G
Sbjct: 128 IASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG- 183
Query: 757 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 798
H +R ++ PE + ++ T +SDV+SFGVIL E+ +
Sbjct: 184 -HTMLPIR----WMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 7e-21
Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 18/204 (8%)
Query: 605 KKIGSGGFGVVY---YGKLKD--GKEIAVKVLTS-NSYQGKREFTNEVTLLSRIHHRNLV 658
+ +G G FG V Y D G+ +AVK L Q + E+ +L ++H N+V
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 659 QFLGYCQEEGRSV--LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 716
++ G C E+G L+ E++ G+L+++L + ++N + L A+ +G+ YLH
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-----PKHKLNLAQLLLFAQQICEGMAYLH 124
Query: 717 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH--VSSIVRGTVGYLDPEY 774
+ IHRDL + N+LLD K+ DFGL+K +G + V V + E
Sbjct: 125 S---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVEC 181
Query: 775 YISQQLTDKSDVYSFGVILLELIS 798
+ + SDV+SFGV L EL++
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 7e-21
Identities = 66/211 (31%), Positives = 104/211 (49%), Gaps = 28/211 (13%)
Query: 607 IGSGGFGVVYYG-KLKDGKEIAVK--VLTSNSYQGKRE-------FTNEVTLLSRIHHRN 656
IGSG FG VY G G+ +AVK L S S K E+ LL + H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 657 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEY 714
+VQ+LG + + E++ G++ L YG N+++++ KG+ Y
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQI------LKGLNY 121
Query: 715 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK------FAVDGASHVSSIVRGTVG 768
LH IIHRD+K +NIL+D K+SDFG+SK + S+ +G+V
Sbjct: 122 LHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSL-QGSVF 177
Query: 769 YLDPEYYISQQLTDKSDVYSFGVILLELISG 799
++ PE T K+D++S G +++E+++G
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 9e-21
Identities = 81/293 (27%), Positives = 126/293 (43%), Gaps = 60/293 (20%)
Query: 602 MLEKKIGSGGFGVVYYGK---------LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI 652
+L++++G G FG VY K LK KEI V L N + E LLS++
Sbjct: 3 ILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNE---TVQANQEAQLLSKL 59
Query: 653 HHRNLVQFLG-------------YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI 699
H +V+F YC+ + E H G TL+ Q W
Sbjct: 60 DHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGK-------TLSENQVCEWF 112
Query: 700 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759
+L + G+ Y+H I+HRDLK+ NI L ++ K+ DFG+S+ + G+ +
Sbjct: 113 IQLLL------GVHYMH---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLM-GSCDL 161
Query: 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA 819
++ GT Y+ PE Q KSD++S G IL E+ A + F + IV+
Sbjct: 162 ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE-- 219
Query: 820 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872
G PSL + Y + + I + L +RPS +E+L++
Sbjct: 220 ------GPT-----PSLPETYS-RQLNSIMQSMLN---KDPSLRPSAAEILRN 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 1e-20
Identities = 64/224 (28%), Positives = 106/224 (47%), Gaps = 35/224 (15%)
Query: 604 EKKIGSGGFGVVYYGK---LKDGKE---IAVKVLTSN-SYQGKREFTNEVTLLSRIHHRN 656
+ IG G FG V+ + L + +AVK+L S + +F E L++ H N
Sbjct: 10 VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPN 69
Query: 657 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQ------------------RINW 698
+V+ LG C L++E+M G L E L Q ++
Sbjct: 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129
Query: 699 IKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAVD-- 754
++L IA+ A G+ YL +HRDL + N L+ ++M K++DFGLS+ ++ D
Sbjct: 130 TEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186
Query: 755 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 798
AS +I + ++ PE + T +SDV+++GV+L E+ S
Sbjct: 187 KASENDAI---PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 60/209 (28%), Positives = 94/209 (44%), Gaps = 30/209 (14%)
Query: 605 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN--EVTLLSRIHHRNLVQFL 661
KIG G +GVVY + K EI A+K + T E+ LL ++H N+++ L
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 662 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIE 713
+ +G LV+EFM LY + QR + E K G+
Sbjct: 65 DVFRHKGDLYLVFEFMD-----TDLYKLIKDRQR-------GLPESLIKSYLYQLLQGLA 112
Query: 714 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDP 772
+ H+ I+HRDLK N+L++ K++DFGL++ F + +V T Y P
Sbjct: 113 FCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV--TRWYRAP 167
Query: 773 E-YYISQQLTDKSDVYSFGVILLELISGQ 800
E + + D++S G I EL+S +
Sbjct: 168 ELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 59/202 (29%), Positives = 86/202 (42%), Gaps = 23/202 (11%)
Query: 607 IGSGGFGVVYYGKLKDGKEI-------AVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQ 659
IG G FG V + +D K++ K + S + NE +L ++H LV
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVL---NERRILQELNHPFLVN 64
Query: 660 FLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 717
Q+E LV + + G L+ HL + EQ + I E +EYLH+
Sbjct: 65 LWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQ-----VKFWICE-IVLALEYLHS 118
Query: 718 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 777
IIHRD+K NILLD+ ++DF ++ S GT GY+ PE
Sbjct: 119 ---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTS--TSGTPGYMAPEVLCR 173
Query: 778 QQLTDKSDVYSFGVILLELISG 799
Q + D +S GV E + G
Sbjct: 174 QGYSVAVDWWSLGVTAYECLRG 195
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 30/214 (14%)
Query: 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-----QGKREFTNEVTLLSRIHHRNLV 658
+ IG G FG V + K DGK + K + Y + K++ +EV +L + H N+V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEI---DYGNMTEKEKQQLVSEVNILRELKHPNIV 62
Query: 659 QFLGYCQEEGRSVL--VYEFMHNGTL--------KEHLYGTLTHEQRINWIKRLEIAEDA 708
++ + L V E+ G L KE Y + E + +L +A
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKY--IEEEFIWRILTQLLLA--- 117
Query: 709 AKGIEYLHTGCVP--AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT 766
+ H P ++HRDLK +NI LD + K+ DFGL+K +S + V GT
Sbjct: 118 ---LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GT 173
Query: 767 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 800
Y+ PE +KSD++S G ++ EL +
Sbjct: 174 PYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-20
Identities = 59/196 (30%), Positives = 98/196 (50%), Gaps = 7/196 (3%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 662
L KK+G+G FG V+ G ++AVK L + F E ++ ++ H LVQ
Sbjct: 10 LIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYA 68
Query: 663 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 722
EE +V E+M G+L + L + + +++A A G+ Y+
Sbjct: 69 VVSEE-PIYIVTEYMSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIER---MN 122
Query: 723 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 782
IHRDL+S+NIL+ + K++DFGL++ D + + + PE + + T
Sbjct: 123 YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 783 KSDVYSFGVILLELIS 798
KSDV+SFG++L EL++
Sbjct: 183 KSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 67/211 (31%), Positives = 104/211 (49%), Gaps = 19/211 (9%)
Query: 603 LEKKIGSGGFGVVYYGKLK----DGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHR 655
L + +G G FG VY G + D E+ V V T S S Q + +F E ++S+ +H+
Sbjct: 10 LLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQ 69
Query: 656 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR---INWIKRLEIAEDAAKGI 712
N+V+ +G E ++ E M G LK L +R + L A D AKG
Sbjct: 70 NIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129
Query: 713 EYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFGLSKFAVDGASHVSSIVRGT--V 767
+YL IHRD+ + N LL AK++DFG+++ + AS+ R +
Sbjct: 130 KYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR-DIYRASYYRKGGRAMLPI 185
Query: 768 GYLDPEYYISQQLTDKSDVYSFGVILLELIS 798
++ PE ++ T K+DV+SFGV+L E+ S
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 3e-20
Identities = 60/216 (27%), Positives = 109/216 (50%), Gaps = 23/216 (10%)
Query: 602 MLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR 655
+L+ ++G G FG V+ + +D +AVK L S +++F E LL+ + H+
Sbjct: 8 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQ 67
Query: 656 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY-----------GTLTHEQRINWIKRLEI 704
++V+F G C E ++V+E+M +G L L G ++ + L I
Sbjct: 68 HIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 705 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAVDGASHVSSI 762
A A G+ YL + +HRDL + N L+ + + K+ DFG+S+ ++ D V
Sbjct: 128 ASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD-YYRVGGR 183
Query: 763 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 798
+ ++ PE + ++ T +SD++SFGV+L E+ +
Sbjct: 184 TMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 6e-20
Identities = 62/209 (29%), Positives = 107/209 (51%), Gaps = 29/209 (13%)
Query: 605 KKIGSGGFGVVYYGK-LKDGKEIAVK-VLTSNSYQG-----KREFTNEVTLLSRIHHRNL 657
+IG G +G VY + K G+ +A+K + N +G RE + LL ++ H N+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIRE----IKLLQKLRHPNI 60
Query: 658 VQFLGYCQEEGR-SV-LVYEFM-H--NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 712
V+ +G+ S+ +V+E+M H G L T Q ++K+L +G+
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEV-KFTESQIKCYMKQL------LEGL 113
Query: 713 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLD 771
+YLH+ I+HRD+K SNIL++ K++DFGL+ + ++ ++ V T+ Y
Sbjct: 114 QYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRP 169
Query: 772 PEYYI-SQQLTDKSDVYSFGVILLELISG 799
PE + + + + D++S G IL EL G
Sbjct: 170 PELLLGATRYGPEVDMWSVGCILAELFLG 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 6e-20
Identities = 60/222 (27%), Positives = 102/222 (45%), Gaps = 41/222 (18%)
Query: 603 LEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSYQGKR-EFTNEVTLLSRIHHR 655
L +++G G FG+VY G K +A+K + N+ +R EF NE +++ +
Sbjct: 10 LIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCH 69
Query: 656 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIKRLE 703
++V+ LG +++V E M G LK +L G T ++ I
Sbjct: 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM----- 124
Query: 704 IAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-------FAVDGA 756
A + A G+ YL +HRDL + N ++ + + K+ DFG+++ + G
Sbjct: 125 -AAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGK 180
Query: 757 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 798
+ VR ++ PE T KSDV+SFGV+L E+ +
Sbjct: 181 GLLP--VR----WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 7e-20
Identities = 60/194 (30%), Positives = 99/194 (51%), Gaps = 9/194 (4%)
Query: 607 IGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLGYCQ 665
+G G FG V+ G LKD +AVK + Q K +F +E +L + H N+V+ +G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 666 EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAII 724
+ +V E + G L + + + ++ A DAA G+ YL + C I
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLR---KKKDELKTKQLVKFALDAAAGMAYLESKNC----I 115
Query: 725 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS 784
HRDL + N L+ ++ K+SDFG+S+ DG S + + + + PE + + +S
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 785 DVYSFGVILLELIS 798
DV+S+G++L E S
Sbjct: 176 DVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 7e-20
Identities = 65/204 (31%), Positives = 106/204 (51%), Gaps = 16/204 (7%)
Query: 605 KKIGSGGFGVV---YYGKLKD--GKEIAVKVLTSNSYQGK-REFTNEVTLLSRIHHRNLV 658
+ +G G FG V Y D G+++AVK L S + E+ +L ++H N+V
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 659 QFLGYCQEEG-RSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 716
++ G C E+G + L+ EF+ +G+LKE+L IN ++L+ A KG++YL
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK---INLKQQLKYAVQICKGMDYLG 126
Query: 717 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH--VSSIVRGTVGYLDPEY 774
+ +HRDL + N+L++ + K+ DFGL+K + V + V + PE
Sbjct: 127 S---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC 183
Query: 775 YISQQLTDKSDVYSFGVILLELIS 798
I + SDV+SFGV L EL++
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (225), Expect = 8e-20
Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 34/211 (16%)
Query: 605 KKIGSGGFGVVYYGK-LKDGKEIAVKV---------LTSNSYQGKREFTNEVTLLSRIHH 654
+K+G G +GVVY + K G+ +A+K + S + + E++LL + H
Sbjct: 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR-------EISLLKELKH 57
Query: 655 RNLVQFLGYCQEEGRSVLVYEFMHNGTLK---EHLYGTLTHEQRINWIKRLEIAEDAAKG 711
N+V+ L E + LV+E+ LK + G L+ N IK I +G
Sbjct: 58 PNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLS----PNLIKS--IMYQLLRG 110
Query: 712 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYL 770
+ Y H+ I+HRDLK NIL+++ K++DFGL++ F + ++ +V T+ Y
Sbjct: 111 LAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYR 165
Query: 771 DPEYYISQQLTDKS-DVYSFGVILLELISGQ 800
PE + + + D++S G I E+I+G+
Sbjct: 166 APEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 54/201 (26%), Positives = 103/201 (51%), Gaps = 7/201 (3%)
Query: 598 DATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL 657
++ K++ KK+G+G FG V+ G + ++AVK L + + F E L+ + H L
Sbjct: 6 ESIKLV-KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKL 63
Query: 658 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 717
V+ +E ++ E+M G+L + L ++ K ++ + A+G+ Y+
Sbjct: 64 VRLYAVVTKEEPIYIITEYMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIER 121
Query: 718 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 777
IHRDL+++N+L+ + + K++DFGL++ D + + + PE
Sbjct: 122 ---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF 178
Query: 778 QQLTDKSDVYSFGVILLELIS 798
T KSDV+SFG++L E+++
Sbjct: 179 GSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 3e-19
Identities = 56/204 (27%), Positives = 101/204 (49%), Gaps = 7/204 (3%)
Query: 595 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH 654
+I + LEKK+G+G FG V+ ++AVK + S F E ++ + H
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQH 60
Query: 655 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 714
LV+ +E ++ EFM G+L + L +Q + K ++ + A+G+ +
Sbjct: 61 DKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAF 117
Query: 715 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 774
+ IHRDL+++NIL+ + K++DFGL++ D + + + PE
Sbjct: 118 IEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 174
Query: 775 YISQQLTDKSDVYSFGVILLELIS 798
T KSDV+SFG++L+E+++
Sbjct: 175 INFGSFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 63/206 (30%), Positives = 91/206 (44%), Gaps = 16/206 (7%)
Query: 605 KKIGSGGFGVVYYGKLKD--GKEI--AVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQ 659
KK+G G FGVV G+ GK I AVK L S+ +F E ++ + H NL++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 660 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL-EIAEDAAKGIEYLHTG 718
G ++V E G+L + L I L + A A G+ YL +
Sbjct: 61 LYGVVLTH-PLMMVTELAPLGSLLDRLR---KDALGHFLISTLCDYAVQIANGMRYLES- 115
Query: 719 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV--GYLDPEYYI 776
IHRDL + NILL + K+ DFGL + H V + PE
Sbjct: 116 --KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR 173
Query: 777 SQQLTDKSDVYSFGVILLELIS-GQE 801
++ + SDV+ FGV L E+ + G+E
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGEE 199
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 3e-19
Identities = 66/214 (30%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 603 LEKKIGSGGFGVVYYGKLK--DGK--EIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRN 656
L K +G G FG V G+L DG ++AVK L ++Y EF +E + H N
Sbjct: 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPN 62
Query: 657 LVQFLGYC------QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI--KRLEIAEDA 708
+++ +G C Q+ + +++ FM +G L L + L+ D
Sbjct: 63 VMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDI 122
Query: 709 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS-IVRGTV 767
A G+EYL IHRDL + N +L + M V+DFGLSK G + I + V
Sbjct: 123 ALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179
Query: 768 GYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQ 800
++ E + T KSDV++FGV + E+ + GQ
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-19
Identities = 75/278 (26%), Positives = 128/278 (46%), Gaps = 44/278 (15%)
Query: 605 KKIGSGGFGVVYYGK-LKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 661
KK+G G +G VY K L D + A+K L S S + + + NE+ +L+ ++H N++ +
Sbjct: 6 KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYK 65
Query: 662 GYCQEEGRSVLVYEFMHNGTL-----KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 716
+ + +V E+ G L K L EQ I W +++ +G++ LH
Sbjct: 66 EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEI-WRIFIQLL----RGLQALH 120
Query: 717 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 776
I+HRDLKS+NILL + K+ D G+SK +++ GT Y+ PE +
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQIGTPHYMAPEVWK 174
Query: 777 SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL----HIESGDIQGII 832
+ + KSD++S G +L E+ + + + R VQ K I S D+Q I
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPPF-EARSMQDLRYKVQRGKYPPIPPIYSQDLQNFI 233
Query: 833 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVL 870
++++ V P +RP+ ++L
Sbjct: 234 ------------------RSMLQVKP--KLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 4e-19
Identities = 65/206 (31%), Positives = 106/206 (51%), Gaps = 24/206 (11%)
Query: 605 KKIGSGGFGVVYYGKLKDGKE----IAVKVLTSNSYQGKREF--TNEVTLLSRIHHRNLV 658
K +G G FG V+ + G + A+KVL + + + E +L+ ++H +V
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 659 QFLGYCQEEGRSVLVYEFMHNGTL-----KEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 713
+ Q EG+ L+ +F+ G L KE ++ T E + +AE A ++
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF---TEED-----VKFYLAE-LALALD 112
Query: 714 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 773
+LH+ II+RDLK NILLD+ K++DFGLSK ++D S GTV Y+ PE
Sbjct: 113 HLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPE 168
Query: 774 YYISQQLTDKSDVYSFGVILLELISG 799
+ T +D +SFGV++ E+++G
Sbjct: 169 VVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 4e-19
Identities = 60/222 (27%), Positives = 108/222 (48%), Gaps = 28/222 (12%)
Query: 602 MLEKKIGSGGFGVVYYGKLKDGKE---------------IAVKVLTSNSYQGKR-EFTNE 645
L++K+G G FG V+ + + E +AVK+L ++ + R +F E
Sbjct: 8 RLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKE 67
Query: 646 VTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL-----YGTLTHEQRINWIK 700
+ ++SR+ + N+++ LG C + ++ E+M NG L + L T TH I +
Sbjct: 68 IKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127
Query: 701 R---LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757
L +A A G++YL + +HRDL + N L+ H K++DFG+S+ G
Sbjct: 128 IANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY 184
Query: 758 H-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 798
+ + + ++ E + + T SDV++FGV L E+ +
Sbjct: 185 YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 5e-19
Identities = 74/230 (32%), Positives = 111/230 (48%), Gaps = 46/230 (20%)
Query: 597 EDATKMLEKKIGSGGFGVVYYGKLK-DGKEI--AVKVLTS-NSYQGKREFTNEVTLLSRI 652
ED E IG G FG V +K DG ++ A+K+L S R+F E+ +L ++
Sbjct: 2 EDIK--FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKL 59
Query: 653 -HHRNLVQFLGYCQEEGRSVLVYEFMHNGTL-----------------KEH-LYGTLTHE 693
HH N++ LG C+ G + E+ G L KEH TLT +
Sbjct: 60 GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119
Query: 694 QRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 753
Q L+ A D A G++YL IHRDL + N+L+ +++ +K++DFGLS+
Sbjct: 120 QL------LQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSRGE- 169
Query: 754 DGASHVSSIVRGTVGYLDPEYYISQQL-----TDKSDVYSFGVILLELIS 798
V+ T+G L + + L T KSDV+SFGV+L E++S
Sbjct: 170 ------EVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 5e-19
Identities = 63/221 (28%), Positives = 109/221 (49%), Gaps = 26/221 (11%)
Query: 599 ATKMLEKKIGSGGFGVVYYGKL-----KDGKEIAVKVLTS-NSYQGKREFTNEVTLLSRI 652
A + +E+ +G FG +Y G L + +A+K L N+ Q EF E +L++ +
Sbjct: 6 AVRFMEE-LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL 64
Query: 653 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH-------------EQRINWI 699
HH N+V LG +E +++E+++ G L E L H + ++
Sbjct: 65 HHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHG 124
Query: 700 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAVDGAS 757
L IA A G+EYL + +H+DL + NIL+ + + K+SD GLS+ ++ D
Sbjct: 125 DFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLSREIYSAD-YY 180
Query: 758 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 798
V + ++ PE + + + SD++SFGV+L E+ S
Sbjct: 181 RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 9e-19
Identities = 63/208 (30%), Positives = 106/208 (50%), Gaps = 29/208 (13%)
Query: 607 IGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ 665
+G G +G+VY + L IA+K + + + E+ L S + HRN+VQ+LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 666 EEGRSVLVYEFMHNGTLKEHL---YGTLT-HEQRINWIKRLEIAEDAAKGIEYLHTGCVP 721
E G + E + G+L L +G L +EQ I + + +I E G++YLH
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-QILE----GLKYLHDN--- 127
Query: 722 AIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 780
I+HRD+K N+L++ + K+SDFG SK + G + + GT+ Y+ PE +
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSK-RLAGINPCTETFTGTLQYMAPE------V 180
Query: 781 TDK--------SDVYSFGVILLELISGQ 800
DK +D++S G ++E+ +G+
Sbjct: 181 IDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 9e-19
Identities = 71/223 (31%), Positives = 104/223 (46%), Gaps = 30/223 (13%)
Query: 607 IGSGGFGVVYYGKLKD----GKE---IAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLV 658
+GSG FG VY G D G +AVK L + Q K+EF E L+S +H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 659 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYG---TLTHEQRINWIKRLEIAEDAAKGIEYL 715
+ LG C ++ E M G L +L + + L+I D AKG YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 716 HTGCVPAIIHRDLKSSNILL-----DKHMRAKVSDFGLSKFAVDGASHVSSIVRG----T 766
IHRDL + N L+ D K+ DFGL++ D G
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR---DIYKSDYYRKEGEGLLP 176
Query: 767 VGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQE---AISN 805
V ++ PE + + T +SDV+SFGV++ E+++ GQ+ A++N
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN 219
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 79/275 (28%), Positives = 133/275 (48%), Gaps = 36/275 (13%)
Query: 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQFL 661
KKIG G FG K K DGK+ +K + + K E EV +LS + H N+VQ+
Sbjct: 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65
Query: 662 GYCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRI-NWIKRLEIAEDAAKGIEYLHT 717
+E G +V ++ G L + + G L E +I +W ++ +A ++++H
Sbjct: 66 ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LKHVHD 119
Query: 718 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 777
I+HRD+KS NI L K K+ DFG+++ ++ ++ GT YL PE +
Sbjct: 120 ---RKILHRDIKSQNIFLTKDGTIKLGDFGIAR-VLNSTVELARTCIGTPYYLSPEICEN 175
Query: 778 QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP-SL 836
+ +KSD+++ G +L E+ + + A N +N+V L I I+G P S
Sbjct: 176 RPYNNKSDIWALGCVLYEMCTLKHAFE----AGNMKNLV----LKI----IRGSYPPVSS 223
Query: 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 871
YD++++ L P RPS++ +L+
Sbjct: 224 HYSYDLRNLV----SQLFKRNPRD--RPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 1e-18
Identities = 66/214 (30%), Positives = 103/214 (48%), Gaps = 32/214 (14%)
Query: 607 IGSGGFGVVYYGKLK-DGKEI--AVKVLTS-NSYQGKREFTNEVTLLSRI-HHRNLVQFL 661
IG G FG V ++K DG + A+K + S R+F E+ +L ++ HH N++ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 662 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR------------LEIAEDAA 709
G C+ G L E+ +G L + L + E + L A D A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 710 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 769
+G++YL IHRDL + NIL+ ++ AK++DFGLS+ V+ T+G
Sbjct: 123 RGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQ-------EVYVKKTMGR 172
Query: 770 LDPEYYISQQL-----TDKSDVYSFGVILLELIS 798
L + + L T SDV+S+GV+L E++S
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-18
Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 32/214 (14%)
Query: 607 IGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQGK---REFTNEVTLLSRI-HHRNLVQFL 661
IG G FG V ++ KDG + + Y K R+F E+ +L ++ HH N++ L
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 662 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE------------QRINWIKRLEIAEDAA 709
G C+ G L E+ +G L + L + E ++ + L A D A
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 710 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 769
+G++YL IHRDL + NIL+ ++ AK++DFGLS+ V+ T+G
Sbjct: 135 RGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQ-------EVYVKKTMGR 184
Query: 770 LDPEYYISQQL-----TDKSDVYSFGVILLELIS 798
L + + L T SDV+S+GV+L E++S
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 2e-18
Identities = 67/253 (26%), Positives = 95/253 (37%), Gaps = 49/253 (19%)
Query: 605 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT----NEVTLLSRIHHRNLVQ 659
K IG G FG V+ + KD ++ A+KVL S KR E +L+ +V+
Sbjct: 7 KVIGRGAFGEVWLVRDKDTGQVYAMKVL-RKSDMIKRNQIAHVRAERDILADADSPWIVK 65
Query: 660 FLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 717
Q+E LV E+M G L L E R IAE ++ +H
Sbjct: 66 LYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEE-----TARFYIAELVL-ALDSVHK 119
Query: 718 -GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGAS------------------ 757
G IHRD+K NIL+D K++DFGL K
Sbjct: 120 LGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175
Query: 758 ----------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 807
+S V GT Y+ PE + D +S GVIL E++ G ++
Sbjct: 176 RRRDHKQRRVRANSTV-GTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234
Query: 808 FGANCRNIVQWAK 820
I+ W +
Sbjct: 235 LQETYNKIINWKE 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 61/225 (27%), Positives = 110/225 (48%), Gaps = 31/225 (13%)
Query: 602 MLEKKIGSGGFGVVYYGKLKDGK------EIAVKVLTSNSYQGK-REFTNEVTLLSRIHH 654
+L K +G G FG V K +AVK+L N+ + R+ +E LL +++H
Sbjct: 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNH 62
Query: 655 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------------YGTLTH--EQ 694
++++ G C ++G +L+ E+ G+L+ L L + E+
Sbjct: 63 PHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122
Query: 695 RINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 754
+ + A ++G++YL ++HRDL + N+L+ + + K+SDFGLS+ +
Sbjct: 123 ALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE 179
Query: 755 GASHVS-SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 798
S+V S R V ++ E T +SDV+SFGV+L E+++
Sbjct: 180 EDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-18
Identities = 57/197 (28%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 662
L+ K+G G FG V+ G ++A+K L + F E ++ ++ H LV
Sbjct: 10 LDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM-PEAFLQEAQIMKKLRHDKLVPLYA 68
Query: 663 YCQEEGRSVLVYEFMHNGTLKEHLY-GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 721
EE +V EFM G+L + L G + + + +++A A G+ Y+
Sbjct: 69 VVSEE-PIYIVTEFMGKGSLLDFLKEGDGKY---LKLPQLVDMAAQIADGMAYIER---M 121
Query: 722 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 781
IHRDL+++NIL+ ++ K++DFGL++ D + + + PE + + T
Sbjct: 122 NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 782 DKSDVYSFGVILLELIS 798
KSDV+SFG++L EL++
Sbjct: 182 IKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 67/208 (32%), Positives = 104/208 (50%), Gaps = 17/208 (8%)
Query: 607 IGSGGFGVVYYGKLK-DGKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLG 662
+G GGFG V +++ GK A K L +G+ NE +L +++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVS-LA 66
Query: 663 YCQEEGRSV-LVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 719
Y E ++ LV M+ G LK H+Y G E+ + + A + G+E LH
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEG----RAVFYAAEICCGLEDLHQ-- 120
Query: 720 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 779
I++RDLK NILLD H ++SD GL+ +G + + GTVGY+ PE +++
Sbjct: 121 -ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVVKNER 177
Query: 780 LTDKSDVYSFGVILLELISGQEAISNEK 807
T D ++ G +L E+I+GQ K
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQSPFQQRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 61/200 (30%), Positives = 90/200 (45%), Gaps = 15/200 (7%)
Query: 607 IGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLG 662
+G GGFG V ++K GK A K L + ++ NE +L ++ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVS-LA 59
Query: 663 YCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI-AEDAAKGIEYLHTGCV 720
Y E + LV M+ G LK H+Y + R A G+E+LH
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIY---NVGEPGFPEARAIFYAAQIICGLEHLHQ--- 113
Query: 721 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 780
I++RDLK N+LLD H ++SD GL+ G GT GY+ PE +
Sbjct: 114 RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA--GTPGYMAPEVLQGEVY 171
Query: 781 TDKSDVYSFGVILLELISGQ 800
D ++ G L E+I+G+
Sbjct: 172 DFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 3e-18
Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLG 662
+IGSG G VY + G+ A+KV+ N +R+ E+ +L ++H N+V+
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 663 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 722
G ++ EFM G+L+ + EQ + ++A GI YLH
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGT---HIADEQFLA-----DVARQILSGIAYLHR---RH 188
Query: 723 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 782
I+HRD+K SN+L++ K++DFG+S+ +S V GT+ Y+ PE I+ L
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPE-RINTDLNH 246
Query: 783 ------KSDVYSFGVILLELISGQ 800
D++S GV +LE G+
Sbjct: 247 GAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 3e-18
Identities = 62/219 (28%), Positives = 112/219 (51%), Gaps = 27/219 (12%)
Query: 605 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT----SNSYQGK--REFTNEVTLLSRIHHRNL 657
+++G+G F Y + +K G +AVK +T ++S Q + E+ L++R++H ++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 658 VQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYL 715
++ LG E+ L E+M G++ L YG IN+ ++L +G+ YL
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQL------LRGLSYL 119
Query: 716 HTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLS-KFAVD--GASHVSSIVRGTVGYLD 771
H IIHRD+K +N+L+D R +++DFG + + A GA + GT+ ++
Sbjct: 120 HEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176
Query: 772 PEYYISQQLTDKSDVYSFGVILLELISGQ-----EAISN 805
PE +Q DV+S G +++E+ + + E SN
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN 215
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 4e-18
Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 12/204 (5%)
Query: 605 KKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 663
KIG G G+V G+++AVK + Q + NEV ++ H N+V+
Sbjct: 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS 84
Query: 664 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 723
+V EF+ G L + + T +E++I + K + +LH +
Sbjct: 85 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----ATVCLAVLKALSFLHA---QGV 136
Query: 724 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD- 782
IHRD+KS +ILL R K+SDFG S+V GT ++ PE IS+
Sbjct: 137 IHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPE-VISRLPYGT 194
Query: 783 KSDVYSFGVILLELISGQEAISNE 806
+ D++S G++++E++ G+ NE
Sbjct: 195 EVDIWSLGIMVIEMVDGEPPYFNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 6e-18
Identities = 64/224 (28%), Positives = 112/224 (50%), Gaps = 34/224 (15%)
Query: 602 MLEKKIGSGGFGVVY----YGKLKDGKE----IAVKVLTSN-SYQGKREFTNEVTLLSRI 652
+L K +G G FG V YG K + +AVK+L N + + + +E+ L+ I
Sbjct: 15 VLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLI 74
Query: 653 -HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY------------GTLTHEQRINWI 699
H+N++ LG C +EG ++ E+ G L+E L T E+++++
Sbjct: 75 GKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFK 134
Query: 700 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759
+ A A+G+EYL + IHRDL + N+L+ + K++DFGL++ G +
Sbjct: 135 DLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVMKIADFGLAR----GVHDI 187
Query: 760 -----SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 798
+S R V ++ PE + T +SDV+SFG+++ E+ +
Sbjct: 188 DYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 6e-18
Identities = 74/291 (25%), Positives = 132/291 (45%), Gaps = 45/291 (15%)
Query: 605 KKIGSGGFGVVY----YGKLKDGKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNL 657
+++G G FG+VY G +KD E V + T N RE F NE +++ + ++
Sbjct: 12 RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71
Query: 658 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI------KRLEIAEDAAKG 711
V+ LG + ++++ E M G LK +L + K +++A + A G
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 712 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG--TVGY 769
+ YL+ +HRDL + N ++ + K+ DFG+++ + + +G V +
Sbjct: 132 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYRKGGKGLLPVRW 187
Query: 770 LDPEYYISQQLTDKSDVYSFGVILLELISGQE----AISNEKFGANCRNIVQWAKLHIES 825
+ PE T SDV+SFGV+L E+ + E +SNE+
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV----------------- 230
Query: 826 GDIQGIIDPSLLDEYD-IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 875
++ +++ LLD+ D M + E MC + MRPS E++ I++
Sbjct: 231 --LRFVMEGGLLDKPDNCPDM--LFELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 9e-18
Identities = 74/277 (26%), Positives = 123/277 (44%), Gaps = 32/277 (11%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIA---VKVLTSNSYQGKREFTNEVTLLSRIHHRNLV 658
+EKKIG G F VVY L DG+ +A V++ + +++ E+ LL ++ H N++
Sbjct: 6 IEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVI 65
Query: 659 QFLGYCQEEGRSVLVYEFMHNGTLKEHL-----YGTLTHEQRINWIKRLEIAEDAAKGIE 713
++L E +V E G L + L E+ I W +++ +E
Sbjct: 66 KYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTI-WKYFVQLCS----ALE 120
Query: 714 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 773
++H+ I+HRD+K +N+ + K+ D GL +F + S+V GT Y+ PE
Sbjct: 121 HMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 176
Query: 774 YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 833
KSD++S G +L E+ + Q +K N ++ + IE D
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK--MNLYSLCK----KIEKCDYP---- 226
Query: 834 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVL 870
P D Y + + + C+ P RP IS VL
Sbjct: 227 PLPADHYSEE----LRDLVSRCINPDPEKRPDISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 57/201 (28%), Positives = 105/201 (52%), Gaps = 16/201 (7%)
Query: 603 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 661
+ +K+G G +G VY K+ G+ +A+KV+ +E E+++L + +V++
Sbjct: 7 ILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVKYY 64
Query: 662 GYCQEEGRSVLVYEFMHNGT---LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 718
G + +V E+ G+ + + TLT E+ I I KG+EYLH+
Sbjct: 65 GSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLT-EEEIAAILY-----QTLKGLEYLHSN 118
Query: 719 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 778
IHRD+K+ NILL++ +AK++DFG+S D + ++++ GT ++ PE
Sbjct: 119 ---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVIQEI 174
Query: 779 QLTDKSDVYSFGVILLELISG 799
+K+D++S G+ +E+ G
Sbjct: 175 GYNNKADIWSLGITAIEMAEG 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 1e-17
Identities = 65/229 (28%), Positives = 102/229 (44%), Gaps = 53/229 (23%)
Query: 593 LSDIEDATKMLE--KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKR------EFT 643
L +D K+ ++IG G FG VY+ + E+ A+K + SY GK+ +
Sbjct: 7 LFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKM---SYSGKQSNEKWQDII 63
Query: 644 NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF----------MHNGTLKEHLYGTLTHE 693
EV L ++ H N +++ G E + LV E+ +H L+E
Sbjct: 64 KEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQE--------- 114
Query: 694 QRINWIKRLEIA---EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 750
+EIA A +G+ YLH+ IHRD+K+ NILL + K++DFG +
Sbjct: 115 --------VEIAAICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSAS 163
Query: 751 FAVDGASHVSSIVRGTVGYLDPEYYISQ---QLTDKSDVYSFGVILLEL 796
S V GT ++ PE ++ Q K DV+S G+ +EL
Sbjct: 164 LVSPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-17
Identities = 68/240 (28%), Positives = 107/240 (44%), Gaps = 15/240 (6%)
Query: 606 KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 664
KIG G G+V K GK++AVK + Q + NEV ++ HH N+V
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 665 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 724
+V EF+ G L + + T +E++I + + + YLH +I
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----ATVCLSVLRALSYLHN---QGVI 140
Query: 725 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS 784
HRD+KS +ILL R K+SDFG S+V GT ++ PE +
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEV 199
Query: 785 DVYSFGVILLELISGQEAISNEKFGANCRNI-----VQWAKLHIESGDIQGIIDPSLLDE 839
D++S G++++E+I G+ NE R I + H S ++G +D L+ E
Sbjct: 200 DIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVRE 259
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 598 DATKMLEKKIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSYQGK-REFTNEVTLLSRIHHR 655
D +++E IG G VVY E +A+K + Q E EV +S+ +H
Sbjct: 1 DDYELIEV-IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHP 59
Query: 656 NLVQFLGYCQ-EEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIA---EDAAK 710
N+V++ Y G + LV ++ G+L + + IA ++ K
Sbjct: 60 NVVKY--YTSFVVGDELWLVMPYLSGGSL----LDIMKSSYPRGGLDEAIIATVLKEVLK 113
Query: 711 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR----GT 766
G+EYLH+ IHRD+K+ NILL + K++DFG+S DG + VR GT
Sbjct: 114 GLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD-RTRKVRKTFVGT 169
Query: 767 VGYLDPEYYISQQ--LTDKSDVYSFGVILLELISG 799
++ PE + Q K+D++SFG+ +EL +G
Sbjct: 170 PCWMAPE-VMEQVHGYDFKADIWSFGITAIELATG 203
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 2e-17
Identities = 60/218 (27%), Positives = 104/218 (47%), Gaps = 12/218 (5%)
Query: 592 TLSDIEDATKMLEK--KIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTL 648
T+ I D K + KIG G G V+ + G+E+A+K + K NE+ +
Sbjct: 10 TIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILV 69
Query: 649 LSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDA 708
+ + + N+V FL +V E++ G+L + + T E +I + R +
Sbjct: 70 MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCR-----EC 124
Query: 709 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 768
+ +E+LH +IHRD+KS N+LL K++DFG S S++V GT
Sbjct: 125 LQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPY 180
Query: 769 YLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 806
++ PE + K D++S G++ +E++ G+ NE
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 23/205 (11%)
Query: 606 KIGSGGFGVVYYGKLKDGKEI-AVK-VLTSNSYQGKREFT-NEVTLLSRIHHRNLVQFLG 662
+G G +GVV + K EI A+K S + ++ EV +L ++ H N+V
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 663 YCQEEGRSVLVYEFMHNGTLKEHL----YGTLTHE-QRINWIKRLEIAEDAAKGIEYLHT 717
+ +GR LV+E++ TL E L G + W + I Y H+
Sbjct: 68 AFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIW--------QLLQAIAYCHS 118
Query: 718 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYI 776
IIHRD+K NIL+ + K+ DFG ++ AS ++ V T Y PE +
Sbjct: 119 H---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPELLV 174
Query: 777 SQQLTDKS-DVYSFGVILLELISGQ 800
K DV++ G I+ EL+ G+
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 31/212 (14%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 661
L ++IGSG +G VY + + G+ +A+KV+ E+++L H N+V +
Sbjct: 7 LIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYF 66
Query: 662 GYCQEEGRSVLVYEFMHNGTLKEHLY----GTLTHEQRINWIKRLEIAEDAAKGIEYLHT 717
G + +V E+ G+L++ +Y G L+ E +I ++ R + KG+ YLH
Sbjct: 67 GSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLS-ELQIAYVCR-----ETLKGLAYLHE 119
Query: 718 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR-----GTVGYLDP 772
IHRD+K +NILL + K++DFG+S A ++I + GT ++ P
Sbjct: 120 TGK---IHRDIKGANILLTEDGDVKLADFGVS------AQLTATIAKRKSFIGTPYWMAP 170
Query: 773 EYYISQQLTD----KSDVYSFGVILLELISGQ 800
E + + K D+++ G+ +EL Q
Sbjct: 171 E-VAAVERKGGYDGKCDIWALGITAIELAELQ 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 3e-17
Identities = 64/219 (29%), Positives = 106/219 (48%), Gaps = 14/219 (6%)
Query: 592 TLSDIEDATKMLEK--KIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEVTL 648
T+ + D K + KIG G G VY + G+E+A+K + K NE+ +
Sbjct: 10 TIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILV 69
Query: 649 LSRIHHRNLVQFL-GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED 707
+ H N+V +L Y + V V E++ G+L + + T E +I + R +
Sbjct: 70 MRENKHPNIVNYLDSYLVGDELWV-VMEYLAGGSLTDVVTETCMDEGQIAAVCR-----E 123
Query: 708 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 767
+ +E+LH+ V IHRD+KS NILL K++DFG S S++V GT
Sbjct: 124 CLQALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTP 179
Query: 768 GYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 806
++ PE + K D++S G++ +E++ G+ NE
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 16/205 (7%)
Query: 605 KKIGSGGFGVV---YYGKLKDGKEIAVKVLT--SNSYQGKREFTNEVTLLSRIHHRNLVQ 659
++GSG FG V Y K K +AVK+L +N K E E ++ ++ + +V+
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 660 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 719
+G C+ E +LV E G L + L + + E+ + G++YL
Sbjct: 61 MIGICEAESW-MLVMELAELGPLNKFL----QKNKHVTEKNITELVHQVSMGMKYLEET- 114
Query: 720 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT--VGYLDPEYYIS 777
+HRDL + N+LL AK+SDFGLSK ++ + G V + PE
Sbjct: 115 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY 172
Query: 778 QQLTDKSDVYSFGVILLELIS-GQE 801
+ + KSDV+SFGV++ E S GQ+
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 72/278 (25%), Positives = 125/278 (44%), Gaps = 30/278 (10%)
Query: 602 MLEKKIGSGGFGVVYYGK-LKDGKEIAVK---VLTSNSYQGKREFTNEVTLLSRIHHRNL 657
+EKKIG G F VY L D K +A+K + + +++ E+ LL +++H N+
Sbjct: 5 QIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNV 64
Query: 658 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE----QRINWIKRLEIAEDAAKGIE 713
+++L E+ +V E G L + + + +R W +++ +E
Sbjct: 65 IKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS----AVE 120
Query: 714 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 773
++H+ ++HRD+K +N+ + K+ D GL +F + S+V GT Y+ PE
Sbjct: 121 HMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 176
Query: 774 YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 833
KSD++S G +L E+ + Q +K N ++ Q IE D
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLFSLCQ----KIEQCDY----- 225
Query: 834 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 871
P L E+ + K+ E MC+ P RP I V +
Sbjct: 226 PPLPTEHYSE---KLRELVSMCIYPDPDQRPDIGYVHQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 25/208 (12%)
Query: 605 KKIGSGGFGVVYYG-KLKDGKEIAVKVLT--SNSYQGKREFTN---EVTLLSRIHHRNLV 658
K +G G FG VY + G+E+A K + S + +E + E+ LL + H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 659 QFLGYCQEEGRSVLV--YEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEY 714
Q+ G ++ L E+M G++K+ L YG LT + +++ +G+ Y
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQI------LEGMSY 121
Query: 715 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK----FAVDGASHVSSIVRGTVGYL 770
LH+ I+HRD+K +NIL D K+ DFG SK + G S V GT ++
Sbjct: 122 LHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS--VTGTPYWM 176
Query: 771 DPEYYISQQLTDKSDVYSFGVILLELIS 798
PE + K+DV+S G ++E+++
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 25/210 (11%)
Query: 603 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSN--SYQGKREFTN---EVTLLSRIHHRN 656
L K +G G FG VY D G+E+AVK + + S + +E E+ LL + H
Sbjct: 6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHER 65
Query: 657 LVQFLGYCQEEGRSVL--VYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGI 712
+VQ+ G ++ L E M G++K+ L YG LT + +++ +G+
Sbjct: 66 IVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI------LEGV 119
Query: 713 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK----FAVDGASHVSSIVRGTVG 768
YLH+ I+HRD+K +NIL D K+ DFG SK + G S V GT
Sbjct: 120 SYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS--VTGTPY 174
Query: 769 YLDPEYYISQQLTDKSDVYSFGVILLELIS 798
++ PE + K+D++S G ++E+++
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 5e-17
Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 14/210 (6%)
Query: 595 DIEDATKMLEK--KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSR 651
D D +LE KIG G G+V + K G+++AVK++ Q + NEV ++
Sbjct: 15 DQGDPRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRD 74
Query: 652 IHHRNLVQ-FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK 710
H+N+V+ + Y E VL+ EF+ G L + + + R+N + + E +
Sbjct: 75 YQHQNVVEMYKSYLVGEELWVLM-EFLQGGALTD-----IVSQTRLNEEQIATVCESVLQ 128
Query: 711 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 770
+ YLH+ +IHRD+KS +ILL R K+SDFG S+V GT ++
Sbjct: 129 ALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWM 184
Query: 771 DPEYYISQQLTDKSDVYSFGVILLELISGQ 800
PE + D++S G++++E++ G+
Sbjct: 185 APEVISRTPYGTEVDIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 6e-17
Identities = 59/202 (29%), Positives = 106/202 (52%), Gaps = 17/202 (8%)
Query: 610 GGFGVVYYGKLKDGK-----EIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQFLGY 663
G FG ++YG L D K E+ VK + ++ + + E LL + H+N++ L
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76
Query: 664 CQEEGRSVLV-YEFMHNGTLKEHL----YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 718
C E+G V Y +M+ G LK L G + Q ++ + + +A A G+ YLH
Sbjct: 77 CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK- 135
Query: 719 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAVDGASHVSSIVRGTVGYLDPEYYI 776
+IH+D+ + N ++D+ ++ K++D LS+ F +D + R V ++ E +
Sbjct: 136 --RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR-PVKWMALESLV 192
Query: 777 SQQLTDKSDVYSFGVILLELIS 798
+++ + SDV+SFGV+L EL++
Sbjct: 193 NKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 6e-17
Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 33/208 (15%)
Query: 605 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSY--QGKREFT-NEVTLLSRIHHRNLVQF 660
K +G+G FG V + K + A+K+L+ + E NE +L I H LV
Sbjct: 7 KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNL 66
Query: 661 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GI 712
G Q++ LV E++ G L HL R E A+ +
Sbjct: 67 YGSFQDDSNLYLVMEYVPGGELFSHL----------RKSGRFP--EPVARFYAAQVVLAL 114
Query: 713 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 772
EYLH+ I++RDLK N+LLD K++DFG +K + GT YL P
Sbjct: 115 EYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC----GTPEYLAP 167
Query: 773 EYYISQQLTDKS-DVYSFGVILLELISG 799
E I + K+ D ++ G+++ E+++G
Sbjct: 168 E-IILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 8e-17
Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 22/207 (10%)
Query: 605 KKIGSGGFGVVY----YGKLKDGK--EIAVKVLTSNSYQGKRE-FTNEVTLLSRI-HHRN 656
K +G+G FG V YG K ++AVK+L ++ +RE +E+ ++S + +H N
Sbjct: 41 KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100
Query: 657 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 716
+V LG C G +++ E+ G L L E + L + AKG+ +L
Sbjct: 101 IVNLLGACTIGGPILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLA 158
Query: 717 T-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT----VGYLD 771
+ C IHRDL + N+LL K+ DFGL++ D + + +V+G V ++
Sbjct: 159 SKNC----IHRDLAARNVLLTHGKIVKICDFGLAR---DIMNDSNYVVKGNARLPVKWMA 211
Query: 772 PEYYISQQLTDKSDVYSFGVILLELIS 798
PE + T +SDV+S+G++L E+ S
Sbjct: 212 PESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 1e-16
Identities = 66/220 (30%), Positives = 107/220 (48%), Gaps = 25/220 (11%)
Query: 597 EDATKMLE--KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKR------EFTNEVTL 648
ED K+ ++IG G FG VY+ + D + V + SY GK+ + EV
Sbjct: 21 EDPEKLFTDLREIGHGSFGAVYFAR--DVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKF 78
Query: 649 LSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDA 708
L RI H N +++ G E + LV E+ G+ + L H++ + ++ I A
Sbjct: 79 LQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLE---VHKKPLQEVEIAAITHGA 134
Query: 709 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 768
+G+ YLH+ +IHRD+K+ NILL + + K++DFG + A S V GT
Sbjct: 135 LQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPY 186
Query: 769 YLDPEYYISQ---QLTDKSDVYSFGVILLELISGQEAISN 805
++ PE ++ Q K DV+S G+ +EL + + N
Sbjct: 187 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 25/210 (11%)
Query: 603 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVL--TSNSYQGKREFTN---EVTLLSRIHHRN 656
L K +G G FG VY D G+E+AVK + +S + +E E+ LL + H
Sbjct: 6 LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDR 65
Query: 657 LVQFLGYCQ--EEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGI 712
+VQ+ G + EE + + E+M G++K+ L YG LT + +++ +G+
Sbjct: 66 IVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI------LQGV 119
Query: 713 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK----FAVDGASHVSSIVRGTVG 768
YLH+ I+HRD+K +NIL D K+ DFG SK + G S V GT
Sbjct: 120 SYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS--VTGTPY 174
Query: 769 YLDPEYYISQQLTDKSDVYSFGVILLELIS 798
++ PE + K+DV+S ++E+++
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 56/199 (28%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 605 KKIGSGGFGVVYYGK-LKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 661
+KIG G +GVVY + G+ +A+K L + + E++LL ++H N+V+ L
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 65
Query: 662 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 721
E + LV+EF+H LK+ + + + IK +G+ + H+ V
Sbjct: 66 DVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIK--SYLFQLLQGLAFCHSHRV- 121
Query: 722 AIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI-SQQ 779
+HRDLK N+L++ K++DFGL++ F V ++ +V T+ Y PE + +
Sbjct: 122 --LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGCKY 177
Query: 780 LTDKSDVYSFGVILLELIS 798
+ D++S G I E+++
Sbjct: 178 YSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 10/202 (4%)
Query: 606 KIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 664
KIG G G+V +K GK +AVK + Q + NEV ++ H N+V+
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 665 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 724
+V EF+ G L + + T +E++I + K + LH +I
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHA---QGVI 138
Query: 725 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS 784
HRD+KS +ILL R K+SDFG S+V GT ++ PE +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEV 197
Query: 785 DVYSFGVILLELISGQEAISNE 806
D++S G++++E++ G+ NE
Sbjct: 198 DIWSLGIMVIEMVDGEPPYFNE 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 63/209 (30%), Positives = 101/209 (48%), Gaps = 19/209 (9%)
Query: 607 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLG 662
+G GGFG V +++ GK A K L + ++ NE +L +++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS-LA 66
Query: 663 YCQEEGRSV-LVYEFMHNGTLKEHLYGTLT---HEQRINWIKRLEIAEDAAKGIEYLHTG 718
Y E ++ LV M+ G LK H+Y E+R + A + G+E LH
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFY-----AAEITCGLEDLHR- 120
Query: 719 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 778
I++RDLK NILLD + ++SD GL+ +G + + GTVGY+ PE ++
Sbjct: 121 --ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV--GTVGYMAPEVVKNE 176
Query: 779 QLTDKSDVYSFGVILLELISGQEAISNEK 807
+ T D + G ++ E+I G+ K
Sbjct: 177 RYTFSPDWWGLGCLIYEMIEGKSPFRQRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 14/203 (6%)
Query: 606 KIGSGGFGVVYYGKLKDGK---EIAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRNLVQFL 661
++GSG FG V G K K ++A+KVL + + + R E E ++ ++ + +V+ +
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 662 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 721
G C+ E +LV E G L + L G + I +E+ + G++YL
Sbjct: 62 GVCEAEAL-MLVMEMASGGPLNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEG---K 114
Query: 722 AIIHRDLKSSNILLDKHMRAKVSDFGLSKF--AVDGASHVSSIVRGTVGYLDPEYYISQQ 779
+HRDL + N+LL AK+SDFGLSK A D S + + + PE ++
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK 174
Query: 780 LTDKSDVYSFGVILLELIS-GQE 801
+ +SDV+S+G+ + E S GQ+
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 2e-16
Identities = 57/203 (28%), Positives = 99/203 (48%), Gaps = 10/203 (4%)
Query: 605 KKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 663
+KIG G G VY + G+E+A++ + K NE+ ++ + N+V +L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 664 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 723
+V E++ G+L + + T E +I + R + + +E+LH+ +
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHSN---QV 137
Query: 724 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDK 783
IHRD+KS NILL K++DFG S S++V GT ++ PE + K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 196
Query: 784 SDVYSFGVILLELISGQEAISNE 806
D++S G++ +E+I G+ NE
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNE 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 55/205 (26%), Positives = 94/205 (45%), Gaps = 23/205 (11%)
Query: 604 EKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTN-----EVTLLSRIHHRNL 657
KK+G G + VVY + + G+ +A+K + + ++ N E+ LL + H N+
Sbjct: 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNI 64
Query: 658 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG----TLTHEQRINWIKRLEIAEDAAKGIE 713
+ L + LV+EFM T E + LT +++ +G+E
Sbjct: 65 IGLLDVFGHKSNINLVFEFME--TDLEKVIKDKSIVLTPADIKSYMLMT------LRGLE 116
Query: 714 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 773
YLH I+HRDLK +N+L+ K++DFGL++ ++ V T Y PE
Sbjct: 117 YLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPE 172
Query: 774 -YYISQQLTDKSDVYSFGVILLELI 797
+ ++ D++S G I EL+
Sbjct: 173 LLFGARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 64/225 (28%), Positives = 100/225 (44%), Gaps = 27/225 (12%)
Query: 606 KIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGK---REFTNEVTLLSRIHHRNLVQFL 661
++G GG+G V+ K KD EI A+K + + R E +L+ LV+ L
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67
Query: 662 GYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 719
Q++ L E++ G + L G L+ + R +AE ++ LH
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDH-----ARFYMAEMFE-AVDALHE-- 119
Query: 720 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 779
IHRDLK N L+D K++DFGLSK V ++ +S+V G+ Y+ PE +
Sbjct: 120 -LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV---TYANSVV-GSPDYMAPEVLRGKG 174
Query: 780 LTDKSDVYSFGVILLELISGQEAIS----NEKFGANCRNIVQWAK 820
D +S G +L E + G S NE + N+ W +
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW----ENLKYWKE 215
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 10/203 (4%)
Query: 605 KKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 663
+KIG G G VY + G+E+A+K + K NE+ ++ + N+V +L
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84
Query: 664 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 723
+V E++ G+L + + T E +I + R + + +++LH+ +
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALDFLHSN---QV 136
Query: 724 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDK 783
IHRD+KS NILL K++DFG S S++V GT ++ PE + K
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 195
Query: 784 SDVYSFGVILLELISGQEAISNE 806
D++S G++ +E++ G+ NE
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 603 LEKKIGSGGFGVVY---YGKLKDGK-EIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNL 657
L + IG G FG VY Y ++ K +AVK + + RE F E ++ + H ++
Sbjct: 10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHI 69
Query: 658 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI---AEDAAKGIEY 714
V+ +G E +V E G L+ +L + + + + + + Y
Sbjct: 70 VKLIGVI-TENPVWIVMELAPLGELRSYL------QVNKYSLDLASLILYSYQLSTALAY 122
Query: 715 LH-TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 773
L V HRD+ + N+L+ K+ DFGLS++ D + + +S + + ++ PE
Sbjct: 123 LESKRFV----HRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE 178
Query: 774 YYISQQLTDKSDVYSFGVILLELIS 798
++ T SDV+ FGV + E++
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-16
Identities = 66/209 (31%), Positives = 100/209 (47%), Gaps = 19/209 (9%)
Query: 607 IGSGGFGVVYYGKLK-DGKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLG 662
+G GGFG V +++ GK A K L +G+ NE +L +++ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVN-LA 66
Query: 663 YCQEEGRSV-LVYEFMHNGTLKEHLYGTLT---HEQRINWIKRLEIAEDAAKGIEYLHTG 718
Y E ++ LV M+ G LK H+Y E+R L A + G+E LH
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERA-----LFYAAEILCGLEDLHR- 120
Query: 719 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 778
++RDLK NILLD + ++SD GL+ +G S + GTVGY+ PE +Q
Sbjct: 121 --ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV--GTVGYMAPEVLNNQ 176
Query: 779 QLTDKSDVYSFGVILLELISGQEAISNEK 807
+ T D + G ++ E+I GQ K
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 22/213 (10%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQF 660
L + IG G +G VY + K G+ +A+K++ + E E +L + +H N+ F
Sbjct: 10 LVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATF 68
Query: 661 LG-YCQEEGRSV-----LVYEFMHNGTLKEHLYGTLTHEQRI--NWIKRLEIAEDAAKGI 712
G + ++ LV E G++ + + G +R+ WI I + +G+
Sbjct: 69 YGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY--ILRETLRGL 126
Query: 713 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 772
YLH V IHRD+K NILL K+ K+ DFG+S +D + GT ++ P
Sbjct: 127 AYLHENKV---IHRDIKGQNILLTKNAEVKLVDFGVSA-QLDSTLGRRNTFIGTPYWMAP 182
Query: 773 EYYISQQLTD-----KSDVYSFGVILLELISGQ 800
E + D +SDV+S G+ +EL G+
Sbjct: 183 EVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 3e-16
Identities = 62/224 (27%), Positives = 113/224 (50%), Gaps = 34/224 (15%)
Query: 602 MLEKKIGSGGFGVVYYG------KLKDGK--EIAVKVLTSNSYQGK-REFTNEVTLLSRI 652
+L K +G G FG V K K + ++AVK+L S++ + + +E+ ++ I
Sbjct: 21 VLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 80
Query: 653 -HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG------------TLTHEQRINWI 699
H+N++ LG C ++G ++ E+ G L+E+L T E+++++
Sbjct: 81 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140
Query: 700 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759
+ A A+G+EYL + IHRDL + N+L+ + K++DFGL++ H+
Sbjct: 141 DLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHI 193
Query: 760 SSIVRGTVG-----YLDPEYYISQQLTDKSDVYSFGVILLELIS 798
+ T G ++ PE + T +SDV+SFGV+L E+ +
Sbjct: 194 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 3e-16
Identities = 57/220 (25%), Positives = 108/220 (49%), Gaps = 28/220 (12%)
Query: 603 LEKKIGSGGFGVVYYG--------KLKDGKEIAVKVLTSNSYQGK-REFTNEVTLLSRI- 652
L K +G G FG V K K+ +AVK+L ++ + + +E+ ++ I
Sbjct: 19 LGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 78
Query: 653 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG------------TLTHEQRINWIK 700
H+N++ LG C ++G ++ E+ G L+E+L ++++ +
Sbjct: 79 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138
Query: 701 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 760
+ A+G+EYL + IHRDL + N+L+ ++ K++DFGL++ V+ +
Sbjct: 139 LVSCTYQVARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLAR-DVNNIDYYK 194
Query: 761 SIVRG--TVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 798
G V ++ PE + T +SDV+SFGV++ E+ +
Sbjct: 195 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 4e-16
Identities = 58/225 (25%), Positives = 103/225 (45%), Gaps = 40/225 (17%)
Query: 603 LEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSYQGK-REFTNEVTLLSRI-HH 654
L K +G G FG V + +AVK+L ++ + + +E+ ++ I H
Sbjct: 16 LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 75
Query: 655 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIKRL 702
+N++ LG C +EG +V E+ +G L++ L E+ + +
Sbjct: 76 KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV 135
Query: 703 EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS---------KFAV 753
A A+G+E+L + IHRDL + N+L+ + K++DFGL+ +
Sbjct: 136 SFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTT 192
Query: 754 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 798
+G R V ++ PE + T +SDV+SFGV+L E+ +
Sbjct: 193 NG--------RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 5e-16
Identities = 66/201 (32%), Positives = 94/201 (46%), Gaps = 15/201 (7%)
Query: 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNLVQ 659
K IG G FG V K K DGK AVKVL + K+E LL + H LV
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 660 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 719
Q + V ++++ G L HL E+ + A + A + YLH+
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHL----QRERSFPEPRARFYAAEIASALGYLHS-- 114
Query: 720 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 779
II+RDLK NILLD ++DFGL K ++ + S+ GT YL PE + +Q
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC-GTPEYLAPE-VLRKQ 171
Query: 780 LTDKS-DVYSFGVILLELISG 799
D++ D + G +L E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 6e-16
Identities = 54/207 (26%), Positives = 105/207 (50%), Gaps = 17/207 (8%)
Query: 607 IGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGK-REFTNEVTLLSRIHH---RNLVQFL 661
IG G +G VY GK + G+ +A+K++ ++ + EV LLS++ N+ ++
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 662 GYCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 720
G +G + ++ E+ G+++ + E+ I+ I R + ++Y+H
Sbjct: 69 G-SYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIR-----EVLVALKYIHKV-- 120
Query: 721 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 780
+IHRD+K++NIL+ K+ DFG++ +S S+ V GT ++ PE +
Sbjct: 121 -GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKY 178
Query: 781 TD-KSDVYSFGVILLELISGQEAISNE 806
D K+D++S G+ + E+ +G S+
Sbjct: 179 YDTKADIWSLGITIYEMATGNPPYSDV 205
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 7e-16
Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 603 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTN-EVTLLSRIHHRNLVQF 660
L + IG G FG VY K + +A+KV+ + + E E+ LS+ + ++
Sbjct: 5 LLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKY 64
Query: 661 LGYCQEEGRSVLVYEFMHNGTLKEHL-YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 719
G + + ++ E+ G+ + L G L E I +I R + G+EYLH
Sbjct: 65 YGSFLKGSKLWIIMEYCGGGSCLDLLKPGKL-DETYIAFILR-----EVLLGLEYLHEEG 118
Query: 720 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 779
IHRD+K++NILL + K++DFG+S S ++ V GT ++ PE I Q
Sbjct: 119 K---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPE-VIKQS 173
Query: 780 LTD-KSDVYSFGVILLELISG 799
D K+D++S G+ +EL G
Sbjct: 174 GYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 9e-16
Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 25/210 (11%)
Query: 606 KIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKR------EFTNEVTLLSRIHHRNLV 658
+IG G FG VY+ E+ AVK + SY GK+ + EV L ++ H N +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKM---SYSGKQTNEKWQDIIKEVKFLQQLKHPNTI 84
Query: 659 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 718
++ G +E + LV E+ G+ + L H++ + ++ I A +G+ YLH+
Sbjct: 85 EYKGCYLKEHTAWLVMEYCL-GSASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSH 140
Query: 719 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 778
+IHRD+K+ NILL + + K++DFG + + S V GT ++ PE ++
Sbjct: 141 N---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAM 192
Query: 779 ---QLTDKSDVYSFGVILLELISGQEAISN 805
Q K DV+S G+ +EL + + N
Sbjct: 193 DEGQYDGKVDVWSLGITCIELAERKPPLFN 222
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 9e-16
Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 19/214 (8%)
Query: 603 LEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTS--NSYQGKREFTNEVTLLSRIHHRN 656
L + +G G FG V +LK +++AVK+L + S EF E + H N
Sbjct: 3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPN 62
Query: 657 LVQFLG---YCQEEGR---SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR--LEIAEDA 708
+++ +G + +GR +++ FM +G L L + E+ + + D
Sbjct: 63 VIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDI 122
Query: 709 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTV 767
A G+EYL + IHRDL + N +L+++M V+DFGLSK G + + V
Sbjct: 123 ASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPV 179
Query: 768 GYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQ 800
+L E T SDV++FGV + E+++ GQ
Sbjct: 180 KWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 53/201 (26%), Positives = 96/201 (47%), Gaps = 16/201 (7%)
Query: 602 MLEKKIGSGGFG--VVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQ 659
+ + +G G FG ++ D K ++ S + E LL+++ H N+V
Sbjct: 3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVA 62
Query: 660 FLGYCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRI-NWIKRLEIAEDAAKGIEYL 715
F + +G +V E+ G L + + G L E I W ++ + G++++
Sbjct: 63 FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHI 116
Query: 716 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY 775
H ++HRD+KS NI L ++ + K+ DFG ++ ++ + V GT Y+ PE +
Sbjct: 117 HE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIW 172
Query: 776 ISQQLTDKSDVYSFGVILLEL 796
+ +KSD++S G IL EL
Sbjct: 173 ENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 68/275 (24%), Positives = 127/275 (46%), Gaps = 35/275 (12%)
Query: 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLT--SNSYQGKREFTNEVTLLSRIHHRNLVQFL 661
+ +G G +G V + + DGK+ +K L + S + ++ E LLS++ H N+V +
Sbjct: 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65
Query: 662 GYCQ-EEGRSVLVYEFMHNG----TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 716
+ E+G +V F G LKE L Q + W ++ +A ++YLH
Sbjct: 66 ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMA------LQYLH 119
Query: 717 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 776
I+HRDLK+ N+ L + KV D G+++ ++ ++S + GT Y+ PE +
Sbjct: 120 E---KHILHRDLKTQNVFLTRTNIIKVGDLGIAR-VLENQCDMASTLIGTPYYMSPELFS 175
Query: 777 SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836
++ KSDV++ G + E+ + + A + + + I++ KL P +
Sbjct: 176 NKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE-GKL------------PPM 222
Query: 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 871
+Y + I ++ P RPS+ +L+
Sbjct: 223 PKDYSPELGELI--ATMLSKRP--EKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-15
Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKEI---AVKVLTSN--SYQGKREFTNEVTLLSRIHHRNL 657
L K +G G FG V G+L I AVK + + +F +E + H N+
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNV 62
Query: 658 VQFLGYC----QEEG--RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL--EIAEDAA 709
++ +G C + EG V++ FM +G L L + + ++ + D A
Sbjct: 63 MRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122
Query: 710 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS-IVRGTVG 768
G+EYL + + IHRDL + N +L+++M V+DFGLSK +G + I + V
Sbjct: 123 SGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179
Query: 769 YLDPEYYISQQLTDKSDVYSFGVILLELIS-GQ 800
++ E + T KSDV+SFGV + E+ + GQ
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQ 212
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 17/202 (8%)
Query: 606 KIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQFLG 662
+IG G G+V+ K + G+ +A+K + +G + E+ L H +V+ L
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 663 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR---INWIKRLEIAEDAAKGIEYLHTGC 719
VLV E+M + L L E+R +K KG+ Y+H
Sbjct: 67 VFPHGSGFVLVMEYMPSD-----LSEVLRDEERPLPEAQVKSY--MRMLLKGVAYMHAN- 118
Query: 720 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE-YYISQ 778
I+HRDLK +N+L+ K++DFGL++ + + S T Y PE Y ++
Sbjct: 119 --GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR 176
Query: 779 QLTDKSDVYSFGVILLELISGQ 800
+ D+++ G I EL++G
Sbjct: 177 KYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 23/203 (11%)
Query: 607 IGSGGFGVVYYGK-LKDGKEIAVK-VLTSNSYQGKREFT-NEVTLLSRI---HHRNLVQF 660
IG G +G VY + L G+ +A+K V S +G T E+ LL ++ H N+V+
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 661 LGYCQ----EEGRSV-LVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 713
L C + + LV+E + T + I + R ++ +G++
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMR-QLL----RGVD 121
Query: 714 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 773
+LH+ I+HRDLK NIL+ + K++DFGL++ + S +V T+ Y PE
Sbjct: 122 FLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV--TLWYRAPE 176
Query: 774 YYISQQLTDKSDVYSFGVILLEL 796
+ D++S G I EL
Sbjct: 177 VLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 15/200 (7%)
Query: 605 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLG 662
+G+G G V K + G +A KV+ + +++ E+ ++ +V F G
Sbjct: 11 SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYG 70
Query: 663 YCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 720
E + EFM G+L G + E +IA +G+ YL+ V
Sbjct: 71 AFLNENNICMCMEFMDCGSLDRIYKKGGPIPVE------ILGKIAVAVVEGLTYLYN--V 122
Query: 721 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 780
I+HRD+K SNIL++ + K+ DFG+S ++ ++ GT Y+ PE +
Sbjct: 123 HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---IADTFVGTSTYMSPERIQGGKY 179
Query: 781 TDKSDVYSFGVILLELISGQ 800
T KSDV+S G+ ++EL G+
Sbjct: 180 TVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 63/214 (29%), Positives = 96/214 (44%), Gaps = 27/214 (12%)
Query: 605 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT-----NEVTLLSR------I 652
K +G G FG V +LK E A+K L K++ E T++ R
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKAL-------KKDVVLEDDDVECTMVERRVLALAW 53
Query: 653 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 712
H L Q + V E+++ G L H+ + ++ EI G+
Sbjct: 54 EHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEII----CGL 109
Query: 713 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 772
++LH II+RDLK N+LLDK K++DFG+ K ++G S+ GT Y+ P
Sbjct: 110 QFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAP 165
Query: 773 EYYISQQLTDKSDVYSFGVILLELISGQEAISNE 806
E Q+ + D +SFGV+L E++ GQ E
Sbjct: 166 EILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 604 EK--KIGSGGFGVVYYGKLKDGKEIAV--KVLTSNSYQG-KREFTNEVTLLSRIHHRNLV 658
EK +IG G +G+VY + EI KV N G E+TLL + H N+V
Sbjct: 10 EKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIV 69
Query: 659 QFLGYCQEEGRSV----LVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 712
+ G+ + LV E+ +L +++ + Q +K L + +G+
Sbjct: 70 ELKEVVV--GKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQ----VKCLML--QLLRGL 121
Query: 713 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 772
+YLH IIHRDLK SN+LL K++DFGL++ A ++ V T+ Y P
Sbjct: 122 QYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAP 177
Query: 773 EYYI-SQQLTDKSDVYSFGVILLELISGQ 800
E + T D+++ G IL EL++ +
Sbjct: 178 ELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 3e-15
Identities = 62/206 (30%), Positives = 107/206 (51%), Gaps = 14/206 (6%)
Query: 598 DATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHH 654
D TK+ +KIG G +GVVY G+ K G+ +A+K + S + T E++LL + H
Sbjct: 1 DYTKI--EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQH 58
Query: 655 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 714
N+V +E R L++EF+ + LK++L +L Q ++ +GI +
Sbjct: 59 PNIVCLQDVLMQESRLYLIFEFL-SMDLKKYL-DSLPKGQYMDAELVKSYLYQILQGILF 116
Query: 715 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPE 773
H+ ++HRDLK N+L+D K++DFGL++ F + + +V T+ Y PE
Sbjct: 117 CHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV--TLWYRAPE 171
Query: 774 YYI-SQQLTDKSDVYSFGVILLELIS 798
+ S + + D++S G I E+ +
Sbjct: 172 VLLGSPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 3e-15
Identities = 59/208 (28%), Positives = 107/208 (51%), Gaps = 12/208 (5%)
Query: 595 DIEDATKMLEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRI 652
D E+ LEK IG G FG V+ G + K +A+K++ + + E E+T+LS+
Sbjct: 1 DPEELFTKLEK-IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59
Query: 653 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 712
+ ++ G ++ + ++ E++ G+ + L E +I I R + KG+
Sbjct: 60 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-----EILKGL 114
Query: 713 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 772
+YLH+ IHRD+K++N+LL +H K++DFG++ D ++ V GT ++ P
Sbjct: 115 DYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAP 170
Query: 773 EYYISQQLTDKSDVYSFGVILLELISGQ 800
E K+D++S G+ +EL G+
Sbjct: 171 EVIKQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-15
Identities = 60/237 (25%), Positives = 99/237 (41%), Gaps = 30/237 (12%)
Query: 607 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQFLG 662
+G GGFG V +++ GK A K L + ++ + E +L+++H R +V
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 663 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 722
Q + LV M+ G L+ H+Y + G+E+LH
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---R 117
Query: 723 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 782
II+RDLK N+LLD ++SD GL+ DG S GT G++ PE ++
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-GTPGFMAPELLQGEEYDF 176
Query: 783 KSDVYSFGVILLELISGQ-------EAISN---------------EKFGANCRNIVQ 817
D ++ GV L E+I+ + E + N +KF ++ +
Sbjct: 177 SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCE 233
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 63/221 (28%), Positives = 107/221 (48%), Gaps = 26/221 (11%)
Query: 586 EAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKR---- 640
+ A F D E L ++IG G FG VY+ + +++ + +A+K + SY GK+
Sbjct: 3 DVAELFFKDDPEKLFSDL-REIGHGSFGAVYFARDVRNSEVVAIKKM---SYSGKQSNEK 58
Query: 641 --EFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINW 698
+ EV L ++ H N +Q+ G E + LV E+ G+ + L H++ +
Sbjct: 59 WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLE---VHKKPLQE 114
Query: 699 IKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758
++ + A +G+ YLH+ +IHRD+K+ NILL + K+ DFG +
Sbjct: 115 VEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF 171
Query: 759 VSSIVRGTVGYLDPEYYISQ---QLTDKSDVYSFGVILLEL 796
V GT ++ PE ++ Q K DV+S G+ +EL
Sbjct: 172 V-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 67/216 (31%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 595 DIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVL--TSNSYQGKREFTN-EVTLLS 650
D+ D + E IGSG G VY + K G +AVK + T N + KR + +V L S
Sbjct: 13 DLNDLENLGE--IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKS 70
Query: 651 RIHHR--NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDA 708
H +V+ GY + + E M T + L + + + ++ +A
Sbjct: 71 ---HDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVA--I 123
Query: 709 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 768
K + YL +IHRD+K SNILLD K+ DFG+S VD + S G
Sbjct: 124 VKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS--AGCAA 179
Query: 769 YLDPEYYISQQLTDK----SDVYSFGVILLELISGQ 800
Y+ PE K +DV+S G+ L+EL +GQ
Sbjct: 180 YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 4e-15
Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 22/205 (10%)
Query: 605 KKIGSGGFGVVYYGK-LKDGKEI----AVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLV 658
K +GSG FG V+ G + +G I A+K + S Q +E T+ + + + H +V
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 659 QFLGYCQEEGRSV-LVYEFMHNGTLKEHLY---GTLTHEQRINWIKRLEIAEDAAKGIEY 714
+ LG C G S+ LV + G+L +H+ +L ++ +NW ++ AKG+ Y
Sbjct: 73 RLLGIC--PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKGMYY 124
Query: 715 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASHVSSIVRGTVGYLDPE 773
L ++HR+L + NILL +++DFG++ D + S + + ++ E
Sbjct: 125 LEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181
Query: 774 YYISQQLTDKSDVYSFGVILLELIS 798
+ + T +SDV+S+GV + E++S
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 5e-15
Identities = 69/234 (29%), Positives = 99/234 (42%), Gaps = 33/234 (14%)
Query: 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR-----NLV 658
K I G FG VY K + G A+KVL + K + TN V I +
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTN-VKAERAIMMIQGESPYVA 60
Query: 659 QFLGYCQEEGRSVLVYEFMHNG---TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 715
+ Q + LV E+++ G +L + L G L + W K+ IAE G+E L
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTL-GGLPED----WAKQY-IAE-VVLGVEDL 113
Query: 716 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY 775
H IIHRD+K N+L+D+ K++DFGLS+ + GT YL PE
Sbjct: 114 HQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSR-----NGLENKKFVGTPDYLAPETI 165
Query: 776 ISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 829
+ SD +S G ++ E + G F A + V + I S I
Sbjct: 166 LGVGDDKMSDWWSLGCVIFEFLFGYPP-----FHAETPDAV-FDN--ILSRRIN 211
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 7e-15
Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 17/203 (8%)
Query: 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSR------IHHRNL 657
K +G G FG V+ +LK + A+K L + + E T++ + H L
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDV--ECTMVEKRVLSLAWEHPFL 58
Query: 658 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 717
Q + V E+++ G L H+ + + + A + G+++LH+
Sbjct: 59 THLYCTFQTKENLFFVMEYLNGGDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLHS 114
Query: 718 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 777
I++RDLK NILLD K++DFG+ K + G + + GT Y+ PE +
Sbjct: 115 ---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEILLG 170
Query: 778 QQLTDKSDVYSFGVILLELISGQ 800
Q+ D +SFGV+L E++ GQ
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 9e-15
Identities = 65/209 (31%), Positives = 99/209 (47%), Gaps = 19/209 (9%)
Query: 607 IGSGGFGVVYYGKLK-DGKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLG 662
+G GGFG V +++ GK A K L +G+ NE +L +++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVS-LA 66
Query: 663 YCQEEGRSV-LVYEFMHNGTLKEHLYGTLT---HEQRINWIKRLEIAEDAAKGIEYLHTG 718
Y E ++ LV M+ G LK H+Y EQR + A + G+E L
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRA-----IFYAAELCCGLEDLQR- 120
Query: 719 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 778
I++RDLK NILLD ++SD GL+ +G + + GTVGY+ PE ++
Sbjct: 121 --ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV--GTVGYMAPEVINNE 176
Query: 779 QLTDKSDVYSFGVILLELISGQEAISNEK 807
+ T D + G ++ E+I GQ K
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 1e-14
Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 14/201 (6%)
Query: 605 KKIGSGGFGVVYYGK-LKDGKEI----AVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLV 658
K +GSG FG VY G + +G+ + A+K+L + + EF +E +++ + H +LV
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 659 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 718
+ LG C LV + M +G L ++++ H+ I L AKG+ YL
Sbjct: 73 RLLGVCLSPTIQ-LVTQLMPHGCLLDYVH---EHKDNIGSQLLLNWCVQIAKGMMYLEE- 127
Query: 719 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASHVSSIVRGTVGYLDPEYYIS 777
++HRDL + N+L+ K++DFGL++ D + + + + ++ E
Sbjct: 128 --RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 185
Query: 778 QQLTDKSDVYSFGVILLELIS 798
++ T +SDV+S+GV + EL++
Sbjct: 186 RKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-14
Identities = 65/206 (31%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV----- 658
K +G G FG V +LK G+ AVK L + + E T++ + R L
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDV--ECTMVEK---RVLALAWEN 55
Query: 659 QFLG--YC--QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 714
FL YC Q + V EF++ G L H+ + R + + A + G+++
Sbjct: 56 PFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHI----QDKGRFDLYRATFYAAEIVCGLQF 111
Query: 715 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 774
LH+ II+RDLK N++LD+ K++DFG+ K V G + S+ GT Y+ PE
Sbjct: 112 LHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEI 167
Query: 775 YISQQLTDKSDVYSFGVILLELISGQ 800
+ T D +SFGV+L E++ GQ
Sbjct: 168 LQGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 67/271 (24%), Positives = 118/271 (43%), Gaps = 22/271 (8%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVK---VLTSNSYQGKREFTNEVTLLSRIHHRNLV 658
+EKKIG G F VY L DG +A+K + + + + E+ LL +++H N++
Sbjct: 6 IEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVI 65
Query: 659 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 718
++ E+ +V E G L + ++ I + +E++H+
Sbjct: 66 KYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS- 124
Query: 719 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 778
++HRD+K +N+ + K+ D GL +F + S+V GT Y+ PE
Sbjct: 125 --RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHEN 181
Query: 779 QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 838
KSD++S G +L E+ + Q +K N+ K IE D P L
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCK-KIEQCDY-----PPLPS 230
Query: 839 EYDIQSMWKIEEKALMCVLPHGHMRPSISEV 869
++ + + ++ MC+ P RP I+ V
Sbjct: 231 DHYSEELRQLVN---MCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 56/204 (27%), Positives = 105/204 (51%), Gaps = 20/204 (9%)
Query: 605 KKIGSGGFGVVYYGK-LKDGKEI----AVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLV 658
K +GSG FG VY G + DG+ + A+KVL N S + +E +E +++ + +
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 659 QFLGYCQEEGRSVLVYEFMHNGTLKEHLY---GTLTHEQRINWIKRLEIAEDAAKGIEYL 715
+ LG C LV + M G L +++ + + +NW ++ AKG+ YL
Sbjct: 73 RLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYL 125
Query: 716 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA-VDGASHVSSIVRGTVGYLDPEY 774
++HRDL + N+L+ K++DFGL++ +D + + + + ++ E
Sbjct: 126 EE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 182
Query: 775 YISQQLTDKSDVYSFGVILLELIS 798
+ ++ T +SDV+S+GV + EL++
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 57/199 (28%), Positives = 92/199 (46%), Gaps = 19/199 (9%)
Query: 607 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ 665
+G G FG VY + K+ A K++ S + +F E+ +LS H N+V
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 666 EEGRSVLVYEFMHNGTLK---EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 722
E + ++ EF G L L LT E +I ++ R + + +LH+
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLT-EPQIRYVCR-----QMLEALNFLHSH---K 123
Query: 723 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 782
+IHRDLK+ NILL K++DFG+S + + GT ++ PE + D
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKD 182
Query: 783 -----KSDVYSFGVILLEL 796
K+D++S G+ L+EL
Sbjct: 183 NPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 59/208 (28%), Positives = 109/208 (52%), Gaps = 22/208 (10%)
Query: 601 KMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT-NEVTLLSRIHHRNLV 658
K LEK +G G + VY G+ + EI A+K + ++ +G E++L+ + H N+V
Sbjct: 3 KQLEK-LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 659 QFLGYCQEEGRSVLVYEFMHNGTLKEHL-----YGTLTHEQRINWIKRLEIAEDAAKGIE 713
+ E + +LV+E+M + LK+++ G L ++ +L KGI
Sbjct: 62 RLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQL------LKGIA 114
Query: 714 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDP 772
+ H ++HRDLK N+L++K K++DFGL++ F + + + +V T+ Y P
Sbjct: 115 FCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAP 169
Query: 773 EYYI-SQQLTDKSDVYSFGVILLELISG 799
+ + S+ + D++S G I+ E+I+G
Sbjct: 170 DVLLGSRTYSTSIDIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 74/225 (32%), Positives = 109/225 (48%), Gaps = 28/225 (12%)
Query: 592 TLSDIEDATKMLEKKIGSGGFGVVY-YGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLS 650
+L D D +++E IG G +G VY KDG AVK+L S E E +L
Sbjct: 16 SLGDPTDTWEIIET-IGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQ 73
Query: 651 RI-HHRNLVQFLG--YCQEE---GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI 704
+ +H N+V+F G Y ++ G+ LV E + G++ E + G L QR++ I
Sbjct: 74 SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYI 133
Query: 705 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 764
A G+++LH IIHRD+K +NILL K+ DFG+S A S+ +R
Sbjct: 134 LYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVS------AQLTSTRLR 184
Query: 765 -----GTVGYLDPEYYISQQLTDKS-----DVYSFGVILLELISG 799
GT ++ PE +Q D S DV+S G+ +EL G
Sbjct: 185 RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 56/197 (28%), Positives = 101/197 (51%), Gaps = 13/197 (6%)
Query: 606 KIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 664
++G G FG VY K K+ G A KV+ + S + ++ E+ +L+ +H +V+ LG
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 665 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 724
+G+ ++ EF G + + L ++ + + I + ++YLH+ II
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIM---LELDRGLTEPQIQVICRQMLEALQYLHS---MKII 132
Query: 725 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD-- 782
HRDLK+ N+LL K++DFG+S V S + GT ++ PE + + + D
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-GTPYWMAPEVVMCETMKDTP 191
Query: 783 ---KSDVYSFGVILLEL 796
K+D++S G+ L+E+
Sbjct: 192 YDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 28/202 (13%)
Query: 607 IGSGGFGVVYYG-KLKDGKEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYC 664
+G G G VY L + +AVKV+ + + + +++ +E+ +L + ++ F G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 665 QEEGRSVLVYEFMHNGTLK------EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 718
E R + EFM G+L EH+ G IA KG+ YL +
Sbjct: 69 FVENRISICTEFMDGGSLDVYRKIPEHVLG--------------RIAVAVVKGLTYLWS- 113
Query: 719 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 778
I+HRD+K SN+L++ + K+ DFG+S V+ ++ GT Y+ PE +
Sbjct: 114 --LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYVGTNAYMAPERISGE 168
Query: 779 QLTDKSDVYSFGVILLELISGQ 800
Q SDV+S G+ +EL G+
Sbjct: 169 QYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 57/231 (24%), Positives = 112/231 (48%), Gaps = 37/231 (16%)
Query: 602 MLEKKIGSGGFGVVYYGKLKDGKE-----------------IAVKVLTSNSYQGKR-EFT 643
+ ++K+G G FG V+ ++ + ++ +AVK+L ++ + R +F
Sbjct: 8 LFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFL 67
Query: 644 NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR-------- 695
EV +LSR+ N+++ LG C +E ++ E+M NG L + L ++
Sbjct: 68 KEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVP 127
Query: 696 -------INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 748
I++ L +A A G++YL + +HRDL + N L+ +++ K++DFG+
Sbjct: 128 PAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIADFGM 184
Query: 749 SKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 798
S+ G + + + ++ E + + T SDV++FGV L E++
Sbjct: 185 SRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 3e-14
Identities = 57/206 (27%), Positives = 102/206 (49%), Gaps = 20/206 (9%)
Query: 607 IGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYC 664
+G+G +G VY G+ +K G+ A+KV+ + + E E+ +L + HHRN+ + G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 665 QEEG------RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 718
++ + LV EF G++ + + T + + WI I + +G+ +LH
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQH 130
Query: 719 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 778
+IHRD+K N+LL ++ K+ DFG+S +D + GT ++ PE
Sbjct: 131 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSA-QLDRTVGRRNTFIGTPYWMAPEVIACD 186
Query: 779 QLTD-----KSDVYSFGVILLELISG 799
+ D KSD++S G+ +E+ G
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 3e-14
Identities = 65/200 (32%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVT----LLSRIHHRNLVQ 659
K IG G FG V K K DG AVKVL + K+E + + LL + H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 660 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 719
Q + V ++++ G L HL E+ + A + A I YLH+
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHL----QRERCFLEPRARFYAAEVASAIGYLHS-- 114
Query: 720 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 779
II+RDLK NILLD ++DFGL K V+ S+ GT YL PE +
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC-GTPEYLAPEVLRKEP 172
Query: 780 LTDKSDVYSFGVILLELISG 799
D + G +L E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 3e-14
Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 26/200 (13%)
Query: 623 GKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQFL--GYCQEEGRSVLVYEFM 677
G E+A+K+L +++ + + + F E L +R++H N+V L G G V+E++
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 678 HNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL 735
TL+E L G L + + ++ A A H I+HRDLK NI++
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLDALACA------HNQ---GIVHRDLKPQNIMV 112
Query: 736 ---DKHMRAKVSDFGLSKFAVD-GASHVSSIVR-----GTVGYLDPEYYISQQLTDKSDV 786
AKV DFG+ + V+++ R GT Y PE + +T SD+
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDL 172
Query: 787 YSFGVILLELISGQEAISNE 806
Y++G+I LE ++GQ +
Sbjct: 173 YAWGLIFLECLTGQRVVQGA 192
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 65/224 (29%), Positives = 96/224 (42%), Gaps = 33/224 (14%)
Query: 591 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTN----- 644
FT D++D +IG G FG V K G +AVK + S ++E
Sbjct: 1 FTAEDLKD-----LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTV--DEKEQKRLLMDL 53
Query: 645 EVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL-- 702
+V + S +V+F G EG + E M + Y + + + +
Sbjct: 54 DVVMRSS-DCPYIVKFYGALFREGDCWICMELMD--ISLDKFYKYVYEVLKSVIPEEILG 110
Query: 703 EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 762
+IA K + YL IIHRD+K SNILLD++ K+ DFG+S VD SI
Sbjct: 111 KIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD------SI 162
Query: 763 VR----GTVGYLDPEYYISQQLTD---KSDVYSFGVILLELISG 799
+ G Y+ PE +SDV+S G+ L E+ +G
Sbjct: 163 AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 63/236 (26%), Positives = 104/236 (44%), Gaps = 61/236 (25%)
Query: 605 KKIGSGGFGVVYYGK--------LKDGKE---------IAVKVLTSN-SYQGKREFTNEV 646
+K+G G FG V+ + K E +AVKVL + S + +F EV
Sbjct: 11 EKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEV 70
Query: 647 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR----- 701
+LSR+ N+ + LG C + ++ E+M NG L + L H + +
Sbjct: 71 KILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQ---KHVAETSGLACNSKSL 127
Query: 702 -----LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK------ 750
L +A A G+ YL + +HRDL + N L+ K+ K++DFG+S+
Sbjct: 128 SFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD 184
Query: 751 -FAVDGASHV-------SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 798
+ V G + + S++ G + T KSDV++FGV L E+++
Sbjct: 185 YYRVQGRAPLPIRWMAWESVLLG-------------KFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 59/204 (28%), Positives = 105/204 (51%), Gaps = 13/204 (6%)
Query: 605 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQFLG 662
++IG G FG VY G KE+ A+K++ + + E E+T+LS+ + ++ G
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 663 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 722
+ + ++ E++ G+ + L E I I R + KG++YLH+
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR-----EILKGLDYLHS---ER 121
Query: 723 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 782
IHRD+K++N+LL + K++DFG++ D ++ V GT ++ PE I Q D
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPE-VIKQSAYD 179
Query: 783 -KSDVYSFGVILLELISGQEAISN 805
K+D++S G+ +EL G+ S+
Sbjct: 180 FKADIWSLGITAIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 4e-14
Identities = 66/201 (32%), Positives = 89/201 (44%), Gaps = 15/201 (7%)
Query: 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNLVQ 659
K IG G FG V K K DGK AVKVL ++E LL + H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 660 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH-EQRINWIKRLEIAEDAAKGIEYLHTG 718
Q + V +F++ G L HL + E R R AE A + YLH+
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPR----ARFYAAE-IASALGYLHS- 114
Query: 719 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 778
I++RDLK NILLD ++DFGL K + + ++ GT YL PE Q
Sbjct: 115 --INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC-GTPEYLAPEVIRKQ 171
Query: 779 QLTDKSDVYSFGVILLELISG 799
+ D + G +L E++ G
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-14
Identities = 74/293 (25%), Positives = 136/293 (46%), Gaps = 45/293 (15%)
Query: 603 LEKKIGSGGFGVVYYGKLKD------GKEIAVKVLT-SNSYQGKREFTNEVTLLSRIHHR 655
L +++G G FG+VY G +D +AVK + S S + + EF NE +++
Sbjct: 10 LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 69
Query: 656 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRIN-------WIKRLEIAEDA 708
++V+ LG + +++V E M +G LK +L +L E N + +++A +
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLR-SLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 709 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG--T 766
A G+ YL+ +HRDL + N ++ K+ DFG+++ + + +G
Sbjct: 129 ADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR-DIYETDYYRKGGKGLLP 184
Query: 767 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE----AISNEKFGANCRNIVQWAKLH 822
V ++ PE T SD++SFGV+L E+ S E +SNE+
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV-------------- 230
Query: 823 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 875
++ ++D LD+ D ++ + MC + MRP+ E++ ++D
Sbjct: 231 -----LKFVMDGGYLDQPD-NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 7e-14
Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 28/220 (12%)
Query: 603 LEKKIGSGGFGVVYYG------KLKDGK--EIAVKVLTSNSY-QGKREFTNEVTLLSRI- 652
L K +G G FG V K K K +AVK+L ++ + + +E+ ++ I
Sbjct: 16 LGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIG 75
Query: 653 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL---------YGTLT---HEQRINWIK 700
H+N++ LG C ++G ++ E+ G L+E+L Y T E+++ +
Sbjct: 76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 701 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 760
+ A A+G+EYL + IHRDL + N+L+ + K++DFGL++ V +
Sbjct: 136 LVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVTEDNVMKIADFGLAR-DVHNIDYYK 191
Query: 761 SIVRG--TVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 798
G V ++ PE + T +SDV+SFGV+L E+ +
Sbjct: 192 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-14
Identities = 60/222 (27%), Positives = 109/222 (49%), Gaps = 22/222 (9%)
Query: 593 LSDIEDATKMLE--KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLL 649
LS + D + E + +G+G +G VY G+ +K G+ A+KV+ + + E E+ +L
Sbjct: 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINML 66
Query: 650 SRI-HHRNLVQFLGY------CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL 702
+ HHRN+ + G + + LV EF G++ + + T + + +WI
Sbjct: 67 KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY- 125
Query: 703 EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 762
I + +G+ +LH +IHRD+K N+LL ++ K+ DFG+S +D +
Sbjct: 126 -ICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSA-QLDRTVGRRNT 180
Query: 763 VRGTVGYLDPEYYISQQLTD-----KSDVYSFGVILLELISG 799
GT ++ PE + D +SD++S G+ +E+ G
Sbjct: 181 FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 7e-14
Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 12/206 (5%)
Query: 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVT---LLSRIHHRNLVQF 660
K +G G FG V + K GK A+K+L K E + +T +L H L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 661 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 720
Q + R V E+++ G L HL + E+ + + + ++YLH+G
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHL----SRERVFSEDRTRFYGAEIVSALDYLHSG-- 114
Query: 721 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 780
I++RDLK N++LDK K++DFGL K + A+ + + GT YL PE
Sbjct: 115 -KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC-GTPEYLAPEVLEDNDY 172
Query: 781 TDKSDVYSFGVILLELISGQEAISNE 806
D + GV++ E++ G+ N+
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQ 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 7e-14
Identities = 70/225 (31%), Positives = 95/225 (42%), Gaps = 48/225 (21%)
Query: 593 LSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREF--------- 642
LSD E + + +G+G FG V K K G+ A+K L KRE
Sbjct: 17 LSDFE-----MGETLGTGSFGRVRIAKHKGTGEYYAIKCLK------KREILKMKQVQHV 65
Query: 643 TNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL 702
E ++L + H +V + Q+E R + EF+ G L HL K
Sbjct: 66 AQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLR------------KAG 113
Query: 703 EIAEDAAK--------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 754
D AK EYLH+ II+RDLK N+LLD KV+DFG +K D
Sbjct: 114 RFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170
Query: 755 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 799
+ GT YL PE S+ D ++ GV+L E I+G
Sbjct: 171 RTFTLC----GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 7e-14
Identities = 61/218 (27%), Positives = 108/218 (49%), Gaps = 38/218 (17%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKEI-AVKVLT---SNSYQGKREFTNEVTLLSRI-HHRNL 657
+ +K+G G +G+V+ + KE+ A+K + N+ +R F E+ L + H N+
Sbjct: 11 ILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF-REIMFLQELGDHPNI 69
Query: 658 VQFLG-YCQEEGRSV-LVYEFM----HN----GTLKEHLYGTLTHEQRINWIKRLEIAED 707
V+ L E + + LV+E+M H L++ H++ I +
Sbjct: 70 VKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILED------VHKRYIMY--------Q 115
Query: 708 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGT 766
K ++Y+H+G +IHRDLK SNILL+ R K++DFGL++ + + + ++
Sbjct: 116 LLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDY 172
Query: 767 VG---YLDPEYYI-SQQLTDKSDVYSFGVILLELISGQ 800
V Y PE + S + T D++S G IL E++ G+
Sbjct: 173 VATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 7e-14
Identities = 54/201 (26%), Positives = 102/201 (50%), Gaps = 14/201 (6%)
Query: 605 KKIGSGGFGVVYYGK-LKDGKEI----AVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLV 658
K +GSG FG VY G + +G+++ A+K L + S + +E +E +++ + + ++
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 659 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 718
+ LG C L+ + M G L +++ H+ I L AKG+ YL
Sbjct: 73 RLLGICLTSTVQ-LITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLEE- 127
Query: 719 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYIS 777
++HRDL + N+L+ K++DFGL+K D + + + + ++ E +
Sbjct: 128 --RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILH 185
Query: 778 QQLTDKSDVYSFGVILLELIS 798
+ T +SDV+S+GV + EL++
Sbjct: 186 RIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 14/201 (6%)
Query: 604 EKKIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQF 660
+KIG G +GVVY + + E IA+K + T E++LL + H N+V+
Sbjct: 7 VEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66
Query: 661 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 720
E R LV+E++ + LK+H+ + + IK +GI Y H+
Sbjct: 67 QDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTY--LYQILRGIAYCHSH-- 121
Query: 721 PAIIHRDLKSSNILLDKHMRA-KVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI-S 777
++HRDLK N+L+D+ A K++DFGL++ F + + +V T+ Y PE + S
Sbjct: 122 -RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TLWYRAPEILLGS 178
Query: 778 QQLTDKSDVYSFGVILLELIS 798
+ + D++S G I E+++
Sbjct: 179 RHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 21/205 (10%)
Query: 607 IGSGGFGVVYYGKLKDG-------KEIAVKVLTSNSYQGKRE-------FTNEVTLL-SR 651
+GSG FG VY + K+ KEI V + KRE +EVT++ +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNP--AFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 652 IHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 711
+ H N+V++ E R +V + + L EH +QR + I
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125
Query: 712 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 771
+ YLH I+HRDL +NI+L + + ++DFGL+K S ++S+V GT+ Y
Sbjct: 126 LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKLTSVV-GTILYSC 181
Query: 772 PEYYISQQLTDKSDVYSFGVILLEL 796
PE ++ +K+DV++FG IL ++
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-13
Identities = 44/120 (36%), Positives = 68/120 (56%), Gaps = 8/120 (6%)
Query: 403 WSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGC 460
W + CN+ + + I LS KN++G I S + +L + + L N L+GPIPD F+
Sbjct: 60 WQGITCNNSSR--VVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTS 117
Query: 461 PDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNI 518
LR ++L +N TG +P ++PNL L + NNMLSG +P+ + S VL+ GN+
Sbjct: 118 SSLRYLNLSNNNFTGSIPRG--SIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNV 175
|
Length = 968 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 62/204 (30%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 607 IGSGGFGVVYYGKLKD-GKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRN--LVQF 660
IG GGFG VY + D GK A+K L QG+ NE +LS + + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 661 LGYC-QEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 717
+ Y + + + M+ G L HL +G + + + A + G+E++H
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFY------AAEIILGLEHMHN 115
Query: 718 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 777
V ++RDLK +NILLD+H ++SD GL+ H S GT GY+ PE
Sbjct: 116 RFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQK 169
Query: 778 QQLTDKS-DVYSFGVILLELISGQ 800
D S D +S G +L +L+ G
Sbjct: 170 GVAYDSSADWFSLGCMLFKLLRGH 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 607 IGSGGFGVVYYGKLK---DGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQFL 661
+G G +GVV K++ G +AVK + T NS + KR + + + V F
Sbjct: 9 LGRGAYGVVD--KMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 662 GYCQEEGRSVLVYEFMHNGTLKEHLY-GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 720
G EG + E M T + Y I +IA K +EYLH+
Sbjct: 67 GALFREGDVWICMEVMD--TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL- 123
Query: 721 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY---IS 777
++IHRD+K SN+L++++ + K+ DFG+S + VD S +I G Y+ PE ++
Sbjct: 124 -SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD--SVAKTIDAGCKPYMAPERINPELN 180
Query: 778 QQLTD-KSDVYSFGVILLELISG 799
Q+ D KSDV+S G+ ++EL +G
Sbjct: 181 QKGYDVKSDVWSLGITMIELATG 203
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 52/211 (24%), Positives = 101/211 (47%), Gaps = 15/211 (7%)
Query: 595 DIEDATKMLEKKIGSGGFGVVYYG--KLKDGKEIAVKVLT---SNSYQGKREFTNEVTLL 649
++++ + +E+ +G+G FG + G KL +E+ V + T S + +R F E L
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60
Query: 650 SRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA 709
+ H N+V+ G ++V E+M NG L L HE ++ + + + A
Sbjct: 61 GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLR---KHEGQLVAGQLMGMLPGLA 117
Query: 710 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG--TV 767
G++YL +H+ L + +L++ + K+S F + D + + + + G V
Sbjct: 118 SGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPV 172
Query: 768 GYLDPEYYISQQLTDKSDVYSFGVILLELIS 798
+ PE + SDV+SFG+++ E++S
Sbjct: 173 LWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (176), Expect = 3e-13
Identities = 60/219 (27%), Positives = 95/219 (43%), Gaps = 39/219 (17%)
Query: 602 MLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNL 657
L K IGSG +GVV + G+++A+K ++ + KR E+ LL + H N+
Sbjct: 3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRIL-REIKLLRHLRHENI 61
Query: 658 VQ----FLGYCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIK-RLEIAEDAAK- 710
+ E+ V +V E M T H IK + +D +
Sbjct: 62 IGLLDILRPPSPEDFNDVYIVTELME----------TDLH----KVIKSPQPLTDDHIQY 107
Query: 711 -------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV 763
G++YLH+ +IHRDLK SNIL++ + K+ DFGL++ +
Sbjct: 108 FLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT 164
Query: 764 RGTVG--YLDPEYYISQQLTDKS-DVYSFGVILLELISG 799
V Y PE +S K+ D++S G I EL++
Sbjct: 165 EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 4e-13
Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 31/210 (14%)
Query: 605 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN-----EVTLLS-RI----- 652
K +G G FG V +LK E+ AVKVL K++ E T+ R+
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVL-------KKDVILQDDDVECTMTEKRVLALAG 53
Query: 653 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAK 710
H L Q Q + R V E+++ G L H+ G + + A +
Sbjct: 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFY------AAEIVL 107
Query: 711 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 770
G+++LH II+RDLK N+LLD K++DFG+ K + G S+ GT Y+
Sbjct: 108 GLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC-GTPDYI 163
Query: 771 DPEYYISQQLTDKSDVYSFGVILLELISGQ 800
PE Q D ++ GV+L E+++GQ
Sbjct: 164 APEILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-13
Identities = 63/211 (29%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 607 IGSGGFGVVYYGKLKD-GKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRN--LVQF 660
IG GGFG VY + D GK A+K L QG+ NE +LS + + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 661 LGYC-QEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 717
+ Y + + + M+ G L HL +G + ++ + A + G+E++H
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFY------ATEIILGLEHMHN 115
Query: 718 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 777
V ++RDLK +NILLD+H ++SD GL+ H S GT GY+ PE
Sbjct: 116 RFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQK 169
Query: 778 QQLTDKS-DVYSFGVILLELISGQEAISNEK 807
D S D +S G +L +L+ G K
Sbjct: 170 GTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 24/211 (11%)
Query: 603 LEKKIGSGGFGVVYY----GKLKDGKEIAVKVLTSNSYQGKR---EFT-NEVTLLSRIHH 654
L + +G+G +G V+ G GK A+KVL + K E T E +L +
Sbjct: 4 LLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRR 63
Query: 655 RNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIK---RLEIAEDAAK 710
+ L Y Q + + L+ ++++ G L HLY QR ++ + R+ IAE
Sbjct: 64 CPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY------QREHFTESEVRVYIAE-IVL 116
Query: 711 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 770
+++LH II+RD+K NILLD ++DFGLSK + + GT+ Y+
Sbjct: 117 ALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYM 173
Query: 771 DPEYYISQQL--TDKSDVYSFGVILLELISG 799
PE D +S GV+ EL++G
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 5e-13
Identities = 40/154 (25%), Positives = 71/154 (46%), Gaps = 19/154 (12%)
Query: 605 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN--EVTLLSRI-HHRNLVQF 660
K++G G FG VY + K+ E+ A+K + + E N EV L ++ H N+V+
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMK-KKFYSWEECMNLREVKSLRKLNEHPNIVKL 63
Query: 661 LGYCQEEGRSVLVYEFMHN---GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 717
+E V+E+M +K+ + + I ++ +G+ ++H
Sbjct: 64 KEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQI------LQGLAHIHK 117
Query: 718 -GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 750
G HRDLK N+L+ K++DFGL++
Sbjct: 118 HG----FFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 7e-13
Identities = 54/208 (25%), Positives = 105/208 (50%), Gaps = 12/208 (5%)
Query: 595 DIEDATKMLEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRI 652
D E+ LE+ IG G FG V+ G + + +A+K++ + + E E+T+LS+
Sbjct: 1 DPEELFTKLER-IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59
Query: 653 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 712
+ ++ G + + ++ E++ G+ + L E +I + ++ KG+
Sbjct: 60 DSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQI-----ATMLKEILKGL 114
Query: 713 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 772
+YLH+ IHRD+K++N+LL + K++DFG++ D ++ V GT ++ P
Sbjct: 115 DYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAP 170
Query: 773 EYYISQQLTDKSDVYSFGVILLELISGQ 800
E K+D++S G+ +EL G+
Sbjct: 171 EVIQQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 8e-13
Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 20/203 (9%)
Query: 606 KIGSGGFGVVYYGKLKD-GKEIAVK--VLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 662
KIG G +GVV+ + ++ G+ +A+K V + + K+ E+ +L ++ H NLV +
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 663 YCQEEGRSVLVYEFMHNGTLKE---HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-G 718
+ + + LV+E+ + L E + G H IK+ I + + + H
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHL-----IKK--IIWQTLQAVNFCHKHN 120
Query: 719 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 778
C IHRD+K NIL+ K + K+ DFG ++ + V T Y PE +
Sbjct: 121 C----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPELLVGD 175
Query: 779 -QLTDKSDVYSFGVILLELISGQ 800
Q DV++ G + EL++GQ
Sbjct: 176 TQYGPPVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 9e-13
Identities = 65/216 (30%), Positives = 98/216 (45%), Gaps = 14/216 (6%)
Query: 607 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQFLG 662
IG G FG V + +D + I A+K + + E T+ E T+L++++ +V
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 663 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIK-RLEIAEDAAKGIEYLHTGCVP 721
Q + LV F++ G L HL E R + + R AE +E LH V
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHL----QREGRFDLSRARFYTAE-LLCALENLHKFNV- 114
Query: 722 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 781
I+RDLK NILLD + DFGL K + ++ GT YL PE + T
Sbjct: 115 --IYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC-GTPEYLAPELLLGHGYT 171
Query: 782 DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 817
D ++ GV+L E+++G +E R I+Q
Sbjct: 172 KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ 207
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-12
Identities = 43/106 (40%), Positives = 64/106 (60%), Gaps = 3/106 (2%)
Query: 415 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQL 473
S+ + L+S L G IP +L ++ SL ++L N+L+G IP + G L + L N L
Sbjct: 189 SLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNL 248
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 517
TGP+PSSL NL NL+ L++ N LSG +P S+ L K + L+ + N
Sbjct: 249 TGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDN 294
|
Length = 968 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 59/210 (28%), Positives = 90/210 (42%), Gaps = 26/210 (12%)
Query: 605 KKIGSGGFGVVYYGKLKDGKEIA---VKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQF 660
+IG+G FG V G+ G A VK L S + + F EV ++H N++Q
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 661 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLE-IAEDAAKGIEYLHTGC 719
LG C E +LV EF G LK +L ++ L+ +A + A G+ +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA- 119
Query: 720 VPAIIHRDLKSSNILLDKHMRAKVSDFGLS------KFAVDGASHVSSIVRGTVGYLDPE 773
IH DL N L + K+ D+GL+ + + H + +L PE
Sbjct: 120 --DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPL-----RWLAPE 172
Query: 774 YYISQQ-------LTDKSDVYSFGVILLEL 796
+ T KS+++S GV + EL
Sbjct: 173 LVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 62/231 (26%), Positives = 100/231 (43%), Gaps = 58/231 (25%)
Query: 603 LEKKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSYQGK-------REFTNEVTLLSRI 652
+E IG G +G VY K K DGKE A+K + Q RE + LL +
Sbjct: 4 IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACRE----IALLREL 59
Query: 653 HHRNLVQFLGYCQEEG-RSV-LVYEFMHNGTLKEH-LYGTLTHEQRINWIKRLEIAEDAA 709
H N+V + E +SV L++++ EH L+ + ++ KR+ I
Sbjct: 60 KHENVVSLVEVFLEHADKSVYLLFDY------AEHDLWQIIKFHRQA---KRVSIPPSMV 110
Query: 710 K--------GIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSK------- 750
K G+ YLH+ ++HRDLK +NIL+ + K+ D GL++
Sbjct: 111 KSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLK 167
Query: 751 --FAVDGASHVSSIVRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELIS 798
+D V T+ Y PE + ++ T D+++ G I EL++
Sbjct: 168 PLADLDP-------VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 15/206 (7%)
Query: 607 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVT---LLSRIHHRNLVQFLG 662
+G G FG V +LK G+ AVKVL + + +T +LS + + L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 663 YC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 721
C Q R V EF++ G L H+ + +R + + A + + +LH
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKS----RRFDEARARFYAAEITSALMFLHD---K 115
Query: 722 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASHVSSIVRGTVGYLDPEYYISQQL 780
II+RDLK N+LLD K++DFG+ K + +G + +S GT Y+ PE
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYIAPEILQEMLY 173
Query: 781 TDKSDVYSFGVILLELISGQEAISNE 806
D ++ GV+L E++ G E
Sbjct: 174 GPSVDWWAMGVLLYEMLCGHAPFEAE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 20/217 (9%)
Query: 598 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHH 654
D+ + LEK +G G + VY GK K +GK +A+KV+ +G FT E +LL + H
Sbjct: 5 DSYEKLEK-LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-PFTAIREASLLKGLKH 62
Query: 655 RNLVQFLGYCQEEGRSVLVYEFMHNGT---LKEHLYGTLTHEQRINWIKRLEIAEDAAKG 711
N+V + LV+E++H + +H G ++ + L +G
Sbjct: 63 ANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLL-------RG 115
Query: 712 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 771
+ Y+H I+HRDLK N+L+ K++DFGL++ A SH S T+ Y
Sbjct: 116 LSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRP 171
Query: 772 PEYYI-SQQLTDKSDVYSFGVILLELISGQEAISNEK 807
P+ + S + + D++ G I +E+I G A K
Sbjct: 172 PDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK 208
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 54/221 (24%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 590 CFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK---REFTNEV 646
C DI+ T +L I +Y G + KE+ ++ K NE+
Sbjct: 14 CIESDDIDKYTSVL---IKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEI 69
Query: 647 TLLSRIHHRNLVQFLGY----CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL 702
L RI N+++ G+ + R L+ E+ G L+E L E+ +++ +L
Sbjct: 70 KNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLD----KEKDLSFKTKL 125
Query: 703 EIAEDAAKGIEYLHTGC-VPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVS 760
++A D KG+ L+ P +++L S + L+ ++ + K+ GL K + +V+
Sbjct: 126 DMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVN 182
Query: 761 SIVRGTVGYLDPEYY--ISQQLTDKSDVYSFGVILLELISG 799
+V Y + I + T K D+YS GV+L E+ +G
Sbjct: 183 FMV-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTG 218
|
Length = 283 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 53/201 (26%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 606 KIGSGGFGVVYYGKLKDGKEIAV--KVLTSNSYQGKREFT-NEVTLLSRIHHRNLVQFLG 662
KIG G +G V+ K ++ EI +V + +G E+ LL + H+N+V+
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 663 YCQEEGRSVLVYEFMHNGTLK--EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 720
+ + LV+E+ K + G + E +++ +L KG+ + H+
Sbjct: 67 VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQL------LKGLAFCHS--- 117
Query: 721 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 779
++HRDLK N+L++K+ K++DFGL++ F + + + +V T+ Y P+ +
Sbjct: 118 HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAK 175
Query: 780 LTDKS-DVYSFGVILLELISG 799
L S D++S G I EL +
Sbjct: 176 LYSTSIDMWSAGCIFAELANA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 61/212 (28%), Positives = 107/212 (50%), Gaps = 37/212 (17%)
Query: 607 IGSGGFGVVYYGKLKDGKEIAV--KVLTSNSYQGKREF----TNEVTLLSRIHHRNLVQF 660
IG G +G VY + KD E+ KV N +G F E+ +L +++HRN+V
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG---FPITAIREIKILRQLNHRNIVNL 71
Query: 661 ----------LGYCQEEGRSVLVYEFM-HN--GTLKEHLYGTLTHEQRINWIKRLEIAED 707
L + +++G LV+E+M H+ G L+ L + + +++K+L
Sbjct: 72 KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLV-HFSEDHIKSFMKQL----- 125
Query: 708 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF--AVDGASHVSSIVRG 765
+G+ Y H +HRD+K SNILL+ + K++DFGL++ + + + + ++
Sbjct: 126 -LEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-- 179
Query: 766 TVGYLDPEYYISQQLTDKS-DVYSFGVILLEL 796
T+ Y PE + ++ + DV+S G IL EL
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGEL 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 60/203 (29%), Positives = 89/203 (43%), Gaps = 18/203 (8%)
Query: 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVT---LLSRIHHRNLVQF 660
K +G G FG V + K GK A+K+L K E + +T +L H L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 661 LGYCQEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 718
Q R V E+ + G L HL + ++ R AE + YLH+
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAE-IVSALGYLHSC 114
Query: 719 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASHVSSIVRGTVGYLDPEYYIS 777
+++RDLK N++LDK K++DFGL K + DGA+ GT YL PE
Sbjct: 115 ---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLED 169
Query: 778 QQLTDKSDVYSFGVILLELISGQ 800
D + GV++ E++ G+
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 29/205 (14%)
Query: 606 KIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFLG 662
KIG G +GVVY + G+ +A+K + + T E++LL ++H N+V+ L
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 663 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIEY 714
E + LV+EF+ LK+++ + + K GI Y
Sbjct: 66 VVHSENKLYLVFEFLDL-DLKKYM----------DSSPLTGLDPPLIKSYLYQLLQGIAY 114
Query: 715 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPE 773
H+ ++HRDLK N+L+D+ K++DFGL++ F V ++ +V T+ Y PE
Sbjct: 115 CHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV--TLWYRAPE 169
Query: 774 YYI-SQQLTDKSDVYSFGVILLELI 797
+ S+Q + D++S G I E++
Sbjct: 170 ILLGSRQYSTPVDIWSIGCIFAEMV 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 70/218 (32%), Positives = 99/218 (45%), Gaps = 18/218 (8%)
Query: 607 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN---EVTLLSRIHHRN---LVQ 659
IG G FG VY + KD + I A+KVL+ K+E + E +L R +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 660 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIK-RLEIAEDAAKGIEYLHTG 718
Q + LV ++M G L HL E R + + + IAE +E+LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHL----QKEGRFSEDRAKFYIAE-LVLALEHLHKY 115
Query: 719 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 778
I++RDLK NILLD + DFGLSK A + ++ GT YL PE + +
Sbjct: 116 ---DIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPEVLLDE 171
Query: 779 Q-LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 815
+ T D +S GV++ E+ G E RNI
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI 209
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 58/208 (27%), Positives = 86/208 (41%), Gaps = 30/208 (14%)
Query: 607 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT---NEVTLL----------SRI 652
+G G FG V + K E+ A+K L K+ +EV L +
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKAL-------KKGDIIARDEVESLMCEKRIFETANSE 59
Query: 653 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 712
H LV Q E V E+ G L H+ H + + + A G+
Sbjct: 60 RHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHI-----HTDVFSEPRAVFYAACVVLGL 114
Query: 713 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 772
+YLH I++RDLK N+LLD K++DFGL K + G +S GT +L P
Sbjct: 115 QYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM-GFGDRTSTFCGTPEFLAP 170
Query: 773 EYYISQQLTDKSDVYSFGVILLELISGQ 800
E T D + GV++ E++ G+
Sbjct: 171 EVLTETSYTRAVDWWGLGVLIYEMLVGE 198
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 51/204 (25%), Positives = 97/204 (47%), Gaps = 22/204 (10%)
Query: 606 KIGSGGFGVVYYGKLKD-GKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 662
+G G +G+V K K+ G+ +A+K + + K+ E+ +L ++ H NLV +
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 663 YCQEEGRSVLVYEFMHNGTLK--EHLYGTLTHE--QRINWIKRLEIAEDAAKGIEYLHTG 718
+ + R LV+EF+ + L E L ++ + +GIE+ H+
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLF--------QILRGIEFCHSH 119
Query: 719 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYIS 777
IIHRD+K NIL+ + K+ DFG ++ A G + + T Y PE +
Sbjct: 120 ---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV--ATRWYRAPELLVG 174
Query: 778 QQLTDKS-DVYSFGVILLELISGQ 800
++ D+++ G ++ E+++G+
Sbjct: 175 DTKYGRAVDIWAVGCLVTEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 606 KIGSGGFGVVYYGK-LKDGKEIAVK-VLTSNSYQGKREFT-NEVTLLSRIH---HRNLVQ 659
+IG G +G VY + G +A+K V + G T EV LL R+ H N+V+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 660 FLGYC-----QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 714
+ C E + LV+E + + L+ +L IK ++ +G+++
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIK--DLMRQFLRGLDF 123
Query: 715 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 774
LH C I+HRDLK NIL+ + K++DFGL++ + +V T+ Y PE
Sbjct: 124 LHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV--TLWYRAPEV 178
Query: 775 YISQQLTDKSDVYSFGVILLEL 796
+ D++S G I E+
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 39/180 (21%)
Query: 590 CFTLSDIEDATKMLEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFT--NEV 646
C L D E + K+G G FG VY ++K G+ +A+K + ++ + T E+
Sbjct: 4 CSKLRDYE-----ILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREI 58
Query: 647 TLLSRIHHRNLVQFLGYCQEEGRSV--------LVYEFM--------HNGTLKEHLYGTL 690
+L ++ H N+V + E +V +M N ++K L
Sbjct: 59 KILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK------L 112
Query: 691 THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 750
T Q ++ +L +GI YLH I+HRD+K++NIL+D K++DFGL++
Sbjct: 113 TESQIKCYMLQL------LEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLAR 163
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 54/197 (27%), Positives = 94/197 (47%), Gaps = 13/197 (6%)
Query: 606 KIGSGGFGVVYYGKLKDGKEIAV-KVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 664
++G G FG VY + K+ +A KV+ + S + ++ E+ +L+ H N+V+ L
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 665 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 724
E ++ EF G + + L E+ + + + + + + YLH II
Sbjct: 72 YYENNLWILIEFCAGGAVDAVM---LELERPLTEPQIRVVCKQTLEALNYLHEN---KII 125
Query: 725 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD-- 782
HRDLK+ NIL K++DFG+S S + GT ++ PE + + D
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRP 184
Query: 783 ---KSDVYSFGVILLEL 796
K+DV+S G+ L+E+
Sbjct: 185 YDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 62/201 (30%), Positives = 88/201 (43%), Gaps = 15/201 (7%)
Query: 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNLVQ 659
K IG G FG V + K + K AVKVL + K+E + LL + H LV
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 660 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI-AEDAAKGIEYLHTG 718
Q + V ++++ G L HL +R R A + A + YLH+
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHL-----QRERCFLEPRARFYAAEIASALGYLHS- 114
Query: 719 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 778
I++RDLK NILLD ++DFGL K ++ S+ GT YL PE Q
Sbjct: 115 --LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC-GTPEYLAPEVLHKQ 171
Query: 779 QLTDKSDVYSFGVILLELISG 799
D + G +L E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 55/206 (26%), Positives = 103/206 (50%), Gaps = 21/206 (10%)
Query: 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFL 661
+K+G G + VY G + +G+ +A+KV++ + +G FT E +LL + H N+V
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGV-PFTAIREASLLKGLKHANIVLLH 69
Query: 662 GYCQEEGRSVLVYEFMHNGT---LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 718
+ V+E+MH + +H G + R+ + L +G+ Y+H
Sbjct: 70 DIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLL-------RGLAYIHG- 121
Query: 719 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYI- 776
I+HRDLK N+L+ K++DFGL++ ++ ++ S +V T+ Y P+ +
Sbjct: 122 --QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLG 177
Query: 777 SQQLTDKSDVYSFGVILLELISGQEA 802
+ + D++ G I +E++ GQ A
Sbjct: 178 ATDYSSALDIWGAGCIFIEMLQGQPA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 63/210 (30%), Positives = 93/210 (44%), Gaps = 26/210 (12%)
Query: 605 KKIGSGGFGVVYYGKLKDG---KEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQF 660
K+IG+G FG V G++ G ++ VK L + S Q + +F E + H NL+Q
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 661 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLE-IAEDAAKGIEYLHTGC 719
LG C E +LV EF G LK +L E L+ +A + A G+ +LH
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN- 119
Query: 720 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 779
IH DL N LL + K+ D+GLS +V+ P +I+ +
Sbjct: 120 --NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWV-----PLRWIAPE 172
Query: 780 LTDK-------------SDVYSFGVILLEL 796
L D+ S+V+S GV + EL
Sbjct: 173 LVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 4e-12
Identities = 62/234 (26%), Positives = 98/234 (41%), Gaps = 60/234 (25%)
Query: 595 DIEDATKMLEKKIGSGGFGVVYYG-KLKDGKEIAVK-------VLTSNSYQGKREFTNEV 646
D+ K +E IGSG +GVV + GK++A+K V T KR E+
Sbjct: 2 DVGSRYKPIEN-IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTL----AKRTL-REL 55
Query: 647 TLLSRIHHRNLV---QFLGYCQEEGRSV-LVYEFM----H-----NGTLKEH-----LYG 688
+L H N++ L + + V +V + M H + L E LY
Sbjct: 56 KILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQ 115
Query: 689 TLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG- 747
L +G++Y+H+ V IHRDLK SN+L+++ ++ DFG
Sbjct: 116 LL-------------------RGLKYIHSANV---IHRDLKPSNLLVNEDCELRIGDFGM 153
Query: 748 ---LSKFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELI 797
LS + ++ V T Y PE +S + T D++S G I E++
Sbjct: 154 ARGLSSSPTEHKYFMTEYV-ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 4e-12
Identities = 55/222 (24%), Positives = 104/222 (46%), Gaps = 29/222 (13%)
Query: 603 LEKKIGSGGFGVVYY----GKLKDGKE-------------IAVKVLTSNSYQGKR-EFTN 644
++K+G G FG V+ G K + +AVK+L ++ + R +F
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 645 EVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY-------GTLTHEQRIN 697
E+ ++SR+ N+++ L C ++ E+M NG L + L I+
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 698 WIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757
+ + +A A G++YL + +HRDL + N L+ K+ K++DFG+S+ G
Sbjct: 129 YSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185
Query: 758 H-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 798
+ + + ++ E + + T SDV++FGV L E+++
Sbjct: 186 YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 5e-12
Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 1/99 (1%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
P + + +S+ NL G I S + SL L L N G +PD G L + L NQ
Sbjct: 428 PLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQF 487
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS-KNVV 511
+G +P L +L L +L + N LSG +P L S K +V
Sbjct: 488 SGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLV 526
|
Length = 968 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 53/200 (26%), Positives = 99/200 (49%), Gaps = 16/200 (8%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 661
L ++IGSG +G VY + + G+ A+KV+ + E+ ++ H N+V +
Sbjct: 13 LIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYF 72
Query: 662 GYCQEEGRSVLVYEFMHNGTLKE--HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 719
G + + EF G+L++ H+ G L+ E +I ++ R + +G+ YLH+
Sbjct: 73 GSYLRRDKLWICMEFCGGGSLQDIYHVTGPLS-ESQIAYVSR-----ETLQGLYYLHS-- 124
Query: 720 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 779
+HRD+K +NILL + K++DFG+S + S + GT ++ PE ++
Sbjct: 125 -KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVER 182
Query: 780 ---LTDKSDVYSFGVILLEL 796
D+++ G+ +EL
Sbjct: 183 KGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 7e-12
Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 23/205 (11%)
Query: 605 KKIGSGGFGVVYYG-KLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQF 660
K IGSG G+V G +AVK L+ N KR + E+ LL ++H+N++
Sbjct: 27 KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY-RELVLLKCVNHKNIISL 85
Query: 661 LGY-----CQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 714
L EE + V LV E M + L + ++ L HE R++++ + GI++
Sbjct: 86 LNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDHE-RMSYLLYQMLC-----GIKH 138
Query: 715 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 774
LH+ IIHRDLK SNI++ K+ DFGL++ A +V T Y PE
Sbjct: 139 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV--TRYYRAPEV 193
Query: 775 YISQQLTDKSDVYSFGVILLELISG 799
+ + D++S G I+ EL+ G
Sbjct: 194 ILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 9e-12
Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 27/208 (12%)
Query: 605 KKIGSGGFGVV---YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLV 658
K IGSG G+V Y G+ +A+K L+ N KR + E+ L+ ++H+N++
Sbjct: 22 KPIGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAY-RELVLMKLVNHKNII 78
Query: 659 QFLGYCQ-----EEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 712
L EE + V LV E M + L + + L HE R++++ + GI
Sbjct: 79 GLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMDLDHE-RMSYLLYQMLC-----GI 131
Query: 713 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 772
++LH+ IIHRDLK SNI++ K+ DFGL++ A +V T Y P
Sbjct: 132 KHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAP 186
Query: 773 EYYISQQLTDKSDVYSFGVILLELISGQ 800
E + + D++S G I+ E+I G
Sbjct: 187 EVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-11
Identities = 36/89 (40%), Positives = 54/89 (60%), Gaps = 1/89 (1%)
Query: 415 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQL 473
S+ I+L NL+G IP ++ L+SL L L N+LTGPIP +L+ + L N+L
Sbjct: 213 SLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKL 272
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVP 502
+GP+P S+ +L L L + +N LSG +P
Sbjct: 273 SGPIPPSIFSLQKLISLDLSDNSLSGEIP 301
|
Length = 968 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 63/226 (27%), Positives = 109/226 (48%), Gaps = 18/226 (7%)
Query: 592 TLSDIEDATKMLEKKIGSGGFGVVY-YGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLS 650
+ D D +++E IG G +G V+ K+G + AVK+L + E E +L
Sbjct: 12 SFPDPSDTWEIIET-IGKGTYGKVFKVLNKKNGSKAAVKILDP-IHDIDEEIEAEYNILK 69
Query: 651 RIH-HRNLVQFLG-YCQEEGRS----VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI 704
+ H N+V+F G Y +++ ++ LV E + G++ + + G L +R+ I
Sbjct: 70 ALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYI 129
Query: 705 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 764
+A G+++LH V IHRD+K +NILL K+ DFG+S + +
Sbjct: 130 LHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSA-QLTSTRLRRNTSV 185
Query: 765 GTVGYLDPEYYISQQLTDKS-----DVYSFGVILLELISGQEAISN 805
GT ++ PE +Q D + DV+S G+ +EL G +++
Sbjct: 186 GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLAD 231
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-11
Identities = 38/92 (41%), Positives = 50/92 (54%), Gaps = 1/92 (1%)
Query: 413 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDN 471
++TV+ LS+ NLTG IP L +L +L L NSL G IP C LR + L+DN
Sbjct: 355 HNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDN 414
Query: 472 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPS 503
+G LPS LP + L + NN L G + S
Sbjct: 415 SFSGELPSEFTKLPLVYFLDISNNNLQGRINS 446
|
Length = 968 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-11
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 34/219 (15%)
Query: 605 KKIGSGGFGVVYYGKLKDGKE----IAVKVLTSNSYQGKREFTN----EVTLLSRIHHRN 656
K +G GG+G V+ + G + A+KVL + ++ T E +L + H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 657 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI-AEDAAK----- 710
+V + Q G+ L+ E++ G L HL +R I ED A
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHL-------------EREGIFMEDTACFYLSE 108
Query: 711 ---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 767
+E+LH II+RDLK NILLD K++DFGL K ++ + V+ GT+
Sbjct: 109 ISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGTI 164
Query: 768 GYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 806
Y+ PE + D +S G ++ ++++G + E
Sbjct: 165 EYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE 203
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 56/225 (24%), Positives = 105/225 (46%), Gaps = 25/225 (11%)
Query: 595 DIEDATKMLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNSYQGKRE-FTNEVT 647
+I +T +++G FG VY G L + + +A+K L + RE F +E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 648 LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH------------EQR 695
+ SR+ H N+V LG +E +++ + + L E L H +
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 696 INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAV 753
+ + I A G+E+L + V +H+DL + N+L+ + K+SD GL + +A
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSHHV---VHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 754 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 798
D + + + + ++ PE + + + SD++S+GV+L E+ S
Sbjct: 178 DYYKLMGNSLL-PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 33/209 (15%)
Query: 607 IGSGGFGVVYYGKLKDGKEI-AVKVLTSN----------SYQGKREFTNEVTLLSRIHHR 655
+G G FG V + K E+ A+K+L + + KR + L +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRV----LALPGKPPF- 62
Query: 656 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK---GI 712
L Q Q R V E+++ G L H+ Q++ K AA+ G+
Sbjct: 63 -LTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-------QQVGKFKEPHAVFYAAEIAIGL 114
Query: 713 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 772
+LH+ II+RDLK N++LD K++DFG+ K + G + GT Y+ P
Sbjct: 115 FFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC-GTPDYIAP 170
Query: 773 EYYISQQLTDKS-DVYSFGVILLELISGQ 800
E I+ Q KS D ++FGV+L E+++GQ
Sbjct: 171 E-IIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 2e-11
Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 25/204 (12%)
Query: 605 KKIGSGGFGVV--YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQ 659
K IGSG G+V Y + D + +A+K L+ N KR + E+ L+ ++H+N++
Sbjct: 23 KPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIS 80
Query: 660 FLGY-----CQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 713
L EE + V LV E M + L + + L HE R++++ + GI+
Sbjct: 81 LLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMELDHE-RMSYLLYQMLC-----GIK 133
Query: 714 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 773
+LH+ IIHRDLK SNI++ K+ DFGL++ A G S + + T Y PE
Sbjct: 134 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPE 188
Query: 774 YYISQQLTDKSDVYSFGVILLELI 797
+ + D++S G I+ E++
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 54/201 (26%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 603 LEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 661
L +++GSG +G VY L G+ AVK++ E+ ++ H N+V +
Sbjct: 13 LIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYF 72
Query: 662 GYCQEEGRSVLVYEFMHNGTLKE--HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 719
G + + E+ G+L++ H+ G L+ E +I ++ R + +G+ YLH+
Sbjct: 73 GSYLSREKLWICMEYCGGGSLQDIYHVTGPLS-ELQIAYVCR-----ETLQGLAYLHS-- 124
Query: 720 VPAIIHRDLKSSNILLDKHMRAKVSDFGL-SKFAVDGASHVSSIVRGTVGYLDPEYYISQ 778
+HRD+K +NILL + K++DFG+ +K A S I GT ++ PE +
Sbjct: 125 -KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI--GTPYWMAPEVAAVE 181
Query: 779 Q---LTDKSDVYSFGVILLEL 796
+ D+++ G+ +EL
Sbjct: 182 KNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 52/199 (26%), Positives = 94/199 (47%), Gaps = 15/199 (7%)
Query: 605 KKIGSGGFGVVYYGKLKDGKE-IAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQF 660
K +G+G FG V+ + + + A+KV+ + ++ NE +L + H +++
Sbjct: 7 KTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL 66
Query: 661 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 720
++ ++ E++ G L+ L + R + L A + +EYLH+
Sbjct: 67 FWTEHDQRFLYMLMEYVPGG----ELFSYLRNSGRFSNSTGLFYASEIVCALEYLHS--- 119
Query: 721 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 780
I++RDLK NILLDK K++DFG +K D + GT YL PE S+
Sbjct: 120 KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC----GTPEYLAPEVIQSKGH 175
Query: 781 TDKSDVYSFGVILLELISG 799
D ++ G+++ E++ G
Sbjct: 176 NKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 4e-11
Identities = 65/227 (28%), Positives = 110/227 (48%), Gaps = 31/227 (13%)
Query: 591 FTLSDIEDATKMLEKK------IGSGGFGVV---YYGKLKDGKEIAVKVLT---SNSYQG 638
F +I D+T + K+ IGSG G+V Y L+ + +A+K L+ N
Sbjct: 10 FYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHA 67
Query: 639 KREFTNEVTLLSRIHHRNLVQFLGY-----CQEEGRSVLVYEFMHNGTLKEHLYGTLTHE 693
KR + E+ L+ ++H+N++ L EE + V + + + L + + L HE
Sbjct: 68 KRAY-RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE 126
Query: 694 QRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 753
R++++ + GI++LH+ IIHRDLK SNI++ K+ DFGL++ A
Sbjct: 127 -RMSYLLYQMLC-----GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA- 176
Query: 754 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 800
G S + + T Y PE + + D++S G I+ E+I G
Sbjct: 177 -GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 4e-11
Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 28/207 (13%)
Query: 606 KIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTN--EVTLLSRIHHRNLVQ 659
+I G +GVVY + K EI A+K L + ++E T+ E+ +L ++ H N+V
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALKKL---KMEKEKEGFPITSLREINILLKLQHPNIVT 68
Query: 660 F----LGYCQEEGRSVLVYEFMHNG--TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 713
+G + + +V E++ + +L E + + + +L G+
Sbjct: 69 VKEVVVGSNLD--KIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQL------LSGVA 120
Query: 714 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 773
+LH I+HRDLK+SN+LL+ K+ DFGL++ + +V T+ Y PE
Sbjct: 121 HLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRAPE 176
Query: 774 YYISQQL-TDKSDVYSFGVILLELISG 799
+ + + D++S G I EL++
Sbjct: 177 LLLGAKEYSTAIDMWSVGCIFAELLTK 203
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 6e-11
Identities = 67/260 (25%), Positives = 101/260 (38%), Gaps = 58/260 (22%)
Query: 605 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEV----TLLSRIHHRNLVQ 659
K IG G FG V + KD G A+K L S ++E V +L+ + +V+
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKL-RKSEMLEKEQVAHVRAERDILAEADNPWVVK 65
Query: 660 FLGYC--QEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYL 715
Y Q+E L+ E++ G + L T T E+ R IAE I+ +
Sbjct: 66 L--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEE-----TRFYIAE-TILAIDSI 117
Query: 716 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK---------------------FAVD 754
H IHRD+K N+LLD K+SDFGL F
Sbjct: 118 HK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDF 174
Query: 755 GASHVSSIVR----------------GTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 798
+ +SS + GT Y+ PE ++ + D +S GVI+ E++
Sbjct: 175 ISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234
Query: 799 GQEAISNEKFGANCRNIVQW 818
G ++ R I+ W
Sbjct: 235 GYPPFCSDNPQETYRKIINW 254
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 6e-11
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 35/215 (16%)
Query: 603 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT-NEVTLLSRIHHRNLVQF 660
IG G +G+V K G ++A+K ++ +Q + T E+ +L R H N++
Sbjct: 9 NLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGI 68
Query: 661 LGYCQ----EEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK----- 710
L + E V +V E M + LY IK ++ D +
Sbjct: 69 LDIIRPPSFESFNDVYIVQELM-----ETDLYKL---------IKTQHLSNDHIQYFLYQ 114
Query: 711 ---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR--G 765
G++Y+H+ V +HRDLK SN+LL+ + K+ DFGL++ A H +
Sbjct: 115 ILRGLKYIHSANV---LHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171
Query: 766 TVGYLDPEYYISQQLTDKS-DVYSFGVILLELISG 799
T Y PE ++ + K+ D++S G IL E++S
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 8e-11
Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 13/207 (6%)
Query: 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVT---LLSRIHHRNLVQF 660
K +G G FG V K K G+ A+K+L K E + +T +L H L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 661 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 720
Q R V E+ + G L HL + E+ + + + ++YLH+
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALDYLHSE-- 114
Query: 721 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASHVSSIVRGTVGYLDPEYYISQQ 779
+++RDLK N++LDK K++DFGL K + DGA+ + GT YL PE
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC--GTPEYLAPEVLEDND 172
Query: 780 LTDKSDVYSFGVILLELISGQEAISNE 806
D + GV++ E++ G+ N+
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLPFYNQ 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 9e-11
Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 52/217 (23%)
Query: 606 KIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTN--EVTLLSRI-HHRNLVQFL 661
KIG G F V + K GK A+K + ++ + N E+ L R+ H N+++ +
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRLI 64
Query: 662 G--YCQEEGRSVLVYEFMHNGTLKEHLYGTLTH--EQRI-NWIKRLEIAEDAAKGIEYLH 716
+ ++ GR LV+E M + L E + G E+R+ +++ +L K ++++H
Sbjct: 65 EVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQL------LKSLDHMH 117
Query: 717 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY-- 774
I HRD+K NIL+ K++DFG S RG Y P Y
Sbjct: 118 RN---GIFHRDIKPENILIKDD-ILKLADFG-------------SC-RGI--YSKPPYTE 157
Query: 775 YISQQ--------LTD-----KSDVYSFGVILLELIS 798
YIS + LTD K D+++ G + E++S
Sbjct: 158 YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 13/206 (6%)
Query: 607 IGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLG 662
+G GGFG V ++K+ GK A K L + G++ E +L +++ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVN-LA 59
Query: 663 YCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 721
Y E + LV M+ G LK H+Y + + + + GI +LH+
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERV--IHYSAQITCGILHLHS---M 114
Query: 722 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 781
I++RD+K N+LLD ++SD GL+ DG + GT GY+ PE + +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA--GTNGYMAPEILKEEPYS 172
Query: 782 DKSDVYSFGVILLELISGQEAISNEK 807
D ++ G + E+++G+ + K
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTPFKDHK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 57/206 (27%), Positives = 90/206 (43%), Gaps = 12/206 (5%)
Query: 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVT---LLSRIHHRNLVQF 660
K +G G FG V + K G+ A+K+L K E + VT +L H L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 661 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 720
Q R V E+ + G L HL + E+ + + +EYLH+ V
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHSRDV 116
Query: 721 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 780
++RD+K N++LDK K++DFGL K + + + + GT YL PE
Sbjct: 117 ---VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDY 172
Query: 781 TDKSDVYSFGVILLELISGQEAISNE 806
D + GV++ E++ G+ N+
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQ 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 1e-10
Identities = 53/205 (25%), Positives = 86/205 (41%), Gaps = 29/205 (14%)
Query: 607 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLG 662
+G GGFG V K+K + A+K + + +E +L +H +V+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 663 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIEY 714
+++ ++ E+ G L L R E A+ EY
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILR------------DRGLFDEYTARFYIACVVLAFEY 108
Query: 715 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 774
LH II+RDLK N+LLD + K+ DFG +K G + GT Y+ PE
Sbjct: 109 LHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC--GTPEYVAPEI 163
Query: 775 YISQQLTDKSDVYSFGVILLELISG 799
+++ D +S G++L EL++G
Sbjct: 164 ILNKGYDFSVDYWSLGILLYELLTG 188
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 51/229 (22%), Positives = 89/229 (38%), Gaps = 41/229 (17%)
Query: 603 LEKKIGSGGFGVVY-YGKLKDGKEIAVKVLTSNSYQGKRE------------FT--NEVT 647
+G G +G V GK +A+K + FT E+
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 648 LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED 707
+++ I H N++ + E LV + M + K E ++ I L+I
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCI-LLQIL-- 129
Query: 708 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGAS--------- 757
G+ LH +HRDL +NI ++ K++DFGL+ ++ S
Sbjct: 130 --NGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 758 -----HVSSIVRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQ 800
S +V T+ Y PE + +++ D++S G I EL++G+
Sbjct: 185 QRREEMTSKVV--TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-10
Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 29/213 (13%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQG----KREFTNEVTLLSRIHHRNL 657
++ IG G FGVV+ +DGK +A+K + N +Q KR F E+ +L H N+
Sbjct: 4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMP-NVFQNLVSCKRVF-RELKMLCFFKHDNV 61
Query: 658 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK------- 710
+ L Q ++ ++ L+ + Q + + D K
Sbjct: 62 LSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPL--------SSDHVKVFLYQIL 113
Query: 711 -GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVG 768
G++YLH+ I+HRD+K N+L++ + K+ DFGL++ D + H++ V T
Sbjct: 114 RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQY 169
Query: 769 YLDPEYYI-SQQLTDKSDVYSFGVILLELISGQ 800
Y PE + S+ T D++S G I EL+ +
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.4 bits (156), Expect = 2e-10
Identities = 64/227 (28%), Positives = 101/227 (44%), Gaps = 36/227 (15%)
Query: 605 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-----KREFTNEVTLLSRIHHRNLVQ 659
KKIG+G FG V+ K K +E + SY+G K + EV ++ + H+N+V+
Sbjct: 19 KKIGNGRFGEVFLVKHKRTQEFFC--WKAISYRGLKEREKSQLVIEVNVMRELKHKNIVR 76
Query: 660 FLGYCQEEGRSVL--VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 717
++ + L + EF G L ++ +I ++I + Y H
Sbjct: 77 YIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHN 136
Query: 718 ----GCVPAIIHRDLKSSNILLDKHMR-----------------AKVSDFGLSK-FAVDG 755
++HRDLK NI L +R AK+ DFGLSK ++
Sbjct: 137 LKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES 196
Query: 756 ASHVSSIVRGTVGYLDPEYYI--SQQLTDKSDVYSFGVILLELISGQ 800
+H S V GT Y PE + ++ DKSD+++ G I+ EL SG+
Sbjct: 197 MAH--SCV-GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 49/149 (32%), Positives = 75/149 (50%), Gaps = 13/149 (8%)
Query: 657 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI--NWIKRLEIAEDAAKGIEY 714
+V F G +G + E M G+L + L RI N + ++ IA +G+ Y
Sbjct: 61 IVGFYGAFYSDGEISICMEHMDGGSLDQ----VLKKAGRIPENILGKISIA--VLRGLTY 114
Query: 715 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 774
L I+HRD+K SNIL++ K+ DFG+S +D S +S V GT Y+ PE
Sbjct: 115 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFV-GTRSYMSPER 169
Query: 775 YISQQLTDKSDVYSFGVILLELISGQEAI 803
T +SD++S G+ L+E+ G+ I
Sbjct: 170 LQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 44/167 (26%), Positives = 74/167 (44%), Gaps = 9/167 (5%)
Query: 638 GKREFT-NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI 696
G+R T E +L I+H +++Q G + L+ K LY L ++ I
Sbjct: 125 GQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP-----RYKTDLYCYLAAKRNI 179
Query: 697 NWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756
L I + I+YLH IIHRD+K+ NI ++ + DFG + F VD
Sbjct: 180 AICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236
Query: 757 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAI 803
++ GT+ PE D++S G++L E+ + +++
Sbjct: 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 15/202 (7%)
Query: 606 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG--KREFTNEVTLLSRIHHRNLVQFLGY 663
++G+G GVV + K I + L + + + E+ +L + +V F G
Sbjct: 12 ELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71
Query: 664 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI--NWIKRLEIAEDAAKGIEYLHTGCVP 721
+G + E M G+L + L +RI + ++ IA +G+ YL
Sbjct: 72 FYSDGEISICMEHMDGGSLDQ----VLKEAKRIPEEILGKVSIA--VLRGLAYLREK--H 123
Query: 722 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 781
I+HRD+K SNIL++ K+ DFG+S +D S +S V GT Y+ PE +
Sbjct: 124 QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFV-GTRSYMSPERLQGTHYS 180
Query: 782 DKSDVYSFGVILLELISGQEAI 803
+SD++S G+ L+EL G+ I
Sbjct: 181 VQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 16/206 (7%)
Query: 607 IGSGGFGVVYYGKLKDGKEIAV--KVLTSNSYQGKREFT-NEVTLLSRIHHRNLVQFLGY 663
+G G +GVV + K+ KEI K S + +E T E+ +L + N+V+
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 664 CQEEGRSVLVYEFMHNGTLK---EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 720
+ G+ LV+E++ L+ E G + R ++I +L K I + H
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVR-SYIYQL------IKAIHWCHKN-- 119
Query: 721 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 780
I+HRD+K N+L+ + K+ DFG ++ +G++ + T Y PE +
Sbjct: 120 -DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPY 178
Query: 781 TDKSDVYSFGVILLELISGQEAISNE 806
D++S G IL EL GQ E
Sbjct: 179 GKAVDMWSVGCILGELSDGQPLFPGE 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 24/218 (11%)
Query: 598 DATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVK-VLTSNSYQGKREFT-NEVTLLSRIHH 654
DA + LEK IG G +G VY + GK +A+K +G E++LL +
Sbjct: 1 DAYEKLEK-IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSE 59
Query: 655 RN-LVQFLGYCQEEGRS-----VLVYEFMHNGTLKEHL---YGTLTHEQRINWIKRLEIA 705
+V+ L E ++ LV+E++ + LK+ + IK
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMY- 117
Query: 706 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSK-FAVDGASHVSSIV 763
KG+ + H ++HRDLK N+L+DK K++D GL + F++ S+ IV
Sbjct: 118 -QLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV 173
Query: 764 RGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQ 800
T+ Y PE + S + D++S G I E+ Q
Sbjct: 174 --TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 607 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTNEVTLLSR--IHHRN----LVQ 659
+G G FG V + K E+ A+K+L + + E T++ + + ++ L Q
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDV--ECTMVEKRVLALQDKPPFLTQ 65
Query: 660 FLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 717
Q R V E+++ G L H+ G Q + + A + + G+ +LH
Sbjct: 66 LHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY------AAEISVGLFFLHR 119
Query: 718 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI 776
II+RDLK N++LD K++DFG+ K VDG + + GT Y+ PE
Sbjct: 120 ---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT--TRTFCGTPDYIAPEIIA 174
Query: 777 SQQLTDKSDVYSFGVILLELISGQEAISNE 806
Q D +++GV+L E+++GQ E
Sbjct: 175 YQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 35/216 (16%)
Query: 603 LEKKIGSGGFGVVYY----GKLKDGKEIAVKVLTSNSYQGKREFTNEVT-----LLSRIH 653
L K +G+G +G V+ GK A+KVL + ++ T E T +L +
Sbjct: 4 LLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALV-QKAKTVEHTRTERNVLEHVR 62
Query: 654 HRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-- 710
+ L Y Q E + L+ +++ G + HLY QR N+ +ED +
Sbjct: 63 QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY------QRDNF------SEDEVRFY 110
Query: 711 ------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 764
+E+LH I++RD+K NILLD ++DFGLSK + +
Sbjct: 111 SGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC 167
Query: 765 GTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISG 799
GT+ Y+ PE + K+ D +S G+++ EL++G
Sbjct: 168 GTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 28/208 (13%)
Query: 605 KKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQ 659
K++GSG +G V + G+++A+K L S +Q KR + E+TLL + H N++
Sbjct: 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKL-SRPFQSEIFAKRAY-RELTLLKHMQHENVIG 78
Query: 660 FLGY--CQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 713
L G LV +M K + G E ++ ++ G++
Sbjct: 79 LLDVFTSAVSGDEFQDFYLVMPYMQTDLQK--IMGHPLSEDKVQYL-----VYQMLCGLK 131
Query: 714 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 773
Y+H+ IIHRDLK N+ +++ K+ DFGL++ A A +V T Y PE
Sbjct: 132 YIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHA--DAEMTGYVV--TRWYRAPE 184
Query: 774 YYIS-QQLTDKSDVYSFGVILLELISGQ 800
++ D++S G I+ E+++G+
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 4e-10
Identities = 52/201 (25%), Positives = 88/201 (43%), Gaps = 13/201 (6%)
Query: 605 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNLVQ 659
K +G G FG V +LK E+ A+KVL + + T + L H L
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 660 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 719
Q + R V E+++ G L + ++ + + A + + +LH
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQI----QRSRKFDEPRSRFYAAEVTLALMFLHRH- 115
Query: 720 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 779
+I+RDLK NILLD K++DFG+ K + ++ GT Y+ PE +
Sbjct: 116 --GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC-GTPDYIAPEILQELE 172
Query: 780 LTDKSDVYSFGVILLELISGQ 800
D ++ GV++ E+++GQ
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-10
Identities = 48/164 (29%), Positives = 81/164 (49%), Gaps = 20/164 (12%)
Query: 644 NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLE 703
+E+ L+ H +V+ + + + +L+ E+ G L + + +QR+ + L
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI------KQRLK--EHLP 165
Query: 704 IAEDAAKGIEY--------LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755
E + Y +H+ ++HRDLKS+NI L K+ DFG SK D
Sbjct: 166 FQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222
Query: 756 AS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 798
S V+S GT YL PE + ++ + K+D++S GVIL EL++
Sbjct: 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 5e-10
Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 25/211 (11%)
Query: 607 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTNEVTLLS-RIHHRN-----LVQ 659
+G G FG V + K E+ A+K+L + + E T++ R+ + L Q
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDV--ECTMVEKRVLALSGKPPFLTQ 65
Query: 660 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR---LEIAEDAAKGIEYLH 716
Q R V E+++ G L + Q++ K + A + A G+ +LH
Sbjct: 66 LHSCFQTMDRLYFVMEYVNGGDLMYQI-------QQVGRFKEPHAVFYAAEIAIGLFFLH 118
Query: 717 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASHVSSIVRGTVGYLDPEYY 775
+ II+RDLK N++LD K++DFG+ K + DG + + GT Y+ PE
Sbjct: 119 S---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT--TKTFCGTPDYIAPEII 173
Query: 776 ISQQLTDKSDVYSFGVILLELISGQEAISNE 806
Q D ++FGV+L E+++GQ E
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 7e-10
Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 11/200 (5%)
Query: 606 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG--KREFTNEVTLLSRIHHRNLVQFLGY 663
++G+G GVV+ K I + L + + + E+ +L + +V F G
Sbjct: 12 ELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71
Query: 664 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 723
+G + E M G+L + L ++I + ++ IA KG+ YL I
Sbjct: 72 FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI--LGKVSIA--VIKGLTYLREK--HKI 125
Query: 724 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDK 783
+HRD+K SNIL++ K+ DFG+S +D S +S V GT Y+ PE + +
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFV-GTRSYMSPERLQGTHYSVQ 182
Query: 784 SDVYSFGVILLELISGQEAI 803
SD++S G+ L+E+ G+ I
Sbjct: 183 SDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 8e-10
Identities = 51/163 (31%), Positives = 82/163 (50%), Gaps = 32/163 (19%)
Query: 606 KIGSGGFGVVYYGKLKDGKEIAV--KVLTSNSYQGKREFT----NEVTLLSRIHHRNLVQ 659
KIG G FG V+ + K K+I KVL N +G F E+ +L + H N+V
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG---FPITALREIKILQLLKHENVVN 75
Query: 660 FLGYCQEE--------GRSVLVYEFMHNGTLKEH-LYGTLTHEQ---RINWIKRLEIAED 707
+ C+ + G LV+EF EH L G L+++ ++ IK+ + +
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFC------EHDLAGLLSNKNVKFTLSEIKK--VMKM 127
Query: 708 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 750
G+ Y+H I+HRD+K++NIL+ K K++DFGL++
Sbjct: 128 LLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 8e-10
Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 37/219 (16%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQ 659
+ + +GSG G V K + DG+ AVKV+ K EV L ++V+
Sbjct: 36 ISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVK 95
Query: 660 FLGYCQEE------------GRSVLVYEFMHNGTLKEHLYGT-------LTHEQRINWIK 700
C E+ LV ++ + G L++ + HE + +I+
Sbjct: 96 ----CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQ 151
Query: 701 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHV 759
L + ++H+ +IHRD+KS+NILL + K+ DFG SK +A + V
Sbjct: 152 VL-------LAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDV 201
Query: 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 798
GT Y+ PE + + + K+D++S GV+L EL++
Sbjct: 202 GRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLT 240
|
Length = 496 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 9e-10
Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 34/212 (16%)
Query: 605 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNLVQF 660
K IG G FG V + K +++ L S KR F E +++ + +VQ
Sbjct: 49 KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 661 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GI 712
Q++ +V E+M G L +N + ++ E AK +
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDL-------------VNLMSNYDVPEKWAKFYTAEVVLAL 155
Query: 713 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLD 771
+ +H+ +IHRD+K N+LLDKH K++DFG K G + V GT Y+
Sbjct: 156 DAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYIS 211
Query: 772 PEYYISQ----QLTDKSDVYSFGVILLELISG 799
PE SQ + D +S GV L E++ G
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 1e-09
Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 34/212 (16%)
Query: 605 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 660
K IG G FG V + K K++ A+K+L+ + + F E +++ + +VQ
Sbjct: 49 KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL 108
Query: 661 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GI 712
Q++ +V E+M G L +N + +I E A+ +
Sbjct: 109 HYAFQDDKYLYMVMEYMPGGDL-------------VNLMSNYDIPEKWARFYTAEVVLAL 155
Query: 713 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLD 771
+ +H+ IHRD+K N+LLDK K++DFG K +G + V GT Y+
Sbjct: 156 DAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYIS 211
Query: 772 PEYYISQ----QLTDKSDVYSFGVILLELISG 799
PE SQ + D +S GV L E++ G
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 26/212 (12%)
Query: 603 LEKKIGSGGFGVVYYGKL----KDGKEIAVKVLTSNSYQGKREFT----NEVTLLSRIHH 654
L K +G+G +G V+ + GK A+KVL + K + T E +L I
Sbjct: 4 LLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 63
Query: 655 RNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIK---RLEIAEDAAK 710
+ L Y Q + + L+ ++++ G L HL QR + + ++ E
Sbjct: 64 SPFLVTLHYAFQTDTKLHLILDYINGGELFTHL------SQRERFKEQEVQIYSGE-IVL 116
Query: 711 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGY 769
+E+LH II+RD+K NILLD + ++DFGLSK F D S GT+ Y
Sbjct: 117 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFC-GTIEY 172
Query: 770 LDPEYYISQQLT-DKS-DVYSFGVILLELISG 799
+ P+ DK+ D +S GV++ EL++G
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 43/214 (20%)
Query: 607 IGSGGFGVVYYGKLKDGKE-IAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 661
+GSG +G V +A+K L S +Q KR + E+ LL + H N++ L
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKL-SRPFQSAIHAKRTY-RELRLLKHMDHENVIGLL 80
Query: 662 -----GYCQEEGRSV-LVYEFMH---NGTLKEHLYGTLTHEQRINWIKRL--EIAEDAAK 710
E+ + V LV M N +K L+ + I+ L +I +
Sbjct: 81 DVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQ---KLSDDH----IQFLVYQIL----R 129
Query: 711 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG-- 768
G++Y+H+ IIHRDLK SNI +++ K+ DFGL A H + G V
Sbjct: 130 GLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGL-------ARHTDDEMTGYVATR 179
Query: 769 -YLDPEYYIS-QQLTDKSDVYSFGVILLELISGQ 800
Y PE ++ D++S G I+ EL++G+
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 37/213 (17%)
Query: 605 KKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQ 659
K++GSG +G V + G ++A+K L +Q KR + E+ LL + H N++
Sbjct: 21 KQVGSGAYGTVCSALDRRTGAKVAIKKL-YRPFQSELFAKRAY-RELRLLKHMKHENVIG 78
Query: 660 FLG-YCQEEGRS-----VLVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 711
L + + LV FM G L +H E RI ++ KG
Sbjct: 79 LLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH---EKLSEDRIQFL-----VYQMLKG 130
Query: 712 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV---G 768
++Y+H IIHRDLK N+ +++ K+ DFGL A S + G V
Sbjct: 131 LKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL-------ARQTDSEMTGYVVTRW 180
Query: 769 YLDPEYYIS-QQLTDKSDVYSFGVILLELISGQ 800
Y PE ++ T D++S G I+ E+++G+
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 49/205 (23%), Positives = 93/205 (45%), Gaps = 18/205 (8%)
Query: 607 IGSGGFGVVYYGKLKDGK--------EIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV 658
+G G F ++ G ++ E+ +KVL + F +++S++ H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 659 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 718
G C S++V E++ G+L +L ++ IN +LE+A+ A + +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLK---KNKNLINISWKLEVAKQLAWALHFLED- 118
Query: 719 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV---SSIVRGTVGYLDPE-Y 774
+ H ++ + N+LL + K + K + G S I+ + ++ PE
Sbjct: 119 --KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECI 176
Query: 775 YISQQLTDKSDVYSFGVILLELISG 799
Q L+ +D +SFG L E+ SG
Sbjct: 177 ENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-09
Identities = 37/100 (37%), Positives = 54/100 (54%), Gaps = 3/100 (3%)
Query: 421 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF-SGCPDLRIIHLEDNQLTGPLPS 479
L L+G IP + L L+ L L NSL+G IP+ +L I+HL N TG +P
Sbjct: 267 LYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPV 326
Query: 480 SLMNLPNLRELYVQNNMLSGTVPSSLLSKN--VVLNYAGN 517
+L +LP L+ L + +N SG +P +L N VL+ + N
Sbjct: 327 ALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTN 366
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-09
Identities = 35/92 (38%), Positives = 50/92 (54%), Gaps = 1/92 (1%)
Query: 415 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQL 473
++ ++HL S N TG IP LT L L L L N +G IP + +L ++ L N L
Sbjct: 309 NLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNL 368
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 505
TG +P L + NL +L + +N L G +P SL
Sbjct: 369 TGEIPEGLCSSGNLFKLILFSNSLEGEIPKSL 400
|
Length = 968 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 26/208 (12%)
Query: 606 KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGK-REFTNEVTLLSRIHHRNLVQFLGY 663
++G G +G VY + G +A+K + + K + E+ +L + +V F G
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 664 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL---HTGCV 720
EG + E+M G+L + LY + I I KG+++L H
Sbjct: 68 FFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--- 123
Query: 721 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG---YLDPEYYIS 777
IIHRD+K +N+L++ + + K+ DFG+S + V+S+ + +G Y+ PE S
Sbjct: 124 --IIHRDVKPTNVLVNGNGQVKLCDFGVS------GNLVASLAKTNIGCQSYMAPERIKS 175
Query: 778 QQLTD------KSDVYSFGVILLELISG 799
+SDV+S G+ +LE+ G
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 30/207 (14%)
Query: 605 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQF 660
+ +G G FG+V + G+ +A+K + S KR + E+ LL + H N++
Sbjct: 16 QPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY-RELKLLKHLRHENII-- 72
Query: 661 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLE------IAEDAAKGIEY 714
S + + + L GT H R+ + LE +G++Y
Sbjct: 73 -------SLSDIFISPLEDIYFVTELLGTDLH--RLLTSRPLEKQFIQYFLYQILRGLKY 123
Query: 715 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 774
+H+ V +HRDLK SNIL++++ K+ DFGL++ ++ V T Y PE
Sbjct: 124 VHSAGV---VHRDLKPSNILINENCDLKICDFGLARIQ---DPQMTGYV-STRYYRAPEI 176
Query: 775 YISQQLTD-KSDVYSFGVILLELISGQ 800
++ Q D + D++S G I E++ G+
Sbjct: 177 MLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 606 KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRNLVQFLGY 663
K+G G + V+ G+ K +A+K + +G EV+LL + H N+V
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 664 CQEEGRSVLVYEFMHNGTLKEHL--YGTL--THEQRINWIKRLEIAEDAAKGIEYLHTGC 719
E LV+E++ + LK++L G L H +I + L +G+ Y H
Sbjct: 72 IHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLL-------RGLSYCHK-- 121
Query: 720 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYI-S 777
I+HRDLK N+L+++ K++DFGL++ +V ++ + +V T+ Y P+ + S
Sbjct: 122 -RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGS 178
Query: 778 QQLTDKSDVYSFGVILLELISGQ 800
+ + D++ G IL E+ +G+
Sbjct: 179 TEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-09
Identities = 54/171 (31%), Positives = 79/171 (46%), Gaps = 29/171 (16%)
Query: 596 IEDATKMLEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH 654
IE+ + K I G FG VY G K + K AVKV+ K + N+ +
Sbjct: 3 IEEFV--IVKPISRGAFGKVYLGRKKNNSKLYAVKVVK------KADMINKNMVHQVQAE 54
Query: 655 RNLV-----QF---LGYCQEEGRSV-LVYEFMHNGTLKE--HLYGTLTHEQRINWIKRLE 703
R+ + F L Y + +V LV E++ G +K H+YG E + +I +
Sbjct: 55 RDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVA 114
Query: 704 IAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 754
+A D YLH IIHRDLK N+L+ K++DFGLSK ++
Sbjct: 115 LALD------YLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN 156
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 46/191 (24%), Positives = 86/191 (45%), Gaps = 21/191 (10%)
Query: 645 EVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR-INWIKRLE 703
E LL ++H ++++ + +V LY LT R + + L
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLP-----HYSSDLYTYLTKRSRPLPIDQALI 161
Query: 704 IAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV 763
I + +G+ YLH IIHRD+K+ NI ++ + + D G ++F V + + +
Sbjct: 162 IEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--L 216
Query: 764 RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAI------SNEKFGANCRN--- 814
GTV PE + K+D++S G++L E+++ I + E++ +C +
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLL 276
Query: 815 -IVQWAKLHIE 824
I+ K+H E
Sbjct: 277 KIISTLKVHPE 287
|
Length = 357 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-09
Identities = 34/93 (36%), Positives = 51/93 (54%), Gaps = 1/93 (1%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSG-CPDLRIIHLEDNQ 472
P++ + LS+ L+G IP+D+ SSL L L GN L G IP+ L + L NQ
Sbjct: 140 PNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQ 199
Query: 473 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 505
L G +P L + +L+ +Y+ N LSG +P +
Sbjct: 200 LVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEI 232
|
Length = 968 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 37/219 (16%)
Query: 605 KKIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSY----QGKREFTNEVTLLSRIHHRNLVQ 659
K I +G +G VY + K+ ++ A+K + + Q ++ F E +L+ + +V
Sbjct: 7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFV-ERDILTFAENPFVVS 65
Query: 660 FLGYCQEEGRSVL--VYEFMHNG---TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 714
+C E + L V E++ G TL +++ G L + + R+ AE +EY
Sbjct: 66 M--FCSFETKRHLCMVMEYVEGGDCATLLKNI-GALPVD-----MARMYFAE-TVLALEY 116
Query: 715 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF--------------AVDGASHVS 760
LH I+HRDLK N+L+ K++DFGLSK D +
Sbjct: 117 LHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD 173
Query: 761 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 799
V GT Y+ PE + Q D ++ G+IL E + G
Sbjct: 174 KQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 66/264 (25%), Positives = 105/264 (39%), Gaps = 71/264 (26%)
Query: 603 LEKKIGSGGFGVVY------YGKLKDGKEIAVKVLTSNSYQGK-REFTNEVTLLSRI-HH 654
L K +G G FG V K +AVK+L + + + +E+ +L I +H
Sbjct: 11 LGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNH 70
Query: 655 RNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHL---------YGTLTHEQRINWIKRLEI 704
N+V LG C + G +++ EF G L L Y + +QR + +E
Sbjct: 71 LNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQ 130
Query: 705 A------------------------------------------ED-------AAKGIEYL 715
+ ED A+G+E+L
Sbjct: 131 SRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL 190
Query: 716 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTVGYLDPEY 774
+ IHRDL + NILL ++ K+ DFGL++ +V R + ++ PE
Sbjct: 191 AS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPES 247
Query: 775 YISQQLTDKSDVYSFGVILLELIS 798
+ T +SDV+SFGV+L E+ S
Sbjct: 248 IFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 34/92 (36%), Positives = 53/92 (57%), Gaps = 6/92 (6%)
Query: 709 AKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGT 766
A+G+E+L + C IHRDL + NILL ++ K+ DFGL++ +V R
Sbjct: 183 ARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 767 VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 798
+ ++ PE + T +SDV+SFGV+L E+ S
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 37/211 (17%)
Query: 607 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 661
+GSG +G V K G +AVK L S +Q KR + E+ LL + H N++ L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 82
Query: 662 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 713
RS E ++ L HL G + N +K ++ +D +G++
Sbjct: 83 DVFTP-ARS---LEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 134
Query: 714 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG---YL 770
Y+H+ IIHRDLK SN+ +++ K+ DFGL A H + G V Y
Sbjct: 135 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL-------ARHTDDEMTGYVATRWYR 184
Query: 771 DPEYYISQQLTDKS-DVYSFGVILLELISGQ 800
PE ++ +++ D++S G I+ EL++G+
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 51/202 (25%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 606 KIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRNLVQFLGY 663
K+G G + VY G+ K +A+K + +G EV+LL + H N+V
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 664 CQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRIN-WIKRLEIAEDAAKGIEYLHTGCV 720
E LV+E++ + LK++L G + + ++ +L +G+ Y H
Sbjct: 73 IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQL------LRGLNYCHR--- 122
Query: 721 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYI-SQ 778
++HRDLK N+L+++ K++DFGL++ ++ ++ + +V T+ Y P+ + S
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGST 180
Query: 779 QLTDKSDVYSFGVILLELISGQ 800
+ + D++ G I E+ +G+
Sbjct: 181 DYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 56/226 (24%), Positives = 95/226 (42%), Gaps = 54/226 (23%)
Query: 605 KKIGSGGFGVV---YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIH-HRNL 657
K++G G +G+V + + + +A+K +T S KR E+ LL H+N+
Sbjct: 6 KELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL-RELKLLRHFRGHKNI 64
Query: 658 V-----------QFLG-YCQEEGRSVLVYEFMHNGT------LKEHLYGTLTHEQRINWI 699
F Y EE +++ + +G + +Y L
Sbjct: 65 TCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILC-------- 116
Query: 700 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK----FAVDG 755
G++Y+H+ V +HRDLK N+L++ K+ DFGL++ +
Sbjct: 117 -----------GLKYIHSANV---LHRDLKPGNLLVNADCELKICDFGLARGFSENPGEN 162
Query: 756 ASHVSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 800
A ++ V T Y PE +S Q K+ DV+S G IL EL+ +
Sbjct: 163 AGFMTEYV-ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 29/207 (14%)
Query: 607 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREF---TNEVTLLSRIHHRNLVQFLG 662
IG G + V +LK +I A+KV+ + E + + + L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 663 YC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIE 713
C Q R LV E+++ G L H+ QR ++ E+ A+ +
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHM-----QRQR-------KLPEEHARFYAAEICIALN 110
Query: 714 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 773
+LH II+RDLK N+LLD K++D+G+ K + G +S GT Y+ PE
Sbjct: 111 FLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGL-GPGDTTSTFCGTPNYIAPE 166
Query: 774 YYISQQLTDKSDVYSFGVILLELISGQ 800
++ D ++ GV++ E+++G+
Sbjct: 167 ILRGEEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 25/218 (11%)
Query: 605 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 660
K IG G FG V KLK+ ++ A+K+L + E F E +L ++ +
Sbjct: 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66
Query: 661 LGYCQEEGRSVLVYEFMHNG---TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 717
Q+E LV ++ G TL L + ++ + IA D+ + Y
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY--- 123
Query: 718 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 777
+HRD+K NIL+D + +++DFG ++ + SS+ GT Y+ PE I
Sbjct: 124 ------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE--IL 175
Query: 778 QQLTD-------KSDVYSFGVILLELISGQEAISNEKF 808
Q + D + D +S GV + E++ G+ E
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 15/204 (7%)
Query: 605 KKIGSGGFGVVYYGKLKDGKEIA---VKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQF 660
++IG+G FG V ++ +A VK L +N S + + EF + + H N++Q
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 661 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 720
LG C E +LV+E+ G LK +L H + + +A + A G+ ++H
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK--- 117
Query: 721 PAIIHRDLKSSNILLDKHMRAKVSDFGL--SKFAVD---GASHVSSIVRGTVGYLDPEYY 775
+H DL N L + KV D+G+ S++ D +R L E++
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFH 177
Query: 776 ---ISQQLTDKSDVYSFGVILLEL 796
I+ + T S+V++ GV L EL
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 34/91 (37%), Positives = 52/91 (57%), Gaps = 4/91 (4%)
Query: 709 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTV 767
AKG+E+L + IHRDL + NILL ++ K+ DFGL++ +V R +
Sbjct: 189 AKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245
Query: 768 GYLDPEYYISQQLTDKSDVYSFGVILLELIS 798
++ PE + T +SDV+SFGV+L E+ S
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 50.2 bits (121), Expect = 4e-08
Identities = 25/61 (40%), Positives = 33/61 (54%), Gaps = 3/61 (4%)
Query: 439 SLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 496
+L L L N LT IPD F G P+L+++ L N LT P + LP+LR L + N
Sbjct: 1 NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 497 L 497
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 52/204 (25%), Positives = 103/204 (50%), Gaps = 21/204 (10%)
Query: 605 KKIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRNLVQFLG 662
+K+G G + V+ G+ K + +A+K + +G EV+LL + H N+V
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 663 YCQEEGRSVLVYEFMHNGTLKEHL--YGTLT--HEQRINWIKRLEIAEDAAKGIEYLHTG 718
+ LV+E++ + LK+++ G + H +I + L +G+ Y H
Sbjct: 72 IVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQIL-------RGLAYCHR- 122
Query: 719 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYI- 776
++HRDLK N+L+++ K++DFGL++ +V ++ + +V T+ Y P+ +
Sbjct: 123 --RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLG 178
Query: 777 SQQLTDKSDVYSFGVILLELISGQ 800
S + + + D++ G I E+ SG+
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 5e-08
Identities = 57/237 (24%), Positives = 92/237 (38%), Gaps = 41/237 (17%)
Query: 605 KKIGSGGFGVVYYG-KLKDGKEIAVKV----LTSNSYQGKREFTNEVTLLSRIHHRNLVQ 659
+ IG GG G VY + +A+K L+ N KR F E + + + H +V
Sbjct: 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKR-FLREAKIAADLIHPGIVP 66
Query: 660 FLGYCQEEGRSVLVY---EFMHNGTLKEHLYGTLT-------HEQRINWIKRLEIAEDAA 709
C + VY ++ TLK L ++ + L I
Sbjct: 67 VYSICSD---GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123
Query: 710 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-------------AVDGA 756
IEY+H+ ++HRDLK NILL + D+G + F
Sbjct: 124 ATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 757 SHVS-----SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF 808
+ S IV GT Y+ PE + ++ +D+Y+ GVIL ++++ +K
Sbjct: 181 CYSSMTIPGKIV-GTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG 236
|
Length = 932 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 17/201 (8%)
Query: 606 KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFLG 662
K+G G + VY G+ K G+ +A+K + +G FT E +LL + H N+V
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-PFTAIREASLLKDLKHANIVTLHD 70
Query: 663 YCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 720
+ LV+E++ LK+++ G + RL + + +G+ Y H
Sbjct: 71 IIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNV----RLFLFQ-LLRGLAYCHQ--- 121
Query: 721 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI-SQQ 779
++HRDLK N+L+ + K++DFGL++ A S S T+ Y P+ + S +
Sbjct: 122 RRVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYSNEVVTLWYRPPDVLLGSTE 180
Query: 780 LTDKSDVYSFGVILLELISGQ 800
+ D++ G I E+ +G+
Sbjct: 181 YSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 6e-08
Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 605 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTS---NSYQGKREFTNEVTLLSRIHHRNLVQF 660
K IG G +G+V K + +++A+K + + N KR E+ LL + H N++
Sbjct: 11 KPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTL-REIKLLRHLDHENVIAI 69
Query: 661 LGYCQEEGRSV-----LVYEFMHNGTLKEHLYG--TLTHEQRINWIKRLEIAEDAAKGIE 713
R +VYE M + L + + TL+ + ++ +L +G++
Sbjct: 70 KDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQL------LRGLK 122
Query: 714 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 773
Y+H+ ++HRDLK SN+LL+ + K+ DFGL++ + ++ V T Y PE
Sbjct: 123 YIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRAPE 178
Query: 774 YYIS-QQLTDKSDVYSFGVILLELISGQ 800
++ + T DV+S G I EL+ +
Sbjct: 179 LLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 8e-08
Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 29/207 (14%)
Query: 607 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREF----TNEVTLLSRIHHRNLVQFL 661
IG G + V +LK + I A+KV+ + T + +H LV
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 662 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIE 713
Q E R V E+++ G L H+ QR ++ E+ A+ +
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHM-----QRQR-------KLPEEHARFYSAEISLALN 110
Query: 714 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 773
YLH II+RDLK N+LLD K++D+G+ K + S+ GT Y+ PE
Sbjct: 111 YLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPE 166
Query: 774 YYISQQLTDKSDVYSFGVILLELISGQ 800
+ D ++ GV++ E+++G+
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 9e-08
Identities = 67/274 (24%), Positives = 98/274 (35%), Gaps = 77/274 (28%)
Query: 605 KKIGSGGFGVV-YYGKLKDGKEIAVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQF 660
K IG G FG V K GK A+K L + K + + E +L+ +V
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 661 LGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 718
Q+ L+ EF+ G L L Y T + + + R +AE
Sbjct: 67 YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSED-----VTRFYMAE------------ 109
Query: 719 CVPAI--------IHRDLKSSNILLDKHMRAKVSDFGLS------------------KFA 752
CV AI IHRD+K NIL+D+ K+SDFGLS K
Sbjct: 110 CVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSN 169
Query: 753 VDGASHVSSIV----------------------------RGTVGYLDPEYYISQQLTDKS 784
+ + +S+ GT Y+ PE ++ Q +
Sbjct: 170 KNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQEC 229
Query: 785 DVYSFGVILLELISGQEAISNEKFGANCRNIVQW 818
D +S G I+ E + G +E R I+ W
Sbjct: 230 DWWSLGAIMFECLIGWPPFCSENSHETYRKIINW 263
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-07
Identities = 35/102 (34%), Positives = 56/102 (54%), Gaps = 12/102 (11%)
Query: 702 LEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 760
L + AKG+ +L + C IHRDL + NILL K+ DFGL++ D + +
Sbjct: 217 LSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLAR---DIRNDSN 269
Query: 761 SIVRGT----VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 798
+V+G V ++ PE + T +SDV+S+G++L E+ S
Sbjct: 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 29/207 (14%)
Query: 607 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREF----TNEVTLLSRIHHRNLVQFL 661
IG G + V +LK + I A+KV+ + T + + +H LV
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 662 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIE 713
Q E R V EF+ G L H+ QR ++ E+ A+ +
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHM-----QRQR-------KLPEEHARFYSAEISLALN 110
Query: 714 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 773
+LH II+RDLK N+LLD K++D+G+ K + +S GT Y+ PE
Sbjct: 111 FLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI-RPGDTTSTFCGTPNYIAPE 166
Query: 774 YYISQQLTDKSDVYSFGVILLELISGQ 800
+ D ++ GV++ E+++G+
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 62/254 (24%), Positives = 97/254 (38%), Gaps = 49/254 (19%)
Query: 605 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQF 660
K IG G FG V + KD I A+K+L K + + E +L +V+
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66
Query: 661 LGYCQEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 718
Q++ L+ EF+ G + L TL+ E +I +A DA + +
Sbjct: 67 FYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF---- 122
Query: 719 CVPAIIHRDLKSSNILLDKHMRAKVSDFGL---------------------SKFAVDGAS 757
IHRD+K N+LLD K+SDFGL S F+ +
Sbjct: 123 -----IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 758 -------------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAIS 804
++ GT Y+ PE ++ D +S GVI+ E++ G
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 805 NEKFGANCRNIVQW 818
+E R ++ W
Sbjct: 238 SETPQETYRKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-07
Identities = 31/88 (35%), Positives = 48/88 (54%), Gaps = 1/88 (1%)
Query: 421 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPS 479
LS +L+G IP + +L +L L L N+ TG IP + P L+++ L N+ +G +P
Sbjct: 291 LSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPK 350
Query: 480 SLMNLPNLRELYVQNNMLSGTVPSSLLS 507
+L NL L + N L+G +P L S
Sbjct: 351 NLGKHNNLTVLDLSTNNLTGEIPEGLCS 378
|
Length = 968 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 52/200 (26%), Positives = 91/200 (45%), Gaps = 16/200 (8%)
Query: 605 KKIGSGGFGVVYYGKLKDGK--EIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQ 659
+ +G+G FG V K+ +A+K + +++ +E +L+ I+H V
Sbjct: 36 RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVN 95
Query: 660 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 719
G ++E LV EF+ G + L +R A EYL +
Sbjct: 96 LYGSFKDESYLYLVLEFVIGG----EFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS-- 149
Query: 720 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 779
I++RDLK N+LLDK K++DFG +K VD ++ + GT Y+ PE ++
Sbjct: 150 -LNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-VDTRTYT---LCGTPEYIAPEILLNVG 204
Query: 780 LTDKSDVYSFGVILLELISG 799
+D ++ G+ + E++ G
Sbjct: 205 HGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 2e-07
Identities = 63/236 (26%), Positives = 90/236 (38%), Gaps = 55/236 (23%)
Query: 605 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQG----KREFTNEVTLLSRIHHRNLVQ 659
K +G G G V+ +LK GK A+KVL KR T E +L+ + H L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLT-EQEILATLDHPFLPT 65
Query: 660 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------G 711
Q E LV ++ G L+ L + K L E+ A+
Sbjct: 66 LYASFQTETYLCLVMDYCPGG----ELFRLLQRQPG----KCLS--EEVARFYAAEVLLA 115
Query: 712 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR------- 764
+EYLH I++RDLK NILL + +SDF LSK + VS +R
Sbjct: 116 LEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSS 172
Query: 765 ---------------------GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 799
GT Y+ PE D ++ G++L E++ G
Sbjct: 173 VNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 61/254 (24%), Positives = 97/254 (38%), Gaps = 49/254 (19%)
Query: 605 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQF 660
K IG G FG V + KD G A+K+L K + + E +L +V+
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66
Query: 661 LGYCQEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 718
Q++ L+ EF+ G + L TLT E+ +I +A D+ + +
Sbjct: 67 FYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF---- 122
Query: 719 CVPAIIHRDLKSSNILLDKHMRAKVSDFGL---------------------SKFAVDGAS 757
IHRD+K N+LLD K+SDFGL S F +
Sbjct: 123 -----IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177
Query: 758 -------------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAIS 804
++ GT Y+ PE ++ D +S GVI+ E++ G
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 805 NEKFGANCRNIVQW 818
+E + ++ W
Sbjct: 238 SETPQETYKKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-07
Identities = 34/102 (33%), Positives = 57/102 (55%), Gaps = 12/102 (11%)
Query: 702 LEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 760
L A+G+E+L + CV HRDL + N+LL + K+ DFGL++ + +++VS
Sbjct: 240 LSFTYQVARGMEFLASKNCV----HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS 295
Query: 761 SIVRGT----VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 798
+G+ V ++ PE T SDV+S+G++L E+ S
Sbjct: 296 ---KGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 5e-07
Identities = 53/222 (23%), Positives = 101/222 (45%), Gaps = 42/222 (18%)
Query: 605 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 663
+ +G G G+V+ D K +AVK + Q + E+ ++ R+ H N+V+
Sbjct: 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK---- 66
Query: 664 CQEEGRSVLVYEFM-HNGTLKEHLYGTLTHEQRI------------NWIKRLEIAEDAAK 710
VYE + +G+ G+LT + N +++ ++E+ A+
Sbjct: 67 ---------VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHAR 117
Query: 711 --------GIEYLHTGCVPAIIHRDLKSSNILLD-KHMRAKVSDFGLSKFAVDGASHVSS 761
G++Y+H+ V +HRDLK +N+ ++ + + K+ DFGL++ SH
Sbjct: 118 LFMYQLLRGLKYIHSANV---LHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY 174
Query: 762 IVRGTVG--YLDPEYYIS-QQLTDKSDVYSFGVILLELISGQ 800
+ G V Y P +S T D+++ G I E+++G+
Sbjct: 175 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 5e-07
Identities = 55/213 (25%), Positives = 102/213 (47%), Gaps = 41/213 (19%)
Query: 607 IGSGGFGVV---YYGKLKDGKEIAVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQF 660
+GSG +G V Y +L+ +++AVK L S +Q R E+ LL + H N++
Sbjct: 23 VGSGAYGSVCSAYDTRLR--QKVAVKKL-SRPFQSLIHARRTYRELRLLKHMKHENVIGL 79
Query: 661 LGYCQEEGRSVLVYEFMHNGTLKE----HLYGTLTHEQRINWIKRLEIAEDAA------- 709
L F +++ +L L N +K +++++
Sbjct: 80 LDV------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQL 127
Query: 710 -KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 768
+G++Y+H+ IIHRDLK SN+ +++ ++ DFGL++ A D ++ V T
Sbjct: 128 LRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADD---EMTGYV-ATRW 180
Query: 769 YLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 800
Y PE ++ +++ D++S G I+ EL+ G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 20/203 (9%)
Query: 606 KIGSGGFGVVYYGK-LKDG-KEIAVK-VLTSNSYQGKREFT-NEVTLLSRIH---HRNLV 658
+IG G +G V+ + LK+G + +A+K V +G T EV +L + H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 659 QFLGYC-----QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 713
+ C E + LV+E + + L +L IK ++ +G++
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIK--DMMFQLLRGLD 124
Query: 714 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 773
+LH+ ++HRDLK NIL+ + K++DFGL++ + S +V T+ Y PE
Sbjct: 125 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAPE 179
Query: 774 YYISQQLTDKSDVYSFGVILLEL 796
+ D++S G I E+
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 6e-07
Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 34/212 (16%)
Query: 605 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNLVQF 660
K IG G FG V + K +++ L S KR F E +++ + +VQ
Sbjct: 49 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 661 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GI 712
Q++ +V E+M G L +N + ++ E A+ +
Sbjct: 109 FYAFQDDRYLYMVMEYMPGGDL-------------VNLMSNYDVPEKWARFYTAEVVLAL 155
Query: 713 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLD 771
+ +H+ IHRD+K N+LLDK K++DFG K +G + V GT Y+
Sbjct: 156 DAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYIS 211
Query: 772 PEYYISQ----QLTDKSDVYSFGVILLELISG 799
PE SQ + D +S GV L E++ G
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 6e-07
Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 27/211 (12%)
Query: 605 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 660
K IG G FG V K+K+ ++ A+K+L + E F E +L R +
Sbjct: 7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL 66
Query: 661 LGYCQEEGRSVLVYEFMHNG---TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 717
Q+E LV ++ G TL L + ++ + +A D+ + Y
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGY--- 123
Query: 718 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLDPEYYI 776
+HRD+K N+LLDK+ +++DFG + DG S++ GT Y+ PE I
Sbjct: 124 ------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ-SNVAVGTPDYISPE--I 174
Query: 777 SQQLTD-------KSDVYSFGVILLELISGQ 800
Q + D + D +S GV + E++ G+
Sbjct: 175 LQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 6e-07
Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 25/213 (11%)
Query: 607 IGSGGFGVVYYGKLKDGKE-IAVK-VLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 664
IG+G FGVVY D E +A+K VL Y+ + E+ ++ ++H N++ Y
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR-----ELLIMKNLNHINIIFLKDYY 128
Query: 665 QEEG-----RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE----DAAKGIEYL 715
E +++ + M H Y + H R N L + + + + Y+
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKY--MKHYARNNHALPLFLVKLYSYQLCRALAYI 186
Query: 716 HTGCVPAIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 774
H+ I HRDLK N+L+D + K+ DFG +K + G VS I + Y PE
Sbjct: 187 HS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC--SRFYRAPEL 241
Query: 775 YI-SQQLTDKSDVYSFGVILLELISGQEAISNE 806
+ + T D++S G I+ E+I G S +
Sbjct: 242 MLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQ 274
|
Length = 440 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 8e-07
Identities = 50/181 (27%), Positives = 66/181 (36%), Gaps = 50/181 (27%)
Query: 701 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL---------SKF 751
R IAE IE +H IHRD+K NIL+D+ K++DFGL SK+
Sbjct: 104 RFYIAE-LTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159
Query: 752 AVDGASH----------VSSIVR-----------------------GTVGYLDPEYYISQ 778
G H S I R GT Y+ PE +
Sbjct: 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT 219
Query: 779 QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK-LHIESGDIQGIIDPSLL 837
T D +S GVIL E++ GQ + ++ W LHI S Q +
Sbjct: 220 GYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPS---QAKLSREAS 276
Query: 838 D 838
D
Sbjct: 277 D 277
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 9e-07
Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 25/210 (11%)
Query: 605 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 660
K IG G FG V K+K + I A+K+L + E F E +L + +
Sbjct: 7 KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTL 66
Query: 661 LGYCQEEGRSVLVYEFMHNG---TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 717
Q+E LV ++ G TL L + +I + +A + + Y
Sbjct: 67 HYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHY--- 123
Query: 718 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 777
+HRD+K N+LLD + +++DFG + SS+ GT Y+ PE I
Sbjct: 124 ------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE--IL 175
Query: 778 QQLTD-------KSDVYSFGVILLELISGQ 800
Q + D + D +S GV + E++ G+
Sbjct: 176 QAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 58/233 (24%), Positives = 98/233 (42%), Gaps = 43/233 (18%)
Query: 593 LSDIEDATKMLEKKIGSGGFGVVYYGKLK----------------DGKEIAVKVLTSNSY 636
L DI ++K IG GGFG VY + + + I ++ L N+
Sbjct: 6 LIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNI 65
Query: 637 QGKREFTNEVTLLSRIH---HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE 693
+++ L IH H + ++ G C R + Y F+ L E L T E
Sbjct: 66 YDI----DKIALWKNIHNIDHLGIPKYYG-CGSFKRCRMYYRFI----LLEKLVEN-TKE 115
Query: 694 --QRI-NWIKRL--EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 748
+RI K+L I +D +EY+H I H D+K NI++D + R + D+G+
Sbjct: 116 IFKRIKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGI 172
Query: 749 SKFAVDGASHVS------SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLE 795
+ + H+ + RGT+ Y + + +T + D+ S G +L+
Sbjct: 173 ASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-06
Identities = 33/102 (32%), Positives = 59/102 (57%), Gaps = 12/102 (11%)
Query: 702 LEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 760
L + A+G+++L + C IHRD+ + N+LL AK+ DFGL++ ++ +++V
Sbjct: 215 LRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV- 269
Query: 761 SIVRGT----VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 798
V+G V ++ PE T +SDV+S+G++L E+ S
Sbjct: 270 --VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 37/219 (16%)
Query: 606 KIGSGGFGVVYYGKLKDG---KEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLV-- 658
K+G G +G VY K KDG KE A+K + T S R E+ LL + H N++
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACR----EIALLRELKHPNVIAL 63
Query: 659 QFLGYCQEEGRSVLVYEFMHNGTLKEH-LYGTLT-HEQRINWIKRLEIAEDAAK------ 710
Q + + + L++++ EH L+ + H K +++ K
Sbjct: 64 QKVFLSHSDRKVWLLFDY------AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQI 117
Query: 711 --GIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSI-- 762
GI YLH V +HRDLK +NIL+ + R K++D G ++ ++ +
Sbjct: 118 LDGIHYLHANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174
Query: 763 VRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQ 800
V T Y PE + ++ T D+++ G I EL++ +
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 6e-06
Identities = 56/228 (24%), Positives = 98/228 (42%), Gaps = 26/228 (11%)
Query: 580 LNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK 639
++D PA A + + +T+ E G GK K + IA +V +
Sbjct: 153 IDDLPAGAFGKIFICALRASTEEAEA---RRGVNSTNQGKPKCERLIAKRV--KAGSRAA 207
Query: 640 REFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV--------YEFMHNGTLKEHLYGTLT 691
+ NE+ L R++H N+++ + E + ++ Y FM++ L
Sbjct: 208 IQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLK 267
Query: 692 HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG-LSK 750
+ I +K+L A +EY+H +IHRD+K NI L+ + + DFG
Sbjct: 268 QTRAI--MKQLLCA------VEYIHD---KKLIHRDIKLENIFLNCDGKIVLGDFGTAMP 316
Query: 751 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 798
F + + V GTV PE + +D++S G+ILL+++S
Sbjct: 317 FEKEREAFDYGWV-GTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 6e-06
Identities = 37/150 (24%), Positives = 63/150 (42%), Gaps = 16/150 (10%)
Query: 605 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV--QFLG 662
K + G VY KD +K+ S RE EV +L + + L + L
Sbjct: 4 KLLKGGLTNRVYLLGTKDED-YVLKINPSREKGADRE--REVAILQLLARKGLPVPKVLA 60
Query: 663 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 722
+ +G S L+ E++ TL E ++ E++ + IAE A+ + LH +
Sbjct: 61 SGESDGWSYLLMEWIEGETLDE-----VSEEEKED------IAEQLAELLAKLHQLPLLV 109
Query: 723 IIHRDLKSSNILLDKHMRAKVSDFGLSKFA 752
+ H DL NIL+D + D+ + +
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 7e-06
Identities = 28/80 (35%), Positives = 40/80 (50%), Gaps = 8/80 (10%)
Query: 723 IIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 781
IIH D+K N+L D+ R + D+GL K S GT+ Y PE I
Sbjct: 130 IIHNDIKLENVLYDRAKDRIYLCDYGLCK-----IIGTPSCYDGTLDYFSPE-KIKGHNY 183
Query: 782 DKS-DVYSFGVILLELISGQ 800
D S D ++ GV+ EL++G+
Sbjct: 184 DVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 7e-06
Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLV 658
+++ IG G +GVV G+++A+K + + ++ + T E+ LL + H ++V
Sbjct: 4 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIV 62
Query: 659 Q----FLGYCQEEGRSV-LVYEFMH---------NGTL-KEH----LYGTLTHEQRINWI 699
+ L + E + + +V+E M N L EH LY L
Sbjct: 63 EIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLL--------- 113
Query: 700 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASH 758
+ ++Y+HT V HRDLK NIL + + K+ DFGL++ A D +
Sbjct: 114 ----------RALKYIHTANV---FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 160
Query: 759 V--SSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQ 800
+ + V T Y PE S + T D++S G I E+++G+
Sbjct: 161 IFWTDYV-ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 8e-06
Identities = 55/207 (26%), Positives = 88/207 (42%), Gaps = 22/207 (10%)
Query: 607 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQFLG 662
+G G FG V + K +I A+KV+ + + F E +LS + + Q
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68
Query: 663 YCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 720
Q++ LV E+ G L L Y E + +AE + +H+
Sbjct: 69 AFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMA----QFYLAEL----VLAIHSVHQ 120
Query: 721 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR-GTVGYLDPEYYISQQ 779
+HRD+K N+L+D+ K++DFG S + V+S + GT Y+ PE +
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFG-SAARLTANKMVNSKLPVGTPDYIAPEVLTTMN 179
Query: 780 LTDKS------DVYSFGVILLELISGQ 800
K D +S GVI E+I G+
Sbjct: 180 GDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-06
Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 606 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLG-Y 663
K+G G +G VY K KDGK+ L G E+ LL + H N++ +
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 664 CQEEGRSV-LVYEFMHNG---TLKEHLYGTLTHEQRINWIKRL--EIAEDAAKGIEYLHT 717
R V L++++ + +K H + +++ + + + + GI YLH
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFH-RASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126
Query: 718 GCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSI--VRGTVGYLD 771
V +HRDLK +NIL+ + R K++D G ++ ++ + V T Y
Sbjct: 127 NWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 772 PEYYI-SQQLTDKSDVYSFGVILLELISGQ 800
PE + ++ T D+++ G I EL++ +
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 1e-05
Identities = 48/211 (22%), Positives = 82/211 (38%), Gaps = 30/211 (14%)
Query: 608 GSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLGY 663
+V+ K K +AVK + K + E+ ++ H N++ ++
Sbjct: 9 CFEDLMIVHLAKHKPTNTLVAVKK-INLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTS 67
Query: 664 CQEEGRSVLVYEFMHNGT----LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-G 718
+ +V M G+ LK H L E I +I + D ++Y+H+ G
Sbjct: 68 FIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP-ELAIAFILK-----DVLNALDYIHSKG 121
Query: 719 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG------YLDP 772
IHR +K+S+ILL + +S S + + +L P
Sbjct: 122 F----IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177
Query: 773 EYYISQQL---TDKSDVYSFGVILLELISGQ 800
E + Q L +KSD+YS G+ EL +G
Sbjct: 178 EV-LQQNLQGYNEKSDIYSVGITACELANGH 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 30/95 (31%), Positives = 56/95 (58%), Gaps = 12/95 (12%)
Query: 709 AKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT- 766
A G+E+L + CV HRDL + N+L+ + K+ DFGL++ + ++++S +G+
Sbjct: 249 ANGMEFLASKNCV----HRDLAARNVLICEGKLVKICDFGLARDIMRDSNYIS---KGST 301
Query: 767 ---VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 798
+ ++ PE + T SDV+SFG++L E+ +
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 5e-05
Identities = 27/76 (35%), Positives = 41/76 (53%), Gaps = 1/76 (1%)
Query: 423 SKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLM 482
S N ++P ++ LS+L EL L NS+ + S +L + L +N+L LP S+
Sbjct: 194 SGNKISDLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLE-DLPESIG 252
Query: 483 NLPNLRELYVQNNMLS 498
NL NL L + NN +S
Sbjct: 253 NLSNLETLDLSNNQIS 268
|
Length = 394 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 41/220 (18%)
Query: 607 IGSGGFGVVYYGKLKD---------GKEIAV--KVLTSNSYQGKREFTNEVTLLSRIHHR 655
+G G F +Y G L+ G+E++V KVL S+ ++ F +L+S++ H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSD-HRDSLAFFETASLMSQLSHK 61
Query: 656 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRIN----WIKRLEIAEDAAKG 711
+LV+ G C + +++V E++ G L L H ++ N W +L++A+ A
Sbjct: 62 HLVKLYGVCVRDE-NIMVEEYVKFGPLDVFL-----HREKNNVSLHW--KLDVAKQLASA 113
Query: 712 IEYLHTGCVPAIIHRDLKSSNILLDKH-------MRAKVSDFGLSKFAVDGASHVSSIVR 764
+ YL ++H ++ NIL+ ++ K+SD G+ + V I
Sbjct: 114 LHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI-- 168
Query: 765 GTVGYLDPEYY--ISQQLTDKSDVYSFGVILLELISGQEA 802
++ PE LT +D +SFG LLE+ S E
Sbjct: 169 ---PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEE 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 7e-05
Identities = 47/195 (24%), Positives = 81/195 (41%), Gaps = 25/195 (12%)
Query: 643 TNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL 702
+E LL R+ H ++ L G + LV + LY L R+ +
Sbjct: 208 VHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRS-----DLYTYLG--ARLRPLGLA 260
Query: 703 EIAEDAAK---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759
++ A + I+Y+H IIHRD+K+ N+L++ + DFG + FA S
Sbjct: 261 QVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFA--RGSWS 315
Query: 760 SSIVRGTVGYLD---PEYYISQQLTDKSDVYSFGVILLE-------LISGQEAISNEKFG 809
+ G G +D PE T D++S G+++ E L S +
Sbjct: 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYD 375
Query: 810 ANCRNIVQWAKLHIE 824
A I++ A++H++
Sbjct: 376 AQILRIIRQAQVHVD 390
|
Length = 461 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 9e-05
Identities = 27/88 (30%), Positives = 47/88 (53%), Gaps = 8/88 (9%)
Query: 603 LEKKIGSGGFGVVY------YGKLKDGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRI-HH 654
K +G+G FG V GK + +AVK+L ++++ +RE +E+ +LS + H
Sbjct: 42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQH 101
Query: 655 RNLVQFLGYCQEEGRSVLVYEFMHNGTL 682
+N+V LG C G +++ E+ G L
Sbjct: 102 KNIVNLLGACTHGGPVLVITEYCCYGDL 129
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 9e-05
Identities = 58/230 (25%), Positives = 96/230 (41%), Gaps = 28/230 (12%)
Query: 578 SSLNDAPAEAAHCFTLSDIEDATKM---LEKKIGSGGFGVVY----YGKLKDGKEIAVKV 630
S D E + SD +M + + G G V+ +G + K++ VK
Sbjct: 68 SPQTDVCQEPCETTSSSDPASVVRMQYNILSSLTPGSEGEVFVCTKHGD-EQRKKVIVKA 126
Query: 631 LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL-GYCQEEGRSVLVYEFMHNGTLKEHLYGT 689
+T G + E+ +L I HR ++ + Y + +++ ++ + G
Sbjct: 127 VT-----GGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGP 181
Query: 690 LTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 749
L EQ I +RL A + YLH IIHRD+K+ NI LD+ A + DFG +
Sbjct: 182 LPLEQAITIQRRLLEA------LAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAA 232
Query: 750 KFAVDGASHVSSIVRGTVGYLD---PEYYISQQLTDKSDVYSFGVILLEL 796
A + G G L+ PE K+D++S G++L E+
Sbjct: 233 --CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 39/146 (26%), Positives = 60/146 (41%), Gaps = 15/146 (10%)
Query: 656 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIE 713
N+V Y E LV + G L H+ + + E W + +A DA
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100
Query: 714 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 773
LH I+ RDL +NILLD +++ F V+ + ++ Y PE
Sbjct: 101 -LHR---EGIVCRDLNPNNILLDDRGHIQLTYFS-RWSEVEDSCDGEAVENM---YCAPE 152
Query: 774 YYISQQLTDKSDVYSFGVILLELISG 799
+ T+ D +S G IL EL++G
Sbjct: 153 VGGISEETEACDWWSLGAILFELLTG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-04
Identities = 73/296 (24%), Positives = 103/296 (34%), Gaps = 105/296 (35%)
Query: 603 LEKKIGSGGFGVVYYG-----KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN- 656
L KK+G G FGVVY + K + +K + Y + NE R N
Sbjct: 136 LGKKLGEGAFGVVYKASLVNKQSKKEGKYVLK--KATEYGAVEIWMNERV---RRACPNS 190
Query: 657 ----LVQFLGYCQEEGRSV--LVYEFMHNGTL------KEHLYGTLTHEQRINWIKRLEI 704
+ FL + LV+ + TL KE Y E + L
Sbjct: 191 CADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNV---EPYL-----LGK 242
Query: 705 AEDAAKGIEY------------------LH-TGCVPAIIHRDLKSSNILLDKHMRA-KVS 744
+D KG+E LH TG I+HRD+K NI+ + + K+
Sbjct: 243 VQDLPKGLERENKIIQTIMRQILFALDGLHSTG----IVHRDVKPQNIIFSEGSGSFKII 298
Query: 745 DFGLSKFAVDGASHVSSIVRGTVGY------LDP------EYYISQQ------------- 779
D G A D +R + Y LDP +Y +S Q
Sbjct: 299 DLGA---AAD--------LRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATAL 347
Query: 780 --------LTDKSDVYSFGVILLE-----LISGQEAIS-NEKFGANCRNIVQWAKL 821
L D+ D+YS G+I L+ L S I N + N ++V W KL
Sbjct: 348 SPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKL 403
|
Length = 566 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 6e-04
Identities = 60/248 (24%), Positives = 93/248 (37%), Gaps = 61/248 (24%)
Query: 605 KKIGSGGFG-VVYYGKLKDGKEIAVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQF 660
K +G G FG V K+ A+K L + + + E +L+ + +V+
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 661 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 720
Q++ V +++ G + L + + R IAE IE +H
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVL---ARFYIAE-LTLAIESVHK--- 119
Query: 721 PAIIHRDLKSSNILLDKHMRAKVSDFGL---------SKFAVDGASHVS----------- 760
IHRD+K NIL+D K++DFGL SK+ G SH+
Sbjct: 120 MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKG-SHIRQDSMEPSDLWD 178
Query: 761 ----------------------------SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVI 792
S+V GT Y+ PE + + T D +S GVI
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLV-GTPNYIAPEVLLRKGYTQLCDWWSVGVI 237
Query: 793 LLELISGQ 800
L E++ GQ
Sbjct: 238 LFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 9e-04
Identities = 49/191 (25%), Positives = 84/191 (43%), Gaps = 21/191 (10%)
Query: 622 DGKEIAV--KVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679
+G+E+ V KVL + F +L+S++ H +L G C +++V EF+ +
Sbjct: 41 NGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEH 100
Query: 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM 739
G L L + W ++ +A+ A + YL ++H ++ + NILL +
Sbjct: 101 GPLDVCLRKEKGR-VPVAW--KITVAQQLASALSYLED---KNLVHGNVCAKNILLARLG 154
Query: 740 RA-------KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGV 791
A K+SD G+S A+ V I ++ PE L+ +D +SFG
Sbjct: 155 LAEGTSPFIKLSDPGVSFTALSREERVERI-----PWIAPECVPGGNSLSTAADKWSFGT 209
Query: 792 ILLELISGQEA 802
LLE+ E
Sbjct: 210 TLLEICFDGEV 220
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 35/114 (30%), Positives = 58/114 (50%), Gaps = 15/114 (13%)
Query: 605 KKIGSGGFGVVY----YGKLKDGK--EIAVKVLTSNSYQGKRE-FTNEVTLLSRI-HHRN 656
K +G+G FG V YG K +AVK+L +++ +RE +E+ +LS + +H N
Sbjct: 41 KTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHIN 100
Query: 657 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI--KRLEIAEDA 708
+V LG C G ++++ E+ G L L +R ++I K + AE A
Sbjct: 101 IVNLLGACTVGGPTLVITEYCCYGDLLNFL-----RRKRDSFICPKHEDHAEAA 149
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 36/112 (32%), Positives = 54/112 (48%), Gaps = 33/112 (29%)
Query: 708 AAKGIEYLH-TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV--- 763
A +G+ YLH G IHR++K+S+IL +S GL ++ G SH+ S+V
Sbjct: 110 ALRGLNYLHQNGY----IHRNIKASHIL--------ISGDGL--VSLSGLSHLYSLVRNG 155
Query: 764 -RGTVGYLDPEYYIS-----------QQLTD---KSDVYSFGVILLELISGQ 800
+ V Y P++ S Q L KSD+YS G+ EL +G+
Sbjct: 156 QKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.004
Identities = 40/149 (26%), Positives = 55/149 (36%), Gaps = 51/149 (34%)
Query: 724 IHRDLKSSNILLDKHMRAKVSDFGL---------SKFAVDGASHVS-------------- 760
IHRD+K NIL+D+ K++DFGL SK+ G HV
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSG-DHVRQDSMDFSNEWGDPA 181
Query: 761 -------------------------SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLE 795
S+V GT Y+ PE + T D +S GVIL E
Sbjct: 182 NCRCGDRLKPLERRAARQHQRCLAHSLV-GTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240
Query: 796 LISGQEAISNEKFGANCRNIVQW-AKLHI 823
++ GQ + ++ W LHI
Sbjct: 241 MLVGQPPFLAQTPLETQMKVINWQTSLHI 269
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 927 | |||
| PLN03150 | 623 | hypothetical protein; Provisional | 100.0 | |
| PF12819 | 347 | Malectin_like: Carbohydrate-binding protein of the | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.98 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.98 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.98 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.98 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.98 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.98 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.98 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.98 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.98 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.98 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.94 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.92 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.89 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.82 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.8 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.79 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.78 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.78 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.77 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.76 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.72 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.72 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.72 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.7 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.7 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.69 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.66 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.65 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.63 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.62 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.59 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.58 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.58 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.53 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.52 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.52 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.45 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.43 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.38 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.32 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.32 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.17 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.15 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.15 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.07 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.05 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.01 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.97 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.95 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.88 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.76 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.68 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 98.68 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.66 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 98.64 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.64 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.58 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.58 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.54 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.53 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.53 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.49 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.47 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.39 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.34 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.31 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.28 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.26 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.23 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.19 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.19 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 98.19 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.17 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.09 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.07 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.06 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.05 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.03 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.03 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.01 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.0 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.96 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 97.94 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 97.93 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 97.93 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 97.92 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.87 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 97.87 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.85 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.82 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 97.8 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 97.8 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.8 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 97.74 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 97.67 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.66 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 97.63 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 97.59 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.59 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 97.54 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.54 |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-84 Score=773.80 Aligned_cols=490 Identities=24% Similarity=0.402 Sum_probs=396.4
Q ss_pred HHhcccccCCCCceEecCCCCCcc-ccCCCeEEccCCccccCcceeeecCcccccccceeeeecCC-CCcceeeecccCC
Q 002409 20 LLLDSSSAQMPGFVSLNCGGNENF-TDEIGLQWIADDHLIYGEISNISVANETRKQYMTLRHFPAD-SRKYCYKLDVITR 97 (927)
Q Consensus 20 ~~~~~~~~~~~~~~~idcG~~~~~-~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~tlR~Fp~~-~~~~cy~l~~~~~ 97 (927)
+++..++.+.+++++||||++.++ +|.+|++|++|..|+.|.......+....+++.|+|+||.. ++++||+||++++
T Consensus 13 ~~~~~~~~~~~~~~~I~CGs~~~~~~d~~~~~w~~D~~~~~~~~~~~~~~~~~~~~~~t~R~F~~~~g~~~cY~~~~~~~ 92 (623)
T PLN03150 13 AVLASLASPEPFTMRISCGARVNVRTAPTNTLWYKDFAYTGGIPANATRPSFIAPPLKTLRYFPLSDGPENCYNINRVPK 92 (623)
T ss_pred HhhcccccCCCccEEEeCCCCCCcccCCCCCEEcCCcccccCccccccCcccccchhhccccCCcccccccceEeeecCC
Confidence 444444555779999999999987 67899999999998766555555555567889999999963 5667999999999
Q ss_pred ceEEEeEEeeecCcCCCCCCCeeEEEECCceeeEEeeC--CCCccEEEEEEEEecCCCceEEEecCCCCCceeeeeeeee
Q 002409 98 TRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVIS--DAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQ 175 (927)
Q Consensus 98 ~~ylvr~~f~yg~~d~~~~~p~fd~~~~~~~w~~v~~~--~~~~~~~~e~~~~~~~~~~~vcl~~~~~~~pfis~le~~~ 175 (927)
|||+||++|+|||||+.+++|.||+++|||+|.+|+.+ .++...++|+|+.+++++++|||+++++|.||||+||||+
T Consensus 93 g~ylVRl~F~~~~y~~~~~~~~Fdv~~~~~~~~tv~~~~~~~~~~v~~E~i~~~~~~~l~vcf~~~~~~~pFIs~iEv~~ 172 (623)
T PLN03150 93 GHYSVRVFFGLVAEPNFDSEPLFDVSVEGTQISSLKSGWSSHDEQVFAEALVFLTDGSASICFHSTGHGDPAILSIEILQ 172 (623)
T ss_pred CcEEEEEEeecCCcCCCCCCCceEEEECcEEEEEEecCcccCCCcEEEEEEEEecCCcEEEEEecCCCCCCceeEEEEEE
Confidence 99999999999999999999999999999999999873 3455788999999999999999999999999999999999
Q ss_pred cCCccccCc--ccCceeEEEEeeeccCCCC-CCCccCCCCCC--CCccccCccccccccccccCcccccccccccCC--C
Q 002409 176 FNGSVYLTP--FEDRYYLSVSARINFGADS-EAPVRYPDDPF--DRIWESDSLKKANYLVDVAAGTEKVSTKLPIDL--R 248 (927)
Q Consensus 176 l~~~~y~~~--~~~~~~l~~~~r~~~g~~~-~~~iryp~D~~--dR~W~p~~~~~~~~~~~~~~~~~~~st~~~i~~--~ 248 (927)
|++++|+.. .+.+.+|.+++|.++|+.. ...+|||||+| ||+|+|+..+. ...+.++++...|.. .
T Consensus 173 l~~~~y~~~~~~~~~~~L~~~~R~n~G~~~~~~~~d~~~D~~~~dR~W~~d~~~~-------~~~~~~~st~~~I~~~~~ 245 (623)
T PLN03150 173 VDDKAYNFGPSWGQGVILRTAKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFG-------SGSDQAISTENVIKKASN 245 (623)
T ss_pred cCcccccccccccCceEEEEEEEEEecCcccccccCCCCCcccCccccCcCcccC-------CCcccccccccccccccC
Confidence 999999644 2446789999999999853 34589999999 99999975321 112445566555553 3
Q ss_pred CCCCChHHHHhhcccccC--CceEEeecCCCCCCcceeEEeeccccC-CCCCcceEEEEEECCccccccceeccccccCc
Q 002409 249 SDELPPQKVMQTAVVGTN--GSLTYRLNLDGFPGFGWAVTYFAEIED-LDPDESRKFRLVLPGQPDVSKAIVNIQENAQG 325 (927)
Q Consensus 249 ~~~~pP~~V~qtA~t~~~--~~l~~~~~~~~~~~~~y~~~yFae~~~-~~~~~~R~F~i~in~~~~~~~~~~~~~~~~~~ 325 (927)
.++.+|+.|||||.++.+ ..++|.|++++.. .++++|||||++. ....++|+|||||||+...++.++... +.+
T Consensus 246 ~~~~~P~~VyqTA~~~~~~~~~lty~~~v~~~~-~Y~VrLhFaEi~~~~~~~~~R~F~V~ing~~~~~~~di~~~--~g~ 322 (623)
T PLN03150 246 APNFYPESLYQSALVSTDTQPDLSYTMDVDPNR-NYSVWLHFAEIDNSITAEGKRVFDVLINGDTAFKDVDIVKM--SGE 322 (623)
T ss_pred CCccChHHHhhhhccccCCCCceEEEeecCCCC-CEEEEEEEEeccCccCCCceEEEEEEECCEEeecccChhhh--cCC
Confidence 577889999999988766 3588888865433 4467999999984 567789999999999987776554321 112
Q ss_pred ceEEeccccccccccceeeeecccccccccCcccchhhhchhcccCC----CchHHHHHHHHhcCC---CCcCCCCCCCC
Q 002409 326 KYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERND----GSIDAIVSVISLYSS---ADWAQEGGDPC 398 (927)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~t~~s~lpPlina~e~~~~l~~~~----~~~dal~~~~~~~~~---~~w~~~~~dpC 398 (927)
.+..+...+...+..+.++++++++..+ +|+|||+|||++.+... .+++||..+|+.+.. .+| ++|||
T Consensus 323 ~~~~~~~~~~v~~~~g~l~isl~p~~~s--~pilNaiEI~~~~~~~~~t~~~~~~aL~~~k~~~~~~~~~~W---~g~~C 397 (623)
T PLN03150 323 RYTALVLNKTVAVSGRTLTIVLQPKKGT--HAIINAIEVFEIITAESKTLLEEVSALQTLKSSLGLPLRFGW---NGDPC 397 (623)
T ss_pred cccceEEEeEEeecCCeEEEEEeeCCCC--cceeeeeeeeeccccccccCchHHHHHHHHHHhcCCcccCCC---CCCCC
Confidence 2222221222212235678888887655 79999999999987543 456799999998753 378 68999
Q ss_pred CCC--CcceeecCCCC---CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCC
Q 002409 399 LPV--PWSWLQCNSDP---QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 472 (927)
Q Consensus 399 ~~~--~~~~v~C~~~~---~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~ 472 (927)
.|. .|.||.|+.+. ...++.|+|++|+|+|.+|..|++|++|+.|+|++|+|+|.+|. ++++++|+.|+|++|+
T Consensus 398 ~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~ 477 (623)
T PLN03150 398 VPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNS 477 (623)
T ss_pred CCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCC
Confidence 876 79999996432 23599999999999999999999999999999999999999996 8999999999999999
Q ss_pred cCCCCCccccCCCccccccccccccccccccccccc---cccccccCCcccccCC
Q 002409 473 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK---NVVLNYAGNINLHEGG 524 (927)
Q Consensus 473 l~g~~P~~l~~l~~L~~L~l~~N~l~g~iP~~l~~~---~~~l~~~~n~~l~~~~ 524 (927)
|+|.+|+.+++|++|+.|+|++|+|+|.+|..+... +..+.+.+|+.+|+.+
T Consensus 478 lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 478 FNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532 (623)
T ss_pred CCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCccccCCC
Confidence 999999999999999999999999999999987543 3467889999999764
|
|
| >PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan [] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-62 Score=548.10 Aligned_cols=319 Identities=36% Similarity=0.564 Sum_probs=251.0
Q ss_pred ecCCCCCc---ccc-CCCeEEccCCccc-cCcceeeec-----CcccccccceeeeecCCCCcceeeeccc--CCceEEE
Q 002409 35 LNCGGNEN---FTD-EIGLQWIADDHLI-YGEISNISV-----ANETRKQYMTLRHFPADSRKYCYKLDVI--TRTRYLI 102 (927)
Q Consensus 35 idcG~~~~---~~~-~~~~~~~~d~~~~-~~~~~~~~~-----~~~~~~~~~tlR~Fp~~~~~~cy~l~~~--~~~~ylv 102 (927)
||||++.+ |+| .+|++|++|++|+ +|..++++. .....++++|+|+||.|.| +||+||+. +|+||||
T Consensus 1 IdCG~~~~~s~y~D~~tg~~~~~D~~~~~~g~~~~i~~~~~~~~~~~~~~y~taR~F~~g~r-~cY~l~~~~~~~~~yli 79 (347)
T PF12819_consen 1 IDCGSSSNSSSYVDDSTGRTWVSDDDFIDTGKSGNISSQPDSSSSDSSPPYQTARIFPEGSR-NCYTLPVTPPGGGKYLI 79 (347)
T ss_pred CcCCCCCCCcccccCCCCcEEeCCCCcccCCCccccccccCCcCCccccccceEEEcCCCCc-cEEEeeccCCCCceEEE
Confidence 89998866 555 6899999999999 566666632 2234679999999998877 59999998 5779999
Q ss_pred eEEeeecCcCCCC-----CCCeeEEEECCceeeEEeeCCC-CccEEEEEEEEe-cCCCceEEEecCCCCC-ceeeeeeee
Q 002409 103 RATFLYGNFDNNN-----VYPKFDISLGPTHWSTIVISDA-ATIEVRELIFLA-SSPKIDVCLSNATTGQ-PFISTLELR 174 (927)
Q Consensus 103 r~~f~yg~~d~~~-----~~p~fd~~~~~~~w~~v~~~~~-~~~~~~e~~~~~-~~~~~~vcl~~~~~~~-pfis~le~~ 174 (927)
|++|+|||||+++ +||.|||++|+|.|++|+.++. ....++|.|+.+ ++++++|||+++++|+ ||||+||||
T Consensus 80 Rl~F~~gnyd~~~fs~~~~~~~FdL~~~~n~~~tV~~~~~~~~~~~~E~ii~v~~~~~l~vclv~~~~g~~pFIsaiEl~ 159 (347)
T PF12819_consen 80 RLHFYYGNYDGLNFSVSSSPPTFDLLLGFNFWSTVNLSNSPSSPVVKEFIINVTWSDTLSVCLVPTGSGTFPFISAIELR 159 (347)
T ss_pred EEEeccccccccccccccCCcceEEEECCceeEEEEecCCCcceEEEEEEEEEcCCCcEEEEEEeCCCCCCCceeEEEEE
Confidence 9999999999874 3789999999999999998762 246889955555 4899999999999999 999999999
Q ss_pred ecCCccccCc-ccCceeEEEEeeeccCCCCCCCccCCCCCCCCccccCccccccccccccCcccccccccccC---CCCC
Q 002409 175 QFNGSVYLTP-FEDRYYLSVSARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPID---LRSD 250 (927)
Q Consensus 175 ~l~~~~y~~~-~~~~~~l~~~~r~~~g~~~~~~iryp~D~~dR~W~p~~~~~~~~~~~~~~~~~~~st~~~i~---~~~~ 250 (927)
+|++++|+.. ...+.+|.++.|.++|+... .||||+|+|||+|+|+.. ...|.+++++.+++ ...+
T Consensus 160 ~lp~~ly~~~~~~~s~~L~~~~R~n~G~~~~-~iryp~D~~dR~W~~~~~---------~~~~~~ist~~~i~~~~~~~~ 229 (347)
T PF12819_consen 160 PLPDSLYPDTDANSSQALETVYRLNVGGSSS-FIRYPDDTYDRIWQPYSS---------SPGWSNISTTSNININSSNNP 229 (347)
T ss_pred ECCccceeccccCCCceeEEEEeecCCCccc-ccCCCCCcceeecccccc---------CccccccccceeeecccCCcc
Confidence 9999999533 35678899999999998654 399999999999998621 23456677766664 2358
Q ss_pred CCChHHHHhhcccccCCc--eEEeecCCCCCCcceeEEeeccccCCCCCc-ceEEEEEECCccccccceecc-ccccCcc
Q 002409 251 ELPPQKVMQTAVVGTNGS--LTYRLNLDGFPGFGWAVTYFAEIEDLDPDE-SRKFRLVLPGQPDVSKAIVNI-QENAQGK 326 (927)
Q Consensus 251 ~~pP~~V~qtA~t~~~~~--l~~~~~~~~~~~~~y~~~yFae~~~~~~~~-~R~F~i~in~~~~~~~~~~~~-~~~~~~~ 326 (927)
+.||++|||||+++.+.+ +.+.|..++....+|++|||||++....++ +|+|||||||+.+++ .+.+ .....+.
T Consensus 230 ~~~P~~V~~TA~~~~~~s~~~nltw~~~~~~~~y~v~lHFaEi~~~~~~~~~R~F~IyiN~~~~~~--~~~~~~~~~~~~ 307 (347)
T PF12819_consen 230 YDAPSAVYQTARTPSNSSDPLNLTWSFVDPGFSYYVRLHFAEIQSLSPNNNQREFDIYINGQTAYS--DVSPPYLGADTV 307 (347)
T ss_pred CcChHHHHHhhhcccccccceEEEeccCCCCccEEEEEEEeecccccCCCCeEEEEEEECCeEccC--ccCcccccCcce
Confidence 999999999999988775 888888755555567899999999985444 799999999998876 2322 1111111
Q ss_pred eEEeccccccccccceeeeecccccccccCcccchhhhchh
Q 002409 327 YRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKY 367 (927)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~t~~s~lpPlina~e~~~~ 367 (927)
..|..........+.++++|.++..|++||+|||+|||++
T Consensus 308 -~~~~d~~~~~~~~~~~~isL~~t~~S~lppiLNalEIy~v 347 (347)
T PF12819_consen 308 -PYYSDYVVNVPDSGFLNISLGPTPDSTLPPILNALEIYKV 347 (347)
T ss_pred -EeecceEEEecCCCEEEEEEEeCCCCCcCceeEeeeeEeC
Confidence 1222222233334467889999999999999999999974
|
This entry represents a malectin-like domain found in a number of plant receptor kinases. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-52 Score=528.35 Aligned_cols=440 Identities=27% Similarity=0.459 Sum_probs=309.3
Q ss_pred CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCcccccc
Q 002409 413 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 491 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~ 491 (927)
.++|+.|+|++|.+.|.+|..+.+|++|+.|+|++|.++|.+|. +.++++|+.|+|++|+++|.+|..+.++++|+.|+
T Consensus 498 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ 577 (968)
T PLN00113 498 LSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVN 577 (968)
T ss_pred hhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEe
Confidence 34566777777777777777777777777777777777777765 66677777777777777777777777777777777
Q ss_pred cccccccccccccc-ccccccccccCCcccccCCC-----------CcccceeeeccchhhhhhhhhhheeeeeeecCCC
Q 002409 492 VQNNMLSGTVPSSL-LSKNVVLNYAGNINLHEGGR-----------GAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKK 559 (927)
Q Consensus 492 l~~N~l~g~iP~~l-~~~~~~l~~~~n~~l~~~~~-----------~~~~~~vii~~~~~~~~lll~~~l~~~~~~~~kk 559 (927)
+++|+++|.+|..- +.......+.||+.+|+... +.....++++++++++++++++++++++++++++
T Consensus 578 ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 657 (968)
T PLN00113 578 ISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNN 657 (968)
T ss_pred ccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhc
Confidence 77777777777542 22333456789999997531 1111223333333333333222222222222211
Q ss_pred ccCcccccccCCCccCCCCCCCCCccccccccCHHHHHHHHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchh
Q 002409 560 NNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG 638 (927)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~ei~~~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~ 638 (927)
.+ .+..... ................+++.++... ....+.||+|+||.||+|+.. +++.||||++.....
T Consensus 658 ~~-~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-- 728 (968)
T PLN00113 658 LE-LKRVENE-----DGTWELQFFDSKVSKSITINDILSS-LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-- 728 (968)
T ss_pred cc-ccccccc-----cccccccccccccchhhhHHHHHhh-CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc--
Confidence 11 1100000 0000000000111122444454432 233568999999999999874 789999999864322
Q ss_pred hHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhC
Q 002409 639 KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 718 (927)
Q Consensus 639 ~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 718 (927)
...+|++.+++++||||++++++|.+.+..++||||+++|+|.++++ .++|..+.+|+.|+++||+|||..
T Consensus 729 --~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~ 799 (968)
T PLN00113 729 --IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCR 799 (968)
T ss_pred --ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccC
Confidence 22356889999999999999999999999999999999999999984 378999999999999999999977
Q ss_pred CCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh
Q 002409 719 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 798 (927)
Q Consensus 719 ~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt 798 (927)
+.++|+||||||+||+++.++.+++. ||.+...... ....||+.|+|||++.+..++.++|||||||++|||++
T Consensus 800 ~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~t 873 (968)
T PLN00113 800 CSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLT 873 (968)
T ss_pred CCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHh
Confidence 66799999999999999999988876 6665432211 12257899999999999999999999999999999999
Q ss_pred CCCcccccccccccchhhHHHHhhhccCCcccccCCcccCc--cCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHH
Q 002409 799 GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE--YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 876 (927)
Q Consensus 799 G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~ 876 (927)
|+.||+... .....+++|++...........+|+.+... .+.++..++.+++.+|++.+|++||+|.||++.|+++
T Consensus 874 g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 874 GKSPADAEF--GVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951 (968)
T ss_pred CCCCCCccc--CCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence 999995432 233467888887666666667777776543 3456777899999999999999999999999999987
Q ss_pred HH
Q 002409 877 IV 878 (927)
Q Consensus 877 ~~ 878 (927)
..
T Consensus 952 ~~ 953 (968)
T PLN00113 952 SR 953 (968)
T ss_pred hc
Confidence 54
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-52 Score=464.19 Aligned_cols=288 Identities=49% Similarity=0.859 Sum_probs=254.9
Q ss_pred cccccCHHHHHHHHHHHh--ccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecce
Q 002409 587 AAHCFTLSDIEDATKMLE--KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 664 (927)
Q Consensus 587 ~~~~~~~~ei~~~~~~~~--~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~ 664 (927)
..+.|++.++..+|.+|. +.||+|+||.||+|.+++++.||||++.....+..++|..|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 456799999999999996 799999999999999999999999988765433156699999999999999999999999
Q ss_pred eecC-eEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEE
Q 002409 665 QEEG-RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV 743 (927)
Q Consensus 665 ~~~~-~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL 743 (927)
.+.+ +.+||||||++|+|.++|+..... .++|..|++||.++|+||+|||+.+.+.|+||||||+|||||+++++||
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 9998 599999999999999999875433 8899999999999999999999999889999999999999999999999
Q ss_pred EeecCcccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhh
Q 002409 744 SDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 823 (927)
Q Consensus 744 ~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~ 823 (927)
+|||+|+.......+......||.+|+|||++..+..+.|+|||||||+|+||++|+.+.+... +.....+++|++..+
T Consensus 219 sDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~-~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR-PRGELSLVEWAKPLL 297 (361)
T ss_pred cCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC-CcccccHHHHHHHHH
Confidence 9999997554312222222179999999999999999999999999999999999999887655 344556999999999
Q ss_pred ccCCcccccCCccc-CccCH-HHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHH
Q 002409 824 ESGDIQGIIDPSLL-DEYDI-QSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 877 (927)
Q Consensus 824 ~~~~~~~~~d~~l~-~~~~~-~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~ 877 (927)
.++++.+++|+++. +.+.. +++.++.+++.+|++.+|++||+|.||++.|+.+.
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 99999999999997 66665 78899999999999999999999999999996553
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=392.98 Aligned_cols=253 Identities=35% Similarity=0.573 Sum_probs=210.8
Q ss_pred HhccccccCceEEEEEEECCCcE-EEEEEeecCCch--hhHhHHHHHHHHhhccCCCccceecceeecC-eEEEEEEecc
Q 002409 603 LEKKIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEEG-RSVLVYEFMH 678 (927)
Q Consensus 603 ~~~~IG~G~fG~Vy~~~~~~g~~-VAVK~l~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~~~lV~E~~~ 678 (927)
+.+.||+|+||+||+|.++ |+. ||||++...... ..+.|.+|+.+|.+++|||||+++|+|.+.. ..++|||||+
T Consensus 45 ~~~~iG~G~~g~V~~~~~~-g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWR-GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhcccCCceeEEEEEeC-CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 4566999999999999999 555 999999765322 2568999999999999999999999999987 7999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCc-eecCCCCCCCeEECCCC-cEEEEeecCcccccCCC
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA-IIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~-ivHrDLkp~NILl~~~~-~vkL~DFGla~~~~~~~ 756 (927)
+|+|.++++.. ....+++..++.++.|||+||.|||++ + ||||||||+|||++.++ ++||+|||+++......
T Consensus 124 ~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 124 GGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 99999999754 467899999999999999999999998 7 99999999999999997 99999999998654432
Q ss_pred CceeeeeccCCCccCccccc--cCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCC
Q 002409 757 SHVSSIVRGTVGYLDPEYYI--SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 834 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~--~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 834 (927)
...+...||+.|||||++. ...|+.|+||||||++||||+||+.||..... ..+...+.. .
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~----~~~~~~v~~---~--------- 261 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP----VQVASAVVV---G--------- 261 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH----HHHHHHHHh---c---------
Confidence 2223367999999999999 66999999999999999999999999987652 122222111 1
Q ss_pred cccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 835 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 835 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
..+...+......+..++.+|++.+|+.||++.|++..|+.+..
T Consensus 262 ~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 262 GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 11222333355678899999999999999999999999998865
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=386.43 Aligned_cols=261 Identities=28% Similarity=0.445 Sum_probs=220.4
Q ss_pred HHHHHHHHHhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEE
Q 002409 595 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 674 (927)
Q Consensus 595 ei~~~~~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~ 674 (927)
++......+.+.||+|-||.||.|+++....||+|.++... ...+.|.+|+++|++++|+|||+++|+|..++.++|||
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt 280 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT 280 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence 45556667789999999999999999977799999998653 34577889999999999999999999999999999999
Q ss_pred EeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccC
Q 002409 675 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 754 (927)
Q Consensus 675 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 754 (927)
|||+.|+|.++|.. ..+..+...+.+.++.|||+||+||+++ ++|||||.++||||+++..+||+|||+|+...+
T Consensus 281 E~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGD 355 (468)
T ss_pred EecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCC
Confidence 99999999999975 3467789999999999999999999999 999999999999999999999999999996555
Q ss_pred CCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccC
Q 002409 755 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 833 (927)
Q Consensus 755 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 833 (927)
..........-+..|.|||.+..+.++.|||||||||+||||+| |+.|+......+ +++ .+++|
T Consensus 356 ~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e----v~~----~le~G------- 420 (468)
T KOG0197|consen 356 DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE----VLE----LLERG------- 420 (468)
T ss_pred CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH----HHH----HHhcc-------
Confidence 54444444445678999999999999999999999999999999 888887655221 222 22222
Q ss_pred CcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 834 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 834 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
.+-..+..++..+.+++..|++.+|++|||+..+...|+.+..
T Consensus 421 --yRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 421 --YRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred --CcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 2223345566789999999999999999999999999888754
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=365.18 Aligned_cols=257 Identities=28% Similarity=0.398 Sum_probs=211.7
Q ss_pred ccCHHHHHHHHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecC-CchhhHhHHHHHHHHhhccCCCccceecceeec
Q 002409 590 CFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE 667 (927)
Q Consensus 590 ~~~~~ei~~~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~ 667 (927)
.++..|++. .+.||+|..|+|||++++ +++-+|+|++..+ .....+++.+|++++++++||+||.++|.|...
T Consensus 75 ~i~~~dle~-----~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~ 149 (364)
T KOG0581|consen 75 GISLSDLER-----LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSN 149 (364)
T ss_pred ccCHHHhhh-----hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC
Confidence 356666653 367999999999999988 5778999999654 345578899999999999999999999999999
Q ss_pred C-eEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEee
Q 002409 668 G-RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF 746 (927)
Q Consensus 668 ~-~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DF 746 (927)
+ ...++||||.+|+|++.+.. .+++++...-+|+.++++||.|||+. .+||||||||+|||++..|++|||||
T Consensus 150 ~~~isI~mEYMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDF 223 (364)
T KOG0581|consen 150 GEEISICMEYMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDF 223 (364)
T ss_pred CceEEeehhhcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccc
Confidence 8 49999999999999999853 36789999999999999999999974 29999999999999999999999999
Q ss_pred cCcccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCccccccc-ccccchhhHHHHhhhcc
Q 002409 747 GLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF-GANCRNIVQWAKLHIES 825 (927)
Q Consensus 747 Gla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~-~~~~~~l~~~~~~~~~~ 825 (927)
|.++...+. ......||..|||||.+.+..|+.++||||||+.++|+.+|+.|+..... ....-.+..++-...
T Consensus 224 GVS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~p-- 298 (364)
T KOG0581|consen 224 GVSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEP-- 298 (364)
T ss_pred cccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCC--
Confidence 999876554 44567799999999999999999999999999999999999999976421 112223333322211
Q ss_pred CCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 826 GDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 826 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.|++..+ ....++..++..|++.||.+||++.|+++|
T Consensus 299 -------pP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 299 -------PPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred -------CCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1222222 233468899999999999999999999987
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=370.78 Aligned_cols=253 Identities=26% Similarity=0.394 Sum_probs=204.5
Q ss_pred HHHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCch-------hhHhHHHHHHHHhhccCCCccceecceeecCe
Q 002409 598 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR 669 (927)
Q Consensus 598 ~~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~-------~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~ 669 (927)
...|.+.+.||+|+||.|-+|..+ +|+.||||++.+.... ......+|+++|++++|||||++++++...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 345567899999999999999754 7999999999765211 22346799999999999999999999999999
Q ss_pred EEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCC---CcEEEEee
Q 002409 670 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH---MRAKVSDF 746 (927)
Q Consensus 670 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~---~~vkL~DF 746 (927)
.||||||++||+|.+.+-. .+.+.+..-..++.|++.|+.|||++ ||+||||||+|||+..+ ..+||+||
T Consensus 251 ~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred eEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence 9999999999999999843 44566666678999999999999999 99999999999999866 78999999
Q ss_pred cCcccccCCCCceeeeeccCCCccCccccccCc---CCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhh
Q 002409 747 GLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ---LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 823 (927)
Q Consensus 747 Gla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~ 823 (927)
|+|+... ....+.+.+||+.|.|||++.+.. +..++|+||+|||||-+++|.+||.....+... +.++
T Consensus 324 GlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl-------~eQI 394 (475)
T KOG0615|consen 324 GLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSL-------KEQI 394 (475)
T ss_pred chhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccH-------HHHH
Confidence 9999765 345667789999999999998654 334789999999999999999999876543311 1122
Q ss_pred ccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 824 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 824 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
..|++.. ......+...+..+|+.+||..||++|||+.|+++|
T Consensus 395 ~~G~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 395 LKGRYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred hcCcccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 2333211 111223344578999999999999999999999987
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=384.54 Aligned_cols=248 Identities=25% Similarity=0.414 Sum_probs=212.0
Q ss_pred HHHHHhccccccCceEEEEEEE-CCCcEEEEEEeecC---CchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEE
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 674 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~-~~g~~VAVK~l~~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~ 674 (927)
.+|...+.||+|||+.+|.++. ..|+.||+|++.+. .....+.+.+|+++.++++|||||+++++|++.++.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4566678999999999999988 78999999999864 2334566889999999999999999999999999999999
Q ss_pred EeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccC
Q 002409 675 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 754 (927)
Q Consensus 675 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 754 (927)
|+|++++|.+++. .+..+++.++..+..||+.||.|||++ +|+|||||..|+||+++.++||+|||||.....
T Consensus 98 ELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999984 467899999999999999999999998 999999999999999999999999999986654
Q ss_pred CCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCC
Q 002409 755 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 834 (927)
Q Consensus 755 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 834 (927)
. .+...+.+|||-|+|||++....++..+||||+||+||-|+.|++||+.....+.+..|.. .+-.+
T Consensus 171 ~-~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~------~~Y~~------ 237 (592)
T KOG0575|consen 171 D-GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL------NEYSM------ 237 (592)
T ss_pred c-ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh------cCccc------
Confidence 3 2444567899999999999999999999999999999999999999997764444433322 11111
Q ss_pred cccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 835 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 835 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
+.....+..+|+.++|+++|.+|||+++|+.+
T Consensus 238 ------P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 238 ------PSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ------ccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11122356799999999999999999999976
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=354.46 Aligned_cols=259 Identities=27% Similarity=0.425 Sum_probs=211.3
Q ss_pred HHHHHhccccccCceEEEEEE-ECCCcEEEEEEeecC--CchhhHhHHHHHHHHhhccCCCccceec-ceeecCe-EEEE
Q 002409 599 ATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLG-YCQEEGR-SVLV 673 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~-~~~g~~VAVK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g-~~~~~~~-~~lV 673 (927)
+.+.+.++||+|.||+||++. ..+|+.+|.|.+.-. ..+.......|+.+|++++|||||++++ -+.++.. +.||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 346678899999999999996 458999999988733 3344567889999999999999999998 3444444 8999
Q ss_pred EEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCc--eecCCCCCCCeEECCCCcEEEEeecCccc
Q 002409 674 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA--IIHRDLKSSNILLDKHMRAKVSDFGLSKF 751 (927)
Q Consensus 674 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivHrDLkp~NILl~~~~~vkL~DFGla~~ 751 (927)
||+|..|+|...+.....+.+.+++..+++++.|++.||.++|.+. ++ |+||||||.||+|+.+|.+||+|||++++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 9999999999999877778889999999999999999999999942 25 99999999999999999999999999997
Q ss_pred ccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccc
Q 002409 752 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 831 (927)
Q Consensus 752 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 831 (927)
+....+ .....+|||.||+||.+....|+.|+||||+||++|||+.-+.||.+...-+.+ .++..|+...+
T Consensus 178 l~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~--------~KI~qgd~~~~ 248 (375)
T KOG0591|consen 178 LSSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLC--------KKIEQGDYPPL 248 (375)
T ss_pred hcchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHH--------HHHHcCCCCCC
Confidence 765443 334556999999999999999999999999999999999999999876422222 23444544322
Q ss_pred cCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHH
Q 002409 832 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 875 (927)
Q Consensus 832 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~ 875 (927)
-| .-....+.+|+..|+..||+.||+.-.+++.++.
T Consensus 249 p~--------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 249 PD--------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred cH--------HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 21 1223468899999999999999996666665554
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=366.60 Aligned_cols=198 Identities=31% Similarity=0.559 Sum_probs=177.9
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecC--CchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
|.+.+.||+|+||+||+|+++ ++.+||||.+... ..+..+.+..|+.+|+.++|||||++++++..++..+||||||
T Consensus 12 y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC 91 (429)
T KOG0595|consen 12 YELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYC 91 (429)
T ss_pred ceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeC
Confidence 334566999999999999887 5789999998765 4556677899999999999999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCC------CcEEEEeecCccc
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH------MRAKVSDFGLSKF 751 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~------~~vkL~DFGla~~ 751 (927)
.+|+|.+||+. .+.+++..+..++.|+|.||++||++ +||||||||+||||+.. -.+||+|||+|+.
T Consensus 92 ~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 92 NGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred CCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 99999999953 45899999999999999999999999 99999999999999865 4689999999998
Q ss_pred ccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccc
Q 002409 752 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 807 (927)
Q Consensus 752 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~ 807 (927)
+.++ ......+|++-|||||+++.++|+.|+|+||+|+|||||++|+.||+...
T Consensus 165 L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 165 LQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred CCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 7643 34456789999999999999999999999999999999999999998655
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=383.45 Aligned_cols=266 Identities=25% Similarity=0.443 Sum_probs=222.1
Q ss_pred HHHHHHHHHhccccccCceEEEEEEEC----CCcEEEEEEeecCCc-hhhHhHHHHHHHHhhccCCCccceecceeecCe
Q 002409 595 DIEDATKMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR 669 (927)
Q Consensus 595 ei~~~~~~~~~~IG~G~fG~Vy~~~~~----~g~~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~ 669 (927)
||......++++||.|.||.||+|+++ ....||||.++.... +..++|..|+.||.++.||||++|.|+......
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P 704 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP 704 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce
Confidence 344444456789999999999999987 234699999987643 446789999999999999999999999999999
Q ss_pred EEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCc
Q 002409 670 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 749 (927)
Q Consensus 670 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla 749 (927)
.++|+|||++|+|+.+|+.. ..++.+.+...|..+||.||.||.+. ++|||||.++|||++.+..+|++|||++
T Consensus 705 vMIiTEyMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLS 778 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLS 778 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccce
Confidence 99999999999999999765 35699999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeecc--CCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccC
Q 002409 750 KFAVDGASHVSSIVRG--TVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESG 826 (927)
Q Consensus 750 ~~~~~~~~~~~~~~~g--t~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~ 826 (927)
|...+......+...| +.+|.|||.+..++++.++||||||+||||.++ |.+|+.+...++.. ..
T Consensus 779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVI--------ka---- 846 (996)
T KOG0196|consen 779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI--------KA---- 846 (996)
T ss_pred eecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHH--------HH----
Confidence 9765554222222222 469999999999999999999999999999888 99999876633211 11
Q ss_pred CcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHHHHHH
Q 002409 827 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIEREA 883 (927)
Q Consensus 827 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~~~~~ 883 (927)
+++.++-..+.+++..|.+|++.|++.|-.+||.+.||+..|.+++.....-
T Consensus 847 -----Ie~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SL 898 (996)
T KOG0196|consen 847 -----IEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSL 898 (996)
T ss_pred -----HHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhh
Confidence 2223334446778889999999999999999999999999999998655433
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=385.40 Aligned_cols=264 Identities=28% Similarity=0.470 Sum_probs=218.1
Q ss_pred HHHHHHHHHhccccccCceEEEEEEEC------CCcEEEEEEeecCCch-hhHhHHHHHHHHhhccCCCccceecceeec
Q 002409 595 DIEDATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEE 667 (927)
Q Consensus 595 ei~~~~~~~~~~IG~G~fG~Vy~~~~~------~g~~VAVK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~ 667 (927)
++......+.+.||+|+||+||+|+.. +..-||||.++..... ...+|++|++++..++|||||+|+|.|.++
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 333334446788999999999999754 3456999999877554 678999999999999999999999999999
Q ss_pred CeEEEEEEeccCCchhhhcccccc------c----ccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECC
Q 002409 668 GRSVLVYEFMHNGTLKEHLYGTLT------H----EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK 737 (927)
Q Consensus 668 ~~~~lV~E~~~~gsL~~~L~~~~~------~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~ 737 (927)
+.+++|+|||..|||.++|+.... . ...++..+.+.||.|||.||+||-++ .+|||||..+|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceecc
Confidence 999999999999999999964321 1 23388999999999999999999998 9999999999999999
Q ss_pred CCcEEEEeecCcccccCCCCceee-eeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchh
Q 002409 738 HMRAKVSDFGLSKFAVDGASHVSS-IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNI 815 (927)
Q Consensus 738 ~~~vkL~DFGla~~~~~~~~~~~~-~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l 815 (927)
+..|||+|||+++.....+.+... ...-..+||+||.+..++++.+||||||||||||+++ |+.|+.....+ .+
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~----EV 714 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ----EV 714 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH----HH
Confidence 999999999999966554443322 2334679999999999999999999999999999999 88998765522 23
Q ss_pred hHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 816 VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 816 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
++. +..|.+ -+.+..++.++.+|+..|++.+|++||+++||-..|+....
T Consensus 715 Ie~----i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 715 IEC----IRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred HHH----HHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 332 233332 22345677789999999999999999999999999998654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=345.55 Aligned_cols=246 Identities=28% Similarity=0.418 Sum_probs=203.0
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
.+.++||+|+||+||.++.+ +++-+|+|++++.. ....+....|..+|.+++||.||+++-.|++.+.++||+||+
T Consensus 28 ~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~ 107 (357)
T KOG0598|consen 28 EILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYL 107 (357)
T ss_pred eeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEecc
Confidence 46789999999999999766 57889999998653 234567889999999999999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
.||.|..+| ++++.+++..+.-++.+|+.||.|||++ +||||||||+|||||++|+++|+|||+++..... .
T Consensus 108 ~GGeLf~hL----~~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~-~ 179 (357)
T KOG0598|consen 108 NGGELFYHL----QREGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD-G 179 (357)
T ss_pred CCccHHHHH----HhcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccC-C
Confidence 999999998 4567899999999999999999999998 9999999999999999999999999999843332 2
Q ss_pred ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCccc
Q 002409 758 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 837 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 837 (927)
..+..++||+.|||||++.+..|+..+|.||+|+++|||++|.+||.........+.+.. ++. ...
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~--------~k~------~~~ 245 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILK--------GKL------PLP 245 (357)
T ss_pred CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhc--------CcC------CCC
Confidence 344557899999999999999999999999999999999999999987663333322222 110 001
Q ss_pred CccCHHHHHHHHHHHhhhcCCCCCCCC----cHHHHHHH
Q 002409 838 DEYDIQSMWKIEEKALMCVLPHGHMRP----SISEVLKD 872 (927)
Q Consensus 838 ~~~~~~~~~~l~~L~~~Cl~~dP~~RP----sm~eV~~~ 872 (927)
+.+ ...+..+++...++.+|++|- +..+|.+|
T Consensus 246 p~~---ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 246 PGY---LSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred Ccc---CCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence 111 123567899999999999995 55565544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=328.92 Aligned_cols=267 Identities=21% Similarity=0.281 Sum_probs=205.1
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
+...++|+|+||+||+++.+ +|+-||||++.... +.-.+-..+|+++|++++|+|+|.++++|.....++||+|||+
T Consensus 5 E~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~d 84 (396)
T KOG0593|consen 5 EKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCD 84 (396)
T ss_pred hhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecc
Confidence 34467999999999999987 58899999986542 3345668899999999999999999999999999999999998
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
.--|.++-+ ....++.....+++.|+++|+.|+|++ +++||||||+||||+.++.+||||||+|+.... ...
T Consensus 85 hTvL~eLe~----~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd 156 (396)
T KOG0593|consen 85 HTVLHELER----YPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGD 156 (396)
T ss_pred hHHHHHHHh----ccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-Ccc
Confidence 855544332 234578888999999999999999999 999999999999999999999999999997664 233
Q ss_pred eeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhh-----------hcc-
Q 002409 759 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH-----------IES- 825 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~-----------~~~- 825 (927)
..+..+.|.+|+|||.+.+ .+|...+|||++||++.||++|.+.|.+..- ..++. .+... +..
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SD---iDQLy-~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSD---IDQLY-LIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcch---HHHHH-HHHHHHcccCHHHHHHhccC
Confidence 4445568999999999987 7899999999999999999999998876441 11111 11111 111
Q ss_pred C-----CcccccCCcc-cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH--HHHHHHHHH
Q 002409 826 G-----DIQGIIDPSL-LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD--IQDAIVIER 881 (927)
Q Consensus 826 ~-----~~~~~~d~~l-~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~--L~~~~~~~~ 881 (927)
. .+.+.-++.- ...| +....-+++++..|++.||.+|++-+|++.| ++..++++.
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~er~~ 295 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIEREL 295 (396)
T ss_pred CceeeeecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHHHHH
Confidence 1 1222111111 1112 1222367899999999999999999999876 566555543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=346.76 Aligned_cols=264 Identities=23% Similarity=0.312 Sum_probs=204.0
Q ss_pred HHHhccccccCceEEEEEEE-CCCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeec--CeEEEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLVYE 675 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~-~~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--~~~~lV~E 675 (927)
++-.++||+|.||.||+|+. .+|+.||+|+++-+. ........+||.||++++||||++|.+...+. +..|||+|
T Consensus 119 feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFe 198 (560)
T KOG0600|consen 119 FEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFE 198 (560)
T ss_pred HHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEe
Confidence 34457899999999999975 479999999987553 44456788999999999999999999998876 68999999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCC
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 755 (927)
||++ +|..++.. ....|+..++..++.|++.||+|||.+ +|+|||||.+|||||++|.+||+|||||+++...
T Consensus 199 YMdh-DL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 199 YMDH-DLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred cccc-hhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 9987 78777743 356799999999999999999999999 9999999999999999999999999999977666
Q ss_pred CCceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhh---------HHHHhhhcc
Q 002409 756 ASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIV---------QWAKLHIES 825 (927)
Q Consensus 756 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~---------~~~~~~~~~ 825 (927)
.....+..+-|++|.|||++.+ ..|+.++|+||.||||.||+.|++.|.+...-+....|. .|.+..+..
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence 5555566668999999999987 579999999999999999999999997655211111111 122111110
Q ss_pred CCcc---cccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 826 GDIQ---GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 826 ~~~~---~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
-... .-...++.+. -.......++|+..+|..||.+|.|+.++++.
T Consensus 352 ~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 352 ATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred ccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 0000 0000111111 01122467899999999999999999998864
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=351.90 Aligned_cols=265 Identities=27% Similarity=0.479 Sum_probs=212.1
Q ss_pred CHHHHHHHHHHHhccccccCceEEEEEEECCCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecCe
Q 002409 592 TLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR 669 (927)
Q Consensus 592 ~~~ei~~~~~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~ 669 (927)
...||......+.+.||+|.||+||+|+|. .+||||++.... .+..+.|++|+..+++-+|.||+-+.|||..++.
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 344555555667899999999999999987 579999998663 3446789999999999999999999999999887
Q ss_pred EEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCc
Q 002409 670 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 749 (927)
Q Consensus 670 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla 749 (927)
.+|+.+|+|.+|..+|+.. +.+|+..+.+.||+|+|+||.|||.+ +|||||||..||++.+++.|||+|||++
T Consensus 463 -AIiTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred -eeeehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccce
Confidence 9999999999999999854 57788999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCC-CCceeeeeccCCCccCcccccc---CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhcc
Q 002409 750 KFAVDG-ASHVSSIVRGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES 825 (927)
Q Consensus 750 ~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~---~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 825 (927)
..-..- .........|...|||||++.. .+|++.+||||||+|+|||++|..||...... .+..++..
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d--------qIifmVGr 607 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD--------QIIFMVGR 607 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh--------heEEEecc
Confidence 532111 1111222347889999999974 46899999999999999999999999843311 11122333
Q ss_pred CCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 826 GDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 826 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
|.+.. |.. .....+.+++.+|+..|+..++++||.+.+|+..|++++.
T Consensus 608 G~l~p--d~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 608 GYLMP--DLS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred cccCc--cch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 32211 111 1123456678899999999999999999999999998765
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=353.88 Aligned_cols=262 Identities=26% Similarity=0.419 Sum_probs=203.6
Q ss_pred HHHHHHhccccccCceEEEEEEEC------CCcEEEEEEeecCCc-hhhHhHHHHHHHHhhc-cCCCccceecceeec-C
Q 002409 598 DATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE-G 668 (927)
Q Consensus 598 ~~~~~~~~~IG~G~fG~Vy~~~~~------~g~~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~-~ 668 (927)
...+.+.++||+|+||.||+|.+. +++.||||+++.... .....+.+|+.+++++ +||||++++++|... +
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 445677889999999999999742 356799999875432 3346788999999999 899999999988764 4
Q ss_pred eEEEEEEeccCCchhhhcccccc---------------------------------------------------------
Q 002409 669 RSVLVYEFMHNGTLKEHLYGTLT--------------------------------------------------------- 691 (927)
Q Consensus 669 ~~~lV~E~~~~gsL~~~L~~~~~--------------------------------------------------------- 691 (927)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 57899999999999998854211
Q ss_pred -cccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce-eeeeccCCCc
Q 002409 692 -HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTVGY 769 (927)
Q Consensus 692 -~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~Y 769 (927)
....+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++......... .....+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 013477888999999999999999998 99999999999999999999999999997543322221 2233467889
Q ss_pred cCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCcccCccCHHHHHHH
Q 002409 770 LDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKI 848 (927)
Q Consensus 770 ~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 848 (927)
+|||++.+..++.++|||||||++|||++ |+.||......+ .+.. ....+.... . +......+
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~---~~~~----~~~~~~~~~-----~----~~~~~~~l 306 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE---EFCQ----RLKDGTRMR-----A----PENATPEI 306 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH---HHHH----HHhcCCCCC-----C----CCCCCHHH
Confidence 99999999999999999999999999997 999997643211 1111 111121110 0 11223468
Q ss_pred HHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 849 EEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 849 ~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
.+++.+|++.+|++||++.||++.|++++.
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=380.63 Aligned_cols=264 Identities=29% Similarity=0.437 Sum_probs=215.9
Q ss_pred HHHHHHHHhccccccCceEEEEEEECC--Cc----EEEEEEeecC-CchhhHhHHHHHHHHhhccCCCccceecceeecC
Q 002409 596 IEDATKMLEKKIGSGGFGVVYYGKLKD--GK----EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG 668 (927)
Q Consensus 596 i~~~~~~~~~~IG~G~fG~Vy~~~~~~--g~----~VAVK~l~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~ 668 (927)
+......+.+.||+|.||.||+|...+ |. .||||.+++. +.+...+|.+|..+|++++|||||+++|+|.+.+
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 444555567899999999999998763 33 4899998766 4566788999999999999999999999999999
Q ss_pred eEEEEEEeccCCchhhhccccc---ccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEe
Q 002409 669 RSVLVYEFMHNGTLKEHLYGTL---THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD 745 (927)
Q Consensus 669 ~~~lV~E~~~~gsL~~~L~~~~---~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~D 745 (927)
..++++|||++|+|..+|++.. .....+...+.+.++.|||+|+.||+++ ++|||||.++|+||++...+||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcc
Confidence 9999999999999999997642 2245688999999999999999999998 999999999999999999999999
Q ss_pred ecCcccccCCCCceeeee-ccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhh
Q 002409 746 FGLSKFAVDGASHVSSIV-RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHI 823 (927)
Q Consensus 746 FGla~~~~~~~~~~~~~~-~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~ 823 (927)
||+|+...+......... .-...|||||.+..+.++.|+|||||||+|||++| |..||...+.. .+.. ...
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~----~v~~---~~~ 918 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF----EVLL---DVL 918 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH----HHHH---HHH
Confidence 999995544433322222 23468999999999999999999999999999999 88898765521 1111 112
Q ss_pred ccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHH
Q 002409 824 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 879 (927)
Q Consensus 824 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~ 879 (927)
+.|++ +.+..++.++.+++.+|++.+|++||++..+++.+..+...
T Consensus 919 ~ggRL----------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 919 EGGRL----------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred hCCcc----------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 23322 23445566889999999999999999999999999988764
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=313.89 Aligned_cols=261 Identities=21% Similarity=0.304 Sum_probs=202.6
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCch--hhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
+|...++||+|.||.||+|+.. +|+.||||+++..... -.....+|++.|+.++|+||+.++++|...+...||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 4555688999999999999754 7999999999755322 245688999999999999999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
|+. +|...+++ ....++..+...++.++++|++|||++ .|+||||||.|+|++.+|.+||+|||+|+......
T Consensus 83 m~t-dLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 83 MPT-DLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ccc-cHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 976 89888864 356788899999999999999999999 99999999999999999999999999999776544
Q ss_pred CceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCC--------
Q 002409 757 SHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD-------- 827 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~-------- 827 (927)
..... .+-|.+|.|||.+.+ +.|+..+|+||.|||+.||+-|.+-|.+.. +.+++... -..+....
T Consensus 156 ~~~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~s---DidQL~~I-f~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 156 RIQTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDS---DIDQLSKI-FRALGTPTPDQWPEMT 230 (318)
T ss_pred ccccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCc---hHHHHHHH-HHHcCCCCcccCcccc
Confidence 33322 257999999999986 679999999999999999999988776543 11122111 11111110
Q ss_pred -cccccC-----CcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 828 -IQGIID-----PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 828 -~~~~~d-----~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
+.+.+. .......-..+....++|+..|+..+|.+|+++.|++++
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 111000 000111112233456999999999999999999999876
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=344.82 Aligned_cols=266 Identities=21% Similarity=0.249 Sum_probs=207.0
Q ss_pred HHHHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC-chhhHhHHHHHHHHhhcc-CCCccceecceeecC-eEEE
Q 002409 597 EDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEG-RSVL 672 (927)
Q Consensus 597 ~~~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~-~~~l 672 (927)
...+|.+.++||.|.||.||+|+-. +|+.||||.++..- ...+..-.+|+..|++++ ||||+++.+.+.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 4467788899999999999999755 68999999987552 344455678999999998 999999999999888 8999
Q ss_pred EEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccc
Q 002409 673 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 752 (927)
Q Consensus 673 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 752 (927)
|||||+. +|.++++++ ++.+++..+..|+.||++||+|+|++ |+.|||+||+|||+.....+||+|||+||..
T Consensus 88 VfE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eHHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence 9999965 899988654 67899999999999999999999999 9999999999999999999999999999966
Q ss_pred cCCCCceeeeeccCCCccCccccc-cCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccC-----
Q 002409 753 VDGASHVSSIVRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG----- 826 (927)
Q Consensus 753 ~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~----- 826 (927)
..... .+..+.|.+|+|||++. .+-|+.+.|+|++|||++|+.+-++.|.+...-+..-.|.+-......+.
T Consensus 161 ~SkpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 161 RSKPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred ccCCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 54332 23345799999999986 57899999999999999999999999976552211111221111100000
Q ss_pred --------CcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 827 --------DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 827 --------~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
++..+..-.+..- -.....+.++|+.+|+++||.+|||+.|.+++
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L-~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDL-LPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHhccCCCcCCCCChHHh-CcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 0111111111111 12255688999999999999999999999987
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=339.86 Aligned_cols=254 Identities=25% Similarity=0.358 Sum_probs=201.2
Q ss_pred HHHhccccccCceEEEEEEECC-CcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecC--eEEEEEEec
Q 002409 601 KMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG--RSVLVYEFM 677 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~~-g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~~~lV~E~~ 677 (927)
+...+.||+|+||.||++...+ |+..|||.+........+.+.+|+.+|.+++|||||+.+|...... .+++.|||+
T Consensus 19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~ 98 (313)
T KOG0198|consen 19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYA 98 (313)
T ss_pred hhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeecc
Confidence 4456889999999999998764 8899999987654333667899999999999999999999855444 689999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECC-CCcEEEEeecCcccccC--
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLSKFAVD-- 754 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~-~~~vkL~DFGla~~~~~-- 754 (927)
++|+|.+++.+.. ..+++..+..+..|+++||+|||++ +|+||||||+|||++. ++.+||+|||+++....
T Consensus 99 ~~GsL~~~~~~~g---~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 99 PGGSLSDLIKRYG---GKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred CCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999996432 2699999999999999999999998 9999999999999999 79999999999986542
Q ss_pred CCCceeeeeccCCCccCccccccCc-CCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccC
Q 002409 755 GASHVSSIVRGTVGYLDPEYYISQQ-LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 833 (927)
Q Consensus 755 ~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 833 (927)
..........||+.|||||++..+. ...++||||+||++.||+||+.||.... ...++......++...
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~------~~~~~~~~ig~~~~~P---- 242 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF------EEAEALLLIGREDSLP---- 242 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc------chHHHHHHHhccCCCC----
Confidence 2222334567999999999998643 3359999999999999999999997531 1112222222222111
Q ss_pred CcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHH
Q 002409 834 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 875 (927)
Q Consensus 834 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~ 875 (927)
..+.....+..+++.+|++.+|++|||+.|+++|---
T Consensus 243 -----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 243 -----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred -----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 1222233457889999999999999999999998553
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=345.48 Aligned_cols=247 Identities=26% Similarity=0.341 Sum_probs=204.6
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhc-cCCCccceecceeecCeEEEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE 675 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~lV~E 675 (927)
+.|++.||+|+|++|++|+.+ .++++|||++.+.- ....+-+..|-..|.+| .||.|++|+-.|.+...+|+|+|
T Consensus 75 F~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe 154 (604)
T KOG0592|consen 75 FKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLE 154 (604)
T ss_pred cchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEE
Confidence 457889999999999999865 68999999987542 22234567788899999 89999999999999999999999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCC
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 755 (927)
|+++|+|.++|. +.+.|++.....++.||+.||+|||++ |||||||||+|||||.+|++||+|||.|+.+.+.
T Consensus 155 ~A~nGdll~~i~----K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 155 YAPNGDLLDLIK----KYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred ecCCCcHHHHHH----HhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 999999999995 357899999999999999999999999 9999999999999999999999999999866542
Q ss_pred CCc----------ee--eeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhh
Q 002409 756 ASH----------VS--SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 823 (927)
Q Consensus 756 ~~~----------~~--~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~ 823 (927)
... .+ ..++||-.|.+||++..+..+..+|+|+|||+||+|+.|++||.....=-.++.|+..
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l----- 302 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL----- 302 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh-----
Confidence 211 11 4477999999999999999999999999999999999999999876521222222221
Q ss_pred ccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 824 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 824 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
|= +++......+.+|+.+.|..||.+|++..||.+|
T Consensus 303 ---------~y----~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 303 ---------DY----EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ---------cc----cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 11 1122223467899999999999999999999988
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=349.98 Aligned_cols=246 Identities=26% Similarity=0.433 Sum_probs=203.9
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecC----Cc-hhhHhHHHHHHHHhhcc-CCCccceecceeecCeEEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN----SY-QGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVL 672 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~----~~-~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~~~~l 672 (927)
.|.+.+.||+|.||+|+.|+.. +++.||+|++... .. .....+.+|+.++++++ ||||+++++++......++
T Consensus 18 ~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~i 97 (370)
T KOG0583|consen 18 KYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYI 97 (370)
T ss_pred ceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEE
Confidence 4566789999999999999765 6899999977653 12 23456778999999998 9999999999999999999
Q ss_pred EEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCC-CcEEEEeecCccc
Q 002409 673 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKF 751 (927)
Q Consensus 673 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~-~~vkL~DFGla~~ 751 (927)
||||+.+|+|.+++.. ..++.+..+..++.|++.|++|||++ +|+||||||+|||++.+ +++||+|||++..
T Consensus 98 vmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 98 VMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred EEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 9999999999999953 56788899999999999999999998 99999999999999999 9999999999986
Q ss_pred ccCCCCceeeeeccCCCccCccccccCc-CC-CccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCC--
Q 002409 752 AVDGASHVSSIVRGTVGYLDPEYYISQQ-LT-DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD-- 827 (927)
Q Consensus 752 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s-~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~-- 827 (927)
.. .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||++....... . .+..+.
T Consensus 171 ~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~----~----ki~~~~~~ 241 (370)
T KOG0583|consen 171 SP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLY----R----KIRKGEFK 241 (370)
T ss_pred cC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHH----H----HHhcCCcc
Confidence 63 3334456678999999999999877 86 6889999999999999999999875422211 1 122221
Q ss_pred cccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 828 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 828 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
+...++ -.++..|+.+|+..+|.+|+++.||+++
T Consensus 242 ~p~~~~-----------S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 242 IPSYLL-----------SPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred CCCCcC-----------CHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 111111 3468899999999999999999999944
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=342.44 Aligned_cols=248 Identities=29% Similarity=0.446 Sum_probs=204.7
Q ss_pred cCHHHHHHHHHHHhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeE
Q 002409 591 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS 670 (927)
Q Consensus 591 ~~~~ei~~~~~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~ 670 (927)
+.+++|.+.. -||.|+-|.||.|+++ ++.||||+++.- -+.+|+-|++|+||||+.+.|+|.....+
T Consensus 121 iPFe~IsELe-----WlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcy 187 (904)
T KOG4721|consen 121 IPFEEISELE-----WLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCY 187 (904)
T ss_pred CCHHHhhhhh-----hhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCcee
Confidence 4455655443 4899999999999998 899999986522 23578889999999999999999999999
Q ss_pred EEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcc
Q 002409 671 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 750 (927)
Q Consensus 671 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 750 (927)
|||||||..|-|.+.|+ .++.+.......+..+||.||.|||.+ .|||||||.-||||..+..+||+|||.++
T Consensus 188 CIiMEfCa~GqL~~VLk----a~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~ 260 (904)
T KOG4721|consen 188 CIIMEFCAQGQLYEVLK----AGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSK 260 (904)
T ss_pred EEeeeccccccHHHHHh----ccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchH
Confidence 99999999999999995 356677778888999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCccc
Q 002409 751 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 830 (927)
Q Consensus 751 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 830 (927)
...+. .....++||..|||||++.....++|+||||||||||||+||..|+.+...... =| -+.
T Consensus 261 e~~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI-----Iw---GVG------ 324 (904)
T KOG4721|consen 261 ELSDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI-----IW---GVG------ 324 (904)
T ss_pred hhhhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee-----EE---ecc------
Confidence 66554 223446799999999999999999999999999999999999999976541110 01 001
Q ss_pred ccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHH
Q 002409 831 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 876 (927)
Q Consensus 831 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~ 876 (927)
...+.-..+..++..+.-|+.+|++..|..||++++|+.||+-.
T Consensus 325 --sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 325 --SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred --CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 11122233455667788999999999999999999999999854
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=342.99 Aligned_cols=245 Identities=27% Similarity=0.409 Sum_probs=205.5
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCCch
Q 002409 604 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 682 (927)
Q Consensus 604 ~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 682 (927)
-++||+|+.|.||.++.. +++.||||++.......++-+.+|+.+|+..+|+|||.+++.+...+.++.|||||++|+|
T Consensus 278 ~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsL 357 (550)
T KOG0578|consen 278 FKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSL 357 (550)
T ss_pred hhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCch
Confidence 467999999999999654 6889999999877666677889999999999999999999999999999999999999999
Q ss_pred hhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCceeee
Q 002409 683 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 762 (927)
Q Consensus 683 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 762 (927)
.|.+. ...+++.++..|+.++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++........ ....
T Consensus 358 TDvVt-----~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR~T 428 (550)
T KOG0578|consen 358 TDVVT-----KTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KRST 428 (550)
T ss_pred hhhhh-----cccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC-cccc
Confidence 99884 34588999999999999999999999 999999999999999999999999999886655544 4445
Q ss_pred eccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCccCH
Q 002409 763 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 842 (927)
Q Consensus 763 ~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 842 (927)
..||+.|||||++....|..|.||||||++.+||+.|.+||-.+.. ++-.+.....|.. .+. ...
T Consensus 429 mVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P-------lrAlyLIa~ng~P------~lk--~~~ 493 (550)
T KOG0578|consen 429 MVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP-------LRALYLIATNGTP------KLK--NPE 493 (550)
T ss_pred ccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh-------HHHHHHHhhcCCC------CcC--Ccc
Confidence 6699999999999999999999999999999999999999976441 1111111122221 111 112
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 843 QSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 843 ~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
..-..+.+++.+||..|+++||++.|+++|
T Consensus 494 klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 494 KLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 233468899999999999999999999987
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=340.77 Aligned_cols=245 Identities=27% Similarity=0.378 Sum_probs=209.2
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
|.+.+.||+|.||+||||+-+ +.+.||+|.+.+.. .+..+.+.+|++++++++||||+.++++|+...+.++|.||+
T Consensus 4 yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a 83 (808)
T KOG0597|consen 4 YHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYA 83 (808)
T ss_pred hhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhh
Confidence 445678999999999999766 67889999987543 334567899999999999999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
.+ +|..+| .....+++..+..|+.+++.||.|||+. +|+|||+||+|||++..+.+|++|||+|+.+... .
T Consensus 84 ~g-~L~~il----~~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t 154 (808)
T KOG0597|consen 84 VG-DLFTIL----EQDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-T 154 (808)
T ss_pred hh-hHHHHH----HhccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC-c
Confidence 77 999988 4567899999999999999999999999 9999999999999999999999999999976653 4
Q ss_pred ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCccc
Q 002409 758 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 837 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 837 (927)
...+...|||.|||||++.++.|+..+|+||+|||+|||++|++||-.. .+.+.++....+.-
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-------si~~Lv~~I~~d~v---------- 217 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-------SITQLVKSILKDPV---------- 217 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-------HHHHHHHHHhcCCC----------
Confidence 5556778999999999999999999999999999999999999999754 34444444333221
Q ss_pred CccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 838 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 838 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.++......+..++...+..||..|.+-.+++.|
T Consensus 218 -~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 218 -KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred -CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 1122444568899999999999999999999877
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=329.72 Aligned_cols=261 Identities=25% Similarity=0.380 Sum_probs=206.3
Q ss_pred HHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCch-hhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
..|++.+.||.|.-++||+|+.. .++.||||++.-.... ....+.+|+..|+.++||||++++..|..+..+++||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 34667889999999999999754 6899999999755433 347899999999999999999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
|.+|++.+.++.... ..+++..+..|.+++++||.|||++ |.||||||+.||||+.+|.|||+|||.+..+.+..
T Consensus 106 Ma~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 999999999976543 3489999999999999999999999 99999999999999999999999999886554432
Q ss_pred Cce--e-eeeccCCCccCcccccc--CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccc
Q 002409 757 SHV--S-SIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 831 (927)
Q Consensus 757 ~~~--~-~~~~gt~~Y~aPE~~~~--~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 831 (927)
... . ....||++|||||++.. ..|+.|+||||||+...||.+|..||..... .+.+..-.+ +.....
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP---mkvLl~tLq-----n~pp~~ 252 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP---MKVLLLTLQ-----NDPPTL 252 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh---HHHHHHHhc-----CCCCCc
Confidence 211 1 44579999999999643 5799999999999999999999999976541 112222111 111111
Q ss_pred cCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 832 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 832 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.-..+..+........+.+++..|++.||++|||+.+++++
T Consensus 253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 10001111112223478899999999999999999999865
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=352.57 Aligned_cols=256 Identities=29% Similarity=0.440 Sum_probs=206.8
Q ss_pred HHhccccccCceEEEEEEECC--C--cE-EEEEEeecC---CchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEE
Q 002409 602 MLEKKIGSGGFGVVYYGKLKD--G--KE-IAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 673 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~~--g--~~-VAVK~l~~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV 673 (927)
.+.++||+|+||.||+|+++. + .. ||||..+.. ......+|.+|+++|++++|||||+++|++..+..+++|
T Consensus 160 ~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~iv 239 (474)
T KOG0194|consen 160 ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLV 239 (474)
T ss_pred cccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEE
Confidence 355899999999999998763 2 23 899998852 345567899999999999999999999999999999999
Q ss_pred EEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccccc
Q 002409 674 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 753 (927)
Q Consensus 674 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 753 (927)
||+|.||+|.++|... ...++..+++.++.++|+||+|||++ +++||||.++|+|++.++.+||+|||+++...
T Consensus 240 mEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 240 MELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred EEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 9999999999999643 23689999999999999999999999 99999999999999999999999999987543
Q ss_pred CCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCccccc
Q 002409 754 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 832 (927)
Q Consensus 754 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 832 (927)
..... .....-+..|+|||.+..+.++.++|||||||++||+++ |..|+...... .+..++.. .+
T Consensus 314 ~~~~~-~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~----~v~~kI~~---~~------ 379 (474)
T KOG0194|consen 314 QYVMK-KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY----EVKAKIVK---NG------ 379 (474)
T ss_pred ceeec-cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH----HHHHHHHh---cC------
Confidence 11111 111235679999999999999999999999999999999 88898765522 23333211 11
Q ss_pred CCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHHH
Q 002409 833 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 880 (927)
Q Consensus 833 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~~ 880 (927)
.+...+...+..+..+..+|+..+|++||+|.+|.+.|+.+....
T Consensus 380 ---~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 380 ---YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred ---ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 111122244556788888999999999999999999999886543
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=333.79 Aligned_cols=245 Identities=22% Similarity=0.306 Sum_probs=197.8
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeecCCchh---hHhHHHHHHHHhhccCCCccceecceee----cCeEEEEEEec
Q 002409 605 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQFLGYCQE----EGRSVLVYEFM 677 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~---~~~~~~Ei~iL~~l~HpnIv~l~g~~~~----~~~~~lV~E~~ 677 (927)
..||+|++|.||+|.+. |+.||||+++...... .+.+.+|+.+|++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 46999999999999985 8999999987653322 3567899999999999999999999876 35679999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
++|+|.+++.. ...+++...+.++.|++.||.|||+. .+++||||||+|||+++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 99999999853 35688999999999999999999984 278899999999999999999999999987543321
Q ss_pred ceeeeeccCCCccCcccccc--CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCc
Q 002409 758 HVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 835 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~~~--~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 835 (927)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...... .+...+. ..+. . .
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~----~~~~~i~---~~~~-~----~- 241 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK----EIYDLII---NKNN-S----L- 241 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH----HHHHHHH---hcCC-C----C-
Confidence 12347899999999976 68999999999999999999999999765422 2222111 1110 0 0
Q ss_pred ccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHH
Q 002409 836 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 876 (927)
Q Consensus 836 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~ 876 (927)
..+......+.+++.+|++.+|++|||+.||++.|+..
T Consensus 242 ---~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 242 ---KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred ---CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 11112344688999999999999999999999999875
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=337.21 Aligned_cols=263 Identities=25% Similarity=0.393 Sum_probs=201.5
Q ss_pred HHHHHhccccccCceEEEEEEECC-----------------CcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccce
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLKD-----------------GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQF 660 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~~-----------------g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l 660 (927)
..+.+.++||+|+||.||++.+++ +..||+|++.... .....++.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 445667899999999999997642 3369999987643 2335678999999999999999999
Q ss_pred ecceeecCeEEEEEEeccCCchhhhccccc---------------ccccccCHHHHHHHHHHHHhHhHHHhhCCCCceec
Q 002409 661 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTL---------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIH 725 (927)
Q Consensus 661 ~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~---------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH 725 (927)
++++.+.+..++||||+++|+|.+++.... .....+++..++.++.|++.||+|||+. +|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 999999999999999999999999885421 1123478889999999999999999998 9999
Q ss_pred CCCCCCCeEECCCCcEEEEeecCcccccCCCCc-eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh--CCCc
Q 002409 726 RDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS--GQEA 802 (927)
Q Consensus 726 rDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt--G~~p 802 (927)
|||||+|||++.++.+||+|||+++........ ......++..|+|||++..+.++.++|||||||++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999755333221 1223345789999999988899999999999999999987 5566
Q ss_pred ccccccccccchhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHH
Q 002409 803 ISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 874 (927)
Q Consensus 803 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~ 874 (927)
|...... .+...+........... ....+......+.+++.+|++.+|++|||+.||.+.|+
T Consensus 242 ~~~~~~~----~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDE----QVIENAGEFFRDQGRQV------YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHH----HHHHHHHHHhhhccccc------cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 6543311 22222222211111000 00011223356899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=348.65 Aligned_cols=260 Identities=25% Similarity=0.390 Sum_probs=202.7
Q ss_pred HHHHHHhccccccCceEEEEEEE------CCCcEEEEEEeecCC-chhhHhHHHHHHHHhhc-cCCCccceecceeecCe
Q 002409 598 DATKMLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGR 669 (927)
Q Consensus 598 ~~~~~~~~~IG~G~fG~Vy~~~~------~~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~ 669 (927)
...+.+.+.||+|+||.||+|++ ..+..||||+++... ......+.+|+++++.+ +||||++++++|...+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 34566789999999999999964 235689999987543 23345688999999999 89999999999999999
Q ss_pred EEEEEEeccCCchhhhcccccc----------------------------------------------------------
Q 002409 670 SVLVYEFMHNGTLKEHLYGTLT---------------------------------------------------------- 691 (927)
Q Consensus 670 ~~lV~E~~~~gsL~~~L~~~~~---------------------------------------------------------- 691 (927)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999998854210
Q ss_pred -------------cccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 692 -------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 692 -------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 112478889999999999999999998 9999999999999999999999999999755432221
Q ss_pred -eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 759 -VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 759 -~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
......++..|+|||.+.+..++.++|||||||++|||++ |..||....... .+.++.. .+... .
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~---~~~~~~~----~~~~~--~---- 337 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS---KFYKMIK----EGYRM--L---- 337 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH---HHHHHHH----hCccC--C----
Confidence 1122335678999999999999999999999999999998 888886543111 1222211 11100 0
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 876 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~ 876 (927)
.+.....++.+++.+|++.+|++||++.||++.|++.
T Consensus 338 ---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 338 ---SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ---CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0111234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=343.31 Aligned_cols=245 Identities=24% Similarity=0.376 Sum_probs=207.4
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc---hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
+.+++.||+|+.|.|..|++. +|+.+|||++.+... .....+++|+.+|+.+.||||+++++++.+..++|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 446788999999999999865 799999999976522 2235688999999999999999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
+++|-|.+++ ...+.+++.++.+++.||+.|+.|+|.. +|+||||||+|+|||...++||+|||+|....++
T Consensus 94 v~gGELFdyl----v~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g- 165 (786)
T KOG0588|consen 94 VPGGELFDYL----VRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG- 165 (786)
T ss_pred cCCchhHHHH----HhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCC-
Confidence 9999999998 3567899999999999999999999998 9999999999999999999999999999754433
Q ss_pred CceeeeeccCCCccCccccccCcCC-CccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCc
Q 002409 757 SHVSSIVRGTVGYLDPEYYISQQLT-DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 835 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~~~~s-~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 835 (927)
..-.+-+|++.|.+||++.+.+|. .++||||+|||||.|++|+.||+++. .+.+... +..|.++-
T Consensus 166 -klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN----ir~LLlK----V~~G~f~M----- 231 (786)
T KOG0588|consen 166 -KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN----IRVLLLK----VQRGVFEM----- 231 (786)
T ss_pred -ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc----HHHHHHH----HHcCcccC-----
Confidence 334556799999999999999986 58999999999999999999999654 3344443 33343211
Q ss_pred ccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 836 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 836 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
+.....++.+|+.+|+..||++|.|+.||.+|
T Consensus 232 -----Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 232 -----PSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred -----CCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 12233467899999999999999999999998
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=332.30 Aligned_cols=257 Identities=22% Similarity=0.340 Sum_probs=203.8
Q ss_pred HHHHHHHhccccccCceEEEEEEEC----CCcEEEEEEeecCCc-hhhHhHHHHHHHHhhccCCCccceecceeecCeEE
Q 002409 597 EDATKMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 671 (927)
Q Consensus 597 ~~~~~~~~~~IG~G~fG~Vy~~~~~----~g~~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~ 671 (927)
....+.+.+.||+|+||.||+|.++ .+..||+|+++.... .....+.+|+.++++++||||+++++++...+..+
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 3445667889999999999999764 356899999876532 33457889999999999999999999999999999
Q ss_pred EEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccc
Q 002409 672 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 751 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 751 (927)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||++ +++||||||+|||++.++.+|++|||.+..
T Consensus 83 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 83 IVTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred EEEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccc
Confidence 999999999999998542 34688999999999999999999998 999999999999999999999999998764
Q ss_pred ccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCccc
Q 002409 752 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQG 830 (927)
Q Consensus 752 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 830 (927)
.............++..|+|||.+.+..++.++|||||||++||+++ |+.||...... .+.... .++...
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~----~~~~~~----~~~~~~- 227 (266)
T cd05064 157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ----DVIKAV----EDGFRL- 227 (266)
T ss_pred ccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH----HHHHHH----HCCCCC-
Confidence 32221111112335678999999999999999999999999999875 99999754421 122211 111100
Q ss_pred ccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHH
Q 002409 831 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 876 (927)
Q Consensus 831 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~ 876 (927)
..+......+.+++.+|++.+|++||++.||.+.|+++
T Consensus 228 --------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 --------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 01122344688999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=346.20 Aligned_cols=262 Identities=25% Similarity=0.404 Sum_probs=203.6
Q ss_pred HHHHHHHhccccccCceEEEEEEEC------CCcEEEEEEeecCC-chhhHhHHHHHHHHhhc-cCCCccceecceeecC
Q 002409 597 EDATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEG 668 (927)
Q Consensus 597 ~~~~~~~~~~IG~G~fG~Vy~~~~~------~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~ 668 (927)
....+.+.+.||+|+||.||+|+.. +++.||||+++... ......+.+|+++++++ +|+||++++++|...+
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 3445667899999999999998742 34579999997543 23345688999999999 8999999999999999
Q ss_pred eEEEEEEeccCCchhhhccccc----------------------------------------------------------
Q 002409 669 RSVLVYEFMHNGTLKEHLYGTL---------------------------------------------------------- 690 (927)
Q Consensus 669 ~~~lV~E~~~~gsL~~~L~~~~---------------------------------------------------------- 690 (927)
..++||||+++|+|.+++....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 9999999999999999885321
Q ss_pred --------ccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc-eee
Q 002409 691 --------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH-VSS 761 (927)
Q Consensus 691 --------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~ 761 (927)
.....+++..+++++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++........ ...
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 0123478889999999999999999998 9999999999999999999999999998754332221 112
Q ss_pred eeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCcccCcc
Q 002409 762 IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 840 (927)
Q Consensus 762 ~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 840 (927)
...++..|+|||++....++.++|||||||++|||++ |+.||........ +... ...+. ... .
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~---~~~~----~~~~~-----~~~----~ 336 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK---FYKM----VKRGY-----QMS----R 336 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH---HHHH----HHccc-----Ccc----C
Confidence 2335678999999998999999999999999999997 9999975432111 1111 11110 000 0
Q ss_pred CHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHH
Q 002409 841 DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 877 (927)
Q Consensus 841 ~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~ 877 (927)
+.....++.+++.+|++.+|++||++.||++.|++++
T Consensus 337 ~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 337 PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 1112346889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=338.31 Aligned_cols=242 Identities=24% Similarity=0.324 Sum_probs=196.4
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCC
Q 002409 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 680 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 680 (927)
+.||+|+||.||+++.+ +|+.||||+++... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999875 68899999997542 223356778999999999999999999999999999999999999
Q ss_pred chhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCcee
Q 002409 681 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 760 (927)
Q Consensus 681 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 760 (927)
+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~ 152 (323)
T cd05571 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 152 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccc
Confidence 99988843 45688999999999999999999998 99999999999999999999999999987432221 222
Q ss_pred eeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCcc
Q 002409 761 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 840 (927)
Q Consensus 761 ~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 840 (927)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+..... .+.. . +
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~----~~~~~~~----~~~~------~----~ 214 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KLFELIL----MEEI------R----F 214 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH----HHHHHHH----cCCC------C----C
Confidence 3456999999999999999999999999999999999999999754311 1111111 1110 1 1
Q ss_pred CHHHHHHHHHHHhhhcCCCCCCCC-----cHHHHHHH
Q 002409 841 DIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 872 (927)
Q Consensus 841 ~~~~~~~l~~L~~~Cl~~dP~~RP-----sm~eV~~~ 872 (927)
+.....++.+++.+|++.||++|| ++.|++++
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 112234678999999999999999 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=331.00 Aligned_cols=249 Identities=26% Similarity=0.373 Sum_probs=198.7
Q ss_pred HhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 603 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 603 ~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
..+.||+|+||.||++... +++.||+|++.... ......+.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05631 4 HYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMN 83 (285)
T ss_pred EEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecC
Confidence 4578999999999999864 78999999987542 2233467889999999999999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
+|+|.+++... ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05631 84 GGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-- 156 (285)
T ss_pred CCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--
Confidence 99998887532 234588999999999999999999998 99999999999999999999999999997643322
Q ss_pred eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccC
Q 002409 759 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 838 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 838 (927)
......||..|+|||++.+..++.++|||||||++|||++|+.||...........+... ..... .
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~----~~~~~----------~ 222 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRR----VKEDQ----------E 222 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHH----hhccc----------c
Confidence 123346899999999999999999999999999999999999999765421111111111 11110 1
Q ss_pred ccCHHHHHHHHHHHhhhcCCCCCCCCc-----HHHHHHH
Q 002409 839 EYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 872 (927)
Q Consensus 839 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----m~eV~~~ 872 (927)
.+.......+.+++.+|++.+|++||+ +.|++++
T Consensus 223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 111222346789999999999999997 7888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=323.18 Aligned_cols=250 Identities=21% Similarity=0.381 Sum_probs=212.5
Q ss_pred HHHHHHHhccccccCceEEEEEEE-CCCcEEEEEEeecCCchhh---HhHHHHHHHHhhccCCCccceecceeecCeEEE
Q 002409 597 EDATKMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQGK---REFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 672 (927)
Q Consensus 597 ~~~~~~~~~~IG~G~fG~Vy~~~~-~~g~~VAVK~l~~~~~~~~---~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~l 672 (927)
.+.+|+|.+.||+|.||.|-+|+. ..|+.||||.++++..+++ -.+.+|++||..++||||+.++++|...+...+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 456788899999999999999975 6799999999987754443 457889999999999999999999999999999
Q ss_pred EEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccc
Q 002409 673 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 752 (927)
Q Consensus 673 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 752 (927)
||||..+|.|.|++ ...+.+++.++..++.||..|+.|+|.+ +++|||||.+|||+|+++++||+|||++.++
T Consensus 131 vMEYaS~GeLYDYi----Ser~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 131 VMEYASGGELYDYI----SERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLY 203 (668)
T ss_pred EEEecCCccHHHHH----HHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhh
Confidence 99999999999999 4578899999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCceeeeeccCCCccCccccccCcCC-CccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccc
Q 002409 753 VDGASHVSSIVRGTVGYLDPEYYISQQLT-DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 831 (927)
Q Consensus 753 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 831 (927)
.+. ....+++|++-|.+||++.+..|. +.+|-|||||+||-|+.|.-||++.+. ..+++. +..|.+.+
T Consensus 204 ~~~--kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh----k~lvrQ----Is~GaYrE- 272 (668)
T KOG0611|consen 204 ADK--KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH----KRLVRQ----ISRGAYRE- 272 (668)
T ss_pred ccc--cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH----HHHHHH----hhcccccC-
Confidence 543 344667899999999999998885 579999999999999999999987652 233332 22232211
Q ss_pred cCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHH
Q 002409 832 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 874 (927)
Q Consensus 832 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~ 874 (927)
++.+....-|+.+|+..+|++|.|+.+|..|.-
T Consensus 273 ----------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 273 ----------PETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred ----------CCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 222334567999999999999999999998853
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=306.49 Aligned_cols=254 Identities=25% Similarity=0.398 Sum_probs=213.1
Q ss_pred cccCHHHHHHHHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecC---CchhhHhHHHHHHHHhhccCCCccceecce
Q 002409 589 HCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLGYC 664 (927)
Q Consensus 589 ~~~~~~ei~~~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~ 664 (927)
..+++.+++ +++.||+|.||.||.|+.+ ++--||+|++.+. ..+..+++.+|+++-..++||||+++++++
T Consensus 17 ~~~~l~dfe-----igr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f 91 (281)
T KOG0580|consen 17 KTWTLDDFE-----IGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF 91 (281)
T ss_pred cccchhhcc-----ccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe
Confidence 445666654 7789999999999999876 4667999999765 234467899999999999999999999999
Q ss_pred eecCeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEE
Q 002409 665 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 744 (927)
Q Consensus 665 ~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~ 744 (927)
.+....||++||..+|.|...|.+. ...++++.....+..|+|.||.|+|.+ +|+||||||+|+|++..+..||+
T Consensus 92 hd~~riyLilEya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiA 166 (281)
T KOG0580|consen 92 HDSKRIYLILEYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIA 166 (281)
T ss_pred eccceeEEEEEecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeecc
Confidence 9999999999999999999998643 356688888899999999999999998 99999999999999999999999
Q ss_pred eecCcccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhc
Q 002409 745 DFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE 824 (927)
Q Consensus 745 DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~ 824 (927)
|||-+.... .....+.+||..|++||+..+..++..+|+|++|++.||++.|.+||+....++.+..|...
T Consensus 167 dfGwsV~~p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~------ 237 (281)
T KOG0580|consen 167 DFGWSVHAP---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV------ 237 (281)
T ss_pred CCCceeecC---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc------
Confidence 999886432 34456678999999999999999999999999999999999999999876645444444331
Q ss_pred cCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHH
Q 002409 825 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 873 (927)
Q Consensus 825 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L 873 (927)
+..+| ........+++.+|+..+|.+|.+..||+++-
T Consensus 238 -----~~~~p-------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 238 -----DLKFP-------STISGGAADLISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred -----cccCC-------cccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence 11112 22234678999999999999999999999873
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=332.91 Aligned_cols=248 Identities=23% Similarity=0.321 Sum_probs=206.2
Q ss_pred HhccccccCceEEEEEEEC-CCcEEEEEEeecCCc---hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 603 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 603 ~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
+...||+|+||.||.++-+ +|+.+|+|++++... ...+.+..|-.+|...++|+||+|+-.|.+.+++||||||++
T Consensus 145 ~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylP 224 (550)
T KOG0605|consen 145 LLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLP 224 (550)
T ss_pred hheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecC
Confidence 4678999999999999766 688999999987643 234557789999999999999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccC----
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD---- 754 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~---- 754 (927)
||++..+|. ..+.|++..+..++.+++.|++-||+. |+|||||||+|+|||..|++||+||||+.-...
T Consensus 225 GGD~mTLL~----~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~ 297 (550)
T KOG0605|consen 225 GGDMMTLLM----RKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI 297 (550)
T ss_pred CccHHHHHH----hcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence 999999984 457788999999999999999999998 999999999999999999999999999842110
Q ss_pred ------------------CCCc-----e-------------------eeeeccCCCccCccccccCcCCCccceeeHHHH
Q 002409 755 ------------------GASH-----V-------------------SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVI 792 (927)
Q Consensus 755 ------------------~~~~-----~-------------------~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvv 792 (927)
.... . .....|||.|||||++.+..|+..+|.||||||
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~I 377 (550)
T KOG0605|consen 298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCI 377 (550)
T ss_pred hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHH
Confidence 0000 0 011349999999999999999999999999999
Q ss_pred HHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCc---HHHH
Q 002409 793 LLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS---ISEV 869 (927)
Q Consensus 793 L~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs---m~eV 869 (927)
+||||.|.+||......+.++.|+.|........+. ....+..+||.+|+. ||++|-. +.||
T Consensus 378 myEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~--------------~~s~eA~DLI~rll~-d~~~RLG~~G~~EI 442 (550)
T KOG0605|consen 378 MYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEV--------------DLSDEAKDLITRLLC-DPENRLGSKGAEEI 442 (550)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcC--------------cccHHHHHHHHHHhc-CHHHhcCcccHHHH
Confidence 999999999999999889999999996543221110 011467889999999 9999985 6666
Q ss_pred HHH
Q 002409 870 LKD 872 (927)
Q Consensus 870 ~~~ 872 (927)
.+|
T Consensus 443 K~H 445 (550)
T KOG0605|consen 443 KKH 445 (550)
T ss_pred hcC
Confidence 554
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=325.84 Aligned_cols=256 Identities=25% Similarity=0.429 Sum_probs=206.0
Q ss_pred HHHHHHHhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 597 EDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 597 ~~~~~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
....+.+.+.||+|+||.||+|...+++.||+|.++... ...+++.+|++++++++||||+++++++...+..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 344566789999999999999998888899999987543 3356789999999999999999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
+++++|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 83 MKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred ccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 99999999985432 35689999999999999999999998 99999999999999999999999999998654322
Q ss_pred CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCc
Q 002409 757 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 835 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 835 (927)
.........+..|+|||++....++.++||||||+++|||++ |+.||...... .+..... .+..
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~~~----~~~~------- 222 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA----EVLQQVD----QGYR------- 222 (261)
T ss_pred ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH----HHHHHHH----cCCC-------
Confidence 221112223457999999998899999999999999999999 99998654311 1111111 1100
Q ss_pred ccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHH
Q 002409 836 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 875 (927)
Q Consensus 836 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~ 875 (927)
..........+.+++.+|++.+|++||++.++++.|++
T Consensus 223 --~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 223 --MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred --CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 00111223568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=337.88 Aligned_cols=251 Identities=23% Similarity=0.312 Sum_probs=202.2
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
|.+.+.||+|+||.||+|+.. +++.||||+++... ......+.+|++++.+++||||+++++++...+..++||||
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 82 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY 82 (333)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence 345688999999999999887 58899999997542 22345688899999999999999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
+++|+|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 83 ~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 83 VPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred CCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 999999999843 34678889999999999999999998 999999999999999999999999999975433
Q ss_pred CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 757 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+..|.... .. ....++.
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~---~~~~~~~- 226 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETL-QR---PVYDDPR- 226 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccc-cC---CCCCccc-
Confidence 2233458999999999999999999999999999999999999997654322222333221110 00 0000000
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.....++.+++.+|+..+|++||++.|++++
T Consensus 227 -----~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 227 -----FNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred -----cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 1223467899999999999999999999987
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=326.97 Aligned_cols=265 Identities=21% Similarity=0.252 Sum_probs=199.7
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
|.+.+.||+|+||.||+++.+ +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV 82 (287)
T ss_pred ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence 445688999999999999986 57889999987542 223456788999999999999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
+++.+..+.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 83 EKNMLELLEE----MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred CCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 9887765432 234588889999999999999999998 999999999999999999999999999986543332
Q ss_pred ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHH--------HhhhccCCcc
Q 002409 758 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA--------KLHIESGDIQ 829 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~--------~~~~~~~~~~ 829 (927)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.... +.........
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 22334568999999999998889999999999999999999999997543211111111100 0000111111
Q ss_pred cccCCcccC------ccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 830 GIIDPSLLD------EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 830 ~~~d~~l~~------~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
....+.... .+.......+.+++.+|++.+|++|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 100011000 0011123468999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=333.40 Aligned_cols=240 Identities=24% Similarity=0.326 Sum_probs=193.3
Q ss_pred ccccCceEEEEEEEC-CCcEEEEEEeecC---CchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCCch
Q 002409 607 IGSGGFGVVYYGKLK-DGKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 682 (927)
Q Consensus 607 IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 682 (927)
||+|+||.||+++.. +++.||+|+++.. .......+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999876 5788999998753 223345678899999999999999999999999999999999999999
Q ss_pred hhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCceeee
Q 002409 683 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 762 (927)
Q Consensus 683 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 762 (927)
.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 152 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNT 152 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccc
Confidence 998843 35688999999999999999999998 99999999999999999999999999987533222 22334
Q ss_pred eccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCccCH
Q 002409 763 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 842 (927)
Q Consensus 763 ~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 842 (927)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....... +.. .++.
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~-------~~~~~~~-~~~----------~~~~ 214 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE-------MYRKILQ-EPL----------RFPD 214 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH-------HHHHHHc-CCC----------CCCC
Confidence 569999999999999999999999999999999999999997543211 1111111 110 0111
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCc---HHHHHHH
Q 002409 843 QSMWKIEEKALMCVLPHGHMRPS---ISEVLKD 872 (927)
Q Consensus 843 ~~~~~l~~L~~~Cl~~dP~~RPs---m~eV~~~ 872 (927)
.....+.+++.+|++.+|++||+ +.|++.+
T Consensus 215 ~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 22246789999999999999985 5666654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=324.59 Aligned_cols=254 Identities=24% Similarity=0.434 Sum_probs=204.7
Q ss_pred HHHHHhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
..+.+.++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++.+...+..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 3455678999999999999998888899999876433 235678999999999999999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
+|+|.+++... ....+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++........
T Consensus 85 ~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 85 KGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 99999998643 234678889999999999999999998 9999999999999999999999999999865433222
Q ss_pred eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCccc
Q 002409 759 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 837 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 837 (927)
......++..|+|||++....++.++|||||||++|||++ |+.||...... .+..+... +... + ..
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~----~~~~~~~~----~~~~----~-~~ 226 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS----DVMSALQR----GYRM----P-RM 226 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH----HHHHHHHc----CCCC----C-CC
Confidence 2222345678999999988889999999999999999998 99998654311 22222111 1100 0 01
Q ss_pred CccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHH
Q 002409 838 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 875 (927)
Q Consensus 838 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~ 875 (927)
. ....++.+++.+|+..+|++||+++++.+.|++
T Consensus 227 ~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 227 E----NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred C----CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1 123468899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=324.26 Aligned_cols=254 Identities=29% Similarity=0.445 Sum_probs=203.8
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
.+.+.+.||+|+||.||+|..+ .++.||+|++.... ....++.+|++++++++|+||+++++++...+..+++|||++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 3445688999999999999876 57889999987543 335678899999999999999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
+++|.+++... ....+++..++.++.|+++||+|||++ +++||||||+||++++++.+||+|||+++........
T Consensus 86 ~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 86 YGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 99999988543 234588999999999999999999998 9999999999999999999999999998765443222
Q ss_pred eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCccc
Q 002409 759 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 837 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 837 (927)
......++..|+|||.+.+..++.++|||||||++|||++ |..||...... .+.+. ...+ ..
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~----~~~~~----~~~~---------~~ 223 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----QVYEL----LEKG---------YR 223 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHH----HHCC---------CC
Confidence 2222234678999999998999999999999999999998 89998654311 11111 1111 00
Q ss_pred CccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHH
Q 002409 838 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 876 (927)
Q Consensus 838 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~ 876 (927)
...+......+.+++.+|++.+|++||++.|+++.|+.+
T Consensus 224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 111122335688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=321.31 Aligned_cols=250 Identities=29% Similarity=0.498 Sum_probs=201.1
Q ss_pred HHHhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCC
Q 002409 601 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 680 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 680 (927)
+.+.+.||+|+||.||+++++++..+|+|.+.... .....+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~ 84 (256)
T cd05114 6 LTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENG 84 (256)
T ss_pred cEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCC
Confidence 44567899999999999999888899999876443 33567889999999999999999999999999999999999999
Q ss_pred chhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCcee
Q 002409 681 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 760 (927)
Q Consensus 681 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 760 (927)
+|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++..........
T Consensus 85 ~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 85 CLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred cHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 999988543 23588999999999999999999998 999999999999999999999999999875533222222
Q ss_pred eeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCcccCc
Q 002409 761 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 839 (927)
Q Consensus 761 ~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 839 (927)
....++..|+|||.+....++.++||||||+++|||++ |+.||...... .+...+.. +.. ...+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~----~~~~~i~~----~~~--~~~~~---- 224 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY----EVVEMISR----GFR--LYRPK---- 224 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHHC----CCC--CCCCC----
Confidence 22335678999999988889999999999999999999 89998654421 22222211 110 01111
Q ss_pred cCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHH
Q 002409 840 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 874 (927)
Q Consensus 840 ~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~ 874 (927)
.....+.+++.+|++.+|++||++.|+++.|.
T Consensus 225 ---~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 225 ---LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred ---CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11246889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=332.78 Aligned_cols=271 Identities=25% Similarity=0.383 Sum_probs=221.7
Q ss_pred cCHHHHHHHHHHHhccccccCceEEEEEEECCCcEEEEEEeecCCchh-hHhHHHHHHHHhhccCCCccceecceeecCe
Q 002409 591 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLGYCQEEGR 669 (927)
Q Consensus 591 ~~~~ei~~~~~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~-~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~ 669 (927)
-.+.|+.+....|.++||+|.||.|..+....+..||||+++...... .++|.+|+++|.+++||||++++|+|..++.
T Consensus 530 ~al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP 609 (807)
T KOG1094|consen 530 PALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP 609 (807)
T ss_pred cchhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc
Confidence 355677777777899999999999999999878999999999876544 5889999999999999999999999999999
Q ss_pred EEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCc
Q 002409 670 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 749 (927)
Q Consensus 670 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla 749 (927)
+++|+|||++|+|.+++.....+ .+.-....+|+.||+.||+||.+. ++|||||.++|||++.++++||+|||++
T Consensus 610 icmI~EYmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgms 684 (807)
T KOG1094|consen 610 LCMITEYMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMS 684 (807)
T ss_pred hHHHHHHHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccc
Confidence 99999999999999999654322 245556678999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCcee-eeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh--CCCcccccccccccchhhHHHHhhhccC
Q 002409 750 KFAVDGASHVS-SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS--GQEAISNEKFGANCRNIVQWAKLHIESG 826 (927)
Q Consensus 750 ~~~~~~~~~~~-~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt--G~~p~~~~~~~~~~~~l~~~~~~~~~~~ 826 (927)
+....++.+.. ....-+.+|||+|.+.-++++.++|||+||+.+||+++ ...||.... .+++++-.......+
T Consensus 685 R~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt----~e~vven~~~~~~~~ 760 (807)
T KOG1094|consen 685 RNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT----DEQVVENAGEFFRDQ 760 (807)
T ss_pred cccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh----HHHHHHhhhhhcCCC
Confidence 97766655443 33445789999999999999999999999999999876 667886544 223444333333322
Q ss_pred CcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHH
Q 002409 827 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 876 (927)
Q Consensus 827 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~ 876 (927)
.... ....+.-++.++.+++.+|+..+-++||+++++...|++.
T Consensus 761 ~~~~------~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 761 GRQV------VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred Ccce------eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 2111 1122344566899999999999999999999999999864
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=330.93 Aligned_cols=243 Identities=23% Similarity=0.326 Sum_probs=197.9
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
+.+.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|++++++++||||+++++++.+....++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 82 (291)
T cd05612 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY 82 (291)
T ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence 345688999999999999876 68899999986432 22345688999999999999999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 83 VPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred CCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence 999999998843 34688889999999999999999998 9999999999999999999999999998755332
Q ss_pred CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 757 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ..+..
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i--------~~~~~-------- 215 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI--------LAGKL-------- 215 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------HhCCc--------
Confidence 12345899999999999888999999999999999999999999764421111111 11111
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCCc-----HHHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 872 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----m~eV~~~ 872 (927)
.++......+.+++.+|++.||++||+ +.|++++
T Consensus 216 --~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 --EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred --CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 011111235789999999999999995 8888876
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=336.16 Aligned_cols=243 Identities=27% Similarity=0.365 Sum_probs=198.3
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
+.+.+.||+|+||.||+|+.+ +++.||||++.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 20 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 99 (329)
T PTZ00263 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEF 99 (329)
T ss_pred eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcC
Confidence 456789999999999999886 58899999987542 22345688999999999999999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
+.+|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 100 VVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred CCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 999999998853 34678888899999999999999998 99999999999999999999999999997553321
Q ss_pred CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 757 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.+ .+.++.+.
T Consensus 173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----~~~~----~i~~~~~~------- 233 (329)
T PTZ00263 173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF----RIYE----KILAGRLK------- 233 (329)
T ss_pred ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH----HHHH----HHhcCCcC-------
Confidence 2346899999999999999999999999999999999999999754311 1111 11112110
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCCc-----HHHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 872 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----m~eV~~~ 872 (927)
++......+.+++.+|++.||++||+ +.|+++|
T Consensus 234 ---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 234 ---FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ---CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 01111235789999999999999996 7888876
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=322.15 Aligned_cols=255 Identities=27% Similarity=0.437 Sum_probs=209.3
Q ss_pred HHHHHHhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 598 DATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 598 ~~~~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
...+.+.++||+|+||.||+|...+++.+|+|++..........+..|+.+++.++|+||+++++++......++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 34567789999999999999999889999999998766555677899999999999999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
++++|.+++... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||.+........
T Consensus 85 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 85 EKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 999999999653 245688999999999999999999998 999999999999999999999999999976543222
Q ss_pred ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 758 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
. .....++..|+|||.+....++.++||||||+++++|++ |+.||..... ..+........ .
T Consensus 160 ~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~----~~~~~~~~~~~---~--------- 222 (261)
T cd05148 160 L-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN----HEVYDQITAGY---R--------- 222 (261)
T ss_pred c-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH----HHHHHHHHhCC---c---------
Confidence 1 123335778999999988899999999999999999998 8999965431 12222222110 0
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 875 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~ 875 (927)
...+......+.+++.+|++.+|++|||+.++++.|+.
T Consensus 223 -~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 223 -MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred -CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 01112233468899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=325.21 Aligned_cols=257 Identities=26% Similarity=0.475 Sum_probs=206.1
Q ss_pred HHHHHHhccccccCceEEEEEEECC------CcEEEEEEeecCCch-hhHhHHHHHHHHhhccCCCccceecceeecCeE
Q 002409 598 DATKMLEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS 670 (927)
Q Consensus 598 ~~~~~~~~~IG~G~fG~Vy~~~~~~------g~~VAVK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~ 670 (927)
...+.+.+.||+|+||.||+|+..+ ++.||||.++..... ....+.+|++++++++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3456778899999999999998643 478999998765443 457899999999999999999999999999999
Q ss_pred EEEEEeccCCchhhhccccc----------ccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCc
Q 002409 671 VLVYEFMHNGTLKEHLYGTL----------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR 740 (927)
Q Consensus 671 ~lV~E~~~~gsL~~~L~~~~----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~ 740 (927)
++||||+++++|.+++.... .....+++..+..++.|++.||+|||++ +++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 99999999999999986431 2235578999999999999999999998 9999999999999999999
Q ss_pred EEEEeecCcccccCCCC-ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHH
Q 002409 741 AKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQW 818 (927)
Q Consensus 741 vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~ 818 (927)
+||+|||+++....... .......++..|+|||++....++.++|||||||++|||++ |+.||...... .+...
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~----~~~~~ 236 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE----EVIEC 236 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH----HHHHH
Confidence 99999999875432221 11223345788999999999999999999999999999998 99998654321 22222
Q ss_pred HHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHH
Q 002409 819 AKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 874 (927)
Q Consensus 819 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~ 874 (927)
.. .+.... .+......+.+++.+|++.+|++||++.||++.|+
T Consensus 237 ~~----~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 237 IT----QGRLLQ---------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HH----cCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 21 121111 11123346889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=322.42 Aligned_cols=260 Identities=26% Similarity=0.364 Sum_probs=201.8
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecC-----eEEEEEEec
Q 002409 604 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG-----RSVLVYEFM 677 (927)
Q Consensus 604 ~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-----~~~lV~E~~ 677 (927)
.+++|.|+||.||+|... +++.||||+.-.+. +.-.+|+++|+++.|||||+++-++.... ...+|||||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 478999999999999876 46899999876442 23357999999999999999998885432 346899999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCC-CcEEEEeecCcccccCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~-~~vkL~DFGla~~~~~~~ 756 (927)
+. +|.+.++.....+++++...+.-+..||.+||+|||+. +|+||||||+|+|+|.+ |.+||||||.|+....+.
T Consensus 105 P~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e 180 (364)
T KOG0658|consen 105 PE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE 180 (364)
T ss_pred hH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence 86 89998876555567788888889999999999999997 99999999999999977 899999999999887776
Q ss_pred CceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhc--c-------C
Q 002409 757 SHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE--S-------G 826 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~--~-------~ 826 (927)
...+.. -|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+... ..+++..++..-. + .
T Consensus 181 pniSYi--cSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~---~dQL~eIik~lG~Pt~e~I~~mn~ 255 (364)
T KOG0658|consen 181 PNISYI--CSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS---VDQLVEIIKVLGTPTREDIKSMNP 255 (364)
T ss_pred CceeEE--EeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH---HHHHHHHHHHhCCCCHHHHhhcCc
Confidence 665554 4889999999986 6799999999999999999999999987542 2233333322100 0 0
Q ss_pred CcccccCCcccC-----ccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH--HHHH
Q 002409 827 DIQGIIDPSLLD-----EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD--IQDA 876 (927)
Q Consensus 827 ~~~~~~d~~l~~-----~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~--L~~~ 876 (927)
...+.-.+.+.. -+......+.++++.++++.+|.+|.++.|++++ ++++
T Consensus 256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL 312 (364)
T ss_pred ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence 111111222211 1233445678999999999999999999999876 4444
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=333.50 Aligned_cols=242 Identities=24% Similarity=0.328 Sum_probs=195.2
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCC
Q 002409 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 680 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 680 (927)
+.||+|+||.||+++.. +|+.||+|+++... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46899999999999875 68999999997542 223456778999999999999999999999999999999999999
Q ss_pred chhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCcee
Q 002409 681 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 760 (927)
Q Consensus 681 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 760 (927)
+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~ 152 (323)
T cd05595 81 ELFFHLS----RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 152 (323)
T ss_pred cHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccc
Confidence 9988874 234688999999999999999999998 99999999999999999999999999987432221 122
Q ss_pred eeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCcc
Q 002409 761 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 840 (927)
Q Consensus 761 ~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 840 (927)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... +..... ..... +
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~----~~~~~~--~~~~~------------~ 214 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----LFELIL--MEEIR------------F 214 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH----HHHHHh--cCCCC------------C
Confidence 33568999999999999999999999999999999999999997543211 111100 00001 1
Q ss_pred CHHHHHHHHHHHhhhcCCCCCCCC-----cHHHHHHH
Q 002409 841 DIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 872 (927)
Q Consensus 841 ~~~~~~~l~~L~~~Cl~~dP~~RP-----sm~eV~~~ 872 (927)
+......+.+++.+|++.+|++|| ++.+++++
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 112234678999999999999998 89998876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=333.18 Aligned_cols=242 Identities=25% Similarity=0.353 Sum_probs=196.0
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCC
Q 002409 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 680 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 680 (927)
+.||+|+||.||+++.. +++.||+|++.... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999875 68899999997542 233456788999999999999999999999999999999999999
Q ss_pred chhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCcee
Q 002409 681 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 760 (927)
Q Consensus 681 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 760 (927)
+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~ 152 (328)
T cd05593 81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATM 152 (328)
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccc
Confidence 99888743 35688999999999999999999998 99999999999999999999999999987532221 122
Q ss_pred eeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCcc
Q 002409 761 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 840 (927)
Q Consensus 761 ~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 840 (927)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+... .. .+. ..+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~----~~~~~---~~-~~~------~~~---- 214 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KLFEL---IL-MED------IKF---- 214 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH----HHHHH---hc-cCC------ccC----
Confidence 3356999999999999889999999999999999999999999754321 11111 10 010 011
Q ss_pred CHHHHHHHHHHHhhhcCCCCCCCC-----cHHHHHHH
Q 002409 841 DIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 872 (927)
Q Consensus 841 ~~~~~~~l~~L~~~Cl~~dP~~RP-----sm~eV~~~ 872 (927)
+.....++.+++.+|++.+|++|| ++.|++++
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 215 PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 111224578999999999999997 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=321.59 Aligned_cols=254 Identities=25% Similarity=0.440 Sum_probs=203.4
Q ss_pred HHHHhccccccCceEEEEEEECC----CcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 674 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~~----g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~ 674 (927)
.+.+.+.||+|+||.||+|++.. ...||||+++... ......+.+|+.++++++||||+++++++...+..+++|
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 84 (266)
T cd05033 5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIIT 84 (266)
T ss_pred HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEE
Confidence 34567899999999999998752 4579999987543 333567889999999999999999999999999999999
Q ss_pred EeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccC
Q 002409 675 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 754 (927)
Q Consensus 675 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 754 (927)
||+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 85 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 85 EYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 999999999998543 23688999999999999999999998 999999999999999999999999999986642
Q ss_pred CCCc-eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCccccc
Q 002409 755 GASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 832 (927)
Q Consensus 755 ~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 832 (927)
.... ......++..|+|||.+....++.++||||||+++|||++ |..||...... .+..... ++...
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~----~~~~~~~----~~~~~--- 227 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ----DVIKAVE----DGYRL--- 227 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH----HHHHHHH----cCCCC---
Confidence 2221 2222335678999999998899999999999999999998 99998654311 1222111 11100
Q ss_pred CCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHH
Q 002409 833 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 876 (927)
Q Consensus 833 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~ 876 (927)
..+......+.+++.+|++.+|++||++.||+++|+++
T Consensus 228 ------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 ------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01112334688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=331.99 Aligned_cols=262 Identities=23% Similarity=0.312 Sum_probs=201.4
Q ss_pred HHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
..+.+.+.||+|+||.||+++.. ++..+|+|++.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 34556688999999999999876 67889999987543 23356789999999999999999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 85 MDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 999999998843 345888899999999999999999852 6999999999999999999999999998754332
Q ss_pred CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccC---Ccc----
Q 002409 757 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG---DIQ---- 829 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~---~~~---- 829 (927)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+..........+ ...
T Consensus 158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 231 (331)
T cd06649 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK----ELEAIFGRPVVDGEEGEPHSISP 231 (331)
T ss_pred --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHhcccccccccCCccccCc
Confidence 122345899999999999889999999999999999999999999653311 1111111000000 000
Q ss_pred -----------------------c----ccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHH
Q 002409 830 -----------------------G----IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 873 (927)
Q Consensus 830 -----------------------~----~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L 873 (927)
+ +...............++.+++.+|++.+|++|||+.|++++-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred ccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0 0000000000011234688999999999999999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=323.88 Aligned_cols=253 Identities=25% Similarity=0.339 Sum_probs=197.2
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCch---------h-----hHhHHHHHHHHhhccCCCccceecce
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---------G-----KREFTNEVTLLSRIHHRNLVQFLGYC 664 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~---------~-----~~~~~~Ei~iL~~l~HpnIv~l~g~~ 664 (927)
.|.+.+.||+|.||.|-+|+.. +++.||||++.+.... . .+...+|+.+|++++|||||+|+++.
T Consensus 98 qy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvL 177 (576)
T KOG0585|consen 98 QYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVL 177 (576)
T ss_pred heehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEee
Confidence 4556788999999999999866 6889999999753211 0 14678999999999999999999998
Q ss_pred eec--CeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEE
Q 002409 665 QEE--GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAK 742 (927)
Q Consensus 665 ~~~--~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vk 742 (927)
.+. +..|||+|||..|.+...= .....++..++++++.++..||+|||.+ +|+||||||+|+||+++|++|
T Consensus 178 DDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 178 DDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred cCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEE
Confidence 764 5789999999998875432 1223389999999999999999999999 999999999999999999999
Q ss_pred EEeecCcccccCCCC----ceeeeeccCCCccCccccccCc----CCCccceeeHHHHHHHHHhCCCcccccccccccch
Q 002409 743 VSDFGLSKFAVDGAS----HVSSIVRGTVGYLDPEYYISQQ----LTDKSDVYSFGVILLELISGQEAISNEKFGANCRN 814 (927)
Q Consensus 743 L~DFGla~~~~~~~~----~~~~~~~gt~~Y~aPE~~~~~~----~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~ 814 (927)
|+|||.+..+..+.. .......|||.|+|||.+.++. .+.+.||||+||.||.|+.|+.||-++..-+.+..
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~K 330 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDK 330 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHH
Confidence 999999976532211 1122356999999999998743 34577999999999999999999976652222222
Q ss_pred hhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHH
Q 002409 815 IVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 875 (927)
Q Consensus 815 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~ 875 (927)
| +...+.-....+....+.+|+.++|..||+.|.+..+|..|.--
T Consensus 331 I----------------vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 331 I----------------VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred H----------------hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 2 11122111112344568899999999999999999999988653
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=325.31 Aligned_cols=255 Identities=27% Similarity=0.472 Sum_probs=203.4
Q ss_pred HHHhccccccCceEEEEEEECC------CcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 673 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~~------g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV 673 (927)
+.+.+.||+|+||.||+|.... .+.||+|.+.... ......+.+|++++++++||||+++++++...+..+++
T Consensus 7 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 86 (283)
T cd05048 7 VRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCML 86 (283)
T ss_pred cchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEE
Confidence 4467889999999999998652 2579999987543 23346689999999999999999999999998999999
Q ss_pred EEeccCCchhhhcccccc------------cccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcE
Q 002409 674 YEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRA 741 (927)
Q Consensus 674 ~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~v 741 (927)
|||+++|+|.+++..... ....+++...+.++.|++.||+|||+. +++||||||+||++++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05048 87 FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTV 163 (283)
T ss_pred EecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCcE
Confidence 999999999999854311 114678899999999999999999998 99999999999999999999
Q ss_pred EEEeecCcccccCCCC-ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHH
Q 002409 742 KVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWA 819 (927)
Q Consensus 742 kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~ 819 (927)
||+|||+++....... .......+++.|+|||.+....++.++|||||||++|||++ |..||...... .+.+.+
T Consensus 164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~----~~~~~i 239 (283)
T cd05048 164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ----EVIEMI 239 (283)
T ss_pred EECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHH
Confidence 9999999975433221 12223346788999999988899999999999999999998 99998754321 222221
Q ss_pred HhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHH
Q 002409 820 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 875 (927)
Q Consensus 820 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~ 875 (927)
. .+... ..+.....++.+++.+|++.+|++||++.||+++|+.
T Consensus 240 ~----~~~~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 240 R----SRQLL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred H----cCCcC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1 11111 1122334578999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=323.22 Aligned_cols=248 Identities=25% Similarity=0.331 Sum_probs=196.8
Q ss_pred ccccCceEEEEEEEC-CCcEEEEEEeecCCc---hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCCch
Q 002409 607 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 682 (927)
Q Consensus 607 IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 682 (927)
||+|+||+||++... +++.+|+|++..... .....+..|++++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999876 688999999875422 2234577899999999999999999999999999999999999999
Q ss_pred hhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCceeee
Q 002409 683 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 762 (927)
Q Consensus 683 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 762 (927)
.+++.........+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 988765444456789999999999999999999998 999999999999999999999999999875543322 2233
Q ss_pred eccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCccCH
Q 002409 763 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 842 (927)
Q Consensus 763 ~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 842 (927)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.. ....+. ..++.
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~----~~~~~~----------~~~~~ 222 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ----RILNDS----------VTYPD 222 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHH----hhcccC----------CCCcc
Confidence 4689999999999999999999999999999999999999975431111111111 110010 01112
Q ss_pred HHHHHHHHHHhhhcCCCCCCCC-----cHHHHHHH
Q 002409 843 QSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 872 (927)
Q Consensus 843 ~~~~~l~~L~~~Cl~~dP~~RP-----sm~eV~~~ 872 (927)
.....+.+++.+|++.+|++|| +++|++++
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 2334688999999999999999 67777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=307.55 Aligned_cols=232 Identities=26% Similarity=0.356 Sum_probs=194.5
Q ss_pred HhccccccCceEEEEEEEC-CCcEEEEEEeecCCch---hhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 603 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 603 ~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~---~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
+.+.||.|+||+|..++.+ +|..+|+|++.+...- ..+...+|..+|+.+.||.++++.+.+.+.+..+|||||++
T Consensus 48 ~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~ 127 (355)
T KOG0616|consen 48 RLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVP 127 (355)
T ss_pred heeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccC
Confidence 5578999999999999987 5778999999765332 23456789999999999999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
||.|..+|+ ..+++++..+.-+|.||+.||+|||+. +|++|||||+|||+|.+|.+||+|||.|+....
T Consensus 128 GGElFS~Lr----k~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~---- 196 (355)
T KOG0616|consen 128 GGELFSYLR----KSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG---- 196 (355)
T ss_pred CccHHHHHH----hcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC----
Confidence 999999995 457899999999999999999999998 999999999999999999999999999987643
Q ss_pred eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccC
Q 002409 759 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 838 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 838 (927)
...+.+|||.|+|||++++..+..++|-|+|||++|||+.|..||.....-..++.|+. +++
T Consensus 197 rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~--------~~v---------- 258 (355)
T KOG0616|consen 197 RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILE--------GKV---------- 258 (355)
T ss_pred cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHh--------Ccc----------
Confidence 25667899999999999999999999999999999999999999987663222222222 211
Q ss_pred ccCHHHHHHHHHHHhhhcCCCCCCC
Q 002409 839 EYDIQSMWKIEEKALMCVLPHGHMR 863 (927)
Q Consensus 839 ~~~~~~~~~l~~L~~~Cl~~dP~~R 863 (927)
.++.-....+.+|+...++.|-.+|
T Consensus 259 ~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 1122222356778888888887777
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=326.86 Aligned_cols=264 Identities=21% Similarity=0.285 Sum_probs=197.3
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
|.+.++||+|+||.||+|+.+ +++.||+|+++... ......+.+|++++++++||||+++++++...+..++||||+.
T Consensus 7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (288)
T cd07871 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD 86 (288)
T ss_pred ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC
Confidence 455688999999999999876 68899999987543 2234567899999999999999999999999999999999997
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
+ +|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 87 ~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~- 158 (288)
T cd07871 87 S-DLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK- 158 (288)
T ss_pred c-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence 5 888887432 33578889999999999999999998 999999999999999999999999999875432221
Q ss_pred eeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhcc--------CCcc
Q 002409 759 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES--------GDIQ 829 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~--------~~~~ 829 (927)
......+++.|+|||++.+ ..++.++||||+||++|||++|+.||......+....+.+.......+ ..+.
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 1223457999999999865 568999999999999999999999997654222221221111100000 0001
Q ss_pred cccCCcccCcc----CHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 830 GIIDPSLLDEY----DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 830 ~~~d~~l~~~~----~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
....+...... ......++.+++.+|++.||++|||++|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 11111110000 01122457899999999999999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=332.72 Aligned_cols=262 Identities=26% Similarity=0.418 Sum_probs=203.6
Q ss_pred HHHHHHhccccccCceEEEEEEEC------CCcEEEEEEeecCCc-hhhHhHHHHHHHHhhc-cCCCccceecceee-cC
Q 002409 598 DATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQE-EG 668 (927)
Q Consensus 598 ~~~~~~~~~IG~G~fG~Vy~~~~~------~g~~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~-~~ 668 (927)
...+.+.+.||+|+||.||+|... .++.||+|+++.... ...+.+..|+++++++ +|+||++++++|.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 456778899999999999999643 247899999875432 2345678899999999 89999999998865 45
Q ss_pred eEEEEEEeccCCchhhhcccccc---------------------------------------------------------
Q 002409 669 RSVLVYEFMHNGTLKEHLYGTLT--------------------------------------------------------- 691 (927)
Q Consensus 669 ~~~lV~E~~~~gsL~~~L~~~~~--------------------------------------------------------- 691 (927)
..++++||+++++|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999988853211
Q ss_pred cccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce-eeeeccCCCcc
Q 002409 692 HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTVGYL 770 (927)
Q Consensus 692 ~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~Y~ 770 (927)
....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......... .....++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 023688999999999999999999998 99999999999999999999999999998654332222 22334677899
Q ss_pred CccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCcccCccCHHHHHHHH
Q 002409 771 DPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIE 849 (927)
Q Consensus 771 aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 849 (927)
|||++.+..++.++|||||||++|||++ |+.||......+ .+.. .+..+... ..+.....++.
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~---~~~~----~~~~~~~~---------~~~~~~~~~~~ 306 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE---EFCR----RLKEGTRM---------RAPEYATPEIY 306 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH---HHHH----HHhccCCC---------CCCccCCHHHH
Confidence 9999999999999999999999999998 999986533111 1111 11111110 00112234688
Q ss_pred HHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 850 EKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 850 ~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
+++.+|++.+|++||++.||+++|+++++
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=326.20 Aligned_cols=248 Identities=33% Similarity=0.539 Sum_probs=192.7
Q ss_pred hccccccCceEEEEEEEC-----CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 604 EKKIGSGGFGVVYYGKLK-----DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 604 ~~~IG~G~fG~Vy~~~~~-----~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
.+.||.|.||.||+|.+. .+..|+||+++... ....+.+.+|++.+++++||||++++|++...+..++|+||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 578999999999999877 35679999996543 334678999999999999999999999999888899999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
++|+|.++|... ....+++..++.|+.|+++||+|||++ +++|+||+++||+++.++.+||+|||+++.......
T Consensus 84 ~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 84 PGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccc--ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 999999999654 245689999999999999999999998 999999999999999999999999999976532221
Q ss_pred -ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCc
Q 002409 758 -HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 835 (927)
Q Consensus 758 -~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 835 (927)
...........|+|||.+....++.++||||||+++|||++ |+.|+..... ..+.... .++...
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~----~~~~~~~----~~~~~~------ 224 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN----EEIIEKL----KQGQRL------ 224 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH----HHHHHHH----HTTEET------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc----ccccccc----cccccc------
Confidence 22233446789999999999999999999999999999999 6788765431 1222221 111110
Q ss_pred ccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHH
Q 002409 836 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 873 (927)
Q Consensus 836 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L 873 (927)
..+......+.+++.+|++.+|++||++.|+++.|
T Consensus 225 ---~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 ---PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11112234688999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=349.62 Aligned_cols=252 Identities=22% Similarity=0.305 Sum_probs=203.6
Q ss_pred HHHhccccccCceEEEEEEEC-C-CcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-D-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~-g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
|.+.+.||+|+||.||+|... + ++.||+|.+..........+.+|+++++.++||||+++++++...+..++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 556789999999999999755 3 57788887765554445678889999999999999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC-
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS- 757 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~- 757 (927)
+|+|.+++.........+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 9999998865544456688999999999999999999998 999999999999999999999999999986543222
Q ss_pred ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCccc
Q 002409 758 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 837 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 837 (927)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+..... .+....
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~----~~~~~~~----~~~~~~------- 290 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR----EIMQQVL----YGKYDP------- 290 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHH----hCCCCC-------
Confidence 2233456999999999999999999999999999999999999999754311 1111111 111110
Q ss_pred CccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 838 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 838 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.+......+.+++.+|++.+|++||++.|++++
T Consensus 291 --~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 291 --FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred --CCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 111122468899999999999999999999754
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=329.54 Aligned_cols=242 Identities=26% Similarity=0.373 Sum_probs=194.2
Q ss_pred ccccccCceEEEEEEEC----CCcEEEEEEeecCC----chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 605 KKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS----YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~----~g~~VAVK~l~~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
+.||+|+||.||+++.. .++.||||+++... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999753 57889999987532 12234577899999999999999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
+++|+|.+++.. ...+.+..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 999999988843 34577888889999999999999998 99999999999999999999999999987433222
Q ss_pred CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 757 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... .+..+.. .+
T Consensus 155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~----~~~----~~~~~~~------~~ 219 (323)
T cd05584 155 T-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK----TID----KILKGKL------NL 219 (323)
T ss_pred C-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH----HHH----HHHcCCC------CC
Confidence 2 2233468999999999998889999999999999999999999997544211 111 1111111 01
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCC-----cHHHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 872 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----sm~eV~~~ 872 (927)
+......+.+++.+|++.+|++|| ++.+++++
T Consensus 220 ----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 220 ----PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred ----CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 111224578999999999999999 88888775
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=318.75 Aligned_cols=249 Identities=28% Similarity=0.462 Sum_probs=199.8
Q ss_pred HHHhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCC
Q 002409 601 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 680 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 680 (927)
+.+.+.||+|+||.||++++++++.+|+|++..... ....+.+|++++++++||||+++++++...+..++||||++++
T Consensus 6 ~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05059 6 LTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG 84 (256)
T ss_pred cchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence 456788999999999999988778899999864432 3456888999999999999999999999999999999999999
Q ss_pred chhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCcee
Q 002409 681 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 760 (927)
Q Consensus 681 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 760 (927)
+|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++...+......
T Consensus 85 ~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 85 CLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 999998543 23688999999999999999999998 999999999999999999999999999875543222221
Q ss_pred eeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCcccCc
Q 002409 761 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 839 (927)
Q Consensus 761 ~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 839 (927)
....++..|+|||.+....++.++||||||+++|||++ |+.||...... .+.... ..+. . ..
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~~~----~~~~-----~----~~ 221 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS----EVVESV----SAGY-----R----LY 221 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH----HHHHHH----HcCC-----c----CC
Confidence 22224567999999998899999999999999999999 88888654321 111111 1110 0 01
Q ss_pred cCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHH
Q 002409 840 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 873 (927)
Q Consensus 840 ~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L 873 (927)
.+.....++.+++.+|+..+|++||++.|+++.|
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 1112344689999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=326.46 Aligned_cols=244 Identities=25% Similarity=0.390 Sum_probs=203.2
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEeecCCc-hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCCc
Q 002409 604 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 681 (927)
Q Consensus 604 ~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gs 681 (927)
.+.||+|.||.||+|... .++.||+|++.-... ....++++|+.+|.+++++||.++++.+..+..++++||||.+|+
T Consensus 18 ~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGs 97 (467)
T KOG0201|consen 18 LELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGS 97 (467)
T ss_pred chhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcc
Confidence 378999999999999865 688899999976543 335678999999999999999999999999999999999999999
Q ss_pred hhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCceee
Q 002409 682 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 761 (927)
Q Consensus 682 L~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 761 (927)
+.+.|.. ...+++.....|++++..||.|||.+ +.+|||||+.|||+..+|.+||+|||.+-......... .
T Consensus 98 v~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-~ 169 (467)
T KOG0201|consen 98 VLDLLKS----GNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-K 169 (467)
T ss_pred hhhhhcc----CCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhcc-c
Confidence 9999843 33346667777899999999999999 99999999999999999999999999997655443333 5
Q ss_pred eeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCccC
Q 002409 762 IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD 841 (927)
Q Consensus 762 ~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 841 (927)
++.||+.|||||++....|+.|+||||||++.+||.+|.+|+..... ..... -+.+-..|.+.+.+.
T Consensus 170 tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP-mrvlf------------lIpk~~PP~L~~~~S 236 (467)
T KOG0201|consen 170 TFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP-MRVLF------------LIPKSAPPRLDGDFS 236 (467)
T ss_pred cccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc-ceEEE------------eccCCCCCccccccC
Confidence 67799999999999988999999999999999999999999976552 11111 122223344445433
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 842 IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 842 ~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
..+.+++..|+..+|+.||++.++++|
T Consensus 237 ----~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 237 ----PPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ----HHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 357889999999999999999999876
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=321.46 Aligned_cols=265 Identities=24% Similarity=0.378 Sum_probs=201.5
Q ss_pred HHhccccccCceEEEEEEE-----CCCcEEEEEEeecCCc-hhhHhHHHHHHHHhhccCCCccceecceeec--CeEEEE
Q 002409 602 MLEKKIGSGGFGVVYYGKL-----KDGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLV 673 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~-----~~g~~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--~~~~lV 673 (927)
.+.+.||+|+||+||++.. .+++.||+|+++.... .....+.+|++++++++||||+++++++... ...+++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 5668899999999988653 3577899999875432 3456788999999999999999999988653 457899
Q ss_pred EEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccccc
Q 002409 674 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 753 (927)
Q Consensus 674 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 753 (927)
|||+++++|.+++.. ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 87 ~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 87 MEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred ecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccC
Confidence 999999999998843 3589999999999999999999998 99999999999999999999999999997654
Q ss_pred CCCCc--eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccc
Q 002409 754 DGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 831 (927)
Q Consensus 754 ~~~~~--~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 831 (927)
..... ......++..|+|||.+....++.++|||||||+++||++|+.|+..... ....+..+.........+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPK--KFEEMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcc--hhhhhhcccccccchhhhhhh
Confidence 32221 11222356679999999888899999999999999999999999864321 111111111111111111111
Q ss_pred cCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHH
Q 002409 832 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 876 (927)
Q Consensus 832 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~ 876 (927)
++.......+.....++.+++.+|++.+|++||++++|++.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 222221122223445799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=339.72 Aligned_cols=261 Identities=24% Similarity=0.387 Sum_probs=203.5
Q ss_pred HHHHHHhccccccCceEEEEEEEC------CCcEEEEEEeecCCc-hhhHhHHHHHHHHhhcc-CCCccceecceeecCe
Q 002409 598 DATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGR 669 (927)
Q Consensus 598 ~~~~~~~~~IG~G~fG~Vy~~~~~------~g~~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~~ 669 (927)
...+.+.+.||+|+||.||+|+.. .+..||||+++.... .....+.+|+++++++. ||||++++++|.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 345567789999999999999853 234799999975433 33457899999999996 9999999999999999
Q ss_pred EEEEEEeccCCchhhhcccccc----------------------------------------------------------
Q 002409 670 SVLVYEFMHNGTLKEHLYGTLT---------------------------------------------------------- 691 (927)
Q Consensus 670 ~~lV~E~~~~gsL~~~L~~~~~---------------------------------------------------------- 691 (927)
.++||||+++|+|.+++.....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999998854210
Q ss_pred ----------------------------------cccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECC
Q 002409 692 ----------------------------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK 737 (927)
Q Consensus 692 ----------------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~ 737 (927)
....+++..++.++.|+++||+|||+. +|+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence 013478888899999999999999998 9999999999999999
Q ss_pred CCcEEEEeecCcccccCCCCc-eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchh
Q 002409 738 HMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNI 815 (927)
Q Consensus 738 ~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l 815 (927)
++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||....... .+
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~---~~ 349 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS---TF 349 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH---HH
Confidence 999999999999754332221 1222346788999999998899999999999999999997 889986543111 11
Q ss_pred hHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHH
Q 002409 816 VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 877 (927)
Q Consensus 816 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~ 877 (927)
.. ....+.. ...+......+.+++.+|++.+|++||++.+|.+.|++++
T Consensus 350 ~~----~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 350 YN----KIKSGYR---------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HH----HHhcCCC---------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 11 1111100 0011123356889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=329.42 Aligned_cols=258 Identities=22% Similarity=0.375 Sum_probs=201.7
Q ss_pred HHHHHHhccccccCceEEEEEEEC-CCc----EEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEE
Q 002409 598 DATKMLEKKIGSGGFGVVYYGKLK-DGK----EIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 671 (927)
Q Consensus 598 ~~~~~~~~~IG~G~fG~Vy~~~~~-~g~----~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~ 671 (927)
...+...+.||+|+||.||+|++. +++ .||+|+++... ....+++.+|+.+++.++||||++++++|... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 344556789999999999999864 333 38999987543 34456788999999999999999999999765 467
Q ss_pred EEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccc
Q 002409 672 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 751 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 751 (927)
+++||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 85 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence 999999999999998643 34578889999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCCcee-eeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcc
Q 002409 752 AVDGASHVS-SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQ 829 (927)
Q Consensus 752 ~~~~~~~~~-~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 829 (927)
......... ....++..|+|||++....++.++|||||||++|||++ |+.||...... .+.+... .+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~----~~~~~~~----~~~~~ 230 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----EISSILE----KGERL 230 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHh----CCCCC
Confidence 543322211 12234678999999999999999999999999999998 99998754311 1212111 11000
Q ss_pred cccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHH
Q 002409 830 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 879 (927)
Q Consensus 830 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~ 879 (927)
..+......+.+++.+|++.+|++||++.|+++.|..+...
T Consensus 231 ---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 231 ---------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred ---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 00111224678999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=335.46 Aligned_cols=250 Identities=24% Similarity=0.295 Sum_probs=201.4
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
|.+.+.||+|+||.||+|+.. +++.||||+++... ......+.+|++++..++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (350)
T cd05573 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEY 82 (350)
T ss_pred ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcC
Confidence 345688999999999999876 68899999987542 23345688999999999999999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 83 MPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred CCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999999853 25688999999999999999999998 99999999999999999999999999997554332
Q ss_pred ----------------------------CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCccccccc
Q 002409 757 ----------------------------SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF 808 (927)
Q Consensus 757 ----------------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~ 808 (927)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 1122334689999999999999999999999999999999999999976542
Q ss_pred ccccchhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCc-HHHHHHH
Q 002409 809 GANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS-ISEVLKD 872 (927)
Q Consensus 809 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-m~eV~~~ 872 (927)
.+....+..|... ..+.. .......+.+++.+|+. +|++||+ +.|++++
T Consensus 236 ~~~~~~i~~~~~~----~~~p~----------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 236 QETYNKIINWKES----LRFPP----------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHHHHhccCCc----ccCCC----------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 2222222222110 00000 00123467889999997 9999999 9999987
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=323.67 Aligned_cols=261 Identities=26% Similarity=0.467 Sum_probs=206.9
Q ss_pred HHHHHHhccccccCceEEEEEEEC------CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEE
Q 002409 598 DATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 671 (927)
Q Consensus 598 ~~~~~~~~~IG~G~fG~Vy~~~~~------~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~ 671 (927)
+..+.+.+.||+|+||.||++... ++..+|+|.+..........+.+|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 344556789999999999999752 34568999987665555667999999999999999999999999999999
Q ss_pred EEEEeccCCchhhhccccc---------ccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEE
Q 002409 672 LVYEFMHNGTLKEHLYGTL---------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAK 742 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vk 742 (927)
+||||+++++|.+++.... .....+++..++.++.|++.||+|||++ +++||||||+|||++.++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence 9999999999999985432 1223589999999999999999999998 999999999999999999999
Q ss_pred EEeecCcccccCCCCc-eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHH
Q 002409 743 VSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAK 820 (927)
Q Consensus 743 L~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~ 820 (927)
|+|||+++........ ......++..|+|||++....++.++|||||||+++||++ |+.||...... .+...
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~----~~~~~-- 234 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN----EVIEC-- 234 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHH--
Confidence 9999999754332211 1122335778999999998899999999999999999998 89998654311 12221
Q ss_pred hhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 821 LHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 821 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
...+.... ... .....+.+++.+|++.+|.+||++.||.+.|+++..
T Consensus 235 --i~~~~~~~-----~~~----~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 235 --ITQGRVLQ-----RPR----TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred --HHcCCcCC-----CCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 11121111 011 122468999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=330.05 Aligned_cols=250 Identities=24% Similarity=0.314 Sum_probs=196.6
Q ss_pred HHhccccccCceEEEEEEEC----CCcEEEEEEeecCC----chhhHhHHHHHHHHhhc-cCCCccceecceeecCeEEE
Q 002409 602 MLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS----YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVL 672 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~----~g~~VAVK~l~~~~----~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~l 672 (927)
.+.+.||+|+||.||+++.. +++.||+|++.... ....+.+..|+++++++ +|+||+++++++...+..++
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (332)
T cd05614 3 ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHL 82 (332)
T ss_pred eEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEE
Confidence 45688999999999998753 57899999987532 12235678899999999 59999999999999999999
Q ss_pred EEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccc
Q 002409 673 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 752 (927)
Q Consensus 673 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 752 (927)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 83 v~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 83 ILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 9999999999998853 35688899999999999999999998 9999999999999999999999999999755
Q ss_pred cCCCCceeeeeccCCCccCccccccC-cCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccc
Q 002409 753 VDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 831 (927)
Q Consensus 753 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 831 (927)
............||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+.. ....
T Consensus 156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~----~~~~------ 225 (332)
T cd05614 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR----RILK------ 225 (332)
T ss_pred cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHH----HHhc------
Confidence 43333333345699999999999765 478899999999999999999999964331111111111 1111
Q ss_pred cCCcccCccCHHHHHHHHHHHhhhcCCCCCCCC-----cHHHHHHH
Q 002409 832 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 872 (927)
Q Consensus 832 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----sm~eV~~~ 872 (927)
.++.+.. .....+.+++.+|++.+|++|| ++.|++++
T Consensus 226 ~~~~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 226 CDPPFPS----FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCCCCCC----CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 1111111 1234578999999999999999 77788876
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=345.12 Aligned_cols=258 Identities=23% Similarity=0.324 Sum_probs=208.3
Q ss_pred HHHHhccccccCceEEEEEEECCC-cEEEEEEeecCCchhhHhHHHHHHHHhhcc-CCCccceecc-eee------cCeE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLKDG-KEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGY-CQE------EGRS 670 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~~g-~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~-~~~------~~~~ 670 (927)
...+++.|.+|||+.||.|+...+ .++|+|++-....+..+.+.+|+++|++|. |+|||.+++. ... .-+.
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev 117 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV 117 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence 344678999999999999998765 999999998777777889999999999996 9999999993 221 2367
Q ss_pred EEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcc
Q 002409 671 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 750 (927)
Q Consensus 671 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 750 (927)
+|.||||.+|.|-|++..+.. .+|++.++++|+.|+++|+++||.. .++|||||||-+||||+.+++.||||||.+.
T Consensus 118 llLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 899999999999999976653 3499999999999999999999995 5689999999999999999999999999986
Q ss_pred cccCCCCce--e------eeeccCCCccCcccc---ccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHH
Q 002409 751 FAVDGASHV--S------SIVRGTVGYLDPEYY---ISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA 819 (927)
Q Consensus 751 ~~~~~~~~~--~------~~~~gt~~Y~aPE~~---~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~ 819 (927)
-........ . -...-|+-|+|||++ .+..+++|+|||+|||+||-|+....||+....
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----------- 263 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----------- 263 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-----------
Confidence 332222110 0 012368999999997 467899999999999999999999999986531
Q ss_pred HhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHHH
Q 002409 820 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 880 (927)
Q Consensus 820 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~~ 880 (927)
..+++....-.-.......+.+||..||+++|.+||++.||++++.++...+
T Consensus 264 ---------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 264 ---------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred ---------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 1112222111112345568999999999999999999999999999887643
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=319.46 Aligned_cols=250 Identities=30% Similarity=0.482 Sum_probs=201.0
Q ss_pred HHHhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCC
Q 002409 601 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 680 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 680 (927)
+.+.+.||+|+||.||+|++.++..+|+|.+.... .....+.+|++++++++||||+++++++......+++|||+.+|
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05113 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNG 84 (256)
T ss_pred eEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCC
Confidence 45668899999999999998877789999887443 23567899999999999999999999999888999999999999
Q ss_pred chhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCcee
Q 002409 681 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 760 (927)
Q Consensus 681 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 760 (927)
+|.+++... ...+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++..........
T Consensus 85 ~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 85 CLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred cHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 999988542 23688999999999999999999998 999999999999999999999999999876544322222
Q ss_pred eeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCcccCc
Q 002409 761 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 839 (927)
Q Consensus 761 ~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 839 (927)
....++..|++||.+....++.++|||||||++|||++ |+.||.....+ .+...+ ..+....
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~----~~~~~~----~~~~~~~--------- 221 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS----ETVEKV----SQGLRLY--------- 221 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH----HHHHHH----hcCCCCC---------
Confidence 22335678999999988889999999999999999998 99998654311 111211 1111000
Q ss_pred cCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHH
Q 002409 840 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 874 (927)
Q Consensus 840 ~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~ 874 (927)
........+.+++.+|++.+|++||++.+|++.|+
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 00112357889999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=322.27 Aligned_cols=268 Identities=28% Similarity=0.402 Sum_probs=196.8
Q ss_pred HhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhh--ccCCCccceecceeecC----eEEEEEEe
Q 002409 603 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSR--IHHRNLVQFLGYCQEEG----RSVLVYEF 676 (927)
Q Consensus 603 ~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~--l~HpnIv~l~g~~~~~~----~~~lV~E~ 676 (927)
+.+.||+|+||.||||.+. ++.||||++.. +....|..|-+|++. ++|+||++++++-.... .++||+||
T Consensus 214 l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f 289 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF 289 (534)
T ss_pred hHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence 4578999999999999998 69999999864 345567777777654 58999999999876555 88999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCC------CCceecCCCCCCCeEECCCCcEEEEeecCcc
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC------VPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 750 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~------~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 750 (927)
.+.|+|.++|. ...++|....+|+..+++||+|||+.. .++|+|||||++||||.+|+++.|+|||+|.
T Consensus 290 h~kGsL~dyL~-----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 290 HPKGSLCDYLK-----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred ccCCcHHHHHH-----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 99999999995 456899999999999999999999754 3689999999999999999999999999998
Q ss_pred cccCCCCc-eeeeeccCCCccCccccccCc-CC-----CccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhh
Q 002409 751 FAVDGASH-VSSIVRGTVGYLDPEYYISQQ-LT-----DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 823 (927)
Q Consensus 751 ~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~-~s-----~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~ 823 (927)
.+..+... .....+||.+|||||++.+.- +. .+.||||+|.|||||++....+.....++-.--..+-+..+.
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 66544322 223367999999999997532 22 368999999999999997655431110100000000000000
Q ss_pred ccCCcc-----cccCCcccCcc-CHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHH
Q 002409 824 ESGDIQ-----GIIDPSLLDEY-DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 879 (927)
Q Consensus 824 ~~~~~~-----~~~d~~l~~~~-~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~ 879 (927)
.-+++. +...|.+.+.. ....+.-+.+.+..|++.||+.|.|+.=|.+.+.++...
T Consensus 445 t~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 445 TLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred CHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 000000 11112221111 124456788999999999999999999999999987543
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=330.50 Aligned_cols=261 Identities=27% Similarity=0.397 Sum_probs=215.8
Q ss_pred HHHHHHHHHhccccccCceEEEEEEECC-CcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEE
Q 002409 595 DIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 673 (927)
Q Consensus 595 ei~~~~~~~~~~IG~G~fG~Vy~~~~~~-g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV 673 (927)
|+++......++||-|.||.||.|.|+. .-.||||.++.+.. ..++|.+|..+|+.++|||+|+|+|+|..+...|||
T Consensus 263 EmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIi 341 (1157)
T KOG4278|consen 263 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYII 341 (1157)
T ss_pred hccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEE
Confidence 3333333456899999999999999884 45699999986644 367899999999999999999999999999999999
Q ss_pred EEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccccc
Q 002409 674 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 753 (927)
Q Consensus 674 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 753 (927)
+|||..|+|.++|++.. +..++-...+.|+.||+.||+||..+ ++|||||.++|+|+.++..+||+|||+++++.
T Consensus 342 TEfM~yGNLLdYLRecn--r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 342 TEFMCYGNLLDYLRECN--RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred EecccCccHHHHHHHhc--hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 99999999999997653 44566777889999999999999998 99999999999999999999999999999876
Q ss_pred CCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCccccc
Q 002409 754 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 832 (927)
Q Consensus 754 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 832 (927)
...........-...|.|||-+....++.|+|||+|||+|||+.| |..|+.+.+.. .+...++
T Consensus 417 gDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS--------qVY~LLE-------- 480 (1157)
T KOG4278|consen 417 GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------QVYGLLE-------- 480 (1157)
T ss_pred CCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH--------HHHHHHh--------
Confidence 543322223334678999999999999999999999999999998 88888754421 1222222
Q ss_pred CCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 833 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 833 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
...+-+.+..++.++.+|+..|++++|.+||++.|+-+.++.++.
T Consensus 481 -kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 481 -KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred -ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 223334455677789999999999999999999999999998875
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=316.89 Aligned_cols=254 Identities=26% Similarity=0.433 Sum_probs=202.8
Q ss_pred HHHHHHhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 598 DATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 598 ~~~~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
...+.+.++||+|+||.||+|...++..+|+|.++.... ....+.+|+.++++++|+|++++++++.. ...+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEec
Confidence 345677889999999999999988888999999875433 34678999999999999999999998754 5678999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
++++|.+++... ....+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++........
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 83 SKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 999999998643 234588999999999999999999998 999999999999999999999999999976543322
Q ss_pred ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 758 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
.......++..|+|||++....++.++||||||+++|||++ |+.||..... ..+.+..... ..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~----~~~~~~~~~~---~~--------- 221 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN----REVLEQVERG---YR--------- 221 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH----HHHHHHHHcC---CC---------
Confidence 22222335678999999988889999999999999999999 8889865431 1222221110 00
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 875 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~ 875 (927)
...+......+.+++.+|+..+|++|||+.++.+.|++
T Consensus 222 -~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 -MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01112233468899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=331.60 Aligned_cols=242 Identities=24% Similarity=0.326 Sum_probs=194.8
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCC
Q 002409 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 680 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 680 (927)
+.||+|+||.||+++.. +++.||+|++.... ......+..|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999865 68899999997542 223456778999999999999999999999999999999999999
Q ss_pred chhhhcccccccccccCHHHHHHHHHHHHhHhHHHhh-CCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 681 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 681 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
+|.+++. ....+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (325)
T cd05594 81 ELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-T 152 (325)
T ss_pred cHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-c
Confidence 9988874 24568899999999999999999997 5 899999999999999999999999999874332221 2
Q ss_pred eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCc
Q 002409 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 839 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 839 (927)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+..... .+.. .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~----~~~~~i~----~~~~------~~--- 215 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KLFELIL----MEEI------RF--- 215 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH----HHHHHHh----cCCC------CC---
Confidence 23346999999999999999999999999999999999999999654311 1111111 0000 01
Q ss_pred cCHHHHHHHHHHHhhhcCCCCCCCC-----cHHHHHHH
Q 002409 840 YDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 872 (927)
Q Consensus 840 ~~~~~~~~l~~L~~~Cl~~dP~~RP-----sm~eV~~~ 872 (927)
+.....++.+++.+|++.+|++|+ ++.|++++
T Consensus 216 -p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 216 -PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred -CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 111234578999999999999996 89999877
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=318.42 Aligned_cols=256 Identities=25% Similarity=0.426 Sum_probs=203.5
Q ss_pred HHHHHHhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 598 DATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 598 ~~~~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
...+.+.++||+|+||.||+|++.++..||+|+++... .....+.+|++++++++|+||+++++.+.+ ...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 34567789999999999999998877789999987533 234578999999999999999999998754 5578999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
++|+|.+++... ....+++..++.++.|+++||+|||+. +++||||||+||++++++.+||+|||.++.......
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 83 SKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred CCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 999999998643 234578999999999999999999998 999999999999999999999999999976543332
Q ss_pred ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 758 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
.......++..|+|||+.....++.++|||||||++|||++ |+.||...... .+.. ....+. .
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~----~~~~----~~~~~~-----~--- 221 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLD----QVERGY-----R--- 221 (262)
T ss_pred ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH----HHHH----HHhcCC-----C---
Confidence 22223346778999999988899999999999999999999 88888654311 1111 111110 0
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 877 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~ 877 (927)
.....+....+.+++.+|++.+|++||++.++++.|++..
T Consensus 222 -~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 222 -MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred -CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 0111233456889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=324.17 Aligned_cols=258 Identities=26% Similarity=0.462 Sum_probs=206.6
Q ss_pred HHHhccccccCceEEEEEEEC------CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 674 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~------~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~ 674 (927)
+.+.+.||+|+||.||+|+.. ++..+++|.+........+.+.+|++++++++|+||+++++++......++||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (291)
T cd05094 7 IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVF 86 (291)
T ss_pred eEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEE
Confidence 445688999999999999753 34568999987665555677999999999999999999999999999999999
Q ss_pred EeccCCchhhhccccc------------ccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEE
Q 002409 675 EFMHNGTLKEHLYGTL------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAK 742 (927)
Q Consensus 675 E~~~~gsL~~~L~~~~------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vk 742 (927)
||+++++|.+++.... .....+++..++.++.|++.||+|||++ +++||||||+|||++.++.+|
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 163 (291)
T cd05094 87 EYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVK 163 (291)
T ss_pred ecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence 9999999999985432 1234588999999999999999999998 999999999999999999999
Q ss_pred EEeecCcccccCCCC-ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHH
Q 002409 743 VSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAK 820 (927)
Q Consensus 743 L~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~ 820 (927)
|+|||+++....... .......++..|+|||++....++.++|||||||++|||++ |+.||...... ...+.
T Consensus 164 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~----~~~~~-- 237 (291)
T cd05094 164 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT----EVIEC-- 237 (291)
T ss_pred ECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHH--
Confidence 999999975443221 11223446788999999998999999999999999999999 99998654311 12221
Q ss_pred hhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 821 LHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 821 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
...+.... ........+.+++.+|++.+|++||++.+|++.|+++..
T Consensus 238 --~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 238 --ITQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred --HhCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 11221111 011123468899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=327.00 Aligned_cols=250 Identities=22% Similarity=0.303 Sum_probs=195.6
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhc-cCCCccceecceeecCeEEEEEEeccC
Q 002409 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
+.||+|+||.||+++.. +++.+|+|+++... ......+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999876 57889999997542 23345577888888776 899999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~ 152 (329)
T cd05618 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DT 152 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cc
Confidence 999888742 35688999999999999999999998 99999999999999999999999999987432221 12
Q ss_pred eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccc-cchhhHHHHhhhccCCcccccCCcccC
Q 002409 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGAN-CRNIVQWAKLHIESGDIQGIIDPSLLD 838 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~d~~l~~ 838 (927)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......+.......+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---------- 222 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---------- 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------
Confidence 2345689999999999999999999999999999999999999964221111 11222222222222211
Q ss_pred ccCHHHHHHHHHHHhhhcCCCCCCCCc------HHHHHHH
Q 002409 839 EYDIQSMWKIEEKALMCVLPHGHMRPS------ISEVLKD 872 (927)
Q Consensus 839 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs------m~eV~~~ 872 (927)
..+.....++.+++.+|++.+|++||+ +.|+++|
T Consensus 223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 223 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 111222346789999999999999998 5677766
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=300.50 Aligned_cols=266 Identities=20% Similarity=0.295 Sum_probs=209.8
Q ss_pred HHHHHHHhccccccCceEEEEEE-ECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecC-----eE
Q 002409 597 EDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG-----RS 670 (927)
Q Consensus 597 ~~~~~~~~~~IG~G~fG~Vy~~~-~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-----~~ 670 (927)
...+|.+.+.||+|||+-||.++ ..+++-+|+|++.-.+.++.+..++|++..++++||||+++++++..+. ..
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 34567788999999999999997 4578899999987777677888999999999999999999999885443 48
Q ss_pred EEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcc
Q 002409 671 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 750 (927)
Q Consensus 671 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 750 (927)
+|+++|...|+|.+.+.....++..+++.+.+.|+.++++||++||+. .++++||||||.|||+++++.++|.|||.++
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 999999999999999987766777899999999999999999999997 3469999999999999999999999999886
Q ss_pred cccCC---CCce-----eeeeccCCCccCccccc---cCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHH
Q 002409 751 FAVDG---ASHV-----SSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA 819 (927)
Q Consensus 751 ~~~~~---~~~~-----~~~~~gt~~Y~aPE~~~---~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~ 819 (927)
...-. .... .....-|..|+|||.+. ....++++|||||||+||+|+.|..||+..-..+.-..+
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL---- 253 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL---- 253 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE----
Confidence 43211 1000 01123588999999985 456789999999999999999999999754321111000
Q ss_pred HhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHH
Q 002409 820 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 877 (927)
Q Consensus 820 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~ 877 (927)
.+..+.+.-.-+......+.+++..|++.||.+||++.|++.+++.++
T Consensus 254 ----------Av~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 254 ----------AVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ----------eeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 001111110111123457899999999999999999999999998764
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=323.32 Aligned_cols=264 Identities=21% Similarity=0.279 Sum_probs=193.7
Q ss_pred HHHhccccccCceEEEEEEEC--CCcEEEEEEeecCCc--hhhHhHHHHHHHHhhc---cCCCccceeccee-----ecC
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK--DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRI---HHRNLVQFLGYCQ-----EEG 668 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~--~g~~VAVK~l~~~~~--~~~~~~~~Ei~iL~~l---~HpnIv~l~g~~~-----~~~ 668 (927)
|.+.+.||+|+||.||+|+.. +++.||+|+++.... .....+.+|+.+++++ +||||++++++|. ...
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~ 82 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 82 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence 456788999999999999863 467899999875432 2234566777777665 6999999999885 345
Q ss_pred eEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecC
Q 002409 669 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 748 (927)
Q Consensus 669 ~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGl 748 (927)
..++||||+. ++|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 83 KLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred cEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 6899999996 5888888543 234588999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCc
Q 002409 749 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 828 (927)
Q Consensus 749 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 828 (927)
++..... .......||+.|+|||.+....++.++|||||||++|||++|+.||......+....+.+...........
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 9754332 22234568999999999988899999999999999999999999997654222222222221110000000
Q ss_pred ------ccccCCccc---CccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 829 ------QGIIDPSLL---DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 829 ------~~~~d~~l~---~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
...+.+.-. ..........+.+++.+|++.+|++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 000000000 00011223457799999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=330.54 Aligned_cols=245 Identities=25% Similarity=0.375 Sum_probs=190.6
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc-hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
.+.++||+|+||.||+|++. +++.||||++..... .....+.+|++++++++|+||+++++++...+..++||||+++
T Consensus 77 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 156 (353)
T PLN00034 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDG 156 (353)
T ss_pred hhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCC
Confidence 35578999999999999876 689999999865432 3356788999999999999999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
|+|.+.. ...+..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 157 ~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~ 224 (353)
T PLN00034 157 GSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-P 224 (353)
T ss_pred Ccccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc-c
Confidence 9986532 245667788999999999999998 999999999999999999999999999975533221 1
Q ss_pred eeeeccCCCccCcccccc-----CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCC
Q 002409 760 SSIVRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 834 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~-----~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 834 (927)
.....||..|+|||++.. ...+.++|||||||++|||++|+.||......+ ...+...... ..
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~----~~------- 292 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD-WASLMCAICM----SQ------- 292 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc-HHHHHHHHhc----cC-------
Confidence 233468999999998743 233468999999999999999999997433111 1111111100 00
Q ss_pred cccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 835 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 835 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
..........++.+++.+|++.+|++||++.|++++
T Consensus 293 --~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 --PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred --CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001111223468899999999999999999999986
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=333.66 Aligned_cols=238 Identities=26% Similarity=0.359 Sum_probs=200.7
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc---hhhHhHHHHHHHHhhc-cCCCccceecceeecCeEEEEEEe
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
.+.++||+|.||+|+++..+ +++.+|||++++... ...+..+.|.+++... +||.+++++..+..++++++||||
T Consensus 371 ~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey 450 (694)
T KOG0694|consen 371 RLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEY 450 (694)
T ss_pred EEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEe
Confidence 46789999999999999887 577899999988743 3345677888888777 599999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
+.||++..+. ..+.+++..+.-++..|+.||+|||++ +|||||||.+|||||.+|.+||+|||+++...- .
T Consensus 451 ~~Ggdm~~~~-----~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~-~ 521 (694)
T KOG0694|consen 451 VAGGDLMHHI-----HTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG-Q 521 (694)
T ss_pred cCCCcEEEEE-----ecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCC-C
Confidence 9999954443 357799999999999999999999999 999999999999999999999999999984322 2
Q ss_pred CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 757 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
...+.+++|||.|||||++.++.|+..+|-|||||+|||||.|+.||.+++.++.+.+|+. ++
T Consensus 522 g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~-----------d~------ 584 (694)
T KOG0694|consen 522 GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN-----------DE------ 584 (694)
T ss_pred CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc-----------CC------
Confidence 3356778999999999999999999999999999999999999999997775554444433 11
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCCcH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPSI 866 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm 866 (927)
.-|+.....+.+.++.+++..+|++|..+
T Consensus 585 -~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 585 -VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 12333444578899999999999999976
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=325.97 Aligned_cols=201 Identities=27% Similarity=0.407 Sum_probs=173.1
Q ss_pred HHHHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEE
Q 002409 597 EDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 674 (927)
Q Consensus 597 ~~~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~ 674 (927)
....|.+.++||+|+||.||++... +++.+|+|++.... ......+.+|++++++++|+||+++++++...+..++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 3456677889999999999999877 67889999887543 233467889999999999999999999999999999999
Q ss_pred EeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccC
Q 002409 675 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 754 (927)
Q Consensus 675 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 754 (927)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+. .+++||||||+|||++.++.+||+|||++.....
T Consensus 83 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 83 EHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 99999999999843 34578888999999999999999974 2799999999999999999999999999875432
Q ss_pred CCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCccccc
Q 002409 755 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 806 (927)
Q Consensus 755 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~ 806 (927)
. ......|+..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 157 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 157 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred h---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 2 122345899999999999888999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=316.89 Aligned_cols=256 Identities=25% Similarity=0.419 Sum_probs=205.4
Q ss_pred HHHHHHHHhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEE
Q 002409 596 IEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 675 (927)
Q Consensus 596 i~~~~~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E 675 (927)
+....+++.++||+|+||.||+|..++++.||+|.+..... ....+.+|+.++++++|+||+++++++. .+..+++||
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 45667788899999999999999998899999999875443 3567889999999999999999999874 456899999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCC
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 755 (927)
|+++++|.+++... ....+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 81 YMENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred cCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 99999999988543 245688999999999999999999998 9999999999999999999999999998765432
Q ss_pred CCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCC
Q 002409 756 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 834 (927)
Q Consensus 756 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 834 (927)
.........++..|+|||++....++.++||||||+++|||++ |+.||.....+ .+.... ..+...
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~~~----~~~~~~----- 222 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP----EVIQNL----ERGYRM----- 222 (260)
T ss_pred CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH----HHHHHH----HcCCCC-----
Confidence 2222223345678999999988889999999999999999999 99999754321 122211 111000
Q ss_pred cccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHH
Q 002409 835 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 875 (927)
Q Consensus 835 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~ 875 (927)
........++.+++.+|++.+|++||+++++.+.|+.
T Consensus 223 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 ----PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0111123468999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=329.69 Aligned_cols=250 Identities=25% Similarity=0.360 Sum_probs=209.5
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecCe-EEEEEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR-SVLVYE 675 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~-~~lV~E 675 (927)
.|...+++|+|+||.++..+++ +++.+++|.+.-.. ....+....|+.++++++|||||.+.+.+.+++. .+|||+
T Consensus 5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~ 84 (426)
T KOG0589|consen 5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVME 84 (426)
T ss_pred hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEe
Confidence 3556789999999999999776 57889999987542 3334578899999999999999999999998888 999999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCC
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 755 (927)
||+||+|.+.+.... ..-+++..++.++.|++.|+.|||++ +|+|||||+.||+++.+..|||+|||+|+.....
T Consensus 85 Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 85 YCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred ecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 999999999996543 56688999999999999999999988 9999999999999999999999999999987665
Q ss_pred CCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCc
Q 002409 756 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 835 (927)
Q Consensus 756 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 835 (927)
.. ....+.||+.||.||++.+.+|..|+|||||||++|||++-+++|...........+.+-.
T Consensus 160 ~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~---------------- 222 (426)
T KOG0589|consen 160 DS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL---------------- 222 (426)
T ss_pred hh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc----------------
Confidence 43 3445679999999999999999999999999999999999999998766433322222210
Q ss_pred ccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 836 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 836 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
....+.....++..++..|++.+|+.||++.+++.+
T Consensus 223 -~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 -YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 111122233468899999999999999999999987
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=327.56 Aligned_cols=242 Identities=22% Similarity=0.331 Sum_probs=193.8
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhc-cCCCccceecceeecCeEEEEEEeccC
Q 002409 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
+.||+|+||.||+|+.. +++.||||+++... ......+..|.++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46899999999999876 57899999987542 22334567788888866 799999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
|+|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (321)
T cd05591 81 GDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VT 152 (321)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-cc
Confidence 999888743 45688899999999999999999998 99999999999999999999999999987533222 12
Q ss_pred eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCc
Q 002409 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 839 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 839 (927)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ +.+.. ..+.. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~----~~~~i----~~~~~---~------- 214 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD----LFESI----LHDDV---L------- 214 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH----HHHHH----HcCCC---C-------
Confidence 234568999999999998899999999999999999999999997654221 11111 11110 0
Q ss_pred cCHHHHHHHHHHHhhhcCCCCCCCC-------cHHHHHHH
Q 002409 840 YDIQSMWKIEEKALMCVLPHGHMRP-------SISEVLKD 872 (927)
Q Consensus 840 ~~~~~~~~l~~L~~~Cl~~dP~~RP-------sm~eV~~~ 872 (927)
++.....++.+++.+|++.+|++|| ++.+++++
T Consensus 215 ~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 215 YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 0111224678999999999999999 78888776
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=332.03 Aligned_cols=244 Identities=23% Similarity=0.268 Sum_probs=197.6
Q ss_pred HHHHhccccccCceEEEEEEECC--CcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLKD--GKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 674 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~~--g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~ 674 (927)
.+.+.+.||+|+||.||+|.++. +..||+|++.... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 31 ~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 110 (340)
T PTZ00426 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVL 110 (340)
T ss_pred hcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEE
Confidence 45567899999999999998653 3689999986432 223456788999999999999999999999999999999
Q ss_pred EeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccC
Q 002409 675 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 754 (927)
Q Consensus 675 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 754 (927)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 111 Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 111 EFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999998853 34688999999999999999999998 999999999999999999999999999975432
Q ss_pred CCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCC
Q 002409 755 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 834 (927)
Q Consensus 755 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 834 (927)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||......... + .+..+..
T Consensus 184 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~----~----~i~~~~~------ 245 (340)
T PTZ00426 184 R----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIY----Q----KILEGII------ 245 (340)
T ss_pred C----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHH----H----HHhcCCC------
Confidence 2 22356999999999999888999999999999999999999999754411111 1 1111111
Q ss_pred cccCccCHHHHHHHHHHHhhhcCCCCCCCC-----cHHHHHHH
Q 002409 835 SLLDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 872 (927)
Q Consensus 835 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----sm~eV~~~ 872 (927)
. ++......+.+++.+|++.+|++|+ ++.|++++
T Consensus 246 ~----~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 Y----FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred C----CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 0 1111123577999999999999995 89998877
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=336.28 Aligned_cols=249 Identities=23% Similarity=0.342 Sum_probs=196.6
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
.+.+.||+|+||.||+++.. +++.||||++.... ......+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~ 83 (364)
T cd05599 4 ESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYL 83 (364)
T ss_pred eEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCC
Confidence 34688999999999999876 68899999997532 223456788999999999999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 84 PGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 99999998853 34688999999999999999999998 999999999999999999999999999864322110
Q ss_pred c-------------------------------------eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCC
Q 002409 758 H-------------------------------------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 800 (927)
Q Consensus 758 ~-------------------------------------~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~ 800 (927)
. ......||+.|+|||++....++.++|||||||++|||++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 0 011235999999999999999999999999999999999999
Q ss_pred CcccccccccccchhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCc---HHHHHHH
Q 002409 801 EAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS---ISEVLKD 872 (927)
Q Consensus 801 ~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs---m~eV~~~ 872 (927)
.||......+....+..|... +. +. .. ......+.+++.+|+. +|++|++ +.|++++
T Consensus 237 ~Pf~~~~~~~~~~~i~~~~~~------~~--~~----~~--~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 237 PPFCSDNPQETYRKIINWKET------LQ--FP----DE--VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCHHHHHHHHHcCCCc------cC--CC----CC--CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999765422222222222110 00 00 00 0112356788888986 8999998 9998876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=310.05 Aligned_cols=270 Identities=21% Similarity=0.252 Sum_probs=201.4
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCCch--hhHhHHHHHHHHhhccCCC-ccceecceeecC------eEE
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRN-LVQFLGYCQEEG------RSV 671 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~--~~~~~~~Ei~iL~~l~Hpn-Iv~l~g~~~~~~------~~~ 671 (927)
...++||+|+||+||+|+.+ +|+.||+|+++-...+ ......+|+.+|++++|+| |+++++++...+ ..+
T Consensus 14 ~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~ 93 (323)
T KOG0594|consen 14 EKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLY 93 (323)
T ss_pred HHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEE
Confidence 33467999999999999865 6889999999865432 3456789999999999999 999999998877 789
Q ss_pred EEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccc
Q 002409 672 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 751 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 751 (927)
+|+||+.. +|..++.........++...+..++.|+++||+|||++ +|+||||||+||||+++|.+||+|||+|+.
T Consensus 94 lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 94 LVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLARA 169 (323)
T ss_pred EEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchHHH
Confidence 99999965 89998865432224566688899999999999999999 999999999999999999999999999985
Q ss_pred ccCCCCceeeeeccCCCccCccccccC-cCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCccc
Q 002409 752 AVDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 830 (927)
Q Consensus 752 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 830 (927)
..-. ....+...+|.+|.|||++.+. .|+...||||+||++.||++++..|.+....+....|.+-....-++.+-..
T Consensus 170 ~~ip-~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 170 FSIP-MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV 248 (323)
T ss_pred hcCC-cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence 4422 2223445689999999999875 7999999999999999999999999765521111111111111111111110
Q ss_pred ccCCcccCcc---------CH---HHHHHHHHHHhhhcCCCCCCCCcHHHHHHH--HHHH
Q 002409 831 IIDPSLLDEY---------DI---QSMWKIEEKALMCVLPHGHMRPSISEVLKD--IQDA 876 (927)
Q Consensus 831 ~~d~~l~~~~---------~~---~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~--L~~~ 876 (927)
..-+.....+ .. .......+++.+|++.+|++|.|++..++| ++.+
T Consensus 249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 0000100000 00 111367899999999999999999999988 5543
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=333.65 Aligned_cols=252 Identities=23% Similarity=0.289 Sum_probs=198.0
Q ss_pred HHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEE
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 674 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~ 674 (927)
..+.+.+.||+|+||.||+++.. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM 122 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence 34556788999999999999876 58899999986432 223445788999999999999999999999999999999
Q ss_pred EeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccC
Q 002409 675 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 754 (927)
Q Consensus 675 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 754 (927)
||+++|+|.+++.. ..++...+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 123 Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 123 EYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred cCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999998843 3477788888999999999999998 999999999999999999999999999976543
Q ss_pred CCCceeeeeccCCCccCccccccC----cCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCccc
Q 002409 755 GASHVSSIVRGTVGYLDPEYYISQ----QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 830 (927)
Q Consensus 755 ~~~~~~~~~~gt~~Y~aPE~~~~~----~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 830 (927)
..........||+.|+|||++... .++.++|||||||++|||++|+.||...........+.. ....+.
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~------~~~~~~- 267 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMD------HKNSLT- 267 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHc------CCCcCC-
Confidence 322223345699999999998653 478899999999999999999999976542211111111 000000
Q ss_pred ccCCcccCccCHHHHHHHHHHHhhhcCCCCCC--CCcHHHHHHH
Q 002409 831 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHM--RPSISEVLKD 872 (927)
Q Consensus 831 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~--RPsm~eV~~~ 872 (927)
... .......+.+++.+|++.+|++ ||++.|++++
T Consensus 268 -----~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 268 -----FPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred -----CCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 001 0112346789999999999988 9999999887
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=335.02 Aligned_cols=250 Identities=20% Similarity=0.281 Sum_probs=193.2
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
.+.+.||+|+||+||+|+.. +++.||||++.... ......+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 4 ~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~ 83 (381)
T cd05626 4 VKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYI 83 (381)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecC
Confidence 34578999999999999875 57899999997542 223456889999999999999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC-
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA- 756 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~- 756 (927)
++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++++||+|||+++......
T Consensus 84 ~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 84 PGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 99999998853 34578888899999999999999998 99999999999999999999999999975321000
Q ss_pred ---------------------------------------------CceeeeeccCCCccCccccccCcCCCccceeeHHH
Q 002409 757 ---------------------------------------------SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGV 791 (927)
Q Consensus 757 ---------------------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGv 791 (927)
........||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 00012346999999999999889999999999999
Q ss_pred HHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhh--hcCCCCCCCCcHHHH
Q 002409 792 ILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALM--CVLPHGHMRPSISEV 869 (927)
Q Consensus 792 vL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~--Cl~~dP~~RPsm~eV 869 (927)
++|||++|+.||......+....+..|.. .+ ..... .....++.+++.+ |+..+|..||++.|+
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~------~~------~~~~~--~~~s~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQLKVINWEN------TL------HIPPQ--VKLSPEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHHHHHcccc------cc------CCCCC--CCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence 99999999999976542221112222110 00 00000 0112345667766 566777779999999
Q ss_pred HHH
Q 002409 870 LKD 872 (927)
Q Consensus 870 ~~~ 872 (927)
++|
T Consensus 303 l~h 305 (381)
T cd05626 303 KAH 305 (381)
T ss_pred hcC
Confidence 987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=326.28 Aligned_cols=250 Identities=22% Similarity=0.307 Sum_probs=196.6
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhc-cCCCccceecceeecCeEEEEEEeccC
Q 002409 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
+.||+|+||.||+++.+ +++.||||+++... ......+..|..+++++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999876 68899999997542 22345578899999888 799999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (329)
T cd05588 81 GDLMFHMQ----RQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DT 152 (329)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC-Cc
Confidence 99988874 235689999999999999999999998 99999999999999999999999999987432211 22
Q ss_pred eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccc-cchhhHHHHhhhccCCcccccCCcccC
Q 002409 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGAN-CRNIVQWAKLHIESGDIQGIIDPSLLD 838 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~d~~l~~ 838 (927)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ......+....+..+.. .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~-- 224 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------RI-- 224 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------CC--
Confidence 2345699999999999999999999999999999999999999964321111 11122222222222211 01
Q ss_pred ccCHHHHHHHHHHHhhhcCCCCCCCCc------HHHHHHH
Q 002409 839 EYDIQSMWKIEEKALMCVLPHGHMRPS------ISEVLKD 872 (927)
Q Consensus 839 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs------m~eV~~~ 872 (927)
+.....++.+++.+|++.+|++||+ +.|+++|
T Consensus 225 --p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 225 --PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred --CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 1112346789999999999999997 6788765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=321.78 Aligned_cols=259 Identities=25% Similarity=0.422 Sum_probs=204.5
Q ss_pred HHHHHhccccccCceEEEEEEECC------CcEEEEEEeecCC-chhhHhHHHHHHHHhhc-cCCCccceecceeecCeE
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRS 670 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~~------g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~ 670 (927)
..+.+.+.||+|+||.||++.... ...+|+|++.... .+....+.+|+++++++ +|+||+++++++...+..
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPL 91 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCe
Confidence 345567899999999999998642 3579999987542 23345688999999999 899999999999999999
Q ss_pred EEEEEeccCCchhhhccccc------------ccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCC
Q 002409 671 VLVYEFMHNGTLKEHLYGTL------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH 738 (927)
Q Consensus 671 ~lV~E~~~~gsL~~~L~~~~------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~ 738 (927)
+++|||+++|+|.+++.... .....+++..++.++.|++.||+|||+. +|+||||||+|||++.+
T Consensus 92 ~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~ 168 (293)
T cd05053 92 YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTED 168 (293)
T ss_pred EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcCC
Confidence 99999999999999985421 2345689999999999999999999998 99999999999999999
Q ss_pred CcEEEEeecCcccccCCCCce-eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhh
Q 002409 739 MRAKVSDFGLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIV 816 (927)
Q Consensus 739 ~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~ 816 (927)
+.+||+|||+++......... .....++..|+|||.+....++.++|||||||++|||++ |..||......+ +.
T Consensus 169 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----~~ 244 (293)
T cd05053 169 HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE----LF 244 (293)
T ss_pred CeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH----HH
Confidence 999999999998654332211 122235678999999988899999999999999999998 888886543211 11
Q ss_pred HHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHH
Q 002409 817 QWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 877 (927)
Q Consensus 817 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~ 877 (927)
+. ...+.. ...+......+.+++.+|++.+|++|||+.|+++.|++++
T Consensus 245 ~~----~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 245 KL----LKEGYR---------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HH----HHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11 111110 0111223446889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=322.48 Aligned_cols=261 Identities=23% Similarity=0.301 Sum_probs=194.3
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc-hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
|.+.+.||+|+||.||+|+.. +++.||||+++.... .....+.+|++++++++||||+++++++......++||||+.
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (303)
T cd07869 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH 86 (303)
T ss_pred ceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC
Confidence 456789999999999999876 688999999875432 223467789999999999999999999999999999999996
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
++|.+++... ...++...+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 87 -~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 158 (303)
T cd07869 87 -TDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-H 158 (303)
T ss_pred -cCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-c
Confidence 5777777432 34578888999999999999999998 99999999999999999999999999987433221 2
Q ss_pred eeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhcc---CC------c
Q 002409 759 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES---GD------I 828 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~---~~------~ 828 (927)
......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ............. .. .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI---QDQLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH---HHHHHHHHHHhCCCChhhccchhhc
Confidence 2233458999999999865 45788999999999999999999999754311 1111111100000 00 0
Q ss_pred ccccCCccc--CccCH-------HHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 829 QGIIDPSLL--DEYDI-------QSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 829 ~~~~d~~l~--~~~~~-------~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
......... ..... .....+.+++.+|++.+|++|||+.|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 000000000 00000 012357799999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=312.84 Aligned_cols=247 Identities=27% Similarity=0.412 Sum_probs=198.6
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeecCCc-hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCCchh
Q 002409 605 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK 683 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~ 683 (927)
+.||+|+||.||+|...+++.+|+|++..... .....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 46899999999999988889999999875543 23456889999999999999999999999999999999999999999
Q ss_pred hhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCceeeee
Q 002409 684 EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV 763 (927)
Q Consensus 684 ~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 763 (927)
+++... ...+++..++.++.|++.+|.|||+. +++||||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 81 SFLRKK---KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 988532 34578999999999999999999998 999999999999999999999999999875433222222223
Q ss_pred ccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCcccCccCH
Q 002409 764 RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 842 (927)
Q Consensus 764 ~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 842 (927)
.++..|+|||++.+..++.++|||||||++|||++ |..||...... .... ....+.. ...+.
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~----~~~~----~~~~~~~---------~~~~~ 217 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ----QARE----QVEKGYR---------MSCPQ 217 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH----HHHH----HHHcCCC---------CCCCC
Confidence 34678999999998899999999999999999998 99998654311 1111 1111110 01111
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHH
Q 002409 843 QSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 874 (927)
Q Consensus 843 ~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~ 874 (927)
.....+.+++.+|++.+|++||++.|+++.|.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 23357899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=314.21 Aligned_cols=247 Identities=29% Similarity=0.433 Sum_probs=195.8
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCCch
Q 002409 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 682 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 682 (927)
+.||+|+||.||+|+.. +++.+|+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46899999999999875 68899999876443 33456789999999999999999999999999999999999999999
Q ss_pred hhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce-ee
Q 002409 683 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-SS 761 (927)
Q Consensus 683 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~ 761 (927)
.+++... ...+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++......... ..
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTE---GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 9998532 34578999999999999999999998 99999999999999999999999999987543221111 01
Q ss_pred eeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCcccCcc
Q 002409 762 IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 840 (927)
Q Consensus 762 ~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 840 (927)
...++..|+|||.+..+.++.++|||||||++|||++ |..||...... .... ....+. ....
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~----~~~~----~~~~~~---------~~~~ 217 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ----QTRE----AIEQGV---------RLPC 217 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH----HHHH----HHHcCC---------CCCC
Confidence 1123457999999998899999999999999999998 88888643311 1111 111110 0011
Q ss_pred CHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHH
Q 002409 841 DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 874 (927)
Q Consensus 841 ~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~ 874 (927)
+......+.+++.+|++.+|++||++.||.+.|+
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 1122346889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=326.31 Aligned_cols=242 Identities=25% Similarity=0.363 Sum_probs=189.7
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhh-ccCCCccceecceeecCeEEEEEEeccC
Q 002409 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSR-IHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~-l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
+.||+|+||.||+|+.. +++.||||+++... ......+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 57889999997542 1223345566666665 4899999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~ 152 (316)
T cd05592 81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence 999988843 34688889999999999999999998 99999999999999999999999999997543322 22
Q ss_pred eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCc
Q 002409 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 839 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 839 (927)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+..-+ .... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~----~~~~~i----~~~~----------~~ 214 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED----ELFDSI----LNDR----------PH 214 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH----HHHHHH----HcCC----------CC
Confidence 33456999999999999889999999999999999999999999754411 111111 1100 01
Q ss_pred cCHHHHHHHHHHHhhhcCCCCCCCCcHH-HHHHH
Q 002409 840 YDIQSMWKIEEKALMCVLPHGHMRPSIS-EVLKD 872 (927)
Q Consensus 840 ~~~~~~~~l~~L~~~Cl~~dP~~RPsm~-eV~~~ 872 (927)
++.....++.+++.+|++.+|++||++. ++.++
T Consensus 215 ~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 215 FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 1111233578899999999999999875 55443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=327.56 Aligned_cols=242 Identities=26% Similarity=0.386 Sum_probs=192.8
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhc-cCCCccceecceeecCeEEEEEEeccC
Q 002409 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
+.||+|+||.||+|+.+ +++.||||+++... ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999876 57899999987532 22345567788888876 699999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~ 152 (320)
T cd05590 81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KT 152 (320)
T ss_pred chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cc
Confidence 999988843 35688999999999999999999998 99999999999999999999999999987532221 22
Q ss_pred eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCc
Q 002409 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 839 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 839 (927)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.... ..+.. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~----~~~~~i----~~~~~---~------- 214 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED----DLFEAI----LNDEV---V------- 214 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH----HHHHHH----hcCCC---C-------
Confidence 23456999999999999889999999999999999999999999754421 111111 11111 0
Q ss_pred cCHHHHHHHHHHHhhhcCCCCCCCCcH------HHHHHH
Q 002409 840 YDIQSMWKIEEKALMCVLPHGHMRPSI------SEVLKD 872 (927)
Q Consensus 840 ~~~~~~~~l~~L~~~Cl~~dP~~RPsm------~eV~~~ 872 (927)
++......+.+++.+|++.+|++||++ ++++++
T Consensus 215 ~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 215 YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 011122357899999999999999998 666554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=331.36 Aligned_cols=251 Identities=22% Similarity=0.242 Sum_probs=199.2
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
+.+.+.||+|+||.||+++.. +++.||+|+++... ......+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY 82 (330)
T ss_pred ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence 345688999999999999876 68899999997542 22345688999999999999999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 83 QPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 9999999998543 24688999999999999999999998 99999999999999999999999999998654433
Q ss_pred CceeeeeccCCCccCccccc------cCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCccc
Q 002409 757 SHVSSIVRGTVGYLDPEYYI------SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 830 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~------~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 830 (927)
........||+.|+|||++. ...++.++|||||||++|||++|+.||...........+..+ .....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~-------~~~~~ 229 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF-------QRFLK 229 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC-------CCccC
Confidence 33334456899999999986 456788999999999999999999999754422111111111 11000
Q ss_pred ccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 831 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 831 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.- . .......+.+++..|++ +|++||++.+++++
T Consensus 230 ~~-----~--~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 230 FP-----E--DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CC-----C--CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 00 0 11123457889999998 99999999999876
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=313.17 Aligned_cols=258 Identities=25% Similarity=0.389 Sum_probs=205.0
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
+.+.+.||+|+||.||+|+.. +++.||||.++... ......+.+|++++++++||||+++++++...+..++++||
T Consensus 4 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08228 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEe
Confidence 446788999999999999875 68999999876432 23345688999999999999999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
+++|+|.+++.........+++..+..++.|++.||+|||++ +++||||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 84 ADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred cCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 999999988854333345678889999999999999999998 99999999999999999999999999987654322
Q ss_pred CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 757 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
. ......|++.|+|||.+.+..++.++|+||||+++|||++|+.||..... ....+... ...+... ..
T Consensus 161 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-----~~~~~~~~-~~~~~~~-----~~ 228 (267)
T cd08228 161 T-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLFSLCQK-IEQCDYP-----PL 228 (267)
T ss_pred H-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc-----cHHHHHHH-HhcCCCC-----CC
Confidence 1 11233588899999999888899999999999999999999999864431 11121111 1111111 11
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 876 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~ 876 (927)
........+.+++.+|++.+|++||++.||++.|+++
T Consensus 229 ---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 229 ---PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred ---ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1112234688999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=319.70 Aligned_cols=257 Identities=22% Similarity=0.378 Sum_probs=202.0
Q ss_pred HHHHHhccccccCceEEEEEEEC------CCcEEEEEEeecCCch-hhHhHHHHHHHHhhccCCCccceecceeecCeEE
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 671 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~------~g~~VAVK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~ 671 (927)
..+.+.+.||+|+||.||+|+.. +++.||+|+++..... ....+.+|+.++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 44667889999999999999864 2478999998755332 2456889999999999999999999999999999
Q ss_pred EEEEeccCCchhhhccccc------------ccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCC
Q 002409 672 LVYEFMHNGTLKEHLYGTL------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM 739 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~ 739 (927)
+++||+.+++|.+++.... .....+++..++.++.|++.||+|||+. +|+||||||+|||+++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence 9999999999999984221 1134578889999999999999999998 999999999999999999
Q ss_pred cEEEEeecCcccccCCCC-ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhH
Q 002409 740 RAKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQ 817 (927)
Q Consensus 740 ~vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~ 817 (927)
.+||+|||+++....... .......+++.|+|||.+..+.++.++|||||||++|||++ |..||..... ..+.+
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----~~~~~ 237 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN----QDVIE 237 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH----HHHHH
Confidence 999999999875433221 11223345789999999988889999999999999999998 8888865331 12222
Q ss_pred HHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHH
Q 002409 818 WAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 875 (927)
Q Consensus 818 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~ 875 (927)
... .+... ..+......+.+++.+|++.+|++||+++||++.|+.
T Consensus 238 ~i~----~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 MIR----NRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHH----cCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 211 11111 1112233458899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=320.64 Aligned_cols=257 Identities=26% Similarity=0.428 Sum_probs=203.3
Q ss_pred HHhccccccCceEEEEEEEC------CCcEEEEEEeecCCc-hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEE
Q 002409 602 MLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 674 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~------~g~~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~ 674 (927)
.+.+.||+|+||.||+|+.. ....+++|.+..... .....+.+|+.++++++||||+++++.+...+..++++
T Consensus 3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (290)
T cd05045 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIV 82 (290)
T ss_pred cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEE
Confidence 45678999999999999763 235789998875533 33467889999999999999999999999999999999
Q ss_pred EeccCCchhhhccccc--------------------ccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeE
Q 002409 675 EFMHNGTLKEHLYGTL--------------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL 734 (927)
Q Consensus 675 E~~~~gsL~~~L~~~~--------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIL 734 (927)
||+.+|+|.+++.... .....+++..++.++.|++.||+|||+. +++||||||+|||
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nil 159 (290)
T cd05045 83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVL 159 (290)
T ss_pred EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEE
Confidence 9999999999875421 1224578999999999999999999998 9999999999999
Q ss_pred ECCCCcEEEEeecCcccccCCCCc-eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCccccccccccc
Q 002409 735 LDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANC 812 (927)
Q Consensus 735 l~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~ 812 (927)
+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||++++||++ |+.||.....
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---- 235 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP---- 235 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH----
Confidence 999999999999999754333221 1222345778999999988889999999999999999998 9999865431
Q ss_pred chhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 813 RNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 813 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
..+.++..... ....+......+.+++.+|++.+|++||++.|+++.|++++.
T Consensus 236 ~~~~~~~~~~~-------------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 236 ERLFNLLKTGY-------------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHHHHhCCC-------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 12222222111 001111223468899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=312.94 Aligned_cols=258 Identities=24% Similarity=0.373 Sum_probs=206.0
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
+.+.+.||+|+||.||+++.. +++.+|||.+.... .....++.+|+.++++++|+||+++++++...+..+++|||
T Consensus 4 y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08229 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 83 (267)
T ss_pred hhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEe
Confidence 556788999999999999864 78999999876432 22345788999999999999999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
+++++|.+++.........+++..++.++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 84 ADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred cCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 999999998864333456689999999999999999999998 99999999999999999999999999987554322
Q ss_pred CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 757 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
. ......|+..|+|||.+.+..++.++|+||||+++|||++|..||...... ..+..+.. .... .+..
T Consensus 161 ~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~-~~~~-----~~~~ 228 (267)
T cd08229 161 T-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----LYSLCKKI-EQCD-----YPPL 228 (267)
T ss_pred c-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-----HHHHhhhh-hcCC-----CCCC
Confidence 2 122345889999999998888999999999999999999999998643311 11111111 1110 1111
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 876 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~ 876 (927)
. .......+.+++.+|++.+|++||||.+|++.++++
T Consensus 229 ~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 229 P---SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred C---cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 1 112334688999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=333.33 Aligned_cols=259 Identities=20% Similarity=0.261 Sum_probs=194.1
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
.|.+.+.||+|+||.||++... +++.||+|... ...+.+|++++++++||||+++++++......++|+|++.
T Consensus 93 ~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~ 166 (391)
T PHA03212 93 GFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK 166 (391)
T ss_pred CcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence 4666789999999999999875 67899999753 2346789999999999999999999999999999999985
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
++|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 167 -~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 167 -TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred -CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 688877742 35688999999999999999999998 9999999999999999999999999999754333222
Q ss_pred eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCccccccc-ccc---cchhhHHHHhh---hcc------
Q 002409 759 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF-GAN---CRNIVQWAKLH---IES------ 825 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~-~~~---~~~l~~~~~~~---~~~------ 825 (927)
......||+.|+|||++.+..++.++|||||||++|||++|+.|+-.... ... ...+....... ..+
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 33345699999999999988999999999999999999999987643211 000 00111100000 000
Q ss_pred CCcccc---------cCCcccCcc--CHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 826 GDIQGI---------IDPSLLDEY--DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 826 ~~~~~~---------~d~~l~~~~--~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
..+... ..+...... ......++.+++.+|++.||++|||+.|++++
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000 000000000 01233468899999999999999999999875
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=314.13 Aligned_cols=246 Identities=28% Similarity=0.424 Sum_probs=195.1
Q ss_pred cccccCceEEEEEEEC---CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCC
Q 002409 606 KIGSGGFGVVYYGKLK---DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 680 (927)
Q Consensus 606 ~IG~G~fG~Vy~~~~~---~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 680 (927)
.||+|+||.||+|.++ +++.+|+|+++... ....+++.+|+.++++++||||+++++++.. +..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 5899999999999753 57889999986443 2335678899999999999999999998864 4678999999999
Q ss_pred chhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCcee
Q 002409 681 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 760 (927)
Q Consensus 681 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 760 (927)
+|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99998843 34688999999999999999999998 999999999999999999999999999986544332211
Q ss_pred --eeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCccc
Q 002409 761 --SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 837 (927)
Q Consensus 761 --~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 837 (927)
....++..|+|||.+....++.++|||||||++|||++ |+.||...... .+.+.. .++...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~i----~~~~~~-------- 217 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN----EVTQMI----ESGERM-------- 217 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHH----HCCCCC--------
Confidence 12234578999999988889999999999999999998 99999754311 222221 111111
Q ss_pred CccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHH
Q 002409 838 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 876 (927)
Q Consensus 838 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~ 876 (927)
..+.....++.+++.+|++.+|++||++.+|++.|++.
T Consensus 218 -~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 218 -ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred -CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 11112334688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=332.25 Aligned_cols=251 Identities=22% Similarity=0.304 Sum_probs=194.8
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 675 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E 675 (927)
.+.+.+.||+|+||.||+++.. +++.+|+|++.... ......+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 44 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~E 123 (370)
T cd05621 44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVME 123 (370)
T ss_pred HCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEc
Confidence 4455678999999999999876 57889999986431 2234567889999999999999999999999999999999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCC
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 755 (927)
|+++|+|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 124 y~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 124 YMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred CCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 9999999998843 3478888899999999999999998 9999999999999999999999999999865433
Q ss_pred CCceeeeeccCCCccCccccccC----cCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccc
Q 002409 756 ASHVSSIVRGTVGYLDPEYYISQ----QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 831 (927)
Q Consensus 756 ~~~~~~~~~gt~~Y~aPE~~~~~----~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 831 (927)
.........||+.|+|||++... .++.++||||+||++|||++|+.||......+....+.. ....+.
T Consensus 196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~------~~~~~~-- 267 (370)
T cd05621 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMD------HKNSLN-- 267 (370)
T ss_pred CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHh------CCcccC--
Confidence 22223345699999999998754 378899999999999999999999975442111111111 000000
Q ss_pred cCCcccCccCHHHHHHHHHHHhhhcCCCCCC--CCcHHHHHHH
Q 002409 832 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHM--RPSISEVLKD 872 (927)
Q Consensus 832 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~--RPsm~eV~~~ 872 (927)
... .......+.+++..|+..++.+ ||++.|+++|
T Consensus 268 ----~p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 268 ----FPE--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ----CCC--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 000 1112335678888898755543 8999999987
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=319.77 Aligned_cols=256 Identities=25% Similarity=0.429 Sum_probs=200.9
Q ss_pred HHHHhccccccCceEEEEEEE-----CCCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKL-----KDGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 673 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~-----~~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV 673 (927)
.+.+.+.||+|+||.||+|.. ..++.+|+|.+.... .+....+.+|++++++++||||+++++++......++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 85 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML 85 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEE
Confidence 345678999999999999975 245789999987543 33346788999999999999999999999999999999
Q ss_pred EEeccCCchhhhccccc-------------ccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCc
Q 002409 674 YEFMHNGTLKEHLYGTL-------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR 740 (927)
Q Consensus 674 ~E~~~~gsL~~~L~~~~-------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~ 740 (927)
|||+++++|.+++.... .....+++...+.++.|++.||+|||++ +++||||||+|||+++++.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCc
Confidence 99999999999885321 0123578889999999999999999998 9999999999999999999
Q ss_pred EEEEeecCcccccCCCC-ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHH
Q 002409 741 AKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQW 818 (927)
Q Consensus 741 vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~ 818 (927)
+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||..... ..+.+.
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~----~~~~~~ 238 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN----QEVIEM 238 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH----HHHHHH
Confidence 99999999975433221 12223345678999999988889999999999999999998 8888864331 122222
Q ss_pred HHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHH
Q 002409 819 AKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 875 (927)
Q Consensus 819 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~ 875 (927)
+. .+.... .+.....++.+++.+|++.+|++||++.+|.++|..
T Consensus 239 ~~----~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 VR----KRQLLP---------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HH----cCCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11 111110 111223468899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=319.68 Aligned_cols=257 Identities=24% Similarity=0.421 Sum_probs=200.6
Q ss_pred HHHHHhccccccCceEEEEEEEC------CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEE
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 671 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~------~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~ 671 (927)
..+.+.+.||+|+||.||+|.+. .++.||||++.... .....++.+|+.++++++||||+++++++......+
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~ 85 (277)
T cd05062 6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 85 (277)
T ss_pred HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeE
Confidence 44566789999999999999754 24679999886443 233456889999999999999999999999999999
Q ss_pred EEEEeccCCchhhhccccccc------ccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEe
Q 002409 672 LVYEFMHNGTLKEHLYGTLTH------EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD 745 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~~~------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~D 745 (927)
+||||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|
T Consensus 86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~d 162 (277)
T cd05062 86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEECC
Confidence 999999999999998543211 23467888999999999999999998 999999999999999999999999
Q ss_pred ecCcccccCCCCce-eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhh
Q 002409 746 FGLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHI 823 (927)
Q Consensus 746 FGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~ 823 (927)
||+++......... .....++..|+|||++..+.++.++|||||||++|||++ |..||...... .....+
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~----~~~~~~---- 234 (277)
T cd05062 163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE----QVLRFV---- 234 (277)
T ss_pred CCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHH----
Confidence 99987543322211 112335778999999998899999999999999999999 68888654311 122211
Q ss_pred ccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHH
Q 002409 824 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 875 (927)
Q Consensus 824 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~ 875 (927)
.++.... .+......+.+++.+|++.+|++||++.|++++|++
T Consensus 235 ~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 235 MEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HcCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1111111 111223468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=304.50 Aligned_cols=262 Identities=21% Similarity=0.231 Sum_probs=198.0
Q ss_pred HhccccccCceEEEEEEEC-CCcEEEEEEeecCCch--hhHhHHHHHHHHhhccCCCccceecceee--cCeEEEEEEec
Q 002409 603 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVLVYEFM 677 (927)
Q Consensus 603 ~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--~~~~~lV~E~~ 677 (927)
..++|++|.||.||+|+.+ +++-||+|+++..... -.-...+||.+|.+++|||||.+-++... -+..|+|||||
T Consensus 80 ~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~ 159 (419)
T KOG0663|consen 80 KLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYV 159 (419)
T ss_pred HHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHH
Confidence 4578999999999999876 6788999999754321 12346799999999999999999887754 35689999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
+. +|...+... .+++...++..++.|+++|++|||.+ .|+|||||++|+|+.+.|.+||+|||+|+.+.....
T Consensus 160 Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k 232 (419)
T KOG0663|consen 160 EH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK 232 (419)
T ss_pred Hh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCCcc
Confidence 87 888888654 46788899999999999999999998 999999999999999999999999999998766533
Q ss_pred ceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhcc---C-------
Q 002409 758 HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES---G------- 826 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~---~------- 826 (927)
.. +..+-|.+|.|||.+.+ ..|+...|+||+|||+.||+++++.|.+...-+....|.+.....-+. |
T Consensus 233 ~~-T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~ 311 (419)
T KOG0663|consen 233 PY-TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV 311 (419)
T ss_pred cC-cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence 33 34457999999999986 579999999999999999999999987654222111222111100000 0
Q ss_pred ---CcccccCCcccCccCHH-HHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 827 ---DIQGIIDPSLLDEYDIQ-SMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 827 ---~~~~~~d~~l~~~~~~~-~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.+.......++..+... ....-.+|....+..||++|-|+.|.+++
T Consensus 312 k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 312 KKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred hccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 00011111122222221 22456789999999999999999999876
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=302.54 Aligned_cols=251 Identities=24% Similarity=0.345 Sum_probs=203.1
Q ss_pred HHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecC--CchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEE
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 675 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E 675 (927)
..|.+.+.||+|.|+.||+.... +|+.+|+|++... +..+.+++.+|+.|-+.++||||+++.+.+.+.+..+||+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 34566788999999999998654 6889999987543 33456789999999999999999999999999999999999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECC---CCcEEEEeecCcccc
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFA 752 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~---~~~vkL~DFGla~~~ 752 (927)
+|.|++|..-+- .+...++..+-..++||+.+|.|+|.+ +|||||+||+|+|+.. .--+||+|||+|...
T Consensus 91 ~m~G~dl~~eIV----~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 91 LVTGGELFEDIV----AREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred cccchHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 999999976652 335577888889999999999999999 9999999999999954 346999999999877
Q ss_pred cCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCccccc
Q 002409 753 VDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 832 (927)
Q Consensus 753 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 832 (927)
. .......+.|||+|||||++...+|+..+|||+.|||||-|+.|..||.+......++.|.+ |... +
T Consensus 164 ~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~--------g~yd--~ 231 (355)
T KOG0033|consen 164 N--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKA--------GAYD--Y 231 (355)
T ss_pred C--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhc--------cccC--C
Confidence 6 33445567799999999999999999999999999999999999999987553433333322 2111 1
Q ss_pred CCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 833 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 833 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
++...+ ...++..+|+.+|+..||++|.|+.|.+.|
T Consensus 232 ~~~~w~----~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 232 PSPEWD----TVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred CCcccC----cCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 221111 122357799999999999999999998754
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=315.21 Aligned_cols=255 Identities=27% Similarity=0.438 Sum_probs=200.2
Q ss_pred HHhccccccCceEEEEEEECC----CcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecCe------
Q 002409 602 MLEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR------ 669 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~~----g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~------ 669 (927)
.+.+.||+|+||.||+|.+.. +..||+|+++... ......+.+|++.+++++||||+++++++.....
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 356789999999999998652 3679999987542 2334578899999999999999999998866554
Q ss_pred EEEEEEeccCCchhhhccccc--ccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeec
Q 002409 670 SVLVYEFMHNGTLKEHLYGTL--THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG 747 (927)
Q Consensus 670 ~~lV~E~~~~gsL~~~L~~~~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFG 747 (927)
.++++||+++|+|.+++.... .....+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCcc
Confidence 799999999999999885432 1234688999999999999999999998 99999999999999999999999999
Q ss_pred CcccccCCCCce-eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhcc
Q 002409 748 LSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIES 825 (927)
Q Consensus 748 la~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~ 825 (927)
+++......... .....++..|+|||++....++.++|||||||++|||++ |..||...... .+.++.. .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~----~~~~~~~----~ 230 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH----EIYDYLR----H 230 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHH----c
Confidence 998654332221 122335678999999988889999999999999999999 88888654311 2222221 1
Q ss_pred CCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHH
Q 002409 826 GDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 876 (927)
Q Consensus 826 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~ 876 (927)
+.... .+......+.+++.+|++.+|++||++.||+++|+++
T Consensus 231 ~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GNRLK---------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCCC---------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111 1122344789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=333.61 Aligned_cols=263 Identities=24% Similarity=0.396 Sum_probs=204.1
Q ss_pred HHHHHHHHhccccccCceEEEEEEEC------CCcEEEEEEeecCCch-hhHhHHHHHHHHhhcc-CCCccceecceeec
Q 002409 596 IEDATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIH-HRNLVQFLGYCQEE 667 (927)
Q Consensus 596 i~~~~~~~~~~IG~G~fG~Vy~~~~~------~g~~VAVK~l~~~~~~-~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~ 667 (927)
+....+.+.+.||+|+||.||+|++. .++.||||+++..... ....+.+|+++|.++. ||||++++++|...
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 33444556789999999999999864 2467999999754322 2346889999999997 99999999999999
Q ss_pred CeEEEEEEeccCCchhhhcccccc--------------------------------------------------------
Q 002409 668 GRSVLVYEFMHNGTLKEHLYGTLT-------------------------------------------------------- 691 (927)
Q Consensus 668 ~~~~lV~E~~~~gsL~~~L~~~~~-------------------------------------------------------- 691 (927)
+..++|+||+++|+|.++++....
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 999999999999999999864311
Q ss_pred --------------------------------------cccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCe
Q 002409 692 --------------------------------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI 733 (927)
Q Consensus 692 --------------------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NI 733 (927)
....+++...+.++.|++.||+|||+. +++||||||+||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~Ni 270 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNV 270 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceE
Confidence 112467788899999999999999998 999999999999
Q ss_pred EECCCCcEEEEeecCcccccCCCCc-eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccc
Q 002409 734 LLDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGAN 811 (927)
Q Consensus 734 Ll~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~ 811 (927)
|+++++.+||+|||+++........ ......++..|+|||.+....++.++|||||||++|||++ |+.||......+.
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~ 350 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ 350 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence 9999999999999999754322211 1122346789999999998889999999999999999998 8889865331111
Q ss_pred cchhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHH
Q 002409 812 CRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 877 (927)
Q Consensus 812 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~ 877 (927)
+. ..+..+. ....+.....++.+++.+|+..+|++||+++||++.|++++
T Consensus 351 ---~~----~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 351 ---FY----NAIKRGY---------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred ---HH----HHHHcCC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11 1111111 00111122346889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=323.86 Aligned_cols=242 Identities=25% Similarity=0.401 Sum_probs=191.4
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhh-ccCCCccceecceeecCeEEEEEEeccC
Q 002409 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSR-IHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~-l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
+.||+|+||.||+|+.. +++.||||+++... ......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46899999999999876 57889999997542 1223456667777776 4899999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05619 81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AK 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cc
Confidence 999998843 34678889999999999999999998 99999999999999999999999999987432221 12
Q ss_pred eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCc
Q 002409 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 839 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 839 (927)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.+.+.. +. +.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~----~~~~~i~~----~~------~~---- 214 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE----ELFQSIRM----DN------PC---- 214 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH----HHHHHHHh----CC------CC----
Confidence 23456899999999999889999999999999999999999999754421 22221111 10 00
Q ss_pred cCHHHHHHHHHHHhhhcCCCCCCCCcHH-HHHHH
Q 002409 840 YDIQSMWKIEEKALMCVLPHGHMRPSIS-EVLKD 872 (927)
Q Consensus 840 ~~~~~~~~l~~L~~~Cl~~dP~~RPsm~-eV~~~ 872 (927)
++.....++.+++.+|++.+|++||++. ++.++
T Consensus 215 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 215 YPRWLTREAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred CCccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 1111223578999999999999999997 66543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=320.83 Aligned_cols=266 Identities=22% Similarity=0.359 Sum_probs=200.9
Q ss_pred HHHHHHHhccccccCceEEEEEEECC---------------CcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccce
Q 002409 597 EDATKMLEKKIGSGGFGVVYYGKLKD---------------GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQF 660 (927)
Q Consensus 597 ~~~~~~~~~~IG~G~fG~Vy~~~~~~---------------g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l 660 (927)
.+..+.+.+.||+|+||.||+++... ...||+|+++... ......+.+|++++++++|+|++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 34556778899999999999987642 2348999987543 2334578999999999999999999
Q ss_pred ecceeecCeEEEEEEeccCCchhhhcccccc--------cccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCC
Q 002409 661 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLT--------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSN 732 (927)
Q Consensus 661 ~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~--------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~N 732 (927)
++++...+..++||||+.+++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhh
Confidence 9999999999999999999999998854211 112468889999999999999999998 99999999999
Q ss_pred eEECCCCcEEEEeecCcccccCCCCc-eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh--CCCcccccccc
Q 002409 733 ILLDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS--GQEAISNEKFG 809 (927)
Q Consensus 733 ILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt--G~~p~~~~~~~ 809 (927)
|+++.++.+||+|||+++........ ......++..|+|||.+..+.++.++|||||||+++||++ |..||......
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 99999999999999998754332211 1122335678999999998899999999999999999998 55676543311
Q ss_pred cccchhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHH
Q 002409 810 ANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 875 (927)
Q Consensus 810 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~ 875 (927)
.++............ ......+......+.+++.+|++.+|++||+|.+|++.|++
T Consensus 240 ----~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 240 ----QVIENTGEFFRNQGR------QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred ----HHHHHHHHhhhhccc------cccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 122211111111100 00000111123478999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=324.71 Aligned_cols=242 Identities=26% Similarity=0.365 Sum_probs=191.2
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhc-cCCCccceecceeecCeEEEEEEeccC
Q 002409 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
+.||+|+||.||+|+.+ +++.||+|+++... ......+..|..++... +||||+++++++...+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999876 58899999987542 12234566777777754 899999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05620 81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NR 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cc
Confidence 999988843 35688889999999999999999998 99999999999999999999999999987432221 22
Q ss_pred eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCc
Q 002409 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 839 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 839 (927)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.+.... +. +.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~----~~~~~~~~----~~------~~~--- 215 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED----ELFESIRV----DT------PHY--- 215 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHHh----CC------CCC---
Confidence 23456899999999999999999999999999999999999999754421 12111111 10 011
Q ss_pred cCHHHHHHHHHHHhhhcCCCCCCCCcHH-HHHHH
Q 002409 840 YDIQSMWKIEEKALMCVLPHGHMRPSIS-EVLKD 872 (927)
Q Consensus 840 ~~~~~~~~l~~L~~~Cl~~dP~~RPsm~-eV~~~ 872 (927)
+.....++.+++.+|++.+|++||++. ++.+|
T Consensus 216 -~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 216 -PRWITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred -CCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 111223578999999999999999984 66543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=326.71 Aligned_cols=264 Identities=20% Similarity=0.274 Sum_probs=193.0
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecC--CchhhHhHHHHHHHHhhccCCCccceecceeec-----CeEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-----GRSVL 672 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~-----~~~~l 672 (927)
|.+.+.||+|+||.||+|+.. +++.||||++... .......+.+|++++++++||||+++++++... ...++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 345688999999999999876 6889999998643 223345688999999999999999999987543 24799
Q ss_pred EEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccc
Q 002409 673 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 752 (927)
Q Consensus 673 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 752 (927)
||||+. ++|.+++. ....+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 82 v~e~~~-~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 82 VFELME-SDLHQVIK----ANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEecCC-CCHHHHHH----hcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 999995 68888774 234688999999999999999999998 9999999999999999999999999999754
Q ss_pred cCCCC--ceeeeeccCCCccCcccccc--CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHH-------h
Q 002409 753 VDGAS--HVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK-------L 821 (927)
Q Consensus 753 ~~~~~--~~~~~~~gt~~Y~aPE~~~~--~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~-------~ 821 (927)
..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+..... .
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 32211 11233468999999999865 6789999999999999999999999965431110000000000 0
Q ss_pred hhccCCcccc---cCCcccC---ccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 822 HIESGDIQGI---IDPSLLD---EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 822 ~~~~~~~~~~---~d~~l~~---~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.+......+. +.+.... .........+.+++.+|++.+|++||++.|++++
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000000 0000000 0001122457899999999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=325.71 Aligned_cols=243 Identities=24% Similarity=0.337 Sum_probs=191.6
Q ss_pred HhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHH---hhccCCCccceecceeecCeEEEEEE
Q 002409 603 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLL---SRIHHRNLVQFLGYCQEEGRSVLVYE 675 (927)
Q Consensus 603 ~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL---~~l~HpnIv~l~g~~~~~~~~~lV~E 675 (927)
+.+.||+|+||.||+|... +++.||||+++... ....+.+..|++++ ++++||||+++++++...+..++|||
T Consensus 3 i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E 82 (324)
T cd05589 3 CLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVME 82 (324)
T ss_pred EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEc
Confidence 4578999999999999876 68899999997542 22234566666554 56689999999999999999999999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCC
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 755 (927)
|+++|+|..++. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 83 YAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred CCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 999999988774 24689999999999999999999998 9999999999999999999999999998743222
Q ss_pred CCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCc
Q 002409 756 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 835 (927)
Q Consensus 756 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 835 (927)
. .......|++.|+|||++.+..++.++|||||||++|||++|+.||...... .+... +..+.. .
T Consensus 155 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~----~~~~~----i~~~~~------~ 219 (324)
T cd05589 155 G-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE----EVFDS----IVNDEV------R 219 (324)
T ss_pred C-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH----HHHHH----HHhCCC------C
Confidence 1 2223456899999999999999999999999999999999999999754421 11111 111110 0
Q ss_pred ccCccCHHHHHHHHHHHhhhcCCCCCCCC-----cHHHHHHH
Q 002409 836 LLDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 872 (927)
Q Consensus 836 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----sm~eV~~~ 872 (927)
++......+.+++.+|++.+|++|| ++.+++++
T Consensus 220 ----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 220 ----YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred ----CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 1111234578999999999999999 56777665
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=330.92 Aligned_cols=250 Identities=24% Similarity=0.359 Sum_probs=192.3
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
.+.+.||+|+||+||+++.. +++.||||+++... ......+.+|+.++.+++|+||+++++.+.+....++||||+
T Consensus 4 ~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~ 83 (363)
T cd05628 4 ESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFL 83 (363)
T ss_pred eEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCC
Confidence 35678999999999999876 58899999997542 222356788999999999999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 84 PGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 99999999843 45688999999999999999999998 999999999999999999999999999874322100
Q ss_pred ----------------------------------ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcc
Q 002409 758 ----------------------------------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAI 803 (927)
Q Consensus 758 ----------------------------------~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~ 803 (927)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0012346999999999999999999999999999999999999999
Q ss_pred cccccccccchhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcC--CCCCCCCcHHHHHHH
Q 002409 804 SNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVL--PHGHMRPSISEVLKD 872 (927)
Q Consensus 804 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~--~dP~~RPsm~eV~~~ 872 (927)
......+....+..|... + .+.+.. ... .++.+++.+++. .++..||++.||+++
T Consensus 237 ~~~~~~~~~~~i~~~~~~------~--~~p~~~--~~s----~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 237 CSETPQETYKKVMNWKET------L--IFPPEV--PIS----EKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCHHHHHHHHHcCcCc------c--cCCCcC--CCC----HHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 765422222222222100 0 011110 011 234555555333 344567999999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=319.17 Aligned_cols=262 Identities=26% Similarity=0.387 Sum_probs=198.9
Q ss_pred HHHHhccccccCceEEEEEEEC-----CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceee--cCeEEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-----DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVL 672 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-----~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--~~~~~l 672 (927)
.+.+.+.||+|+||.||++..+ +++.||+|.+........+.+.+|++++++++||||+++++++.. ....++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 84 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL 84 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence 3445688999999999999753 578899999876655556788999999999999999999998753 346889
Q ss_pred EEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccc
Q 002409 673 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 752 (927)
Q Consensus 673 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 752 (927)
|+||+++|+|.+++... ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++..
T Consensus 85 v~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 85 VMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 99999999999998532 24588999999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCCcee--eeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCccccccccc------c-c-chhhHHHHhh
Q 002409 753 VDGASHVS--SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGA------N-C-RNIVQWAKLH 822 (927)
Q Consensus 753 ~~~~~~~~--~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~------~-~-~~l~~~~~~~ 822 (927)
........ ....++..|+|||++.+..++.++|||||||+++||++|..++......- . . ..+.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 43322111 11223456999999988889999999999999999999887654322000 0 0 0000000001
Q ss_pred hccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHH
Q 002409 823 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 876 (927)
Q Consensus 823 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~ 876 (927)
...+ ............+.+++.+|++.+|++|||+.||++.|+.+
T Consensus 239 ~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 239 LKNN---------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HhcC---------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 1111 00011122334688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=325.51 Aligned_cols=237 Identities=29% Similarity=0.368 Sum_probs=187.3
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHH-HHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVT-LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~-iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
+.||+|+||+||+|+.. +++.||+|++.... ......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46899999999999876 68899999987532 122234444544 56789999999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (323)
T cd05575 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KT 152 (323)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cc
Confidence 999988843 45688889999999999999999998 99999999999999999999999999987432222 22
Q ss_pred eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCc
Q 002409 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 839 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 839 (927)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ . .+.. .+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i-------~-~~~~------~~~~~ 218 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI-------L-NKPL------RLKPN 218 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHH-------H-cCCC------CCCCC
Confidence 23456899999999999999999999999999999999999999754321111111 1 1110 11111
Q ss_pred cCHHHHHHHHHHHhhhcCCCCCCCCcHH
Q 002409 840 YDIQSMWKIEEKALMCVLPHGHMRPSIS 867 (927)
Q Consensus 840 ~~~~~~~~l~~L~~~Cl~~dP~~RPsm~ 867 (927)
....+.+++.+|++.+|++||++.
T Consensus 219 ----~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 219 ----ISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred ----CCHHHHHHHHHHhhcCHHhCCCCC
Confidence 234678999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=322.30 Aligned_cols=262 Identities=25% Similarity=0.404 Sum_probs=219.5
Q ss_pred HHHHHHHHHhccccccCceEEEEEEECC---Cc--EEEEEEeecC-CchhhHhHHHHHHHHhhccCCCccceecceeecC
Q 002409 595 DIEDATKMLEKKIGSGGFGVVYYGKLKD---GK--EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG 668 (927)
Q Consensus 595 ei~~~~~~~~~~IG~G~fG~Vy~~~~~~---g~--~VAVK~l~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~ 668 (927)
++.++...+.++||+|-||.||+|.+.+ |+ .||||..+.+ .....+.|..|..+|+.++||||++++|+|.+.
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~- 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ- 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-
Confidence 4445555667899999999999997642 33 4889998875 345577899999999999999999999999765
Q ss_pred eEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecC
Q 002409 669 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 748 (927)
Q Consensus 669 ~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGl 748 (927)
..++|||.++-|.|.++|... ...++......++.||+.+|+|||+. .+|||||..+|||+.....+||+|||+
T Consensus 464 P~WivmEL~~~GELr~yLq~n---k~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQN---KDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred ceeEEEecccchhHHHHHHhc---cccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccch
Confidence 579999999999999999643 46688889999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCC
Q 002409 749 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGD 827 (927)
Q Consensus 749 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 827 (927)
++...+..........-+..|||||.+.-++++.++|||-|||.+||++. |..||......+... ++++|+
T Consensus 538 SR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~--------~iEnGe 609 (974)
T KOG4257|consen 538 SRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG--------HIENGE 609 (974)
T ss_pred hhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE--------EecCCC
Confidence 99888776666655556778999999999999999999999999999887 999998655332221 223332
Q ss_pred cccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHHH
Q 002409 828 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 880 (927)
Q Consensus 828 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~~ 880 (927)
+-..+..++..+..|..+|++.+|.+||.++|+...|+.+++.+
T Consensus 610 ---------RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qee 653 (974)
T KOG4257|consen 610 ---------RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEE 653 (974)
T ss_pred ---------CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHh
Confidence 22335567778999999999999999999999999999998744
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=310.83 Aligned_cols=258 Identities=26% Similarity=0.393 Sum_probs=207.2
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecC---CchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
+.+.+.||+|+||.||+|... +++.+|+|.++.. .......+.+|++++++++|+|++++++++...+..++||||
T Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (267)
T cd08224 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEec
Confidence 456788999999999999887 7899999988642 223356788999999999999999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
+++|+|.+++.........+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++......
T Consensus 84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 84 ADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred CCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence 999999998865444456689999999999999999999998 99999999999999999999999999987543322
Q ss_pred CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 757 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
.. .....++..|+|||.+.+..++.++|||||||++|||++|+.||..... ++.+... ....+......
T Consensus 161 ~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~-~~~~~~~~~~~---- 229 (267)
T cd08224 161 TA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCK-KIEKCDYPPLP---- 229 (267)
T ss_pred cc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc-----cHHHHHh-hhhcCCCCCCC----
Confidence 21 2234588999999999888899999999999999999999999864431 1111111 11111111100
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 876 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~ 876 (927)
.......+.+++.+|+..+|++||++.+|++.|+++
T Consensus 230 ----~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 230 ----ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred ----hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 112334688999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=317.89 Aligned_cols=250 Identities=26% Similarity=0.369 Sum_probs=198.9
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc---hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
...+.||+|+||.||++... +++.||||++..... .....+.+|+.++++++||||+++++.+..++..++||||+
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05605 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 82 (285)
T ss_pred eEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEecc
Confidence 44678999999999999875 688999999875422 22345778999999999999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
++|+|.+++... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||+++.......
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 83 NGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred CCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 999999888543 234688999999999999999999998 999999999999999999999999999876433221
Q ss_pred ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCccc
Q 002409 758 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 837 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 837 (927)
.....|++.|+|||++.+..++.++||||+||++|||++|+.||...........+ ...+..+.
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~----~~~~~~~~---------- 221 (285)
T cd05605 158 --IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV----ERRVKEDQ---------- 221 (285)
T ss_pred --cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHH----HHHhhhcc----------
Confidence 12345899999999999888999999999999999999999999754321111111 11111110
Q ss_pred CccCHHHHHHHHHHHhhhcCCCCCCCC-----cHHHHHHH
Q 002409 838 DEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 872 (927)
Q Consensus 838 ~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----sm~eV~~~ 872 (927)
..++......+.+++.+|++.||++|| ++.+++++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 111222334678999999999999999 88888776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=343.46 Aligned_cols=253 Identities=24% Similarity=0.332 Sum_probs=201.8
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecC--------
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG-------- 668 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-------- 668 (927)
.|.+.+.||+|+||+||+++.. +++.||||++.... ......+.+|+.++..++|+||+++++.+...+
T Consensus 33 rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~ 112 (496)
T PTZ00283 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVL 112 (496)
T ss_pred CEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccce
Confidence 5567789999999999999765 68999999987542 333456889999999999999999988765332
Q ss_pred eEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecC
Q 002409 669 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 748 (927)
Q Consensus 669 ~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGl 748 (927)
..++||||+++|+|.+++.........+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 113 ~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFGl 189 (496)
T PTZ00283 113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFGF 189 (496)
T ss_pred EEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEeccc
Confidence 36799999999999999876544556789999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCC-CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCC
Q 002409 749 SKFAVDGA-SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 827 (927)
Q Consensus 749 a~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 827 (927)
++...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.. .. ..+.
T Consensus 190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~----~~~~---~~-~~~~ 261 (496)
T PTZ00283 190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME----EVMH---KT-LAGR 261 (496)
T ss_pred CeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH----HHHH---HH-hcCC
Confidence 97654322 12233456999999999999999999999999999999999999999754311 1111 11 1111
Q ss_pred cccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 828 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 828 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
... .+.....++.+++.+|++.+|++||++.|++++
T Consensus 262 ~~~---------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 262 YDP---------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 110 111223468899999999999999999999875
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=326.49 Aligned_cols=238 Identities=26% Similarity=0.338 Sum_probs=191.1
Q ss_pred ccccccCceEEEEEEE----CCCcEEEEEEeecCCc--hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 605 KKIGSGGFGVVYYGKL----KDGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~----~~g~~VAVK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
+.||+|+||.||+++. .+++.+|+|++..... .....+..|++++++++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 3578999999975422 223457789999999999999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
+|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~- 153 (318)
T cd05582 82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK- 153 (318)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence 9999988843 35688999999999999999999998 999999999999999999999999999875433222
Q ss_pred eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccC
Q 002409 759 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 838 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 838 (927)
......||+.|+|||.+....++.++|||||||++|||++|+.||...... ...... .....
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~----~~~~~i----~~~~~---------- 215 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK----ETMTMI----LKAKL---------- 215 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH----HHHHHH----HcCCC----------
Confidence 223456899999999999888999999999999999999999999754311 111111 11111
Q ss_pred ccCHHHHHHHHHHHhhhcCCCCCCCCcHHH
Q 002409 839 EYDIQSMWKIEEKALMCVLPHGHMRPSISE 868 (927)
Q Consensus 839 ~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~e 868 (927)
..+......+.+++.+|++.+|++||++.+
T Consensus 216 ~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 011112235789999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=332.93 Aligned_cols=249 Identities=21% Similarity=0.263 Sum_probs=191.0
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
.+.++||+|+||.||+|+.. +++.+|+|++.... ......+.+|+.++++++|+||+++++.+.+.+..++||||+
T Consensus 4 ~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~ 83 (382)
T cd05625 4 VKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYI 83 (382)
T ss_pred EEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCC
Confidence 34678999999999999875 57889999987542 223456888999999999999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC-
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA- 756 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~- 756 (927)
++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 84 PGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 99999998853 34578888889999999999999998 99999999999999999999999999975221000
Q ss_pred ---------------------------------------------CceeeeeccCCCccCccccccCcCCCccceeeHHH
Q 002409 757 ---------------------------------------------SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGV 791 (927)
Q Consensus 757 ---------------------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGv 791 (927)
........||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00012246899999999999999999999999999
Q ss_pred HHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCc---HHH
Q 002409 792 ILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS---ISE 868 (927)
Q Consensus 792 vL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs---m~e 868 (927)
++|||++|+.||......+....+..|... ..+ +. ... ...++.+++.+|+ .+|++|++ +.|
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~----~~~-----p~-~~~----~s~~~~~li~~l~-~~p~~R~~~~~~~e 301 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLETQMKVINWQTS----LHI-----PP-QAK----LSPEASDLIIKLC-RGPEDRLGKNGADE 301 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHccCCC----cCC-----CC-ccc----CCHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence 999999999999765422211122221100 000 00 011 1234566666665 49999997 888
Q ss_pred HHHH
Q 002409 869 VLKD 872 (927)
Q Consensus 869 V~~~ 872 (927)
+++|
T Consensus 302 i~~h 305 (382)
T cd05625 302 IKAH 305 (382)
T ss_pred HhcC
Confidence 8775
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=325.49 Aligned_cols=265 Identities=24% Similarity=0.432 Sum_probs=206.6
Q ss_pred HHHHHHHHHhccccccCceEEEEEEEC--------CCcEEEEEEeecCC-chhhHhHHHHHHHHhhc-cCCCccceecce
Q 002409 595 DIEDATKMLEKKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYC 664 (927)
Q Consensus 595 ei~~~~~~~~~~IG~G~fG~Vy~~~~~--------~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~ 664 (927)
++...++.+.+.||+|+||.||+++.. .+..||+|+++... ....+++.+|+++++++ +||||+++++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 344456778899999999999999753 12368999887542 33456789999999999 899999999999
Q ss_pred eecCeEEEEEEeccCCchhhhccccc------------ccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCC
Q 002409 665 QEEGRSVLVYEFMHNGTLKEHLYGTL------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSN 732 (927)
Q Consensus 665 ~~~~~~~lV~E~~~~gsL~~~L~~~~------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~N 732 (927)
...+..++++||+++|+|.+++.... .....+++..++.++.|++.||+|||++ +++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence 99999999999999999999986431 1244688999999999999999999998 99999999999
Q ss_pred eEECCCCcEEEEeecCcccccCCCCce-eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCccccccccc
Q 002409 733 ILLDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGA 810 (927)
Q Consensus 733 ILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~ 810 (927)
||++.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~- 243 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE- 243 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 999999999999999987553322111 111224567999999999999999999999999999998 88888654311
Q ss_pred ccchhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHH
Q 002409 811 NCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 879 (927)
Q Consensus 811 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~ 879 (927)
.+.... ..+... ........++.+++.+|++.+|++||++.|+++.|+++...
T Consensus 244 ---~~~~~~----~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 244 ---ELFKLL----KEGHRM---------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred ---HHHHHH----HcCCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 111111 111110 11112234688999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=313.65 Aligned_cols=256 Identities=25% Similarity=0.438 Sum_probs=205.4
Q ss_pred HHHHHHHhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 597 EDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 597 ~~~~~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
....+.+.++||+|+||.||+|..++++.+|||.+.... ....++.+|+.++++++|+||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 344556778999999999999998888899999987543 3356789999999999999999999999988899999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
+++++|.+++... ....+++..+..++.|++.||+|||++ +++|+||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 83 MSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred cCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 9999999998653 234688999999999999999999998 99999999999999999999999999987654322
Q ss_pred CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCc
Q 002409 757 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 835 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 835 (927)
........++..|+|||.+.+..++.++|||||||+++||++ |+.||...... ...+.......
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~----~~~~~~~~~~~----------- 222 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR----EVLEQVERGYR----------- 222 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHHcCCC-----------
Confidence 111222234678999999998889999999999999999998 99998654311 12221111100
Q ss_pred ccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHH
Q 002409 836 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 875 (927)
Q Consensus 836 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~ 875 (927)
...+......+.+++.+|++.+|++||+++|+.+.|+.
T Consensus 223 --~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 --MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 00011123468899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=332.60 Aligned_cols=249 Identities=25% Similarity=0.322 Sum_probs=193.9
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
.+.+.||+|+||.||+++.. +++.||||++.... ......+.+|++++++++||||+++++++.+....++||||+
T Consensus 4 ~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 83 (377)
T cd05629 4 HTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFL 83 (377)
T ss_pred eEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCC
Confidence 45688999999999999865 68899999986532 223456788999999999999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 84 PGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 99999998853 35678888899999999999999998 999999999999999999999999999863211000
Q ss_pred ------------c----------------------------------eeeeeccCCCccCccccccCcCCCccceeeHHH
Q 002409 758 ------------H----------------------------------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGV 791 (927)
Q Consensus 758 ------------~----------------------------------~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGv 791 (927)
. ......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 001245999999999999999999999999999
Q ss_pred HHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCC---CcHHH
Q 002409 792 ILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMR---PSISE 868 (927)
Q Consensus 792 vL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~R---Psm~e 868 (927)
++|||++|+.||......+....+..|.... .+ ... ......+.+++.+|+. +|.+| |++.|
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~----~~--------p~~--~~~s~~~~dli~~lL~-~~~~r~~r~~~~~ 301 (377)
T cd05629 237 IMFECLIGWPPFCSENSHETYRKIINWRETL----YF--------PDD--IHLSVEAEDLIRRLIT-NAENRLGRGGAHE 301 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHccCCcc----CC--------CCC--CCCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence 9999999999997644222222222221100 00 000 0112357789999997 66665 69999
Q ss_pred HHHH
Q 002409 869 VLKD 872 (927)
Q Consensus 869 V~~~ 872 (927)
++++
T Consensus 302 ~l~h 305 (377)
T cd05629 302 IKSH 305 (377)
T ss_pred HhcC
Confidence 9887
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=313.34 Aligned_cols=253 Identities=25% Similarity=0.416 Sum_probs=200.9
Q ss_pred HHHHHhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
..+.+.+.||+|+||.||++....+..+|+|.+.... ...+.+.+|++++++++|+|++++++++. .+..+++|||+.
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4456778999999999999998877789999876443 23466889999999999999999999875 456789999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
+++|.+++... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++........
T Consensus 84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 84 KGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 99999998643 234578999999999999999999998 9999999999999999999999999999755433222
Q ss_pred eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCccc
Q 002409 759 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 837 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 837 (927)
......++..|+|||......++.++|||||||++|||++ |+.||...... ...++.. .+.. .
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~~~----~~~~-----~--- 222 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR----EVLEQVE----RGYR-----M--- 222 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHH----cCCC-----C---
Confidence 2222346678999999988889999999999999999999 89998754311 1222111 1100 0
Q ss_pred CccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHH
Q 002409 838 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 875 (927)
Q Consensus 838 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~ 875 (927)
..+......+.+++.+|++.+|++||++.+|++.|++
T Consensus 223 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 -PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0111233568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=320.84 Aligned_cols=265 Identities=23% Similarity=0.429 Sum_probs=207.6
Q ss_pred HHHHHHHHhccccccCceEEEEEEEC--------CCcEEEEEEeecCC-chhhHhHHHHHHHHhhc-cCCCccceeccee
Q 002409 596 IEDATKMLEKKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQ 665 (927)
Q Consensus 596 i~~~~~~~~~~IG~G~fG~Vy~~~~~--------~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~ 665 (927)
+....+.+.+.||+|+||.||+++.. ++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 33455567789999999999999742 24579999886542 33456788999999999 8999999999999
Q ss_pred ecCeEEEEEEeccCCchhhhcccccc------------cccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCe
Q 002409 666 EEGRSVLVYEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI 733 (927)
Q Consensus 666 ~~~~~~lV~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NI 733 (927)
..+..+++|||+.+|+|.+++..... ....+++..++.++.|+++||+|||++ +++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence 99999999999999999999865321 234578899999999999999999998 999999999999
Q ss_pred EECCCCcEEEEeecCcccccCCCCc-eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccc
Q 002409 734 LLDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGAN 811 (927)
Q Consensus 734 Ll~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~ 811 (927)
+++.++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-- 246 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-- 246 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--
Confidence 9999999999999999865432222 1222345678999999988889999999999999999998 77887644311
Q ss_pred cchhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHHH
Q 002409 812 CRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 880 (927)
Q Consensus 812 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~~ 880 (927)
.+... ...+... ..+......+.+++.+|++.+|++||++.||++.|++++...
T Consensus 247 --~~~~~----~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 247 --ELFKL----LKEGHRM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred --HHHHH----HHcCCcC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 11111 1111100 011223456889999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=314.15 Aligned_cols=254 Identities=28% Similarity=0.446 Sum_probs=196.7
Q ss_pred HhccccccCceEEEEEEECCCc---EEEEEEeecC--CchhhHhHHHHHHHHhhccCCCccceecceeec------CeEE
Q 002409 603 LEKKIGSGGFGVVYYGKLKDGK---EIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRSV 671 (927)
Q Consensus 603 ~~~~IG~G~fG~Vy~~~~~~g~---~VAVK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~------~~~~ 671 (927)
+.+.||+|+||.||+|++.+.. .+|+|.++.. .......+.+|++++++++|+||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 4678999999999999876432 5899988654 233356788999999999999999999987432 2468
Q ss_pred EEEEeccCCchhhhccccc--ccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCc
Q 002409 672 LVYEFMHNGTLKEHLYGTL--THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 749 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla 749 (927)
+++||+++|+|.+++.... .....+++.....++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcc
Confidence 9999999999998874221 1234588999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCce-eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCC
Q 002409 750 KFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGD 827 (927)
Q Consensus 750 ~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 827 (927)
+......... .....+++.|++||+.....++.++|||||||++|||++ |+.||...... .+... ...+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----~~~~~----~~~~~ 231 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS----EIYDY----LRQGN 231 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHH----HHcCC
Confidence 8654332211 122346778999999998899999999999999999999 78888653311 12121 11221
Q ss_pred cccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHH
Q 002409 828 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 876 (927)
Q Consensus 828 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~ 876 (927)
... ........+.+++.+|++.+|++|||+.|+++.|+++
T Consensus 232 ~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 RLK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 110 1112234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=322.39 Aligned_cols=262 Identities=24% Similarity=0.433 Sum_probs=205.2
Q ss_pred HHHHHHhccccccCceEEEEEEEC--------CCcEEEEEEeecCC-chhhHhHHHHHHHHhhc-cCCCccceecceeec
Q 002409 598 DATKMLEKKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE 667 (927)
Q Consensus 598 ~~~~~~~~~IG~G~fG~Vy~~~~~--------~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~ 667 (927)
...+.+.+.||+|+||.||+++.. +...+|+|.+.... .....++.+|+++++++ +|+||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 345677899999999999999753 23469999987542 33345688899999999 799999999999999
Q ss_pred CeEEEEEEeccCCchhhhcccccc------------cccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEE
Q 002409 668 GRSVLVYEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL 735 (927)
Q Consensus 668 ~~~~lV~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl 735 (927)
+..++||||+++|+|.+++..... ....+++.+++.++.|++.||+|||+. +++||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence 999999999999999999965321 234588999999999999999999998 99999999999999
Q ss_pred CCCCcEEEEeecCcccccCCCCce-eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccc
Q 002409 736 DKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCR 813 (927)
Q Consensus 736 ~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~ 813 (927)
+.++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |+.||......
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~---- 249 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---- 249 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH----
Confidence 999999999999987543321111 111224568999999988889999999999999999998 88888654311
Q ss_pred hhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHH
Q 002409 814 NIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 879 (927)
Q Consensus 814 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~ 879 (927)
.+... ...+... ..+.....++.+++.+|++.+|++||+|.||++.|++++..
T Consensus 250 ~~~~~----~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 250 ELFKL----LKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHHH----HHcCCCC---------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 11111 1111110 11122334688999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=311.53 Aligned_cols=247 Identities=27% Similarity=0.436 Sum_probs=195.1
Q ss_pred cccccCceEEEEEEEC---CCcEEEEEEeecCCc-hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCCc
Q 002409 606 KIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 681 (927)
Q Consensus 606 ~IG~G~fG~Vy~~~~~---~g~~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gs 681 (927)
.||+|+||.||+|.+. .+..||+|++..... ...+.+.+|+.++++++|+||+++++++.. ...++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 3899999999999764 355799999875532 334668999999999999999999998854 56799999999999
Q ss_pred hhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCcee-
Q 002409 682 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS- 760 (927)
Q Consensus 682 L~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~- 760 (927)
|.+++... ...+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++..........
T Consensus 81 L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 99988532 34688999999999999999999998 999999999999999999999999999975443322211
Q ss_pred -eeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCcccC
Q 002409 761 -SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 838 (927)
Q Consensus 761 -~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 838 (927)
....++..|+|||.+....++.++|||||||++|||++ |+.||...... .+... ...+.. .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~~----~~~~~~---------~ 217 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP----EVMSF----IEQGKR---------L 217 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH----HHHHH----HHCCCC---------C
Confidence 11223578999999988889999999999999999996 99999754311 11111 111111 1
Q ss_pred ccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHH
Q 002409 839 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 876 (927)
Q Consensus 839 ~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~ 876 (927)
..+.....++.+++.+|++.+|++||++.+|.+.|+..
T Consensus 218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 11222345788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=324.99 Aligned_cols=245 Identities=24% Similarity=0.314 Sum_probs=193.4
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccC-CCccceecceeecCeEEEEEEe
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHH-RNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~H-pnIv~l~g~~~~~~~~~lV~E~ 676 (927)
.+.+.||+|+||.||+|+.. +++.||||+++... ....+.+..|.+++..++| ++|+++++++...+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 82 (324)
T cd05587 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY 82 (324)
T ss_pred eEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcC
Confidence 45688999999999999876 56789999987542 2334567789999999876 5688899999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 83 VNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 999999988843 34578899999999999999999998 99999999999999999999999999987432221
Q ss_pred CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 757 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .+...+. +..
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~----~~~~~i~----~~~--------- 217 (324)
T cd05587 156 -KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED----ELFQSIM----EHN--------- 217 (324)
T ss_pred -CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHH----cCC---------
Confidence 1223456999999999999999999999999999999999999999754421 1111111 111
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCCcH-----HHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPSI-----SEVLKD 872 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm-----~eV~~~ 872 (927)
..++.....++.+++.+|++.+|++||+. .++.++
T Consensus 218 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 218 -VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred -CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 01111223467899999999999999976 566554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=323.88 Aligned_cols=242 Identities=26% Similarity=0.363 Sum_probs=194.0
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhc-cCCCccceecceeecCeEEEEEEeccC
Q 002409 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
+.||+|+||.||+++.. +++.||||+++... ......+..|.++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999876 57899999997542 22345567888888887 799999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (318)
T cd05570 81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VT 152 (318)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cc
Confidence 999888743 34689999999999999999999998 99999999999999999999999999987432221 12
Q ss_pred eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCc
Q 002409 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 839 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 839 (927)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.... ..... .
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~----~~~~~i----~~~~~----------~ 214 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED----ELFQSI----LEDEV----------R 214 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH----HHHHHH----HcCCC----------C
Confidence 23346899999999999999999999999999999999999999754311 111111 11110 0
Q ss_pred cCHHHHHHHHHHHhhhcCCCCCCCCcH-----HHHHHH
Q 002409 840 YDIQSMWKIEEKALMCVLPHGHMRPSI-----SEVLKD 872 (927)
Q Consensus 840 ~~~~~~~~l~~L~~~Cl~~dP~~RPsm-----~eV~~~ 872 (927)
++......+.+++.+|++.+|++||++ .+++++
T Consensus 215 ~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 215 YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 111123467899999999999999999 888765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=317.90 Aligned_cols=263 Identities=25% Similarity=0.395 Sum_probs=203.6
Q ss_pred HHHHHhccccccCceEEEEEEECC-----------------CcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccce
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLKD-----------------GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQF 660 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~~-----------------g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l 660 (927)
..+.+.+.||+|+||.||+++..+ +..||+|++.... ......+.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 345677899999999999987652 2458999987553 2345678899999999999999999
Q ss_pred ecceeecCeEEEEEEeccCCchhhhcccccc-------cccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCe
Q 002409 661 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLT-------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI 733 (927)
Q Consensus 661 ~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~-------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NI 733 (927)
++++...+..++++||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhce
Confidence 9999999999999999999999999865321 123689999999999999999999998 999999999999
Q ss_pred EECCCCcEEEEeecCcccccCCCC-ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh--CCCccccccccc
Q 002409 734 LLDKHMRAKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS--GQEAISNEKFGA 810 (927)
Q Consensus 734 Ll~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt--G~~p~~~~~~~~ 810 (927)
+++.++.++|+|||+++....... .......++..|+|||++....++.++|||||||++|||++ |..||......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~- 240 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ- 240 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH-
Confidence 999999999999999875433221 12233446788999999988889999999999999999998 66777543311
Q ss_pred ccchhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHH
Q 002409 811 NCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 874 (927)
Q Consensus 811 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~ 874 (927)
.+.+........+...... ..+.....++.+++.+|++.+|++||++.||++.|+
T Consensus 241 ---~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 ---QVIENAGHFFRDDGRQIYL------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ---HHHHHHHhccccccccccC------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 2222222221111111111 111122357899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=316.70 Aligned_cols=261 Identities=25% Similarity=0.365 Sum_probs=206.4
Q ss_pred HHHHHHhccccccCceEEEEEEECC-----CcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceee-cCeE
Q 002409 598 DATKMLEKKIGSGGFGVVYYGKLKD-----GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE-EGRS 670 (927)
Q Consensus 598 ~~~~~~~~~IG~G~fG~Vy~~~~~~-----g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~-~~~~ 670 (927)
...+.+.+.||+|+||.||+|.+.+ ++.|++|++.... ......+.+|+.++++++|+||+++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 3455667899999999999998775 6889999887543 2335668899999999999999999998766 4678
Q ss_pred EEEEEeccCCchhhhccccccc----ccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEee
Q 002409 671 VLVYEFMHNGTLKEHLYGTLTH----EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF 746 (927)
Q Consensus 671 ~lV~E~~~~gsL~~~L~~~~~~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DF 746 (927)
++++||+.+|+|.+++...... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998543221 25689999999999999999999998 9999999999999999999999999
Q ss_pred cCcccccCCCCce-eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhc
Q 002409 747 GLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIE 824 (927)
Q Consensus 747 Gla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~ 824 (927)
|+++.......+. .....++..|+|||++....++.++|||||||++||+++ |+.||..... ..+..+....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~~~~~~~~-- 235 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP----FEMAAYLKDG-- 235 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH----HHHHHHHHcC--
Confidence 9998654333221 122346778999999988889999999999999999999 9999975431 1222222211
Q ss_pred cCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 825 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 825 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
..+. ........+.+++.+|++.+|++||++.||++.|+.+..
T Consensus 236 -~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 236 -YRLA----------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred -CCCC----------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0110 011123468899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=317.61 Aligned_cols=264 Identities=23% Similarity=0.371 Sum_probs=200.9
Q ss_pred HHHHHhccccccCceEEEEEEEC-----------------CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccce
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLK-----------------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQF 660 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~-----------------~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l 660 (927)
..+.+.++||+|+||.||++... +...+|+|+++... ......+.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 34567789999999999998543 23468999987543 3345678999999999999999999
Q ss_pred ecceeecCeEEEEEEeccCCchhhhcccccc-------cccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCe
Q 002409 661 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLT-------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI 733 (927)
Q Consensus 661 ~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~-------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NI 733 (927)
++++...+..+++|||+.+|+|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 9999999999999999999999999865321 123478889999999999999999998 999999999999
Q ss_pred EECCCCcEEEEeecCcccccCCCCce-eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh--CCCccccccccc
Q 002409 734 LLDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS--GQEAISNEKFGA 810 (927)
Q Consensus 734 Ll~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt--G~~p~~~~~~~~ 810 (927)
|++.++.+||+|||+++......... .....++..|++||....+.++.++|||||||++|||++ |..||......+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 99999999999999987553322211 122234678999999888889999999999999999998 667876443221
Q ss_pred ccchhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHH
Q 002409 811 NCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 875 (927)
Q Consensus 811 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~ 875 (927)
.......+.. ........ ..+......+.+++.+|++.+|++||++.||++.|++
T Consensus 242 ~~~~~~~~~~----~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 VIENTGEFFR----DQGRQVYL------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHHHh----hccccccC------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1111111111 11000000 0011223578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=319.84 Aligned_cols=260 Identities=27% Similarity=0.438 Sum_probs=201.7
Q ss_pred HHHHhccccccCceEEEEEEEC-CCc--EEEEEEeecC-CchhhHhHHHHHHHHhhc-cCCCccceecceeecCeEEEEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGK--EIAVKVLTSN-SYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVY 674 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~--~VAVK~l~~~-~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~lV~ 674 (927)
.+.+.+.||+|+||.||+|.++ ++. .+|+|.++.. .......+.+|++++.++ +|+||+++++++...+..++||
T Consensus 8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 87 (303)
T cd05088 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 87 (303)
T ss_pred hceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEE
Confidence 3456789999999999999875 344 4577776543 233456788999999999 8999999999999999999999
Q ss_pred EeccCCchhhhcccccc------------cccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEE
Q 002409 675 EFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAK 742 (927)
Q Consensus 675 E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vk 742 (927)
||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+|||++.++.+|
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~k 164 (303)
T cd05088 88 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK 164 (303)
T ss_pred EeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcEE
Confidence 99999999999864321 123578999999999999999999998 999999999999999999999
Q ss_pred EEeecCcccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHh
Q 002409 743 VSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKL 821 (927)
Q Consensus 743 L~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~ 821 (927)
|+|||+++...... ......++..|+|||++....++.++|||||||++|||++ |..||...... ......
T Consensus 165 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~~~~~~-- 236 (303)
T cd05088 165 IADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----ELYEKL-- 236 (303)
T ss_pred eCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH----HHHHHH--
Confidence 99999986321111 1111224668999999988889999999999999999998 99998654311 111111
Q ss_pred hhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHHHH
Q 002409 822 HIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIER 881 (927)
Q Consensus 822 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~~~ 881 (927)
..+. ....+......+.+++.+|++.+|++||++.++++.|++++..+.
T Consensus 237 --~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 237 --PQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred --hcCC---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 1110 000111123467899999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=338.68 Aligned_cols=263 Identities=22% Similarity=0.268 Sum_probs=193.3
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeec--------CeE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--------GRS 670 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--------~~~ 670 (927)
.|.+.+.||+|+||.||+|... +++.||||++.... ....+|+.+|++++||||+++++++... ...
T Consensus 67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 142 (440)
T PTZ00036 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL 142 (440)
T ss_pred eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence 3556789999999999999875 57899999886432 2345799999999999999998876432 246
Q ss_pred EEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCC-cEEEEeecCc
Q 002409 671 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLS 749 (927)
Q Consensus 671 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-~vkL~DFGla 749 (927)
++||||+++ +|.+++.........+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||++
T Consensus 143 ~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 143 NVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred EEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 799999975 67776654434456789999999999999999999998 999999999999999665 7999999999
Q ss_pred ccccCCCCceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhh------
Q 002409 750 KFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH------ 822 (927)
Q Consensus 750 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~------ 822 (927)
+....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+.+.....
T Consensus 219 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 296 (440)
T PTZ00036 219 KNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK 296 (440)
T ss_pred hhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 86543222 223458999999999875 468999999999999999999999997654222222222111000
Q ss_pred -----hccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 823 -----IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 823 -----~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
..+-.+.......+...++.....++.+++.+|++.+|++|||+.|+++|
T Consensus 297 ~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 297 EMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00000111111111111222233578899999999999999999999977
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=318.50 Aligned_cols=258 Identities=27% Similarity=0.424 Sum_probs=200.8
Q ss_pred HHHhccccccCceEEEEEEECC-Cc--EEEEEEeecC-CchhhHhHHHHHHHHhhc-cCCCccceecceeecCeEEEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLKD-GK--EIAVKVLTSN-SYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE 675 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~~-g~--~VAVK~l~~~-~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~lV~E 675 (927)
+.+.+.||+|+||.||+|..++ +. .+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..++++|
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 83 (297)
T cd05089 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIE 83 (297)
T ss_pred ceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEE
Confidence 4467889999999999998763 33 4788887743 233456788999999999 79999999999999999999999
Q ss_pred eccCCchhhhcccccc------------cccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEE
Q 002409 676 FMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV 743 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL 743 (927)
|+++|+|.+++..... ....+++..++.++.|++.||+|||++ +++||||||+|||+++++.+||
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEE
Confidence 9999999999854321 123588999999999999999999998 9999999999999999999999
Q ss_pred EeecCcccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhh
Q 002409 744 SDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLH 822 (927)
Q Consensus 744 ~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~ 822 (927)
+|||++....... .......+..|+|||++....++.++|||||||++|||++ |+.||...... .+.+.
T Consensus 161 ~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~----~~~~~---- 230 (297)
T cd05089 161 ADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA----ELYEK---- 230 (297)
T ss_pred CCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHH----
Confidence 9999986322110 1111223567999999988889999999999999999997 99999654321 12221
Q ss_pred hccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHHH
Q 002409 823 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 880 (927)
Q Consensus 823 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~~ 880 (927)
...+. ....+......+.+++.+|++.+|.+||++.+|++.|+.++...
T Consensus 231 ~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 231 LPQGY---------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HhcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 11110 00111122346889999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=312.75 Aligned_cols=251 Identities=27% Similarity=0.451 Sum_probs=196.1
Q ss_pred ccccccCceEEEEEEECC-Cc--EEEEEEeecCC-chhhHhHHHHHHHHhhc-cCCCccceecceeecCeEEEEEEeccC
Q 002409 605 KKIGSGGFGVVYYGKLKD-GK--EIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~~-g~--~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
+.||+|+||.||+|++++ +. .+++|.++... ......+.+|+++++++ +||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999998764 43 46888876432 33456788999999999 899999999999999999999999999
Q ss_pred Cchhhhccccc------------ccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeec
Q 002409 680 GTLKEHLYGTL------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG 747 (927)
Q Consensus 680 gsL~~~L~~~~------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFG 747 (927)
|+|.+++.... .....+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 99999986432 1223578999999999999999999998 99999999999999999999999999
Q ss_pred CcccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccC
Q 002409 748 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESG 826 (927)
Q Consensus 748 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~ 826 (927)
++...... ........+..|+|||++....++.++|||||||+++||++ |+.||...... ...+.. ..+
T Consensus 158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~----~~~~~~----~~~ 227 (270)
T cd05047 158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----ELYEKL----PQG 227 (270)
T ss_pred Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH----HHHHHH----hCC
Confidence 98532111 11111224567999999988889999999999999999997 99999654311 111111 111
Q ss_pred CcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHH
Q 002409 827 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 877 (927)
Q Consensus 827 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~ 877 (927)
... .........+.+++.+|++.+|.+||++.|+++.|++++
T Consensus 228 ~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 YRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCC---------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 000 011112346889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=311.09 Aligned_cols=254 Identities=20% Similarity=0.315 Sum_probs=199.6
Q ss_pred HHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
..+.+.+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++++++||||+++++++...+..++|+||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 34567789999999999999874 67889999987554444567889999999999999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 89 ~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 89 GGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 99999998843 34678899999999999999999998 999999999999999999999999999875533221
Q ss_pred ceeeeeccCCCccCccccc---cCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCC
Q 002409 758 HVSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 834 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~~---~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 834 (927)
......|+..|+|||.+. ...++.++|||||||++|||++|+.||......+.. ..+ ....+ ..+
T Consensus 162 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~---~~~-----~~~~~---~~~ 229 (267)
T cd06646 162 -KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL---FLM-----SKSNF---QPP 229 (267)
T ss_pred -ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh---eee-----ecCCC---CCC
Confidence 112345889999999884 345788999999999999999999998643311110 000 00000 001
Q ss_pred cccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHH
Q 002409 835 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 873 (927)
Q Consensus 835 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L 873 (927)
.... .......+.+++.+|++.+|++||++.+++++|
T Consensus 230 ~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 KLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1111 112234688999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=321.05 Aligned_cols=249 Identities=22% Similarity=0.289 Sum_probs=194.6
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeecCCc---hhhHhHHHHHHHHhhc-cCCCccceecceeecCeEEEEEEeccC
Q 002409 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
+.||+|+||.||+++.. +++.+|+|+++.... .....+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999876 578899999975422 2345578899999888 699999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~----~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (327)
T cd05617 81 GDLMFHMQ----RQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DT 152 (327)
T ss_pred CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cc
Confidence 99988874 235689999999999999999999998 99999999999999999999999999987432221 22
Q ss_pred eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCc
Q 002409 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 839 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 839 (927)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ....++.......... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~------~---- 221 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPD-MNTEDYLFQVILEKPI------R---- 221 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcc-cccHHHHHHHHHhCCC------C----
Confidence 2345699999999999999999999999999999999999999964321111 1111222222211111 0
Q ss_pred cCHHHHHHHHHHHhhhcCCCCCCCCc------HHHHHHH
Q 002409 840 YDIQSMWKIEEKALMCVLPHGHMRPS------ISEVLKD 872 (927)
Q Consensus 840 ~~~~~~~~l~~L~~~Cl~~dP~~RPs------m~eV~~~ 872 (927)
.+......+.+++.+|++.+|++||+ +.++.+|
T Consensus 222 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 222 IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 11112245789999999999999998 4577665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=313.98 Aligned_cols=253 Identities=24% Similarity=0.423 Sum_probs=200.6
Q ss_pred HHHhccccccCceEEEEEEEC-CC---cEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DG---KEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 675 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g---~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E 675 (927)
+...+.||+|+||.||+|+.. ++ ..+|+|.++... ......+..|++++++++|+|++++++++...+..++|||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (268)
T cd05063 7 ITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITE 86 (268)
T ss_pred ceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEE
Confidence 345688999999999999875 23 368999887543 3335678899999999999999999999999999999999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCC
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 755 (927)
|+++++|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 87 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 87 YMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred cCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999998532 35688999999999999999999998 9999999999999999999999999998755433
Q ss_pred CCceee--eeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCccccc
Q 002409 756 ASHVSS--IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 832 (927)
Q Consensus 756 ~~~~~~--~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 832 (927)
...... ....+..|+|||++....++.++|||||||++|||++ |+.||...... .+...... ....
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~----~~~~~i~~---~~~~---- 229 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH----EVMKAIND---GFRL---- 229 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH----HHHHHHhc---CCCC----
Confidence 222111 1223457999999988889999999999999999997 99998654311 11111111 0111
Q ss_pred CCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHH
Q 002409 833 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 876 (927)
Q Consensus 833 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~ 876 (927)
.........+.+++.+|++.+|++||+|.+|++.|+++
T Consensus 230 ------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 ------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01112335688999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=316.75 Aligned_cols=255 Identities=27% Similarity=0.414 Sum_probs=199.1
Q ss_pred HHHHhccccccCceEEEEEEECC------CcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 672 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~~------g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~l 672 (927)
.+.+.+.||+|+||.||+|.+.+ +..||+|.+.... ......+.+|+.++++++|+||+++++++.+.+..++
T Consensus 7 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 86 (277)
T cd05036 7 SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFI 86 (277)
T ss_pred HcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEE
Confidence 34556889999999999998753 4678999876543 3335678999999999999999999999999999999
Q ss_pred EEEeccCCchhhhcccccc---cccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCC---cEEEEee
Q 002409 673 VYEFMHNGTLKEHLYGTLT---HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM---RAKVSDF 746 (927)
Q Consensus 673 V~E~~~~gsL~~~L~~~~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~---~vkL~DF 746 (927)
||||+++++|.+++..... ....+++..++.++.||+.||+|||++ +++||||||+||+++.++ .+||+||
T Consensus 87 v~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~df 163 (277)
T cd05036 87 LLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADF 163 (277)
T ss_pred EEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEeccC
Confidence 9999999999999854321 123589999999999999999999998 999999999999998754 5999999
Q ss_pred cCcccccCCCCce-eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhc
Q 002409 747 GLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIE 824 (927)
Q Consensus 747 Gla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~ 824 (927)
|+++......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||.....+ .+...+. .
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~----~~~~~~~---~ 236 (277)
T cd05036 164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ----EVMEFVT---G 236 (277)
T ss_pred ccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHH---c
Confidence 9998653221111 111223568999999999999999999999999999997 99999754422 1222111 1
Q ss_pred cCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHH
Q 002409 825 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 874 (927)
Q Consensus 825 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~ 874 (927)
... ...+......+.+++.+|++.+|++||++.||+++|+
T Consensus 237 ~~~----------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 237 GGR----------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCc----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111 0111223356889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=314.85 Aligned_cols=253 Identities=24% Similarity=0.400 Sum_probs=196.9
Q ss_pred HHhccccccCceEEEEEEEC-CCc----EEEEEEeecCCc-hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEE
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGK----EIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 675 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~----~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E 675 (927)
.+.+.||+|+||.||+|.+. +++ .+++|.+..... ....++..|+..+++++||||+++++++.. ...++++|
T Consensus 10 ~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e 88 (279)
T cd05111 10 RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQ 88 (279)
T ss_pred eeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEE
Confidence 45678999999999999875 344 477787754332 234567888889999999999999998864 45678999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCC
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 755 (927)
|+++|+|.+++... ...+++..++.++.|++.||+|||+. +++||||||+|||+++++.+||+|||+++.....
T Consensus 89 ~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 89 LSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred eCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 99999999998532 34688999999999999999999998 9999999999999999999999999999865433
Q ss_pred CCc-eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccC
Q 002409 756 ASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 833 (927)
Q Consensus 756 ~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 833 (927)
... ......++..|+|||.+..+.++.++|||||||++|||++ |+.||...... .+.+.. ..+.... .
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~----~~~~~~----~~~~~~~--~ 232 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH----EVPDLL----EKGERLA--Q 232 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHH----HCCCcCC--C
Confidence 221 2233457789999999998899999999999999999998 99998654311 112211 1121110 1
Q ss_pred CcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 834 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 834 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
+. .....+.+++.+|+..+|++||++.|+++.|..+..
T Consensus 233 ~~-------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 233 PQ-------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CC-------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 11 112357789999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=332.98 Aligned_cols=250 Identities=22% Similarity=0.281 Sum_probs=193.1
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
|.+.+.||+|+||.||+++.. +++.||||++.... ......+.+|++++++++|+||+++++.+.+.+..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence 345688999999999999876 58899999986432 12245678899999999999999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCC-
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG- 755 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~- 755 (927)
+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 83 IPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 999999999853 34578888889999999999999998 9999999999999999999999999997422100
Q ss_pred -----------------------------------------CCceeeeeccCCCccCccccccCcCCCccceeeHHHHHH
Q 002409 756 -----------------------------------------ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILL 794 (927)
Q Consensus 756 -----------------------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ 794 (927)
.........||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 000011246999999999999999999999999999999
Q ss_pred HHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCC---cHHHHHH
Q 002409 795 ELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP---SISEVLK 871 (927)
Q Consensus 795 elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP---sm~eV~~ 871 (927)
||++|+.||......+....+..|... . . + + ........+.+++.+|+ .+|++|+ ++.|+++
T Consensus 236 ell~G~~Pf~~~~~~~~~~~i~~~~~~------~-~-~-~-----~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 236 EMLVGQPPFLADTPAETQLKVINWETT------L-H-I-P-----SQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred ehhhCCCCCCCCCHHHHHHHHhccCcc------c-c-C-C-----CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 999999999765422211111111100 0 0 0 0 00111234566777765 4999999 8999998
Q ss_pred H
Q 002409 872 D 872 (927)
Q Consensus 872 ~ 872 (927)
+
T Consensus 301 h 301 (376)
T cd05598 301 H 301 (376)
T ss_pred C
Confidence 7
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=324.07 Aligned_cols=240 Identities=25% Similarity=0.308 Sum_probs=187.6
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHH-HHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEV-TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei-~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
+.||+|+||.||+++.. +++.+|+|++.... ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999876 56789999987532 12223344444 456788999999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
|+|.+++.. ...+....+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~ 152 (325)
T cd05602 81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GT 152 (325)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CC
Confidence 999988843 34577888888999999999999998 99999999999999999999999999987533222 22
Q ss_pred eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCc
Q 002409 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 839 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 839 (927)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+. .+.... ... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----~~~i~~----~~~------~---- 214 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM----YDNILN----KPL------Q---- 214 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH----HHHHHh----CCc------C----
Confidence 3345699999999999999999999999999999999999999975442211 111110 100 0
Q ss_pred cCHHHHHHHHHHHhhhcCCCCCCCCcHHHHH
Q 002409 840 YDIQSMWKIEEKALMCVLPHGHMRPSISEVL 870 (927)
Q Consensus 840 ~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~ 870 (927)
........+.+++.+|++.+|++||++.+.+
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 215 LKPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 1112234578999999999999999877433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=324.63 Aligned_cols=263 Identities=27% Similarity=0.422 Sum_probs=201.9
Q ss_pred HHHHHHHhccccccCceEEEEEEE------CCCcEEEEEEeecCCc-hhhHhHHHHHHHHhhc-cCCCccceecceeec-
Q 002409 597 EDATKMLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE- 667 (927)
Q Consensus 597 ~~~~~~~~~~IG~G~fG~Vy~~~~------~~g~~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~- 667 (927)
....+.+.+.||+|+||.||+|.. .+++.||||+++.... .....+.+|+.++.++ +|+||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 345677889999999999999974 2467899999975432 2345688999999999 789999999988654
Q ss_pred CeEEEEEEeccCCchhhhcccccc--------------------------------------------------------
Q 002409 668 GRSVLVYEFMHNGTLKEHLYGTLT-------------------------------------------------------- 691 (927)
Q Consensus 668 ~~~~lV~E~~~~gsL~~~L~~~~~-------------------------------------------------------- 691 (927)
...+++|||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 467899999999999998854210
Q ss_pred -------cccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc-eeeee
Q 002409 692 -------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH-VSSIV 763 (927)
Q Consensus 692 -------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~ 763 (927)
....+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++........ .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 012467888899999999999999998 9999999999999999999999999998754332211 11223
Q ss_pred ccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCcccCccCH
Q 002409 764 RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 842 (927)
Q Consensus 764 ~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 842 (927)
.++..|+|||.+....++.++|||||||++|||++ |..||....... .+.. ...++.... ....
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~----~~~~~~~~~-----~~~~--- 306 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---EFCR----RLKEGTRMR-----APDY--- 306 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH---HHHH----HHhccCCCC-----CCCC---
Confidence 35678999999988899999999999999999997 888886533111 1111 111111100 0001
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 843 QSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 843 ~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
...++.+++.+|++.+|++||++.||+++|+.+++
T Consensus 307 -~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 307 -TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred -CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 12358899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=315.54 Aligned_cols=257 Identities=25% Similarity=0.422 Sum_probs=203.4
Q ss_pred HHHHHHhccccccCceEEEEEEECC------CcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeE
Q 002409 598 DATKMLEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS 670 (927)
Q Consensus 598 ~~~~~~~~~IG~G~fG~Vy~~~~~~------g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~ 670 (927)
...+.+.+.||+|+||.||+|...+ ++.||+|.+.... ......+.+|+.+++.++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3455567899999999999998652 3689999986553 23345788999999999999999999999999999
Q ss_pred EEEEEeccCCchhhhccccccc------ccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEE
Q 002409 671 VLVYEFMHNGTLKEHLYGTLTH------EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 744 (927)
Q Consensus 671 ~lV~E~~~~gsL~~~L~~~~~~------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~ 744 (927)
++||||+++|+|.+++...... ...+++..++.++.|++.||.|||+. +++||||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 9999999999999998653321 23478889999999999999999998 99999999999999999999999
Q ss_pred eecCcccccCCCC-ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhh
Q 002409 745 DFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLH 822 (927)
Q Consensus 745 DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~ 822 (927)
|||+++....... .......++..|+|||.+..+.++.++|||||||++|||++ |+.||..... ..+..+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~----~~~~~~~~-- 235 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN----EEVLKFVI-- 235 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH----HHHHHHHh--
Confidence 9999875443321 11223346789999999988889999999999999999998 8889865431 12222211
Q ss_pred hccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHH
Q 002409 823 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 874 (927)
Q Consensus 823 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~ 874 (927)
.+.... .+......+.+++.+|++.+|++|||+.|+++.|+
T Consensus 236 --~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 --DGGHLD---------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred --cCCCCC---------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 111111 11112457889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=323.02 Aligned_cols=245 Identities=24% Similarity=0.304 Sum_probs=193.8
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc---hhhHhHHHHHHHHhhc-cCCCccceecceeecCeEEEEEEe
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
.+.+.||+|+||.||+|+.. +++.||||+++.... .....+..|..++..+ +|++|+++++++...+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 82 (323)
T cd05616 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEY 82 (323)
T ss_pred eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcC
Confidence 45678999999999999876 577999999875421 2234566778888777 589999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 83 VNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred CCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 999999988843 34688899999999999999999998 99999999999999999999999999987433221
Q ss_pred CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 757 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
.......||+.|+|||++....++.++|||||||++|||++|+.||...... .+.+.+.. ...
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~----~~~~~i~~----~~~-------- 218 (323)
T cd05616 156 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED----ELFQSIME----HNV-------- 218 (323)
T ss_pred -CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH----HHHHHHHh----CCC--------
Confidence 1223456899999999999999999999999999999999999999764421 22221111 110
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCCcH-----HHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPSI-----SEVLKD 872 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm-----~eV~~~ 872 (927)
.++.....++.+++.+|++.+|++|++. .++.++
T Consensus 219 --~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 219 --AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred --CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 1111223467899999999999999984 666554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=311.64 Aligned_cols=255 Identities=23% Similarity=0.395 Sum_probs=203.5
Q ss_pred HHHHHHHhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 597 EDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 597 ~~~~~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
....+.+.+.||+|+||.||++...++..+|+|.+.... .....+.+|++++++++|+||+++++.+.. ...+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 344566788999999999999998878889999887442 335678899999999999999999999887 778999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
+++++|.+++... ....+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 82 MAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred CCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 9999999998643 244678889999999999999999998 99999999999999999999999999987554332
Q ss_pred CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCc
Q 002409 757 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 835 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 835 (927)
........++..|+|||++....++.++|+|||||++|||++ |+.||...... .+..+.. .+....
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~----~~~~~~~----~~~~~~----- 223 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP----EVIRALE----RGYRMP----- 223 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH----HHHHHHh----CCCCCC-----
Confidence 222222345678999999998889999999999999999999 89998754311 2222211 111100
Q ss_pred ccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHH
Q 002409 836 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 875 (927)
Q Consensus 836 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~ 875 (927)
.......++.+++.+|++.+|++||++.++.+.|+.
T Consensus 224 ----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 ----RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ----CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111223468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=308.54 Aligned_cols=248 Identities=24% Similarity=0.397 Sum_probs=201.5
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecC--CchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
.+.+.||+|++|.||+++.+ +++.|++|.+... .......+.+|++++++++||||+++++++...+..++||||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08529 3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAE 82 (256)
T ss_pred eEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCC
Confidence 34678999999999999876 6889999998643 23345678899999999999999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
+++|.+++... ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~- 156 (256)
T cd08529 83 NGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN- 156 (256)
T ss_pred CCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence 99999998643 235688999999999999999999998 999999999999999999999999999875543322
Q ss_pred eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccC
Q 002409 759 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 838 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 838 (927)
......|++.|+|||++.+..++.++|+|||||+++||++|+.||...... ...... ..+....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~----~~~~~~~-------- 220 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG----ALILKI----IRGVFPP-------- 220 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH----HHHHHH----HcCCCCC--------
Confidence 223345889999999999989999999999999999999999999754411 111111 1111111
Q ss_pred ccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 839 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 839 ~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
........+.+++.+|++.+|++||++.|++++
T Consensus 221 -~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 221 -VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 111223468999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=324.74 Aligned_cols=238 Identities=28% Similarity=0.354 Sum_probs=187.8
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHH-HHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVT-LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~-iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
+.||+|+||.||+++.. +|+.+|+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46899999999999875 68899999987542 222344555554 56778999999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~ 152 (325)
T cd05604 81 GELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DT 152 (325)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CC
Confidence 99988874 345688999999999999999999998 99999999999999999999999999987432221 22
Q ss_pred eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCc
Q 002409 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 839 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 839 (927)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ +.+ ... .+.+ .+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~----~~~---~~~-~~~~------~~~~~ 218 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE----MYD---NIL-HKPL------VLRPG 218 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH----HHH---HHH-cCCc------cCCCC
Confidence 234569999999999999999999999999999999999999997544221 111 111 1111 01111
Q ss_pred cCHHHHHHHHHHHhhhcCCCCCCCCcHHH
Q 002409 840 YDIQSMWKIEEKALMCVLPHGHMRPSISE 868 (927)
Q Consensus 840 ~~~~~~~~l~~L~~~Cl~~dP~~RPsm~e 868 (927)
....+.+++.+|++.+|++||++.+
T Consensus 219 ----~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 219 ----ASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred ----CCHHHHHHHHHHhccCHHhcCCCCC
Confidence 2235778999999999999998863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=323.09 Aligned_cols=237 Identities=27% Similarity=0.341 Sum_probs=186.3
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeecCCc---hhhHhHHHHH-HHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEV-TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei-~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
+.||+|+||.||+|+.. +++.||+|++..... .....+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 578999999875421 2233445554 467889999999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (321)
T cd05603 81 GELFFHLQ----RERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ET 152 (321)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cc
Confidence 99988774 245678888899999999999999998 99999999999999999999999999987432222 22
Q ss_pred eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCc
Q 002409 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 839 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 839 (927)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .+.+.+ ..+.. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~i----~~~~~----------~ 214 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS----QMYDNI----LHKPL----------Q 214 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH----HHHHHH----hcCCC----------C
Confidence 23456899999999999889999999999999999999999999754311 111111 11110 1
Q ss_pred cCHHHHHHHHHHHhhhcCCCCCCCCcHH
Q 002409 840 YDIQSMWKIEEKALMCVLPHGHMRPSIS 867 (927)
Q Consensus 840 ~~~~~~~~l~~L~~~Cl~~dP~~RPsm~ 867 (927)
.+......+.+++.+|++.+|++||+..
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 215 LPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 1112234678999999999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=312.07 Aligned_cols=247 Identities=23% Similarity=0.348 Sum_probs=193.1
Q ss_pred ccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCCch
Q 002409 607 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 682 (927)
Q Consensus 607 IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 682 (927)
||+|+||.||+++.+ +|+.+|+|.+.... ......+..|++++++++||||+++++++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999876 58999999986432 12234566799999999999999999999999999999999999999
Q ss_pred hhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCceeee
Q 002409 683 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 762 (927)
Q Consensus 683 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 762 (927)
.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....... ....
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~ 153 (277)
T cd05607 81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQ 153 (277)
T ss_pred HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeec
Confidence 9887532 234578899999999999999999998 99999999999999999999999999987554322 2233
Q ss_pred eccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCccCH
Q 002409 763 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 842 (927)
Q Consensus 763 ~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 842 (927)
..|+..|+|||++.+..++.++||||+||++|||++|+.||...........+. .... .+.+.. . ..
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~---~~~~-~~~~~~----~-~~---- 220 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELK---RRTL-EDEVKF----E-HQ---- 220 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHH---HHhh-cccccc----c-cc----
Confidence 458999999999998889999999999999999999999996533111111111 1111 111100 0 01
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCcHHHHHHHH
Q 002409 843 QSMWKIEEKALMCVLPHGHMRPSISEVLKDI 873 (927)
Q Consensus 843 ~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L 873 (927)
....++.+++.+|++.+|++||++.|+++.+
T Consensus 221 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 221 NFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred cCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 1223578999999999999999997766443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=327.76 Aligned_cols=253 Identities=22% Similarity=0.273 Sum_probs=195.8
Q ss_pred HHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEE
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 674 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~ 674 (927)
..+.+.+.||+|+||.||+++.+ +++.+|+|++.... ......+.+|+.+++.++||||+++++.+...+..++||
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 122 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 45566789999999999999877 57889999986432 223455788999999999999999999999999999999
Q ss_pred EeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccC
Q 002409 675 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 754 (927)
Q Consensus 675 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 754 (927)
||+++|+|.+++.. ..++...+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 123 Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~ 194 (371)
T cd05622 123 EYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 194 (371)
T ss_pred cCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence 99999999998843 3477888889999999999999998 999999999999999999999999999986543
Q ss_pred CCCceeeeeccCCCccCccccccC----cCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCccc
Q 002409 755 GASHVSSIVRGTVGYLDPEYYISQ----QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 830 (927)
Q Consensus 755 ~~~~~~~~~~gt~~Y~aPE~~~~~----~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 830 (927)
..........||+.|+|||++... .++.++|||||||++|||++|+.||...........+ ........
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i-------~~~~~~~~ 267 (371)
T cd05622 195 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI-------MNHKNSLT 267 (371)
T ss_pred CCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHH-------HcCCCccc
Confidence 332233445699999999998753 3788999999999999999999999765421111111 11110000
Q ss_pred ccCCcccCccCHHHHHHHHHHHhhhcCCCCCC--CCcHHHHHHHH
Q 002409 831 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHM--RPSISEVLKDI 873 (927)
Q Consensus 831 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~--RPsm~eV~~~L 873 (927)
..+ .......+.+++.+|+...+.+ ||++.|++++.
T Consensus 268 ~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 268 FPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 000 0112335778999999844433 78999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=319.09 Aligned_cols=257 Identities=25% Similarity=0.393 Sum_probs=202.4
Q ss_pred HHHHHhccccccCceEEEEEEEC------CCcEEEEEEeecCC-chhhHhHHHHHHHHhhc-cCCCccceecceeecCeE
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRS 670 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~------~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~ 670 (927)
..+.+.+.||+|+||.||+++.. .+..||||+++... ......+.+|+++++++ +|+||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 44566789999999999999742 34579999987543 23345688999999999 799999999999999999
Q ss_pred EEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcc
Q 002409 671 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 750 (927)
Q Consensus 671 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 750 (927)
+++|||+.+|+|.+++.... ...+++.++..++.|++.||+|||++ +++|+||||+|||++.++.+||+|||+++
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccc
Confidence 99999999999999985422 23389999999999999999999998 99999999999999999999999999997
Q ss_pred cccCCCCc-eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCc
Q 002409 751 FAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDI 828 (927)
Q Consensus 751 ~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 828 (927)
........ ......++..|+|||.+....++.++|||||||++|||++ |+.||......+. .... ...+..
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~---~~~~----~~~~~~ 262 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK---FYKL----IKEGYR 262 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH---HHHH----HHcCCc
Confidence 55433221 1122335778999999998899999999999999999998 9999865432111 1111 111110
Q ss_pred ccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHH
Q 002409 829 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 876 (927)
Q Consensus 829 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~ 876 (927)
...+.....++.+++.+|++.+|++||++.||++.|+++
T Consensus 263 ---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 263 ---------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 000111234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=328.50 Aligned_cols=261 Identities=24% Similarity=0.313 Sum_probs=195.2
Q ss_pred HhccccccCceEEEEEEEC-CCcEEEEEEeecC--CchhhHhHHHHHHHHhhccCCCccceecceeecC-----eEEEEE
Q 002409 603 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG-----RSVLVY 674 (927)
Q Consensus 603 ~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-----~~~lV~ 674 (927)
+.+.||+|+||.||+++.. +++.||||++... .....+.+.+|+++++.++|+||+++++++...+ ..++|+
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 83 (372)
T cd07853 4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVT 83 (372)
T ss_pred ccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEe
Confidence 4678999999999999875 6899999998643 2233467889999999999999999999998776 789999
Q ss_pred EeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccC
Q 002409 675 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 754 (927)
Q Consensus 675 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 754 (927)
||+. ++|.+.+. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 84 e~~~-~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 84 ELMQ-SDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred eccc-cCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 9996 57777663 245688999999999999999999998 999999999999999999999999999975443
Q ss_pred CCCceeeeeccCCCccCccccccC-cCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHH---------------
Q 002409 755 GASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQW--------------- 818 (927)
Q Consensus 755 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~--------------- 818 (927)
..........+++.|+|||++.+. .++.++||||+||++|||++|+.||...........+.+.
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 235 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG 235 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence 332223334578999999998764 5789999999999999999999999754422111111110
Q ss_pred HHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 819 AKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 819 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
...............+.+ -........++.+++.+|++.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 236 ARAHILRGPHKPPSLPVL-YTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHhCCCCCCchHHh-cccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000000000000000 00111123468899999999999999999999886
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=316.00 Aligned_cols=254 Identities=26% Similarity=0.425 Sum_probs=200.9
Q ss_pred HHHhccccccCceEEEEEEEC------CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 674 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~------~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~ 674 (927)
..+.++||+|+||.||++... ++..+|+|.+..........+.+|++++++++|+||+++++++...+..+++|
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (280)
T cd05092 7 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVF 86 (280)
T ss_pred ceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEE
Confidence 345788999999999999642 35678999887665555678999999999999999999999999999999999
Q ss_pred EeccCCchhhhcccccc-----------cccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEE
Q 002409 675 EFMHNGTLKEHLYGTLT-----------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV 743 (927)
Q Consensus 675 E~~~~gsL~~~L~~~~~-----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL 743 (927)
||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+|||+++++.+||
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~kL 163 (280)
T cd05092 87 EYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKI 163 (280)
T ss_pred ecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEEE
Confidence 99999999999864321 123578999999999999999999998 9999999999999999999999
Q ss_pred EeecCcccccCCCCc-eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHh
Q 002409 744 SDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKL 821 (927)
Q Consensus 744 ~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~ 821 (927)
+|||+++........ ......+++.|+|||++....++.++|||||||++|||++ |+.||......+ ..+..
T Consensus 164 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----~~~~~-- 237 (280)
T cd05092 164 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE----AIECI-- 237 (280)
T ss_pred CCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH----HHHHH--
Confidence 999998754332211 1122335678999999998899999999999999999998 899986543211 11111
Q ss_pred hhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHH
Q 002409 822 HIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 874 (927)
Q Consensus 822 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~ 874 (927)
..+... ..+......+.+++.+|++.+|++||++.||++.|+
T Consensus 238 --~~~~~~---------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 238 --TQGREL---------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred --HcCccC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 111100 001112345789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=312.36 Aligned_cols=254 Identities=25% Similarity=0.440 Sum_probs=201.8
Q ss_pred HHHHhccccccCceEEEEEEEC----CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 674 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~----~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~ 674 (927)
.+.+.+.||+|+||.||+|++. .+..+|+|.++... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (267)
T cd05066 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVT 84 (267)
T ss_pred HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence 4456789999999999999864 23479999886543 233567899999999999999999999999999999999
Q ss_pred EeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccC
Q 002409 675 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 754 (927)
Q Consensus 675 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 754 (927)
||+++++|.+++... ...+++.+++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++....
T Consensus 85 e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 85 EYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 999999999998542 24578999999999999999999998 999999999999999999999999999986544
Q ss_pred CCCceeee--eccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccc
Q 002409 755 GASHVSSI--VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 831 (927)
Q Consensus 755 ~~~~~~~~--~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 831 (927)
........ ..++..|+|||++....++.++|||||||++||+++ |+.||...... .+....... ...
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~----~~~~~~~~~---~~~--- 228 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ----DVIKAIEEG---YRL--- 228 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH----HHHHHHhCC---CcC---
Confidence 33222211 223568999999998899999999999999999887 99998654311 122221111 000
Q ss_pred cCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHH
Q 002409 832 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 876 (927)
Q Consensus 832 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~ 876 (927)
.........+.+++.+|++.+|++||+|.++++.|+++
T Consensus 229 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 -------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 00112234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=307.08 Aligned_cols=250 Identities=31% Similarity=0.496 Sum_probs=202.9
Q ss_pred ccccccCceEEEEEEECC----CcEEEEEEeecCCchh-hHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 605 KKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~~----g~~VAVK~l~~~~~~~-~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
+.||+|+||.||+|.... +..+++|+++...... .+.+.+|++.+++++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999998764 7889999987654333 67889999999999999999999999999999999999999
Q ss_pred Cchhhhccccccc-----ccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccC
Q 002409 680 GTLKEHLYGTLTH-----EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 754 (927)
Q Consensus 680 gsL~~~L~~~~~~-----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 754 (927)
++|.+++...... ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999998654211 36789999999999999999999998 999999999999999999999999999986544
Q ss_pred CCC-ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCccccc
Q 002409 755 GAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 832 (927)
Q Consensus 755 ~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 832 (927)
... .......++..|+|||.+....++.++||||+||+++||++ |+.||...... .+.+.... +..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~~~~~----~~~---- 225 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE----EVLEYLRK----GYR---- 225 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH----HHHHHHHc----CCC----
Confidence 321 12233457889999999988889999999999999999999 69998765311 22222111 110
Q ss_pred CCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHH
Q 002409 833 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 874 (927)
Q Consensus 833 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~ 874 (927)
...+.....++.+++.+|++.+|++||++.|++++|+
T Consensus 226 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 -----LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -----CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0111122357889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=313.10 Aligned_cols=254 Identities=26% Similarity=0.477 Sum_probs=201.1
Q ss_pred HHHHhccccccCceEEEEEEECC-C---cEEEEEEeecC-CchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLKD-G---KEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 674 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~~-g---~~VAVK~l~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~ 674 (927)
.+.+.+.||+|+||.||+|.+.. + ..||||++... ......+|..|+.++++++||||+++++++.++...++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 34567899999999999998753 3 36999998754 2334567999999999999999999999999999999999
Q ss_pred EeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccC
Q 002409 675 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 754 (927)
Q Consensus 675 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 754 (927)
||+++|+|.+++... ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++....
T Consensus 85 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 85 EFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred ecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 999999999988542 34688999999999999999999998 999999999999999999999999999875543
Q ss_pred CCCcee--eeec--cCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcc
Q 002409 755 GASHVS--SIVR--GTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQ 829 (927)
Q Consensus 755 ~~~~~~--~~~~--gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 829 (927)
...... .... .+..|+|||++....++.++|||||||++|||++ |..||..... ..+..++... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~----~~~~~~i~~~---~~~~ 231 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN----QDVINAIEQD---YRLP 231 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH----HHHHHHHHcC---CcCC
Confidence 322111 1111 2457999999998999999999999999999886 9999865431 1223322111 0000
Q ss_pred cccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHH
Q 002409 830 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 876 (927)
Q Consensus 830 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~ 876 (927)
.+.+....+.+++.+|++.+|++||++.+|++.|+++
T Consensus 232 ----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 232 ----------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0112234678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=314.94 Aligned_cols=263 Identities=25% Similarity=0.400 Sum_probs=201.7
Q ss_pred HHHHHHhccccccCceEEEEEEEC-----CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeec--Ce
Q 002409 598 DATKMLEKKIGSGGFGVVYYGKLK-----DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GR 669 (927)
Q Consensus 598 ~~~~~~~~~IG~G~fG~Vy~~~~~-----~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--~~ 669 (927)
+..+.+.+.||+|+||.||.+++. +++.||+|.++... ......+.+|++++++++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 345667788999999999999743 57889999987543 33346789999999999999999999998775 56
Q ss_pred EEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCc
Q 002409 670 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 749 (927)
Q Consensus 670 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla 749 (927)
.++||||+++++|.+++... ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred eEEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccc
Confidence 88999999999999988532 23578999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCc--eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCccccccc-------cc-ccchhhHHH
Q 002409 750 KFAVDGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF-------GA-NCRNIVQWA 819 (927)
Q Consensus 750 ~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~-------~~-~~~~l~~~~ 819 (927)
+........ ......++..|+|||++.+..++.++|||||||++|||++++.|...... +. .......+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 865433221 11234467789999999888899999999999999999998776432110 00 000111111
Q ss_pred HhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHH
Q 002409 820 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 876 (927)
Q Consensus 820 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~ 876 (927)
.....+... .........+.+++.+|++.+|++||++.|+++.|+++
T Consensus 237 -~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 237 -RVLEEGKRL---------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred -HHHHcCccC---------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111111110 01112345789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=306.80 Aligned_cols=260 Identities=23% Similarity=0.352 Sum_probs=194.9
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEeecC--CchhhHhHHHHHHHHhhccCCCccceecceee-----cCeEEEEEE
Q 002409 604 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE-----EGRSVLVYE 675 (927)
Q Consensus 604 ~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~-----~~~~~lV~E 675 (927)
.+.||+|+||.|+.+..+ +|+.||||++... ..-..++..+|+.+|+.++|+||+.+.+++.. -...++|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 478999999999999876 6899999998733 33446778899999999999999999998865 346799999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCC
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 755 (927)
+|+ -+|...++ .++.++......++.|+++||.|+|+. +|+||||||+|+|++.+..+||+|||+|+.....
T Consensus 107 lMe-tDL~~iik----~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~ 178 (359)
T KOG0660|consen 107 LME-TDLHQIIK----SQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF 178 (359)
T ss_pred HHh-hHHHHHHH----cCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeecccc
Confidence 994 48888774 345588889999999999999999998 9999999999999999999999999999966432
Q ss_pred -CCceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHH-------hhhccC
Q 002409 756 -ASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK-------LHIESG 826 (927)
Q Consensus 756 -~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~-------~~~~~~ 826 (927)
.....+....|.+|.|||++.. ..|+.+.||||.|||+.||++|+..|.+.+.-....-+.+... ..+...
T Consensus 179 ~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~ 258 (359)
T KOG0660|consen 179 FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSE 258 (359)
T ss_pred CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccH
Confidence 1222244457999999999864 6899999999999999999999999976442111111111000 000000
Q ss_pred C-------cccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 827 D-------IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 827 ~-------~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
. +...-...+..-+ .......++|+.+|+..||.+|+|++|.++|
T Consensus 259 ~ar~yi~slp~~p~~~f~~~f-p~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 259 KARPYIKSLPQIPKQPFSSIF-PNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHHhCCCCCCCCHHHHc-CCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 0000000000111 1233467899999999999999999999887
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=307.34 Aligned_cols=248 Identities=27% Similarity=0.405 Sum_probs=199.0
Q ss_pred ccccccCceEEEEEEECC--C--cEEEEEEeecCCc-hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 605 KKIGSGGFGVVYYGKLKD--G--KEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~~--g--~~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
+.||+|++|.||+|.+.+ + ..||||.++.... ...+.+.+|++++++++||||+++++.+.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998753 2 3689999987655 556789999999999999999999999988 889999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
++|.+++..... ..+++...+.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999865421 4689999999999999999999998 99999999999999999999999999998654422221
Q ss_pred --eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 760 --SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 760 --~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
.....++..|+|||++....++.++|||||||++|||++ |+.||...... .+...... .+...
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~~~~---~~~~~------- 220 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS----QILKKIDK---EGERL------- 220 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHHh---cCCcC-------
Confidence 122346789999999998899999999999999999998 99998654311 12111111 11000
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 874 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~ 874 (927)
..+......+.+++.+|++.+|++||++.||++.|.
T Consensus 221 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 --ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred --CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 001122346889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=309.53 Aligned_cols=248 Identities=30% Similarity=0.462 Sum_probs=202.5
Q ss_pred HHHHhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
.+.+.+.||+|+||.||+|... ++.||+|.+..... ..+++.+|+.++++++|+||+++++++......++||||+++
T Consensus 7 ~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 7 ELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred hccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 4456789999999999999876 88999999976544 466789999999999999999999999989999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
++|.+++... ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||.++.......
T Consensus 85 ~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 85 GSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 9999998543 123689999999999999999999998 999999999999999999999999999986533221
Q ss_pred eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCcccC
Q 002409 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 838 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 838 (927)
....+..|+|||++..+.++.++||||||++++||++ |+.||..... ..+...... +.. .
T Consensus 158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~~~~~~----~~~---------~ 218 (256)
T cd05039 158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVVPHVEK----GYR---------M 218 (256)
T ss_pred --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH----HHHHHHHhc----CCC---------C
Confidence 2234678999999988889999999999999999997 9999865431 122221111 100 0
Q ss_pred ccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHH
Q 002409 839 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 875 (927)
Q Consensus 839 ~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~ 875 (927)
..+......+.+++.+|+..+|++||++.|+++.|+.
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 0111223568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=308.59 Aligned_cols=249 Identities=25% Similarity=0.354 Sum_probs=197.6
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc-----hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-----QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 674 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~-----~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~ 674 (927)
+.+.+.||+|++|.||++... +++.+|+|.+..... .....+.+|++++++++||||+++++++...+..++|+
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 83 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM 83 (263)
T ss_pred ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence 345689999999999999865 688999999864321 12346888999999999999999999999999999999
Q ss_pred EeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccC
Q 002409 675 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 754 (927)
Q Consensus 675 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 754 (927)
||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++....
T Consensus 84 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 84 EYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 99999999998843 34578888899999999999999998 999999999999999999999999999875433
Q ss_pred CCCcee--eeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCccccc
Q 002409 755 GASHVS--SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 832 (927)
Q Consensus 755 ~~~~~~--~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 832 (927)
...... ....|+..|+|||.+.+..++.++||||||+++|||++|+.||....... .... ......
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~---~~~~~~----- 224 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA----AIFK---IATQPT----- 224 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH----HHHH---HhccCC-----
Confidence 221111 23457889999999999889999999999999999999999986543111 1111 100000
Q ss_pred CCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 833 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 833 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
....+......+.+++.+|+..+|++||++.|++++
T Consensus 225 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 225 ----NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ----CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 011112233468899999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=307.24 Aligned_cols=263 Identities=23% Similarity=0.362 Sum_probs=198.3
Q ss_pred HHhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhc--cCCCccceecceeecC----eEEEEEE
Q 002409 602 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI--HHRNLVQFLGYCQEEG----RSVLVYE 675 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l--~HpnIv~l~g~~~~~~----~~~lV~E 675 (927)
.+.+.||+|.||.||+|+++ |+.||||++... +++.+.+|.++++.+ +|+||+.+++.-..+. .++||++
T Consensus 214 ~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTd 289 (513)
T KOG2052|consen 214 VLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTD 289 (513)
T ss_pred EEEEEecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeee
Confidence 45788999999999999998 999999998744 356678888888875 9999999999875543 5799999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhC-----CCCceecCCCCCCCeEECCCCcEEEEeecCcc
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG-----CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 750 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-----~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 750 (927)
|.+.|||.|||. ...++....++++..+|.||+|||.. ..|.|.|||||+.|||+..++.+.|+|+|||.
T Consensus 290 YHe~GSL~DyL~-----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv 364 (513)
T KOG2052|consen 290 YHEHGSLYDYLN-----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 364 (513)
T ss_pred cccCCcHHHHHh-----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence 999999999994 35688899999999999999999963 34799999999999999999999999999997
Q ss_pred cccCCCC---ceeeeeccCCCccCccccccCc------CCCccceeeHHHHHHHHHhC----------CCcccccccccc
Q 002409 751 FAVDGAS---HVSSIVRGTVGYLDPEYYISQQ------LTDKSDVYSFGVILLELISG----------QEAISNEKFGAN 811 (927)
Q Consensus 751 ~~~~~~~---~~~~~~~gt~~Y~aPE~~~~~~------~s~~sDVwSlGvvL~elltG----------~~p~~~~~~~~~ 811 (927)
....... ......+||.+|||||++...- --..+||||||.|+||+... +.||.+.-..+-
T Consensus 365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP 444 (513)
T KOG2052|consen 365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP 444 (513)
T ss_pred EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC
Confidence 6544322 2234567999999999996432 12368999999999999863 234432110000
Q ss_pred cchhhHHHHhhhccCCcccccCCcccC-ccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHHH
Q 002409 812 CRNIVQWAKLHIESGDIQGIIDPSLLD-EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 880 (927)
Q Consensus 812 ~~~l~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~~ 880 (927)
+..+ +++---.+.+.|.+.. ..+.+.+..+.+++..|+..+|..|-|+--|.+.|.++.+.+
T Consensus 445 --s~ee-----MrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~ 507 (513)
T KOG2052|consen 445 --SFEE-----MRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSD 507 (513)
T ss_pred --CHHH-----HhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcCh
Confidence 0000 0000000111111111 123577888999999999999999999999999999886533
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=311.40 Aligned_cols=256 Identities=22% Similarity=0.351 Sum_probs=202.1
Q ss_pred HHHHHhccccccCceEEEEEEECCC----cEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEE
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLKDG----KEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 673 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~~g----~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV 673 (927)
..+.+.+.||+|+||.||+|.+.+. ..||||...... ....+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 4455678999999999999986532 468999887554 3445678999999999999999999998875 456899
Q ss_pred EEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccccc
Q 002409 674 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 753 (927)
Q Consensus 674 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 753 (927)
|||+++|+|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 85 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 85 MELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecc
Confidence 9999999999998542 23588999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCccccc
Q 002409 754 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 832 (927)
Q Consensus 754 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 832 (927)
...........++..|+|||.+....++.++|||||||+++||++ |+.||...... ....+.. .+...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~----~~~~~~~----~~~~~--- 227 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN----DVIGRIE----NGERL--- 227 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHH----cCCcC---
Confidence 432222222334568999999988889999999999999999986 99999754421 1112111 11100
Q ss_pred CCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 833 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 833 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
. .+......+.+++.+|+..+|++||++.|+++.|+++..
T Consensus 228 --~----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 228 --P----MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred --C----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0 111223468899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=307.65 Aligned_cols=247 Identities=29% Similarity=0.433 Sum_probs=196.8
Q ss_pred ccccccCceEEEEEEECC----CcEEEEEEeecCCc-hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 605 KKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~~----g~~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
++||+|+||.||+|++.. +..+|+|.+..... ...+++.+|+++++++.|+||+++++++.. ...++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence 469999999999997542 26899999876543 345678999999999999999999998764 467999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
|+|.+++... ..+++..++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 9999998532 3688999999999999999999998 99999999999999999999999999998654433222
Q ss_pred ee--eeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 760 SS--IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 760 ~~--~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
.. ...++..|+|||.+....++.++|||||||++|||++ |+.||..... ..+..+... +...
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~----~~~~~~~~~----~~~~------- 217 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG----AEVIAMLES----GERL------- 217 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH----HHHHHHHHc----CCcC-------
Confidence 11 1223568999999998899999999999999999998 9999975431 122222221 1100
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 876 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~ 876 (927)
..+......+.+++.+|+..+|++||++.+|++.|+++
T Consensus 218 --~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 218 --PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred --CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 01112234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=309.14 Aligned_cols=250 Identities=30% Similarity=0.533 Sum_probs=200.1
Q ss_pred HHHhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCC
Q 002409 601 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 680 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 680 (927)
+.+.+.||+|+||.||++.+.+++.+|+|.++.... ....+.+|++++++++|||++++++++......++|+||++++
T Consensus 6 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (256)
T cd05112 6 LTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHG 84 (256)
T ss_pred eEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCC
Confidence 345688999999999999887788999998864432 3457889999999999999999999999999999999999999
Q ss_pred chhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCcee
Q 002409 681 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 760 (927)
Q Consensus 681 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 760 (927)
+|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++..........
T Consensus 85 ~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 85 CLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred cHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 999988532 24578899999999999999999998 999999999999999999999999999875543322212
Q ss_pred eeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCcccCc
Q 002409 761 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 839 (927)
Q Consensus 761 ~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 839 (927)
....++.+|+|||.+.++.++.++||||||+++|||++ |+.||...... .+.+.. .++. ....+..
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~----~~~~~~----~~~~--~~~~~~~--- 225 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS----EVVETI----NAGF--RLYKPRL--- 225 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH----HHHHHH----hCCC--CCCCCCC---
Confidence 22235678999999998899999999999999999998 99998654311 122211 1110 1111111
Q ss_pred cCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHH
Q 002409 840 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 874 (927)
Q Consensus 840 ~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~ 874 (927)
....+.+++.+|++.+|++||++.||+++|.
T Consensus 226 ----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 ----ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ----CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1246889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=317.53 Aligned_cols=261 Identities=25% Similarity=0.438 Sum_probs=203.6
Q ss_pred HHHHHHhccccccCceEEEEEEEC--------CCcEEEEEEeecCC-chhhHhHHHHHHHHhhc-cCCCccceecceeec
Q 002409 598 DATKMLEKKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE 667 (927)
Q Consensus 598 ~~~~~~~~~IG~G~fG~Vy~~~~~--------~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~ 667 (927)
...+.+.+.||+|+||.||+++.. ....+|+|+++... ......+..|+++++++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 345567899999999999999752 24568999887543 23345688999999999 699999999999999
Q ss_pred CeEEEEEEeccCCchhhhccccc------------ccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEE
Q 002409 668 GRSVLVYEFMHNGTLKEHLYGTL------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL 735 (927)
Q Consensus 668 ~~~~lV~E~~~~gsL~~~L~~~~------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl 735 (927)
+..+++|||+++|+|.+++.... .....+++.++..++.|++.||+|||++ +++||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEE
Confidence 99999999999999999985432 1234588999999999999999999998 99999999999999
Q ss_pred CCCCcEEEEeecCcccccCCCCce-eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccc
Q 002409 736 DKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCR 813 (927)
Q Consensus 736 ~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~ 813 (927)
+.++.+||+|||+++......... .....++..|+|||.+....++.++|||||||++|||++ |..||......
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~---- 243 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE---- 243 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH----
Confidence 999999999999997554322111 111224567999999998899999999999999999999 88888654311
Q ss_pred hhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 814 NIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 814 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
.+... ...+... ..+.....++.+++.+|++.+|++||++.|+++.|+++..
T Consensus 244 ~~~~~----~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 244 ELFKL----LREGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HHHHH----HHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 11111 1111111 1112223467899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=315.04 Aligned_cols=260 Identities=23% Similarity=0.413 Sum_probs=201.6
Q ss_pred HHHHHHhccccccCceEEEEEEEC------CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeE
Q 002409 598 DATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS 670 (927)
Q Consensus 598 ~~~~~~~~~IG~G~fG~Vy~~~~~------~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~ 670 (927)
..++.+.+.||+|+||.||+|..+ .+..||+|.+.... ......+.+|+.++++++||||+++++++......
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 456667889999999999999754 24579999876443 22345678899999999999999999999999999
Q ss_pred EEEEEeccCCchhhhcccccc------cccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEE
Q 002409 671 VLVYEFMHNGTLKEHLYGTLT------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 744 (927)
Q Consensus 671 ~lV~E~~~~gsL~~~L~~~~~------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~ 744 (927)
++||||+++|+|.+++..... ....+.+..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEEC
Confidence 999999999999999964321 123456778889999999999999998 99999999999999999999999
Q ss_pred eecCcccccCCCCc-eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhh
Q 002409 745 DFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLH 822 (927)
Q Consensus 745 DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~ 822 (927)
|||+++........ ......++..|+|||.+.++.++.++|||||||++|||++ |..||...... .+... .
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~----~~~~~---~ 234 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE----QVLKF---V 234 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHH---H
Confidence 99998754332211 1122235678999999998899999999999999999998 78888643311 11111 1
Q ss_pred hccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHH
Q 002409 823 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 877 (927)
Q Consensus 823 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~ 877 (927)
. .+.... .+......+.+++.+|++.+|++||++.|+++.|++.+
T Consensus 235 ~-~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 235 M-DGGYLD---------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred H-cCCCCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 1 111110 01112347899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=308.95 Aligned_cols=252 Identities=31% Similarity=0.471 Sum_probs=199.3
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhH--hHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKR--EFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~--~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
.+.+.||+|+||+||+++.. +++.+|+|++......... ...+|+.++++++||||+++++++......++||||+.
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~ 81 (260)
T PF00069_consen 2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCP 81 (260)
T ss_dssp EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEET
T ss_pred EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccc
Confidence 35678999999999999887 4568999999876543322 34569999999999999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
+++|.+++. ....+++..++.++.|+++||.+||+. +++|+||||+||+++.++.++|+|||.+.... ....
T Consensus 82 ~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~ 153 (260)
T PF00069_consen 82 GGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNE 153 (260)
T ss_dssp TEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTS
T ss_pred ccccccccc----ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-cccc
Confidence 999999985 456789999999999999999999998 99999999999999999999999999987542 2223
Q ss_pred eeeeeccCCCccCccccc-cCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCccc
Q 002409 759 VSSIVRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 837 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~-~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 837 (927)
......++..|+|||.+. ...++.++||||+|+++++|++|..||...........+.+-........ ..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~ 224 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSS---------SQ 224 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHH---------TT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccc---------cc
Confidence 334456899999999998 78899999999999999999999999986521111111111111000000 00
Q ss_pred CccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 838 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 838 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
. .......+.+++.+|++.+|++||++.|++++
T Consensus 225 ~--~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 225 Q--SREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp S--HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred c--cchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00112579999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=320.67 Aligned_cols=251 Identities=28% Similarity=0.389 Sum_probs=209.1
Q ss_pred HHHHHHhccccccCceEEEEEEECC-CcEEEEEEeecCCch---hhHhHHHHHHHHhhcc-CCCccceecceeecCeEEE
Q 002409 598 DATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVL 672 (927)
Q Consensus 598 ~~~~~~~~~IG~G~fG~Vy~~~~~~-g~~VAVK~l~~~~~~---~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~~~~l 672 (927)
...|.+.+.||+|.||.||+++.+. |+.+|+|++.+.... ....+.+|+++|+++. ||||+.+.+.+......++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 3456667899999999999998874 999999999876443 3458999999999998 9999999999999999999
Q ss_pred EEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCC----CcEEEEeecC
Q 002409 673 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH----MRAKVSDFGL 748 (927)
Q Consensus 673 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~----~~vkL~DFGl 748 (927)
|||++.||.|.+.+... .+++..+..++.|++.++.|||+. +|+||||||+|+|+... +.+|++|||+
T Consensus 114 vmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 99999999999998544 289999999999999999999998 99999999999999643 5799999999
Q ss_pred cccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCc
Q 002409 749 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 828 (927)
Q Consensus 749 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 828 (927)
+..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||......+.... +..+++
T Consensus 186 a~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~--------i~~~~~ 255 (382)
T KOG0032|consen 186 AKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLA--------ILRGDF 255 (382)
T ss_pred ceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHH--------HHcCCC
Confidence 987655 4455667899999999999999999999999999999999999999987663333221 222222
Q ss_pred ccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 829 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 829 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
+ ++ .++-......+.+++..|+..||.+|+++.++++|
T Consensus 256 -~-f~----~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 -D-FT----SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -C-CC----CCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 1 11 11112223467899999999999999999999996
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=308.18 Aligned_cols=254 Identities=27% Similarity=0.344 Sum_probs=191.4
Q ss_pred ccccccCceEEEEEEECC---CcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCC
Q 002409 605 KKIGSGGFGVVYYGKLKD---GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 680 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~~---g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 680 (927)
+.||+|+||.||+|.+.+ +..+|+|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998653 4578999887543 233457889999999999999999999999999999999999999
Q ss_pred chhhhcccccc-cccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 681 TLKEHLYGTLT-HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 681 sL~~~L~~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
+|.+++..... .....++..+..++.|++.||+|||+. +++||||||+||+++.++++||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999865322 223466778888999999999999998 99999999999999999999999999987543322111
Q ss_pred -eeeeccCCCccCccccccC-------cCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCccc
Q 002409 760 -SSIVRGTVGYLDPEYYISQ-------QLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQG 830 (927)
Q Consensus 760 -~~~~~gt~~Y~aPE~~~~~-------~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 830 (927)
.....++..|+|||++... .++.++|||||||++|||++ |+.||......+ ...... . +....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~----~~~~~~---~-~~~~~ 229 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ----VLTYTV---R-EQQLK 229 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH----HHHHHh---h-cccCC
Confidence 1234467889999998642 35789999999999999996 999996543211 111110 0 11111
Q ss_pred ccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHH
Q 002409 831 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 874 (927)
Q Consensus 831 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~ 874 (927)
..++.+... ....+.+++.+|+ .+|++|||+.||++.|+
T Consensus 230 ~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRLKLP----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCccCCC----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 122222211 1234677888898 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=312.24 Aligned_cols=256 Identities=25% Similarity=0.405 Sum_probs=200.3
Q ss_pred HHHHHhccccccCceEEEEEEEC-CCc----EEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEE
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLK-DGK----EIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 672 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~-~g~----~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~l 672 (927)
..+.+.++||+|+||+||+|++. +++ .||+|+++... ......+.+|+.+++.++|+||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence 34455688999999999999854 444 48999987543 33456788999999999999999999998754 4679
Q ss_pred EEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccc
Q 002409 673 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 752 (927)
Q Consensus 673 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 752 (927)
++||+++|+|.+++... ...+++..++.++.|++.||+|||++ +++||||||+|||+++++.+||+|||+++..
T Consensus 86 ~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 86 VTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeec
Confidence 99999999999998542 34688999999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCCce-eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCccc
Q 002409 753 VDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQG 830 (927)
Q Consensus 753 ~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 830 (927)
....... .....++..|+|||.+.+..++.++|||||||++|||++ |..||..... ..+..+... +....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~~~~----~~~~~ 231 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA----REIPDLLEK----GERLP 231 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHHC----CCcCC
Confidence 4332221 112234678999999998899999999999999999998 8899865431 122222221 11000
Q ss_pred ccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 831 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 831 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
.+......+.+++.+|++.+|++||++.|+++.|+++..
T Consensus 232 ---------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 232 ---------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred ---------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 011223468899999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=308.50 Aligned_cols=248 Identities=24% Similarity=0.380 Sum_probs=199.6
Q ss_pred HHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
..+...+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++......++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 34555678999999999999865 57889999987443 33356788999999999999999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
+++++|.+++.. ..+++..+..++.|+++||.|||++ +++|+||+|+||++++++.+||+|||++.......
T Consensus 84 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 84 LGGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred cCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 999999988742 4578889999999999999999998 99999999999999999999999999987554322
Q ss_pred CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 757 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
. ......|+..|+|||++.+..++.++|||||||+++||++|+.|+...... ....+ ...+. .+.+
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~----~~~~~----~~~~~-----~~~~ 221 (277)
T cd06642 156 I-KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM----RVLFL----IPKNS-----PPTL 221 (277)
T ss_pred h-hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh----hHHhh----hhcCC-----CCCC
Confidence 1 122345788999999999888999999999999999999999998643311 11111 11111 1111
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.......+.+++.+|++.+|++||+|.||+++
T Consensus 222 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 ----EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ----CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 12234568899999999999999999999986
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=304.45 Aligned_cols=247 Identities=32% Similarity=0.456 Sum_probs=198.0
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeecCCch-hhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCCchh
Q 002409 605 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK 683 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~ 683 (927)
++||+|+||.||++...+++.||+|.++..... ....+.+|++++++++|+||+++++++......++||||+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 468999999999999877999999998765433 4567899999999999999999999999999999999999999999
Q ss_pred hhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCcee-ee
Q 002409 684 EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS-SI 762 (927)
Q Consensus 684 ~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~-~~ 762 (927)
+++... ...+++..++.++.+++.+|+|||++ +++||||||+|||++.++.+||+|||+++.......... ..
T Consensus 81 ~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 988542 23578889999999999999999998 999999999999999999999999999875432221111 12
Q ss_pred eccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCcccCccC
Q 002409 763 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD 841 (927)
Q Consensus 763 ~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 841 (927)
..++..|+|||.+.++.++.++|+|||||++|||++ |..||...... ........ +. ....+
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~----~~~~~~~~----~~---------~~~~~ 217 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ----QTRERIES----GY---------RMPAP 217 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH----HHHHHHhc----CC---------CCCCC
Confidence 224567999999988899999999999999999999 88888654311 11111111 00 00011
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHH
Q 002409 842 IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 874 (927)
Q Consensus 842 ~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~ 874 (927)
......+.+++.+|+..+|++||++.||++.|+
T Consensus 218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 122346889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=314.13 Aligned_cols=249 Identities=24% Similarity=0.353 Sum_probs=200.1
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
.+.+.+.||+|+||.||+|+.. +++.||+|.+..........+.+|+.++++++|+||+++++.+......++||||++
T Consensus 21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~ 100 (296)
T cd06654 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (296)
T ss_pred ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccC
Confidence 3445678999999999999864 688999999876655556778899999999999999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
+++|.+++.. ..+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.........
T Consensus 101 ~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 172 (296)
T cd06654 101 GGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (296)
T ss_pred CCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence 9999998842 3478889999999999999999998 9999999999999999999999999998754332211
Q ss_pred eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccC
Q 002409 759 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 838 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 838 (927)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||...... ..+..+ ...+. .. +
T Consensus 173 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~---~~~~~~----~~~~~-~~-----~-- 236 (296)
T cd06654 173 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL---RALYLI----ATNGT-PE-----L-- 236 (296)
T ss_pred -cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH---HhHHHH----hcCCC-CC-----C--
Confidence 22345889999999999888999999999999999999999999754311 111111 11110 00 0
Q ss_pred ccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 839 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 839 ~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
..+......+.+++.+|+..+|++||++.||+++
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 0111223457899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=319.58 Aligned_cols=239 Identities=23% Similarity=0.303 Sum_probs=189.8
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhcc-CCCccceecceeecCeEEEEEEe
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
++.+.||+|+||.||+++.. +++.||+|++.... ....+.+..|..+++.+. |++|+++++++...+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey 82 (323)
T cd05615 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEY 82 (323)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcC
Confidence 45678999999999999876 68899999987542 223355777888888875 57788899999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 83 VNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 999999988843 35688999999999999999999998 99999999999999999999999999987432221
Q ss_pred CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 757 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.+.... +..
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~----~~~~~i~~----~~~-------- 218 (323)
T cd05615 156 -VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED----ELFQSIME----HNV-------- 218 (323)
T ss_pred -ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHHh----CCC--------
Confidence 1223345899999999999889999999999999999999999999765421 12221111 110
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCCcH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPSI 866 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm 866 (927)
.++......+.+++.+|++.+|++|++.
T Consensus 219 --~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 --SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred --CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 0111122467899999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=307.21 Aligned_cols=250 Identities=23% Similarity=0.337 Sum_probs=198.1
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
+.+.+.||+|+||.||+|... ++..+++|.+..........+.+|+++++.++||||+++++++...+..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 566788999999999999876 4678899988765555566788999999999999999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
++|.+++... ...+++..+..++.|+++||.|||+. +++||||||+|||++.++.+||+|||++....... ..
T Consensus 87 ~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~ 159 (282)
T cd06643 87 GAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 159 (282)
T ss_pred CcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-cc
Confidence 9998887532 34688999999999999999999998 99999999999999999999999999987543322 12
Q ss_pred eeeeccCCCccCccccc-----cCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCC
Q 002409 760 SSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 834 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~-----~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 834 (927)
.....++..|+|||++. ...++.++|||||||++|||++|+.||......+ .+..... ........
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~~~~~~-----~~~~~~~~- 230 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR---VLLKIAK-----SEPPTLAQ- 230 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH---HHHHHhh-----cCCCCCCC-
Confidence 23345899999999984 3457789999999999999999999986543111 1111111 00000000
Q ss_pred cccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 835 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 835 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
+......+.+++.+|++.+|++||++.+++++
T Consensus 231 ------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 231 ------PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11122468899999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=307.23 Aligned_cols=239 Identities=21% Similarity=0.379 Sum_probs=187.5
Q ss_pred ccccccCceEEEEEEECC-------------CcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEE
Q 002409 605 KKIGSGGFGVVYYGKLKD-------------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 671 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~~-------------g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~ 671 (927)
+.||+|+||.||+|++.. ...|++|++..........+.+|+.++++++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998542 2258889876554444567888999999999999999999999999999
Q ss_pred EEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCc-------EEEE
Q 002409 672 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR-------AKVS 744 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~-------vkL~ 744 (927)
+||||+++|+|..++... ...+++..++.++.|+++||+|||++ +|+||||||+|||++.++. +|++
T Consensus 81 lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 999999999998887532 34588999999999999999999998 9999999999999987664 8999
Q ss_pred eecCcccccCCCCceeeeeccCCCccCccccc-cCcCCCccceeeHHHHHHHHH-hCCCcccccccccccchhhHHHHhh
Q 002409 745 DFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELI-SGQEAISNEKFGANCRNIVQWAKLH 822 (927)
Q Consensus 745 DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~~sDVwSlGvvL~ell-tG~~p~~~~~~~~~~~~l~~~~~~~ 822 (927)
|||++...... ....++..|+|||.+. ...++.++|||||||++|||+ .|+.|+......+ ...
T Consensus 155 d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~----~~~----- 220 (262)
T cd05077 155 DPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE----KER----- 220 (262)
T ss_pred CCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH----HHH-----
Confidence 99998644321 1234788999999886 467899999999999999998 5888876433111 000
Q ss_pred hccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHH
Q 002409 823 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 873 (927)
Q Consensus 823 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L 873 (927)
...+... .. ......+.+++.+|++.+|++||++.||++++
T Consensus 221 ~~~~~~~------~~----~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 221 FYEGQCM------LV----TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HHhcCcc------CC----CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0011100 00 11234678999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=307.12 Aligned_cols=248 Identities=25% Similarity=0.346 Sum_probs=194.8
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++...+..++||||+++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 83 (279)
T cd06619 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDG 83 (279)
T ss_pred hheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCC
Confidence 45678999999999999864 68899999987542 33456788999999999999999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
++|..+ ..+++..+..++.|++.||+|||+. +|+|+||||+|||++.++.+||+|||++.......
T Consensus 84 ~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--- 149 (279)
T cd06619 84 GSLDVY--------RKIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--- 149 (279)
T ss_pred CChHHh--------hcCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---
Confidence 998654 2357778889999999999999998 99999999999999999999999999987543321
Q ss_pred eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCc
Q 002409 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 839 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 839 (927)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||..............+........ .+.+..
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~- 222 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED------PPVLPV- 222 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC------CCCCCC-
Confidence 2234589999999999988999999999999999999999999965331111111111111111000 011100
Q ss_pred cCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 840 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 840 ~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.....++.+++.+|++.+|++||++.|++++
T Consensus 223 --~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 223 --GQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred --CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1122357899999999999999999999887
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=323.67 Aligned_cols=245 Identities=26% Similarity=0.400 Sum_probs=200.6
Q ss_pred cccccCceEEEEEEECC-CcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCCchhh
Q 002409 606 KIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKE 684 (927)
Q Consensus 606 ~IG~G~fG~Vy~~~~~~-g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~ 684 (927)
+||+|.||+||.|++.+ ...+|||-+..........+.+|+.+.++++|+|||+++|.|.+.+..-+.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999999774 45789999987766667789999999999999999999999999999999999999999999
Q ss_pred hccccccccccc--CHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECC-CCcEEEEeecCcccccCCCCceee
Q 002409 685 HLYGTLTHEQRI--NWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLSKFAVDGASHVSS 761 (927)
Q Consensus 685 ~L~~~~~~~~~l--~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~ 761 (927)
+|+... +++ ++.+.-.+..||++||.|||++ .|||||||-.|||++. .|.+||+|||.++.... ....+.
T Consensus 662 LLrskW---GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TE 734 (1226)
T KOG4279|consen 662 LLRSKW---GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTE 734 (1226)
T ss_pred HHHhcc---CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc-CCcccc
Confidence 997543 333 6677778899999999999999 9999999999999974 68999999999986533 344556
Q ss_pred eeccCCCccCccccccC--cCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCc
Q 002409 762 IVRGTVGYLDPEYYISQ--QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 839 (927)
Q Consensus 762 ~~~gt~~Y~aPE~~~~~--~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 839 (927)
++.||..|||||++..+ .|..++|||||||.+.||.||++||-....+.....-+...+ + .+.
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyK-----------v----HP~ 799 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYK-----------V----HPP 799 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhccee-----------c----CCC
Confidence 67799999999999764 689999999999999999999999975442221111111000 1 123
Q ss_pred cCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 840 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 840 ~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.+.+...+....+.+|+.++|.+||+++++++.
T Consensus 800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred CcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 344555678899999999999999999999864
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=318.36 Aligned_cols=253 Identities=22% Similarity=0.280 Sum_probs=193.3
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
|.+.+.||+|+||.||+++.. +++.||+|++.... ......+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (331)
T cd05597 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY 82 (331)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence 345688999999999999876 58899999987431 22345588899999999999999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
+++|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 83 YVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred CCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 9999999998532 34688889999999999999999998 99999999999999999999999999987554433
Q ss_pred CceeeeeccCCCccCcccccc-----CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccc
Q 002409 757 SHVSSIVRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 831 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~-----~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 831 (927)
........||+.|+|||++.. ..++.++|||||||++|||++|+.||......+....+ ........
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i-------~~~~~~~~- 228 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI-------MNHKEHFQ- 228 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHH-------HcCCCccc-
Confidence 333333569999999999863 45788999999999999999999999754321111111 11110000
Q ss_pred cCCcccCccCHHHHHHHHHHHhhhcC--CCCCCCCcHHHHHHH
Q 002409 832 IDPSLLDEYDIQSMWKIEEKALMCVL--PHGHMRPSISEVLKD 872 (927)
Q Consensus 832 ~d~~l~~~~~~~~~~~l~~L~~~Cl~--~dP~~RPsm~eV~~~ 872 (927)
+.+. .......+.+++.+|+. .++..||++.+++++
T Consensus 229 ~~~~-----~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 FPPD-----VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCCc-----cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0000 01122346667777664 444458899999988
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=314.04 Aligned_cols=256 Identities=25% Similarity=0.437 Sum_probs=201.2
Q ss_pred HHHHhccccccCceEEEEEEEC------CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 672 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~------~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~l 672 (927)
.+.+.+.||+|+||.||++..+ +++.||+|+++... .....++.+|+.++++++||||+++++++......++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~l 85 (288)
T cd05050 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCL 85 (288)
T ss_pred hceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEE
Confidence 3456688999999999999864 46789999987543 3345678999999999999999999999999999999
Q ss_pred EEEeccCCchhhhccccc------------------ccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeE
Q 002409 673 VYEFMHNGTLKEHLYGTL------------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL 734 (927)
Q Consensus 673 V~E~~~~gsL~~~L~~~~------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIL 734 (927)
++||+++|+|.+++.... .....+++..++.++.|++.||+|||+. +++||||||+||+
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil 162 (288)
T cd05050 86 LFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCL 162 (288)
T ss_pred EEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhheE
Confidence 999999999999986421 1123578889999999999999999998 9999999999999
Q ss_pred ECCCCcEEEEeecCcccccCCCC-ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCccccccccccc
Q 002409 735 LDKHMRAKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANC 812 (927)
Q Consensus 735 l~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~ 812 (927)
++.++.+||+|||+++....... ........+..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 163 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~--- 239 (288)
T cd05050 163 VGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE--- 239 (288)
T ss_pred ecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---
Confidence 99999999999999875432221 11122234678999999988899999999999999999998 88888543311
Q ss_pred chhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHH
Q 002409 813 RNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 875 (927)
Q Consensus 813 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~ 875 (927)
.+... ...+.... .+.....++.+++.+|++.+|++||++.|+++.|++
T Consensus 240 -~~~~~----~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 -EVIYY----VRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -HHHHH----HhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 22221 12222211 011223468899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=311.66 Aligned_cols=249 Identities=28% Similarity=0.402 Sum_probs=197.0
Q ss_pred HhccccccCceEEEEEEEC-CCcEEEEEEeecCCc---hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 603 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 603 ~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
..+.||+|+||.||++... +++.+|||.+..... .....+.+|+.++++++|+|++++++.+...+..++||||++
T Consensus 4 ~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05630 4 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN 83 (285)
T ss_pred eeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecC
Confidence 4578999999999999876 688999999865422 223457789999999999999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
+++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++........
T Consensus 84 g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05630 84 GGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 157 (285)
T ss_pred CCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence 99999988542 234588999999999999999999998 999999999999999999999999999875433221
Q ss_pred eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccC
Q 002409 759 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 838 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 838 (927)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||................. . .. .
T Consensus 158 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~----~------~~----~ 222 (285)
T cd05630 158 -IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK----E------VQ----E 222 (285)
T ss_pred -ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhh----h------hh----h
Confidence 1234689999999999998999999999999999999999999975431111111111000 0 00 0
Q ss_pred ccCHHHHHHHHHHHhhhcCCCCCCCCc-----HHHHHHH
Q 002409 839 EYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 872 (927)
Q Consensus 839 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----m~eV~~~ 872 (927)
.+.......+.+++.+|++.+|++||+ +.|++++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 111122345789999999999999999 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=306.39 Aligned_cols=248 Identities=28% Similarity=0.444 Sum_probs=197.9
Q ss_pred HHHHhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceeccee-ecCeEEEEEEecc
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ-EEGRSVLVYEFMH 678 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~-~~~~~~lV~E~~~ 678 (927)
.+.+.+.||+|+||.||++... ++.+|+|.++... ..+.+.+|+.++++++|+|++++++++. ..+..++++||++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred hCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 4556789999999999999876 8889999986442 2456889999999999999999999764 4567899999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
+++|.+++... ....+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||+++......
T Consensus 84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 84 KGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 99999998543 233578999999999999999999998 99999999999999999999999999987543221
Q ss_pred eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCccc
Q 002409 759 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 837 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 837 (927)
....++..|+|||++....++.++|||||||++|||++ |+.||..... ..+..+... +.-.
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~----~~~~~~~~~----~~~~-------- 218 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVVPRVEK----GYKM-------- 218 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHhc----CCCC--------
Confidence 12235678999999988889999999999999999998 9999864331 122222211 1100
Q ss_pred CccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHH
Q 002409 838 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 876 (927)
Q Consensus 838 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~ 876 (927)
.........+.+++.+|++.+|++||++.++++.|+++
T Consensus 219 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 219 -DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 11112234688999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=310.02 Aligned_cols=239 Identities=23% Similarity=0.377 Sum_probs=187.0
Q ss_pred cccccCceEEEEEEECC-------------------------CcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccce
Q 002409 606 KIGSGGFGVVYYGKLKD-------------------------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQF 660 (927)
Q Consensus 606 ~IG~G~fG~Vy~~~~~~-------------------------g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l 660 (927)
.||+|+||.||+|.+.. ...|++|++..........+.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997521 13588998865544445678889999999999999999
Q ss_pred ecceeecCeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCC-
Q 002409 661 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM- 739 (927)
Q Consensus 661 ~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~- 739 (927)
+++|.+....++||||+++|+|..++... ...+++..+..++.|+++||+|||++ +|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE---KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence 99999999999999999999999888532 34678899999999999999999998 999999999999997643
Q ss_pred ------cEEEEeecCcccccCCCCceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHH-hCCCcccccccccc
Q 002409 740 ------RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELI-SGQEAISNEKFGAN 811 (927)
Q Consensus 740 ------~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~ell-tG~~p~~~~~~~~~ 811 (927)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||......+
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~- 229 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE- 229 (274)
T ss_pred ccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH-
Confidence 4899999987643221 12347888999998875 56889999999999999995 6899886543211
Q ss_pred cchhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHH
Q 002409 812 CRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 874 (927)
Q Consensus 812 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~ 874 (927)
...+.... ..+ ... ....+.+++.+|++.+|++||++.||++.|+
T Consensus 230 ---~~~~~~~~---~~~--------~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 ---KERFYEKK---HRL--------PEP----SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ---HHHHHHhc---cCC--------CCC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11111110 000 011 1135889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=302.56 Aligned_cols=252 Identities=22% Similarity=0.342 Sum_probs=198.5
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
.+.+.+.||+|+||.||+|+.. +++.||+|+++.........+.+|+.+++.++||||+++++.+...+..++|+||++
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 89 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCG 89 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Confidence 5567789999999999999865 688999999876654445668889999999999999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
+++|.+++.. ...+++.+++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++....... .
T Consensus 90 ~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~ 161 (267)
T cd06645 90 GGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-A 161 (267)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-c
Confidence 9999998743 34688999999999999999999998 99999999999999999999999999987543322 1
Q ss_pred eeeeeccCCCccCccccc---cCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCc
Q 002409 759 VSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 835 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~---~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 835 (927)
......|+..|+|||++. ...++.++|||||||++|||++|+.||....... .+..... .... .+.
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~---~~~~~~~-----~~~~---~~~ 230 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR---ALFLMTK-----SNFQ---PPK 230 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh---hHHhhhc-----cCCC---CCc
Confidence 123345899999999974 4568889999999999999999999986433111 1111000 0000 011
Q ss_pred ccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 836 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 836 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.... ......+.+++.+|++.+|++||++.+|+++
T Consensus 231 ~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 231 LKDK--MKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred cccc--CCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 1110 0112357899999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=306.67 Aligned_cols=254 Identities=25% Similarity=0.327 Sum_probs=188.2
Q ss_pred ccccccCceEEEEEEECC---CcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCC
Q 002409 605 KKIGSGGFGVVYYGKLKD---GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 680 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~~---g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 680 (927)
+.||+|+||.||+|+..+ ...+|+|.+.... ......+.+|+++++.++|+||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 358999999999997543 3468888776443 233456889999999999999999999999999999999999999
Q ss_pred chhhhccccccc-ccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc-
Q 002409 681 TLKEHLYGTLTH-EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH- 758 (927)
Q Consensus 681 sL~~~L~~~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~- 758 (927)
+|.+++...... ....++.....++.|++.||+|||++ +|+||||||+|||++.++++||+|||+++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999998654321 23456778889999999999999998 9999999999999999999999999998643322111
Q ss_pred eeeeeccCCCccCcccccc-------CcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCccc
Q 002409 759 VSSIVRGTVGYLDPEYYIS-------QQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQG 830 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~-------~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 830 (927)
......++..|+|||++.. ..++.++|||||||++|||++ |..||......+ .... ....+. ..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~----~~~~---~~~~~~-~~ 229 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ----VLKQ---VVREQD-IK 229 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH----HHHH---HhhccC-cc
Confidence 1122335678999999743 356789999999999999999 778886543111 1111 111111 11
Q ss_pred ccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHH
Q 002409 831 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 874 (927)
Q Consensus 831 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~ 874 (927)
..++.+.. .....+.+++..|+ .+|++||+++||++.|.
T Consensus 230 ~~~~~~~~----~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 230 LPKPQLDL----KYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCCcccc----cCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11122211 22234567777887 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=310.49 Aligned_cols=264 Identities=23% Similarity=0.317 Sum_probs=192.8
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc--hhhHhHHHHHHHHhhc---cCCCccceecceee-----cCe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRI---HHRNLVQFLGYCQE-----EGR 669 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~iL~~l---~HpnIv~l~g~~~~-----~~~ 669 (927)
|.+.+.||+|+||.||+|+.. +++.||+|.++.... .....+.+|+++++++ +||||+++++++.. ...
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 345678999999999999876 688999999875422 1234566777777665 69999999998754 345
Q ss_pred EEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCc
Q 002409 670 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 749 (927)
Q Consensus 670 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla 749 (927)
.+++|||+.+ +|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 82 ~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 82 VTLVFEHVDQ-DLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred EEEEEccccc-CHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcc
Confidence 7999999974 888877543 234588999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCC--
Q 002409 750 KFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD-- 827 (927)
Q Consensus 750 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~-- 827 (927)
+...... ......||..|+|||++.+..++.++||||+||++|||++|+.||......+....+..+.........
T Consensus 156 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07863 156 RIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233 (288)
T ss_pred ccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 7553321 122345799999999999889999999999999999999999999654422222222222111000000
Q ss_pred ---c-ccccCCccc---CccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 828 ---I-QGIIDPSLL---DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 828 ---~-~~~~d~~l~---~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
. ...+.+... .....+...++.+++.+|++.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 000000000 01111233467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=316.54 Aligned_cols=264 Identities=20% Similarity=0.290 Sum_probs=195.3
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc-hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
|.+.+.||+|+||.||+|+.+ +++.||+|.++.... .....+.+|++++++++||||+++++++..++..++||||++
T Consensus 8 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 87 (309)
T cd07872 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD 87 (309)
T ss_pred eEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC
Confidence 445688999999999999876 578899999875432 234467789999999999999999999999999999999997
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
+ +|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 88 ~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 159 (309)
T cd07872 88 K-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK- 159 (309)
T ss_pred C-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence 5 787777432 34578888999999999999999998 999999999999999999999999999875432221
Q ss_pred eeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhh-------hcc-CCcc
Q 002409 759 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH-------IES-GDIQ 829 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~-------~~~-~~~~ 829 (927)
......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+....... ... ....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 1223457899999999865 568899999999999999999999997654222111111100000 000 0000
Q ss_pred cccCCcccCc----cCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 830 GIIDPSLLDE----YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 830 ~~~d~~l~~~----~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
..-.+..... .......++.+++.+|++.+|++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 0000000000 001123457899999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=310.24 Aligned_cols=249 Identities=27% Similarity=0.364 Sum_probs=196.4
Q ss_pred HhccccccCceEEEEEEEC-CCcEEEEEEeecCCc---hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 603 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 603 ~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
..+.||+|+||+||++... +++.+|+|.+..... .....+.+|++++++++|+||+++.+.+..++..+++|||++
T Consensus 4 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05632 4 QYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMN 83 (285)
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEecc
Confidence 3467999999999999875 688999999865422 223457889999999999999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
+++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 157 (285)
T cd05632 84 GGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES- 157 (285)
T ss_pred CccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc-
Confidence 99999888543 234689999999999999999999998 999999999999999999999999999875433221
Q ss_pred eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccC
Q 002409 759 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 838 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 838 (927)
.....|+..|+|||++.+..++.++|+|||||++|||++|+.||........... .......+. .
T Consensus 158 -~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~----~~~~~~~~~--~-------- 222 (285)
T cd05632 158 -IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE----VDRRVLETE--E-------- 222 (285)
T ss_pred -ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHHhhhccc--c--------
Confidence 1234689999999999988999999999999999999999999975431111111 111111111 0
Q ss_pred ccCHHHHHHHHHHHhhhcCCCCCCCCc-----HHHHHHH
Q 002409 839 EYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 872 (927)
Q Consensus 839 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----m~eV~~~ 872 (927)
.+.......+.+++.+|++.+|++||+ +.|++++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 111122335789999999999999999 6666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=308.31 Aligned_cols=251 Identities=29% Similarity=0.430 Sum_probs=197.1
Q ss_pred ccccccCceEEEEEEECC-------CcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 605 KKIGSGGFGVVYYGKLKD-------GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~~-------g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
+.||+|+||.||+|+..+ ++.+|+|.+.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998653 2578999876543 23456788999999999999999999999999999999999
Q ss_pred ccCCchhhhcccccc---cccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCC-----cEEEEeecC
Q 002409 677 MHNGTLKEHLYGTLT---HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-----RAKVSDFGL 748 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-----~vkL~DFGl 748 (927)
+++++|.+++..... ....+++..++.++.|++.||+|||+. +++|+||||+||+++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999864322 224578899999999999999999998 999999999999999877 899999999
Q ss_pred cccccCCCC-ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccC
Q 002409 749 SKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESG 826 (927)
Q Consensus 749 a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~ 826 (927)
++....... .......++..|+|||++.++.++.++|||||||++|||++ |+.||...... ....... .+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~----~~~~~~~----~~ 229 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ----EVLQHVT----AG 229 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH----HHHHHHh----cC
Confidence 875433221 11122335688999999999999999999999999999998 99998644311 1222111 11
Q ss_pred CcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHH
Q 002409 827 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 875 (927)
Q Consensus 827 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~ 875 (927)
.. ..........+.+++.+|++.+|++||++.+|++.|++
T Consensus 230 ~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 230 GR---------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred Cc---------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 00 01111233568899999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=312.34 Aligned_cols=197 Identities=23% Similarity=0.377 Sum_probs=159.4
Q ss_pred hccccccCceEEEEEEEC---CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceee--cCeEEEEEEecc
Q 002409 604 EKKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVLVYEFMH 678 (927)
Q Consensus 604 ~~~IG~G~fG~Vy~~~~~---~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--~~~~~lV~E~~~ 678 (927)
.++||+|+||+||+|+.. +++.+|+|.+.... ....+.+|++++++++||||+++++++.. ....+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999865 45789999986442 23457889999999999999999998854 456789999986
Q ss_pred CCchhhhccccc-----ccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEE----CCCCcEEEEeecCc
Q 002409 679 NGTLKEHLYGTL-----THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLS 749 (927)
Q Consensus 679 ~gsL~~~L~~~~-----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl----~~~~~vkL~DFGla 749 (927)
+ +|.+++.... .....+++..+..++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4 7777764221 1223588899999999999999999998 99999999999999 45678999999999
Q ss_pred ccccCCCCc--eeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCccccc
Q 002409 750 KFAVDGASH--VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNE 806 (927)
Q Consensus 750 ~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~ 806 (927)
+........ ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 865432211 1233568999999999876 45889999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=305.79 Aligned_cols=253 Identities=25% Similarity=0.391 Sum_probs=198.9
Q ss_pred HHhccccccCceEEEEEEECC--CcEEEEEEeecCC----------chhhHhHHHHHHHHhh-ccCCCccceecceeecC
Q 002409 602 MLEKKIGSGGFGVVYYGKLKD--GKEIAVKVLTSNS----------YQGKREFTNEVTLLSR-IHHRNLVQFLGYCQEEG 668 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~~--g~~VAVK~l~~~~----------~~~~~~~~~Ei~iL~~-l~HpnIv~l~g~~~~~~ 668 (927)
.+.+.||+|+||.||+|.... ++.+|+|.+.... .....++..|+.++.+ ++||||+++++++...+
T Consensus 3 ~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 82 (269)
T cd08528 3 AVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEND 82 (269)
T ss_pred hhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCC
Confidence 456789999999999999875 6789999875321 1123456678888765 79999999999999999
Q ss_pred eEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecC
Q 002409 669 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 748 (927)
Q Consensus 669 ~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGl 748 (927)
..+++|||+++++|.+++.........+++..++.++.|++.||.|||+. .+++||||||+||+++.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 83 RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecccc
Confidence 99999999999999998854434456689999999999999999999963 1899999999999999999999999999
Q ss_pred cccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCc
Q 002409 749 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 828 (927)
Q Consensus 749 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 828 (927)
+....... ......|+..|++||.+.+..++.++||||||+++|||++|+.||...... ..... ..++..
T Consensus 161 ~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~----~~~~~----~~~~~~ 230 (269)
T cd08528 161 AKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML----SLATK----IVEAVY 230 (269)
T ss_pred eeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH----HHHHH----HhhccC
Confidence 97654432 223445889999999999888999999999999999999999998654311 11111 111111
Q ss_pred ccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHH
Q 002409 829 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 874 (927)
Q Consensus 829 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~ 874 (927)
.... . ......+.+++.+|++.+|++||++.||.++++
T Consensus 231 ~~~~----~----~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 231 EPLP----E----GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CcCC----c----ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1100 0 112246889999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=304.81 Aligned_cols=250 Identities=29% Similarity=0.450 Sum_probs=191.8
Q ss_pred ccccccCceEEEEEEEC----CCcEEEEEEeecC-CchhhHhHHHHHHHHhhccCCCccceeccee-ecCeEEEEEEecc
Q 002409 605 KKIGSGGFGVVYYGKLK----DGKEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ-EEGRSVLVYEFMH 678 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~----~g~~VAVK~l~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~-~~~~~~lV~E~~~ 678 (927)
+.||+|+||.||+|.+. +...+|+|.+... .......+.+|+.+++.++||||+++++++. .++..++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999864 2357999988543 2334567889999999999999999999875 4556789999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
+|+|.+++... ...+.+..++.++.|++.||+|||+. +++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999998542 23456778889999999999999998 9999999999999999999999999998754332111
Q ss_pred ---eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhC-CCcccccccccccchhhHHHHhhhccCCcccccCC
Q 002409 759 ---VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG-QEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 834 (927)
Q Consensus 759 ---~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG-~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 834 (927)
......++..|+|||++....++.++|||||||++|||++| ..||..... ..+.... ..+....
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~~~~~~----~~~~~~~---- 222 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS----FDITVYL----LQGRRLL---- 222 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHH----hcCCCCC----
Confidence 11123457789999999888999999999999999999995 455543321 1222211 1111000
Q ss_pred cccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHH
Q 002409 835 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 877 (927)
Q Consensus 835 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~ 877 (927)
.+......+.+++.+|++.+|++||++.||++.|+++.
T Consensus 223 -----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 223 -----QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred -----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 00112246889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=303.12 Aligned_cols=254 Identities=24% Similarity=0.347 Sum_probs=189.8
Q ss_pred ccccccCceEEEEEEECCCc---EEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCC
Q 002409 605 KKIGSGGFGVVYYGKLKDGK---EIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 680 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~~g~---~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 680 (927)
+.||+|+||.||+|+..++. .+++|.+.... ....+.+.+|+.+++.++||||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 35899999999999755433 45667665443 334567999999999999999999999999999999999999999
Q ss_pred chhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC-Cce
Q 002409 681 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA-SHV 759 (927)
Q Consensus 681 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~ 759 (927)
+|.+++..........++.....++.|+++||+|||+. +++||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999965433334567777889999999999999998 99999999999999999999999999986422211 111
Q ss_pred eeeeccCCCccCcccccc-------CcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccc
Q 002409 760 SSIVRGTVGYLDPEYYIS-------QQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 831 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~-------~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 831 (927)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||...... .+... ... +.....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~----~~~~~---~~~-~~~~~~ 229 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR----EVLNH---VIK-DQQVKL 229 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH----HHHHH---HHh-hccccc
Confidence 223457889999999753 245789999999999999997 56677543311 11111 111 112223
Q ss_pred cCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHH
Q 002409 832 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 874 (927)
Q Consensus 832 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~ 874 (927)
.++.+...++ ..+.+++..|+ .+|++||++.||++.|.
T Consensus 230 ~~~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 230 FKPQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 3444433333 35677888898 67999999999998774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=321.64 Aligned_cols=250 Identities=24% Similarity=0.377 Sum_probs=206.3
Q ss_pred HhccccccCceEEEEEEEC--CCc--EEEEEEeecCCch-hhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 603 LEKKIGSGGFGVVYYGKLK--DGK--EIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 603 ~~~~IG~G~fG~Vy~~~~~--~g~--~VAVK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
+.++||+|.||.|++|.|. .|+ .||||.++..... ...+|.+|+.+|.+|+|+|+++|+|+..+ ....||+|.+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 4578999999999999886 344 5899999876543 56789999999999999999999999988 6789999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
+.|+|.+.|++ .....|.......++.|||.||.||..+ ++|||||..+|+||-....+||+||||.+.+.....
T Consensus 193 plGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 193 PLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred ccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 99999999976 3456788889999999999999999998 999999999999999999999999999997765544
Q ss_pred cee--eeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCC
Q 002409 758 HVS--SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 834 (927)
Q Consensus 758 ~~~--~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 834 (927)
+.. ....-...|+|||.+..+.++.++|||+|||.+|||++ |..||.+... ..|++ .+|.
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g----~qIL~-------------~iD~ 330 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG----IQILK-------------NIDA 330 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH----HHHHH-------------hccc
Confidence 432 12234568999999999999999999999999999999 7788876541 12222 1222
Q ss_pred cccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHH
Q 002409 835 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 875 (927)
Q Consensus 835 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~ 875 (927)
.-+-..+..+.+.+.+++..|+..+|++||++..|.+.+-.
T Consensus 331 ~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 331 GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 22223345567789999999999999999999999865443
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=324.29 Aligned_cols=249 Identities=24% Similarity=0.355 Sum_probs=193.1
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
.+.+.||+|+||.||+++.. +++.||+|+++... ......+.+|+.++.+++|+||+++++.+.+.+..++||||+
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~ 83 (360)
T cd05627 4 ESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFL 83 (360)
T ss_pred eEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCC
Confidence 34578999999999999876 58899999997532 223456788999999999999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 84 PGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred CCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 99999998843 45688999999999999999999998 999999999999999999999999999864321100
Q ss_pred ----------------------------------ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcc
Q 002409 758 ----------------------------------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAI 803 (927)
Q Consensus 758 ----------------------------------~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~ 803 (927)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0012346999999999999999999999999999999999999999
Q ss_pred cccccccccchhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCc---HHHHHHH
Q 002409 804 SNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS---ISEVLKD 872 (927)
Q Consensus 804 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs---m~eV~~~ 872 (927)
...........+..|.. .+ .+.+ .. ....++.+++.+|+. +|++|++ +.|+++|
T Consensus 237 ~~~~~~~~~~~i~~~~~------~~--~~p~----~~--~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 237 CSETPQETYRKVMNWKE------TL--VFPP----EV--PISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCHHHHHHHHHcCCC------ce--ecCC----CC--CCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 76542222222222100 00 0111 00 012346677777664 9999985 6777766
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=293.66 Aligned_cols=246 Identities=27% Similarity=0.397 Sum_probs=197.9
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEeecCCc----hh----hHhHHHHHHHHhhc-cCCCccceecceeecCeEEEE
Q 002409 604 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY----QG----KREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLV 673 (927)
Q Consensus 604 ~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~----~~----~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~lV 673 (927)
.+.||+|..++|.++.++ .|++.|+|++..... +. .+.-..|+.+|+++ .||+|+++.+++..+...++|
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV 101 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV 101 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence 567999999999988765 688999999864321 11 23345799999998 699999999999999999999
Q ss_pred EEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccccc
Q 002409 674 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 753 (927)
Q Consensus 674 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 753 (927)
+|.|+.|.|.|+| ...-.++++...+|+.|+..|++|||.+ .|+||||||+|||++++.++||+|||.++...
T Consensus 102 Fdl~prGELFDyL----ts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 102 FDLMPRGELFDYL----TSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred hhhcccchHHHHh----hhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeeccC
Confidence 9999999999999 4567789999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCceeeeeccCCCccCcccccc------CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCC
Q 002409 754 DGASHVSSIVRGTVGYLDPEYYIS------QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 827 (927)
Q Consensus 754 ~~~~~~~~~~~gt~~Y~aPE~~~~------~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 827 (927)
++ ......+|||+|+|||.+.. ..|+..+|+|++||+||-|+.|.+||...+ +++.. ..+-+|.
T Consensus 175 ~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk------QmlML--R~ImeGk 244 (411)
T KOG0599|consen 175 PG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK------QMLML--RMIMEGK 244 (411)
T ss_pred Cc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH------HHHHH--HHHHhcc
Confidence 54 33456789999999999863 357889999999999999999999998655 22211 1111222
Q ss_pred cccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 828 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 828 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
+. .-.|. -.+......+|+.+|++.||.+|.|++|+++|
T Consensus 245 yq-F~spe-----Wadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 245 YQ-FRSPE-----WADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred cc-cCCcc-----hhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 11 00000 01222357799999999999999999999987
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=305.92 Aligned_cols=247 Identities=25% Similarity=0.377 Sum_probs=194.1
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCCch
Q 002409 604 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 682 (927)
Q Consensus 604 ~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 682 (927)
...||+|+||.||+|+.. ++..||+|.+........+.+.+|++++++++|+||+++++++...+..++|+||+++++|
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 92 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSL 92 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCH
Confidence 357999999999999865 5778999998766555667899999999999999999999999999999999999999999
Q ss_pred hhhccccccccccc--CHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECC-CCcEEEEeecCcccccCCCCce
Q 002409 683 KEHLYGTLTHEQRI--NWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 683 ~~~L~~~~~~~~~l--~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~-~~~vkL~DFGla~~~~~~~~~~ 759 (927)
.+++.... ..+ ++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||++........ .
T Consensus 93 ~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~-~ 165 (268)
T cd06624 93 SALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-C 165 (268)
T ss_pred HHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-c
Confidence 99986431 223 7788888999999999999998 9999999999999986 67999999999875433222 1
Q ss_pred eeeeccCCCccCccccccC--cCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCccc
Q 002409 760 SSIVRGTVGYLDPEYYISQ--QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 837 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~--~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 837 (927)
.....|++.|+|||++... .++.++||||||+++|||++|+.||...... ....+...... ..
T Consensus 166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~----~~~~~~~~~~~-----------~~ 230 (268)
T cd06624 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP----QAAMFKVGMFK-----------IH 230 (268)
T ss_pred cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh----hhhHhhhhhhc-----------cC
Confidence 2223478999999998654 3788999999999999999999998643211 11111111000 00
Q ss_pred CccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 838 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 838 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
...+.....++.+++.+|++.+|++||++.|++++
T Consensus 231 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 231 PEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred CCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 11122233468899999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=341.08 Aligned_cols=261 Identities=22% Similarity=0.310 Sum_probs=202.3
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc---hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
|.+.++||+|+||.||+|+.. +++.||+|+++.... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 4 YeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY 83 (932)
T PRK13184 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPY 83 (932)
T ss_pred eEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEc
Confidence 445688999999999999876 588999999875422 2345788999999999999999999999999999999999
Q ss_pred ccCCchhhhcccccc-------cccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCc
Q 002409 677 MHNGTLKEHLYGTLT-------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 749 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~-------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla 749 (927)
+++|+|.+++..... ....+++..++.++.|+++||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 84 ~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 84 IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred CCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCcc
Confidence 999999998854211 123466778899999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCC-----------------ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCccccccccccc
Q 002409 750 KFAVDGAS-----------------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANC 812 (927)
Q Consensus 750 ~~~~~~~~-----------------~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~ 812 (927)
+....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~--- 237 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR--- 237 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh---
Confidence 75521110 0111245999999999999999999999999999999999999999753311
Q ss_pred chhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCC-cHHHHHHHHHHHHHH
Q 002409 813 RNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP-SISEVLKDIQDAIVI 879 (927)
Q Consensus 813 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-sm~eV~~~L~~~~~~ 879 (927)
.+... ... .++.-... ..+....+.+++.+|++.+|++|| ++.++.+.|+..+..
T Consensus 238 -ki~~~--~~i--------~~P~~~~p-~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 238 -KISYR--DVI--------LSPIEVAP-YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred -hhhhh--hhc--------cChhhccc-cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 11110 000 00000000 012234678999999999999996 677888888887653
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=306.54 Aligned_cols=260 Identities=23% Similarity=0.316 Sum_probs=205.3
Q ss_pred HHHHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEE
Q 002409 597 EDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 674 (927)
Q Consensus 597 ~~~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~ 674 (927)
....+.+.+.||+|+||+||++... +++.+|+|++.... ....+.+.+|+++++.++||||+++++++......++||
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 3455677889999999999999866 58889999886543 334567899999999999999999999999999999999
Q ss_pred EeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccC
Q 002409 675 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 754 (927)
Q Consensus 675 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 754 (927)
||+++++|.+++.. ...+++..+..++.+++.||.|||+. .+++||||||+||+++.++.++|+|||++.....
T Consensus 83 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 83 EFMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred ecCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 99999999988743 34688999999999999999999974 2899999999999999999999999999864422
Q ss_pred CCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccc----cccchhhHHHHhhhccCCccc
Q 002409 755 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG----ANCRNIVQWAKLHIESGDIQG 830 (927)
Q Consensus 755 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~----~~~~~l~~~~~~~~~~~~~~~ 830 (927)
.. .....|+..|+|||++.+..++.++|||||||++|||++|+.||...... .....+..+........
T Consensus 157 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 229 (284)
T cd06620 157 SI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP---- 229 (284)
T ss_pred hc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc----
Confidence 21 12345899999999998889999999999999999999999999754421 11122223322222111
Q ss_pred ccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHH
Q 002409 831 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 874 (927)
Q Consensus 831 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~ 874 (927)
.+.+.. ......+.+++.+|++.+|++||++.||+++.-
T Consensus 230 --~~~~~~---~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 230 --PPRLPS---SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred --CCCCCc---hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 011111 113346889999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=308.26 Aligned_cols=262 Identities=25% Similarity=0.405 Sum_probs=202.6
Q ss_pred HHHHhccccccCceEEEEEEEC-----CCcEEEEEEeecCCch-hhHhHHHHHHHHhhccCCCccceecceee--cCeEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-----DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSV 671 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-----~g~~VAVK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--~~~~~ 671 (927)
.+.+.+.||+|+||.||++++. +++.+|||+++..... ....+.+|++++++++|+||+++++++.. ....+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4456688999999999999864 3678999999765443 46789999999999999999999999877 55789
Q ss_pred EEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccc
Q 002409 672 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 751 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 751 (927)
++|||+++++|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++..
T Consensus 85 lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 999999999999998543 23589999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCCce--eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCccccccccccc-------chhhHHHHhh
Q 002409 752 AVDGASHV--SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANC-------RNIVQWAKLH 822 (927)
Q Consensus 752 ~~~~~~~~--~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~-------~~l~~~~~~~ 822 (927)
........ .....++..|++||.+....++.++||||||++++||++|+.|+......... ..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 54322211 11223556799999998889999999999999999999999988643211100 0001111111
Q ss_pred hccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHH
Q 002409 823 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 876 (927)
Q Consensus 823 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~ 876 (927)
+..+. ....+.....++.+++.+|++.+|++||+|.||+++|+++
T Consensus 239 ~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGE---------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCC---------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11110 0011112235688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=317.33 Aligned_cols=253 Identities=22% Similarity=0.266 Sum_probs=194.1
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
+.+.+.||+|+||.||+++.. +++.||+|++.... ......+.+|..++..++|+||+++++++.+.+..++||||
T Consensus 3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey 82 (331)
T cd05624 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY 82 (331)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 345688999999999999876 57889999986431 22234578899999999999999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
+++|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 83 YVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred CCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999998532 34678888999999999999999998 99999999999999999999999999997654433
Q ss_pred CceeeeeccCCCccCcccccc-----CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccc
Q 002409 757 SHVSSIVRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 831 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~-----~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 831 (927)
........||+.|+|||++.+ +.++.++|||||||++|||++|+.||......+....+.. ....+.
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~------~~~~~~-- 228 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN------HEERFQ-- 228 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHc------CCCccc--
Confidence 323334569999999999875 4678899999999999999999999975442111111110 000000
Q ss_pred cCCcccCccCHHHHHHHHHHHhhhcCCCCCC--CCcHHHHHHH
Q 002409 832 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHM--RPSISEVLKD 872 (927)
Q Consensus 832 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~--RPsm~eV~~~ 872 (927)
+.+.. .....++.+++.+|+...+++ |+++.+++++
T Consensus 229 ~p~~~-----~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 229 FPSHI-----TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CCCcc-----ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 11111 112345778888888765544 5688888876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=305.15 Aligned_cols=250 Identities=24% Similarity=0.388 Sum_probs=194.4
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhc-cCCCccceecceeec------CeEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE------GRSV 671 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~------~~~~ 671 (927)
.+.+.+.||+|+||.||+|... +++.||+|++.... .....+..|+.+++++ +|+||+++++++... ...+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (272)
T cd06637 7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 85 (272)
T ss_pred hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEE
Confidence 4556678999999999999876 57889999986543 3356788999999998 799999999998653 4578
Q ss_pred EEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccc
Q 002409 672 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 751 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 751 (927)
++|||+.+++|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++.
T Consensus 86 iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 86 LVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred EEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 999999999999988542 234688999999999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCceeeeeccCCCccCccccc-----cCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccC
Q 002409 752 AVDGASHVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG 826 (927)
Q Consensus 752 ~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 826 (927)
..... .......|+..|+|||++. ...++.++|||||||++|||++|+.||...... ...... ...
T Consensus 161 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~------~~~~~~--~~~ 231 (272)
T cd06637 161 LDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------RALFLI--PRN 231 (272)
T ss_pred ccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH------HHHHHH--hcC
Confidence 43221 1223355899999999986 345788999999999999999999999643311 111000 000
Q ss_pred CcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 827 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 827 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.. +... .......+.+++.+|+..+|.+||++.|++++
T Consensus 232 ~~-----~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 232 PA-----PRLK---SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CC-----CCCC---CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 00 1111 11122467899999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=315.24 Aligned_cols=265 Identities=18% Similarity=0.257 Sum_probs=193.4
Q ss_pred Hhcccccc--CceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 603 LEKKIGSG--GFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 603 ~~~~IG~G--~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
+.++||+| +|++||+++.+ +|+.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 67899999775 68899999987542 233456788999999999999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
++|+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 9999999985432 23588999999999999999999998 999999999999999999999999986543221111
Q ss_pred c------eeeeeccCCCccCcccccc--CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhH-HHHhhhc----
Q 002409 758 H------VSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ-WAKLHIE---- 824 (927)
Q Consensus 758 ~------~~~~~~gt~~Y~aPE~~~~--~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~-~~~~~~~---- 824 (927)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||.............. .+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI 236 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence 0 1112346778999999976 4688999999999999999999999975331110000000 0000000
Q ss_pred --------------cCCccccc---------CCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 825 --------------SGDIQGII---------DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 825 --------------~~~~~~~~---------d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
+..+.+.. .......+.......+.+++.+|++.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 00000000 0000001112223468899999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=326.09 Aligned_cols=257 Identities=23% Similarity=0.297 Sum_probs=192.1
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
+.+.+.||+|+||.||++.+. .++.||||... ...+.+|+++|++++|+||+++++++...+..++|||++.
T Consensus 171 y~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~- 243 (461)
T PHA03211 171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR- 243 (461)
T ss_pred eEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-
Confidence 445688999999999999876 47889999643 2346789999999999999999999999999999999995
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC-c
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS-H 758 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~-~ 758 (927)
++|.+++... ...+++..++.++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 244 ~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 244 SDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 6888877432 34689999999999999999999998 999999999999999999999999999975433221 1
Q ss_pred eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccc-------cccchhhHHHHhhhccCCcccc
Q 002409 759 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG-------ANCRNIVQWAKLHIESGDIQGI 831 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~-------~~~~~l~~~~~~~~~~~~~~~~ 831 (927)
......||+.|+|||++.+..++.++|||||||+||||++|..++-..... .....++++..... ..+...
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~--~~~~~~ 395 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHV--DEFPQH 395 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccc--ccCCCC
Confidence 223456999999999999999999999999999999999988765322111 01112222211110 000000
Q ss_pred cCCcc------------cCccCH-------HHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 832 IDPSL------------LDEYDI-------QSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 832 ~d~~l------------~~~~~~-------~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
...++ ...+.. .....+.+|+.+|++.||++|||+.|++++
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000 000000 111257889999999999999999999986
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=301.63 Aligned_cols=249 Identities=25% Similarity=0.393 Sum_probs=200.7
Q ss_pred HHHHhccccccCceEEEEEEECC-CcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~~-g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
.+.+.+.||+|+||.||+|+..+ ++.+++|.++.... ..++.+|++++++++|+||+++++++......++++||+.
T Consensus 4 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred cchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 35567889999999999999874 78999999875432 6789999999999999999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
+++|.+++... ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||++........
T Consensus 82 ~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 82 AGSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 99999988532 35689999999999999999999998 999999999999999999999999999876543321
Q ss_pred eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccC
Q 002409 759 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 838 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 838 (927)
......++..|+|||++.+..++.++|||||||++|||++|+.||........ .... .... .+.+.
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~---~~~~-----~~~~-----~~~~~- 220 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA---IFMI-----PNKP-----PPTLS- 220 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh---hhhh-----ccCC-----CCCCC-
Confidence 22334578999999999988999999999999999999999999975431110 1000 0000 00000
Q ss_pred ccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 839 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 839 ~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.+......+.+++.+|++.+|++||++.||+++
T Consensus 221 -~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 221 -DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred -chhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 111222468899999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=328.95 Aligned_cols=255 Identities=26% Similarity=0.396 Sum_probs=207.4
Q ss_pred HHHHhccccccCceEEEEEEEC-CCc----EEEEEEeecC-CchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGK----EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 673 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~----~VAVK~l~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV 673 (927)
...-.++||+|+||+||+|.+- +|+ +||+|++... ..+...++.+|+.+|.+++|||+++++|+|..+. ..||
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 3344678999999999999753 443 5899998765 3455688999999999999999999999998776 7899
Q ss_pred EEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccccc
Q 002409 674 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 753 (927)
Q Consensus 674 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 753 (927)
++||+.|+|.++++.. +..+-....+.++.|||+||.|||++ +++||||.++|||+..-..+||.|||+++...
T Consensus 776 tq~mP~G~LlDyvr~h---r~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREH---RDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HHhcccchHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 9999999999999753 55677788899999999999999998 99999999999999999999999999999765
Q ss_pred CCCCcee-eeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccc
Q 002409 754 DGASHVS-SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 831 (927)
Q Consensus 754 ~~~~~~~-~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 831 (927)
....... ....-.+.|||-|.+....|+.++|||||||.+||++| |..|++.....+ | ...++.|+
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e----I----~dlle~ge---- 917 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE----I----PDLLEKGE---- 917 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH----h----hHHHhccc----
Confidence 5443332 23334678999999999999999999999999999999 889987655221 1 11222221
Q ss_pred cCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 832 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 832 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
+-..++.+...+..++.+|+..|++.||+++++.+.+.++..
T Consensus 918 -----RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 918 -----RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred -----cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 122234455578899999999999999999999999887754
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=302.32 Aligned_cols=248 Identities=21% Similarity=0.362 Sum_probs=199.0
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
.+.+.||+|+||.||+++.. +++.+|+|.++... ....+.+.+|+.++++++|+||+++++.+...+..+++|||+++
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 82 (255)
T cd08219 3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDG 82 (255)
T ss_pred eEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCC
Confidence 45688999999999999876 68899999986432 33456788899999999999999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
|+|.+++... ....++...++.++.|++.||.|||++ +++|+||||+||+++.++.++++|||+++...... ..
T Consensus 83 ~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~ 156 (255)
T cd08219 83 GDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-AY 156 (255)
T ss_pred CcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccc-cc
Confidence 9999887532 234578889999999999999999998 99999999999999999999999999987553322 12
Q ss_pred eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCc
Q 002409 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 839 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 839 (927)
.....|++.|+|||++.+..++.++|+||||+++|+|++|+.||...... .... ....+.... +
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~----~~~~----~~~~~~~~~-~------- 220 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK----NLIL----KVCQGSYKP-L------- 220 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH----HHHH----HHhcCCCCC-C-------
Confidence 23345889999999999888999999999999999999999999754311 1111 111121111 1
Q ss_pred cCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 840 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 840 ~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
+......+.+++.+|++.+|++||++.||+..
T Consensus 221 -~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 -PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11122357899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=303.37 Aligned_cols=247 Identities=22% Similarity=0.356 Sum_probs=201.1
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
.+...+.||.|+||.||+|... +++.||+|++.... ......+.+|++++++++|+||+++++++.+....++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4455678999999999999876 58899999987543 334567889999999999999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
++|+|.+++.. ..+++.....++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 85 GGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 99999998842 3578888999999999999999998 999999999999999999999999999975543321
Q ss_pred ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCccc
Q 002409 758 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 837 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 837 (927)
......++..|+|||++.+..++.++|+|||||++|||++|+.||....... ... ....+ ..
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----~~~----~~~~~---------~~ 218 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR----VLF----LIPKN---------NP 218 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh----Hhh----hhhcC---------CC
Confidence 2233457889999999988889999999999999999999999987543111 110 00011 01
Q ss_pred CccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 838 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 838 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
..........+.+++.+|++.+|++||++.|++++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 12223445678899999999999999999999887
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=304.56 Aligned_cols=247 Identities=28% Similarity=0.424 Sum_probs=196.4
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCCch---------hhHhHHHHHHHHhhccCCCccceecceeecCeEE
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 671 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~---------~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~ 671 (927)
.+.+.||+|+||.||+|... +++.+|+|.+...... ..+.+.+|++++++++||||+++++++.+.+..+
T Consensus 3 ~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (267)
T cd06628 3 IKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLN 82 (267)
T ss_pred cccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccE
Confidence 45678999999999999865 5789999988654221 1246788999999999999999999999999999
Q ss_pred EEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccc
Q 002409 672 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 751 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 751 (927)
+++||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 83 lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 83 IFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred EEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 99999999999998843 34578888999999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCc-----eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccC
Q 002409 752 AVDGASH-----VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG 826 (927)
Q Consensus 752 ~~~~~~~-----~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 826 (927)
....... ......|+..|+|||.+.+..++.++|||||||++|||++|+.||....... .+.. ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~-----~~~~ 227 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ---AIFK-----IGEN 227 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH---HHHH-----Hhcc
Confidence 5421111 1112347889999999998889999999999999999999999997543111 1110 0011
Q ss_pred CcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 827 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 827 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
..+ ..+......+.+++.+|++.+|++||++.||+++
T Consensus 228 -----~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 228 -----ASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred -----CCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 111 1112233468899999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=307.21 Aligned_cols=255 Identities=24% Similarity=0.381 Sum_probs=200.2
Q ss_pred HHHhccccccCceEEEEEEEC------CCcEEEEEEeecCCch-hhHhHHHHHHHHhhccCCCccceecceeecCeEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 673 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~------~g~~VAVK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV 673 (927)
+.+.+.||+|+||.||+|+.+ +.+.+++|.+...... ....+.+|++++++++|+||+++++++.+.+..++|
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 86 (275)
T cd05046 7 LQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMI 86 (275)
T ss_pred ceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEE
Confidence 335678999999999999864 3467999988654433 356789999999999999999999999999999999
Q ss_pred EEeccCCchhhhccccccc-----ccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecC
Q 002409 674 YEFMHNGTLKEHLYGTLTH-----EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 748 (927)
Q Consensus 674 ~E~~~~gsL~~~L~~~~~~-----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGl 748 (927)
|||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++++|||+
T Consensus 87 ~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~~ 163 (275)
T cd05046 87 LEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSL 163 (275)
T ss_pred EEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccccc
Confidence 9999999999998643211 12689999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCC
Q 002409 749 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGD 827 (927)
Q Consensus 749 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 827 (927)
++..............++..|+|||.+.+..++.++||||||++++||++ |..||..... ..+..... .+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~----~~~~~~~~----~~~ 235 (275)
T cd05046 164 SKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD----EEVLNRLQ----AGK 235 (275)
T ss_pred ccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch----HHHHHHHH----cCC
Confidence 87443322222223346778999999988888999999999999999999 7788854331 12222211 111
Q ss_pred cccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHH
Q 002409 828 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 874 (927)
Q Consensus 828 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~ 874 (927)
..... .......+.+++.+|++.+|++||++.|+++.|+
T Consensus 236 ~~~~~--------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 236 LELPV--------PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred cCCCC--------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11100 1122346889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=318.90 Aligned_cols=261 Identities=23% Similarity=0.310 Sum_probs=192.0
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecC--CchhhHhHHHHHHHHhhccCCCccceecceeecC------eE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------RS 670 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~------~~ 670 (927)
.|.+.+.||+|+||.||+++.. +++.||||++... .......+.+|+.++++++||||+++++++...+ ..
T Consensus 22 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 101 (359)
T cd07876 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDV 101 (359)
T ss_pred ceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccccee
Confidence 4556789999999999999875 5889999998643 2233566789999999999999999999886443 47
Q ss_pred EEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcc
Q 002409 671 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 750 (927)
Q Consensus 671 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 750 (927)
++||||+.+ +|.+.+. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 102 ~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 102 YLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred EEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 999999975 5555552 2467788889999999999999998 99999999999999999999999999997
Q ss_pred cccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhh--------------
Q 002409 751 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIV-------------- 816 (927)
Q Consensus 751 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~-------------- 816 (927)
..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+.
T Consensus 172 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 172 TACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred ccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 54322 12233458999999999999999999999999999999999999997543111000000
Q ss_pred -HHHHhhhcc-C-----CcccccCCccc---CccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 817 -QWAKLHIES-G-----DIQGIIDPSLL---DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 817 -~~~~~~~~~-~-----~~~~~~d~~l~---~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
..+...... . .+.+....... ..........+.+++.+|++.||++|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000000 0 00000000000 00011123467899999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=309.55 Aligned_cols=250 Identities=23% Similarity=0.330 Sum_probs=200.5
Q ss_pred HHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
..|.+.+.||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 34556788999999999999864 78999999997655555667889999999999999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
++++|.+++.. ..+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred CCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 99999998842 3478889999999999999999998 999999999999999999999999999875433222
Q ss_pred ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCccc
Q 002409 758 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 837 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 837 (927)
. .....+++.|+|||.+.+..++.++|+|||||++|+|++|+.||....... .+.. ....+ ...
T Consensus 171 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~---~~~~----~~~~~-~~~------- 234 (297)
T cd06656 171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR---ALYL----IATNG-TPE------- 234 (297)
T ss_pred C-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch---heee----eccCC-CCC-------
Confidence 1 223458899999999998889999999999999999999999996543111 0000 00000 000
Q ss_pred CccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 838 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 838 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
...+......+.+++.+|++.+|++||++.+|+++
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 235 LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111222457789999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=303.50 Aligned_cols=251 Identities=23% Similarity=0.352 Sum_probs=199.0
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
.|.+.+.||+|+||.||+|+.. +++.+++|++........+.+.+|++++++++|+||+++++.+..++..++||||++
T Consensus 13 ~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 92 (292)
T cd06644 13 VWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCP 92 (292)
T ss_pred hhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCC
Confidence 4567788999999999999876 488999999986665566778899999999999999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
+++|..++... ...+++..+..++.|++++|+|||+. +++||||||+||+++.++.+||+|||++....... .
T Consensus 93 ~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~ 165 (292)
T cd06644 93 GGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-Q 165 (292)
T ss_pred CCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc-c
Confidence 99998877432 34588999999999999999999998 99999999999999999999999999986533221 1
Q ss_pred eeeeeccCCCccCccccc-----cCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccC
Q 002409 759 VSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 833 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~-----~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 833 (927)
......+++.|+|||++. ...++.++|||||||++|||++|+.||....... .+... ..........
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~~~~~-----~~~~~~~~~~ 237 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR---VLLKI-----AKSEPPTLSQ 237 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH---HHHHH-----hcCCCccCCC
Confidence 223345889999999985 3456789999999999999999999986543110 11111 1111101000
Q ss_pred CcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 834 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 834 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
+.....++.+++.+|++.+|++||++.||+++
T Consensus 238 -------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 238 -------PSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred -------CcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11223357899999999999999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=304.13 Aligned_cols=247 Identities=25% Similarity=0.373 Sum_probs=200.0
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
|.+.+.||.|+||.||+|+.. +++.||+|++.... ......+.+|++++++++|+||+++++++.+....++|+||++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCG 82 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeC
Confidence 456788999999999999876 68899999987543 3345678899999999999999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
+++|.+++.. ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||+++.......
T Consensus 83 ~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 153 (274)
T cd06609 83 GGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS- 153 (274)
T ss_pred CCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc-
Confidence 9999998853 2688999999999999999999998 999999999999999999999999999976544322
Q ss_pred eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccC
Q 002409 759 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 838 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 838 (927)
......++..|+|||++.+..++.++|||||||++|||++|+.||....... ... ....+... .+..
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~----~~~----~~~~~~~~-----~~~~ 220 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR----VLF----LIPKNNPP-----SLEG 220 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH----HHH----HhhhcCCC-----CCcc
Confidence 2223458889999999998889999999999999999999999996543111 111 11111111 1111
Q ss_pred ccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 839 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 839 ~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
. .....+.+++.+|+..+|++||++++++++
T Consensus 221 ~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 221 N---KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred c---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1 022357899999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=306.25 Aligned_cols=240 Identities=24% Similarity=0.398 Sum_probs=188.6
Q ss_pred ccccccCceEEEEEEECC--------CcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 605 KKIGSGGFGVVYYGKLKD--------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~~--------g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
+.||+|+||.||+|.... ...+|+|.+..........+.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999997642 234888887655444456788999999999999999999999998999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCc--------EEEEeecC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR--------AKVSDFGL 748 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~--------vkL~DFGl 748 (927)
+.+|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++. ++++|||+
T Consensus 81 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 9999999998643 23678889999999999999999998 9999999999999987765 69999998
Q ss_pred cccccCCCCceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCC-CcccccccccccchhhHHHHhhhccC
Q 002409 749 SKFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQ-EAISNEKFGANCRNIVQWAKLHIESG 826 (927)
Q Consensus 749 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~-~p~~~~~~~~~~~~l~~~~~~~~~~~ 826 (927)
+...... ....++..|+|||++.+ ..++.++|||||||++|||++|. .|+...... ..... .....
T Consensus 155 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~----~~~~~---~~~~~ 222 (258)
T cd05078 155 SITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ----KKLQF---YEDRH 222 (258)
T ss_pred ccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH----HHHHH---HHccc
Confidence 8644321 22457889999999986 45789999999999999999995 555432210 01110 00000
Q ss_pred CcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHH
Q 002409 827 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 874 (927)
Q Consensus 827 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~ 874 (927)
..+.....++.+++.+|++.+|++|||++|+++.|+
T Consensus 223 ------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 223 ------------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ------------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 111122246889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=315.68 Aligned_cols=253 Identities=23% Similarity=0.272 Sum_probs=193.1
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
+.+.++||+|+||.||+++.+ .++.+|+|++.+.. ......+.+|+.++..++|+||+++++++.+.+..++||||
T Consensus 3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey 82 (332)
T cd05623 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY 82 (332)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence 345688999999999999877 46789999986431 22234578899999999999999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 83 YVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred cCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 9999999998532 34688888999999999999999998 99999999999999999999999999987544333
Q ss_pred CceeeeeccCCCccCccccc-----cCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccc
Q 002409 757 SHVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 831 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~-----~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 831 (927)
........||+.|+|||++. ...++.++|||||||++|||++|+.||......+....+.. ......+..
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~----~~~~~~~p~- 231 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN----HKERFQFPA- 231 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhC----CCccccCCC-
Confidence 33333456999999999986 34678899999999999999999999975442211111110 000000000
Q ss_pred cCCcccCccCHHHHHHHHHHHhhhcCC--CCCCCCcHHHHHHH
Q 002409 832 IDPSLLDEYDIQSMWKIEEKALMCVLP--HGHMRPSISEVLKD 872 (927)
Q Consensus 832 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~--dP~~RPsm~eV~~~ 872 (927)
........+.+++.+|+.. ++..||++.|++++
T Consensus 232 --------~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 232 --------QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred --------ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0011234567788887754 44447899999988
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=309.67 Aligned_cols=258 Identities=23% Similarity=0.320 Sum_probs=196.9
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
.+.+.||+|+||.||++... ++..+|+|.+.... .....++.+|++++++++||||+++++++..++..++||||+++
T Consensus 4 ~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~ 83 (308)
T cd06615 4 EKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 83 (308)
T ss_pred eEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCC
Confidence 45678999999999999876 57788999886542 23345688999999999999999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
++|.+++.. ...+++..+..++.|+++||.|||+.+ +++||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 154 (308)
T cd06615 84 GSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 154 (308)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc---
Confidence 999999853 356788899999999999999999742 89999999999999999999999999987543221
Q ss_pred eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcc----------
Q 002409 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ---------- 829 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~---------- 829 (927)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||...... ....+...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK----ELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh----hHHHhhcCccccccccCCcccccCCC
Confidence 22345889999999998888999999999999999999999998643311 1111111000000000
Q ss_pred ----------cccCCcc---cCccC-HHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 830 ----------GIIDPSL---LDEYD-IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 830 ----------~~~d~~l---~~~~~-~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
+..+... ....+ .....++.+++.+|++.+|++||++.||+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 00000 0122358899999999999999999999987
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=301.91 Aligned_cols=238 Identities=24% Similarity=0.423 Sum_probs=188.5
Q ss_pred ccccccCceEEEEEEECCCc-----------EEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEE
Q 002409 605 KKIGSGGFGVVYYGKLKDGK-----------EIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 673 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~~g~-----------~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV 673 (927)
+.||+|+||.||+|.+.+.. .+++|++...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999886433 4788877644333 6778899999999999999999999988 778999
Q ss_pred EEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCC-------cEEEEee
Q 002409 674 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-------RAKVSDF 746 (927)
Q Consensus 674 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-------~vkL~DF 746 (927)
|||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+||+||
T Consensus 79 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 79 EEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCC
Confidence 9999999999998543 22688899999999999999999998 999999999999999887 7999999
Q ss_pred cCcccccCCCCceeeeeccCCCccCccccccC--cCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhh
Q 002409 747 GLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ--QLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHI 823 (927)
Q Consensus 747 Gla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~ 823 (927)
|+++.... .....++..|+|||++... .++.++|||||||++|||++ |..|+...... ....+..
T Consensus 153 g~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~----~~~~~~~--- 220 (259)
T cd05037 153 GIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS----EKERFYQ--- 220 (259)
T ss_pred Cccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch----hHHHHHh---
Confidence 99875433 1223467789999999876 78999999999999999999 56777544311 1111111
Q ss_pred ccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHH
Q 002409 824 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 874 (927)
Q Consensus 824 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~ 874 (927)
..... +......+.+++.+|+..+|.+||++.||++.|+
T Consensus 221 ~~~~~------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 DQHRL------------PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred cCCCC------------CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00000 0001157889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=319.91 Aligned_cols=261 Identities=22% Similarity=0.287 Sum_probs=193.2
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeec------CeE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRS 670 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~------~~~ 670 (927)
.|.+.+.||+|+||.||++... .++.||||++.... ......+.+|+.+++.++||||+++++++... ...
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~ 104 (364)
T cd07875 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 104 (364)
T ss_pred ceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeE
Confidence 4556789999999999999865 57889999987532 23345678899999999999999999987543 357
Q ss_pred EEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcc
Q 002409 671 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 750 (927)
Q Consensus 671 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 750 (927)
++||||+.+ +|.+.+. ..+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 105 ~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 105 YIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred EEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 999999975 6666652 2467888899999999999999998 99999999999999999999999999997
Q ss_pred cccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHH------------
Q 002409 751 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQW------------ 818 (927)
Q Consensus 751 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~------------ 818 (927)
..... .......||..|+|||++.+..++.++|||||||++|||++|+.||......+....+...
T Consensus 175 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 175 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred ccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 54332 1223345899999999999999999999999999999999999999754422111111110
Q ss_pred ---HHhhhcc-CCc-----ccccCCcc---cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 819 ---AKLHIES-GDI-----QGIIDPSL---LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 819 ---~~~~~~~-~~~-----~~~~d~~l---~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
....... ... ........ ...........+.+++.+|++.||++|||+.|++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000 000 00000000 000111123467899999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=303.14 Aligned_cols=249 Identities=25% Similarity=0.409 Sum_probs=197.2
Q ss_pred HHhccccccCceEEEEEEECCCcEEEEEEeecCCc------hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEE
Q 002409 602 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY------QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 675 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~------~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E 675 (927)
...+.||+|+||.||+|...+++.+|+|.+..... .....+.+|++++++++|+||+++++++.+.+..++++|
T Consensus 3 ~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (265)
T cd06631 3 TKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFME 82 (265)
T ss_pred cccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEe
Confidence 34678999999999999988899999998864321 123458889999999999999999999999999999999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCC
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 755 (927)
|+++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 83 FVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 9999999999843 24578889999999999999999998 9999999999999999999999999998754221
Q ss_pred C-----CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCccc
Q 002409 756 A-----SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 830 (927)
Q Consensus 756 ~-----~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 830 (927)
. ........|+..|+|||++.+..++.++|||||||+++||++|+.||....... ..... ....+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~~~---~~~~~~~-- 227 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA---AMFYI---GAHRGLM-- 227 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH---HHHHh---hhccCCC--
Confidence 1 111223458899999999998889999999999999999999999997543111 11110 0000111
Q ss_pred ccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 831 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 831 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
+.+... ....+.+++.+|++.+|++||++.|++++
T Consensus 228 ---~~~~~~----~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 228 ---PRLPDS----FSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred ---CCCCCC----CCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 111122 23457899999999999999999999763
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=303.94 Aligned_cols=253 Identities=25% Similarity=0.364 Sum_probs=195.5
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhc-cCCCccceeccee-----ecCeEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQ-----EEGRSVLV 673 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~-----~~~~~~lV 673 (927)
+.+.+.||+|+||.||++... +++.+|+|++.... .....+.+|+.+++++ +||||+++++++. .++..++|
T Consensus 20 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv 98 (286)
T cd06638 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLV 98 (286)
T ss_pred eeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEE
Confidence 445678999999999999875 57899999876432 2245688899999999 6999999999874 34568999
Q ss_pred EEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccccc
Q 002409 674 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 753 (927)
Q Consensus 674 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 753 (927)
|||+++++|.+++.........+++..+..++.|+++||.|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 175 (286)
T cd06638 99 LELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 175 (286)
T ss_pred EeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeecc
Confidence 999999999998865444456788999999999999999999998 99999999999999999999999999987553
Q ss_pred CCCCceeeeeccCCCccCcccccc-----CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCc
Q 002409 754 DGASHVSSIVRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 828 (927)
Q Consensus 754 ~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 828 (927)
... .......|+..|+|||++.. ..++.++|||||||++|||++|+.||....... .+... .....
T Consensus 176 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~---~~~~~-----~~~~~ 246 (286)
T cd06638 176 STR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR---ALFKI-----PRNPP 246 (286)
T ss_pred cCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH---HHhhc-----cccCC
Confidence 322 12233458999999999853 457889999999999999999999987543111 11110 01100
Q ss_pred ccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHH
Q 002409 829 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 873 (927)
Q Consensus 829 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L 873 (927)
....++. .....+.+++.+|++.+|++||++.||++++
T Consensus 247 ~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 247 PTLHQPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred CcccCCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 1111111 1123588999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=320.01 Aligned_cols=264 Identities=19% Similarity=0.247 Sum_probs=198.6
Q ss_pred HHHHHHHHHhccccccCceEEEEEEEC---CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEE
Q 002409 595 DIEDATKMLEKKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 671 (927)
Q Consensus 595 ei~~~~~~~~~~IG~G~fG~Vy~~~~~---~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~ 671 (927)
.+....|.+.+.||+|+||.||++... .++.||+|.+... +...+|++++++++||||+++++++......+
T Consensus 88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 334456777899999999999999754 3567999987542 34568999999999999999999999999999
Q ss_pred EEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccc
Q 002409 672 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 751 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 751 (927)
++||++. ++|.+++. ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 163 lv~e~~~-~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~ 234 (392)
T PHA03207 163 MVMPKYK-CDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACK 234 (392)
T ss_pred EEehhcC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccc
Confidence 9999985 68888772 345689999999999999999999998 999999999999999999999999999975
Q ss_pred ccCCCCc-eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCC--c
Q 002409 752 AVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD--I 828 (927)
Q Consensus 752 ~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~--~ 828 (927)
....... ......||+.|+|||++....++.++|||||||++|||++|+.||...........+....+ .+.... +
T Consensus 235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~-~~~~~~~~~ 313 (392)
T PHA03207 235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR-CMQVHPLEF 313 (392)
T ss_pred cCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHH-HhccCcccc
Confidence 5433221 22345699999999999999999999999999999999999999965442221111111111 000000 0
Q ss_pred cc-----------ccCCcccCccC-------HHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 829 QG-----------IIDPSLLDEYD-------IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 829 ~~-----------~~d~~l~~~~~-------~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.. .+....+..+. ......+.+++.+|++.+|++||++.|++.+
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 00000000000 0112357789999999999999999999987
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=311.02 Aligned_cols=255 Identities=25% Similarity=0.406 Sum_probs=197.8
Q ss_pred HHhccccccCceEEEEEEEC-CCc----EEEEEEeecCCc-hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEE
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGK----EIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 675 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~----~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E 675 (927)
...+.||+|+||.||+|.+. +++ .+|+|.+..... ....++.+|+.++++++||||+++++++... ..++++|
T Consensus 10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e 88 (303)
T cd05110 10 KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQ 88 (303)
T ss_pred eeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeeh
Confidence 34578999999999999864 344 478888765432 2244688999999999999999999998754 4679999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCC
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 755 (927)
|+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 89 ~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 89 LMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred hcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCc
Confidence 99999999988532 33578889999999999999999998 9999999999999999999999999999865432
Q ss_pred CCce-eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccC
Q 002409 756 ASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 833 (927)
Q Consensus 756 ~~~~-~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 833 (927)
.... .....++..|+|||++.+..++.++|||||||++|||++ |+.||..... ..+.++... +....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~----~~~~~~~~~----~~~~~--- 231 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT----REIPDLLEK----GERLP--- 231 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHC----CCCCC---
Confidence 2211 122335678999999988899999999999999999997 8899865431 122222221 11000
Q ss_pred CcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHHH
Q 002409 834 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 880 (927)
Q Consensus 834 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~~ 880 (927)
........+.+++.+|+..+|++||++.|+++.|+++...+
T Consensus 232 ------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 232 ------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred ------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 01112246789999999999999999999999999875443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=301.98 Aligned_cols=251 Identities=24% Similarity=0.337 Sum_probs=200.6
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
.+.+.+.||+|+||.||++... +++.+|+|++..........+..|++++++++|+||+++++.+......++||||++
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCD 85 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccC
Confidence 4667788999999999999875 688999999876655556678899999999999999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
+++|.+++... ...+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++........
T Consensus 86 ~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (280)
T cd06611 86 GGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ- 158 (280)
T ss_pred CCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence 99999988532 34688999999999999999999998 999999999999999999999999999865433222
Q ss_pred eeeeeccCCCccCccccc-----cCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccC
Q 002409 759 VSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 833 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~-----~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 833 (927)
......++..|+|||.+. ...++.++|||||||++|||++|+.||...... +.+..+ ..+.......
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~---~~~~~~-----~~~~~~~~~~ 230 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM---RVLLKI-----LKSEPPTLDQ 230 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH---HHHHHH-----hcCCCCCcCC
Confidence 223345899999999975 345678999999999999999999999754311 111111 1111111000
Q ss_pred CcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 834 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 834 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
+......+.+++.+|++.+|++||++.+|+++
T Consensus 231 -------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 231 -------PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -------cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 11122357899999999999999999999886
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=317.32 Aligned_cols=241 Identities=26% Similarity=0.323 Sum_probs=186.1
Q ss_pred ccccCceEEEEEEEC-CCcEEEEEEeecCCc---hhhHhHHHHHHHHhhc---cCCCccceecceeecCeEEEEEEeccC
Q 002409 607 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRI---HHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 607 IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~iL~~l---~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
||+|+||+||+|+.. +++.||||++..... .....+..|..++.+. +||||+++++++......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999876 588999999864321 1223345566676665 699999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~----~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~ 152 (330)
T cd05586 81 GELFWHLQ----KEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KT 152 (330)
T ss_pred ChHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CC
Confidence 99998874 345688999999999999999999998 99999999999999999999999999987533222 12
Q ss_pred eeeeccCCCccCccccccC-cCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccC
Q 002409 760 SSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 838 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 838 (927)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+ +.. .+..+.. .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~----~~~----~i~~~~~------~~~~ 218 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ----MYR----NIAFGKV------RFPK 218 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH----HHH----HHHcCCC------CCCC
Confidence 2345699999999998754 48899999999999999999999997543211 111 1111111 0000
Q ss_pred ccCHHHHHHHHHHHhhhcCCCCCCCC----cHHHHHHH
Q 002409 839 EYDIQSMWKIEEKALMCVLPHGHMRP----SISEVLKD 872 (927)
Q Consensus 839 ~~~~~~~~~l~~L~~~Cl~~dP~~RP----sm~eV~~~ 872 (927)
. .....+.+++.+|++.+|++|| ++.|++++
T Consensus 219 ~---~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 219 N---VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred c---cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 0 1123577899999999999998 56666654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=302.26 Aligned_cols=253 Identities=24% Similarity=0.344 Sum_probs=200.4
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceee--cCeEEEEEEe
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVLVYEF 676 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--~~~~~lV~E~ 676 (927)
.+.+.||.|+||.||++... +++.+|+|++.... ....+.+..|++++++++|+||+++++++.. ....+++|||
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~ 82 (265)
T cd08217 3 EVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEY 82 (265)
T ss_pred eeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehh
Confidence 45678999999999999765 67889999986432 3334568889999999999999999998754 4567899999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCC--CCceecCCCCCCCeEECCCCcEEEEeecCcccccC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC--VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 754 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 754 (927)
+++++|.+++.........+++..++.++.|++.||+|||..+ ..+++|+||||+||+++.++.+||+|||++.....
T Consensus 83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~ 162 (265)
T cd08217 83 CEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH 162 (265)
T ss_pred ccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccC
Confidence 9999999998655445667899999999999999999999221 22999999999999999999999999999886544
Q ss_pred CCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCC
Q 002409 755 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 834 (927)
Q Consensus 755 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 834 (927)
.... .....++..|+|||.+....++.++|+||||+++++|++|+.||..... ..+.+. ...+...
T Consensus 163 ~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~----~~~~~~~----- 228 (265)
T cd08217 163 DSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ----LQLASK----IKEGKFR----- 228 (265)
T ss_pred Cccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH----HHHHHH----HhcCCCC-----
Confidence 3321 2234589999999999988899999999999999999999999975431 122221 1112111
Q ss_pred cccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 835 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 835 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
..+......+.+++.+|++.+|++||++.||+++
T Consensus 229 ----~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 ----RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ----CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1112233568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=318.52 Aligned_cols=261 Identities=22% Similarity=0.292 Sum_probs=193.0
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeec------CeE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRS 670 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~------~~~ 670 (927)
.|.+.+.||+|+||.||++... .++.||||++.... ......+.+|+.+++.++||||+++++++... ...
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 97 (355)
T cd07874 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDV 97 (355)
T ss_pred ceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccccee
Confidence 4556788999999999999865 58899999987542 23345677899999999999999999987543 356
Q ss_pred EEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcc
Q 002409 671 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 750 (927)
Q Consensus 671 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 750 (927)
++||||+++ +|.+.+. ..+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 98 ~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 98 YLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred EEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccc
Confidence 999999975 5665552 2477888899999999999999998 99999999999999999999999999997
Q ss_pred cccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhH-------------
Q 002409 751 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ------------- 817 (927)
Q Consensus 751 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~------------- 817 (927)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+..
T Consensus 168 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 168 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred cCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 54332 122334589999999999988999999999999999999999999975432111111110
Q ss_pred --HHHhhhcc-CCcc-----cccCCccc---CccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 818 --WAKLHIES-GDIQ-----GIIDPSLL---DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 818 --~~~~~~~~-~~~~-----~~~d~~l~---~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
........ .... ......+. ..........+.+++.+|++.||++|||+.|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000000 0000 00000000 00111223467899999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=310.47 Aligned_cols=263 Identities=22% Similarity=0.311 Sum_probs=195.8
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
|.+.+.||+|+||.||+|+.+ +++.||+|.++... ......+.+|++++++++||||+++++++...+..++||||+.
T Consensus 8 y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~ 87 (301)
T cd07873 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 87 (301)
T ss_pred eEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc
Confidence 445678999999999999876 57899999987543 2234567789999999999999999999999999999999997
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
++|.+++... ...+++..+..++.|+++||+|||+. +++||||||+|||++.++.+||+|||++........
T Consensus 88 -~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 159 (301)
T cd07873 88 -KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 159 (301)
T ss_pred -cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence 5888877532 34578889999999999999999998 999999999999999999999999999875432221
Q ss_pred eeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccC----
Q 002409 759 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID---- 833 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d---- 833 (927)
......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+.+...... ......+++
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 238 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPT-EETWPGILSNEEF 238 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC-hhhchhhhccccc
Confidence 1222346889999999865 4578899999999999999999999975442211111111100000 000000000
Q ss_pred -----CcccCc----cCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 834 -----PSLLDE----YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 834 -----~~l~~~----~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
+..... ........+.+++.+|++.+|++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 110000 011223467899999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=307.16 Aligned_cols=265 Identities=21% Similarity=0.261 Sum_probs=199.7
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
+.+.+.||+|+||.||+|..+ +++.||+|+++... ......+.+|++++++++|+||+++++++...+..+++|||+
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 82 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV 82 (288)
T ss_pred eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence 445688999999999999876 57899999886432 233467899999999999999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
+++.+..+.. ....+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||++........
T Consensus 83 ~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 83 ERTLLELLEA----SPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred CCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 9877766553 234578999999999999999999998 999999999999999999999999999876554433
Q ss_pred ceeeeeccCCCccCccccccC-cCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHh--------hhccCC-
Q 002409 758 HVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL--------HIESGD- 827 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~--------~~~~~~- 827 (927)
.......++..|+|||++.+. .++.++||||||+++|||++|+.||......+....+...... ......
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence 233334578999999999887 8899999999999999999999998754321111111110000 000000
Q ss_pred ----cccccCCcc-cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 828 ----IQGIIDPSL-LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 828 ----~~~~~d~~l-~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
+....++.. ...++.....++.+++.+|+..+|++||++++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000000000 001112224678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=299.22 Aligned_cols=249 Identities=23% Similarity=0.380 Sum_probs=198.1
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceee-cCeEEEEEEe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE-EGRSVLVYEF 676 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~-~~~~~lV~E~ 676 (927)
|.+.+.||+|++|.||+++.+ +++.+|+|.+.... ....+.+.+|++++++++|+|++++++.+.. ....+++|||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 346788999999999999876 57889999986542 2334568899999999999999999988764 4467899999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
+++++|.+++... ....+++.+++.++.|++.|+++||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 82 CEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred cCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 9999999988642 234588999999999999999999998 99999999999999999999999999987553322
Q ss_pred CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 757 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
. ......+++.|+|||++.+..++.++|||||||+++||++|+.||...... ...... ..+.+..
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-------~~~~~~-~~~~~~~------ 221 (257)
T cd08223 157 D-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN-------SLVYRI-IEGKLPP------ 221 (257)
T ss_pred C-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-------HHHHHH-HhcCCCC------
Confidence 2 223345889999999999999999999999999999999999998743311 111111 1121111
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.+......+.+++.+|++.+|++||++.|++++
T Consensus 222 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 222 ---MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ---CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 112233468899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=316.97 Aligned_cols=189 Identities=22% Similarity=0.346 Sum_probs=160.9
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
.|.+.+.||+|+||.||+|+.. +++.||+|+.... ....|+.++++++|+||+++++++......++|+|++.
T Consensus 67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 140 (357)
T PHA03209 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS 140 (357)
T ss_pred CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC
Confidence 4566789999999999999876 4678999975422 23568999999999999999999999999999999995
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
++|.+++.. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 141 -~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~ 211 (357)
T PHA03209 141 -SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--P 211 (357)
T ss_pred -CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC--c
Confidence 688888753 245689999999999999999999998 9999999999999999999999999998743322 1
Q ss_pred eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcc
Q 002409 759 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAI 803 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~ 803 (927)
......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 223345899999999999999999999999999999999865554
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=307.84 Aligned_cols=244 Identities=25% Similarity=0.391 Sum_probs=197.0
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCCchh
Q 002409 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK 683 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~ 683 (927)
..||+|+||.||++... +++.||||.+........+.+.+|+.++++++|+||+++++.+...+..++||||+++++|.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 56999999999999875 68899999987655555667889999999999999999999999999999999999999999
Q ss_pred hhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCceeeee
Q 002409 684 EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV 763 (927)
Q Consensus 684 ~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 763 (927)
+++. ...+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||++........ .....
T Consensus 108 ~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~ 178 (292)
T cd06658 108 DIVT-----HTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSL 178 (292)
T ss_pred HHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCcee
Confidence 8873 23578899999999999999999998 999999999999999999999999999875433222 22334
Q ss_pred ccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCccCHH
Q 002409 764 RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQ 843 (927)
Q Consensus 764 ~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 843 (927)
.|+..|+|||++.+..++.++|||||||++|||++|+.||...... ......... +.+.+.... .
T Consensus 179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----~~~~~~~~~---------~~~~~~~~~--~ 243 (292)
T cd06658 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL----QAMRRIRDN---------LPPRVKDSH--K 243 (292)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhc---------CCCcccccc--c
Confidence 5899999999998888999999999999999999999998754311 111111110 111111111 1
Q ss_pred HHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 844 SMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 844 ~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
....+.+++.+|+..+|++|||+.|++++
T Consensus 244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 244 VSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 22357789999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=305.32 Aligned_cols=265 Identities=23% Similarity=0.287 Sum_probs=199.4
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
|.+.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.++++++||||+++++++......++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 345678999999999999875 68899999987553 233567899999999999999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
+++|.+++... ...+++..++.++.|+++||+|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 82 -~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 82 -PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred -CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 99999988543 25688999999999999999999998 999999999999999999999999999886544332
Q ss_pred ceeeeeccCCCccCccccccC-cCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhc----c-CCc---
Q 002409 758 HVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE----S-GDI--- 828 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~----~-~~~--- 828 (927)
.......|+..|+|||.+.+. .++.++||||+||+++||++|+.+|...........+......... + ..+
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence 222334589999999998654 4688999999999999999998887644311111111110000000 0 000
Q ss_pred ccccCCccc----CccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 829 QGIIDPSLL----DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 829 ~~~~d~~l~----~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
..+..+.-. .....+....+.+++.+|++.+|++||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000 00011223678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=302.95 Aligned_cols=252 Identities=25% Similarity=0.373 Sum_probs=197.9
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecC-CchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
+++.+.||+|+||.||++... +++.+|+|.++.. .......+.+|++++++++|+||+++++.+...+..++||||++
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMD 82 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecC
Confidence 567789999999999999876 7899999988754 22334678899999999999999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
+++|.+++... .....+++..+..++.|++.||.|||+. .+++||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~l~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 156 (286)
T cd06622 83 AGSLDKLYAGG-VATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--- 156 (286)
T ss_pred CCCHHHHHHhc-cccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC---
Confidence 99998888542 1234689999999999999999999974 28999999999999999999999999998754322
Q ss_pred eeeeeccCCCccCccccccC------cCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCccccc
Q 002409 759 VSSIVRGTVGYLDPEYYISQ------QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 832 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~~------~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 832 (927)
......++..|+|||.+.+. .++.++|+|||||++|||++|+.||...........+. ....+..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~-----~~~~~~~---- 227 (286)
T cd06622 157 LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLS-----AIVDGDP---- 227 (286)
T ss_pred ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHH-----HHhhcCC----
Confidence 12233478899999998554 35789999999999999999999996543211111111 1111111
Q ss_pred CCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 833 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 833 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
+. .+......+.+++.+|++.+|++||++.|++++
T Consensus 228 -~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 228 -PT----LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred -CC----CCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 11 112233467899999999999999999999885
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=304.65 Aligned_cols=256 Identities=24% Similarity=0.401 Sum_probs=202.4
Q ss_pred HHHHHhccccccCceEEEEEEECC-Cc----EEEEEEeecCCc-hhhHhHHHHHHHHhhccCCCccceecceeecCeEEE
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLKD-GK----EIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 672 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~~-g~----~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~l 672 (927)
..+.+.+.||+|+||.||+|.+++ ++ .+|+|.+..... .....+.+|++++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 445567899999999999998652 33 589998875543 345678899999999999999999999987 78899
Q ss_pred EEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccc
Q 002409 673 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 752 (927)
Q Consensus 673 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 752 (927)
|+||+++|+|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 86 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 99999999999998543 33588999999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCCcee-eeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCccc
Q 002409 753 VDGASHVS-SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQG 830 (927)
Q Consensus 753 ~~~~~~~~-~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 830 (927)
........ ....++..|+|||.+....++.++|+|||||++||+++ |+.||...... .+.+... .+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~~~~----~~~~~- 230 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV----EIPDLLE----KGERL- 230 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH----HHHHHHh----CCCCC-
Confidence 43322221 11223568999999988899999999999999999998 99999764421 2222221 11100
Q ss_pred ccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 831 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 831 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
..+......+.+++.+|+..+|++||++.++++.|+++..
T Consensus 231 --------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 231 --------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0011122357899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=318.90 Aligned_cols=267 Identities=22% Similarity=0.257 Sum_probs=203.3
Q ss_pred HHHHHHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhcc-C-----CCccceecceeec
Q 002409 595 DIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-H-----RNLVQFLGYCQEE 667 (927)
Q Consensus 595 ei~~~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~-H-----pnIv~l~g~~~~~ 667 (927)
|....+|.+.+.||+|.||.|-+|... +++.||||+++... .-.++...|+.+|..++ | -|+|++++++..+
T Consensus 182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr 260 (586)
T KOG0667|consen 182 DHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR 260 (586)
T ss_pred ceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence 333336777899999999999999765 68999999998543 34566788999999996 4 5899999999999
Q ss_pred CeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCC--CcEEEEe
Q 002409 668 GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH--MRAKVSD 745 (927)
Q Consensus 668 ~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~--~~vkL~D 745 (927)
++.|||+|.+. -+|.++|+.. ....++...+..|+.||+.||.+||+. +|||+||||+||||.+. ..+||+|
T Consensus 261 ~HlciVfELL~-~NLYellK~n--~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVID 334 (586)
T KOG0667|consen 261 NHLCIVFELLS-TNLYELLKNN--KFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVID 334 (586)
T ss_pred cceeeeehhhh-hhHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEe
Confidence 99999999885 4999999765 345688999999999999999999998 99999999999999764 3799999
Q ss_pred ecCcccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHh----
Q 002409 746 FGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL---- 821 (927)
Q Consensus 746 FGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~---- 821 (927)
||.|+....... ....+..|+|||++.+.+|+.+.||||||||++||++|.+.|.+...-+....|++-...
T Consensus 335 FGSSc~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~ 410 (586)
T KOG0667|consen 335 FGSSCFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPK 410 (586)
T ss_pred cccccccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHH
Confidence 999986543221 334688999999999999999999999999999999998888764422222222211100
Q ss_pred ----------hhcc-CCcc------c----------------ccCCcccC--------ccCHHHHHHHHHHHhhhcCCCC
Q 002409 822 ----------HIES-GDIQ------G----------------IIDPSLLD--------EYDIQSMWKIEEKALMCVLPHG 860 (927)
Q Consensus 822 ----------~~~~-~~~~------~----------------~~d~~l~~--------~~~~~~~~~l~~L~~~Cl~~dP 860 (927)
.+.. .... + ..+..... ......-..+++++.+|+.+||
T Consensus 411 mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP 490 (586)
T KOG0667|consen 411 MLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDP 490 (586)
T ss_pred HHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCc
Confidence 0000 0000 0 00110000 1112344578999999999999
Q ss_pred CCCCcHHHHHHH
Q 002409 861 HMRPSISEVLKD 872 (927)
Q Consensus 861 ~~RPsm~eV~~~ 872 (927)
.+|+|..|.++|
T Consensus 491 ~~R~tp~qal~H 502 (586)
T KOG0667|consen 491 AERITPAQALNH 502 (586)
T ss_pred hhcCCHHHHhcC
Confidence 999999999988
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=306.51 Aligned_cols=264 Identities=23% Similarity=0.263 Sum_probs=194.8
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
.+.+.||+|++|.||+|+.. +++.||+|+++... ......+.+|+.++++++||||+++++++..++..++||||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (285)
T cd07861 3 TKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS 82 (285)
T ss_pred eEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC
Confidence 34578999999999999876 68899999986432 2224568899999999999999999999999999999999997
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
++|.+++.... ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....... .
T Consensus 83 -~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~ 156 (285)
T cd07861 83 -MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-R 156 (285)
T ss_pred -CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-c
Confidence 68888775432 235689999999999999999999998 99999999999999999999999999987543321 1
Q ss_pred eeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhcc--------C---
Q 002409 759 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES--------G--- 826 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~--------~--- 826 (927)
......+++.|+|||.+.+ ..++.++|||||||+++||++|+.||...........+.+........ .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 1222346889999998865 457889999999999999999999997543211111111100000000 0
Q ss_pred -CcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 827 -DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 827 -~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.........+ .........++.+++.+|++.+|++|||+.||+++
T Consensus 237 ~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 237 NTFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hhccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000000000 00011123467799999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=307.66 Aligned_cols=248 Identities=23% Similarity=0.352 Sum_probs=199.3
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
+.+.+.||.|+||.||+|... +++.||+|.+..........+.+|+.+++.++||||+++++++......++|+||+++
T Consensus 21 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 100 (296)
T cd06655 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAG 100 (296)
T ss_pred EEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCC
Confidence 344578999999999999864 6899999998765555567788999999999999999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
++|.+++. ...+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........ .
T Consensus 101 ~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~ 171 (296)
T cd06655 101 GSLTDVVT-----ETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-K 171 (296)
T ss_pred CcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc-c
Confidence 99999874 23578999999999999999999998 999999999999999999999999999875433222 1
Q ss_pred eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCc
Q 002409 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 839 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 839 (927)
.....++..|+|||.+.+..++.++|||||||++|+|++|+.||....... .+... .. ..... + .
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~---~~~~~----~~-~~~~~-----~--~ 236 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR---ALYLI----AT-NGTPE-----L--Q 236 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH----Hh-cCCcc-----c--C
Confidence 223458899999999998889999999999999999999999997644111 11111 00 00000 0 0
Q ss_pred cCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 840 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 840 ~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.+......+.+++.+|+..+|++||++.+|+++
T Consensus 237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 011122357889999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=299.50 Aligned_cols=249 Identities=32% Similarity=0.504 Sum_probs=199.5
Q ss_pred HhccccccCceEEEEEEECC-----CcEEEEEEeecCCch-hhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 603 LEKKIGSGGFGVVYYGKLKD-----GKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 603 ~~~~IG~G~fG~Vy~~~~~~-----g~~VAVK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
+.+.||+|+||.||+++..+ +..||+|++...... ..+.+..|++++++++|+||+++++++.+.+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 45789999999999998764 378999999765433 467889999999999999999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
+++++|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++......
T Consensus 83 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 83 MEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred cCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 99999999985432 12289999999999999999999998 99999999999999999999999999997655442
Q ss_pred CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCc
Q 002409 757 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 835 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 835 (927)
........++..|+|||.+....++.++||||+|++++||++ |+.||..... ..+.+... .+....
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~----~~~~~~~~----~~~~~~----- 224 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN----EEVLEYLK----KGYRLP----- 224 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHh----cCCCCC-----
Confidence 222222336789999999988889999999999999999998 7888865331 12222211 111110
Q ss_pred ccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHH
Q 002409 836 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 873 (927)
Q Consensus 836 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L 873 (927)
.......++.+++.+|+..+|++|||+.|+++.|
T Consensus 225 ----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 ----KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ----CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0111334688999999999999999999998864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=304.47 Aligned_cols=246 Identities=24% Similarity=0.351 Sum_probs=205.3
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
.|.+++.||+|-|+.|-.|++- .|+.||||++.+.. ......+.+|++.|+.++|||||+++++......+|||.|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 3556788999999999999765 79999999997653 23456788999999999999999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEEC-CCCcEEEEeecCcccccCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD-KHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~-~~~~vkL~DFGla~~~~~~ 755 (927)
-.+|+|.+|+.. ....+.+..+.+++.||+.|+.|+|+. .+|||||||+||.+- .-|-+||.|||++..+.++
T Consensus 99 GD~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 99 GDGGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred cCCchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 999999999964 356788999999999999999999998 999999999998775 4588999999999866554
Q ss_pred CCceeeeeccCCCccCccccccCcCCC-ccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCC
Q 002409 756 ASHVSSIVRGTVGYLDPEYYISQQLTD-KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 834 (927)
Q Consensus 756 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~-~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 834 (927)
. .....+|++.|-|||++.+..|+. ++||||||||||.|++|+.||+...-.+....| +|.
T Consensus 173 ~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI----------------mDC 234 (864)
T KOG4717|consen 173 K--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI----------------MDC 234 (864)
T ss_pred c--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh----------------hcc
Confidence 3 345567999999999999999875 679999999999999999999865533322222 222
Q ss_pred cccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHH
Q 002409 835 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 871 (927)
Q Consensus 835 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~ 871 (927)
.+ ..+.....++.+|+..|+..||++|.+.+||+.
T Consensus 235 KY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 235 KY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred cc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 21 123445567999999999999999999999875
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=308.32 Aligned_cols=197 Identities=24% Similarity=0.382 Sum_probs=159.0
Q ss_pred hccccccCceEEEEEEEC---CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceee--cCeEEEEEEecc
Q 002409 604 EKKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVLVYEFMH 678 (927)
Q Consensus 604 ~~~IG~G~fG~Vy~~~~~---~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--~~~~~lV~E~~~ 678 (927)
..+||+|+||.||+|+.. +++.||+|.+.... ....+.+|++++++++||||+++++++.. ....++|+||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 357999999999999875 35689999886442 23457889999999999999999998853 557799999987
Q ss_pred CCchhhhccccc-----ccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEE----CCCCcEEEEeecCc
Q 002409 679 NGTLKEHLYGTL-----THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLS 749 (927)
Q Consensus 679 ~gsL~~~L~~~~-----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl----~~~~~vkL~DFGla 749 (927)
+ +|.+++.... .....+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 6776663211 1234588899999999999999999998 99999999999999 56679999999999
Q ss_pred ccccCCCCc--eeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCccccc
Q 002409 750 KFAVDGASH--VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNE 806 (927)
Q Consensus 750 ~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~ 806 (927)
+........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 865433221 1223458999999999876 45889999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=296.76 Aligned_cols=250 Identities=25% Similarity=0.297 Sum_probs=207.0
Q ss_pred HHhccccccCceEEEEEEECC-CcEEEEEEeecCCc---hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 602 MLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~~-g~~VAVK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
++.+.||+|.-|+||.+++++ +...|+|++.+... +...+.+.|-+||+.++||.+..|+..+..+...|++||||
T Consensus 80 ~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyC 159 (459)
T KOG0610|consen 80 RLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYC 159 (459)
T ss_pred HHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecC
Confidence 456789999999999999884 47899999986643 33456778999999999999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCC--
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG-- 755 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-- 755 (927)
+||+|..+++. +..+.+++..+.-++.+++.||+|||-. |||.|||||+||||.++|++.|+||.|+..+...
T Consensus 160 pGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 160 PGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred CCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 99999988854 4577899999999999999999999998 9999999999999999999999999987532110
Q ss_pred --------------------------C-----C----------------------ceeeeeccCCCccCccccccCcCCC
Q 002409 756 --------------------------A-----S----------------------HVSSIVRGTVGYLDPEYYISQQLTD 782 (927)
Q Consensus 756 --------------------------~-----~----------------------~~~~~~~gt~~Y~aPE~~~~~~~s~ 782 (927)
. . ..+..++||-.|+|||++.+...+.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 0 0 0112345999999999999999999
Q ss_pred ccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCC
Q 002409 783 KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHM 862 (927)
Q Consensus 783 ~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~ 862 (927)
++|.|+|||+||||+.|..||.+....+...+++.. .+.-.........+.+||.+.|..||++
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~----------------~l~Fp~~~~vs~~akDLIr~LLvKdP~k 378 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ----------------PLKFPEEPEVSSAAKDLIRKLLVKDPSK 378 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC----------------CCcCCCCCcchhHHHHHHHHHhccChhh
Confidence 999999999999999999999887766665555541 1100011234457889999999999999
Q ss_pred CCc----HHHHHHH
Q 002409 863 RPS----ISEVLKD 872 (927)
Q Consensus 863 RPs----m~eV~~~ 872 (927)
|.. +.||.+|
T Consensus 379 Rlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 379 RLGSKRGAAEIKRH 392 (459)
T ss_pred hhccccchHHhhcC
Confidence 998 8888876
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=311.83 Aligned_cols=259 Identities=23% Similarity=0.307 Sum_probs=191.4
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeec------CeE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRS 670 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~------~~~ 670 (927)
.|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07878 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEV 95 (343)
T ss_pred hhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcE
Confidence 4556789999999999999865 67899999986532 22345677899999999999999999987543 356
Q ss_pred EEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcc
Q 002409 671 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 750 (927)
Q Consensus 671 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 750 (927)
++++|++ +++|.+++. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~ 166 (343)
T cd07878 96 YLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLAR 166 (343)
T ss_pred EEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccce
Confidence 8999987 778887763 34588999999999999999999998 99999999999999999999999999997
Q ss_pred cccCCCCceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHh-------h
Q 002409 751 FAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL-------H 822 (927)
Q Consensus 751 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~-------~ 822 (927)
..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+...... .
T Consensus 167 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07878 167 QADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK 242 (343)
T ss_pred ecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 54332 123458999999999876 56889999999999999999999999654321111111111000 0
Q ss_pred hccC-------CcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 823 IESG-------DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 823 ~~~~-------~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.... .+...-...+...+ ......+.+++.+|++.||++|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 243 ISSEHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred cchhhHHHHhhccccccchhHHHhc-cCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 00000000000000 0112346799999999999999999999986
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=297.91 Aligned_cols=249 Identities=23% Similarity=0.327 Sum_probs=200.8
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecC--CchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
.+.+.||+|+||.||.++.. +++.+++|.+... .....+.+.+|++++++++|+||+++++++.+.+..+++|||++
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (256)
T cd08221 3 IPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYAN 82 (256)
T ss_pred eEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecC
Confidence 45678999999999998765 5889999987644 23445678899999999999999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
+++|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 83 GGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred CCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 999999986432 35688999999999999999999998 999999999999999999999999999875544332
Q ss_pred eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccC
Q 002409 759 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 838 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 838 (927)
......|++.|+|||++.+..++.++||||||+++|||++|+.||......+ .. ... ..+.....
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~----~~---~~~-~~~~~~~~------- 221 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN----LV---VKI-VQGNYTPV------- 221 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH----HH---HHH-HcCCCCCC-------
Confidence 2233458999999999988888999999999999999999999997543211 11 111 11211110
Q ss_pred ccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHH
Q 002409 839 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 873 (927)
Q Consensus 839 ~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L 873 (927)
......++.+++.+|++.+|++||++.|+++++
T Consensus 222 --~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 222 --VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred --ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 112234688999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=302.10 Aligned_cols=264 Identities=22% Similarity=0.271 Sum_probs=197.3
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
+.+.+.||+|+||.||+|+.+ +++.||+|++.... ....+.+.+|++++++++|+|++++++++......++||||+
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~ 82 (286)
T cd07847 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYC 82 (286)
T ss_pred eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEecc
Confidence 345678999999999999887 58899999886442 223456889999999999999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
+++.|..++.. ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 83 ~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 83 DHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred CccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 99888777632 34588999999999999999999998 999999999999999999999999999976543321
Q ss_pred ceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhh-------hccCCc-
Q 002409 758 HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH-------IESGDI- 828 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~-------~~~~~~- 828 (927)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||......+....+....... ......
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence 1222347889999999876 567899999999999999999999997544221111111111000 000000
Q ss_pred ccccCCcccCccC-----HHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 829 QGIIDPSLLDEYD-----IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 829 ~~~~d~~l~~~~~-----~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.....+......+ ......+.+++.+|++.+|++||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0000011000000 1123468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=297.91 Aligned_cols=252 Identities=23% Similarity=0.357 Sum_probs=201.1
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
+.+.+.||+|+||.||+|... +++.+++|++........+.+.+|++++++++||||+++++++...+..+++|||+++
T Consensus 5 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~ 84 (262)
T cd06613 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGG 84 (262)
T ss_pred eEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCC
Confidence 445688999999999999875 5788999999866555567899999999999999999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
++|.+++... ...+++..+..++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++....... ..
T Consensus 85 ~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~ 157 (262)
T cd06613 85 GSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-AK 157 (262)
T ss_pred CcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh-hc
Confidence 9999987532 25688999999999999999999998 99999999999999999999999999987543321 12
Q ss_pred eeeeccCCCccCccccccC---cCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 760 SSIVRGTVGYLDPEYYISQ---QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~---~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
.....++..|+|||.+... .++.++|||||||++|||++|+.||....... ....... ..+ ..+.+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~---~~~~~~~-----~~~---~~~~~ 226 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR---ALFLISK-----SNF---PPPKL 226 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHh-----ccC---CCccc
Confidence 2234578899999999776 88999999999999999999999996543111 1111111 100 00011
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
. ........+.+++.+|+..+|++||++.||+.+
T Consensus 227 ~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 227 K--DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred c--chhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1 112334568899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=305.45 Aligned_cols=245 Identities=23% Similarity=0.362 Sum_probs=196.9
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCCch
Q 002409 604 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 682 (927)
Q Consensus 604 ~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 682 (927)
...||+|+||.||++... +++.||+|++........+.+.+|+.+++.++||||+++++++...+..++|+||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 357999999999999875 6889999998755444566788999999999999999999999999999999999999999
Q ss_pred hhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCceeee
Q 002409 683 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 762 (927)
Q Consensus 683 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 762 (927)
.+++. ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....... .....
T Consensus 106 ~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~ 176 (297)
T cd06659 106 TDIVS-----QTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKS 176 (297)
T ss_pred HHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccccc
Confidence 88763 24578999999999999999999998 99999999999999999999999999987543322 12233
Q ss_pred eccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCccCH
Q 002409 763 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 842 (927)
Q Consensus 763 ~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 842 (927)
..|+..|+|||++.+..++.++|||||||+++||++|+.||...... ....... ...... ... ..
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~~~~~~----~~~~~~-----~~~--~~ 241 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV----QAMKRLR----DSPPPK-----LKN--AH 241 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHh----ccCCCC-----ccc--cC
Confidence 45899999999999888999999999999999999999998643311 1111111 110000 000 01
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 843 QSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 843 ~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.....+.+++.+|++.+|++||++.|++++
T Consensus 242 ~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 242 KISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 122357899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=305.71 Aligned_cols=264 Identities=22% Similarity=0.318 Sum_probs=197.6
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc--hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
+.+.+.||+|+||.||+|..+ +++.||+|++..... ...+.+.+|++++++++||||+++++++...+..++|+||+
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (286)
T cd07846 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFV 82 (286)
T ss_pred eeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecC
Confidence 345678999999999999886 588999998764322 23456889999999999999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
++++|.++... ...+++..++.++.|+++||+|||+. +++||||+|+||++++++.+||+|||++.......
T Consensus 83 ~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 83 DHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred CccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 99988876632 33488999999999999999999998 99999999999999999999999999987544332
Q ss_pred ceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhh-------hccCCc-
Q 002409 758 HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH-------IESGDI- 828 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~-------~~~~~~- 828 (927)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||......+....+..+.... .....+
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence 22223447889999999875 457889999999999999999999986544221111222111110 000000
Q ss_pred ccccCCcccCc-----cCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 829 QGIIDPSLLDE-----YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 829 ~~~~d~~l~~~-----~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.....+..... ........+.+++.+|++.+|++||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00000000000 011223568899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=300.45 Aligned_cols=247 Identities=26% Similarity=0.386 Sum_probs=189.6
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCC-----chhhHhHHHHHHHHhhccCCCccceecceee--cCeEEEE
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-----YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVLV 673 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~-----~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--~~~~~lV 673 (927)
...+.||+|+||.||+|... +++.||+|++.... .+....+.+|++++++++||||+++++++.. ....+++
T Consensus 5 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~ 84 (266)
T cd06651 5 RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIF 84 (266)
T ss_pred cccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEE
Confidence 34678999999999999875 58899999886432 1223568889999999999999999998865 3567899
Q ss_pred EEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccccc
Q 002409 674 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 753 (927)
Q Consensus 674 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 753 (927)
+||+++++|.+++.. ...+++...+.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 85 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 85 MEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 999999999998853 33578888999999999999999998 99999999999999999999999999987543
Q ss_pred CCCC--ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccc
Q 002409 754 DGAS--HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 831 (927)
Q Consensus 754 ~~~~--~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 831 (927)
.... .......++..|+|||++.+..++.++|||||||++|||++|+.||....... .+ .......
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~---~~----~~~~~~~----- 225 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA---AI----FKIATQP----- 225 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH---HH----HHHhcCC-----
Confidence 2111 11122447899999999998889999999999999999999999997543111 11 1111111
Q ss_pred cCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 832 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 832 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
..+. .+......+.+++ +|+..+|++||+++||+++
T Consensus 226 ~~~~----~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 226 TNPQ----LPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred CCCC----CchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 0111 1112223455555 6888999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=299.02 Aligned_cols=246 Identities=27% Similarity=0.414 Sum_probs=197.3
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCC-----chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEE
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-----YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 675 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~-----~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E 675 (927)
...+.||+|+||.||+|... +++.|++|.+.... .+..+.+.+|++++++++|+||+++++++......++++|
T Consensus 3 ~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 82 (258)
T cd06632 3 RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLE 82 (258)
T ss_pred cccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEE
Confidence 34578999999999999877 78999999986543 2234678899999999999999999999999999999999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCC
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 755 (927)
|+++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++......
T Consensus 83 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 83 LVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred ecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 9999999998843 34578889999999999999999998 9999999999999999999999999998754332
Q ss_pred CCceeeeeccCCCccCccccccCc-CCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCC
Q 002409 756 ASHVSSIVRGTVGYLDPEYYISQQ-LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 834 (927)
Q Consensus 756 ~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 834 (927)
. ......|+..|++||.+.... ++.++|+|||||++|+|++|+.||..... ...+..+. ......
T Consensus 156 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~---~~~~~~~~----~~~~~~----- 221 (258)
T cd06632 156 S--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG---VAAVFKIG----RSKELP----- 221 (258)
T ss_pred c--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH---HHHHHHHH----hcccCC-----
Confidence 2 223345889999999987766 89999999999999999999999965431 11111111 101111
Q ss_pred cccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 835 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 835 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
..+......+.+++.+|++.+|++||++.|++++
T Consensus 222 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 222 ----PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ----CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 1111223467889999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=299.18 Aligned_cols=246 Identities=29% Similarity=0.480 Sum_probs=195.8
Q ss_pred HHHHhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
.+.+.+.||+|+||.||++.. .++.+|+|+++... ....+.+|+.++++++|||++++++++... ..+++|||+.+
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~ 82 (254)
T cd05083 7 KLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSK 82 (254)
T ss_pred HceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCC
Confidence 355678999999999999975 47889999986442 245688999999999999999999998665 46899999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
++|.+++... ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 83 GNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 9999998643 234578899999999999999999998 99999999999999999999999999987543221
Q ss_pred eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCcccC
Q 002409 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 838 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 838 (927)
.....+..|+|||++.+..++.++|+|||||++|||++ |+.||......+ +... ...+...
T Consensus 155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~----~~~~----~~~~~~~--------- 216 (254)
T cd05083 155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE----VKEC----VEKGYRM--------- 216 (254)
T ss_pred -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH----HHHH----HhCCCCC---------
Confidence 11224568999999988899999999999999999998 999987544211 1111 1111100
Q ss_pred ccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHH
Q 002409 839 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 875 (927)
Q Consensus 839 ~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~ 875 (927)
.........+.+++.+|++.+|++||++.+|++.|++
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 0011223467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=297.89 Aligned_cols=249 Identities=26% Similarity=0.400 Sum_probs=199.5
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecC--CchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
|.+.+.||+|+||.+|+++.. +++.+|+|.+... .....+++.+|+.++++++||||+++++++...+..++|+||+
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 345688999999999999865 6889999998643 2333467899999999999999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
.+++|.+++... ....+++..++.++.|++.||+|||++ +++|+||+|+|||++.++.++|+|||++........
T Consensus 82 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 82 EGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 999999988532 233578889999999999999999998 999999999999999999999999999875433221
Q ss_pred ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCccc
Q 002409 758 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 837 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 837 (927)
......|++.|+|||++.++.++.++|+|||||++++|++|+.||...... .+.. ... .+....
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~----~~~~---~~~-~~~~~~------- 220 (256)
T cd08218 157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK----NLVL---KII-RGSYPP------- 220 (256)
T ss_pred -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH----HHHH---HHh-cCCCCC-------
Confidence 122345888999999999888999999999999999999999998654311 1111 111 111111
Q ss_pred CccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 838 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 838 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.+......+.+++.+|++.+|++||+|.||+++
T Consensus 221 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 221 --VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred --CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 111223468899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=338.92 Aligned_cols=255 Identities=24% Similarity=0.359 Sum_probs=196.1
Q ss_pred HHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceee--cCeEEEE
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVLV 673 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--~~~~~lV 673 (927)
..|.+.+.||+|+||.||+++.. .++.+|+|++.... ......+..|+.++++++||||+++++++.. ....+||
T Consensus 13 ~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIV 92 (1021)
T PTZ00266 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYIL 92 (1021)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEE
Confidence 34567789999999999999876 46788999886442 2335678899999999999999999998854 4568999
Q ss_pred EEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCC----CceecCCCCCCCeEECC------------
Q 002409 674 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV----PAIIHRDLKSSNILLDK------------ 737 (927)
Q Consensus 674 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~----~~ivHrDLkp~NILl~~------------ 737 (927)
|||+++|+|.++|.........+++..++.|+.||+.||+|||+... .+|+||||||+||||+.
T Consensus 93 MEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~ 172 (1021)
T PTZ00266 93 MEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172 (1021)
T ss_pred EeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccc
Confidence 99999999999986544445678999999999999999999998521 25999999999999964
Q ss_pred -----CCcEEEEeecCcccccCCCCceeeeeccCCCccCcccccc--CcCCCccceeeHHHHHHHHHhCCCccccccccc
Q 002409 738 -----HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFGA 810 (927)
Q Consensus 738 -----~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~ 810 (927)
.+.+||+|||+++...... ......||+.|+|||++.. ..++.++|||||||+||||++|+.||.....
T Consensus 173 ~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~-- 248 (1021)
T PTZ00266 173 NNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN-- 248 (1021)
T ss_pred cccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc--
Confidence 2358999999997553321 2234468999999999854 4588999999999999999999999965331
Q ss_pred ccchhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 811 NCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 811 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
...+.. . +..+. +.. ... ....+.+|+..||+.+|++||++.|++++
T Consensus 249 -~~qli~---~-lk~~p-----~lp-i~~----~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 249 -FSQLIS---E-LKRGP-----DLP-IKG----KSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred -HHHHHH---H-HhcCC-----CCC-cCC----CCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 111111 1 11110 000 011 12468899999999999999999999854
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=299.50 Aligned_cols=248 Identities=25% Similarity=0.401 Sum_probs=199.3
Q ss_pred HHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
..+.+.+.||+|+||.||+|... +++.+|+|++.... ......+.+|+.++++++||||+++++++..+...++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 34556688999999999999865 67899999886443 23346788999999999999999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
+++++|.+++.. ..+++..+..++.|++.++.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06641 84 LGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence 999999988842 3578999999999999999999998 99999999999999999999999999987543322
Q ss_pred CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 757 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
.......++..|+|||.+.+..++.++|+|||||++|||++|..||...... ..... ...+.. +.+
T Consensus 156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----~~~~~----~~~~~~-----~~~ 221 (277)
T cd06641 156 -IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM----KVLFL----IPKNNP-----PTL 221 (277)
T ss_pred -hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH----HHHHH----HhcCCC-----CCC
Confidence 1222345788999999998888899999999999999999999998643311 11111 111111 111
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.......+.+++.+|++.+|++||++.|++++
T Consensus 222 ----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 ----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ----CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11223467899999999999999999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=300.73 Aligned_cols=254 Identities=26% Similarity=0.402 Sum_probs=196.6
Q ss_pred HhccccccCceEEEEEEEC----CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecC------eE
Q 002409 603 LEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------RS 670 (927)
Q Consensus 603 ~~~~IG~G~fG~Vy~~~~~----~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~------~~ 670 (927)
+.+.||+|+||.||+|.+. .++.||||++.... ....+++.+|++++++++||||+++++++.... ..
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05074 3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP 82 (273)
T ss_pred chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence 4678999999999999764 36789999987542 334567889999999999999999999885432 24
Q ss_pred EEEEEeccCCchhhhccccc--ccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecC
Q 002409 671 VLVYEFMHNGTLKEHLYGTL--THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 748 (927)
Q Consensus 671 ~lV~E~~~~gsL~~~L~~~~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGl 748 (927)
++++||+.+|+|.+++.... .....+++...+.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcccc
Confidence 78899999999988874322 1223578889999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCc-eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccC
Q 002409 749 SKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESG 826 (927)
Q Consensus 749 a~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~ 826 (927)
++........ ......+++.|++||.+....++.++|||||||++|||++ |+.||..... ..+..+.... .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~----~~~~~~~~~~---~ 232 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN----SEIYNYLIKG---N 232 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH----HHHHHHHHcC---C
Confidence 8855432211 1122335678999999988889999999999999999999 8888865431 1222221110 1
Q ss_pred CcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHH
Q 002409 827 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 876 (927)
Q Consensus 827 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~ 876 (927)
... .+......+.+++.+|++.+|++||++.|+++.|+++
T Consensus 233 ~~~----------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 233 RLK----------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred cCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 100 0112234789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=297.96 Aligned_cols=251 Identities=26% Similarity=0.406 Sum_probs=199.0
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc--hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
|.+.+.||+|+||.||+|... +++.+++|.++.... ...+.+.+|++++++++|+||+++++.+...+..++|+||+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 345688999999999999865 688999999876543 25677899999999999999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
++++|.+++.. ...+++..+..++.|+++||+|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 82 ~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 82 SGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 99999998853 34578888999999999999999998 999999999999999999999999999876544332
Q ss_pred ceee---eeccCCCccCccccccCc---CCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccc
Q 002409 758 HVSS---IVRGTVGYLDPEYYISQQ---LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 831 (927)
Q Consensus 758 ~~~~---~~~gt~~Y~aPE~~~~~~---~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 831 (927)
.... ...++..|+|||++.... ++.++||||||++++||++|+.||...... ..+..... .+.
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~---~~~~~~~~----~~~---- 223 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE---FQIMFHVG----AGH---- 223 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch---HHHHHHHh----cCC----
Confidence 2221 345788999999998766 889999999999999999999999643211 01111111 010
Q ss_pred cCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 832 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 832 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.+.+... ......+.+++.+|++.+|++||++.|++.+
T Consensus 224 -~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 224 -KPPIPDS--LQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred -CCCCCcc--cccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0111111 1123457799999999999999999998763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=325.96 Aligned_cols=261 Identities=19% Similarity=0.267 Sum_probs=187.1
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccC------CCccceecceeec-CeEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH------RNLVQFLGYCQEE-GRSV 671 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~H------pnIv~l~g~~~~~-~~~~ 671 (927)
.|.+.++||+|+||+||+|... .++.||||+++... ...+.+..|++++++++| .+++++++++... .+.+
T Consensus 130 ~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~ 208 (467)
T PTZ00284 130 RFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMC 208 (467)
T ss_pred cEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEE
Confidence 4556789999999999999875 57889999986432 224456677887777755 4588888888654 5788
Q ss_pred EEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCC------------
Q 002409 672 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM------------ 739 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~------------ 739 (927)
+|||++ +++|.+++.. ...+++..+..|+.||+.||+|||++ .+|+||||||+|||++.++
T Consensus 209 iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 209 IVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred EEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccC
Confidence 999987 6788887743 35688999999999999999999973 2899999999999998765
Q ss_pred ----cEEEEeecCcccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchh
Q 002409 740 ----RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 815 (927)
Q Consensus 740 ----~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l 815 (927)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+
T Consensus 282 ~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i 357 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM 357 (467)
T ss_pred CCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 49999999875322 1223456999999999999999999999999999999999999999754321111111
Q ss_pred hH--------HHHhh--------h-ccCCcccccCCccc----C---ccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHH
Q 002409 816 VQ--------WAKLH--------I-ESGDIQGIIDPSLL----D---EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 871 (927)
Q Consensus 816 ~~--------~~~~~--------~-~~~~~~~~~d~~l~----~---~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~ 871 (927)
.. |.... . ..+.+....++... . .........+.+|+.+||+.||++|||++|+++
T Consensus 358 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 358 EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 00 10000 0 00000000010000 0 000011245779999999999999999999998
Q ss_pred H
Q 002409 872 D 872 (927)
Q Consensus 872 ~ 872 (927)
|
T Consensus 438 H 438 (467)
T PTZ00284 438 H 438 (467)
T ss_pred C
Confidence 6
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=302.09 Aligned_cols=252 Identities=27% Similarity=0.380 Sum_probs=195.7
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhc-cCCCccceecceeec-----CeEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE-----GRSVLV 673 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~-----~~~~lV 673 (927)
+.+.+.||+|+||.||++... +++.+|+|++.... .....+.+|+.+++++ +|||++++++++... +..++|
T Consensus 24 y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv 102 (291)
T cd06639 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLV 102 (291)
T ss_pred eEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEE
Confidence 345678999999999999875 68899999986432 2345678899999998 899999999998653 357999
Q ss_pred EEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccccc
Q 002409 674 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 753 (927)
Q Consensus 674 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 753 (927)
+||+++++|.+++.........+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 103 ~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~ 179 (291)
T cd06639 103 LELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 179 (291)
T ss_pred EEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchhcc
Confidence 999999999998865444456789999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCCceeeeeccCCCccCccccccC-----cCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCc
Q 002409 754 DGASHVSSIVRGTVGYLDPEYYISQ-----QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 828 (927)
Q Consensus 754 ~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 828 (927)
.... ......|+..|+|||.+... .++.++|||||||++|||++|+.||....... .+..+ ..+..
T Consensus 180 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~---~~~~~-----~~~~~ 250 (291)
T cd06639 180 STRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK---TLFKI-----PRNPP 250 (291)
T ss_pred cccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH---HHHHH-----hcCCC
Confidence 3221 12234588999999998643 36889999999999999999999997543111 11111 11111
Q ss_pred ccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 829 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 829 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
..+.+ ..+....+.+++.+|++.+|++||++.|++++
T Consensus 251 ~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 251 PTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11111 11222468899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=302.91 Aligned_cols=263 Identities=20% Similarity=0.259 Sum_probs=192.6
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc--hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
.+.+.||+|+||.||+|+.. +|+.+|+|+++.... .....+.+|++++++++||||+++++++.+.+..++|+||+.
T Consensus 3 ~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (284)
T cd07839 3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD 82 (284)
T ss_pred eeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC
Confidence 45678999999999999876 688999999865322 223567889999999999999999999999999999999997
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
++|.+++... ...+++..++.++.|+++||.|||+. +++||||||+||+++.++.+||+|||+++.......
T Consensus 83 -~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 154 (284)
T cd07839 83 -QDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR- 154 (284)
T ss_pred -CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence 4777776432 34589999999999999999999998 999999999999999999999999999875433221
Q ss_pred eeeeeccCCCccCccccccC-cCCCccceeeHHHHHHHHHhCCCccccccc-ccccchhhH---------HHHhh-hccC
Q 002409 759 VSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKF-GANCRNIVQ---------WAKLH-IESG 826 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvL~elltG~~p~~~~~~-~~~~~~l~~---------~~~~~-~~~~ 826 (927)
......++..|+|||.+.+. .++.++|||||||++|||++|+.|+..... .+....+.. |.... ....
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 12223478899999998764 468899999999999999999988643221 111111110 10000 0000
Q ss_pred CcccccCCccc-CccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 827 DIQGIIDPSLL-DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 827 ~~~~~~d~~l~-~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
........... .+.......++.+++.+|++.+|++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00000000000 01111223467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=296.80 Aligned_cols=251 Identities=24% Similarity=0.396 Sum_probs=197.3
Q ss_pred HHhccccccCceEEEEEEE-CCCcEEEEEEeecCCc------hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEE
Q 002409 602 MLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNSY------QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 674 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~-~~g~~VAVK~l~~~~~------~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~ 674 (927)
...+.||+|+||.||++.. .+++.+|+|++..... ...+.+..|++++++++|+||+++++++.+.+..++|+
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 82 (268)
T cd06630 3 LKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV 82 (268)
T ss_pred cccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEE
Confidence 3457899999999999986 4688999999864321 12457889999999999999999999999999999999
Q ss_pred EeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCC-cEEEEeecCccccc
Q 002409 675 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAV 753 (927)
Q Consensus 675 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-~vkL~DFGla~~~~ 753 (927)
||+++++|.+++.. ...+++..+..++.|++.||+|||++ +++|+||||+||+++.++ .+||+|||.+....
T Consensus 83 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 83 EWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred eccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 99999999998843 34678899999999999999999998 999999999999998776 59999999987554
Q ss_pred CCCC---ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCccc
Q 002409 754 DGAS---HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 830 (927)
Q Consensus 754 ~~~~---~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 830 (927)
.... .......|+..|+|||.+.+..++.++||||+|+++++|++|+.||......... ...........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~--- 228 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL----ALIFKIASATT--- 228 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH----HHHHHHhccCC---
Confidence 3211 1122345789999999998888999999999999999999999999654321111 11111100000
Q ss_pred ccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 831 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 831 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
....+......+.+++.+|++.+|++||++.|++++
T Consensus 229 ------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 229 ------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred ------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 111222233568899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=298.93 Aligned_cols=252 Identities=27% Similarity=0.390 Sum_probs=195.7
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCCch----------hhHhHHHHHHHHhhccCCCccceecceeecCeE
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ----------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS 670 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~----------~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~ 670 (927)
...+.||+|+||.||+|... +++.+|+|.++..... ..+.+.+|+.++++++|+|++++++++...+..
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (272)
T cd06629 4 VKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYL 83 (272)
T ss_pred eecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCce
Confidence 34678999999999999765 6889999987532111 123577899999999999999999999999999
Q ss_pred EEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcc
Q 002409 671 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 750 (927)
Q Consensus 671 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 750 (927)
++||||+.+++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++
T Consensus 84 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 84 SIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred EEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 9999999999999988543 4688889999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCc-eeeeeccCCCccCccccccCc--CCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCC
Q 002409 751 FAVDGASH-VSSIVRGTVGYLDPEYYISQQ--LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 827 (927)
Q Consensus 751 ~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~--~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 827 (927)
........ ......|+..|+|||.+.... ++.++|+||||+++|||++|+.||..... ...... .. ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~~-~~-~~~ 228 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA------IAAMFK-LG-NKR 228 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch------HHHHHH-hh-ccc
Confidence 54332211 123345889999999987654 88999999999999999999999964331 111111 00 011
Q ss_pred cccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 828 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 828 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
....++.... ......+.+++.+|++.+|++||++.||+++
T Consensus 229 ~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 229 SAPPIPPDVS----MNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cCCcCCcccc----ccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 1111111111 1223568899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=295.46 Aligned_cols=255 Identities=25% Similarity=0.372 Sum_probs=201.8
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
+.+.+.||.|+||+||+|... ++..+|+|++.... ......+.+|+++++.++|+||+++++.+...+..++|+|+++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 82 (267)
T cd06610 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82 (267)
T ss_pred ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence 445688999999999999865 67889999986543 2345778999999999999999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
+++|.+++.... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++.........
T Consensus 83 ~~~l~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 83 GGSLLDIMKSSY-PRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred CCcHHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 999999986432 124688999999999999999999998 9999999999999999999999999998755443222
Q ss_pred ---eeeeeccCCCccCccccccC-cCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCC
Q 002409 759 ---VSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 834 (927)
Q Consensus 759 ---~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 834 (927)
......|+..|+|||++... .++.++|+|||||+++||++|+.||......+ .+...... .. +
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~---~~~~~~~~--~~--------~ 225 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK---VLMLTLQN--DP--------P 225 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh---hHHHHhcC--CC--------C
Confidence 22334588999999998876 78999999999999999999999997544221 11111111 00 0
Q ss_pred cccCcc-CHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 835 SLLDEY-DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 835 ~l~~~~-~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.+.... .......+.+++.+|++.+|++||++.|++++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 111110 11223568899999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=294.25 Aligned_cols=248 Identities=26% Similarity=0.380 Sum_probs=198.1
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
|.+.+.||+|+||.||++... +++.+|+|.+.... ......+.+|++++++++||||+++++.+...+..++||||+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 345678999999999999875 67889999986542 334567889999999999999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCC-CcEEEEeecCcccccCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~-~~vkL~DFGla~~~~~~~ 756 (927)
++++|.+++... ....+++..+..++.|++.+|+|||++ +++||||||+||+++.+ +.+||+|||++.......
T Consensus 82 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 82 PGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 999999998543 234578999999999999999999998 99999999999999865 468999999997654322
Q ss_pred CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 757 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
......|+..|+|||.+....++.++||||||+++|+|++|+.||...... ........ +....
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~----~~~~~~~~----~~~~~------ 220 (256)
T cd08220 157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP----ALVLKIMS----GTFAP------ 220 (256)
T ss_pred --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH----HHHHHHHh----cCCCC------
Confidence 122345889999999999888999999999999999999999999754421 11111111 11111
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
........+.+++.+|++.+|++|||+.|++++
T Consensus 221 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 221 ---ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ---CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 111123468899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=301.36 Aligned_cols=251 Identities=25% Similarity=0.378 Sum_probs=192.6
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCC-chhhHhHHHHHHH-HhhccCCCccceecceeecCeEEEEEEecc
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTL-LSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~i-L~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
.+.+.||+|+||.||+++.. +|+.||+|+++... ......+..|+.. ++..+||||+++++++...+..+++|||++
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~ 83 (283)
T cd06617 4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD 83 (283)
T ss_pred eEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc
Confidence 35678999999999999876 68999999987542 2334455566665 566789999999999999999999999996
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
|+|.+++.........+++..++.++.|++.||+|||+++ +++||||||+||+++.++.+||+|||+++......
T Consensus 84 -~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 158 (283)
T cd06617 84 -TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV-- 158 (283)
T ss_pred -ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccccccc--
Confidence 6888877654444567899999999999999999999852 89999999999999999999999999987553321
Q ss_pred eeeeeccCCCccCcccccc----CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCC
Q 002409 759 VSSIVRGTVGYLDPEYYIS----QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 834 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~----~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 834 (927)
......|+..|+|||.+.+ ..++.++|+|||||++|||++|+.||..... ....+..... +.. +
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~-----~~~-----~ 226 (283)
T cd06617 159 AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT--PFQQLKQVVE-----EPS-----P 226 (283)
T ss_pred ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc--CHHHHHHHHh-----cCC-----C
Confidence 1223458899999998864 4568899999999999999999999964321 1111211111 101 1
Q ss_pred cccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 835 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 835 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.+.. ......+.+++.+|+..+|++||++.||+++
T Consensus 227 ~~~~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 227 QLPA---EKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred CCCc---cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1100 0122468899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=295.79 Aligned_cols=251 Identities=28% Similarity=0.398 Sum_probs=200.4
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
.+.+.||+|+||.||++..+ +++.+|+|.+.... .....++.+|++++++++||||+++++.+......++++||+++
T Consensus 4 ~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (265)
T cd06605 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDG 83 (265)
T ss_pred hHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCC
Confidence 45678999999999999887 68899999987653 34456788999999999999999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhh-CCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
++|.+++.... ..++......++.|++.||+|||+ . +++||||||+||++++++.+||+|||.+.........
T Consensus 84 ~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 157 (265)
T cd06605 84 GSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK 157 (265)
T ss_pred CcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence 99999885431 567888999999999999999999 7 9999999999999999999999999998754332211
Q ss_pred eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccC
Q 002409 759 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 838 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 838 (927)
...++..|+|||.+.+..++.++||||||+++++|++|+.||...... .....+......... . +.+..
T Consensus 158 ---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~-~-----~~~~~ 226 (265)
T cd06605 158 ---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP--PDGIFELLQYIVNEP-P-----PRLPS 226 (265)
T ss_pred ---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc--cccHHHHHHHHhcCC-C-----CCCCh
Confidence 155889999999999889999999999999999999999999654211 011222222111111 0 01111
Q ss_pred ccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 839 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 839 ~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
. .....+.+++.+|+..+|++||++.|++.+
T Consensus 227 ~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 227 G---KFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred h---hcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1 133458899999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=297.94 Aligned_cols=254 Identities=26% Similarity=0.396 Sum_probs=198.0
Q ss_pred HHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhc-cCCCccceecceeecC------eE
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEG------RS 670 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~------~~ 670 (927)
..|.+.+.||+|+||.||+|..+ +++.+++|++..... ....+.+|+++++++ +|+||+++++++.... ..
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL 84 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence 34566789999999999999886 578899999875543 346789999999999 7999999999997644 48
Q ss_pred EEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcc
Q 002409 671 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 750 (927)
Q Consensus 671 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 750 (927)
++||||+++++|.+++.........+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||+|||++.
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCccce
Confidence 999999999999998865433356789999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCceeeeeccCCCccCcccccc-----CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhcc
Q 002409 751 FAVDGASHVSSIVRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES 825 (927)
Q Consensus 751 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 825 (927)
...... .......|+..|+|||++.. ..++.++|||||||+++||++|+.||...... ..+.+ ...
T Consensus 162 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~-----~~~ 232 (275)
T cd06608 162 QLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM---RALFK-----IPR 232 (275)
T ss_pred ecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH---HHHHH-----hhc
Confidence 543322 12233458899999998753 34678899999999999999999999643211 11111 111
Q ss_pred CCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 826 GDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 826 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
+.... +.. .......+.+++.+|+..+|++|||+.|++++
T Consensus 233 ~~~~~-----~~~--~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 233 NPPPT-----LKS--PENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred cCCCC-----CCc--hhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11111 111 11233468899999999999999999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=302.52 Aligned_cols=263 Identities=21% Similarity=0.253 Sum_probs=196.5
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCCch-----hhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEE
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-----GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 675 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~-----~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E 675 (927)
.+.+.||+|+||.||+|... +++.||||.++..... ....+..|++++++++|+||+++++++.+.+..++|||
T Consensus 3 ~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 82 (298)
T cd07841 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFE 82 (298)
T ss_pred eeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEc
Confidence 44578999999999999875 6889999999755322 23457789999999999999999999999999999999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCC
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 755 (927)
|+ +|+|.+++... ...+++..++.++.|+++||+|||++ +++||||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~-~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 83 FM-ETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred cc-CCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 99 89999998542 13689999999999999999999998 9999999999999999999999999999765433
Q ss_pred CCceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhcc-----CCcc
Q 002409 756 ASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES-----GDIQ 829 (927)
Q Consensus 756 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~-----~~~~ 829 (927)
... .....++..|+|||.+.+ ..++.++|||||||+++||++|..+|......+....+.......... ....
T Consensus 156 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (298)
T cd07841 156 NRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP 234 (298)
T ss_pred Ccc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence 221 122346788999998864 467889999999999999999988776543211111111111000000 0000
Q ss_pred cccCCcccCcc-----CHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 830 GIIDPSLLDEY-----DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 830 ~~~d~~l~~~~-----~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
........... .......+.+++.+|++.+|++||++.||+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000111 11223578899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=300.49 Aligned_cols=265 Identities=21% Similarity=0.222 Sum_probs=197.1
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCch--hhHhHHHHHHHHhhccCCCccceecceeec--CeEEEEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLVY 674 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--~~~~lV~ 674 (927)
.+.+.+.||+|+||.||+|..+ +++.+|+|.++..... ....+.+|+.++++++||||+++++++... ...++||
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence 3556788999999999999886 5788999998754322 234567899999999999999999998877 8899999
Q ss_pred EeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccC
Q 002409 675 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 754 (927)
Q Consensus 675 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 754 (927)
||+. ++|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 86 e~~~-~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 86 EYVE-HDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred hhcC-cCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 9997 4888887532 23689999999999999999999998 999999999999999999999999999886544
Q ss_pred CCCceeeeeccCCCccCccccccC-cCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHh------------
Q 002409 755 GASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL------------ 821 (927)
Q Consensus 755 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~------------ 821 (927)
.... .....+++.|+|||.+.+. .++.++|+||||+++|||++|+.||...........+......
T Consensus 159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 159 PLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred Cccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence 3211 1233478899999998754 4688999999999999999999999754322211122111100
Q ss_pred -hhccCCcccccCCcccCccCHH-HHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 822 -HIESGDIQGIIDPSLLDEYDIQ-SMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 822 -~~~~~~~~~~~d~~l~~~~~~~-~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
..............+...+... ....+.+++.+|++.+|++||++.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000001111111111112211 24567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=297.35 Aligned_cols=247 Identities=25% Similarity=0.352 Sum_probs=190.9
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCC-----chhhHhHHHHHHHHhhccCCCccceecceeec--CeEEEE
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-----YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLV 673 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~-----~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--~~~~lV 673 (927)
.+.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|++++++++||||+++++++.+. ...+++
T Consensus 5 ~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v 84 (265)
T cd06652 5 RLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIF 84 (265)
T ss_pred eEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEE
Confidence 34678999999999999875 58899999885321 12235688899999999999999999988663 467899
Q ss_pred EEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccccc
Q 002409 674 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 753 (927)
Q Consensus 674 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 753 (927)
|||+++++|.+++.. ...+++...+.++.|++.||+|||++ +++|+||||+||+++.++.+||+|||+++...
T Consensus 85 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 85 MEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 999999999998843 24577888899999999999999998 99999999999999999999999999987543
Q ss_pred CCCC--ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccc
Q 002409 754 DGAS--HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 831 (927)
Q Consensus 754 ~~~~--~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 831 (927)
.... .......|+..|+|||.+....++.++|||||||++|||++|+.||....... .+.+ ......
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~~~~----~~~~~~---- 226 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA---AIFK----IATQPT---- 226 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH---HHHH----HhcCCC----
Confidence 2111 11223458899999999988889999999999999999999999996543111 1111 110000
Q ss_pred cCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 832 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 832 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
....+......+.+++.+|+. +|++||+++||+++
T Consensus 227 -----~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 227 -----NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred -----CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 111122333467788888884 89999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=306.75 Aligned_cols=240 Identities=27% Similarity=0.430 Sum_probs=194.7
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeecCCc---hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCC
Q 002409 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 680 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 680 (927)
+.||.|.||.||-|+.. +.+.||||++.-... +...++.+|+..|++++|||++.+-|+|..+...+||||||-|
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClG- 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLG- 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhc-
Confidence 56999999999999865 577899999875433 3356789999999999999999999999999999999999964
Q ss_pred chhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCcee
Q 002409 681 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 760 (927)
Q Consensus 681 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 760 (927)
+-.|++.- ..+++.+.++..|+.+.+.||+|||+. +.||||||+.|||+++.|.|||+|||.|....+ .
T Consensus 111 SAsDlleV---hkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-----A 179 (948)
T KOG0577|consen 111 SASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-----A 179 (948)
T ss_pred cHHHHHHH---HhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc-----h
Confidence 66666632 246678889999999999999999998 999999999999999999999999999876543 2
Q ss_pred eeeccCCCccCccccc---cCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCccc
Q 002409 761 SIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 837 (927)
Q Consensus 761 ~~~~gt~~Y~aPE~~~---~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 837 (927)
..+.|||.|||||++. .++|+.++||||||+...||...++|+-... ..-+..++...+- |-+.
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN--------AMSALYHIAQNes-----PtLq 246 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNES-----PTLQ 246 (948)
T ss_pred hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch--------HHHHHHHHHhcCC-----CCCC
Confidence 3467999999999985 4789999999999999999999999875433 1112222222221 1111
Q ss_pred CccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 838 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 838 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
..+....+..++..|++.-|++|||..+++.|
T Consensus 247 ---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 247 ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred ---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 22344568899999999999999999998765
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=300.58 Aligned_cols=249 Identities=24% Similarity=0.345 Sum_probs=199.7
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
.+.+.+.||+|+||.||++... +++.||+|.+........+.+.+|+.++++++||||+++++.+...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~ 99 (293)
T cd06647 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLA 99 (293)
T ss_pred hceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCC
Confidence 4556788999999999999864 678999999865544445678899999999999999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
+++|.+++.. ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 100 ~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~- 170 (293)
T cd06647 100 GGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (293)
T ss_pred CCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence 9999998843 3477888999999999999999998 999999999999999999999999998875443322
Q ss_pred eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccC
Q 002409 759 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 838 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 838 (927)
......|++.|++||.+....++.++|||||||++|||++|+.||......... ... ...+. . ..
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~---~~~----~~~~~-~-----~~-- 235 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL---YLI----ATNGT-P-----EL-- 235 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe---eeh----hcCCC-C-----CC--
Confidence 222345888999999998888999999999999999999999999754421111 000 00000 0 00
Q ss_pred ccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 839 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 839 ~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.........+.+++.+|++.+|++||++.|++.+
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011223468899999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=301.44 Aligned_cols=262 Identities=21% Similarity=0.271 Sum_probs=194.3
Q ss_pred HhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 603 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 603 ~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
..+.||+|++|.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++.+.+..++||||+.
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~- 82 (284)
T cd07860 4 KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH- 82 (284)
T ss_pred eeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-
Confidence 4578999999999999876 68899999886442 2233568899999999999999999999999999999999996
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
++|.+++... ....+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||+|||+++....... .
T Consensus 83 ~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-~ 156 (284)
T cd07860 83 QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-T 156 (284)
T ss_pred cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-c
Confidence 6888887542 245688999999999999999999998 999999999999999999999999999875433221 1
Q ss_pred eeeeccCCCccCccccccCc-CCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhc------------cC
Q 002409 760 SSIVRGTVGYLDPEYYISQQ-LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE------------SG 826 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~-~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~------------~~ 826 (927)
.....++..|+|||.+.+.. ++.++|||||||++|||++|+.||...........+.++...... ..
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence 12234688999999887644 688999999999999999999999654321111111111110000 00
Q ss_pred CcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 827 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 827 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.+.......+... .......+.+++.+|++.+|++||++.|++++
T Consensus 237 ~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 237 SFPKWARQDFSKV-VPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hcccccccCHHHH-cccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000000000000 01122357789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-32 Score=295.98 Aligned_cols=257 Identities=25% Similarity=0.325 Sum_probs=200.2
Q ss_pred HhccccccCceEEEEEEEC-CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeec--CeEEEEEEecc
Q 002409 603 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLVYEFMH 678 (927)
Q Consensus 603 ~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--~~~~lV~E~~~ 678 (927)
..+.||.|++|.||++... +++.+|+|.+.... ......+.+|++++++++||||+++++++... +..++||||++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~ 84 (287)
T cd06621 5 ELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCE 84 (287)
T ss_pred EEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecC
Confidence 3578999999999999885 57889999987543 23456789999999999999999999988653 46899999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
+++|.+++.........++...+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 160 (287)
T cd06621 85 GGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA- 160 (287)
T ss_pred CCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccccc-
Confidence 9999988755444456688899999999999999999998 999999999999999999999999999875432211
Q ss_pred eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccc-cccchhhHHHHhhhccCCcccccCCccc
Q 002409 759 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG-ANCRNIVQWAKLHIESGDIQGIIDPSLL 837 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~-~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 837 (927)
....++..|+|||.+.+..++.++|||||||++|||++|+.||.....+ .....+..+..... ... +.....
T Consensus 161 --~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~-~~~~~~ 233 (287)
T cd06621 161 --GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP----NPE-LKDEPG 233 (287)
T ss_pred --ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC----chh-hccCCC
Confidence 2334788999999999889999999999999999999999999765321 11112333322210 000 110100
Q ss_pred CccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 838 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 838 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
. .......+.+++.+|++.+|++|||+.||+++
T Consensus 234 ~--~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 234 N--GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred C--CCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 0 01233568899999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=305.03 Aligned_cols=250 Identities=24% Similarity=0.291 Sum_probs=196.6
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCCch---hhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~---~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
.+.+.||+|+||.||++... +++.+|+|.+...... ..+.+.+|++++++++|+||+++++.+......++||||+
T Consensus 4 ~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (316)
T cd05574 4 KKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYC 83 (316)
T ss_pred EEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEec
Confidence 34578999999999999876 4889999998765322 3456889999999999999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
.+++|.+++... ....+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 84 PGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred CCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 999999988532 245688999999999999999999998 999999999999999999999999999864422111
Q ss_pred c----------------------------eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccc
Q 002409 758 H----------------------------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG 809 (927)
Q Consensus 758 ~----------------------------~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~ 809 (927)
. ......|+..|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 0 111235788999999999888999999999999999999999999754421
Q ss_pred cccchhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCc----HHHHHHH
Q 002409 810 ANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS----ISEVLKD 872 (927)
Q Consensus 810 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs----m~eV~~~ 872 (927)
.....+. .... .... .......+.+++.+|++.+|++||+ +.|++++
T Consensus 239 ~~~~~~~--------~~~~------~~~~--~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 239 ETFSNIL--------KKEV------TFPG--SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HHHHHHh--------cCCc------cCCC--ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 1111110 0000 0000 0113457899999999999999999 5555553
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=300.03 Aligned_cols=262 Identities=23% Similarity=0.270 Sum_probs=195.0
Q ss_pred HhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 603 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 603 ~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
+.+.||.|++|.||+|... +|+.||+|++.... ......+.+|++++++++|||++++++++.+.+..+++|||+.
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~- 81 (283)
T cd07835 3 KVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD- 81 (283)
T ss_pred hheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-
Confidence 4578999999999999875 68999999987543 2223568889999999999999999999999999999999995
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
++|.+++.... ...+++..++.++.|+++||+|||+. +++||||+|+||+++.++.++|+|||+++........
T Consensus 82 ~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~- 155 (283)
T cd07835 82 LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT- 155 (283)
T ss_pred cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-
Confidence 68988875432 24689999999999999999999998 9999999999999999999999999998754322211
Q ss_pred eeeeccCCCccCccccccC-cCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccC------------
Q 002409 760 SSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG------------ 826 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~------------ 826 (927)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||...........+.++........
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP 235 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence 1222468899999988664 578899999999999999999999965432111111111111000000
Q ss_pred CcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 827 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 827 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.......+.. ..........+.+++.+|++.+|++||+++|++++
T Consensus 236 ~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 236 TFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000000 01111222468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=297.24 Aligned_cols=251 Identities=25% Similarity=0.387 Sum_probs=193.1
Q ss_pred HHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhc-cCCCccceecceee------cCeE
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQE------EGRS 670 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~------~~~~ 670 (927)
..+.+.+.||+|+||.||+|+.. +++.+|+|++.... .....+..|+.+++++ +|+||+++++++.. ....
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 94 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL 94 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence 34556789999999999999875 57889999986543 2345688899999998 79999999998853 4578
Q ss_pred EEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcc
Q 002409 671 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 750 (927)
Q Consensus 671 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 750 (927)
+++|||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.++|+|||++.
T Consensus 95 ~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 95 WLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred EEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 99999999999999885432 34577888899999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCceeeeeccCCCccCccccc-----cCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhcc
Q 002409 751 FAVDGASHVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES 825 (927)
Q Consensus 751 ~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 825 (927)
....... ......|+..|+|||.+. ...++.++|||||||++|||++|+.||........ +.. ...
T Consensus 170 ~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~---~~~-----~~~ 240 (282)
T cd06636 170 QLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA---LFL-----IPR 240 (282)
T ss_pred hhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh---hhh-----Hhh
Confidence 5432211 122345889999999985 34678899999999999999999999965431111 100 000
Q ss_pred CCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 826 GDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 826 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.. .+... .......+.+++.+|++.+|++||++.|++++
T Consensus 241 ~~-----~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 241 NP-----PPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred CC-----CCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 00 01111 01123468899999999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=300.74 Aligned_cols=261 Identities=21% Similarity=0.287 Sum_probs=192.7
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc-hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
+.+.+.||+|++|.||+|+.+ +++.||+|.+..... .....+.+|++++++++|+||+++++++.+.+..++||||+.
T Consensus 7 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07844 7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD 86 (291)
T ss_pred eeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC
Confidence 345678999999999999876 688999999875432 223457789999999999999999999999999999999997
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
+ +|.+++... ...+++..+..++.|+++||.|||+. +++||||||+||+++.++.+||+|||+++...... .
T Consensus 87 ~-~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~ 158 (291)
T cd07844 87 T-DLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-K 158 (291)
T ss_pred C-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC-c
Confidence 5 898887543 23678899999999999999999998 99999999999999999999999999986432211 1
Q ss_pred eeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhcc---CCc------
Q 002409 759 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES---GDI------ 828 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~---~~~------ 828 (927)
......++..|+|||++.+ ..++.++||||+||++|||++|+.||....... .........+.. ...
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE---DQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH---HHHHHHHHhcCCCChhhhhhhhhc
Confidence 1122346889999999875 458899999999999999999999996443110 000000000000 000
Q ss_pred --------ccccCCcccCcc-CHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 829 --------QGIIDPSLLDEY-DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 829 --------~~~~d~~l~~~~-~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.......+.... .......+.+++.+|++.+|++||++.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 000000000000 01112467899999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=300.69 Aligned_cols=243 Identities=26% Similarity=0.358 Sum_probs=197.0
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
|.+.+.||+|+||.||++... +++.+|+|+++... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (290)
T cd05580 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY 82 (290)
T ss_pred eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence 345688999999999999876 58899999987542 22345688999999999999999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
+++++|.+++.. ...++...+..++.|++.||.|||+. +++||||+|+|||++.++.+||+|||+++.....
T Consensus 83 ~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 83 VPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred CCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 999999998843 35688999999999999999999998 9999999999999999999999999998765433
Q ss_pred CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 757 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
.....|++.|+|||.+.+...+.++||||||+++|+|++|+.||...... ...+. ...+.. .+
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~----~~~~~~------~~ 217 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI----QIYEK----ILEGKV------RF 217 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH----HHHHH----HhcCCc------cC
Confidence 22345889999999998888899999999999999999999999754411 11111 111111 01
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCC-----cHHHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 872 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----sm~eV~~~ 872 (927)
+......+.+++.+|++.+|++|| +++|++++
T Consensus 218 ----~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 218 ----PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred ----CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 111134678999999999999999 77777655
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=297.15 Aligned_cols=245 Identities=24% Similarity=0.357 Sum_probs=197.3
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCCch
Q 002409 604 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 682 (927)
Q Consensus 604 ~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 682 (927)
.+.||+|++|.||++... +++.+++|++........+.+.+|+.++++++||||+++++++...+..++++||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L 103 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence 368999999999999865 6889999998755545556788999999999999999999999999999999999999999
Q ss_pred hhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCceeee
Q 002409 683 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 762 (927)
Q Consensus 683 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 762 (927)
.+++.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++....... .....
T Consensus 104 ~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~ 174 (285)
T cd06648 104 TDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-PRRKS 174 (285)
T ss_pred HHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC-ccccc
Confidence 998843 4578889999999999999999998 99999999999999999999999999887543322 12233
Q ss_pred eccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCccCH
Q 002409 763 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 842 (927)
Q Consensus 763 ~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 842 (927)
..|+..|+|||.+.+..++.++|||||||++|||++|+.||...... ..... ...+.. +.... ..
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~----~~~~~----~~~~~~-----~~~~~--~~ 239 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL----QAMKR----IRDNLP-----PKLKN--LH 239 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH----HHHHH----HHhcCC-----CCCcc--cc
Confidence 45889999999998888999999999999999999999998654311 11111 111110 01100 11
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 843 QSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 843 ~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.....+.+++.+|++.+|++||++.|++++
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 240 KVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred cCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 123468999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-32 Score=295.22 Aligned_cols=247 Identities=25% Similarity=0.380 Sum_probs=196.6
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC-chhhHhHHHHHHHHhhcc---CCCccceecceeecCeEEEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIH---HRNLVQFLGYCQEEGRSVLVYE 675 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~---HpnIv~l~g~~~~~~~~~lV~E 675 (927)
|.+.+.||+|+||.||+|... +++.+|+|.+.... .....++.+|++++++++ |||++++++++......++|||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e 82 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME 82 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence 345678999999999999874 68899999987542 333456889999999997 9999999999999999999999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCC
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 755 (927)
|+++++|.+++.. ..+++..++.++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 83 YAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred cCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 9999999998742 3688999999999999999999998 9999999999999999999999999998765443
Q ss_pred CCceeeeeccCCCccCccccccC-cCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCC
Q 002409 756 ASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 834 (927)
Q Consensus 756 ~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 834 (927)
.. ......|+..|+|||.+.++ .++.++|||||||++|+|++|+.||....... +.. ..... ..+
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-------~~~-~~~~~-----~~~ 220 (277)
T cd06917 155 SS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-------AMM-LIPKS-----KPP 220 (277)
T ss_pred cc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh-------hhh-ccccC-----CCC
Confidence 32 22334588999999998754 46889999999999999999999997543111 110 00011 111
Q ss_pred cccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 835 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 835 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.+... .....+.+++.+|++.+|++||++.|++++
T Consensus 221 ~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 221 RLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 11111 123468899999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=302.23 Aligned_cols=252 Identities=22% Similarity=0.274 Sum_probs=195.8
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc---hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
.+.+.||+|+||.||++... .++.|++|.+..... .....+.+|+++++.++||||+++++.+..++..++||||+
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (305)
T cd05609 4 ETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYV 83 (305)
T ss_pred eEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecC
Confidence 34678999999999999876 578899999875532 23456789999999999999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC-
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA- 756 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~- 756 (927)
++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 84 ~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 84 EGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 99999999843 34688899999999999999999998 99999999999999999999999999986321100
Q ss_pred -------------CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhh
Q 002409 757 -------------SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 823 (927)
Q Consensus 757 -------------~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~ 823 (927)
........++..|+|||.+....++.++|+|||||++|||++|+.||...... .+.+ ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~----~~~~---~~~ 229 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE----ELFG---QVI 229 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHH---HHH
Confidence 00111234788999999998888999999999999999999999999754311 1111 111
Q ss_pred ccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHH
Q 002409 824 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 875 (927)
Q Consensus 824 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~ 875 (927)
.+.. ..+.... .....+.+++.+|++.+|++||++.++.+.|+.
T Consensus 230 -~~~~---~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 230 -SDDI---EWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred -hccc---CCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 1110 0011111 123357899999999999999997666665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=291.98 Aligned_cols=249 Identities=28% Similarity=0.389 Sum_probs=203.3
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc-hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
++.+.||+|++|.||+++.. +++.|+||++..... .....+.+|++.+++++|+|++++++++...+..++|+||+++
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (264)
T cd06623 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDG 83 (264)
T ss_pred eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCC
Confidence 45688999999999999887 489999999876543 4467899999999999999999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhh-CCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
++|.+++.. ...+++..++.++.|+++||+|||+ . +++||||+|+||+++.++.++|+|||++.........
T Consensus 84 ~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 84 GSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 999999853 2568899999999999999999999 8 9999999999999999999999999998765433322
Q ss_pred eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccC
Q 002409 759 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 838 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 838 (927)
.....++..|+|||.+....++.++|+||||+++|||++|+.||..... .....+..+... .... .
T Consensus 157 -~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-~~~~~~~~~~~~----~~~~-----~--- 222 (264)
T cd06623 157 -CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ-PSFFELMQAICD----GPPP-----S--- 222 (264)
T ss_pred -ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-cCHHHHHHHHhc----CCCC-----C---
Confidence 2234578999999999988999999999999999999999999976532 111222222221 1110 1
Q ss_pred ccCHH-HHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 839 EYDIQ-SMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 839 ~~~~~-~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.+.. ....+.+++.+|+..+|++||++.|++++
T Consensus 223 -~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 223 -LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1111 33578999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=322.70 Aligned_cols=270 Identities=20% Similarity=0.267 Sum_probs=187.4
Q ss_pred HHHHHHhccccccCceEEEEEEECC--CcEEEEE------------------EeecCCchhhHhHHHHHHHHhhccCCCc
Q 002409 598 DATKMLEKKIGSGGFGVVYYGKLKD--GKEIAVK------------------VLTSNSYQGKREFTNEVTLLSRIHHRNL 657 (927)
Q Consensus 598 ~~~~~~~~~IG~G~fG~Vy~~~~~~--g~~VAVK------------------~l~~~~~~~~~~~~~Ei~iL~~l~HpnI 657 (927)
...|.+.+.||+|+||+||++.++. +...++| .+. ........+.+|+++|++++||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCCc
Confidence 4456778899999999999987642 2222222 111 111234568899999999999999
Q ss_pred cceecceeecCeEEEEEEeccCCchhhhccccc-ccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEEC
Q 002409 658 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTL-THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD 736 (927)
Q Consensus 658 v~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~ 736 (927)
+++++++...+..++|+|++. ++|.+++.... ..........+..++.|++.||+|||++ +|+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 999999999999999999985 57777664322 1122334566778999999999999998 999999999999999
Q ss_pred CCCcEEEEeecCcccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhh
Q 002409 737 KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIV 816 (927)
Q Consensus 737 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~ 816 (927)
.++.+||+|||+++..............||..|+|||++.+..++.++|||||||++|||++|..++...........+.
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 99999999999998665443333334569999999999999999999999999999999999875433221111111111
Q ss_pred HHHHhh-hccCCcc-------cccCC--------cccCcc-CHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 817 QWAKLH-IESGDIQ-------GIIDP--------SLLDEY-DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 817 ~~~~~~-~~~~~~~-------~~~d~--------~l~~~~-~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
+..... .....+. +.++. .+.... .......+.+++.+|++.||++|||+.|++++
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 111100 0000000 00000 000000 00112356778999999999999999999986
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=298.29 Aligned_cols=263 Identities=22% Similarity=0.293 Sum_probs=197.2
Q ss_pred HhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeec--CeEEEEEEec
Q 002409 603 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLVYEFM 677 (927)
Q Consensus 603 ~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--~~~~lV~E~~ 677 (927)
+.+.||+|+||.||+|+.. +++.+|+|++.... ......+.+|++++++++|+|++++++++... +..++|+||+
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07840 3 KIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYM 82 (287)
T ss_pred eeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccc
Confidence 4578999999999999877 47899999998653 23345688999999999999999999999888 8899999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
++ +|.+++... ...+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||++........
T Consensus 83 ~~-~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 83 DH-DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred cc-cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 75 888877432 24688999999999999999999998 999999999999999999999999999986544332
Q ss_pred ceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhcc--CCcc-----
Q 002409 758 HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES--GDIQ----- 829 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~--~~~~----- 829 (927)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.......... ..+.
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF 235 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence 22233456889999998764 467899999999999999999999997654222211221111000000 0000
Q ss_pred ------cccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 830 ------GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 830 ------~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
......+...+.......+.+++.+|++.+|++||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0000001111111124578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=286.02 Aligned_cols=247 Identities=30% Similarity=0.488 Sum_probs=201.1
Q ss_pred HhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCCc
Q 002409 603 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 681 (927)
Q Consensus 603 ~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gs 681 (927)
..+.||+|++|.||++... +++.+++|++..........+.+|++++++++|+|++++++++......++++||+++++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~ 83 (253)
T cd05122 4 ILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGS 83 (253)
T ss_pred eeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCc
Confidence 4578999999999999886 688999999976655456789999999999999999999999999999999999999999
Q ss_pred hhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCceee
Q 002409 682 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 761 (927)
Q Consensus 682 L~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 761 (927)
|.+++... ...+++..+..++.|++.+|.+||+. +++||||+|+||+++.++.++|+|||.+........ ..
T Consensus 84 L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~ 155 (253)
T cd05122 84 LKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RN 155 (253)
T ss_pred HHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--cc
Confidence 99988543 25689999999999999999999998 999999999999999999999999999876544332 23
Q ss_pred eeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCccC
Q 002409 762 IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD 841 (927)
Q Consensus 762 ~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 841 (927)
...++..|++||.+....++.++||||||+++++|++|+.||...... ..+... .. .......+ .
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~-~~----~~~~~~~~-------~ 220 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM---KALFKI-AT----NGPPGLRN-------P 220 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH---HHHHHH-Hh----cCCCCcCc-------c
Confidence 456889999999998888999999999999999999999998754311 111110 10 11111110 0
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 842 IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 842 ~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
......+.+++.+|++.+|++|||+.|++++
T Consensus 221 ~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 221 EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1113468899999999999999999999874
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=292.66 Aligned_cols=248 Identities=23% Similarity=0.358 Sum_probs=201.8
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
.+.+.||+|+||.||+++.. +++.+|+|.+.... ......+.+|++++++++|+||+++++++......++|+||++
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd08530 3 KVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAP 82 (256)
T ss_pred eEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcC
Confidence 35678999999999999765 67899999987542 2334567889999999999999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
+++|.+++.........+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||+++.....
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 83 FGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred CCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 9999999865444456789999999999999999999998 9999999999999999999999999999765443
Q ss_pred eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccC
Q 002409 759 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 838 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 838 (927)
......++..|++||.+.+..++.++|+||||++++||++|+.||...... .+... ...+....
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~----~~~~~----~~~~~~~~-------- 220 (256)
T cd08530 157 MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ----DLRYK----VQRGKYPP-------- 220 (256)
T ss_pred CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHH----HhcCCCCC--------
Confidence 122244788999999999989999999999999999999999999754421 11111 11111111
Q ss_pred ccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 839 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 839 ~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.......++.+++.+|++.+|++||++.|++++
T Consensus 221 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 221 -IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred -CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 112233568999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=297.09 Aligned_cols=264 Identities=21% Similarity=0.296 Sum_probs=197.3
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCCch-hhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
.+.++||+|++|.||+|+.. +++.||||+++..... ....+.+|++++++++|+||+++++++...+..++||||+++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 82 (284)
T cd07836 3 KQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK 82 (284)
T ss_pred eEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc
Confidence 34678999999999999986 5889999998755322 345677899999999999999999999999999999999985
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
+|.+++.... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++....... .
T Consensus 83 -~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 156 (284)
T cd07836 83 -DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-T 156 (284)
T ss_pred -cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-c
Confidence 8888775432 234689999999999999999999998 999999999999999999999999999875433211 1
Q ss_pred eeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhcc------------C
Q 002409 760 SSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES------------G 826 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~------------~ 826 (927)
.....++..|++||.+.+ ..++.++|||||||++|||++|+.||......+....+.+........ .
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence 122347889999999865 457889999999999999999999997654332222222211100000 0
Q ss_pred CcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 827 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 827 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
......+... ..........+.+++.+|++.+|++||++.|++++
T Consensus 237 ~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 237 TFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred cccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000000000 00111223467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-32 Score=302.21 Aligned_cols=266 Identities=21% Similarity=0.271 Sum_probs=194.7
Q ss_pred HHhccccccCceEEEEEEECC---CcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeec--CeEEEE
Q 002409 602 MLEKKIGSGGFGVVYYGKLKD---GKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLV 673 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~~---g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--~~~~lV 673 (927)
.+.++||+|+||.||+|.... ++.||+|.+.... ......+.+|++++++++||||+++++++... ...++|
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 82 (316)
T cd07842 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLL 82 (316)
T ss_pred eEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEE
Confidence 456789999999999998754 7899999987633 23345678899999999999999999999888 789999
Q ss_pred EEeccCCchhhhccccccc-ccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECC----CCcEEEEeecC
Q 002409 674 YEFMHNGTLKEHLYGTLTH-EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK----HMRAKVSDFGL 748 (927)
Q Consensus 674 ~E~~~~gsL~~~L~~~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~----~~~vkL~DFGl 748 (927)
|||+++ +|.+++...... ...++...+..++.|++.||+|||+. +++||||||+||+++. ++.+||+|||+
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~ 158 (316)
T cd07842 83 FDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGL 158 (316)
T ss_pred EeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence 999975 666665433222 23688999999999999999999998 9999999999999999 89999999999
Q ss_pred cccccCCCC--ceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccc------cchhhHHH
Q 002409 749 SKFAVDGAS--HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGAN------CRNIVQWA 819 (927)
Q Consensus 749 a~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~------~~~l~~~~ 819 (927)
++....... .......++..|+|||.+.+ ..++.++|||||||+++||++|+.||........ ...+...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (316)
T cd07842 159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF 238 (316)
T ss_pred ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence 886543322 11223457889999998876 4578999999999999999999999975442210 00111110
Q ss_pred Hhhhcc------------CCcccccCCcccCccC---------H--HHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 820 KLHIES------------GDIQGIIDPSLLDEYD---------I--QSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 820 ~~~~~~------------~~~~~~~d~~l~~~~~---------~--~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
. .+.. .......+......++ . ....++.+++.+|++.+|++|||+.|++++
T Consensus 239 ~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 239 E-VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred H-HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0 0000 0000000000000011 0 223468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=307.24 Aligned_cols=261 Identities=22% Similarity=0.296 Sum_probs=194.1
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecC--CchhhHhHHHHHHHHhhccCCCccceecceeec------CeE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRS 670 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~------~~~ 670 (927)
.|...+.||+|+||.||+|+.. +++.||+|++... .......+.+|+.++++++|+||+++++++... ...
T Consensus 17 ~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 96 (353)
T cd07850 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDV 96 (353)
T ss_pred ceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcE
Confidence 4555688999999999999875 6889999998643 223345677899999999999999999987543 357
Q ss_pred EEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcc
Q 002409 671 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 750 (927)
Q Consensus 671 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 750 (927)
++||||+. ++|.+.+.. .++...+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++
T Consensus 97 ~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 97 YLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred EEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccce
Confidence 99999996 477777632 278888899999999999999998 99999999999999999999999999997
Q ss_pred cccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHH------------
Q 002409 751 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQW------------ 818 (927)
Q Consensus 751 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~------------ 818 (927)
....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...........+...
T Consensus 167 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T cd07850 167 TAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL 244 (353)
T ss_pred eCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 6533221 22335789999999999999999999999999999999999999654321111111110
Q ss_pred ---HHhhhcc------CCcccccCCcc----cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 819 ---AKLHIES------GDIQGIIDPSL----LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 819 ---~~~~~~~------~~~~~~~d~~l----~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
....... ..+.+.+.... ...........+.+++.+|++.||++||++.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 00111111111 111112234568899999999999999999999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-32 Score=303.34 Aligned_cols=253 Identities=28% Similarity=0.345 Sum_probs=201.0
Q ss_pred HHHHHHHhccccccCceEEEEEEECCCcEEEEEEeec--CCchhhHhHHHHHHHHhhc-cCCCccceecceeecCeEEEE
Q 002409 597 EDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTS--NSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLV 673 (927)
Q Consensus 597 ~~~~~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~--~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~lV 673 (927)
....|.+.++||+||.+.||++...+.+-+|+|++.. .+.+...-|..|+..|.++ .|.+|+++++|-..++.+|||
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 4556777899999999999999988888888887643 3455567799999999999 599999999999999999999
Q ss_pred EEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccccc
Q 002409 674 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 753 (927)
Q Consensus 674 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 753 (927)
|||= ..+|...|.... ..+....+..+..||+.++.++|++ ||||.||||.|+|+-. |.+||+|||+|....
T Consensus 439 mE~G-d~DL~kiL~k~~---~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKK---SIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred eecc-cccHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 9965 458988886432 2233236778999999999999999 9999999999999965 689999999998665
Q ss_pred CCCC-ceeeeeccCCCccCccccccCc-----------CCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHh
Q 002409 754 DGAS-HVSSIVRGTVGYLDPEYYISQQ-----------LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL 821 (927)
Q Consensus 754 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~-----------~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~ 821 (927)
.... -.....+||+.||+||.+.... .+.++||||||||||+|+.|+.||..-. + .|++.
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~------n--~~aKl 582 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII------N--QIAKL 582 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH------H--HHHHH
Confidence 5443 3445567999999999985432 5578999999999999999999996432 1 23332
Q ss_pred hhccCCcccccCCcccCccC-HHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 822 HIESGDIQGIIDPSLLDEYD-IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 822 ~~~~~~~~~~~d~~l~~~~~-~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
..+.||...-+|+ ....+++++++..||++||++||+..|++++
T Consensus 583 -------~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 583 -------HAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred -------HhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 3445554433443 2233449999999999999999999999987
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=292.58 Aligned_cols=246 Identities=24% Similarity=0.303 Sum_probs=198.2
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
.+.+.||+|+||.||+++.. +++.+|+|++.... ....+.+.+|++++++++||||+++++.+......++|+||+
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (258)
T cd05578 3 ELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLL 82 (258)
T ss_pred eEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCC
Confidence 45688999999999999876 58899999987542 234567899999999999999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
.+++|.+++.. ...+++..+..++.|+++||.|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 83 ~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 83 LGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999998843 24688899999999999999999998 99999999999999999999999999987554332
Q ss_pred ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCccc
Q 002409 758 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 837 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 837 (927)
......|+..|+|||.+....++.++|+||||+++|+|++|+.||...... ....+. ...... .
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~----~~~~~~----------~ 218 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-IRDQIR----AKQETA----------D 218 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-HHHHHH----HHhccc----------c
Confidence 223345888999999998888999999999999999999999999765421 111111 111100 0
Q ss_pred CccCHHHHHHHHHHHhhhcCCCCCCCCcH--HHHHH
Q 002409 838 DEYDIQSMWKIEEKALMCVLPHGHMRPSI--SEVLK 871 (927)
Q Consensus 838 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm--~eV~~ 871 (927)
...+......+.+++.+|++.+|.+||++ +|+++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 11112223578899999999999999999 66543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-32 Score=292.06 Aligned_cols=248 Identities=28% Similarity=0.418 Sum_probs=197.9
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
.+.+.||+|+||.||++..+ +|+.+|+|.+.... ....+.+.+|++++++++|+||+++++.+......++|+||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (257)
T cd08225 3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCD 82 (257)
T ss_pred eEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCC
Confidence 35678999999999999876 57899999986542 2334578899999999999999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCC-cEEEEeecCcccccCCCC
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-~vkL~DFGla~~~~~~~~ 757 (927)
+++|.+++... ....+++..+..++.|+++||+|||+. +++|+||||+||++++++ .+||+|||.+.......
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (257)
T cd08225 83 GGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM- 156 (257)
T ss_pred CCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCc-
Confidence 99999988543 233578999999999999999999998 999999999999999885 56999999987554322
Q ss_pred ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCccc
Q 002409 758 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 837 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 837 (927)
.......|++.|+|||++....++.++|+|||||+++||++|+.||..... .++..... .+.....
T Consensus 157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~-~~~~~~~------ 222 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-------HQLVLKIC-QGYFAPI------ 222 (257)
T ss_pred ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHh-cccCCCC------
Confidence 222334588999999999888899999999999999999999999865431 11111111 1111110
Q ss_pred CccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 838 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 838 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.......+.+++.+|++.+|++||++.||+++
T Consensus 223 ---~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 ---SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ---CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11122468899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-32 Score=289.29 Aligned_cols=250 Identities=26% Similarity=0.431 Sum_probs=203.5
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc--hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
.+.+.||+|+||.||++... +++.+++|++..... .....+.+|++++++++|+|++++++.+......++|+||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~ 82 (258)
T cd08215 3 EIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYAD 82 (258)
T ss_pred eEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecC
Confidence 34578999999999999876 688999999875533 445678899999999999999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
+++|.+++.........+++..+..++.+++.||+|||+. +++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~ 158 (258)
T cd08215 83 GGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-D 158 (258)
T ss_pred CCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc-c
Confidence 9999999865443457789999999999999999999998 99999999999999999999999999987654432 2
Q ss_pred eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccC
Q 002409 759 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 838 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 838 (927)
......|++.|+|||.+....++.++|+||+|+++++|++|+.||......+ +.. ... ......
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~----~~~---~~~-~~~~~~-------- 222 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE----LAL---KIL-KGQYPP-------- 222 (258)
T ss_pred eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH----HHH---HHh-cCCCCC--------
Confidence 2333468899999999988889999999999999999999999986543211 111 111 111111
Q ss_pred ccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 839 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 839 ~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.+......+.+++.+|+..+|++||++.|++++
T Consensus 223 -~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 223 -IPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred -CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111223468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-32 Score=295.54 Aligned_cols=253 Identities=26% Similarity=0.347 Sum_probs=192.9
Q ss_pred HhccccccCceEEEEEEEC-CCcEEEEEEeecCC-chhhHhHHHHHHHHhhcc-CCCccceecceeecCeEEEEEEeccC
Q 002409 603 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 603 ~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
..+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.++.++. |+||+++++++..++..+++|||+..
T Consensus 8 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~ 87 (288)
T cd06616 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI 87 (288)
T ss_pred HHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC
Confidence 4568999999999999876 57899999987543 234567889999999996 99999999999999999999999864
Q ss_pred Cchhhhccc-ccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 680 GTLKEHLYG-TLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 680 gsL~~~L~~-~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
++.++... .......+++..+..++.|++.||+|||+. .+++||||||+||+++.++.+||+|||+++.......
T Consensus 88 -~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 163 (288)
T cd06616 88 -SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA- 163 (288)
T ss_pred -CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc-
Confidence 55443311 111235688999999999999999999974 2899999999999999999999999999875433221
Q ss_pred eeeeeccCCCccCccccccC---cCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCc
Q 002409 759 VSSIVRGTVGYLDPEYYISQ---QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 835 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~~---~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 835 (927)
.....|+..|+|||.+... .++.++|||||||++|||++|+.||.... ........... +. .+.
T Consensus 164 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~-~~-----~~~ 230 (288)
T cd06616 164 -KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN------SVFDQLTQVVK-GD-----PPI 230 (288)
T ss_pred -cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc------hHHHHHhhhcC-CC-----CCc
Confidence 1223588999999998765 68899999999999999999999996543 11111111111 11 111
Q ss_pred ccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 836 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 836 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
+..........++.+++.+|++.+|++||++.||+++
T Consensus 231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 231 LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111112234568899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=294.17 Aligned_cols=249 Identities=26% Similarity=0.398 Sum_probs=200.0
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
+.+.+.||+|+||.||+|.++ +++.+++|++..... ....+.+|++++++++|+|++++++.+...+..++++||+++
T Consensus 21 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 99 (286)
T cd06614 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDG 99 (286)
T ss_pred chHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCC
Confidence 345578999999999999887 688999999976544 466788999999999999999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........ .
T Consensus 100 ~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 172 (286)
T cd06614 100 GSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-K 172 (286)
T ss_pred CcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-h
Confidence 99999985431 3789999999999999999999998 999999999999999999999999998865433221 2
Q ss_pred eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCc
Q 002409 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 839 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 839 (927)
.....++..|++||++.+..++.++|||||||++|+|++|+.||....... ...... ........+
T Consensus 173 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~---~~~~~~-----~~~~~~~~~------ 238 (286)
T cd06614 173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR---ALFLIT-----TKGIPPLKN------ 238 (286)
T ss_pred hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH-----hcCCCCCcc------
Confidence 223347889999999988889999999999999999999999987543111 111111 111111010
Q ss_pred cCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 840 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 840 ~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.......+.+++.+|++.+|.+||++.||+++
T Consensus 239 -~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 239 -PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred -hhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11123468899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=298.66 Aligned_cols=248 Identities=26% Similarity=0.396 Sum_probs=194.5
Q ss_pred HHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc---hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEE
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 674 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~ 674 (927)
..+...+.||+|+||.||+++.. +++.+|+|++..... .....+.+|++++++++|+|++++++++.++...++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 33556788999999999999865 688999999874422 23356888999999999999999999999999999999
Q ss_pred EeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccC
Q 002409 675 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 754 (927)
Q Consensus 675 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 754 (927)
||+. |+|.+.+... ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||++.....
T Consensus 105 e~~~-g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 105 EYCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred eCCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 9997 4777766422 34588999999999999999999998 999999999999999999999999999865432
Q ss_pred CCCceeeeeccCCCccCccccc---cCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccc
Q 002409 755 GASHVSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 831 (927)
Q Consensus 755 ~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 831 (927)
. ....|+..|+|||++. .+.++.++|||||||++|||++|+.||....... .+..+.. +...
T Consensus 178 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~~~~~~-----~~~~-- 242 (317)
T cd06635 178 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYHIAQ-----NESP-- 242 (317)
T ss_pred c-----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH---HHHHHHh-----ccCC--
Confidence 2 2235888999999974 4568899999999999999999999986532111 1111111 1000
Q ss_pred cCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHH
Q 002409 832 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 874 (927)
Q Consensus 832 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~ 874 (927)
... .......+.+++.+|++.+|++||++.||++++-
T Consensus 243 ---~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 243 ---TLQ---SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred ---CCC---CccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 000 1122345889999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.9e-32 Score=301.29 Aligned_cols=260 Identities=21% Similarity=0.278 Sum_probs=192.7
Q ss_pred cccccc--CceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 605 KKIGSG--GFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 605 ~~IG~G--~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
..||+| +||+||++++. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 99999999875 78999999987542 22346788999999999999999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
++|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+|||++.++.+|++||+.+..........
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999886532 23578889999999999999999998 99999999999999999999999998654222111100
Q ss_pred ------eeeeccCCCccCccccccC--cCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhh---------
Q 002409 760 ------SSIVRGTVGYLDPEYYISQ--QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH--------- 822 (927)
Q Consensus 760 ------~~~~~gt~~Y~aPE~~~~~--~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~--------- 822 (927)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||........ +.......
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~ 235 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM---LLQKLKGPPYSPLDITT 235 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH---HHHHhcCCCCCCccccc
Confidence 1112356779999999763 478999999999999999999999975432111 11100000
Q ss_pred --------------h---------ccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 823 --------------I---------ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 823 --------------~---------~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
. ..+......+..+...........+.+++.+|++.+|++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0 0000001111112222223345678999999999999999999999877
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.9e-32 Score=290.64 Aligned_cols=242 Identities=23% Similarity=0.310 Sum_probs=193.7
Q ss_pred ccccCceEEEEEEEC-CCcEEEEEEeecCCc---hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCCch
Q 002409 607 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 682 (927)
Q Consensus 607 IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 682 (927)
||+|+||.||+++.. +++.+|+|++..... ...+.+.+|++++++++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999886 488999999875432 3346789999999999999999999999999999999999999999
Q ss_pred hhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCceeee
Q 002409 683 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 762 (927)
Q Consensus 683 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 762 (927)
.+++.. ...+++..+..++.|++.||+|||++ +++|+||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 81 WTILRD----RGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 999853 24578889999999999999999998 99999999999999999999999999998654432 2223
Q ss_pred eccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCccCH
Q 002409 763 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 842 (927)
Q Consensus 763 ~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 842 (927)
..|+..|++||.+....++.++|+||+|+++|||++|+.||..... +..+....... +. ....++.
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~-~~--------~~~~~~~ 217 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE-----DPMEIYNDILK-GN--------GKLEFPN 217 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC-----CHHHHHHHHhc-cC--------CCCCCCc
Confidence 4588999999999888899999999999999999999999975431 01111111110 00 0111112
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCc-----HHHHHH
Q 002409 843 QSMWKIEEKALMCVLPHGHMRPS-----ISEVLK 871 (927)
Q Consensus 843 ~~~~~l~~L~~~Cl~~dP~~RPs-----m~eV~~ 871 (927)
.....+.+++.+|++.+|++||+ ++|+++
T Consensus 218 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 218 YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 22457899999999999999999 555554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.8e-32 Score=297.93 Aligned_cols=245 Identities=26% Similarity=0.384 Sum_probs=193.3
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc---hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 675 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E 675 (927)
.+.+.+.||+|+||.||+|+.. +++.||+|++..... .....+.+|++++++++||||+++++++...+..++|+|
T Consensus 16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e 95 (307)
T cd06607 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVME 95 (307)
T ss_pred hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHH
Confidence 3566788999999999999876 688999999864322 233568899999999999999999999999999999999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCC
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 755 (927)
|+. |+|.+++... ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||++......
T Consensus 96 ~~~-g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 96 YCL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred hhC-CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 997 5676665322 34588999999999999999999998 9999999999999999999999999998754322
Q ss_pred CCceeeeeccCCCccCccccc---cCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCccccc
Q 002409 756 ASHVSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 832 (927)
Q Consensus 756 ~~~~~~~~~gt~~Y~aPE~~~---~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 832 (927)
....++..|+|||++. .+.++.++||||||+++|||++|+.||....... .... .......
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~----~~~~----~~~~~~~--- 232 (307)
T cd06607 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----ALYH----IAQNDSP--- 232 (307)
T ss_pred -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH----HHHH----HhcCCCC---
Confidence 2235788999999884 4568889999999999999999999986543111 1110 0111100
Q ss_pred CCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 833 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 833 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.+. .......+.+++.+|++.+|++||++.+|+++
T Consensus 233 --~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 233 --TLS---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred --CCC---chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 010 11223468899999999999999999999885
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-32 Score=293.60 Aligned_cols=244 Identities=27% Similarity=0.351 Sum_probs=190.9
Q ss_pred ccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCCch
Q 002409 607 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 682 (927)
Q Consensus 607 IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 682 (927)
||+|+||+||++... +++.+|+|++.... ......+..|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999765 68899999986532 22244567899999999999999999999999999999999999999
Q ss_pred hhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCceeee
Q 002409 683 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 762 (927)
Q Consensus 683 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 762 (927)
.+++.... ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||++....... ....
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~ 153 (277)
T cd05577 81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKG 153 (277)
T ss_pred HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccc
Confidence 99986432 24688999999999999999999998 99999999999999999999999999987543321 1223
Q ss_pred eccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCccCH
Q 002409 763 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 842 (927)
Q Consensus 763 ~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 842 (927)
..++..|+|||++.+..++.++|||||||++++|++|+.||...........+... .... . ...+.
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~------~----~~~~~ 219 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR----TLEM------A----VEYPD 219 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhc----cccc------c----ccCCc
Confidence 35788999999998888999999999999999999999999654421111111110 0000 0 01111
Q ss_pred HHHHHHHHHHhhhcCCCCCCCC-----cHHHHHH
Q 002409 843 QSMWKIEEKALMCVLPHGHMRP-----SISEVLK 871 (927)
Q Consensus 843 ~~~~~l~~L~~~Cl~~dP~~RP-----sm~eV~~ 871 (927)
.....+.+++.+|++.+|++|| ++.++++
T Consensus 220 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 220 KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred cCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 1234678999999999999999 5555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=297.44 Aligned_cols=266 Identities=21% Similarity=0.207 Sum_probs=193.1
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc--hhhHhHHHHHHHHhhcc-CCCccceecceeecCe-----EE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGR-----SV 671 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~~-----~~ 671 (927)
+.+.+.||+|+||.||+|... +++.||+|+++.... .....+.+|+.++++++ |+||+++++++...+. .+
T Consensus 3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~ 82 (295)
T cd07837 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY 82 (295)
T ss_pred ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence 345678999999999999876 688999998765422 22356888999999995 6999999999877665 79
Q ss_pred EEEEeccCCchhhhccccccc-ccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECC-CCcEEEEeecCc
Q 002409 672 LVYEFMHNGTLKEHLYGTLTH-EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLS 749 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~-~~~vkL~DFGla 749 (927)
+||||+++ +|.+++...... ...+++..++.++.||++||+|||+. +++||||||+||+++. ++.+||+|||++
T Consensus 83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecccc
Confidence 99999985 788887543222 35689999999999999999999998 9999999999999998 889999999998
Q ss_pred ccccCCCCceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCc
Q 002409 750 KFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 828 (927)
Q Consensus 750 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 828 (927)
+....... ......+++.|+|||++.+ ..++.++|||||||++|||++|..||...........+.+...... ....
T Consensus 159 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 236 (295)
T cd07837 159 RAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPT-EQVW 236 (295)
T ss_pred eecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCC-hhhC
Confidence 75432211 1122346889999998865 4578999999999999999999999975432221111111110000 0000
Q ss_pred ccccC-------Cccc----CccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 829 QGIID-------PSLL----DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 829 ~~~~d-------~~l~----~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
....+ +... .........++.+++.+|++.+|++||++.|++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000 0000 00001233568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-32 Score=291.49 Aligned_cols=245 Identities=26% Similarity=0.360 Sum_probs=195.2
Q ss_pred ccccCceEEEEEEEC-CCcEEEEEEeecCCc---hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCCch
Q 002409 607 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 682 (927)
Q Consensus 607 IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 682 (927)
||+|+||.||+++.. +++.+++|++..... .....+.+|++++++++||||+++++.+......++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999987 489999999875433 3456788999999999999999999999999999999999999999
Q ss_pred hhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC-----
Q 002409 683 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS----- 757 (927)
Q Consensus 683 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~----- 757 (927)
.+++.. ...+++..+..++.|+++||+|||+. +++||||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLEN----VGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 998853 23688999999999999999999998 999999999999999999999999999875433211
Q ss_pred --ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCc
Q 002409 758 --HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 835 (927)
Q Consensus 758 --~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 835 (927)
.......++..|++||.......+.++||||||++++||++|+.||...... .+..... .+....
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----~~~~~~~----~~~~~~----- 220 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE----EIFQNIL----NGKIEW----- 220 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHh----cCCcCC-----
Confidence 1223345788999999998888999999999999999999999999754421 1111111 111100
Q ss_pred ccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHH
Q 002409 836 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 874 (927)
Q Consensus 836 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~ 874 (927)
.. .......+.+++.+|++.+|++||++.+|.+.|+
T Consensus 221 -~~--~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 221 -PE--DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred -Cc--cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 00 0002356889999999999999999966666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-32 Score=293.97 Aligned_cols=260 Identities=20% Similarity=0.229 Sum_probs=191.0
Q ss_pred HhccccccCceEEEEEEEC-CCcEEEEEEeecCC-chhhHhHHHHHHHHhhcc-CCCccceecceeec--CeEEEEEEec
Q 002409 603 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEE--GRSVLVYEFM 677 (927)
Q Consensus 603 ~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~--~~~~lV~E~~ 677 (927)
+.+.||+|+||.||+|+.. +++.+|+|+++... ........+|+.+++++. |+|++++++++.+. +..++|+||+
T Consensus 3 ~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~ 82 (282)
T cd07831 3 ILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELM 82 (282)
T ss_pred eEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecC
Confidence 4578999999999999865 68899999987542 222334457888898885 99999999999887 8899999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
+ |+|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++. +.+||+|||+++.......
T Consensus 83 ~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 83 D-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred C-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 7 5787777432 24689999999999999999999998 9999999999999999 9999999999975533222
Q ss_pred ceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHH-------HhhhccCCcc
Q 002409 758 HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA-------KLHIESGDIQ 829 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~-------~~~~~~~~~~ 829 (927)
. ....++..|+|||.+.. ..++.++|||||||++|||++|+.||......+....+.... ..........
T Consensus 155 ~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07831 155 Y--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM 232 (282)
T ss_pred c--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence 1 22347889999997654 567889999999999999999999997544221111111110 0000000000
Q ss_pred cccCCc-ccC---ccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 830 GIIDPS-LLD---EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 830 ~~~d~~-l~~---~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
....+. ... .........+.+++.+|++.+|++||++.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000000 000 0011234678999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=295.72 Aligned_cols=244 Identities=25% Similarity=0.366 Sum_probs=196.2
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCCchh
Q 002409 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK 683 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~ 683 (927)
.+||+|+||.||++..+ +++.||||++..........+.+|+.++++++|+||+++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 57999999999999875 68899999986555555667899999999999999999999999999999999999999999
Q ss_pred hhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCceeeee
Q 002409 684 EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV 763 (927)
Q Consensus 684 ~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 763 (927)
+++. ...+++.....++.|++.||+|||+. +++||||||+||+++.++.++|+|||++....... ......
T Consensus 106 ~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~ 176 (292)
T cd06657 106 DIVT-----HTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSL 176 (292)
T ss_pred HHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc-cccccc
Confidence 8773 23578889999999999999999998 99999999999999999999999999887543322 122334
Q ss_pred ccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCccCHH
Q 002409 764 RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQ 843 (927)
Q Consensus 764 ~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 843 (927)
.|+..|++||.+.+..++.++|+||+||++|||++|+.||...... .......... .+.+... ..
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~----~~~~~~~~~~---------~~~~~~~--~~ 241 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL----KAMKMIRDNL---------PPKLKNL--HK 241 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhhC---------CcccCCc--cc
Confidence 5889999999998888899999999999999999999998653311 1111111110 1111000 11
Q ss_pred HHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 844 SMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 844 ~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
....+.+++.+|++.+|.+||++.|++++
T Consensus 242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 242 VSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred CCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 22357889999999999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=304.07 Aligned_cols=251 Identities=23% Similarity=0.355 Sum_probs=202.4
Q ss_pred HHHHhccccccCceEEEEEEECCCcE-EEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~~g~~-VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
.+++...||-|+||.||+|..++... .|-|++...+.+...+|.-|++||..+.||+||+|++.|.-.+.+++..|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 45566779999999999998775443 46688877777777889999999999999999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
||-++..+.. -++.+.+.++..++.|++.||.|||++ .|||||||+.|||++-+|.++|+|||.+..... ...
T Consensus 113 GGAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~q 185 (1187)
T KOG0579|consen 113 GGAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQ 185 (1187)
T ss_pred CchHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh-HHh
Confidence 9998887643 356788999999999999999999999 999999999999999999999999998753222 123
Q ss_pred eeeeeccCCCccCccccc-----cCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccC
Q 002409 759 VSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 833 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~-----~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 833 (927)
....+.|||.|||||+.. ..+|+.++||||||+.|.||..+.+|-.... ...+...+...+...++.
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln--------pMRVllKiaKSePPTLlq 257 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN--------PMRVLLKIAKSEPPTLLQ 257 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc--------hHHHHHHHhhcCCCcccC
Confidence 344567999999999975 4689999999999999999999998865432 111222222222233333
Q ss_pred CcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 834 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 834 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
|. .....+.++..+|+..+|..||++.|+++|
T Consensus 258 PS-------~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 258 PS-------HWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred cc-------hhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 22 333468899999999999999999999875
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-32 Score=294.55 Aligned_cols=242 Identities=25% Similarity=0.314 Sum_probs=186.0
Q ss_pred cccccCceEEEEEEEC-CCcEEEEEEeecCCc---hhhHhHHHHHHHHhh---ccCCCccceecceeecCeEEEEEEecc
Q 002409 606 KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSR---IHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 606 ~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~iL~~---l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
.||+|+||.||++... +++.+|+|.+..... .....+.+|..+++. .+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 588999998865421 222334455444443 479999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
+|+|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+|||+++++.+||+|||++........
T Consensus 81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~- 152 (279)
T cd05633 81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (279)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc-
Confidence 9999988843 34689999999999999999999998 999999999999999999999999999875433221
Q ss_pred eeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCccc
Q 002409 759 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 837 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 837 (927)
....|+..|+|||.+.. ..++.++||||+||+++||++|+.||....... ...+... ... ....+
T Consensus 153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~---~~~-------~~~~~- 218 (279)
T cd05633 153 --HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRM---TLT-------VNVEL- 218 (279)
T ss_pred --cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC-HHHHHHH---hhc-------CCcCC-
Confidence 22358999999999864 568899999999999999999999997543111 1111110 000 01111
Q ss_pred CccCHHHHHHHHHHHhhhcCCCCCCCC-----cHHHHHHH
Q 002409 838 DEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 872 (927)
Q Consensus 838 ~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----sm~eV~~~ 872 (927)
+.....++.+++.+|++.+|++|| +++|++++
T Consensus 219 ---~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 219 ---PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ---ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 112234688999999999999999 69999886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-33 Score=309.51 Aligned_cols=246 Identities=28% Similarity=0.445 Sum_probs=192.7
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEee--c--CCchhhHhHHHHHHHHhhccCCCccceecceeecCe--EEEEE
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLT--S--NSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR--SVLVY 674 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~--~--~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~--~~lV~ 674 (927)
.+..+||+|+|-+||+|.+. +|.+||=-.++ . .+......|..|+.+|+.|+||||++++.++.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 35678999999999999875 56677532221 1 133345779999999999999999999999877654 77899
Q ss_pred EeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCC-CcEEEEeecCccccc
Q 002409 675 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAV 753 (927)
Q Consensus 675 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~-~~vkL~DFGla~~~~ 753 (927)
|.|..|+|..|+. +.++++......++.||++||.|||++ .|+|+|||||..||+|+.+ |.|||+|.|||....
T Consensus 123 EL~TSGtLr~Y~k----k~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 123 ELFTSGTLREYRK----KHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred ecccCCcHHHHHH----HhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 9999999999984 456778889999999999999999997 5799999999999999865 899999999998654
Q ss_pred CCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccC
Q 002409 754 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 833 (927)
Q Consensus 754 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 833 (927)
. ++. ..+.|||.|||||++. ..|++.+||||||+.|+||+|+..|+.... +-.+ +.+++..|.-...+.
T Consensus 198 ~--s~a-ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~------n~AQ-IYKKV~SGiKP~sl~ 266 (632)
T KOG0584|consen 198 K--SHA-KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT------NPAQ-IYKKVTSGIKPAALS 266 (632)
T ss_pred c--ccc-ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC------CHHH-HHHHHHcCCCHHHhh
Confidence 3 222 3377999999999987 789999999999999999999999997544 2222 222233332111111
Q ss_pred CcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 834 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 834 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.. ...++.+++.+|+.. .++|||+.|++++
T Consensus 267 -----kV---~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 267 -----KV---KDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred -----cc---CCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 00 012578899999999 8999999999875
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-33 Score=287.81 Aligned_cols=248 Identities=21% Similarity=0.355 Sum_probs=203.9
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
..+.++||+|.||.||++.++ .|+.+|||.+... ....++.+|+.+|++++.|++|+++|.+.....+++|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 445678999999999999776 6899999988644 3457789999999999999999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
|++.+.++. .++.+++.++..++..-++||+|||.. .-+|||||+.|||++.+|.+||+|||.|..+.+. ...
T Consensus 113 GSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-MAK 185 (502)
T KOG0574|consen 113 GSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-MAK 185 (502)
T ss_pred CcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhh-HHh
Confidence 999999864 367799999999999999999999997 7899999999999999999999999998755432 233
Q ss_pred eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCc
Q 002409 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 839 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 839 (927)
...+.||+.|||||++..-.|..++||||||+...||..|++|+.+-..-. .+ ..+.... .|..+.
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR---AI-----FMIPT~P-----PPTF~K- 251 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR---AI-----FMIPTKP-----PPTFKK- 251 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc---ee-----EeccCCC-----CCCCCC-
Confidence 456779999999999999999999999999999999999999997643110 00 0111110 011111
Q ss_pred cCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 840 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 840 ~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
+.....++.+++..|+-..|++|-|+.++++|
T Consensus 252 -PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 252 -PEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred -hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 22333478899999999999999999999886
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=296.01 Aligned_cols=248 Identities=26% Similarity=0.352 Sum_probs=201.3
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEeecC---CchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 604 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 604 ~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
-++||+||||.||-++.+ +|+.+|.|.+.+. ..+++....+|-++|.+++.+.||.+--.+...+.+|+|+..|.|
T Consensus 190 ~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNG 269 (591)
T KOG0986|consen 190 YRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNG 269 (591)
T ss_pred eEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecC
Confidence 368999999999999776 6889999987543 334566788999999999999999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
|+|.-||+..- ...+++..++-++.+|+.||++||+. +||.||+||+|||+|+.|+++|+|.|+|..+..+..+.
T Consensus 270 GDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~ 344 (591)
T KOG0986|consen 270 GDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIR 344 (591)
T ss_pred CceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCCccc
Confidence 99999998653 36799999999999999999999999 99999999999999999999999999999877765544
Q ss_pred eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCc
Q 002409 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 839 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 839 (927)
. .+||.+|||||++....|+...|-||+||+||||+.|+.||.........+.+-+.+... ..+
T Consensus 345 ~--rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~--------------~~e 408 (591)
T KOG0986|consen 345 G--RVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLED--------------PEE 408 (591)
T ss_pred c--ccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcc--------------hhh
Confidence 3 369999999999999999999999999999999999999997654221111111111110 112
Q ss_pred cCHHHHHHHHHHHhhhcCCCCCCCCc-----HHHHHHH
Q 002409 840 YDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 872 (927)
Q Consensus 840 ~~~~~~~~l~~L~~~Cl~~dP~~RPs-----m~eV~~~ 872 (927)
|+.....+..++....++.||++|.. +.+|.+|
T Consensus 409 y~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 409 YSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred cccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 33333345677888889999999874 4455554
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=293.22 Aligned_cols=262 Identities=22% Similarity=0.323 Sum_probs=191.4
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCch-hhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
|.+.+.||+|+||.||+|... +++.||+|++...... ....+.+|++++++++|+||+++++++...+..++|+||+.
T Consensus 7 y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07870 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH 86 (291)
T ss_pred eEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc
Confidence 345678999999999999865 6889999998754322 23467789999999999999999999999999999999996
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
++|.+++... ...+.+..+..++.|++.||.|||+. +|+||||||+|||++.++++||+|||+++.......
T Consensus 87 -~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 158 (291)
T cd07870 87 -TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ- 158 (291)
T ss_pred -CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCC-
Confidence 6776666422 23467788889999999999999998 999999999999999999999999999875432221
Q ss_pred eeeeeccCCCccCccccccC-cCCCccceeeHHHHHHHHHhCCCcccccccccccchhhH-HHHhhhc-----------c
Q 002409 759 VSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ-WAKLHIE-----------S 825 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~-~~~~~~~-----------~ 825 (927)
......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...... .+.+.+ |...... .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEKIWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHHHHHHcCCCChhhhhhhhhcc
Confidence 12233478999999998753 5788999999999999999999999754311 111111 0000000 0
Q ss_pred CCcccccCCcccCcc-----CHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 826 GDIQGIIDPSLLDEY-----DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 826 ~~~~~~~d~~l~~~~-----~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
............... .......+.+++.+|++.+|++|||+.|++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 000000000000000 00113467899999999999999999998764
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-32 Score=306.09 Aligned_cols=268 Identities=23% Similarity=0.373 Sum_probs=204.4
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEeecCCc-hhhHhHHHHHHHHhhccCCCccceecceeecC------eEEEEEE
Q 002409 604 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------RSVLVYE 675 (927)
Q Consensus 604 ~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~------~~~lV~E 675 (927)
.+.||+|+||.||+|+.+ .|+.||||.++.... ...+...+|+++|++++|+|||++++.-.+.. ...+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 568999999999999965 799999999986542 33456788999999999999999999876544 5689999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEEC--CCC--cEEEEeecCccc
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD--KHM--RAKVSDFGLSKF 751 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~--~~~--~vkL~DFGla~~ 751 (927)
||.+|||...|.+.. ....|++.+.+.+..+++.||.|||++ +|+||||||.||++- ++| .-||+|||.|+.
T Consensus 98 yC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred ecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 999999999997653 456799999999999999999999998 999999999999984 334 369999999997
Q ss_pred ccCCCCceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCccc
Q 002409 752 AVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 830 (927)
Q Consensus 752 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 830 (927)
..+.. ......||..|++||++.. +.|+..+|.|||||++||+.||..||.....+..... +.|....-......-
T Consensus 174 l~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~-~~~~~~tkkp~~v~i 250 (732)
T KOG4250|consen 174 LDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKE-IMWHIITKKPSGVAI 250 (732)
T ss_pred CCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccch-hhhhhhccCCCceeE
Confidence 76543 5566789999999999985 8899999999999999999999999976543321111 122211111111111
Q ss_pred ccCCcccCc------------cCHHHHHHHHHHHhhhcCCCCCCCC--cHHHHHHHHHHHHH
Q 002409 831 IIDPSLLDE------------YDIQSMWKIEEKALMCVLPHGHMRP--SISEVLKDIQDAIV 878 (927)
Q Consensus 831 ~~d~~l~~~------------~~~~~~~~l~~L~~~Cl~~dP~~RP--sm~eV~~~L~~~~~ 878 (927)
.+++...+. ........+......++..+|++|- ...+....+..++.
T Consensus 251 ~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 251 GAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred eeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 122221111 1123334566777888889999999 77777777777765
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=285.99 Aligned_cols=248 Identities=25% Similarity=0.383 Sum_probs=200.4
Q ss_pred HhccccccCceEEEEEEEC-CCcEEEEEEeecCCc--hhhHhHHHHHHHHhhccCCCccceecceeec--CeEEEEEEec
Q 002409 603 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLVYEFM 677 (927)
Q Consensus 603 ~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--~~~~lV~E~~ 677 (927)
..+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++++++|+||+++++.+... ...++++||+
T Consensus 4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 83 (260)
T cd06606 4 RGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYV 83 (260)
T ss_pred eeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEec
Confidence 4578999999999999887 688999999876542 3467789999999999999999999999888 8899999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
++++|.+++... ..+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+........
T Consensus 84 ~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 84 SGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred CCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 999999998532 3789999999999999999999998 999999999999999999999999999876544322
Q ss_pred c-eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 758 H-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 758 ~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
. ......++..|++||.+.....+.++||||||+++++|++|+.||.... ..............
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~--------- 221 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG------NPMAALYKIGSSGE--------- 221 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------chHHHHHhccccCC---------
Confidence 1 1233458899999999988889999999999999999999999997543 01111111110011
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
....+......+.+++.+|++.+|++||++.|++++
T Consensus 222 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 222 PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 111112224578899999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=292.42 Aligned_cols=250 Identities=24% Similarity=0.330 Sum_probs=194.2
Q ss_pred HHhccccccCceEEEEEEE----CCCcEEEEEEeecCCc----hhhHhHHHHHHHHhhc-cCCCccceecceeecCeEEE
Q 002409 602 MLEKKIGSGGFGVVYYGKL----KDGKEIAVKVLTSNSY----QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVL 672 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~----~~g~~VAVK~l~~~~~----~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~l 672 (927)
.+.+.||+|+||.||+++. .+|+.||+|+++.... ...+.+.+|+++++++ +|+||+++++.+..+...++
T Consensus 3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (290)
T cd05613 3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHL 82 (290)
T ss_pred eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEE
Confidence 3467899999999999986 3688999999875422 2345678899999999 59999999999999899999
Q ss_pred EEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccc
Q 002409 673 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 752 (927)
Q Consensus 673 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 752 (927)
|+||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++..
T Consensus 83 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 83 ILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 9999999999998843 34578888899999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCceeeeeccCCCccCccccccC--cCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCccc
Q 002409 753 VDGASHVSSIVRGTVGYLDPEYYISQ--QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 830 (927)
Q Consensus 753 ~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 830 (927)
............|+..|+|||.+... .++.++||||||+++|+|++|+.||......... ...........
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~---~~~~~~~~~~~---- 228 (290)
T cd05613 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ---AEISRRILKSE---- 228 (290)
T ss_pred ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccH---HHHHHHhhccC----
Confidence 43322222334588999999998753 4678999999999999999999999643311111 11111111110
Q ss_pred ccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCC-----cHHHHHHH
Q 002409 831 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 872 (927)
Q Consensus 831 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----sm~eV~~~ 872 (927)
+ .++......+.+++.+|++.+|++|| +..+++.+
T Consensus 229 ---~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 229 ---P----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ---C----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 0 11112234678999999999999997 67777665
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=293.66 Aligned_cols=266 Identities=23% Similarity=0.278 Sum_probs=195.8
Q ss_pred HHHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc--hhhHhHHHHHHHHhhccCCCccceecceeecC------
Q 002409 598 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------ 668 (927)
Q Consensus 598 ~~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~------ 668 (927)
...+.+.+.||+|+||.||+|..+ +++.||+|+++.... .....+.+|++++++++||||+++++++.+..
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 345566789999999999999986 588999999875432 22356778999999999999999999887654
Q ss_pred ----eEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEE
Q 002409 669 ----RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 744 (927)
Q Consensus 669 ----~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~ 744 (927)
..++|+||+++ ++.+.+... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+
T Consensus 86 ~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 86 KDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred ccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeC
Confidence 78999999976 666665432 34688999999999999999999998 99999999999999999999999
Q ss_pred eecCcccccCCCCceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhh
Q 002409 745 DFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 823 (927)
Q Consensus 745 DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~ 823 (927)
|||++...............++..|+|||.+.+ ..++.++|||||||+++||++|+.||......+....+.+......
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 238 (302)
T cd07864 159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238 (302)
T ss_pred cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 999987654333222223346788999998864 4578899999999999999999999975432211112222111110
Q ss_pred ccCCcccc--------cCC------cccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 824 ESGDIQGI--------IDP------SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 824 ~~~~~~~~--------~d~------~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
. .....+ .++ ....... .....+.+++.+|++.+|++||++.||+++
T Consensus 239 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 239 P-AVWPDVIKLPYFNTMKPKKQYRRRLREEFS-FIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred h-hhcccccccccccccccccccccchhhhcC-CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 000000 000 0001111 123568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=287.67 Aligned_cols=244 Identities=23% Similarity=0.279 Sum_probs=187.2
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeecCCc---hhhHhHHHHHHH-HhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTL-LSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~i-L~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
+.||+|+||.||+|+.. +++.||+|+++.... .....+..|..+ ....+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999875 588999999875432 112334445444 4455899999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
++|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||+++....
T Consensus 82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 999998843 34578889999999999999999998 999999999999999999999999999875432
Q ss_pred eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCc
Q 002409 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 839 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 839 (927)
.....|+..|++||.+.+..++.++||||||+++|||++|..||...... .+.. . ...+... ......
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~---~-~~~~~~~--~~~~~~-- 217 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD----AVFD---N-ILSRRIN--WPEEVK-- 217 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH----HHHH---H-HHhcccC--CCCccc--
Confidence 12335788999999998888899999999999999999999999654311 1111 0 1111110 000111
Q ss_pred cCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHH
Q 002409 840 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 874 (927)
Q Consensus 840 ~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~ 874 (927)
......+.+++.+|++.+|++||++.++.+.|.
T Consensus 218 --~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 218 --EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred --ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 122346889999999999999998766655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-32 Score=302.94 Aligned_cols=246 Identities=24% Similarity=0.411 Sum_probs=202.2
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc--hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
|.+...||+|.|+.|..|++. .+.+||||.+.+... .....+.+|+++|+.++|||||+++.+...+..+++||||+
T Consensus 58 y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya 137 (596)
T KOG0586|consen 58 YVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYA 137 (596)
T ss_pred eeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEec
Confidence 345688999999999999876 689999999976532 22344889999999999999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
.+|.+.+++.. ..++....+..++.|+.++++|||++ .|+|||||++||||+.+.++||+|||++..+.. .
T Consensus 138 ~~ge~~~yl~~----~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~--~ 208 (596)
T KOG0586|consen 138 SGGELFDYLVK----HGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDY--G 208 (596)
T ss_pred cCchhHHHHHh----cccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecc--c
Confidence 99999999953 44556688889999999999999999 999999999999999999999999999987653 3
Q ss_pred ceeeeeccCCCccCccccccCcC-CCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 758 HVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
......+|++.|.|||++.+.+| .+++|+||+|++||-|+.|..||++....+.....+. ..+
T Consensus 209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~----------------gk~ 272 (596)
T KOG0586|consen 209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR----------------GKY 272 (596)
T ss_pred ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee----------------eee
Confidence 45566789999999999998776 4689999999999999999999997664332211111 011
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 873 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L 873 (927)
+-.+. .-.++.+++++++-.+|.+|++++++.++-
T Consensus 273 rIp~~--ms~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 273 RIPFY--MSCDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred cccce--eechhHHHHHHhhccCccccCCHHHhhhhc
Confidence 11111 112467899999999999999999998773
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=294.29 Aligned_cols=265 Identities=22% Similarity=0.255 Sum_probs=192.5
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc--hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
+.+.+.||+|++|.||+|+.. +++.||+|++..... .....+.+|++++++++||||+++++++......++||||+
T Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (294)
T PLN00009 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL 83 (294)
T ss_pred eEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecc
Confidence 345678999999999999876 688999998864322 23456888999999999999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECC-CCcEEEEeecCcccccCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~-~~~vkL~DFGla~~~~~~~ 756 (927)
+ ++|.+++... ....+++..+..++.|++.||+|||++ +++||||||+||+++. ++.+||+|||++.......
T Consensus 84 ~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 84 D-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred c-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 6 5787776432 223457788889999999999999998 9999999999999985 5679999999997543321
Q ss_pred CceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccC-----Cccc
Q 002409 757 SHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG-----DIQG 830 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~-----~~~~ 830 (927)
. ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+..+........ .+..
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 158 R-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred c-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 1 1122346889999999866 4578899999999999999999999975442222111111111000000 0000
Q ss_pred cc--CCcccC----ccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 831 II--DPSLLD----EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 831 ~~--d~~l~~----~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.. -+.... ........++.+++.+|++.+|++||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 000000 0011223457899999999999999999999875
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=292.33 Aligned_cols=254 Identities=22% Similarity=0.284 Sum_probs=197.1
Q ss_pred HHhccccccCceEEEEEEEC----CCcEEEEEEeecCC----chhhHhHHHHHHHHhhc-cCCCccceecceeecCeEEE
Q 002409 602 MLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS----YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVL 672 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~----~g~~VAVK~l~~~~----~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~l 672 (927)
.+.+.||+|+||.||+++.. +++.||||+++... ......+.+|+++++++ +||||+++++.+......++
T Consensus 3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~l 82 (288)
T cd05583 3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHL 82 (288)
T ss_pred eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEE
Confidence 34678999999999999753 56889999987432 12345678899999999 69999999999999999999
Q ss_pred EEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccc
Q 002409 673 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 752 (927)
Q Consensus 673 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 752 (927)
||||+.+|+|.+++.. ...+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||+++..
T Consensus 83 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 83 ILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 9999999999998843 34578889999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCceeeeeccCCCccCccccccCc--CCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCccc
Q 002409 753 VDGASHVSSIVRGTVGYLDPEYYISQQ--LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 830 (927)
Q Consensus 753 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 830 (927)
............|+..|+|||.+.+.. .+.++||||||+++|||++|..||........ .....+.....
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~~~~~~~~~~~----- 227 (288)
T cd05583 156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS---QSEISRRILKS----- 227 (288)
T ss_pred ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch---HHHHHHHHHcc-----
Confidence 443322233345889999999987654 78899999999999999999999864321111 11111111110
Q ss_pred ccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHH
Q 002409 831 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 876 (927)
Q Consensus 831 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~ 876 (927)
.+..... ....+.+++.+|++.+|++|||+.+|.+.|+..
T Consensus 228 --~~~~~~~----~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 228 --KPPFPKT----MSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred --CCCCCcc----cCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 0111111 223578899999999999999999888777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=300.14 Aligned_cols=261 Identities=21% Similarity=0.206 Sum_probs=193.8
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchh--------------hHhHHHHHHHHhhccCCCccceecceee
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG--------------KREFTNEVTLLSRIHHRNLVQFLGYCQE 666 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~--------------~~~~~~Ei~iL~~l~HpnIv~l~g~~~~ 666 (927)
.+.+.||+|+||.||+|... +++.||||+++...... ...+.+|++++++++|+||+++++++..
T Consensus 12 ~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 91 (335)
T PTZ00024 12 QKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVE 91 (335)
T ss_pred hhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEec
Confidence 45678999999999999866 68899999986542211 1247789999999999999999999999
Q ss_pred cCeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEee
Q 002409 667 EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF 746 (927)
Q Consensus 667 ~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DF 746 (927)
.+..++||||+. |+|.+++. ....+++.....++.|++.||+|||+. +++||||||+||+++.++.+||+||
T Consensus 92 ~~~~~lv~e~~~-~~l~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 92 GDFINLVMDIMA-SDLKKVVD----RKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred CCcEEEEEeccc-cCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCc
Confidence 999999999997 58888874 244688899999999999999999998 9999999999999999999999999
Q ss_pred cCcccccCCC-------------CceeeeeccCCCccCccccccC-cCCCccceeeHHHHHHHHHhCCCccccccccccc
Q 002409 747 GLSKFAVDGA-------------SHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANC 812 (927)
Q Consensus 747 Gla~~~~~~~-------------~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~ 812 (927)
|+++...... ........++..|+|||.+.+. .++.++|||||||++|||++|+.||......+..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9987544110 1111223467899999998764 4688999999999999999999999765422211
Q ss_pred chhhHHHHhhhccCCccc------------ccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 813 RNIVQWAKLHIESGDIQG------------IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 813 ~~l~~~~~~~~~~~~~~~------------~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
..+......... ..... ...+..... .......+.+++.+|++.+|++||++.|++.+
T Consensus 244 ~~i~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 244 GRIFELLGTPNE-DNWPQAKKLPLYTEFTPRKPKDLKTI-FPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHhCCCch-hhCcchhhcccccccCcCCcccHHHh-CcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 122221111000 00000 000000000 11123468899999999999999999999874
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=277.26 Aligned_cols=261 Identities=25% Similarity=0.387 Sum_probs=201.1
Q ss_pred CHHHHHHHHHHHhccccccCceEEEEEE-ECCCcEEEEEEeecCCchhhHhHHHHHHHHhhc-cCCCccceecceeecCe
Q 002409 592 TLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGR 669 (927)
Q Consensus 592 ~~~ei~~~~~~~~~~IG~G~fG~Vy~~~-~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~ 669 (927)
++.|+.+.+ .+.||+|+|+.|--+. ..+|.++|||++.+..........+|++++.+. .|+||++++++|+++..
T Consensus 74 ~F~d~YkLt---~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~ 150 (463)
T KOG0607|consen 74 KFEDMYKLT---SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR 150 (463)
T ss_pred hHHHHHHhH---HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence 344444333 5789999999998875 568999999999888777788899999999998 59999999999999999
Q ss_pred EEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCC---cEEEEee
Q 002409 670 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM---RAKVSDF 746 (927)
Q Consensus 670 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~---~vkL~DF 746 (927)
.|||||.|.||+|..+|. +..-+++.++.++..+|+.||.+||.+ ||.||||||+|||-.... -+||+||
T Consensus 151 FYLVfEKm~GGplLshI~----~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 151 FYLVFEKMRGGPLLSHIQ----KRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred EEEEEecccCchHHHHHH----HhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeecc
Confidence 999999999999999984 456789999999999999999999999 999999999999997543 4899999
Q ss_pred cCccccc--C----CCCceeeeeccCCCccCccccc-----cCcCCCccceeeHHHHHHHHHhCCCcccccc-------c
Q 002409 747 GLSKFAV--D----GASHVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEK-------F 808 (927)
Q Consensus 747 Gla~~~~--~----~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~~sDVwSlGvvL~elltG~~p~~~~~-------~ 808 (927)
.+..-.. . ..+......+|+..|||||+.. ...|+.++|.||||||||-|++|..||.+.- .
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr 303 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR 303 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC
Confidence 8874221 1 1112223456889999999973 3468899999999999999999999996432 2
Q ss_pred ccccchhhHHHHhhhccCCcccccCCcccCccCHHHH----HHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 809 GANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSM----WKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 809 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~----~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
++.++.-.+..-..+.+|.+ +++.+++ .+..+++...+..++..|-++.+++++
T Consensus 304 Ge~Cr~CQ~~LFesIQEGkY----------eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 304 GEVCRVCQNKLFESIQEGKY----------EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred CCccHHHHHHHHHHHhccCC----------cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 33332111111122223321 2222222 345678888888999999999999874
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-32 Score=303.73 Aligned_cols=259 Identities=23% Similarity=0.314 Sum_probs=191.4
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeec-----CeEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-----GRSVLV 673 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~-----~~~~lV 673 (927)
|.+.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.++++++|+||+++++++... ...+++
T Consensus 7 y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 86 (336)
T cd07849 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIV 86 (336)
T ss_pred eEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEE
Confidence 456789999999999999865 68899999986432 23345678899999999999999999987544 357999
Q ss_pred EEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccccc
Q 002409 674 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 753 (927)
Q Consensus 674 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 753 (927)
+||+.+ +|.+.+. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 87 ~e~~~~-~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 87 QELMET-DLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred ehhccc-CHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 999974 7776663 34688999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCCc--eeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhcc---CC
Q 002409 754 DGASH--VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES---GD 827 (927)
Q Consensus 754 ~~~~~--~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~---~~ 827 (927)
..... ......|+..|+|||.+.+ ..++.++||||+||++|||++|+.||........ .......... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~----~~~~~~~~~~~~~~~ 233 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ----LNLILGVLGTPSQED 233 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHcCCCCHHH
Confidence 32211 1123458899999998754 5688999999999999999999999965431111 1111000000 00
Q ss_pred cccccCCcc---------cCc-----cCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 828 IQGIIDPSL---------LDE-----YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 828 ~~~~~d~~l---------~~~-----~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
+..+.+... ... .......++.+++.+|++.+|++||++.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000 000 001123468899999999999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=296.60 Aligned_cols=264 Identities=23% Similarity=0.251 Sum_probs=193.2
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCch--hhHhHHHHHHHHhhccCCCccceecceeec--CeEEEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLVYE 675 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--~~~~lV~E 675 (927)
+.+.+.||+|+||.||+|... +++.||+|+++..... ....+.+|+.++++++|+||+++++++... +..++|||
T Consensus 9 y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (309)
T cd07845 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVME 88 (309)
T ss_pred eeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEe
Confidence 445678999999999999876 5899999998744322 233467899999999999999999998654 56899999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCC
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 755 (927)
|+.+ +|.+++... ...+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||+++.....
T Consensus 89 ~~~~-~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 89 YCEQ-DLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred cCCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 9974 788777532 25688999999999999999999998 9999999999999999999999999999765432
Q ss_pred CCceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhcc-------CC
Q 002409 756 ASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES-------GD 827 (927)
Q Consensus 756 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~-------~~ 827 (927)
... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+.++....... ..
T Consensus 162 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 162 AKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred cCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 211 122235788999999865 457899999999999999999999997544222222222211100000 00
Q ss_pred ccccc--CCcccCcc---CHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 828 IQGII--DPSLLDEY---DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 828 ~~~~~--d~~l~~~~---~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
....+ ........ .......+.+++.+|++.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000 00000000 00123467899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=300.59 Aligned_cols=267 Identities=23% Similarity=0.308 Sum_probs=201.0
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecC-----eEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG-----RSVL 672 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-----~~~l 672 (927)
+.+.+.||+|+||.||+|+.. +++.+|||++.... ....+.+.+|++++++++|+||+++++++.... ..++
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 345688999999999999876 48899999987543 334567889999999999999999999998775 7899
Q ss_pred EEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccc
Q 002409 673 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 752 (927)
Q Consensus 673 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 752 (927)
+|||++ ++|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.++|+|||++...
T Consensus 82 v~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 82 VTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred Eecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 999997 478887743 34789999999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCC--ceeeeeccCCCccCccccccC-cCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhcc----
Q 002409 753 VDGAS--HVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES---- 825 (927)
Q Consensus 753 ~~~~~--~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~---- 825 (927)
..... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+....+.+.......+
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 44321 112234578899999999887 88999999999999999999999997654222222222211100000
Q ss_pred ---CCcccccC---Ccc---cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH--HHH
Q 002409 826 ---GDIQGIID---PSL---LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD--IQD 875 (927)
Q Consensus 826 ---~~~~~~~d---~~l---~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~--L~~ 875 (927)
....+.+. ..- ...........+.+++.+|++.+|++||++.+++++ +++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 294 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ 294 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHh
Confidence 00000000 000 000011133568899999999999999999999986 554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=284.06 Aligned_cols=246 Identities=24% Similarity=0.401 Sum_probs=199.5
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc--hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
.+.+.||+|++|.||+++.. +++.+++|.+..... .....+.+|++++++++|+|++++++++...+..+++|||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (254)
T cd06627 3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAE 82 (254)
T ss_pred eeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCC
Confidence 45678999999999999876 578999999976643 345678999999999999999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
+++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.........
T Consensus 83 ~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 83 NGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 9999998843 35689999999999999999999998 9999999999999999999999999999865443322
Q ss_pred eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccC
Q 002409 759 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 838 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 838 (927)
.....++..|+|||...+..++.++||||+|+++++|++|+.||...... ...|... .....
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-----~~~~~~~---~~~~~--------- 217 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-----AALFRIV---QDDHP--------- 217 (254)
T ss_pred -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-----HHHHHHh---ccCCC---------
Confidence 23345889999999998888899999999999999999999998654310 1111111 11110
Q ss_pred ccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 839 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 839 ~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
..+......+.+++.+|+..+|++||++.|++.+
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 1111223468899999999999999999999753
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=298.05 Aligned_cols=265 Identities=24% Similarity=0.344 Sum_probs=194.2
Q ss_pred HHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecC--CchhhHhHHHHHHHHhhc-cCCCccceecceeec--CeEEE
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE--GRSVL 672 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~--~~~~l 672 (927)
..+.+.+.||+|+||.||+|... +++.+|+|++... .......+.+|+.+++++ +||||+++++++... ...++
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l 86 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence 45667789999999999999876 5788999988543 223345677899999999 999999999988643 36799
Q ss_pred EEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccc
Q 002409 673 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 752 (927)
Q Consensus 673 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 752 (927)
||||+. ++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 87 v~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 87 VFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred Eecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 999997 588887742 2678888999999999999999998 9999999999999999999999999999755
Q ss_pred cCCCC----ceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHh------
Q 002409 753 VDGAS----HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL------ 821 (927)
Q Consensus 753 ~~~~~----~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~------ 821 (927)
..... .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 43321 12223458999999998865 45788999999999999999999999654322111111111100
Q ss_pred -hhccCCcccccC----Ccc--cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 822 -HIESGDIQGIID----PSL--LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 822 -~~~~~~~~~~~d----~~l--~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.+.......+++ ... ..........++.+++.+|++.+|++||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000000010 000 000011123568899999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=289.96 Aligned_cols=263 Identities=21% Similarity=0.274 Sum_probs=195.2
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc-hhhHhHHHHHHHHhhcc-CCCccceecceeecCeEEEEEEecc
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
.+.+.||+|+||.||+|+.. +++.|+||++..... .......+|+..+++++ |+|++++++++...+..++||||+
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 80 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM- 80 (283)
T ss_pred eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence 35678999999999999986 478899999865422 22334567999999998 999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
+|+|.+++.... ...+++..++.++.|++.+|.|||++ +++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (283)
T cd07830 81 EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY 155 (283)
T ss_pred CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence 789988875432 34689999999999999999999998 9999999999999999999999999999755432221
Q ss_pred eeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhH---------HHHhhhccCCc
Q 002409 759 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ---------WAKLHIESGDI 828 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~---------~~~~~~~~~~~ 828 (927)
....++..|+|||++.. ..++.++|+||||++++||++|+.||......+....+.. |.........+
T Consensus 156 --~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 156 --TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred --CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 22347889999998854 5678999999999999999999999865432211111111 11100000011
Q ss_pred ccccCCccc---CccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 829 QGIIDPSLL---DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 829 ~~~~d~~l~---~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
...+..... ..........+.+++.+|++.+|++||+++|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 100000000 00011113568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=293.04 Aligned_cols=261 Identities=18% Similarity=0.254 Sum_probs=192.5
Q ss_pred HhccccccCceEEEEEEECCCcEEEEEEeecC--CchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCC
Q 002409 603 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 680 (927)
Q Consensus 603 ~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 680 (927)
+.+.+|.|+++.||+++. +++.||||++... .....+.+.+|++++++++|+||+++++++...+..+++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 445556666666666655 5899999998754 3344567999999999999999999999999999999999999999
Q ss_pred chhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC---
Q 002409 681 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS--- 757 (927)
Q Consensus 681 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~--- 757 (927)
+|.+++.... ...+++.....++.|+++||+|||++ +|+||||||+||+++.++.+||+|||.+........
T Consensus 85 ~l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 85 SCEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 9999986432 34578888999999999999999998 999999999999999999999999998864432111
Q ss_pred ---ceeeeeccCCCccCcccccc--CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhh----hc----
Q 002409 758 ---HVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH----IE---- 824 (927)
Q Consensus 758 ---~~~~~~~gt~~Y~aPE~~~~--~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~----~~---- 824 (927)
.......++..|+|||++.. ..++.++|||||||++|||++|+.||....... .+.+..... ..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~ 236 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ---MLLEKVRGTVPCLLDKSTY 236 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhccCccccccCch
Confidence 11122347788999999875 458899999999999999999999997543111 111111000 00
Q ss_pred ---cCCccc----ccCCcc----cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 825 ---SGDIQG----IIDPSL----LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 825 ---~~~~~~----~~d~~l----~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
...... ..++.. ..........++.+++.+|++.+|++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000000 000100 011122233568899999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=288.65 Aligned_cols=261 Identities=22% Similarity=0.272 Sum_probs=196.9
Q ss_pred HhccccccCceEEEEEEEC-CCcEEEEEEeecCCc--hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 603 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 603 ~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
+.+.||+|++|.||++... +++.+++|.+..... .....+..|++++++++|+||+++++++..+...++|+||+++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 82 (283)
T cd05118 3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT 82 (283)
T ss_pred cceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC
Confidence 3568999999999999875 688899999875432 2356788899999999999999999999999999999999975
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
+|.+++... ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||.+....... ..
T Consensus 83 -~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~ 154 (283)
T cd05118 83 -DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP 154 (283)
T ss_pred -CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence 888777432 25689999999999999999999998 99999999999999999999999999987654432 11
Q ss_pred eeeeccCCCccCccccccC-cCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHh-------hhcc----C-
Q 002409 760 SSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL-------HIES----G- 826 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~-------~~~~----~- 826 (927)
.....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+....+.+.... ...+ .
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 2223478899999998876 7899999999999999999999999654421111111110000 0000 0
Q ss_pred -CcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 827 -DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 827 -~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.+....+... .........++.+++.+|++.+|.+||++.|++.+
T Consensus 235 ~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 235 FSFPKKAGMPL-PKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhccccccCH-HHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000000000 01112234578999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=294.20 Aligned_cols=261 Identities=20% Similarity=0.253 Sum_probs=190.2
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc--hhhHhHHHHHHHHhhccCCCccceecceeecC--------e
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG--------R 669 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--------~ 669 (927)
|.+.+.||+|+||.||+|+.. +++.||||.+..... .....+.+|++++++++||||+++++++...+ .
T Consensus 14 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 93 (310)
T cd07865 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGS 93 (310)
T ss_pred eEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCce
Confidence 456788999999999999876 688999998864422 22345678999999999999999999886544 4
Q ss_pred EEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCc
Q 002409 670 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 749 (927)
Q Consensus 670 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla 749 (927)
.++||||+.+ +|.+.+.. ....+++.+++.++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++
T Consensus 94 ~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 94 FYLVFEFCEH-DLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred EEEEEcCCCc-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 5999999964 77777643 234688999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCc---eeeeeccCCCccCccccccC-cCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhcc
Q 002409 750 KFAVDGASH---VSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES 825 (927)
Q Consensus 750 ~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 825 (927)
......... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||......... ..+.........
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~-~~~~~~~~~~~~ 245 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQL-TLISQLCGSITP 245 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCCh
Confidence 755432211 11233478899999988654 4788999999999999999999998654321111 111111100000
Q ss_pred CCccc------------------ccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 826 GDIQG------------------IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 826 ~~~~~------------------~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
..... .+...+... .....+.+++.+|+..+|++||+++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPY---VKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccc---cCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00000 000000000 012356789999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=287.70 Aligned_cols=250 Identities=26% Similarity=0.380 Sum_probs=195.2
Q ss_pred HHHhccccccCceEEEEEEECC-CcEEEEEEeecC-----CchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSN-----SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 674 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~~-g~~VAVK~l~~~-----~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~ 674 (927)
|.+.+.||+|+||.||+++... +..+++|+++.. ......++..|+.++++++||||+++++++.+....++|+
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 4567889999999999998763 445666665532 1223345778999999999999999999999999999999
Q ss_pred EeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccC
Q 002409 675 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 754 (927)
Q Consensus 675 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 754 (927)
||+++++|.+++.........+++..++.++.|++.||.|||+. +++|+||||+||+++. +.+||+|||+++....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecCC
Confidence 99999999998865444456789999999999999999999998 9999999999999975 5699999999876543
Q ss_pred CCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCC
Q 002409 755 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 834 (927)
Q Consensus 755 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 834 (927)
.. .......|+..|+|||.+....++.++|+||||+++|+|++|+.||..... ....... ..+...
T Consensus 158 ~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-------~~~~~~~-~~~~~~----- 223 (260)
T cd08222 158 SC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-------LSVVLRI-VEGPTP----- 223 (260)
T ss_pred Cc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-------HHHHHHH-HcCCCC-----
Confidence 22 222334578899999999888889999999999999999999999864331 1111111 111111
Q ss_pred cccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 835 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 835 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
. .+......+.+++.+|++.+|++||++.|++++
T Consensus 224 ~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 224 S----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred C----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 1 112233468899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=288.22 Aligned_cols=262 Identities=22% Similarity=0.280 Sum_probs=193.7
Q ss_pred HhccccccCceEEEEEEEC-CCcEEEEEEeecCCc--hhhHhHHHHHHHHhhc---cCCCccceecceeecCe-----EE
Q 002409 603 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRI---HHRNLVQFLGYCQEEGR-----SV 671 (927)
Q Consensus 603 ~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~iL~~l---~HpnIv~l~g~~~~~~~-----~~ 671 (927)
+.+.||+|+||.||+|+.+ +++.+|+|+++.... .....+.+|+.+++++ +|+|++++++++...+. .+
T Consensus 3 ~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~ 82 (287)
T cd07838 3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLT 82 (287)
T ss_pred EEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeE
Confidence 4578999999999999987 489999999874322 2234566788777666 59999999999988776 89
Q ss_pred EEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccc
Q 002409 672 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 751 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 751 (927)
++|||+.+ +|.+++.... ...+++..++.++.|+++||+|||+. +++|+||+|+||+++.++.+||+|||++..
T Consensus 83 l~~e~~~~-~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 83 LVFEHVDQ-DLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred EEehhccc-CHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCccee
Confidence 99999974 7888775422 23589999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCc---
Q 002409 752 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI--- 828 (927)
Q Consensus 752 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~--- 828 (927)
...... .....++..|+|||.+.+..++.++|+|||||++|||++|+.||......+....+.+...........
T Consensus 157 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 157 YSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred ccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 533221 122347889999999998899999999999999999999999987654322222222211100000000
Q ss_pred ---ccccCCccc---CccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 829 ---QGIIDPSLL---DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 829 ---~~~~d~~l~---~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
......... ..........+.+++.+|++.+|++||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 000000000 01111233567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=293.23 Aligned_cols=258 Identities=19% Similarity=0.225 Sum_probs=181.5
Q ss_pred HHHHHHHHhccccccCceEEEEEEECC----CcEEEEEEeecCCchh--h---------HhHHHHHHHHhhccCCCccce
Q 002409 596 IEDATKMLEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNSYQG--K---------REFTNEVTLLSRIHHRNLVQF 660 (927)
Q Consensus 596 i~~~~~~~~~~IG~G~fG~Vy~~~~~~----g~~VAVK~l~~~~~~~--~---------~~~~~Ei~iL~~l~HpnIv~l 660 (927)
+....+.+.+.||+|+||.||+|...+ +..+|+|+........ + .....+...+..+.|+|++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 334456778899999999999998764 3456666543222111 0 111223345566789999999
Q ss_pred ecceeecC----eEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEEC
Q 002409 661 LGYCQEEG----RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD 736 (927)
Q Consensus 661 ~g~~~~~~----~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~ 736 (927)
++++.... ..++++|++.. ++.+.+.. ....++..+..++.|++.||+|||+. +|+||||||+|||++
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~ 160 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVD 160 (294)
T ss_pred EEeeeEecCCceEEEEEEehhcc-CHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEc
Confidence 99765543 34677776643 45544421 22356777889999999999999998 999999999999999
Q ss_pred CCCcEEEEeecCcccccCCCCc------eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCccccccccc
Q 002409 737 KHMRAKVSDFGLSKFAVDGASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGA 810 (927)
Q Consensus 737 ~~~~vkL~DFGla~~~~~~~~~------~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~ 810 (927)
.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||+++||++|+.||.......
T Consensus 161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~ 240 (294)
T PHA02882 161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG 240 (294)
T ss_pred CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence 9999999999999755322111 1123459999999999999999999999999999999999999997653211
Q ss_pred ccchh--hHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHH
Q 002409 811 NCRNI--VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 873 (927)
Q Consensus 811 ~~~~l--~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L 873 (927)
..... .++. ..+..+.+. .......+.+++..|++.+|++||++.++.+.|
T Consensus 241 ~~~~~~~~~~~-~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 241 NLIHAAKCDFI-KRLHEGKIK-----------IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHHhHHHHH-HHhhhhhhc-----------cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 11111 1111 111111110 011235688999999999999999999999876
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=292.62 Aligned_cols=249 Identities=24% Similarity=0.369 Sum_probs=194.1
Q ss_pred HHHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecC---CchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEE
Q 002409 598 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 673 (927)
Q Consensus 598 ~~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV 673 (927)
..++...+.||+|+||.||+|+.. +++.+|+|.+... ......++.+|+++++.++|+|++++++++......++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 344555678999999999999876 5788999988643 222345678899999999999999999999999999999
Q ss_pred EEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccccc
Q 002409 674 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 753 (927)
Q Consensus 674 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 753 (927)
|||+. |+|.+.+... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 94 ~e~~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 94 MEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred EEccC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 99996 5777766422 34578899999999999999999998 99999999999999999999999999987543
Q ss_pred CCCCceeeeeccCCCccCccccc---cCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCccc
Q 002409 754 DGASHVSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 830 (927)
Q Consensus 754 ~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 830 (927)
.. ....|+..|+|||.+. ...++.++|||||||++|||++|+.||......+ .+..+ ..+....
T Consensus 167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~-----~~~~~~~ 233 (308)
T cd06634 167 PA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYHI-----AQNESPA 233 (308)
T ss_pred Cc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH---HHHHH-----hhcCCCC
Confidence 22 2234788999999975 3567889999999999999999999986533110 11111 1111111
Q ss_pred ccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHH
Q 002409 831 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 874 (927)
Q Consensus 831 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~ 874 (927)
.. .......+.+++.+|++.+|++||++.+|+++..
T Consensus 234 -----~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 234 -----LQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred -----cC---cccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 00 1122345789999999999999999999998744
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=286.94 Aligned_cols=248 Identities=23% Similarity=0.329 Sum_probs=192.7
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecC-----CchhhHhHHHHHHHHhhccCCCccceecceeec--CeEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN-----SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVL 672 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~-----~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--~~~~l 672 (927)
+.+.+.||+|+||.||+|+.. +++.+|+|++... ..+....+.+|++++++++|+||+++++++.+. ...++
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI 83 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence 345688999999999999865 5889999987532 123345788999999999999999999988654 45789
Q ss_pred EEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccc
Q 002409 673 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 752 (927)
Q Consensus 673 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 752 (927)
++||+++++|.+++.. ...+++.....++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++..
T Consensus 84 v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 84 FVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 9999999999998843 23478888999999999999999998 9999999999999999999999999998754
Q ss_pred cCCC--CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCccc
Q 002409 753 VDGA--SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 830 (927)
Q Consensus 753 ~~~~--~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 830 (927)
.... ........|+..|+|||++.+..++.++|+|||||+++||++|+.||...... ..+.+. ...+
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~----~~~~---- 225 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM---AAIFKI----ATQP---- 225 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH---HHHHHH----HcCC----
Confidence 3211 11112345889999999998888999999999999999999999999754311 111111 1111
Q ss_pred ccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 831 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 831 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.....+......+.+++.+|++ +|.+||+..+++.|
T Consensus 226 -----~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 226 -----TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred -----CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 0011222233568899999999 47999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=300.74 Aligned_cols=265 Identities=21% Similarity=0.300 Sum_probs=195.2
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecC--CchhhHhHHHHHHHHhhccCCCccceecceeec-----CeEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-----GRSVL 672 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~-----~~~~l 672 (927)
|.+.+.||+|+||.||+++.. +++.||||.+... .......+.+|+.++++++|+||+++++++... ...++
T Consensus 7 y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l 86 (337)
T cd07858 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYI 86 (337)
T ss_pred eeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEE
Confidence 445678999999999999865 6889999998653 223345677899999999999999999988654 34799
Q ss_pred EEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccc
Q 002409 673 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 752 (927)
Q Consensus 673 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 752 (927)
|+||+. ++|.+++.. ...+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++..
T Consensus 87 v~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 87 VYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 999996 688877742 35688999999999999999999998 9999999999999999999999999999755
Q ss_pred cCCCCceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhh-------hc
Q 002409 753 VDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH-------IE 824 (927)
Q Consensus 753 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~-------~~ 824 (927)
.... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||...........+.+..... ..
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07858 159 SEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR 237 (337)
T ss_pred CCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence 4322 22223457889999998865 468899999999999999999999996543111111111110000 00
Q ss_pred cCCc-------ccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH--HHH
Q 002409 825 SGDI-------QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD--IQD 875 (927)
Q Consensus 825 ~~~~-------~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~--L~~ 875 (927)
.... ....++.... .......++.+++.+|++.+|++||++.|++++ ++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 238 NEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred chhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 0000 0000000000 011233568899999999999999999999998 554
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=319.52 Aligned_cols=265 Identities=27% Similarity=0.427 Sum_probs=209.4
Q ss_pred HHHHHHHHHhccccccCceEEEEEEEC----C----CcEEEEEEeecCCc-hhhHhHHHHHHHHhhc-cCCCccceecce
Q 002409 595 DIEDATKMLEKKIGSGGFGVVYYGKLK----D----GKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYC 664 (927)
Q Consensus 595 ei~~~~~~~~~~IG~G~fG~Vy~~~~~----~----g~~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~ 664 (927)
|+.+....+.+.||+|.||.|++|... . ...||||+++.... ...+.+..|+++|+.+ +|+||+.++|+|
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 333343456679999999999999754 1 34699999986533 4467899999999998 699999999999
Q ss_pred eecCeEEEEEEeccCCchhhhccccc----------ccc--cccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCC
Q 002409 665 QEEGRSVLVYEFMHNGTLKEHLYGTL----------THE--QRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSN 732 (927)
Q Consensus 665 ~~~~~~~lV~E~~~~gsL~~~L~~~~----------~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~N 732 (927)
..++..++|+||+..|+|.++|+... ... ..++....+.++.|||.||+||++. +++||||.++|
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRN 448 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARN 448 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhhh
Confidence 99999999999999999999997554 111 2388999999999999999999998 89999999999
Q ss_pred eEECCCCcEEEEeecCcccccCCCCceeeeecc--CCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccc
Q 002409 733 ILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG--TVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFG 809 (927)
Q Consensus 733 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~g--t~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~ 809 (927)
||++.+..+||+|||+++...+..........| ...|||||.+....|+.++|||||||+||||++ |..|+.....
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~- 527 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP- 527 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc-
Confidence 999999999999999998655443333222223 346999999999999999999999999999999 7788865220
Q ss_pred cccchhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 810 ANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 810 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
...+.+ .+++|.- .+.+..+..++.+++..|++.+|++||++.|+++.++..+.
T Consensus 528 --~~~l~~----~l~~G~r---------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 528 --TEELLE----FLKEGNR---------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred --HHHHHH----HHhcCCC---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 112222 2333321 12233345578899999999999999999999999999653
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=287.86 Aligned_cols=242 Identities=25% Similarity=0.337 Sum_probs=186.1
Q ss_pred cccccCceEEEEEEEC-CCcEEEEEEeecCCc---hhhHhHHHHHHH---HhhccCCCccceecceeecCeEEEEEEecc
Q 002409 606 KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTL---LSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 606 ~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~i---L~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
.||+|+||.||++... +++.||+|.+..... .....+..|..+ ++..+||||+++++++...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999865 588999999875422 222234444433 444579999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
+|+|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 9999988742 35689999999999999999999998 99999999999999999999999999987543222
Q ss_pred eeeeeccCCCccCccccccC-cCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCccc
Q 002409 759 VSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 837 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 837 (927)
.....|+..|+|||.+.++ .++.++||||+||++|||++|+.||........ ..+ . .... . .+..+.
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~-~~~-~--~~~~-~------~~~~~~ 219 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEI-D--RMTL-T------MAVELP 219 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch-HHH-H--HHhh-c------cCCCCC
Confidence 1234589999999998754 689999999999999999999999976431111 011 0 0000 0 011111
Q ss_pred CccCHHHHHHHHHHHhhhcCCCCCCCC-----cHHHHHHH
Q 002409 838 DEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 872 (927)
Q Consensus 838 ~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----sm~eV~~~ 872 (927)
.. ....+.+++.+|+..+|++|| ++.|++++
T Consensus 220 ~~----~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 220 DS----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred Cc----CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 11 234688999999999999999 99999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=297.62 Aligned_cols=264 Identities=19% Similarity=0.279 Sum_probs=193.6
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceee----cCeEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE----EGRSVLV 673 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~----~~~~~lV 673 (927)
+.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++.. ....++|
T Consensus 7 y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 86 (334)
T cd07855 7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVV 86 (334)
T ss_pred eeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEE
Confidence 445678999999999999866 68999999987542 2334567789999999999999999998753 3467999
Q ss_pred EEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccccc
Q 002409 674 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 753 (927)
Q Consensus 674 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 753 (927)
|||+. ++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 87 ~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 87 MDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred Eehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 99996 588888743 34589999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCCc---eeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHH-------hh
Q 002409 754 DGASH---VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK-------LH 822 (927)
Q Consensus 754 ~~~~~---~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~-------~~ 822 (927)
..... ......|+..|+|||.+.. ..++.++|||||||++|||++|+.||...........+..... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~ 238 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence 32211 1123458899999999865 4688999999999999999999999965431111000000000 00
Q ss_pred hccCCcccccCC-cccCcc-----CHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 823 IESGDIQGIIDP-SLLDEY-----DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 823 ~~~~~~~~~~d~-~l~~~~-----~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.....+.+..+. ...... ......++.+++.+|++.+|++||++.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000000000000 000000 11234578999999999999999999998886
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=287.88 Aligned_cols=261 Identities=24% Similarity=0.272 Sum_probs=197.0
Q ss_pred HhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 603 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 603 ~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
+.+.||+|+||.||+|+.. +++.+|+|++.... ......+..|++++++++|+|++++++++...+..++|+||++
T Consensus 3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~- 81 (282)
T cd07829 3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD- 81 (282)
T ss_pred eehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-
Confidence 3467999999999999877 48999999987653 2234567889999999999999999999999999999999997
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
++|.+++.... ..+++..++.++.|++.||+|||+. +++||||+|+||++++++.+||+|||+++........
T Consensus 82 ~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~- 154 (282)
T cd07829 82 MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT- 154 (282)
T ss_pred cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCccc-
Confidence 58999885421 4688999999999999999999998 9999999999999999999999999998755432221
Q ss_pred eeeeccCCCccCccccccC-cCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhc------------cC
Q 002409 760 SSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE------------SG 826 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~------------~~ 826 (927)
.....++..|+|||.+.+. .++.++|||||||+++||++|+.||......+....+.+....... +.
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 1223357789999998776 7899999999999999999999999765422222222211110000 00
Q ss_pred CcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 827 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 827 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
............. .......+.+++.+|++.+|++||++.||+.+
T Consensus 235 ~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 235 TFPKFPPKDLEKV-LPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccCccchHHh-cccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0000000000000 01113568999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=288.81 Aligned_cols=247 Identities=25% Similarity=0.330 Sum_probs=197.9
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhcc-CCCccceecceeecCeEEEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYE 675 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~~~~lV~E 675 (927)
|.+.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|++++++++ |+||+++++++...+..++|||
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE 82 (280)
T ss_pred ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence 345678999999999999876 68999999986532 233467888999999998 9999999999999999999999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCC
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 755 (927)
++++++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 83 YAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 9999999998853 34689999999999999999999998 9999999999999999999999999998754432
Q ss_pred CC-------------------ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhh
Q 002409 756 AS-------------------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIV 816 (927)
Q Consensus 756 ~~-------------------~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~ 816 (927)
.. .......++..|+|||......++.++||||||++++++++|+.||...... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~ 231 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY----LTF 231 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH----HHH
Confidence 21 1122345788999999998888999999999999999999999999754411 111
Q ss_pred HHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcH----HHHHHH
Q 002409 817 QWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSI----SEVLKD 872 (927)
Q Consensus 817 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm----~eV~~~ 872 (927)
+... ... ...+......+.+++.+|++.+|++||++ .|++++
T Consensus 232 ~~~~----~~~----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 232 QKIL----KLE----------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HHHH----hcC----------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 1111 000 01111123468899999999999999999 777653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-32 Score=286.23 Aligned_cols=260 Identities=24% Similarity=0.325 Sum_probs=207.0
Q ss_pred HHHHHHHhccccccCceEEEEEEEC------CCcEEEEEEeecCCch-hhHhHHHHHHHHhhccCCCccceecceeec-C
Q 002409 597 EDATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEE-G 668 (927)
Q Consensus 597 ~~~~~~~~~~IG~G~fG~Vy~~~~~------~g~~VAVK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~-~ 668 (927)
.+.+..+...+-+|.||+||+|.+. +.++|.||.++....+ ....+..|..++..+.|||+.++.+++.+. .
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~ 361 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA 361 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC
Confidence 3344444567899999999999655 3456788887655333 345688899999999999999999998765 4
Q ss_pred eEEEEEEeccCCchhhhcccc----cccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEE
Q 002409 669 RSVLVYEFMHNGTLKEHLYGT----LTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 744 (927)
Q Consensus 669 ~~~lV~E~~~~gsL~~~L~~~----~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~ 744 (927)
..+.+|.++.-|+|..+|..- ....+.++..+...++.|++.|++|||++ +|||.||.++|++|++..++||+
T Consensus 362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEec
Confidence 678899999999999999621 12345677888899999999999999999 99999999999999999999999
Q ss_pred eecCcccccCCCCcee-eeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhh
Q 002409 745 DFGLSKFAVDGASHVS-SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLH 822 (927)
Q Consensus 745 DFGla~~~~~~~~~~~-~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~ 822 (927)
|-.++|...+.+.+.- .....+..||+||.+....|+.++|||||||+||||+| |+.|+..-+..+.. .+
T Consensus 439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~----~y---- 510 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME----HY---- 510 (563)
T ss_pred cchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH----HH----
Confidence 9999997777665543 33446789999999999999999999999999999999 88888654422211 11
Q ss_pred hccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHH
Q 002409 823 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 876 (927)
Q Consensus 823 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~ 876 (927)
+.+| .+-..+.+++.++..++.-|++..|++||++.|++.-|.+.
T Consensus 511 lkdG---------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 511 LKDG---------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred Hhcc---------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 1111 12223456677899999999999999999999999998875
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=287.31 Aligned_cols=250 Identities=25% Similarity=0.346 Sum_probs=190.2
Q ss_pred HHHhccccccCceEEEEEEECC-CcEEEEEEeecCC-chhhHhHHHHHHHHhhcc-CCCccceecceeecCeEEEEEEec
Q 002409 601 KMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~~-g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
+.+.+.||+|+||.||+|.+++ ++.||||+++... ......+..|+.++.+.. |+||+++++++.+....+++|||+
T Consensus 17 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 96 (296)
T cd06618 17 LENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM 96 (296)
T ss_pred heeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeecc
Confidence 4567899999999999999875 8899999987543 233455667777777765 999999999999999999999998
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
. ++|.+++... ...+++..+..++.|+++||+|||+. .+|+||||+|+||++++++.+||+|||++........
T Consensus 97 ~-~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 97 S-TCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred C-cCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 5 4666655321 34688999999999999999999973 2899999999999999999999999999875543222
Q ss_pred ceeeeeccCCCccCccccccCc----CCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccC
Q 002409 758 HVSSIVRGTVGYLDPEYYISQQ----LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 833 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~~~~~----~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 833 (927)
. ....++..|+|||.+.+.. ++.++||||||+++|||++|+.||...... ...+... .... ...
T Consensus 171 ~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~----~~~~-~~~--- 238 (296)
T cd06618 171 K--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVLTKI----LQEE-PPS--- 238 (296)
T ss_pred c--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHHHHH----hcCC-CCC---
Confidence 1 2234788999999987553 788999999999999999999999653211 1111111 1110 000
Q ss_pred CcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 834 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 834 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
... ......++.+++.+|++.+|++||++.+++++
T Consensus 239 --~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 239 --LPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred --CCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 00123468899999999999999999999877
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=291.78 Aligned_cols=265 Identities=20% Similarity=0.275 Sum_probs=190.8
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCch--hhHhHHHHHHHHhhccCCCccceecceeecC--------
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEEG-------- 668 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-------- 668 (927)
.+.+.++||+|+||.||+|+.. +++.+|||++...... ....+.+|++++++++||||+++++++.+..
T Consensus 9 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 88 (311)
T cd07866 9 DYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRG 88 (311)
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCc
Confidence 3445688999999999999876 5889999988654322 2345778999999999999999999875433
Q ss_pred eEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecC
Q 002409 669 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 748 (927)
Q Consensus 669 ~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGl 748 (927)
..++|+||+.+ +|.+.+.. ....+++..+..++.|+++||+|||+. +++||||||+||++++++.+||+|||+
T Consensus 89 ~~~lv~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 89 SVYMVTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred eEEEEEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCcc
Confidence 46999999975 66665542 234689999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCc----------eeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhH
Q 002409 749 SKFAVDGASH----------VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 817 (927)
Q Consensus 749 a~~~~~~~~~----------~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~ 817 (927)
++........ ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...........+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 8754322111 1122357888999998865 4588999999999999999999999975432111111111
Q ss_pred HHHhhhcc-----CCcccc--------cCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 818 WAKLHIES-----GDIQGI--------IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 818 ~~~~~~~~-----~~~~~~--------~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
........ ..+... ..+.+...+ ......+.+++.+|++.+|++|||+.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 11000000 000000 001110000 1122468899999999999999999998864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=288.47 Aligned_cols=242 Identities=25% Similarity=0.404 Sum_probs=190.0
Q ss_pred HhccccccCceEEEEEEEC-CCcEEEEEEeecCCc---hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 603 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 603 ~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
..+.||+|+||.||+|+.. +++.|++|++..... .....+.+|++++++++|||++++++++.+....++||||+.
T Consensus 25 ~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 104 (313)
T cd06633 25 GLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL 104 (313)
T ss_pred cceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC
Confidence 3467999999999999875 688999999874422 223567889999999999999999999999999999999996
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
|+|.+++.. ....+++..++.++.|++.+|.|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 105 -~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 105 -GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred -CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 577776643 234588999999999999999999998 999999999999999999999999998864322
Q ss_pred eeeeeccCCCccCccccc---cCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCc
Q 002409 759 VSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 835 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~---~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 835 (927)
.....|+..|+|||++. ...++.++|||||||++|||++|+.||...... ....... ........
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~----~~~~~~~----~~~~~~~~--- 241 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SALYHIA----QNDSPTLQ--- 241 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHH----hcCCCCCC---
Confidence 12345889999999984 456888999999999999999999998654311 1111111 01111111
Q ss_pred ccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 836 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 836 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.. .....+.+++.+|++.+|++||++.+++++
T Consensus 242 -~~----~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 -SN----EWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -cc----ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01 112357889999999999999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=273.98 Aligned_cols=245 Identities=24% Similarity=0.312 Sum_probs=197.0
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchh---hHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~---~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
.+.++||+|.||+|-.++-+ .++.+|+|++++...-. ...-..|-++|+..+||.+..+--.+...+++|+||||.
T Consensus 171 dfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeya 250 (516)
T KOG0690|consen 171 DFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYA 250 (516)
T ss_pred hHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEc
Confidence 36789999999999999866 68899999998764322 233457899999999999999988899999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
.||.|.-+| ...+.+++....-+..+|..||.|||++ +||.||||.+|.|+|.+|++||+|||+++.-.. ..
T Consensus 251 nGGeLf~HL----srer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~-~g 322 (516)
T KOG0690|consen 251 NGGELFFHL----SRERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK-YG 322 (516)
T ss_pred cCceEeeeh----hhhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccc-cc
Confidence 999998888 3467788888888999999999999998 999999999999999999999999999874322 23
Q ss_pred ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCccc
Q 002409 758 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 837 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 837 (927)
.....++|||.|+|||++....|..++|-|.+|||+|||++|+.||...+.+..+.-|.. ++-++
T Consensus 323 ~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~------ed~kF--------- 387 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM------EDLKF--------- 387 (516)
T ss_pred ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh------hhccC---------
Confidence 345678899999999999999999999999999999999999999986553322221111 11111
Q ss_pred CccCHHHHHHHHHHHhhhcCCCCCCCC-----cHHHHHHH
Q 002409 838 DEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 872 (927)
Q Consensus 838 ~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----sm~eV~~~ 872 (927)
+.....+...|..-.+..||.+|. .++||.++
T Consensus 388 ---Pr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 388 ---PRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred ---CccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 111122456778888999999997 45555544
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=281.31 Aligned_cols=235 Identities=20% Similarity=0.298 Sum_probs=182.1
Q ss_pred ccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhc-cCCCccceecceeecCeEEEEEEeccCCchhh
Q 002409 607 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKE 684 (927)
Q Consensus 607 IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~ 684 (927)
||+|+||.||+++.+ +++.+|+|++...... . .|+.....+ +||||+++++.+...+..++||||+++++|.+
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~--~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~ 98 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN---A--IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD 98 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcc---h--hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHH
Confidence 599999999999865 6788999998643211 1 122222222 79999999999999999999999999999999
Q ss_pred hcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCC-cEEEEeecCcccccCCCCceeeee
Q 002409 685 HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIV 763 (927)
Q Consensus 685 ~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-~vkL~DFGla~~~~~~~~~~~~~~ 763 (927)
++.. ...+++..+..++.|+++||.|||+. +++||||||+||+++.++ .++|+|||+++...... ..
T Consensus 99 ~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-----~~ 166 (267)
T PHA03390 99 LLKK----EGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS-----CY 166 (267)
T ss_pred HHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc-----cC
Confidence 9853 23789999999999999999999998 999999999999999998 99999999987543221 23
Q ss_pred ccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCccCHH
Q 002409 764 RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQ 843 (927)
Q Consensus 764 ~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 843 (927)
.|+..|+|||++.+..++.++|||||||+++||++|+.||....... ..+..+.... .... . . ...
T Consensus 167 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~--~~~~-~-----~----~~~ 232 (267)
T PHA03390 167 DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE--LDLESLLKRQ--QKKL-P-----F----IKN 232 (267)
T ss_pred CCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch--hhHHHHHHhh--cccC-C-----c----ccc
Confidence 58899999999998899999999999999999999999997443111 1122222211 0000 0 0 012
Q ss_pred HHHHHHHHHhhhcCCCCCCCCc-HHHHHHH
Q 002409 844 SMWKIEEKALMCVLPHGHMRPS-ISEVLKD 872 (927)
Q Consensus 844 ~~~~l~~L~~~Cl~~dP~~RPs-m~eV~~~ 872 (927)
....+.+++.+|++.+|++||+ ++|++++
T Consensus 233 ~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 233 VSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred cCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 2346889999999999999995 6888754
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=323.82 Aligned_cols=245 Identities=25% Similarity=0.390 Sum_probs=193.1
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCC
Q 002409 604 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 680 (927)
Q Consensus 604 ~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 680 (927)
...||.|.||.||-|... +|+-.|+|-++... ....+...+|..++..++|||+|+++|+-..++..+|.||||++|
T Consensus 1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence 457999999999999754 67888999876443 334567889999999999999999999999999999999999999
Q ss_pred chhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc--
Q 002409 681 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH-- 758 (927)
Q Consensus 681 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~-- 758 (927)
+|.+.+. ..+..++.....+..|++.|++|||++ |||||||||.||+|+.+|.+|++|||.|.........
T Consensus 1320 sLa~ll~----~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1320 SLASLLE----HGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred cHHHHHH----hcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence 9999883 334455666667889999999999999 9999999999999999999999999999866544211
Q ss_pred -eeeeeccCCCccCccccccC---cCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHh-hhccCCcccccC
Q 002409 759 -VSSIVRGTVGYLDPEYYISQ---QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL-HIESGDIQGIID 833 (927)
Q Consensus 759 -~~~~~~gt~~Y~aPE~~~~~---~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~-~~~~~~~~~~~d 833 (927)
......||+.|||||++.+. ....++||||+|||..||+||++||...+. +|+.+ ++.-|..
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn--------e~aIMy~V~~gh~----- 1459 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN--------EWAIMYHVAAGHK----- 1459 (1509)
T ss_pred HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc--------hhHHHhHHhccCC-----
Confidence 12335699999999999753 356689999999999999999999975441 23221 2222222
Q ss_pred CcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 834 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 834 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
++.+.....+-.+.+.+|+..||++|.++.|++++
T Consensus 1460 ----Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1460 ----PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ----CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 22222333456789999999999999888766654
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=277.19 Aligned_cols=236 Identities=29% Similarity=0.360 Sum_probs=191.2
Q ss_pred ccccCceEEEEEEEC-CCcEEEEEEeecCCc---hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCCch
Q 002409 607 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 682 (927)
Q Consensus 607 IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 682 (927)
||+|+||.||++... +++.+|+|++..... .....+..|++++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999876 588999999875532 2345788999999999999999999999999999999999999999
Q ss_pred hhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCceeee
Q 002409 683 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 762 (927)
Q Consensus 683 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 762 (927)
.+++.. ...+++.....++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 152 (250)
T cd05123 81 FSHLSK----EGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT 152 (250)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccC
Confidence 999843 33688999999999999999999998 99999999999999999999999999987654332 12233
Q ss_pred eccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCccCH
Q 002409 763 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 842 (927)
Q Consensus 763 ~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 842 (927)
..++..|++||...+...+.++|+||||+++|||++|+.||..... ..+.+.+.. +.. ..+.
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----~~~~~~~~~----~~~----------~~~~ 214 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR----KEIYEKILK----DPL----------RFPE 214 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHhc----CCC----------CCCC
Confidence 4578899999999888889999999999999999999999965432 111121111 100 1111
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCcHHH
Q 002409 843 QSMWKIEEKALMCVLPHGHMRPSISE 868 (927)
Q Consensus 843 ~~~~~l~~L~~~Cl~~dP~~RPsm~e 868 (927)
.....+.+++.+|+..+|++||++.+
T Consensus 215 ~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 215 FLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 11346789999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=292.34 Aligned_cols=264 Identities=20% Similarity=0.263 Sum_probs=190.6
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeec-----------
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE----------- 667 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~----------- 667 (927)
++.+.+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++.+...
T Consensus 6 ~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (342)
T cd07854 6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSL 85 (342)
T ss_pred ceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccc
Confidence 3445688999999999999875 5889999998766555567788999999999999999999876544
Q ss_pred ---CeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECC-CCcEEE
Q 002409 668 ---GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKV 743 (927)
Q Consensus 668 ---~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~-~~~vkL 743 (927)
...++|+||+. ++|.+++. ...+++..+..++.|++.||.|||+. +++||||||+||+++. ++.+||
T Consensus 86 ~~~~~~~lv~e~~~-~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 86 TELNSVYIVQEYME-TDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred cccceEEEEeeccc-ccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEE
Confidence 35789999997 58887763 23588899999999999999999998 9999999999999984 567899
Q ss_pred EeecCcccccCCCCce--eeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHH
Q 002409 744 SDFGLSKFAVDGASHV--SSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK 820 (927)
Q Consensus 744 ~DFGla~~~~~~~~~~--~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~ 820 (927)
+|||+++......... .....++..|+|||.+.. ..++.++|||||||++|||++|+.||......+....+..-..
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 236 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999987543221111 122347889999998754 5678899999999999999999999965431111111110000
Q ss_pred hhh--ccCCcccccCCcc-----cC-----ccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 821 LHI--ESGDIQGIIDPSL-----LD-----EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 821 ~~~--~~~~~~~~~d~~l-----~~-----~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
... ............+ .. ........++.+++.+|++.+|++||++.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 000 0000000000000 00 0001123467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=289.64 Aligned_cols=261 Identities=21% Similarity=0.302 Sum_probs=190.0
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeec------CeEEE
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRSVL 672 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~------~~~~l 672 (927)
.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++... ...++
T Consensus 18 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l 97 (342)
T cd07879 18 TSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYL 97 (342)
T ss_pred EEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEE
Confidence 34578999999999999865 68999999986432 22235678999999999999999999988654 34689
Q ss_pred EEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccc
Q 002409 673 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 752 (927)
Q Consensus 673 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 752 (927)
|+||+.. +|.+++ ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 98 v~e~~~~-~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 98 VMPYMQT-DLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred Eeccccc-CHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 9999864 666544 23578889999999999999999998 9999999999999999999999999998754
Q ss_pred cCCCCceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHH-------hhhc
Q 002409 753 VDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK-------LHIE 824 (927)
Q Consensus 753 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~-------~~~~ 824 (927)
... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+..... ....
T Consensus 168 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (342)
T cd07879 168 DAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE 243 (342)
T ss_pred CCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhc
Confidence 321 122347889999999876 4688999999999999999999999975432111111111000 0000
Q ss_pred cCC-------cccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH--HHHHH
Q 002409 825 SGD-------IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD--IQDAI 877 (927)
Q Consensus 825 ~~~-------~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~--L~~~~ 877 (927)
... ........+...+ ......+.+++.+|++.+|++||++.|++++ ++...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 244 DKAAKSYIKSLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred ccchHHHHhhcCCcccchHHHHh-cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 000 0000000000000 1123457899999999999999999999977 66653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=267.17 Aligned_cols=247 Identities=25% Similarity=0.355 Sum_probs=192.1
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEeecCC-chhhHhHHHHHHHHhhcc-CCCccceecceeecCeEEEEEEeccCC
Q 002409 604 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMHNG 680 (927)
Q Consensus 604 ~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~~~~lV~E~~~~g 680 (927)
...||.|..|.|++++++ .|.-+|||.+.... .+..+.+...+.++.+.+ +|.||+.+|||......++.||.|..
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~- 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST- 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-
Confidence 456999999999999877 57889999998664 344566777777776665 89999999999999888999998853
Q ss_pred chhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCcee
Q 002409 681 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 760 (927)
Q Consensus 681 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 760 (927)
.++.++... .+.+++.-+-++...+.+||.||.+++ +|+|||+||+|||+|+.|++|+||||++-++.+...+
T Consensus 176 C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh-- 248 (391)
T KOG0983|consen 176 CAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH-- 248 (391)
T ss_pred HHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccccc--
Confidence 455555332 345778778889999999999999984 9999999999999999999999999999877665443
Q ss_pred eeeccCCCccCcccccc---CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCccc
Q 002409 761 SIVRGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 837 (927)
Q Consensus 761 ~~~~gt~~Y~aPE~~~~---~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 837 (927)
+...|.+.|||||.+.. ..|+.++||||||+.|+||.||+.||.....+ + .....+.. +. .|.+.
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--F-e~ltkvln-----~e----PP~L~ 316 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--F-EVLTKVLN-----EE----PPLLP 316 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--H-HHHHHHHh-----cC----CCCCC
Confidence 34469999999999864 46889999999999999999999999875421 1 11221111 11 12232
Q ss_pred CccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 838 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 838 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
... .....+.+++..|++.|+.+||...++++|
T Consensus 317 ~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 317 GHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred ccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 211 122357899999999999999999999886
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=271.17 Aligned_cols=202 Identities=25% Similarity=0.368 Sum_probs=167.0
Q ss_pred HHHHhccccccCceEEEEEEEC---C--CcEEEEEEeecCCch--hhHhHHHHHHHHhhccCCCccceecceee-cCeEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK---D--GKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQE-EGRSV 671 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~---~--g~~VAVK~l~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~-~~~~~ 671 (927)
.|+....||+|.||.||+|.-+ + .+.+|+|+++..... -.....+|+.+++.++||||+.+..++.. +...+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 3455678999999999999543 2 347899998755322 23557899999999999999999999977 77889
Q ss_pred EEEEeccCCchhhhcccc-cccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCC----CcEEEEee
Q 002409 672 LVYEFMHNGTLKEHLYGT-LTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH----MRAKVSDF 746 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~-~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~----~~vkL~DF 746 (927)
|++||.+. +|.+.++-. ....+.++...+..|+.||+.|+.|||++ -|+||||||.|||+..+ |.|||+|+
T Consensus 105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999987 888877432 23346789999999999999999999999 89999999999999877 89999999
Q ss_pred cCcccccCCCCce--eeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccc
Q 002409 747 GLSKFAVDGASHV--SSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISN 805 (927)
Q Consensus 747 Gla~~~~~~~~~~--~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~ 805 (927)
|+++.+.+.-... ...++-|.+|.|||.+.+ ..|+.+.|||+.|||+.||++-.+.|..
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 9999766543322 244667999999999987 5799999999999999999999888754
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=289.63 Aligned_cols=258 Identities=21% Similarity=0.287 Sum_probs=190.3
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecC------eEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------RSV 671 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~------~~~ 671 (927)
|.+.+.||+|+||.||++... +++.||||++.... ......+.+|++++++++||||+++++++.... ..+
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07880 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFY 96 (343)
T ss_pred eEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEE
Confidence 445678999999999999765 68899999985432 223456789999999999999999999886543 458
Q ss_pred EEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccc
Q 002409 672 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 751 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 751 (927)
+||||+ +++|.+++. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 97 lv~e~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 97 LVMPFM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred EEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 999998 678887773 24588999999999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHH-------hhh
Q 002409 752 AVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK-------LHI 823 (927)
Q Consensus 752 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~-------~~~ 823 (927)
..... ....+++.|+|||.+.+ ..++.++|+|||||++++|++|+.||...........+..... ..+
T Consensus 168 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07880 168 TDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL 243 (343)
T ss_pred cccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 43221 22347889999999876 4588899999999999999999999975432111111111000 000
Q ss_pred ccCC-------cccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 824 ESGD-------IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 824 ~~~~-------~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.... +.......+ ..........+.+++.+|++.+|++||++.+++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 244 QSEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred cchhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 000000000 00011223357899999999999999999999865
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=289.76 Aligned_cols=262 Identities=22% Similarity=0.280 Sum_probs=188.7
Q ss_pred HHhccccccCceEEEEEEEC-C--CcEEEEEEeecCC--chhhHhHHHHHHHHhhc-cCCCccceecceeec----CeEE
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-D--GKEIAVKVLTSNS--YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE----GRSV 671 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~--g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~----~~~~ 671 (927)
.+.+.||+|+||.||+++.. . ++.||+|++.... ....+.+.+|+++++++ +||||+++++.+... ...+
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 82 (332)
T cd07857 3 ELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELY 82 (332)
T ss_pred eEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEE
Confidence 45678999999999999876 3 6789999986432 22345678899999999 599999999875432 4568
Q ss_pred EEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccc
Q 002409 672 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 751 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 751 (927)
+++||+. ++|.+++. ....+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++.
T Consensus 83 ~~~e~~~-~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 83 LYEELME-ADLHQIIR----SGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEeccc-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 8889886 68888874 245688999999999999999999998 999999999999999999999999999975
Q ss_pred ccCCCCc---eeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHh------
Q 002409 752 AVDGASH---VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL------ 821 (927)
Q Consensus 752 ~~~~~~~---~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~------ 821 (927)
....... ......|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||...........+......
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL 234 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 4332211 1123458999999998765 46889999999999999999999998754321111111111000
Q ss_pred -hhccCC-------cccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 822 -HIESGD-------IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 822 -~~~~~~-------~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
...... ....-...+ ..........+.+++.+|++.+|++||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPF-ESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcch-HhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000 000000000 00001123468899999999999999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=307.49 Aligned_cols=246 Identities=25% Similarity=0.373 Sum_probs=182.7
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceee---------------
Q 002409 604 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--------------- 666 (927)
Q Consensus 604 ~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--------------- 666 (927)
.+.||+||||.||+++.+ ||+++|||++.... ......+.+|+..|.+++|||||+++..+.+
T Consensus 484 L~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~ 563 (1351)
T KOG1035|consen 484 LELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDS 563 (1351)
T ss_pred HHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccch
Confidence 367999999999999987 89999999997653 3334568899999999999999997632100
Q ss_pred --------------------------------------------------------------------------------
Q 002409 667 -------------------------------------------------------------------------------- 666 (927)
Q Consensus 667 -------------------------------------------------------------------------------- 666 (927)
T Consensus 564 ~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d 643 (1351)
T KOG1035|consen 564 ESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILD 643 (1351)
T ss_pred hhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccC
Confidence
Q ss_pred ----------------c--------CeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCc
Q 002409 667 ----------------E--------GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 722 (927)
Q Consensus 667 ----------------~--------~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ 722 (927)
+ ..+|+-||||+.-.|.++++...-.. .....++++.+|+.||+|+|++ |
T Consensus 644 ~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaYIH~~---g 717 (1351)
T KOG1035|consen 644 DTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAYIHDQ---G 717 (1351)
T ss_pred cchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHHHHhC---c
Confidence 0 12467788888777776664332110 3556789999999999999999 9
Q ss_pred eecCCCCCCCeEECCCCcEEEEeecCccccc------C-----------CCCceeeeeccCCCccCccccccC---cCCC
Q 002409 723 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAV------D-----------GASHVSSIVRGTVGYLDPEYYISQ---QLTD 782 (927)
Q Consensus 723 ivHrDLkp~NILl~~~~~vkL~DFGla~~~~------~-----------~~~~~~~~~~gt~~Y~aPE~~~~~---~~s~ 782 (927)
||||||||.||+++++..|||+|||+|+... + ......+...||.-|+|||++.+. .|+.
T Consensus 718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~ 797 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS 797 (1351)
T ss_pred eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence 9999999999999999999999999997521 0 011123445699999999999764 5999
Q ss_pred ccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCC
Q 002409 783 KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHM 862 (927)
Q Consensus 783 ~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~ 862 (927)
|+|+||+|||++||+. ||.... +.. -+...+++|.+..- .++.......-..++.+|+++||.+
T Consensus 798 KiDmYSLGIVlFEM~y---PF~TsM-----ERa--~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~k 861 (1351)
T KOG1035|consen 798 KIDMYSLGIVLFEMLY---PFGTSM-----ERA--SILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSK 861 (1351)
T ss_pred hhhhHHHHHHHHHHhc---cCCchH-----HHH--HHHHhcccCCCCCC------cccccccchHHHHHHHHHhcCCCcc
Confidence 9999999999999986 354221 111 12234455555443 1222333344578999999999999
Q ss_pred CCcHHHHHH
Q 002409 863 RPSISEVLK 871 (927)
Q Consensus 863 RPsm~eV~~ 871 (927)
|||+.|++.
T Consensus 862 RPtA~eLL~ 870 (1351)
T KOG1035|consen 862 RPTATELLN 870 (1351)
T ss_pred CCCHHHHhh
Confidence 999999885
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=287.40 Aligned_cols=259 Identities=19% Similarity=0.268 Sum_probs=190.4
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecC--CchhhHhHHHHHHHHhhccCCCccceecceee-cCeEEEEEEe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE-EGRSVLVYEF 676 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~-~~~~~lV~E~ 676 (927)
|.+.+.||+|+||.||+++.. +++.||||++... .....+.+.+|++++++++||||+++++++.. ....++++||
T Consensus 12 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~ 91 (328)
T cd07856 12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTEL 91 (328)
T ss_pred eEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeeh
Confidence 445688999999999999866 7899999987643 22234667889999999999999999998865 5578999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
+ +++|.+++. ...+++.....++.|+++||+|||+. +++||||||+||++++++.+||+|||++......
T Consensus 92 ~-~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~- 161 (328)
T cd07856 92 L-GTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ- 161 (328)
T ss_pred h-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCCC-
Confidence 8 568887774 23467788888999999999999998 9999999999999999999999999998743221
Q ss_pred CceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHH--------HHhhhccCC
Q 002409 757 SHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQW--------AKLHIESGD 827 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~--------~~~~~~~~~ 827 (927)
.....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.++ .........
T Consensus 162 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd07856 162 ---MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENT 238 (328)
T ss_pred ---cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhh
Confidence 122346889999998866 56899999999999999999999999654321111111111 000000000
Q ss_pred cccccCCcccCccC-----HHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 828 IQGIIDPSLLDEYD-----IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 828 ~~~~~d~~l~~~~~-----~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
..-..........+ ......+.+++.+|++.+|++||++.|++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 239 LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000111 1123578899999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=285.53 Aligned_cols=254 Identities=25% Similarity=0.394 Sum_probs=198.9
Q ss_pred HHHHHHHHH-hccccccCceEEEEEEEC-CCcEEEEEEeecC--CchhhHhHHHHHHHHhhccCCCccceecceeecCeE
Q 002409 595 DIEDATKML-EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS 670 (927)
Q Consensus 595 ei~~~~~~~-~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~ 670 (927)
|+...+..| ++.||+|.||+||-|+++ +|+.||||++.+. ..+.+.++.+|++||++++||.||.+-.-|+..++.
T Consensus 559 d~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~erv 638 (888)
T KOG4236|consen 559 DISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERV 638 (888)
T ss_pred hHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceE
Confidence 333333334 688999999999999876 7999999999764 345567899999999999999999999999999999
Q ss_pred EEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCC---CcEEEEeec
Q 002409 671 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH---MRAKVSDFG 747 (927)
Q Consensus 671 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~---~~vkL~DFG 747 (927)
+.|||.+.| +..+.+.. .+..++++.....++.||+.||.|||.+ +|+|+||||+|||+... -++||||||
T Consensus 639 FVVMEKl~G-DMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFG 712 (888)
T KOG4236|consen 639 FVVMEKLHG-DMLEMILS--SEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFG 712 (888)
T ss_pred EEEehhhcc-hHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeecccc
Confidence 999999954 65555533 3467788888888999999999999998 99999999999999754 479999999
Q ss_pred CcccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCC
Q 002409 748 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 827 (927)
Q Consensus 748 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 827 (927)
.|+...+. .....+.||+.|+|||++..+.|...-|+||.|||+|--++|..||..+. ...+.++-+..+
T Consensus 713 fARiIgEk--sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE---dIndQIQNAaFM----- 782 (888)
T KOG4236|consen 713 FARIIGEK--SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE---DINDQIQNAAFM----- 782 (888)
T ss_pred ceeecchh--hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc---chhHHhhccccc-----
Confidence 99977553 34456789999999999999999999999999999999999999997543 111112211111
Q ss_pred cccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 828 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 828 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
..+.-.. +.....++|+...++..-++|-+.++-+.+
T Consensus 783 ----yPp~PW~----eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 783 ----YPPNPWS----EISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred ----cCCCchh----hcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 1111111 222356788888888888889888775543
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=292.39 Aligned_cols=259 Identities=22% Similarity=0.306 Sum_probs=192.2
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecC--CchhhHhHHHHHHHHhhccCCCccceecceeecCe------EE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR------SV 671 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~------~~ 671 (927)
|.+.+.||+|+||.||+|+.. +++.||||++... .......+.+|+.++++++|+|++++++++...+. .+
T Consensus 17 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07851 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVY 96 (343)
T ss_pred eEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEE
Confidence 345678999999999999886 5789999988643 22234567789999999999999999998876554 89
Q ss_pred EEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccc
Q 002409 672 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 751 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 751 (927)
+|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 97 lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 97 LVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred EEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccccc
Confidence 999998 5689888742 4689999999999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHh-------hh
Q 002409 752 AVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL-------HI 823 (927)
Q Consensus 752 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~-------~~ 823 (927)
.... .....++..|+|||.+.. ..++.++|||||||++|||++|+.||......+....+.+.... ..
T Consensus 168 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (343)
T cd07851 168 TDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243 (343)
T ss_pred cccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence 4332 223357889999999865 46788999999999999999999999754322111111111000 00
Q ss_pred ccCCcccc---cCCcccCcc---CHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 824 ESGDIQGI---IDPSLLDEY---DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 824 ~~~~~~~~---~d~~l~~~~---~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
........ +...-...+ ......++.+++.+|++.+|++|||+.||+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00000000 000000000 01123578899999999999999999999876
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-30 Score=290.52 Aligned_cols=258 Identities=22% Similarity=0.292 Sum_probs=189.0
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeec------CeEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRSV 671 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~------~~~~ 671 (927)
+.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++... ...+
T Consensus 19 y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 98 (345)
T cd07877 19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 98 (345)
T ss_pred eEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEE
Confidence 334678999999999999764 68899999986532 22345678899999999999999999987543 3467
Q ss_pred EEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccc
Q 002409 672 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 751 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 751 (927)
++++++ +++|.+++. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 99 lv~~~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~~~ 169 (345)
T cd07877 99 LVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH 169 (345)
T ss_pred EEehhc-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEeccccccc
Confidence 888876 778887763 23588999999999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHh-------hh
Q 002409 752 AVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL-------HI 823 (927)
Q Consensus 752 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~-------~~ 823 (927)
.... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.+.... ..
T Consensus 170 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (345)
T cd07877 170 TDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 245 (345)
T ss_pred cccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 4322 223457899999999866 56888999999999999999999999654321111111111100 00
Q ss_pred ccCC-------cccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 824 ESGD-------IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 824 ~~~~-------~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.... +......... .........+.+++.+|++.+|++||++.|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 246 SSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred ccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000 0000000000 0000123457899999999999999999999877
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=270.85 Aligned_cols=221 Identities=21% Similarity=0.175 Sum_probs=175.1
Q ss_pred cCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCCchhhhccc
Q 002409 610 GGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG 688 (927)
Q Consensus 610 G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~ 688 (927)
|.||.||+++.. +++.+|+|+++... .+..|...+....||||+++++++...+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999875 68899999987542 233455555566799999999999999999999999999999998843
Q ss_pred ccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCceeeeeccCCC
Q 002409 689 TLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 768 (927)
Q Consensus 689 ~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~ 768 (927)
...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++|||.+...... .....++..
T Consensus 79 ----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~ 147 (237)
T cd05576 79 ----FLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENM 147 (237)
T ss_pred ----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcc
Confidence 34588999999999999999999998 9999999999999999999999999987644322 122345778
Q ss_pred ccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCccCHHHHHHH
Q 002409 769 YLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKI 848 (927)
Q Consensus 769 Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 848 (927)
|+|||.+....++.++||||+||++|||++|+.|+...... + . ......+.. .....+
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~-~------------~~~~~~~~~----~~~~~~ 205 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----I-N------------THTTLNIPE----WVSEEA 205 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c-c------------cccccCCcc----cCCHHH
Confidence 99999998888999999999999999999999887532210 0 0 000000111 122457
Q ss_pred HHHHhhhcCCCCCCCCcHHH
Q 002409 849 EEKALMCVLPHGHMRPSISE 868 (927)
Q Consensus 849 ~~L~~~Cl~~dP~~RPsm~e 868 (927)
.+++.+|++.||++||++.+
T Consensus 206 ~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 206 RSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred HHHHHHHccCCHHHhcCCCc
Confidence 89999999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-31 Score=266.77 Aligned_cols=264 Identities=27% Similarity=0.374 Sum_probs=197.9
Q ss_pred ccccCHHHHHHHHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc-hhhHhHHHHHHHHhh-ccCCCccceecce
Q 002409 588 AHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSR-IHHRNLVQFLGYC 664 (927)
Q Consensus 588 ~~~~~~~ei~~~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~iL~~-l~HpnIv~l~g~~ 664 (927)
.+.|+-.++++. ..||.|+||+|+|-.++ .|+..|||+++.... ..++++..|.+...+ -+.||||+++|.+
T Consensus 58 ~~~F~~~~Lqdl-----g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~ 132 (361)
T KOG1006|consen 58 LHTFTSDNLQDL-----GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGAL 132 (361)
T ss_pred ccccccchHHHH-----HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhh
Confidence 455555555543 45899999999999876 689999999987644 456778888876554 4789999999999
Q ss_pred eecCeEEEEEEeccCCchhhhcc-cccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEE
Q 002409 665 QEEGRSVLVYEFMHNGTLKEHLY-GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV 743 (927)
Q Consensus 665 ~~~~~~~lV~E~~~~gsL~~~L~-~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL 743 (927)
-.++..++.||.|.- +|+.+-. -...+...+++.-.-.|..-...||.||.+. ..|+|||+||+|||++..|.+||
T Consensus 133 F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKL 209 (361)
T KOG1006|consen 133 FSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKL 209 (361)
T ss_pred hcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEee
Confidence 999999999999954 5544321 1123456678777778888889999999987 58999999999999999999999
Q ss_pred EeecCcccccCCCCceeeeeccCCCccCcccccc--CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHh
Q 002409 744 SDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL 821 (927)
Q Consensus 744 ~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~ 821 (927)
||||++-...+. ...+.-.|...|||||.+.. ..|+.++||||||+.|+|+.||+.|+.... ..++++.+-+
T Consensus 210 CDFGIcGqLv~S--iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~--svfeql~~Vv-- 283 (361)
T KOG1006|consen 210 CDFGICGQLVDS--IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD--SVFEQLCQVV-- 283 (361)
T ss_pred ecccchHhHHHH--HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH--HHHHHHHHHH--
Confidence 999998655432 23334568999999999964 358999999999999999999999997655 1222333322
Q ss_pred hhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 822 HIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 822 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.|+...+.. +.-..+....+...+..|+..|-..||...++.++
T Consensus 284 ---~gdpp~l~~----~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 284 ---IGDPPILLF----DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ---cCCCCeecC----cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 222221111 11112334468889999999999999999998764
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-30 Score=304.13 Aligned_cols=253 Identities=23% Similarity=0.272 Sum_probs=201.1
Q ss_pred HHHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecC---CchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEE
Q 002409 598 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 673 (927)
Q Consensus 598 ~~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV 673 (927)
...+.+.++||+|+||.|..++++ .++.+|+|++.+- .......|.+|-.+|...+.+-|+.++-.|.+..++|+|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence 334567789999999999999887 5778899998763 233456788999999999999999999999999999999
Q ss_pred EEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccccc
Q 002409 674 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 753 (927)
Q Consensus 674 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 753 (927)
||||+||+|..++.. ..++++.-+..++.+|+.||.-||+- |+|||||||+|||||..|++||+|||.+-.+.
T Consensus 154 MdY~pGGDlltLlSk----~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~ 226 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSK----FDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD 226 (1317)
T ss_pred EecccCchHHHHHhh----cCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcC
Confidence 999999999999843 34788888889999999999999998 99999999999999999999999999887666
Q ss_pred CCCCceeeeeccCCCccCcccccc-----CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCc
Q 002409 754 DGASHVSSIVRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 828 (927)
Q Consensus 754 ~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 828 (927)
......+...+|||.|++||++.. +.|+..+|.||+||++|||+.|..||..+..-+.+..|... +..+ .+
T Consensus 227 ~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h-k~~l---~F 302 (1317)
T KOG0612|consen 227 ADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH-KESL---SF 302 (1317)
T ss_pred CCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch-hhhc---CC
Confidence 555556666789999999999963 56889999999999999999999999877644444444332 0000 11
Q ss_pred ccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCc---HHHHHHH
Q 002409 829 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS---ISEVLKD 872 (927)
Q Consensus 829 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs---m~eV~~~ 872 (927)
++. .+...+..+|+.+.+. +|+.|-. +.++..|
T Consensus 303 P~~----------~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 303 PDE----------TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred Ccc----------cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 111 1233355667666554 4566776 7777766
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=307.76 Aligned_cols=142 Identities=31% Similarity=0.425 Sum_probs=126.4
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
.+.++||+|+||.||+|.+. +++.||||+++... ......+..|+.+++.++||||+++++++......++||||+
T Consensus 7 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~ 86 (669)
T cd05610 7 VIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYL 86 (669)
T ss_pred EEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCC
Confidence 45688999999999999877 68899999987543 222467889999999999999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcc
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 750 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 750 (927)
.+++|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 87 ~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 87 IGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999998843 34578888999999999999999998 99999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-30 Score=289.54 Aligned_cols=238 Identities=21% Similarity=0.322 Sum_probs=189.9
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhc-cCCCccceecceeecCeEEEEEEec
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
.+.+...+|.|+|+.|-++.+. +++..+||++.+. ..+..+|+.++.+. +||||+++.+.+.+..+.++|||.+
T Consensus 323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l 398 (612)
T KOG0603|consen 323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELL 398 (612)
T ss_pred hhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeehhc
Confidence 4556778999999999998765 6888999998755 23455677666555 7999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEE-CCCCcEEEEeecCcccccCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL-DKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl-~~~~~vkL~DFGla~~~~~~~ 756 (927)
.++-+.+.+... +.....+..|+.+|+.++.|||++ ||+||||||+|||+ ++.++++|+|||.++.....
T Consensus 399 ~g~ell~ri~~~-----~~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 399 DGGELLRRIRSK-----PEFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred cccHHHHHHHhc-----chhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 999887776432 122256778999999999999998 99999999999999 68899999999999865443
Q ss_pred CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 757 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
....+-|..|.|||++....|++++|+||||++||+|++|+.||.....+ ..+. ..+..+.+.
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~----~~i~~~~~s------- 532 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIH----TRIQMPKFS------- 532 (612)
T ss_pred ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHH----HhhcCCccc-------
Confidence 22234588999999999999999999999999999999999999765522 1121 222223222
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
........+|+.+||+.+|++||+|.|+..+
T Consensus 533 -----~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 533 -----ECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred -----cccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 2223457899999999999999999999876
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=241.35 Aligned_cols=261 Identities=20% Similarity=0.281 Sum_probs=191.0
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCC
Q 002409 604 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 680 (927)
Q Consensus 604 ~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 680 (927)
.++||+|.||+|++|+.. .++-||+|.++-+. ........+|+.+|+.++|+|||++++....+..+.+|+|||..
T Consensus 7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq- 85 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ- 85 (292)
T ss_pred HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-
Confidence 468999999999999866 46779999987543 23346688999999999999999999999999999999999964
Q ss_pred chhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCcee
Q 002409 681 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 760 (927)
Q Consensus 681 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 760 (927)
+|..+.... .+.++...+..++.|+++||.++|++ ++.|||+||.|.|++.+|+.|++|||+++-++-.... .
T Consensus 86 dlkkyfdsl---ng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvrc-y 158 (292)
T KOG0662|consen 86 DLKKYFDSL---NGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC-Y 158 (292)
T ss_pred HHHHHHHhc---CCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceEe-e
Confidence 777665332 45678888899999999999999999 9999999999999999999999999999866543322 2
Q ss_pred eeeccCCCccCccccccC-cCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccC--CcccccCCcc
Q 002409 761 SIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESG--DIQGIIDPSL 836 (927)
Q Consensus 761 ~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~d~~l 836 (927)
....-|.+|.+|.++.+. -|+...|+||-||++.|+.. |++.|.+.+..+....|.......-++. .+...-|=..
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~ 238 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP 238 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence 233469999999999875 57888999999999999997 5555655442221111211111111111 1222222222
Q ss_pred cCccCHH-----HH----HHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 837 LDEYDIQ-----SM----WKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 837 ~~~~~~~-----~~----~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
...|+.. .+ ..=.++..+.+.-+|..|.++++.+++
T Consensus 239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 2333211 11 123477778888899999998877664
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-30 Score=273.00 Aligned_cols=241 Identities=24% Similarity=0.299 Sum_probs=193.9
Q ss_pred HHHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchh---hHhHHHHHHHHhhc-cCCCccceecceeecCeEEE
Q 002409 598 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG---KREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVL 672 (927)
Q Consensus 598 ~~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~---~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~l 672 (927)
....+|..+||+|+||.|-.|.-+ ..+.+|||+++++..-. .+--+.|-++|... +-|.+++++.++..-+++++
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 344578899999999999999766 45668999998763221 12234566666655 56899999999999999999
Q ss_pred EEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccc
Q 002409 673 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 752 (927)
Q Consensus 673 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 752 (927)
||||+.||+|.-++ ++-+++-+..+.-+|.+||-||-+||++ +|+.||||..|||++.+|++||+|||+++.-
T Consensus 428 VMEyvnGGDLMyhi----QQ~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHI----QQVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred EEEEecCchhhhHH----HHhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccc
Confidence 99999999998887 4456778888899999999999999999 9999999999999999999999999998743
Q ss_pred cCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCccccc
Q 002409 753 VDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 832 (927)
Q Consensus 753 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 832 (927)
.- ....+.+.+||+.|+|||++..++|...+|.|||||+||||+.|+.||++.+..+.++.|.+.
T Consensus 501 i~-~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh-------------- 565 (683)
T KOG0696|consen 501 IF-DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH-------------- 565 (683)
T ss_pred cc-CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc--------------
Confidence 22 233456688999999999999999999999999999999999999999987755444444331
Q ss_pred CCcccCccCHHHHHHHHHHHhhhcCCCCCCCC
Q 002409 833 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP 864 (927)
Q Consensus 833 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP 864 (927)
.-.|+.....+.+++....+...|.+|.
T Consensus 566 ----nvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 566 ----NVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ----cCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 1123333445677788888888898886
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=269.79 Aligned_cols=264 Identities=23% Similarity=0.330 Sum_probs=202.1
Q ss_pred ccCHHHHHHHHHHHhccccccCceEEEEEEE-CCCcEEEEEEeecCCchh-------hHhHHHHHHHHhhccCCCcccee
Q 002409 590 CFTLSDIEDATKMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQG-------KREFTNEVTLLSRIHHRNLVQFL 661 (927)
Q Consensus 590 ~~~~~ei~~~~~~~~~~IG~G~fG~Vy~~~~-~~g~~VAVK~l~~~~~~~-------~~~~~~Ei~iL~~l~HpnIv~l~ 661 (927)
.|.-......+|.+.+.||+|||+.||+|.+ ...+.||||+-..+..+. .+...+|..|.+.+.||.||+++
T Consensus 454 QFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlY 533 (775)
T KOG1151|consen 454 QFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLY 533 (775)
T ss_pred hhccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeee
Confidence 3333344556778889999999999999964 457889999865443221 23467899999999999999999
Q ss_pred cceee-cCeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECC---
Q 002409 662 GYCQE-EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK--- 737 (927)
Q Consensus 662 g~~~~-~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~--- 737 (927)
+++.- .+..|-|.|||+|.+|+-+|. ..+.+++.++..|+.||+.||.||.+. .++|||-||||.|||+.+
T Consensus 534 DyfslDtdsFCTVLEYceGNDLDFYLK----QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~Gta 608 (775)
T KOG1151|consen 534 DYFSLDTDSFCTVLEYCEGNDLDFYLK----QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTA 608 (775)
T ss_pred eeeeeccccceeeeeecCCCchhHHHH----hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcc
Confidence 99864 556789999999999999884 456789999999999999999999986 468999999999999954
Q ss_pred CCcEEEEeecCcccccCCCC------ceeeeeccCCCccCccccccC----cCCCccceeeHHHHHHHHHhCCCcccccc
Q 002409 738 HMRAKVSDFGLSKFAVDGAS------HVSSIVRGTVGYLDPEYYISQ----QLTDKSDVYSFGVILLELISGQEAISNEK 807 (927)
Q Consensus 738 ~~~vkL~DFGla~~~~~~~~------~~~~~~~gt~~Y~aPE~~~~~----~~s~~sDVwSlGvvL~elltG~~p~~~~~ 807 (927)
.|.+||+|||+++.+.+... ..+....||.+|++||.+.-+ +++.|+||||.|||+|+.+.|+.||....
T Consensus 609 cGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq 688 (775)
T KOG1151|consen 609 CGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ 688 (775)
T ss_pred cceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch
Confidence 57899999999997765432 233446799999999998643 57889999999999999999999998654
Q ss_pred cccccchhhHHHHhhhccCCcccccCCcccCccC--HHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 808 FGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD--IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 808 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~--~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
. .+.|++.... ...-+ -.|+ +....+...++.+|++...++|...-|+..+
T Consensus 689 s---QQdILqeNTI-------lkAtE----VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 689 S---QQDILQENTI-------LKATE----VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred h---HHHHHhhhch-------hccee----ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 2 2234432111 11000 1111 1223456789999999999999887776543
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=259.58 Aligned_cols=243 Identities=24% Similarity=0.275 Sum_probs=190.5
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhc-cCCCccceecceee----cCeEEEEEEec
Q 002409 604 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQE----EGRSVLVYEFM 677 (927)
Q Consensus 604 ~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~----~~~~~lV~E~~ 677 (927)
.++||-|-.|.|-.+..+ +++.+|+|++... ....+|+++.-.. .|||||.+++++.. ...+.+|||.|
T Consensus 67 ~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~m 141 (400)
T KOG0604|consen 67 WQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECM 141 (400)
T ss_pred hhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecc
Confidence 478999999999998766 6889999998632 3356788775554 69999999998854 45678999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECC---CCcEEEEeecCcccccC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVD 754 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~---~~~vkL~DFGla~~~~~ 754 (927)
+||.|...+.+. ..+.+++.++..|+.||+.|+.|||+. +|.||||||+|+|... +-.+||+|||+|+....
T Consensus 142 eGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~ 216 (400)
T KOG0604|consen 142 EGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE 216 (400)
T ss_pred cchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccCC
Confidence 999999888543 345689999999999999999999998 9999999999999975 45799999999986543
Q ss_pred CCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCC
Q 002409 755 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 834 (927)
Q Consensus 755 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 834 (927)
. ......+-|+.|.|||++-..+|+..+|+||+||++|-|++|.+||..... ..+.--.+..+..|.+
T Consensus 217 ~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg----~aispgMk~rI~~gqy------ 284 (400)
T KOG0604|consen 217 P--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG----LAISPGMKRRIRTGQY------ 284 (400)
T ss_pred C--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC----ccCChhHHhHhhccCc------
Confidence 2 233445679999999999999999999999999999999999999976541 1121112222222211
Q ss_pred cccCccCH----HHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 835 SLLDEYDI----QSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 835 ~l~~~~~~----~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
+|+. ...+...++++.++..+|.+|.|+.|++.+
T Consensus 285 ----~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 285 ----EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred ----cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 1222 223456789999999999999999999875
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=261.17 Aligned_cols=263 Identities=21% Similarity=0.305 Sum_probs=192.8
Q ss_pred HhccccccCceEEEEEEEC-CCcEEEEEEeec-CCch-hhHhHHHHHHHHhhccCCCccceecceee--------cCeEE
Q 002409 603 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTS-NSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQE--------EGRSV 671 (927)
Q Consensus 603 ~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~-~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--------~~~~~ 671 (927)
-..+||+|.||.||+|+.+ .|+.||+|++-- +... -.....+|+.+|+.++|+|++.+++.|.. ....+
T Consensus 21 k~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~y 100 (376)
T KOG0669|consen 21 KLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFY 100 (376)
T ss_pred HHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceee
Confidence 3468999999999999876 577889876532 2222 23457789999999999999999999853 23479
Q ss_pred EEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccc
Q 002409 672 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 751 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 751 (927)
+|+.+|+. +|..+|.. ...+++..++.+++.++..||.|+|+. .|+|||+||.|+||+.++.+||+|||+++.
T Consensus 101 lVf~~ceh-DLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 101 LVFDFCEH-DLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred eeHHHhhh-hHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 99999986 78777743 246788999999999999999999998 999999999999999999999999999975
Q ss_pred ccCCCC---ceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHH-------HH
Q 002409 752 AVDGAS---HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQW-------AK 820 (927)
Q Consensus 752 ~~~~~~---~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~-------~~ 820 (927)
+..... ...+...-|.+|++||.+.+ +.|+.+.|||.-|||+.||+++.+-+..........-|.+. ++
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW 253 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW 253 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence 543221 12233456999999999986 67999999999999999999999988765532221111111 11
Q ss_pred hhhccCCccccc--CCcccCccC--HHHH------HHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 821 LHIESGDIQGII--DPSLLDEYD--IQSM------WKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 821 ~~~~~~~~~~~~--d~~l~~~~~--~~~~------~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
+.+.+-.+.+.+ .|--.+.+. .+.+ .+.++|+..++..||.+|+++.|++.+
T Consensus 254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 111111111111 110111111 1111 257789999999999999999998865
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-29 Score=262.03 Aligned_cols=238 Identities=27% Similarity=0.423 Sum_probs=192.4
Q ss_pred CceEEEEEEEC-CCcEEEEEEeecCCchh-hHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCCchhhhccc
Q 002409 611 GFGVVYYGKLK-DGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG 688 (927)
Q Consensus 611 ~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~-~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~ 688 (927)
+||.||+|+.. +++.+|+|++....... .+.+.+|++.+++++|+|++++++++......++++||+.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999987 48999999997655444 67899999999999999999999999999999999999999999998853
Q ss_pred ccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCceeeeeccCCC
Q 002409 689 TLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 768 (927)
Q Consensus 689 ~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~ 768 (927)
. ..+++..++.++.++++++.|||+. +++|+||+|+||+++.++.++|+|||.+....... ......++..
T Consensus 81 ~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~ 151 (244)
T smart00220 81 R----GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE 151 (244)
T ss_pred c----cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence 2 2278899999999999999999998 99999999999999999999999999987654432 2233457889
Q ss_pred ccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCccCHHHHHHH
Q 002409 769 YLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKI 848 (927)
Q Consensus 769 Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 848 (927)
|++||.+....++.++||||||+++++|++|..||.... ....+.++... +.... .........++
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~---~~~~~~~~~~~----~~~~~-------~~~~~~~~~~~ 217 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD---QLLELFKKIGK----PKPPF-------PPPEWKISPEA 217 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHhc----cCCCC-------ccccccCCHHH
Confidence 999999988889999999999999999999999986522 11122222211 11100 00000023468
Q ss_pred HHHHhhhcCCCCCCCCcHHHHHH
Q 002409 849 EEKALMCVLPHGHMRPSISEVLK 871 (927)
Q Consensus 849 ~~L~~~Cl~~dP~~RPsm~eV~~ 871 (927)
.+++.+|+..+|++||++.++++
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhh
Confidence 89999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=288.41 Aligned_cols=250 Identities=25% Similarity=0.375 Sum_probs=202.1
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhc-cCCCccceecceee-----cCeEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQE-----EGRSVLV 673 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~-----~~~~~lV 673 (927)
..|.+.||+|.+|.||+++.. +++-.|+|++.... ...++.+.|.++|+.. +|||++.++|++.. ++.++||
T Consensus 21 ~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLV 99 (953)
T KOG0587|consen 21 FEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLV 99 (953)
T ss_pred cEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEE
Confidence 456789999999999999765 67888999887554 3466788899999887 79999999999853 5688999
Q ss_pred EEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccccc
Q 002409 674 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 753 (927)
Q Consensus 674 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 753 (927)
||||.+|+..|++.+.. ..++.|..+..|+++++.|+.|||.+ .++|||||-.|||++.++.+||+|||++....
T Consensus 100 MEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 100 MEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 174 (953)
T ss_pred eeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence 99999999999998776 78899999999999999999999999 99999999999999999999999999987554
Q ss_pred CCCCceeeeeccCCCccCcccccc-----CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCc
Q 002409 754 DGASHVSSIVRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 828 (927)
Q Consensus 754 ~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 828 (927)
.. .....+..||+.|||||++.. ..|+.++|+||||++..||--|.+|+-+...- .+...+...
T Consensus 175 sT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm--------raLF~IpRN-- 243 (953)
T KOG0587|consen 175 ST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM--------RALFLIPRN-- 243 (953)
T ss_pred cc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh--------hhhccCCCC--
Confidence 33 233455679999999999964 34777899999999999999999998654411 111111111
Q ss_pred ccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 829 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 829 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
|...-..+.....++.+.+..|+..|-++||++.++++|
T Consensus 244 -----PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 244 -----PPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred -----CCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 111111234455689999999999999999999998865
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=267.54 Aligned_cols=273 Identities=20% Similarity=0.254 Sum_probs=206.5
Q ss_pred cccCHHHHHHHHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccC--C----Ccccee
Q 002409 589 HCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH--R----NLVQFL 661 (927)
Q Consensus 589 ~~~~~~ei~~~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~H--p----nIv~l~ 661 (927)
..+..+|....+|.+...+|+|.||.|-.+.+. .+..||||+++... .-.+...-|+++|+++.+ | -++++.
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~ 157 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMR 157 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence 446677888888999999999999999999765 46889999987543 234556779999999943 2 357888
Q ss_pred cceeecCeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEEC-----
Q 002409 662 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD----- 736 (927)
Q Consensus 662 g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~----- 736 (927)
+|+.-.++.|+|+|.+ |-++.++|... ....++...+..|+.|+++++++||+. +++|-||||+|||+.
T Consensus 158 ~wFdyrghiCivfell-G~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~ 231 (415)
T KOG0671|consen 158 DWFDYRGHICIVFELL-GLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYF 231 (415)
T ss_pred hhhhccCceEEEEecc-ChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceE
Confidence 9999999999999988 56999999653 467788999999999999999999998 999999999999993
Q ss_pred ---------------CCCcEEEEeecCcccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCC
Q 002409 737 ---------------KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE 801 (927)
Q Consensus 737 ---------------~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~ 801 (927)
.+..+||+|||.|+...... .....|..|.|||++.+..++..+||||+||||.|+.+|..
T Consensus 232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~ 307 (415)
T KOG0671|consen 232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGET 307 (415)
T ss_pred EEeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccce
Confidence 13458999999998543322 34567999999999999999999999999999999999999
Q ss_pred ccccccccc-----------ccchhhHH--HHhhhccCCcc-----------cccCCccc----CccCHHHHHHHHHHHh
Q 002409 802 AISNEKFGA-----------NCRNIVQW--AKLHIESGDIQ-----------GIIDPSLL----DEYDIQSMWKIEEKAL 853 (927)
Q Consensus 802 p~~~~~~~~-----------~~~~l~~~--~~~~~~~~~~~-----------~~~d~~l~----~~~~~~~~~~l~~L~~ 853 (927)
.|.....-+ ....++.. +......|++. ...++... -.....+..++.+|+.
T Consensus 308 LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~ 387 (415)
T KOG0671|consen 308 LFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLR 387 (415)
T ss_pred ecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHH
Confidence 886433111 00111111 11111222211 11111110 0113455668999999
Q ss_pred hhcCCCCCCCCcHHHHHHH
Q 002409 854 MCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 854 ~Cl~~dP~~RPsm~eV~~~ 872 (927)
+|+..||.+|+|+.|++.|
T Consensus 388 ~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 388 RMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHccCccccccHHHHhcC
Confidence 9999999999999999875
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=244.86 Aligned_cols=199 Identities=27% Similarity=0.405 Sum_probs=169.2
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEeecC-CchhhHhHHHHHHHHhh-ccCCCccceecceeecCeEEEEEEeccCC
Q 002409 604 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN-SYQGKREFTNEVTLLSR-IHHRNLVQFLGYCQEEGRSVLVYEFMHNG 680 (927)
Q Consensus 604 ~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~-~~~~~~~~~~Ei~iL~~-l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 680 (927)
...||+|++|.|-+-++. +|+-.|+|.++.. ..+..++...|+.+..+ ..+|.+|.++|...+.+..++.||.|..
T Consensus 51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t- 129 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT- 129 (282)
T ss_pred hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-
Confidence 467999999999888765 6889999999755 34556677788877555 4799999999999999999999999964
Q ss_pred chhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCcee
Q 002409 681 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 760 (927)
Q Consensus 681 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 760 (927)
+|..+-......+..+++.-.-+|+..+.+||.|||++ ..++|||+||+|||++.+|++|+||||++-.+.+. -..
T Consensus 130 Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS--iAk 205 (282)
T KOG0984|consen 130 SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS--IAK 205 (282)
T ss_pred hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhh--hHH
Confidence 88877766667788899999999999999999999998 58999999999999999999999999999766543 222
Q ss_pred eeeccCCCccCcccccc----CcCCCccceeeHHHHHHHHHhCCCcccccc
Q 002409 761 SIVRGTVGYLDPEYYIS----QQLTDKSDVYSFGVILLELISGQEAISNEK 807 (927)
Q Consensus 761 ~~~~gt~~Y~aPE~~~~----~~~s~~sDVwSlGvvL~elltG~~p~~~~~ 807 (927)
+.-.|...|||||.+.. ..|+-|+||||||+.+.||.+++.|++...
T Consensus 206 t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 206 TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 33458899999999853 478999999999999999999999998765
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=292.21 Aligned_cols=259 Identities=24% Similarity=0.271 Sum_probs=167.7
Q ss_pred HHHhccccccCceEEEEEEECC-----CcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecc------eeecCe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLKD-----GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY------CQEEGR 669 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~~-----g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~------~~~~~~ 669 (927)
+.+.+.||+|+||.||+|++.+ ++.||||++...... +....| .++...+.++..++.. +.....
T Consensus 134 y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (566)
T PLN03225 134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDE 209 (566)
T ss_pred eEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccccCCc
Confidence 4567899999999999998764 689999987643211 111111 1222223333332222 245567
Q ss_pred EEEEEEeccCCchhhhcccccc----------------cccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCe
Q 002409 670 SVLVYEFMHNGTLKEHLYGTLT----------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI 733 (927)
Q Consensus 670 ~~lV~E~~~~gsL~~~L~~~~~----------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NI 733 (927)
.++||||+.+++|.+++..... .........+..++.|++.||+|||++ +|+||||||+||
T Consensus 210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~NI 286 (566)
T PLN03225 210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNI 286 (566)
T ss_pred eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHHE
Confidence 8999999999999988853210 001112334567999999999999998 999999999999
Q ss_pred EECC-CCcEEEEeecCcccccCCCCceeeeeccCCCccCccccccC----------------------cCCCccceeeHH
Q 002409 734 LLDK-HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ----------------------QLTDKSDVYSFG 790 (927)
Q Consensus 734 Ll~~-~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----------------------~~s~~sDVwSlG 790 (927)
|++. ++.+||+|||+++..............+++.|+|||.+... .+..++||||||
T Consensus 287 Ll~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG 366 (566)
T PLN03225 287 IFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 366 (566)
T ss_pred EEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence 9986 57999999999986544433444456789999999965321 234567999999
Q ss_pred HHHHHHHhCCCccccccc------ccccchhhHHHHhhhccCCcccccCCcccCccC--HHHHHHHHHHHhhhcCCCCCC
Q 002409 791 VILLELISGQEAISNEKF------GANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD--IQSMWKIEEKALMCVLPHGHM 862 (927)
Q Consensus 791 vvL~elltG~~p~~~~~~------~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~--~~~~~~l~~L~~~Cl~~dP~~ 862 (927)
|+||||+++..+.+.... ......+..|....... ..+.+...+. ........+|+.+|++.||++
T Consensus 367 viL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 367 LIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred HHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 999999998766543210 00001122222211100 0000000010 001123458999999999999
Q ss_pred CCcHHHHHHH
Q 002409 863 RPSISEVLKD 872 (927)
Q Consensus 863 RPsm~eV~~~ 872 (927)
|||++|+++|
T Consensus 441 R~ta~e~L~H 450 (566)
T PLN03225 441 RISAKAALAH 450 (566)
T ss_pred CCCHHHHhCC
Confidence 9999999987
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-28 Score=282.22 Aligned_cols=259 Identities=22% Similarity=0.345 Sum_probs=177.6
Q ss_pred HHHhccccccCceEEEEEEE-----------------CCCcEEEEEEeecCCchhhHh--------------HHHHHHHH
Q 002409 601 KMLEKKIGSGGFGVVYYGKL-----------------KDGKEIAVKVLTSNSYQGKRE--------------FTNEVTLL 649 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~-----------------~~g~~VAVK~l~~~~~~~~~~--------------~~~Ei~iL 649 (927)
+.+.++||+|+||.||+|.+ ..++.||||++........++ ...|+.++
T Consensus 147 F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l 226 (507)
T PLN03224 147 FQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMC 226 (507)
T ss_pred ceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHH
Confidence 44578999999999999964 235679999986543222222 33467777
Q ss_pred hhccCCCc-----cceecceee--------cCeEEEEEEeccCCchhhhcccccc--------------------ccccc
Q 002409 650 SRIHHRNL-----VQFLGYCQE--------EGRSVLVYEFMHNGTLKEHLYGTLT--------------------HEQRI 696 (927)
Q Consensus 650 ~~l~HpnI-----v~l~g~~~~--------~~~~~lV~E~~~~gsL~~~L~~~~~--------------------~~~~l 696 (927)
.+++|.++ ++++++|.. .+..+|||||+++++|.++++.... ....+
T Consensus 227 ~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~ 306 (507)
T PLN03224 227 AKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKR 306 (507)
T ss_pred HHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccC
Confidence 77776654 677787753 3567999999999999999864211 11235
Q ss_pred CHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCceeeeeccCCCccCccccc
Q 002409 697 NWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 776 (927)
Q Consensus 697 ~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~ 776 (927)
++..+..++.|++.+|.|||+. +|+||||||+|||++.++.+||+|||+++..............+|+.|+|||.+.
T Consensus 307 ~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~ 383 (507)
T PLN03224 307 DINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELV 383 (507)
T ss_pred CHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhc
Confidence 6778889999999999999998 9999999999999999999999999999754333222222233578999999985
Q ss_pred cCc--------------------C--CCccceeeHHHHHHHHHhCCC-ccccccc-----ccccchhhHHHHhhhccCCc
Q 002409 777 SQQ--------------------L--TDKSDVYSFGVILLELISGQE-AISNEKF-----GANCRNIVQWAKLHIESGDI 828 (927)
Q Consensus 777 ~~~--------------------~--s~~sDVwSlGvvL~elltG~~-p~~~~~~-----~~~~~~l~~~~~~~~~~~~~ 828 (927)
... + ..+.||||+||+++||++|.. |+..... ......+..|.... ....
T Consensus 384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~--~~~~ 461 (507)
T PLN03224 384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK--GQKY 461 (507)
T ss_pred CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc--ccCC
Confidence 422 1 124699999999999999875 6643210 00011222232211 1111
Q ss_pred ccccCCcccCccCHHHHHHHHHHHhhhcCCCC---CCCCcHHHHHHH
Q 002409 829 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHG---HMRPSISEVLKD 872 (927)
Q Consensus 829 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP---~~RPsm~eV~~~ 872 (927)
+-...+ .......+++.+|+..+| .+|+|+.|+++|
T Consensus 462 ----~~~~~d----~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 462 ----DFSLLD----RNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred ----Cccccc----ccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 100111 112356788889998765 789999999876
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-29 Score=273.62 Aligned_cols=244 Identities=22% Similarity=0.281 Sum_probs=200.2
Q ss_pred hccccccCceEEEEEEECCCcE-EEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 604 EKKIGSGGFGVVYYGKLKDGKE-IAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 604 ~~~IG~G~fG~Vy~~~~~~g~~-VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
...||-|+||.|=..+.+.... +|+|++++.. ...++.+..|-.+|..++.|.||+++.-|.+..+.|+.||-|-|
T Consensus 425 iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClG 504 (732)
T KOG0614|consen 425 IATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLG 504 (732)
T ss_pred hhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcC
Confidence 3569999999999998874433 7888887542 33345577899999999999999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
|.|+..|+ .++.++..+...++..+++|++|||++ +||.|||||+|++++.+|-+||.|||+|+....+ ..
T Consensus 505 GElWTiLr----dRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g--~K 575 (732)
T KOG0614|consen 505 GELWTILR----DRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG--RK 575 (732)
T ss_pred chhhhhhh----hcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccC--Cc
Confidence 99999985 456788888888999999999999999 9999999999999999999999999999976543 45
Q ss_pred eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCc
Q 002409 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 839 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 839 (927)
+.+++||+.|.|||++.....+.++|.||||+++|||++|.+||...+.-..+..|+.-+. . -+
T Consensus 576 TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid---------~-------i~ 639 (732)
T KOG0614|consen 576 TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID---------K-------IE 639 (732)
T ss_pred eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh---------h-------hh
Confidence 6778999999999999999999999999999999999999999987663222322222111 0 01
Q ss_pred cCHHHHHHHHHHHhhhcCCCCCCCCc-----HHHHHHH
Q 002409 840 YDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 872 (927)
Q Consensus 840 ~~~~~~~~l~~L~~~Cl~~dP~~RPs-----m~eV~~~ 872 (927)
++....+...+|+.+.+..+|.+|.. +.||.+|
T Consensus 640 ~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 640 FPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred cccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 23334456778999999999999986 5666655
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-29 Score=287.62 Aligned_cols=244 Identities=27% Similarity=0.385 Sum_probs=188.0
Q ss_pred hccccccCce-EEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhc-cCCCccceecceeecCeEEEEEEeccCCc
Q 002409 604 EKKIGSGGFG-VVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHNGT 681 (927)
Q Consensus 604 ~~~IG~G~fG-~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~gs 681 (927)
.+.+|.|+-| .||+|... |++||||++-.. ......+|+..|+.- +|||||++++.-.+++..|+..|.|.. +
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-s 588 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-S 588 (903)
T ss_pred HHHcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-h
Confidence 4678999998 68999997 899999987532 345678999999988 699999999999999999999999965 9
Q ss_pred hhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECC---C--CcEEEEeecCcccccCCC
Q 002409 682 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---H--MRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 682 L~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~---~--~~vkL~DFGla~~~~~~~ 756 (927)
|.+++.....+.........+.+..|++.||+|||+. +||||||||.||||+. + .+++|+|||+++....+.
T Consensus 589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 9999965311111112245567889999999999997 9999999999999976 3 579999999999776655
Q ss_pred Ccee--eeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhC-CCcccccccccccchhhHHHHhhhccCCcccccC
Q 002409 757 SHVS--SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG-QEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 833 (927)
Q Consensus 757 ~~~~--~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG-~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 833 (927)
+..+ ....||-+|+|||++....-+.++||+|+|||+|..++| ..||.+.-. ...+|+.-. ..+..
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~--R~~NIl~~~------~~L~~--- 734 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANILTGN------YTLVH--- 734 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH--hhhhhhcCc------cceee---
Confidence 4433 345699999999999988888899999999999999886 899976431 111222210 00100
Q ss_pred CcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 834 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 834 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
+... .++ +..+|+.+|+.++|..||++.+|+.|
T Consensus 735 --L~~~--~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 735 --LEPL--PDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred --eccC--chH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 0111 111 67899999999999999999999865
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-29 Score=252.23 Aligned_cols=264 Identities=22% Similarity=0.279 Sum_probs=193.4
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEeecC--CchhhHhHHHHHHHHhhccCCCccceecceeecC-----eEEEEEE
Q 002409 604 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG-----RSVLVYE 675 (927)
Q Consensus 604 ~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-----~~~lV~E 675 (927)
++.||.|+||.||..++. +|+.||+|++... .-...+.+.+|+++|..++|.|++..+++..... +.|.++|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 367999999999999865 7999999988643 2234567889999999999999999988775543 4577888
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCC
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 755 (927)
.|. .+|...+ ...+.++-..+.-+..||++||.|||+. +|.||||||.|.|++.+..+||+|||+++.....
T Consensus 138 LmQ-SDLHKII----VSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 138 LMQ-SDLHKII----VSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHH-hhhhhee----ccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchh
Confidence 875 3676665 4456778888888999999999999998 9999999999999999999999999999865544
Q ss_pred CCceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccc---------------hhhHHH
Q 002409 756 ASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCR---------------NIVQWA 819 (927)
Q Consensus 756 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~---------------~l~~~~ 819 (927)
.....+...-|..|.|||++++ +.|+.+.||||.||++.||+..+..|.....-+..+ .-.+-+
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA 289 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA 289 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence 4444445557899999999987 679999999999999999999888876433211111 111222
Q ss_pred HhhhccCCcccccCCcccCcc-CHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHH
Q 002409 820 KLHIESGDIQGIIDPSLLDEY-DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 875 (927)
Q Consensus 820 ~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~ 875 (927)
+.++-.+....---+.+..-. ....-.+.+.+.++++..+|.+|.+..+.+.++-.
T Consensus 290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~ 346 (449)
T KOG0664|consen 290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL 346 (449)
T ss_pred HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence 222222211110001111100 11222346778889999999999999998887653
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-27 Score=263.47 Aligned_cols=208 Identities=25% Similarity=0.388 Sum_probs=174.3
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeecCCc---hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCC
Q 002409 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 680 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 680 (927)
+.||-|+||+|.+++.. +...+|+|.+++.+. ......+.|-.||.....+-||+|+-.|.+++.+|+||+|++||
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG 714 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 714 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence 56999999999999654 456689999876542 22345678999999999999999999999999999999999999
Q ss_pred chhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcc---------c
Q 002409 681 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK---------F 751 (927)
Q Consensus 681 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~---------~ 751 (927)
++..+|.. -+.+.+..+..++.++.+|+++.|.. |+|||||||.|||||.+|++||+||||+. +
T Consensus 715 DmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY 787 (1034)
T KOG0608|consen 715 DMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 787 (1034)
T ss_pred cHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecccccc
Confidence 99998853 34567777778889999999999998 99999999999999999999999999974 1
Q ss_pred ccCCCCce---------------------------------eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh
Q 002409 752 AVDGASHV---------------------------------SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 798 (927)
Q Consensus 752 ~~~~~~~~---------------------------------~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt 798 (927)
+..+ .|. ....+||+.|+|||++....|+..+|.||.|||||||+.
T Consensus 788 Yq~g-dH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~ 866 (1034)
T KOG0608|consen 788 YQEG-DHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLV 866 (1034)
T ss_pred ccCC-CccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhh
Confidence 1111 110 011349999999999999999999999999999999999
Q ss_pred CCCcccccccccccchhhHHHH
Q 002409 799 GQEAISNEKFGANCRNIVQWAK 820 (927)
Q Consensus 799 G~~p~~~~~~~~~~~~l~~~~~ 820 (927)
|+.||......+....++.|-.
T Consensus 867 g~~pf~~~tp~~tq~kv~nw~~ 888 (1034)
T KOG0608|consen 867 GQPPFLADTPGETQYKVINWRN 888 (1034)
T ss_pred CCCCccCCCCCcceeeeeehhh
Confidence 9999998887777777777744
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-27 Score=244.35 Aligned_cols=244 Identities=22% Similarity=0.296 Sum_probs=189.4
Q ss_pred HhccccccCceEEEEEEEC-CCcEEEEEEeecC---CchhhHhHHHHHHHHhhc-cCCCccceecceeecCeEEEEEEec
Q 002409 603 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN---SYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 603 ~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
+.++||+|.|++|-.++++ +.+-+|+|++++. ..+...-.+.|-.+..+. +||.+|.++.++..+.++++|.||+
T Consensus 254 ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv 333 (593)
T KOG0695|consen 254 LLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYV 333 (593)
T ss_pred eeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEe
Confidence 4578999999999999876 5677899998764 223334456666666655 7999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
++|+|.-++ +..+++++..+..+..+|..||.|||++ ||+.||||..|+|+|.+|++||+|+|+.+.-. ...
T Consensus 334 ~ggdlmfhm----qrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l-~~g 405 (593)
T KOG0695|consen 334 NGGDLMFHM----QRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL-GPG 405 (593)
T ss_pred cCcceeeeh----hhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCC-CCC
Confidence 999998776 4567899999999999999999999999 99999999999999999999999999987432 233
Q ss_pred ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCccc
Q 002409 758 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 837 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 837 (927)
..+.+++||+.|+|||++.+..|...+|.|++||+++||+.|+.||+-.......++-.++.-+.+-+.. ++
T Consensus 406 d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq--------ir 477 (593)
T KOG0695|consen 406 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ--------IR 477 (593)
T ss_pred cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc--------cc
Confidence 4556788999999999999999999999999999999999999999754322222233333222221111 11
Q ss_pred CccCHHHHHHHHHHHhhhcCCCCCCCC
Q 002409 838 DEYDIQSMWKIEEKALMCVLPHGHMRP 864 (927)
Q Consensus 838 ~~~~~~~~~~l~~L~~~Cl~~dP~~RP 864 (927)
- +.....+...+...-+..||.+|.
T Consensus 478 i--prslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 478 I--PRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred c--cceeehhhHHHHHHhhcCCcHHhc
Confidence 0 111112345667778889998875
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.7e-26 Score=233.40 Aligned_cols=211 Identities=35% Similarity=0.609 Sum_probs=182.6
Q ss_pred ccccCceEEEEEEECC-CcEEEEEEeecCCch-hhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCCchhh
Q 002409 607 IGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKE 684 (927)
Q Consensus 607 IG~G~fG~Vy~~~~~~-g~~VAVK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~ 684 (927)
||+|.+|.||++.... ++.+++|++...... ....+.+|++.++.+.|++++++++++......++++|++.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998874 889999998765432 34678999999999999999999999999999999999999999999
Q ss_pred hcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECC-CCcEEEEeecCcccccCCCCceeeee
Q 002409 685 HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLSKFAVDGASHVSSIV 763 (927)
Q Consensus 685 ~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~~ 763 (927)
++.... ..+++..+..++.++++++++||+. +++|+||+|.||+++. +++++|+|||.+........ .....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 885321 4678899999999999999999998 9999999999999999 89999999999875543321 12234
Q ss_pred ccCCCccCccccccC-cCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCccCH
Q 002409 764 RGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 842 (927)
Q Consensus 764 ~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 842 (927)
.+...|++||..... ..+.+.|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 478899999999877 888999999999999999
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCcHHHHHHHH
Q 002409 843 QSMWKIEEKALMCVLPHGHMRPSISEVLKDI 873 (927)
Q Consensus 843 ~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L 873 (927)
..+.+++..|++.+|++||++.++++++
T Consensus 188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ---PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ---HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3578899999999999999999998754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-26 Score=249.07 Aligned_cols=278 Identities=21% Similarity=0.333 Sum_probs=204.7
Q ss_pred cccccccCHHHHHH-HHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhcc-----C---
Q 002409 585 AEAAHCFTLSDIED-ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-----H--- 654 (927)
Q Consensus 585 ~~~~~~~~~~ei~~-~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~-----H--- 654 (927)
....|+...+|... .+|.+.++||-|-|++||.+.+. ..+.||+|+.+.. ..-.+....||++|++++ |
T Consensus 63 kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~ 141 (590)
T KOG1290|consen 63 KGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGK 141 (590)
T ss_pred cCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCC
Confidence 34457777888777 88999999999999999999765 5678999998744 233556788999999994 2
Q ss_pred CCccceecceee----cCeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCC
Q 002409 655 RNLVQFLGYCQE----EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKS 730 (927)
Q Consensus 655 pnIv~l~g~~~~----~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp 730 (927)
..||+|++.|.. +.+.|||+|++ |.+|..+|... ..+.++...+.+|+.||+.||.|||++| +|||-||||
T Consensus 142 ~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKP 216 (590)
T KOG1290|consen 142 KCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKP 216 (590)
T ss_pred ceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCc
Confidence 578999999964 45889999988 56788887543 4677889999999999999999999998 999999999
Q ss_pred CCeEECC-------------------------------------------------------------------------
Q 002409 731 SNILLDK------------------------------------------------------------------------- 737 (927)
Q Consensus 731 ~NILl~~------------------------------------------------------------------------- 737 (927)
+|||+..
T Consensus 217 ENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~ 296 (590)
T KOG1290|consen 217 ENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEE 296 (590)
T ss_pred ceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccc
Confidence 9999910
Q ss_pred --------------------------------------------------------------------------------
Q 002409 738 -------------------------------------------------------------------------------- 737 (927)
Q Consensus 738 -------------------------------------------------------------------------------- 737 (927)
T Consensus 297 ~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~ 376 (590)
T KOG1290|consen 297 EPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIAS 376 (590)
T ss_pred cccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCcccccc
Confidence
Q ss_pred -------------CCcEEEEeecCcccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCccc
Q 002409 738 -------------HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAIS 804 (927)
Q Consensus 738 -------------~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~ 804 (927)
+.++||+|||-|+.... + .+.-..|..|+|||++.+..|+..+||||++|+++||.||...|+
T Consensus 377 n~~v~p~~~~~~~di~vKIaDlGNACW~~k---h-FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFe 452 (590)
T KOG1290|consen 377 NPLVNPDIPLPECDIRVKIADLGNACWVHK---H-FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFE 452 (590)
T ss_pred ccccCCCCCCCccceeEEEeeccchhhhhh---h-hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeec
Confidence 00145555555554321 1 111226889999999999999999999999999999999999886
Q ss_pred ccc---cccccchhhHHHH---h----hhccCCc-ccccCCc----------c-------cC--ccCHHHHHHHHHHHhh
Q 002409 805 NEK---FGANCRNIVQWAK---L----HIESGDI-QGIIDPS----------L-------LD--EYDIQSMWKIEEKALM 854 (927)
Q Consensus 805 ~~~---~~~~~~~l~~~~~---~----~~~~~~~-~~~~d~~----------l-------~~--~~~~~~~~~l~~L~~~ 854 (927)
... ......+|...+. . ....|+. .++++.+ . .. +++.+...++.+++.-
T Consensus 453 PhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~P 532 (590)
T KOG1290|consen 453 PHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSP 532 (590)
T ss_pred CCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHH
Confidence 433 1222222222111 1 1111111 1122211 1 11 3467788899999999
Q ss_pred hcCCCCCCCCcHHHHHHH
Q 002409 855 CVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 855 Cl~~dP~~RPsm~eV~~~ 872 (927)
||+.+|++|||+.+.+++
T Consensus 533 mLef~PeKR~tA~~cl~h 550 (590)
T KOG1290|consen 533 MLEFDPEKRPTAAQCLKH 550 (590)
T ss_pred HHhcCccccccHHHHhcC
Confidence 999999999999999876
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-26 Score=228.71 Aligned_cols=256 Identities=20% Similarity=0.337 Sum_probs=194.4
Q ss_pred HHHHhccccccCceEEEEEE-ECCCcEEEEEEeecCCchhhHhHHHHHHHHhhcc-CCCccceecceeec--CeEEEEEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEE--GRSVLVYE 675 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~-~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~--~~~~lV~E 675 (927)
.|++.+++|+|.|+.|+.|. ..+.++++||+++.. ..+.+.+|+.+|+.++ ||||+++++...+. ....||+|
T Consensus 39 dYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE 115 (338)
T KOG0668|consen 39 DYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE 115 (338)
T ss_pred hHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence 46678899999999999996 446788999999743 3567899999999997 99999999998765 45689999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCC-CcEEEEeecCcccccC
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVD 754 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~-~~vkL~DFGla~~~~~ 754 (927)
|+.+.+...+- +.++...+...+.++++||.|+|+. ||+|||+||.|+++|.. ..++|+|+|+|.+..+
T Consensus 116 ~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 116 YVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 99987765432 4567777888999999999999998 99999999999999975 5699999999987655
Q ss_pred CCCceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhcc------CC
Q 002409 755 GASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES------GD 827 (927)
Q Consensus 755 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~------~~ 827 (927)
+.. ......+..|..||.+.. +.|+..-|+|||||+|..|+..+.||-... +...+++..++-.-.+ ++
T Consensus 186 ~~e--YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~--dN~DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 186 GKE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH--DNYDQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred Cce--eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC--CCHHHHHHHHHHhChHHHHHHHHH
Confidence 433 223446788999999875 567888999999999999999999985432 2333555444321100 00
Q ss_pred cccccCCcccC---cc------------C-HHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 828 IQGIIDPSLLD---EY------------D-IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 828 ~~~~~d~~l~~---~~------------~-~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
..-.+|++..+ .+ + .-...+.++++.+.+..|-++|||++|.++|
T Consensus 262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 11113333211 11 0 1112478899999999999999999999887
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-26 Score=240.18 Aligned_cols=249 Identities=25% Similarity=0.341 Sum_probs=187.5
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeecC--CchhhHhHHHHHHHHhhccCCCccceecceeecC------eEEEEEE
Q 002409 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------RSVLVYE 675 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~------~~~lV~E 675 (927)
+.+|.|.- .|..+.+. .++.||+|++... .....+...+|..++..++|+||++++.++.... ..++|||
T Consensus 23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e 101 (369)
T KOG0665|consen 23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME 101 (369)
T ss_pred cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence 45777777 55555433 5789999987543 2344567889999999999999999999986543 5689999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCC
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 755 (927)
+|. ++|...+. ..++-.+...|..|+++|+.|||+. +|+||||||+||++..+..+||.|||+|+.....
T Consensus 102 ~m~-~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 102 LMD-ANLCQVIL------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD 171 (369)
T ss_pred hhh-hHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCcc
Confidence 995 48877764 3466677889999999999999998 9999999999999999999999999999854332
Q ss_pred CCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccC---------
Q 002409 756 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG--------- 826 (927)
Q Consensus 756 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~--------- 826 (927)
...+....|..|.|||++.+..+.+.+||||.||++.||++|+.-|.+.. .+-+|.+....-|
T Consensus 172 --~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d------~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 172 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD------HIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred --cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch------HHHHHHHHHHHhcCCCHHHHHH
Confidence 23344557899999999999889999999999999999999999887533 4444544211111
Q ss_pred ------------------CcccccCCcc-cC--ccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 827 ------------------DIQGIIDPSL-LD--EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 827 ------------------~~~~~~d~~l-~~--~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.+.+.+...+ .. +.+.-....+.+++.+|+..+|++|-+..++++|
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0111111110 00 1112223457799999999999999999999987
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-26 Score=252.20 Aligned_cols=279 Identities=18% Similarity=0.274 Sum_probs=211.3
Q ss_pred cccccccCHHHHHHHHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhcc------CCCc
Q 002409 585 AEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH------HRNL 657 (927)
Q Consensus 585 ~~~~~~~~~~ei~~~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~------HpnI 657 (927)
++....+.++|+.+.+|.+....|+|-|++|.+|... .|..||||+++.+... .+.=+.|+++|++|+ .-+.
T Consensus 418 aEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hc 496 (752)
T KOG0670|consen 418 AEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHC 496 (752)
T ss_pred ccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHH
Confidence 4566778899999999999999999999999999865 5789999999876433 344568999999995 3578
Q ss_pred cceecceeecCeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECC
Q 002409 658 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK 737 (927)
Q Consensus 658 v~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~ 737 (927)
++++-.|...+++|||+|-+ ..+|.+.|... .....|....+..++.|+..||.+|... +|+|.||||.|||+++
T Consensus 497 lrl~r~F~hknHLClVFE~L-slNLRevLKKy-G~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE 571 (752)
T KOG0670|consen 497 LRLFRHFKHKNHLCLVFEPL-SLNLREVLKKY-GRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNE 571 (752)
T ss_pred HHHHHHhhhcceeEEEehhh-hchHHHHHHHh-CcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEecc
Confidence 99999999999999999976 46899988654 4566788889999999999999999998 9999999999999998
Q ss_pred CC-cEEEEeecCcccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhh
Q 002409 738 HM-RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIV 816 (927)
Q Consensus 738 ~~-~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~ 816 (927)
.. .+||||||.|....+... + ...-+..|.|||++.+..|+...|+||.||.||||.||+..|.+........-..
T Consensus 572 ~k~iLKLCDfGSA~~~~enei--t-PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~m 648 (752)
T KOG0670|consen 572 SKNILKLCDFGSASFASENEI--T-PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFM 648 (752)
T ss_pred CcceeeeccCccccccccccc--c-HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHH
Confidence 64 689999999976554321 1 1123567999999999999999999999999999999999997654322211111
Q ss_pred HHH----HhhhccCC---------------------------cccccCC------ccc-----CccCHHHHHHHHHHHhh
Q 002409 817 QWA----KLHIESGD---------------------------IQGIIDP------SLL-----DEYDIQSMWKIEEKALM 854 (927)
Q Consensus 817 ~~~----~~~~~~~~---------------------------~~~~~d~------~l~-----~~~~~~~~~~l~~L~~~ 854 (927)
+.. ..+++.|. +...+.| .+. .+-....+..+.+|+..
T Consensus 649 e~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdk 728 (752)
T KOG0670|consen 649 ELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDK 728 (752)
T ss_pred HhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHH
Confidence 100 00111110 0011111 011 11123455678899999
Q ss_pred hcCCCCCCCCcHHHHHHH
Q 002409 855 CVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 855 Cl~~dP~~RPsm~eV~~~ 872 (927)
|+..||++|.|..|.++|
T Consensus 729 ml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 729 MLILDPEKRITVNQALKH 746 (752)
T ss_pred HhccChhhcCCHHHHhcC
Confidence 999999999999998875
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-25 Score=231.49 Aligned_cols=196 Identities=35% Similarity=0.547 Sum_probs=170.1
Q ss_pred HhccccccCceEEEEEEECC-CcEEEEEEeecCCch-hhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCC
Q 002409 603 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 680 (927)
Q Consensus 603 ~~~~IG~G~fG~Vy~~~~~~-g~~VAVK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 680 (927)
+.+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++|+++++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 82 (225)
T smart00221 3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGG 82 (225)
T ss_pred eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCC
Confidence 45789999999999999875 889999999866544 5678899999999999999999999999999999999999999
Q ss_pred chhhhcccccccccc-cCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 681 TLKEHLYGTLTHEQR-INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 681 sL~~~L~~~~~~~~~-l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
+|.+++... .. +++.....++.+++.++.+||+. +++|+||+|+||+++.++.++|+|||.+..........
T Consensus 83 ~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 83 DLFDYLRKK----GGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred CHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 999988543 22 78889999999999999999998 99999999999999999999999999988654432112
Q ss_pred eeeeccCCCccCcccc-ccCcCCCccceeeHHHHHHHHHhCCCcccc
Q 002409 760 SSIVRGTVGYLDPEYY-ISQQLTDKSDVYSFGVILLELISGQEAISN 805 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~-~~~~~s~~sDVwSlGvvL~elltG~~p~~~ 805 (927)
.....++..|++||.+ ....++.++|+|+||++++||++|+.||..
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 2334578899999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=248.07 Aligned_cols=193 Identities=22% Similarity=0.421 Sum_probs=164.1
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCCch----h----hHhHHHHHHHHhhcc---CCCccceecceeecCe
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ----G----KREFTNEVTLLSRIH---HRNLVQFLGYCQEEGR 669 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~----~----~~~~~~Ei~iL~~l~---HpnIv~l~g~~~~~~~ 669 (927)
...+.+|+|+||.|+.+.++ +..+|+||++.+...- - .-....|++||..++ |+||++++++|++.++
T Consensus 564 ttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~ 643 (772)
T KOG1152|consen 564 TTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDY 643 (772)
T ss_pred eeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCe
Confidence 34578999999999999887 4568999998754211 1 123567999999997 9999999999999999
Q ss_pred EEEEEEec-cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecC
Q 002409 670 SVLVYEFM-HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 748 (927)
Q Consensus 670 ~~lV~E~~-~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGl 748 (927)
++|+||-. ++-+|.+++ .....+++.++..|+.|++.|++|||++ +|+|||||-+|+.++.+|-+||+|||.
T Consensus 644 yyl~te~hg~gIDLFd~I----E~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 644 YYLETEVHGEGIDLFDFI----EFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred eEEEecCCCCCcchhhhh----hccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccc
Confidence 99999975 445788887 4567799999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCceeeeeccCCCccCccccccCcCCCc-cceeeHHHHHHHHHhCCCccc
Q 002409 749 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDK-SDVYSFGVILLELISGQEAIS 804 (927)
Q Consensus 749 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~-sDVwSlGvvL~elltG~~p~~ 804 (927)
+.+...+. ...+.||..|.|||++.+.+|--| -|||++|++||-++....||.
T Consensus 717 aa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 717 AAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 98765543 345679999999999998887654 599999999999998888874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.4e-25 Score=248.71 Aligned_cols=251 Identities=22% Similarity=0.325 Sum_probs=198.6
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
|.+..++|.|.||.|||++.. .++..|+|+++-.......-.+.|+-+++..+||||+.++|-+...+..++.||||.+
T Consensus 17 yellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgg 96 (829)
T KOG0576|consen 17 YELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGG 96 (829)
T ss_pred hhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCC
Confidence 445678999999999999876 6888999999877666677788999999999999999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
|+|++.-+. -..+++.+...++++..+||.|||+. +=+|||||-.|||+++.|.+|++|||.+-..... ...
T Consensus 97 gslQdiy~~----TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitat-i~K 168 (829)
T KOG0576|consen 97 GSLQDIYHV----TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITAT-IAK 168 (829)
T ss_pred Ccccceeee----cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhh-hhh
Confidence 999987643 35688888899999999999999998 8899999999999999999999999988643321 223
Q ss_pred eeeeccCCCccCcccc---ccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 760 SSIVRGTVGYLDPEYY---ISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~---~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
...+.||+.|||||+. ..+.|...+|||++|+.-.|+-.-+.|.-+.. .+.+...+..- .+++.-
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh--------pmr~l~LmTkS----~~qpp~ 236 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH--------PMRALFLMTKS----GFQPPT 236 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc--------hHHHHHHhhcc----CCCCCc
Confidence 3456799999999997 35779999999999999999988877754322 11111112111 111111
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
..+ ....-..+.++++.|+..+|++||+++.+++|
T Consensus 237 lkD-k~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 237 LKD-KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred ccC-CccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 111 11223457899999999999999999987764
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.6e-24 Score=215.06 Aligned_cols=253 Identities=20% Similarity=0.299 Sum_probs=183.3
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhc-cCCCccceecc-eeecCeEEEEEEe
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGY-CQEEGRSVLVYEF 676 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~-~~~~~~~~lV~E~ 676 (927)
.|.+.+.+|+|.||.+-.+.++ ..+.+++|.+... ....++|.+|..---.+ .|.||+.-++. |...+.+++++||
T Consensus 25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~ 103 (378)
T KOG1345|consen 25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF 103 (378)
T ss_pred hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence 4667889999999999999987 4667899987643 33467888888764444 69999988764 6677888999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEEC--CCCcEEEEeecCcccccC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD--KHMRAKVSDFGLSKFAVD 754 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~--~~~~vkL~DFGla~~~~~ 754 (927)
++.|+|.+-+.. ..+-+....+++.|++.||.|||++ .+||||||.+||||- +..++||||||+++..+.
T Consensus 104 aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 104 APRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred CccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 999999887732 4466777889999999999999999 999999999999994 234899999999874432
Q ss_pred CCCceeeeeccCCCccCccccccC-----cCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcc
Q 002409 755 GASHVSSIVRGTVGYLDPEYYISQ-----QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 829 (927)
Q Consensus 755 ~~~~~~~~~~gt~~Y~aPE~~~~~-----~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 829 (927)
. .....-+..|.+||.+... ...+.+|||.||++++.+++|+.||...... .... |...+...+...
T Consensus 176 t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~--d~~Y--~~~~~w~~rk~~ 247 (378)
T KOG1345|consen 176 T----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM--DKPY--WEWEQWLKRKNP 247 (378)
T ss_pred e----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc--CchH--HHHHHHhcccCc
Confidence 1 1223346789999987542 3566789999999999999999999844311 1122 222222222222
Q ss_pred cccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHH
Q 002409 830 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 875 (927)
Q Consensus 830 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~ 875 (927)
. -|+.-..+. .+++++-.+-+.++|++|=-..++.+....
T Consensus 248 ~--~P~~F~~fs----~~a~r~Fkk~lt~~~~drcki~~~kk~rk~ 287 (378)
T KOG1345|consen 248 A--LPKKFNPFS----EKALRLFKKSLTPRFKDRCKIWTAKKMRKC 287 (378)
T ss_pred c--CchhhcccC----HHHHHHHHHhcCCcccccchhHHHHHHHHH
Confidence 1 111112222 356778888899999999666666555443
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-24 Score=269.30 Aligned_cols=196 Identities=18% Similarity=0.271 Sum_probs=138.9
Q ss_pred hccC-CCccceecce-------eecCeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCc
Q 002409 651 RIHH-RNLVQFLGYC-------QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 722 (927)
Q Consensus 651 ~l~H-pnIv~l~g~~-------~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ 722 (927)
.++| +||+++++++ ......+.++|++ +++|.++|... ...+++.+++.++.||++||+|||++ +
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---g 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQ---G 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 4456 6888888887 2234567788877 56999999532 35689999999999999999999998 9
Q ss_pred eecCCCCCCCeEECC-------------------CCcEEEEeecCcccccCCCC---------------ceeeeeccCCC
Q 002409 723 IIHRDLKSSNILLDK-------------------HMRAKVSDFGLSKFAVDGAS---------------HVSSIVRGTVG 768 (927)
Q Consensus 723 ivHrDLkp~NILl~~-------------------~~~vkL~DFGla~~~~~~~~---------------~~~~~~~gt~~ 768 (927)
|+||||||+||||+. ++.+|++|||+++....... .......||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999964 34556666666653211000 00111347889
Q ss_pred ccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCccCHHHHHHH
Q 002409 769 YLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKI 848 (927)
Q Consensus 769 Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 848 (927)
|||||++.+..++.++|||||||+||||++|..|+.... ..+...... .+.+.. .....+.
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~~~~~~~---------~~~~~~-----~~~~~~~ 241 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTMSSLRHR---------VLPPQI-----LLNWPKE 241 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHHHHHHHh---------hcChhh-----hhcCHHH
Confidence 999999999999999999999999999999988765321 011111000 011110 1112345
Q ss_pred HHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 849 EEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 849 ~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.+++.+|++++|.+||+|.||+++
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhhc
Confidence 678889999999999999999764
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.5e-23 Score=223.61 Aligned_cols=257 Identities=22% Similarity=0.331 Sum_probs=188.7
Q ss_pred HHhccccccCceEEEEEEEC----CCcEEEEEEeecCCchhhHhHHHHHHHHhhc-cCCCccceecceeecCeEEEEEEe
Q 002409 602 MLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~----~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
...++||+|.|++||++.+. ..+.||+|.+...+ ....+..|+++|..+ -+.||+++.+++...+..++|+||
T Consensus 39 ~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~ 116 (418)
T KOG1167|consen 39 KVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPY 116 (418)
T ss_pred hhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecc
Confidence 44689999999999999754 36789999886543 345688999999998 599999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCC-CcEEEEeecCcccccC-
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVD- 754 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~-~~vkL~DFGla~~~~~- 754 (927)
++.....++.. .++...+..++..+.+||.++|.+ |||||||||+|+|.+.. +.-.|.|||+|.....
T Consensus 117 ~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~ 186 (418)
T KOG1167|consen 117 FEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY 186 (418)
T ss_pred cCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHHhh
Confidence 99988877763 356778888999999999999999 99999999999999865 6789999999861100
Q ss_pred -------C-----CC------------------------------ceeeeeccCCCccCcccccc-CcCCCccceeeHHH
Q 002409 755 -------G-----AS------------------------------HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGV 791 (927)
Q Consensus 755 -------~-----~~------------------------------~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGv 791 (927)
. .. .......||+||.|||++.. ...+.++||||.||
T Consensus 187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GV 266 (418)
T KOG1167|consen 187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGV 266 (418)
T ss_pred hhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccc
Confidence 0 00 00112359999999999875 56788999999999
Q ss_pred HHHHHHhCCCcccccccccccchhhHHHH---------hhhccCC--ccc---------------ccC-CcccC-cc---
Q 002409 792 ILLELISGQEAISNEKFGANCRNIVQWAK---------LHIESGD--IQG---------------IID-PSLLD-EY--- 840 (927)
Q Consensus 792 vL~elltG~~p~~~~~~~~~~~~l~~~~~---------~~~~~~~--~~~---------------~~d-~~l~~-~~--- 840 (927)
|++.+++++.||-... .....+.+.+. .....|. +.+ -++ +.+.. +.
T Consensus 267 I~Lslls~~~PFf~a~--dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~ 344 (418)
T KOG1167|consen 267 ILLSLLSRRYPFFKAK--DDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT 344 (418)
T ss_pred eeehhhccccccccCc--cccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence 9999999999985432 11122222111 0111122 111 000 00000 00
Q ss_pred -----CHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 841 -----DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 841 -----~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.......++++..+|+..+|.+|.|++|.++|
T Consensus 345 ~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 345 EREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred eeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 01112367899999999999999999999987
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.1e-23 Score=207.20 Aligned_cols=169 Identities=20% Similarity=0.178 Sum_probs=126.5
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
|+|.+++... ...+++..++.++.|+++||+|||++ + ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 6888888532 35699999999999999999999997 4 999999999999999 99987654322
Q ss_pred eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCc
Q 002409 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 839 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 839 (927)
..||+.|||||++.+..++.++|||||||++|||++|+.||...... ...+..+... .... ++.-. .
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~-~~~~------~~~~~-~ 130 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNG-MPAD------DPRDR-S 130 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHH-hccC------Ccccc-c
Confidence 24899999999999999999999999999999999999999654311 1111111111 1110 00000 0
Q ss_pred cCHHHH--HHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 840 YDIQSM--WKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 840 ~~~~~~--~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
...... ..+.+++.+|++.+|++||++.|+++++.....
T Consensus 131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 011111 258999999999999999999999999987643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=6e-21 Score=213.09 Aligned_cols=261 Identities=21% Similarity=0.242 Sum_probs=194.4
Q ss_pred HHHHhccccccCceEEEEEEECCC--cEEEEEEeecCCchhhHhHHHHHHHHhhccC----CCccceecce-eecCeEEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLKDG--KEIAVKVLTSNSYQGKREFTNEVTLLSRIHH----RNLVQFLGYC-QEEGRSVL 672 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~~g--~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~H----pnIv~l~g~~-~~~~~~~l 672 (927)
.+.+.++||+|+||.||.+..... +.+|+|............+..|..++..+.+ +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 566788999999999999987653 4789998765533333378889999988863 5788888888 47778899
Q ss_pred EEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCC-----CcEEEEeec
Q 002409 673 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-----MRAKVSDFG 747 (927)
Q Consensus 673 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~-----~~vkL~DFG 747 (927)
||+.+ |.+|.++..... .+.++..+.+.|+.|++.+|++||+. |++||||||.|+++... ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99976 779998764432 57899999999999999999999998 99999999999999865 469999999
Q ss_pred Ccc--cccCCCC----ce---eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHH
Q 002409 748 LSK--FAVDGAS----HV---SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQW 818 (927)
Q Consensus 748 la~--~~~~~~~----~~---~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~ 818 (927)
+++ ....... .. .....||..|.+++...+...+.+.|+||++.++.|++.|..||...........+.+
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~- 251 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEK- 251 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHH-
Confidence 998 3222111 11 2235599999999999999999999999999999999999999965442211111111
Q ss_pred HHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHH
Q 002409 819 AKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 879 (927)
Q Consensus 819 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~ 879 (927)
....... .. ........+.++...+-..+..++|....+...|+.....
T Consensus 252 ---~~~~~~~----~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 252 ---DPRKLLT----DR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred ---Hhhhhcc----cc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 1111101 00 1111223455566666668999999999999998887654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-21 Score=216.09 Aligned_cols=162 Identities=19% Similarity=0.159 Sum_probs=124.3
Q ss_pred HHHHhccccccCceEEEEEEEC--CCcEEEEEEeecCC-----chhhHhHHHHHHHHhhccCCCccceecceeecCeEEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK--DGKEIAVKVLTSNS-----YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 672 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~--~g~~VAVK~l~~~~-----~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~l 672 (927)
.|.+.+.||+|+||+||+|+++ +++.+|||++.... ....+.+.+|+++|++++|+|+++.+.. .+..++
T Consensus 19 ~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~L 95 (365)
T PRK09188 19 RFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGL 95 (365)
T ss_pred CceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEE
Confidence 3556789999999999999875 46778999875331 1234568999999999999999853322 245799
Q ss_pred EEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCC-CCCCeEECCCCcEEEEeecCccc
Q 002409 673 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDL-KSSNILLDKHMRAKVSDFGLSKF 751 (927)
Q Consensus 673 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDL-kp~NILl~~~~~vkL~DFGla~~ 751 (927)
||||+++++|... . ... ...++.|++++|.|||+. +|+|||| ||+|||++.++++||+|||+++.
T Consensus 96 VmE~~~G~~L~~~-~----~~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 96 VRGWTEGVPLHLA-R----PHG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred EEEccCCCCHHHh-C----ccc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 9999999999632 1 111 135788999999999998 9999999 99999999999999999999986
Q ss_pred ccCCCCce-------eeeeccCCCccCccccccC
Q 002409 752 AVDGASHV-------SSIVRGTVGYLDPEYYISQ 778 (927)
Q Consensus 752 ~~~~~~~~-------~~~~~gt~~Y~aPE~~~~~ 778 (927)
........ .....+++.|+|||++...
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 54432111 1245688899999998643
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5e-22 Score=201.80 Aligned_cols=248 Identities=21% Similarity=0.332 Sum_probs=189.5
Q ss_pred HHhccccccCceEEEEEEECCCcEEEEEEeecC--CchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 602 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
++..+|.+...|..|+|+++ |..+++|++... .....++|.+|.-.|+.+.||||++++|.|.......++..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 45677899999999999998 677788887643 233357899999999999999999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEE--eecCcccccCCCC
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS--DFGLSKFAVDGAS 757 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~--DFGla~~~~~~~~ 757 (927)
|+|...|++. ..-..+..++.+++.++|+|++|||+. .+-|..--|.+..+++|++.+++|. |--++- ..
T Consensus 272 gslynvlhe~--t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsf---qe-- 343 (448)
T KOG0195|consen 272 GSLYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSF---QE-- 343 (448)
T ss_pred hHHHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeee---ec--
Confidence 9999999865 345577788999999999999999996 3334445689999999999988874 221111 00
Q ss_pred ceeeeeccCCCccCccccccCcC---CCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCC
Q 002409 758 HVSSIVRGTVGYLDPEYYISQQL---TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 834 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~~~~~~---s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 834 (927)
....-.+.||+||.++..+- -.++|+|||.+++|||.|...||.+...- .+.. + +.-+
T Consensus 344 ---~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspm-ecgm-------k--------iale 404 (448)
T KOG0195|consen 344 ---VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM-ECGM-------K--------IALE 404 (448)
T ss_pred ---cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch-hhhh-------h--------hhhc
Confidence 11224689999999987653 34789999999999999999999765421 1110 0 0111
Q ss_pred cccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHH
Q 002409 835 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 877 (927)
Q Consensus 835 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~ 877 (927)
.++...++.....+.+|+.-|+..||.+||.+..|+-.||++.
T Consensus 405 glrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 405 GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 2223333334456788899999999999999999999999763
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.1e-19 Score=196.94 Aligned_cols=260 Identities=28% Similarity=0.416 Sum_probs=195.5
Q ss_pred HHhccccccCceEEEEEEECCCcEEEEEEeecCCch---hhHhHHHHHHHHhhccCC-CccceecceeecCeEEEEEEec
Q 002409 602 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHR-NLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~---~~~~~~~Ei~iL~~l~Hp-nIv~l~g~~~~~~~~~lV~E~~ 677 (927)
.+.+.||.|+||.||++... +.+++|.+...... ....+.+|+.+++.+.|+ +++++.+.+......+++++++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 3 RILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred eeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 34578999999999999887 88899998765332 367799999999999988 7999999997777789999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCC-cEEEEeecCcccccCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-~vkL~DFGla~~~~~~~ 756 (927)
.++++.+++...... ..+.......++.|++.++.|+|+. +++|||+||+||+++..+ .++++|||.++......
T Consensus 81 ~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 81 DGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999666432111 3678889999999999999999998 899999999999999998 79999999997544333
Q ss_pred Cc-----eeeeeccCCCccCcccccc---CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCc
Q 002409 757 SH-----VSSIVRGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 828 (927)
Q Consensus 757 ~~-----~~~~~~gt~~Y~aPE~~~~---~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 828 (927)
.. ......||..|++||.+.. ..+....|+||+|++++++++|..|+......................
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--- 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP--- 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc---
Confidence 22 2345679999999999987 578889999999999999999999976543110011111211111110
Q ss_pred ccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 829 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 829 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.................+.+++..|+..+|..|.++.+....
T Consensus 234 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 --SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred --ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000001111002223467899999999999999999988776
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3e-20 Score=220.73 Aligned_cols=253 Identities=23% Similarity=0.247 Sum_probs=183.4
Q ss_pred HhccccccCceEEEEEEEC-CCcEEEEEEee----cCCc--hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEE
Q 002409 603 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLT----SNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 675 (927)
Q Consensus 603 ~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~----~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E 675 (927)
..+.+|.|++|.|+..... ..+..+.|..+ .... +....+..|+.+=..++|+|++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 3578999999977777543 33334444332 1111 111225668888888999999998888877766666699
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccC-
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD- 754 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~- 754 (927)
||+. +|..++.. ...+...++..++.|+..|+.|||+. ||.|||+|++|+++..+|.+||+|||.+....-
T Consensus 402 ~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 402 YCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred cccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 9999 99988832 34678888999999999999999998 999999999999999999999999999864322
Q ss_pred CC--CceeeeeccCCCccCccccccCcCCCc-cceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccc
Q 002409 755 GA--SHVSSIVRGTVGYLDPEYYISQQLTDK-SDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 831 (927)
Q Consensus 755 ~~--~~~~~~~~gt~~Y~aPE~~~~~~~s~~-sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 831 (927)
.. .+......|+..|+|||.+....|.+. .||||.|+++..|.+|+.||......+... ......++...
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~------~~~~~~~~~~~- 546 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF------KTNNYSDQRNI- 546 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch------hhhcccccccc-
Confidence 22 255667789999999999999999875 699999999999999999997655322110 00000000000
Q ss_pred cCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 832 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 832 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
..-..........+...++.+|++++|.+|-||.+|++.
T Consensus 547 --~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 547 --FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred --ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 000000112333466789999999999999999999863
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.2e-19 Score=179.17 Aligned_cols=262 Identities=22% Similarity=0.294 Sum_probs=192.8
Q ss_pred HHHHHHhccccccCceEEEEEE-ECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccC-CCccceecceeecCeEEEEEE
Q 002409 598 DATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH-RNLVQFLGYCQEEGRSVLVYE 675 (927)
Q Consensus 598 ~~~~~~~~~IG~G~fG~Vy~~~-~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~H-pnIv~l~g~~~~~~~~~lV~E 675 (927)
...+.+.++||.|+||.+|.|. ..+|++||||+-+... ...++..|..+...++| ..|..+..+..++.+-.+||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 3455667899999999999996 4579999999865443 23567889999999976 677777778888889999999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCC---CcEEEEeecCcccc
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH---MRAKVSDFGLSKFA 752 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~---~~vkL~DFGla~~~ 752 (927)
.. |-+|.++..- -.+.++.++++.++.|++.-++|+|.+ +++||||||+|+|..-+ ..+.++|||+|+..
T Consensus 92 LL-GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 92 LL-GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred cc-CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhh
Confidence 87 6788887631 246688899999999999999999999 99999999999999743 46899999999866
Q ss_pred cCCCC--ce----eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccC
Q 002409 753 VDGAS--HV----SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG 826 (927)
Q Consensus 753 ~~~~~--~~----~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 826 (927)
.+..+ |. .....||.+|.+-....+...+.+.|+-|+|.+|..+.-|..||.+....... ...+.+.+.
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~-----QKyEkI~Ek 239 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK-----QKYEKISEK 239 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH-----HHHHHHHHh
Confidence 55332 21 22345999999988877778889999999999999999999999875421111 111112222
Q ss_pred CcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 827 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 827 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
++.-.+. .+-..++ .++...+.-|-..--++-|...-+-+.+.-++.
T Consensus 240 K~s~~ie-~LC~G~P----~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr 286 (341)
T KOG1163|consen 240 KMSTPIE-VLCKGFP----AEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR 286 (341)
T ss_pred hcCCCHH-HHhCCCc----HHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence 2211111 1112222 346666777877788888988888777766543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.4e-19 Score=182.38 Aligned_cols=139 Identities=19% Similarity=0.182 Sum_probs=108.2
Q ss_pred hccccccCceEEEEEEECCCcEEEEEEeecCCch--h------------------------hHhHHHHHHHHhhccCCCc
Q 002409 604 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ--G------------------------KREFTNEVTLLSRIHHRNL 657 (927)
Q Consensus 604 ~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~--~------------------------~~~~~~Ei~iL~~l~HpnI 657 (927)
...||+|+||.||+|...+|+.||||+++..... . ......|++++.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3679999999999999888999999999754211 0 0122459999999988877
Q ss_pred cceecceeecCeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHH-hhCCCCceecCCCCCCCeEEC
Q 002409 658 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL-HTGCVPAIIHRDLKSSNILLD 736 (927)
Q Consensus 658 v~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yL-H~~~~~~ivHrDLkp~NILl~ 736 (927)
.....+.. ...++||||++++++...+. ....++......++.|++.+|.+| |+. +|+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 44333222 23489999999877654431 234678889999999999999999 677 999999999999998
Q ss_pred CCCcEEEEeecCcccc
Q 002409 737 KHMRAKVSDFGLSKFA 752 (927)
Q Consensus 737 ~~~~vkL~DFGla~~~ 752 (927)
++.++|+|||+|...
T Consensus 153 -~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 -DGKLYIIDVSQSVEH 167 (190)
T ss_pred -CCcEEEEEccccccC
Confidence 478999999998744
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.7e-19 Score=183.11 Aligned_cols=260 Identities=20% Similarity=0.283 Sum_probs=189.5
Q ss_pred HHHhccccccCceEEEEEE-ECCCcEEEEEEeecCCchhhHhHHHHHHHHhhcc-CCCccceecceeecCeEEEEEEecc
Q 002409 601 KMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~-~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
+.++++||+|.||+++.|+ +-+++.||||.-... ....++..|.+.++.|. .++|...+-+..++.+-.||+|.+
T Consensus 30 yrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL- 106 (449)
T KOG1165|consen 30 YRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL- 106 (449)
T ss_pred ceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence 4568999999999999997 447999999975432 23456888999998885 688888888878888889999987
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCC-----cEEEEeecCccccc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-----RAKVSDFGLSKFAV 753 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-----~vkL~DFGla~~~~ 753 (927)
|-+|.|+.. . -.++++.++++.+|.|++.-++|+|++ .+|.|||||+|+||...+ .+.++|||+|+...
T Consensus 107 GPSLEDLFD-~--CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 107 GPSLEDLFD-L--CGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred CcCHHHHHH-H--hcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 668877652 1 256799999999999999999999999 999999999999997543 58999999999776
Q ss_pred CCCCce------eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCC
Q 002409 754 DGASHV------SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 827 (927)
Q Consensus 754 ~~~~~~------~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 827 (927)
+..+.. .....||.+||+-....+++.+.+.|+-|||-++...+-|..||.+..-+...+ . .+++.+.+
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~---k--YeKIGe~K 255 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKE---K--YEKIGETK 255 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHH---H--HHHhcccc
Confidence 654321 223459999999999999999999999999999999999999998755221110 0 11111111
Q ss_pred cccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHH
Q 002409 828 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 879 (927)
Q Consensus 828 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~ 879 (927)
-..-++. +-..+ +++....++.+. ..+-.+-|..+-+...+..++..
T Consensus 256 r~T~i~~-Lc~g~-P~efa~Yl~yvR---~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 256 RSTPIEV-LCEGF-PEEFATYLRYVR---RLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred ccCCHHH-HHhcC-HHHHHHHHHHHH---hcCcccCCCHHHHHHHHHHHHHh
Confidence 0000100 01112 223333333333 34556678898888888887764
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.6e-20 Score=214.80 Aligned_cols=250 Identities=21% Similarity=0.278 Sum_probs=178.5
Q ss_pred HHHhccccccCceEEEEEEECCCcEEEEEEeecCC-chhhHhHHHHHHH--HhhccCCCccceecceeecCeEEEEEEec
Q 002409 601 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS-YQGKREFTNEVTL--LSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~-~~~~~~~~~Ei~i--L~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
..+.+.||++.|=+|.+|+++.|. |+||++-+.. .-..+.|.++++- ...++|||.+++..+-......|||-+|.
T Consensus 25 ~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv 103 (1431)
T KOG1240|consen 25 CHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV 103 (1431)
T ss_pred eeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH
Confidence 345678999999999999998776 8999987654 2233444443333 44558999999988877777778888888
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccccc--CC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV--DG 755 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~--~~ 755 (927)
.+ +|.|.| ..+..+...+...|+.|+++||..+|+. +|+|||||.+||||+.-.-+.|+||..=+... +.
T Consensus 104 kh-nLyDRl----STRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 104 KH-NLYDRL----STRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred hh-hhhhhh----ccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 55 777776 4566678888889999999999999998 99999999999999999999999998655322 22
Q ss_pred CCceeeee----ccCCCccCccccccC-----------cCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHH
Q 002409 756 ASHVSSIV----RGTVGYLDPEYYISQ-----------QLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWA 819 (927)
Q Consensus 756 ~~~~~~~~----~gt~~Y~aPE~~~~~-----------~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~ 819 (927)
.......+ ..-..|+|||.+... ..+++.||||+||++.||++ |+++|.-.. +..+-
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ-------L~aYr 248 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ-------LLAYR 248 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH-------HHhHh
Confidence 21111222 233579999998542 15678899999999999998 677775322 22221
Q ss_pred HhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHH
Q 002409 820 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 876 (927)
Q Consensus 820 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~ 876 (927)
.+. ......-+.. .+ ...+.+|+..|++.||++|-+++++++.-.+.
T Consensus 249 -----~~~-~~~~e~~Le~-Ie---d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 249 -----SGN-ADDPEQLLEK-IE---DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred -----ccC-ccCHHHHHHh-Cc---CccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 110 0000000000 00 01578899999999999999999999985443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.2e-19 Score=185.06 Aligned_cols=174 Identities=14% Similarity=0.171 Sum_probs=133.4
Q ss_pred HHHHHHHHHHhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHh---------HHHHHHHHhhccCCCccceecce
Q 002409 594 SDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKRE---------FTNEVTLLSRIHHRNLVQFLGYC 664 (927)
Q Consensus 594 ~ei~~~~~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~---------~~~Ei~iL~~l~HpnIv~l~g~~ 664 (927)
.++.+..+...+.+|.|+||.||.... +++.+|||+++......+.. +++|++.+.+++|++|..+.+++
T Consensus 26 ~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 26 DDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred HHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 345555666788999999999999766 57789999997553332222 68899999999999999998886
Q ss_pred eec--------CeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEEC
Q 002409 665 QEE--------GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD 736 (927)
Q Consensus 665 ~~~--------~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~ 736 (927)
... +..+|+|||++|.+|.++.. ++. ....+++.+|..||+. +++|||+||+||+++
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~ 169 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVS 169 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEe
Confidence 533 35789999999999977631 121 2456899999999998 999999999999999
Q ss_pred CCCcEEEEeecCcccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHH
Q 002409 737 KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELI 797 (927)
Q Consensus 737 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ell 797 (927)
.++ ++|+|||..+........ ..+.....+..++|+||||+.+..+.
T Consensus 170 ~~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 170 KNG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 988 999999987644221111 01344556778999999999987654
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.4e-18 Score=197.49 Aligned_cols=218 Identities=25% Similarity=0.395 Sum_probs=167.1
Q ss_pred HhhccCCCccceecceeecCeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCC
Q 002409 649 LSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDL 728 (927)
Q Consensus 649 L~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDL 728 (927)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.|.+.. ....+++.....+.+++++||+|||.. +-..|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeee
Confidence 4678999999999999999999999999999999999965 467799999999999999999999997 23399999
Q ss_pred CCCCeEECCCCcEEEEeecCcccccCCC-CceeeeeccCCCccCccccccC-------cCCCccceeeHHHHHHHHHhCC
Q 002409 729 KSSNILLDKHMRAKVSDFGLSKFAVDGA-SHVSSIVRGTVGYLDPEYYISQ-------QLTDKSDVYSFGVILLELISGQ 800 (927)
Q Consensus 729 kp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~-------~~s~~sDVwSlGvvL~elltG~ 800 (927)
+++|++++....+||+|||+........ ........-..-|.|||.+... ..+.+.||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 9999999999999999999987553210 0111111234579999998753 1467799999999999999999
Q ss_pred CcccccccccccchhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 801 EAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 801 ~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
.||...........++.+++. + -...+-|.+.... +....+..++.+|+..+|++||++++|-..++.+..
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~----~-~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKK----G-GSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred CccccccccCChHHHHHHHHh----c-CCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 999875544333445555443 0 1111222222211 333368999999999999999999999888776543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=4e-18 Score=175.55 Aligned_cols=140 Identities=20% Similarity=0.203 Sum_probs=110.2
Q ss_pred hccccccCceEEEEEEECCCcEEEEEEeecCCchh--------------------------hHhHHHHHHHHhhccCCCc
Q 002409 604 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG--------------------------KREFTNEVTLLSRIHHRNL 657 (927)
Q Consensus 604 ~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~--------------------------~~~~~~Ei~iL~~l~HpnI 657 (927)
...||+|+||.||+|+..+|+.||||+++...... ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46799999999999998889999999987642110 1123578999999999988
Q ss_pred cceecceeecCeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhh-CCCCceecCCCCCCCeEEC
Q 002409 658 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLD 736 (927)
Q Consensus 658 v~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDLkp~NILl~ 736 (927)
.....+... ..+|||||++++++..... ....++......++.|++.++.+||+ . +|+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence 554444332 2489999999885543321 22456778889999999999999999 7 999999999999999
Q ss_pred CCCcEEEEeecCccccc
Q 002409 737 KHMRAKVSDFGLSKFAV 753 (927)
Q Consensus 737 ~~~~vkL~DFGla~~~~ 753 (927)
++.++|+|||++....
T Consensus 153 -~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 -DGKPYIIDVSQAVELD 168 (190)
T ss_pred -CCCEEEEEcccceecC
Confidence 8899999999997553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.6e-16 Score=188.59 Aligned_cols=90 Identities=31% Similarity=0.475 Sum_probs=81.3
Q ss_pred CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCC-Cccccc
Q 002409 413 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNL-PNLREL 490 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l-~~L~~L 490 (927)
+++|+.|+|++|+|+|.+|..+++|++|+.|+|++|+|+|.+|+ +++|++|++|+|++|+|+|.+|..++.+ .++..+
T Consensus 441 L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l 520 (623)
T PLN03150 441 LRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASF 520 (623)
T ss_pred CCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceE
Confidence 56899999999999999999999999999999999999999997 8999999999999999999999998874 467788
Q ss_pred cccccccccccc
Q 002409 491 YVQNNMLSGTVP 502 (927)
Q Consensus 491 ~l~~N~l~g~iP 502 (927)
++++|...+..|
T Consensus 521 ~~~~N~~lc~~p 532 (623)
T PLN03150 521 NFTDNAGLCGIP 532 (623)
T ss_pred EecCCccccCCC
Confidence 999998553444
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.7e-17 Score=168.02 Aligned_cols=185 Identities=14% Similarity=0.137 Sum_probs=137.9
Q ss_pred hccccccCceEEEEEEECCCcEEEEEEeecCCchhh----HhHHHHHHHHhhcc-CCCccceecceeecCeEEEEEEecc
Q 002409 604 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK----REFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 604 ~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~----~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
...|++|+||+||.+.. .+.+++.+.+........ ..+.+|+++|+++. |+++.+++++ +..+++|||+.
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 46799999999997766 578888777765443211 25789999999995 5889999886 34699999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCC-CCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDL-KSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDL-kp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
|.+|.+.+. . ....++.|++.+|.++|++ ||+|||| ||+|||++.++.++|+|||++........
T Consensus 82 G~~L~~~~~-----~------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 82 GAAMYQRPP-----R------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred CccHHhhhh-----h------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 988865431 1 1134678999999999998 9999999 79999999999999999999985433221
Q ss_pred c----e--------eeeeccCCCccCccccccC-cCC-CccceeeHHHHHHHHHhCCCcccccc
Q 002409 758 H----V--------SSIVRGTVGYLDPEYYISQ-QLT-DKSDVYSFGVILLELISGQEAISNEK 807 (927)
Q Consensus 758 ~----~--------~~~~~gt~~Y~aPE~~~~~-~~s-~~sDVwSlGvvL~elltG~~p~~~~~ 807 (927)
. . ......++.|++|+...-. ..+ ...+.++.|+-+|.++|++.+...+.
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 0 1122367888888864321 222 45688899999999999998875544
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.1e-17 Score=176.13 Aligned_cols=230 Identities=19% Similarity=0.241 Sum_probs=146.1
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhcc----------CCCccceecce-----
Q 002409 604 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIH----------HRNLVQFLGYC----- 664 (927)
Q Consensus 604 ~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~----------HpnIv~l~g~~----- 664 (927)
.+.||.|+++.||.+++. +++++|||+..... ....+++.+|.-....+. |-.++..++..
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 468999999999999987 48999999886443 223456666665555532 21222222221
Q ss_pred ----eec---C-----eEEEEEEeccCCchhhhccc---ccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCC
Q 002409 665 ----QEE---G-----RSVLVYEFMHNGTLKEHLYG---TLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLK 729 (927)
Q Consensus 665 ----~~~---~-----~~~lV~E~~~~gsL~~~L~~---~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLk 729 (927)
... . ..+++|+-+ .++|.+++.. .......+....++.+..|+.+.+++||+. |++|+|||
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi~ 172 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDIK 172 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-S
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecccc
Confidence 111 1 236788877 4588777532 212233455666778889999999999998 99999999
Q ss_pred CCCeEECCCCcEEEEeecCcccccCCCCceeeeeccCCCccCccccccC--------cCCCccceeeHHHHHHHHHhCCC
Q 002409 730 SSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ--------QLTDKSDVYSFGVILLELISGQE 801 (927)
Q Consensus 730 p~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--------~~s~~sDVwSlGvvL~elltG~~ 801 (927)
|+|++++.+|.++|+||+.....+.. ......+..|.+||..... .++.+.|.|++|+++|.|++|+.
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTR----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEE----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred eeeEEEcCCCCEEEcChHHHeecCce----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 99999999999999999876543221 1112356789999987542 47788999999999999999999
Q ss_pred cccccccccccchhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCC
Q 002409 802 AISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMR 863 (927)
Q Consensus 802 p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~R 863 (927)
||+........ .| .+ .... +.++.+..|+..+++++|++|
T Consensus 249 Pf~~~~~~~~~----~~------------~f-----~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADP----EW------------DF-----SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTS----GG------------GG-----TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCccccc----cc------------cc-----hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99865421111 11 11 1122 455678899999999999988
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.5e-18 Score=194.94 Aligned_cols=225 Identities=25% Similarity=0.314 Sum_probs=176.0
Q ss_pred cccccCceEEEEEE----ECCCcEEEEEEeecCCchh--hHhHHHHHHHHhhcc-CCCccceecceeecCeEEEEEEecc
Q 002409 606 KIGSGGFGVVYYGK----LKDGKEIAVKVLTSNSYQG--KREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 606 ~IG~G~fG~Vy~~~----~~~g~~VAVK~l~~~~~~~--~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
.+|+|.||.|+..+ .+.|+.+|+|++++..... ......|..++..++ ||.++++.-.+..+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999763 3357778999887653211 124456778888886 9999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
+|.|...+. ....+.+.........++-+++++|+. +++|||+|++||+++.+|++|+.|||+++...+....
T Consensus 81 gg~lft~l~----~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 81 GGDLFTRLS----KEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred cchhhhccc----cCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence 999988874 345667777777888999999999998 9999999999999999999999999999866554332
Q ss_pred eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccC
Q 002409 759 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 838 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 838 (927)
+||..|||||++. .....+|-||||++++||++|..||... ....|.. ..-
T Consensus 154 -----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~----~~~~Il~------------------~~~ 204 (612)
T KOG0603|consen 154 -----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD----TMKRILK------------------AEL 204 (612)
T ss_pred -----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH----HHHHHhh------------------hcc
Confidence 7999999999997 6678899999999999999999999751 1111111 011
Q ss_pred ccCHHHHHHHHHHHhhhcCCCCCCCCcH
Q 002409 839 EYDIQSMWKIEEKALMCVLPHGHMRPSI 866 (927)
Q Consensus 839 ~~~~~~~~~l~~L~~~Cl~~dP~~RPsm 866 (927)
..+.+......++...++..+|..|--.
T Consensus 205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 205 EMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred CCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 2233344456677788888888888755
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=8.2e-17 Score=194.85 Aligned_cols=253 Identities=19% Similarity=0.223 Sum_probs=183.1
Q ss_pred HHHHHHHHHHhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhcc---CCCccceecceeecCeE
Q 002409 594 SDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH---HRNLVQFLGYCQEEGRS 670 (927)
Q Consensus 594 ~ei~~~~~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~---HpnIv~l~g~~~~~~~~ 670 (927)
-++....+.+.+.||+|+||.||+|...+|+.||+|+-+....+. |.-=.+++.+|+ -+.|+.+...+.-.+..
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 344445556778999999999999999889999999977665542 111123333443 24455555666667778
Q ss_pred EEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECC-------CCcEEE
Q 002409 671 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-------HMRAKV 743 (927)
Q Consensus 671 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~-------~~~vkL 743 (927)
+||+||.+.|+|.+++. ..+.++|.-.+.+..|+++.+++||.. +||||||||+|+||.. ...++|
T Consensus 770 ~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred eeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEE
Confidence 99999999999999995 567788999999999999999999998 9999999999999952 346999
Q ss_pred EeecCcccccCC-CCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhh
Q 002409 744 SDFGLSKFAVDG-ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH 822 (927)
Q Consensus 744 ~DFGla~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~ 822 (927)
+|||.+-.+..- .......+++|-.+-.+|+..++.++..+|.|.+.-+++-|+.|+..=
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q------------------- 903 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME------------------- 903 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-------------------
Confidence 999998633221 223445677899999999999999999999999999999999996421
Q ss_pred hccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHH
Q 002409 823 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 879 (927)
Q Consensus 823 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~ 879 (927)
...|. ...+++.+..-...+.+-++.++ +|.++-..=|...++...|++.+..
T Consensus 904 ~~~g~-~~~~~~~~~Ry~~~~~W~~~F~~---lLN~~~~~~p~l~~lr~~~~~~~~~ 956 (974)
T KOG1166|consen 904 VKNGS-SWMVKTNFPRYWKRDMWNKFFDL---LLNPDCDTLPNLQELRTELEEVLAE 956 (974)
T ss_pred hcCCc-ceeccccchhhhhHHHHHHHHHH---HhCcCcccchhHHHHHHHHHHHHHH
Confidence 11111 11222222221223333344444 4447767778888888888887753
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.4e-16 Score=165.68 Aligned_cols=132 Identities=18% Similarity=0.257 Sum_probs=103.4
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhc-----cCCCccceecceeecC---e-EEEEEE
Q 002409 605 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-----HHRNLVQFLGYCQEEG---R-SVLVYE 675 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l-----~HpnIv~l~g~~~~~~---~-~~lV~E 675 (927)
+.||+|+||.||. +.+....+||++........+.+.+|+.+++++ .||||++++|++.++. . ..+|+|
T Consensus 8 ~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e 85 (210)
T PRK10345 8 SPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD 85 (210)
T ss_pred ceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence 6799999999996 443333479988765444567899999999999 5799999999998763 3 337899
Q ss_pred e--ccCCchhhhcccccccccccCHHHHHHHHHHHHhHh-HHHhhCCCCceecCCCCCCCeEECC----CCcEEEEeecC
Q 002409 676 F--MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI-EYLHTGCVPAIIHRDLKSSNILLDK----HMRAKVSDFGL 748 (927)
Q Consensus 676 ~--~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL-~yLH~~~~~~ivHrDLkp~NILl~~----~~~vkL~DFGl 748 (927)
| +.+|+|.+++.+. .+++. ..++.|++.++ +|||++ +|+||||||+|||++. +.+++|+||+-
T Consensus 86 ~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 86 FDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred CCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 9 5579999999432 24444 34577888777 999998 9999999999999974 34899999543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.9e-16 Score=164.11 Aligned_cols=140 Identities=22% Similarity=0.252 Sum_probs=108.0
Q ss_pred HHHhccccccCceEEEEEE--ECCCcEEEEEEeecCCch------------------------hhHhHHHHHHHHhhccC
Q 002409 601 KMLEKKIGSGGFGVVYYGK--LKDGKEIAVKVLTSNSYQ------------------------GKREFTNEVTLLSRIHH 654 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~--~~~g~~VAVK~l~~~~~~------------------------~~~~~~~Ei~iL~~l~H 654 (927)
+.+.+.||+|+||.||+|. ..+|+.||||+++..... ....+..|++++.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 4567899999999999998 558999999998753210 01235689999999976
Q ss_pred CC--ccceecceeecCeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCc-eecCCCCCC
Q 002409 655 RN--LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA-IIHRDLKSS 731 (927)
Q Consensus 655 pn--Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~-ivHrDLkp~ 731 (927)
.. +.+.+++ ...++||||+++++|...... ...+.......++.|++.++.+||++ + ++||||||+
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~ 178 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEY 178 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChh
Confidence 33 2333332 235899999999888765421 22345556778999999999999998 8 999999999
Q ss_pred CeEECCCCcEEEEeecCcccc
Q 002409 732 NILLDKHMRAKVSDFGLSKFA 752 (927)
Q Consensus 732 NILl~~~~~vkL~DFGla~~~ 752 (927)
||+++ ++.++|+|||.+...
T Consensus 179 NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hEEEE-CCCEEEEEChhhhcc
Confidence 99999 889999999998744
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=1e-15 Score=160.10 Aligned_cols=134 Identities=25% Similarity=0.427 Sum_probs=112.9
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeecCCch--------hhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 605 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ--------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~--------~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
+.||+|++|.||+|.. .|..+++|+....... ....+.+|++++.+++|+++.....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5789999999999988 5788999986543211 124577899999999999998888887777888999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccc
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 751 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 751 (927)
++|++|.+++... .. .+..++.+++.+|.+||+. +++|||++|.|||++ ++.++|+|||+++.
T Consensus 81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999887432 11 7788999999999999998 999999999999999 78999999998763
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.8e-15 Score=156.80 Aligned_cols=130 Identities=26% Similarity=0.450 Sum_probs=106.6
Q ss_pred cccccCceEEEEEEECCCcEEEEEEeecCCch--------hhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 606 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ--------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 606 ~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~--------~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
.||+|+||.||+|.+. ++.+++|+....... ....+.+|++++.+++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 3899999999999964 788999986543211 1255778999999999988766666666677779999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccc
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 751 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 751 (927)
++++|.+.+... .. .++.+++++|.+||+. +++|||++|.||+++ ++.++++|||+++.
T Consensus 80 ~g~~l~~~~~~~----~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEG----ND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhc----HH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999998877321 10 6899999999999998 999999999999999 88999999998864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.3e-15 Score=154.86 Aligned_cols=135 Identities=21% Similarity=0.217 Sum_probs=106.7
Q ss_pred HHHhccccccCceEEEEEEECCCcEEEEEEeecCCch----------------------hhHhHHHHHHHHhhccCCC--
Q 002409 601 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ----------------------GKREFTNEVTLLSRIHHRN-- 656 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~----------------------~~~~~~~Ei~iL~~l~Hpn-- 656 (927)
+.+.+.||+|+||.||++..++|+.||||+++..... ....+..|+.++.++.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 5567889999999999999888999999987643210 0123567899999998874
Q ss_pred ccceecceeecCeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEEC
Q 002409 657 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD 736 (927)
Q Consensus 657 Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~ 736 (927)
+...++ ....++||||+++++|.+.... .....++.+++.++.++|+. +++||||||+||+++
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~ 159 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVD 159 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEc
Confidence 334443 2456899999999998765420 23456889999999999998 999999999999999
Q ss_pred CCCcEEEEeecCcccc
Q 002409 737 KHMRAKVSDFGLSKFA 752 (927)
Q Consensus 737 ~~~~vkL~DFGla~~~ 752 (927)
+++.++|+|||++...
T Consensus 160 ~~~~~~liDfg~~~~~ 175 (198)
T cd05144 160 DDEKIYIIDWPQMVST 175 (198)
T ss_pred CCCcEEEEECCccccC
Confidence 9999999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.6e-15 Score=158.79 Aligned_cols=198 Identities=18% Similarity=0.195 Sum_probs=136.5
Q ss_pred cCCCccceecceee---------------------------cCeEEEEEEeccCCchhhhcccccccccccCHHHHHHHH
Q 002409 653 HHRNLVQFLGYCQE---------------------------EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIA 705 (927)
Q Consensus 653 ~HpnIv~l~g~~~~---------------------------~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~ 705 (927)
+|||||++.++|.+ ...+|+||..... +|.+++.. +..+.....-|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc-----CCCchHHHHHHH
Confidence 58999888876532 2355788887644 88888853 234556677789
Q ss_pred HHHHhHhHHHhhCCCCceecCCCCCCCeEEC--CC--CcEEEEeecCcccccCC---CCce--eeeeccCCCccCccccc
Q 002409 706 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLD--KH--MRAKVSDFGLSKFAVDG---ASHV--SSIVRGTVGYLDPEYYI 776 (927)
Q Consensus 706 ~qia~gL~yLH~~~~~~ivHrDLkp~NILl~--~~--~~vkL~DFGla~~~~~~---~~~~--~~~~~gt~~Y~aPE~~~ 776 (927)
.|+++|+.|||++ +|.|||+|++|||+. +| -...|+|||++--.... -... .....|.-.-||||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999999 999999999999994 33 35789999987422110 0011 11234777889999986
Q ss_pred cCc------CCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHH
Q 002409 777 SQQ------LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEE 850 (927)
Q Consensus 777 ~~~------~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 850 (927)
..+ .-.|+|.|+.|.+-||++....||.... +..-+...+ .+..+ ...+..+...+.+
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG--em~L~~r~Y-----qe~qL---------Palp~~vpp~~rq 488 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG--EMLLDTRTY-----QESQL---------PALPSRVPPVARQ 488 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccc--hheechhhh-----hhhhC---------CCCcccCChHHHH
Confidence 532 2358999999999999999999997632 111111111 11111 1222334456789
Q ss_pred HHhhhcCCCCCCCCcHHHHHHHHHH
Q 002409 851 KALMCVLPHGHMRPSISEVLKDIQD 875 (927)
Q Consensus 851 L~~~Cl~~dP~~RPsm~eV~~~L~~ 875 (927)
++...++++|.+||+..-....|.-
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl~L 513 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVLNL 513 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHHHH
Confidence 9999999999999998877766653
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.58 E-value=6e-15 Score=175.98 Aligned_cols=132 Identities=23% Similarity=0.339 Sum_probs=108.2
Q ss_pred HhccccccCceEEEEEEECCCcEEEEEEeecC--Cc------hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEE
Q 002409 603 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSN--SY------QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 674 (927)
Q Consensus 603 ~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~--~~------~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~ 674 (927)
..+.||+|+||+||+|.+.. ..+++|+.... .. .....+.+|++++++++|++++....++......++||
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~~-~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 415 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYLG-RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVM 415 (535)
T ss_pred ccceeccCCcEEEEEEeecC-ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEE
Confidence 35789999999999998864 34444443211 11 11345789999999999999998888887777889999
Q ss_pred EeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccc
Q 002409 675 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 751 (927)
Q Consensus 675 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 751 (927)
||+++++|.+++. ....++.+++++|.+||+. +++||||||+|||+ .++.++|+|||+++.
T Consensus 416 E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 416 EYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 9999999988773 3467899999999999998 99999999999999 678999999999874
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.9e-16 Score=175.19 Aligned_cols=175 Identities=28% Similarity=0.373 Sum_probs=130.1
Q ss_pred CeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeec
Q 002409 668 GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG 747 (927)
Q Consensus 668 ~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFG 747 (927)
.+.++.|++|...+|.++|.... .....++...+.++.|++.|+.| + +.+|+|+||.||+...+.++||.|||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhh
Confidence 35789999999999999996543 34556788889999999999999 5 89999999999999999999999999
Q ss_pred CcccccCCC-----CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHh
Q 002409 748 LSKFAVDGA-----SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKL 821 (927)
Q Consensus 748 la~~~~~~~-----~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~ 821 (927)
+........ ....+...||..||+||.+.+..|+.|+||||||++|+|++. =..+++... +..
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~-----------t~~ 470 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA-----------TLT 470 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH-----------hhh
Confidence 987554433 112234569999999999999999999999999999999997 223332211 001
Q ss_pred hhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHH
Q 002409 822 HIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEV 869 (927)
Q Consensus 822 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV 869 (927)
-+++|.+ ++....+++. =..+..+++.+.|.+||+..++
T Consensus 471 d~r~g~i----p~~~~~d~p~-----e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 471 DIRDGII----PPEFLQDYPE-----EYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred hhhcCCC----ChHHhhcCcH-----HHHHHHHhcCCCcccCchHHHH
Confidence 1222222 2222223332 3478889999999999954444
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.53 E-value=4.2e-14 Score=144.90 Aligned_cols=136 Identities=22% Similarity=0.277 Sum_probs=96.7
Q ss_pred hccccccCceEEEEEEECCCcEEEEEEeecCCchh--hHh----------------------HHHHHHHHhhccCCC--c
Q 002409 604 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG--KRE----------------------FTNEVTLLSRIHHRN--L 657 (927)
Q Consensus 604 ~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~--~~~----------------------~~~Ei~iL~~l~Hpn--I 657 (927)
.+.||+|+||.||+|...+++.||||+++...... ... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998889999999987542211 111 134555555554432 3
Q ss_pred cceecceeecCeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhh-CCCCceecCCCCCCCeEEC
Q 002409 658 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLD 736 (927)
Q Consensus 658 v~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDLkp~NILl~ 736 (927)
.+.++. ...++||||++++.+........ ... .....++.+++.++.++|. . +|+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~----~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV----RLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh----hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE
Confidence 333332 24589999999965432211110 001 4567889999999999999 6 999999999999999
Q ss_pred CCCcEEEEeecCcccc
Q 002409 737 KHMRAKVSDFGLSKFA 752 (927)
Q Consensus 737 ~~~~vkL~DFGla~~~ 752 (927)
++.++|+|||.+...
T Consensus 150 -~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 -DGKVYIIDVPQAVEI 164 (187)
T ss_pred -CCcEEEEECcccccc
Confidence 899999999998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.52 E-value=4.3e-15 Score=176.24 Aligned_cols=202 Identities=25% Similarity=0.311 Sum_probs=139.3
Q ss_pred hccccccCceEEEEEEECC-CcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCCch
Q 002409 604 EKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 682 (927)
Q Consensus 604 ~~~IG~G~fG~Vy~~~~~~-g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 682 (927)
.+.|..|+||.||..+++. .+..|+|+=+.+ .+.+- ++.....|.+| |+=
T Consensus 88 IklisngAygavylvrh~~trqrfa~kiNkq~------lilRn--ilt~a~npfvv---------------------gDc 138 (1205)
T KOG0606|consen 88 IKLISNGAYGAVYLVRHKETRQRFAMKINKQN------LILRN--ILTFAGNPFVV---------------------GDC 138 (1205)
T ss_pred eEeeccCCCCceeeeeccccccchhhcccccc------hhhhc--cccccCCccee---------------------chh
Confidence 5789999999999998874 556787542211 11110 23333334333 232
Q ss_pred hhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC------
Q 002409 683 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA------ 756 (927)
Q Consensus 683 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~------ 756 (927)
...+.. -+.++ .+++.+++|||+. +|+|||+||+|.+|+.-|++|++|||+++......
T Consensus 139 ~tllk~----~g~lP--------vdmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~e 203 (1205)
T KOG0606|consen 139 ATLLKN----IGPLP--------VDMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKE 203 (1205)
T ss_pred hhhccc----CCCCc--------chhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhh
Confidence 233321 11222 1337899999998 99999999999999999999999999987322110
Q ss_pred --------CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCc
Q 002409 757 --------SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 828 (927)
Q Consensus 757 --------~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 828 (927)
......++||+.|+|||++..+.|...+|.|++|+|+||.+.|+.||..+..++.+..++.......++
T Consensus 204 g~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~--- 280 (1205)
T KOG0606|consen 204 GHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE--- 280 (1205)
T ss_pred cchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc---
Confidence 111234679999999999999999999999999999999999999999887555555444422221111
Q ss_pred ccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCC
Q 002409 829 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP 864 (927)
Q Consensus 829 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP 864 (927)
+.....+..+++.+.++.+|..|-
T Consensus 281 ------------dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 281 ------------DEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred ------------CcCCCHHHHHHHHHHHHhChHhhc
Confidence 222234577888899999999987
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.1e-13 Score=135.22 Aligned_cols=134 Identities=25% Similarity=0.296 Sum_probs=113.1
Q ss_pred hccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccC--CCccceecceeecCeEEEEEEeccCCc
Q 002409 604 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH--RNLVQFLGYCQEEGRSVLVYEFMHNGT 681 (927)
Q Consensus 604 ~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~g~~~~~~~~~lV~E~~~~gs 681 (927)
.+.||+|.++.||+++..+ +.+++|....... ...+..|+.+++.++| ..+.+++++....+..++++||++++.
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 3679999999999999864 7899998865433 4678899999999977 588899988888888999999999877
Q ss_pred hhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccc
Q 002409 682 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 751 (927)
Q Consensus 682 L~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 751 (927)
+..+ +......++.++++++++||.....+++|+|++|+||+++..+.++++|||.++.
T Consensus 80 ~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 6543 4456677899999999999986445799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.45 E-value=5.3e-13 Score=142.31 Aligned_cols=135 Identities=18% Similarity=0.224 Sum_probs=104.3
Q ss_pred hcccc-ccCceEEEEEEECCCcEEEEEEeecCC-------------chhhHhHHHHHHHHhhccCCCc--cceecceeec
Q 002409 604 EKKIG-SGGFGVVYYGKLKDGKEIAVKVLTSNS-------------YQGKREFTNEVTLLSRIHHRNL--VQFLGYCQEE 667 (927)
Q Consensus 604 ~~~IG-~G~fG~Vy~~~~~~g~~VAVK~l~~~~-------------~~~~~~~~~Ei~iL~~l~HpnI--v~l~g~~~~~ 667 (927)
...|| .|+.|+||..... +..++||.+.... ......+.+|++++.+++|+++ .+.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35688 8999999999886 7889999875321 1223457889999999998885 6667664432
Q ss_pred C----eEEEEEEeccC-CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEE
Q 002409 668 G----RSVLVYEFMHN-GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAK 742 (927)
Q Consensus 668 ~----~~~lV~E~~~~-gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vk 742 (927)
. ..++|+|++++ .+|.+++.. ..++.. .+.+++.+|.+||+. ||+||||||.|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence 2 23599999997 688887742 223332 357899999999998 999999999999999989999
Q ss_pred EEeecCccc
Q 002409 743 VSDFGLSKF 751 (927)
Q Consensus 743 L~DFGla~~ 751 (927)
|+|||.++.
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999998864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.3e-14 Score=170.79 Aligned_cols=253 Identities=20% Similarity=0.272 Sum_probs=182.3
Q ss_pred HHhccccccCceEEEEEEECC--CcEEEEEEeecCC--chhhHhHHHHHHHHhhcc-CCCccceecceeecCeEEEEEEe
Q 002409 602 MLEKKIGSGGFGVVYYGKLKD--GKEIAVKVLTSNS--YQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~~--g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
.+.+.||+|.|+.|-...... ...+|+|.+.... .........|..+-..+. |+|++.+++.....+..+++.+|
T Consensus 23 ~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~ 102 (601)
T KOG0590|consen 23 KLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSY 102 (601)
T ss_pred cccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCc
Confidence 344669999999998876543 3345666654432 122333445777777776 99999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHh-hCCCCceecCCCCCCCeEECCCC-cEEEEeecCcccccC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH-TGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVD 754 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH-~~~~~~ivHrDLkp~NILl~~~~-~vkL~DFGla~~~~~ 754 (927)
..++++.+.+.. ......+....-..+.|+..++.|+| +. ++.||||||+|.+++..+ ..+++|||+|.....
T Consensus 103 s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 103 SDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccccccccccc--CCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999887731 11113445566678999999999999 76 999999999999999999 999999999986554
Q ss_pred --CCCceeeeecc-CCCccCccccccC-cCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCccc
Q 002409 755 --GASHVSSIVRG-TVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 830 (927)
Q Consensus 755 --~~~~~~~~~~g-t~~Y~aPE~~~~~-~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 830 (927)
+........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+....... .....|.... +...
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~--~~~~~~~~~~---~~~~- 251 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD--GRYSSWKSNK---GRFT- 251 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc--ccceeecccc---cccc-
Confidence 44444455668 9999999999885 44567899999999999999999997654221 1112222111 0000
Q ss_pred ccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 831 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 831 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
..... .......++..+++..+|..|.+.+++...
T Consensus 252 ---~~~~~----~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 252 ---QLPWN----SISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred ---cCccc----cCChhhhhcccccccCCchhcccccccccc
Confidence 00011 112246678888898999999999887654
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=7.8e-13 Score=139.08 Aligned_cols=204 Identities=23% Similarity=0.331 Sum_probs=144.0
Q ss_pred HHHhhccCCCccceecceeec-----CeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCC
Q 002409 647 TLLSRIHHRNLVQFLGYCQEE-----GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 721 (927)
Q Consensus 647 ~iL~~l~HpnIv~l~g~~~~~-----~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ 721 (927)
.-|-++.|.||++++.|+.+. .+..++.|||..|++..+|++.......+......+++.||..||.|||+ |.|
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence 345566799999999998654 35789999999999999998877667778888888999999999999999 678
Q ss_pred ceecCCCCCCCeEECCCCcEEEEeecCcccc---cCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh
Q 002409 722 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFA---VDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 798 (927)
Q Consensus 722 ~ivHrDLkp~NILl~~~~~vkL~DFGla~~~---~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt 798 (927)
.|+|+++..+-|++..++-+|+.--.-.... ............+-++|.+||+-.....+.++|||+||+..+||.-
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 9999999999999999998887421111000 0001111112236789999999887888889999999999999988
Q ss_pred CCCcccccccc-cccchhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 799 GQEAISNEKFG-ANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 799 G~~p~~~~~~~-~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
|..--...... ....++.. +....+ +. .-...+..|++..|..||+|++++.|
T Consensus 278 lEiq~tnseS~~~~ee~ia~-~i~~le-------------n~-------lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIAN-VIIGLE-------------NG-------LQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred heeccCCCcceeehhhhhhh-heeecc-------------Cc-------cccCcCcccccCCCCCCcchhhhhcC
Confidence 76432211100 00011111 000000 00 11245678999999999999998876
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.32 E-value=4.8e-12 Score=146.44 Aligned_cols=139 Identities=23% Similarity=0.287 Sum_probs=98.1
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeecCCchh----------------------------------------hHhHHH
Q 002409 605 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG----------------------------------------KREFTN 644 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~----------------------------------------~~~~~~ 644 (927)
+.||.|++|.||+|++++|+.||||+.+...... +-+|..
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5799999999999999999999999986542110 012445
Q ss_pred HHHHHhhcc-----CCCccceecce-eecCeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHh-HhHHHhh
Q 002409 645 EVTLLSRIH-----HRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-GIEYLHT 717 (927)
Q Consensus 645 Ei~iL~~l~-----HpnIv~l~g~~-~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~-gL~yLH~ 717 (927)
|.+.+.+++ ++++ .+-..+ ......+|||||++|++|.+..... .... .+..++.+++. .+..+|.
T Consensus 203 Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~---~~~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALD---EAGL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHH---hcCC---CHHHHHHHHHHHHHHHHHh
Confidence 665555552 2333 222222 2234578999999999998876321 1111 23456666666 4678898
Q ss_pred CCCCceecCCCCCCCeEECCCCcEEEEeecCccccc
Q 002409 718 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 753 (927)
Q Consensus 718 ~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 753 (927)
. |++|+|+||.||+++.+++++++|||++....
T Consensus 276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred C---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 7 99999999999999999999999999987543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.32 E-value=4.1e-12 Score=163.03 Aligned_cols=140 Identities=31% Similarity=0.615 Sum_probs=94.9
Q ss_pred CchHHHHHHHHhcC-----CCCcCCCCCCCCCCCCcceeecCCCCCCceEEEEecCCCCCccCCchhhcCCCCcEEeccC
Q 002409 373 GSIDAIVSVISLYS-----SADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDG 447 (927)
Q Consensus 373 ~~~dal~~~~~~~~-----~~~w~~~~~dpC~~~~~~~v~C~~~~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~ 447 (927)
.+++|+.++++.+. ..+|.. +.||| .|.||.|+. ..+++.|+|++|+++|.+|..+..|++|+.|+|++
T Consensus 29 ~~~~~l~~~~~~~~~~~~~~~~w~~-~~~~c---~w~gv~c~~--~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~ 102 (968)
T PLN00113 29 EELELLLSFKSSINDPLKYLSNWNS-SADVC---LWQGITCNN--SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSN 102 (968)
T ss_pred HHHHHHHHHHHhCCCCcccCCCCCC-CCCCC---cCcceecCC--CCcEEEEEecCCCccccCChHHhCCCCCCEEECCC
Confidence 56778999998863 467964 57888 799999975 34788888888888877777777777777777777
Q ss_pred CcCCCCCCC--CCCCCCccEEEecCCCcC----------------------CCCCccccCCCcccccccccccccccccc
Q 002409 448 NSLTGPIPD--FSGCPDLRIIHLEDNQLT----------------------GPLPSSLMNLPNLRELYVQNNMLSGTVPS 503 (927)
Q Consensus 448 N~l~g~~p~--~~~l~~L~~L~Ls~N~l~----------------------g~~P~~l~~l~~L~~L~l~~N~l~g~iP~ 503 (927)
|+++|.+|. +.++++|++|+|++|+++ +.+|..++++++|+.|+|++|.+++.+|.
T Consensus 103 n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~ 182 (968)
T PLN00113 103 NQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPN 182 (968)
T ss_pred CccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCCh
Confidence 777776664 335555555555555555 45555566666666666666666666665
Q ss_pred ccc--cccccccccCCc
Q 002409 504 SLL--SKNVVLNYAGNI 518 (927)
Q Consensus 504 ~l~--~~~~~l~~~~n~ 518 (927)
.+. +.+..+++.+|.
T Consensus 183 ~~~~l~~L~~L~L~~n~ 199 (968)
T PLN00113 183 SLTNLTSLEFLTLASNQ 199 (968)
T ss_pred hhhhCcCCCeeeccCCC
Confidence 542 334555555553
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.17 E-value=1e-10 Score=117.54 Aligned_cols=129 Identities=20% Similarity=0.160 Sum_probs=96.1
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccc-eecceeecCeEEEEEEeccCCchh
Q 002409 605 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQ-FLGYCQEEGRSVLVYEFMHNGTLK 683 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~-l~g~~~~~~~~~lV~E~~~~gsL~ 683 (927)
+.|+.|.++.||+++.. ++.+++|+...... ....+..|+++++.+.+.++++ ++.+. ....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 46889999999999876 78899998754422 2345688999999987666554 44332 33457999999998875
Q ss_pred hhcccccccccccCHHHHHHHHHHHHhHhHHHhhCC--CCceecCCCCCCCeEECCCCcEEEEeecCcc
Q 002409 684 EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC--VPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 750 (927)
Q Consensus 684 ~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 750 (927)
+.. . ....++.+++++|+.||+.. ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus 80 ~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 80 TED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 430 0 11235678999999999972 12369999999999999 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.15 E-value=7.1e-11 Score=138.38 Aligned_cols=139 Identities=19% Similarity=0.232 Sum_probs=89.1
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeecCCchh----------------------------------h------HhHH
Q 002409 605 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQG----------------------------------K------REFT 643 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~~-g~~VAVK~l~~~~~~~----------------------------------~------~~~~ 643 (927)
+.||+|++|.||+|++++ |++||||+++....+. . -++.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 579999999999999987 9999999997542110 0 1233
Q ss_pred HHHHHHhhcc----CCCccceecceee-cCeEEEEEEeccCCchhhhc--ccccccccccCHHHHHHHHHHHHhHhHHHh
Q 002409 644 NEVTLLSRIH----HRNLVQFLGYCQE-EGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLH 716 (927)
Q Consensus 644 ~Ei~iL~~l~----HpnIv~l~g~~~~-~~~~~lV~E~~~~gsL~~~L--~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 716 (927)
+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.+.- .........+.......++.|+ +
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------F 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------H
Confidence 4444444442 2332332222222 34567999999999997742 1110011123332333333333 4
Q ss_pred hCCCCceecCCCCCCCeEECCCC----cEEEEeecCccccc
Q 002409 717 TGCVPAIIHRDLKSSNILLDKHM----RAKVSDFGLSKFAV 753 (927)
Q Consensus 717 ~~~~~~ivHrDLkp~NILl~~~~----~vkL~DFGla~~~~ 753 (927)
.. |++|+|+||.||+++.++ +++++|||+.....
T Consensus 278 ~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 45 999999999999999988 99999999987553
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.4e-11 Score=136.69 Aligned_cols=254 Identities=21% Similarity=0.200 Sum_probs=182.1
Q ss_pred HHHHHHHHHHhccccc--cCceEEEEEEE--C-CCcEEEEEEeecC--CchhhHhHHHHHHHHhhc-cCCCccceeccee
Q 002409 594 SDIEDATKMLEKKIGS--GGFGVVYYGKL--K-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQ 665 (927)
Q Consensus 594 ~ei~~~~~~~~~~IG~--G~fG~Vy~~~~--~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~ 665 (927)
.+..+....+.+.+|. |.+|.+|.++. . ++..+|+|.-+.. .......=.+|+....++ .|+|.++....+.
T Consensus 109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e 188 (524)
T KOG0601|consen 109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE 188 (524)
T ss_pred cchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc
Confidence 4455556667788999 99999999977 3 6788999874322 223333334566666666 4999999999999
Q ss_pred ecCeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHh----HhHHHhhCCCCceecCCCCCCCeEECCC-Cc
Q 002409 666 EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK----GIEYLHTGCVPAIIHRDLKSSNILLDKH-MR 740 (927)
Q Consensus 666 ~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~----gL~yLH~~~~~~ivHrDLkp~NILl~~~-~~ 740 (927)
..+..++-+|++. .+|.++.+.. ...++....+....+..+ |+.++|.. .++|-|+||.||+...+ ..
T Consensus 189 ~~~~lfiqtE~~~-~sl~~~~~~~---~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s 261 (524)
T KOG0601|consen 189 GSGILFIQTELCG-ESLQSYCHTP---CNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTS 261 (524)
T ss_pred cCCcceeeecccc-chhHHhhhcc---cccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccce
Confidence 9999999999885 6888776543 233555666677777777 99999998 99999999999999999 89
Q ss_pred EEEEeecCcccccCCCCce----eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhh
Q 002409 741 AKVSDFGLSKFAVDGASHV----SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIV 816 (927)
Q Consensus 741 vkL~DFGla~~~~~~~~~~----~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~ 816 (927)
++++|||+.....+..... .....|...|++||... +.++.+.|+|++|.+..+..++......... .
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~-------~ 333 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKN-------S 333 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCC-------C
Confidence 9999999988766654222 22225788999999764 5678899999999999999998766543310 1
Q ss_pred HHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 817 QWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 817 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.|. ..+.+. +..++......++...+.+|++++|..|++..++..+
T Consensus 334 ~W~--~~r~~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 334 SWS--QLRQGY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred Ccc--cccccc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 121 111111 1122222222345558899999999999988877654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.2e-09 Score=123.87 Aligned_cols=167 Identities=19% Similarity=0.244 Sum_probs=124.3
Q ss_pred EECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCCchhhhcccccccccccCH
Q 002409 619 KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINW 698 (927)
Q Consensus 619 ~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~ 698 (927)
+..++.+|.|+..+...........+-++.|+.++||||++++.....++..|||+|.+. .|..++.. +..
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~~ 103 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LGK 103 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hHH
Confidence 344688999988876655445567788899999999999999999999999999999874 45555532 224
Q ss_pred HHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCceeeeeccCCCccCccccccC
Q 002409 699 IKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 778 (927)
Q Consensus 699 ~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~ 778 (927)
......+.||++||.|||+.| +++|++|.-.-|+++..|..||++|.+......... ......---.|..|+.+...
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCcc
Confidence 455667899999999999775 899999999999999999999999987753321111 00111112245666654322
Q ss_pred cCCCccceeeHHHHHHHHHhC
Q 002409 779 QLTDKSDVYSFGVILLELISG 799 (927)
Q Consensus 779 ~~s~~sDVwSlGvvL~elltG 799 (927)
. -..|.|-|||+++|++.|
T Consensus 181 ~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c--cchhhhhHHHHHHHHhCc
Confidence 2 235999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.8e-09 Score=110.65 Aligned_cols=135 Identities=19% Similarity=0.185 Sum_probs=96.0
Q ss_pred ccccccCceEEEEEEECC-------CcEEEEEEeecCCc----------------------hhhHh----HHHHHHHHhh
Q 002409 605 KKIGSGGFGVVYYGKLKD-------GKEIAVKVLTSNSY----------------------QGKRE----FTNEVTLLSR 651 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~~-------g~~VAVK~l~~~~~----------------------~~~~~----~~~Ei~iL~~ 651 (927)
..||.|.-+.||.|...+ +..+|||+.+.... ...+. .++|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997553 47999998753210 00112 2379999999
Q ss_pred ccC--CCccceecceeecCeEEEEEEeccCCchhh-hcccccccccccCHHHHHHHHHHHHhHhHHH-hhCCCCceecCC
Q 002409 652 IHH--RNLVQFLGYCQEEGRSVLVYEFMHNGTLKE-HLYGTLTHEQRINWIKRLEIAEDAAKGIEYL-HTGCVPAIIHRD 727 (927)
Q Consensus 652 l~H--pnIv~l~g~~~~~~~~~lV~E~~~~gsL~~-~L~~~~~~~~~l~~~~~~~i~~qia~gL~yL-H~~~~~~ivHrD 727 (927)
+.. -++.+++++ ...++||||+.+..+.. .+. ...++......+..+++.+|..| |+. +++|||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 854 344455543 45789999997653321 121 12234445567789999999999 777 999999
Q ss_pred CCCCCeEECCCCcEEEEeecCcccc
Q 002409 728 LKSSNILLDKHMRAKVSDFGLSKFA 752 (927)
Q Consensus 728 Lkp~NILl~~~~~vkL~DFGla~~~ 752 (927)
|++.|||++ ++.+.|+|||.+...
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCceeC
Confidence 999999997 468999999988644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.1e-11 Score=117.38 Aligned_cols=158 Identities=24% Similarity=0.381 Sum_probs=130.3
Q ss_pred ceeeeecccccccccCcccchhhhchhcccCCCchHHHHHHHHhcCCCCcCCCCCC--CCCCCCcceeecCCCCCCceEE
Q 002409 341 FVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDAIVSVISLYSSADWAQEGGD--PCLPVPWSWLQCNSDPQPSITV 418 (927)
Q Consensus 341 ~~~~~~~~~t~~s~lpPlina~e~~~~l~~~~~~~dal~~~~~~~~~~~w~~~~~d--pC~~~~~~~v~C~~~~~~~l~~ 418 (927)
..+++++.++.-+.+||-|..+...+++++.++.++.++.-++++....-.+-+.+ --.| .| .+..|.|++
T Consensus 34 ~ITrLtLSHNKl~~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~~lp---rg----fgs~p~lev 106 (264)
T KOG0617|consen 34 NITRLTLSHNKLTVVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLNILP---RG----FGSFPALEV 106 (264)
T ss_pred hhhhhhcccCceeecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhhcCc---cc----cCCCchhhh
Confidence 34566778999999999999999999999999998888777777653221111111 1111 12 235789999
Q ss_pred EEecCCCCC-ccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCcccccccccccc
Q 002409 419 IHLSSKNLT-GNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNML 497 (927)
Q Consensus 419 L~L~~n~l~-g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l 497 (927)
|||..|+|. ..+|..|.-|+.|+-|+|++|.|.-.+|+++.|++||.|.|..|.+- .+|.+++.|..|++|++++|.|
T Consensus 107 ldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl 185 (264)
T KOG0617|consen 107 LDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRL 185 (264)
T ss_pred hhccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccccee
Confidence 999999997 56899999999999999999999999999999999999999999988 8999999999999999999999
Q ss_pred cccccccccc
Q 002409 498 SGTVPSSLLS 507 (927)
Q Consensus 498 ~g~iP~~l~~ 507 (927)
+ .+|+++..
T Consensus 186 ~-vlppel~~ 194 (264)
T KOG0617|consen 186 T-VLPPELAN 194 (264)
T ss_pred e-ecChhhhh
Confidence 9 99998853
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.97 E-value=5.5e-09 Score=109.67 Aligned_cols=141 Identities=18% Similarity=0.337 Sum_probs=107.5
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeecCCc-hhhHhHHHHHHHHhhccCC--Cccceecceeec---CeEEEEEEecc
Q 002409 605 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHR--NLVQFLGYCQEE---GRSVLVYEFMH 678 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l~Hp--nIv~l~g~~~~~---~~~~lV~E~~~ 678 (927)
+.|+.|..+.+|++...+|+.+++|+...... .....+..|+++++.+++. ++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 46899999999999887778999998764322 1345788999999999764 456677776654 25689999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCC---------------------------------------
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC--------------------------------------- 719 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--------------------------------------- 719 (927)
+.++.+.+.. ..++......++.+++++|..||+..
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9888775521 23566666777888888888887521
Q ss_pred --------------CCceecCCCCCCCeEECC--CCcEEEEeecCcc
Q 002409 720 --------------VPAIIHRDLKSSNILLDK--HMRAKVSDFGLSK 750 (927)
Q Consensus 720 --------------~~~ivHrDLkp~NILl~~--~~~vkL~DFGla~ 750 (927)
...++|+|+++.||+++. ++.+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 246899999999999998 6678999999875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=6.2e-09 Score=103.17 Aligned_cols=131 Identities=24% Similarity=0.405 Sum_probs=102.2
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeecCCc---h-----hhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 605 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY---Q-----GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~---~-----~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
..+++|+-+.+|.+.+. |..+++|.-.+... + ......+|+.++.+++--.|...+-+..+.....++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999776 44566665332211 1 123467899999999877777777777888888999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccc
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 751 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 751 (927)
++|-.|.+.+... ...++..+-.-+.-||.. +|+|+||.++||++..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999998888432 245677788888899998 999999999999998765 99999999863
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.3e-08 Score=100.24 Aligned_cols=140 Identities=25% Similarity=0.274 Sum_probs=104.9
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeecCC--------chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 605 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS--------YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~--------~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
..|-+|+-+.|+++.+. |+...||.-.... .-..+...+|+++|.+++--.|.-..-++.+...-.|+|||
T Consensus 13 ~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred eeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 56889999999999988 7776777532211 11245678899999999776776666677777778899999
Q ss_pred ccC-CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCC---cEEEEeecCcc
Q 002409 677 MHN-GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM---RAKVSDFGLSK 750 (927)
Q Consensus 677 ~~~-gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~---~vkL~DFGla~ 750 (927)
+++ .++.+++...... .........++.++-+.+.-||.+ +|+||||..+||++..++ .+.++|||++.
T Consensus 92 ~~g~~~vk~~i~~~~~~--~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 92 IDGASTVKDFILSTMED--ESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred ccchhHHHHHHHHHccC--cccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence 976 4777877554321 222223357888899999999999 999999999999997665 35899999975
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.76 E-value=6.3e-09 Score=119.24 Aligned_cols=242 Identities=21% Similarity=0.210 Sum_probs=167.0
Q ss_pred HhccccccCceEEEEEEEC--CCcEEEEEEeecCCchh--hHhHHHHHHHHhhc-cCCCccceecceeecCeEEEEEEec
Q 002409 603 LEKKIGSGGFGVVYYGKLK--DGKEIAVKVLTSNSYQG--KREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 603 ~~~~IG~G~fG~Vy~~~~~--~g~~VAVK~l~~~~~~~--~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
+...||.|.|+.|++...+ ++..+++|.+.+..... ...-..|+.+...+ .|.++++....+..-...++=-|||
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~ 348 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFC 348 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhh
Confidence 3567999999999988644 56788999876553322 22234566666655 5788888776666666677899999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCC-CcEEEEeecCcccccCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~-~~vkL~DFGla~~~~~~~ 756 (927)
+++++...+ .-...++...++++..|++.++.++|+. .++|+|+||+||++..+ +..++.|||++..+.-..
T Consensus 349 ~~~s~~l~~----~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~ 421 (524)
T KOG0601|consen 349 EGGSSSLRS----VTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS 421 (524)
T ss_pred cCcchhhhh----HHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccccceec
Confidence 999887665 2244567778889999999999999997 99999999999999987 788999999986321110
Q ss_pred CceeeeeccCCCc-cCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCc
Q 002409 757 SHVSSIVRGTVGY-LDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 835 (927)
Q Consensus 757 ~~~~~~~~gt~~Y-~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 835 (927)
.....++..| .+++......+-.+.|++|||.-+.|..++..--... .+|.. +..+.+. .
T Consensus 422 ---~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~---------~~~~~--i~~~~~p-----~ 482 (524)
T KOG0601|consen 422 ---GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG---------VQSLT--IRSGDTP-----N 482 (524)
T ss_pred ---ccccccccccccchhhccccccccccccccccccccccccCcccCccc---------cccee--eeccccc-----C
Confidence 0111123334 3555555677888999999999999999886533221 12211 1111111 1
Q ss_pred ccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHH
Q 002409 836 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 875 (927)
Q Consensus 836 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~ 875 (927)
+.+ ....+..++..++.+++..||.+.+...+.+.
T Consensus 483 ~~~-----~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 483 LPG-----LKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred CCc-----hHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 111 11456778888999999999999888776654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.1e-07 Score=97.08 Aligned_cols=125 Identities=26% Similarity=0.319 Sum_probs=80.4
Q ss_pred EEEEEEECCCcEEEEEEeecCCch--------------------------hhHhHHHHHHHHhhccCCC--ccceeccee
Q 002409 614 VVYYGKLKDGKEIAVKVLTSNSYQ--------------------------GKREFTNEVTLLSRIHHRN--LVQFLGYCQ 665 (927)
Q Consensus 614 ~Vy~~~~~~g~~VAVK~l~~~~~~--------------------------~~~~~~~Ei~iL~~l~Hpn--Iv~l~g~~~ 665 (927)
.||.|...+|..+|||+.+..... ......+|++.|.++...+ +.+++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 489999988999999987542100 0124667999999997664 44555432
Q ss_pred ecCeEEEEEEecc--CCchhhhcccccccccccCHHHHHHHHHHHHhHhHH-HhhCCCCceecCCCCCCCeEECCCCcEE
Q 002409 666 EEGRSVLVYEFMH--NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY-LHTGCVPAIIHRDLKSSNILLDKHMRAK 742 (927)
Q Consensus 666 ~~~~~~lV~E~~~--~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~y-LH~~~~~~ivHrDLkp~NILl~~~~~vk 742 (927)
..++||||++ +..+..+.... ++......++.+++..+.. +|.. +|+||||.+.|||++++ .+.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 3579999998 55554432111 1122345567778776666 4676 99999999999999988 999
Q ss_pred EEeecCcccc
Q 002409 743 VSDFGLSKFA 752 (927)
Q Consensus 743 L~DFGla~~~ 752 (927)
++|||.+...
T Consensus 147 iIDf~qav~~ 156 (188)
T PF01163_consen 147 IIDFGQAVDS 156 (188)
T ss_dssp E--GTTEEET
T ss_pred EEecCcceec
Confidence 9999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.68 E-value=2.9e-09 Score=102.82 Aligned_cols=83 Identities=31% Similarity=0.456 Sum_probs=79.3
Q ss_pred CceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCcccccccc
Q 002409 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 493 (927)
Q Consensus 414 ~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~ 493 (927)
..++.|.|++|+|+ .+|+.|..|.+|+.|++++|++...++.++.+++|+.|+++-|++. .+|..|+.++.|+.|||.
T Consensus 33 s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldlt 110 (264)
T KOG0617|consen 33 SNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLT 110 (264)
T ss_pred hhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhcc
Confidence 46888999999999 8999999999999999999999999999999999999999999998 899999999999999999
Q ss_pred ccccc
Q 002409 494 NNMLS 498 (927)
Q Consensus 494 ~N~l~ 498 (927)
.|+|+
T Consensus 111 ynnl~ 115 (264)
T KOG0617|consen 111 YNNLN 115 (264)
T ss_pred ccccc
Confidence 99997
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.6e-06 Score=95.16 Aligned_cols=262 Identities=13% Similarity=0.146 Sum_probs=156.4
Q ss_pred hccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhc-cCCCccceecc------eeec-CeEEEEEE
Q 002409 604 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGY------CQEE-GRSVLVYE 675 (927)
Q Consensus 604 ~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~------~~~~-~~~~lV~E 675 (927)
.+.||+|+-+.+|-.--- +.. +-|+..........+. ++.|... .||-+-.-+.| ..++ ...-+.|+
T Consensus 16 gr~LgqGgea~ly~l~e~-~d~-VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV-RDQ-VAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CccccCCccceeeecchh-hch-hheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 467999999999954211 122 4477765543333322 2233333 56644331221 1122 22567777
Q ss_pred eccCCchhhhcccc---cccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccc
Q 002409 676 FMHNGTLKEHLYGT---LTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 752 (927)
Q Consensus 676 ~~~~gsL~~~L~~~---~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 752 (927)
.+.+.---..++.. .......+|...++++..+|.+.+.||+. |.+-+|+.++|+|+++++.+.|.|-..-...
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceeec
Confidence 77664221122221 12334478999999999999999999998 9999999999999999999999985533322
Q ss_pred cCCCCceeeeeccCCCccCccccc-----cCcCCCccceeeHHHHHHHHHhC-CCcccccccccccchhhHHHHhhhccC
Q 002409 753 VDGASHVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISG-QEAISNEKFGANCRNIVQWAKLHIESG 826 (927)
Q Consensus 753 ~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~~sDVwSlGvvL~elltG-~~p~~~~~~~~~~~~l~~~~~~~~~~~ 826 (927)
..+ .......|...|.+||... +-.-+...|-|.|||++++++.| +.||.+-......-.-.+ ..+..|
T Consensus 168 ~ng--~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E---~~Ia~g 242 (637)
T COG4248 168 ANG--TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE---TDIAHG 242 (637)
T ss_pred cCC--ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch---hhhhcc
Confidence 222 2223345889999999864 23456678999999999999886 899975331110000000 001112
Q ss_pred CcccccCCcc--c---CccCHH-HHHHHHHHHhhhcCC--CCCCCCcHHHHHHHHHHHHH
Q 002409 827 DIQGIIDPSL--L---DEYDIQ-SMWKIEEKALMCVLP--HGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 827 ~~~~~~d~~l--~---~~~~~~-~~~~l~~L~~~Cl~~--dP~~RPsm~eV~~~L~~~~~ 878 (927)
.+...-|.+. . .+.+.. -...+..|-.+|+.. .+.-||+++-.+..|.++..
T Consensus 243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 2211111111 0 011111 113456677788875 36789999999999887654
|
|
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=98.64 E-value=4.3e-08 Score=99.14 Aligned_cols=134 Identities=25% Similarity=0.436 Sum_probs=76.5
Q ss_pred eEecCCCCCccccCCCeEEccCCccccCcce--------------eeecCcc-cccccceeeeecCCCCcceeeecccCC
Q 002409 33 VSLNCGGNENFTDEIGLQWIADDHLIYGEIS--------------NISVANE-TRKQYMTLRHFPADSRKYCYKLDVITR 97 (927)
Q Consensus 33 ~~idcG~~~~~~~~~~~~~~~d~~~~~~~~~--------------~~~~~~~-~~~~~~tlR~Fp~~~~~~cy~l~~~~~ 97 (927)
+.|+||++.. +|..|+.|.+|..|..|... ....... ..+.++|-|+=| ....|.+|+.++
T Consensus 3 ~~IN~Gg~~~-~~~~g~~w~~D~~~~~g~~~y~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~---~~f~Y~ip~~~~ 78 (174)
T PF11721_consen 3 LRINAGGPAY-TDSSGIVWEADQYYTGGSWGYYVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGP---SSFSYDIPVVPN 78 (174)
T ss_dssp EEEEETSSSE-EETTTEEE-SSSSSTTSS-----------SSTTS--TTS-HHHHHTTT-----S---SSEEEEEE--S-
T ss_pred EEEECCCCcc-cCCCCCEEcCCCCCCCCCcccccccccccccccccccccCCCchhhhHhhcCCC---CceEEEEecCCC
Confidence 4799999998 88899999999999866551 0111111 124678999933 357999999999
Q ss_pred ceEEEeEEe---eecCcCCCCCCC---eeEEEECCce-eeEEeeC-CC--Cc-cEEEEE-EEEecCCCceEEEec-----
Q 002409 98 TRYLIRATF---LYGNFDNNNVYP---KFDISLGPTH-WSTIVIS-DA--AT-IEVREL-IFLASSPKIDVCLSN----- 160 (927)
Q Consensus 98 ~~ylvr~~f---~yg~~d~~~~~p---~fd~~~~~~~-w~~v~~~-~~--~~-~~~~e~-~~~~~~~~~~vcl~~----- 160 (927)
|.|-||+.| +++. ++....| +||+.++|+. ..-+++. .+ .. +...+. -+.+.+..+.++|..
T Consensus 79 G~Y~V~L~FaE~~~~~-~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~~~~~~v~v~dg~L~i~f~~~~~~~ 157 (174)
T PF11721_consen 79 GTYTVRLHFAELYFGA-SGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAVRRFFNVTVTDGTLNIQFVWAGKGT 157 (174)
T ss_dssp EEEEEEEEEE-SSS---------SSSS-EEEEETTEEEEEEE-HHHHHSSSS---EEEEEEEEEETTEEETTEEEE--SE
T ss_pred cEEEEEEEeccccccc-cccccCCCceEEEEEecceEEEeccCHHHHcCCCceEEEEEEEEEEEeCCcEEEEEEecCCCc
Confidence 999999999 3333 3333344 8999999963 2222221 11 11 233344 234578889999985
Q ss_pred ------CCCCCceeeee
Q 002409 161 ------ATTGQPFISTL 171 (927)
Q Consensus 161 ------~~~~~pfis~l 171 (927)
...+.|.||||
T Consensus 158 ~~i~~~~~~~~p~IsaI 174 (174)
T PF11721_consen 158 LCIPFIGSYGNPLISAI 174 (174)
T ss_dssp EEEEEESSSSSSSEEEE
T ss_pred EEeeccccCCCcEEeeC
Confidence 45667888886
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.64 E-value=3.4e-07 Score=102.82 Aligned_cols=169 Identities=21% Similarity=0.307 Sum_probs=128.7
Q ss_pred eEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceeccee----ecCeEEEEEEeccC-Cchhhhc
Q 002409 613 GVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ----EEGRSVLVYEFMHN-GTLKEHL 686 (927)
Q Consensus 613 G~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~----~~~~~~lV~E~~~~-gsL~~~L 686 (927)
.+.|++... ||..+++|+++.+..+.......-++.++++.|.|+|++.+++. .+..+++||+|.++ ++|.++-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 588999765 89999999996544333333445688899999999999999886 34568999999876 5777765
Q ss_pred ccc-----------cccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCC
Q 002409 687 YGT-----------LTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 687 ~~~-----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 755 (927)
... .......++...|.++.|+..||.++|+. |+.-+-|.+++||++.+.+++|+..|........
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 332 12345578899999999999999999998 9999999999999999999999888876544332
Q ss_pred CCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCc
Q 002409 756 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEA 802 (927)
Q Consensus 756 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p 802 (927)
.. |.+.. ..+-|.=.||.+++.|.+|..-
T Consensus 447 ~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 447 PT---------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CC---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 20 11211 1256778899999999999653
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.58 E-value=3.1e-08 Score=81.89 Aligned_cols=59 Identities=46% Similarity=0.616 Sum_probs=32.7
Q ss_pred CCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCcccccccccccc
Q 002409 439 SLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNML 497 (927)
Q Consensus 439 ~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l 497 (927)
+|+.|+|++|+|+...+. |.++++|++|+|++|+++...|..|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 455555555555544443 45555566666665555544444555666666666665553
|
... |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.58 E-value=5.8e-07 Score=97.21 Aligned_cols=140 Identities=14% Similarity=0.096 Sum_probs=99.1
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeecCCch-----------hhHhHHHHHHHHhhccCCCcc--ceecceee-----
Q 002409 605 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ-----------GKREFTNEVTLLSRIHHRNLV--QFLGYCQE----- 666 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~-----------~~~~~~~Ei~iL~~l~HpnIv--~l~g~~~~----- 666 (927)
+.+-.-....|.+..+. |+.+.||........ ....+.+|...+.++...+|. .++++...
T Consensus 28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 34444444557777664 788999976433211 011377899999888654443 44555533
Q ss_pred cCeEEEEEEeccCC-chhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECC-------C
Q 002409 667 EGRSVLVYEFMHNG-TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-------H 738 (927)
Q Consensus 667 ~~~~~lV~E~~~~g-sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~-------~ 738 (927)
....++|+|++++- +|.+++.... ....+...+..++.+++..+.-||.. ||+|+|++++|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence 23578999999875 7888874221 12344556678999999999999999 9999999999999975 4
Q ss_pred CcEEEEeecCcc
Q 002409 739 MRAKVSDFGLSK 750 (927)
Q Consensus 739 ~~vkL~DFGla~ 750 (927)
..+.++||+.++
T Consensus 182 ~~~~LIDl~r~~ 193 (268)
T PRK15123 182 LKLSVIDLHRAQ 193 (268)
T ss_pred ceEEEEECCccc
Confidence 689999999875
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.3e-08 Score=122.23 Aligned_cols=242 Identities=19% Similarity=0.185 Sum_probs=156.4
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEeecCCc---hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 604 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 604 ~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
.+.+-+|.++.+..++-. .|.-.++|+...... ...+....+-.++-..+||-++...--+.......|+++|..+
T Consensus 809 ~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~ 888 (1205)
T KOG0606|consen 809 TKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNG 888 (1205)
T ss_pred cccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhcc
Confidence 346788999988876543 233333443322211 1112222233333334567776665555567788999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCC----
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---- 755 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~---- 755 (927)
++|...|+..- ..+..-.......+.+.+++||.. .+.|+|++|.|+|...+++.+++|||........
T Consensus 889 ~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~ 961 (1205)
T KOG0606|consen 889 GDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTT 961 (1205)
T ss_pred CCchhhhhcCC----CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccCcC
Confidence 99988886432 223223334455678899999997 6899999999999999999999999843211100
Q ss_pred -C-------------------C------ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccc
Q 002409 756 -A-------------------S------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG 809 (927)
Q Consensus 756 -~-------------------~------~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~ 809 (927)
. . .......||+.|.+||...+......+|.|+.|++++|.++|..||.....+
T Consensus 962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq 1041 (1205)
T KOG0606|consen 962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQ 1041 (1205)
T ss_pred CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchh
Confidence 0 0 0112245899999999999999999999999999999999999999887755
Q ss_pred cccchhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHH
Q 002409 810 ANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSIS 867 (927)
Q Consensus 810 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~ 867 (927)
..++++... .+.. .....+......+++...+..+|.+|-.|.
T Consensus 1042 ~~f~ni~~~--------~~~~-------p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1042 QIFENILNR--------DIPW-------PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhhccccC--------CCCC-------CCCccccChhhhhhhhhhhccCchhccCcc
Confidence 555444331 1110 000111112345566677777777777766
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.8e-08 Score=113.82 Aligned_cols=148 Identities=21% Similarity=0.223 Sum_probs=98.1
Q ss_pred eecccccccccCcccchhhhchhcccCCCchHHHHHHHHhcC-CCCcCCCCCCCCCCCCcceeecCCCCCCceEEEEecC
Q 002409 345 FKFGKTYDSSRGPLLNAMEINKYLERNDGSIDAIVSVISLYS-SADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSS 423 (927)
Q Consensus 345 ~~~~~t~~s~lpPlina~e~~~~l~~~~~~~dal~~~~~~~~-~~~w~~~~~dpC~~~~~~~v~C~~~~~~~l~~L~L~~ 423 (927)
+.|..|.--.+|--+.++.-+..+...-+....+..-.+.++ +.+-.. .|.-+ ..+|+.-+.-.+..|+.||||+
T Consensus 37 LkLnrt~L~~vPeEL~~lqkLEHLs~~HN~L~~vhGELs~Lp~LRsv~~--R~N~L--KnsGiP~diF~l~dLt~lDLSh 112 (1255)
T KOG0444|consen 37 LKLNRTKLEQVPEELSRLQKLEHLSMAHNQLISVHGELSDLPRLRSVIV--RDNNL--KNSGIPTDIFRLKDLTILDLSH 112 (1255)
T ss_pred EEechhhhhhChHHHHHHhhhhhhhhhhhhhHhhhhhhccchhhHHHhh--hcccc--ccCCCCchhcccccceeeecch
Confidence 445566666677777776666655544332222211111110 000000 00000 1234443333456789999999
Q ss_pred CCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCccccccccccccc
Q 002409 424 KNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLS 498 (927)
Q Consensus 424 n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l~ 498 (927)
|+|. ..|..+..-+++..|+||+|+|..++.. +.+|+.|-+||||+|++. .+|+.+..|..|+.|.|++|.|.
T Consensus 113 NqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~ 186 (1255)
T KOG0444|consen 113 NQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLN 186 (1255)
T ss_pred hhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhh
Confidence 9999 8999999999999999999999865544 788999999999999998 88888999999999999999875
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=8e-07 Score=93.37 Aligned_cols=135 Identities=21% Similarity=0.242 Sum_probs=97.6
Q ss_pred HHHhccccccCceEEEEEEECCCcEEEEEEeecCCc----------------------hhhHhHHHHHHHHhhccCC--C
Q 002409 601 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY----------------------QGKREFTNEVTLLSRIHHR--N 656 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~----------------------~~~~~~~~Ei~iL~~l~Hp--n 656 (927)
+.+++.||.|.-+.||.|....|.++|||.=+.... ......++|.++|+++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 456789999999999999999999999996432100 0123467899999998654 5
Q ss_pred ccceecceeecCeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEEC
Q 002409 657 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD 736 (927)
Q Consensus 657 Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~ 736 (927)
|.+.+++ ++..+|||++++-.|...- ++....-.|+..|++-+..+-.. ||+|+|+.+-||+++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~ 236 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVT 236 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEe
Confidence 5555554 4678999999886554321 12223334555555655555565 999999999999999
Q ss_pred CCCcEEEEeecCccc
Q 002409 737 KHMRAKVSDFGLSKF 751 (927)
Q Consensus 737 ~~~~vkL~DFGla~~ 751 (927)
++|.+.++||-.+..
T Consensus 237 ~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 237 EDGDIVVIDWPQAVP 251 (304)
T ss_pred cCCCEEEEeCccccc
Confidence 999999999986653
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.2e-07 Score=78.29 Aligned_cols=60 Identities=38% Similarity=0.606 Sum_probs=54.2
Q ss_pred CceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCc
Q 002409 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQL 473 (927)
Q Consensus 414 ~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l 473 (927)
|+|+.|+|++|+|+..-+..+..+++|++|+|++|+++...|. |.++++|++|+|++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 5799999999999955556889999999999999999988876 89999999999999986
|
... |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.47 E-value=7.8e-08 Score=96.71 Aligned_cols=100 Identities=33% Similarity=0.530 Sum_probs=38.4
Q ss_pred ceEEEEecCCCCCccCCchhh-cCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccc-cCCCccccccc
Q 002409 415 SITVIHLSSKNLTGNIPSDLT-KLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSL-MNLPNLRELYV 492 (927)
Q Consensus 415 ~l~~L~L~~n~l~g~ip~~i~-~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l-~~l~~L~~L~l 492 (927)
+++.|+|.+|.|+ .|. .++ .|.+|+.|||++|.|+. ++.+..++.|+.|+|++|+|+ .+++.+ ..+++|+.|+|
T Consensus 20 ~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~-l~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L 95 (175)
T PF14580_consen 20 KLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITK-LEGLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYL 95 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---TT----TT--EEE--SS----S-CHHHHHH-TT--EEE-
T ss_pred ccccccccccccc-ccc-chhhhhcCCCEEECCCCCCcc-ccCccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEEC
Confidence 6899999999998 554 566 58899999999999995 567888999999999999999 566555 46899999999
Q ss_pred cccccccccc----cccccccccccccCCcc
Q 002409 493 QNNMLSGTVP----SSLLSKNVVLNYAGNIN 519 (927)
Q Consensus 493 ~~N~l~g~iP----~~l~~~~~~l~~~~n~~ 519 (927)
++|+|. .+- -+-++.+..+.+.|||-
T Consensus 96 ~~N~I~-~l~~l~~L~~l~~L~~L~L~~NPv 125 (175)
T PF14580_consen 96 SNNKIS-DLNELEPLSSLPKLRVLSLEGNPV 125 (175)
T ss_dssp TTS----SCCCCGGGGG-TT--EEE-TT-GG
T ss_pred cCCcCC-ChHHhHHHHcCCCcceeeccCCcc
Confidence 999997 332 22255667788899975
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.39 E-value=4.5e-08 Score=110.70 Aligned_cols=163 Identities=20% Similarity=0.276 Sum_probs=122.0
Q ss_pred ccccccccCcccchhhhchhcccCCCch----HHHHHHHHh--cCCCCcCCCCCCCCCCCCcceeecCCCCCCceEEEEe
Q 002409 348 GKTYDSSRGPLLNAMEINKYLERNDGSI----DAIVSVISL--YSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHL 421 (927)
Q Consensus 348 ~~t~~s~lpPlina~e~~~~l~~~~~~~----dal~~~~~~--~~~~~w~~~~~dpC~~~~~~~v~C~~~~~~~l~~L~L 421 (927)
+...-+.+||-|..+.++.-+.+..++. |.+-.+... +++++-...--.-|. +.-.+|+.|+|
T Consensus 207 TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp~vPecly~l~~LrrLNLS~N~iteL~~~~-----------~~W~~lEtLNl 275 (1255)
T KOG0444|consen 207 TQRTLDNIPTSLDDLHNLRDVDLSENNLPIVPECLYKLRNLRRLNLSGNKITELNMTE-----------GEWENLETLNL 275 (1255)
T ss_pred ccchhhcCCCchhhhhhhhhccccccCCCcchHHHhhhhhhheeccCcCceeeeeccH-----------HHHhhhhhhcc
Confidence 3444567888888888777766654433 333222221 223322111111221 11236889999
Q ss_pred cCCCCCccCCchhhcCCCCcEEeccCCcCC--CCCCCCCCCCCccEEEecCCCcCCCCCccccCCCcccccccccccccc
Q 002409 422 SSKNLTGNIPSDLTKLSSLVELWLDGNSLT--GPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSG 499 (927)
Q Consensus 422 ~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~--g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l~g 499 (927)
|.|+|+ .+|+.+++|++|+.|++.+|+|+ |.+..++.|.+|+++++++|++. ..|+.++.+..|+.|.|++|+|-
T Consensus 276 SrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi- 352 (1255)
T KOG0444|consen 276 SRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI- 352 (1255)
T ss_pred ccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-
Confidence 999999 89999999999999999999875 44445999999999999999998 89999999999999999999999
Q ss_pred cccccc--ccccccccccCCcccccCC
Q 002409 500 TVPSSL--LSKNVVLNYAGNINLHEGG 524 (927)
Q Consensus 500 ~iP~~l--~~~~~~l~~~~n~~l~~~~ 524 (927)
++|..+ +..+..|++..|+++.-++
T Consensus 353 TLPeaIHlL~~l~vLDlreNpnLVMPP 379 (1255)
T KOG0444|consen 353 TLPEAIHLLPDLKVLDLRENPNLVMPP 379 (1255)
T ss_pred echhhhhhcCCcceeeccCCcCccCCC
Confidence 999887 6677888999999997665
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.8e-07 Score=108.71 Aligned_cols=150 Identities=19% Similarity=0.343 Sum_probs=102.4
Q ss_pred HHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC--------ceeeeeccCCCccCcccccc
Q 002409 706 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS--------HVSSIVRGTVGYLDPEYYIS 777 (927)
Q Consensus 706 ~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~--------~~~~~~~gt~~Y~aPE~~~~ 777 (927)
.+++.||.|+|.. .++||++|.|++|.++..+..||+.|+.+........ .......-...|.|||++..
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 3455899999998 5999999999999999999999999998753322111 11111234568999999999
Q ss_pred CcCCCccceeeHHHHHHHHHhCCCc-ccccccccccchhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhc
Q 002409 778 QQLTDKSDVYSFGVILLELISGQEA-ISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCV 856 (927)
Q Consensus 778 ~~~s~~sDVwSlGvvL~elltG~~p-~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl 856 (927)
...+.++|+||+||++|.+..|..+ +.... ......... ..+..-.-.+..+.+.++.+=+.+++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~-~~~~~~~~~-------------~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANG-GLLSYSFSR-------------NLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccC-Ccchhhhhh-------------cccccccccccccCcHHHHHHHHHHh
Confidence 8889999999999999999955444 33322 111101110 01111111222345567888888999
Q ss_pred CCCCCCCCcHHHHHH
Q 002409 857 LPHGHMRPSISEVLK 871 (927)
Q Consensus 857 ~~dP~~RPsm~eV~~ 871 (927)
..++..||++.++..
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999998777654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.31 E-value=3e-06 Score=99.17 Aligned_cols=144 Identities=23% Similarity=0.269 Sum_probs=92.8
Q ss_pred HHHh-ccccccCceEEEEEEECCCcEEEEEEeecCCchh----------------------------------------h
Q 002409 601 KMLE-KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG----------------------------------------K 639 (927)
Q Consensus 601 ~~~~-~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~----------------------------------------~ 639 (927)
..|. +.|+.++-|.||+|++++|++||||+.+..-.+. +
T Consensus 126 ~eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~E 205 (517)
T COG0661 126 SEFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREE 205 (517)
T ss_pred HHcCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHH
Confidence 3443 6799999999999999999999999987542110 0
Q ss_pred HhHHHHHHHHhhcc-----CCCccceecceeecCeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhH-hH
Q 002409 640 REFTNEVTLLSRIH-----HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG-IE 713 (927)
Q Consensus 640 ~~~~~Ei~iL~~l~-----HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~g-L~ 713 (927)
-++..|...+.+++ .+++.-.--|..-.+...|+|||++|-.+.+...- +...++.. .++..++++ +.
T Consensus 206 lDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l---~~~g~d~k---~ia~~~~~~f~~ 279 (517)
T COG0661 206 LDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAAL---KSAGIDRK---ELAELLVRAFLR 279 (517)
T ss_pred hCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHH---HhcCCCHH---HHHHHHHHHHHH
Confidence 11334444444442 23332222222334567899999999888877421 11333422 233333332 23
Q ss_pred HHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccccc
Q 002409 714 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 753 (927)
Q Consensus 714 yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 753 (927)
.+-.. |++|.|.+|.||+++.++++.+.|||+.....
T Consensus 280 q~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 280 QLLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred HHHhc---CccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 33334 89999999999999999999999999986543
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.28 E-value=9.5e-08 Score=113.28 Aligned_cols=106 Identities=36% Similarity=0.465 Sum_probs=91.8
Q ss_pred CCceEEEEecCCCCCccCC-chhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCcccccc
Q 002409 413 QPSITVIHLSSKNLTGNIP-SDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 491 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~ip-~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~ 491 (927)
..+|+.|+|++|.|. .+| ..+.+|..|++|+||||+|+...-.+.+|..|++|..-+|+|. .+| .+..++.|+.+|
T Consensus 382 ~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lD 458 (1081)
T KOG0618|consen 382 FKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLTTLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLD 458 (1081)
T ss_pred ccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEe
Confidence 468999999999999 555 4788999999999999999977766999999999999999998 778 899999999999
Q ss_pred ccccccc-cccccccc-cccccccccCCcccc
Q 002409 492 VQNNMLS-GTVPSSLL-SKNVVLNYAGNINLH 521 (927)
Q Consensus 492 l~~N~l~-g~iP~~l~-~~~~~l~~~~n~~l~ 521 (927)
||.|+|+ +.+|..+- +.+..|+++||..+.
T Consensus 459 lS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~ 490 (1081)
T KOG0618|consen 459 LSCNNLSEVTLPEALPSPNLKYLDLSGNTRLV 490 (1081)
T ss_pred cccchhhhhhhhhhCCCcccceeeccCCcccc
Confidence 9999997 45566555 677889999998643
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.1e-05 Score=83.02 Aligned_cols=137 Identities=18% Similarity=0.185 Sum_probs=101.5
Q ss_pred ccccCceEEEEEEECCCcEEEEEEeecC---C---chhhHhHHHHHHHHhhccCCC--ccceeccee-e----cCeEEEE
Q 002409 607 IGSGGFGVVYYGKLKDGKEIAVKVLTSN---S---YQGKREFTNEVTLLSRIHHRN--LVQFLGYCQ-E----EGRSVLV 673 (927)
Q Consensus 607 IG~G~fG~Vy~~~~~~g~~VAVK~l~~~---~---~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~g~~~-~----~~~~~lV 673 (927)
-|+||-+.|++-.+. |+.+-+|.-... + +.+...|.+|+..|+++...+ +.+.+ ++. . .-..+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 477999999998776 557888876421 1 335678999999999996433 34444 332 1 1245899
Q ss_pred EEeccC-CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCc--EEEEeecCcc
Q 002409 674 YEFMHN-GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR--AKVSDFGLSK 750 (927)
Q Consensus 674 ~E~~~~-gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~--vkL~DFGla~ 750 (927)
+|-+.+ -+|.+++.+. ...+.+...+..+..++++.++-||+. ++.|+|+.+.|||++.++. ++++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 997764 5788877432 122446666778999999999999998 9999999999999986666 9999998765
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.23 E-value=7.4e-06 Score=85.51 Aligned_cols=106 Identities=26% Similarity=0.338 Sum_probs=82.0
Q ss_pred hHhHHHHHHHHhhccCCCc--cceecceeecC----eEEEEEEeccCC-chhhhcccccccccccCHHHHHHHHHHHHhH
Q 002409 639 KREFTNEVTLLSRIHHRNL--VQFLGYCQEEG----RSVLVYEFMHNG-TLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 711 (927)
Q Consensus 639 ~~~~~~Ei~iL~~l~HpnI--v~l~g~~~~~~----~~~lV~E~~~~g-sL~~~L~~~~~~~~~l~~~~~~~i~~qia~g 711 (927)
.....+|...+.++....| .+.+++..... ..++|+|++++- +|.+++.... ..+......++.+++..
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHH
Confidence 4467889888888864433 45566655432 458999999874 7888875321 14555667899999999
Q ss_pred hHHHhhCCCCceecCCCCCCCeEECCCC---cEEEEeecCccc
Q 002409 712 IEYLHTGCVPAIIHRDLKSSNILLDKHM---RAKVSDFGLSKF 751 (927)
Q Consensus 712 L~yLH~~~~~~ivHrDLkp~NILl~~~~---~vkL~DFGla~~ 751 (927)
++-||+. ||+|+|+++.|||++.+. .+.++||+.++.
T Consensus 131 i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 131 IAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999 999999999999999887 899999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.3e-07 Score=106.61 Aligned_cols=105 Identities=28% Similarity=0.349 Sum_probs=77.6
Q ss_pred CceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCc---cccCCCcccc
Q 002409 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPS---SLMNLPNLRE 489 (927)
Q Consensus 414 ~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~---~l~~l~~L~~ 489 (927)
++|..|+|++|+|+..-+..+.-|..|+.|+|++|+++-.-.. |..+++|+.|||++|.|++.|-+ .+..|++|+.
T Consensus 317 qkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~Lrk 396 (873)
T KOG4194|consen 317 QKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRK 396 (873)
T ss_pred ccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhh
Confidence 4788888888888855566777788888888888888766554 67788888888888888876654 3566788888
Q ss_pred ccccccccccccccccccc---cccccccCCcc
Q 002409 490 LYVQNNMLSGTVPSSLLSK---NVVLNYAGNIN 519 (927)
Q Consensus 490 L~l~~N~l~g~iP~~l~~~---~~~l~~~~n~~ 519 (927)
|.|.+|+|. +||..-+.. +..|++.+|..
T Consensus 397 L~l~gNqlk-~I~krAfsgl~~LE~LdL~~Nai 428 (873)
T KOG4194|consen 397 LRLTGNQLK-SIPKRAFSGLEALEHLDLGDNAI 428 (873)
T ss_pred eeecCceee-ecchhhhccCcccceecCCCCcc
Confidence 888888888 777766443 35566667753
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.8e-07 Score=101.56 Aligned_cols=105 Identities=29% Similarity=0.347 Sum_probs=72.1
Q ss_pred CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCcccccc
Q 002409 413 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 491 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~ 491 (927)
.++|+.|+|++|-|. .+|.+++.+..|+.||||.|+|.. +|. +-.+..|+.+-.++|++...-|+.+.+|.+|..||
T Consensus 434 l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr~-lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLD 511 (565)
T KOG0472|consen 434 LQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFRM-LPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLD 511 (565)
T ss_pred hhcceeeecccchhh-hcchhhhhhhhhheeccccccccc-chHHHhhHHHHHHHHhccccccccChHHhhhhhhcceec
Confidence 578999999999998 899999999999999999998764 343 33344455555555666533333366666777777
Q ss_pred ccccccccccccccccc--cccccccCCccc
Q 002409 492 VQNNMLSGTVPSSLLSK--NVVLNYAGNINL 520 (927)
Q Consensus 492 l~~N~l~g~iP~~l~~~--~~~l~~~~n~~l 520 (927)
|++|.|. +||+.+.++ +..+.+.||+..
T Consensus 512 L~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 512 LQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred cCCCchh-hCChhhccccceeEEEecCCccC
Confidence 7777766 666666443 355666666543
|
|
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.3e-06 Score=88.30 Aligned_cols=115 Identities=18% Similarity=0.197 Sum_probs=61.1
Q ss_pred EeeeccCCCCCCCccCCCCCCCCccccCccccccccccccCcc-cccccccccCCCCCCCChHHHHhhcccccCCceEEe
Q 002409 194 SARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGT-EKVSTKLPIDLRSDELPPQKVMQTAVVGTNGSLTYR 272 (927)
Q Consensus 194 ~~r~~~g~~~~~~iryp~D~~dR~W~p~~~~~~~~~~~~~~~~-~~~st~~~i~~~~~~~pP~~V~qtA~t~~~~~l~~~ 272 (927)
+.|.|+|+. .| .|..++.|+++.......+ ....+. .+.. .........+..+..+|||+=.+.+ ++.|.
T Consensus 2 ~~~IN~Gg~-----~~-~~~~g~~w~~D~~~~~g~~-~y~~~~~~~~~-~~~~~~~i~~t~d~~Lyqt~R~g~~-~f~Y~ 72 (174)
T PF11721_consen 2 VLRINAGGP-----AY-TDSSGIVWEADQYYTGGSW-GYYVSSDNNGS-TSSTNSSIPGTTDDPLYQTERYGPS-SFSYD 72 (174)
T ss_dssp EEEEEETSS-----SE-EETTTEEE-SSSSSTTSS------------S-STTS--TTS-HHHHHTTT-----SS-SEEEE
T ss_pred EEEEECCCC-----cc-cCCCCCEEcCCCCCCCCCc-ccccccccccc-cccccccccCCCchhhhHhhcCCCC-ceEEE
Confidence 468999982 34 8999999999876543332 000000 0000 0111122345567899999977543 67888
Q ss_pred ecCCCCCCcceeEEeeccccCCC-----CCcceEEEEEECCccccccceec
Q 002409 273 LNLDGFPGFGWAVTYFAEIEDLD-----PDESRKFRLVLPGQPDVSKAIVN 318 (927)
Q Consensus 273 ~~~~~~~~~~y~~~yFae~~~~~-----~~~~R~F~i~in~~~~~~~~~~~ 318 (927)
+|..+.-.| -+.|||||+..-. ..+.|+|||+|||+.+.+++++.
T Consensus 73 ip~~~~G~Y-~V~L~FaE~~~~~~~~~~~~G~RvFdV~v~g~~vl~~~Di~ 122 (174)
T PF11721_consen 73 IPVVPNGTY-TVRLHFAELYFGASGGASGPGQRVFDVYVNGETVLKNFDIY 122 (174)
T ss_dssp EE--S-EEE-EEEEEEE-SSS--------SSSS-EEEEETTEEEEEEE-HH
T ss_pred EecCCCcEE-EEEEEeccccccccccccCCCceEEEEEecceEEEeccCHH
Confidence 872222222 3689999987533 37799999999999988876554
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.17 E-value=8.1e-07 Score=89.44 Aligned_cols=84 Identities=25% Similarity=0.383 Sum_probs=42.0
Q ss_pred CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCC-CCCCCccEEEecCCCcCCCC-CccccCCCccccc
Q 002409 413 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF-SGCPDLRIIHLEDNQLTGPL-PSSLMNLPNLREL 490 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~-~~l~~L~~L~Ls~N~l~g~~-P~~l~~l~~L~~L 490 (927)
..+|+.|||++|+|+ .++ .+..|+.|+.|+|++|+|+..-+.+ ..+++|+.|+|++|+|...- -..+..+++|+.|
T Consensus 41 l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L 118 (175)
T PF14580_consen 41 LDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVL 118 (175)
T ss_dssp -TT--EEE-TTS--S---T-T----TT--EEE--SS---S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EE
T ss_pred hcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCccee
Confidence 458999999999999 565 5888999999999999999765544 36899999999999997421 1467889999999
Q ss_pred cccccccc
Q 002409 491 YVQNNMLS 498 (927)
Q Consensus 491 ~l~~N~l~ 498 (927)
+|.+|.++
T Consensus 119 ~L~~NPv~ 126 (175)
T PF14580_consen 119 SLEGNPVC 126 (175)
T ss_dssp E-TT-GGG
T ss_pred eccCCccc
Confidence 99999998
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.09 E-value=3e-06 Score=96.01 Aligned_cols=103 Identities=28% Similarity=0.353 Sum_probs=86.7
Q ss_pred ceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCC-CCCccEEEecCCCcCCCCCccccCCCcccccccc
Q 002409 415 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSG-CPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 493 (927)
Q Consensus 415 ~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~-l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~ 493 (927)
..+.|||++|.|+-.-+..|-+|++|+.++|..|.|+ .||.++. ..+|+.|+|.+|.|+..--+++..++.|+.||||
T Consensus 79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS 157 (873)
T KOG4194|consen 79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS 157 (873)
T ss_pred ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence 3567999999999777888999999999999999997 6787776 5569999999999997777889999999999999
Q ss_pred ccccccccccccccc---cccccccCCcc
Q 002409 494 NNMLSGTVPSSLLSK---NVVLNYAGNIN 519 (927)
Q Consensus 494 ~N~l~g~iP~~l~~~---~~~l~~~~n~~ 519 (927)
.|.|+ .||..-++. ...|++++|..
T Consensus 158 rN~is-~i~~~sfp~~~ni~~L~La~N~I 185 (873)
T KOG4194|consen 158 RNLIS-EIPKPSFPAKVNIKKLNLASNRI 185 (873)
T ss_pred hchhh-cccCCCCCCCCCceEEeeccccc
Confidence 99999 888776654 25566677743
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.07 E-value=3.4e-07 Score=99.41 Aligned_cols=105 Identities=24% Similarity=0.370 Sum_probs=93.1
Q ss_pred CCCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCcccccc
Q 002409 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 491 (927)
Q Consensus 412 ~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~ 491 (927)
++..+++|++++|+++ ++|++|+.+..|+.|+.++|+++..++.+.++.+|..|++++|.+. .+|++++.+..|..|+
T Consensus 66 nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~ 143 (565)
T KOG0472|consen 66 NLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLSELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLD 143 (565)
T ss_pred cccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHhhccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhh
Confidence 3566899999999999 8999999999999999999999998889999999999999999998 8999999999999999
Q ss_pred ccccccccccccccccc--cccccccCCcc
Q 002409 492 VQNNMLSGTVPSSLLSK--NVVLNYAGNIN 519 (927)
Q Consensus 492 l~~N~l~g~iP~~l~~~--~~~l~~~~n~~ 519 (927)
..+|+++ ++|..+... +..+...+|.-
T Consensus 144 ~~~N~i~-slp~~~~~~~~l~~l~~~~n~l 172 (565)
T KOG0472|consen 144 ATNNQIS-SLPEDMVNLSKLSKLDLEGNKL 172 (565)
T ss_pred ccccccc-cCchHHHHHHHHHHhhccccch
Confidence 9999999 888887554 35566677743
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.06 E-value=2.1e-06 Score=104.77 Aligned_cols=73 Identities=37% Similarity=0.528 Sum_probs=44.1
Q ss_pred CCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCccccccccccccccccccccc--ccccccccc
Q 002409 438 SSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL--SKNVVLNYA 515 (927)
Q Consensus 438 ~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l~g~iP~~l~--~~~~~l~~~ 515 (927)
.+|+.|+|++|+|++ +|.. .++|+.|+|++|+|+ .+|... .+|+.|+|++|+|+ .+|.++. ..+..++++
T Consensus 382 ~~L~~LdLs~N~Lt~-LP~l--~s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs 453 (788)
T PRK15387 382 SGLKELIVSGNRLTS-LPVL--PSELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE 453 (788)
T ss_pred cccceEEecCCcccC-CCCc--ccCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECC
Confidence 356677777777765 3322 245677777777776 356432 35666777777777 6776653 334555666
Q ss_pred CCc
Q 002409 516 GNI 518 (927)
Q Consensus 516 ~n~ 518 (927)
+|+
T Consensus 454 ~N~ 456 (788)
T PRK15387 454 GNP 456 (788)
T ss_pred CCC
Confidence 664
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.05 E-value=5e-06 Score=101.90 Aligned_cols=95 Identities=25% Similarity=0.390 Sum_probs=55.7
Q ss_pred CceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCcccccccc
Q 002409 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 493 (927)
Q Consensus 414 ~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~ 493 (927)
+.|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|++.+..+. .+|+.|+|++|+++ .+|..+. ++|+.|+|+
T Consensus 199 ~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~LtsLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls 270 (754)
T PRK15370 199 EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLTSIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLF 270 (754)
T ss_pred cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccccCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECc
Confidence 35677777777777 5666554 467777777777764322222 34666666666665 5555443 356666666
Q ss_pred ccccccccccccccccccccccCC
Q 002409 494 NNMLSGTVPSSLLSKNVVLNYAGN 517 (927)
Q Consensus 494 ~N~l~g~iP~~l~~~~~~l~~~~n 517 (927)
+|+|+ .+|..+...+..|.+++|
T Consensus 271 ~N~L~-~LP~~l~~sL~~L~Ls~N 293 (754)
T PRK15370 271 HNKIS-CLPENLPEELRYLSVYDN 293 (754)
T ss_pred CCccC-ccccccCCCCcEEECCCC
Confidence 66666 455555544555555554
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.03 E-value=4.7e-05 Score=80.59 Aligned_cols=138 Identities=15% Similarity=0.224 Sum_probs=84.2
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCc--cceecceeecCeEEEEEEeccCCc-
Q 002409 605 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL--VQFLGYCQEEGRSVLVYEFMHNGT- 681 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnI--v~l~g~~~~~~~~~lV~E~~~~gs- 681 (927)
..||+|..+.||+. .+..+++|..+... ......+|.++++.+..-.+ .+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999983 25567788876432 33457889999999865444 566777777777889999999863
Q ss_pred hhhhc---------------------ccccccccccCHHHHH-HHHH----------HHHh-HhHHHhhC-CCCceecCC
Q 002409 682 LKEHL---------------------YGTLTHEQRINWIKRL-EIAE----------DAAK-GIEYLHTG-CVPAIIHRD 727 (927)
Q Consensus 682 L~~~L---------------------~~~~~~~~~l~~~~~~-~i~~----------qia~-gL~yLH~~-~~~~ivHrD 727 (927)
+.+.+ |........+ .... .+-. .+.. ...+|... ..+.++|+|
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l--~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTF--QSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcH--HHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 21111 1100000001 0000 0000 0001 12222211 123678999
Q ss_pred CCCCCeEECCCCcEEEEeecCcc
Q 002409 728 LKSSNILLDKHMRAKVSDFGLSK 750 (927)
Q Consensus 728 Lkp~NILl~~~~~vkL~DFGla~ 750 (927)
+.|.||++++++ +.|+||+.+.
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcC
Confidence 999999999888 9999999764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.03 E-value=2.4e-06 Score=98.38 Aligned_cols=182 Identities=16% Similarity=0.169 Sum_probs=133.6
Q ss_pred hccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCC-ccceecceeecCeEEEEEEeccCC-c
Q 002409 604 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN-LVQFLGYCQEEGRSVLVYEFMHNG-T 681 (927)
Q Consensus 604 ~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~g~~~~~~~~~lV~E~~~~g-s 681 (927)
-+.+++|++++++|.+....+....+.+... ....-++++|.+++||| .+..++-+..+....++++++.++ +
T Consensus 247 fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs 321 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS 321 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence 3557899999999987654444445554322 34556889999999999 777777777888899999999887 2
Q ss_pred hhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCceee
Q 002409 682 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 761 (927)
Q Consensus 682 L~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 761 (927)
-.... ......+...+...+...-++++++||+. .=+|+| ||+..+ +..|..||+....+.... ...
T Consensus 322 ~~~~~---~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~ 388 (829)
T KOG0576|consen 322 SALEM---TVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPR 388 (829)
T ss_pred ccccC---ChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--ccc
Confidence 22211 12233445555566777788999999986 347898 777766 678999999876544332 234
Q ss_pred eeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcc
Q 002409 762 IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAI 803 (927)
Q Consensus 762 ~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~ 803 (927)
...+|+.++|||+.....+..+.|+|++|+--.+|--|-.|-
T Consensus 389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred cCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 456899999999999999999999999998777777776654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.01 E-value=6.4e-05 Score=78.57 Aligned_cols=137 Identities=21% Similarity=0.250 Sum_probs=91.1
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeecCCchhh------------------------HhHHHHHHHHhhccC--CCcc
Q 002409 605 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK------------------------REFTNEVTLLSRIHH--RNLV 658 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~------------------------~~~~~Ei~iL~~l~H--pnIv 658 (927)
-.|+.|.-+.||+|.-.++..+|||+.+....... ....+|+..|+++.. -.+.
T Consensus 54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 35778888999999988899999999875422111 113456666666632 2223
Q ss_pred ceecceeecCeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCC
Q 002409 659 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH 738 (927)
Q Consensus 659 ~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~ 738 (927)
+.+++. ...|||||+...-. -........+.......+..++++.+.-|-..+ ++||+||..-|||+. +
T Consensus 134 ~Pi~~~----~nVLvMEfIg~~g~----pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a--~LVHgDLSEyNiL~~-~ 202 (268)
T COG1718 134 EPIAFR----NNVLVMEFIGDDGL----PAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEA--GLVHGDLSEYNILVH-D 202 (268)
T ss_pred Cceeec----CCeEEEEeccCCCC----CCCCcccCCcCchhHHHHHHHHHHHHHHHHHhc--CcccccchhhheEEE-C
Confidence 333333 34799999865311 011111122222256667788888888887742 899999999999999 8
Q ss_pred CcEEEEeecCcccc
Q 002409 739 MRAKVSDFGLSKFA 752 (927)
Q Consensus 739 ~~vkL~DFGla~~~ 752 (927)
+.+.++|+|.|...
T Consensus 203 ~~p~iID~~QaV~~ 216 (268)
T COG1718 203 GEPYIIDVSQAVTI 216 (268)
T ss_pred CeEEEEECcccccc
Confidence 89999999988644
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.00 E-value=9.1e-06 Score=105.83 Aligned_cols=107 Identities=23% Similarity=0.319 Sum_probs=91.9
Q ss_pred CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCccccccc
Q 002409 413 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 492 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 492 (927)
..+|+.|+|.+|+|. .+|..+..|++|+.|+|++|...+.+|+++.+++|+.|+|++|.....+|.++.+|++|+.|+|
T Consensus 610 ~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L 688 (1153)
T PLN03210 610 PENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPDLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDM 688 (1153)
T ss_pred ccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCccccCCcccEEEecCCCCccccchhhhccCCCCEEeC
Confidence 357999999999998 7899999999999999999987788999999999999999998877799999999999999999
Q ss_pred ccccccccccccc-ccccccccccCCccc
Q 002409 493 QNNMLSGTVPSSL-LSKNVVLNYAGNINL 520 (927)
Q Consensus 493 ~~N~l~g~iP~~l-~~~~~~l~~~~n~~l 520 (927)
++|..-+.+|..+ ++.+..+.+.||..+
T Consensus 689 ~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~L 717 (1153)
T PLN03210 689 SRCENLEILPTGINLKSLYRLNLSGCSRL 717 (1153)
T ss_pred CCCCCcCccCCcCCCCCCCEEeCCCCCCc
Confidence 9976555888876 445566777776543
|
syringae 6; Provisional |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.96 E-value=4.6e-05 Score=89.02 Aligned_cols=141 Identities=18% Similarity=0.183 Sum_probs=88.3
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeecCCchh-------------------------------------hHhHHHHHH
Q 002409 605 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-------------------------------------KREFTNEVT 647 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~-------------------------------------~~~~~~Ei~ 647 (927)
+.||.-..|.||+|++++|+.||||+-+..-... +-+|..|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6799999999999999999999999976432110 012344444
Q ss_pred HHhhc----cCCCccc---eecc-eeecCeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCC
Q 002409 648 LLSRI----HHRNLVQ---FLGY-CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 719 (927)
Q Consensus 648 iL~~l----~HpnIv~---l~g~-~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 719 (927)
...++ .|-+... +=.+ ..-.....|+||||+|..+.|.-.- ....++...+ +..+.++...+ -.
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i---~~~gi~~~~i---~~~l~~~~~~q--If 318 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI---DKRGISPHDI---LNKLVEAYLEQ--IF 318 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH---HHcCCCHHHH---HHHHHHHHHHH--HH
Confidence 44333 3444111 1111 2223467899999999888775321 2233444433 33333332221 11
Q ss_pred CCceecCCCCCCCeEECC----CCcEEEEeecCccccc
Q 002409 720 VPAIIHRDLKSSNILLDK----HMRAKVSDFGLSKFAV 753 (927)
Q Consensus 720 ~~~ivHrDLkp~NILl~~----~~~vkL~DFGla~~~~ 753 (927)
..|++|+|-+|.||++.. ++++.+-|||+.....
T Consensus 319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred hcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 128999999999999983 6789999999986543
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=97.94 E-value=8.4e-06 Score=99.93 Aligned_cols=96 Identities=28% Similarity=0.391 Sum_probs=77.1
Q ss_pred CceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCcccccccc
Q 002409 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 493 (927)
Q Consensus 414 ~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~ 493 (927)
..|+.|+|++|++. .+|..+. ++|+.|+|++|+|+..+..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|+
T Consensus 241 ~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls 312 (754)
T PRK15370 241 DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKISCLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQ 312 (754)
T ss_pred ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccCccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhc
Confidence 36899999999998 7888775 589999999999996433343 58999999999999 5776654 479999999
Q ss_pred ccccccccccccccccccccccCCc
Q 002409 494 NNMLSGTVPSSLLSKNVVLNYAGNI 518 (927)
Q Consensus 494 ~N~l~g~iP~~l~~~~~~l~~~~n~ 518 (927)
+|+|+ .+|..+...+..|.+..|.
T Consensus 313 ~N~Lt-~LP~~l~~sL~~L~Ls~N~ 336 (754)
T PRK15370 313 SNSLT-ALPETLPPGLKTLEAGENA 336 (754)
T ss_pred CCccc-cCCccccccceeccccCCc
Confidence 99999 6888777777777777764
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.93 E-value=2.1e-06 Score=102.27 Aligned_cols=100 Identities=26% Similarity=0.380 Sum_probs=88.0
Q ss_pred ceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCccccccccc
Q 002409 415 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 494 (927)
Q Consensus 415 ~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~ 494 (927)
.|+.|||++|.++ ..|..|..+.+|+.|+++.|.+...+-+.+++++|++|+|.+|++. .+|.++..+++|+.|+++.
T Consensus 46 ~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~ 123 (1081)
T KOG0618|consen 46 KLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIRSVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSF 123 (1081)
T ss_pred eeEEeeccccccc-cCCchhhhHHHHhhcccchhhHhhCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccch
Confidence 4899999999998 8999999999999999999999987777889999999999999998 8999999999999999999
Q ss_pred cccccccccccccc--cccccccCC
Q 002409 495 NMLSGTVPSSLLSK--NVVLNYAGN 517 (927)
Q Consensus 495 N~l~g~iP~~l~~~--~~~l~~~~n 517 (927)
|++. .+|..+... ...+.+.+|
T Consensus 124 N~f~-~~Pl~i~~lt~~~~~~~s~N 147 (1081)
T KOG0618|consen 124 NHFG-PIPLVIEVLTAEEELAASNN 147 (1081)
T ss_pred hccC-CCchhHHhhhHHHHHhhhcc
Confidence 9998 899887433 345556666
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=97.93 E-value=1e-05 Score=98.77 Aligned_cols=92 Identities=29% Similarity=0.440 Sum_probs=62.2
Q ss_pred CceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCcccccccc
Q 002409 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 493 (927)
Q Consensus 414 ~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~ 493 (927)
.+|+.|+|++|+|+ .+|.. ..+|+.|++++|+|++ +|.+ +.+|+.|+|++|+|+ .+|.. .++|+.|+|+
T Consensus 342 ~~Lq~LdLS~N~Ls-~LP~l---p~~L~~L~Ls~N~L~~-LP~l--~~~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS 410 (788)
T PRK15387 342 SGLQELSVSDNQLA-SLPTL---PSELYKLWAYNNRLTS-LPAL--PSGLKELIVSGNRLT-SLPVL---PSELKELMVS 410 (788)
T ss_pred cccceEecCCCccC-CCCCC---Ccccceehhhcccccc-Cccc--ccccceEEecCCccc-CCCCc---ccCCCEEEcc
Confidence 36778888888888 46653 2466777888888875 5543 356888888888888 46653 2567888888
Q ss_pred ccccccccccccccccccccccCCc
Q 002409 494 NNMLSGTVPSSLLSKNVVLNYAGNI 518 (927)
Q Consensus 494 ~N~l~g~iP~~l~~~~~~l~~~~n~ 518 (927)
+|+|+ .+|.. ...+..+.+..|.
T Consensus 411 ~N~Ls-sIP~l-~~~L~~L~Ls~Nq 433 (788)
T PRK15387 411 GNRLT-SLPML-PSGLLSLSVYRNQ 433 (788)
T ss_pred CCcCC-CCCcc-hhhhhhhhhccCc
Confidence 88888 57753 3344455555553
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.92 E-value=1.3e-06 Score=99.01 Aligned_cols=101 Identities=25% Similarity=0.340 Sum_probs=73.4
Q ss_pred ceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCccccccccc
Q 002409 415 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 494 (927)
Q Consensus 415 ~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~ 494 (927)
-|..|-+++|+|+ .+|++|+.+..|..||.+.|.+...++.+.+|.+|+.|++..|++. .+|+++..| .|..||+|+
T Consensus 144 pLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfSc 220 (722)
T KOG0532|consen 144 PLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSC 220 (722)
T ss_pred cceeEEEecCccc-cCCcccccchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeeccc
Confidence 3777788888887 7888888777888888888888877777777777777777777776 667777655 367777777
Q ss_pred ccccccccccccc--ccccccccCCcc
Q 002409 495 NMLSGTVPSSLLS--KNVVLNYAGNIN 519 (927)
Q Consensus 495 N~l~g~iP~~l~~--~~~~l~~~~n~~ 519 (927)
|+++ .||.++.. .++.+.++.|+-
T Consensus 221 Nkis-~iPv~fr~m~~Lq~l~LenNPL 246 (722)
T KOG0532|consen 221 NKIS-YLPVDFRKMRHLQVLQLENNPL 246 (722)
T ss_pred Ccee-ecchhhhhhhhheeeeeccCCC
Confidence 7777 77777643 345566666653
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00013 Score=76.84 Aligned_cols=143 Identities=19% Similarity=0.228 Sum_probs=84.4
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCC--ccceeccee---ecCeEEEEEEeccC
Q 002409 605 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN--LVQFLGYCQ---EEGRSVLVYEFMHN 679 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~g~~~---~~~~~~lV~E~~~~ 679 (927)
+.|+.|..+.||+....+ +.+++|..... .....+.+|..+++.+.... +.+++.++. .....+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 568999999999999886 69999986543 44667889999998886443 345565432 23356899999999
Q ss_pred Cchhh----------------hc---ccccccccccCHHH---------HHH------------HHHHHHh-HhHHHhhC
Q 002409 680 GTLKE----------------HL---YGTLTHEQRINWIK---------RLE------------IAEDAAK-GIEYLHTG 718 (927)
Q Consensus 680 gsL~~----------------~L---~~~~~~~~~l~~~~---------~~~------------i~~qia~-gL~yLH~~ 718 (927)
..+.. .+ +..........+.. ... ....+.+ .++.+++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 87777 11 11100001111000 000 0112222 33333321
Q ss_pred ----CCCceecCCCCCCCeEEC-CCCcEEEEeecCcc
Q 002409 719 ----CVPAIIHRDLKSSNILLD-KHMRAKVSDFGLSK 750 (927)
Q Consensus 719 ----~~~~ivHrDLkp~NILl~-~~~~vkL~DFGla~ 750 (927)
....++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 234799999999999999 66666899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.87 E-value=3.1e-06 Score=92.12 Aligned_cols=110 Identities=25% Similarity=0.394 Sum_probs=86.3
Q ss_pred eecCCCC--------CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecC-CCcCC
Q 002409 406 LQCNSDP--------QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLED-NQLTG 475 (927)
Q Consensus 406 v~C~~~~--------~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~-N~l~g 475 (927)
|.|+..+ ++..+.|+|..|+|+-..|..|+.|++|+.||||+|+|+-+-|. |.+|.+|..|-|-+ |+|+
T Consensus 51 VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~- 129 (498)
T KOG4237|consen 51 VDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT- 129 (498)
T ss_pred EEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-
Confidence 7787654 35678999999999944445788999999999999999999897 99999987666555 8999
Q ss_pred CCCc-cccCCCcccccccccccccccccccccc---ccccccccCC
Q 002409 476 PLPS-SLMNLPNLRELYVQNNMLSGTVPSSLLS---KNVVLNYAGN 517 (927)
Q Consensus 476 ~~P~-~l~~l~~L~~L~l~~N~l~g~iP~~l~~---~~~~l~~~~n 517 (927)
.+|. .|++|..|+.|.+.-|++. .++...+. .+..|++..|
T Consensus 130 ~l~k~~F~gL~slqrLllNan~i~-Cir~~al~dL~~l~lLslyDn 174 (498)
T KOG4237|consen 130 DLPKGAFGGLSSLQRLLLNANHIN-CIRQDALRDLPSLSLLSLYDN 174 (498)
T ss_pred hhhhhHhhhHHHHHHHhcChhhhc-chhHHHHHHhhhcchhcccch
Confidence 6665 7899999999999999999 66665543 3334444444
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.85 E-value=1.1e-05 Score=61.76 Aligned_cols=36 Identities=47% Similarity=0.720 Sum_probs=16.9
Q ss_pred CccEEEecCCCcCCCCCccccCCCccccccccccccc
Q 002409 462 DLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLS 498 (927)
Q Consensus 462 ~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l~ 498 (927)
+|++|+|++|+|+ .+|..+++|++|+.|++++|+|+
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 3445555555554 34444555555555555555544
|
... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00012 Score=75.79 Aligned_cols=113 Identities=19% Similarity=0.290 Sum_probs=72.8
Q ss_pred CCcEEEEEEeecCCchhhHh---------HHHHHHHHhhccCCCc---cceecceee-----cCeEEEEEEeccCCchhh
Q 002409 622 DGKEIAVKVLTSNSYQGKRE---------FTNEVTLLSRIHHRNL---VQFLGYCQE-----EGRSVLVYEFMHNGTLKE 684 (927)
Q Consensus 622 ~g~~VAVK~l~~~~~~~~~~---------~~~Ei~iL~~l~HpnI---v~l~g~~~~-----~~~~~lV~E~~~~gsL~~ 684 (927)
+|+.+.+|..+......++. ..+++..+.+++...+ ..++.+... ....+|+|||++|..|.+
T Consensus 53 ~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d 132 (229)
T PF06176_consen 53 DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELND 132 (229)
T ss_pred CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEEEEEEecCeeccc
Confidence 47888888776543222222 2334444444433222 222222221 234578999999988766
Q ss_pred hcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcc
Q 002409 685 HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 750 (927)
Q Consensus 685 ~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 750 (927)
... ++. .++..+.+++.-||+. |++|+|.+|.|++++.+ .++++||+..+
T Consensus 133 ~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 133 IED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN-GIRIIDTQGKR 182 (229)
T ss_pred chh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-cEEEEECcccc
Confidence 531 121 2456677889999998 99999999999999865 49999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.80 E-value=3.9e-06 Score=88.05 Aligned_cols=81 Identities=22% Similarity=0.338 Sum_probs=47.5
Q ss_pred ceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCccccccccc
Q 002409 415 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 494 (927)
Q Consensus 415 ~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~ 494 (927)
.|+.|||++|.++ .|..++.-++.++.|+||+|.|... ..+..|.+|+.||||+|.++ .+-..-.+|-+.+.|.|++
T Consensus 285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v-~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~ 361 (490)
T KOG1259|consen 285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV-QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQ 361 (490)
T ss_pred hhhhccccccchh-hhhhhhhhccceeEEeccccceeee-hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhh
Confidence 4566666666666 5666666666666666666666532 22555666666666666665 3333333445555555666
Q ss_pred cccc
Q 002409 495 NMLS 498 (927)
Q Consensus 495 N~l~ 498 (927)
|.|.
T Consensus 362 N~iE 365 (490)
T KOG1259|consen 362 NKIE 365 (490)
T ss_pred hhHh
Confidence 6554
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=97.80 E-value=2.8e-05 Score=101.30 Aligned_cols=104 Identities=22% Similarity=0.272 Sum_probs=75.9
Q ss_pred CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCccccccc
Q 002409 413 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 492 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 492 (927)
.++|+.|+|++|...+.+|.++++|++|+.|+|++|...+.+|...++++|+.|+|++|.....+|.. ..+|+.|+|
T Consensus 777 ~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~L 853 (1153)
T PLN03210 777 SPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGINLESLESLDLSGCSRLRTFPDI---STNISDLNL 853 (1153)
T ss_pred cccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCCCccccCEEECCCCCcccccccc---ccccCEeEC
Confidence 35789999999988889999999999999999999876667776557888888888887655556543 246777777
Q ss_pred ccccccccccccc--ccccccccccCCccc
Q 002409 493 QNNMLSGTVPSSL--LSKNVVLNYAGNINL 520 (927)
Q Consensus 493 ~~N~l~g~iP~~l--~~~~~~l~~~~n~~l 520 (927)
++|.|+ .+|.++ ++.+..+.+.+++++
T Consensus 854 s~n~i~-~iP~si~~l~~L~~L~L~~C~~L 882 (1153)
T PLN03210 854 SRTGIE-EVPWWIEKFSNLSFLDMNGCNNL 882 (1153)
T ss_pred CCCCCc-cChHHHhcCCCCCEEECCCCCCc
Confidence 777777 677665 334455555554443
|
syringae 6; Provisional |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00018 Score=77.09 Aligned_cols=141 Identities=18% Similarity=0.164 Sum_probs=84.7
Q ss_pred cccccCc-eEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhcc-CCCccceecceeecCeEEEEEEeccCCchh
Q 002409 606 KIGSGGF-GVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMHNGTLK 683 (927)
Q Consensus 606 ~IG~G~f-G~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~ 683 (927)
.|-.|.. ..||+.... +..+.||+..... ...+.+|+++++.+. +--+.+++++....+..++|||+++|.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3455666 689999765 4788888875432 345778999988884 333456677776666789999999987776
Q ss_pred hhc-------------------ccccccccccCH--HHHHHHHH--------------------HHHhHhHHHhh----C
Q 002409 684 EHL-------------------YGTLTHEQRINW--IKRLEIAE--------------------DAAKGIEYLHT----G 718 (927)
Q Consensus 684 ~~L-------------------~~~~~~~~~l~~--~~~~~i~~--------------------qia~gL~yLH~----~ 718 (927)
+.. +........+.. ........ .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 432 110000001100 00000000 01111122211 1
Q ss_pred CCCceecCCCCCCCeEECCCCcEEEEeecCcc
Q 002409 719 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 750 (927)
Q Consensus 719 ~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 750 (927)
..+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 12469999999999999998778999998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.74 E-value=2.1e-06 Score=99.47 Aligned_cols=125 Identities=30% Similarity=0.421 Sum_probs=95.0
Q ss_pred CCCCCCCCCcce---eecCCCC----------CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC--CC
Q 002409 394 GGDPCLPVPWSW---LQCNSDP----------QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FS 458 (927)
Q Consensus 394 ~~dpC~~~~~~~---v~C~~~~----------~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~--~~ 458 (927)
+||-|....|.- ..|+.+. ++.++.|||++|+++. .. .|..|++|++|||+.|.|.- +|. ..
T Consensus 154 ggd~~ns~~Wn~L~~a~fsyN~L~~mD~SLqll~ale~LnLshNk~~~-v~-~Lr~l~~LkhLDlsyN~L~~-vp~l~~~ 230 (1096)
T KOG1859|consen 154 GGDISNSPVWNKLATASFSYNRLVLMDESLQLLPALESLNLSHNKFTK-VD-NLRRLPKLKHLDLSYNCLRH-VPQLSMV 230 (1096)
T ss_pred ccccccchhhhhHhhhhcchhhHHhHHHHHHHHHHhhhhccchhhhhh-hH-HHHhcccccccccccchhcc-ccccchh
Confidence 566665444542 4455432 3678999999999983 33 78899999999999999984 554 34
Q ss_pred CCCCccEEEecCCCcCCCCCccccCCCccccccccccccccc---cccccccccccccccCCcccccCC
Q 002409 459 GCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGT---VPSSLLSKNVVLNYAGNINLHEGG 524 (927)
Q Consensus 459 ~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l~g~---iP~~l~~~~~~l~~~~n~~l~~~~ 524 (927)
+++ |+.|.|++|-++. + -.+.+|++|+.|||+.|-|++- .|-+.+..+..|.+.|||-.|.+.
T Consensus 231 gc~-L~~L~lrnN~l~t-L-~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p~ 296 (1096)
T KOG1859|consen 231 GCK-LQLLNLRNNALTT-L-RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAPW 296 (1096)
T ss_pred hhh-heeeeecccHHHh-h-hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCHH
Confidence 566 9999999999883 2 3478999999999999998853 244445566778899999988764
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.67 E-value=6.7e-06 Score=77.33 Aligned_cols=89 Identities=24% Similarity=0.311 Sum_probs=54.2
Q ss_pred CceEEEEecCCCCCccCCchhhcC-CCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCccccccc
Q 002409 414 PSITVIHLSSKNLTGNIPSDLTKL-SSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 492 (927)
Q Consensus 414 ~~l~~L~L~~n~l~g~ip~~i~~L-~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 492 (927)
..|+.++|++|.+. .+|+.|... +.++.|+|++|.|+..+.++..++.|+.|+++.|.|. ..|.-+..|.+|-.|+.
T Consensus 53 ~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neisdvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds 130 (177)
T KOG4579|consen 53 YELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEISDVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDS 130 (177)
T ss_pred ceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhhhchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcC
Confidence 35566666666666 455544433 3666666666666665555666666666666666666 55665666666666666
Q ss_pred ccccccccccccc
Q 002409 493 QNNMLSGTVPSSL 505 (927)
Q Consensus 493 ~~N~l~g~iP~~l 505 (927)
.+|.+. .||-.+
T Consensus 131 ~~na~~-eid~dl 142 (177)
T KOG4579|consen 131 PENARA-EIDVDL 142 (177)
T ss_pred CCCccc-cCcHHH
Confidence 666666 555443
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.66 E-value=2.8e-05 Score=59.47 Aligned_cols=37 Identities=32% Similarity=0.543 Sum_probs=22.7
Q ss_pred CCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcC
Q 002409 438 SSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLT 474 (927)
Q Consensus 438 ~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~ 474 (927)
++|++|+|++|+|+...|.+++|++|++|+|++|+|+
T Consensus 1 ~~L~~L~l~~N~i~~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 1 KNLEELDLSNNQITDLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp TT-SEEEETSSS-SSHGGHGTTCTTSSEEEETSSCCS
T ss_pred CcceEEEccCCCCcccCchHhCCCCCCEEEecCCCCC
Confidence 3566667777766654334667777777777777666
|
... |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=97.63 E-value=2.3e-05 Score=90.22 Aligned_cols=102 Identities=32% Similarity=0.457 Sum_probs=86.4
Q ss_pred CceEEEEecCCCCCccCCchhhcCC-CCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCccccccc
Q 002409 414 PSITVIHLSSKNLTGNIPSDLTKLS-SLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 492 (927)
Q Consensus 414 ~~l~~L~L~~n~l~g~ip~~i~~L~-~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 492 (927)
..++.|++.+|.++ .||+.+..++ +|+.|++++|++......+.+++.|+.|++++|+++ .+|...+.+++|+.|++
T Consensus 116 ~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~l 193 (394)
T COG4886 116 TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDL 193 (394)
T ss_pred cceeEEecCCcccc-cCccccccchhhcccccccccchhhhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheec
Confidence 57899999999999 8998888885 999999999999876667888999999999999998 78887778899999999
Q ss_pred cccccccccccc--cccccccccccCCc
Q 002409 493 QNNMLSGTVPSS--LLSKNVVLNYAGNI 518 (927)
Q Consensus 493 ~~N~l~g~iP~~--l~~~~~~l~~~~n~ 518 (927)
++|+++ .+|.. ....+..+....|.
T Consensus 194 s~N~i~-~l~~~~~~~~~L~~l~~~~N~ 220 (394)
T COG4886 194 SGNKIS-DLPPEIELLSALEELDLSNNS 220 (394)
T ss_pred cCCccc-cCchhhhhhhhhhhhhhcCCc
Confidence 999999 88886 44446666667773
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.59 E-value=1.4e-05 Score=83.95 Aligned_cols=82 Identities=23% Similarity=0.309 Sum_probs=54.5
Q ss_pred CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCccccccc
Q 002409 413 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 492 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 492 (927)
.|.++.|+|+.|+|. .+.. +..|.+|+.||||+|.|+...---..|-+.+.|.|+.|.+.. -..+.+|-+|..||+
T Consensus 306 ~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls~~~Gwh~KLGNIKtL~La~N~iE~--LSGL~KLYSLvnLDl 381 (490)
T KOG1259|consen 306 APKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLAECVGWHLKLGNIKTLKLAQNKIET--LSGLRKLYSLVNLDL 381 (490)
T ss_pred ccceeEEecccccee-eehh-hhhcccceEeecccchhHhhhhhHhhhcCEeeeehhhhhHhh--hhhhHhhhhheeccc
Confidence 578999999999998 4444 888999999999999887543322334455556666665541 123455555666666
Q ss_pred cccccc
Q 002409 493 QNNMLS 498 (927)
Q Consensus 493 ~~N~l~ 498 (927)
++|+|.
T Consensus 382 ~~N~Ie 387 (490)
T KOG1259|consen 382 SSNQIE 387 (490)
T ss_pred cccchh
Confidence 666654
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00024 Score=72.91 Aligned_cols=103 Identities=24% Similarity=0.315 Sum_probs=81.5
Q ss_pred HHHHHHHhhccC-CCccceecceeecCeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCC
Q 002409 643 TNEVTLLSRIHH-RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 721 (927)
Q Consensus 643 ~~Ei~iL~~l~H-pnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ 721 (927)
..|..+++.+++ +++.+++|+|. .+++.||...+++... +....+-...+|..+.+||.++++.+.+|++...-
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~-~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGI-YRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccc-ccccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 358888888876 69999999994 4678999987766432 11111223468999999999999999999985443
Q ss_pred ceecCCCCCCCeEECCCCcEEEEeecCcc
Q 002409 722 AIIHRDLKSSNILLDKHMRAKVSDFGLSK 750 (927)
Q Consensus 722 ~ivHrDLkp~NILl~~~~~vkL~DFGla~ 750 (927)
.+.-.|++++|+-+++++++|++|.....
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVF 110 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcc
Confidence 68889999999999999999999998653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.54 E-value=7.3e-06 Score=77.09 Aligned_cols=91 Identities=23% Similarity=0.348 Sum_probs=77.4
Q ss_pred CceEEEEecCCCCCccCCchhhc---CCCCcEEeccCCcCCCCCCCCCC-CCCccEEEecCCCcCCCCCccccCCCcccc
Q 002409 414 PSITVIHLSSKNLTGNIPSDLTK---LSSLVELWLDGNSLTGPIPDFSG-CPDLRIIHLEDNQLTGPLPSSLMNLPNLRE 489 (927)
Q Consensus 414 ~~l~~L~L~~n~l~g~ip~~i~~---L~~L~~L~Ls~N~l~g~~p~~~~-l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~ 489 (927)
..+..|||+++.|- .|++.+.. ...|+.++|++|.|..-++.|.. .+.++.|+|++|+|+ .+|.++..++.|+.
T Consensus 27 kE~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~ 104 (177)
T KOG4579|consen 27 KELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRS 104 (177)
T ss_pred HHhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhh
Confidence 35778899999887 67776555 45677779999999988888755 668999999999999 89999999999999
Q ss_pred cccccccccccccccccc
Q 002409 490 LYVQNNMLSGTVPSSLLS 507 (927)
Q Consensus 490 L~l~~N~l~g~iP~~l~~ 507 (927)
|+++.|.|. ..|.-+++
T Consensus 105 lNl~~N~l~-~~p~vi~~ 121 (177)
T KOG4579|consen 105 LNLRFNPLN-AEPRVIAP 121 (177)
T ss_pred cccccCccc-cchHHHHH
Confidence 999999999 77777765
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00054 Score=68.07 Aligned_cols=126 Identities=22% Similarity=0.328 Sum_probs=86.5
Q ss_pred hccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccc-eecceeecCeEEEEEEeccCCch
Q 002409 604 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQ-FLGYCQEEGRSVLVYEFMHNGTL 682 (927)
Q Consensus 604 ~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~-l~g~~~~~~~~~lV~E~~~~gsL 682 (927)
.+.||+|++|.||.|.+. |.++|+|+-+.+++ ...++.|+++|..+.-.++.+ ++.|.. -++.|||+.|-.|
T Consensus 27 ~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~L 99 (201)
T COG2112 27 EKELAKGTTSVVYLGEWR-GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRPL 99 (201)
T ss_pred hhhhhcccccEEEEeecc-CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcch
Confidence 467999999999999998 77999998776543 567899999999988776654 333322 2355999998788
Q ss_pred hhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCC-CCCeEECCCCcEEEEeecCcc
Q 002409 683 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLK-SSNILLDKHMRAKVSDFGLSK 750 (927)
Q Consensus 683 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLk-p~NILl~~~~~vkL~DFGla~ 750 (927)
.+.-... +..+.. .++.. +|.-+. .||-|+.|. |...+|..+..+.|+||..|+
T Consensus 100 ~~~~~~~-------~rk~l~----~vlE~-a~~LD~--~GI~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 100 GKLEIGG-------DRKHLL----RVLEK-AYKLDR--LGIEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred hhhhhcc-------cHHHHH----HHHHH-HHHHHH--hccchhhhcCCceeEEecCCcEEEEEccchh
Confidence 7654221 222222 23333 333222 288899986 555555555599999999886
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 927 | ||||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-57 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-56 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-49 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-48 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-33 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 9e-33 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-32 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-32 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-31 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-31 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-26 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-26 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-26 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-26 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-26 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-26 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-26 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-26 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-26 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-26 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-26 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-25 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-25 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-25 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-25 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-25 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-25 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-25 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-25 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-25 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-24 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-24 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-24 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-24 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-24 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-24 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-24 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 7e-24 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-23 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-23 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-23 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-23 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-23 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-23 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-23 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-23 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-23 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-23 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-23 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-23 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-23 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-23 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-23 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 6e-23 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-23 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-23 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-22 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-22 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-21 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-21 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-21 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-21 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-21 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-21 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-21 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-21 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-21 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-21 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-21 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-21 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-21 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-21 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-21 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-21 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-21 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-21 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-21 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-21 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-21 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-21 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-21 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-21 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-21 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-20 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-20 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-20 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-20 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-20 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-20 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-20 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-20 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-20 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-20 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-20 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-20 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-20 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-20 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-20 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-20 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-20 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-20 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-20 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-20 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 9e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 9e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 9e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-19 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-19 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-19 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-19 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-19 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-19 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-19 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-19 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-19 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-19 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-19 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-19 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-19 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-19 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-19 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 9e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 9e-19 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 9e-19 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 9e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-18 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-18 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-18 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-18 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-17 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-17 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-17 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-17 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-17 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-17 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-17 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-17 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 8e-17 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-16 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-16 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-16 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-16 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-16 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-16 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-16 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-16 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-16 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-16 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-16 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-16 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-16 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-16 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-16 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-16 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-16 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-16 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-16 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-16 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-16 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-16 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-16 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-16 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-16 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-16 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-16 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-15 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-15 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-15 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-15 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-15 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-15 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-15 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-15 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-14 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-14 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-14 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-14 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-14 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-14 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-14 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-14 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 8e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-14 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-14 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-13 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-13 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-13 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-13 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-13 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-13 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-13 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-13 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-13 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-13 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-13 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-13 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-13 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-13 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-13 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 8e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-13 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 8e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 8e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 8e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-13 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 9e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 9e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 9e-13 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 9e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-12 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-12 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-12 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-12 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-12 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-12 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-12 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-12 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-12 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-12 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-12 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-12 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-12 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-12 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-12 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-12 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-12 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-12 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-12 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-12 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-12 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 8e-12 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 8e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 8e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 9e-12 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 9e-12 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-11 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-11 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-11 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-11 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-11 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-11 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-11 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-11 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-11 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-11 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-11 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-11 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-11 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-11 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 7e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-11 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 9e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 9e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-10 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-10 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 9e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 9e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 9e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 7e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 8e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 8e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 8e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 8e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 8e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 9e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 9e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-06 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 3e-06 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 4e-06 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 5e-06 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 5e-06 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 5e-06 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 6e-06 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-06 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 6e-06 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 6e-06 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 6e-06 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 6e-06 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 6e-06 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 6e-06 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 6e-06 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 6e-06 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 6e-06 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 6e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-06 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 7e-06 |
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 448 bits (1155), Expect = e-151
Identities = 122/312 (39%), Positives = 187/312 (59%), Gaps = 7/312 (2%)
Query: 575 RPVSSLNDAPAEAAHCFTLSDIEDATKMLEKK--IGSGGFGVVYYGKLKDGKEIAVKVLT 632
S + ++ L D+E+AT + K IG G FG VY G L+DG ++A+K T
Sbjct: 13 NDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRT 72
Query: 633 SNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH 692
S QG EF E+ LS H +LV +G+C E +L+Y++M NG LK HLYG+
Sbjct: 73 PESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLP 132
Query: 693 EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-F 751
++W +RLEI AA+G+ YLHT IIHRD+KS NILLD++ K++DFG+SK
Sbjct: 133 TMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKG 189
Query: 752 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGAN 811
+H+S++V+GT+GY+DPEY+I +LT+KSDVYSFGV+L E++ + AI +
Sbjct: 190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI-VQSLPRE 248
Query: 812 CRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 871
N+ +WA +G ++ I+DP+L D+ +S+ K + A+ C+ RPS+ +VL
Sbjct: 249 MVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLW 308
Query: 872 DIQDAIVIEREA 883
++ A+ ++
Sbjct: 309 KLEYALRLQESV 320
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 377 bits (970), Expect = e-124
Identities = 103/288 (35%), Positives = 168/288 (58%), Gaps = 4/288 (1%)
Query: 588 AHCFTLSDIEDATKM--LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-KREFTN 644
F+L +++ A+ + +G GGFG VY G+L DG +AVK L QG + +F
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 645 EVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI 704
EV ++S HRNL++ G+C +LVY +M NG++ L + ++W KR I
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 705 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 764
A +A+G+ YLH C P IIHRD+K++NILLD+ A V DFGL+K +HV++ VR
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 196
Query: 765 GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF-GANCRNIVQWAKLHI 823
GT+G++ PEY + + ++K+DV+ +GV+LLELI+GQ A + + ++ W K +
Sbjct: 197 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256
Query: 824 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 871
+ ++ ++D L Y + + ++ + AL+C RP +SEV++
Sbjct: 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 304
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 356 bits (917), Expect = e-116
Identities = 97/305 (31%), Positives = 166/305 (54%), Gaps = 27/305 (8%)
Query: 589 HCFTLSDIEDATK--------MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTS----NSY 636
H F+ ++++ T + K+G GGFGVVY G + + +AVK L + +
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71
Query: 637 QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI 696
+ K++F E+ ++++ H NLV+ LG+ + LVY +M NG+L + L L +
Sbjct: 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC-LDGTPPL 130
Query: 697 NWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDG 755
+W R +IA+ AA GI +LH IHRD+KS+NILLD+ AK+SDFGL++
Sbjct: 131 SWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 756 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 815
+ ++S + GT Y+ PE + ++T KSD+YSFGV+LLE+I+G A+ + + +
Sbjct: 188 QTVMTSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR---EPQLL 243
Query: 816 VQWAK-LHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEV---LK 871
+ + + E I+ ID +++ D S+ + A C+ + RP I +V L+
Sbjct: 244 LDIKEEIEDEEKTIEDYIDKK-MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
Query: 872 DIQDA 876
++ +
Sbjct: 303 EMTAS 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 2e-75
Identities = 77/310 (24%), Positives = 124/310 (40%), Gaps = 33/310 (10%)
Query: 591 FTLSDIEDATKMLE--KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTL 648
++ + L+ + G FG V+ +L + +AVK+ Q + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSW-QNEYEVYS 71
Query: 649 LSRIHHRNLVQFLGYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI 704
L + H N++QF+G + L+ F G+L + L ++W + I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-----KANVVSWNELCHI 126
Query: 705 AEDAAKGIEYLHT-------GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757
AE A+G+ YLH G PAI HRD+KS N+LL ++ A ++DFGL+ G S
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 758 HVSSIVR-GTVGYLDPEY-----YISQQLTDKSDVYSFGVILLELISGQEAISNEKFGAN 811
+ + GT Y+ PE + + D+Y+ G++L EL S A
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP-VDEY 245
Query: 812 CRNIVQWAKLHIESGDIQGII-----DPSLLDEYD-IQSMWKIEEKALMCVLPHGHMRPS 865
+ H D+Q ++ P L D + M + E C R S
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 866 ISEVLKDIQD 875
V + I
Sbjct: 306 AGCVGERITQ 315
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 3e-70
Identities = 82/240 (34%), Positives = 125/240 (52%), Gaps = 6/240 (2%)
Query: 564 KEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDG 623
K H H + + + + A DI +++KIG+G FG V+ + G
Sbjct: 2 KHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-G 60
Query: 624 KEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 681
++AVK+L + + EF EV ++ R+ H N+V F+G + +V E++ G+
Sbjct: 61 SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120
Query: 682 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRA 741
L L+ + EQ ++ +RL +A D AKG+ YLH P I+HR+LKS N+L+DK
Sbjct: 121 LYRLLHKSGAREQ-LDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTV 178
Query: 742 KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE 801
KV DFGLS+ S GT ++ PE + +KSDVYSFGVIL EL + Q+
Sbjct: 179 KVCDFGLSRLKASTFLSSKS-AAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ 237
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 9e-63
Identities = 68/211 (32%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLV 658
LE+ IG GGFG VY G E+AVK + + E L + + H N++
Sbjct: 11 LEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 659 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 718
G C +E LV EF G L L +RI + A A+G+ YLH
Sbjct: 70 ALRGVCLKEPNLCLVMEFARGGPLNRVL-----SGKRIPPDILVNWAVQIARGMNYLHDE 124
Query: 719 CVPAIIHRDLKSSNILLDK--------HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 770
+ IIHRDLKSSNIL+ + + K++DFGL++ + S G ++
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR--TTKMSAA-GAYAWM 181
Query: 771 DPEYYISQQLTDKSDVYSFGVILLELISGQE 801
PE + + SDV+S+GV+L EL++G+
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEV 212
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 2e-62
Identities = 80/338 (23%), Positives = 141/338 (41%), Gaps = 59/338 (17%)
Query: 593 LSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI 652
+IE +E+ +G G FGVV K + K++A+K + S S ++ F E+ LSR+
Sbjct: 7 YKEIE-----VEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESE--RKAFIVELRQLSRV 58
Query: 653 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 712
+H N+V+ G C LV E+ G+L L+G + ++G+
Sbjct: 59 NHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPY-YTAAHAMSWCLQCSQGV 115
Query: 713 EYLHTGCVPAIIHRDLKSSNILLDKHMR-AKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 771
YLH+ A+IHRDLK N+LL K+ DFG + + +G+ ++
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTHMTNNKGSAAWMA 171
Query: 772 PEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 831
PE + ++K DV+S+G+IL E+I+ ++ + ++ + I
Sbjct: 172 PEVFEGSNYSEKCDVFSWGIILWEVITRRKP---------------FDEIGGPAFRIMWA 216
Query: 832 ID----PSLLDEYD------IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIER 881
+ P L+ + W + P RPS+ E++K + + R
Sbjct: 217 VHNGTRPPLIKNLPKPIESLMTRCWSKD--------P--SQRPSMEEIVKIMTH---LMR 263
Query: 882 EAAAARDGNSDDMSRNSLHSSLNVGSFGGTENFLSLDE 919
+D+ + SL G G E ++ E
Sbjct: 264 YFP-----GADEPLQYPCQHSLPPGEDGRVEPYVDFAE 296
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 2e-62
Identities = 85/291 (29%), Positives = 137/291 (47%), Gaps = 45/291 (15%)
Query: 603 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGK-------REFTNEVTLLSRIHH 654
EK+IG GGFG+V+ G+L D +A+K L +G+ +EF EV ++S ++H
Sbjct: 23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 655 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 714
N+V+ G +V EF+ G L L I W +L + D A GIEY
Sbjct: 83 PNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEY 137
Query: 715 LHTGCVPAIIHRDLKSSNILLDK-----HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 769
+ P I+HRDL+S NI L + AKV+DFGLS+ + H S + G +
Sbjct: 138 MQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQW 192
Query: 770 LDPEYYISQQL--TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG- 826
+ PE +++ T+K+D YSF +IL +++G+ +G +++ + E G
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-----IKFINMIREEGL 247
Query: 827 --DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 875
I P L + I+ W + P RP S ++K++ +
Sbjct: 248 RPTIPEDCPPRLRNV--IELCWSGD--------P--KKRPHFSYIVKELSE 286
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 4e-62
Identities = 50/209 (23%), Positives = 90/209 (43%), Gaps = 23/209 (11%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQF 660
K+ G ++ G+ + G +I VKVL + + R+F E L H N++
Sbjct: 14 FLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72
Query: 661 LGYCQE--EGRSVLVYEFMHNGTLKEHLYGTLTHEQR---INWIKRLEIAEDAAKGIEYL 715
LG CQ L+ +M G+L L HE ++ + ++ A D A+G+ +L
Sbjct: 73 LGACQSPPAPHPTLITHWMPYGSLYNVL-----HEGTNFVVDQSQAVKFALDMARGMAFL 127
Query: 716 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY 775
HT P I L S ++++D+ M A++S + ++ PE
Sbjct: 128 HT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPG------RMYAPAWVAPEAL 180
Query: 776 ISQQL---TDKSDVYSFGVILLELISGQE 801
+ +D++SF V+L EL++ +
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREV 209
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 2e-61
Identities = 71/322 (22%), Positives = 122/322 (37%), Gaps = 46/322 (14%)
Query: 591 FTLSDIEDATKMLE--KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNE--V 646
S+ L+ + IG G +G VY G L D + +AVKV + + Q F NE +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58
Query: 647 TLLSRIHHRNLVQFLGYCQEEGRSV-----LVYEFMHNGTLKEHLYGTLTHEQRINWIKR 701
+ + H N+ +F+ + LV E+ NG+L ++L +W+
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-----SLHTSDWVSS 113
Query: 702 LEIAEDAAKGIEYLHT------GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF---- 751
+A +G+ YLHT PAI HRDL S N+L+ +SDFGLS
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 752 ---AVDGASHVSSIVRGTVGYLDPEY-------YISQQLTDKSDVYSFGVILLELISGQE 801
+ + GT+ Y+ PE + + D+Y+ G+I E+
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 802 AISNEKFGANCRNIVQW-AKLHIESGDIQGIID-----PSLLDEYDIQSMWKIEEKALM- 854
+ + + Q H D+Q ++ P + + S+ K +
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 855 -CVLPHGHMRPSISEVLKDIQD 875
C R + + + +
Sbjct: 294 DCWDQDAEARLTAQXAEERMAE 315
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 205 bits (525), Expect = 3e-60
Identities = 70/205 (34%), Positives = 114/205 (55%), Gaps = 15/205 (7%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQF 660
+ ++IGSG FG VY GK ++AVK+L + + + F NEV +L + H N++ F
Sbjct: 28 VGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85
Query: 661 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 720
+GY ++ V ++ +L HL+ E + K ++IA A+G++YLH
Sbjct: 86 MGYSTAPQLAI-VTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLHA--- 138
Query: 721 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPE---YYI 776
+IIHRDLKS+NI L + K+ DFGL+ + SH + G++ ++ PE
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 777 SQQLTDKSDVYSFGVILLELISGQE 801
S + +SDVY+FG++L EL++GQ
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQL 223
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 7e-60
Identities = 61/290 (21%), Positives = 111/290 (38%), Gaps = 44/290 (15%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQF 660
+ + IG G FG VY+G+ E+A++++ + F EV + H N+V F
Sbjct: 37 IGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 661 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 720
+G C ++ TL + + ++ K +IA++ KG+ YLH
Sbjct: 95 MGACMSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHA--- 148
Query: 721 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKF----AVDGASHVSSIVRGTVGYLDPEYYI 776
I+H+DLKS N+ D + ++DFGL I G + +L PE
Sbjct: 149 KGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207
Query: 777 SQQL---------TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 827
+ SDV++ G I EL + + + A + W + +G
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA-----IIWQ---MGTGM 259
Query: 828 IQGIIDPSLLDEYD--IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 875
+ + E + W E RP+ ++++ ++
Sbjct: 260 KPNLSQIGMGKEISDILLFCWAFE--------Q--EERPTFTKLMDMLEK 299
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 2e-59
Identities = 59/214 (27%), Positives = 106/214 (49%), Gaps = 20/214 (9%)
Query: 603 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 661
+ +G G FG ++ G+ + +K L + +R F EV ++ + H N+++F+
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 662 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 721
G ++ R + E++ GTL+ + + + + W +R+ A+D A G+ YLH+
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGII---KSMDSQYPWSQRVSFAKDIASGMAYLHS---M 127
Query: 722 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI-------------VRGTVG 768
IIHRDL S N L+ ++ V+DFGL++ VD + + V G
Sbjct: 128 NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187
Query: 769 YLDPEYYISQQLTDKSDVYSFGVILLELISGQEA 802
++ PE + +K DV+SFG++L E+I A
Sbjct: 188 WMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 2e-55
Identities = 69/303 (22%), Positives = 126/303 (41%), Gaps = 45/303 (14%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNE--VTLLSRIHHRNLVQF 660
+ K+IG G +G V+ GK + G+++AVKV + + + E + + H N++ F
Sbjct: 41 MVKQIGKGRYGEVWMGKWR-GEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGF 96
Query: 661 LGYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 716
+ + S L+ ++ NG+L ++L ++ L++A + G+ +LH
Sbjct: 97 IAADIKGTGSWTQLYLITDYHENGSLYDYL-----KSTTLDAKSMLKLAYSSVSGLCHLH 151
Query: 717 T-----GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV---SSIVRGTVG 768
T PAI HRDLKS NIL+ K+ ++D GL+ + + V + GT
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211
Query: 769 YLDPE------YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH 822
Y+ PE Q +D+YSFG+IL E+ + + + + +
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS 271
Query: 823 IESGDIQGIID--------PSLLDEYDIQSMWK--IEEKALMCVLPHGHMRPSISEVLKD 872
E D++ I+ P+ + + E C + R + V K
Sbjct: 272 YE--DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTE----CWAHNPASRLTALRVKKT 325
Query: 873 IQD 875
+
Sbjct: 326 LAK 328
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 2e-54
Identities = 52/217 (23%), Positives = 96/217 (44%), Gaps = 29/217 (13%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNE--VTLLSRIHHRNLVQF 660
L + +G G +G V+ G + G+ +AVK+ +S + ++ + E + + H N++ F
Sbjct: 12 LLECVGKGRYGEVWRGSWQ-GENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGF 67
Query: 661 LGYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 716
+ S L+ + G+L ++L ++ + L I A G+ +LH
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLH 122
Query: 717 T-----GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG--- 768
PAI HRDLKS NIL+ K+ + ++D GL+ + + VG
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 769 YLDPE------YYISQQLTDKSDVYSFGVILLELISG 799
Y+ PE + D+++FG++L E+
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 2e-52
Identities = 65/303 (21%), Positives = 128/303 (42%), Gaps = 45/303 (14%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNE--VTLLSRIHHRNLVQF 660
L++ IG G FG V+ GK + G+E+AVK+ +S + +R + E + + H N++ F
Sbjct: 46 LQESIGKGRFGEVWRGKWR-GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGF 101
Query: 661 LGYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 716
+ ++ + LV ++ +G+L ++L + + +++A A G+ +LH
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLH 156
Query: 717 -----TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV---SSIVRGTVG 768
T PAI HRDLKS NIL+ K+ ++D GL+ + + GT
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216
Query: 769 YLDPE------YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH 822
Y+ PE + ++D+Y+ G++ E+ + + +
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 276
Query: 823 IESGDIQGI---------IDPSLLDEYDIQSMWK-IEEKALMCVLPHGHMRPSISEVLKD 872
+E +++ + I ++ M K + E C +G R + + K
Sbjct: 277 VE--EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRE----CWYANGAARLTALRIKKT 330
Query: 873 IQD 875
+
Sbjct: 331 LSQ 333
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 5e-42
Identities = 73/282 (25%), Positives = 124/282 (43%), Gaps = 40/282 (14%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQ 659
+ +IG G F VY G + E+A + ++ F E +L + H N+V+
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 660 FLGY----CQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIE 713
F + + VLV E M +GTLK +L + + + +W + +I + G++
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCR--QILK----GLQ 143
Query: 714 YLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 772
+LHT P IIHRDLK NI + K+ D GL+ + AS +++ GT ++ P
Sbjct: 144 FLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT--LKRASFAKAVI-GTPEFMAP 199
Query: 773 EYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 832
E Y ++ + DVY+FG+ +LE+ + E + C+N Q + + SG
Sbjct: 200 EMY-EEKYDESVDVYAFGMCMLEMATS------EYPYSECQNAAQIYRR-VTSGVKPASF 251
Query: 833 DPSLLDEYDIQSMWKIEEKA--LMCVLPHGHMRPSISEVLKD 872
+ E K C+ + R SI ++L
Sbjct: 252 -DKVAIP---------EVKEIIEGCIRQNKDERYSIKDLLNH 283
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 6e-40
Identities = 65/203 (32%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGK-EIAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQF 660
L ++IG G FG V+ G+L+ +AVK + K +F E +L + H N+V+
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 661 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 720
+G C ++ +V E + G L T R+ L++ DAA G+EYL + C
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFL---RTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234
Query: 721 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI-----VRGTVGYLDPEYY 775
IHRDL + N L+ + K+SDFG+S+ DG S V+ T PE
Sbjct: 235 ---IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTA----PEAL 287
Query: 776 ISQQLTDKSDVYSFGVILLELIS 798
+ + +SDV+SFG++L E S
Sbjct: 288 NYGRYSSESDVWSFGILLWETFS 310
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 5e-38
Identities = 66/280 (23%), Positives = 121/280 (43%), Gaps = 46/280 (16%)
Query: 605 KKIGSGGFGVVYYGK-LKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 661
+KIG G FG K +DG++ +K ++ S + + E EV +L+ + H N+VQ+
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 662 GYCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRI-NWIKRLEIAEDAAKGIEYLHT 717
+E G +V ++ G L + + G L E +I +W ++ ++++H
Sbjct: 90 ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQI------CLALKHVHD 143
Query: 718 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 777
I+HRD+KS NI L K ++ DFG+++ + + GT YL PE +
Sbjct: 144 ---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICEN 199
Query: 778 QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 837
+ +KSD+++ G +L EL + + A I+ G P +
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS--------GSF-----PPVS 246
Query: 838 DEYD------IQSMWKIEEKALMCVLPHGHMRPSISEVLK 871
Y + ++K RPS++ +L+
Sbjct: 247 LHYSYDLRSLVSQLFKRNP----------RDRPSVNSILE 276
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 8e-38
Identities = 73/262 (27%), Positives = 114/262 (43%), Gaps = 52/262 (19%)
Query: 566 QHRHSLPVQRPVSSLNDAPAEAAHCFTLSD---IEDATKMLEKKIGSGGFGVVYYGKL-- 620
H H P + F D E+ +++G G FG V +
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDP 64
Query: 621 ---KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV--LVYE 675
G+ +AVK L ++ + R+F E+ +L + H N+V++ G C GR L+ E
Sbjct: 65 LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 124
Query: 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNIL 734
++ G+L+++L H++RI+ IK L+ KG+EYL T IHRDL + NIL
Sbjct: 125 YLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGTKRY----IHRDLATRNIL 177
Query: 735 LDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL-------------- 780
++ R K+ DFGL+K D EYY ++
Sbjct: 178 VENENRVKIGDFGLTKVLPQ----------------DKEYYKVKEPGESPIFWYAPESLT 221
Query: 781 ----TDKSDVYSFGVILLELIS 798
+ SDV+SFGV+L EL +
Sbjct: 222 ESKFSVASDVWSFGVVLYELFT 243
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 9e-38
Identities = 65/315 (20%), Positives = 118/315 (37%), Gaps = 40/315 (12%)
Query: 569 HSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIA 627
S +Q P + + + KKIG G F VY L DG +A
Sbjct: 4 QSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIE--KKIGRGQFSEVYRAACLLDGVPVA 61
Query: 628 VK---VLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKE 684
+K + + + + E+ LL +++H N++++ E+ +V E G L
Sbjct: 62 LKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSR 121
Query: 685 HL-----YGTLTHEQRI-NWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH 738
+ L E+ + + +L +E++H+ ++HRD+K +N+ +
Sbjct: 122 MIKHFKKQKRLIPERTVWKYFVQL------CSALEHMHS---RRVMHRDIKPANVFITAT 172
Query: 739 MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 798
K+ D GL +F + S+V GT Y+ PE KSD++S G +L E+ +
Sbjct: 173 GVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA 231
Query: 799 GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD--IQSMWKIEEKALMCV 856
Q F + N+ IE D + +E + +
Sbjct: 232 LQSP-----FYGDKMNLYS-LCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDP------ 279
Query: 857 LPHGHMRPSISEVLK 871
RP ++ V
Sbjct: 280 ----EKRPDVTYVYD 290
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 66/286 (23%), Positives = 111/286 (38%), Gaps = 47/286 (16%)
Query: 605 KKIGSGGFGVVYYGK-LKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 661
IG+G +G + DGK + K S + K+ +EV LL + H N+V++
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 662 GYCQEEGRSVL--VYEFMHNGTLKEHL-----YGTLTHEQRINWIKRLEIAEDAAKGIEY 714
+ + L V E+ G L + E+ + L + ++
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV-----LRVMTQLTLALKE 126
Query: 715 LHTGCVPA--IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 772
H ++HRDLK +N+ LD K+ DFGL++ S + V GT Y+ P
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSP 185
Query: 773 EYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 832
E +KSD++S G +L EL + F A + + A I G
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYELCALMPP-----FTAF--SQKELAGK-IREGKF---- 233
Query: 833 DPSLLDEYD------IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872
+ Y I M +++ + RPS+ E+L++
Sbjct: 234 -RRIPYRYSDELNEIITRMLNLKD----------YHRPSVEEILEN 268
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 65/222 (29%), Positives = 106/222 (47%), Gaps = 49/222 (22%)
Query: 603 LEKKIGSGGFGVVYYGKLK-----DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL 657
+++G G FG V + G+ +AVK L ++ + R+F E+ +L + H N+
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 658 VQFLGYCQEEGRSV--LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 715
V++ G C GR L+ E++ G+L+++L H++RI+ IK L+ KG+EYL
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 716 HT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 774
T IHRDL + NIL++ R K+ DFGL+K D E+
Sbjct: 131 GTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQ----------------DKEF 170
Query: 775 YISQQ------------------LTDKSDVYSFGVILLELIS 798
+ ++ + SDV+SFGV+L EL +
Sbjct: 171 FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-37
Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 9/197 (4%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 662
LE K+G G FG V+ G +A+K L + F E ++ ++ H LVQ
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 663 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE-QRINWIKRLEIAEDAAKGIEYLHTGCVP 721
EE +V E+M G+L + L + + + +++A A G+ Y+
Sbjct: 247 VVSEEPI-YIVTEYMSKGSLLDFLK---GETGKYLRLPQLVDMAAQIASGMAYVERMN-- 300
Query: 722 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 781
+HRDL+++NIL+ +++ KV+DFGL++ D + + + PE + + T
Sbjct: 301 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 359
Query: 782 DKSDVYSFGVILLELIS 798
KSDV+SFG++L EL +
Sbjct: 360 IKSDVWSFGILLTELTT 376
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-37
Identities = 64/200 (32%), Positives = 105/200 (52%), Gaps = 15/200 (7%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 662
++IGSG FG+V+ G + ++A+K + + + +F E ++ ++ H LVQ G
Sbjct: 12 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 663 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 722
C E+ LV EFM +G L ++L T L + D +G+ YL CV
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEACV-- 125
Query: 723 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSI-VRGTVGYLDPEYYISQ 778
IHRDL + N L+ ++ KVSDFG+++F +D +S + V+ PE +
Sbjct: 126 -IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS----PEVFSFS 180
Query: 779 QLTDKSDVYSFGVILLELIS 798
+ + KSDV+SFGV++ E+ S
Sbjct: 181 RYSSKSDVWSFGVLMWEVFS 200
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 5e-37
Identities = 60/293 (20%), Positives = 108/293 (36%), Gaps = 44/293 (15%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 661
+K+G GGF V + L DG A+K + + Q + E E + +H N+++ +
Sbjct: 33 FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLV 92
Query: 662 GYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 717
YC E + L+ F GTL + + + L + +G+E +H
Sbjct: 93 AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA 152
Query: 718 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR--------GTVGY 769
HRDLK +NILL + + D G A + T+ Y
Sbjct: 153 ---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
Query: 770 LDPE---YYISQQLTDKSDVYSFGVILLELISGQ-----EAISNEKFGANCRNIVQWAKL 821
PE + +++DV+S G +L ++ G+ + +N + +
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQS 269
Query: 822 HIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 874
S + ++ ++M V P H RP I +L ++
Sbjct: 270 PRHSSALWQLL------------------NSMMTVDP--HQRPHIPLLLSQLE 302
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 9e-37
Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 15/200 (7%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 662
K++G+G FGVV YGK + ++A+K++ S + EF E ++ + H LVQ G
Sbjct: 28 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 663 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 722
C ++ ++ E+M NG L +L R + LE+ +D + +EYL +
Sbjct: 87 VCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLESKQF-- 141
Query: 723 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSI-VRGTVGYLDPEYYISQ 778
+HRDL + N L++ KVSDFGLS++ +D +S S VR + PE +
Sbjct: 142 -LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP----PEVLMYS 196
Query: 779 QLTDKSDVYSFGVILLELIS 798
+ + KSD+++FGV++ E+ S
Sbjct: 197 KFSSKSDIWAFGVLMWEIYS 216
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 65/298 (21%), Positives = 106/298 (35%), Gaps = 58/298 (19%)
Query: 605 KKIGSGGFGVVYYGKLK-DGKEIAVK-VLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 662
+ +G GGFGVV+ K K D A+K + N + + EV L+++ H +V++
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 663 YCQEEG---------RSVLVY---EFMHNGTLKEHL----YGTLTHEQRINWIKRLEIAE 706
E+ V +Y + LK+ + L I
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC-----LHIFL 125
Query: 707 DAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-----------FAVDG 755
A+ +E+LH+ ++HRDLK SNI KV DFGL
Sbjct: 126 QIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 756 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 815
A + GT Y+ PE + K D++S G+IL EL+ F +
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--------PFSTQMERV 234
Query: 816 VQWAKLHIESGDIQGIIDPSLLDEYD-IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872
+ + + EY +Q M + P RP ++++
Sbjct: 235 RTLTD--VRNLKFPPLFTQKYPCEYVMVQDM--------LSPSP--MERPEAINIIEN 280
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-36
Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 9/197 (4%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 662
LE K+G G FG V+ G +A+K L + F E ++ ++ H LVQ
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYA 329
Query: 663 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE-QRINWIKRLEIAEDAAKGIEYLHTGCVP 721
EE +V E+M G+L + L + + + +++A A G+ Y+
Sbjct: 330 VVSEEPI-YIVTEYMSKGSLLDFLK---GETGKYLRLPQLVDMAAQIASGMAYVERMN-- 383
Query: 722 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 781
+HRDL+++NIL+ +++ KV+DFGL++ D + + + PE + + T
Sbjct: 384 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 442
Query: 782 DKSDVYSFGVILLELIS 798
KSDV+SFG++L EL +
Sbjct: 443 IKSDVWSFGILLTELTT 459
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 65/200 (32%), Positives = 112/200 (56%), Gaps = 15/200 (7%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 662
L K++GSG FGVV GK K ++AVK++ S + EF E + ++ H LV+F G
Sbjct: 12 LLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYG 70
Query: 663 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 722
C +E +V E++ NG L +L +H + + + LE+ D +G+ +L +
Sbjct: 71 VCSKEYPIYIVTEYISNGCLLNYL---RSHGKGLEPSQLLEMCYDVCEGMAFLESHQF-- 125
Query: 723 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSI-VRGTVGYLDPEYYISQ 778
IHRDL + N L+D+ + KVSDFG++++ +D +S + V+ + PE +
Sbjct: 126 -IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSA----PEVFHYF 180
Query: 779 QLTDKSDVYSFGVILLELIS 798
+ + KSDV++FG+++ E+ S
Sbjct: 181 KYSSKSDVWAFGILMWEVFS 200
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 57/226 (25%), Positives = 104/226 (46%), Gaps = 22/226 (9%)
Query: 582 DAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE-----IAVKVL-TSNS 635
+AP +A +++ K +GSG FG VY G E +A+K L + S
Sbjct: 2 EAPNQALLRI----LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 57
Query: 636 YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR 695
+ +E +E +++ + + ++ + LG C L+ + M G L +++ H+
Sbjct: 58 PKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYV---REHKDN 113
Query: 696 INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755
I L AKG+ YL ++HRDL + N+L+ K++DFGL+K
Sbjct: 114 IGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
Query: 756 ASHVSSIVRGT---VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 798
+ G + ++ E + + T +SDV+S+GV + EL++
Sbjct: 171 EKEYHA--EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-36
Identities = 61/223 (27%), Positives = 104/223 (46%), Gaps = 50/223 (22%)
Query: 603 LEKKIGSGGFGVVYYGKLK-----DGKEIAVKVL-TSNSYQGKREFTNEVTLLSRIHHRN 656
+ +G G FG V + G+++AVK L + + E+ +L ++H N
Sbjct: 25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84
Query: 657 LVQFLGYCQEEGRSV--LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 714
+V++ G C E+G + L+ EF+ +G+LKE+L ++ +IN ++L+ A KG++Y
Sbjct: 85 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKNKINLKQQLKYAVQICKGMDY 141
Query: 715 LHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 773
L + +HRDL + N+L++ + K+ DFGL+K D E
Sbjct: 142 LGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAI----------------ETDKE 181
Query: 774 YYISQQL------------------TDKSDVYSFGVILLELIS 798
YY + SDV+SFGV L EL++
Sbjct: 182 YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-36
Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 13/208 (6%)
Query: 597 EDATKMLEKKIGSGGFGVVYYGKLKDGKE---IAVKVLTSN-SYQGKREFTNEVTLLSRI 652
D + + ++G G FG V G + K+ +A+KVL E E ++ ++
Sbjct: 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 67
Query: 653 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 712
+ +V+ +G CQ E +LV E G L + L + + I E+ + G+
Sbjct: 68 DNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGM 123
Query: 713 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT--VGYL 770
+YL +HRDL + N+LL AK+SDFGLSK S+ ++ G + +
Sbjct: 124 KYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 180
Query: 771 DPEYYISQQLTDKSDVYSFGVILLELIS 798
PE ++ + +SDV+S+GV + E +S
Sbjct: 181 APECINFRKFSSRSDVWSYGVTMWEALS 208
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-36
Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 49/222 (22%)
Query: 603 LEKKIGSGGFGVVYYGKLK-----DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL 657
++G G FG V + G +AVK L + +R+F E+ +L +H +
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 658 VQFLGYCQEEGRSV--LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 715
V++ G GR LV E++ +G L++ L H R++ + L + KG+EYL
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL---QRHRARLDASRLLLYSSQICKGMEYL 143
Query: 716 HT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 774
+ C +HRDL + NIL++ K++DFGL+K D +Y
Sbjct: 144 GSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPL----------------DKDY 183
Query: 775 YISQQL------------------TDKSDVYSFGVILLELIS 798
Y+ ++ + +SDV+SFGV+L EL +
Sbjct: 184 YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-36
Identities = 61/198 (30%), Positives = 99/198 (50%), Gaps = 9/198 (4%)
Query: 603 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 661
++ K+G G +G VY G K +AVK L ++ + EF E ++ I H NLVQ L
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 282
Query: 662 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE-QRINWIKRLEIAEDAAKGIEYLHTGCV 720
G C E ++ EFM G L ++L Q ++ + L +A + +EYL
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKKN- 338
Query: 721 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 780
IHR+L + N L+ ++ KV+DFGLS+ + + + + PE +
Sbjct: 339 --FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 396
Query: 781 TDKSDVYSFGVILLELIS 798
+ KSDV++FGV+L E+ +
Sbjct: 397 SIKSDVWAFGVLLWEIAT 414
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 7e-36
Identities = 72/341 (21%), Positives = 126/341 (36%), Gaps = 24/341 (7%)
Query: 464 RIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEG 523
I + + P + L L V+ L L + + A N +
Sbjct: 212 LISQDKAGKYCIPEGTKFDTLWQL----VEYLKLKADGLIYCLKEACPNSSASNASGAAA 267
Query: 524 GRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDA 583
H + + L +P+ V +
Sbjct: 268 PTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSP-------DKPRPMPMDTSVFESPFS 320
Query: 584 PAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE---IAVKVLTSN-SYQGK 639
E L D + + ++G G FG V G + K+ +A+KVL
Sbjct: 321 DPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT 380
Query: 640 REFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI 699
E E ++ ++ + +V+ +G CQ E +LV E G L + L + + I
Sbjct: 381 EEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFL---VGKREEIPVS 436
Query: 700 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759
E+ + G++YL +HR+L + N+LL AK+SDFGLSK S+
Sbjct: 437 NVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY 493
Query: 760 SSIVRGT--VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 798
++ G + + PE ++ + +SDV+S+GV + E +S
Sbjct: 494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-35
Identities = 63/199 (31%), Positives = 105/199 (52%), Gaps = 15/199 (7%)
Query: 602 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 661
L + IG G FG V G + G ++AVK + +++ + F E ++++++ H NLVQ L
Sbjct: 196 KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLL 252
Query: 662 GYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 720
G +E+G +V E+M G+L ++L + L+ + D + +EYL
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN- 309
Query: 721 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI-VRGTVGYLDPEYYISQQ 779
+HRDL + N+L+ + AKVSDFGL+K + V+ T PE ++
Sbjct: 310 --FVHRDLAARNVLVSEDNVAKVSDFGLTKE-ASSTQDTGKLPVKWTA----PEALREKK 362
Query: 780 LTDKSDVYSFGVILLELIS 798
+ KSDV+SFG++L E+ S
Sbjct: 363 FSTKSDVWSFGILLWEIYS 381
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 63/261 (24%), Positives = 101/261 (38%), Gaps = 58/261 (22%)
Query: 565 EQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK--- 621
H H + L P + + + +G G FG V
Sbjct: 3 HHHHHHHHHHGALEVLFQGPGDP------TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTN 56
Query: 622 DGKEI--AVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV--LVYEF 676
DG AVK L Q + + E+ +L ++H +++++ G C++ G + LV E+
Sbjct: 57 DGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEY 116
Query: 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILL 735
+ G+L+++L I + L A+ +G+ YLH IHRDL + N+LL
Sbjct: 117 VPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAYLHAQHY----IHRDLAARNVLL 167
Query: 736 DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL--------------- 780
D K+ DFGL+K EYY ++
Sbjct: 168 DNDRLVKIGDFGLAKAV----------------PEGHEYYRVREDGDSPVFWYAPECLKE 211
Query: 781 ---TDKSDVYSFGVILLELIS 798
SDV+SFGV L EL++
Sbjct: 212 YKFYYASDVWSFGVTLYELLT 232
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 56/221 (25%), Positives = 85/221 (38%), Gaps = 46/221 (20%)
Query: 602 MLEKKIGSGGFGVVYYGKLK--DGKEI--AVKVL---TSNSYQGKREFTNEVTLLSRIHH 654
L +K+G G FGVV G+ GK + AVK L + + +F EV + + H
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 655 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 714
RNL++ G +V E G+L + L H+ A A+G+ Y
Sbjct: 81 RNLIRLYGVVLTP-PMKMVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAVQVAEGMGY 136
Query: 715 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 774
L + IHRDL + N+LL K+ DFGL + + D Y
Sbjct: 137 LESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA---------------LPQNDDHY 178
Query: 775 YISQ-----------------QLTDKSDVYSFGVILLELIS 798
+ + + SD + FGV L E+ +
Sbjct: 179 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 66/254 (25%), Positives = 120/254 (47%), Gaps = 29/254 (11%)
Query: 562 YDKEQHRHS-LPVQR---PVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYY 617
Y H +P ++ P +A FT ++I + +K IG+G FG VY
Sbjct: 4 YHHHHHHDYDIPTTENLYFQGAMGSDPNQAVLKFT-TEIHPSCVTRQKVIGAGEFGEVYK 62
Query: 618 GKLKDGKE-----IAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 671
G LK +A+K L + + + + +F E ++ + H N+++ G + +
Sbjct: 63 GMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122
Query: 672 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKS 730
++ E+M NG L + L + + ++ + + A G++YL +HRDL +
Sbjct: 123 IITEYMENGALDKFL---REKDGEFSVLQLVGMLRGIAAGMKYLANMNY----VHRDLAA 175
Query: 731 SNILLDKHMRAKVSDFGLSKFAVDG-----ASHVSSI-VRGTVGYLDPEYYISQQLTDKS 784
NIL++ ++ KVSDFGLS+ D + I +R T PE ++ T S
Sbjct: 176 RNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA----PEAISYRKFTSAS 231
Query: 785 DVYSFGVILLELIS 798
DV+SFG+++ E+++
Sbjct: 232 DVWSFGIVMWEVMT 245
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 15/205 (7%)
Query: 601 KMLEKKIGSGGFGVVYYGKLKDGK---EIAVKVL--TSNSYQGKREFTNEVTLLSRIHHR 655
+ +K++GSG FG V G + K +AVK+L +N K E E ++ ++ +
Sbjct: 19 TLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP 78
Query: 656 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 715
+V+ +G C+ E +LV E G L ++L + + +E+ + G++YL
Sbjct: 79 YIVRMIGICEAESW-MLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYL 133
Query: 716 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT--VGYLDPE 773
+HRDL + N+LL AK+SDFGLSK ++ + G V + PE
Sbjct: 134 EESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 190
Query: 774 YYISQQLTDKSDVYSFGVILLELIS 798
+ + KSDV+SFGV++ E S
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 74/289 (25%), Positives = 119/289 (41%), Gaps = 58/289 (20%)
Query: 605 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 663
+ IGSGGFG V+ K DGK +K + N + EV L+++ H N+V + G
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----NEKAEREVKALAKLDHVNIVHYNGC 72
Query: 664 CQEEGRSVLVYEFMHNGTLKEHLY--------GTLTHEQRINWIKR-----------LEI 704
+ + + L+ GTL WI++ LE+
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQ-----WIEKRRGEKLDKVLALEL 127
Query: 705 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 764
E KG++Y+H+ +I+RDLK SNI L + K+ DFGL + S
Sbjct: 128 FEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK-- 182
Query: 765 GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE-AISNEKFGANCRNIVQWAKLHI 823
GT+ Y+ PE SQ + D+Y+ G+IL EL+ + A KF + R+ +
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIF-- 240
Query: 824 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872
+ ++ + L+ P RP+ SE+L+
Sbjct: 241 -DKKEKTLL------------------QKLLSKKP--EDRPNTSEILRT 268
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-35
Identities = 67/269 (24%), Positives = 122/269 (45%), Gaps = 48/269 (17%)
Query: 555 HKGKKNNYDKEQHRHSLPVQRPV--SSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGF 612
H + + + LP + + P A FT +IE + +EK IGSG
Sbjct: 4 HHHHSSGRENLYFQGKLPEPQFYAEPHTYEEPGRAGRSFT-REIEASRIHIEKIIGSGDS 62
Query: 613 GVVYYGKLK--DGKEI--AVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE 667
G V YG+L+ +++ A+K L + + + +R+F +E +++ + H N+++ G
Sbjct: 63 GEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122
Query: 668 GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRD 727
+++V E+M NG+L L TH+ + ++ + + G+ YL +HRD
Sbjct: 123 RLAMIVTEYMENGSLDTFL---RTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY---VHRD 176
Query: 728 LKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ-------- 779
L + N+L+D ++ KVSDFGLS+ D DP+ +
Sbjct: 177 LAARNVLVDSNLVCKVSDFGLSRVLED----------------DPDAAYTTTGGKIPIRW 220
Query: 780 ----------LTDKSDVYSFGVILLELIS 798
+ SDV+SFGV++ E+++
Sbjct: 221 TAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 5e-35
Identities = 53/196 (27%), Positives = 95/196 (48%), Gaps = 7/196 (3%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 662
LEKK+G+G FG V+ ++AVK + F E ++ + H LV+
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHA 250
Query: 663 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 722
+E + + EFM G+L + L + K ++ + A+G+ ++
Sbjct: 251 VVTKEPIYI-ITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN--- 304
Query: 723 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 782
IHRDL+++NIL+ + K++DFGL++ D + + + PE T
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI 364
Query: 783 KSDVYSFGVILLELIS 798
KSDV+SFG++L+E+++
Sbjct: 365 KSDVWSFGILLMEIVT 380
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 7e-35
Identities = 70/250 (28%), Positives = 126/250 (50%), Gaps = 22/250 (8%)
Query: 563 DKEQHRHSLPVQRP-VSSLND-----APAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVY 616
+K H + ++ P + + D P + H F +++ ++K +G+G FG V
Sbjct: 4 EKRLHFGNGHLKLPGLRTFVDPHTFEDPTQTVHEFA-KELDATNISIDKVVGAGEFGEVC 62
Query: 617 YGKLK--DGKEI--AVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 671
G+LK KEI A+K L + + +R+F E +++ + H N+++ G + +
Sbjct: 63 SGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122
Query: 672 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKS 730
+V E+M NG+L L H+ + I+ + + A G++YL G V HRDL +
Sbjct: 123 IVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV----HRDLAA 175
Query: 731 SNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT--VGYLDPEYYISQQLTDKSDVYS 788
NIL++ ++ KVSDFGL + D + G + + PE ++ T SDV+S
Sbjct: 176 RNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWS 235
Query: 789 FGVILLELIS 798
+G++L E++S
Sbjct: 236 YGIVLWEVMS 245
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 8e-35
Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 24/207 (11%)
Query: 603 LEKKIGSGGFGVVYYGKLK--DGKEI--AVKVLTSN-SYQGKREFTNEVTLLSRIHHRNL 657
L + +G G FG VY G G++I AVK + + K +F +E ++ + H ++
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 658 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 717
V+ +G +EE + ++ E G L +L ++ + + + + K + YL +
Sbjct: 76 VKLIGIIEEE-PTWIIMELYPYGELGHYL---ERNKNSLKVLTLVLYSLQICKAMAYLES 131
Query: 718 -GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL-----D 771
C +HRD+ NIL+ K+ DFGLS++ D + +V L
Sbjct: 132 INC----VHRDIAVRNILVASPECVKLGDFGLSRYIED-----EDYYKASVTRLPIKWMS 182
Query: 772 PEYYISQQLTDKSDVYSFGVILLELIS 798
PE ++ T SDV+ F V + E++S
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILS 209
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 8e-35
Identities = 58/200 (29%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 662
L +++G+G FG V+ G ++AVK L S F E L+ ++ H+ LV+
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 663 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 722
+E + + E+M NG+L + L ++ K L++A A+G+ ++
Sbjct: 76 VVTQEPIYI-ITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERNY-- 130
Query: 723 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSI-VRGTVGYLDPEYYISQ 778
IHRDL+++NIL+ + K++DFGL++ D A + ++ T PE
Sbjct: 131 -IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA----PEAINYG 185
Query: 779 QLTDKSDVYSFGVILLELIS 798
T KSDV+SFG++L E+++
Sbjct: 186 TFTIKSDVWSFGILLTEIVT 205
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 62/197 (31%), Positives = 100/197 (50%), Gaps = 7/197 (3%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGK-EIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 661
++ K+G G +G VY G K +AVK L ++ + EF E ++ I H NLVQ L
Sbjct: 17 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 75
Query: 662 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 721
G C E ++ EFM G L ++L + Q ++ + L +A + +EYL
Sbjct: 76 GVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKNF- 132
Query: 722 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 781
IHRDL + N L+ ++ KV+DFGLS+ + + + + PE + +
Sbjct: 133 --IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 782 DKSDVYSFGVILLELIS 798
KSDV++FGV+L E+ +
Sbjct: 191 IKSDVWAFGVLLWEIAT 207
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 47/202 (23%), Positives = 92/202 (45%), Gaps = 14/202 (6%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNL 657
L + IG G FG V+ G + +A+K + S + +F E + + H ++
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 658 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 717
V+ +G E ++ E G L+ L + ++ + A + + YL +
Sbjct: 79 VKLIGVITEN-PVWIIMELCTLGELRSFL---QVRKYSLDLASLILYAYQLSTALAYLES 134
Query: 718 -GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 776
+HRD+ + N+L+ + K+ DFGLS++ D + +S + + ++ PE
Sbjct: 135 KRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 190
Query: 777 SQQLTDKSDVYSFGVILLELIS 798
++ T SDV+ FGV + E++
Sbjct: 191 FRRFTSASDVWMFGVCMWEILM 212
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 60/275 (21%), Positives = 105/275 (38%), Gaps = 41/275 (14%)
Query: 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRI-HHRNLVQF 660
++G G +G V+ + K DG+ AVK S + + EV ++ H V+
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 661 LGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 718
+E G L E +L++H +G E ++ D + +LH+
Sbjct: 123 EQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQV-----WGYLRDTLLALAHLHS- 175
Query: 719 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 778
++H D+K +NI L R K+ DFGL + A G Y+ PE +
Sbjct: 176 --QGLVHLDVKPANIFLGPRGRCKLGDFGLLV-ELGTAGAGEVQE-GDPRYMAPE-LLQG 230
Query: 779 QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 838
+DV+S G+ +LE+ E + W +L QG + P
Sbjct: 231 SYGTAADVFSLGLTILEVACNMELPHGGE---------GWQQL------RQGYLPPEFTA 275
Query: 839 EY--DIQSMWKIEEKALMCVLPHGHMRPSISEVLK 871
+++S+ M + P +R + +L
Sbjct: 276 GLSSELRSVLV------MMLEPDPKLRATAEALLA 304
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 64/199 (32%), Positives = 106/199 (53%), Gaps = 17/199 (8%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 662
L + IG G FG V G + G ++AVK + +++ + F E ++++++ H NLVQ LG
Sbjct: 25 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLG 81
Query: 663 YC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL-HTGCV 720
+E+G +V E+M G+L ++L + L+ + D + +EYL
Sbjct: 82 VIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNNF- 138
Query: 721 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI-VRGTVGYLDPEYYISQQ 779
+HRDL + N+L+ + AKVSDFGL+K A + V+ T PE ++
Sbjct: 139 ---VHRDLAARNVLVSEDNVAKVSDFGLTKEASS-TQDTGKLPVKWTA----PEALREKK 190
Query: 780 LTDKSDVYSFGVILLELIS 798
+ KSDV+SFG++L E+ S
Sbjct: 191 FSTKSDVWSFGILLWEIYS 209
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-34
Identities = 57/226 (25%), Positives = 104/226 (46%), Gaps = 22/226 (9%)
Query: 582 DAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE-----IAVKVL-TSNS 635
+AP +A +++ K +GSG FG VY G E +A+K L + S
Sbjct: 2 EAPNQALLRI----LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 57
Query: 636 YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR 695
+ +E +E +++ + + ++ + LG C L+ + M G L +++ H+
Sbjct: 58 PKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYV---REHKDN 113
Query: 696 INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755
I L AKG+ YL ++HRDL + N+L+ K++DFGL+K
Sbjct: 114 IGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
Query: 756 ASHVSSIVRGT---VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 798
+ G + ++ E + + T +SDV+S+GV + EL++
Sbjct: 171 EKEYHA--EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-34
Identities = 74/284 (26%), Positives = 121/284 (42%), Gaps = 26/284 (9%)
Query: 527 AKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAE 586
A + + GS + + + + L+ G +N Y + + + + S+LN +
Sbjct: 22 AAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDL----SALNPELVQ 77
Query: 587 AAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTSN-SYQGKRE 641
A + + IG G FG VY+G L D AVK L +
Sbjct: 78 AVQHVVI-GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ 136
Query: 642 FTNEVTLLSRIHHRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIK 700
F E ++ H N++ LG C + EG ++V +M +G L+ +
Sbjct: 137 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKD 193
Query: 701 RLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759
+ AKG+++L + V HRDL + N +LD+ KV+DFGL++ D
Sbjct: 194 LIGFGLQVAKGMKFLASKKFV----HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD- 248
Query: 760 SSIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 798
S+ T L E +Q+ T KSDV+SFGV+L EL++
Sbjct: 249 -SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-34
Identities = 55/203 (27%), Positives = 99/203 (48%), Gaps = 13/203 (6%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNL 657
+ K+G GG VY + ++A+K + + K E F EV S++ H+N+
Sbjct: 15 IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIP-PREKEETLKRFEREVHNSSQLSHQNI 73
Query: 658 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 717
V + +E+ LV E++ TL E++ ++ + GI++ H
Sbjct: 74 VSMIDVDEEDDCYYLVMEYIEGPTLSEYI----ESHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 718 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 777
I+HRD+K NIL+D + K+ DFG++K + + ++ V GTV Y PE
Sbjct: 130 M---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG 186
Query: 778 QQLTDKSDVYSFGVILLELISGQ 800
+ + +D+YS G++L E++ G+
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGE 209
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-34
Identities = 67/231 (29%), Positives = 105/231 (45%), Gaps = 18/231 (7%)
Query: 578 SSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTS 633
S+LN +A + + IG G FG VY+G L D AVK L
Sbjct: 5 SALNPELVQAVQHVVI-GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR 63
Query: 634 N-SYQGKREFTNEVTLLSRIHHRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLT 691
+F E ++ H N++ LG C + EG ++V +M +G L+ +
Sbjct: 64 ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RN 120
Query: 692 HEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 750
+ AKG++YL + V HRDL + N +LD+ KV+DFGL++
Sbjct: 121 ETHNPTVKDLIGFGLQVAKGMKYLASKKFV----HRDLAARNCMLDEKFTVKVADFGLAR 176
Query: 751 FAVDG---ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 798
D + H + + V ++ E +Q+ T KSDV+SFGV+L EL++
Sbjct: 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 9e-34
Identities = 50/206 (24%), Positives = 93/206 (45%), Gaps = 18/206 (8%)
Query: 602 MLEKKIGSGGFGVVYYGKLKDGKE-----IAVKVL-TSNSYQGKREFTNEVTLLSRIHHR 655
K +GSG FG V+ G E + +KV+ + Q + T+ + + + H
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHA 75
Query: 656 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 715
++V+ LG C LV +++ G+L +H+ H + L AKG+ YL
Sbjct: 76 HIVRLLGLCPGS-SLQLVTQYLPLGSLLDHV---RQHRGALGPQLLLNWGVQIAKGMYYL 131
Query: 716 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT---VGYLDP 772
++HR+L + N+LL + +V+DFG++ + + ++
Sbjct: 132 EEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY--SEAKTPIKWMAL 186
Query: 773 EYYISQQLTDKSDVYSFGVILLELIS 798
E + T +SDV+S+GV + EL++
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 51/216 (23%), Positives = 97/216 (44%), Gaps = 32/216 (14%)
Query: 602 MLEKKIGSGGFGVVYYGKLKDGK--------EIAVKVLTSNSYQGKREFTNEVTLLSRIH 653
+ + +G G F ++ G ++ E+ +KVL F +++S++
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS 70
Query: 654 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 713
H++LV G C ++LV EF+ G+L +L ++ IN + +LE+A+ A +
Sbjct: 71 HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL---KKNKNCINILWKLEVAKQLAAAMH 127
Query: 714 YLHTGCVPAIIHRDLKSSNILLDKHMR--------AKVSDFGLSKFAVDGASHVSSIVRG 765
+L + IH ++ + NILL + K+SD G+S + I++
Sbjct: 128 FLEENTL---IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP-----KDILQE 179
Query: 766 TVGYLDPE---YYISQQLTDKSDVYSFGVILLELIS 798
+ ++ PE + L +D +SFG L E+ S
Sbjct: 180 RIPWVPPECIENP--KNLNLATDKWSFGTTLWEICS 213
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNL 657
++ IG G FGVVY+G+ D + A+K L+ Q F E L+ ++H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 658 VQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 716
+ +G EG ++ +M +G L + + + ++ + A+G+EYL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFI---RSPQRNPTVKDLISFGLQVARGMEYLA 141
Query: 717 T-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT---VGYLDP 772
+HRDL + N +LD+ KV+DFGL++ +D + R V +
Sbjct: 142 EQKF----VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197
Query: 773 EYYISQQLTDKSDVYSFGVILLELIS 798
E + + T KSDV+SFGV+L EL++
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-33
Identities = 59/257 (22%), Positives = 110/257 (42%), Gaps = 43/257 (16%)
Query: 576 PVSSLNDAPAEAAHCFTLS-DIEDATKMLE-----KKIGSGGFGVVYYGKLKDGKEIAVK 629
P+ S+ D + ++ L+ +++ K + + + G F + + KD K A+K
Sbjct: 2 PLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCE-KDNKFYALK 60
Query: 630 VLTSNSYQGKREFT-----------------NEVTLLSRIHHRNLVQFLGYCQEEGRSVL 672
+ + KR+FT NE+ +++ I + + G +
Sbjct: 61 KYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYI 120
Query: 673 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIEYLHTGCVPAII 724
+YE+M N ++ + + ++ I K Y+H I
Sbjct: 121 IYEYMENDSILKFD----EYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK--NIC 174
Query: 725 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD-- 782
HRD+K SNIL+DK+ R K+SDFG S++ VD S RGT ++ PE++ ++ +
Sbjct: 175 HRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS---RGTYEFMPPEFFSNESSYNGA 231
Query: 783 KSDVYSFGVILLELISG 799
K D++S G+ L +
Sbjct: 232 KVDIWSLGICLYVMFYN 248
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 8e-33
Identities = 63/299 (21%), Positives = 103/299 (34%), Gaps = 53/299 (17%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQF 660
+ + + GGF VY + + G+E A+K L SN + R EV + ++ H N+VQF
Sbjct: 32 VRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQF 91
Query: 661 LGYC-------QEEGRSVLVYEFMHNGTLKEHLYGTLTH----EQRINWIKRLEIAEDAA 709
L+ + G L E L + + L+I
Sbjct: 92 CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTV-----LKIFYQTC 146
Query: 710 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI------- 762
+ ++++H P IIHRDLK N+LL K+ DFG + + S
Sbjct: 147 RAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 763 ----VRGTVGYLDPE---YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 815
T Y PE Y + + +K D+++ G IL L Q +
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK 265
Query: 816 VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 874
+ +I + + R SI+EV+ +Q
Sbjct: 266 YSIPPHDTQYTVFHSLIR--------------------AMLQVNPEERLSIAEVVHQLQ 304
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 57/209 (27%), Positives = 103/209 (49%), Gaps = 19/209 (9%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNL 657
L + +G GG V+ + L+D +++AVKVL ++ F E + ++H +
Sbjct: 16 LGEILGFGGMSEVHLARDLRDHRDVAVKVLRAD-LARDPSFYLRFRREAQNAAALNHPAI 74
Query: 658 VQFLGYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 713
V + E + +V E++ TL++ + E + + +E+ DA + +
Sbjct: 75 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV----HTEGPMTPKRAIEVIADACQALN 130
Query: 714 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV--SSIVRGTVGYLD 771
+ H IIHRD+K +NI++ KV DFG+++ D + V ++ V GT YL
Sbjct: 131 FSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 772 PEYYISQQLTDKSDVYSFGVILLELISGQ 800
PE + +SDVYS G +L E+++G+
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 67/306 (21%), Positives = 113/306 (36%), Gaps = 67/306 (21%)
Query: 603 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 661
+G G FG V + D + A+K + ++ + +EV LL+ ++H+ +V++
Sbjct: 10 EIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVRYY 68
Query: 662 GYCQEEGRSV-------------LVYEFMHNGTLKEHL--YGTLTHEQRI-NWIKRLEIA 705
E V + E+ NGTL + + + +I
Sbjct: 69 AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR--QIL 126
Query: 706 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR- 764
E + Y+H+ IIHRDLK NI +D+ K+ DFGL+K + +
Sbjct: 127 E----ALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 765 ------------GTVGYLDPE------YYISQQLTDKSDVYSFGVILLELISGQEAISNE 806
GT Y+ E +Y +K D+YS G+I E+I
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHY-----NEKIDMYSLGIIFFEMIYP------- 227
Query: 807 KFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSI 866
R + K + S I+ P D+ ++ KI L+ P + RP
Sbjct: 228 FSTGMERVNI-LKK--LRSVSIE---FPPDFDDNKMKVEKKIIRL-LIDHDP--NKRPGA 278
Query: 867 SEVLKD 872
+L
Sbjct: 279 RTLLNS 284
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 60/232 (25%), Positives = 98/232 (42%), Gaps = 60/232 (25%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKE---IAVKVLTSN-SYQGKREFTNEVTLLSRI-HHRNL 657
+ IG G FG V ++K A+K + S R+F E+ +L ++ HH N+
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 658 VQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIKRLEIA 705
+ LG C+ G L E+ +G L + L + ++ + L A
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 706 EDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 764
D A+G++YL IHRDL + NIL+ ++ AK++DFGLS+
Sbjct: 149 ADVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSR-------------- 190
Query: 765 GTVGYLDPEYYISQQL------------------TDKSDVYSFGVILLELIS 798
E Y+ + + T SDV+S+GV+L E++S
Sbjct: 191 ------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 3e-32
Identities = 51/229 (22%), Positives = 97/229 (42%), Gaps = 19/229 (8%)
Query: 576 PVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE----IAVKVL 631
P+ + IE L + IG G FG V+ G + +A+K
Sbjct: 372 DEEDTYTMPSTRDYEIQRERIE-----LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC 426
Query: 632 TSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTL 690
+ S + +F E + + H ++V+ +G E ++ E G L+ L
Sbjct: 427 KNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFL---Q 482
Query: 691 THEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 749
+ ++ + A + + YL + V HRD+ + N+L+ + K+ DFGLS
Sbjct: 483 VRKFSLDLASLILYAYQLSTALAYLESKRFV----HRDIAARNVLVSSNDCVKLGDFGLS 538
Query: 750 KFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 798
++ D + +S + + ++ PE ++ T SDV+ FGV + E++
Sbjct: 539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-32
Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 29/218 (13%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSNSYQGKREFTNEVTLLSRIHHRN 656
L+ ++G G FG V+ + + +AVK L S +++F E LL+ + H++
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 657 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHL-----------YGTLTHEQRINWIKRLEIA 705
+V+F G C E ++V+E+M +G L L G + + L +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 706 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG 765
A G+ YL +HRDL + N L+ + + K+ DFG+S+ + G
Sbjct: 165 SQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY----RVG 217
Query: 766 TVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 798
L PE + ++ T +SDV+SFGV+L E+ +
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 60/217 (27%), Positives = 96/217 (44%), Gaps = 27/217 (12%)
Query: 591 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVL---TSNSYQGKREFTNEV 646
+ L D E + + +G G FG VY + K +A+KVL + + EV
Sbjct: 6 WALEDFE-----IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60
Query: 647 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE 706
+ S + H N+++ GY + R L+ E+ GT+ Y L + + +
Sbjct: 61 EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYIT 116
Query: 707 DAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR-- 764
+ A + Y H+ +IHRD+K N+LL K++DFG S H S R
Sbjct: 117 ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV-------HAPSSRRTD 166
Query: 765 --GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 799
GT+ YL PE + +K D++S GV+ E + G
Sbjct: 167 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 203
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 54/214 (25%), Positives = 100/214 (46%), Gaps = 25/214 (11%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRIHHR 655
+ +++G G FG+VY G K + +A+K + S + + EF NE +++ +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 656 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------YGTLTHEQRINWIKRLEIAEDAA 709
++V+ LG + ++++ E M G LK +L + K +++A + A
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 710 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 769
G+ YL+ +HRDL + N ++ + K+ DFG+++ + +G G
Sbjct: 149 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET----DYYRKGGKGL 201
Query: 770 L-----DPEYYISQQLTDKSDVYSFGVILLELIS 798
L PE T SDV+SFGV+L E+ +
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 30/219 (13%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSNSYQGKREFTNEVTLLSRIHHRN 656
L++++G G FG V+ + + +AVK L + +++F E LL+ + H +
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 657 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIKRLEI 704
+V+F G C + ++V+E+M +G L + L + + + L I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 705 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 764
A A G+ YL + +HRDL + N L+ ++ K+ DFG+S+ +
Sbjct: 139 ASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY----RV 191
Query: 765 GTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 798
G L PE + ++ T +SDV+SFGVIL E+ +
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 62/232 (26%), Positives = 107/232 (46%), Gaps = 19/232 (8%)
Query: 578 SSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSY 636
S + + D E +G G +G+VY G+ L + IA+K +
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS 60
Query: 637 QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK---EHLYGTL-TH 692
+ + E+ L + H+N+VQ+LG E G + E + G+L +G L +
Sbjct: 61 RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN 120
Query: 693 EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKF 751
EQ I + + +I E G++YLH I+HRD+K N+L++ + K+SDFG SK
Sbjct: 121 EQTIGFYTK-QILE----GLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKR 172
Query: 752 AVDGASHVSSIVRGTVGYLDPEYYISQQLTD---KSDVYSFGVILLELISGQ 800
+ GT+ Y+ PE I + +D++S G ++E+ +G+
Sbjct: 173 LAGINPCTET-FTGTLQYMAPE-IIDKGPRGYGKAADIWSLGCTIIEMATGK 222
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 63/214 (29%), Positives = 96/214 (44%), Gaps = 25/214 (11%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKE----IAVKVL--TSNSYQGKREFTNEVTLLSRIHHRN 656
L K +G G FG V G LK +AVK + ++S + EF +E + H N
Sbjct: 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 657 LVQFLGYCQEEG-----RSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAA 709
+++ LG C E + +++ FM G L +L T + I L+ D A
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 710 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 769
G+EYL +HRDL + N +L M V+DFGLSK G + +G +
Sbjct: 158 LGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY----RQGRIAK 210
Query: 770 L-----DPEYYISQQLTDKSDVYSFGVILLELIS 798
+ E + T KSDV++FGV + E+ +
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 29/216 (13%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNL--V 658
+ K+IGSGG V+ + + A+K L Q + NE+ L+++ + +
Sbjct: 32 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 91
Query: 659 QFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLH 716
+ Y + +V E N L L ++ +R ++ K + E + +H
Sbjct: 92 RLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWK--NMLE----AVHTIH 144
Query: 717 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPE-- 773
I+H DLK +N L+ M K+ DFG++ D S V GTV Y+ PE
Sbjct: 145 QH---GIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200
Query: 774 ---------YYISQQLTDKSDVYSFGVILLELISGQ 800
+++ KSDV+S G IL + G+
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 54/215 (25%), Positives = 88/215 (40%), Gaps = 26/215 (12%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTSN--SYQGKREFTNEVTLLSRIHHRN 656
L + +G G FG V +LK +AVK+L ++ + EF E + H +
Sbjct: 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 657 LVQFLGYCQEEGRSV------LVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDA 708
+ + +G ++ FM +G L L + + + D
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 709 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 768
A G+EYL + IHRDL + N +L + M V+DFGLS+ G + +G
Sbjct: 147 ACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY----RQGCAS 199
Query: 769 YL-----DPEYYISQQLTDKSDVYSFGVILLELIS 798
L E T SDV++FGV + E+++
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 25/214 (11%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGK------EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHR 655
L + +G G FG VY G++ ++AVK L S Q + +F E ++S+ +H+
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 656 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRINWIKRLEIAEDAAKGI 712
N+V+ +G + ++ E M G LK L + + + L +A D A G
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 713 EYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 769
+YL IHRD+ + N LL AK+ DFG+++ S +G
Sbjct: 154 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA----SYYRKGGCAM 206
Query: 770 L-----DPEYYISQQLTDKSDVYSFGVILLELIS 798
L PE ++ T K+D +SFGV+L E+ S
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 57/221 (25%), Positives = 90/221 (40%), Gaps = 35/221 (15%)
Query: 591 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVL---TSNSYQGKREFTNEV 646
FT+ D + + + +G G FG VY + K +A+KVL + + E+
Sbjct: 11 FTIDDFD-----IGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREI 65
Query: 647 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE 706
+ S + H N+++ Y + R L+ EF G L Y L R + E
Sbjct: 66 EIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFD--------E 113
Query: 707 DAAK--------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758
+ + Y H V IHRD+K N+L+ K++DFG S A
Sbjct: 114 QRSATFMEELADALHYCHERKV---IHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR 170
Query: 759 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 799
GT+ YL PE + +K D++ GV+ E + G
Sbjct: 171 TMC---GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 5e-31
Identities = 70/292 (23%), Positives = 117/292 (40%), Gaps = 52/292 (17%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRI--HHRNLV 658
+ K+IGSGG V+ + + A+K L Q + NE+ L+++ H ++
Sbjct: 13 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 72
Query: 659 QFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLH 716
+ Y + +V E N L L ++ +R ++ K + + + +H
Sbjct: 73 RLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNM------LEAVHTIH 125
Query: 717 T-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPE- 773
G I+H DLK +N L+ M K+ DFG++ D S V GTV Y+ PE
Sbjct: 126 QHG----IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180
Query: 774 ----------YYISQQLTDKSDVYSFGVILLELISGQ---EAISNEKFGANCRNIVQWAK 820
+++ KSDV+S G IL + G+ + I N+ + I+
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--SKLHAIID-PN 237
Query: 821 LHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872
IE I + L D ++ K + K R SI E+L
Sbjct: 238 HEIE---FPDIPEKDLQDV--LKCCLKRDPK----------QRISIPELLAH 274
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-31
Identities = 67/267 (25%), Positives = 109/267 (40%), Gaps = 28/267 (10%)
Query: 553 FMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSD---IEDATKMLEKKIGS 609
F E L ++ N A ++SD + L + +G
Sbjct: 22 FQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGH 81
Query: 610 GGFGVVYYGKLKDGK------EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLG 662
G FG VY G++ ++AVK L S Q + +F E ++S+ +H+N+V+ +G
Sbjct: 82 GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIG 141
Query: 663 YCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 719
+ ++ E M G LK L + + + L +A D A G +YL
Sbjct: 142 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH 201
Query: 720 VPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL-----D 771
IHRD+ + N LL AK+ DFG+++ +G L
Sbjct: 202 ---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA----GYYRKGGCAMLPVKWMP 254
Query: 772 PEYYISQQLTDKSDVYSFGVILLELIS 798
PE ++ T K+D +SFGV+L E+ S
Sbjct: 255 PEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 51/234 (21%), Positives = 88/234 (37%), Gaps = 59/234 (25%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRIHHR 655
+++G FG VY G L +A+K L + EF +E L +R+ H
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 656 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIKRLE 703
N+V LG ++ +++ + +G L E L T + + +
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 704 IAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 762
+ A G+EYL + V H+DL + N+L+ + K+SD GL +
Sbjct: 133 LVAQIAAGMEYLSSHHVV----HKDLATRNVLVYDKLNVKISDLGLFREVYAA------- 181
Query: 763 VRGTVGYLDPEYYISQQL------------------TDKSDVYSFGVILLELIS 798
+YY + SD++S+GV+L E+ S
Sbjct: 182 ----------DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-30
Identities = 60/262 (22%), Positives = 105/262 (40%), Gaps = 34/262 (12%)
Query: 558 KKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYY 617
K+ K + +H + A + A C + ++ + K+IGSGG V+
Sbjct: 18 KETAAAKFERQHMDSPDLGTDDDDKASSSANECIS---VKGRIYSILKQIGSGGSSKVFQ 74
Query: 618 GKLKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNL--VQFLGYCQEEGRSVLV 673
+ + A+K L Q + NE+ L+++ + ++ Y + +V
Sbjct: 75 VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134
Query: 674 YEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKS 730
E N L L ++ +R ++ K + E + +H G I+H DLK
Sbjct: 135 MEC-GNIDLNSWLKKKKSIDPWERKSYWK--NMLE----AVHTIHQHG----IVHSDLKP 183
Query: 731 SNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPE-----------YYISQ 778
+N L+ M K+ DFG++ D S V G V Y+ PE
Sbjct: 184 ANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKS 242
Query: 779 QLTDKSDVYSFGVILLELISGQ 800
+++ KSDV+S G IL + G+
Sbjct: 243 KISPKSDVWSLGCILYYMTYGK 264
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-30
Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 27/211 (12%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFL 661
+ +G G G + Y + D +++AVK + + EV LL H N++++
Sbjct: 28 PKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD---REVQLLRESDEHPNVIRY- 83
Query: 662 GYCQEEGRSV--LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-G 718
+C E+ R + E TL+E++ + ++ + + + G+ +LH+
Sbjct: 84 -FCTEKDRQFQYIAIELC-AATLQEYV---EQKDFAHLGLEPITLLQQTTSGLAHLHSLN 138
Query: 719 CVPAIIHRDLKSSNILL-----DKHMRAKVSDFGLSKFAVDGAS--HVSSIVRGTVGYLD 771
I+HRDLK NIL+ ++A +SDFGL K G S V GT G++
Sbjct: 139 ----IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 772 PEYY---ISQQLTDKSDVYSFGVILLELISG 799
PE + T D++S G + +IS
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 43/208 (20%), Positives = 86/208 (41%), Gaps = 23/208 (11%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSN-----SYQGKREFTNEVTLLSRIHHRN 656
L + +G GG G VY + + +A+K+++ ++ + E R+ +
Sbjct: 38 LRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTR--MQREARTAGRLQEPH 95
Query: 657 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEY 714
+V + + +G+ + ++ L L G L + + I ++
Sbjct: 96 VVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRA------VAIVRQIGSALDA 149
Query: 715 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS--HVSSIVRGTVGYLDP 772
H HRD+K NIL+ A + DFG++ A + + V GT+ Y+ P
Sbjct: 150 AHAA---GATHRDVKPENILVSADDFAYLVDFGIAS-ATTDEKLTQLGNTV-GTLYYMAP 204
Query: 773 EYYISQQLTDKSDVYSFGVILLELISGQ 800
E + T ++D+Y+ +L E ++G
Sbjct: 205 ERFSESHATYRADIYALTCVLYECLTGS 232
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-30
Identities = 56/223 (25%), Positives = 105/223 (47%), Gaps = 34/223 (15%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKE--------IAVKVLTSN-SYQGKREFTNEVTLLSRI- 652
L K +G G FG V + + +AVK+L + + + + +E+ ++ I
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 653 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIK 700
H+N++ LG C ++G ++ E+ G L+E+L E+++ +
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 701 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 760
+ A+G+EYL + IHRDL + N+L+ ++ K++DFGL++ +
Sbjct: 159 LVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNI----D 211
Query: 761 SIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 798
+ T G L PE + T +SDV+SFGV++ E+ +
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-30
Identities = 63/222 (28%), Positives = 96/222 (43%), Gaps = 33/222 (14%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRI-HH 654
L K +G G FG V + +AVK+L ++ R +E+ +L I HH
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 655 RNLVQFLGYCQEEGRSV-LVYEFMHNGTLKEHL------------YGTLTHEQRINWIKR 701
N+V LG C + G + ++ EF G L +L ++ +
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 702 LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 761
+ + AKG+E+L + IHRDL + NILL + K+ DFGL++
Sbjct: 151 ICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKD----PD 203
Query: 762 IVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 798
VR L PE + T +SDV+SFGV+L E+ S
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-30
Identities = 70/300 (23%), Positives = 117/300 (39%), Gaps = 54/300 (18%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFL 661
EK +G G G V + G+ +AVK + + E+ LL+ H N++++
Sbjct: 19 SEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIAL---MEIKLLTESDDHPNVIRY- 74
Query: 662 GYCQEEGRSV--LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE---DAAKGIEYLH 716
YC E + E N L++ + ++ + K A G+ +LH
Sbjct: 75 -YCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 717 TGCVPAIIHRDLKSSNILLD-------------KHMRAKVSDFGLSKFAVDGASHVSSIV 763
+ IIHRDLK NIL+ +++R +SDFGL K G S + +
Sbjct: 133 SLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 764 R---GTVGYLDPE-------YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCR 813
GT G+ PE ++LT D++S G + ++S FG
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK----GKHPFGDKYS 245
Query: 814 NIVQWAKLHIESGDIQGIIDPSLLDE-YD-IQSMWKIEEKALMCVLPHGHMRPSISEVLK 871
+ +++ + D SL+ E D I M + P RP+ +VL+
Sbjct: 246 RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQM--------IDHDP--LKRPTAMKVLR 295
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 8e-30
Identities = 60/224 (26%), Positives = 94/224 (41%), Gaps = 36/224 (16%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRI-HH 654
K +G+G FG V + +AVK+L + + +E+ +LS + +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 655 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--------------YGTLTHEQRINWIK 700
N+V LG C G ++++ E+ G L L E ++
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 701 RLEIAEDAAKGIEYLH-TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759
L + AKG+ +L C IHRDL + NILL K+ DFGL++ +
Sbjct: 147 LLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKND---- 198
Query: 760 SSIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 798
S+ V L PE + T +SDV+S+G+ L EL S
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 9e-30
Identities = 62/249 (24%), Positives = 108/249 (43%), Gaps = 13/249 (5%)
Query: 554 MHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFG 613
MH ++ + +L Q V + A D K IG G G
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVK-IGEGSTG 59
Query: 614 VVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 672
+V + G+++AVK++ Q + NEV ++ H N+V+ +
Sbjct: 60 IVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWV 119
Query: 673 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSN 732
+ EF+ G L + + +E++I + + + YLH +IHRD+KS +
Sbjct: 120 LMEFLQGGALTDIVSQVRLNEEQIATVCE-----AVLQALAYLHA---QGVIHRDIKSDS 171
Query: 733 ILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD-KSDVYSFGV 791
ILL R K+SDFG S+V GT ++ PE IS+ L + D++S G+
Sbjct: 172 ILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPE-VISRSLYATEVDIWSLGI 229
Query: 792 ILLELISGQ 800
+++E++ G+
Sbjct: 230 MVIEMVDGE 238
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 59/231 (25%), Positives = 104/231 (45%), Gaps = 45/231 (19%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRIHHR 655
L K +G G FG V K +AVK+L N S R+ +E +L +++H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 656 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--------------------YGTLTHEQR 695
++++ G C ++G +L+ E+ G+L+ L E+
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 696 INWIKRLEIAEDAAKGIEYL---HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 752
+ + A ++G++YL ++HRDL + NIL+ + + K+SDFGLS+
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMK------LVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 753 VDGASHVSSIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 798
+ S V+ + G + E T +SDV+SFGV+L E+++
Sbjct: 201 YEE----DSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 53/217 (24%), Positives = 87/217 (40%), Gaps = 28/217 (12%)
Query: 603 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 660
L +G G V+ G+ K G A+KV + S+ + E +L +++H+N+V+
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 661 LGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE---DAAKGIEYL 715
+E VL+ EF G+L L + E D G+ +L
Sbjct: 73 FAIEEETTTRHKVLIMEFCPCGSLYTVL----EEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 716 HTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 771
I+HR++K NI+ D K++DFG ++ D VS GT YL
Sbjct: 129 REN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--GTEEYLH 183
Query: 772 PEYY--------ISQQLTDKSDVYSFGVILLELISGQ 800
P+ Y ++ D++S GV +G
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 51/205 (24%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKR---EFTNEVTLLSRIHHRNLV 658
+ +G GGF + + A K++ + + + E+++ + H+++V
Sbjct: 19 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVV 78
Query: 659 QFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLH 716
F G+ ++ +V E +L E LT + +++++ G +YLH
Sbjct: 79 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI------VLGCQYLH 132
Query: 717 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLDPEYY 775
V IHRDLK N+ L++ + K+ DFGL+ K DG GT Y+ PE
Sbjct: 133 RNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYIAPE-V 186
Query: 776 ISQQLTD-KSDVYSFGVILLELISG 799
+S++ + DV+S G I+ L+ G
Sbjct: 187 LSKKGHSFEVDVWSIGCIMYTLLVG 211
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-29
Identities = 59/223 (26%), Positives = 106/223 (47%), Gaps = 34/223 (15%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGK--------EIAVKVLTSN-SYQGKREFTNEVTLLSRI- 652
L K +G G FG V + ++AVK+L S+ + + + +E+ ++ I
Sbjct: 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 653 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIK 700
H+N++ LG C ++G ++ E+ G L+E+L + E++++
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 701 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 760
+ A A+G+EYL + IHRDL + N+L+ + K++DFGL++
Sbjct: 193 LVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI----D 245
Query: 761 SIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 798
+ T G L PE + T +SDV+SFGV+L E+ +
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-29
Identities = 45/207 (21%), Positives = 84/207 (40%), Gaps = 26/207 (12%)
Query: 603 LEKKIGSGGFGVVYYGK--LKDGKEIAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQ 659
++ I GG G +Y +G+ + +K L S + + E L+ + H ++VQ
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 660 FLGYCQEEGRSV-----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 714
+ + R +V E++ +LK L + I + + Y
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAI------AYLLEILPALSY 197
Query: 715 LHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 773
LH+ G +++ DLK NI+L + + K+ D G ++ ++ GT G+ PE
Sbjct: 198 LHSIG----LVYNDLKPENIMLTEE-QLKLIDLGAVS-RINSFGYLY----GTPGFQAPE 247
Query: 774 YYISQQLTDKSDVYSFGVILLELISGQ 800
+ T +D+Y+ G L L
Sbjct: 248 I-VRTGPTVATDIYTVGRTLAALTLDL 273
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 51/205 (24%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKR---EFTNEVTLLSRIHHRNLV 658
+ +G GGF + + A K++ + + + E+++ + H+++V
Sbjct: 45 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVV 104
Query: 659 QFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLH 716
F G+ ++ +V E +L E LT + +++++ G +YLH
Sbjct: 105 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI------VLGCQYLH 158
Query: 717 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLDPEYY 775
V IHRDLK N+ L++ + K+ DFGL+ K DG GT Y+ PE
Sbjct: 159 RNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYIAPE-V 212
Query: 776 ISQQLTD-KSDVYSFGVILLELISG 799
+S++ + DV+S G I+ L+ G
Sbjct: 213 LSKKGHSFEVDVWSIGCIMYTLLVG 237
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-29
Identities = 56/220 (25%), Positives = 93/220 (42%), Gaps = 32/220 (14%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRI-HH 654
K +G+G FG V + +AVK+L S K +E+ ++S + H
Sbjct: 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 655 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL----------YGTLTHEQRINWIKRLEI 704
N+V LG C G +++ E+ G L L + L
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 705 AEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV 763
+ A+G+ +L + C IHRD+ + N+LL AK+ DFGL++ ++ S+ +
Sbjct: 170 SSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMND----SNYI 221
Query: 764 RGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 798
L PE T +SDV+S+G++L E+ S
Sbjct: 222 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 52/205 (25%), Positives = 98/205 (47%), Gaps = 19/205 (9%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLV 658
+ +G G F VY + + G E+A+K++ + + NEV + ++ H +++
Sbjct: 15 VGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSIL 74
Query: 659 QFLGYCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRINWIKRLEIAEDAAKGIEYL 715
+ Y ++ LV E HNG + +L + + +++ ++ G+ YL
Sbjct: 75 ELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI------ITGMLYL 128
Query: 716 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLDPEY 774
H+ + +HRDL SN+LL ++M K++DFGL+ + + H + GT Y+ PE
Sbjct: 129 HSHGI---LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC--GTPNYISPEI 183
Query: 775 YISQQLTDKSDVYSFGVILLELISG 799
+SDV+S G + L+ G
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIG 208
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-29
Identities = 53/217 (24%), Positives = 87/217 (40%), Gaps = 28/217 (12%)
Query: 603 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 660
L +G G V+ G+ K G A+KV + S+ + E +L +++H+N+V+
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 661 LGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE---DAAKGIEYL 715
+E VL+ EF G+L L + E D G+ +L
Sbjct: 73 FAIEEETTTRHKVLIMEFCPCGSLYTVL----EEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 716 HTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 771
I+HR++K NI+ D K++DFG ++ D VS GT YL
Sbjct: 129 REN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--GTEEYLH 183
Query: 772 PEYY--------ISQQLTDKSDVYSFGVILLELISGQ 800
P+ Y ++ D++S GV +G
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 4e-29
Identities = 56/226 (24%), Positives = 104/226 (46%), Gaps = 40/226 (17%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKE--------IAVKVLTSN-SYQGKREFTNEVTLLSRI- 652
L K +G G FG V + + +AVK+L + + + + +E+ ++ I
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 653 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIK 700
H+N++ LG C ++G ++ E+ G L+E+L E+++ +
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 701 RLEIAEDAAKGIEYL---HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757
+ A+G+EYL IHRDL + N+L+ ++ K++DFGL++ +
Sbjct: 205 LVSCTYQLARGMEYLASQK------CIHRDLAARNVLVTENNVMKIADFGLARDINNI-- 256
Query: 758 HVSSIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 798
+ T G L PE + T +SDV+SFGV++ E+ +
Sbjct: 257 --DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-29
Identities = 50/204 (24%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 605 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 663
++G G FG V+ K + G + AVK + ++ E+ + + +V G
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGA 118
Query: 664 CQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 721
+E + E + G+L + + G L E R + A +G+EYLHT
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGCLP-EDRALYYLG-----QALEGLEYLHTRR-- 170
Query: 722 AIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGASHVSSI----VRGTVGYLDPEYYI 776
I+H D+K+ N+LL RA + DFG + S + + GT ++ PE +
Sbjct: 171 -ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229
Query: 777 SQQLTDKSDVYSFGVILLELISGQ 800
+ K D++S ++L +++G
Sbjct: 230 GKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 7e-29
Identities = 58/228 (25%), Positives = 93/228 (40%), Gaps = 39/228 (17%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRI-HH 654
K +GSG FG V + +AVK+L + +E+ +++++ H
Sbjct: 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 108
Query: 655 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL-------------YGTLTHEQRINWIKR 701
N+V LG C G L++E+ G L +L Y + +
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 702 L------EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755
L A AKG+E+L +HRDL + N+L+ K+ DFGL++ +
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 756 ASHVSSIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 798
S+ V L PE T KSDV+S+G++L E+ S
Sbjct: 226 ----SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 1e-28
Identities = 27/271 (9%), Positives = 67/271 (24%), Gaps = 41/271 (15%)
Query: 564 KEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD- 622
+E + + V++ +L + L + + G VV+ + +
Sbjct: 27 EEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVER 86
Query: 623 GKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQFLGYCQEEGRS--------- 670
++ A+KV T + + E +R+ + + + S
Sbjct: 87 LEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP 146
Query: 671 -----------------VLVYEFMH--NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 711
+L+ L L + + +
Sbjct: 147 PFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRL 206
Query: 712 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 771
L + ++H N+ + R + D V Y
Sbjct: 207 AANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW----KVGTRGPASSVPVTYAP 259
Query: 772 PEYYISQ--QLTDKSDVYSFGVILLELISGQ 800
E+ + T + + G+ + +
Sbjct: 260 REFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 58/229 (25%), Positives = 94/229 (41%), Gaps = 41/229 (17%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRIHHR 655
+ IG G FG V+ + +AVK+L S + +F E L++ +
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 656 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--------------------YGTLTHEQR 695
N+V+ LG C L++E+M G L E L +
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 696 INWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 754
++ ++L IA A G+ YL V HRDL + N L+ ++M K++DFGLS+
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSERKFV----HRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 755 GASHVSSIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 798
+ PE + T +SDV+++GV+L E+ S
Sbjct: 227 A----DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-28
Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 23/212 (10%)
Query: 603 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 660
+++++G+GGFG V +D G+++A+K RE + E+ ++ +++H N+V
Sbjct: 18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77
Query: 661 L------GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE---DAAKG 711
+L E+ G L+++L + +K I D +
Sbjct: 78 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL----NQFENCCGLKEGPIRTLLSDISSA 133
Query: 712 IEYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 768
+ YLH IIHRDLK NI+L + + K+ D G +K G + V GT+
Sbjct: 134 LRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFV-GTLQ 188
Query: 769 YLDPEYYISQQLTDKSDVYSFGVILLELISGQ 800
YL PE ++ T D +SFG + E I+G
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 12/212 (5%)
Query: 592 TLSDIEDATKMLEK--KIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTL 648
++ + D K + KIG G G VY + G+E+A++ + K NE+ +
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 649 LSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDA 708
+ + N+V +L +V E++ G+L + + T E +I + R +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----EC 125
Query: 709 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 768
+ +E+LH+ +IHRD+KS NILL K++DFG S S++V GT
Sbjct: 126 LQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPY 181
Query: 769 YLDPEYYISQQLTDKSDVYSFGVILLELISGQ 800
++ PE + K D++S G++ +E+I G+
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 63/338 (18%), Positives = 111/338 (32%), Gaps = 91/338 (26%)
Query: 604 EKKIGSGGFGVVYYGKLK-DGKEIAVK-VLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 661
+ +G GGFGVV+ K K D A+K + N + + EV L+++ H +V++
Sbjct: 11 IQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYF 70
Query: 662 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI------------------------- 696
E E E L+ +
Sbjct: 71 NAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPS 130
Query: 697 -------------------NWIKR------------LEIAEDAAKGIEYLHTGCVPAIIH 725
+W+ R L I A+ +E+LH+ ++H
Sbjct: 131 SPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS---KGLMH 187
Query: 726 RDLKSSNILLDKHMRAKVSDFGLSK---FAVDGASHVSSIVR--------GTVGYLDPEY 774
RDLK SNI KV DFGL + + ++ + GT Y+ PE
Sbjct: 188 RDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQ 247
Query: 775 YISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 834
+ K D++S G+IL EL+ F + +
Sbjct: 248 IHGNNYSHKVDIFSLGLILFELLYS--------FSTQMERVRIITDVR------NLKFPL 293
Query: 835 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872
+Y + M + + ++ P RP ++++++
Sbjct: 294 LFTQKYPQEHMM-V--QDMLSPSP--TERPEATDIIEN 326
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-28
Identities = 67/212 (31%), Positives = 96/212 (45%), Gaps = 33/212 (15%)
Query: 603 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLV 658
++ +G G FG V K K G+E AVKV++ + K + EV LL ++ H N++
Sbjct: 30 GQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIM 89
Query: 659 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-------- 710
+ + +++G LV E G L + I I R +E A
Sbjct: 90 KLYEFFEDKGYFYLVGEVYTGGELFD----------EI--ISRKRFSEVDAARIIRQVLS 137
Query: 711 GIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 767
GI Y+H I+HRDLK N+LL K ++ DFGLS I GT
Sbjct: 138 GITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTA 192
Query: 768 GYLDPEYYISQQLTDKSDVYSFGVILLELISG 799
Y+ PE + +K DV+S GVIL L+SG
Sbjct: 193 YYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-28
Identities = 40/217 (18%), Positives = 69/217 (31%), Gaps = 22/217 (10%)
Query: 603 LEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN 656
+ +G G F VY D ++ +KV + T + L
Sbjct: 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHM 128
Query: 657 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHL-YGTLTHEQRINWIKRLEIAEDAAKGIEYL 715
++F + SVLV E GTL + T E+ + + A IE +
Sbjct: 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV 188
Query: 716 HTGCVPAIIHRDLKSSNILLDKHMRA-----------KVSDFGLSKFA-VDGASHVSSIV 763
H IIH D+K N +L + D G S + + +
Sbjct: 189 HDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245
Query: 764 RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 800
T G+ E ++ + D + + ++ G
Sbjct: 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-28
Identities = 61/295 (20%), Positives = 116/295 (39%), Gaps = 56/295 (18%)
Query: 603 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 660
++K+GSG FG V+ + + G E +K + + Q E E+ +L + H N+++
Sbjct: 26 FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKI 85
Query: 661 LGYCQEEGRSVLVYEFMHNGTL------KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 714
++ +V E G L + L+ +K++ + Y
Sbjct: 86 FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQM------MNALAY 139
Query: 715 LHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 770
H+ ++H+DLK NIL H K+ DFGL++ H ++ GT Y+
Sbjct: 140 FHSQH----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-EHSTNAA-GTALYM 193
Query: 771 DPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 830
PE + +T K D++S GV++ L++G F ++
Sbjct: 194 APE-VFKRDVTFKCDIWSAGVVMYFLLTGCLP-----F---------TGT------SLEE 232
Query: 831 IIDPSLLDEYDIQSMWK-IEEKA------LMCVLPHGHMRPSISEVLKD--IQDA 876
+ + E + + + +A ++ P RPS ++VL + A
Sbjct: 233 VQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDP--ERRPSAAQVLHHEWFKQA 285
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 6e-28
Identities = 68/250 (27%), Positives = 103/250 (41%), Gaps = 34/250 (13%)
Query: 566 QHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKM--LEKKIGSGGFGVVYYGKLK-D 622
H H R F S ++M KK+GSG +G V + K
Sbjct: 2 HHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVT 61
Query: 623 GKEIAVKVLTSNSYQGKRE--FTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 680
E A+K++ S EV +L + H N+++ + +++ LV E G
Sbjct: 62 HVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGG 121
Query: 681 TLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIEYLHTGCVPAIIHRDLKSSN 732
L + I I R++ E A G+ YLH I+HRDLK N
Sbjct: 122 ELFD----------EI--IHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPEN 166
Query: 733 ILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSF 789
+LL +K K+ DFGLS + + GT Y+ PE + ++ +K DV+S
Sbjct: 167 LLLESKEKDALIKIVDFGLSAVFENQKKMKERL--GTAYYIAPE-VLRKKYDEKCDVWSI 223
Query: 790 GVILLELISG 799
GVIL L++G
Sbjct: 224 GVILFILLAG 233
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 7e-28
Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 32/210 (15%)
Query: 603 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 661
+ +GSG F V+ K + GK A+K + + NE+ +L +I H N+V
Sbjct: 13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 662 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE-DAAK-------GIE 713
+ LV + + G L + RI ++R E DA+ ++
Sbjct: 73 DIYESTTHYYLVMQLVSGGELFD----------RI--LERGVYTEKDASLVIQQVLSAVK 120
Query: 714 YLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 769
YLH G I+HRDLK N+L +++ + ++DFGLSK +G +S+ GT GY
Sbjct: 121 YLHENG----IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTAC-GTPGY 173
Query: 770 LDPEYYISQQLTDKSDVYSFGVILLELISG 799
+ PE + + D +S GVI L+ G
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 50/213 (23%), Positives = 89/213 (41%), Gaps = 27/213 (12%)
Query: 603 LEKKIGSGGFGVVYYGKLKD-GKEIAVKV-----LTSNSYQGKREFTNEVTLLSRIHHRN 656
L + IG G F VV ++ G++ AVK+ TS+ + E ++ + H +
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 657 LVQFLGYCQEEGRSVLVYEFMHNGTL------KEHLYGTLTHEQRINWIKRLEIAEDAAK 710
+V+ L +G +V+EFM L + + ++++++ +
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI------LE 141
Query: 711 GIEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGT 766
+ Y H IIHRD+K +LL + K+ FG++ + V GT
Sbjct: 142 ALRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GT 196
Query: 767 VGYLDPEYYISQQLTDKSDVYSFGVILLELISG 799
++ PE + DV+ GVIL L+SG
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 58/226 (25%), Positives = 107/226 (47%), Gaps = 20/226 (8%)
Query: 584 PAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREF 642
E H D + +++ + +G G FG VY K + G A KV+ + S + ++
Sbjct: 5 SREYEHVRRDLDPNEVWEIVGE-LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDY 63
Query: 643 TNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK---EHLYGTLTHEQRINWI 699
E+ +L+ H +V+ LG +G+ ++ EF G + L LT E +I +
Sbjct: 64 IVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLT-EPQIQVV 122
Query: 700 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759
R + + +LH+ IIHRDLK+ N+L+ +++DFG+S +
Sbjct: 123 CR-----QMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR 174
Query: 760 SSIVRGTVGYLDPEYYISQQLTD-----KSDVYSFGVILLELISGQ 800
S + GT ++ PE + + + D K+D++S G+ L+E+ +
Sbjct: 175 DSFI-GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-27
Identities = 68/212 (32%), Positives = 97/212 (45%), Gaps = 34/212 (16%)
Query: 603 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQ 659
+ +G G FG V K + +E AVKV+ S + K EV LL ++ H N+++
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 660 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE-DAAK-------G 711
++ +V E G L + I IKR +E DAA+ G
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFD----------EI--IKRKRFSEHDAARIIKQVFSG 133
Query: 712 IEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 767
I Y+H I+HRDLK NILL +K K+ DFGLS + + + GT
Sbjct: 134 ITYMHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTA 187
Query: 768 GYLDPEYYISQQLTDKSDVYSFGVILLELISG 799
Y+ PE + +K DV+S GVIL L+SG
Sbjct: 188 YYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-27
Identities = 43/308 (13%), Positives = 86/308 (27%), Gaps = 61/308 (19%)
Query: 565 EQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDG 623
VS+ + + T + +G + G
Sbjct: 39 TSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETG 98
Query: 624 KEIAVKVLTSNSYQG-------KRE---------------------FTNEVTLLSRIHHR 655
+ V V K E F L+ +
Sbjct: 99 ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKK 158
Query: 656 NLVQFLGYCQEEGRS--VLVYEFMH--NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 711
+++ ++ +Y M T E L + + + RL++ +
Sbjct: 159 KMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRL 218
Query: 712 IEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 770
+ LH G ++H L+ +I+LD+ ++ F DGA VS + G+
Sbjct: 219 LASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLVR--DGARVVS---SVSRGFE 269
Query: 771 DPEYYISQQL-----------TDKSDVYSFGVILLELISGQ-------EAISNEKFGANC 812
PE + T D ++ G+++ + +E +C
Sbjct: 270 PPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSC 329
Query: 813 RNIVQWAK 820
+NI Q +
Sbjct: 330 KNIPQPVR 337
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 56/246 (22%), Positives = 99/246 (40%), Gaps = 37/246 (15%)
Query: 570 SLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AV 628
+ P S + P D + K +G G F V + A+
Sbjct: 6 AEPRPGAGSLQHAQPPPQPRKKRPEDFK-----FGKILGEGSFSTVVLARELATSREYAI 60
Query: 629 KVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEH 685
K+L + + E ++SR+ H V+ Q++ + + NG L ++
Sbjct: 61 KILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKY 120
Query: 686 LYGTLTHEQRINWIKRLEIAEDAAK--------GIEYLHTGCVPAIIHRDLKSSNILLDK 737
+ + E + +EYLH IIHRDLK NILL++
Sbjct: 121 IR----KIGSFD--------ETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNE 165
Query: 738 HMRAKVSDFGLSKFAVDGASHV--SSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILL 794
M +++DFG +K + +S V GT Y+ PE ++++ KS D+++ G I+
Sbjct: 166 DMHIQITDFGTAKVLSPESKQARANSFV-GTAQYVSPE-LLTEKSACKSSDLWALGCIIY 223
Query: 795 ELISGQ 800
+L++G
Sbjct: 224 QLVAGL 229
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 8e-27
Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 2/94 (2%)
Query: 414 PSITVIHLSSKN-LTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF-SGCPDLRIIHLEDN 471
P + +++ N L G IP + KL+ L L++ +++G IPDF S L + N
Sbjct: 76 PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYN 135
Query: 472 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 505
L+G LP S+ +LPNL + N +SG +P S
Sbjct: 136 ALSGTLPPSISSLPNLVGITFDGNRISGAIPDSY 169
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 2e-26
Identities = 29/107 (27%), Positives = 44/107 (41%), Gaps = 1/107 (0%)
Query: 415 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLT 474
++ + LS L G+ + ++ L NSL + +L + L +N++
Sbjct: 198 NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIY 257
Query: 475 GPLPSSLMNLPNLRELYVQNNMLSGTVPSSL-LSKNVVLNYAGNINL 520
G LP L L L L V N L G +P L + V YA N L
Sbjct: 258 GTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCL 304
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 40/145 (27%), Positives = 64/145 (44%), Gaps = 9/145 (6%)
Query: 380 SVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP-SITVIHLSSKNLTG--NIPSDLTK 436
+ + + + W C W + C++D Q + + LS NL IPS L
Sbjct: 17 DLGNPTTLSSWL--PTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLAN 74
Query: 437 LSSLVELWL-DGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 494
L L L++ N+L GPIP + L +++ ++G +P L + L L
Sbjct: 75 LPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSY 134
Query: 495 NMLSGTVPSSL--LSKNVVLNYAGN 517
N LSGT+P S+ L V + + GN
Sbjct: 135 NALSGTLPPSISSLPNLVGITFDGN 159
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 28/109 (25%), Positives = 55/109 (50%), Gaps = 12/109 (11%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQ 472
+ ++++ N++G IP L+++ +LV L N+L+G +P S P+L I + N+
Sbjct: 101 TQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160
Query: 473 LTGPLPSSLMNLPNLRE-LYVQNNMLSGTVPSSLLSKNVVLNYAGNINL 520
++G +P S + L + + N L+G +P + N+NL
Sbjct: 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTF----------ANLNL 199
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 1e-21
Identities = 21/91 (23%), Positives = 37/91 (40%), Gaps = 1/91 (1%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVE-LWLDGNSLTGPIPDFSGCPDLRIIHLEDNQ 472
P++ I ++G IP S L + + N LTG IP +L + L N
Sbjct: 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNM 208
Query: 473 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPS 503
L G + N +++++ N L+ +
Sbjct: 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGK 239
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 2e-09
Identities = 17/68 (25%), Positives = 30/68 (44%), Gaps = 2/68 (2%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
++ + L + + G +P LT+L L L + N+L G IP + +N+
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKC 303
Query: 474 T--GPLPS 479
PLP+
Sbjct: 304 LCGSPLPA 311
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 55/220 (25%), Positives = 102/220 (46%), Gaps = 23/220 (10%)
Query: 591 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE-FTNEVT- 647
D+E ++G G +GVV + G+ +AVK + + +++ ++
Sbjct: 4 VKADDLEP-----IMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDI 58
Query: 648 LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI--NWIKRLEIA 705
+ + V F G EG + E M + +L + + Q I + + + IA
Sbjct: 59 SMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK--IA 115
Query: 706 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG 765
K +E+LH+ ++IHRD+K SN+L++ + K+ DFG+S + VD + G
Sbjct: 116 VSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA--G 171
Query: 766 TVGYLDPEYYISQQLTD-----KSDVYSFGVILLELISGQ 800
Y+ PE I+ +L KSD++S G+ ++EL +
Sbjct: 172 CKPYMAPE-RINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-26
Identities = 67/223 (30%), Positives = 99/223 (44%), Gaps = 45/223 (20%)
Query: 603 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVL-------------TSNSYQGKREFTNEVTL 648
+K+GSG +G V K K E A+KV+ N + E NE++L
Sbjct: 40 KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99
Query: 649 LSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDA 708
L + H N+++ +++ LV EF G L E +I I R + E
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFE----------QI--INRHKFDECD 147
Query: 709 AK--------GIEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGA 756
A GI YLH I+HRD+K NILL + + K+ DFGLS F
Sbjct: 148 AANIMKQILSGICYLHKHN----IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD- 202
Query: 757 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 799
+ + GT Y+ PE + ++ +K DV+S GVI+ L+ G
Sbjct: 203 YKLRDRL-GTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 49/210 (23%), Positives = 78/210 (37%), Gaps = 32/210 (15%)
Query: 603 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 661
LE IG G +G V K A K + + F E+ ++ + H N+++
Sbjct: 13 LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLY 72
Query: 662 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIE 713
++ LV E G L E R+ + + E A +
Sbjct: 73 ETFEDNTDIYLVMELCTGGELFE----------RV--VHKRVFRESDAARIMKDVLSAVA 120
Query: 714 YLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 769
Y H + HRDLK N L K+ DFGL+ G + + V GT Y
Sbjct: 121 YCHKLN----VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTKV-GTPYY 174
Query: 770 LDPEYYISQQLTDKSDVYSFGVILLELISG 799
+ P+ + + D +S GV++ L+ G
Sbjct: 175 VSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 203
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-26
Identities = 22/118 (18%), Positives = 50/118 (42%), Gaps = 4/118 (3%)
Query: 400 PVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSG 459
W+ + + + +S ++G++ +++ +L L + N+ + IP
Sbjct: 166 ANVVGWVLSDGCG--ELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLGD 221
Query: 460 CPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
C L+ + + N+L+G ++ L+ L + +N G +P L L+ A N
Sbjct: 222 CSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAEN 279
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-25
Identities = 39/111 (35%), Positives = 54/111 (48%), Gaps = 4/111 (3%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 472
+ +HLS L+G IPS L LS L +L L N L G IP L + L+ N
Sbjct: 418 SELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFND 477
Query: 473 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINLH 521
LTG +PS L N NL + + NN L+G +P + L +L + N +
Sbjct: 478 LTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNN-SFS 527
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-24
Identities = 37/121 (30%), Positives = 57/121 (47%), Gaps = 6/121 (4%)
Query: 400 PVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFS 458
P+ + Q P+ ++ ++L + TG IP L+ S LV L L N L+G IP
Sbjct: 383 PILPNLCQN---PKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLG 439
Query: 459 GCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAG 516
LR + L N L G +P LM + L L + N L+G +PS L + ++ +
Sbjct: 440 SLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSN 499
Query: 517 N 517
N
Sbjct: 500 N 500
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 7e-24
Identities = 31/128 (24%), Positives = 58/128 (45%), Gaps = 3/128 (2%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQ 472
++ + L +LTG IPS L+ ++L + L N LTG IP +L I+ L +N
Sbjct: 466 KTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNS 525
Query: 473 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINLHEGGRGAKHL 530
+G +P+ L + +L L + N+ +GT+P+++ S + N+
Sbjct: 526 FSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKK 585
Query: 531 NIIIGSSV 538
++
Sbjct: 586 ECHGAGNL 593
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-23
Identities = 39/95 (41%), Positives = 54/95 (56%), Gaps = 3/95 (3%)
Query: 414 PSITVIHLSSKNLTGNIPSDL--TKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLED 470
S+ + LSS N +G I +L ++L EL+L N TG IP S C +L +HL
Sbjct: 368 ASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSF 427
Query: 471 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 505
N L+G +PSSL +L LR+L + NML G +P L
Sbjct: 428 NYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQEL 462
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 9e-23
Identities = 38/124 (30%), Positives = 57/124 (45%), Gaps = 13/124 (10%)
Query: 400 PVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLT-KLSSLVELWLDGNSLTGPIPD-F 457
P+P L S+ + L+ TG IP L+ +L L L GN G +P F
Sbjct: 262 PIPPLPL-------KSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFF 314
Query: 458 SGCPDLRIIHLEDNQLTGPLP-SSLMNLPNLRELYVQNNMLSGTVPSSL--LSKN-VVLN 513
C L + L N +G LP +L+ + L+ L + N SG +P SL LS + + L+
Sbjct: 315 GSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLD 374
Query: 514 YAGN 517
+ N
Sbjct: 375 LSSN 378
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-22
Identities = 31/97 (31%), Positives = 42/97 (43%), Gaps = 4/97 (4%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSG--CPDLRIIHLEDN 471
+ ++++SS G IP L SL L L N TG IPDF C L + L N
Sbjct: 247 TELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGN 304
Query: 472 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 508
G +P + L L + +N SG +P L K
Sbjct: 305 HFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLK 341
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-20
Identities = 31/97 (31%), Positives = 49/97 (50%), Gaps = 5/97 (5%)
Query: 414 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 470
+ + LSS N +G +P D L K+ L L L N +G +P+ + L + L
Sbjct: 318 SLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSS 377
Query: 471 NQLTGPLPSSLMN--LPNLRELYVQNNMLSGTVPSSL 505
N +GP+ +L L+ELY+QNN +G +P +L
Sbjct: 378 NNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTL 414
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 7e-20
Identities = 36/128 (28%), Positives = 53/128 (41%), Gaps = 16/128 (12%)
Query: 388 ADWAQEGGDPCLPVPWSWL--QCNSDPQPSITVIHLSSKNLT---GNIPSDLTKLSSLVE 442
DW +PC ++ C D +T I LSSK L + S L L+ L
Sbjct: 31 PDW-SSNKNPC-----TFDGVTCRDD---KVTSIDLSSKPLNVGFSAVSSSLLSLTGLES 81
Query: 443 LWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPS--SLMNLPNLRELYVQNNMLSGT 500
L+L + + G + F L + L N L+GP+ + SL + L+ L V +N L
Sbjct: 82 LFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFP 141
Query: 501 VPSSLLSK 508
S K
Sbjct: 142 GKVSGGLK 149
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 4e-19
Identities = 25/111 (22%), Positives = 44/111 (39%), Gaps = 7/111 (6%)
Query: 414 PSITVIHLSSKNLTGNIPSD--LTKLSSLVELWLDGNSLTG--PIPDFSGCPDLRIIHLE 469
S+T + LS +L+G + + L S L L + N+L + L ++ L
Sbjct: 100 ASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLS 159
Query: 470 DNQLTGPLPSSLM---NLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
N ++G + L+ L + N +SG V S L+ + N
Sbjct: 160 ANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSN 210
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-18
Identities = 32/108 (29%), Positives = 50/108 (46%), Gaps = 2/108 (1%)
Query: 415 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQL 473
S+ + +S L+G IP ++ + L L L N ++G IPD L I+ L N+L
Sbjct: 633 SMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKL 692
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSS-LLSKNVVLNYAGNINL 520
G +P ++ L L E+ + NN LSG +P + N L
Sbjct: 693 DGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGL 740
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-16
Identities = 18/97 (18%), Positives = 37/97 (38%), Gaps = 1/97 (1%)
Query: 410 SDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHL 468
+D + G L +LS+ + G F + + +
Sbjct: 580 NDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDM 639
Query: 469 EDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 505
N L+G +P + ++P L L + +N +SG++P +
Sbjct: 640 SYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEV 676
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 7e-13
Identities = 17/102 (16%), Positives = 33/102 (32%), Gaps = 5/102 (4%)
Query: 421 LSSKNLTGNIPSDLTKLSSLVELWLDGN--SLTGPIP-DFSGCPDLRIIHLEDNQLTGPL 477
+++ + G + E GN G + ++ G
Sbjct: 565 IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHT 624
Query: 478 PSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 517
+ N ++ L + NMLSG +P + + +LN N
Sbjct: 625 SPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHN 666
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 6e-04
Identities = 14/56 (25%), Positives = 26/56 (46%), Gaps = 4/56 (7%)
Query: 466 IHLEDNQLT---GPLPSSLMNLPNLRELYVQNNMLSGTVPS-SLLSKNVVLNYAGN 517
I L L + SSL++L L L++ N+ ++G+V + L+ + N
Sbjct: 55 IDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRN 110
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-26
Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 26/207 (12%)
Query: 607 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLG 662
+G GGFG V+ ++K ++ A K L + ++ + E +L+++H R +V L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS-LA 251
Query: 663 YC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIE 713
Y + + LV M+ G ++ H+Y E A G+E
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ--------EPRAIFYTAQIVSGLE 303
Query: 714 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 773
+LH II+RDLK N+LLD ++SD GL+ G + GT G++ PE
Sbjct: 304 HLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPE 359
Query: 774 YYISQQLTDKSDVYSFGVILLELISGQ 800
+ ++ D ++ GV L E+I+ +
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-26
Identities = 60/230 (26%), Positives = 98/230 (42%), Gaps = 18/230 (7%)
Query: 574 QRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLT 632
QR + D E ++G+G GVV+ K + A K++
Sbjct: 13 QRKRLEAFLTQKQKVGELKDDDFE-----KISELGAGNGGVVFKVSHKPSGLVMARKLIH 67
Query: 633 SNSYQGKREF-TNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL-YGTL 690
R E+ +L + +V F G +G + E M G+L + L
Sbjct: 68 LEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR 127
Query: 691 THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 750
EQ + +++ KG+ YL I+HRD+K SNIL++ K+ DFG+S
Sbjct: 128 IPEQILG-----KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 180
Query: 751 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 800
+D S +S V GT Y+ PE + +SD++S G+ L+E+ G+
Sbjct: 181 QLID--SMANSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-26
Identities = 47/206 (22%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 603 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 661
+ +++GSG FGVV+ K G+ K + + K NE+++++++HH L+
Sbjct: 55 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH 114
Query: 662 GYCQEEGRSVLVYEFMHNGTL------KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 715
+++ VL+ EF+ G L +++ + + IN+++ + E G++++
Sbjct: 115 DAFEDKYEMVLILEFLSGGELFDRIAAEDYKM---SEAEVINYMR--QACE----GLKHM 165
Query: 716 HTGCVPAIIHRDLKSSNILLDKHMRA--KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 773
H +I+H D+K NI+ + + K+ DFGL+ + + T + PE
Sbjct: 166 HEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPE 220
Query: 774 YYISQQLTDKSDVYSFGVILLELISG 799
+ + +D+++ GV+ L+SG
Sbjct: 221 IVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 44/223 (19%)
Query: 603 LEKKIGSGGFGVVYYGKLKD-GKEIAVKV--------LTSNSYQGKRE-FTNEVTLLSRI 652
++ +G G VV K KE AVK+ ++ Q RE EV +L ++
Sbjct: 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 653 -HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK- 710
H N++Q + LV++ M G L + + +++ ++E +
Sbjct: 81 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFD----------YL--TEKVTLSEKETRK 128
Query: 711 -------GIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 762
I LH I+HRDLK NILLD M K++DFG S +D + +
Sbjct: 129 IMRALLEVICALHKLN----IVHRDLKPENILLDDDMNIKLTDFGFSCQ-LDPGEKLREV 183
Query: 763 VRGTVGYLDPE------YYISQQLTDKSDVYSFGVILLELISG 799
GT YL PE + D++S GVI+ L++G
Sbjct: 184 C-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 66/212 (31%), Positives = 94/212 (44%), Gaps = 34/212 (16%)
Query: 603 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE--FTNEVTLLSRIHHRNLVQ 659
+ +G G FG V K + +E AVKV+ S + K EV LL ++ H N+++
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 660 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------G 711
++ +V E G L + I IKR +E A G
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFD----------EI--IKRKRFSEHDAARIIKQVFSG 133
Query: 712 IEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 767
I Y+H I+HRDLK NILL +K K+ DFGLS + + + GT
Sbjct: 134 ITYMHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTA 187
Query: 768 GYLDPEYYISQQLTDKSDVYSFGVILLELISG 799
Y+ PE + +K DV+S GVIL L+SG
Sbjct: 188 YYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 58/201 (28%), Positives = 106/201 (52%), Gaps = 13/201 (6%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 660
+KIG G FG V+ G + K +A+K++ + + E E+T+LS+ + ++
Sbjct: 26 KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 85
Query: 661 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 720
G ++ + ++ E++ G+ + L E +I I R + KG++YLH+
Sbjct: 86 YGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-----EILKGLDYLHSE-- 138
Query: 721 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 780
IHRD+K++N+LL +H K++DFG++ D ++ V GT ++ PE I Q
Sbjct: 139 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPE-VIKQSA 195
Query: 781 TD-KSDVYSFGVILLELISGQ 800
D K+D++S G+ +EL G+
Sbjct: 196 YDSKADIWSLGITAIELARGE 216
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 71/310 (22%), Positives = 114/310 (36%), Gaps = 54/310 (17%)
Query: 594 SDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRI 652
ED ++ E +G G V +E AVK++ + EV +L +
Sbjct: 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQC 67
Query: 653 -HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE-DAAK 710
HRN+++ + + +EE R LV+E M G++ I KR E +A+
Sbjct: 68 QGHRNVLELIEFFEEEDRFYLVFEKMRGGSILS----------HI--HKRRHFNELEASV 115
Query: 711 -------GIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVS 760
+++LH I HRDLK NIL ++ K+ DF L
Sbjct: 116 VVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSP 172
Query: 761 SIVR------GTVGYLDPE----YYISQQLTDKS-DVYSFGVILLELISGQEAISNEKFG 809
G+ Y+ PE + + DK D++S GVIL L+SG F
Sbjct: 173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP-----FV 227
Query: 810 ANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQS-MWK-IEEKA------LMCVLPHGH 861
C + W + + + +Y+ W I A L+
Sbjct: 228 GRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDA--K 285
Query: 862 MRPSISEVLK 871
R S ++VL+
Sbjct: 286 QRLSAAQVLQ 295
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 7e-26
Identities = 56/258 (21%), Positives = 112/258 (43%), Gaps = 24/258 (9%)
Query: 555 HKGKKNNYDKEQHRHSLPVQRPVSSLNDAP-AEAAHCFTLSDIEDATK------MLEKKI 607
+ ++ YD ++ + + VSS D + + +E + +++
Sbjct: 106 ERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEEL 165
Query: 608 GSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE 666
G+G FGVV+ + G A K + + K E+ +S + H LV ++
Sbjct: 166 GTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED 225
Query: 667 EGRSVLVYEFMHNGTLKEHL---YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 723
+ V++YEFM G L E + + ++ ++ + +++ ++ + G+ ++H
Sbjct: 226 DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR--QVCK----GLCHMHEN---NY 276
Query: 724 IHRDLKSSNILLDKHMRA--KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 781
+H DLK NI+ K+ DFGL+ +D V GT + PE + +
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAH-LDPKQSVKVTT-GTAEFAAPEVAEGKPVG 334
Query: 782 DKSDVYSFGVILLELISG 799
+D++S GV+ L+SG
Sbjct: 335 YYTDMWSVGVLSYILLSG 352
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 63/225 (28%), Positives = 95/225 (42%), Gaps = 22/225 (9%)
Query: 586 EAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKV--LTSNSYQGKREF 642
E FT D++ +IG G +G V K G+ +AVK T + + K+
Sbjct: 14 EQHWDFTAEDLK-----DLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLL 68
Query: 643 TNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI--NWIK 700
+ ++ +VQF G EG + E M K + Y + I +
Sbjct: 69 MDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILG 128
Query: 701 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 760
+ I K + +L IIHRD+K SNILLD+ K+ DFG+S VD +
Sbjct: 129 K--ITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTR 184
Query: 761 SIVRGTVGYLDPEYYISQQLTD-----KSDVYSFGVILLELISGQ 800
G Y+ PE I + +SDV+S G+ L EL +G+
Sbjct: 185 DA--GCRPYMAPE-RIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 52/296 (17%), Positives = 109/296 (36%), Gaps = 62/296 (20%)
Query: 605 KKIGSGGFGVVYYG-KLKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRI-HHRNLVQF 660
+KIGSG FG V+ K DG A+K ++ EV + + H ++V++
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76
Query: 661 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 720
E+ ++ E+ + G+L + + + ++ +G+ Y+H+
Sbjct: 77 FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS--- 133
Query: 721 PAIIHRDLKSSNILLDKH-------------------MRAKVSDFGLSKFAVDGASHVSS 761
+++H D+K SNI + + + K+ D G + +SS
Sbjct: 134 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH-------VTRISS 186
Query: 762 --IVRGTVGYLDPEYYISQQL--TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 817
+ G +L E + + K+D+++ + ++ + N Q
Sbjct: 187 PQVEEGDSRFLANE-VLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---------Q 236
Query: 818 WAKLHIESGDIQGIIDPSLLDEY--DIQSMWKIEEKALMCVLPHGHMRPSISEVLK 871
W + I G + P + + + K + + P RPS ++K
Sbjct: 237 WHE--IRQGRL-----PRIPQVLSQEFTELLK------VMIHPDPERRPSAMALVK 279
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 55/247 (22%), Positives = 83/247 (33%), Gaps = 54/247 (21%)
Query: 603 LEKKIGSGGFGVVYYGKLKD-GKEIAVKV-----LTSNSYQGKREFTNEVTLLSRIHHRN 656
L+ IG G +GVV A+K+ + + + EV L+ ++HH N
Sbjct: 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89
Query: 657 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHL----------------------------YG 688
+ + ++E LV E H G L + L
Sbjct: 90 IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 689 TLTHEQRINWIKRLEIAEDAAK--------GIEYLHT-GCVPAIIHRDLKSSNILL--DK 737
E + YLH G I HRD+K N L +K
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG----ICHRDIKPENFLFSTNK 205
Query: 738 HMRAKVSDFGLSKFAVDGASHVSSIVR---GTVGYLDPE--YYISQQLTDKSDVYSFGVI 792
K+ DFGLSK + + GT ++ PE ++ K D +S GV+
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 793 LLELISG 799
L L+ G
Sbjct: 266 LHLLLMG 272
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 67/239 (28%), Positives = 116/239 (48%), Gaps = 30/239 (12%)
Query: 581 NDAPAEAAHCFTLSDIEDATKM--LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQ 637
+D+PA + LS + D + L + +G+G +G VY G+ +K G+ A+KV+
Sbjct: 4 SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-D 62
Query: 638 GKREFTNEVTLLSRI-HHRNLVQFLG-YCQEEGRSV-----LVYEFMHNGT----LKEHL 686
+ E E+ +L + HHRN+ + G + ++ + LV EF G+ +K
Sbjct: 63 EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK 122
Query: 687 YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF 746
TL E+ I +I R + +G+ +LH V IHRD+K N+LL ++ K+ DF
Sbjct: 123 GNTLK-EEWIAYICR-----EILRGLSHLHQHKV---IHRDIKGQNVLLTENAEVKLVDF 173
Query: 747 GLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD-----KSDVYSFGVILLELISGQ 800
G+S ++ + GT ++ PE + D KSD++S G+ +E+ G
Sbjct: 174 GVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 63/219 (28%), Positives = 108/219 (49%), Gaps = 25/219 (11%)
Query: 594 SDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVL------TSNSYQGKREFTNEV 646
S +ED + + +++GSG F +V + K GKE A K + +S + E EV
Sbjct: 1 SMVEDHYE-MGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREV 59
Query: 647 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEI 704
+L I H N++ + + VL+ E + G L + L +LT ++ ++K +I
Sbjct: 60 NILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK--QI 117
Query: 705 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVS 760
+ G+ YLH+ I H DLK NI+L + R K+ DFG++ ++ +
Sbjct: 118 LD----GVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK-IEAGNEFK 169
Query: 761 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 799
+I GT ++ PE + L ++D++S GVI L+SG
Sbjct: 170 NIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 603 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVL------TSNSYQGKREFTNEVTLLSRIHHR 655
+ +++GSG F +V + K G E A K + S + E EV++L ++ H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH 75
Query: 656 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIE 713
N++ + VL+ E + G L + L +L+ E+ ++IK +I + G+
Sbjct: 76 NVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK--QILD----GVN 129
Query: 714 YLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 769
YLHT I H DLK NI+L K+ DFGL+ ++ +I GT +
Sbjct: 130 YLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE-IEDGVEFKNIF-GTPEF 184
Query: 770 LDPEYYISQQLTDKSDVYSFGVILLELISG 799
+ PE + L ++D++S GVI L+SG
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-25
Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 607 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLG 662
+G GGFG V +++ ++ A K L + ++ NE +L +++ R +V L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS-LA 250
Query: 663 YC-QEEGRSVLVYEFMHNGTLKEHLYGTLTH---EQRINWIKRLEIAEDAAKGIEYLHTG 718
Y + + LV M+ G LK H+Y E R AE G+E LH
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARA----VFYAAE-ICCGLEDLHRE 305
Query: 719 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 778
I++RDLK NILLD H ++SD GL+ +G + + V GTVGY+ PE ++
Sbjct: 306 ---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNE 360
Query: 779 QLTDKSDVYSFGVILLELISGQ 800
+ T D ++ G +L E+I+GQ
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQ 382
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 55/218 (25%), Positives = 91/218 (41%), Gaps = 24/218 (11%)
Query: 594 SDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVL--TSNSYQGKREFTNEVTLLS 650
+ + + K++G G F VV K G+E A K L + E +E+ +L
Sbjct: 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLE 83
Query: 651 RI-HHRNLVQFLGYCQEEGRSVLVYEFMHNGTL----KEHLYGTLTHEQRINWIKRLEIA 705
++ + +L+ E+ G + L ++ I IK +I
Sbjct: 84 LAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIK--QIL 141
Query: 706 EDAAKGIEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSS 761
E G+ YLH I+H DLK NILL K+ DFG+S+ + A +
Sbjct: 142 E----GVYYLHQNN----IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK-IGHACELRE 192
Query: 762 IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 799
I+ GT YL PE +T +D+++ G+I L++
Sbjct: 193 IM-GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-25
Identities = 28/235 (11%), Positives = 59/235 (25%), Gaps = 43/235 (18%)
Query: 605 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQG-------KREFTNEVTLLSRIH--- 653
+G + G+ V V K E L +
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 654 ---------------HRNLVQFLGYCQEEGRSVLVYEF-------MHNGTLKEHLYGTLT 691
+ + +E ++ F + T E L +
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 692 HEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 750
+ + RL++ + + LH G ++H L+ +I+LD+ ++ F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 751 FAVDGASHVSSIVRGTVGYLDPEYYISQQ-----LTDKSDVYSFGVILLELISGQ 800
A Q +T D ++ G+ + +
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-25
Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 603 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVL------TSNSYQGKREFTNEVTLLSRIHHR 655
+ +++GSG F +V + K G E A K + S + E EV++L ++ H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHP 75
Query: 656 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIE 713
N++ + VL+ E + G L + L +L+ E+ ++IK +I + G+
Sbjct: 76 NIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK--QILD----GVN 129
Query: 714 YLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 769
YLHT I H DLK NI+L K+ DFGL+ ++ +I GT +
Sbjct: 130 YLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE-IEDGVEFKNIF-GTPEF 184
Query: 770 LDPEYYISQQLTDKSDVYSFGVILLELISG 799
+ PE + L ++D++S GVI L+SG
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 52/203 (25%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 602 MLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQF 660
+ +K+G G +G VY + G+ +A+K + +E E++++ + ++V++
Sbjct: 32 DVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKY 89
Query: 661 LGYCQEEGRSVLVYEFMHNGTLK---EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 717
G + +V E+ G++ TLT E I I + KG+EYLH
Sbjct: 90 YGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLT-EDEIATILQ-----STLKGLEYLHF 143
Query: 718 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 777
IHRD+K+ NILL+ AK++DFG++ D + ++++ GT ++ PE
Sbjct: 144 M---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQE 199
Query: 778 QQLTDKSDVYSFGVILLELISGQ 800
+D++S G+ +E+ G+
Sbjct: 200 IGYNCVADIWSLGITAIEMAEGK 222
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 6e-25
Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 605 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT---NEVTLLSRIH---HRNL 657
+ IG GGFG VY + D ++ A+K L + K+ T NE +LS + +
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 658 VQFLGYC-QEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEY 714
V + Y + + + M+ G L HL G + E + R AE G+E+
Sbjct: 255 VC-MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-EADM----RFYAAE-IILGLEH 307
Query: 715 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 774
+H +++RDLK +NILLD+H ++SD GL+ H + V GT GY+ PE
Sbjct: 308 MHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYMAPEV 361
Query: 775 YISQQLTDKS-DVYSFGVILLELISGQ 800
D S D +S G +L +L+ G
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-25
Identities = 63/252 (25%), Positives = 111/252 (44%), Gaps = 30/252 (11%)
Query: 564 KEQHRHSLPVQRPVSSLNDAPAEAA---HCFTLS---DIEDATKMLEKK-IGSGGFGVVY 616
R + +R + D PA A H + + + + + +G G FG V+
Sbjct: 47 DLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVH 106
Query: 617 YGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 675
+ G ++A K++ + + K E NE+++++++ H NL+Q + + VLV E
Sbjct: 107 KCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVME 166
Query: 676 FMHNGTL------KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLK 729
++ G L + + T I ++K +I E GI ++H I+H DLK
Sbjct: 167 YVDGGELFDRIIDESYNL---TELDTILFMK--QICE----GIRHMHQM---YILHLDLK 214
Query: 730 SSNILLDKHMRA--KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVY 787
NIL K+ DFGL++ + GT +L PE ++ +D++
Sbjct: 215 PENILCVNRDAKQIKIIDFGLARR-YKPREKLKVNF-GTPEFLAPEVVNYDFVSFPTDMW 272
Query: 788 SFGVILLELISG 799
S GVI L+SG
Sbjct: 273 SVGVIAYMLLSG 284
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 30/217 (13%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 660
L++ IGSG VV +++A+K + Q + E+ +S+ HH N+V +
Sbjct: 19 LQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSY 78
Query: 661 LGYCQEEGRSVLVYEFMHNGTL----------KEHLYGTLTHEQRINWIKRLEIAEDAAK 710
+ LV + + G++ EH G L E I I R + +
Sbjct: 79 YTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD-ESTIATILR-----EVLE 132
Query: 711 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT-VG- 768
G+EYLH IHRD+K+ NILL + +++DFG+S F G + VR T VG
Sbjct: 133 GLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 769 --YLDPEYYISQQLTD---KSDVYSFGVILLELISGQ 800
++ PE + +Q+ K+D++SFG+ +EL +G
Sbjct: 190 PCWMAPE--VMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 21/218 (9%)
Query: 591 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE-FTNEV-T 647
++D+E ++GSG G V+ + + + AVK + + + + + ++
Sbjct: 22 AEINDLE-----NLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDV 76
Query: 648 LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED 707
+L +VQ G + E M K L + + + +
Sbjct: 77 VLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEK--LKKRMQGPIPERILGK--MTVA 132
Query: 708 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 767
K + YL +IHRD+K SNILLD+ + K+ DFG+S VD + S G
Sbjct: 133 IVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA--GCA 188
Query: 768 GYLDPEYYISQQLTD-----KSDVYSFGVILLELISGQ 800
Y+ PE T ++DV+S G+ L+EL +GQ
Sbjct: 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 58/211 (27%), Positives = 90/211 (42%), Gaps = 31/211 (14%)
Query: 603 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE--FTNEVTLLSRIHHRNLVQ 659
+++++G G F VV K G E A K++ + + E + ++ H N+V+
Sbjct: 10 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 69
Query: 660 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KG 711
QEE LV++ + G L E I + R +E A +
Sbjct: 70 LHDSIQEESFHYLVFDLVTGGELFE----------DI--VAREFYSEADASHCIQQILES 117
Query: 712 IEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 768
I Y H+ I+HR+LK N+LL K K++DFGL+ D GT G
Sbjct: 118 IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFA-GTPG 172
Query: 769 YLDPEYYISQQLTDKSDVYSFGVILLELISG 799
YL PE + D+++ GVIL L+ G
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVG 203
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 8e-25
Identities = 54/222 (24%), Positives = 93/222 (41%), Gaps = 43/222 (19%)
Query: 603 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE--------FTNEVTLLSRIH 653
+ IG G VV + G E AVK++ + + E E +L ++
Sbjct: 98 PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA 157
Query: 654 -HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-- 710
H +++ + + LV++ M G L + + +++ ++E +
Sbjct: 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFD----------YL--TEKVALSEKETRSI 205
Query: 711 ------GIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV 763
+ +LH I+HRDLK NILLD +M+ ++SDFG S G + +
Sbjct: 206 MRSLLEAVSFLHANN----IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG-EKLRELC 260
Query: 764 RGTVGYLDPE------YYISQQLTDKSDVYSFGVILLELISG 799
GT GYL PE + D+++ GVIL L++G
Sbjct: 261 -GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-25
Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 22/208 (10%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLV 658
+ + IG G FG V + D K++ A+K + + E N E+ ++ + H LV
Sbjct: 19 ILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLV 78
Query: 659 QFLGYC-QEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYL 715
L Y Q+E +V + + G L+ HL E+ + +L I E ++YL
Sbjct: 79 N-LWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFK-EETV----KLFICE-LVMALDYL 131
Query: 716 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY 775
IIHRD+K NILLD+H ++DF ++ + + GT Y+ PE +
Sbjct: 132 QNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEMF 186
Query: 776 ISQQLT--DKS-DVYSFGVILLELISGQ 800
S++ + D +S GV EL+ G+
Sbjct: 187 SSRKGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 62/291 (21%), Positives = 110/291 (37%), Gaps = 55/291 (18%)
Query: 565 EQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKM-----LEKKIGSGGFGVVYYGK 619
H H + AP H L+ ++ + + +GSGGFG VY G
Sbjct: 4 SHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGI 63
Query: 620 -LKDGKEIAVKVLTSNSYQGKREFTN------EVTLLSRIHHR--NLVQFLGYCQEEGRS 670
+ D +A+K + + E N EV LL ++ +++ L + +
Sbjct: 64 RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 123
Query: 671 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIEYLHTGCVPA 722
VL+ E ++ L+ +T + E+ A+ + + H V
Sbjct: 124 VLILERPEPV--QD-LFDFITERGALQ--------EELARSFFWQVLEAVRHCHNCGV-- 170
Query: 723 IIHRDLKSSNILLD-KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 781
+HRD+K NIL+D K+ DFG D GT Y PE +I
Sbjct: 171 -LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTRVYSPPE-WIRYHRY 225
Query: 782 D--KSDVYSFGVILLELISG------QEAISNEKFG------ANCRNIVQW 818
+ V+S G++L +++ G E I + + C+++++W
Sbjct: 226 HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRW 276
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 56/219 (25%), Positives = 96/219 (43%), Gaps = 40/219 (18%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTN------EVTLLSRIH-- 653
L +G GGFG V+ G L D ++A+KV+ N G ++ EV LL ++
Sbjct: 35 LGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAG 94
Query: 654 --HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK- 710
H +++ L + + + +LV E + L+ +T + + E ++
Sbjct: 95 GGHPGVIRLLDWFETQEGFMLVLERPLPA---QDLFDYITEKGPLG--------EGPSRC 143
Query: 711 -------GIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSI 762
I++ H+ V +HRD+K NIL+D AK+ DFG D
Sbjct: 144 FFGQVVAAIQHCHSRGV---VHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD- 199
Query: 763 VRGTVGYLDPEYYISQQLTD--KSDVYSFGVILLELISG 799
GT Y PE +IS+ + V+S G++L +++ G
Sbjct: 200 --GTRVYSPPE-WISRHQYHALPATVWSLGILLYDMVCG 235
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 37/214 (17%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL-----TSNSYQGKREFTNEVTLLSRIHHRN 656
L + +G G +G V + +AVK++ K+E + + ++H N
Sbjct: 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHEN 66
Query: 657 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK------ 710
+V+F G+ +E L E+ G L + + + + E A+
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRI------------EPDIGMPEPDAQRFFHQL 114
Query: 711 --GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS-HVSSIVRGTV 767
G+ YLH I HRD+K N+LLD+ K+SDFGL+ + + + GT+
Sbjct: 115 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 768 GYLDPEYYISQQLTD--KSDVYSFGVILLELISG 799
Y+ PE + ++ DV+S G++L +++G
Sbjct: 172 PYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 603 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVL------TSNSYQGKREFTNEVTLLSRIHHR 655
+++GSG F VV + K G + A K + +S + + EV++L I H
Sbjct: 15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 656 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIE 713
N++ + + +L+ E + G L + L +LT E+ ++K +I G+
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK--QILN----GVY 128
Query: 714 YLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 769
YLH+ I H DLK NI+L R K+ DFGL+ +D + +I GT +
Sbjct: 129 YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK-IDFGNEFKNIF-GTPEF 183
Query: 770 LDPEYYISQQLTDKSDVYSFGVILLELISG 799
+ PE + L ++D++S GVI L+SG
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-24
Identities = 53/221 (23%), Positives = 93/221 (42%), Gaps = 43/221 (19%)
Query: 603 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE--------FTNEVTLLSRIH 653
+ K +GSG G V + K++A+++++ + E+ +L +++
Sbjct: 139 MSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN 198
Query: 654 HRNLVQFLGYCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-- 710
H +++ + E +V E M G L + ++ + + E K
Sbjct: 199 HPCIIKIKNFFDAE--DYYIVLELMEGGELFD----------KV--VGNKRLKEATCKLY 244
Query: 711 ------GIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSS 761
++YLH IIHRDLK N+LL ++ K++DFG SK + S + +
Sbjct: 245 FYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRT 300
Query: 762 IVRGTVGYLDPE---YYISQQLTDKSDVYSFGVILLELISG 799
+ GT YL PE + D +S GVIL +SG
Sbjct: 301 LC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 37/203 (18%), Positives = 88/203 (43%), Gaps = 18/203 (8%)
Query: 603 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 661
+ + +G G FG+V+ K K + + E+++L+ HRN++
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLH 67
Query: 662 GYCQEEGRSVLVYEFMHNGTLKEHLY---GTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 718
+ V+++EF+ + E + L + ++++ ++ E +++LH+
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH--QVCE----ALQFLHSH 121
Query: 719 CVPAIIHRDLKSSNILL--DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 776
I H D++ NI+ + K+ +FG ++ + + + Y PE +
Sbjct: 122 ---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ-LKPGDNFRLLF-TAPEYYAPEVHQ 176
Query: 777 SQQLTDKSDVYSFGVILLELISG 799
++ +D++S G ++ L+SG
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSG 199
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 31/211 (14%)
Query: 603 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE--FTNEVTLLSRIHHRNLVQ 659
+++++G G F VV K G E A K++ + + E + ++ H N+V+
Sbjct: 33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92
Query: 660 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KG 711
QEE LV++ + G L E I + R +E A +
Sbjct: 93 LHDSIQEESFHYLVFDLVTGGELFE----------DI--VAREFYSEADASHCIQQILES 140
Query: 712 IEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 768
I Y H+ I+HR+LK N+LL K K++DFGL+ V+ + GT G
Sbjct: 141 IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE-VNDSEAWHGFA-GTPG 195
Query: 769 YLDPEYYISQQLTDKSDVYSFGVILLELISG 799
YL PE + D+++ GVIL L+ G
Sbjct: 196 YLSPEVLKKDPYSKPVDIWACGVILYILLVG 226
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-24
Identities = 45/216 (20%), Positives = 82/216 (37%), Gaps = 28/216 (12%)
Query: 603 LEKKIGSG--GFGVVYYGK-LKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNL 657
L IG G V + G+ + V+ L + S + E+ + +H N+
Sbjct: 29 LLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNI 88
Query: 658 VQFLGYCQEEGRSVLVYEFMHNGT----LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 713
V + + +V FM G+ + H + E I +I + K ++
Sbjct: 89 VPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMN-ELAIAYILQ-----GVLKALD 142
Query: 714 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR------GTV 767
Y+H +HR +K+S+IL+ + +S + + + +
Sbjct: 143 YIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199
Query: 768 GYLDPEYYISQQL---TDKSDVYSFGVILLELISGQ 800
+L PE + Q L KSD+YS G+ EL +G
Sbjct: 200 PWLSPE-VLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-24
Identities = 54/212 (25%), Positives = 86/212 (40%), Gaps = 32/212 (15%)
Query: 603 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE--FTNEVTLLSRIHHRNLVQ 659
L +++G G F VV G+E A ++ + + E + + H N+V+
Sbjct: 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74
Query: 660 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE-DAAK-------G 711
EEG L+++ + G L E I + R +E DA+
Sbjct: 75 LHDSISEEGHHYLIFDLVTGGELFE----------DI--VAREYYSEADASHCIQQILEA 122
Query: 712 IEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 767
+ + H G ++HR+LK N+LL K K++DFGL+ GT
Sbjct: 123 VLHCHQMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTP 177
Query: 768 GYLDPEYYISQQLTDKSDVYSFGVILLELISG 799
GYL PE D+++ GVIL L+ G
Sbjct: 178 GYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 66/240 (27%), Positives = 106/240 (44%), Gaps = 26/240 (10%)
Query: 570 SLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAV 628
+P SL D + A F D E L + IG G FG VY+ + +++ + +A+
Sbjct: 28 PMPAGGRAGSLKDP--DVAELFFKDDPEKLFSDLRE-IGHGSFGAVYFARDVRNSEVVAI 84
Query: 629 KVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG--TLK 683
K ++ + Q ++ EV L ++ H N +Q+ G E + LV E+ L
Sbjct: 85 KKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLL 144
Query: 684 EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV 743
E L E I + A +G+ YLH+ +IHRD+K+ NILL + K+
Sbjct: 145 EVHKKPLQ-EVEIAAVTH-----GALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKL 195
Query: 744 SDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD---KSDVYSFGVILLELISGQ 800
DFG + S V GT ++ PE ++ K DV+S G+ +EL +
Sbjct: 196 GDFGSASIMAPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-24
Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 37/214 (17%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL-----TSNSYQGKREFTNEVTLLSRIHHRN 656
L + +G G +G V + +AVK++ K+E + + ++H N
Sbjct: 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHEN 66
Query: 657 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK------ 710
+V+F G+ +E L E+ G L + + + + E A+
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRI------------EPDIGMPEPDAQRFFHQL 114
Query: 711 --GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS-HVSSIVRGTV 767
G+ YLH I HRD+K N+LLD+ K+SDFGL+ + + + GT+
Sbjct: 115 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 768 GYLDPEYYISQQLTD--KSDVYSFGVILLELISG 799
Y+ PE + ++ DV+S G++L +++G
Sbjct: 172 PYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 69/267 (25%), Positives = 108/267 (40%), Gaps = 42/267 (15%)
Query: 554 MHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCF--------TLSDIEDATKMLEK 605
MH ++ + +L Q S A A + D + +E
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFE-VES 59
Query: 606 KIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 664
++G G +VY K K K A+KVL K+ E+ +L R+ H N+++
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVL--KKTVDKKIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 665 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE-DAAK-------GIEYLH 716
+ LV E + G L + RI +++ +E DAA + YLH
Sbjct: 118 ETPTEISLVLELVTGGELFD----------RI--VEKGYYSERDAADAVKQILEAVAYLH 165
Query: 717 T-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 772
G I+HRDLK N+L K++DFGLSK V+ + ++ GT GY P
Sbjct: 166 ENG----IVHRDLKPENLLYATPAPDAPLKIADFGLSKI-VEHQVLMKTVC-GTPGYCAP 219
Query: 773 EYYISQQLTDKSDVYSFGVILLELISG 799
E + D++S G+I L+ G
Sbjct: 220 EILRGCAYGPEVDMWSVGIITYILLCG 246
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 52/217 (23%), Positives = 87/217 (40%), Gaps = 38/217 (17%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL--------TSNSYQGKREFTNEVTLLSRIH 653
+GSG FG V+ + KE+ VK + + T E+ +LSR+
Sbjct: 28 TMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE 87
Query: 654 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--- 710
H N+++ L + +G LV E +G L+ + R++ E A
Sbjct: 88 HANIIKVLDIFENQGFFQLVMEKHGSGL---DLFAFIDRHPRLD--------EPLASYIF 136
Query: 711 -----GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS-HVSSIVR 764
+ YL IIHRD+K NI++ + K+ DFG + + G +
Sbjct: 137 RQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC--- 190
Query: 765 GTVGYLDPEYYISQQLTD--KSDVYSFGVILLELISG 799
GT+ Y PE + + +++S GV L L+
Sbjct: 191 GTIEYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFE 226
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 54/221 (24%), Positives = 93/221 (42%), Gaps = 43/221 (19%)
Query: 603 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE--------FTNEVTLLSRIH 653
+ K +GSG G V + K++A+K+++ + E+ +L +++
Sbjct: 14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 654 HRNLVQFLGYCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-- 710
H +++ + E +V E M G L + ++ + + E K
Sbjct: 74 HPCIIKIKNFFDAE--DYYIVLELMEGGELFD----------KV--VGNKRLKEATCKLY 119
Query: 711 ------GIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSS 761
++YLH IIHRDLK N+LL ++ K++DFG SK + S + +
Sbjct: 120 FYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRT 175
Query: 762 IVRGTVGYLDPE---YYISQQLTDKSDVYSFGVILLELISG 799
+ GT YL PE + D +S GVIL +SG
Sbjct: 176 LC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 8e-23
Identities = 54/223 (24%), Positives = 97/223 (43%), Gaps = 38/223 (17%)
Query: 594 SDIEDATKM--LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLS 650
S + +K +G G F + K + AVK+++ + E+T L
Sbjct: 4 SPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ---KEITALK 60
Query: 651 RI-HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE-DA 708
H N+V+ ++ + LV E ++ G L E RI K+ +E +A
Sbjct: 61 LCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFE----------RI--KKKKHFSETEA 108
Query: 709 AK-------GIEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGAS 757
+ + ++H G ++HRDLK N+L + ++ K+ DFG ++
Sbjct: 109 SYIMRKLVSAVSHMHDVG----VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164
Query: 758 HVSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISG 799
+ + T+ Y PE ++Q D+S D++S GVIL ++SG
Sbjct: 165 PLKTPC-FTLHYAAPE-LLNQNGYDESCDLWSLGVILYTMLSG 205
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 9e-23
Identities = 53/222 (23%), Positives = 89/222 (40%), Gaps = 46/222 (20%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL--------TSNSYQGKREFTNEVTLLSRIH 653
+ +G G +G V + AVK+L + K+E + LL R+
Sbjct: 9 MGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKE----IQLLRRLR 64
Query: 654 HRNLVQFLGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK- 710
H+N++Q + E + +V E+ G ++E + ++ KR A
Sbjct: 65 HKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQE-MLDSVPE-------KRFP--VCQAHG 113
Query: 711 -------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS----KFAVDGASHV 759
G+EYLH+ I+H+D+K N+LL K+S G++ FA D
Sbjct: 114 YFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170
Query: 760 SSIVRGTVGYLDPEYYISQQLTD--KSDVYSFGVILLELISG 799
S G+ + PE K D++S GV L + +G
Sbjct: 171 SQ---GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 51/213 (23%), Positives = 91/213 (42%), Gaps = 38/213 (17%)
Query: 603 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSR-IHHRNLVQF 660
+++ IG G + V K E AVK++ + E + +L R H N++
Sbjct: 26 VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE----IEILLRYGQHPNIITL 81
Query: 661 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE-DAAK-------GI 712
+ +V E M G L + +I +++ +E +A+ +
Sbjct: 82 KDVYDDGKYVYVVTELMKGGELLD----------KI--LRQKFFSEREASAVLFTITKTV 129
Query: 713 EYLHT-GCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 767
EYLH G ++HRDLK SNIL ++ DFG +K + + T
Sbjct: 130 EYLHAQG----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTA 184
Query: 768 GYLDPEYYISQQLTDKS-DVYSFGVILLELISG 799
++ PE + +Q D + D++S GV+L +++G
Sbjct: 185 NFVAPE-VLERQGYDAACDIWSLGVLLYTMLTG 216
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-22
Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 38/213 (17%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL---TSNSYQGKREFTNEVTLLSRIHHRNLV 658
K IGSG FGV + + +AVK + + +RE + + H N+V
Sbjct: 24 FVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQRE----IINHRSLRHPNIV 79
Query: 659 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-------- 710
+F ++ E+ G L E + +ED A+
Sbjct: 80 RFKEVILTPTHLAIIMEYASGGELYERI------------CNAGRFSEDEARFFFQQLLS 127
Query: 711 GIEYLHTGCVPAIIHRDLKSSNILLDKH--MRAKVSDFGLSKFAVDGASHVSSIVRGTVG 768
G+ Y H+ + HRDLK N LLD R K+ DFG SK +V + S++ GT
Sbjct: 128 GVSYCHSMQI---CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPA 182
Query: 769 YLDPEYYISQQLTD--KSDVYSFGVILLELISG 799
Y+ PE + +Q D +DV+S GV L ++ G
Sbjct: 183 YIAPE-VLLRQEYDGKIADVWSCGVTLYVMLVG 214
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 4e-22
Identities = 58/211 (27%), Positives = 85/211 (40%), Gaps = 25/211 (11%)
Query: 605 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 660
K IG G F V K+K ++ A+K++ + E F E +L R + Q
Sbjct: 67 KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ- 125
Query: 661 LGYC-QEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 717
L + Q+E LV E+ G L L +G + R +AE I+ +H
Sbjct: 126 LHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMA----RFYLAE-IVMAIDSVHR 180
Query: 718 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI 776
+HRD+K NILLD+ +++DFG DG V GT YL PE
Sbjct: 181 L---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQ 236
Query: 777 SQQLTDKSDVY-------SFGVILLELISGQ 800
+ + Y + GV E+ GQ
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 5e-22
Identities = 62/215 (28%), Positives = 95/215 (44%), Gaps = 40/215 (18%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL-------TSNSYQGKREFTNEVTLLSRIHH 654
L +G G FG V G+ G ++AVK+L + KRE + L H
Sbjct: 15 LGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKRE----IQNLKLFRH 70
Query: 655 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK---- 710
++++ +V E++ G L +++ K + E A+
Sbjct: 71 PHIIKLYQVISTPTDFFMVMEYVSGGELFDYI------------CKHGRVEEMEARRLFQ 118
Query: 711 ----GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT 766
++Y H ++HRDLK N+LLD HM AK++DFGLS DG +S G+
Sbjct: 119 QILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC--GS 173
Query: 767 VGYLDPEYYISQQLTD--KSDVYSFGVILLELISG 799
Y PE IS +L + D++S GVIL L+ G
Sbjct: 174 PNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCG 207
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 39/214 (18%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL------TSNSYQGKREFTNEVTLLSRIHHR 655
L K IG G F V + + G+E+A+K++ ++ + RE V ++ ++H
Sbjct: 19 LLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFRE----VRIMKILNHP 74
Query: 656 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK----- 710
N+V+ + E L+ E+ G + ++L + + E A+
Sbjct: 75 NIVKLFEVIETEKTLYLIMEYASGGEVFDYL------------VAHGRMKEKEARSKFRQ 122
Query: 711 ---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 767
++Y H I+HRDLK+ N+LLD M K++DFG S G + + G
Sbjct: 123 IVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDAFC-GAP 177
Query: 768 GYLDPEYYISQQLTD--KSDVYSFGVILLELISG 799
Y PE + D + DV+S GVIL L+SG
Sbjct: 178 PYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSG 210
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-21
Identities = 66/243 (27%), Positives = 104/243 (42%), Gaps = 30/243 (12%)
Query: 572 PVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVK-V 630
P+ N A + + K IG+G FGVV+ KL + E+A+K V
Sbjct: 13 VKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKV 72
Query: 631 LTSNSYQGKREFTN-EVTLLSRIHHRNLVQFLGYCQEEGRSV------LVYEFMHNGTLK 683
L Q KR F N E+ ++ + H N+V + G LV E++ T+
Sbjct: 73 L-----QDKR-FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVY 125
Query: 684 EHLYGTLTHEQRI--NWIKRL--EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM 739
+Q + IK ++ + + Y+H+ I HRD+K N+LLD
Sbjct: 126 RASRHYAKLKQTMPMLLIKLYMYQL----LRSLAYIHSI---GICHRDIKPQNLLLDPPS 178
Query: 740 RA-KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELI 797
K+ DFG +K + G +VS I + Y PE + T D++S G ++ EL+
Sbjct: 179 GVLKLIDFGSAKILIAGEPNVSYIC--SRYYRAPELIFGATNYTTNIDIWSTGCVMAELM 236
Query: 798 SGQ 800
GQ
Sbjct: 237 QGQ 239
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 1e-21
Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 33/214 (15%)
Query: 605 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 660
K IG G FG V KLK+ ++ A+K+L + E F E +L + +
Sbjct: 80 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITT- 138
Query: 661 LGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------G 711
L Y Q++ LV ++ G L L E R+ E+ A+
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDLLTLLS---KFEDRLP--------EEMARFYLAEMVIA 187
Query: 712 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 771
I+ +H +HRD+K NIL+D + +++DFG ++ + SS+ GT Y+
Sbjct: 188 IDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 244
Query: 772 PEYYISQQLTDKS-----DVYSFGVILLELISGQ 800
PE + + D +S GV + E++ G+
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-21
Identities = 62/307 (20%), Positives = 111/307 (36%), Gaps = 70/307 (22%)
Query: 594 SDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE-FTNEVTLLSR 651
+ D ++ ++ +G G G V + G++ A+K+L EV +
Sbjct: 24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY------DSPKARQEVDHHWQ 77
Query: 652 I-HHRNLVQFLGYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIA- 705
++V L + ++ E M G L RI +R + A
Sbjct: 78 ASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFS----------RI--QERGDQAF 125
Query: 706 --EDAAK-------GIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAV 753
+AA+ I++LH+ I HRD+K N+L +K K++DFG +K
Sbjct: 126 TEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182
Query: 754 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCR 813
A + + T Y+ PE ++ D++S GVI+ L+ G F +N
Sbjct: 183 QNA--LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP-----FYSNTG 234
Query: 814 NIVQWAKLH-IESGDIQGIIDPSLLDEYDIQSMW-KIEEKA------LMCVLPHGHMRPS 865
+ I G + W ++ E A L+ P R +
Sbjct: 235 QAISPGMKRRIRLGQY------GFPNPE-----WSEVSEDAKQLIRLLLKTDP--TERLT 281
Query: 866 ISEVLKD 872
I++ +
Sbjct: 282 ITQFMNH 288
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 3e-21
Identities = 58/255 (22%), Positives = 99/255 (38%), Gaps = 47/255 (18%)
Query: 567 HRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKE 625
H + P P ++ + I D K+ + +G G G V K ++
Sbjct: 30 HPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEK 89
Query: 626 IAVKVLTSNSYQGKRE-FTNEVTLLSRI-HHRNLVQFLGYCQEEGRSV----LVYEFMHN 679
A+K+L EV L R ++V+ + + +V E +
Sbjct: 90 FALKMLQ------DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 143
Query: 680 GTLKEHLYGTLTHEQRINWIKRLEIA---EDAA-------KGIEYLHT-GCVPAIIHRDL 728
G L RI R + A +A+ + I+YLH+ I HRD+
Sbjct: 144 GELFS----------RI--QDRGDQAFTEREASEIMKSIGEAIQYLHSIN----IAHRDV 187
Query: 729 KSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS- 784
K N+L + K++DFG +K + +++ T Y+ PE + + DKS
Sbjct: 188 KPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPC-YTPYYVAPE-VLGPEKYDKSC 244
Query: 785 DVYSFGVILLELISG 799
D++S GVI+ L+ G
Sbjct: 245 DMWSLGVIMYILLCG 259
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 5e-21
Identities = 54/223 (24%), Positives = 94/223 (42%), Gaps = 38/223 (17%)
Query: 591 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT---NEV 646
L + K +G+G FG V K K+ A+K+L ++ NE
Sbjct: 38 AQLDQFD-----RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 647 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE 706
+L ++ LV+ ++ +V E++ G + HL R + E
Sbjct: 93 RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFS--------E 140
Query: 707 DAAK--------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758
A+ EYLH+ +I+RDLK N+L+D+ +V+DFG +K
Sbjct: 141 PHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---- 193
Query: 759 VSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 800
+ + GT L PE I + +K+ D ++ GV++ E+ +G
Sbjct: 194 RTWTLCGTPEALAPE-IILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 94.1 bits (235), Expect = 5e-21
Identities = 60/223 (26%), Positives = 106/223 (47%), Gaps = 38/223 (17%)
Query: 591 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT---NEV 646
++L D + + + +G+G FG V+ + + A+KVL ++ +E
Sbjct: 3 YSLQDFQ-----ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDER 57
Query: 647 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE 706
+LS + H +++ G Q+ + ++ +++ G L L QR
Sbjct: 58 LMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR----KSQRFP--------N 105
Query: 707 DAAK--------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758
AK +EYLH+ II+RDLK NILLDK+ K++DFG +K+ D
Sbjct: 106 PVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-- 160
Query: 759 VSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 800
+ GT Y+ PE +S + +KS D +SFG+++ E+++G
Sbjct: 161 --YTLCGTPDYIAPE-VVSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 6e-21
Identities = 68/251 (27%), Positives = 103/251 (41%), Gaps = 23/251 (9%)
Query: 558 KKNNYDKEQHRHSLPVQRP-VSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVY 616
KK + R P + + A+ H T+++ E K +G G FG V
Sbjct: 111 KKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFE-----YLKLLGKGTFGKVI 165
Query: 617 YGKLKDGKEI-AVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQFLGYC-QEEGRSV 671
K K A+K+L K E + E +L H L L Y Q R
Sbjct: 166 LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA-LKYSFQTHDRLC 224
Query: 672 LVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLK 729
V E+ + G L HL + E R R AE ++YLH+ +++RDLK
Sbjct: 225 FVMEYANGGELFFHLSRERVFS-EDRA----RFYGAE-IVSALDYLHSEK--NVVYRDLK 276
Query: 730 SSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSF 789
N++LDK K++DFGL K + + + + GT YL PE D +
Sbjct: 277 LENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVLEDNDYGRAVDWWGL 335
Query: 790 GVILLELISGQ 800
GV++ E++ G+
Sbjct: 336 GVVMYEMMCGR 346
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 7e-21
Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 40/215 (18%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL-------TSNSYQGKREFTNEVTLLSRIHH 654
L +G G FG V GK G ++AVK+L + +RE + L H
Sbjct: 20 LGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRRE----IQNLKLFRH 75
Query: 655 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK---- 710
++++ +V E++ G L +++ K + E ++
Sbjct: 76 PHIIKLYQVISTPSDIFMVMEYVSGGELFDYI------------CKNGRLDEKESRRLFQ 123
Query: 711 ----GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT 766
G++Y H V +HRDLK N+LLD HM AK++DFGLS DG +S G+
Sbjct: 124 QILSGVDYCHRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC--GS 178
Query: 767 VGYLDPEYYISQQLTD--KSDVYSFGVILLELISG 799
Y PE IS +L + D++S GVIL L+ G
Sbjct: 179 PNYAAPE-VISGRLYAGPEVDIWSSGVILYALLCG 212
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 9e-21
Identities = 61/245 (24%), Positives = 100/245 (40%), Gaps = 71/245 (28%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL-------------------TSNSYQGKREF 642
L+ +IG G +GVV D A+KVL T + G +
Sbjct: 17 LKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQP 76
Query: 643 TN-------EVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY-------- 687
E+ +L ++ H N+V+ + E + + ++HLY
Sbjct: 77 RGPIEQVYQEIAILKKLDHPNVVK-------------LVEVLDDPN-EDHLYMVFELVNQ 122
Query: 688 GTLTHEQRINWIKRLEIAEDAAK--------GIEYLHTGCVPAIIHRDLKSSNILLDKHM 739
G + + ++ED A+ GIEYLH IIHRD+K SN+L+ +
Sbjct: 123 GPV-----MEVPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDG 174
Query: 740 RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD----KSDVYSFGVILLE 795
K++DFG+S + +S+ V GT ++ PE +S+ DV++ GV L
Sbjct: 175 HIKIADFGVSNEFKGSDALLSNTV-GTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYC 232
Query: 796 LISGQ 800
+ GQ
Sbjct: 233 FVFGQ 237
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-20
Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 33/218 (15%)
Query: 602 MLEKKIGSGGFGVVYYGKLKD-GKEIAVK-VLTSNSYQGKREFTNEVTLLSRIHHRNLVQ 659
+E+ G G FG V GK K G +A+K V+ ++ RE + L+ +HH N+VQ
Sbjct: 26 QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR-NRELQ-IMQDLAVLHHPNIVQ 83
Query: 660 ----FLGYCQEEGRSV---LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-- 710
F + + R + +V E++ TL R + +++ K
Sbjct: 84 LQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCC--------RNYYRRQVAPPPILIKVF 134
Query: 711 ------GIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIV 763
I LH V + HRD+K N+L+++ K+ DFG +K +V+ I
Sbjct: 135 LFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC 193
Query: 764 RGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQ 800
+ Y PE +Q T D++S G I E++ G+
Sbjct: 194 --SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-20
Identities = 73/247 (29%), Positives = 109/247 (44%), Gaps = 27/247 (10%)
Query: 563 DKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD 622
+ + + P P +N P+ H SD K IG G FG V + K
Sbjct: 8 PELMNANPAPPPAPSQQINLGPSSNPH-AKPSDFH-----FLKVIGKGSFGKVLLARHKA 61
Query: 623 GKEI-AVKVLTSNSYQGKREFTNEVT----LLSRIHHRNLVQFLGYC-QEEGRSVLVYEF 676
+ AVKVL + K+E + ++ LL + H LV L + Q + V ++
Sbjct: 62 EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG-LHFSFQTADKLYFVLDY 120
Query: 677 MHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL 734
++ G L HL E R R AE A + YLH+ I++RDLK NIL
Sbjct: 121 INGGELFYHLQRERCFL-EPRA----RFYAAE-IASALGYLHSL---NIVYRDLKPENIL 171
Query: 735 LDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVIL 793
LD ++DFGL K ++ S S+ GT YL PE + +Q D++ D + G +L
Sbjct: 172 LDSQGHIVLTDFGLCKENIEHNSTTSTFC-GTPEYLAPE-VLHKQPYDRTVDWWCLGAVL 229
Query: 794 LELISGQ 800
E++ G
Sbjct: 230 YEMLYGL 236
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 5e-20
Identities = 68/218 (31%), Positives = 98/218 (44%), Gaps = 39/218 (17%)
Query: 602 MLEKKIGSGGFGVVYYGKLKD-GKEIAVK-VLTSNSYQGKREFTN-EVTLLSRIHHRNLV 658
K IG+G FGVVY KL D G+ +A+K VL Q KR F N E+ ++ ++ H N+V
Sbjct: 57 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKR-FKNRELQIMRKLDHCNIV 110
Query: 659 QFLGYCQEEGRSV------LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-- 710
+ + G LV +++ E +Y H R + K
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAK----QTLPVIYVKLY 161
Query: 711 ------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIV 763
+ Y+H+ I HRD+K N+LLD K+ DFG +K V G +VS I
Sbjct: 162 MYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 218
Query: 764 RGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQ 800
+ Y PE + T DV+S G +L EL+ GQ
Sbjct: 219 --SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 5e-20
Identities = 54/213 (25%), Positives = 89/213 (41%), Gaps = 34/213 (15%)
Query: 605 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 660
K IG G FG V + K +++ A+K+L+ + + F E +++ + +VQ
Sbjct: 75 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ- 133
Query: 661 LGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------G 711
L Y Q++ +V E+M G L + ++ E A+
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDLVNLM-------------SNYDVPEKWARFYTAEVVLA 180
Query: 712 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 771
++ +H+ IHRD+K N+LLDK K++DFG GT Y+
Sbjct: 181 LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 237
Query: 772 PEYYISQQLT---DKS-DVYSFGVILLELISGQ 800
PE SQ + D +S GV L E++ G
Sbjct: 238 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 5e-20
Identities = 54/216 (25%), Positives = 97/216 (44%), Gaps = 43/216 (19%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL-------TSNSYQGKREFTNEVTLLSRIHH 654
+ + +G G FG V K +++A+K + + + +RE ++ L + H
Sbjct: 13 IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVERE----ISYLKLLRH 68
Query: 655 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK---- 710
++++ V+V E+ G L +++ +++ + ED +
Sbjct: 69 PHIIKLYDVITTPTDIVMVIEYA-GGELFDYI------------VEKKRMTEDEGRRFFQ 115
Query: 711 ----GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS-HVSSIVRG 765
IEY H I+HRDLK N+LLD ++ K++DFGLS DG S G
Sbjct: 116 QIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---G 169
Query: 766 TVGYLDPEYYISQQLTD--KSDVYSFGVILLELISG 799
+ Y PE I+ +L + DV+S G++L ++ G
Sbjct: 170 SPNYAAPE-VINGKLYAGPEVDVWSCGIVLYVMLVG 204
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 7e-20
Identities = 24/203 (11%), Positives = 56/203 (27%), Gaps = 43/203 (21%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLV 658
L G + +++A+ + +E + LSRI +
Sbjct: 35 LLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 659 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH-T 717
+ L ++V E++ G+L+E + + + + A + H
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGA------IRAMQSLAAAADAAHRA 148
Query: 718 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 777
G + S + + ++ T+ +P+
Sbjct: 149 G----VALSIDHPSRVRVSIDGDVVLAYP------------------ATMPDANPQ---- 182
Query: 778 QQLTDKSDVYSFGVILLELISGQ 800
D+ G L L+ +
Sbjct: 183 ------DDIRGIGASLYALLVNR 199
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 1e-19
Identities = 70/232 (30%), Positives = 116/232 (50%), Gaps = 27/232 (11%)
Query: 579 SLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVY---YGKLKDGKEI-AVKVLTSN 634
++ E S E L K +G G FG V+ D +++ A+KVL
Sbjct: 9 AITHHVKEGHEKADPSQFE-----LLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKA 63
Query: 635 SYQGKREF--TNEVTLLSRIHHRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLY--GT 689
+ + + E +L ++H +V+ L Y Q EG+ L+ +F+ G L L
Sbjct: 64 TLKVRDRVRTKMERDILVEVNHPFIVK-LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM 122
Query: 690 LTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 749
T E+ + + +AE A +++LH+ II+RDLK NILLD+ K++DFGLS
Sbjct: 123 FT-EEDV----KFYLAE-LALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLS 173
Query: 750 KFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 800
K ++D S GTV Y+ PE ++++ +S D +SFGV++ E+++G
Sbjct: 174 KESIDHEKKAYSFC-GTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 3e-19
Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 32/210 (15%)
Query: 605 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQF 660
K +G G FG V + K A+K+L K E + E +L H L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA- 69
Query: 661 LGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------G 711
L Y Q R V E+ + G L HL E+ E+ A+
Sbjct: 70 LKYAFQTHDRLCFVMEYANGGELFFHLS----RERVFT--------EERARFYGAEIVSA 117
Query: 712 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 771
+EYLH+ +++RD+K N++LDK K++DFGL K + + + + GT YL
Sbjct: 118 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLA 173
Query: 772 PEYYISQQLTDKS-DVYSFGVILLELISGQ 800
PE + ++ D + GV++ E++ G+
Sbjct: 174 PE-VLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-19
Identities = 24/108 (22%), Positives = 42/108 (38%), Gaps = 4/108 (3%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 471
++ + +S + LSSL L + GNS F+ +L + L
Sbjct: 421 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 480
Query: 472 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN--VVLNYAGN 517
QL P++ +L +L+ L + +N N VL+Y+ N
Sbjct: 481 QLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 528
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 7e-18
Identities = 22/109 (20%), Positives = 39/109 (35%), Gaps = 5/109 (4%)
Query: 414 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDN 471
S+ V+ ++ + N D T+L +L L L L P F+ L+++++ N
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHN 504
Query: 472 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSS---LLSKNVVLNYAGN 517
L +L+ L N + + S LN N
Sbjct: 505 NFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 553
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 9e-18
Identities = 23/96 (23%), Positives = 36/96 (37%), Gaps = 1/96 (1%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 472
P + V+ LS + LS L L L GN + FSG L+ + +
Sbjct: 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111
Query: 473 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 508
L + +L L+EL V +N++ S
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-17
Identities = 20/106 (18%), Positives = 37/106 (34%), Gaps = 2/106 (1%)
Query: 403 WSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCP 461
++L ++T + LS L P+ LSSL L + N+ +
Sbjct: 459 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLN 518
Query: 462 DLRIIHLEDNQLTGPLPSSLMNLP-NLRELYVQNNMLSGTVPSSLL 506
L+++ N + L + P +L L + N + T
Sbjct: 519 SLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSF 564
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 9e-17
Identities = 14/97 (14%), Positives = 29/97 (29%), Gaps = 3/97 (3%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 471
S+ + LS + + S+ L L L ++L F +L + +
Sbjct: 373 TSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 431
Query: 472 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 508
L +L L + N + ++
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-15
Identities = 27/109 (24%), Positives = 40/109 (36%), Gaps = 5/109 (4%)
Query: 414 PSITVIHLSSKNLT--GNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDN 471
PS+ + LS L+ G +SL L L N + +F G L + + +
Sbjct: 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHS 406
Query: 472 QLTGPLPSS-LMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 517
L S ++L NL L + + LS VL AGN
Sbjct: 407 NLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN 455
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-14
Identities = 21/111 (18%), Positives = 39/111 (35%), Gaps = 7/111 (6%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPD-FSGCPDLRIIHLEDN 471
S+ + NL + L +L EL + N + +P+ FS +L + L N
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159
Query: 472 QLTGPLPSSLMNLPNLR----ELYVQNNMLSGTVPSSLLSKN-VVLNYAGN 517
++ + L L + L + N ++ P + L N
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN 210
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-14
Identities = 20/93 (21%), Positives = 34/93 (36%), Gaps = 5/93 (5%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQ 472
P+IT N IP +L S L L N L F P+L+++ L +
Sbjct: 8 PNITY-QCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCE 63
Query: 473 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 505
+ + +L +L L + N + +
Sbjct: 64 IQTIEDGAYQSLSHLSTLILTGNPIQSLALGAF 96
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 6e-12
Identities = 23/107 (21%), Positives = 37/107 (34%), Gaps = 4/107 (3%)
Query: 411 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLT--GPIPD-FSGCPDLRIIH 467
++ L+ + G L SL L L N L+ G G L+ +
Sbjct: 320 PTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379
Query: 468 LEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 514
L N + + S+ + L L L Q++ L S+ L Y
Sbjct: 380 LSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 425
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 6e-10
Identities = 16/102 (15%), Positives = 31/102 (30%), Gaps = 5/102 (4%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSL----VELWLDGNSLTGPIPDFSGCPDLRIIHLE 469
++ + LSS + +DL L + + L L N + P L + L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLR 208
Query: 470 DNQLTGPLPS-SLMNLPNLRELYVQNNMLSGTVPSSLLSKNV 510
+N + + + L L + K+
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 8e-10
Identities = 15/125 (12%), Positives = 36/125 (28%), Gaps = 11/125 (8%)
Query: 404 SWLQCNSDPQPSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTG----PIPDFS 458
+++Q + + + + L + + N+ + L+ L L D S
Sbjct: 190 NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKS 249
Query: 459 GCPDLRIIHLEDNQLT------GPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVL 512
L + +E+ +L + L N+ + + + S L
Sbjct: 250 ALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHL 309
Query: 513 NYAGN 517
Sbjct: 310 ELVNC 314
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 9e-08
Identities = 22/130 (16%), Positives = 43/130 (33%), Gaps = 25/130 (19%)
Query: 412 PQPSITVIHLSSKNLTGN-IPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLED 470
+I L+ + + I L+++ L ++ + DFS + + L +
Sbjct: 255 CNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVN 313
Query: 471 NQLT-------------------GPLPSSLMNLPNLRELYVQNNMLS--GTVPSSL--LS 507
+ G S ++LP+L L + N LS G S +
Sbjct: 314 CKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTT 373
Query: 508 KNVVLNYAGN 517
L+ + N
Sbjct: 374 SLKYLDLSFN 383
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 3e-05
Identities = 16/100 (16%), Positives = 25/100 (25%), Gaps = 28/100 (28%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPD-LRIIHLEDN 471
S+ V+++S N L+SL L N + P L ++L N
Sbjct: 494 SSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 553
Query: 472 QLTG--------------------------PLPSSLMNLP 485
PS +P
Sbjct: 554 DFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP 593
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 6e-19
Identities = 54/214 (25%), Positives = 94/214 (43%), Gaps = 36/214 (16%)
Query: 605 KKIGSGGFGVVY---YGKLKDGKEI-AVKVLTSNSYQGKREFT----NEVTLLSRIHHRN 656
+ +G GG+G V+ + +I A+KVL + T E +L + H
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 657 LVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK----- 710
+V L Y Q G+ L+ E++ G L L E ED A
Sbjct: 83 IVD-LIYAFQTGGKLYLILEYLSGGELFMQLE----REGIFM--------EDTACFYLAE 129
Query: 711 ---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 767
+ +LH II+RDLK NI+L+ K++DFGL K ++ + + GT+
Sbjct: 130 ISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC-GTI 185
Query: 768 GYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 800
Y+ PE + + +++ D +S G ++ ++++G
Sbjct: 186 EYMAPE-ILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 9e-19
Identities = 48/205 (23%), Positives = 95/205 (46%), Gaps = 21/205 (10%)
Query: 605 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLG 662
+K+G G + V+ + + +++ VK+L K++ E+ +L + N++
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLAD 98
Query: 663 --YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 720
LV+E ++N K LY TLT ++ + K ++Y H+
Sbjct: 99 IVKDPVSRTPALVFEHVNNTDFK-QLYQTLTDYDIRFYMYEI------LKALDYCHSM-- 149
Query: 721 PAIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 779
I+HRD+K N+++D R ++ D+GL++F G + + + + PE + Q
Sbjct: 150 -GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA--SRYFKGPELLVDYQ 206
Query: 780 LTDKS-DVYSFGVILLELISGQEAI 803
+ D S D++S G +L +I +E
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 1e-18
Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 23/205 (11%)
Query: 605 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKRE---FTN--EVTLLSRIHHRNLVQ 659
+K+G G +GVVY K G+ +A+K + ++ + E T E++LL +HH N+V
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRIRLDA---EDEGIPSTAIREISLLKELHHPNIVS 83
Query: 660 FLGYCQEEGRSVLVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 717
+ E LV+EFM + + L Q ++ +L +G+ + H
Sbjct: 84 LIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQL------LRGVAHCHQ 137
Query: 718 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI 776
I+HRDLK N+L++ K++DFGL++ F + S+ +V T+ Y P+ +
Sbjct: 138 HR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYRAPDVLM 192
Query: 777 -SQQLTDKSDVYSFGVILLELISGQ 800
S++ + D++S G I E+I+G+
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 25/212 (11%)
Query: 602 MLEK-----KIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTN--EVTLLSRIH 653
M+EK KIG G +GVV+ + +D G+ +A+K + + E+ +L ++
Sbjct: 1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK 60
Query: 654 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRI-NWIKRLEIAEDAAK 710
H NLV L + + R LV+E+ + T+ L Y E + + + +
Sbjct: 61 HPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQT------LQ 113
Query: 711 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGY 769
+ + H IHRD+K NIL+ KH K+ DFG ++ + + T Y
Sbjct: 114 AVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA--TRWY 168
Query: 770 LDPEYYISQQLTDKS-DVYSFGVILLELISGQ 800
PE + DV++ G + EL+SG
Sbjct: 169 RSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 3e-18
Identities = 63/243 (25%), Positives = 103/243 (42%), Gaps = 40/243 (16%)
Query: 574 QRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLT 632
+ N +++ + + E + +G G FG V ++K+ ++ AVKVL
Sbjct: 3 KESSKEGNGIGVNSSNRLGIDNFE-----FIRVLGKGSFGKVMLARVKETGDLYAVKVL- 56
Query: 633 SNSYQGKREF---TNEVT--------LLSRIHHRNLVQFLGYC-QEEGRSVLVYEFMHNG 680
K++ ++V L +H L Q L C Q R V EF++ G
Sbjct: 57 ------KKDVILQDDDVECTMTEKRILSLARNHPFLTQ-LFCCFQTPDRLFFVMEFVNGG 109
Query: 681 TLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH 738
L H+ E R R AE + +LH II+RDLK N+LLD
Sbjct: 110 DLMFHIQKSRRFD-EARA----RFYAAE-IISALMFLHDK---GIIYRDLKLDNVLLDHE 160
Query: 739 MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELI 797
K++DFG+ K + ++ GT Y+ PE + + L + D ++ GV+L E++
Sbjct: 161 GHCKLADFGMCKEGICNGVTTATFC-GTPDYIAPE-ILQEMLYGPAVDWWAMGVLLYEML 218
Query: 798 SGQ 800
G
Sbjct: 219 CGH 221
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 4e-18
Identities = 24/96 (25%), Positives = 41/96 (42%), Gaps = 2/96 (2%)
Query: 415 SITVIHLSSKNL-TGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
I +I++ NL T + + L K+ L L N L G +P F L ++L NQ+
Sbjct: 306 KIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQI 365
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN 509
T + + L +N L +P+ +K+
Sbjct: 366 TEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKS 400
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 7e-16
Identities = 15/111 (13%), Positives = 32/111 (28%), Gaps = 8/111 (7%)
Query: 399 LPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-F 457
PV S + + ++ L G +P+ L L L N +T +
Sbjct: 320 FPVETSLQKM-----KKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEIPANFC 373
Query: 458 SGCPDLRIIHLEDNQLTG-PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 507
+ + N+L P ++ + + N + +
Sbjct: 374 GFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDP 424
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-15
Identities = 25/119 (21%), Positives = 40/119 (33%), Gaps = 14/119 (11%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG--------PIPDFSGCPDLRI 465
+++ I+LS+ ++ + S L + L GN LT +F L
Sbjct: 433 INVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTS 492
Query: 466 IHLEDNQLTGPLPSSLM--NLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINL 520
I L N+LT L LP L + + N S P+ S +
Sbjct: 493 IDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDA 549
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 7e-15
Identities = 25/116 (21%), Positives = 42/116 (36%), Gaps = 10/116 (8%)
Query: 414 PSITVIHLSSKNLTGNIPSDL--TKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLED- 470
+T I L LT + D T L LV + L NS + L+ + +
Sbjct: 488 YLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQ 546
Query: 471 -----NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 521
N+ P + P+L +L + +N + V + VL+ N N+
Sbjct: 547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKITPNISVLDIKDNPNIS 601
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-14
Identities = 19/115 (16%), Positives = 39/115 (33%), Gaps = 13/115 (11%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVEL------WLDGNSLTGPIPD-FSGCPDLRII 466
P + I LS + + P+ S+L GN P+ + CP L +
Sbjct: 513 PYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQL 571
Query: 467 HLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNIN 519
+ N + + + PN+ L +++N S + + + +
Sbjct: 572 QIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKT 623
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-14
Identities = 12/104 (11%), Positives = 32/104 (30%), Gaps = 10/104 (9%)
Query: 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLED 470
+ + L L ++ + +P P++++I++
Sbjct: 223 ICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVAC 282
Query: 471 NQLT--------GPLPSSLMNLPNLRELYVQNNML-SGTVPSSL 505
N+ + ++ +Y+ N L + V +SL
Sbjct: 283 NRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSL 326
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 9e-14
Identities = 16/128 (12%), Positives = 36/128 (28%), Gaps = 22/128 (17%)
Query: 415 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP------------------- 455
T I S N+T + + +L+ L + ++ +
Sbjct: 184 KDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTED 242
Query: 456 -DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 514
+ DL + + + LP+ L LP ++ + V N + +
Sbjct: 243 LKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS-GEQLKDDWQALADA 301
Query: 515 AGNINLHE 522
+
Sbjct: 302 PVGEKIQI 309
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-13
Identities = 22/172 (12%), Positives = 55/172 (31%), Gaps = 22/172 (12%)
Query: 368 LERNDGSIDAIVSVISLYSSAD---WAQEGGDPCLPVPWSWLQ--CNSDPQPSITV---- 418
L R I +++ ++ + + W+Q+G W++ + QP +++
Sbjct: 22 LSRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNG 81
Query: 419 ----IHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF-----SGCPDLRIIHLE 469
+ L +G +P + +L+ L L L + F S
Sbjct: 82 RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKM 141
Query: 470 DNQLTGPLPSSLM--NLPNLRELYVQNNMLSGTVPSS--LLSKNVVLNYAGN 517
+ +L + + ++ ++ S + K+ + N
Sbjct: 142 RMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSN 193
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 4e-13
Identities = 13/92 (14%), Positives = 27/92 (29%), Gaps = 4/92 (4%)
Query: 419 IHLSSKNLTGNIPSDLTKL--SSLVELWLDGNSLTGPIPDFSG-CPDLRIIHLEDNQLTG 475
+ + S L++ ++ + I S I N +T
Sbjct: 138 KQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF 197
Query: 476 PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 507
+ ++M L LR+ Y+ N+
Sbjct: 198 -VSKAVMRLTKLRQFYMGNSPFVAENICEAWE 228
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 6e-13
Identities = 15/102 (14%), Positives = 31/102 (30%), Gaps = 11/102 (10%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD---FSGCPDLRIIHLED 470
+ ++L+ +T + + L N L IP+ + I
Sbjct: 353 IKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSY 411
Query: 471 NQLTG-------PLPSSLMNLPNLRELYVQNNMLSGTVPSSL 505
N++ PL + N+ + + NN +S
Sbjct: 412 NEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELF 453
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-12
Identities = 17/124 (13%), Positives = 37/124 (29%), Gaps = 21/124 (16%)
Query: 415 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLT 474
+ ++S +I ++ N++T LR ++ ++
Sbjct: 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFV 219
Query: 475 GP-------------------LPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLN 513
NL +L ++ V N +P+ L L + ++N
Sbjct: 220 AENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLIN 279
Query: 514 YAGN 517
A N
Sbjct: 280 VACN 283
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 2e-12
Identities = 18/109 (16%), Positives = 37/109 (33%), Gaps = 11/109 (10%)
Query: 414 PSITVIHLSSKNLTGNIPS--DLTKLSSLVELWLDGNSLTGPI--------PDFSGCPDL 463
+ + + L IP+ D +S + + N + P ++
Sbjct: 377 EQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINV 435
Query: 464 RIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVL 512
I+L +NQ++ L + + NML+ +SL +N
Sbjct: 436 SSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENF 484
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 5e-08
Identities = 14/113 (12%), Positives = 32/113 (28%), Gaps = 10/113 (8%)
Query: 414 PSITVIHLSSKNLTGN----IPSDLTKLSSLVELWLDGNSLTGPIPDFSG---CPDLRII 466
+ V+ L S N P ++ S + D+ DL
Sbjct: 105 TELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKD 164
Query: 467 HLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 517
+ + + S ++ +N ++ V ++ L+K +
Sbjct: 165 CINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNS 216
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 4e-18
Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 605 KKIGSGGFGVVYYGKLKDGKEI-AVK-VLTSNSYQGKREFTN--EVTLLSRIHHRNLVQF 660
+G G +G+V + KD I A+K L S+ + + E+ LL ++ H NLV
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVK-KIAMREIKLLKQLRHENLVNL 89
Query: 661 LGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRI-NWIKRLEIAEDAAKGIEYLHT 717
L C+++ R LV+EF+ + T+ + L + Q + ++ ++ GI + H+
Sbjct: 90 LEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQI------INGIGFCHS 142
Query: 718 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI 776
IIHRD+K NIL+ + K+ DFG ++ A G + + T Y PE +
Sbjct: 143 HN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA--TRWYRAPELLV 197
Query: 777 -SQQLTDKSDVYSFGVILLELISGQ 800
+ DV++ G ++ E+ G+
Sbjct: 198 GDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-18
Identities = 63/230 (27%), Positives = 101/230 (43%), Gaps = 41/230 (17%)
Query: 591 FTLSDIEDATKMLEKKIGSGGFGVVY---YGKLKDGKEI-AVKVLTSNSYQGKREFT--- 643
+ + E L K +G+G +G V+ D ++ A+KVL + K + T
Sbjct: 51 VGIENFE-----LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHT 105
Query: 644 -NEVTLLSRI-HHRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIK 700
E +L I LV L Y Q E + L+ ++++ G L HL +R
Sbjct: 106 RTERQVLEHIRQSPFLVT-LHYAFQTETKLHLILDYINGGELFTHLS----QRERFT--- 157
Query: 701 RLEIAEDAAK--------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 752
E + +E+LH II+RD+K NILLD + ++DFGLSK
Sbjct: 158 -----EHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209
Query: 753 VDGASHVSSIVRGTVGYLDPE-YYISQQLTDKS-DVYSFGVILLELISGQ 800
V + + GT+ Y+ P+ DK+ D +S GV++ EL++G
Sbjct: 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 7e-18
Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 605 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTNEVT----LLSRIHHRNLVQ 659
+ IG G + V +LK I A+KV+ + T +H LV
Sbjct: 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 660 FLGYC-QEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLH 716
L C Q E R V E+++ G L H+ L E+ R AE + + YLH
Sbjct: 75 -LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP-EEHA----RFYSAE-ISLALNYLH 127
Query: 717 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 776
II+RDLK N+LLD K++D+G+ K + S+ GT Y+ PE +
Sbjct: 128 ER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPE-IL 182
Query: 777 SQQLTDKS-DVYSFGVILLELISGQ 800
+ S D ++ GV++ E+++G+
Sbjct: 183 RGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 7e-18
Identities = 56/204 (27%), Positives = 99/204 (48%), Gaps = 23/204 (11%)
Query: 606 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKRE---FTN--EVTLLSRIHHRNLVQF 660
KIG G +GVVY + G+ A+K + + E T E+++L + H N+V+
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEK---EDEGIPSTTIREISILKELKHSNIVKL 65
Query: 661 LGYCQEEGRSVLVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 718
+ R VLV+E + L + G L +++ +L GI Y H
Sbjct: 66 YDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL------LNGIAYCHDR 119
Query: 719 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI- 776
++HRDLK N+L+++ K++DFGL++ F + + IV T+ Y P+ +
Sbjct: 120 R---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV--TLWYRAPDVLMG 174
Query: 777 SQQLTDKSDVYSFGVILLELISGQ 800
S++ + D++S G I E+++G
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 8e-18
Identities = 58/210 (27%), Positives = 102/210 (48%), Gaps = 30/210 (14%)
Query: 606 KIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGK-----REFTNEVTLLSRIHHRNLVQ 659
K+G+G + VY G K A+K + +S +G RE ++L+ + H N+V+
Sbjct: 12 KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIRE----ISLMKELKHENIVR 67
Query: 660 FLGYCQEEGRSVLVYEFMHNGTLKEH-LYGTLTHEQRINWIKRLEIAEDAA------KGI 712
E + LV+EFM ++ L + N + LE+ +G+
Sbjct: 68 LYDVIHTENKLTLVFEFM------DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 713 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLD 771
+ H I+HRDLK N+L++K + K+ DFGL++ F + + S +V T+ Y
Sbjct: 122 AFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--TLWYRA 176
Query: 772 PEYYI-SQQLTDKSDVYSFGVILLELISGQ 800
P+ + S+ + D++S G IL E+I+G+
Sbjct: 177 PDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 87.4 bits (216), Expect = 9e-18
Identities = 60/204 (29%), Positives = 90/204 (44%), Gaps = 19/204 (9%)
Query: 605 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTNEVT----LLSRIHHRNLVQ 659
+G G FG V + K E+ AVK+L + + + L L Q
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406
Query: 660 FLGYC-QEEGRSVLVYEFMHNGTLKEHLYGT-LTHEQRINWIKRLEIAEDAAKGIEYLHT 717
L C Q R V E+++ G L H+ E AE A G+ +L +
Sbjct: 407 -LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA----VFYAAE-IAIGLFFLQS 460
Query: 718 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 777
II+RDLK N++LD K++DFG+ K + + GT Y+ PE I+
Sbjct: 461 K---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPE-IIA 515
Query: 778 QQLTDKS-DVYSFGVILLELISGQ 800
Q KS D ++FGV+L E+++GQ
Sbjct: 516 YQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 2e-17
Identities = 57/235 (24%), Positives = 98/235 (41%), Gaps = 49/235 (20%)
Query: 596 IEDATKMLEKKIGSGGFGVVYYGKLKD---GKEIAVKVLTSNSYQGKREFTN--EVTLLS 650
+ED + K+G G +G VY K KD K+ A+K + + E+ LL
Sbjct: 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG----ISMSACREIALLR 73
Query: 651 RIHHRNLVQFLGYCQEEG-RSV-LVYEFMHNGTLKEH-LYGTL-THEQRINWIKRLEIAE 706
+ H N++ R V L++++ EH L+ + H K +++
Sbjct: 74 ELKHPNVISLQKVFLSHADRKVWLLFDYA------EHDLWHIIKFHRASKANKKPVQLPR 127
Query: 707 DAAK--------GIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKF--- 751
K GI YLH ++HRDLK +NIL+ + R K++D G ++
Sbjct: 128 GMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 184
Query: 752 AVDGASHVSSIVRGTVGYLDPE------YYISQQLTDKSDVYSFGVILLELISGQ 800
+ + + +V T Y PE +Y T D+++ G I EL++ +
Sbjct: 185 PLKPLADLDPVVV-TFWYRAPELLLGARHY-----TKAIDIWAIGCIFAELLTSE 233
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-17
Identities = 61/236 (25%), Positives = 100/236 (42%), Gaps = 26/236 (11%)
Query: 574 QRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLT 632
+ + +A+ L D + L + IG G + V +LK I A++V+
Sbjct: 32 EEKEAMNTRESGKASSSLGLQDFD-----LLRVIGRGSYAKVLLVRLKKTDRIYAMRVVK 86
Query: 633 SNSYQGKREFTNEVT----LLSRIHHRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLY 687
+ T +H LV L C Q E R V E+++ G L H+
Sbjct: 87 KELVNDDEDIDWVQTEKHVFEQASNHPFLVG-LHSCFQTESRLFFVIEYVNGGDLMFHMQ 145
Query: 688 --GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD 745
L E+ R AE + + YLH II+RDLK N+LLD K++D
Sbjct: 146 RQRKLP-EEHA----RFYSAE-ISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTD 196
Query: 746 FGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 800
+G+ K + S+ GT Y+ PE + + S D ++ GV++ E+++G+
Sbjct: 197 YGMCKEGLRPGDTTSTFC-GTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-17
Identities = 63/212 (29%), Positives = 94/212 (44%), Gaps = 35/212 (16%)
Query: 605 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREF---TNEVT--------LLSRI 652
+G G FG V + K E+ AVK+L K++ ++V L
Sbjct: 26 MVLGKGSFGKVMLSERKGTDELYAVKIL-------KKDVVIQDDDVECTMVEKRVLALPG 78
Query: 653 HHRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAA 709
L Q L C Q R V E+++ G L H+ G E AE A
Sbjct: 79 KPPFLTQ-LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK-EPHA----VFYAAE-IA 131
Query: 710 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 769
G+ +L + II+RDLK N++LD K++DFG+ K + + GT Y
Sbjct: 132 IGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDY 187
Query: 770 LDPEYYISQQLTDKS-DVYSFGVILLELISGQ 800
+ PE I+ Q KS D ++FGV+L E+++GQ
Sbjct: 188 IAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 3e-17
Identities = 51/208 (24%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 606 KIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTN--EVTLLSRIHHRNLVQ 659
KIG G +G V+ K ++ EI A+K + + E + E+ LL + H+N+V+
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDD---DDEGVPSSALREICLLKELKHKNIVR 65
Query: 660 FLGYCQEEGRSVLVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 717
+ + LV+EF + G L E +++ +L KG+ + H+
Sbjct: 66 LHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL------LKGLGFCHS 119
Query: 718 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI 776
++HRDLK N+L++++ K+++FGL++ F + + + +V T+ Y P+
Sbjct: 120 RN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYRPPDVLF 174
Query: 777 -SQQLTDKSDVYSFGVILLELISGQEAI 803
++ + D++S G I EL + +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 3e-17
Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 21/205 (10%)
Query: 605 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTNEVT----LLSRIHHRNLVQ 659
K +G G FG V+ + K + A+K L + + + L H L
Sbjct: 23 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82
Query: 660 FLGYC-QEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLH 716
+ Q + V E+++ G L H+ + AE G+++LH
Sbjct: 83 -MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRA-----TFYAAE-IILGLQFLH 135
Query: 717 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 776
+ I++RDLK NILLDK K++DFG+ K + G + ++ GT Y+ PE +
Sbjct: 136 SK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPE-IL 190
Query: 777 SQQLTDKS-DVYSFGVILLELISGQ 800
Q + S D +SFGV+L E++ GQ
Sbjct: 191 LGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 7e-17
Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 605 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE---FTN--EVTLLSRIHHRNLV 658
+G G F VY + + +A+K + ++ T E+ LL + H N++
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 659 QFLGYCQEEGRSVLVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 716
L + LV++FM + + LT ++ +G+EYLH
Sbjct: 76 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMT------LQGLEYLH 129
Query: 717 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEY- 774
I+HRDLK +N+LLD++ K++DFGL+K F ++ +V T Y PE
Sbjct: 130 QHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV--TRWYRAPELL 184
Query: 775 YISQQLTDKSDVYSFGVILLELISGQ 800
+ ++ D+++ G IL EL+
Sbjct: 185 FGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-16
Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 24/157 (15%)
Query: 606 KIGSGGFGVVYYGKLKDGKEI-AVK-VLTSNSYQGKREFTN--EVTLLSRIHHRNLVQFL 661
KIG G FG V+ + + + A+K VL N +G T E+ +L + H N+V +
Sbjct: 24 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP-ITALREIKILQLLKHENVVNLI 82
Query: 662 GYCQEEGRSV--------LVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 711
C+ + LV++F + L ++ T + ++ L G
Sbjct: 83 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML------LNG 136
Query: 712 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 748
+ Y+H I+HRD+K++N+L+ + K++DFGL
Sbjct: 137 LYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 49/206 (23%), Positives = 94/206 (45%), Gaps = 25/206 (12%)
Query: 605 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGK-----REFTNEVTLLSRIHHRNLV 658
K+G G + VY GK K +A+K + +G RE V+LL + H N+V
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIRE----VSLLKDLKHANIV 63
Query: 659 QFLGYCQEEGRSVLVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 716
E LV+E++ + + ++ +L +G+ Y H
Sbjct: 64 TLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQL------LRGLAYCH 117
Query: 717 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYY 775
++HRDLK N+L+++ K++DFGL++ ++ ++ + +V T+ Y P+
Sbjct: 118 RQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDIL 172
Query: 776 I-SQQLTDKSDVYSFGVILLELISGQ 800
+ S + + D++ G I E+ +G+
Sbjct: 173 LGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-16
Identities = 26/109 (23%), Positives = 43/109 (39%), Gaps = 5/109 (4%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 472
P + V++L L+ ++L EL L NS+ + F +L + L N
Sbjct: 73 PMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNG 132
Query: 473 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL----LSKNVVLNYAGN 517
L+ + + L NL+EL + NN + L S L + N
Sbjct: 133 LSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-16
Identities = 25/107 (23%), Positives = 41/107 (38%), Gaps = 3/107 (2%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 472
+T + + ++ P KL L L L N L+ F+ C +L +HL N
Sbjct: 49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNS 108
Query: 473 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 517
+ + + NL L + +N LS T + L L + N
Sbjct: 109 IQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNN 155
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 4e-16
Identities = 19/97 (19%), Positives = 35/97 (36%), Gaps = 3/97 (3%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD---FSGCPDLRIIHLED 470
++ + LS L+ +L +L EL L N + + L+ + L
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180
Query: 471 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 507
NQ+ P + L L++ N L ++ L
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCL 217
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-15
Identities = 20/112 (17%), Positives = 45/112 (40%), Gaps = 6/112 (5%)
Query: 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLE 469
+ +++L+ ++ + L L L L N + + + G ++ I+L
Sbjct: 379 AHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLS 438
Query: 470 DNQLTGPLPSSLMNLPNLRELYVQNNMLSG--TVPSSL--LSKNVVLNYAGN 517
N+ +S +P+L+ L ++ L + PS L +L+ + N
Sbjct: 439 YNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNN 490
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-15
Identities = 26/116 (22%), Positives = 40/116 (34%), Gaps = 12/116 (10%)
Query: 414 PSITVIHLSSKNLT--------GNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLR 464
+ ++ L NL G L LS L L L+ N + F +L+
Sbjct: 504 EKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELK 563
Query: 465 IIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGN 517
II L N L S N +L+ L +Q N+++ L+ N
Sbjct: 564 IIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFN 619
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-15
Identities = 25/100 (25%), Positives = 40/100 (40%), Gaps = 8/100 (8%)
Query: 407 QCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRI 465
+C S V S LT +P DL +++ L L N L +F+ L
Sbjct: 1 KCTV----SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTS 53
Query: 466 IHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 505
+ + N ++ P LP L+ L +Q+N LS +
Sbjct: 54 LDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTF 93
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 8e-15
Identities = 24/112 (21%), Positives = 39/112 (34%), Gaps = 4/112 (3%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD---FSGCPDLRIIHLED 470
+I I+LS + + SL L L +L F +L I+ L +
Sbjct: 430 ENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSN 489
Query: 471 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 522
N + L L L L +Q+N L+ + + G +LH
Sbjct: 490 NNIANINDDMLEGLEKLEILDLQHNNLA-RLWKHANPGGPIYFLKGLSHLHI 540
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-14
Identities = 15/106 (14%), Positives = 36/106 (33%), Gaps = 5/106 (4%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG---PIPDFSGCP--DLRIIHL 468
+ +++ ++ G + T L +L L L + + F L I++L
Sbjct: 329 KCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNL 388
Query: 469 EDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 514
N+++ + L +L L + N + + +
Sbjct: 389 TKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFE 434
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-13
Identities = 27/104 (25%), Positives = 43/104 (41%), Gaps = 3/104 (2%)
Query: 408 CNSDPQPSITVIHLSSKNLTGNIPSDLT--KLSSLVELWLDGNSLTGPIPD-FSGCPDLR 464
C SI + LS+ L+ + K ++L L L N+L D F+ P L
Sbjct: 216 CLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLE 275
Query: 465 IIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 508
LE N + SL L N+R L ++ + ++ + L K
Sbjct: 276 YFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPK 319
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-13
Identities = 20/100 (20%), Positives = 38/100 (38%), Gaps = 6/100 (6%)
Query: 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD----FSGCPDLRIIH 467
S+ + LSS + P + L L+L+ L + + +R +
Sbjct: 169 ANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLS 228
Query: 468 LEDNQLTGPLPSSLMNL--PNLRELYVQNNMLSGTVPSSL 505
L ++QL+ ++ + L NL L + N L+ S
Sbjct: 229 LSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSF 268
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-13
Identities = 20/110 (18%), Positives = 38/110 (34%), Gaps = 10/110 (9%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD----------FSGCPDL 463
P + L N+ L L ++ L L + I F L
Sbjct: 272 PQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCL 331
Query: 464 RIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLN 513
+++EDN + G + L NL+ L + N+ S ++ ++ +
Sbjct: 332 EHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHS 381
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 1e-06
Identities = 15/69 (21%), Positives = 24/69 (34%), Gaps = 2/69 (2%)
Query: 439 SLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLS 498
S LT +PD ++ +++L NQL ++ L L V N +S
Sbjct: 5 SHEVADCSHLKLTQ-VPDDLP-TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62
Query: 499 GTVPSSLLS 507
P
Sbjct: 63 KLEPELCQK 71
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 51/227 (22%), Positives = 82/227 (36%), Gaps = 66/227 (29%)
Query: 594 SDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE-FTNEVTLLSR 651
+ I D K+ + +G G G V K ++ A+K+L EV L R
Sbjct: 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ------DCPKARREVELHWR 66
Query: 652 I-HHRNLVQFLGYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIA- 705
++V+ + + +V E + G L RI R + A
Sbjct: 67 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFS----------RI--QDRGDQAF 114
Query: 706 --EDAA-------KGIEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFA 752
+A+ + I+YLH+ I HRD+K N+L + K++DFG +K
Sbjct: 115 TEREASEIMKSIGEAIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAK-- 168
Query: 753 VDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 799
G Y D D++S GVI+ L+ G
Sbjct: 169 ---------ETTGE-KY-DKS----------CDMWSLGVIMYILLCG 194
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 3e-16
Identities = 60/272 (22%), Positives = 95/272 (34%), Gaps = 83/272 (30%)
Query: 603 LEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSYQG-KREFTNEVTLLSRI-HH 654
L K +G G FG V + +AVK+L + R +E+ +L I HH
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 655 RN--------------------------LVQFL-------------GYCQEEGRSVLVYE 675
N L +L G +G+ +
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI 145
Query: 676 FMH----------------NGTLKEHLYGTLTHEQRINWIKR--------LEIAEDAAKG 711
+ +G ++E + E+ + + + + AKG
Sbjct: 146 PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKG 205
Query: 712 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 771
+E+L + IHRDL + NILL + K+ DFGL++ VR L
Sbjct: 206 MEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD----PDYVRKGDARLP 258
Query: 772 -----PEYYISQQLTDKSDVYSFGVILLELIS 798
PE + T +SDV+SFGV+L E+ S
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 5e-16
Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 23/206 (11%)
Query: 605 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQF 660
K IGSG G+V + +A+K L+ N KR + E+ L+ ++H+N++
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIGL 89
Query: 661 L-----GYCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 714
L EE + V +V E M L + + L HE+ + ++ GI++
Sbjct: 90 LNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQM------LCGIKH 142
Query: 715 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 774
LH+ + IHRDLK SNI++ K+ DFGL++ A +V T Y PE
Sbjct: 143 LHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEV 197
Query: 775 YISQQLTDKSDVYSFGVILLELISGQ 800
+ + D++S G I+ E+I G
Sbjct: 198 ILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 6e-16
Identities = 47/254 (18%), Positives = 94/254 (37%), Gaps = 65/254 (25%)
Query: 595 DIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTN-EVTLLSRI 652
+ L K +G+G FG+V + GK A+K + + + N E+ ++ +
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-----PRYKNRELDIMKVL 57
Query: 653 HHRNLVQFLGYCQEEGRSV--------------------------------------LVY 674
H N+++ + Y G ++
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 675 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE------DAAKGIEYLHTGCVPAIIHRDL 728
E++ + L+ L R + + + + + ++H+ I HRD+
Sbjct: 118 EYV-----PDTLHKVLKSFIRSG--RSIPMNLISIYIYQLFRAVGFIHSL---GICHRDI 167
Query: 729 KSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI-SQQLTDKSDV 786
K N+L++ K+ DFG +K + V+ I + Y PE + + + T D+
Sbjct: 168 KPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLGATEYTPSIDL 225
Query: 787 YSFGVILLELISGQ 800
+S G + ELI G+
Sbjct: 226 WSIGCVFGELILGK 239
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 50/210 (23%), Positives = 94/210 (44%), Gaps = 30/210 (14%)
Query: 606 KIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE---FTN--EVTLLSRIHHRNLVQ 659
K+G G +G VY + +A+K + + + E T EV+LL + HRN+++
Sbjct: 41 KLGEGTYGEVYKAIDTVTNETVAIKRI---RLEHEEEGVPGTAIREVSLLKELQHRNIIE 97
Query: 660 FLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 717
R L++E+ N LK+++ ++ +++ +L G+ + H+
Sbjct: 98 LKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQL------INGVNFCHS 150
Query: 718 GCVPAIIHRDLKSSNILLDKHMRA-----KVSDFGLSK-FAVDGASHVSSIVRGTVGYLD 771
+HRDLK N+LL + K+ DFGL++ F + I+ T+ Y
Sbjct: 151 ---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII--TLWYRP 205
Query: 772 PEYYI-SQQLTDKSDVYSFGVILLELISGQ 800
PE + S+ + D++S I E++
Sbjct: 206 PEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 2e-15
Identities = 22/116 (18%), Positives = 37/116 (31%), Gaps = 13/116 (11%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPI----------PDFSGCPDL 463
+T + L + +P L L L L + N D P +
Sbjct: 491 KDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKI 550
Query: 464 RIIHLEDNQLTG-PLPSSLMNLPNLRELYVQNNMLSGTVPS-SLLSKNVVLNYAGN 517
+I ++ N L P +SL + L L +N + + + K L N
Sbjct: 551 QIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDLKLDYN 605
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 2e-14
Identities = 19/113 (16%), Positives = 34/113 (30%), Gaps = 10/113 (8%)
Query: 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLED 470
+ N + L L ++ L +PD P+L+ +++
Sbjct: 465 IAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIAC 524
Query: 471 NQLTGP---------LPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 514
N+ L P ++ Y+ N L S+ L K V L
Sbjct: 525 NRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGL 577
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 3e-14
Identities = 23/120 (19%), Positives = 38/120 (31%), Gaps = 16/120 (13%)
Query: 415 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD---------FSGCPDLRI 465
+ + + LS + S + + L N +T IP+ + L
Sbjct: 674 NASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTS-IPENSLKPKDGNYKNTYLLTT 732
Query: 466 IHLEDNQLTGPLPSSLM--NLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINLH 521
I L N+LT L LP L + V N S + P+ S+ +
Sbjct: 733 IDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAE 790
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 5e-14
Identities = 24/117 (20%), Positives = 44/117 (37%), Gaps = 12/117 (10%)
Query: 414 PSITVIHLSSKNLTGNIPSDL--TKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLE- 469
+T I L LT + D T L L + + N + P L+ +
Sbjct: 728 YLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRH 785
Query: 470 -----DNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 521
N++ P+ + P+L +L + +N + V L + +L+ A N N+
Sbjct: 786 QRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKLTPQLYILDIADNPNIS 841
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 5e-13
Identities = 20/98 (20%), Positives = 37/98 (37%), Gaps = 5/98 (5%)
Query: 414 PSITVIHLSSKNLTG-NIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQ 472
P I + ++ NL + L K+ L L N + + F L + L+ NQ
Sbjct: 548 PKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRH-LEAFGTNVKLTDLKLDYNQ 606
Query: 473 LTGPLPSSLM-NLPNLRELYVQNNMLSGTVPSSLLSKN 509
+ +P + L +N L +P+ +K+
Sbjct: 607 IEE-IPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKS 642
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 2e-12
Identities = 17/110 (15%), Positives = 30/110 (27%), Gaps = 20/110 (18%)
Query: 420 HLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--------------------FSG 459
+ N I + +L+ L ++ + T +S
Sbjct: 430 IGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSN 489
Query: 460 CPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN 509
DL + L + LP L +LP L+ L + N
Sbjct: 490 LKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTR 539
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 6e-12
Identities = 21/115 (18%), Positives = 39/115 (33%), Gaps = 15/115 (13%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVEL------WLDGNSLTGPIPD-FSGCPDLRII 466
P ++ + +S + P+ S L +GN + P + CP L +
Sbjct: 753 PYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQL 811
Query: 467 HLEDNQLTGPLPSSLMNLPNLRELYVQNNMLS----GTVPSSLLSKNVVLNYAGN 517
+ N + + L P L L + +N +V + + VL Y
Sbjct: 812 QIGSNDIRK-VDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKT 863
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 6e-11
Identities = 13/102 (12%), Positives = 33/102 (32%), Gaps = 10/102 (9%)
Query: 414 PSITVIHLSSKNLTGNIPSD--LTKLSSLVELWLDGNSLTGPIPDFSGCPD------LRI 465
+ + S L IP+ + + + N + + S D
Sbjct: 619 DQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINAST 677
Query: 466 IHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 507
+ L N++ + + + NN+++ ++P + L
Sbjct: 678 VTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLK 718
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 1e-09
Identities = 20/118 (16%), Positives = 35/118 (29%), Gaps = 21/118 (17%)
Query: 421 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGP---- 476
++ I D ++ N +T L+II+ ++ T
Sbjct: 408 INRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAV 467
Query: 477 ---------------LPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 517
S NL +L ++ + N +P L L + LN A N
Sbjct: 468 DWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACN 525
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 13/120 (10%), Positives = 38/120 (31%), Gaps = 4/120 (3%)
Query: 396 DPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP 455
+ + + ++ +T + L+ G +P + +L+ L L +S T
Sbjct: 307 ELDMWGDQPGVDLDN--NGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGR 364
Query: 456 DFSG-CPDLRIIHLEDNQLTGPLPS-SLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLN 513
F + +++ L L + + ++ + K+ ++
Sbjct: 365 LFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRIS 424
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 3e-08
Identities = 17/122 (13%), Positives = 41/122 (33%), Gaps = 11/122 (9%)
Query: 410 SDPQPSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHL 468
D + + + + + L L L +++ P+ I L
Sbjct: 367 GDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINR-NPEMKPIKKDSRISL 425
Query: 469 ED-------NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 521
+D N++T + ++ L L+ +Y N+ + ++ ++ +YA
Sbjct: 426 KDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTY-DNIAVDWEDANSDYAKQYENE 483
Query: 522 EG 523
E
Sbjct: 484 EL 485
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 8e-06
Identities = 9/62 (14%), Positives = 22/62 (35%), Gaps = 3/62 (4%)
Query: 463 LRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSS---LLSKNVVLNYAGNIN 519
+ + L G +P ++ L L+ L + + + L+ ++ I
Sbjct: 325 VTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIR 384
Query: 520 LH 521
+H
Sbjct: 385 MH 386
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-15
Identities = 18/108 (16%), Positives = 34/108 (31%), Gaps = 4/108 (3%)
Query: 414 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDN 471
S+ + ++ + N S+ ++L L L L F L+++++ N
Sbjct: 448 TSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHN 507
Query: 472 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 517
L S L +L L N + + N N
Sbjct: 508 NLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNN 555
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-14
Identities = 15/101 (14%), Positives = 30/101 (29%), Gaps = 3/101 (2%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP--DFSGCPDLRIIHLEDN 471
S+ + LS + ++ L L L ++L F L + +
Sbjct: 376 NSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYT 434
Query: 472 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVL 512
+ L +L L + N S++ + L
Sbjct: 435 NTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNL 475
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 4e-14
Identities = 20/96 (20%), Positives = 33/96 (34%), Gaps = 1/96 (1%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 472
+ + LS + L L L L GN + P FSG L + + +
Sbjct: 56 SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETK 115
Query: 473 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 508
L + L L++L V +N + + S
Sbjct: 116 LASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN 151
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 8e-14
Identities = 18/99 (18%), Positives = 32/99 (32%), Gaps = 4/99 (4%)
Query: 408 CNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRII 466
+ L+ +P D+ SS + L N L FS +L+ +
Sbjct: 5 NPCIEVVPNITYQCMDQKLS-KVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSELQWL 61
Query: 467 HLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 505
L ++ + L +L L + N + P S
Sbjct: 62 DLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSF 100
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-13
Identities = 14/86 (16%), Positives = 28/86 (32%), Gaps = 1/86 (1%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 472
++T + LS L L L L + N+L ++ L + N+
Sbjct: 473 TNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNR 532
Query: 473 LTGPLPSSLMNLPNLRELYVQNNMLS 498
+ +L + NN ++
Sbjct: 533 IETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-11
Identities = 21/116 (18%), Positives = 37/116 (31%), Gaps = 7/116 (6%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPD-FSGCPDLRIIHLEDN 471
S+ + L + +L +L +L + N + +P FS +L + L N
Sbjct: 104 TSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYN 163
Query: 472 QLTGPLPSSLMNLPNLR----ELYVQNNMLSGTVPSSL-LSKNVVLNYAGNINLHE 522
+ + L L L + N + + K L GN N
Sbjct: 164 YIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSN 219
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-11
Identities = 24/109 (22%), Positives = 40/109 (36%), Gaps = 5/109 (4%)
Query: 414 PSITVIHLSSKNLT--GNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDN 471
PS++ + LS L+ G +SL L L N +F G +L+ + + +
Sbjct: 350 PSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHS 409
Query: 472 QLTG-PLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 517
L S+ ++L L L + L+ L AGN
Sbjct: 410 TLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGN 458
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-10
Identities = 20/106 (18%), Positives = 39/106 (36%), Gaps = 4/106 (3%)
Query: 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDN 471
+I L+ N + L+++ + L G S+ + D + + +
Sbjct: 259 CDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY-LEDVPKHFKWQSLSIIRC 317
Query: 472 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
QL P+ +LP L+ L + N S + L L+ + N
Sbjct: 318 QLKQ-FPTL--DLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRN 360
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 5e-07
Identities = 20/108 (18%), Positives = 35/108 (32%), Gaps = 9/108 (8%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
+ + L DL L L L N + P L + L N L
Sbjct: 307 FKWQSLSIIRCQLKQFPTLDL---PFLKSLTLTMNKGSI-SFKKVALPSLSYLDLSRNAL 362
Query: 474 T--GPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 517
+ G S + +LR L + N + ++ L + L++ +
Sbjct: 363 SFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHS 409
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 1e-06
Identities = 14/114 (12%), Positives = 24/114 (21%), Gaps = 10/114 (8%)
Query: 414 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTG-------PIPDFSGCPDLRI 465
+ + L + NI L L+ L L G D+ I
Sbjct: 204 IKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTI 263
Query: 466 IHLED--NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
L N+ + + + K L+
Sbjct: 264 DEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRC 317
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 14/102 (13%), Positives = 30/102 (29%), Gaps = 5/102 (4%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLS----SLVELWLDGNSLTGPIPDFSGCPDLRIIHLE 469
++ + LS + +DL L + L + N + L + L
Sbjct: 153 TNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLR 212
Query: 470 DNQLTG-PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNV 510
N + + + L NL L + + ++
Sbjct: 213 GNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSI 254
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 4e-15
Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 605 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQF 660
K IGSG G+V + +A+K L+ N KR + E+ L+ ++H+N++
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISL 126
Query: 661 L-----GYCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 714
L EE + V LV E M L + + L HE+ + ++ GI++
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQM------LCGIKH 179
Query: 715 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 774
LH+ + IHRDLK SNI++ K+ DFGL++ + ++ V T Y PE
Sbjct: 180 LHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYV-VTRYYRAPEV 234
Query: 775 YISQQLTDKSDVYSFGVILLELISGQ 800
+ + D++S G I+ E++ +
Sbjct: 235 ILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 5e-15
Identities = 48/233 (20%), Positives = 87/233 (37%), Gaps = 62/233 (26%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKEIAVK--VLTSNSYQGKREFTN---------EVTLLSR 651
+++ I SG +G V G +G +A+K T + + ++ E+ LL+
Sbjct: 26 VQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNH 85
Query: 652 IHHRNLVQ----FLGYCQEEGRSV-LVYEFM----------HNGTLKEH-----LYGTLT 691
HH N++ F+ + + + LV E M + +Y L
Sbjct: 86 FHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHIL- 144
Query: 692 HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 751
G+ LH V +HRDL NILL + + DF L++
Sbjct: 145 ------------------LGLHVLHEAGV---VHRDLHPGNILLADNNDITICDFNLARE 183
Query: 752 AVDGAS---HVSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 800
A+ +V+ Y PE + + K D++S G ++ E+ + +
Sbjct: 184 DTADANKTHYVT-----HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 6e-15
Identities = 14/98 (14%), Positives = 31/98 (31%), Gaps = 5/98 (5%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD---FSGCPDLRIIHLED 470
S+ + LS + + S+ L L L ++L + + F +L + +
Sbjct: 373 TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ-MSEFSVFLSLRNLIYLDISH 430
Query: 471 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 508
L +L L + N + ++
Sbjct: 431 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 2e-14
Identities = 26/110 (23%), Positives = 45/110 (40%), Gaps = 6/110 (5%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 471
++ + +S + LSSL L + GNS F+ +L + L
Sbjct: 421 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 480
Query: 472 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 521
QL P++ +L +L+ L + +N L +VP + + L I LH
Sbjct: 481 QLEQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQK---IWLH 526
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 7e-12
Identities = 19/97 (19%), Positives = 33/97 (34%), Gaps = 5/97 (5%)
Query: 417 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQLTG 475
N IP +L S L L N L F P+L+++ L ++
Sbjct: 10 ITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66
Query: 476 PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVL 512
+ +L +L L + N + ++ S L
Sbjct: 67 IEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSL 102
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-11
Identities = 21/104 (20%), Positives = 37/104 (35%), Gaps = 4/104 (3%)
Query: 414 PSITVIHLSSKNLT--GNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDN 471
PS+ + LS L+ G +SL L L N + +F G L + + +
Sbjct: 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHS 406
Query: 472 QLTG-PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 514
L S ++L NL L + + + + + L
Sbjct: 407 NLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEV 449
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 2e-11
Identities = 19/89 (21%), Positives = 39/89 (43%), Gaps = 2/89 (2%)
Query: 414 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDN 471
S+ V+ ++ + N D T+L +L L L L P F+ L+++++ N
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASN 504
Query: 472 QLTGPLPSSLMNLPNLRELYVQNNMLSGT 500
QL L +L+++++ N +
Sbjct: 505 QLKSVPDGIFDRLTSLQKIWLHTNPWDCS 533
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 20/115 (17%), Positives = 40/115 (34%), Gaps = 8/115 (6%)
Query: 411 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLE 469
++ + L+ + + LSSL +L +L L+ +++
Sbjct: 73 QSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA 132
Query: 470 DNQLT-GPLPSSLMNLPNLRELYVQNNMLSGTVP------SSLLSKNVVLNYAGN 517
N + LP NL NL L + +N + + N+ L+ + N
Sbjct: 133 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 1e-10
Identities = 22/86 (25%), Positives = 36/86 (41%), Gaps = 1/86 (1%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQ 472
P + V+ LS + LS L L L GN + + FSG L+ + +
Sbjct: 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111
Query: 473 LTGPLPSSLMNLPNLRELYVQNNMLS 498
L + +L L+EL V +N++
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQ 137
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 21/111 (18%), Positives = 39/111 (35%), Gaps = 7/111 (6%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLT-GPIPD-FSGCPDLRIIHLEDN 471
S+ + NL + L +L EL + N + +P+ FS +L + L N
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159
Query: 472 QLTGPLPSSLMNLPNLR----ELYVQNNMLSGTVPSSLLSKN-VVLNYAGN 517
++ + L L + L + N ++ P + L N
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN 210
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 3e-04
Identities = 20/73 (27%), Positives = 29/73 (39%), Gaps = 3/73 (4%)
Query: 403 WSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGC 460
++L ++T + LS L P+ LSSL L + N L +PD F
Sbjct: 459 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKS-VPDGIFDRL 517
Query: 461 PDLRIIHLEDNQL 473
L+ I L N
Sbjct: 518 TSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 5e-04
Identities = 17/107 (15%), Positives = 38/107 (35%), Gaps = 5/107 (4%)
Query: 412 PQPSITVIHLSSKNLTGN-IPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLED 470
+I L+ + + I L+++ L ++ + DFS + + L +
Sbjct: 255 CNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVN 313
Query: 471 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
+ P+ + L +L+ L +N L L+ + N
Sbjct: 314 CKFGQ-FPT--LKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRN 357
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 7e-15
Identities = 20/96 (20%), Positives = 33/96 (34%)
Query: 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDN 471
+ S+ I+L + S L EL L L+ G L+ + L N
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSAN 311
Query: 472 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 507
+ S N P+L L ++ N + + L
Sbjct: 312 KFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLE 347
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 9e-15
Identities = 23/109 (21%), Positives = 40/109 (36%), Gaps = 5/109 (4%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD----FSGCPDLRIIHLE 469
+ V++LS L + L +L L L GN L I+ L
Sbjct: 425 HLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLS 484
Query: 470 DNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL-LSKNVVLNYAGN 517
L+ + +L + + + +N L+ + +L K + LN A N
Sbjct: 485 FCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASN 533
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-14
Identities = 20/107 (18%), Positives = 32/107 (29%), Gaps = 3/107 (2%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 472
S + S L + ++L +L L L + D F L + L N
Sbjct: 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP 92
Query: 473 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 517
L ++L L+ L+ +S L L N
Sbjct: 93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSN 139
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 6e-14
Identities = 19/109 (17%), Positives = 37/109 (33%), Gaps = 5/109 (4%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 472
+ + L++ L + L+ +L L+ ++ L ++L N
Sbjct: 81 HRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNH 140
Query: 473 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS----KNVVLNYAGN 517
++ L+ L QNN + + S N+ LN GN
Sbjct: 141 ISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGN 189
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 6e-14
Identities = 21/123 (17%), Positives = 45/123 (36%), Gaps = 4/123 (3%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 472
++ + ++ L +L L+L N ++ L+++ ++N
Sbjct: 105 KALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNA 164
Query: 473 LTGPLPSSLMNLPNLR--ELYVQNNMLSGTVPSSLLSKNV-VLNYAGNINLHEGGRGAKH 529
+ + +L L + N ++G P + S LN+ G NL +G K+
Sbjct: 165 IHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKN 224
Query: 530 LNI 532
I
Sbjct: 225 STI 227
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 8e-14
Identities = 16/94 (17%), Positives = 27/94 (28%), Gaps = 2/94 (2%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 471
+ ++LS + L L L L F L++++L +
Sbjct: 376 SHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHS 435
Query: 472 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 505
L LP L+ L +Q N
Sbjct: 436 LLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKT 469
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 6e-13
Identities = 18/99 (18%), Positives = 30/99 (30%), Gaps = 4/99 (4%)
Query: 408 CNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRII 466
+ + + L IP L +S L N L FS +L +
Sbjct: 6 QKCIEKEVNKTYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFL 62
Query: 467 HLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 505
L Q+ + + L L + N L ++L
Sbjct: 63 DLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETAL 101
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-12
Identities = 18/105 (17%), Positives = 33/105 (31%), Gaps = 4/105 (3%)
Query: 414 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD---FSGCPDLRIIHLE 469
PS+T + + + + L L +L EL L + + L+ ++L
Sbjct: 325 PSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLS 384
Query: 470 DNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 514
N+ + P L L + L S +L
Sbjct: 385 YNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKV 429
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 4e-11
Identities = 21/88 (23%), Positives = 37/88 (42%), Gaps = 2/88 (2%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 472
+ ++ LS +L+ T L + + L N LT + S + + +L N
Sbjct: 476 GRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYL-NLASNH 534
Query: 473 LTGPLPSSLMNLPNLRELYVQNNMLSGT 500
++ LPS L L R + ++ N L T
Sbjct: 535 ISIILPSLLPILSQQRTINLRQNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 7e-09
Identities = 21/121 (17%), Positives = 41/121 (33%), Gaps = 8/121 (6%)
Query: 404 SWLQCNSDPQPSITVIHLSSKNLTGNIPSDL--TKLSSLVELWLDGNSLTGPIPD-FSGC 460
+ ++ + ++ I L + + SL + P F G
Sbjct: 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251
Query: 461 PD--LRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAG 516
+ + I+L+ + ++ L+EL + LS +PS L LS L +
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSA 310
Query: 517 N 517
N
Sbjct: 311 N 311
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 32/214 (14%)
Query: 606 KIGSGGFGVVYYGK-LKDGKEIAVK-VLTSNSYQGKREFTN----EVTLLSRIH---HRN 656
+IG G +G VY + G +A+K V N G EV LL R+ H N
Sbjct: 16 EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 657 LVQFL-----GYCQEEGRSVLVYEFMHN---GTLKEHLYGTLTHEQRINWIKRLEIAEDA 708
+V+ + E + LV+E + L + L E + +++
Sbjct: 76 VVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF------ 129
Query: 709 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGA-SHVSSIVRGT 766
+G+++LH C I+HRDLK NIL+ K++DFGL++ ++ A + V +V T
Sbjct: 130 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPV--VV--T 182
Query: 767 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 800
+ Y PE + D++S G I E+ +
Sbjct: 183 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 52/210 (24%), Positives = 98/210 (46%), Gaps = 32/210 (15%)
Query: 605 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQF 660
+GSG +G V + G+++A+K L+ + KR + E+ LL + H N++
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY-RELLLLKHMQHENVIGL 88
Query: 661 L-----GYCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 714
L LV FM L++ + + E+ + ++ KG++Y
Sbjct: 89 LDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQML------KGLKY 141
Query: 715 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG---YLD 771
+H+ ++HRDLK N+ +++ K+ DFGL A H + + G V Y
Sbjct: 142 IHSA---GVVHRDLKPGNLAVNEDCELKILDFGL-------ARHADAEMTGYVVTRWYRA 191
Query: 772 PEYYISQQLTDKS-DVYSFGVILLELISGQ 800
PE +S +++ D++S G I+ E+++G+
Sbjct: 192 PEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 53/252 (21%), Positives = 92/252 (36%), Gaps = 68/252 (26%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLV 658
++ IG G +G VY K +A+K + + KR E+T+L+R+ ++
Sbjct: 30 IKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL-REITILNRLKSDYII 88
Query: 659 Q----FLGYCQEEGRSV-LVYEFM---------HNGTLK-EH----LYGTLTHEQRINWI 699
+ + + + +V E L EH LY L
Sbjct: 89 RLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLL--------- 139
Query: 700 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASH 758
G ++H IIHRDLK +N LL++ KV DFGL+ + ++
Sbjct: 140 ----------LGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTN 186
Query: 759 VSSIVRGTVGYLDPEYYISQQLTD--------------------KS-DVYSFGVILLELI 797
+ + + + +QLT KS D++S G I EL+
Sbjct: 187 IVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246
Query: 798 SGQEAISNEKFG 809
+ ++ N+
Sbjct: 247 NMLQSHINDPTN 258
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 55/229 (24%), Positives = 87/229 (37%), Gaps = 54/229 (23%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLT--SNSYQGKREFTNEVTLLSRIHHRNLVQ 659
L+ +G G +GVV G+ +A+K + R E+ +L H N++
Sbjct: 15 LKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-REIKILKHFKHENIIT 73
Query: 660 ----FLGYCQEEGRSV-LVYEFM--------HNGTLK-EH----LYGTLTHEQRINWIKR 701
E V ++ E M L +H +Y TL
Sbjct: 74 IFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL----------- 122
Query: 702 LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 761
+ ++ LH V IHRDLK SN+L++ + KV DFGL++ + A+ S
Sbjct: 123 --------RAVKVLHGSNV---IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171
Query: 762 IVRGTVG---------YLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 800
G Y PE ++ ++ DV+S G IL EL +
Sbjct: 172 PTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 14/97 (14%), Positives = 29/97 (29%), Gaps = 3/97 (3%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLT--GPIPDFSGCPDLRIIHLEDN 471
S+ + LS + + S+ L L L ++L F +L + +
Sbjct: 78 TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 136
Query: 472 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 508
L +L L + N + ++
Sbjct: 137 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 173
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 9e-13
Identities = 25/104 (24%), Positives = 38/104 (36%), Gaps = 4/104 (3%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG---PIPDFSGCPDLRIIHLED 470
S T + L S L KL+ L +L L N L+ G L+ + L
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87
Query: 471 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 514
N + + S+ + L L L Q++ L S+ L Y
Sbjct: 88 NGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 130
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 19/97 (19%), Positives = 39/97 (40%), Gaps = 5/97 (5%)
Query: 414 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 470
++ + +S + + LSSL L + GNS F+ +L + L
Sbjct: 126 RNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 184
Query: 471 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 507
QL P++ +L +L+ L + +N ++ +
Sbjct: 185 CQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYK 220
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 19/97 (19%), Positives = 36/97 (37%), Gaps = 5/97 (5%)
Query: 414 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 470
S+ V+ ++ + N D T+L +L L L L + F+ L+++++
Sbjct: 150 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ-LSPTAFNSLSSLQVLNMSH 208
Query: 471 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 507
N L +L+ L N + T L
Sbjct: 209 NNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQ 244
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 7e-10
Identities = 20/97 (20%), Positives = 36/97 (37%), Gaps = 4/97 (4%)
Query: 414 PSITVIHLSSKNLT-GNIPSD-LTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDN 471
+T + LSS L+ S +SL L L N + +F G L + + +
Sbjct: 52 TQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHS 111
Query: 472 QLTG-PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 507
L S ++L NL L + + + + +
Sbjct: 112 NLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFN 147
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 17/89 (19%), Positives = 33/89 (37%), Gaps = 6/89 (6%)
Query: 414 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 470
++T + LS L + LSSL L + N+ + + L+++
Sbjct: 175 RNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFS-LDTFPYKCLNSLQVLDYSL 232
Query: 471 NQLTGPLPSSLMNLP-NLRELYVQNNMLS 498
N + L + P +L L + N +
Sbjct: 233 NHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 6e-14
Identities = 21/104 (20%), Positives = 44/104 (42%), Gaps = 3/104 (2%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
+T + + + ++ + + L+ L L + N ++ I + L + L +NQL
Sbjct: 243 SQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD-ISVLNNLSQLNSLFLNNNQL 299
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
+ L NL L++ N ++ P + LSK ++A
Sbjct: 300 GNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSADFANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 4e-12
Identities = 35/107 (32%), Positives = 57/107 (53%), Gaps = 5/107 (4%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
SIT + ++ + + +I + L++L L L+GN +T I S L +++ N++
Sbjct: 44 ESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITD-ISPLSNLVKLTNLYIGTNKI 100
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINL 520
T S+L NL NLRELY+ + +S P + L+K LN N NL
Sbjct: 101 TDI--SALQNLTNLRELYLNEDNISDISPLANLTKMYSLNLGANHNL 145
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 6e-12
Identities = 18/86 (20%), Positives = 35/86 (40%), Gaps = 5/86 (5%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 472
+ ++++ S ++ S L LS L L+L+ N L + G +L + L N
Sbjct: 265 TKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNH 322
Query: 473 LTGPLPSSLMNLPNLRELYVQNNMLS 498
+T L +L + N ++
Sbjct: 323 ITDI--RPLASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 8e-12
Identities = 22/104 (21%), Positives = 46/104 (44%), Gaps = 4/104 (3%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
+T +++ + +T S L L++L EL+L+ ++++ I + + ++L N
Sbjct: 88 VKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD-ISPLANLTKMYSLNLGANHN 144
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
S L N+ L L V + + P + L+ L+ N
Sbjct: 145 LS-DLSPLSNMTGLNYLTVTESKVKDVTPIANLTDLYSLSLNYN 187
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 9e-12
Identities = 25/104 (24%), Positives = 41/104 (39%), Gaps = 5/104 (4%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
+ + L+ + P L L+SL N +T I + L + + +N++
Sbjct: 177 TDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD-ITPVANMTRLNSLKIGNNKI 233
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
T S L NL L L + N +S L+K +LN N
Sbjct: 234 TDL--SPLANLSQLTWLEIGTNQISDINAVKDLTKLKMLNVGSN 275
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 62.9 bits (154), Expect = 1e-10
Identities = 21/104 (20%), Positives = 40/104 (38%), Gaps = 5/104 (4%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
+ + ++ + P + L+ L L L+ N + I + L NQ+
Sbjct: 155 TGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED-ISPLASLTSLHYFTAYVNQI 211
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
T + + N+ L L + NN ++ P + LS+ L N
Sbjct: 212 TDI--TPVANMTRLNSLKIGNNKITDLSPLANLSQLTWLEIGTN 253
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 62.9 bits (154), Expect = 1e-10
Identities = 15/86 (17%), Positives = 36/86 (41%), Gaps = 4/86 (4%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
++ ++L+ N++ S L L+ + L L N + S L + + ++++
Sbjct: 110 TNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKV 167
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSG 499
+ + NL +L L + N +
Sbjct: 168 KD--VTPIANLTDLYSLSLNYNQIED 191
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 8e-08
Identities = 15/86 (17%), Positives = 28/86 (32%), Gaps = 3/86 (3%)
Query: 432 SDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 491
L+ + L S+T + + + + ++ + L NL L
Sbjct: 16 FPDADLAEGIRAVLQKASVTDVVT-QEELESITKLVVAGEKVAS--IQGIEYLTNLEYLN 72
Query: 492 VQNNMLSGTVPSSLLSKNVVLNYAGN 517
+ N ++ P S L K L N
Sbjct: 73 LNGNQITDISPLSNLVKLTNLYIGTN 98
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 1e-13
Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 38/216 (17%)
Query: 606 KIGSGGFGVVYYGK-LKDGKEI-AVK-VLTSNSYQGK-----REFTNEVTLL---SRIHH 654
+IG G +G V+ + LK+G A+K V +G RE V +L H
Sbjct: 18 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE----VAVLRHLETFEH 73
Query: 655 RNLVQFL-----GYCQEEGRSVLVYEFMHN---GTLKEHLYGTLTHEQRINWIKRLEIAE 706
N+V+ E + LV+E + L + + E + + +L
Sbjct: 74 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL---- 129
Query: 707 DAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGA-SHVSSIVR 764
+G+++LH+ ++HRDLK NIL+ + K++DFGL++ ++ A + V +V
Sbjct: 130 --LRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV--VV- 181
Query: 765 GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 800
T+ Y PE + D++S G I E+ +
Sbjct: 182 -TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-13
Identities = 26/104 (25%), Positives = 40/104 (38%), Gaps = 5/104 (4%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
++ + L+ L L L++L +L L N ++ + SG L + L NQ+
Sbjct: 221 TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN-LAPLSGLTKLTELKLGANQI 277
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
+ S L L L L + N L P S L L N
Sbjct: 278 SNI--SPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFN 319
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-13
Identities = 31/104 (29%), Positives = 50/104 (48%), Gaps = 5/104 (4%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
++T + L++ ++ P L+ L+ L EL L N ++ I +G L + L +NQL
Sbjct: 243 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN-ISPLAGLTALTNLELNENQL 299
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
S + NL NL L + N +S P S L+K L + N
Sbjct: 300 EDI--SPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNN 341
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 3e-13
Identities = 17/106 (16%), Positives = 45/106 (42%), Gaps = 6/106 (5%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
++T + L N++ P ++ L+ L L+ N ++ + + ++ + NQ+
Sbjct: 309 KNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD-VSSLANLTNINWLSAGHNQI 365
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNIN 519
+ + L NL + +L + + + P + + + N N+
Sbjct: 366 SDL--TPLANLTRITQLGLNDQAWT-NAPVNYKANVSIPNTVKNVT 408
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-12
Identities = 25/104 (24%), Positives = 45/104 (43%), Gaps = 5/104 (4%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
+T + L + ++ P L L++L L L+ N L I S +L + L N +
Sbjct: 265 TKLTELKLGANQISNISP--LAGLTALTNLELNENQLED-ISPISNLKNLTYLTLYFNNI 321
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
+ P + +L L+ L+ NN +S + L+ L+ N
Sbjct: 322 SDISP--VSSLTKLQRLFFYNNKVSDVSSLANLTNINWLSAGHN 363
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 3e-11
Identities = 23/104 (22%), Positives = 40/104 (38%), Gaps = 5/104 (4%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
+T + + + L++L ++ N LT I L I + +NQ+
Sbjct: 46 DQVTTLQADRLGIK--SIDGVEYLNNLTQINFSNNQLTD-ITPLKNLTKLVDILMNNNQI 102
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
+ L NL NL L + NN ++ P L+ L + N
Sbjct: 103 AD--ITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSN 144
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-11
Identities = 24/104 (23%), Positives = 44/104 (42%), Gaps = 6/104 (5%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
S+ + + +T P L L++L L + N ++ I + +L + +NQ+
Sbjct: 156 TSLQQLSFGN-QVTDLKP--LANLTTLERLDISSNKVSD-ISVLAKLTNLESLIATNNQI 211
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
+ + L L NL EL + N L + L+ L+ A N
Sbjct: 212 SDI--TPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANN 253
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 8e-11
Identities = 28/105 (26%), Positives = 50/105 (47%), Gaps = 5/105 (4%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
++T I+ S+ LT P L L+ LV++ ++ N + I + +L + L +NQ+
Sbjct: 68 NNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-ITPLANLTNLTGLTLFNNQI 124
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNI 518
T L NL NL L + +N +S S L+ L++ +
Sbjct: 125 TDI--DPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQV 167
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 7e-10
Identities = 29/104 (27%), Positives = 48/104 (46%), Gaps = 6/104 (5%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
++ + LSS ++ S L+ L+SL +L GN +T P + L + + N++
Sbjct: 134 TNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKP-LANLTTLERLDISSNKV 189
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
+ S L L NL L NN +S P +L+ L+ GN
Sbjct: 190 SDI--SVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGN 231
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 4e-09
Identities = 19/101 (18%), Positives = 38/101 (37%), Gaps = 7/101 (6%)
Query: 421 LSSKNLTGNIP----SDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGP 476
L S +T + P T L+ ++ L ++T + + + + + +
Sbjct: 3 LGSATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVS-QTDLDQVTTLQADRLGIKSI 61
Query: 477 LPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
+ L NL ++ NN L+ P L+K V + N
Sbjct: 62 --DGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNN 100
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 2e-07
Identities = 12/104 (11%), Positives = 30/104 (28%), Gaps = 3/104 (2%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
+ + + ++ S L L+++ L N ++ + + + + L D
Sbjct: 331 TKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISD-LTPLANLTRITQLGLNDQAW 387
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
T + N+ + L S + N
Sbjct: 388 TNAPVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWN 431
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-13
Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 49/221 (22%)
Query: 605 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT--SNSYQGKREFTNEVTLLSRIHHRNLVQ-- 659
IG G +G+V + +A+K ++ + +R E+ +L R H N++
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGIN 91
Query: 660 --FLGYCQEEGRSV-LVYEFM--------HNGTL-KEH----LYGTLTHEQRINWIKRLE 703
E+ + V +V + M L +H LY L
Sbjct: 92 DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL------------- 138
Query: 704 IAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI- 762
+G++Y+H+ V +HRDLK SN+LL+ K+ DFGL++ A H +
Sbjct: 139 ------RGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 763 --VRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 800
V T Y PE ++ + KS D++S G IL E++S +
Sbjct: 190 EYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 51/271 (18%), Positives = 109/271 (40%), Gaps = 64/271 (23%)
Query: 605 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIH------- 653
+K+G G F V+ K + + +A+K++ + + E + LL R++
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDE----IKLLQRVNDADNTKE 80
Query: 654 ----HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEH-----------LYGTL--THEQRI 696
++++ L + F H G H L + + I
Sbjct: 81 DSMGANHILKLLDH------------FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGI 128
Query: 697 N--WIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRA------KVSDFGL 748
++K+ I++ G++Y+H C IIH D+K N+L++ K++D G
Sbjct: 129 PLIYVKQ--ISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGN 184
Query: 749 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF 808
+ + + H ++ ++ T Y PE + +D++S ++ ELI+G ++
Sbjct: 185 ACWYDE---HYTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG 240
Query: 809 GANCRNIVQWAKLHIESGDIQGIIDPSLLDE 839
+ ++ A+ I ++ G + LL
Sbjct: 241 HSYTKDDDHIAQ--II--ELLGELPSYLLRN 267
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 63/239 (26%), Positives = 102/239 (42%), Gaps = 64/239 (26%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIH-HRNL 657
L KK+G G +G+V+ + G+ +AVK + NS +R F E+ +L+ + H N+
Sbjct: 13 LVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF-REIMILTELSGHENI 71
Query: 658 VQFLGYCQ-EEGRSV-LVYEFM--------HNGTLK-EH----LYGTLTHEQRINWIKRL 702
V L + + R V LV+++M L+ H +Y +
Sbjct: 72 VNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLI------------ 119
Query: 703 EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 762
K I+YLH+G + +HRD+K SNILL+ KV+DFGLS+ V+ ++I
Sbjct: 120 -------KVIKYLHSGGL---LHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 763 VRGTVGYLDPEYYISQQLTD---------------------KSDVYSFGVILLELISGQ 800
+ LTD D++S G IL E++ G+
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 3e-13
Identities = 48/250 (19%), Positives = 90/250 (36%), Gaps = 73/250 (29%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLV 658
+ IG+G +G V + + +A+K + + KR E+ +L+R++H ++V
Sbjct: 57 IRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL-REIAILNRLNHDHVV 115
Query: 659 Q----FLGYCQEEGRSV-LVYEFMH---------NGTLK-EH----LYGTLTHEQRINWI 699
+ + E+ + +V E L H LY L
Sbjct: 116 KVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLL--------- 166
Query: 700 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS------KFAV 753
G++Y+H+ + +HRDLK +N L+++ KV DFGL+ +
Sbjct: 167 ----------VGVKYVHSAGI---LHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGN 213
Query: 754 DGASHVSSIVRGTVGYLDPEYYISQQLTD--------------------KS-DVYSFGVI 792
+ + +QLT ++ DV+S G I
Sbjct: 214 SQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCI 273
Query: 793 LLELISGQEA 802
EL++ +
Sbjct: 274 FAELLNMIKE 283
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 3e-13
Identities = 19/86 (22%), Positives = 35/86 (40%), Gaps = 2/86 (2%)
Query: 414 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQ 472
PS+ + L I L +L L L ++ +P+ + L + + N
Sbjct: 171 PSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MPNLTPLVGLEELEMSGNH 229
Query: 473 LTGPLPSSLMNLPNLRELYVQNNMLS 498
P S L +L++L+V N+ +S
Sbjct: 230 FPEIRPGSFHGLSSLKKLWVMNSQVS 255
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 4e-12
Identities = 26/96 (27%), Positives = 41/96 (42%), Gaps = 4/96 (4%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 471
+ ++L N+ L L L L NS+ I F+G L + L DN
Sbjct: 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQ-IEVGAFNGLASLNTLELFDN 133
Query: 472 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 507
LT + L LREL+++NN + ++PS +
Sbjct: 134 WLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFN 168
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 25/95 (26%), Positives = 49/95 (51%), Gaps = 4/95 (4%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 472
++ ++L N+ ++P +LT L L EL + GN P F G L+ + + ++Q
Sbjct: 196 FNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQ 253
Query: 473 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 507
++ ++ L +L EL + +N LS ++P L +
Sbjct: 254 VSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFT 287
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 21/85 (24%), Positives = 33/85 (38%), Gaps = 5/85 (5%)
Query: 414 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 470
+ V+ L ++ I L+SL L L N LT IP F LR + L +
Sbjct: 99 HHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLTV-IPSGAFEYLSKLRELWLRN 156
Query: 471 NQLTGPLPSSLMNLPNLRELYVQNN 495
N + + +P+L L +
Sbjct: 157 NPIESIPSYAFNRVPSLMRLDLGEL 181
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 5e-09
Identities = 20/87 (22%), Positives = 35/87 (40%), Gaps = 5/87 (5%)
Query: 414 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 470
+ + +S + I LSSL +LW+ + ++ I F G L ++L
Sbjct: 218 VGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSL-IERNAFDGLASLVELNLAH 275
Query: 471 NQLTGPLPSSLMNLPNLRELYVQNNML 497
N L+ L L EL++ +N
Sbjct: 276 NNLSSLPHDLFTPLRYLVELHLHHNPW 302
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 55/223 (24%), Positives = 92/223 (41%), Gaps = 57/223 (25%)
Query: 605 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQF 660
+ +GSG +G V + G ++A+K L + KR + E+ LL + H N++
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHMRHENVIGL 89
Query: 661 L-----GYCQEEGRSV-LVYEFM--------HNGTL-KEH----LYGTLTHEQRINWIKR 701
L ++ LV FM + L ++ +Y L
Sbjct: 90 LDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQML----------- 138
Query: 702 LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 761
KG+ Y+H IIHRDLK N+ +++ K+ DFGL A S
Sbjct: 139 --------KGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL-------ARQADS 180
Query: 762 IVRGTVG---YLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 800
+ G V Y PE ++ ++ D++S G I+ E+I+G+
Sbjct: 181 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 57/223 (25%)
Query: 605 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQF 660
+GSG +G V K G +AVK L+ + KR + E+ LL + H N++
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGL 93
Query: 661 L-----GYCQEEGRSV-LVYEFM--------HNGTLK-EH----LYGTLTHEQRINWIKR 701
L EE V LV M L +H +Y L
Sbjct: 94 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----------- 142
Query: 702 LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 761
+G++Y+H+ IIHRDLK SN+ +++ K+ DFGL A H +
Sbjct: 143 --------RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL-------ARHTAD 184
Query: 762 IVRGTVG---YLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 800
+ G V Y PE ++ +++ D++S G I+ EL++G+
Sbjct: 185 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 38/170 (22%), Positives = 65/170 (38%), Gaps = 30/170 (17%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH-RNLVQF 660
+ KKIG G FG + GK L + +A+K+ S + E ++ + Q
Sbjct: 13 VGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQV 70
Query: 661 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR-------LEIAEDAAKGIE 713
+ + +V E + G E L+ + R L IA +E
Sbjct: 71 YYFGPCGKYNAMVLELL--GPSLEDLF---------DLCDRTFSLKTVLMIAIQLISRME 119
Query: 714 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVS-----DFGLSKFAVDGASH 758
Y+H+ +I+RD+K N L+ + DF L+K +D +
Sbjct: 120 YVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK 166
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 5e-13
Identities = 54/232 (23%), Positives = 97/232 (41%), Gaps = 58/232 (25%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLT-SNSYQGKREFTNEVTLLSRIHHRNLVQF 660
K +G GG G+V+ K +A+K + ++ K E+ ++ R+ H N+V+
Sbjct: 15 DLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL-REIKIIRRLDHDNIVKV 73
Query: 661 L-------------GYCQEEGRSV-LVYEFM--------HNGTL-KEH----LYGTLTHE 693
E SV +V E+M G L +EH +Y L
Sbjct: 74 FEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLL--- 130
Query: 694 QRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD-KHMRAKVSDFGLSKFA 752
+G++Y+H+ V +HRDLK +N+ ++ + + K+ DFGL++
Sbjct: 131 ----------------RGLKYIHSANV---LHRDLKPANLFINTEDLVLKIGDFGLARIM 171
Query: 753 VDGASHVSSI---VRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQ 800
SH + + T Y P +S T D+++ G I E+++G+
Sbjct: 172 DPHYSHKGHLSEGL-VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 5e-13
Identities = 19/101 (18%), Positives = 37/101 (36%), Gaps = 3/101 (2%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
++ ++L + ++ + + L L L N L P+F + I L +N+L
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKL 226
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 514
+ +L NL ++ N SKN +
Sbjct: 227 VL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQT 266
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 3e-11
Identities = 19/86 (22%), Positives = 34/86 (39%), Gaps = 3/86 (3%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 472
+ ++ +L + S ++ EL L GN L+ + L +++L N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 473 LTGPLPSSLMNLPNLRELYVQNNMLS 498
L L +L LR L + NN +
Sbjct: 70 LYE--TLDLESLSTLRTLDLNNNYVQ 93
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 5e-11
Identities = 18/107 (16%), Positives = 41/107 (38%), Gaps = 7/107 (6%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 471
PSI +H ++ N++ + ++L N +T + D ++ + L+ N
Sbjct: 99 PSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITM-LRDLDEGCRSRVQYLDLKLN 154
Query: 472 QLTG-PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
++ + L L +Q N + + +K L+ + N
Sbjct: 155 EIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSN 201
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 6e-10
Identities = 15/82 (18%), Positives = 30/82 (36%), Gaps = 1/82 (1%)
Query: 437 LSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 495
+ + +SL + +++ + L N L+ + L L L + +N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 496 MLSGTVPSSLLSKNVVLNYAGN 517
+L T+ LS L+ N
Sbjct: 69 VLYETLDLESLSTLRTLDLNNN 90
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 14/84 (16%), Positives = 32/84 (38%), Gaps = 4/84 (4%)
Query: 425 NLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQLTGPLPSSLMN 483
+L N +L S+ L N+++ G + I+L +N++T
Sbjct: 86 DLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQG---KKNIYLANNKITMLRDLDEGC 142
Query: 484 LPNLRELYVQNNMLSGTVPSSLLS 507
++ L ++ N + + L +
Sbjct: 143 RSRVQYLDLKLNEIDTVNFAELAA 166
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 6e-06
Identities = 14/108 (12%), Positives = 28/108 (25%), Gaps = 2/108 (1%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
+T I L + L I L +L L GN + R+ + +
Sbjct: 214 AGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTV 272
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 521
+ + +P+ + + L + L
Sbjct: 273 KKLTGQNEEECTVPTLGHYGAYCCE-DLPAPFADRLIALKRKEHALLS 319
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 12/96 (12%), Positives = 22/96 (22%), Gaps = 3/96 (3%)
Query: 420 HLSSKNLTGNIPSDLTKL--SSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPL 477
++L L L L G+ + R I Q +
Sbjct: 293 AYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVI 352
Query: 478 PSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLN 513
+ L + L S+ + L+
Sbjct: 353 DQVTLRKQAKITLEQKKKALD-EQVSNGRRAHAELD 387
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 8e-13
Identities = 25/188 (13%), Positives = 59/188 (31%), Gaps = 46/188 (24%)
Query: 603 LEKKIGSGGFGVVYYGK---------LKDGKEIAVKVLTSNS----------YQGKREFT 643
L+ G++Y ++ ++K+ + K
Sbjct: 46 LKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQV 105
Query: 644 NEVTLLSRIHHRNLVQFLGYCQEEGR-SVLVYEFMHNGTLKEHLYGT-LTHEQRINWIKR 701
N+ L + +G+ + + LV G L + ++ +
Sbjct: 106 NKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLP----------SLGRSL--QSALDVSPK 153
Query: 702 --------LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV--SDFGLSKF 751
L++A +E+LH +H ++ + NI +D +++V + +G +
Sbjct: 154 HVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210
Query: 752 AVDGASHV 759
HV
Sbjct: 211 YCPSGKHV 218
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 19/96 (19%), Positives = 35/96 (36%), Gaps = 3/96 (3%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
++ ++L + ++ + L L L N L P+F + I L +N+L
Sbjct: 169 DTLEHLNLQYNFIY-DVK-GQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKL 226
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN 509
+ +L NL ++ N SKN
Sbjct: 227 VL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKN 261
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 18/106 (16%), Positives = 40/106 (37%), Gaps = 5/106 (4%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQ 472
PSI +H ++ N++ + ++L N +T D ++ + L+ N+
Sbjct: 99 PSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNE 155
Query: 473 LTG-PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
+ + L L +Q N + + +K L+ + N
Sbjct: 156 IDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSN 201
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 20/86 (23%), Positives = 35/86 (40%), Gaps = 3/86 (3%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQ 472
+ ++ +L + S ++ EL L GN L+ D + L +++L N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 473 LTGPLPSSLMNLPNLRELYVQNNMLS 498
L L +L LR L + NN +
Sbjct: 70 LYE--TLDLESLSTLRTLDLNNNYVQ 93
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 16/89 (17%), Positives = 31/89 (34%), Gaps = 1/89 (1%)
Query: 430 IPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 488
I + + +SL + +++ + L N L+ + L L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 489 ELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
L + +N+L T+ LS L+ N
Sbjct: 62 LLNLSSNVLYETLDLESLSTLRTLDLNNN 90
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 14/85 (16%), Positives = 32/85 (37%), Gaps = 4/85 (4%)
Query: 425 NLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQLTGPLPSSLMN 483
+L N +L S+ L N+++ G + I+L +N++T
Sbjct: 86 DLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQG---KKNIYLANNKITMLRDLDEGC 142
Query: 484 LPNLRELYVQNNMLSGTVPSSLLSK 508
++ L ++ N + + L +
Sbjct: 143 RSRVQYLDLKLNEIDTVNFAELAAS 167
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 4e-04
Identities = 15/77 (19%), Positives = 24/77 (31%), Gaps = 9/77 (11%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
+T I L + L I L +L L GN C LR ++ ++
Sbjct: 214 AGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH--------CGTLRDFFSKNQRV 264
Query: 474 TGPLPSSLMNLPNLREL 490
++ L E
Sbjct: 265 QTVAKQTVKKLTGQNEE 281
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 21/86 (24%), Positives = 36/86 (41%), Gaps = 2/86 (2%)
Query: 414 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQ 472
PS+ + L I LS+L L L +L IP+ + L + L N
Sbjct: 160 PSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IPNLTPLIKLDELDLSGNH 218
Query: 473 LTGPLPSSLMNLPNLRELYVQNNMLS 498
L+ P S L +L++L++ + +
Sbjct: 219 LSAIRPGSFQGLMHLQKLWMIQSQIQ 244
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 5e-12
Identities = 23/96 (23%), Positives = 44/96 (45%), Gaps = 4/96 (4%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 471
+ +++L + + L L L L N + I F+G +L + L DN
Sbjct: 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRT-IEIGAFNGLANLNTLELFDN 122
Query: 472 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 507
+LT + + L L+EL+++NN + ++PS +
Sbjct: 123 RLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFN 157
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 6e-11
Identities = 30/109 (27%), Positives = 52/109 (47%), Gaps = 9/109 (8%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 471
++ ++L+ NL IP +LT L L EL L GN L+ I F G L+ + + +
Sbjct: 185 SNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSA-IRPGSFQGLMHLQKLWMIQS 241
Query: 472 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGN 517
Q+ ++ NL +L E+ + +N L+ +P L L ++ N
Sbjct: 242 QIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 22/89 (24%), Positives = 38/89 (42%), Gaps = 6/89 (6%)
Query: 414 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 470
+ ++ LS ++ I L++L L L N LT IP+ F L+ + L +
Sbjct: 88 RHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLTT-IPNGAFVYLSKLKELWLRN 145
Query: 471 NQLTGPLPSSLMNLPNLRELYVQ-NNMLS 498
N + + +P+LR L + LS
Sbjct: 146 NPIESIPSYAFNRIPSLRRLDLGELKRLS 174
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 8e-09
Identities = 19/87 (21%), Positives = 33/87 (37%), Gaps = 5/87 (5%)
Query: 414 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 470
+ + LS +L+ I L L +LW+ + + I F L I+L
Sbjct: 207 IKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQV-IERNAFDNLQSLVEINLAH 264
Query: 471 NQLTGPLPSSLMNLPNLRELYVQNNML 497
N LT L +L +++ +N
Sbjct: 265 NNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 20/98 (20%), Positives = 38/98 (38%), Gaps = 6/98 (6%)
Query: 414 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 470
+ +HL L + L++L L+L N+L +PD F +L + L
Sbjct: 105 GRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHG 162
Query: 471 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 508
N+++ + L +L L + N ++ V
Sbjct: 163 NRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRD 199
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 29/112 (25%), Positives = 52/112 (46%), Gaps = 9/112 (8%)
Query: 414 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 470
++ ++L L +P D L +L L+L GN ++ +P+ F G L + L
Sbjct: 129 AALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISS-VPERAFRGLHSLDRLLLHQ 186
Query: 471 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 522
N++ P + +L L LY+ N LS +P+ L+ L Y + L++
Sbjct: 187 NRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQY---LRLND 234
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 8e-11
Identities = 21/102 (20%), Positives = 41/102 (40%), Gaps = 5/102 (4%)
Query: 407 QCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRI 465
C +P +T + L +P + ++ ++L GN ++ P F C +L I
Sbjct: 5 ACVCYNEPKVTT-SCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTI 60
Query: 466 IHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 507
+ L N L ++ L L +L + +N +V +
Sbjct: 61 LWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFH 102
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 9e-11
Identities = 23/98 (23%), Positives = 35/98 (35%), Gaps = 5/98 (5%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 471
+ I L ++ + +L LWL N L I F+G L + L DN
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLAR-IDAAAFTGLALLEQLDLSDN 90
Query: 472 -QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 508
QL P++ L L L++ L + L
Sbjct: 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRG 127
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 19/85 (22%), Positives = 35/85 (41%), Gaps = 5/85 (5%)
Query: 414 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 470
++T + L ++ ++P L SL L L N + + F L ++L
Sbjct: 153 GNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAH-VHPHAFRDLGRLMTLYLFA 210
Query: 471 NQLTGPLPSSLMNLPNLRELYVQNN 495
N L+ +L L L+ L + +N
Sbjct: 211 NNLSALPTEALAPLRALQYLRLNDN 235
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 42/224 (18%), Positives = 84/224 (37%), Gaps = 48/224 (21%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH-RNLVQF 660
+ ++IG G FGV++ G L + +++A+K S + +E + +
Sbjct: 14 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNV 71
Query: 661 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR-------LEIAEDAAKGIE 713
+ QE +VLV + + G E L + R A+ ++
Sbjct: 72 YYFGQEGLHNVLVIDLL--GPSLEDLL---------DLCGRKFSVKTVAMAAKQMLARVQ 120
Query: 714 YLHTGCVPAIIHRDLKSSNILLDKHMRAK-----VSDFGLSKFAVDGASHV------SSI 762
+H +++RD+K N L+ + V DFG+ KF D +
Sbjct: 121 SIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN 177
Query: 763 VRGTVGYLDPEYYIS------QQLTDKSDVYSFGVILLELISGQ 800
+ GT Y+S ++ + + D+ + G + + + G
Sbjct: 178 LSGTA------RYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 50/209 (23%), Positives = 90/209 (43%), Gaps = 20/209 (9%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH-RNLVQF 660
L +KIGSG FG +Y G + G+E+A+K+ + + E + + +
Sbjct: 13 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTI 70
Query: 661 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 720
E +V+V E + G E L+ + + + + L +A+ IEY+H+
Sbjct: 71 RWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTV--LLLADQMISRIEYIHSKN- 125
Query: 721 PAIIHRDLKSSNILLDKHMRAK---VSDFGLSKFAVDGASHV------SSIVRGTVGYLD 771
IHRD+K N L+ + + DFGL+K D +H + + GT Y
Sbjct: 126 --FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183
Query: 772 PEYYISQQLTDKSDVYSFGVILLELISGQ 800
++ + + + D+ S G +L+ G
Sbjct: 184 INTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 33/94 (35%), Positives = 47/94 (50%), Gaps = 7/94 (7%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 471
++ I ++ N+T IP L SL EL LDGN +T + G +L + L N
Sbjct: 171 KKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITK-VDAASLKGLNNLAKLGLSFN 226
Query: 472 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 505
++ SL N P+LREL++ NN L VP L
Sbjct: 227 SISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL 259
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 22/105 (20%), Positives = 43/105 (40%), Gaps = 9/105 (8%)
Query: 414 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLT-GPIPD--FSGCPDLRIIHLE 469
++ + + +T + L+ ++ + L N L I + F G L I +
Sbjct: 121 KTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIA 179
Query: 470 DNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 514
D +T +P L P+L EL++ N ++ V ++ L L
Sbjct: 180 DTNITT-IPQGL--PPSLTELHLDGNKIT-KVDAASLKGLNNLAK 220
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 28/114 (24%), Positives = 43/114 (37%), Gaps = 8/114 (7%)
Query: 397 PCLPVPWSW-LQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP 455
P +P C Q + V+ S L +P DL L L N +T I
Sbjct: 13 PEVPEIEPMGPVCPFRCQCHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITE-IK 68
Query: 456 --DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 507
DF +L + L +N+++ P + L L LY+ N L +P +
Sbjct: 69 DGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPK 121
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 14/115 (12%), Positives = 40/115 (34%), Gaps = 12/115 (10%)
Query: 414 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQ 472
++ + LS +++ + + L L EL L+ N L + +++++L +N
Sbjct: 216 NNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNN 274
Query: 473 LTG------PLPSSLMNLPNLRELYVQNNMLSGT-VPSSL---LSKNVVLNYAGN 517
++ P + + + +N + + S + +
Sbjct: 275 ISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 6e-09
Identities = 21/108 (19%), Positives = 36/108 (33%), Gaps = 24/108 (22%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 471
P ++ L + +T D L +L L L N ++ I F+ L ++L N
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK-ISPGAFAPLVKLERLYLSKN 110
Query: 472 QLT---GPLPSSLM------------------NLPNLRELYVQNNMLS 498
QL +P +L L + + + N L
Sbjct: 111 QLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLK 158
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 3e-12
Identities = 24/109 (22%), Positives = 43/109 (39%), Gaps = 7/109 (6%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 471
+ V+ +S + + +L L + +LT +P LR ++L N
Sbjct: 200 YRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA-VPYLAVRHLVYLRFLNLSYN 258
Query: 472 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGN 517
++ S L L L+E+ + L+ V L+ VLN +GN
Sbjct: 259 PISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGN 306
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-11
Identities = 20/97 (20%), Positives = 38/97 (39%), Gaps = 6/97 (6%)
Query: 414 PSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 470
++T + +S + + + L +L L + N L I FSG L + LE
Sbjct: 104 SNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVY-ISHRAFSGLNSLEQLTLEK 161
Query: 471 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 507
LT +L +L L L +++ ++ +
Sbjct: 162 CNLTSIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFK 197
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 24/104 (23%), Positives = 45/104 (43%), Gaps = 6/104 (5%)
Query: 414 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 470
S+ + L NLT +IP++ L+ L L+ L L ++ I D F L+++ +
Sbjct: 152 NSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINA-IRDYSFKRLYRLKVLEISH 209
Query: 471 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 514
+ + + NL L + + L+ VP + V L +
Sbjct: 210 WPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRF 252
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-10
Identities = 23/97 (23%), Positives = 41/97 (42%), Gaps = 6/97 (6%)
Query: 414 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 470
P + + L+ ++ + L +L L L N L IP F+G +L + + +
Sbjct: 56 PHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLKL-IPLGVFTGLSNLTKLDISE 113
Query: 471 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 507
N++ L +L NL+ L V +N L + S
Sbjct: 114 NKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFS 149
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 20/96 (20%), Positives = 38/96 (39%), Gaps = 5/96 (5%)
Query: 413 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDN 471
+ K +P + + L L N + +F+ P L + L +N
Sbjct: 10 SAQDRAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNEN 66
Query: 472 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 507
++ P + NL NLR L +++N L +P + +
Sbjct: 67 IVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFT 101
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 9e-09
Identities = 24/88 (27%), Positives = 41/88 (46%), Gaps = 5/88 (5%)
Query: 414 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 470
+ ++LS ++ I L +L L E+ L G L + F G LR++++
Sbjct: 248 VYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAV-VEPYAFRGLNYLRVLNVSG 305
Query: 471 NQLTGPLPSSLMNLPNLRELYVQNNMLS 498
NQLT S ++ NL L + +N L+
Sbjct: 306 NQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 32/122 (26%), Positives = 44/122 (36%), Gaps = 24/122 (19%)
Query: 408 CNSDPQPSITVIHLSSKNLT---GNIPSDLTKL------------------SSLVELWLD 446
C S ++ +NLT ++P D T L + L +L LD
Sbjct: 4 CEVSKVASHLEVNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 447 GNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL 506
LT + P L + L NQL LP LP L L V N L+ ++P L
Sbjct: 64 RAELTK-LQVDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLT-SLPLGAL 120
Query: 507 SK 508
Sbjct: 121 RG 122
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 28/100 (28%), Positives = 47/100 (47%), Gaps = 5/100 (5%)
Query: 411 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHL 468
P + + LS L ++P L +L L + N LT +P G +L+ ++L
Sbjct: 74 GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTS-LPLGALRGLGELQELYL 131
Query: 469 EDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 508
+ N+L P L P L +L + NN L+ +P+ LL+
Sbjct: 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNG 170
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 32/92 (34%), Positives = 45/92 (48%), Gaps = 6/92 (6%)
Query: 414 PSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 470
P++TV+ +S LT ++P L L EL+L GN L +P + P L + L +
Sbjct: 100 PALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKT-LPPGLLTPTPKLEKLSLAN 157
Query: 471 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVP 502
N LT L L NL L +Q N L T+P
Sbjct: 158 NNLTELPAGLLNGLENLDTLLLQENSLY-TIP 188
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 5e-12
Identities = 23/105 (21%), Positives = 38/105 (36%), Gaps = 4/105 (3%)
Query: 414 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQ 472
P + + LS L I K+ L L++ N L P L+++ L N
Sbjct: 254 PGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNH 312
Query: 473 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
L + + L LY+ +N + T+ S L + N
Sbjct: 313 LLH-VERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLKNLTLSHN 355
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 66.9 bits (163), Expect = 2e-11
Identities = 22/107 (20%), Positives = 44/107 (41%), Gaps = 6/107 (5%)
Query: 414 PSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 470
+I +++ + +P + + L L L+ N L+ +P F P L + + +
Sbjct: 99 HTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSN 156
Query: 471 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
N L + +L+ L + +N L+ V SL+ N + N
Sbjct: 157 NNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYN 202
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 66.9 bits (163), Expect = 2e-11
Identities = 21/109 (19%), Positives = 39/109 (35%), Gaps = 7/109 (6%)
Query: 411 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLED 470
++ + S ++ + + L L L N+LT P L + L
Sbjct: 208 AIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSY 263
Query: 471 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 517
N+L + + + L LY+ NN L + + VL+ + N
Sbjct: 264 NELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHN 311
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 7e-11
Identities = 17/102 (16%), Positives = 40/102 (39%), Gaps = 6/102 (5%)
Query: 414 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 470
+ ++ + + +P+ L + L L+ + I F+ ++ +++
Sbjct: 51 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGF 108
Query: 471 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVL 512
N + P N+P L L ++ N LS ++P + L
Sbjct: 109 NAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKL 149
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 5e-09
Identities = 26/88 (29%), Positives = 42/88 (47%), Gaps = 8/88 (9%)
Query: 414 PSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 470
P +TV+ L +L+ ++P + L L + N+L I D F L+ + L
Sbjct: 123 PLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSS 180
Query: 471 NQLTGPLPSSLMNLPNLRELYVQNNMLS 498
N+LT + SL +P+L V N+LS
Sbjct: 181 NRLTH-VDLSL--IPSLFHANVSYNLLS 205
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 16/104 (15%), Positives = 33/104 (31%), Gaps = 4/104 (3%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
+ +++S+ L + + +L L L N L + L ++L+ N +
Sbjct: 278 QRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSI 336
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
L S L+ L + +N +L
Sbjct: 337 V-TLKLS--THHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDA 377
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 7/86 (8%), Positives = 30/86 (34%), Gaps = 2/86 (2%)
Query: 430 IPSDLTKLSSLVELWLDGNSLTGP-IPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 488
I S+L ++ +D + + + +I+ +++ + + L + +
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 78
Query: 489 ELYVQNNMLSGTVPSSLLSKNVVLNY 514
L + + + + + + +
Sbjct: 79 LLNLNDLQIE-EIDTYAFAYAHTIQK 103
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 6e-12
Identities = 22/107 (20%), Positives = 43/107 (40%), Gaps = 6/107 (5%)
Query: 414 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 470
+I +++ + +P + L L L+ N L+ +P F P L + + +
Sbjct: 93 HTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSN 150
Query: 471 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
N L + +L+ L + +N L+ V SL+ N + N
Sbjct: 151 NNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYN 196
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 6e-12
Identities = 18/88 (20%), Positives = 32/88 (36%), Gaps = 4/88 (4%)
Query: 411 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLED 470
++ + S ++ + + L L L N+LT P L + L
Sbjct: 202 AIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSY 257
Query: 471 NQLTGPLPSSLMNLPNLRELYVQNNMLS 498
N+L + + + L LY+ NN L
Sbjct: 258 NELEKIMYHPFVKMQRLERLYISNNRLV 285
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 18/110 (16%), Positives = 43/110 (39%), Gaps = 9/110 (8%)
Query: 414 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 470
+ ++ + + +P+ L + L L+ + I F+ ++ +++
Sbjct: 45 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGF 102
Query: 471 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN---VVLNYAGN 517
N + P N+P L L ++ N LS ++P + L+ + N
Sbjct: 103 NAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNN 151
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 23/95 (24%), Positives = 38/95 (40%), Gaps = 5/95 (5%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQ 472
+T++ L NLT + L LVE+ L N L F L +++ +N+
Sbjct: 226 VELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNR 283
Query: 473 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 507
L L +P L+ L + +N L V +
Sbjct: 284 LVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQ 316
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 25/88 (28%), Positives = 41/88 (46%), Gaps = 8/88 (9%)
Query: 414 PSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 470
P +TV+ L +L+ ++P + L L + N+L I D F L+ + L
Sbjct: 117 PLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSS 174
Query: 471 NQLTGPLPSSLMNLPNLRELYVQNNMLS 498
N+LT + S +P+L V N+LS
Sbjct: 175 NRLTH-VDLS--LIPSLFHANVSYNLLS 199
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 11/100 (11%), Positives = 34/100 (34%), Gaps = 6/100 (6%)
Query: 413 QPSITVIHLSSKNLTGNIPSDLTK--LSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHL 468
Q + T ++ L++ + +++ +P + +++L
Sbjct: 18 QYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNL 76
Query: 469 EDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 508
D Q+ + +++LY+ N + +P +
Sbjct: 77 NDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQN 115
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 22/97 (22%), Positives = 39/97 (40%), Gaps = 7/97 (7%)
Query: 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDN 471
P P++ V+ LS +L ++ + + L L+LD NS+ + S L+ + L N
Sbjct: 293 PIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK-LSTHHTLKNLTLSHN 349
Query: 472 QLTGPLPSSLMNLP-NLRELYVQNNMLSGTVPSSLLS 507
+SL L N+ V + + L
Sbjct: 350 DWD---CNSLRALFRNVARPAVDDADQHCKIDYQLEH 383
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 8e-12
Identities = 23/96 (23%), Positives = 46/96 (47%), Gaps = 5/96 (5%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQ 472
+ V S++ T +IPS L +++ L L N +T D C +L+++ L+ ++
Sbjct: 5 DASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSR 61
Query: 473 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 508
+ + +L +L L + +N LS ++ SS
Sbjct: 62 INTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGP 96
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 2e-10
Identities = 22/97 (22%), Positives = 36/97 (37%), Gaps = 3/97 (3%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 471
++ + LS +T DL ++L L L + + I F L + L DN
Sbjct: 26 AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINT-IEGDAFYSLGSLEHLDLSDN 84
Query: 472 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 508
L+ S L +L+ L + N +SL
Sbjct: 85 HLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPN 121
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 3e-10
Identities = 19/111 (17%), Positives = 39/111 (35%), Gaps = 5/111 (4%)
Query: 414 PSITVIHLSSKNLTGNIP-SDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 470
++ + + + I D L+SL EL + SL D+ + L
Sbjct: 123 TNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRN-YQSQSLKSIRDIHHLTLHL 181
Query: 471 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 521
++ L L ++R L +++ L+ S L + V + +
Sbjct: 182 SESAFLLEIFADILSSVRYLELRDTNLA-RFQFSPLPVDEVSSPMKKLAFR 231
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 5e-10
Identities = 21/82 (25%), Positives = 39/82 (47%), Gaps = 5/82 (6%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
++ V+ +S+ NL + L L EL++ N L +PD S P L ++ + NQL
Sbjct: 431 QTLEVLDVSNNNLD-SFSLFLP---RLQELYISRNKLKT-LPDASLFPVLLVMKISRNQL 485
Query: 474 TGPLPSSLMNLPNLRELYVQNN 495
L +L+++++ N
Sbjct: 486 KSVPDGIFDRLTSLQKIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 1e-09
Identities = 27/124 (21%), Positives = 47/124 (37%), Gaps = 21/124 (16%)
Query: 414 PSITVIHLSSKNLT--GNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDN 471
PS+ + LS +L L L +L L + N+ +R ++L
Sbjct: 361 PSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSST 420
Query: 472 QLT---GPLPSSL--------------MNLPNLRELYVQNNMLSGTVPSSLLSKN-VVLN 513
+ +P +L + LP L+ELY+ N L T+P + L +V+
Sbjct: 421 GIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLK-TLPDASLFPVLLVMK 479
Query: 514 YAGN 517
+ N
Sbjct: 480 ISRN 483
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 6e-09
Identities = 16/98 (16%), Positives = 35/98 (35%), Gaps = 3/98 (3%)
Query: 411 DPQPSITVIHLSSKNLTG-NIPSDLTKLSSLVELWLDGNSLTGPIP--DFSGCPDLRIIH 467
P S+ ++L + S L++L L + I DF+G L +
Sbjct: 95 GPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELE 154
Query: 468 LEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 505
++ L SL ++ ++ L + + + +
Sbjct: 155 IKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFA 192
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 1e-08
Identities = 13/88 (14%), Positives = 33/88 (37%), Gaps = 4/88 (4%)
Query: 415 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQL 473
+I +H+ L ++ + + L + + ++ + + P L + L +N +
Sbjct: 287 TIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLM 346
Query: 474 T---GPLPSSLMNLPNLRELYVQNNMLS 498
+ P+L+ L + N L
Sbjct: 347 VEEYLKNSACKGAWPSLQTLVLSQNHLR 374
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 23/104 (22%), Positives = 37/104 (35%), Gaps = 4/104 (3%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 471
++ V+ L S + L SL L L N L+ + F L+ ++L N
Sbjct: 50 ANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSS-LSSSWFGPLSSLKYLNLMGN 108
Query: 472 QLTG-PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 514
+ S NL NL+ L + N + + LN
Sbjct: 109 PYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNE 152
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 7e-08
Identities = 21/107 (19%), Positives = 43/107 (40%), Gaps = 12/107 (11%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
+ ++LSS + + + + +L L + N+L P L+ +++ N+L
Sbjct: 410 EKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLDS-FS--LFLPRLQELYISRNKL 463
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGN 517
LP + P L + + N L +VP + L+ + N
Sbjct: 464 KT-LPDA-SLFPVLLVMKISRNQLK-SVPDGIFDRLTSLQKIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 13/109 (11%), Positives = 38/109 (34%), Gaps = 8/109 (7%)
Query: 415 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQL 473
+ + S ++ + + ++ L + L + +S ++ I +E++++
Sbjct: 265 GLGDFNPSESDVVSELGK--VETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKV 322
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSG-----TVPSSLLSKNVVLNYAGN 517
S +L +L L + N++ + L + N
Sbjct: 323 FLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQN 371
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 9e-04
Identities = 11/89 (12%), Positives = 22/89 (24%), Gaps = 1/89 (1%)
Query: 411 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLE 469
I + L + LSS+ L L +L +
Sbjct: 169 KSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKL 228
Query: 470 DNQLTGPLPSSLMNLPNLRELYVQNNMLS 498
+ + S L L ++ + +
Sbjct: 229 AFRGSVLTDESFNELLKLLRYILELSEVE 257
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 8e-12
Identities = 25/104 (24%), Positives = 45/104 (43%), Gaps = 8/104 (7%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
++T + + ++T ++ + KL+ L +L N++T D S +L + + N+L
Sbjct: 42 ATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNITTL--DLSQNTNLTYLACDSNKL 97
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
T L + L L L N L+ + S LN A N
Sbjct: 98 TN-LD--VTPLTKLTYLNCDTNKLT-KLDVSQNPLLTYLNCARN 137
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 4e-10
Identities = 23/104 (22%), Positives = 39/104 (37%), Gaps = 9/104 (8%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
+T + S +T D+++ L L D N++T D + L + N+L
Sbjct: 170 TQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNITK--LDLNQNIQLTFLDCSSNKL 224
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
T + + L L N L+ + S LSK L+
Sbjct: 225 TE-IDVT--PLTQLTYFDCSVNPLT-ELDVSTLSKLTTLHCIQT 264
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 6e-10
Identities = 22/109 (20%), Positives = 37/109 (33%), Gaps = 9/109 (8%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
+ ++ + N+T + DL + L L N LT D + L N L
Sbjct: 191 KLLNRLNCDTNNIT-KL--DLNQNIQLTFLDCSSNKLTEI--DVTPLTQLTYFDCSVNPL 245
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 522
T L S L L L+ L + + ++ + G + E
Sbjct: 246 T-ELDVS--TLSKLTTLHCIQTDLL-EIDLTHNTQLIYFQAEGCRKIKE 290
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 7e-10
Identities = 19/99 (19%), Positives = 34/99 (34%), Gaps = 5/99 (5%)
Query: 419 IHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLP 478
I+ ++ D+T + L L +T + D S P L ++L + +LT L
Sbjct: 278 IYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-EL-DLSQNPKLVYLYLNNTELTE-LD 334
Query: 479 SSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
S + L+ L N + + A
Sbjct: 335 VS--HNTKLKSLSCVNAHIQDFSSVGKIPALNNNFEAEG 371
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 1e-09
Identities = 16/105 (15%), Positives = 42/105 (40%), Gaps = 7/105 (6%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
+ ++ + +T + DL++ LV L+L+ LT + D S L+ + + +
Sbjct: 297 TQLYLLDCQAAGIT-EL--DLSQNPKLVYLYLNNTELTE-L-DVSHNTKLKSLSCVNAHI 351
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNI 518
S + +P L + +L + ++ + + ++
Sbjct: 352 QD-FSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDL 394
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 20/97 (20%), Positives = 36/97 (37%), Gaps = 5/97 (5%)
Query: 421 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSS 480
++ + +L++L L +S+T + L + N +T L S
Sbjct: 25 AAAFEMQATDTISEEQLATLTSLDCHNSSITD-MTGIEKLTGLTKLICTSNNITT-LDLS 82
Query: 481 LMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
NL L +N L+ + + L+K LN N
Sbjct: 83 --QNTNLTYLACDSNKLT-NLDVTPLTKLTYLNCDTN 116
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 3e-08
Identities = 27/104 (25%), Positives = 43/104 (41%), Gaps = 8/104 (7%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
++T + S LT N+ +T L+ L L D N LT D S P L ++ N L
Sbjct: 85 TNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTKL--DVSQNPLLTYLNCARNTL 139
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
T + S + L EL N + + ++ L+ + N
Sbjct: 140 T-EIDVS--HNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFN 180
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 6e-08
Identities = 19/104 (18%), Positives = 38/104 (36%), Gaps = 8/104 (7%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
P +T ++ + LT I D++ + L EL N D + L + N++
Sbjct: 127 PLLTYLNCARNTLT-EI--DVSHNTQLTELDCHLNKKI-TKLDVTPQTQLTTLDCSFNKI 182
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
T + L L N ++ + + + L+ + N
Sbjct: 183 TE---LDVSQNKLLNRLNCDTNNIT-KLDLNQNIQLTFLDCSSN 222
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 4e-06
Identities = 25/123 (20%), Positives = 35/123 (28%), Gaps = 25/123 (20%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
+T + SS LT I D+T L+ L N LT D S L +H L
Sbjct: 212 IQLTFLDCSSNKLT-EI--DVTPLTQLTYFDCSVNPLT--ELDVSTLSKLTTLHCIQTDL 266
Query: 474 T----GPLPS---------------SLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 514
+ + L L Q ++ + S K V L
Sbjct: 267 LEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELDLSQNPKLVYLYL 325
Query: 515 AGN 517
Sbjct: 326 NNT 328
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 18/106 (16%), Positives = 37/106 (34%), Gaps = 8/106 (7%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
P + ++L++ LT + D++ + L L + P L + Q
Sbjct: 318 PKLVYLYLNNTELT-EL--DVSHNTKLKSLSCVNAHIQD-FSSVGKIPALNNNFEAEGQT 373
Query: 474 TGPLPSSLMNLPNLRELYVQNNML--SGTVPSSLLSKNVVLNYAGN 517
+P + +L + V ++L G + V + A N
Sbjct: 374 IT-MPKETLTNNSL-TIAVSPDLLDQFGNPMNIEPGDGGVYDQATN 417
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 1e-11
Identities = 19/109 (17%), Positives = 49/109 (44%), Gaps = 5/109 (4%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
S+T I L++ N+T ++ + + ++ +L ++ T SG +L + + +
Sbjct: 44 NSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHATN-YNPISGLSNLERLRIMGKDV 100
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINL 520
T +L L +L L + ++ ++ + + L K ++ + N +
Sbjct: 101 TSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAI 149
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 15/86 (17%), Positives = 37/86 (43%), Gaps = 2/86 (2%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
S+T++ +S +I + + L + + L N I P+L+ ++++ + +
Sbjct: 112 TSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGV 171
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSG 499
+ + P L +LY + + G
Sbjct: 172 HD--YRGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 4e-10
Identities = 19/105 (18%), Positives = 40/105 (38%), Gaps = 2/105 (1%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQ 472
++ + + K++T + +L+ L+SL L + ++ + + P + I L N
Sbjct: 88 SNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNG 147
Query: 473 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
+ L LP L+ L +Q + + K L
Sbjct: 148 AITDI-MPLKTLPELKSLNIQFDGVHDYRGIEDFPKLNQLYAFSQ 191
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 33/179 (18%), Positives = 64/179 (35%), Gaps = 28/179 (15%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKEI------AVKVLTSNSYQGKREFTNEVTLLSRIHHRN 656
+ IG GGFG +Y + + + VKV S++ E ++
Sbjct: 39 VGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTEL-KFYQRAAKPEQIQ 97
Query: 657 LVQFLGYCQEEGRSVLVYEFMHNGTLKEH------LYGT-LTHEQRINWIKR-------L 702
+ G +H+ K + +G+ L ++ + L
Sbjct: 98 KWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDL--QKIYEANAKRFSRKTVL 155
Query: 703 EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV--SDFGLSKFAVDGASHV 759
+++ +EY+H +H D+K+SN+LL+ +V D+GL+ H
Sbjct: 156 QLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 33/93 (35%), Positives = 43/93 (46%), Gaps = 7/93 (7%)
Query: 415 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQ 472
+ + +S LT IP DL +L EL LD N + I L + L NQ
Sbjct: 173 KLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQA-IELEDLLRYSKLYRLGLGHNQ 228
Query: 473 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 505
+ SL LP LREL++ NN LS VP+ L
Sbjct: 229 IRMIENGSLSFLPTLRELHLDNNKLS-RVPAGL 260
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 9e-11
Identities = 26/113 (23%), Positives = 46/113 (40%), Gaps = 7/113 (6%)
Query: 407 QCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP--DFSGCPDLR 464
C + V+ S L +P +++ L L N ++ + DF G L
Sbjct: 26 MCPFGCHCHLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISE-LRKDDFKGLQHLY 81
Query: 465 IIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
+ L +N+++ + L L++LY+ N L +P +L S V L N
Sbjct: 82 ALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPSSLVELRIHDN 133
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 17/91 (18%), Positives = 36/91 (39%), Gaps = 10/91 (10%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLT-------GPIPDFSGCPDLRII 466
P++ +HL + L+ +P+ L L L ++L N++T P+ I
Sbjct: 241 PTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGI 299
Query: 467 HLEDNQLTGPL--PSSLMNLPNLRELYVQNN 495
L +N + P++ + + + N
Sbjct: 300 SLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 24/110 (21%), Positives = 41/110 (37%), Gaps = 24/110 (21%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 471
P T++ L + +++ D L L L L N ++ I + FS L+ +++ N
Sbjct: 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISK-IHEKAFSPLRKLQKLYISKN 112
Query: 472 QLT---GPLPSSL------------------MNLPNLRELYVQNNMLSGT 500
L LPSSL L N+ + + N L +
Sbjct: 113 HLVEIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENS 162
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 17/92 (18%), Positives = 33/92 (35%), Gaps = 8/92 (8%)
Query: 414 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQ 472
+ + L + I + L+ L +L EL LD N L+ L++++L N
Sbjct: 217 SKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNN 275
Query: 473 LTG------PLPSSLMNLPNLRELYVQNNMLS 498
+T + + + NN +
Sbjct: 276 ITKVGVNDFCPVGFGVKRAYYNGISLFNNPVP 307
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 66.6 bits (162), Expect = 2e-11
Identities = 50/216 (23%), Positives = 93/216 (43%), Gaps = 34/216 (15%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV-QF 660
L +KIGSG FG +Y G ++ +E+A+K+ + + E + + +
Sbjct: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNV 68
Query: 661 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR-------LEIAEDAAKGIE 713
+ E +VLV + + G E L+ N+ R L +A+ +E
Sbjct: 69 RWFGVEGDYNVLVMDLL--GPSLEDLF---------NFCSRKLSLKTVLMLADQMINRVE 117
Query: 714 YLHTGCVPAIIHRDLKSSNILLDKHMRAK---VSDFGLSKFAVDGASHV------SSIVR 764
++H+ +HRD+K N L+ RA + DFGL+K D ++H + +
Sbjct: 118 FVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174
Query: 765 GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 800
GT Y ++ + + + D+ S G +L+ + G
Sbjct: 175 GTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 31/111 (27%), Positives = 46/111 (41%), Gaps = 4/111 (3%)
Query: 413 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDN 471
QP + L S L P +LS L + +D L +PD L + L N
Sbjct: 80 QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARN 137
Query: 472 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 522
L LP+S+ +L LREL ++ +P L S + + G +NL
Sbjct: 138 PLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQS 187
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 22/112 (19%), Positives = 46/112 (41%), Gaps = 7/112 (6%)
Query: 415 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLED-NQL 473
++ + L + ++P+ + L +L L + + L+ P P L + L L
Sbjct: 184 NLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTAL 242
Query: 474 TGPLPSSLMNLPNLRELYVQN-NMLSGTVPSSL--LSKNVVLNYAGNINLHE 522
P L+ L +++ + L T+P + L++ L+ G +NL
Sbjct: 243 RN-YPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSR 292
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 18/95 (18%), Positives = 29/95 (30%), Gaps = 4/95 (4%)
Query: 415 SITVIHLSSKNLTGNIPSDLTKLSSLVELWL-DGNSLTGPIPD-FSGCPDLRIIHLEDNQ 472
+ + L N P + L L L D ++L +P L + L
Sbjct: 230 KLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQLEKLDLRGCV 288
Query: 473 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 507
LPS + LP + V + L +
Sbjct: 289 NLSRLPSLIAQLPANCIILVPPH-LQAQLDQHRPV 322
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 18/119 (15%), Positives = 40/119 (33%), Gaps = 12/119 (10%)
Query: 415 SITVIHLSSKNLTGNIPSDL---------TKLSSLVELWLDGNSLTGPIPDFSGCPDLRI 465
+ + + + +P L L +L L L+ + + +L+
Sbjct: 151 RLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKS 210
Query: 466 IHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINLHE 522
+ + ++ L+ L ++ +LP L EL ++ P + L NL
Sbjct: 211 LKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT 268
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 26/124 (20%), Positives = 46/124 (37%), Gaps = 12/124 (9%)
Query: 404 SWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSS--LVELWLDGNSLTGPIPD-FSGC 460
+W Q NS+ + + + + L L + V L L L PD
Sbjct: 49 AWRQANSN---NPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLPQ-FPDQAFRL 103
Query: 461 PDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNI 518
L+ + ++ L LP ++ L L + N L +P+S+ L++ L+
Sbjct: 104 SHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACP 161
Query: 519 NLHE 522
L E
Sbjct: 162 ELTE 165
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 9e-09
Identities = 20/115 (17%), Positives = 42/115 (36%), Gaps = 15/115 (13%)
Query: 415 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLED-NQ 472
+ + + + L +P + + + L L L N L +P + LR + + +
Sbjct: 105 HLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPE 162
Query: 473 LT--------GPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 517
LT L NL+ L ++ + ++P+S+ L L +
Sbjct: 163 LTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNS 216
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 65.3 bits (158), Expect = 2e-11
Identities = 38/268 (14%), Positives = 73/268 (27%), Gaps = 68/268 (25%)
Query: 588 AHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVL--------TSNSYQGK 639
+HC ++ +KIG G FG V+ +A+K++ + +
Sbjct: 14 SHCLPTEKLQRC-----EKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTF 67
Query: 640 REFTNEVTLLSRIH---------HRNLVQFLGYCQEEGRS-------------------- 670
E E+ + + + +G
Sbjct: 68 EEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAND 127
Query: 671 ----------VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 720
+V EF G E + + + I +
Sbjct: 128 RPDFFKDDQLFIVLEFEFGGIDLEQM-----RTKLSSLATAKSILHQLTASLAVAEA--S 180
Query: 721 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 780
HRDL N+LL K K+ K + + + V +D Y +S+
Sbjct: 181 LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGL------QVSIID--YTLSRLE 232
Query: 781 TDKSDVYSFGVILLELISGQEAISNEKF 808
D V+ + +L +G + +
Sbjct: 233 RDGIVVFCDVSMDEDLFTGDGDYQFDIY 260
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 4e-11
Identities = 23/99 (23%), Positives = 43/99 (43%), Gaps = 6/99 (6%)
Query: 417 TVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQL 473
+ LS +L I S+ + +L L L N L + + FS L ++ L +N +
Sbjct: 67 HSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHT-LDEFLFSDLQALEVLLLYNNHI 124
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVL 512
++ ++ L++LY+ N +S P L+ L
Sbjct: 125 VVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKL 162
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 25/99 (25%), Positives = 40/99 (40%), Gaps = 7/99 (7%)
Query: 414 PSITVIHLSSKNLTGNIPSD--LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLE 469
++ LS NL+ + ++ T+L++L L L N L I F P+LR + L
Sbjct: 39 SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNF-ISSEAFVPVPNLRYLDLS 96
Query: 470 DNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 508
N L +L L L + NN + V +
Sbjct: 97 SNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFED 134
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 28/116 (24%), Positives = 47/116 (40%), Gaps = 12/116 (10%)
Query: 414 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 470
P++ + LSS +L + + L +L L L N + + F L+ ++L
Sbjct: 88 PNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVV-VDRNAFEDMAQLQKLYLSQ 145
Query: 471 NQLTGPLP----SSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 522
NQ++ P LP L L + +N L +P + L K G + LH
Sbjct: 146 NQISR-FPVELIKDGNKLPKLMLLDLSSNKLK-KLPLTDLQKLPAWVKNG-LYLHN 198
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 36/185 (19%), Positives = 64/185 (34%), Gaps = 43/185 (23%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLL--SRIHHRNLVQ 659
L KKIGSGGFG++Y ++ A V+ K E+ L + + R
Sbjct: 41 LGKKIGSGGFGLIYLAFPTNKPEKDARHVV-------KVEYQENGPLFSELKFYQR---- 89
Query: 660 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR-----------------INWIKR- 701
+ + + + + G + G + R
Sbjct: 90 -VAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTF 148
Query: 702 -----LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV--SDFGLSKFAVD 754
L++ +EY+H +H D+K++N+LL +V +D+GLS
Sbjct: 149 KKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCP 205
Query: 755 GASHV 759
+H
Sbjct: 206 NGNHK 210
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 6e-11
Identities = 25/112 (22%), Positives = 48/112 (42%), Gaps = 9/112 (8%)
Query: 414 PSITVIHLSSKNLTGNIPSD--LTKLSSLVELWLDGNSLTGPIPD------FSGCPDLRI 465
P + ++ L+ + + D ++ SL +L+L N L F G L++
Sbjct: 426 PHLQILILNQNRFS-SCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQV 484
Query: 466 IHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
++L N L P +L LR L + +N L+ + L + +L+ + N
Sbjct: 485 LYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEILDISRN 536
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 9e-11
Identities = 22/104 (21%), Positives = 34/104 (32%), Gaps = 3/104 (2%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 471
+ + LS + S L L L L I F P+LRI+ L +
Sbjct: 24 NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSS 83
Query: 472 QLTGPLPSSLMNLPNLRELYVQNNMLS-GTVPSSLLSKNVVLNY 514
++ P + L +L EL + LS + L
Sbjct: 84 KIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTR 127
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 19/97 (19%), Positives = 36/97 (37%), Gaps = 2/97 (2%)
Query: 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLED 470
+ S+ + LS + L L L L N + F G +L++++L
Sbjct: 264 ARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSY 323
Query: 471 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 507
N L S+ LP + + +Q N ++ +
Sbjct: 324 NLLGELYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFK 359
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 6e-09
Identities = 19/99 (19%), Positives = 34/99 (34%), Gaps = 7/99 (7%)
Query: 418 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQLTGP 476
+ NLT +P L ++ L L N + F L+++ L
Sbjct: 8 IAFYRFCNLT-QVPQVL---NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLT 63
Query: 477 L-PSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 514
+ + NLPNLR L + ++ + + L
Sbjct: 64 IDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFE 101
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 1e-08
Identities = 30/110 (27%), Positives = 42/110 (38%), Gaps = 9/110 (8%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTK-----LSSLVELWLDGNSLTG-PIPDFSGCPDLRIIH 467
PS+ + L L ++L LS L L+L+ N L P FS LR +
Sbjct: 451 PSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLS 510
Query: 468 LEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
L N+LT + L NL L + N L + VL+ N
Sbjct: 511 LNSNRLTVLSHNDL--PANLEILDISRNQLL-APNPDVFVSLSVLDITHN 557
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 4e-08
Identities = 23/120 (19%), Positives = 48/120 (40%), Gaps = 2/120 (1%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQ 472
+ V++L+ + L +L L L N L +F G P + I L+ N
Sbjct: 290 KDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNH 349
Query: 473 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNI 532
+ + L L+ L +++N L+ T+ ++ L+ + L + A +++
Sbjct: 350 IAIIQDQTFKFLEKLQTLDLRDNALT-TIHFIPSIPDIFLSGNKLVTLPKINLTANLIHL 408
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 5e-08
Identities = 22/115 (19%), Positives = 33/115 (28%), Gaps = 9/115 (7%)
Query: 414 PSITVIHLSSKNLTGNI--PSDLTKLSSLVELWLDGNSLT--GPIPDFSGCPDLRIIHLE 469
+ + L L+ + L +L L L N + P F L+ I
Sbjct: 97 FHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFS 156
Query: 470 DNQLTGPLPSSLMNL--PNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 522
NQ+ L L L + N L V +N N+ L
Sbjct: 157 SNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGK---CMNPFRNMVLEI 208
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 3e-06
Identities = 23/100 (23%), Positives = 43/100 (43%), Gaps = 9/100 (9%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
+ + L LT + + S+ +++L GN L +P + +IHL +N+L
Sbjct: 362 EKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVT-LPKIN--LTANLIHLSENRL 413
Query: 474 TG-PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVL 512
+ L+ +P+L+ L + N S S+N L
Sbjct: 414 ENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSL 453
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 5e-04
Identities = 15/116 (12%), Positives = 36/116 (31%), Gaps = 22/116 (18%)
Query: 413 QPSITVIHLSSKNLTGNIPSDLTKLS------SLVELWLDGNSLTGPIPD---------- 456
+++ L++ +L + D K L L + GN T I
Sbjct: 173 GKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQ 232
Query: 457 ---FSGCPDLRIIHLEDNQLTGPLPSSLMNLP--NLRELYVQNNMLSGTVPSSLLS 507
+ + + P ++ L ++R L + + + ++ S +
Sbjct: 233 AFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF-SLNSRVFE 287
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 7e-11
Identities = 24/106 (22%), Positives = 49/106 (46%), Gaps = 6/106 (5%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
++ + + + ++ ++ + L LS L L D N ++ I + P+L +HL++NQ+
Sbjct: 151 TNLQYLSIGNAQVS-DL-TPLANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQI 207
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNIN 519
+ S L N NL + + N ++ P + VV N +
Sbjct: 208 SDV--SPLANTSNLFIVTLTNQTIT-NQPVFYNNNLVVPNVVKGPS 250
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 29/104 (27%), Positives = 50/104 (48%), Gaps = 5/104 (4%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
SI + L+S +T P L LS+L L+LD N +T I +G +L+ + + + Q+
Sbjct: 107 QSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITN-ISPLAGLTNLQYLSIGNAQV 163
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
+ + L NL L L +N +S P + L + ++ N
Sbjct: 164 SDL--TPLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNN 205
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 25/104 (24%), Positives = 51/104 (49%), Gaps = 5/104 (4%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
++ V++L +T NI S L L++L L + ++ + + L + +DN++
Sbjct: 129 SNLQVLYLDLNQIT-NI-SPLAGLTNLQYLSIGNAQVSD-LTPLANLSKLTTLKADDNKI 185
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
+ S L +LPNL E++++NN +S P + S ++
Sbjct: 186 SDI--SPLASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQ 227
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 9e-09
Identities = 22/104 (21%), Positives = 42/104 (40%), Gaps = 5/104 (4%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
IT + +T I + L++L+ L L N +T + + + L N L
Sbjct: 41 DGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKDNQITD-LAPLKNLTKITELELSGNPL 97
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
S++ L +++ L + + ++ P + LS VL N
Sbjct: 98 KNV--SAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLN 139
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 7e-07
Identities = 14/86 (16%), Positives = 35/86 (40%), Gaps = 3/86 (3%)
Query: 432 SDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 491
L++ +++ +++T + + + + +T + L NL L
Sbjct: 13 FPDPALANAIKIAAGKSNVTDTVT-QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLE 69
Query: 492 VQNNMLSGTVPSSLLSKNVVLNYAGN 517
+++N ++ P L+K L +GN
Sbjct: 70 LKDNQITDLAPLKNLTKITELELSGN 95
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 9e-06
Identities = 17/100 (17%), Positives = 39/100 (39%), Gaps = 5/100 (5%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
+T + ++ +I S L L +L+E+ L N ++ + + +L I+ L + +
Sbjct: 173 SKLTTLKADDNKIS-DI-SPLASLPNLIEVHLKNNQISD-VSPLANTSNLFIVTLTNQTI 229
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLN 513
T NL V+ + P+++ +
Sbjct: 230 TNQPVFYNNNLVVP--NVVKGPSGAPIAPATISDNGTYAS 267
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 8e-11
Identities = 27/114 (23%), Positives = 44/114 (38%), Gaps = 6/114 (5%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 471
++ + LS+ +T SDL + +L L L N + I + FS L + L N
Sbjct: 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINT-IEEDSFSSLGSLEHLDLSYN 110
Query: 472 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGNINLHE 522
L+ S L +L L + N +SL L+K +L +
Sbjct: 111 YLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTK 164
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 6e-10
Identities = 24/132 (18%), Positives = 40/132 (30%), Gaps = 30/132 (22%)
Query: 411 DPQPSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLT------------------ 451
S+ + LS L+ N+ S LSSL L L GN
Sbjct: 97 SSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILR 155
Query: 452 -------GPIPD--FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVP 502
I F+G L + ++ + L P SL ++ N+ L + +
Sbjct: 156 VGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLL 214
Query: 503 SSLLSKNVVLNY 514
+ +
Sbjct: 215 EIFVDVTSSVEC 226
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 8e-10
Identities = 16/114 (14%), Positives = 35/114 (30%), Gaps = 3/114 (2%)
Query: 411 DPQPSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHL 468
+ ++ + + + I L+ L EL +D + L ++ + L
Sbjct: 146 SHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLIL 205
Query: 469 EDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 522
Q L + ++ L +++ L T S LS +
Sbjct: 206 HMKQHILLLEIFVDVTSSVECLELRDTDLD-TFHFSELSTGETNSLIKKFTFRN 258
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 15/93 (16%), Positives = 31/93 (33%), Gaps = 7/93 (7%)
Query: 405 WLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLR 464
L+ + H S L+ + L K + + + SL + + L
Sbjct: 228 ELRDTD-----LDTFHFSE--LSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLL 280
Query: 465 IIHLEDNQLTGPLPSSLMNLPNLRELYVQNNML 497
+ NQL L +L+++++ N
Sbjct: 281 ELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 20/107 (18%), Positives = 32/107 (29%), Gaps = 13/107 (12%)
Query: 411 DPQPSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSL---------TGPIPDFSGC 460
+++ + L K + SS+ L L L TG
Sbjct: 195 KSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKK 253
Query: 461 PDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 507
R + + D L + L + L EL N L +VP +
Sbjct: 254 FTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFD 298
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 23/117 (19%), Positives = 42/117 (35%), Gaps = 10/117 (8%)
Query: 414 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 470
PS + L +L IPS + L ++ +++ + + F + I + +
Sbjct: 31 PSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 471 NQ-LTGPLPSSLMNLPNLRELYVQNNMLSGTVPS----SLLSKNVVLNYAGNINLHE 522
+ LT P +L LP L+ L + N L P +L N +
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTS 145
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 22/111 (19%), Positives = 42/111 (37%), Gaps = 13/111 (11%)
Query: 407 QCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLR 464
+C+ + ++ K++ IPS S L L L IP FS P++
Sbjct: 9 ECHQE-----EDFRVTCKDIQ-RIPS---LPPSTQTLKLIETHLRT-IPSHAFSNLPNIS 58
Query: 465 IIHLEDN-QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 514
I++ + L S NL + + ++N + L + +L +
Sbjct: 59 RIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKF 109
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 21/113 (18%), Positives = 40/113 (35%), Gaps = 9/113 (7%)
Query: 414 PSITVIHLSSKNLTGNIPSD-LTKLSS-LVELWLDGNSLTGPIPD--FSGCPDLRIIHLE 469
++ ++ +IP + L + + L L N T + F+G L ++L
Sbjct: 130 DIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS-VQGYAFNG-TKLDAVYLN 187
Query: 470 DNQ-LTGPLPSSLMNLPN-LRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINL 520
N+ LT + + + L V ++ +PS L L L
Sbjct: 188 KNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNTWTL 239
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 1e-10
Identities = 19/102 (18%), Positives = 36/102 (35%), Gaps = 5/102 (4%)
Query: 417 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQLTG 475
++ S L ++P DL+ L + N ++ D LRI+ + N++
Sbjct: 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQY 59
Query: 476 PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
S L L + +N L + L+ + N
Sbjct: 60 LDISVFKFNQELEYLDLSHNKLV-KISCHPTVNLKHLDLSFN 100
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 2e-09
Identities = 22/93 (23%), Positives = 44/93 (47%), Gaps = 4/93 (4%)
Query: 411 DPQPSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLE 469
S+ + +S +++ + + SL+ L + N LT I P ++++ L
Sbjct: 371 TQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFR-CLPPRIKVLDLH 429
Query: 470 DNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVP 502
N++ +P ++ L L+EL V +N L +VP
Sbjct: 430 SNKIKS-IPKQVVKLEALQELNVASNQLK-SVP 460
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 2e-09
Identities = 20/109 (18%), Positives = 40/109 (36%), Gaps = 6/109 (5%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPD----LRIIHLE 469
+ S+ LT + + L+ L L L N L + + L+ + +
Sbjct: 324 SPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKE-LSKIAEMTTQMKSLQQLDIS 382
Query: 470 DNQLTGPLPSSL-MNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
N ++ +L L + +N+L+ T+ L + VL+ N
Sbjct: 383 QNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSN 431
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 3e-09
Identities = 19/102 (18%), Positives = 35/102 (34%), Gaps = 4/102 (3%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 472
T++++S ++ SD+ LS L L + N + F +L + L N+
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80
Query: 473 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 514
L + NL+ L + N L +
Sbjct: 81 LVK-ISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKF 119
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 1e-07
Identities = 12/85 (14%), Positives = 27/85 (31%), Gaps = 1/85 (1%)
Query: 415 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQL 473
++++ + S S++ + + S + +N L
Sbjct: 277 ALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLL 336
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLS 498
T + + +L L L +Q N L
Sbjct: 337 TDTVFENCGHLTELETLILQMNQLK 361
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 7e-07
Identities = 19/96 (19%), Positives = 35/96 (36%), Gaps = 9/96 (9%)
Query: 400 PVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSG 459
SW S+ +++SS LT I L + L L N +
Sbjct: 392 KGDCSWT-------KSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIKSIPKQVVK 442
Query: 460 CPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 495
L+ +++ NQL L +L+++++ N
Sbjct: 443 LEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 5e-06
Identities = 16/105 (15%), Positives = 27/105 (25%), Gaps = 5/105 (4%)
Query: 411 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLT--GPIPDFSGCPDLRIIHL 468
+ + LS L I +L L L N+ +F L+ + L
Sbjct: 66 KFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGL 122
Query: 469 EDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLN 513
L + +L + L V L +
Sbjct: 123 STTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTES 167
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 23/88 (26%), Positives = 37/88 (42%), Gaps = 5/88 (5%)
Query: 414 PSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 470
P + V+ LS + I LS L L L GN + + FSG L+ + +
Sbjct: 52 PELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQS-LALGAFSGLSSLQKLVAVE 109
Query: 471 NQLTGPLPSSLMNLPNLRELYVQNNMLS 498
L + +L L+EL V +N++
Sbjct: 110 TNLASLENFPIGHLKTLKELNVAHNLIQ 137
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 6e-07
Identities = 18/92 (19%), Positives = 37/92 (40%), Gaps = 8/92 (8%)
Query: 414 PSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTG-PIPD-FSGCPDLRIIHLED 470
S+ + NL ++ + L +L EL + N + +P+ FS +L + L
Sbjct: 100 SSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS 158
Query: 471 NQLTGPLPSSLMNLPNLR----ELYVQNNMLS 498
N++ + L L + L + N ++
Sbjct: 159 NKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 19/115 (16%), Positives = 42/115 (36%), Gaps = 13/115 (11%)
Query: 414 PSITVIHLSSKNLTGNIPSD--LTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLE- 469
++ ++++ + + + L++L L L N + D + +++L
Sbjct: 124 KTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSL 182
Query: 470 ---DNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 521
N + + L+EL + N L +VP + + L I LH
Sbjct: 183 DLSLNPMNF-IQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQK---IWLH 232
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 5e-05
Identities = 19/89 (21%), Positives = 37/89 (41%), Gaps = 10/89 (11%)
Query: 414 PSITVIHLSSKNLTGNIPSD----LTKLSSL-VELWLDGNSLTGPIPD--FSGCPDLRII 466
++ + LSS + +I L ++ L + L L N + I F L+ +
Sbjct: 149 TNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKE-IRLKEL 205
Query: 467 HLEDNQLTGPLPSSLMNLPNLRELYVQNN 495
L+ NQL L +L+++++ N
Sbjct: 206 ALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 14/93 (15%), Positives = 32/93 (34%), Gaps = 4/93 (4%)
Query: 417 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQLT 474
+ + + + L +L EL+++ + G +LR + + + L
Sbjct: 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69
Query: 475 GPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 507
P + P L L + N L ++ +
Sbjct: 70 FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQ 101
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 58.6 bits (141), Expect = 3e-09
Identities = 26/115 (22%), Positives = 45/115 (39%), Gaps = 15/115 (13%)
Query: 396 DPCLPVPWSWLQCNSD----------PQPSITVIHLSSKNLTGNIPS-DLTKLSSLVELW 444
D C P S L+C D ++T +++ ++ ++ DL L L L
Sbjct: 3 DACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLT 62
Query: 445 LDGNSLTGPIPD--FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNML 497
+ + L + F P L ++L N L L + +L+EL + N L
Sbjct: 63 IVKSGLR-FVAPDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPL 115
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 28/111 (25%), Positives = 45/111 (40%), Gaps = 9/111 (8%)
Query: 414 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 470
+ + L+ + I + L+ L++L L N L I F L ++ L
Sbjct: 299 TDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGS-IDSRMFENLDKLEVLDLSY 356
Query: 471 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 521
N + S + LPNL+EL + N L +VP + + L I LH
Sbjct: 357 NHIRALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQK---IWLH 403
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 6e-10
Identities = 19/104 (18%), Positives = 36/104 (34%), Gaps = 3/104 (2%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 471
+ + LS ++ + ++L L L ++ + I + F G L I+ L+ N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 472 QLTGPLPSSLMNLPNLRELYVQNNML-SGTVPSSLLSKNVVLNY 514
Q + L NL L + L + + L
Sbjct: 90 QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEM 133
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 23/85 (27%), Positives = 40/85 (47%), Gaps = 5/85 (5%)
Query: 414 PSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 470
+ ++LS N G+I S + L L L L N + + D F G P+L+ + L+
Sbjct: 323 THLLKLNLSQ-NFLGSIDSRMFENLDKLEVLDLSYNHIRA-LGDQSFLGLPNLKELALDT 380
Query: 471 NQLTGPLPSSLMNLPNLRELYVQNN 495
NQL L +L+++++ N
Sbjct: 381 NQLKSVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 8e-06
Identities = 22/118 (18%), Positives = 43/118 (36%), Gaps = 7/118 (5%)
Query: 411 DPQPSITVIHLSSKNLTG-NIPSDL-TKLSSLVELWLDGNSLT--GPIPDFSGCPDLRII 466
+ ++ V+ L+ NL G + + L+SL L L N++ P F ++
Sbjct: 100 NGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVL 159
Query: 467 HLEDNQLTGPLPSSLMNLP--NLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 522
L N++ L+N + L + + L + L N N ++
Sbjct: 160 DLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQ-DMNEYWLGWEKCGNPFKNTSITT 216
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 51/262 (19%), Positives = 92/262 (35%), Gaps = 80/262 (30%)
Query: 605 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 663
+K+G G F V+ ++ K +A+KV+ S + + +E+ LL + + +
Sbjct: 43 RKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDP------ 95
Query: 664 CQEEGRSVLVY---EFMHNGTLKEH-------LYGTLTHEQRINWIKRL------EIAED 707
+ R ++V +F +G H L L + + L +I +
Sbjct: 96 -NDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQ 154
Query: 708 AAKGIEYLHTGCVPAIIHRDLKSSNILL-------------------------------- 735
+G++YLHT C IIH D+K NILL
Sbjct: 155 VLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212
Query: 736 -----------------DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 778
+ ++ K++D G A H + ++ T Y E I
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGN---ACWVHKHFTEDIQ-TRQYRSLEVLIGS 268
Query: 779 QLTDKSDVYSFGVILLELISGQ 800
+D++S + EL +G
Sbjct: 269 GYNTPADIWSTACMAFELATGD 290
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 6e-10
Identities = 29/109 (26%), Positives = 48/109 (44%), Gaps = 8/109 (7%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
+ + +S LT ++P + L EL + GN LT +P L + + NQL
Sbjct: 221 SGLKELIVSGNRLT-SLPVLPS---ELKELMVSGNRLTS-LPM--LPSGLLSLSVYRNQL 273
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 522
T LP SL++L + + ++ N LS +L Y+G I +
Sbjct: 274 TR-LPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFD 321
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 4e-09
Identities = 25/89 (28%), Positives = 38/89 (42%), Gaps = 8/89 (8%)
Query: 417 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGP 476
V+++ LT +P L + + L + N+LT +P P+LR + + NQLT
Sbjct: 43 AVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLTS-LPA--LPPELRTLEVSGNQLTS- 95
Query: 477 LPSSLMNLPNLRELYVQNNMLSGTVPSSL 505
LP L L L +PS L
Sbjct: 96 LPVLPPGLLELSIFSNPLTHLP-ALPSGL 123
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 6e-06
Identities = 22/92 (23%), Positives = 39/92 (42%), Gaps = 12/92 (13%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
+ + + LT ++P + L EL + N L +P +L + +N+L
Sbjct: 161 SELCKLWAYNNQLT-SLPMLPS---GLQELSVSDNQLAS-LPTLPS--ELYKLWAYNNRL 213
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 505
T LP+ L+EL V N L+ ++P
Sbjct: 214 T-SLPALP---SGLKELIVSGNRLT-SLPVLP 240
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 8e-06
Identities = 30/120 (25%), Positives = 48/120 (40%), Gaps = 33/120 (27%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKL-----------------SSLVELWLDGNSLTGPIPD 456
P + + +S LT ++P L S L +LW+ GN LT +P
Sbjct: 81 PELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTS-LPV 138
Query: 457 FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL-------LSKN 509
L+ + + DNQL LP+ L +L+ NN L+ ++P +S N
Sbjct: 139 LPP--GLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLT-SLPMLPSGLQELSVSDN 191
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 7e-04
Identities = 14/100 (14%), Positives = 27/100 (27%), Gaps = 9/100 (9%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
+ + + LT +P L LSS + L+GN L+ ++ +
Sbjct: 261 SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQA--LREITSAPGYSGPI 317
Query: 474 T------GPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 507
P L ++ P+
Sbjct: 318 IRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWH 357
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 61.7 bits (149), Expect = 8e-10
Identities = 27/104 (25%), Positives = 42/104 (40%), Gaps = 5/104 (4%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
+ + L ++ +I + L L L L+L N +T I S L + LEDNQ+
Sbjct: 109 KKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQI 165
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
+ L L L+ LY+ N +S + L VL
Sbjct: 166 SDI--VPLAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFSQ 207
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 59.4 bits (143), Expect = 4e-09
Identities = 26/104 (25%), Positives = 48/104 (46%), Gaps = 5/104 (4%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
++ + L + ++ S L L L L L+ N ++ I P L ++L +N++
Sbjct: 87 KNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKI 143
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
T + L L L L +++N +S VP + L+K L + N
Sbjct: 144 TDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKN 185
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 54.0 bits (129), Expect = 2e-07
Identities = 25/106 (23%), Positives = 49/106 (46%), Gaps = 6/106 (5%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
P + ++L + +T +I + L++L+ L L L+ N ++ I +G L+ ++L N +
Sbjct: 131 PQLESLYLGNNKIT-DI-TVLSRLTKLDTLSLEDNQISD-IVPLAGLTKLQNLYLSKNHI 187
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNIN 519
+ +L L NL L + + + S VV N N +
Sbjct: 188 SDL--RALAGLKNLDVLELFSQECLNKPINH-QSNLVVPNTVKNTD 230
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 54.0 bits (129), Expect = 2e-07
Identities = 21/104 (20%), Positives = 42/104 (40%), Gaps = 5/104 (4%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
+L K++T + +L+S+ ++ + + + + P++ + L N+L
Sbjct: 21 AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQGIQYLPNVTKLFLNGNKL 77
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
T L NL NL L++ N + L K L+ N
Sbjct: 78 TDI--KPLTNLKNLGWLFLDENKIKDLSSLKDLKKLKSLSLEHN 119
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 47.8 bits (113), Expect = 1e-05
Identities = 14/86 (16%), Positives = 30/86 (34%), Gaps = 3/86 (3%)
Query: 432 SDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 491
+ ++ L S+T + + I ++ + + LPN+ +L+
Sbjct: 15 FPDDAFAETIKDNLKKKSVTD-AVTQNELNSIDQIIANNSDIKS--VQGIQYLPNVTKLF 71
Query: 492 VQNNMLSGTVPSSLLSKNVVLNYAGN 517
+ N L+ P + L L N
Sbjct: 72 LNGNKLTDIKPLTNLKNLGWLFLDEN 97
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 9e-10
Identities = 22/107 (20%), Positives = 39/107 (36%), Gaps = 16/107 (14%)
Query: 407 QCNSDPQPSITVIHLSSKNLT---GNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCP 461
+C + T + S++ L +IP EL L+ N T F P
Sbjct: 8 KCRCEG----TTVDCSNQKLNKIPEHIPQYTA------ELRLNNNEFTVLEATGIFKKLP 57
Query: 462 DLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 508
LR I+ +N++T + + E+ + +N L V +
Sbjct: 58 QLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKG 103
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 23/91 (25%), Positives = 41/91 (45%), Gaps = 4/91 (4%)
Query: 414 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDN 471
P + I+ S+ +T +I S + E+ L N L F G L+ + L N
Sbjct: 57 PQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSN 115
Query: 472 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVP 502
++T S + L ++R L + +N ++ TV
Sbjct: 116 RITCVGNDSFIGLSSVRLLSLYDNQIT-TVA 145
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 5e-08
Identities = 25/88 (28%), Positives = 40/88 (45%), Gaps = 5/88 (5%)
Query: 411 DPQPSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIH 467
+ + I L+S L N+ + L SL L L N +T + + F G +R++
Sbjct: 78 EGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITC-VGNDSFIGLSSVRLLS 135
Query: 468 LEDNQLTGPLPSSLMNLPNLRELYVQNN 495
L DNQ+T P + L +L L + N
Sbjct: 136 LYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-09
Identities = 24/111 (21%), Positives = 41/111 (36%), Gaps = 26/111 (23%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
+ +I + + +L +P SL + N L +P+ P L I+ ++N L
Sbjct: 153 SFLKIIDVDNNSLK-KLPDLPP---SLEFIAAGNNQLEE-LPELQNLPFLTAIYADNNSL 207
Query: 474 TGPLPSSLMNL-------------------PNLRELYVQNNMLSGTVPSSL 505
LP ++L P L +Y NN+L T+P
Sbjct: 208 KK-LPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLK-TLPDLP 256
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 5e-09
Identities = 28/130 (21%), Positives = 42/130 (32%), Gaps = 40/130 (30%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKL-----------------SSLVELWLDGNSLTGPIPD 456
P + + S +LT +P L L L + N L +P+
Sbjct: 91 PHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEK-LPE 148
Query: 457 FSGCPDLRIIHLEDNQLTGPLPSSLMNL-------------------PNLRELYVQNNML 497
L+II +++N L LP +L P L +Y NN L
Sbjct: 149 LQNSSFLKIIDVDNNSLKK-LPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSL 207
Query: 498 SGTVPSSLLS 507
+P LS
Sbjct: 208 K-KLPDLPLS 216
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-08
Identities = 27/99 (27%), Positives = 40/99 (40%), Gaps = 11/99 (11%)
Query: 415 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLT 474
S+ I + L +L L L ++ D N L +PD P L +++ DN LT
Sbjct: 216 SLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLKT-LPD--LPPSLEALNVRDNYLT 270
Query: 475 GPLPSSLMNLPNLRELYVQNNMLSGTVPSSL----LSKN 509
LP +L L + LS +P +L S N
Sbjct: 271 D-LPELPQSLTFLDVSENIFSGLS-ELPPNLYYLNASSN 307
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 3e-07
Identities = 22/92 (23%), Positives = 38/92 (41%), Gaps = 12/92 (13%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
P++ ++ SS + ++ SL EL + N L +P + P L + N L
Sbjct: 297 PNLYYLNASSNEIR-SLCD---LPPSLEELNVSNNKLIE-LP--ALPPRLERLIASFNHL 349
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 505
+P NL++L+V+ N L P
Sbjct: 350 AE-VPEL---PQNLKQLHVEYNPLR-EFPDIP 376
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 24/113 (21%), Positives = 36/113 (31%), Gaps = 22/113 (19%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLS-------------SLVELWLDGNSLTGPIPDFSGC 460
S T + + N P + EL L+ L+ +P+
Sbjct: 34 KSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPEL--P 90
Query: 461 PDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL----LSKN 509
P L + N LT LP +L +L LS +P L +S N
Sbjct: 91 PHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSD-LPPLLEYLGVSNN 141
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 26/109 (23%), Positives = 46/109 (42%), Gaps = 23/109 (21%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
PS+ +++S+ L +P+ +L L N L +P +L+ +H+E N L
Sbjct: 317 PSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLAE-VP--ELPQNLKQLHVEYNPL 369
Query: 474 TG--PLPSSLMNL-------------PNLRELYVQNNMLSGTVPSSLLS 507
+P S+ +L NL++L+V+ N L P S
Sbjct: 370 REFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPES 417
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 5e-06
Identities = 19/99 (19%), Positives = 31/99 (31%), Gaps = 20/99 (20%)
Query: 421 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSG--------------CPDLRII 466
S NLT +P + + S E + + P +G +
Sbjct: 18 RHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHEL 76
Query: 467 HLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 505
L + L+ LP P+L L N L+ +P
Sbjct: 77 ELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP 110
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 9e-06
Identities = 10/79 (12%), Positives = 26/79 (32%), Gaps = 6/79 (7%)
Query: 420 HLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPS 479
L + +P +L +L ++ N L PD + + + ++ P
Sbjct: 381 DLRMNSHLAEVPE---LPQNLKQLHVETNPLRE-FPDIPE--SVEDLRMNSERVVDPYEF 434
Query: 480 SLMNLPNLRELYVQNNMLS 498
+ L + +++
Sbjct: 435 AHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 3e-05
Identities = 26/106 (24%), Positives = 38/106 (35%), Gaps = 20/106 (18%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
P +T I+ + L +P SL L + N LT L + + L
Sbjct: 237 PFLTTIYADNNLLK-TLPD---LPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGL 292
Query: 474 TGPLPSSLMNL--------------PNLRELYVQNNMLSGTVPSSL 505
+ LP +L L P+L EL V NN L +P+
Sbjct: 293 S-ELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP 336
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 27/104 (25%), Positives = 42/104 (40%), Gaps = 5/104 (4%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
+ + L ++ +I + L L L L+L N +T I S L + LEDNQ+
Sbjct: 112 KKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQI 168
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
+ L L L+ LY+ N +S + L VL
Sbjct: 169 SDI--VPLAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFSQ 210
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 26/106 (24%), Positives = 50/106 (47%), Gaps = 6/106 (5%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
P + ++L + +T +I + L++L+ L L L+ N ++ I +G L+ ++L N +
Sbjct: 134 PQLESLYLGNNKIT-DI-TVLSRLTKLDTLSLEDNQISD-IVPLAGLTKLQNLYLSKNHI 190
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNIN 519
+ +L L NL L + + P + S VV N N +
Sbjct: 191 SDL--RALAGLKNLDVLELFSQECL-NKPINHQSNLVVPNTVKNTD 233
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 21/104 (20%), Positives = 42/104 (40%), Gaps = 5/104 (4%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
+L K++T + +L+S+ ++ + + + + P++ + L N+L
Sbjct: 24 AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQGIQYLPNVTKLFLNGNKL 80
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
T L NL NL L++ N + L K L+ N
Sbjct: 81 TDI--KPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHN 122
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 22/85 (25%), Positives = 47/85 (55%), Gaps = 5/85 (5%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
SI I ++ ++ ++ + L ++ +L+L+GN LT I + +L + L++N++
Sbjct: 46 NSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLTD-IKPLANLKNLGWLFLDENKV 102
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLS 498
SSL +L L+ L +++N +S
Sbjct: 103 KDL--SSLKDLKKLKSLSLEHNGIS 125
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 18/101 (17%), Positives = 36/101 (35%), Gaps = 7/101 (6%)
Query: 421 LSSKNLTGNIP----SDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGP 476
L S+ +T P + ++ L S+T + + I ++ +
Sbjct: 3 LGSETITVPTPIKQIFSDDAFAETIKDNLKKKSVTD-AVTQNELNSIDQIIANNSDIKS- 60
Query: 477 LPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
+ LPN+ +L++ N L+ P + L L N
Sbjct: 61 -VQGIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDEN 100
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 49/211 (23%), Positives = 89/211 (42%), Gaps = 32/211 (15%)
Query: 605 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHR----- 655
K IG G FG V K + +A+K++ + Q E+ +L + +
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAA----EEIRILEHLRKQDKDNT 158
Query: 656 -NLVQFLGYCQEEGRSVLVYEFMHNGT---LKEHLYGTLTHEQRINWIKRLEIAEDAAKG 711
N++ L + +E + +K++ + + + +++ A +
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFS----LPLVRK--FAHSILQC 212
Query: 712 IEYLHTGCVPAIIHRDLKSSNILLDKHMRA--KVSDFGLSKFAVDGASHVSSIVRGTVGY 769
++ LH IIH DLK NILL + R+ KV DFG S + V + ++ + Y
Sbjct: 213 LDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ---RVYTYIQ-SRFY 265
Query: 770 LDPEYYISQQLTDKSDVYSFGVILLELISGQ 800
PE + + D++S G IL EL++G
Sbjct: 266 RAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 60.2 bits (145), Expect = 2e-09
Identities = 23/86 (26%), Positives = 36/86 (41%), Gaps = 3/86 (3%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
+T + LS L +P L L L L N+L + + P L+ + L +N+L
Sbjct: 463 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNNRL 520
Query: 474 TG-PLPSSLMNLPNLRELYVQNNMLS 498
L++ P L L +Q N L
Sbjct: 521 QQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 56.3 bits (135), Expect = 3e-08
Identities = 36/163 (22%), Positives = 60/163 (36%), Gaps = 15/163 (9%)
Query: 359 LNAMEINKYLERNDGSIDAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITV 418
+ A++ Y + + +V + A D + V
Sbjct: 392 MRALDPLLYEKETLQYFSTLKAVDPM-----RAAYLDDLRSKFLLEN-SVLKMEYADVRV 445
Query: 419 IHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLP 478
+HL+ K+LT + L +L + L L N L P + L ++ DN L +
Sbjct: 446 LHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALEN-VD 502
Query: 479 SSLMNLPNLRELYVQNNMLSGTVPS----SLLSKNVVLNYAGN 517
+ NLP L+EL + NN L + + V+LN GN
Sbjct: 503 -GVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 21/82 (25%), Positives = 33/82 (40%), Gaps = 7/82 (8%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGP--IPDFSGCPDLRIIHLEDN 471
+ V+ S L N+ + L L EL L N L I CP L +++L+ N
Sbjct: 486 RCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGN 543
Query: 472 QLTG--PLPSSLMN-LPNLREL 490
L + L LP++ +
Sbjct: 544 SLCQEEGIQERLAEMLPSVSSI 565
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 6e-09
Identities = 30/129 (23%), Positives = 52/129 (40%), Gaps = 16/129 (12%)
Query: 405 WLQCNS---------DPQPSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTG-P 453
L+ N+ P + I LS+ ++ + D L SL L L GN +T P
Sbjct: 38 RLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITELP 96
Query: 454 IPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLN 513
F G L+++ L N++ + +L NL L + +N L T+ S +
Sbjct: 97 KSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQ 155
Query: 514 YAGNINLHE 522
++L +
Sbjct: 156 T---MHLAQ 161
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 8e-09
Identities = 27/92 (29%), Positives = 42/92 (45%), Gaps = 13/92 (14%)
Query: 422 SSKNLT---GNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQLTGP 476
K LT N+P +T E+ L+ N++ IP FS LR I L +NQ++
Sbjct: 19 RGKGLTEIPTNLPETIT------EIRLEQNTIKV-IPPGAFSPYKKLRRIDLSNNQISEL 71
Query: 477 LPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 508
P + L +L L + N ++ +P SL
Sbjct: 72 APDAFQGLRSLNSLVLYGNKIT-ELPKSLFEG 102
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 9e-08
Identities = 22/88 (25%), Positives = 37/88 (42%), Gaps = 5/88 (5%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 471
+IT I L + P + L + L N ++ + F G L + L N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLRSLNSLVLYGN 90
Query: 472 QLTGPLPSSLM-NLPNLRELYVQNNMLS 498
++T LP SL L +L+ L + N ++
Sbjct: 91 KITE-LPKSLFEGLFSLQLLLLNANKIN 117
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 19/88 (21%), Positives = 36/88 (40%), Gaps = 5/88 (5%)
Query: 411 DPQPSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIH 467
S+ + L +T +P L L SL L L+ N + + F +L ++
Sbjct: 77 QGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLS 134
Query: 468 LEDNQLTGPLPSSLMNLPNLRELYVQNN 495
L DN+L + L ++ +++ N
Sbjct: 135 LYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 7e-09
Identities = 18/76 (23%), Positives = 30/76 (39%), Gaps = 1/76 (1%)
Query: 423 SKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLM 482
S++ G + + L L LT I + L+ + L DN+++G L
Sbjct: 27 SRSNEGKLEGLTDEFEELEFLSTINVGLTS-IANLPKLNKLKKLELSDNRVSGGLEVLAE 85
Query: 483 NLPNLRELYVQNNMLS 498
PNL L + N +
Sbjct: 86 KCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 23/89 (25%), Positives = 43/89 (48%), Gaps = 4/89 (4%)
Query: 409 NSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFS-GCPDLRIIH 467
+D + + + LT +I ++L KL+ L +L L N ++G + + CP+L ++
Sbjct: 37 LTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94
Query: 468 LEDNQLTGPL-PSSLMNLPNLRELYVQNN 495
L N++ L L NL+ L + N
Sbjct: 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 17/106 (16%), Positives = 35/106 (33%), Gaps = 6/106 (5%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
++ + L + L + L L +L L + N L I L ++ L N++
Sbjct: 106 ACLSRLFLDNNELR-DT-DSLIHLKNLEILSIRNNKLKS-IVMLGFLSKLEVLDLHGNEI 162
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNIN 519
T L L + + + P + + N + +
Sbjct: 163 TNT--GGLTRLKKVNWIDLTGQKCV-NEPVKYQPELYITNTVKDPD 205
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 21/95 (22%), Positives = 37/95 (38%), Gaps = 5/95 (5%)
Query: 425 NLTGNIPSDLTKLS--SLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLM 482
++ N +L + L L+LD N L +L I+ + +N+L L
Sbjct: 91 SVNRNRLKNLNGIPSACLSRLFLDNNELRD-TDSLIHLKNLEILSIRNNKLKSI--VMLG 147
Query: 483 NLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
L L L + N ++ T + L K ++ G
Sbjct: 148 FLSKLEVLDLHGNEITNTGGLTRLKKVNWIDLTGQ 182
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 27/123 (21%), Positives = 49/123 (39%), Gaps = 22/123 (17%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
+ + + N+ ++ + + ++L EL L N ++ + L + + N+L
Sbjct: 41 SGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLSHNQISD-LSPLKDLTKLEELSVNRNRL 97
Query: 474 TG--PLP-----------------SSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 514
+P SL++L NL L ++NN L V LSK VL+
Sbjct: 98 KNLNGIPSACLSRLFLDNNELRDTDSLIHLKNLEILSIRNNKLKSIVMLGFLSKLEVLDL 157
Query: 515 AGN 517
GN
Sbjct: 158 HGN 160
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 16/86 (18%), Positives = 37/86 (43%), Gaps = 3/86 (3%)
Query: 432 SDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 491
L++ V+ L S+T + ++ + +++ + + + NL+EL+
Sbjct: 13 FPDPGLANAVKQNLGKQSVTD-LVSQKELSGVQNFNGDNSNIQSL--AGMQFFTNLKELH 69
Query: 492 VQNNMLSGTVPSSLLSKNVVLNYAGN 517
+ +N +S P L+K L+ N
Sbjct: 70 LSHNQISDLSPLKDLTKLEELSVNRN 95
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 48/211 (22%), Positives = 86/211 (40%), Gaps = 30/211 (14%)
Query: 605 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHR----- 655
IG G FG V + + +A+K++ + Q + EV LL ++
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ----IEVRLLELMNKHDTEMK 115
Query: 656 -NLVQFLGYCQEEGRSVLVYEFMHNGT---LKEHLYGTLTHEQRINWIKRLEIAEDAAKG 711
+V + LV+E + L+ + ++ +N ++ A+
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVS----LNLTRK--FAQQMCTA 169
Query: 712 IEYLHTGCVPAIIHRDLKSSNILL--DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 769
+ +L T + +IIH DLK NILL K K+ DFG S + ++ + Y
Sbjct: 170 LLFLATPEL-SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ---RIYQYIQ-SRFY 224
Query: 770 LDPEYYISQQLTDKSDVYSFGVILLELISGQ 800
PE + D++S G IL+E+ +G+
Sbjct: 225 RSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 17/101 (16%), Positives = 27/101 (26%), Gaps = 21/101 (20%)
Query: 420 HLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQLT--- 474
+ + +G + L L L NSL L ++L L
Sbjct: 210 NAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVP 269
Query: 475 GPLPSSL----------------MNLPNLRELYVQNNMLSG 499
LP+ L LP + L ++ N
Sbjct: 270 KGLPAKLSVLDLSYNRLDRNPSPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 18/109 (16%), Positives = 36/109 (33%), Gaps = 8/109 (7%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPD----LRIIHL 468
P + V+ ++ + + +L L L N G + CP L+++ L
Sbjct: 149 PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLAL 208
Query: 469 EDNQLT---GPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 514
+ + G + L+ L + +N L + LN
Sbjct: 209 RNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNS 257
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 22/115 (19%), Positives = 42/115 (36%), Gaps = 4/115 (3%)
Query: 396 DPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP 455
+PC S SDP+P + + L L +D + G
Sbjct: 4 EPCELDEESCSCNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYL-LKRVDTEADLGQFT 62
Query: 456 DFSGCPDLRIIHLEDNQLTGPLPSS---LMNLPNLRELYVQNNMLSGTVPSSLLS 507
D L+ + + ++ + ++ + L+EL ++N ++GT P LL
Sbjct: 63 DIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLE 117
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 3e-08
Identities = 27/85 (31%), Positives = 39/85 (45%), Gaps = 9/85 (10%)
Query: 417 TVIHLSSKNLT---GNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
TV+ S+K L IP D+T EL+LDGN T + S L +I L +N++
Sbjct: 13 TVVRCSNKGLKVLPKGIPRDVT------ELYLDGNQFTLVPKELSNYKHLTLIDLSNNRI 66
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLS 498
+ S N+ L L + N L
Sbjct: 67 STLSNQSFSNMTQLLTLILSYNRLR 91
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 56.5 bits (136), Expect = 3e-08
Identities = 24/139 (17%), Positives = 47/139 (33%), Gaps = 25/139 (17%)
Query: 415 SITVIHLSSKNLTGNIPSDLTKL-----------------SSLVELWLDGNSLTGPIPD- 456
+ I+ + LT +P T L SL L + N L +P
Sbjct: 141 LLEYINADNNQLT-MLPELPTSLEVLSVRNNQLTFLPELPESLEALDVSTNLLES-LPAV 198
Query: 457 FSGCPDLR----IIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVL 512
+N++T +P ++++L + +++N LS + SL +
Sbjct: 199 PVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQP 257
Query: 513 NYAGNINLHEGGRGAKHLN 531
+Y G G ++
Sbjct: 258 DYHGPRIYFSMSDGQQNTL 276
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 30/109 (27%), Positives = 46/109 (42%), Gaps = 26/109 (23%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKL-----------------SSLVELWLDGNSLTGPIPD 456
P ITV+ ++ L ++P L +SL L +D N LT +P+
Sbjct: 80 PQITVLEITQNALI-SLPELPASLEYLDACDNRLSTLPELPASLKHLDVDNNQLTM-LPE 137
Query: 457 FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 505
L I+ ++NQLT LP +L L V+NN L+ +P
Sbjct: 138 LPA--LLEYINADNNQLTM-LPEL---PTSLEVLSVRNNQLT-FLPELP 179
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 22/91 (24%), Positives = 41/91 (45%), Gaps = 11/91 (12%)
Query: 415 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLT 474
+ + L+ NL+ ++P +L + L + N+L +P+ L + DN+L+
Sbjct: 60 QFSELQLNRLNLS-SLPDNL--PPQITVLEITQNALI-SLPELPA--SLEYLDACDNRLS 113
Query: 475 GPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 505
LP +L+ L V NN L+ +P
Sbjct: 114 T-LPEL---PASLKHLDVDNNQLT-MLPELP 139
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 2e-06
Identities = 21/87 (24%), Positives = 35/87 (40%), Gaps = 9/87 (10%)
Query: 423 SKNLTGNIPSDL--TKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSS 480
S L ++ EL L+ +L+ +PD + P + ++ + N L LP
Sbjct: 42 PGENRNEAVSLLKECLINQFSELQLNRLNLSS-LPD-NLPPQITVLEITQNALI-SLPEL 98
Query: 481 LMNLPNLRELYVQNNMLSGTVPSSLLS 507
+L L +N LS T+P S
Sbjct: 99 ---PASLEYLDACDNRLS-TLPELPAS 121
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 5e-08
Identities = 20/76 (26%), Positives = 31/76 (40%), Gaps = 1/76 (1%)
Query: 423 SKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLM 482
K+ G I + +L L L L + + P L+ + L +N++ G L
Sbjct: 34 CKSNDGKIEGLTAEFVNLEFLSLINVGLIS-VSNLPKLPKLKKLELSENRIFGGLDMLAE 92
Query: 483 NLPNLRELYVQNNMLS 498
LPNL L + N L
Sbjct: 93 KLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 21/89 (23%), Positives = 39/89 (43%), Gaps = 4/89 (4%)
Query: 409 NSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSG-CPDLRIIH 467
+ ++ + L + L ++ S+L KL L +L L N + G + + P+L ++
Sbjct: 44 LTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101
Query: 468 LEDNQLTGPLP-SSLMNLPNLRELYVQNN 495
L N+L L L L+ L + N
Sbjct: 102 LSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 34/115 (29%), Positives = 48/115 (41%), Gaps = 30/115 (26%)
Query: 408 CNSDPQPSITVIHLSSKNLT---GNIPSDLTKL------------------SSLVELWLD 446
CN++ +V SSK LT NIP+D KL + L L+L+
Sbjct: 14 CNNNKN---SV-DCSSKKLTAIPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLN 69
Query: 447 GNSLTGPIPD--FSGCPDLRIIHLEDNQLTGPLPSSLM-NLPNLRELYVQNNMLS 498
N L +P F +L + + DN+L LP + L NL EL + N L
Sbjct: 70 DNKLQT-LPAGIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLK 122
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 5e-07
Identities = 25/101 (24%), Positives = 37/101 (36%), Gaps = 6/101 (5%)
Query: 417 TVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQL 473
+ L L ++P + L+ L L L N L +P F L+ + L +NQL
Sbjct: 112 AELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQS-LPKGVFDKLTSLKELRLYNNQL 169
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 514
+ L L+ L + NN L VP L
Sbjct: 170 KRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKM 209
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 4e-06
Identities = 25/82 (30%), Positives = 41/82 (50%), Gaps = 5/82 (6%)
Query: 417 TVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQL 473
T + L L ++P + KL+SL EL L N L +P+ F +L+ + L++NQL
Sbjct: 136 TYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKR-VPEGAFDKLTELKTLKLDNNQL 193
Query: 474 TGPLPSSLMNLPNLRELYVQNN 495
+ +L L+ L +Q N
Sbjct: 194 KRVPEGAFDSLEKLKMLQLQEN 215
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 20/116 (17%), Positives = 36/116 (31%), Gaps = 6/116 (5%)
Query: 411 DPQPSITVIHLSSKNLTGNIPSD-LTKLSS-LVELWLDGNSLTGPIPD--FSGCPDLRII 466
++ + I + LS V LWL+ N + I + F+G +
Sbjct: 125 IHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELN 183
Query: 467 HLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 522
++N L L + + ++PS L L NL +
Sbjct: 184 LSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLKK 238
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 17/99 (17%), Positives = 39/99 (39%), Gaps = 5/99 (5%)
Query: 414 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWL-DGNSLTGPIPD--FSGCPDLRIIHLE 469
+ I +S ++ I +D + L L E+ + N+L I F P+L+ + +
Sbjct: 54 GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLY-INPEAFQNLPNLQYLLIS 112
Query: 470 DNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 508
+ + ++ L +Q+N+ T+ +
Sbjct: 113 NTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVG 151
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 17/84 (20%), Positives = 26/84 (30%), Gaps = 9/84 (10%)
Query: 415 SITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 471
+ + NL +P+D S V L + + +P LR
Sbjct: 179 LDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARST--Y 234
Query: 472 QLTGPLPSSLMNLPNLRELYVQNN 495
L LP+ L L L E +
Sbjct: 235 NLKK-LPT-LEKLVALMEASLTYP 256
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 8e-07
Identities = 23/89 (25%), Positives = 44/89 (49%), Gaps = 4/89 (4%)
Query: 415 SITVIHLSSKNLTGNIPSDLTKL-SSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
S+ + +S +L + S++ L L N LTG + P ++++ L +N++
Sbjct: 404 SLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFR-CLPPKVKVLDLHNNRI 462
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVP 502
+P + +L L+EL V +N L +VP
Sbjct: 463 MS-IPKDVTHLQALQELNVASNQLK-SVP 489
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 24/144 (16%), Positives = 43/144 (29%), Gaps = 25/144 (17%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 471
P + LS +++ D++ LS L L L N + + F DL + + N
Sbjct: 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRS-LDFHVFLFNQDLEYLDVSHN 110
Query: 472 QLTG----------------------PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN 509
+L P+ NL L L + + +
Sbjct: 111 RLQNISCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLH 170
Query: 510 VVLNYAGNINLHEGGRGAKHLNII 533
+ ++ H G + L I
Sbjct: 171 LSCILLDLVSYHIKGGETESLQIP 194
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 11/85 (12%), Positives = 28/85 (32%), Gaps = 1/85 (1%)
Query: 415 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQL 473
S+ + H+ ++ + + + + + L + + ++ N
Sbjct: 306 SLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVF 365
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLS 498
T + L L+ L +Q N L
Sbjct: 366 TDSVFQGCSTLKRLQTLILQRNGLK 390
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 21/82 (25%), Positives = 38/82 (46%), Gaps = 2/82 (2%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 473
SI V++LSS LTG++ L + L L N + D + L+ +++ NQL
Sbjct: 428 ESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQL 485
Query: 474 TGPLPSSLMNLPNLRELYVQNN 495
L +L+ +++ +N
Sbjct: 486 KSVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 22/113 (19%), Positives = 39/113 (34%), Gaps = 6/113 (5%)
Query: 410 SDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPD-LRIIHL 468
S T ++ + T ++ + L L L L N L + + +
Sbjct: 349 PPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKN-FFKVALMTKNMSSLET 407
Query: 469 EDNQLT----GPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
D L + ++ L + +NML+G+V L K VL+ N
Sbjct: 408 LDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLHNN 460
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 19/113 (16%), Positives = 42/113 (37%), Gaps = 10/113 (8%)
Query: 405 WLQCNS-------DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF 457
L N+ ++ ++ L + I + +L ELW+ N + +
Sbjct: 54 ALSTNNIEKISSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LSGI 111
Query: 458 SGCPDLRIIHLEDNQLTGPLP-SSLMNLPNLRELYVQNNMLSGTVPSSLLSKN 509
+LR++++ +N++T L L L +L + N L + +
Sbjct: 112 EKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSE 164
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 18/79 (22%), Positives = 34/79 (43%), Gaps = 3/79 (3%)
Query: 420 HLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPS 479
H + + + L+ L + L L N++ I SG +LRI+ L N + + +
Sbjct: 31 HGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KISSLSGMENLRILSLGRNLIKK-IEN 87
Query: 480 SLMNLPNLRELYVQNNMLS 498
L EL++ N ++
Sbjct: 88 LDAVADTLEELWISYNQIA 106
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 25/97 (25%), Positives = 39/97 (40%), Gaps = 16/97 (16%)
Query: 407 QCNSDPQPSITVIHLSSKNLT---GNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPD 462
QC+ T + SK IP++ L +L N +T P F +
Sbjct: 16 QCSCSG----TTVDCRSKRHASVPAGIPTNAQIL------YLHDNQITKLEPGVFDSLIN 65
Query: 463 LRIIHLEDNQLTGPLPSSLMN-LPNLRELYVQNNMLS 498
L+ ++L NQL LP + + L L L + N L+
Sbjct: 66 LKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGTNQLT 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 3e-06
Identities = 13/62 (20%), Positives = 24/62 (38%), Gaps = 1/62 (1%)
Query: 437 LSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 496
L + N + + F L+ + + +N++ LP+L EL + NN
Sbjct: 41 LDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNS 99
Query: 497 LS 498
L
Sbjct: 100 LV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 18/82 (21%), Positives = 30/82 (36%), Gaps = 7/82 (8%)
Query: 420 HLSSKNLTGN-IPS--DLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQLT 474
+ + + N I L L L ++ N + I + PDL + L +N L
Sbjct: 43 QFDAIDFSDNEIRKLDGFPLLRRLKTLLVNNNRICR-IGEGLDQALPDLTELILTNNSLV 101
Query: 475 GPLP-SSLMNLPNLRELYVQNN 495
L +L +L L + N
Sbjct: 102 ELGDLDPLASLKSLTYLCILRN 123
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174 | Back alignment and structure |
|---|
Score = 46.9 bits (111), Expect = 5e-06
Identities = 27/165 (16%), Positives = 48/165 (29%), Gaps = 28/165 (16%)
Query: 35 LNCGGNENFTDEIGLQWIADDHLI-------YGEISNISVANETRKQ-YMTLRHFPADSR 86
+N GG D G+ + D YG I +N + Y T R+
Sbjct: 10 VNAGGES-HVDVHGIHYRKDPLEGRVGRASDYGMKLPILRSNPEDQVLYQTERYNEDS-- 66
Query: 87 KYCYKLDVITRTRYLIRATFLYGNFDNNN------------VYPKFDISLGPTHWSTIVI 134
+ Y + + Y++ F F + V DI H +
Sbjct: 67 -FGYDIPIKEEGEYVLVLKFAEVYFAQSQQKVFDVRVNGHTVVKDLDIFDRVGHSTAHDE 125
Query: 135 SDAATIEVRELIF----LASSPKIDVCLSNATTGQPFISTLELRQ 175
+I+ +L + K+ V P + L + +
Sbjct: 126 IIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYYDNPKVCALFIMK 170
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.7 bits (115), Expect = 8e-06
Identities = 99/671 (14%), Positives = 203/671 (30%), Gaps = 195/671 (29%)
Query: 324 QGKYR----VYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDAIV 379
Q +Y+ V+E FV +F D + +L+ EI+ + D +
Sbjct: 15 QYQYKDILSVFED-------AFVDNFDCKDVQDMPK-SILSKEEIDHIIMSKDAVSGTLR 66
Query: 380 SVISLYSS-ADWAQEGGDPCLPVPWSWL------QCNSDPQPS-ITVIHLSSKNLTGNIP 431
+L S + Q+ + L + + +L + QPS +T +++ ++ N
Sbjct: 67 LFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQR---QPSMMTRMYIEQRDRLYNDN 123
Query: 432 SDLTKLS------------SLVEL------WLDG------NSLTGPIPDFSGCPDLRIIH 467
K + +L+EL +DG + C ++
Sbjct: 124 QVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVAL-----DVCLSYKVQC 178
Query: 468 LEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGA 527
D ++ +NL N P ++L L Y + N +
Sbjct: 179 KMDFKI------FWLNLKNCNS------------PETVLEMLQKLLYQIDPNWTSRSDHS 220
Query: 528 KHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEA 587
++ + I S + + L K + + L V V + A
Sbjct: 221 SNIKLRIHS--------IQAELRRLLKSK---------PYENCLLVLLNVQNAKAWNAFN 263
Query: 588 AHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVT 647
C K+L + T ++ T+ ++
Sbjct: 264 LSC----------KIL--------------------------LTTRF-----KQVTDFLS 282
Query: 648 LLSRIHHRNLVQFLGYCQEEGRSVLV-YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE 706
+ H + +E +S+L+ Y L + T+ +R++ I I +
Sbjct: 283 AATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREV--LTTNPRRLSIIAES-IRD 339
Query: 707 DAAKGIEYLHTGCVPAIIHRDLKSS-NILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG 765
A + H C + ++SS N+L R + F +H+ +I+
Sbjct: 340 GLATWDNWKHVNCDK--LTTIIESSLNVLEPAEYRKMFDRLSV--FPPS--AHIPTILLS 393
Query: 766 TVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAIS----NEKFGANCRNIVQWAKL 821
+ + D + +K YS L+E + IS + N L
Sbjct: 394 LI-WFDVIKSDVMVVVNKLHKYS----LVEKQPKESTISIPSIYLELKVKLENEYA---L 445
Query: 822 HIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCV-------LPHGHMRPS--------I 866
H S++D Y+I + ++ + + H H++
Sbjct: 446 HR-----------SIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGH-HLKNIEHPERMTLF 493
Query: 867 SEVLKD---IQDAIVIEREAAAARDGNSDD----------MSRNSLHSSLNVGSFGGTEN 913
V D ++ I + A A + + N V + +
Sbjct: 494 RMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAI---LD 550
Query: 914 FL-SLDESIVR 923
FL ++E+++
Sbjct: 551 FLPKIEENLIC 561
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.7 bits (115), Expect = 9e-06
Identities = 70/617 (11%), Positives = 168/617 (27%), Gaps = 223/617 (36%)
Query: 22 LDSSSAQM------------PGFVS-LNCGGNENFTDEIGLQWIAD---DHLIYGEISNI 65
+D + + FV +C ++ I ++ DH I +
Sbjct: 7 MDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSI----LSKEEIDH-IIMSKDAV 61
Query: 66 SVANETR--------KQYMTLRHFPADSRKYCY-----KLDVITRTRYLIRATFLYGN-- 110
+ T KQ ++ F + + Y + R ++ ++
Sbjct: 62 ---SGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDR 118
Query: 111 -FDNNNVYPKFDISLGPTHWSTIVISDAATIEVRE-LIFLASSPKI-------------- 154
+++N V+ K+++S + ++R+ L+ L + +
Sbjct: 119 LYNDNQVFAKYNVSRLQPYL-----------KLRQALLELRPAKNVLIDGVLGSGKTWVA 167
Query: 155 -DVCLSNATTGQPFISTLELRQFNGSVY-------------LTPFEDRYYL--------- 191
DVCLS + + ++ L + Y
Sbjct: 168 LDVCLSYKV----------QCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRS 217
Query: 192 --SVSARINFGADSEAPVR------YP------DDPFD-RIWES---------------- 220
S + ++ + R Y + + + W +
Sbjct: 218 DHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQV 277
Query: 221 -DSLKKANY----LVDVAAG-TEKVSTKL---PIDLRSDELPPQKV----MQTAVVGT-- 265
D L A L + T L +D R +LP + + + +++
Sbjct: 278 TDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESI 337
Query: 266 -NGSLTY----RLNLDGFPGFGWAVTYFAE--IEDLDPDESRK-FRL--VLPGQPDV--- 312
+G T+ +N D +T E + L+P E RK F V P P
Sbjct: 338 RDGLATWDNWKHVNCD-------KLTTIIESSLNVLEPAEYRKMFDRLSVFP--PSAHIP 388
Query: 313 ------------------------SKAIVNIQENAQGKYRVYEPGYTNLSLPFVLSFKFG 348
++V ++ + + S+ L K
Sbjct: 389 TILLSLIWFDVIKSDVMVVVNKLHKYSLVE-KQPKESTISIP-------SIYLELKVKLE 440
Query: 349 KTYDSSRGPLLNAMEINKYLERNDGSIDAIVSVISLY-----SSADWAQEGGD-PCLPVP 402
Y R +++ I K + +D + + + + + + +
Sbjct: 441 NEYALHR-SIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLD 499
Query: 403 WSWLQ-----------CNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLT 451
+ +L+ + ++ + + N P ++++++ L
Sbjct: 500 FRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDF------LP 553
Query: 452 GPIPDFSGCPDLRIIHL 468
+ ++ +
Sbjct: 554 KIEENLICSKYTDLLRI 570
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 9e-06
Identities = 25/111 (22%), Positives = 44/111 (39%), Gaps = 28/111 (25%)
Query: 417 TVIHLSSKNLT---GNIPSDLT-------------------KLSSLVELWLDGNSLTGPI 454
T + + + L +IP T +L LV+L L N LTG I
Sbjct: 11 TTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG-I 69
Query: 455 PD--FSGCPDLRIIHLEDNQLTGPLPSSLMN-LPNLRELYVQNNMLSGTVP 502
F G ++ + L +N++ + + + L L+ L + +N +S V
Sbjct: 70 EPNAFEGASHIQELQLGENKIKE-ISNKMFLGLHQLKTLNLYDNQIS-CVM 118
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 24/88 (27%), Positives = 40/88 (45%), Gaps = 5/88 (5%)
Query: 411 DPQPSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIH 467
P + + L LT I + S + EL L N + I + F G L+ ++
Sbjct: 51 GRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIKE-ISNKMFLGLHQLKTLN 108
Query: 468 LEDNQLTGPLPSSLMNLPNLRELYVQNN 495
L DNQ++ +P S +L +L L + +N
Sbjct: 109 LYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 24/83 (28%), Positives = 34/83 (40%), Gaps = 3/83 (3%)
Query: 417 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQLTG 475
+ L S L + L+ L L LD N L F +L + L +NQL
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97
Query: 476 PLPSSLM-NLPNLRELYVQNNML 497
LP + +L L +LY+ N L
Sbjct: 98 -LPLGVFDHLTQLDKLYLGGNQL 119
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 25/86 (29%), Positives = 37/86 (43%), Gaps = 7/86 (8%)
Query: 417 TVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQL 473
T ++L L + + + L+ L L L N L +P F L ++L NQL
Sbjct: 62 TWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLAS-LPLGVFDHLTQLDKLYLGGNQL 119
Query: 474 TGPLPSSLM-NLPNLRELYVQNNMLS 498
LPS + L L+EL + N L
Sbjct: 120 KS-LPSGVFDRLTKLKELRLNTNQLQ 144
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 23/88 (26%), Positives = 38/88 (43%), Gaps = 5/88 (5%)
Query: 411 DPQPSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIH 467
D + ++L L +PS + +L+ L EL L+ N L IP F +L+ +
Sbjct: 104 DHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKLTNLQTLS 161
Query: 468 LEDNQLTGPLPSSLMNLPNLRELYVQNN 495
L NQL + L L+ + + N
Sbjct: 162 LSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 49/229 (21%), Positives = 83/229 (36%), Gaps = 50/229 (21%)
Query: 605 KKIGSGGFGVVY--YGKLKDGKEIAVKVLTSN-SY--QGKREFTNEVTLLSRIHHR---- 655
+G G FG V + ++A+K++ + Y + E + +L +I +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE----INVLKKIKEKDKEN 80
Query: 656 --NLVQFLGYCQEEGRSVLVYEFMHNGT---LKEHLYGTLTHEQRINWIKRLEIAEDAAK 710
V + G + +E + T LKE+ + ++ +A
Sbjct: 81 KFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPH----VRH--MAYQLCH 134
Query: 711 GIEYLHTGCVPAIIHRDLKSSNILL-------------------DKHMRAKVSDFGLSKF 751
+ +LH + H DLK NIL K+ +V+DFG + F
Sbjct: 135 ALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF 191
Query: 752 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 800
+ H ++IV T Y PE + DV+S G IL E G
Sbjct: 192 DHE---HHTTIVA-TRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 7e-05
Identities = 59/238 (24%), Positives = 90/238 (37%), Gaps = 64/238 (26%)
Query: 605 KKIGSGGFG-VVYYGKLKDGKEIAVKVLTSN-SY--QGKREFTNEVTLLSRI-----HHR 655
+K+G G FG V+ + + K AVKV+ + Y K E +L +I ++
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE----ADILKKIQNDDINNN 96
Query: 656 NLVQFLGYCQEEGRSVLV--------YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED 707
N+V++ G L+ YE + + Y E IK +
Sbjct: 97 NIVKYHGKFMYYDHMCLIFEPLGPSLYEI-----ITRNNYNGFHIED----IKL--YCIE 145
Query: 708 AAKGIEYLHTGCVPAIIHRDLKSSNILL-------------------------DKHMRAK 742
K + YL ++ H DLK NILL K K
Sbjct: 146 ILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIK 202
Query: 743 VSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 800
+ DFG + F D + SI+ T Y PE ++ SD++SFG +L EL +G
Sbjct: 203 LIDFGCATFKSD---YHGSIIN-TRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 9e-05
Identities = 22/65 (33%), Positives = 35/65 (53%), Gaps = 5/65 (7%)
Query: 436 KLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQLTGPLPSSLMN-LPNLRELYV 492
+L++L L L GN L +P+ F +L+ + L +NQL LP + + L NL L +
Sbjct: 83 ELTNLTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQLQS-LPDGVFDKLTNLTYLNL 140
Query: 493 QNNML 497
+N L
Sbjct: 141 AHNQL 145
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 7e-04
Identities = 17/92 (18%), Positives = 40/92 (43%), Gaps = 12/92 (13%)
Query: 415 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLT 474
+L K++T + + +L+S+ ++ + + + + P++R + L N+L
Sbjct: 20 ETIKANLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS-VQGIQYLPNVRYLALGGNKLH 76
Query: 475 GPLPSSLM---NLPNLRELYVQNNMLSGTVPS 503
+ L NL L + N L ++P+
Sbjct: 77 -----DISALKELTNLTYLILTGNQLQ-SLPN 102
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 9e-04
Identities = 30/114 (26%), Positives = 46/114 (40%), Gaps = 28/114 (24%)
Query: 407 QCNSDPQPSITVIHLSSKNLT---GNIPSDLTKL------------------SSLVELWL 445
+C+ T + S+ T IP+ T L +SL +L+L
Sbjct: 4 RCSCSG----TTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYL 59
Query: 446 DGNSLTG-PIPDFSGCPDLRIIHLEDNQLTGPLPSSLMN-LPNLRELYVQNNML 497
GN L P F+ L ++L NQL LP+ + + L L+EL + N L
Sbjct: 60 GGNKLQSLPNGVFNKLTSLTYLNLSTNQLQS-LPNGVFDKLTQLKELALNTNQL 112
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 927 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.98 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.83 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.71 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.63 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.57 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.55 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.52 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.5 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.39 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.37 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.37 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 99.35 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.35 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.34 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.33 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.31 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.29 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.28 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.27 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.25 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.25 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.21 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.21 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.21 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.21 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.19 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.18 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.17 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.17 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.17 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.16 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.16 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.16 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.16 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.14 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.12 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.11 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.09 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.09 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.08 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.06 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.06 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.05 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.05 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.05 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.05 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.04 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.04 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.03 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.03 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.02 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.02 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 99.01 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.01 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.0 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 98.99 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 98.99 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 98.99 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 98.98 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 98.98 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.97 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.97 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 98.97 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 98.97 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 98.97 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 98.96 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 98.96 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 98.95 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 98.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 98.95 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 98.94 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 98.94 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 98.94 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 98.93 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 98.92 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 98.91 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 98.91 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.9 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 98.89 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 98.89 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 98.89 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 98.88 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 98.88 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 98.87 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 98.87 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 98.86 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 98.86 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 98.86 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.85 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 98.85 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 98.85 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 98.85 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 98.85 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 98.83 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 98.82 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 98.82 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 98.82 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 98.81 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 98.8 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 98.8 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 98.79 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 98.79 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.79 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 98.79 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 98.78 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 98.77 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 98.77 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 98.77 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 98.76 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 98.75 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 98.74 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 98.73 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 98.72 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 98.72 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 98.72 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 98.72 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 98.7 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 98.69 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 98.68 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 98.68 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.67 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 98.66 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 98.64 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.62 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 98.61 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 98.59 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 98.58 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 98.58 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 98.57 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 98.57 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 98.54 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 98.5 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 98.47 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.45 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 98.44 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 98.43 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.43 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 98.38 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 98.29 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 98.27 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.27 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.27 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.25 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.25 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.1 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.08 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.06 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.0 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 97.99 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.98 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 97.9 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.9 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 97.87 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.69 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.64 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 97.63 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.61 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 97.57 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 97.55 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.44 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.34 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 97.3 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.12 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.99 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.93 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.82 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 96.8 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.78 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 96.76 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.73 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 96.72 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.71 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.58 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 96.41 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 96.32 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.29 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.12 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.12 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 96.1 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.03 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 95.9 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.61 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 94.87 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.44 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 94.15 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 93.96 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.95 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 92.75 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 92.74 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 88.83 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 87.26 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 87.07 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 86.2 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 85.37 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 83.47 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 82.66 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=442.95 Aligned_cols=257 Identities=26% Similarity=0.418 Sum_probs=206.3
Q ss_pred HHhccccccCceEEEEEEEC------CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEE
Q 002409 602 MLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 675 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~------~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E 675 (927)
.+.++||+|+||+||+|+++ +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..+||||
T Consensus 44 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E 123 (329)
T 4aoj_A 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFE 123 (329)
T ss_dssp EEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 35688999999999999875 477899999987766667889999999999999999999999999999999999
Q ss_pred eccCCchhhhcccccc-----------cccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEE
Q 002409 676 FMHNGTLKEHLYGTLT-----------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 744 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~-----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~ 744 (927)
||++|+|.++++.... ....++|.+++.|+.|+|+||+|||++ +|+||||||+||||++++++||+
T Consensus 124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~ 200 (329)
T 4aoj_A 124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIG 200 (329)
T ss_dssp CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEEC
T ss_pred cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEEc
Confidence 9999999999965321 234689999999999999999999998 99999999999999999999999
Q ss_pred eecCcccccCCCC-ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhh
Q 002409 745 DFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLH 822 (927)
Q Consensus 745 DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~ 822 (927)
|||+|+....... .......||+.|||||++.+..++.++|||||||+||||+| |+.||...... .+...+.
T Consensus 201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~----~~~~~i~-- 274 (329)
T 4aoj_A 201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT----EAIDCIT-- 274 (329)
T ss_dssp CCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH----HHHHHHH--
T ss_pred ccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH----HHHHHHH--
Confidence 9999986544322 23345679999999999999999999999999999999999 89999765421 2222221
Q ss_pred hccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 823 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 823 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
++.. ...+.....++.+|+.+|++.||++||||.||+++|+.+.+
T Consensus 275 --~g~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 275 --QGRE---------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp --HTCC---------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --cCCC---------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 1211 01122234568899999999999999999999999998764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-50 Score=439.72 Aligned_cols=257 Identities=26% Similarity=0.471 Sum_probs=211.7
Q ss_pred HHhccccccCceEEEEEEEC------CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEE
Q 002409 602 MLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 675 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~------~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E 675 (927)
.+.+.||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+||||
T Consensus 16 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E 95 (299)
T 4asz_A 16 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFE 95 (299)
T ss_dssp EEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEE
Confidence 46789999999999999874 467899999987766667889999999999999999999999999999999999
Q ss_pred eccCCchhhhccccc---------ccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEee
Q 002409 676 FMHNGTLKEHLYGTL---------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF 746 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DF 746 (927)
||++|+|.++|+... .....++|.+++.|+.|+|+||+|||++ +|+||||||+|||+++++++||+||
T Consensus 96 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~DF 172 (299)
T 4asz_A 96 YMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDF 172 (299)
T ss_dssp CCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCC
T ss_pred cCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEECCc
Confidence 999999999996532 2345799999999999999999999998 9999999999999999999999999
Q ss_pred cCcccccCCCCc-eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhc
Q 002409 747 GLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIE 824 (927)
Q Consensus 747 Gla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~ 824 (927)
|+|+........ ......||+.|||||++.++.|+.++|||||||+||||+| |+.||...... .+...+ .
T Consensus 173 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~----~~~~~i----~ 244 (299)
T 4asz_A 173 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN----EVIECI----T 244 (299)
T ss_dssp SCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH----HHHHHH----H
T ss_pred ccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHH----H
Confidence 999865443222 2234569999999999999999999999999999999999 89999765422 222222 2
Q ss_pred cCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 825 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 825 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
.+... ..+.....++.+|+.+|++.||++||||.||++.|+++..
T Consensus 245 ~~~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 245 QGRVL---------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 22211 1122234568899999999999999999999999998643
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=445.47 Aligned_cols=257 Identities=21% Similarity=0.372 Sum_probs=210.6
Q ss_pred HHHHhccccccCceEEEEEEEC------CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 672 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~------~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~l 672 (927)
...|.++||+|+||+||+|++. +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+.+..+|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 3457789999999999999873 46789999997543 3345789999999999999999999999999999999
Q ss_pred EEEeccCCchhhhccccc------------ccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCc
Q 002409 673 VYEFMHNGTLKEHLYGTL------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR 740 (927)
Q Consensus 673 V~E~~~~gsL~~~L~~~~------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~ 740 (927)
|||||++|+|.++|.... .....++|..++.|+.|||+||+|||++ +|+||||||+||||+++++
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCC
Confidence 999999999999995432 1235689999999999999999999998 9999999999999999999
Q ss_pred EEEEeecCcccccCCC-CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHH
Q 002409 741 AKVSDFGLSKFAVDGA-SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQW 818 (927)
Q Consensus 741 vkL~DFGla~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~ 818 (927)
+||+|||+|+...... ........||+.|||||++.++.|+.++|||||||+||||+| |+.||..... ..+.+.
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~----~~~~~~ 259 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN----QDVVEM 259 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH----HHHHHH
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH----HHHHHH
Confidence 9999999998654332 223344679999999999999999999999999999999998 8999976542 233333
Q ss_pred HHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHH
Q 002409 819 AKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 876 (927)
Q Consensus 819 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~ 876 (927)
+. .+... ..+..+...+.+|+.+|++.+|++||||.||+++|+..
T Consensus 260 i~----~~~~~---------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 260 IR----NRQVL---------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HH----TTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HH----cCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 22 22211 11223445688999999999999999999999999854
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=429.40 Aligned_cols=254 Identities=31% Similarity=0.512 Sum_probs=199.8
Q ss_pred HHhccccccCceEEEEEEECCCcEEEEEEeecC--CchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 602 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
.+.++||+|+||+||+|+++ ..||||+++.. ..+..+.|.+|+++|++++|||||+++|+|.+ +..+||||||++
T Consensus 39 ~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~g 115 (307)
T 3omv_A 39 MLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEG 115 (307)
T ss_dssp CEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSS
T ss_pred EEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCC
Confidence 46788999999999999876 36999998754 23445779999999999999999999999865 568999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC-Cc
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA-SH 758 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~ 758 (927)
|+|.++|+.. ...+++..++.|+.|+|+||+|||++ +|+||||||+||||++++++||+|||+|+...... ..
T Consensus 116 GsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 116 SSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp CBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred CCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence 9999999643 45699999999999999999999998 99999999999999999999999999998654322 22
Q ss_pred eeeeeccCCCccCcccccc---CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCc
Q 002409 759 VSSIVRGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 835 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~---~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 835 (927)
......||+.|||||++.. +.|+.++|||||||+||||+||+.||...... ..+...+..... .+.
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~---~~~~~~~~~~~~--------~p~ 258 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR---DQIIFMVGRGYA--------SPD 258 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH---HHHHHHHHTTCC--------CCC
T ss_pred eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH---HHHHHHHhcCCC--------CCC
Confidence 3345679999999999964 46899999999999999999999999754311 111111111111 111
Q ss_pred ccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHH
Q 002409 836 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 876 (927)
Q Consensus 836 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~ 876 (927)
+ ..........+.+|+.+|++.+|++||||.||+++|+.+
T Consensus 259 ~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 259 L-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp S-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred c-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1 111223345788999999999999999999999999865
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-48 Score=426.65 Aligned_cols=250 Identities=22% Similarity=0.275 Sum_probs=204.3
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCC
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 680 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 680 (927)
.+.++||+|+||+||+|+++ +|+.||||+++... ...+|+.+|++++|||||++++++.+++..+||||||++|
T Consensus 61 ~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg 135 (336)
T 4g3f_A 61 THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG 135 (336)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred EeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence 34678999999999999986 68999999997542 2347999999999999999999999999999999999999
Q ss_pred chhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCC-cEEEEeecCcccccCCCCc-
Q 002409 681 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASH- 758 (927)
Q Consensus 681 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-~vkL~DFGla~~~~~~~~~- 758 (927)
+|.++|.. ...+++..+..++.||+.||+|||++ +|+||||||+||||+.++ ++||+|||+|+........
T Consensus 136 ~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 136 SLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp BHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 99999953 45799999999999999999999998 999999999999999987 6999999999865433211
Q ss_pred ---eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCc
Q 002409 759 ---VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 835 (927)
Q Consensus 759 ---~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 835 (927)
.....+||+.|||||++.+..|+.++|||||||+||||++|+.||......+....+.. +...
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~--------~~~~------ 274 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS--------EPPP------ 274 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH--------SCCG------
T ss_pred ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc--------CCCC------
Confidence 12345799999999999999999999999999999999999999976553332222221 1000
Q ss_pred ccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 836 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 836 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
....+......+.+++.+|++.||++|||+.|++++|..++.
T Consensus 275 -~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~ 316 (336)
T 4g3f_A 275 -IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ 316 (336)
T ss_dssp -GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 001122233468899999999999999999999999998765
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-48 Score=428.94 Aligned_cols=248 Identities=24% Similarity=0.331 Sum_probs=206.1
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
|.+.++||+|+||+||+|+++ +|+.||||++........+.+.+|+++|++++|||||++++++.+++..+||||||++
T Consensus 76 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 155 (346)
T 4fih_A 76 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 155 (346)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred cEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 344578999999999999986 6899999999866555567789999999999999999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
|+|.+++. ...+++..+..++.||+.||+|||++ +|+||||||+||||+.++++||+|||+|+....... .
T Consensus 156 g~L~~~l~-----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~ 226 (346)
T 4fih_A 156 GALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R 226 (346)
T ss_dssp EEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-C
T ss_pred CcHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-c
Confidence 99999884 34689999999999999999999998 999999999999999999999999999986644322 3
Q ss_pred eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCc
Q 002409 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 839 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 839 (927)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||...... .+...+.. +. .+.+..
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~----~~~~~i~~----~~-----~~~~~~- 292 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL----KAMKMIRD----NL-----PPRLKN- 292 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHHHHH----SS-----CCCCSC-
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH----HHHHHHHc----CC-----CCCCCc-
Confidence 34567999999999999999999999999999999999999999765421 22221111 10 111110
Q ss_pred cCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 840 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 840 ~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
......++.+++.+||+.||++|||+.|+++|
T Consensus 293 -~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 293 -LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp -GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11223468899999999999999999999876
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=422.23 Aligned_cols=266 Identities=23% Similarity=0.346 Sum_probs=202.0
Q ss_pred HHhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecC----eEEEEEEec
Q 002409 602 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG----RSVLVYEFM 677 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~----~~~lV~E~~ 677 (927)
.+.++||+|+||+||+|++. |+.||||+++.... ....++.|+..+.+++|||||+++++|.+++ ..+||||||
T Consensus 6 ~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~ 83 (303)
T 3hmm_A 6 VLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 83 (303)
T ss_dssp EEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred EEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCC
Confidence 35688999999999999985 89999999965422 2233455677778899999999999998764 579999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCC-----CCceecCCCCCCCeEECCCCcEEEEeecCcccc
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC-----VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 752 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 752 (927)
++|+|.++|+. ..++|..+++++.|+++||+|||+++ .++|+||||||+||||+.++++||+|||+|+..
T Consensus 84 ~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 84 EHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp TTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred CCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 99999999953 45899999999999999999999862 358999999999999999999999999999866
Q ss_pred cCCCCce---eeeeccCCCccCccccccC------cCCCccceeeHHHHHHHHHhCCCcccccccccc-cch------hh
Q 002409 753 VDGASHV---SSIVRGTVGYLDPEYYISQ------QLTDKSDVYSFGVILLELISGQEAISNEKFGAN-CRN------IV 816 (927)
Q Consensus 753 ~~~~~~~---~~~~~gt~~Y~aPE~~~~~------~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~-~~~------l~ 816 (927)
....... .....||+.|||||++.+. .++.++|||||||+||||+||+.|+......+. +.. ..
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~ 238 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence 5443322 2345699999999998754 467899999999999999999888754321110 000 01
Q ss_pred HHHHhhhccCCcccccCCcccCcc-CHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 817 QWAKLHIESGDIQGIIDPSLLDEY-DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 817 ~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
+.......+ ..+++.+.... +.+....+.+|+.+|++.||++||||.||++.|+++.+
T Consensus 239 ~~~~~~~~~----~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 239 EEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHHHTT----SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhc----ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 111111111 11233332222 34566788999999999999999999999999998764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=431.34 Aligned_cols=265 Identities=26% Similarity=0.398 Sum_probs=213.3
Q ss_pred HHHHHHHHhccccccCceEEEEEEECC------CcEEEEEEeecCCc-hhhHhHHHHHHHHhhccC-CCccceecceeec
Q 002409 596 IEDATKMLEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHH-RNLVQFLGYCQEE 667 (927)
Q Consensus 596 i~~~~~~~~~~IG~G~fG~Vy~~~~~~------g~~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l~H-pnIv~l~g~~~~~ 667 (927)
+....+.+.+.||+|+||+||+|++.. ++.||||+++.... ...+.|.+|+++|.+++| ||||+++|+|.+.
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 444556678899999999999998652 36799999976543 335679999999999965 9999999999764
Q ss_pred -CeEEEEEEeccCCchhhhcccccc------------cccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeE
Q 002409 668 -GRSVLVYEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL 734 (927)
Q Consensus 668 -~~~~lV~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIL 734 (927)
+..++|||||++|+|.++|+.... ....+++..++.++.|||+||+|||++ +|+||||||+|||
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NIL 217 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNIL 217 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCcccee
Confidence 568999999999999999965321 134589999999999999999999998 9999999999999
Q ss_pred ECCCCcEEEEeecCcccccCCCCc-eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCccccccccccc
Q 002409 735 LDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANC 812 (927)
Q Consensus 735 l~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~ 812 (927)
+++++.+||+|||+|+........ ......||+.|||||++.++.|+.++|||||||+||||+| |+.||......+
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~-- 295 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-- 295 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--
T ss_pred eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH--
Confidence 999999999999999866544333 3345679999999999999999999999999999999998 999997654221
Q ss_pred chhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHH
Q 002409 813 RNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 879 (927)
Q Consensus 813 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~ 879 (927)
.+.. .+.++... ..+.....++.+++.+|++.||++|||+.||+++|+++++.
T Consensus 296 -~~~~----~i~~g~~~---------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 296 -EFCR----RLKEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp -HHHH----HHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHH----HHHcCCCC---------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 1222 12222111 11122234688999999999999999999999999998764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=410.85 Aligned_cols=247 Identities=28% Similarity=0.439 Sum_probs=196.5
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecC--CchhhHhHHHHHHHHhhccCCCccceecceee----cCeEEEEE
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE----EGRSVLVY 674 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~----~~~~~lV~ 674 (927)
.+.++||+|+||+||+|++. +++.||||++... .....+.|.+|+++|++++|||||++++++.. ++..+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 35678999999999999876 5889999999754 23345679999999999999999999999865 34679999
Q ss_pred EeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECC-CCcEEEEeecCccccc
Q 002409 675 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLSKFAV 753 (927)
Q Consensus 675 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~-~~~vkL~DFGla~~~~ 753 (927)
|||++|+|.+++.. ...+++..+..++.||+.||+|||++. ++|+||||||+||||+. ++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 99999999999953 457899999999999999999999971 13999999999999984 7999999999998543
Q ss_pred CCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccC
Q 002409 754 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 833 (927)
Q Consensus 754 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 833 (927)
. ......+||+.|||||++. +.|+.++|||||||+||||++|+.||...... ..+.. .+..+.....+
T Consensus 184 ~---~~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~---~~~~~----~i~~~~~~~~~- 251 (290)
T 3fpq_A 184 A---SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA---AQIYR----RVTSGVKPASF- 251 (290)
T ss_dssp T---TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH---HHHHH----HHTTTCCCGGG-
T ss_pred C---CccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH---HHHHH----HHHcCCCCCCC-
Confidence 2 2334567999999999886 46999999999999999999999999654311 11212 11122111111
Q ss_pred CcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 834 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 834 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
+.....++.+++.+|++.||++|||+.|+++|
T Consensus 252 -------~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 252 -------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -------CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11122357899999999999999999999875
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-48 Score=428.73 Aligned_cols=249 Identities=24% Similarity=0.376 Sum_probs=199.6
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
|.+.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+.+..+||||||
T Consensus 26 Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~ 105 (350)
T 4b9d_A 26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYC 105 (350)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 556789999999999999876 68999999997543 334567899999999999999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
++|+|.++|... ....+++..++.++.||+.||+|||++ +|+||||||+||||+.++++||+|||+|+..... .
T Consensus 106 ~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-~ 179 (350)
T 4b9d_A 106 EGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-V 179 (350)
T ss_dssp TTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH-H
T ss_pred CCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC-c
Confidence 999999999542 244578899999999999999999998 9999999999999999999999999999865322 1
Q ss_pred ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCccc
Q 002409 758 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 837 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 837 (927)
......+||+.|||||++.+..|+.++|||||||+||||++|+.||......+ +...+ ..+... .+.
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~----~~~~i----~~~~~~-----~~~ 246 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN----LVLKI----ISGSFP-----PVS 246 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHH----HHTCCC-----CCC
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH----HHHHH----HcCCCC-----CCC
Confidence 22344579999999999999999999999999999999999999997654221 22111 112211 111
Q ss_pred CccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 838 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 838 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
. ....++.+|+.+||+.||++|||+.|++++
T Consensus 247 ~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 247 L----HYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp T----TSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred c----cCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 223468899999999999999999999875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=420.56 Aligned_cols=247 Identities=22% Similarity=0.327 Sum_probs=205.9
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
|.+.+.||+|+||+||+|+.. +++.||||++.+.. ....+.+.+|+++|++++|||||++++++.+++..++||||
T Consensus 34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy 113 (311)
T 4aw0_A 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 113 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 567899999999999999876 68999999997542 23346789999999999999999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
|++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 114 ~~gG~L~~~i~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 114 AKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred CCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 99999999994 346799999999999999999999998 99999999999999999999999999998765432
Q ss_pred -CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCc
Q 002409 757 -SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 835 (927)
Q Consensus 757 -~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 835 (927)
.......+||+.|||||++.+..|+.++||||+||++|||++|+.||......+....+. .+.+ .
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~--------~~~~------~ 252 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKII--------KLEY------D 252 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--------HTCC------C
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--------cCCC------C
Confidence 233455679999999999999999999999999999999999999997654222222221 1111 0
Q ss_pred ccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 836 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 836 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
+... ...++.+|+.+||+.||++|||+.|+..+
T Consensus 253 ~p~~----~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 253 FPEK----FFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp CCTT----CCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred CCcc----cCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 1111 22357899999999999999999987543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=429.96 Aligned_cols=248 Identities=24% Similarity=0.331 Sum_probs=206.5
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
|.+.++||+|+||.||+|++. +|+.||||++........+.+.+|+++|++++|||||++++++.+.+..+||||||++
T Consensus 153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g 232 (423)
T 4fie_A 153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 232 (423)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence 344678999999999999986 6899999999876666667899999999999999999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
|+|.+++. ...+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+....... .
T Consensus 233 G~L~~~i~-----~~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~ 303 (423)
T 4fie_A 233 GALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R 303 (423)
T ss_dssp EEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-C
T ss_pred CcHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-c
Confidence 99999884 34589999999999999999999998 999999999999999999999999999986644332 3
Q ss_pred eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCc
Q 002409 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 839 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 839 (927)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||...... .+...+.. +. .+.+..
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~----~~~~~i~~----~~-----~~~~~~- 369 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL----KAMKMIRD----NL-----PPRLKN- 369 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHHHHH----SC-----CCCCSC-
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH----HHHHHHHc----CC-----CCCCcc-
Confidence 34567999999999999999999999999999999999999999765421 22221111 11 011110
Q ss_pred cCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 840 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 840 ~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.......+.+|+.+||+.||++|||+.|+++|
T Consensus 370 -~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 370 -LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp -TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11122468899999999999999999999876
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=405.73 Aligned_cols=245 Identities=23% Similarity=0.382 Sum_probs=189.9
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 675 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E 675 (927)
.|.+.+.||+|+||+||+|+.. +|+.||||++.... ......+.+|+++|++++||||+++++++.+++..++|||
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 93 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 93 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence 3567789999999999999875 68999999997542 2234678999999999999999999999999999999999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCC
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 755 (927)
|+ +|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+|+...+.
T Consensus 94 y~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 94 YA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp CC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred CC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 99 6899998843 45799999999999999999999998 9999999999999999999999999999865432
Q ss_pred CCceeeeeccCCCccCccccccCcC-CCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCC
Q 002409 756 ASHVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 834 (927)
Q Consensus 756 ~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 834 (927)
. ......||+.|||||++.+..+ +.++||||+||++|||++|+.||......+ +.+.+ ..+...
T Consensus 166 ~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~----~~~~i----~~~~~~----- 230 (275)
T 3hyh_A 166 N--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV----LFKNI----SNGVYT----- 230 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHH----HHTCCC-----
T ss_pred C--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH----HHHHH----HcCCCC-----
Confidence 2 2344679999999999998876 579999999999999999999997654222 22211 112110
Q ss_pred cccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 835 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 835 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
+... ...++.+++.+|++.||++|||+.|+++|
T Consensus 231 -~p~~----~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 231 -LPKF----LSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp -CCTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred -CCCC----CCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1111 22457899999999999999999999875
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=412.48 Aligned_cols=246 Identities=26% Similarity=0.330 Sum_probs=194.6
Q ss_pred HHHhccccccCceEEEEEEEC----CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 674 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~----~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~ 674 (927)
|.+.+.||+|+||+||+|+.. .++.||||+++... ......+.+|+++|++++|||||++++++.+++..++||
T Consensus 26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 105 (304)
T 3ubd_A 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLIL 105 (304)
T ss_dssp EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEE
T ss_pred cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 557789999999999999863 46789999997542 223446889999999999999999999999999999999
Q ss_pred EeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccC
Q 002409 675 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 754 (927)
Q Consensus 675 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 754 (927)
|||++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+|||+|+....
T Consensus 106 Ey~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 106 DFLRGGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp CCCTTCEEHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EcCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 9999999999984 345799999999999999999999998 999999999999999999999999999986543
Q ss_pred CCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCC
Q 002409 755 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 834 (927)
Q Consensus 755 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 834 (927)
... .....+||+.|||||++.+..|+.++||||+||++|||++|+.||......+ +...+. ++..
T Consensus 179 ~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~----~~~~i~----~~~~------ 243 (304)
T 3ubd_A 179 HEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE----TMTMIL----KAKL------ 243 (304)
T ss_dssp --C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHH----HCCC------
T ss_pred CCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH----HHHHHH----cCCC------
Confidence 322 2344679999999999999999999999999999999999999997654222 222111 1111
Q ss_pred cccCccCHHHHHHHHHHHhhhcCCCCCCCCc-----HHHHHHH
Q 002409 835 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 872 (927)
Q Consensus 835 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----m~eV~~~ 872 (927)
. ++.....++.+++.+||+.||++||| ++|+++|
T Consensus 244 ~----~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 244 G----MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp C----CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred C----CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 0 11112246789999999999999998 4677654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=395.06 Aligned_cols=249 Identities=24% Similarity=0.328 Sum_probs=186.7
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc-hhhHhHHHHHHHHhhccCCCccceecceeecC----------
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG---------- 668 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~---------- 668 (927)
|.+.+.||+|+||+||+|+.+ +|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+.+
T Consensus 7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~ 86 (299)
T 4g31_A 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP 86 (299)
T ss_dssp EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence 445689999999999999876 689999999975543 33567899999999999999999999987544
Q ss_pred --eEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEee
Q 002409 669 --RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF 746 (927)
Q Consensus 669 --~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DF 746 (927)
..++|||||++|+|.+++.... ......+..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 87 ~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 87 KVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC
T ss_pred CcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEccC
Confidence 3689999999999999996532 223456677889999999999999998 9999999999999999999999999
Q ss_pred cCcccccCCCCc-----------eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchh
Q 002409 747 GLSKFAVDGASH-----------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 815 (927)
Q Consensus 747 Gla~~~~~~~~~-----------~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l 815 (927)
|+|+........ .....+||+.|||||++.+..|+.++|||||||++|||++ ||.... ..
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~------~~ 233 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM------ER 233 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH------HH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc------HH
Confidence 999865432211 1233569999999999999999999999999999999996 665322 01
Q ss_pred hHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 816 VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 816 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.... .......... ........+.+++.+|++.||++|||+.|++++
T Consensus 234 ~~~~-~~~~~~~~p~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 234 VRTL-TDVRNLKFPP---------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHH-HHHHTTCCCH---------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHH-HHHhcCCCCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1100 1111111111 011222346789999999999999999999875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=384.29 Aligned_cols=274 Identities=42% Similarity=0.744 Sum_probs=240.1
Q ss_pred HHhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCCc
Q 002409 602 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 681 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gs 681 (927)
.+.+.||+|+||.||+|++++++.||||++........+.+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 42 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 121 (321)
T 2qkw_B 42 DHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN 121 (321)
T ss_dssp SCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCB
T ss_pred CccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCc
Confidence 34678999999999999988899999999887666667789999999999999999999999999999999999999999
Q ss_pred hhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCC-CCcee
Q 002409 682 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG-ASHVS 760 (927)
Q Consensus 682 L~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-~~~~~ 760 (927)
|.+++.........+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 122 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 198 (321)
T 2qkw_B 122 LKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS 198 (321)
T ss_dssp TGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCB
T ss_pred HHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 9999976544455789999999999999999999998 9999999999999999999999999999754332 22223
Q ss_pred eeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCcc
Q 002409 761 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 840 (927)
Q Consensus 761 ~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 840 (927)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||.... +.....+..|.......+.+...+++.+....
T Consensus 199 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (321)
T 2qkw_B 199 TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL-PREMVNLAEWAVESHNNGQLEQIVDPNLADKI 277 (321)
T ss_dssp CCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSS-SSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCS
T ss_pred cccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccC-cHHHHHHHHHhhhccccccHHHhcChhhcccc
Confidence 34568999999999999999999999999999999999999997654 33344667777777777788888888888888
Q ss_pred CHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHH
Q 002409 841 DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 879 (927)
Q Consensus 841 ~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~ 879 (927)
..+....+.+++.+|++.+|++|||+.||+++|+.++..
T Consensus 278 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 278 RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp CHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 888899999999999999999999999999999998753
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=386.33 Aligned_cols=288 Identities=35% Similarity=0.656 Sum_probs=248.0
Q ss_pred cccCHHHHHHHHHH--HhccccccCceEEEEEEECCCcEEEEEEeecCCc-hhhHhHHHHHHHHhhccCCCccceeccee
Q 002409 589 HCFTLSDIEDATKM--LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQ 665 (927)
Q Consensus 589 ~~~~~~ei~~~~~~--~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~ 665 (927)
..+++.++.....+ +.+.||+|+||.||+|+..+++.||||++..... .....+.+|++++++++||||+++++++.
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 44666666655443 4688999999999999988899999999876532 23446899999999999999999999999
Q ss_pred ecCeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEe
Q 002409 666 EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD 745 (927)
Q Consensus 666 ~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~D 745 (927)
..+..++||||+++|+|.+++.........+++..+..++.|++.||+|||+++.++|+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 99999999999999999999977655566799999999999999999999998667999999999999999999999999
Q ss_pred ecCcccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCccccccc-ccccchhhHHHHhhhc
Q 002409 746 FGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF-GANCRNIVQWAKLHIE 824 (927)
Q Consensus 746 FGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~-~~~~~~l~~~~~~~~~ 824 (927)
||+++..............||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.+|......
T Consensus 178 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 257 (326)
T 3uim_A 178 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257 (326)
T ss_dssp CSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS
T ss_pred CccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh
Confidence 999987655555555556699999999999988999999999999999999999999974332 2233467778888888
Q ss_pred cCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHH
Q 002409 825 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 876 (927)
Q Consensus 825 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~ 876 (927)
...+....+..+...+..+....+.+++.+|++.+|++|||+.||+++|++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 8888888998888888899999999999999999999999999999999864
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=393.67 Aligned_cols=263 Identities=19% Similarity=0.280 Sum_probs=198.6
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceee------cCeEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE------EGRSV 671 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~------~~~~~ 671 (927)
|.+.+.||+|+||+||+|++. +|+.||||+++... ....+.+.+|+++|++++|||||++++++.. .+..+
T Consensus 56 Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ 135 (398)
T 4b99_A 56 YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVY 135 (398)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEE
Confidence 556789999999999999876 68999999997543 2334678899999999999999999998753 36789
Q ss_pred EEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccc
Q 002409 672 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 751 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 751 (927)
||||||+ |+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 136 ivmE~~~-g~L~~~i~----~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 136 VVLDLME-SDLHQIIH----SSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEECCS-EEHHHHHT----SSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEeCCC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeee
Confidence 9999996 68988884 346799999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCC---CceeeeeccCCCccCccccccC-cCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCC
Q 002409 752 AVDGA---SHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 827 (927)
Q Consensus 752 ~~~~~---~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 827 (927)
..... .......+||+.|||||++.+. .++.++||||+||++|||++|+.||......+....+......... ..
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~-~~ 286 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP-AV 286 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG-GG
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh-HH
Confidence 54321 2233456799999999998875 5689999999999999999999999765422222222221110000 00
Q ss_pred ccc-----------ccCCcccC---ccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 828 IQG-----------IIDPSLLD---EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 828 ~~~-----------~~d~~l~~---~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
... .+.+.... ........++.+|+.+||+.||++|||+.|+++|
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 00000000 0001112467899999999999999999999886
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=406.77 Aligned_cols=250 Identities=24% Similarity=0.357 Sum_probs=206.6
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
|.+.+.||+|+||.||+|+.+ +|+.||+|++........+.+.+|+++|++++||||+++++++.+.+..+||||||++
T Consensus 159 Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~g 238 (573)
T 3uto_A 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 238 (573)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred cEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCC
Confidence 456789999999999999886 6899999999876655667889999999999999999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCC--CcEEEEeecCcccccCCCC
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH--MRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~--~~vkL~DFGla~~~~~~~~ 757 (927)
|+|.++|.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 239 g~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-- 310 (573)
T 3uto_A 239 GELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-- 310 (573)
T ss_dssp CBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT--
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCC--
Confidence 999998853 245689999999999999999999998 99999999999999854 89999999999876443
Q ss_pred ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCccc
Q 002409 758 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 837 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 837 (927)
......+||+.|||||++.+..|+.++||||+||++|||++|+.||......+. ...+. .+.. .++....
T Consensus 311 ~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~----~~~i~----~~~~--~~~~~~~ 380 (573)
T 3uto_A 311 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET----LRNVK----SCDW--NMDDSAF 380 (573)
T ss_dssp SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH----HHHHH----TTCC--CCCSGGG
T ss_pred CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH----HHHHH----hCCC--CCCcccc
Confidence 233456799999999999999999999999999999999999999976542221 11111 1110 0111111
Q ss_pred CccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 838 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 838 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.. ....+.+|+.+||+.||++|||+.|+++|
T Consensus 381 ~~----~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 381 SG----ISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp TT----SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cC----CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 22357899999999999999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=382.35 Aligned_cols=194 Identities=25% Similarity=0.376 Sum_probs=165.5
Q ss_pred HHHhccccccCceEEEEEEEC----CCcEEEEEEeecCCchhhHhHHHHHHHHhhc-cCCCccceecceeecCeEEEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE 675 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~----~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~lV~E 675 (927)
|.+.++||+|+||+||+|+.+ .++.||||++.... ....+.+|+++|+++ +||||+++++++.+.++.++|||
T Consensus 23 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE 100 (361)
T 4f9c_A 23 FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMP 100 (361)
T ss_dssp CEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEE
T ss_pred EEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEe
Confidence 556789999999999999764 46789999986543 345678999999998 69999999999999999999999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCC-CcEEEEeecCcccccC
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVD 754 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~-~~vkL~DFGla~~~~~ 754 (927)
|+++|+|.+++. .+++.++..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+...+
T Consensus 101 ~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 101 YLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp CCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred CCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 999999999883 478889999999999999999998 99999999999999877 7999999999975433
Q ss_pred CCC---------------------------ceeeeeccCCCccCccccccC-cCCCccceeeHHHHHHHHHhCCCccccc
Q 002409 755 GAS---------------------------HVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNE 806 (927)
Q Consensus 755 ~~~---------------------------~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvL~elltG~~p~~~~ 806 (927)
... ......+||+.|||||++.+. .|+.++||||+||++|||++|+.||...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 211 112234699999999999775 5899999999999999999999999543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=398.82 Aligned_cols=246 Identities=25% Similarity=0.319 Sum_probs=196.5
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHH---HHHHHhhccCCCccceecceeecCeEEEEE
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTN---EVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 674 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~---Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~ 674 (927)
.+.+.||+|+||+||+|+.+ +|+.||||++.+.. ......+.+ ++.+++.++|||||++++++.+.+..+|||
T Consensus 192 ~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVm 271 (689)
T 3v5w_A 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL 271 (689)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEE
T ss_pred EEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEE
Confidence 34678999999999999886 68999999997532 112223333 466777889999999999999999999999
Q ss_pred EeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccC
Q 002409 675 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 754 (927)
Q Consensus 675 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 754 (927)
|||+||+|.++|. ....+++..+..++.||+.||+|||++ +|+||||||+||||+.+|++||+|||+|+....
T Consensus 272 Ey~~GGdL~~~l~----~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 272 DLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp CCCCSCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 9999999999994 346799999999999999999999998 999999999999999999999999999986644
Q ss_pred CCCceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccC
Q 002409 755 GASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 833 (927)
Q Consensus 755 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 833 (927)
.. ....+||+.|||||++.. ..|+.++|+|||||+||||++|+.||........ ..+..... ...+
T Consensus 345 ~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~-~~i~~~i~----~~~~----- 411 (689)
T 3v5w_A 345 KK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTL----TMAV----- 411 (689)
T ss_dssp CC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH-HHHHHHHH----HCCC-----
T ss_pred CC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhhc----CCCC-----
Confidence 32 234579999999999975 5799999999999999999999999976542211 11222111 1111
Q ss_pred CcccCccCHHHHHHHHHHHhhhcCCCCCCCCc-----HHHHHHH
Q 002409 834 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 872 (927)
Q Consensus 834 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----m~eV~~~ 872 (927)
.+... ...++.+|+.+||+.||++|++ +.||.+|
T Consensus 412 -~~p~~----~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 412 -ELPDS----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp -CCCTT----SCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred -CCCcc----CCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 11111 2235789999999999999998 7888876
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=362.32 Aligned_cols=256 Identities=25% Similarity=0.394 Sum_probs=209.1
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
+.+.+.||+|+||.||+|++. +++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 12 ~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 91 (310)
T 3s95_A 12 LIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKG 91 (310)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCC
Confidence 345689999999999999886 5889999998776666678899999999999999999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 92 ~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 92 GTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp CBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred CcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 9999998642 45689999999999999999999998 99999999999999999999999999998654332211
Q ss_pred -------------eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCccccccccccc--chhhHHHHhhhc
Q 002409 760 -------------SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANC--RNIVQWAKLHIE 824 (927)
Q Consensus 760 -------------~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~--~~l~~~~~~~~~ 824 (927)
.....||+.|+|||.+.+..++.++|||||||++|||++|..|+......... ..........
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~-- 243 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY-- 243 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT--
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccccc--
Confidence 11456999999999999999999999999999999999999998654321111 0111111100
Q ss_pred cCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHH
Q 002409 825 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 879 (927)
Q Consensus 825 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~ 879 (927)
.+......+.+++.+|++.+|++|||+.|+++.|+.+...
T Consensus 244 ---------------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 244 ---------------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp ---------------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0111223588999999999999999999999999988653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=361.71 Aligned_cols=258 Identities=31% Similarity=0.475 Sum_probs=201.5
Q ss_pred HHHHhccccccCceEEEEEEECCCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
.+.+.+.||+|+||.||+|+.. ++.||||++.... ....+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 38 ~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 116 (309)
T 3p86_A 38 DLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYL 116 (309)
T ss_dssp GEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECC
T ss_pred HceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecC
Confidence 4456789999999999999885 8899999987553 233467889999999999999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCc--eecCCCCCCCeEECCCCcEEEEeecCcccccCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA--IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 755 (927)
++|+|.+++... .....+++..++.++.|++.||+|||++ + |+||||||+|||++.++.+||+|||+++.....
T Consensus 117 ~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 117 SRGSLYRLLHKS-GAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp TTCBHHHHHHST-THHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred CCCcHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence 999999998643 2234589999999999999999999998 7 999999999999999999999999999754332
Q ss_pred CCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCc
Q 002409 756 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 835 (927)
Q Consensus 756 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 835 (927)
. .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .+...+.......
T Consensus 193 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~----~~~~~~~~~~~~~--------- 258 (309)
T 3p86_A 193 F-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA----QVVAAVGFKCKRL--------- 258 (309)
T ss_dssp ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH----HHHHHHHHSCCCC---------
T ss_pred c-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhcCCCC---------
Confidence 1 2233456999999999999999999999999999999999999999764421 1222211111111
Q ss_pred ccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHH
Q 002409 836 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 879 (927)
Q Consensus 836 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~ 879 (927)
..+......+.+++.+|++.+|++|||+.||++.|+.++..
T Consensus 259 ---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 259 ---EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred ---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 11112234688999999999999999999999999998754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=368.62 Aligned_cols=261 Identities=26% Similarity=0.442 Sum_probs=209.0
Q ss_pred HHHHHHHHhccccccCceEEEEEEEC----CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeE
Q 002409 596 IEDATKMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS 670 (927)
Q Consensus 596 i~~~~~~~~~~IG~G~fG~Vy~~~~~----~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~ 670 (927)
+....+.+.+.||+|+||.||+|++. .+..||||+++... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 33445566789999999999999985 34569999997653 34456799999999999999999999999999999
Q ss_pred EEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcc
Q 002409 671 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 750 (927)
Q Consensus 671 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 750 (927)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 126 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp EEEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEEeeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccc
Confidence 9999999999999998532 35689999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCCc--eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCC
Q 002409 751 FAVDGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGD 827 (927)
Q Consensus 751 ~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 827 (927)
........ ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+...+.. +.
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~----~~~~~~~~----~~ 271 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR----DVISSVEE----GY 271 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH----HHHHHHHT----TC
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH----HHHHHHHc----CC
Confidence 65443222 2223346788999999998999999999999999999999 99999764421 22221111 10
Q ss_pred cccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHH
Q 002409 828 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 879 (927)
Q Consensus 828 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~ 879 (927)
....+......+.+++.+|++.+|++||++.||++.|+.++..
T Consensus 272 ---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 272 ---------RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ---------CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 0111122334688999999999999999999999999998753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=357.34 Aligned_cols=248 Identities=24% Similarity=0.345 Sum_probs=203.9
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
|.+.+.||+|+||.||+|+.. +++.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 22 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 101 (297)
T 3fxz_A 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (297)
T ss_dssp BCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCC
Confidence 445678999999999999864 6899999999766555567789999999999999999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
|+|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 102 ~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 172 (297)
T 3fxz_A 102 GSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (297)
T ss_dssp CBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred CCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-c
Confidence 999999843 3588999999999999999999998 999999999999999999999999999986544332 2
Q ss_pred eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCc
Q 002409 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 839 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 839 (927)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .+.... ..+.. .. .
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~~~----~~~~~-~~-------~ 237 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR---ALYLIA----TNGTP-EL-------Q 237 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHH----HHCSC-CC-------S
T ss_pred cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH----hCCCC-CC-------C
Confidence 334569999999999999999999999999999999999999997544111 111111 11100 00 0
Q ss_pred cCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 840 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 840 ~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.+......+.+++.+|++.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 238 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 111223468899999999999999999999886
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=350.92 Aligned_cols=281 Identities=35% Similarity=0.579 Sum_probs=226.7
Q ss_pred ccccCHHHHHHHHHHHh--------ccccccCceEEEEEEECCCcEEEEEEeecCC----chhhHhHHHHHHHHhhccCC
Q 002409 588 AHCFTLSDIEDATKMLE--------KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS----YQGKREFTNEVTLLSRIHHR 655 (927)
Q Consensus 588 ~~~~~~~ei~~~~~~~~--------~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~----~~~~~~~~~Ei~iL~~l~Hp 655 (927)
.+.+++.++...+.++. +.||+|+||.||+|+. +++.||||++.... ....+.+.+|++++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 35688899998888774 5699999999999987 48899999987532 23356789999999999999
Q ss_pred CccceecceeecCeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEE
Q 002409 656 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL 735 (927)
Q Consensus 656 nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl 735 (927)
||+++++++...+..++||||+++|+|.+++... .....+++..++.++.|++.||+|||++ +|+||||||+|||+
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili 166 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILL 166 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTG-GGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEE
Confidence 9999999999999999999999999999998643 2345689999999999999999999998 99999999999999
Q ss_pred CCCCcEEEEeecCcccccCCCCc-eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccch
Q 002409 736 DKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRN 814 (927)
Q Consensus 736 ~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~ 814 (927)
+.++.+||+|||+++........ ......||+.|+|||.+.+ .++.++|||||||++|||++|+.||...........
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 245 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 245 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH
Confidence 99999999999999865443222 2334568999999998764 588999999999999999999999986553333222
Q ss_pred hhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHH
Q 002409 815 IVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 877 (927)
Q Consensus 815 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~ 877 (927)
+.+.... ....+.+.+++.+. .........+.+++.+|++.+|++||++.||+++|+++.
T Consensus 246 ~~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 246 IKEEIED--EEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHHT--TSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHhhh--hhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 2221111 12233444444442 345667778999999999999999999999999999863
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=369.90 Aligned_cols=261 Identities=24% Similarity=0.430 Sum_probs=210.3
Q ss_pred HHHHhccccccCceEEEEEEEC--------CCcEEEEEEeecCCc-hhhHhHHHHHHHHhhc-cCCCccceecceeecCe
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGR 669 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~--------~g~~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~ 669 (927)
.+.+.+.||+|+||.||+|++. ++..||||+++.... ...+.+.+|+++++++ +||||+++++++...+.
T Consensus 82 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~ 161 (370)
T 2psq_A 82 KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 161 (370)
T ss_dssp GEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSS
T ss_pred HCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCC
Confidence 3456789999999999999863 345799999976533 3356789999999999 89999999999999999
Q ss_pred EEEEEEeccCCchhhhcccccc------------cccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECC
Q 002409 670 SVLVYEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK 737 (927)
Q Consensus 670 ~~lV~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~ 737 (927)
.++||||+++|+|.+++..... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.
T Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~ 238 (370)
T 2psq_A 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTE 238 (370)
T ss_dssp CEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred EEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEECC
Confidence 9999999999999999965321 234588999999999999999999998 9999999999999999
Q ss_pred CCcEEEEeecCcccccCCCCc-eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchh
Q 002409 738 HMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNI 815 (927)
Q Consensus 738 ~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l 815 (927)
++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+
T Consensus 239 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~----~~ 314 (370)
T 2psq_A 239 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE----EL 314 (370)
T ss_dssp TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----GH
T ss_pred CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH----HH
Confidence 999999999999865433221 2223457889999999999999999999999999999999 99999764422 22
Q ss_pred hHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHHH
Q 002409 816 VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 880 (927)
Q Consensus 816 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~~ 880 (927)
..... .+.. ...+......+.+++.+|++.+|++||++.|++++|++++...
T Consensus 315 ~~~~~----~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 315 FKLLK----EGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp HHHHH----TTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHh----cCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 22111 1111 1111223346889999999999999999999999999998653
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=353.08 Aligned_cols=256 Identities=29% Similarity=0.462 Sum_probs=209.7
Q ss_pred HHHHhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
.+.+.+.||+|+||.||+|+.+++..||||+++.... ...++.+|++++++++||||+++++++...+..++||||+++
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (268)
T 3sxs_A 9 EITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISN 87 (268)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred heeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCC
Confidence 3456789999999999999999888999999975543 356789999999999999999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 88 ~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 161 (268)
T 3sxs_A 88 GCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS 161 (268)
T ss_dssp CBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE
T ss_pred CcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhhc
Confidence 9999998542 34689999999999999999999998 99999999999999999999999999998665543333
Q ss_pred eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCcccC
Q 002409 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 838 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 838 (927)
.....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+ .... ...+. ....+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----~~~~----~~~~~--~~~~~---- 227 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE----VVLK----VSQGH--RLYRP---- 227 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH----HHHH----HHTTC--CCCCC----
T ss_pred ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH----HHHH----HHcCC--CCCCC----
Confidence 334456778999999998899999999999999999999 999997544211 1111 11111 00011
Q ss_pred ccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHH
Q 002409 839 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 879 (927)
Q Consensus 839 ~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~ 879 (927)
......+.+++.+|++.+|++|||+.|++++|+.+...
T Consensus 228 ---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 228 ---HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp ---TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred ---CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 11123688999999999999999999999999987543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=352.37 Aligned_cols=254 Identities=28% Similarity=0.466 Sum_probs=208.5
Q ss_pred HHHhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCC
Q 002409 601 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 680 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 680 (927)
+.+.+.||+|+||.||+|++.+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 90 (269)
T 4hcu_A 12 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG 90 (269)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTC
T ss_pred ceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCC
Confidence 445688999999999999998899999999975543 3567899999999999999999999999999999999999999
Q ss_pred chhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCcee
Q 002409 681 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 760 (927)
Q Consensus 681 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 760 (927)
+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..........
T Consensus 91 ~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (269)
T 4hcu_A 91 CLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 164 (269)
T ss_dssp BHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred cHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence 999998542 34689999999999999999999998 999999999999999999999999999986543322222
Q ss_pred eeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCcccCc
Q 002409 761 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 839 (927)
Q Consensus 761 ~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 839 (927)
....+|+.|+|||.+....++.++||||||+++|||++ |+.||...... .+...... +. ....
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~----~~~~~~~~----~~--~~~~------ 228 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS----EVVEDIST----GF--RLYK------ 228 (269)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHHHHT----TC--CCCC------
T ss_pred cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH----HHHHHHhc----Cc--cCCC------
Confidence 33456788999999998999999999999999999999 99999764421 12221111 10 0001
Q ss_pred cCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 840 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 840 ~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
+......+.+++.+|++.+|++||++.|++++|+++..
T Consensus 229 -~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 229 -PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 11123468899999999999999999999999999864
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=372.12 Aligned_cols=257 Identities=24% Similarity=0.420 Sum_probs=197.9
Q ss_pred HHHHhccccccCceEEEEEEEC----CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 674 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~----~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~ 674 (927)
.+.+.+.||+|+||.||+|++. ++..||||+++... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 46 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 125 (373)
T 2qol_A 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 125 (373)
T ss_dssp GCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEE
Confidence 4456789999999999999875 56789999997653 334567999999999999999999999999999999999
Q ss_pred EeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccC
Q 002409 675 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 754 (927)
Q Consensus 675 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 754 (927)
||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 126 e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 126 EYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp ECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred eCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 999999999999532 34689999999999999999999998 999999999999999999999999999986544
Q ss_pred CCCce--eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccc
Q 002409 755 GASHV--SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 831 (927)
Q Consensus 755 ~~~~~--~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 831 (927)
..... .....+++.|+|||++....++.++|||||||++|||++ |+.||...... .+...+....
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~----~~~~~i~~~~-------- 267 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ----DVIKAVDEGY-------- 267 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH----HHHHHHHTTE--------
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHHcCC--------
Confidence 32221 122335778999999999999999999999999999998 99999754421 2222211110
Q ss_pred cCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHH
Q 002409 832 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 879 (927)
Q Consensus 832 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~ 879 (927)
....+......+.+++.+|++.+|++||++.||++.|++++..
T Consensus 268 -----~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 268 -----RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp -----ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -----CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 0111122345688999999999999999999999999998754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=355.54 Aligned_cols=260 Identities=23% Similarity=0.361 Sum_probs=211.6
Q ss_pred cccCHHHHHHHHHH------------HhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCC
Q 002409 589 HCFTLSDIEDATKM------------LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR 655 (927)
Q Consensus 589 ~~~~~~ei~~~~~~------------~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~Hp 655 (927)
..++..++..++.. ..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 34677787777653 2457999999999999987 7999999999876666667899999999999999
Q ss_pred CccceecceeecCeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEE
Q 002409 656 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL 735 (927)
Q Consensus 656 nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl 735 (927)
||+++++++...+..++||||+++|+|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+|||+
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll 174 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILL 174 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEE
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEE
Confidence 99999999999999999999999999999884 24589999999999999999999998 99999999999999
Q ss_pred CCCCcEEEEeecCcccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchh
Q 002409 736 DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 815 (927)
Q Consensus 736 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l 815 (927)
+.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~----~~ 249 (321)
T 2c30_A 175 TLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV----QA 249 (321)
T ss_dssp CTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HH
T ss_pred CCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HH
Confidence 9999999999999976543322 223456999999999999999999999999999999999999999754311 11
Q ss_pred hHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 816 VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 816 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
...... ... +.+.. .......+.+++.+|++.+|++|||+.|++++
T Consensus 250 ~~~~~~----~~~-----~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 250 MKRLRD----SPP-----PKLKN--SHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHHH----SSC-----CCCTT--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHhc----CCC-----CCcCc--cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111 110 11111 11123468899999999999999999999986
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=355.00 Aligned_cols=256 Identities=28% Similarity=0.455 Sum_probs=207.0
Q ss_pred HHHHhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
.+.+.+.||+|+||.||++++.++..||||+++.... ..+++.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 103 (283)
T 3gen_A 25 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 103 (283)
T ss_dssp GEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTT
T ss_pred HHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCC
Confidence 4556789999999999999999888999999975543 356789999999999999999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 104 ~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (283)
T 3gen_A 104 GCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 177 (283)
T ss_dssp CBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHS
T ss_pred CcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccccc
Confidence 9999998542 35689999999999999999999998 99999999999999999999999999998654322222
Q ss_pred eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCcccC
Q 002409 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 838 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 838 (927)
.....+|+.|+|||.+....++.++||||||+++|||++ |+.||......+ ...... .+. . .
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~----~~~~~~----~~~-----~----~ 240 (283)
T 3gen_A 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE----TAEHIA----QGL-----R----L 240 (283)
T ss_dssp TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH----HHHHHH----TTC-----C----C
T ss_pred ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH----HHHHHh----ccc-----C----C
Confidence 233446788999999998899999999999999999998 999997644211 111111 110 0 0
Q ss_pred ccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHH
Q 002409 839 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 879 (927)
Q Consensus 839 ~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~ 879 (927)
..+......+.+++.+|++.+|++|||+.|++++|++++..
T Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 241 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 01111124688999999999999999999999999998754
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=360.07 Aligned_cols=266 Identities=27% Similarity=0.358 Sum_probs=204.7
Q ss_pred HHHhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecC----eEEEEEEe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG----RSVLVYEF 676 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~----~~~lV~E~ 676 (927)
+.+.+.||+|+||.||+|++. ++.||||++.... .....+..|+.++++++||||+++++++.... ..++||||
T Consensus 26 y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~ 103 (322)
T 3soc_A 26 LQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAF 103 (322)
T ss_dssp EEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred chhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEec
Confidence 446789999999999999987 8999999996543 23445677999999999999999999998754 36999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCC-------CCceecCCCCCCCeEECCCCcEEEEeecCc
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC-------VPAIIHRDLKSSNILLDKHMRAKVSDFGLS 749 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-------~~~ivHrDLkp~NILl~~~~~vkL~DFGla 749 (927)
+++|+|.+++.. ..+++..++.++.|++.||+|||+.+ .++|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a 178 (322)
T 3soc_A 104 HEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178 (322)
T ss_dssp CTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcc
Confidence 999999999843 45899999999999999999999852 238999999999999999999999999999
Q ss_pred ccccCCCCc-eeeeeccCCCccCcccccc-----CcCCCccceeeHHHHHHHHHhCCCcccccccccccc---------h
Q 002409 750 KFAVDGASH-VSSIVRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCR---------N 814 (927)
Q Consensus 750 ~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~-----~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~---------~ 814 (927)
+........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......... .
T Consensus 179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 258 (322)
T 3soc_A 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS 258 (322)
T ss_dssp EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC
T ss_pred cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc
Confidence 765443222 2233569999999999976 356678899999999999999999997543211100 1
Q ss_pred hhHHHHhhhccCCcccccCCcccCcc-CHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 815 IVQWAKLHIESGDIQGIIDPSLLDEY-DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 815 l~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
...+..... ... ..+.+.... .......+.+++.+|++.||++|||+.||++.|+++..
T Consensus 259 ~~~~~~~~~-~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 259 LEDMQEVVV-HKK----KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp HHHHHHHHT-TSC----CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhhhhhhh-ccc----CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 111111111 111 111111111 22455679999999999999999999999999998854
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=360.16 Aligned_cols=265 Identities=27% Similarity=0.395 Sum_probs=205.1
Q ss_pred HHHHHhccccccCceEEEEEEEC-----CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceee--cCeEE
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLK-----DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSV 671 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~-----~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--~~~~~ 671 (927)
..+.+.+.||+|+||.||+|++. +++.||||++........+.+.+|++++++++||||+++++++.. ....+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 34556789999999999999852 588999999987666666789999999999999999999999854 45689
Q ss_pred EEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccc
Q 002409 672 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 751 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 751 (927)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 90 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 999999999999998543 34589999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCCc--eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccc--------cccchhhHHHHh
Q 002409 752 AVDGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG--------ANCRNIVQWAKL 821 (927)
Q Consensus 752 ~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~--------~~~~~l~~~~~~ 821 (927)
....... ......++..|+|||.+.+..++.++|||||||++|||++|..|+...... ............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 5433221 222334677899999999999999999999999999999999988643210 000011111111
Q ss_pred hhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 822 HIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 822 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
....+. ....+......+.+++.+|++.+|++|||+.||++.|+++..
T Consensus 244 ~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 244 LLKNNG---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHHTTC---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhccC---------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 111111 111122334578899999999999999999999999998864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=359.28 Aligned_cols=245 Identities=24% Similarity=0.407 Sum_probs=201.9
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecC--CchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
|.+.+.||+|+||.||+|++. +|+.||||++... .....+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 17 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 96 (328)
T 3fe3_A 17 YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYA 96 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECC
Confidence 445689999999999999884 7899999999754 2334567889999999999999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 97 ~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 168 (328)
T 3fe3_A 97 SGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG- 168 (328)
T ss_dssp TTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC-
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC-
Confidence 99999999843 45689999999999999999999998 99999999999999999999999999998654332
Q ss_pred ceeeeeccCCCccCccccccCcCC-CccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 758 HVSSIVRGTVGYLDPEYYISQQLT-DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~~~~~~s-~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
......||+.|+|||++.+..+. .++|||||||++|||++|+.||...... .+.+. +..+...
T Consensus 169 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~~~~~----i~~~~~~------- 232 (328)
T 3fe3_A 169 -KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK----ELRER----VLRGKYR------- 232 (328)
T ss_dssp -GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHH----HHHCCCC-------
T ss_pred -ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH----HHHHH----HHhCCCC-------
Confidence 23345699999999999888765 7899999999999999999999765422 11111 1111110
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.+......+.+++.+|++.||++|||+.|++++
T Consensus 233 ---~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 233 ---IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ---CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ---CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 011122457899999999999999999999886
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=347.94 Aligned_cols=271 Identities=21% Similarity=0.289 Sum_probs=210.8
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecC--eEEEEEEe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG--RSVLVYEF 676 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~~~lV~E~ 676 (927)
|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++||||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 90 (319)
T 4euu_A 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (319)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred EEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeC
Confidence 445789999999999999887 48999999997543 233567889999999999999999999987655 77999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEE----CCCCcEEEEeecCcccc
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFA 752 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl----~~~~~vkL~DFGla~~~ 752 (927)
+++|+|.+++.... ....+++..++.++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||+++..
T Consensus 91 ~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 91 CPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp CTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred CCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 99999999996532 223489999999999999999999998 99999999999999 78888999999999865
Q ss_pred cCCCCceeeeeccCCCccCccccc--------cCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhc
Q 002409 753 VDGASHVSSIVRGTVGYLDPEYYI--------SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE 824 (927)
Q Consensus 753 ~~~~~~~~~~~~gt~~Y~aPE~~~--------~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~ 824 (927)
..... .....||+.|+|||++. ...++.++|||||||++|||++|+.||...........+.........
T Consensus 167 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p 244 (319)
T 4euu_A 167 EDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (319)
T ss_dssp CTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred CCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence 44322 23346999999999986 467899999999999999999999999754433222222222221111
Q ss_pred cCCccccc-----------CCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHH
Q 002409 825 SGDIQGII-----------DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 877 (927)
Q Consensus 825 ~~~~~~~~-----------d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~ 877 (927)
...+.... +..............+.+++.+|++.||++|||+.|++++.++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 11111000 001112334566678899999999999999999999999998754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=368.19 Aligned_cols=255 Identities=29% Similarity=0.429 Sum_probs=206.6
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
+.+.+.||+|+||.||+|++. +++.||||+++... ......+.+|+++|++++||||+++++++...+..++||||++
T Consensus 116 ~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 195 (377)
T 3cbl_A 116 LVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ 195 (377)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred eEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCC
Confidence 345789999999999999987 78999999987543 2334578899999999999999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
+|+|.+++.. ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 196 ~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 196 GGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp TCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 9999999853 234689999999999999999999998 9999999999999999999999999999754332111
Q ss_pred ee-eeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 759 VS-SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 759 ~~-~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
.. ....+++.|+|||.+....++.++|||||||++|||++ |+.||...... .+.+.+ ..+..
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~----~~~~~~----~~~~~-------- 333 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ----QTREFV----EKGGR-------- 333 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH----HHHHHH----HTTCC--------
T ss_pred ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHH----HcCCC--------
Confidence 11 12235778999999998999999999999999999998 99999764421 122211 11110
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
...+......+.+++.+|++.+|++|||+.||++.|+++..
T Consensus 334 -~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 334 -LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 01111223468899999999999999999999999998754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=352.29 Aligned_cols=259 Identities=24% Similarity=0.386 Sum_probs=203.6
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc---hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 675 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E 675 (927)
.|.+.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 91 (294)
T 4eqm_A 12 RYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVME 91 (294)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEe
Confidence 3456789999999999999876 688999999865432 334678899999999999999999999999999999999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCC
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 755 (927)
|+++++|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 92 ~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 92 YIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp CCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred CCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 9999999999843 35689999999999999999999998 9999999999999999999999999999865544
Q ss_pred CCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCc
Q 002409 756 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 835 (927)
Q Consensus 756 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 835 (927)
.........||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ......... . +.
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-------~~~~~~~~~-~-----~~ 231 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS-------IAIKHIQDS-V-----PN 231 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH-------HHHHHHSSC-C-----CC
T ss_pred cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-------HHHHHhhcc-C-----CC
Confidence 3333444569999999999999999999999999999999999999997644111 111111111 1 01
Q ss_pred ccCccCHHHHHHHHHHHhhhcCCCCCCCC-cHHHHHHHHHHHHH
Q 002409 836 LLDEYDIQSMWKIEEKALMCVLPHGHMRP-SISEVLKDIQDAIV 878 (927)
Q Consensus 836 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-sm~eV~~~L~~~~~ 878 (927)
............+.+++.+|++.+|++|| ++.++.+.|+.++.
T Consensus 232 ~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 11111222335688999999999999999 99999999987653
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=353.83 Aligned_cols=260 Identities=27% Similarity=0.426 Sum_probs=209.7
Q ss_pred HHHHhccccccCceEEEEEEEC------CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 672 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~------~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~l 672 (927)
.+.+.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++...+..++
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 103 (314)
T 2ivs_A 24 NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLL 103 (314)
T ss_dssp GEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred heeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEE
Confidence 3456789999999999999862 45789999997543 3345678999999999999999999999999999999
Q ss_pred EEEeccCCchhhhcccccc--------------------cccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCC
Q 002409 673 VYEFMHNGTLKEHLYGTLT--------------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSN 732 (927)
Q Consensus 673 V~E~~~~gsL~~~L~~~~~--------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~N 732 (927)
||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+|
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~N 180 (314)
T 2ivs_A 104 IVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARN 180 (314)
T ss_dssp EEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGG
T ss_pred EEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchhe
Confidence 9999999999999965322 224589999999999999999999998 99999999999
Q ss_pred eEECCCCcEEEEeecCcccccCCCCce-eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCccccccccc
Q 002409 733 ILLDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGA 810 (927)
Q Consensus 733 ILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~ 810 (927)
||++.++.+||+|||+++......... .....+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......
T Consensus 181 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~- 259 (314)
T 2ivs_A 181 ILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE- 259 (314)
T ss_dssp EEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 999999999999999998654433222 233457889999999999899999999999999999999 99999765422
Q ss_pred ccchhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHH
Q 002409 811 NCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 879 (927)
Q Consensus 811 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~ 879 (927)
.+...... +.. ...+......+.+++.+|++.+|++||++.||+++|++++..
T Consensus 260 ---~~~~~~~~----~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 260 ---RLFNLLKT----GHR---------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp ---GHHHHHHT----TCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---HHHHHhhc----CCc---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 22222111 110 011122234688999999999999999999999999998753
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=362.02 Aligned_cols=263 Identities=27% Similarity=0.409 Sum_probs=207.9
Q ss_pred HHHHHHhccccccCceEEEEEEEC------CCcEEEEEEeecCCc-hhhHhHHHHHHHHhhc-cCCCccceecceeecC-
Q 002409 598 DATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEG- 668 (927)
Q Consensus 598 ~~~~~~~~~IG~G~fG~Vy~~~~~------~g~~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~- 668 (927)
...+.+.+.||+|+||.||+|++. +++.||||+++.... ...+.+.+|+++++++ +||||+++++++.+.+
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 100 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 100 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCC
Confidence 344556789999999999999742 457899999976533 3346799999999999 8999999999988755
Q ss_pred eEEEEEEeccCCchhhhccccccc--------------------------------------------------------
Q 002409 669 RSVLVYEFMHNGTLKEHLYGTLTH-------------------------------------------------------- 692 (927)
Q Consensus 669 ~~~lV~E~~~~gsL~~~L~~~~~~-------------------------------------------------------- 692 (927)
..++||||+++|+|.+++......
T Consensus 101 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (359)
T 3vhe_A 101 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 180 (359)
T ss_dssp CCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------------
T ss_pred ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcc
Confidence 489999999999999999654221
Q ss_pred ------ccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC-ceeeeecc
Q 002409 693 ------EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS-HVSSIVRG 765 (927)
Q Consensus 693 ------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~g 765 (927)
...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .......|
T Consensus 181 ~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 257 (359)
T 3vhe_A 181 APEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257 (359)
T ss_dssp ---CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred cccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCC
Confidence 12288999999999999999999998 999999999999999999999999999986544322 23344568
Q ss_pred CCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCcccCccCHHH
Q 002409 766 TVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQS 844 (927)
Q Consensus 766 t~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 844 (927)
|+.|+|||++.+..++.++|||||||++|||++ |+.||......+ .+... ...+... . .+...
T Consensus 258 t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~~----~~~~~~~-----~----~~~~~ 321 (359)
T 3vhe_A 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---EFCRR----LKEGTRM-----R----APDYT 321 (359)
T ss_dssp CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH---HHHHH----HHHTCCC-----C----CCTTC
T ss_pred CceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH---HHHHH----HHcCCCC-----C----CCCCC
Confidence 999999999999999999999999999999998 999997654221 11111 1111110 0 11112
Q ss_pred HHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHH
Q 002409 845 MWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 879 (927)
Q Consensus 845 ~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~ 879 (927)
..++.+++.+|++.+|++|||+.||+++|++++..
T Consensus 322 ~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 322 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 24688999999999999999999999999998754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=355.66 Aligned_cols=245 Identities=23% Similarity=0.321 Sum_probs=201.7
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
.+.+.||+|+||.||+++.+ +++.||+|+++... ......+.+|+.++++++||||+++++++...+..++||||+
T Consensus 8 ~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~ 87 (337)
T 1o6l_A 8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYA 87 (337)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCC
Confidence 45688999999999999886 68999999997542 233456889999999999999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 88 ~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~- 159 (337)
T 1o6l_A 88 NGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG- 159 (337)
T ss_dssp TTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-
T ss_pred CCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCC-
Confidence 9999999884 345689999999999999999999998 99999999999999999999999999998533222
Q ss_pred ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCccc
Q 002409 758 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 837 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 837 (927)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.+.+. .+.+ .
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~i~----~~~~------~-- 223 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----RLFELIL----MEEI------R-- 223 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHH----HCCC------C--
T ss_pred CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH----HHHHHHH----cCCC------C--
Confidence 2234456999999999999999999999999999999999999999754422 1111111 1111 0
Q ss_pred CccCHHHHHHHHHHHhhhcCCCCCCCC-----cHHHHHHH
Q 002409 838 DEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 872 (927)
Q Consensus 838 ~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----sm~eV~~~ 872 (927)
++......+.+++.+|++.+|++|| ++.||++|
T Consensus 224 --~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 224 --FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 1112234688999999999999999 89999887
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=359.46 Aligned_cols=249 Identities=24% Similarity=0.356 Sum_probs=202.7
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCch------hhHhHHHHHHHHhhccCCCccceecceeecCeEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 673 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~------~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV 673 (927)
|.+.+.||+|+||.||+++.. +|+.||+|++...... ....+.+|+.+|++++||||+++++++.+.+..++|
T Consensus 14 y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 93 (361)
T 2yab_A 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLI 93 (361)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEE
Confidence 456789999999999999886 6899999999765322 246789999999999999999999999999999999
Q ss_pred EEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCC----cEEEEeecCc
Q 002409 674 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM----RAKVSDFGLS 749 (927)
Q Consensus 674 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~----~vkL~DFGla 749 (927)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||++
T Consensus 94 ~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 94 LELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 999999999999843 45689999999999999999999998 999999999999998877 7999999999
Q ss_pred ccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcc
Q 002409 750 KFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 829 (927)
Q Consensus 750 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 829 (927)
+...... ......||+.|+|||++....++.++|||||||++|||++|+.||......+ +...+ ..+...
T Consensus 167 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~----~~~~i----~~~~~~ 236 (361)
T 2yab_A 167 HEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE----TLANI----TAVSYD 236 (361)
T ss_dssp EECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH----HHHHH----HTTCCC
T ss_pred eEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHH----HhcCCC
Confidence 8654432 2234569999999999998899999999999999999999999997654221 11111 111100
Q ss_pred cccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 830 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 830 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
+++.... .....+.+++.+|+..||++|||+.|+++|
T Consensus 237 --~~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 237 --FDEEFFS----QTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp --CCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --CCchhcc----CCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1111111 122457899999999999999999999875
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=352.75 Aligned_cols=251 Identities=24% Similarity=0.325 Sum_probs=203.6
Q ss_pred HHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCch------hhHhHHHHHHHHhhccCCCccceecceeecCeEE
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 671 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~------~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~ 671 (927)
..|.+.+.||+|+||.||+++.. +++.||+|++...... ....+.+|+.++++++||||+++++++...+..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45667889999999999999886 6889999999754322 3567899999999999999999999999999999
Q ss_pred EEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCC----cEEEEeec
Q 002409 672 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM----RAKVSDFG 747 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~----~vkL~DFG 747 (927)
+||||+++|+|.+++.. ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++ .+||+|||
T Consensus 91 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 91 LILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 99999999999999843 45689999999999999999999998 999999999999999887 89999999
Q ss_pred CcccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCC
Q 002409 748 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 827 (927)
Q Consensus 748 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 827 (927)
+++...... ......||+.|+|||++....++.++|||||||++|||++|+.||......+ ....... ..
T Consensus 164 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~~~~----~~ 233 (326)
T 2y0a_A 164 LAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE----TLANVSA----VN 233 (326)
T ss_dssp TCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH----HHHHHHH----TC
T ss_pred CCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH----HHHHHHh----cC
Confidence 998654322 2233569999999999998999999999999999999999999997544211 1111110 00
Q ss_pred cccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 828 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 828 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
. .............+.+++.+|++.+|++|||+.|++++
T Consensus 234 ~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 234 Y------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp C------CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred C------CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 00000001122467899999999999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=348.82 Aligned_cols=257 Identities=22% Similarity=0.363 Sum_probs=197.6
Q ss_pred HHHhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhh--ccCCCccceecceee----cCeEEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSR--IHHRNLVQFLGYCQE----EGRSVLVY 674 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~--l~HpnIv~l~g~~~~----~~~~~lV~ 674 (927)
+.+.+.||+|+||.||+|++ +++.||||++... ....+..|.+++.. ++||||+++++++.. ....++||
T Consensus 10 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~ 85 (301)
T 3q4u_A 10 ITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLIT 85 (301)
T ss_dssp CEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEeh
Confidence 45678999999999999998 4899999998643 23455666666666 799999999998754 34579999
Q ss_pred EeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHh--------hCCCCceecCCCCCCCeEECCCCcEEEEee
Q 002409 675 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH--------TGCVPAIIHRDLKSSNILLDKHMRAKVSDF 746 (927)
Q Consensus 675 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH--------~~~~~~ivHrDLkp~NILl~~~~~vkL~DF 746 (927)
||+++|+|.+++. ...+++..++.++.|++.||+||| +. +|+||||||+|||++.++.+||+||
T Consensus 86 e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 86 HYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp CCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCC
T ss_pred hhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeC
Confidence 9999999999984 346899999999999999999999 66 9999999999999999999999999
Q ss_pred cCcccccCCCCce---eeeeccCCCccCccccccC------cCCCccceeeHHHHHHHHHhC----------CCcccccc
Q 002409 747 GLSKFAVDGASHV---SSIVRGTVGYLDPEYYISQ------QLTDKSDVYSFGVILLELISG----------QEAISNEK 807 (927)
Q Consensus 747 Gla~~~~~~~~~~---~~~~~gt~~Y~aPE~~~~~------~~s~~sDVwSlGvvL~elltG----------~~p~~~~~ 807 (927)
|+++......... .....||+.|+|||++.+. .++.++|||||||++|||++| +.||....
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 9997655443322 2234699999999999876 556789999999999999999 77775433
Q ss_pred cccccchhhHHHHhhhccCCcccccCCccc-CccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHH
Q 002409 808 FGANCRNIVQWAKLHIESGDIQGIIDPSLL-DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 876 (927)
Q Consensus 808 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~ 876 (927)
..... ...........+. .+.+. ..........+.+++.+|++.+|++|||+.||++.|+++
T Consensus 238 ~~~~~--~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 238 PNDPS--FEDMRKVVCVDQQ-----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CSSCC--HHHHHHHHTTSCC-----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcc--hhhhhHHHhccCC-----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 21111 1111111111111 11111 112334567899999999999999999999999999975
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=350.62 Aligned_cols=264 Identities=21% Similarity=0.256 Sum_probs=199.7
Q ss_pred HHHhccccccCceEEEEEEECCCcEEEEEEeecCCc--hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 601 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
|.+.+.||+|+||+||+|+..+++.||+|++..... .....+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 23 y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 102 (311)
T 3niz_A 23 YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME 102 (311)
T ss_dssp EEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS
T ss_pred hHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC
Confidence 445689999999999999998899999999875432 224678899999999999999999999999999999999998
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
+ +|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 103 ~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~- 174 (311)
T 3niz_A 103 K-DLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR- 174 (311)
T ss_dssp E-EHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred C-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCcc-
Confidence 5 787777532 34589999999999999999999998 999999999999999999999999999986543322
Q ss_pred eeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccC-----------
Q 002409 759 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG----------- 826 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~----------- 826 (927)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+...........
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 254 (311)
T 3niz_A 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK 254 (311)
T ss_dssp ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHH
T ss_pred cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhh
Confidence 2233458999999999876 5689999999999999999999999976553332222222111100000
Q ss_pred -CcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 827 -DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 827 -~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
......+.............++.+++.+|++.||++|||+.|++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0000000000000111122467899999999999999999999875
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=365.83 Aligned_cols=262 Identities=25% Similarity=0.427 Sum_probs=211.3
Q ss_pred HHHHHhccccccCceEEEEEEEC--------CCcEEEEEEeecCCc-hhhHhHHHHHHHHhhc-cCCCccceecceeecC
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEG 668 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~--------~g~~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~ 668 (927)
..+.+.+.||+|+||.||+|+.. .++.||||+++.... .....+.+|+++++++ +||||+++++++...+
T Consensus 69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 148 (382)
T 3tt0_A 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 148 (382)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence 34556789999999999999863 235799999976533 3346789999999999 9999999999999999
Q ss_pred eEEEEEEeccCCchhhhcccccc------------cccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEEC
Q 002409 669 RSVLVYEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD 736 (927)
Q Consensus 669 ~~~lV~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~ 736 (927)
..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+|||++
T Consensus 149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~ 225 (382)
T 3tt0_A 149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 225 (382)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEEc
Confidence 99999999999999999965421 134689999999999999999999998 999999999999999
Q ss_pred CCCcEEEEeecCcccccCCCC-ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccch
Q 002409 737 KHMRAKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRN 814 (927)
Q Consensus 737 ~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~ 814 (927)
.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .
T Consensus 226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~----~ 301 (382)
T 3tt0_A 226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE----E 301 (382)
T ss_dssp TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----H
T ss_pred CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----H
Confidence 999999999999986543322 22233457889999999999999999999999999999999 99999754421 2
Q ss_pred hhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHHH
Q 002409 815 IVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 880 (927)
Q Consensus 815 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~~ 880 (927)
+.+.+.. +... ..+.....++.+++.+|++.+|++||++.||+++|++++...
T Consensus 302 ~~~~~~~----~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 302 LFKLLKE----GHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp HHHHHHT----TCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred HHHHHHc----CCCC---------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 2222211 1110 111122346889999999999999999999999999987643
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=358.39 Aligned_cols=256 Identities=21% Similarity=0.297 Sum_probs=204.7
Q ss_pred HHHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC-----chhhHhHHHHHHHHhhccCCCccceecceeecCeEE
Q 002409 598 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-----YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 671 (927)
Q Consensus 598 ~~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~-----~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~ 671 (927)
...|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 446677899999999999999876 68999999986431 123567899999999999999999999999999999
Q ss_pred EEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCc---EEEEeecC
Q 002409 672 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR---AKVSDFGL 748 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~---vkL~DFGl 748 (927)
+||||+++|+|.+++.........+++..+..++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 99999999999988865433344689999999999999999999998 9999999999999987654 99999999
Q ss_pred cccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCc
Q 002409 749 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 828 (927)
Q Consensus 749 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 828 (927)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+...+ ..+..
T Consensus 180 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~~~~~i----~~~~~ 249 (351)
T 3c0i_A 180 AIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-----ERLFEGI----IKGKY 249 (351)
T ss_dssp CEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-----HHHHHHH----HHTCC
T ss_pred eeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-----HHHHHHH----HcCCC
Confidence 98654432 22334569999999999999999999999999999999999999997543 1111111 11111
Q ss_pred ccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 829 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 829 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
. .++.... .....+.+++.+|++.||++|||+.|++++
T Consensus 250 ~--~~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 250 K--MNPRQWS----HISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp C--CCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred C--CCccccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 0110011 122468899999999999999999999875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=350.02 Aligned_cols=257 Identities=21% Similarity=0.334 Sum_probs=196.0
Q ss_pred HHHHhccccccCceEEEEEEECC----CcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 674 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~~----g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~ 674 (927)
.+.+.+.||+|+||.||+|++.. +..||+|++.... ....+.+.+|+.++++++||||+++++++. .+..++||
T Consensus 16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~ 94 (281)
T 1mp8_A 16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM 94 (281)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred HeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEE
Confidence 45567899999999999998753 4569999987543 334567899999999999999999999985 45688999
Q ss_pred EeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccC
Q 002409 675 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 754 (927)
Q Consensus 675 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 754 (927)
||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 95 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 95 ELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp ECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred ecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCc
Confidence 999999999998532 34688999999999999999999998 999999999999999999999999999986654
Q ss_pred CCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccC
Q 002409 755 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 833 (927)
Q Consensus 755 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 833 (927)
..........+|+.|+|||.+....++.++|||||||++|||++ |+.||...... .+...+. .+...
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~----~~~~~i~----~~~~~---- 236 (281)
T 1mp8_A 169 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN----DVIGRIE----NGERL---- 236 (281)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----GHHHHHH----TTCCC----
T ss_pred ccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH----HHHHHHH----cCCCC----
Confidence 33333334457889999999998899999999999999999996 99999765422 2222211 11110
Q ss_pred CcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHHH
Q 002409 834 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 880 (927)
Q Consensus 834 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~~ 880 (927)
..+......+.+++.+|++.+|++||++.|++++|++++..+
T Consensus 237 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 237 -----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 111223346889999999999999999999999999987654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=372.15 Aligned_cols=254 Identities=23% Similarity=0.387 Sum_probs=206.8
Q ss_pred HHHHhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
.+.+.+.||+|+||.||+|++++++.||||+++... ...+.+.+|+++|++++||||+++++++. .+..++||||+++
T Consensus 189 ~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~ 266 (454)
T 1qcf_A 189 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAK 266 (454)
T ss_dssp GEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTT
T ss_pred HeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCC
Confidence 345678999999999999999988999999997654 34678999999999999999999999986 5678999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
|+|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 267 g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 341 (454)
T 1qcf_A 267 GSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 341 (454)
T ss_dssp CBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHT
T ss_pred CcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceec
Confidence 9999999643 234678889999999999999999998 99999999999999999999999999998654322112
Q ss_pred eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCcccC
Q 002409 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 838 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 838 (927)
.....+|..|+|||++....++.++|||||||++|||++ |+.||...... .+.+.+... ..+
T Consensus 342 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~----~~~~~i~~~---~~~---------- 404 (454)
T 1qcf_A 342 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP----EVIRALERG---YRM---------- 404 (454)
T ss_dssp TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----HHHHHHHHT---CCC----------
T ss_pred cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH----HHHHHHHcC---CCC----------
Confidence 223346789999999998999999999999999999999 99999764422 222221111 010
Q ss_pred ccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHH
Q 002409 839 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 877 (927)
Q Consensus 839 ~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~ 877 (927)
..+......+.+++.+|++.+|++|||+.+|++.|+.+.
T Consensus 405 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 405 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 011223356889999999999999999999999999764
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=363.80 Aligned_cols=261 Identities=26% Similarity=0.393 Sum_probs=208.4
Q ss_pred HHHHhccccccCceEEEEEEEC------CCcEEEEEEeecC-CchhhHhHHHHHHHHhhccCCCccceecceeecCeEEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 672 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~------~g~~VAVK~l~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~l 672 (927)
.+.+.+.||+|+||.||+|++. +++.||||+++.. .......+.+|+.++++++||||+++++++......++
T Consensus 72 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 151 (367)
T 3l9p_A 72 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFI 151 (367)
T ss_dssp GEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEE
Confidence 3456789999999999999853 4668999999754 33445678899999999999999999999999999999
Q ss_pred EEEeccCCchhhhccccc---ccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCC---cEEEEee
Q 002409 673 VYEFMHNGTLKEHLYGTL---THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM---RAKVSDF 746 (927)
Q Consensus 673 V~E~~~~gsL~~~L~~~~---~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~---~vkL~DF 746 (927)
||||+++|+|.+++.... .....+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+||+||
T Consensus 152 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~DF 228 (367)
T 3l9p_A 152 LLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDF 228 (367)
T ss_dssp EEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred EEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECCC
Confidence 999999999999996532 2234689999999999999999999998 999999999999999555 5999999
Q ss_pred cCcccccCC-CCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhc
Q 002409 747 GLSKFAVDG-ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIE 824 (927)
Q Consensus 747 Gla~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~ 824 (927)
|+++..... .........||+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+...+..
T Consensus 229 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~----~~~~~i~~--- 301 (367)
T 3l9p_A 229 GMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ----EVLEFVTS--- 301 (367)
T ss_dssp HHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----HHHHHHHT---
T ss_pred ccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHHc---
Confidence 999754222 1122234458999999999999999999999999999999998 99999765421 22222111
Q ss_pred cCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHHH
Q 002409 825 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 880 (927)
Q Consensus 825 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~~ 880 (927)
+.. ...+......+.+++.+|++.+|++||++.||+++|+.+....
T Consensus 302 -~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 302 -GGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp -TCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred -CCC---------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 110 0111122346889999999999999999999999999886544
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=348.32 Aligned_cols=259 Identities=27% Similarity=0.415 Sum_probs=213.6
Q ss_pred HHHHHhccccccCceEEEEEEECC-CcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~~-g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
..+.+.+.||+|+||.||+|++.. ++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 13 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 91 (288)
T 3kfa_A 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 91 (288)
T ss_dssp GGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred cceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcC
Confidence 344567899999999999999874 7889999997543 34577899999999999999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
++++|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 92 ~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 92 TYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp TTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred CCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence 999999998543 245689999999999999999999998 999999999999999999999999999986655444
Q ss_pred ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 758 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
.......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... .+.+......
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~----~~~~~~~~~~------------- 229 (288)
T 3kfa_A 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----QVYELLEKDY------------- 229 (288)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----GHHHHHHTTC-------------
T ss_pred ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHhccC-------------
Confidence 44444567889999999998999999999999999999999 99999765422 2222211110
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 880 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~~ 880 (927)
....+......+.+++.+|++.+|++||++.|+++.|+.++...
T Consensus 230 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 01111222346889999999999999999999999999988654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=358.80 Aligned_cols=265 Identities=25% Similarity=0.363 Sum_probs=208.6
Q ss_pred HHHHhccccccCceEEEEEEE-----CCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceeccee--ecCeEEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKL-----KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ--EEGRSVL 672 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~-----~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~~~l 672 (927)
.+.+.+.||+|+||.||++++ .+++.||||++........+.+.+|++++++++||||+++++++. +....++
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 103 (327)
T 3lxl_A 24 HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRL 103 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEE
T ss_pred hhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEE
Confidence 445678999999999999985 367899999998776666678999999999999999999999886 4567899
Q ss_pred EEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccc
Q 002409 673 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 752 (927)
Q Consensus 673 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 752 (927)
||||+++++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 104 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 104 VMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceec
Confidence 99999999999998532 34689999999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCCc--eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCccccccccc--------ccchhhHHHHhh
Q 002409 753 VDGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGA--------NCRNIVQWAKLH 822 (927)
Q Consensus 753 ~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~--------~~~~l~~~~~~~ 822 (927)
...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ....... ....
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 256 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR-LLEL 256 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHH-HHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHH-HHHH
Confidence 443322 1233457888999999998899999999999999999999999986533110 0000011 1111
Q ss_pred hccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHHH
Q 002409 823 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 880 (927)
Q Consensus 823 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~~ 880 (927)
...+ .....+......+.+++.+|++.+|++|||+.|++++|+.+....
T Consensus 257 ~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 257 LEEG---------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred hhcc---------cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 1111 111122333456889999999999999999999999999986543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=354.03 Aligned_cols=256 Identities=23% Similarity=0.365 Sum_probs=199.6
Q ss_pred HHHhccccccCceEEEEEEEC-CCc----EEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGK----EIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 674 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~----~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~ 674 (927)
+.+.+.||+|+||.||+|++. +++ +||+|.++... ....+.+.+|+.++++++||||++++++|.... .++|+
T Consensus 17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~ 95 (327)
T 3poz_A 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIT 95 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEE
T ss_pred cccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEE
Confidence 456789999999999999865 344 35888775432 344578999999999999999999999998765 78999
Q ss_pred EeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccC
Q 002409 675 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 754 (927)
Q Consensus 675 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 754 (927)
||+.+|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 96 e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 96 QLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp ECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 999999999998643 35689999999999999999999998 999999999999999999999999999986544
Q ss_pred CCCc-eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCccccc
Q 002409 755 GASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 832 (927)
Q Consensus 755 ~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 832 (927)
.... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+...... +.
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~~~~~~~~----~~----- 236 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----EISSILEK----GE----- 236 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----GHHHHHHT----TC-----
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH----HHHHHHHc----CC-----
Confidence 3322 2233457889999999999999999999999999999999 99999765422 12221111 11
Q ss_pred CCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHHH
Q 002409 833 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 880 (927)
Q Consensus 833 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~~ 880 (927)
....+......+.+++.+|++.+|++||++.||+++|+.+....
T Consensus 237 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 280 (327)
T 3poz_A 237 ----RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp ----CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred ----CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence 00111223346889999999999999999999999999986543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=379.35 Aligned_cols=255 Identities=27% Similarity=0.418 Sum_probs=209.6
Q ss_pred HHHhccccccCceEEEEEEECC-CcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 601 KMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~~-g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
+.+.+.||+|+||.||+|+++. ++.||||+++.... ..+.|.+|+++|++++||||++++++|...+..++||||+++
T Consensus 222 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~ 300 (495)
T 1opk_A 222 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 300 (495)
T ss_dssp EEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred ceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCC
Confidence 4567899999999999999874 78999999975533 367799999999999999999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
|+|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 301 g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 375 (495)
T 1opk_A 301 GNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 375 (495)
T ss_dssp CBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEEC
T ss_pred CCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCceee
Confidence 9999999643 235588999999999999999999998 99999999999999999999999999998654432222
Q ss_pred eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCcccC
Q 002409 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 838 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 838 (927)
.....++..|+|||++....++.++|||||||++|||++ |+.||...... .+.+.+.. +. ..
T Consensus 376 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~----~~~~~~~~----~~---------~~ 438 (495)
T 1opk_A 376 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----QVYELLEK----DY---------RM 438 (495)
T ss_dssp CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----GHHHHHHT----TC---------CC
T ss_pred cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH----HHHHHHHc----CC---------CC
Confidence 233446789999999999999999999999999999999 99999765422 22222111 10 11
Q ss_pred ccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 839 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 839 ~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
..+......+.+++.+|++.+|++|||+.||++.|+.++.
T Consensus 439 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 439 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 1122233568899999999999999999999999998753
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=351.35 Aligned_cols=249 Identities=18% Similarity=0.295 Sum_probs=202.5
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
|.+.+.||+|+||.||+++.. +++.+|+|++.... .....+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 7 y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g 85 (321)
T 1tki_A 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG 85 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred eEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCC
Confidence 445688999999999999876 57889999987443 3456788999999999999999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECC--CCcEEEEeecCcccccCCCC
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK--HMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~--~~~vkL~DFGla~~~~~~~~ 757 (927)
|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+++......
T Consensus 86 ~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~- 158 (321)
T 1tki_A 86 LDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp CBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-
Confidence 9999998532 34689999999999999999999998 9999999999999997 7899999999998654432
Q ss_pred ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCccc
Q 002409 758 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 837 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 837 (927)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+...+.. +... .+....
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i~~----~~~~--~~~~~~ 227 (321)
T 1tki_A 159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ----QIIENIMN----AEYT--FDEEAF 227 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHHH----TCCC--CCHHHH
T ss_pred -ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH----HHHHHHHc----CCCC--CChhhh
Confidence 234456999999999999888999999999999999999999999765422 11111111 1100 000001
Q ss_pred CccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 838 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 838 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
. ....++.+++.+|++.||++|||+.|++++
T Consensus 228 ~----~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 228 K----EISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp T----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred c----cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1 123468899999999999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=353.84 Aligned_cols=263 Identities=25% Similarity=0.378 Sum_probs=206.6
Q ss_pred HHHHHhccccccCceEEEEEEE------CCCcEEEEEEeecCC-chhhHhHHHHHHHHhhc-cCCCccceecceeecCeE
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRS 670 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~------~~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~ 670 (927)
..+.+.+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|+.+++++ +||||+++++++...+..
T Consensus 45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 124 (344)
T 1rjb_A 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 124 (344)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence 4455678999999999999986 245689999997542 33456789999999999 899999999999999999
Q ss_pred EEEEEeccCCchhhhccccccc-------------------ccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCC
Q 002409 671 VLVYEFMHNGTLKEHLYGTLTH-------------------EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSS 731 (927)
Q Consensus 671 ~lV~E~~~~gsL~~~L~~~~~~-------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~ 731 (927)
++||||+++|+|.+++...... ...+++..++.++.|++.||+|||++ +|+||||||+
T Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~ 201 (344)
T 1rjb_A 125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 201 (344)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChh
Confidence 9999999999999999653211 13478999999999999999999998 9999999999
Q ss_pred CeEECCCCcEEEEeecCcccccCCCC-ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccc
Q 002409 732 NILLDKHMRAKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFG 809 (927)
Q Consensus 732 NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~ 809 (927)
|||++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||++ |+.||......
T Consensus 202 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 281 (344)
T 1rjb_A 202 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 281 (344)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred hEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH
Confidence 99999999999999999986544332 22334557889999999999999999999999999999998 99999765422
Q ss_pred cccchhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHHH
Q 002409 810 ANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 880 (927)
Q Consensus 810 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~~ 880 (927)
. .+..... .+.. ...+......+.+++.+|++.+|++||++.||+++|+.++...
T Consensus 282 ~---~~~~~~~----~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 282 A---NFYKLIQ----NGFK---------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp H---HHHHHHH----TTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred H---HHHHHHh----cCCC---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 1 1111111 1100 0111122346889999999999999999999999999986543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=343.47 Aligned_cols=251 Identities=30% Similarity=0.431 Sum_probs=191.8
Q ss_pred HHHhccccccCceEEEEEEECCCcEEEEEEeecCCc----hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY----QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
+.+.+.||+|+||.||+|++. ++.||||+++.... ...+.+.+|++++++++||||+++++++...+..++||||
T Consensus 9 ~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (271)
T 3dtc_A 9 LTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEF 87 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEEC
T ss_pred eeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEc
Confidence 345688999999999999986 89999999875432 2246788999999999999999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECC--------CCcEEEEeecC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK--------HMRAKVSDFGL 748 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~--------~~~vkL~DFGl 748 (927)
+++++|.+++. ...+++..++.++.|++.||+|||++...+|+||||||+|||++. ++.+||+|||+
T Consensus 88 ~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 88 ARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp CTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred CCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 99999999884 346899999999999999999999982222999999999999986 67899999999
Q ss_pred cccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCc
Q 002409 749 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 828 (927)
Q Consensus 749 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 828 (927)
++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ....... ....
T Consensus 163 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~----~~~~ 231 (271)
T 3dtc_A 163 AREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL----AVAYGVA----MNKL 231 (271)
T ss_dssp ----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH----HHHHHHH----TSCC
T ss_pred cccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHhhh----cCCC
Confidence 97544322 22346899999999999989999999999999999999999999754311 1111110 0111
Q ss_pred ccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHH
Q 002409 829 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 876 (927)
Q Consensus 829 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~ 876 (927)
....+......+.+++.+|++.+|++|||+.|++++|+++
T Consensus 232 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 232 --------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred --------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0111122334688999999999999999999999999853
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=351.16 Aligned_cols=270 Identities=23% Similarity=0.361 Sum_probs=207.4
Q ss_pred HHhccccccCceEEEEEEEC-----CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeec--CeEEEE
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-----DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLV 673 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-----~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--~~~~lV 673 (927)
.+.+.||+|+||.||++++. +++.||||+++... ......+.+|++++++++||||+++++++.+. ...++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 56789999999999998753 57889999998653 33456789999999999999999999999874 678999
Q ss_pred EEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccccc
Q 002409 674 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 753 (927)
Q Consensus 674 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 753 (927)
|||+++|+|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 114 ~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp ECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 999999999999843 3488999999999999999999998 99999999999999999999999999998665
Q ss_pred CCCCc--eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccc
Q 002409 754 DGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 831 (927)
Q Consensus 754 ~~~~~--~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 831 (927)
..... ......||..|+|||.+.+..++.++|||||||++|||++|+.||........ ....+.........+.+.
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL--ELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH--HHHCSCCHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh--hhhcccccchhHHHHHHH
Confidence 43322 22334578889999999998999999999999999999999999875431100 000000000000000111
Q ss_pred cCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHHHH
Q 002409 832 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIER 881 (927)
Q Consensus 832 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~~~ 881 (927)
++.......+......+.+++.+|++.+|++|||+.|+++.|+++....+
T Consensus 264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 11111112222334578999999999999999999999999999876543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=345.05 Aligned_cols=263 Identities=21% Similarity=0.292 Sum_probs=197.5
Q ss_pred HHhccccccCceEEEEEEECCCcEEEEEEeecCCc--hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 602 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
.+.+.||+|+||.||+|+..+++.||+|++..... .....+.+|++++++++||||+++++++...+..++||||+++
T Consensus 5 ~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (288)
T 1ob3_A 5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ 84 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE
T ss_pred hhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC
Confidence 45678999999999999998899999999875432 2246788999999999999999999999999999999999975
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 85 -~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 156 (288)
T 1ob3_A 85 -DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RK 156 (288)
T ss_dssp -EHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred -CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc-cc
Confidence 888887532 35688999999999999999999998 99999999999999999999999999997654322 12
Q ss_pred eeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccC--Cc--ccccCC
Q 002409 760 SSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG--DI--QGIIDP 834 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~--~~--~~~~d~ 834 (927)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+.+......... .. ....++
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccc
Confidence 233458999999999976 4589999999999999999999999976542222112211110000000 00 000111
Q ss_pred ccc-------CccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 835 SLL-------DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 835 ~l~-------~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
... ..+.......+.+++.+|++.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 110 11111233467899999999999999999999875
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=358.89 Aligned_cols=246 Identities=25% Similarity=0.352 Sum_probs=197.7
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhc-cCCCccceecceeecCeEEEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE 675 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~lV~E 675 (927)
+.+.+.||+|+||.||+|+.+ +++.||||+++... ......+..|..+++++ +||||+++++++.+.+..++|||
T Consensus 25 y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E 104 (353)
T 3txo_A 25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVME 104 (353)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEe
Confidence 456789999999999999876 58899999997542 22345678899999988 79999999999999999999999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCC
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 755 (927)
|+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 105 ~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 105 FVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp CCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 9999999998843 45689999999999999999999998 9999999999999999999999999999753322
Q ss_pred CCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCc
Q 002409 756 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 835 (927)
Q Consensus 756 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 835 (927)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.. +..
T Consensus 178 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--------~~~------- 241 (353)
T 3txo_A 178 -GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN--------DEV------- 241 (353)
T ss_dssp ---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------CCC-------
T ss_pred -CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHc--------CCC-------
Confidence 2233445799999999999999999999999999999999999999976542222211111 111
Q ss_pred ccCccCHHHHHHHHHHHhhhcCCCCCCCCcH------HHHHHH
Q 002409 836 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSI------SEVLKD 872 (927)
Q Consensus 836 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm------~eV~~~ 872 (927)
.++......+.+++.+|++.+|++||++ .|+++|
T Consensus 242 ---~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 242 ---VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred ---CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 1111122457899999999999999998 778775
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=350.98 Aligned_cols=259 Identities=18% Similarity=0.204 Sum_probs=206.3
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhc-cCCCccceecceeecCeEEEEEEecc
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
+.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+|+++++++ +||||+++++++...+..++||||+
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~- 87 (330)
T 2izr_A 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL- 87 (330)
T ss_dssp EEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-
T ss_pred eEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-
Confidence 345688999999999999874 68899999987543 235688999999999 9999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCc-----EEEEeecCccccc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR-----AKVSDFGLSKFAV 753 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~-----vkL~DFGla~~~~ 753 (927)
+++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+++...
T Consensus 88 ~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 88 GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99999998542 45789999999999999999999998 9999999999999999887 9999999998654
Q ss_pred CCCCc------eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCC
Q 002409 754 DGASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 827 (927)
Q Consensus 754 ~~~~~------~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 827 (927)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .....+........
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~-~~~~~i~~~~~~~~ 240 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLK-ERYQKIGDTKRATP 240 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHH-HHHHHHHHHHHHSC
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHH-HHHHHHHhhhccCC
Confidence 43221 123456999999999999999999999999999999999999999865422211 11111111100000
Q ss_pred cccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHH
Q 002409 828 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 879 (927)
Q Consensus 828 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~ 879 (927)
. ........ ++.+++..|++.+|++||++.+|.+.|+++...
T Consensus 241 ~---------~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~ 282 (330)
T 2izr_A 241 I---------EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR 282 (330)
T ss_dssp H---------HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred H---------HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence 0 00001112 789999999999999999999999999987654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=345.55 Aligned_cols=247 Identities=25% Similarity=0.341 Sum_probs=193.1
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCch--------------------------hhHhHHHHHHHHhhcc
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--------------------------GKREFTNEVTLLSRIH 653 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~--------------------------~~~~~~~Ei~iL~~l~ 653 (927)
|.+.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|++++++++
T Consensus 15 y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 94 (298)
T 2zv2_A 15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLD 94 (298)
T ss_dssp EEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCC
T ss_pred eEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCC
Confidence 446789999999999999876 6889999998754211 1356889999999999
Q ss_pred CCCccceecceee--cCeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCC
Q 002409 654 HRNLVQFLGYCQE--EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSS 731 (927)
Q Consensus 654 HpnIv~l~g~~~~--~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~ 731 (927)
||||+++++++.+ .+..++||||+++++|.+++. ...+++..+..++.|++.||+|||++ +|+||||||+
T Consensus 95 h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~ 166 (298)
T 2zv2_A 95 HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPS 166 (298)
T ss_dssp CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGG
T ss_pred CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHH
Confidence 9999999999986 568899999999999988653 34689999999999999999999998 9999999999
Q ss_pred CeEECCCCcEEEEeecCcccccCCCCceeeeeccCCCccCccccccCc---CCCccceeeHHHHHHHHHhCCCccccccc
Q 002409 732 NILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ---LTDKSDVYSFGVILLELISGQEAISNEKF 808 (927)
Q Consensus 732 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~s~~sDVwSlGvvL~elltG~~p~~~~~~ 808 (927)
|||++.++.+||+|||+++....... ......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||.....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 99999999999999999986544322 233456999999999997654 47789999999999999999999975431
Q ss_pred ccccchhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 809 GANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 809 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
. .+... +....... .... .....+.+++.+|++.||++||++.|++++
T Consensus 246 ~----~~~~~----~~~~~~~~----~~~~----~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 246 M----CLHSK----IKSQALEF----PDQP----DIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp H----HHHHH----HHHCCCCC----CSSS----CCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred H----HHHHH----HhcccCCC----CCcc----ccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 1 11111 11111100 0011 122468899999999999999999999865
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=350.86 Aligned_cols=261 Identities=24% Similarity=0.377 Sum_probs=194.9
Q ss_pred HHHHHhccccccCceEEEEEEECCCc----EEEEEEeecC--CchhhHhHHHHHHHHhhccCCCccceecceeecCeE--
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLKDGK----EIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS-- 670 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~~g~----~VAVK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~-- 670 (927)
..+.+.+.||+|+||.||+|++.... .||||+++.. .....+.+.+|++++++++||||+++++++......
T Consensus 23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (323)
T 3qup_A 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR 102 (323)
T ss_dssp --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence 34566789999999999999876432 7999998754 334467799999999999999999999999877655
Q ss_pred ----EEEEEeccCCchhhhcccccc--cccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEE
Q 002409 671 ----VLVYEFMHNGTLKEHLYGTLT--HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 744 (927)
Q Consensus 671 ----~lV~E~~~~gsL~~~L~~~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~ 744 (927)
++||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~ 179 (323)
T 3qup_A 103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVA 179 (323)
T ss_dssp --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEEC
T ss_pred CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEe
Confidence 999999999999999854321 122589999999999999999999998 99999999999999999999999
Q ss_pred eecCcccccCCCCc-eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhh
Q 002409 745 DFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLH 822 (927)
Q Consensus 745 DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~ 822 (927)
|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+ +......
T Consensus 180 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----~~~~~~~- 254 (323)
T 3qup_A 180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE----IYNYLIG- 254 (323)
T ss_dssp CCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHHHHHT-
T ss_pred eccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH----HHHHHhc-
Confidence 99999865433221 2223447889999999999999999999999999999999 999997654221 1111111
Q ss_pred hccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHH
Q 002409 823 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 879 (927)
Q Consensus 823 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~ 879 (927)
+.. ...+......+.+++.+|++.+|++|||+.|+++.|++++..
T Consensus 255 ---~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 255 ---GNR---------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp ---TCC---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ---CCC---------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 110 011122334688999999999999999999999999998763
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=350.00 Aligned_cols=260 Identities=25% Similarity=0.385 Sum_probs=209.3
Q ss_pred HHHHhccccccCceEEEEEEE------CCCcEEEEEEeecCCc-hhhHhHHHHHHHHhhc-cCCCccceecceeecCeEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSV 671 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~------~~g~~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~ 671 (927)
.+.+.+.||+|+||.||+|++ .+++.||||+++.... ...+.+.+|+++++++ +||||+++++++...+..+
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 103 (313)
T 1t46_A 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL 103 (313)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcE
Confidence 445678999999999999985 2467899999975543 3456789999999999 9999999999999999999
Q ss_pred EEEEeccCCchhhhcccccc--------------cccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECC
Q 002409 672 LVYEFMHNGTLKEHLYGTLT--------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK 737 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~~--------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~ 737 (927)
+||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~ 180 (313)
T 1t46_A 104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTH 180 (313)
T ss_dssp EEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEET
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEcC
Confidence 99999999999999864321 123589999999999999999999998 9999999999999999
Q ss_pred CCcEEEEeecCcccccCCCCc-eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchh
Q 002409 738 HMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNI 815 (927)
Q Consensus 738 ~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l 815 (927)
++.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||++ |+.||........ +
T Consensus 181 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~ 257 (313)
T 1t46_A 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK---F 257 (313)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH---H
T ss_pred CCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH---H
Confidence 999999999999865544322 2233457889999999999999999999999999999999 9999976542211 1
Q ss_pred hHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 816 VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 816 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
......... . ..+......+.+++.+|++.+|++|||+.|++++|++++.
T Consensus 258 ~~~~~~~~~---------~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 258 YKMIKEGFR---------M----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp HHHHHHTCC---------C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhccCCC---------C----CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 111111100 0 0111223468899999999999999999999999999875
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=355.90 Aligned_cols=259 Identities=25% Similarity=0.431 Sum_probs=208.0
Q ss_pred HHHHhccccccCceEEEEEEEC------CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 672 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~------~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~l 672 (927)
.+.+.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++...+..++
T Consensus 48 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 127 (343)
T 1luf_A 48 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL 127 (343)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEE
Confidence 3456788999999999999875 34789999997653 3345679999999999999999999999999999999
Q ss_pred EEEeccCCchhhhccccccc--------------------ccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCC
Q 002409 673 VYEFMHNGTLKEHLYGTLTH--------------------EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSN 732 (927)
Q Consensus 673 V~E~~~~gsL~~~L~~~~~~--------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~N 732 (927)
||||+++|+|.+++...... ...+++..++.++.|++.||.|||++ +|+||||||+|
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~N 204 (343)
T 1luf_A 128 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRN 204 (343)
T ss_dssp EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred EEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcce
Confidence 99999999999998653211 25689999999999999999999998 99999999999
Q ss_pred eEECCCCcEEEEeecCcccccCCCC-ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCccccccccc
Q 002409 733 ILLDKHMRAKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGA 810 (927)
Q Consensus 733 ILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~ 810 (927)
||++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......
T Consensus 205 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~- 283 (343)
T 1luf_A 205 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE- 283 (343)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-
T ss_pred EEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChH-
Confidence 9999999999999999975433221 12233457899999999998899999999999999999999 99999754411
Q ss_pred ccchhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 811 NCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 811 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
.+... +..+.... .+......+.+++.+|++.+|++||++.||+++|+++..
T Consensus 284 ---~~~~~----~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 284 ---EVIYY----VRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp ---HHHHH----HHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ---HHHHH----HhCCCcCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 12221 11222111 111223468899999999999999999999999998864
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=352.60 Aligned_cols=250 Identities=22% Similarity=0.369 Sum_probs=199.1
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc-hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
|.+.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 9 y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 88 (323)
T 3tki_A 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88 (323)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred ceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCC
Confidence 345688999999999999877 788999999865432 334678899999999999999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC-C
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA-S 757 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~ 757 (927)
+|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 89 ~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 89 GGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp TEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred CCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 999999884 345689999999999999999999998 99999999999999999999999999997543322 1
Q ss_pred ceeeeeccCCCccCccccccCcC-CCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 758 HVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
.......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... ......|..... . ..+
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~~~~~~~~---~----~~~-- 230 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS--CQEYSDWKEKKT---Y----LNP-- 230 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT--SHHHHHHHTTCT---T----STT--
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH--HHHHHHHhcccc---c----CCc--
Confidence 22234569999999999987765 77899999999999999999999754411 111222211110 0 000
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.......+.+++.+|++.+|++|||+.|++++
T Consensus 231 ----~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 231 ----WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 01123467899999999999999999999876
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=341.80 Aligned_cols=256 Identities=25% Similarity=0.405 Sum_probs=207.7
Q ss_pred HHHHhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
.+.+.+.||+|+||.||+|+..+++.||||++.... ...+.+.+|++++++++||||+++++++.. +..++||||+++
T Consensus 14 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~ 91 (279)
T 1qpc_A 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN 91 (279)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred hhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCC
Confidence 345678999999999999999888899999987543 335678999999999999999999999864 458999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
++|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 92 ~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 166 (279)
T 1qpc_A 92 GSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (279)
T ss_dssp CBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccccc
Confidence 9999998542 234689999999999999999999998 99999999999999999999999999998665433222
Q ss_pred eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCcccC
Q 002409 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 838 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 838 (927)
.....++..|+|||.+....++.++|||||||++|||++ |+.||...... .+.+... .+.. .
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----~~~~~~~----~~~~-----~---- 229 (279)
T 1qpc_A 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP----EVIQNLE----RGYR-----M---- 229 (279)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----HHHHHHH----TTCC-----C----
T ss_pred ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH----HHHHHHh----cccC-----C----
Confidence 333457889999999998889999999999999999999 99999754421 1222111 1100 0
Q ss_pred ccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHH
Q 002409 839 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 879 (927)
Q Consensus 839 ~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~ 879 (927)
..+......+.+++.+|++.+|++|||+.|+++.|+++...
T Consensus 230 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 01112234688999999999999999999999999998754
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=341.74 Aligned_cols=254 Identities=28% Similarity=0.446 Sum_probs=207.4
Q ss_pred HHHhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCC
Q 002409 601 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 680 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 680 (927)
+.+.+.||+|+||.||+|+..+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 88 (267)
T 3t9t_A 10 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHG 88 (267)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTC
T ss_pred eeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCC
Confidence 345688999999999999998889999999976543 3467899999999999999999999999999999999999999
Q ss_pred chhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCcee
Q 002409 681 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 760 (927)
Q Consensus 681 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 760 (927)
+|.+++... ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++..........
T Consensus 89 ~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (267)
T 3t9t_A 89 CLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 162 (267)
T ss_dssp BHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred cHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence 999998542 34688999999999999999999998 999999999999999999999999999976533221222
Q ss_pred eeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCcccCc
Q 002409 761 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 839 (927)
Q Consensus 761 ~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 839 (927)
....++..|+|||.+....++.++||||||+++|||++ |+.||...... .+..... .+.. . .
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~~i~----~~~~-----~----~ 225 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS----EVVEDIS----TGFR-----L----Y 225 (267)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHHHH----TTCC-----C----C
T ss_pred ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH----HHHHHHh----cCCc-----C----C
Confidence 23447788999999998899999999999999999999 89999764421 1222111 1100 0 0
Q ss_pred cCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 840 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 840 ~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
.+......+.+++.+|++.+|++||++.|++++|+++..
T Consensus 226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 226 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 011123468899999999999999999999999998864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=363.51 Aligned_cols=252 Identities=23% Similarity=0.320 Sum_probs=202.3
Q ss_pred HHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc--hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEE
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 675 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E 675 (927)
..|.+.+.||+|+||.||++... +++.+|+|++..... .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 45667889999999999999875 688999999975532 334568899999999999999999999999999999999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEEC---CCCcEEEEeecCcccc
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFGLSKFA 752 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~---~~~~vkL~DFGla~~~ 752 (927)
|+++|+|.+.+.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++ .++.+||+|||+++..
T Consensus 91 ~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 91 LVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp CCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred eCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 9999999998853 45689999999999999999999998 999999999999998 4678999999999765
Q ss_pred cCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCccccc
Q 002409 753 VDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 832 (927)
Q Consensus 753 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 832 (927)
..... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .+.+.+. .+... .
T Consensus 164 ~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~----~~~~~i~----~~~~~--~ 232 (444)
T 3soa_A 164 EGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH----RLYQQIK----AGAYD--F 232 (444)
T ss_dssp CTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHH----HTCCC--C
T ss_pred cCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH----HHHHHHH----hCCCC--C
Confidence 44322 223456999999999999989999999999999999999999999765421 1222111 11110 0
Q ss_pred CCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 833 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 833 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
...... .....+.+++.+|++.||++|||+.|++++
T Consensus 233 ~~~~~~----~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 233 PSPEWD----TVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp CTTTTT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred Cccccc----cCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000011 123468899999999999999999999986
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=354.54 Aligned_cols=252 Identities=24% Similarity=0.346 Sum_probs=203.4
Q ss_pred HHHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEE
Q 002409 598 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 674 (927)
Q Consensus 598 ~~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~ 674 (927)
...|.+.+.||+|+||.||+|..+ +++.||+|++.... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 345667889999999999999876 68899999997543 233467889999999999999999999999999999999
Q ss_pred EeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCC---CcEEEEeecCccc
Q 002409 675 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH---MRAKVSDFGLSKF 751 (927)
Q Consensus 675 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~---~~vkL~DFGla~~ 751 (927)
||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||+++.
T Consensus 108 e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 108 DLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp CCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 99999999998843 45689999999999999999999998 99999999999999865 4599999999986
Q ss_pred ccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccc
Q 002409 752 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 831 (927)
Q Consensus 752 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 831 (927)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+...+. .+...
T Consensus 181 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~----~~~~~i~----~~~~~-- 248 (362)
T 2bdw_A 181 VNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH----RLYAQIK----AGAYD-- 248 (362)
T ss_dssp CTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHH----HTCCC--
T ss_pred ecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHH----hCCCC--
Confidence 54332 223456999999999999989999999999999999999999999764421 1222111 11110
Q ss_pred cCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 832 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 832 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
....... .....+.+++.+|++.||++||++.|++++
T Consensus 249 ~~~~~~~----~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 249 YPSPEWD----TVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CCTTGGG----GSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCccccc----CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000011 123468899999999999999999999876
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=364.38 Aligned_cols=249 Identities=28% Similarity=0.428 Sum_probs=203.4
Q ss_pred HHHhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecC-eEEEEEEeccC
Q 002409 601 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG-RSVLVYEFMHN 679 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~~~lV~E~~~~ 679 (927)
+.+.+.||+|+||.||+|++. ++.||||+++... ..+.+.+|+++|++++||||+++++++.... ..++||||+++
T Consensus 195 ~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~ 271 (450)
T 1k9a_A 195 LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 271 (450)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTT
T ss_pred eEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCC
Confidence 345688999999999999987 7899999997543 4567999999999999999999999987665 78999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
|+|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 272 g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---- 342 (450)
T 1k9a_A 272 GSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 342 (450)
T ss_dssp CBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred CcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc----
Confidence 9999999643 223478899999999999999999998 9999999999999999999999999999854321
Q ss_pred eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCcccC
Q 002409 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 838 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 838 (927)
.....++..|+|||.+....++.++|||||||++|||++ |+.||...... .+...+ ..+.. .
T Consensus 343 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~----~~~~~i----~~~~~---------~ 405 (450)
T 1k9a_A 343 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----DVVPRV----EKGYK---------M 405 (450)
T ss_dssp ----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT----THHHHH----HTTCC---------C
T ss_pred ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHH----HcCCC---------C
Confidence 122357889999999999999999999999999999998 99999765422 122211 11110 1
Q ss_pred ccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 839 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 839 ~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
..+......+.+++.+|++.+|++|||+.||++.|+.+..
T Consensus 406 ~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 406 DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 1122234578899999999999999999999999998764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=354.69 Aligned_cols=247 Identities=25% Similarity=0.372 Sum_probs=197.2
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCCch
Q 002409 604 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 682 (927)
Q Consensus 604 ~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 682 (927)
.+.||+|+||.||+|+.. +|+.||+|+++.......+.+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 457999999999999875 6899999999876656677899999999999999999999999999999999999999999
Q ss_pred hhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEE--CCCCcEEEEeecCcccccCCCCcee
Q 002409 683 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL--DKHMRAKVSDFGLSKFAVDGASHVS 760 (927)
Q Consensus 683 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl--~~~~~vkL~DFGla~~~~~~~~~~~ 760 (927)
.+++.. ....+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++...... ..
T Consensus 174 ~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~ 245 (373)
T 2x4f_A 174 FDRIID---ESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KL 245 (373)
T ss_dssp HHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BC
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--cc
Confidence 998853 235689999999999999999999998 99999999999999 567899999999998654432 22
Q ss_pred eeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCcc
Q 002409 761 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 840 (927)
Q Consensus 761 ~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 840 (927)
....||+.|+|||++....++.++|||||||++|||++|+.||......+....+.. ... . +.......
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~---~~~---~----~~~~~~~~- 314 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILA---CRW---D----LEDEEFQD- 314 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH---TCC---C----SCSGGGTT-
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---ccC---C----CChhhhcc-
Confidence 334599999999999988999999999999999999999999976542211111111 100 0 00111111
Q ss_pred CHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 841 DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 841 ~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
....+.+++.+|++.+|++||++.|++++
T Consensus 315 ---~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 315 ---ISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp ---SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---CCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 22468899999999999999999999985
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=351.07 Aligned_cols=264 Identities=25% Similarity=0.381 Sum_probs=204.8
Q ss_pred HHHHHhccccccCceEEEEEEE-----CCCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeec--CeE
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKL-----KDGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRS 670 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~-----~~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--~~~ 670 (927)
..+.+.+.||+|+||.||+|++ .+++.||||++.... ......+.+|++++++++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 3355678999999999999984 368899999997543 23356789999999999999999999999876 668
Q ss_pred EEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcc
Q 002409 671 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 750 (927)
Q Consensus 671 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 750 (927)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 101 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccc
Confidence 9999999999999998532 34589999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCCc--eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCccccccc-------ccccchhhHHHHh
Q 002409 751 FAVDGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF-------GANCRNIVQWAKL 821 (927)
Q Consensus 751 ~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~-------~~~~~~l~~~~~~ 821 (927)
........ ......||..|+|||.+.+..++.++|||||||++|||++|+.|+..... +............
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 65543321 22334588889999999999999999999999999999999998753210 0000000111111
Q ss_pred hhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHH
Q 002409 822 HIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 877 (927)
Q Consensus 822 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~ 877 (927)
....+. ....+......+.+++.+|++.+|++|||+.|+++.|++++
T Consensus 255 ~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 255 TLKEGK---------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHTTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhccC---------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 111111 11112223356889999999999999999999999999875
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=346.20 Aligned_cols=267 Identities=22% Similarity=0.286 Sum_probs=191.6
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc-hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
.+.+.+.||+|+||.||+|+.. +++.||||+++.... .....+.+|++++++++||||+++++++...+..++||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 85 (317)
T 2pmi_A 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFM 85 (317)
T ss_dssp -------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECC
T ss_pred ceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEec
Confidence 4566789999999999999876 688999999975532 23467889999999999999999999999999999999999
Q ss_pred cCCchhhhccccc--ccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCC
Q 002409 678 HNGTLKEHLYGTL--THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 678 ~~gsL~~~L~~~~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 755 (927)
+ |+|.+++.... .....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 86 D-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp C-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred C-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 8 59998885432 1224588999999999999999999998 9999999999999999999999999999865432
Q ss_pred CCceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCccc----
Q 002409 756 ASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG---- 830 (927)
Q Consensus 756 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~---- 830 (927)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+.+...... ......
T Consensus 162 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~~ 239 (317)
T 2pmi_A 162 VN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPN-ESLWPSVTKL 239 (317)
T ss_dssp CC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC-TTTCGGGGGC
T ss_pred cc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC-hhHhhhhhhh
Confidence 22 2233468999999999976 4689999999999999999999999976542222222221110000 000000
Q ss_pred -ccCCcc------------cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 831 -IIDPSL------------LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 831 -~~d~~l------------~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
...+.+ ...........+.+++.+|++.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 000000 000011123468899999999999999999999876
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=352.16 Aligned_cols=256 Identities=23% Similarity=0.386 Sum_probs=200.8
Q ss_pred HHHhccccccCceEEEEEEEC-CCcE----EEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKE----IAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 674 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~----VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~ 674 (927)
+.+.+.||+|+||.||+|++. +++. ||+|++.... ......+.+|+.++++++||||+++++++. .+..++||
T Consensus 15 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~ 93 (325)
T 3kex_A 15 LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVT 93 (325)
T ss_dssp EEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEE
T ss_pred ceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEE
Confidence 345688999999999999875 3443 7888875442 333456788999999999999999999986 45688999
Q ss_pred EeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccC
Q 002409 675 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 754 (927)
Q Consensus 675 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 754 (927)
||+.+|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 94 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 94 QYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp ECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 999999999998543 35688899999999999999999998 999999999999999999999999999986644
Q ss_pred CCCc-eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCccccc
Q 002409 755 GASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 832 (927)
Q Consensus 755 ~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 832 (927)
.... ......||..|+|||.+.+..++.++|||||||++|||++ |+.||...... .+..... .+...
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~~~~----~~~~~--- 236 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA----EVPDLLE----KGERL--- 236 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT----HHHHHHH----TTCBC---
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH----HHHHHHH----cCCCC---
Confidence 3322 2344568889999999999999999999999999999999 99999765422 1222111 11100
Q ss_pred CCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHHH
Q 002409 833 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 880 (927)
Q Consensus 833 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~~ 880 (927)
..+......+.+++.+|++.+|++||++.|++++|+.+....
T Consensus 237 ------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 237 ------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp ------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred ------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 001111224778999999999999999999999999886543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=355.85 Aligned_cols=251 Identities=21% Similarity=0.326 Sum_probs=205.0
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
.|.+.+.||+|+||.||+|... +++.||+|++..........+.+|+++|++++||||+++++++.+....++||||++
T Consensus 52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 131 (387)
T 1kob_A 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131 (387)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCC
Confidence 3556789999999999999886 688999999987655556789999999999999999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECC--CCcEEEEeecCcccccCCC
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK--HMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~--~~~vkL~DFGla~~~~~~~ 756 (927)
+|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+++......
T Consensus 132 gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 132 GGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp CCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 99999988532 34689999999999999999999998 9999999999999974 4789999999998654432
Q ss_pred CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 757 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.. +.. ..++..
T Consensus 206 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~----~~~~~i~~----~~~--~~~~~~ 273 (387)
T 1kob_A 206 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL----ETLQNVKR----CDW--EFDEDA 273 (387)
T ss_dssp --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH----HHHHHHHH----CCC--CCCSST
T ss_pred --ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH----HHHHHHHh----CCC--CCCccc
Confidence 233456999999999999999999999999999999999999999764421 11111111 110 011111
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.. .....+.+++.+|++.||++|||+.|++++
T Consensus 274 ~~----~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 274 FS----SVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp TT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cc----cCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 11 123468899999999999999999999986
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=364.38 Aligned_cols=252 Identities=22% Similarity=0.287 Sum_probs=204.6
Q ss_pred HHhccccccCceEEEEEEECC-CcEEEEEEeecCCc---hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 602 MLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~~-g~~VAVK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
.+.++||+|+||+||+|+++. ++.||||++++... .....+.+|..++.+++||||+++++++.+.+..++||||+
T Consensus 77 ~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~ 156 (437)
T 4aw2_A 77 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYY 156 (437)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecC
Confidence 346789999999999999874 78899999975321 22344889999999999999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 157 ~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 230 (437)
T 4aw2_A 157 VGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 230 (437)
T ss_dssp TTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred CCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC
Confidence 999999999542 45689999999999999999999998 999999999999999999999999999986655444
Q ss_pred ceeeeeccCCCccCccccc-----cCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCccccc
Q 002409 758 HVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 832 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~~-----~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 832 (927)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||......+....+..+... -.+..
T Consensus 231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~----~~~p~-- 304 (437)
T 4aw2_A 231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER----FQFPT-- 304 (437)
T ss_dssp EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH----CCCCS--
T ss_pred cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc----ccCCc--
Confidence 4445567999999999997 567899999999999999999999999865533333333332111 01111
Q ss_pred CCcccCccCHHHHHHHHHHHhhhcCCCCCC--CCcHHHHHHH
Q 002409 833 DPSLLDEYDIQSMWKIEEKALMCVLPHGHM--RPSISEVLKD 872 (927)
Q Consensus 833 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~--RPsm~eV~~~ 872 (927)
.... ....+.+++.+|+..+|++ ||++.|+++|
T Consensus 305 ---~~~~----~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 305 ---QVTD----VSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp ---SCCC----SCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred ---cccc----CCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 0011 2235789999999988888 9999999987
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=349.04 Aligned_cols=250 Identities=23% Similarity=0.318 Sum_probs=196.3
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecC---------
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG--------- 668 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--------- 668 (927)
.+.+.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++.+..
T Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~ 86 (332)
T 3qd2_B 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMD 86 (332)
T ss_dssp HEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHH
T ss_pred cCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhh
Confidence 3456789999999999999987 78999999997543 334577999999999999999999999886543
Q ss_pred ------------------------------------------------eEEEEEEeccCCchhhhcccccccccccCHHH
Q 002409 669 ------------------------------------------------RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIK 700 (927)
Q Consensus 669 ------------------------------------------------~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~ 700 (927)
..++||||+++|+|.+++.... ......+..
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~ 165 (332)
T 3qd2_B 87 EIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREHGV 165 (332)
T ss_dssp C--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCHHH
T ss_pred hhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-CccchhhHH
Confidence 3799999999999999996543 334457778
Q ss_pred HHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC-----------ceeeeeccCCCc
Q 002409 701 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS-----------HVSSIVRGTVGY 769 (927)
Q Consensus 701 ~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~-----------~~~~~~~gt~~Y 769 (927)
++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .......||+.|
T Consensus 166 ~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 899999999999999998 999999999999999999999999999986544321 112334699999
Q ss_pred cCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCccCHHHHHHHH
Q 002409 770 LDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIE 849 (927)
Q Consensus 770 ~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 849 (927)
+|||++.+..++.++|||||||++|||++|..|+.... .+... ...+... .........+.
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~------~~~~~----~~~~~~~---------~~~~~~~~~~~ 303 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV------RIITD----VRNLKFP---------LLFTQKYPQEH 303 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH------HHHHH----HHTTCCC---------HHHHHHCHHHH
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH------HHHHH----hhccCCC---------cccccCChhHH
Confidence 99999999999999999999999999999977653221 11111 1111110 11122334678
Q ss_pred HHHhhhcCCCCCCCCcHHHHHHH
Q 002409 850 EKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 850 ~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
+++.+|++.+|++||++.|++++
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCCCCcCCCHHHHhhc
Confidence 99999999999999999999875
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=341.02 Aligned_cols=263 Identities=20% Similarity=0.258 Sum_probs=196.7
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc--hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
.+.+.||+|+||+||+|+.. +++.||||++..... .....+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 5 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 84 (292)
T 3o0g_A 5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD 84 (292)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCC
Confidence 45688999999999999886 588999999975432 234678899999999999999999999999999999999997
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
+ +|.+.+.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 85 ~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 156 (292)
T 3o0g_A 85 Q-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-R 156 (292)
T ss_dssp E-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-S
T ss_pred C-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-c
Confidence 6 55555532 245689999999999999999999998 99999999999999999999999999998654332 2
Q ss_pred eeeeeccCCCccCccccccCc-CCCccceeeHHHHHHHHHhCCCcccccc-cccccchhhHHHHhhhccC--CcccccC-
Q 002409 759 VSSIVRGTVGYLDPEYYISQQ-LTDKSDVYSFGVILLELISGQEAISNEK-FGANCRNIVQWAKLHIESG--DIQGIID- 833 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~~~-~s~~sDVwSlGvvL~elltG~~p~~~~~-~~~~~~~l~~~~~~~~~~~--~~~~~~d- 833 (927)
......||+.|+|||++.+.. ++.++|||||||++|||++|+.|+.... ..+....+.+.......+. ......+
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence 223446899999999998765 7999999999999999999988864322 1111111111100000000 0000000
Q ss_pred --------CcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 834 --------PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 834 --------~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
..............+.+++.+|++.||++|||+.|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000001112233567899999999999999999999875
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=368.77 Aligned_cols=254 Identities=25% Similarity=0.419 Sum_probs=202.1
Q ss_pred HHHHhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
.+.+.+.||+|+||.||+|+++++..||||+++... ...+.+.+|+++|++++||||+++++++.+ +..++||||+++
T Consensus 185 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~ 262 (452)
T 1fmk_A 185 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 262 (452)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred HceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcC
Confidence 345678999999999999999988889999997544 335679999999999999999999999876 678999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
|+|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 263 gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 337 (452)
T 1fmk_A 263 GSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337 (452)
T ss_dssp CBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCceec
Confidence 9999999542 234588999999999999999999998 99999999999999999999999999998654433222
Q ss_pred eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCcccC
Q 002409 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 838 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 838 (927)
.....++..|+|||.+....++.++|||||||++|||++ |+.||...... .+.+.+ ..+.. .
T Consensus 338 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~----~~~~~i----~~~~~---------~ 400 (452)
T 1fmk_A 338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLDQV----ERGYR---------M 400 (452)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----HHHHHH----HTTCC---------C
T ss_pred ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH----HHHHHH----HcCCC---------C
Confidence 333457889999999999999999999999999999999 99999754421 122211 11110 1
Q ss_pred ccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHH
Q 002409 839 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 877 (927)
Q Consensus 839 ~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~ 877 (927)
..+......+.+++.+|++.+|++|||+.+|++.|+.+.
T Consensus 401 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 401 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 111223456889999999999999999999999999875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=341.64 Aligned_cols=259 Identities=23% Similarity=0.367 Sum_probs=203.9
Q ss_pred HHHhccccccCceEEEEEEECC----CcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 675 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~~----g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E 675 (927)
+.+.+.||+|+||.||+|++.. +..||||++.... ....+.+.+|+.++++++||||+++++++.+. ..++|||
T Consensus 14 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e 92 (281)
T 3cc6_A 14 VVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIME 92 (281)
T ss_dssp EEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEEE
T ss_pred eEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEEe
Confidence 4457899999999999998652 2359999987653 33457789999999999999999999998654 5689999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCC
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 755 (927)
|+++++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 93 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 93 LYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166 (281)
T ss_dssp CCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred cCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence 99999999998532 34588999999999999999999998 9999999999999999999999999999865543
Q ss_pred CCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCC
Q 002409 756 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 834 (927)
Q Consensus 756 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 834 (927)
.........+|+.|+|||.+....++.++|||||||++|||++ |+.||...... .+...... +....
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~----~~~~~~~~----~~~~~---- 234 (281)
T 3cc6_A 167 DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK----DVIGVLEK----GDRLP---- 234 (281)
T ss_dssp ------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG----GHHHHHHH----TCCCC----
T ss_pred cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH----HHHHHHhc----CCCCC----
Confidence 3333344457889999999998899999999999999999998 99999754322 12221111 11000
Q ss_pred cccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHHHHHH
Q 002409 835 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIEREA 883 (927)
Q Consensus 835 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~~~~~ 883 (927)
.+......+.+++.+|++.+|++||++.|++++|+++...+.+.
T Consensus 235 -----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~i 278 (281)
T 3cc6_A 235 -----KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDI 278 (281)
T ss_dssp -----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHH
T ss_pred -----CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhhhh
Confidence 01112346889999999999999999999999999998776543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=349.21 Aligned_cols=263 Identities=22% Similarity=0.270 Sum_probs=200.1
Q ss_pred CHHHHHHHHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecC-----CchhhHhHHHHHHHHhhccCCCccceeccee
Q 002409 592 TLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN-----SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ 665 (927)
Q Consensus 592 ~~~ei~~~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~-----~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~ 665 (927)
++.++. ..|.+.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|++++++++||||+++++++.
T Consensus 20 ~~~~~~-~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 98 (345)
T 3hko_A 20 SLLELQ-KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE 98 (345)
T ss_dssp CHHHHH-HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhh-hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc
Confidence 334433 44566889999999999999875 6789999998653 2334567899999999999999999999999
Q ss_pred ecCeEEEEEEeccCCchhhhcccccc------------------------------------cccccCHHHHHHHHHHHH
Q 002409 666 EEGRSVLVYEFMHNGTLKEHLYGTLT------------------------------------HEQRINWIKRLEIAEDAA 709 (927)
Q Consensus 666 ~~~~~~lV~E~~~~gsL~~~L~~~~~------------------------------------~~~~l~~~~~~~i~~qia 709 (927)
+.+..++||||+++|+|.+++..... ....+++..++.++.|++
T Consensus 99 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 178 (345)
T 3hko_A 99 DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178 (345)
T ss_dssp CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence 99999999999999999999852111 122346778889999999
Q ss_pred hHhHHHhhCCCCceecCCCCCCCeEECCCC--cEEEEeecCcccccCCCC---ceeeeeccCCCccCcccccc--CcCCC
Q 002409 710 KGIEYLHTGCVPAIIHRDLKSSNILLDKHM--RAKVSDFGLSKFAVDGAS---HVSSIVRGTVGYLDPEYYIS--QQLTD 782 (927)
Q Consensus 710 ~gL~yLH~~~~~~ivHrDLkp~NILl~~~~--~vkL~DFGla~~~~~~~~---~~~~~~~gt~~Y~aPE~~~~--~~~s~ 782 (927)
.||+|||++ +|+||||||+|||++.++ .+||+|||+++....... .......||+.|+|||.+.. ..++.
T Consensus 179 ~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 255 (345)
T 3hko_A 179 SALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255 (345)
T ss_dssp HHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT
T ss_pred HHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc
Confidence 999999998 999999999999998776 899999999985533221 12334569999999999975 67899
Q ss_pred ccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCC
Q 002409 783 KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHM 862 (927)
Q Consensus 783 ~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~ 862 (927)
++|||||||++|||++|+.||......+....+.. .. .. .. ..........+.+++.+|++.+|++
T Consensus 256 ~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~-------~~-~~--~~----~~~~~~~~~~~~~li~~~l~~~p~~ 321 (345)
T 3hko_A 256 KCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLN-------KK-LC--FE----NPNYNVLSPLARDLLSNLLNRNVDE 321 (345)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------CC-CC--TT----SGGGGGSCHHHHHHHHHHSCSCTTT
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHh-------cc-cc--cC----CcccccCCHHHHHHHHHHcCCChhH
Confidence 99999999999999999999976542211111111 00 00 00 0000112346889999999999999
Q ss_pred CCcHHHHHHH
Q 002409 863 RPSISEVLKD 872 (927)
Q Consensus 863 RPsm~eV~~~ 872 (927)
||++.|++++
T Consensus 322 Rps~~~~l~h 331 (345)
T 3hko_A 322 RFDAMRALQH 331 (345)
T ss_dssp SCCHHHHHHS
T ss_pred CCCHHHHhcC
Confidence 9999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=348.92 Aligned_cols=264 Identities=24% Similarity=0.372 Sum_probs=209.6
Q ss_pred HHHHHhccccccCceEEEEEEECC------CcEEEEEEeecCCc-hhhHhHHHHHHHHhhc-cCCCccceecceeecCeE
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRS 670 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~~------g~~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~ 670 (927)
..+.+.+.||+|+||.||+|+... .+.||+|++..... ...+.+.+|+++++++ +||||+++++++...+..
T Consensus 46 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 125 (333)
T 2i1m_A 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPV 125 (333)
T ss_dssp TSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCce
Confidence 344567899999999999998752 24799999976533 3456789999999999 899999999999999999
Q ss_pred EEEEEeccCCchhhhcccccc----------cccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCc
Q 002409 671 VLVYEFMHNGTLKEHLYGTLT----------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR 740 (927)
Q Consensus 671 ~lV~E~~~~gsL~~~L~~~~~----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~ 740 (927)
++||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.
T Consensus 126 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~ 202 (333)
T 2i1m_A 126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHV 202 (333)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGGE
T ss_pred EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCCe
Confidence 999999999999999864321 134578999999999999999999998 9999999999999999999
Q ss_pred EEEEeecCcccccCCCCc-eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHH
Q 002409 741 AKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQW 818 (927)
Q Consensus 741 vkL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~ 818 (927)
+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||++ |..||........ +...
T Consensus 203 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~~~~ 279 (333)
T 2i1m_A 203 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK---FYKL 279 (333)
T ss_dssp EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH---HHHH
T ss_pred EEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH---HHHH
Confidence 999999999865443222 2233457889999999998899999999999999999998 9999975442211 1111
Q ss_pred HHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHHHH
Q 002409 819 AKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIER 881 (927)
Q Consensus 819 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~~~ 881 (927)
...... ...+......+.+++.+|++.+|++|||+.||+++|+++....+
T Consensus 280 ~~~~~~-------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 329 (333)
T 2i1m_A 280 VKDGYQ-------------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDR 329 (333)
T ss_dssp HHHTCC-------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HhcCCC-------------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhh
Confidence 111110 00111123468899999999999999999999999999876543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=346.01 Aligned_cols=252 Identities=21% Similarity=0.304 Sum_probs=196.3
Q ss_pred CHHHHHHHHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc--hhhHhHHHHHHHHhhc-cCCCccceecceeec
Q 002409 592 TLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE 667 (927)
Q Consensus 592 ~~~ei~~~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~ 667 (927)
...++....+.+.++||+|+||+||+|+.. +++.||||++..... ........|+..+.++ +||||+++++++.+.
T Consensus 50 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~ 129 (311)
T 3p1a_A 50 RPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG 129 (311)
T ss_dssp SSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred CccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC
Confidence 344556667777899999999999999987 789999999865422 2334455566666555 899999999999999
Q ss_pred CeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeec
Q 002409 668 GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG 747 (927)
Q Consensus 668 ~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFG 747 (927)
+..++||||+ +++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG 202 (311)
T 3p1a_A 130 GILYLQTELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFG 202 (311)
T ss_dssp TEEEEEEECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCT
T ss_pred CEEEEEEecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccce
Confidence 9999999999 67898887543 35689999999999999999999998 99999999999999999999999999
Q ss_pred CcccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCC
Q 002409 748 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 827 (927)
Q Consensus 748 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 827 (927)
+++..... .......||+.|+|||++.+ .++.++|||||||++|||++|..|+.... . | ..+..+.
T Consensus 203 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~------~---~--~~~~~~~ 268 (311)
T 3p1a_A 203 LLVELGTA--GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE------G---W--QQLRQGY 268 (311)
T ss_dssp TCEECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH------H---H--HHHTTTC
T ss_pred eeeecccC--CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc------H---H--HHHhccC
Confidence 98765432 22334559999999998875 78999999999999999999977664322 0 1 0111111
Q ss_pred cccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 828 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 828 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.. ..+.......+.+++.+|++.+|++|||+.|++++
T Consensus 269 ~~--------~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 269 LP--------PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp CC--------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CC--------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 11 11111223468899999999999999999999874
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=361.45 Aligned_cols=249 Identities=22% Similarity=0.267 Sum_probs=202.2
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
.+.+.||+|+||.||+|+.+ +++.||+|+++... ......+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 72 ~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~ 151 (410)
T 3v8s_A 72 EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYM 151 (410)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence 34578999999999999987 58899999997532 122345889999999999999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
++|+|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 152 ~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~ 223 (410)
T 3v8s_A 152 PGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223 (410)
T ss_dssp TTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE
T ss_pred CCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc
Confidence 99999998843 3588999999999999999999998 999999999999999999999999999986654433
Q ss_pred ceeeeeccCCCccCccccccCc----CCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccC
Q 002409 758 HVSSIVRGTVGYLDPEYYISQQ----LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 833 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~~~~~----~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 833 (927)
.......||+.|+|||++.... ++.++|||||||++|||++|+.||......+....+..+.... .+..
T Consensus 224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~----~~p~--- 296 (410)
T 3v8s_A 224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL----TFPD--- 296 (410)
T ss_dssp EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC----CCCT---
T ss_pred ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccc----cCCC---
Confidence 3344567999999999998655 8899999999999999999999998655333333333221110 0000
Q ss_pred CcccCccCHHHHHHHHHHHhhhcCCCCCC--CCcHHHHHHH
Q 002409 834 PSLLDEYDIQSMWKIEEKALMCVLPHGHM--RPSISEVLKD 872 (927)
Q Consensus 834 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~--RPsm~eV~~~ 872 (927)
.. .....+.+|+.+|++.+|++ ||++.||++|
T Consensus 297 ---~~----~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 297 ---DN----DISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp ---TC----CCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ---cc----cccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 00 11236789999999999998 9999999987
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=347.64 Aligned_cols=243 Identities=24% Similarity=0.382 Sum_probs=200.8
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
+.+.+.||+|+||.||+++.. +|+.||+|+++... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 8 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~ 87 (318)
T 1fot_A 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 87 (318)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeC
Confidence 345688999999999999886 68999999997542 12345678899999999999999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 88 ~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~- 159 (318)
T 1fot_A 88 IEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 159 (318)
T ss_dssp CCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred CCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence 999999999853 35688999999999999999999998 9999999999999999999999999999865332
Q ss_pred CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 757 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.. +.+ .
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~--------~~~------~- 221 (318)
T 1fot_A 160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN--------AEL------R- 221 (318)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--------CCC------C-
T ss_pred ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------CCC------C-
Confidence 2345699999999999999999999999999999999999999976442211111111 111 0
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCC-----cHHHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 872 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----sm~eV~~~ 872 (927)
++.....++.+++.+|++.+|++|| ++.||++|
T Consensus 222 ---~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 222 ---FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 1111224688999999999999999 88999876
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=354.99 Aligned_cols=254 Identities=22% Similarity=0.289 Sum_probs=199.3
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhc-cCCCccceecceeecCeEEEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE 675 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~lV~E 675 (927)
+.+.+.||+|+||.||+++.+ +++.||||++++.. ......+..|..++.++ +||||+++++++.+.+..++|||
T Consensus 54 y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E 133 (396)
T 4dc2_A 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE 133 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEE
Confidence 446789999999999999987 57789999997642 22335578899999887 89999999999999999999999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCC
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 755 (927)
|+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 134 ~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 134 YVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp CCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 9999999998843 45689999999999999999999998 9999999999999999999999999999853322
Q ss_pred CCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCccccccccccc-chhhHHHHhhhccCCcccccCC
Q 002409 756 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANC-RNIVQWAKLHIESGDIQGIIDP 834 (927)
Q Consensus 756 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~ 834 (927)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ....+.....+..+.+
T Consensus 207 -~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------ 279 (396)
T 4dc2_A 207 -GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------ 279 (396)
T ss_dssp -TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC------
T ss_pred -CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc------
Confidence 22334567999999999999999999999999999999999999999643211110 1111111111111111
Q ss_pred cccCccCHHHHHHHHHHHhhhcCCCCCCCCcH------HHHHHH
Q 002409 835 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSI------SEVLKD 872 (927)
Q Consensus 835 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm------~eV~~~ 872 (927)
.++.....++.+++.+|++.||++||++ .||++|
T Consensus 280 ----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 280 ----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred ----CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 1111223467899999999999999985 666665
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=339.64 Aligned_cols=260 Identities=16% Similarity=0.218 Sum_probs=207.1
Q ss_pred HHHhccccccCceEEEEEEE-CCCcEEEEEEeecCCchhhHhHHHHHHHHhhc-cCCCccceecceeecCeEEEEEEecc
Q 002409 601 KMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
|.+.+.||+|+||.||+|+. .+++.||||++.... ....+.+|+.+++++ +|+|++++++++......++||||+
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~- 88 (298)
T 1csn_A 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL- 88 (298)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred eEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-
Confidence 45578899999999999986 468999999986442 345688999999999 8999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCc-----EEEEeecCccccc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR-----AKVSDFGLSKFAV 753 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~-----vkL~DFGla~~~~ 753 (927)
+++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+++...
T Consensus 89 ~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 89 GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 99999998542 34589999999999999999999998 9999999999999987776 9999999998655
Q ss_pred CCCCc------eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCC
Q 002409 754 DGASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 827 (927)
Q Consensus 754 ~~~~~------~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 827 (927)
..... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......... .....+........
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~ 241 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK-QKYERIGEKKQSTP 241 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH-HHHHHHHHHHHHSC
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccH-HHHHHHHhhccCcc
Confidence 43221 223456999999999999999999999999999999999999999764422111 11111111111011
Q ss_pred cccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHH
Q 002409 828 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 879 (927)
Q Consensus 828 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~ 879 (927)
... ........+.+++.+|++.+|++||++.||++.|++++..
T Consensus 242 ~~~---------~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 242 LRE---------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp HHH---------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHH---------HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence 100 0112234688999999999999999999999999998753
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=339.26 Aligned_cols=253 Identities=25% Similarity=0.396 Sum_probs=205.4
Q ss_pred ccccccCceEEEEEEEC---CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCC
Q 002409 605 KKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 680 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~---~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 680 (927)
+.||+|+||.||+|.+. +++.||||+++... ....+.+.+|++++++++||||+++++++ ..+..++||||++++
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 94 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG 94 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence 48999999999999864 57789999998653 33456789999999999999999999999 556789999999999
Q ss_pred chhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce-
Q 002409 681 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV- 759 (927)
Q Consensus 681 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~- 759 (927)
+|.+++.. ....+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 95 ~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 168 (287)
T 1u59_A 95 PLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 168 (287)
T ss_dssp EHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEEC
T ss_pred CHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCcceee
Confidence 99999853 245689999999999999999999998 99999999999999999999999999998654433222
Q ss_pred -eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCccc
Q 002409 760 -SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 837 (927)
Q Consensus 760 -~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 837 (927)
.....+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...... .+...+. .+..
T Consensus 169 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~~~~~i~----~~~~--------- 231 (287)
T 1u59_A 169 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----EVMAFIE----QGKR--------- 231 (287)
T ss_dssp CCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH----HHHHHHH----TTCC---------
T ss_pred ccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH----HHHHHHh----cCCc---------
Confidence 122346889999999988889999999999999999998 99999764421 2222211 1111
Q ss_pred CccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHHHH
Q 002409 838 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIER 881 (927)
Q Consensus 838 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~~~ 881 (927)
...+......+.+++.+|++.+|++||++.|++++|+++.....
T Consensus 232 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 275 (287)
T 1u59_A 232 MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275 (287)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 11112233578899999999999999999999999999876443
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=336.43 Aligned_cols=249 Identities=21% Similarity=0.309 Sum_probs=200.9
Q ss_pred HHHhccccccCceEEEEEEECCCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeec--CeEEEEEEe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLVYEF 676 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--~~~~lV~E~ 676 (927)
+.+.+.||+|+||.||+|+++ ++.||||+++... ....+.+.+|+.++++++||||+++++++... +..++||||
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 90 (271)
T 3kmu_A 12 LNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHW 90 (271)
T ss_dssp CEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEEC
T ss_pred hHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecc
Confidence 445789999999999999986 8999999997553 33456799999999999999999999999877 788999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCc--eecCCCCCCCeEECCCCcEEEEeecCcccccC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA--IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 754 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 754 (927)
+++|+|.+++... ....+++..++.++.|++.||+|||++ + ++||||||+|||++.++.++|+|||++.....
T Consensus 91 ~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 91 MPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp CTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred cCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 9999999999643 233589999999999999999999997 7 99999999999999999999999998753222
Q ss_pred CCCceeeeeccCCCccCccccccCcCCC---ccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccc
Q 002409 755 GASHVSSIVRGTVGYLDPEYYISQQLTD---KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 831 (927)
Q Consensus 755 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~---~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 831 (927)
....||+.|+|||.+.+..++. ++|||||||++|||++|+.||......+ ... .....+.
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~---~~~~~~~---- 228 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME----IGM---KVALEGL---- 228 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH----HHH---HHHHSCC----
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH----HHH---HHHhcCC----
Confidence 2235899999999998765555 7999999999999999999997544211 111 1111110
Q ss_pred cCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHH
Q 002409 832 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 877 (927)
Q Consensus 832 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~ 877 (927)
.+.+ +......+.+++.+|++.+|++|||+.|+++.|+++.
T Consensus 229 -~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 229 -RPTI----PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp -CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred -CCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1111 1222346889999999999999999999999999863
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=348.28 Aligned_cols=262 Identities=24% Similarity=0.430 Sum_probs=209.3
Q ss_pred HHHHHhccccccCceEEEEEEEC--------CCcEEEEEEeecCCc-hhhHhHHHHHHHHhhc-cCCCccceecceeecC
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEG 668 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~--------~g~~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~ 668 (927)
..+.+.+.||+|+||.||+|++. +++.||||+++.... .....+.+|+++++++ +||||+++++++...+
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 114 (334)
T 2pvf_A 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 114 (334)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC
Confidence 44566789999999999999873 467899999975532 3456788999999999 8999999999999999
Q ss_pred eEEEEEEeccCCchhhhcccccc------------cccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEEC
Q 002409 669 RSVLVYEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD 736 (927)
Q Consensus 669 ~~~lV~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~ 736 (927)
..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+|||++
T Consensus 115 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~ 191 (334)
T 2pvf_A 115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVT 191 (334)
T ss_dssp CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEEc
Confidence 99999999999999999965421 123589999999999999999999998 999999999999999
Q ss_pred CCCcEEEEeecCcccccCCCCc-eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccch
Q 002409 737 KHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRN 814 (927)
Q Consensus 737 ~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~ 814 (927)
.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .
T Consensus 192 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~ 267 (334)
T 2pvf_A 192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE----E 267 (334)
T ss_dssp TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----H
T ss_pred CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH----H
Confidence 9999999999999865443221 1223457889999999998899999999999999999999 99999754421 2
Q ss_pred hhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHHH
Q 002409 815 IVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 880 (927)
Q Consensus 815 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~~ 880 (927)
+...... +... ..+......+.+++.+|++.+|++||++.||+++|++++...
T Consensus 268 ~~~~~~~----~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 268 LFKLLKE----GHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp HHHHHHH----TCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHhc----CCCC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 2221111 1110 111122346889999999999999999999999999998654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=351.41 Aligned_cols=244 Identities=22% Similarity=0.348 Sum_probs=199.3
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
|.+.+.||+|+||.||+|++. +++.||||++.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 11 Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 90 (336)
T 3h4j_B 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY 90 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEEC
Confidence 445789999999999999974 68899999987532 12245788999999999999999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
+ +|+|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 91 ~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 91 A-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp C-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred C-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 9 7899888843 45689999999999999999999998 99999999999999999999999999998654332
Q ss_pred CceeeeeccCCCccCccccccCcC-CCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCc
Q 002409 757 SHVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 835 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 835 (927)
......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...........+ ..+.
T Consensus 163 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i--------~~~~-------- 224 (336)
T 3h4j_B 163 --FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--------NSCV-------- 224 (336)
T ss_dssp --TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC--------CSSC--------
T ss_pred --ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH--------HcCC--------
Confidence 2234569999999999988776 67999999999999999999999765432221111 0000
Q ss_pred ccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 836 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 836 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
...+......+.+++.+|++.||++|||+.|++++
T Consensus 225 --~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 225 --YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp --CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred --CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 00111123467899999999999999999999886
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=338.57 Aligned_cols=250 Identities=32% Similarity=0.555 Sum_probs=198.5
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchh-------hHhHHHHHHHHhhccCCCccceecceeecCeEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG-------KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 672 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~-------~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~l 672 (927)
+.+.+.||+|+||.||+|++. +++.||||++....... .+.+.+|++++++++||||+++++++.+.. ++
T Consensus 21 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~l 98 (287)
T 4f0f_A 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RM 98 (287)
T ss_dssp EEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EE
T ss_pred ceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eE
Confidence 456788999999999999885 78899999986543221 167889999999999999999999987665 69
Q ss_pred EEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCc--eecCCCCCCCeEECCCCc-----EEEEe
Q 002409 673 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA--IIHRDLKSSNILLDKHMR-----AKVSD 745 (927)
Q Consensus 673 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivHrDLkp~NILl~~~~~-----vkL~D 745 (927)
||||+++|+|.+++.. ....+++..++.++.|++.||+|||++ + |+||||||+|||++.++. +||+|
T Consensus 99 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 99 VMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp EEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred EEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 9999999999988854 245689999999999999999999998 7 999999999999988776 99999
Q ss_pred ecCcccccCCCCceeeeeccCCCccCccccc--cCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhh
Q 002409 746 FGLSKFAVDGASHVSSIVRGTVGYLDPEYYI--SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 823 (927)
Q Consensus 746 FGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~ 823 (927)
||+++.... ......||+.|+|||.+. ...++.++|||||||++|||++|+.||........ .......
T Consensus 173 fg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~--- 243 (287)
T 4f0f_A 173 FGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI--KFINMIR--- 243 (287)
T ss_dssp CTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH--HHHHHHH---
T ss_pred CCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH--HHHHHHh---
Confidence 999974332 233456999999999983 45678899999999999999999999975442211 1111111
Q ss_pred ccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHH
Q 002409 824 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 876 (927)
Q Consensus 824 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~ 876 (927)
..+ . .+ ..+......+.+++.+|++.+|++||++.||++.|+++
T Consensus 244 ~~~-~----~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 244 EEG-L----RP----TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HSC-C----CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ccC-C----CC----CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 111 1 11 11122334688999999999999999999999999863
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=344.05 Aligned_cols=251 Identities=24% Similarity=0.411 Sum_probs=200.4
Q ss_pred HHHHhccccccCceEEEEEEECC-C-------cEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLKD-G-------KEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 671 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~~-g-------~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~ 671 (927)
.+.+.+.||+|+||.||+|+... + +.||+|++........+.+.+|++++++++||||+++++++...+..+
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (289)
T 4fvq_A 9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENI 88 (289)
T ss_dssp GEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCE
T ss_pred HeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCE
Confidence 34567899999999999998663 3 479999997666566778999999999999999999999999999999
Q ss_pred EEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCc--------EEE
Q 002409 672 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR--------AKV 743 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~--------vkL 743 (927)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++. +||
T Consensus 89 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 89 LVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp EEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred EEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeee
Confidence 999999999999999542 34489999999999999999999998 9999999999999998887 999
Q ss_pred EeecCcccccCCCCceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhh
Q 002409 744 SDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH 822 (927)
Q Consensus 744 ~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~ 822 (927)
+|||++..... .....||+.|+|||.+.+ ..++.++|||||||++|||++|..|+...... ........
T Consensus 163 ~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~---~~~~~~~~-- 232 (289)
T 4fvq_A 163 SDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS---QRKLQFYE-- 232 (289)
T ss_dssp CCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHHHHH--
T ss_pred ccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch---HHHHHHhh--
Confidence 99999864422 123458999999999987 77899999999999999999965544322211 11111111
Q ss_pred hccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHH
Q 002409 823 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 879 (927)
Q Consensus 823 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~ 879 (927)
....+.. . ....+.+++.+|++.+|++|||+.|++++|++++..
T Consensus 233 -~~~~~~~--------~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 233 -DRHQLPA--------P----KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp -TTCCCCC--------C----SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred -ccCCCCC--------C----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 1111111 1 122478899999999999999999999999998653
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=354.19 Aligned_cols=246 Identities=25% Similarity=0.395 Sum_probs=200.1
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhc-cCCCccceecceeecCeEEEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE 675 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~lV~E 675 (927)
+.+.+.||+|+||.||+|+.+ +++.||||+++... ......+..|..+++++ +||||+++++++.+.+..++|||
T Consensus 19 y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E 98 (345)
T 1xjd_A 19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 98 (345)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 445789999999999999986 58899999997542 22345677899999887 99999999999999999999999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCC
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 755 (927)
|+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 99 ~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 99 YLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp CCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence 9999999999843 35689999999999999999999998 9999999999999999999999999999754322
Q ss_pred CCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCc
Q 002409 756 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 835 (927)
Q Consensus 756 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 835 (927)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.+.+. .+. +.
T Consensus 172 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~i~----~~~------~~ 236 (345)
T 1xjd_A 172 D-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE----ELFHSIR----MDN------PF 236 (345)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHH----HCC------CC
T ss_pred C-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH----HHHHHHH----hCC------CC
Confidence 2 2234557999999999999999999999999999999999999999765422 1222111 111 01
Q ss_pred ccCccCHHHHHHHHHHHhhhcCCCCCCCCcHH-HHHHH
Q 002409 836 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSIS-EVLKD 872 (927)
Q Consensus 836 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~-eV~~~ 872 (927)
++......+.+++.+|++.+|++||++. ||.+|
T Consensus 237 ----~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 237 ----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp ----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred ----CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 1111224688999999999999999997 77654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=341.16 Aligned_cols=263 Identities=24% Similarity=0.372 Sum_probs=199.8
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 675 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E 675 (927)
.|.+.+.||+|+||.||+|+.. +++.||||+++... ......+.+|+.++++++||||+++++++...+..++|||
T Consensus 33 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 112 (310)
T 2wqm_A 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 112 (310)
T ss_dssp GEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEe
Confidence 3566789999999999999875 78999999997532 3345678899999999999999999999999999999999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCC
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 755 (927)
|+++++|.+++.........+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.....
T Consensus 113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 113 LADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp CCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred cCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 9999999999865444456689999999999999999999998 9999999999999999999999999998755432
Q ss_pred CCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCc
Q 002409 756 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 835 (927)
Q Consensus 756 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 835 (927)
.. ......|++.|+|||.+.+..++.++|||||||++|||++|+.||..... ....... ....+......
T Consensus 190 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~-~~~~~~~~~~~--- 259 (310)
T 2wqm_A 190 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCK-KIEQCDYPPLP--- 259 (310)
T ss_dssp ----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C-----CHHHHHH-HHHTTCSCCCC---
T ss_pred Cc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch-----hHHHHHH-HhhcccCCCCc---
Confidence 22 22334589999999999998999999999999999999999999975431 1111111 11122111111
Q ss_pred ccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHHH
Q 002409 836 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 880 (927)
Q Consensus 836 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~~ 880 (927)
.. .....+.+++.+|++.||++||++.||++.|+++....
T Consensus 260 -~~----~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 260 -SD----HYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp -TT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -cc----ccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 11 12246889999999999999999999999999986543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=347.36 Aligned_cols=250 Identities=22% Similarity=0.324 Sum_probs=180.3
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhcc-CCCccceecceeecCeEEEEEEeccCCch
Q 002409 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMHNGTL 682 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 682 (927)
+.||+|+||.||+|+.. +++.||||++... ....+.+|+.+++++. ||||+++++++.+....++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 67999999999999886 6889999998643 3466789999999997 99999999999999999999999999999
Q ss_pred hhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCC---cEEEEeecCcccccCCCCce
Q 002409 683 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM---RAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 683 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~---~vkL~DFGla~~~~~~~~~~ 759 (927)
.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++...... ..
T Consensus 94 ~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~ 165 (325)
T 3kn6_A 94 FERIKK----KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QP 165 (325)
T ss_dssp HHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-Cc
Confidence 999853 45689999999999999999999998 999999999999998765 89999999998554332 22
Q ss_pred eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCc
Q 002409 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 839 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 839 (927)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.............+. ...+..+... ....
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~-~~~i~~~~~~------~~~~ 238 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEI-MKKIKKGDFS------FEGE 238 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHH-HHHHTTTCCC------CCSH
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHH-HHHHHcCCCC------CCcc
Confidence 33456899999999999999999999999999999999999999765422211122221 1222222211 0011
Q ss_pred cCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 840 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 840 ~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.......++.+++.+|++.||++|||+.|++++
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 011223468899999999999999999998765
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=347.50 Aligned_cols=247 Identities=22% Similarity=0.320 Sum_probs=192.1
Q ss_pred HHHHhccccccCceEEEEEEE----CCCcEEEEEEeecCC----chhhHhHHHHHHHHhhccCCCccceecceeecCeEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKL----KDGKEIAVKVLTSNS----YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 671 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~----~~g~~VAVK~l~~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~ 671 (927)
.+.+.+.||+|+||.||+++. .+++.||+|+++... ......+.+|++++++++||||+++++++...+..+
T Consensus 18 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 97 (327)
T 3a62_A 18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLY 97 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEE
T ss_pred HeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEE
Confidence 345678999999999999987 478999999997542 223456788999999999999999999999999999
Q ss_pred EEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccc
Q 002409 672 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 751 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 751 (927)
+||||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 98 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 98 LILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 99999999999998843 45688899999999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccc
Q 002409 752 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 831 (927)
Q Consensus 752 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 831 (927)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ +.+.+. .+..
T Consensus 171 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~i~----~~~~--- 238 (327)
T 3a62_A 171 SIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK----TIDKIL----KCKL--- 238 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHH----HTCC---
T ss_pred cccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH----HHHHHH----hCCC---
Confidence 43222 12234569999999999999999999999999999999999999997654221 111111 1110
Q ss_pred cCCcccCccCHHHHHHHHHHHhhhcCCCCCCCC-----cHHHHHHH
Q 002409 832 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 872 (927)
Q Consensus 832 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----sm~eV~~~ 872 (927)
. .+......+.+++.+|++.+|++|| ++.|+++|
T Consensus 239 ---~----~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 239 ---N----LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp ---C----CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred ---C----CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 0 1111234688999999999999999 78888876
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=351.98 Aligned_cols=266 Identities=16% Similarity=0.232 Sum_probs=203.9
Q ss_pred HHHHhccccccCceEEEEEEECC------CcEEEEEEeecCCchhh-----------HhHHHHHHHHhhccCCCccceec
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSYQGK-----------REFTNEVTLLSRIHHRNLVQFLG 662 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~~------g~~VAVK~l~~~~~~~~-----------~~~~~Ei~iL~~l~HpnIv~l~g 662 (927)
.|.+.+.||+|+||.||+|++.. ++.||||++........ ..+..|+..++.++||||+++++
T Consensus 36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~ 115 (364)
T 3op5_A 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG 115 (364)
T ss_dssp EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEE
T ss_pred eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEe
Confidence 45567899999999999998864 47899999876532211 12344666777888999999999
Q ss_pred ceeec----CeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEEC--
Q 002409 663 YCQEE----GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD-- 736 (927)
Q Consensus 663 ~~~~~----~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~-- 736 (927)
++... ...++||||+ +++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 116 SGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEETTEEEEEEEEECE-EEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESS
T ss_pred eeeeccCCcceEEEEEeCC-CCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecC
Confidence 98764 4589999999 99999998542 35689999999999999999999998 999999999999999
Q ss_pred CCCcEEEEeecCcccccCCCCc------eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCccccccccc
Q 002409 737 KHMRAKVSDFGLSKFAVDGASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGA 810 (927)
Q Consensus 737 ~~~~vkL~DFGla~~~~~~~~~------~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~ 810 (927)
.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 8899999999999755432211 1123459999999999999999999999999999999999999998543211
Q ss_pred ccchhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHH
Q 002409 811 NCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 879 (927)
Q Consensus 811 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~ 879 (927)
....+...... ..+.+++++.+... ....++.+++..|++.+|++||++.+|++.|++++..
T Consensus 269 ---~~~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~ 330 (364)
T 3op5_A 269 ---KYVRDSKIRYR-ENIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA 330 (364)
T ss_dssp ---HHHHHHHHHHH-HCHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ---HHHHHHHHHhh-hhHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence 22222222111 12333333333211 1234688999999999999999999999999998764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=353.26 Aligned_cols=273 Identities=21% Similarity=0.279 Sum_probs=211.3
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecC--eEEEEEEe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG--RSVLVYEF 676 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~~~lV~E~ 676 (927)
|.+.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++||||
T Consensus 11 y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~ 90 (396)
T 4eut_A 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECC
T ss_pred eEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEec
Confidence 446789999999999999987 48999999997543 233566789999999999999999999988755 77999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEE----CCCCcEEEEeecCcccc
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFA 752 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl----~~~~~vkL~DFGla~~~ 752 (927)
+++|+|.+++.... ....+++..++.++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||+++..
T Consensus 91 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 91 CPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp CTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred CCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 99999999996532 223489999999999999999999998 99999999999999 77888999999999865
Q ss_pred cCCCCceeeeeccCCCccCcccccc--------CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhc
Q 002409 753 VDGASHVSSIVRGTVGYLDPEYYIS--------QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE 824 (927)
Q Consensus 753 ~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~ 824 (927)
.... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||.....+.....+.........
T Consensus 167 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p 244 (396)
T 4eut_A 167 EDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (396)
T ss_dssp CCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred cCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence 4322 2233569999999999865 56788999999999999999999999754432222222222211111
Q ss_pred cCCccccc-----------CCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHH
Q 002409 825 SGDIQGII-----------DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 879 (927)
Q Consensus 825 ~~~~~~~~-----------d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~ 879 (927)
...+...- +..............+.+++.+|++.||++||++.|+++.+++++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 11111000 00111223456667889999999999999999999999999998763
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=342.10 Aligned_cols=253 Identities=29% Similarity=0.464 Sum_probs=195.6
Q ss_pred HHHhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCC
Q 002409 601 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 680 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 680 (927)
+.+.+.||+|+||.||+|++. ++.||||++... ...+.+.+|++++++++||||+++++++.+ ..++||||+++|
T Consensus 10 ~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~ 84 (307)
T 2eva_A 10 IEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGG 84 (307)
T ss_dssp EEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTC
T ss_pred eeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCC
Confidence 345688999999999999986 789999998643 345678999999999999999999999874 478999999999
Q ss_pred chhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCc-EEEEeecCcccccCCCCce
Q 002409 681 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR-AKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 681 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~-vkL~DFGla~~~~~~~~~~ 759 (927)
+|.+++.... ....+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||+++.....
T Consensus 85 ~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---- 159 (307)
T 2eva_A 85 SLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---- 159 (307)
T ss_dssp BHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------
T ss_pred CHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc----
Confidence 9999996432 2345788899999999999999999932228999999999999998886 799999998754322
Q ss_pred eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCc
Q 002409 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 839 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 839 (927)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ....|... .+.. +.....
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~~~---~~~~-----~~~~~~ 228 (307)
T 2eva_A 160 MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA---FRIMWAVH---NGTR-----PPLIKN 228 (307)
T ss_dssp -----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH---HHHHHHHH---TTCC-----CCCBTT
T ss_pred cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH---HHHHHHHh---cCCC-----CCcccc
Confidence 123458999999999999999999999999999999999999997543111 11111111 1111 111111
Q ss_pred cCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 840 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 840 ~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
....+.+++.+|++.+|++|||+.|++++|+.+..
T Consensus 229 ----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 229 ----LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp ----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred ----cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 22468899999999999999999999999998754
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=350.54 Aligned_cols=243 Identities=23% Similarity=0.307 Sum_probs=201.0
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
+.+.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 43 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 122 (350)
T 1rdq_E 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcC
Confidence 345688999999999999986 68999999997542 22345688999999999999999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 123 ~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 123 VAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp CTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 999999999853 35689999999999999999999998 9999999999999999999999999999865332
Q ss_pred CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 757 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+. .+.+ .
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~--------~~~~------~- 256 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV--------SGKV------R- 256 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--------HCCC------C-
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHH--------cCCC------C-
Confidence 234569999999999999999999999999999999999999997654221111111 1111 0
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCCc-----HHHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 872 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----m~eV~~~ 872 (927)
++......+.+++.+|++.||++||+ +.||++|
T Consensus 257 ---~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 257 ---FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ---CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 11122346889999999999999998 8888876
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=335.56 Aligned_cols=250 Identities=21% Similarity=0.279 Sum_probs=202.3
Q ss_pred HHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
..|.+.+.||+|+||.||+|+.. +++.+|+|++........+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC 88 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence 34566789999999999999887 46789999998765556778999999999999999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEE---CCCCcEEEEeecCcccccC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVD 754 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl---~~~~~vkL~DFGla~~~~~ 754 (927)
++++|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||++.....
T Consensus 89 ~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 89 TGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 99999998843 45689999999999999999999998 99999999999999 7889999999999976543
Q ss_pred CCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCC
Q 002409 755 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 834 (927)
Q Consensus 755 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 834 (927)
.. ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||......+ +... ...+... ...
T Consensus 162 ~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~----~~~~~~~--~~~ 228 (277)
T 3f3z_A 162 GK--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE----VMLK----IREGTFT--FPE 228 (277)
T ss_dssp TS--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH----HHHCCCC--CCH
T ss_pred cc--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHH----HHHH----HHhCCCC--CCc
Confidence 32 2234469999999998865 48999999999999999999999997644211 1111 1111110 000
Q ss_pred cccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 835 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 835 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
... ......+.+++.+|++.+|++||++.|++++
T Consensus 229 ~~~----~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 229 KDW----LNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred hhh----hcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0123468899999999999999999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=351.38 Aligned_cols=256 Identities=25% Similarity=0.418 Sum_probs=200.1
Q ss_pred HHhccccccCceEEEEEEECC-----CcEEEEEEeecCCc-hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEE
Q 002409 602 MLEKKIGSGGFGVVYYGKLKD-----GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 675 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~~-----g~~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E 675 (927)
.+.+.||+|+||.||+|++.. +..||||+++.... .....+.+|++++++++||||+++++++...+..++|||
T Consensus 47 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 126 (333)
T 1mqb_A 47 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITE 126 (333)
T ss_dssp EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEe
Confidence 345789999999999998653 23599999975532 335578999999999999999999999999999999999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCC
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 755 (927)
|+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 127 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 127 YMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200 (333)
T ss_dssp CCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred CCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence 99999999998532 35689999999999999999999998 9999999999999999999999999999865433
Q ss_pred CCc--eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCccccc
Q 002409 756 ASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 832 (927)
Q Consensus 756 ~~~--~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 832 (927)
... ......+|+.|+|||.+....++.++|||||||++|||++ |+.||...... .+...+ ..+..
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~----~~~~~~----~~~~~---- 268 (333)
T 1mqb_A 201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH----EVMKAI----NDGFR---- 268 (333)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHHH----HTTCC----
T ss_pred cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH----HHHHHH----HCCCc----
Confidence 221 1222346789999999998899999999999999999999 99999654321 122211 11110
Q ss_pred CCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHHH
Q 002409 833 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 880 (927)
Q Consensus 833 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~~ 880 (927)
...+......+.+++.+|++.+|++||++.||+++|++++...
T Consensus 269 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 269 -----LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp -----CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred -----CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 0011123346889999999999999999999999999987643
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=341.34 Aligned_cols=269 Identities=24% Similarity=0.360 Sum_probs=201.0
Q ss_pred HHHHHHHHHHhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhh--ccCCCccceecceeec----
Q 002409 594 SDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSR--IHHRNLVQFLGYCQEE---- 667 (927)
Q Consensus 594 ~ei~~~~~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~--l~HpnIv~l~g~~~~~---- 667 (927)
.+.....+.+.+.||+|+||.||+|++. ++.||||++.... ...+..|.+++.. ++||||+++++++...
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 3444556777899999999999999987 8999999986432 3344455555555 4999999999999877
Q ss_pred CeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCC-----CCceecCCCCCCCeEECCCCcEE
Q 002409 668 GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC-----VPAIIHRDLKSSNILLDKHMRAK 742 (927)
Q Consensus 668 ~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~~ivHrDLkp~NILl~~~~~vk 742 (927)
...++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+++ .++|+||||||+|||++.++.+|
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 182 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC 182 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred CceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence 788999999999999999843 46899999999999999999999852 23899999999999999999999
Q ss_pred EEeecCcccccCCCCce---eeeeccCCCccCccccccCcCCCc------cceeeHHHHHHHHHhC----------CCcc
Q 002409 743 VSDFGLSKFAVDGASHV---SSIVRGTVGYLDPEYYISQQLTDK------SDVYSFGVILLELISG----------QEAI 803 (927)
Q Consensus 743 L~DFGla~~~~~~~~~~---~~~~~gt~~Y~aPE~~~~~~~s~~------sDVwSlGvvL~elltG----------~~p~ 803 (927)
|+|||+++......... .....||+.|+|||++.+.....+ +|||||||++|||++| +.||
T Consensus 183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 99999997554332221 123469999999999987766665 9999999999999999 5555
Q ss_pred cccccccccchhhHHHHhhhccCCcccccCCcccCcc-CHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 804 SNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY-DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 804 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
......... . ........... ..+...... ......++.+++.+|++.+|++|||+.||+++|+.+..
T Consensus 263 ~~~~~~~~~--~-~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 263 HDLVPSDPS--Y-EDMREIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp TTTSCSSCC--H-HHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhcCCCCc--h-hhhHHHHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 432211111 0 10111111111 111111111 12566789999999999999999999999999999865
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=343.96 Aligned_cols=262 Identities=27% Similarity=0.416 Sum_probs=207.9
Q ss_pred HHHHHhccccccCceEEEEEEE------CCCcEEEEEEeecCCc-hhhHhHHHHHHHHhhc-cCCCccceecceeecC-e
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEG-R 669 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~------~~g~~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~-~ 669 (927)
..+.+.+.||+|+||.||+|++ .+++.||||+++.... ...+.+.+|+.+++++ +||||+++++++...+ .
T Consensus 27 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 106 (316)
T 2xir_A 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 106 (316)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred hheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCc
Confidence 3455678999999999999975 2467899999976543 3356789999999999 7999999999987654 5
Q ss_pred EEEEEEeccCCchhhhccccccc------------ccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECC
Q 002409 670 SVLVYEFMHNGTLKEHLYGTLTH------------EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK 737 (927)
Q Consensus 670 ~~lV~E~~~~gsL~~~L~~~~~~------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~ 737 (927)
.++||||+++|+|.+++...... ...+++..++.++.|++.||.|||++ +|+||||||+|||++.
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~ 183 (316)
T 2xir_A 107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE 183 (316)
T ss_dssp CEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECG
T ss_pred eEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECC
Confidence 89999999999999999654321 12388999999999999999999998 9999999999999999
Q ss_pred CCcEEEEeecCcccccCCCCc-eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchh
Q 002409 738 HMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNI 815 (927)
Q Consensus 738 ~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l 815 (927)
++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++ |+.||....... .+
T Consensus 184 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~ 260 (316)
T 2xir_A 184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---EF 260 (316)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH---HH
T ss_pred CCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH---HH
Confidence 999999999999865443322 2334558899999999999999999999999999999998 999997644221 11
Q ss_pred hHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHH
Q 002409 816 VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 879 (927)
Q Consensus 816 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~ 879 (927)
... ...+... .. +......+.+++.+|++.+|++|||+.||+++|+.++..
T Consensus 261 ~~~----~~~~~~~-----~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 261 CRR----LKEGTRM-----RA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp HHH----HHHTCCC-----CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHH----hccCccC-----CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 111 1111110 01 111234688999999999999999999999999998764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=352.38 Aligned_cols=251 Identities=26% Similarity=0.318 Sum_probs=192.9
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
.|.+.+.||+|+||.||+++.. +++.||||++..... ....+.+|+.++++++||||+++++++...+..++||||++
T Consensus 21 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 99 (361)
T 3uc3_A 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS 99 (361)
T ss_dssp TEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence 3556789999999999999987 788999999975432 34668899999999999999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCc--EEEEeecCcccccCCC
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR--AKVSDFGLSKFAVDGA 756 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~--vkL~DFGla~~~~~~~ 756 (927)
+|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+++.....
T Consensus 100 ~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~- 171 (361)
T 3uc3_A 100 GGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 171 (361)
T ss_dssp SCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccccc-
Confidence 9999998843 45689999999999999999999998 9999999999999987765 999999999743222
Q ss_pred CceeeeeccCCCccCccccccCcCCCc-cceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCc
Q 002409 757 SHVSSIVRGTVGYLDPEYYISQQLTDK-SDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 835 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~-sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 835 (927)
.......||+.|+|||++.+..++.+ +|||||||++|||++|+.||...........+.+..... ...+.
T Consensus 172 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~------ 242 (361)
T 3uc3_A 172 -SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSV--KYSIP------ 242 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTT--CCCCC------
T ss_pred -CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcC--CCCCC------
Confidence 12233469999999999988877665 899999999999999999998655333333332221111 00000
Q ss_pred ccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 836 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 836 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
. .......+.+++.+|++.+|++|||+.|+++|
T Consensus 243 --~--~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 243 --D--DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp --T--TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred --C--cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0 01122467899999999999999999999987
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=347.34 Aligned_cols=254 Identities=22% Similarity=0.289 Sum_probs=199.8
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhc-cCCCccceecceeecCeEEEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE 675 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~lV~E 675 (927)
+.+.+.||+|+||.||+++.+ +++.||||+++... ....+.+.+|..+++++ +||||+++++++.+.+..++|||
T Consensus 11 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e 90 (345)
T 3a8x_A 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE 90 (345)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEe
Confidence 345688999999999999986 58899999997542 23345688899999988 89999999999999999999999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCC
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 755 (927)
|+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+|||+++.....
T Consensus 91 ~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 91 YVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp CCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 9999999998843 35689999999999999999999998 9999999999999999999999999999853322
Q ss_pred CCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCccccccccccc-chhhHHHHhhhccCCcccccCC
Q 002409 756 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANC-RNIVQWAKLHIESGDIQGIIDP 834 (927)
Q Consensus 756 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~ 834 (927)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..........+..+..
T Consensus 164 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~------ 236 (345)
T 3a8x_A 164 G-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------ 236 (345)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC------
T ss_pred C-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC------
Confidence 2 2234457999999999999999999999999999999999999999653211110 0111111111111111
Q ss_pred cccCccCHHHHHHHHHHHhhhcCCCCCCCCcH------HHHHHH
Q 002409 835 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSI------SEVLKD 872 (927)
Q Consensus 835 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm------~eV~~~ 872 (927)
. ++......+.+++.+|++.+|++||++ .|+++|
T Consensus 237 ~----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 237 R----IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp C----CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred C----CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 0 111223468899999999999999985 666665
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=350.67 Aligned_cols=246 Identities=24% Similarity=0.305 Sum_probs=200.1
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhc-cCCCccceecceeecCeEEEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE 675 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~lV~E 675 (927)
+.+.+.||+|+||.||+|+.+ +++.||||+++... ......+..|..++..+ +||||+++++++.+.+..++|||
T Consensus 22 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E 101 (353)
T 2i0e_A 22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 101 (353)
T ss_dssp EEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEe
Confidence 445689999999999999987 47889999997542 22345678899999987 89999999999999999999999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCC
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 755 (927)
|+++|+|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 102 ~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 102 YVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp CCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 9999999999843 35689999999999999999999998 9999999999999999999999999999853322
Q ss_pred CCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCc
Q 002409 756 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 835 (927)
Q Consensus 756 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 835 (927)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.. +..
T Consensus 175 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--------~~~------- 238 (353)
T 2i0e_A 175 G-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME--------HNV------- 238 (353)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------CCC-------
T ss_pred C-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHh--------CCC-------
Confidence 2 223445799999999999999999999999999999999999999976542221111111 111
Q ss_pred ccCccCHHHHHHHHHHHhhhcCCCCCCCCc-----HHHHHHH
Q 002409 836 LLDEYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 872 (927)
Q Consensus 836 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----m~eV~~~ 872 (927)
.++......+.+++.+|++.+|++||+ +.||++|
T Consensus 239 ---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 239 ---AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 011122346889999999999999994 6788776
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=358.97 Aligned_cols=251 Identities=23% Similarity=0.261 Sum_probs=201.8
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
.+.+.||+|+||.||+++.+ +++.||||++++.. ......+.+|..++.+++||||+++++++.+.+..++||||+
T Consensus 64 ~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~ 143 (412)
T 2vd5_A 64 EILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYY 143 (412)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCC
Confidence 34678999999999999986 68999999997532 122345889999999999999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
++|+|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++.......
T Consensus 144 ~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~ 217 (412)
T 2vd5_A 144 VGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT 217 (412)
T ss_dssp CSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccCCCc
Confidence 999999999532 24689999999999999999999998 999999999999999999999999999986654433
Q ss_pred ceeeeeccCCCccCccccc-------cCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCccc
Q 002409 758 HVSSIVRGTVGYLDPEYYI-------SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 830 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~~-------~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 830 (927)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||......+....+..+.... .+
T Consensus 218 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~----~~-- 291 (412)
T 2vd5_A 218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL----SL-- 291 (412)
T ss_dssp EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC----CC--
T ss_pred cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCc----CC--
Confidence 3344567999999999997 3578999999999999999999999997655333333333321110 00
Q ss_pred ccCCcccCccCHHHHHHHHHHHhhhcCCCCCCC---CcHHHHHHH
Q 002409 831 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMR---PSISEVLKD 872 (927)
Q Consensus 831 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~R---Psm~eV~~~ 872 (927)
+.... ....++.+++.+|+. +|++| |++.||++|
T Consensus 292 ---p~~~~----~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 292 ---PLVDE----GVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp ---C--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred ---Ccccc----CCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 11111 122468899999999 99998 689999876
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=345.19 Aligned_cols=259 Identities=22% Similarity=0.306 Sum_probs=203.1
Q ss_pred HHHHhccccccCceEEEEEEE-CCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceeccee----ecCeEEEEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ----EEGRSVLVY 674 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~----~~~~~~lV~ 674 (927)
.|.+.+.||+|+||.||+++. .+++.||||++........+.+.+|++++++++||||+++++++. .....++||
T Consensus 30 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~ 109 (317)
T 2buj_A 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLL 109 (317)
T ss_dssp EEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEE
T ss_pred EEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEE
Confidence 455678999999999999987 478999999987666666778999999999999999999999986 334789999
Q ss_pred EeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccC
Q 002409 675 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 754 (927)
Q Consensus 675 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 754 (927)
||+++|+|.+++.........+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 186 (317)
T 2buj_A 110 PFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI 186 (317)
T ss_dssp ECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESCE
T ss_pred EeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhccc
Confidence 99999999999976544567799999999999999999999998 999999999999999999999999999874422
Q ss_pred CCCc--------eeeeeccCCCccCccccccCc---CCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhh
Q 002409 755 GASH--------VSSIVRGTVGYLDPEYYISQQ---LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 823 (927)
Q Consensus 755 ~~~~--------~~~~~~gt~~Y~aPE~~~~~~---~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~ 823 (927)
.... ......||+.|+|||.+.... ++.++|||||||++|||++|+.||........ .+.......
T Consensus 187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~~~- 263 (317)
T 2buj_A 187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD--SVALAVQNQ- 263 (317)
T ss_dssp EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS--CHHHHHHCC-
T ss_pred ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc--hhhHHhhcc-
Confidence 1100 011234799999999987543 78999999999999999999999965321111 111111110
Q ss_pred ccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHH
Q 002409 824 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 876 (927)
Q Consensus 824 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~ 876 (927)
... .........+.+++.+|++.+|++||++.||+++|+.+
T Consensus 264 --~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 304 (317)
T 2buj_A 264 --LSI----------PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304 (317)
T ss_dssp ----C----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred --CCC----------CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence 000 00112234688999999999999999999999999976
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=343.03 Aligned_cols=251 Identities=24% Similarity=0.347 Sum_probs=203.7
Q ss_pred HHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCch------hhHhHHHHHHHHhhccCCCccceecceeecCeEE
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 671 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~------~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~ 671 (927)
..|.+.+.||+|+||.||+|+.. +++.||||++...... ....+.+|+.++++++||||+++++++.+.+..+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 45667899999999999999886 6889999999754322 2567899999999999999999999999999999
Q ss_pred EEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCC----cEEEEeec
Q 002409 672 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM----RAKVSDFG 747 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~----~vkL~DFG 747 (927)
+||||+++++|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||
T Consensus 92 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 99999999999999853 35688999999999999999999998 999999999999999888 79999999
Q ss_pred CcccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCC
Q 002409 748 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 827 (927)
Q Consensus 748 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 827 (927)
+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+ ...... .+.
T Consensus 165 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~i~----~~~ 234 (321)
T 2a2a_A 165 LAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE----TLANIT----SVS 234 (321)
T ss_dssp TCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH----HHHHHH----TTC
T ss_pred cceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHH----hcc
Confidence 998654432 2233458999999999999999999999999999999999999997544211 111111 110
Q ss_pred cccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 828 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 828 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
. ..++.... .....+.+++.+|++.+|++|||+.|++++
T Consensus 235 ~--~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 235 Y--DFDEEFFS----HTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp C--CCCHHHHT----TCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred c--ccChhhhc----ccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 01111111 122468899999999999999999999986
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=342.85 Aligned_cols=269 Identities=22% Similarity=0.299 Sum_probs=199.7
Q ss_pred HHHHHHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc-----hhhHhHHHHHHHHhhcc---CCCccceeccee
Q 002409 595 DIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-----QGKREFTNEVTLLSRIH---HRNLVQFLGYCQ 665 (927)
Q Consensus 595 ei~~~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~-----~~~~~~~~Ei~iL~~l~---HpnIv~l~g~~~ 665 (927)
++....|.+.+.||+|+||+||+|+.. +++.||||++..... .....+.+|++++++++ ||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 344455667889999999999999874 688999999874321 12346778888887775 999999999997
Q ss_pred ecC-----eEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCc
Q 002409 666 EEG-----RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR 740 (927)
Q Consensus 666 ~~~-----~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~ 740 (927)
... ..++||||+. |+|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~ 158 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVD-QDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGT 158 (308)
T ss_dssp ECCSSSEEEEEEEEECCC-CBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSC
T ss_pred ccCCCCceeEEEEehhhh-cCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCC
Confidence 755 5799999997 5999988543 233489999999999999999999998 9999999999999999999
Q ss_pred EEEEeecCcccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHH
Q 002409 741 AKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK 820 (927)
Q Consensus 741 vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~ 820 (927)
+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.+...
T Consensus 159 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (308)
T 3g33_A 159 VKLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 236 (308)
T ss_dssp EEECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHC
T ss_pred EEEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999999998554322 22345689999999999999999999999999999999999999976542222222222111
Q ss_pred hhhccCCcccc-------cCCc---ccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 821 LHIESGDIQGI-------IDPS---LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 821 ~~~~~~~~~~~-------~d~~---l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
..... ..... +.+. .......+....+.+++.+|++.||++|||+.|+++|
T Consensus 237 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 237 LPPED-DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCCTT-TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCChh-hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 11000 00000 0000 0000111233568899999999999999999999876
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=351.27 Aligned_cols=249 Identities=24% Similarity=0.331 Sum_probs=193.8
Q ss_pred HHHhccccccCceEEEEEEECCCcEEEEEEeecCC--chhhHhHHHHHHHHhhccC--CCccceecceeecCeEEEEEEe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHH--RNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~H--pnIv~l~g~~~~~~~~~lV~E~ 676 (927)
|.+.+.||+|+||.||++...+++.||||++.... ....+.+.+|+++|++++| +||+++++++...+..++|||
T Consensus 11 y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e- 89 (343)
T 3dbq_A 11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 89 (343)
T ss_dssp EEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-
T ss_pred EEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-
Confidence 44578999999999999999889999999987543 3334678999999999976 999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
+.+|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++ ++.+||+|||+++......
T Consensus 90 ~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 90 CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp CCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 568899999853 45688999999999999999999998 999999999999997 5789999999998654432
Q ss_pred Cc-eeeeeccCCCccCcccccc-----------CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhc
Q 002409 757 SH-VSSIVRGTVGYLDPEYYIS-----------QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE 824 (927)
Q Consensus 757 ~~-~~~~~~gt~~Y~aPE~~~~-----------~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~ 824 (927)
.. ......||+.|+|||++.. ..++.++|||||||++|||++|+.||..... .+.. ....
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~-~~~~-- 233 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISK-LHAI-- 233 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHH-HHHH--
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHH-HHHH--
Confidence 22 2334569999999999865 6788899999999999999999999965321 1111 1111
Q ss_pred cCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHH
Q 002409 825 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 873 (927)
Q Consensus 825 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L 873 (927)
+++.....++......+.+++.+|++.+|++|||+.|++++-
T Consensus 234 -------~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 234 -------IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp -------HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred -------hcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 111111112222234688999999999999999999999873
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=341.09 Aligned_cols=269 Identities=23% Similarity=0.379 Sum_probs=210.1
Q ss_pred cCHHHHHHHHHHHhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhh--ccCCCccceecceeecC
Q 002409 591 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSR--IHHRNLVQFLGYCQEEG 668 (927)
Q Consensus 591 ~~~~ei~~~~~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~--l~HpnIv~l~g~~~~~~ 668 (927)
+...+.....+.+.+.||+|+||.||+|+.. ++.||||++... ....+.+|+++++. ++||||+++++++....
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 4445566667778899999999999999985 899999998643 34567788888887 79999999999998776
Q ss_pred ----eEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHh--------hCCCCceecCCCCCCCeEEC
Q 002409 669 ----RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH--------TGCVPAIIHRDLKSSNILLD 736 (927)
Q Consensus 669 ----~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH--------~~~~~~ivHrDLkp~NILl~ 736 (927)
..++||||+++|+|.+++.. ..+++..++.++.|++.||+||| +. +|+||||||+|||++
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~ 181 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVK 181 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEEC
T ss_pred CccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEEC
Confidence 78999999999999999843 35889999999999999999999 66 999999999999999
Q ss_pred CCCcEEEEeecCcccccCCCCc---eeeeeccCCCccCccccccC------cCCCccceeeHHHHHHHHHhC--------
Q 002409 737 KHMRAKVSDFGLSKFAVDGASH---VSSIVRGTVGYLDPEYYISQ------QLTDKSDVYSFGVILLELISG-------- 799 (927)
Q Consensus 737 ~~~~vkL~DFGla~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~------~~s~~sDVwSlGvvL~elltG-------- 799 (927)
.++++||+|||+++........ ......||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~ 261 (342)
T 1b6c_B 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261 (342)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence 9999999999999865544322 12344699999999998765 344689999999999999999
Q ss_pred --CCcccccccccccchhhHHHHhhhccCCcccccCCcccCc-cCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHH
Q 002409 800 --QEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE-YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 876 (927)
Q Consensus 800 --~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~ 876 (927)
+.||........ ....+.... .... ..+.+... ...+....+.+++.+|++.+|++|||+.||+++|+++
T Consensus 262 ~~~~p~~~~~~~~~--~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 262 DYQLPYYDLVPSDP--SVEEMRKVV-CEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp CCCCTTTTTSCSSC--CHHHHHHHH-TTSC----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccCccccCcCcc--cHHHHHHHH-HHHH----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 667754332111 111111111 1111 11222211 1345667899999999999999999999999999998
Q ss_pred HH
Q 002409 877 IV 878 (927)
Q Consensus 877 ~~ 878 (927)
..
T Consensus 335 ~~ 336 (342)
T 1b6c_B 335 SQ 336 (342)
T ss_dssp HH
T ss_pred HH
Confidence 65
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=346.89 Aligned_cols=256 Identities=23% Similarity=0.363 Sum_probs=198.2
Q ss_pred HHHhccccccCceEEEEEEEC-CCcE----EEEEEeecC-CchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKE----IAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 674 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~----VAVK~l~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~ 674 (927)
|.+.+.||+|+||.||+|++. +++. ||+|.+... .....+.+.+|+.++++++||||+++++++.... .++|+
T Consensus 17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~ 95 (327)
T 3lzb_A 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIT 95 (327)
T ss_dssp EEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEE
T ss_pred ceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEE
Confidence 456789999999999999875 3443 577777543 3345678999999999999999999999998765 78999
Q ss_pred EeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccC
Q 002409 675 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 754 (927)
Q Consensus 675 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 754 (927)
||+.+|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 96 ~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 96 QLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp CCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred EecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 999999999998643 35688999999999999999999998 999999999999999999999999999986543
Q ss_pred CCCc-eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCccccc
Q 002409 755 GASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 832 (927)
Q Consensus 755 ~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 832 (927)
.... ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...... .+...... +..
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~----~~~~~~~~----~~~---- 237 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----EISSILEK----GER---- 237 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----GHHHHHHT----TCC----
T ss_pred ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH----HHHHHHHc----CCC----
Confidence 3221 2233446889999999999999999999999999999999 99999765422 12221111 110
Q ss_pred CCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHHH
Q 002409 833 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 880 (927)
Q Consensus 833 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~~ 880 (927)
...+......+.+++.+|++.+|++||++.|+++.|+++....
T Consensus 238 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 238 -----LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp -----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred -----CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 0111222346889999999999999999999999999987543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=341.28 Aligned_cols=262 Identities=32% Similarity=0.542 Sum_probs=195.4
Q ss_pred HHHHHHHHHhccccccCceEEEEEEECCCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecCeEEE
Q 002409 595 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 672 (927)
Q Consensus 595 ei~~~~~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~l 672 (927)
|+....+.+.++||+|+||.||+|+.. ..||||+++... ....+.+.+|++++++++||||+++++++ .....++
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l 96 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI 96 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence 344445667789999999999999865 369999987543 33456789999999999999999999966 4556899
Q ss_pred EEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccc
Q 002409 673 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 752 (927)
Q Consensus 673 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 752 (927)
||||+++++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 97 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp EEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred EEEecCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccc
Confidence 99999999999988532 45689999999999999999999998 9999999999999999999999999999754
Q ss_pred cCCC-CceeeeeccCCCccCccccc---cCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCc
Q 002409 753 VDGA-SHVSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 828 (927)
Q Consensus 753 ~~~~-~~~~~~~~gt~~Y~aPE~~~---~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 828 (927)
.... ........||+.|+|||.+. ...++.++|||||||++|||++|+.||...... ..+..... .+..
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~~----~~~~ 243 (289)
T 3og7_A 171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR---DQIIEMVG----RGSL 243 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH---HHHHHHHH----HTSC
T ss_pred ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH---HHHHHHhc----cccc
Confidence 3321 22233456899999999986 567888999999999999999999999764311 12222211 1111
Q ss_pred ccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHH
Q 002409 829 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 877 (927)
Q Consensus 829 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~ 877 (927)
..... .........+.+++.+|++.+|++||++.|+++.|+++.
T Consensus 244 ~~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 244 SPDLS-----KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CCCTT-----SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred Ccchh-----hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 11110 111223356899999999999999999999999999874
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=347.83 Aligned_cols=255 Identities=25% Similarity=0.315 Sum_probs=187.3
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhcc-CCCccceeccee--------ecCe
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQ--------EEGR 669 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~--------~~~~ 669 (927)
.+.+.+.||+|+||.||+|++. +++.||||++........+.+.+|+.+++++. ||||+++++++. ....
T Consensus 29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 108 (337)
T 3ll6_A 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE 108 (337)
T ss_dssp EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCce
Confidence 4556789999999999999975 68999999987766666778999999999996 999999999983 3445
Q ss_pred EEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCc--eecCCCCCCCeEECCCCcEEEEeec
Q 002409 670 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA--IIHRDLKSSNILLDKHMRAKVSDFG 747 (927)
Q Consensus 670 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivHrDLkp~NILl~~~~~vkL~DFG 747 (927)
.++||||+. |+|.+++.... ....+++..++.++.|++.||+|||++ + |+||||||+|||++.++.+||+|||
T Consensus 109 ~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 109 FLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp EEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred EEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecCc
Confidence 799999996 79998885432 245689999999999999999999998 7 9999999999999999999999999
Q ss_pred CcccccCCCCce-----------eeeeccCCCccCcccc---ccCcCCCccceeeHHHHHHHHHhCCCcccccccccccc
Q 002409 748 LSKFAVDGASHV-----------SSIVRGTVGYLDPEYY---ISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCR 813 (927)
Q Consensus 748 la~~~~~~~~~~-----------~~~~~gt~~Y~aPE~~---~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~ 813 (927)
+++......... .....||+.|+|||++ ....++.++|||||||++|||++|+.||......
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---- 259 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL---- 259 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH----
Confidence 998654332211 1134589999999998 5667889999999999999999999999754311
Q ss_pred hhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHH
Q 002409 814 NIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 879 (927)
Q Consensus 814 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~ 879 (927)
.+.. +... ..........+.+++.+|++.+|++||++.|++++|+.+...
T Consensus 260 ~~~~--------~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 260 RIVN--------GKYS--------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp --------------CC--------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred Hhhc--------Cccc--------CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 1111 0000 000011112477899999999999999999999999988653
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=337.26 Aligned_cols=258 Identities=26% Similarity=0.385 Sum_probs=205.0
Q ss_pred HHhc-cccccCceEEEEEEEC---CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEE
Q 002409 602 MLEK-KIGSGGFGVVYYGKLK---DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 675 (927)
Q Consensus 602 ~~~~-~IG~G~fG~Vy~~~~~---~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E 675 (927)
.+.+ .||+|+||.||+|.+. .++.||||+++... ....+.+.+|++++++++||||+++++++ ..+..++|||
T Consensus 19 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e 97 (291)
T 1xbb_A 19 TLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVME 97 (291)
T ss_dssp EEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEE
T ss_pred hhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEE
Confidence 3445 8999999999999653 46789999997543 23356799999999999999999999999 5667899999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCC
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 755 (927)
|+++++|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 98 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (291)
T 1xbb_A 98 MAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 170 (291)
T ss_dssp CCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred eCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence 9999999999853 34588999999999999999999998 9999999999999999999999999999865443
Q ss_pred CCcee--eeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCccccc
Q 002409 756 ASHVS--SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 832 (927)
Q Consensus 756 ~~~~~--~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 832 (927)
..... ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .+...+. .+..
T Consensus 171 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~~~~----~~~~---- 238 (291)
T 1xbb_A 171 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS----EVTAMLE----KGER---- 238 (291)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----HHHHHHH----TTCC----
T ss_pred CCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH----HHHHHHH----cCCC----
Confidence 33222 22346789999999998889999999999999999999 99999764421 2222211 1111
Q ss_pred CCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHHHHHHh
Q 002409 833 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIEREAA 884 (927)
Q Consensus 833 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~~~~~~ 884 (927)
...+......+.+++.+|++.+|++||++.||++.|+++........
T Consensus 239 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~ 285 (291)
T 1xbb_A 239 -----MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG 285 (291)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHHH
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhcc
Confidence 11112233468899999999999999999999999999987665443
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=348.88 Aligned_cols=248 Identities=24% Similarity=0.351 Sum_probs=185.9
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
+.+.+.||+|+||.||+|+.. +++.||||+++... ..+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 55 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 132 (349)
T 2w4o_A 55 FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTG 132 (349)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCC
Confidence 456789999999999999987 57889999997543 345688999999999999999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECC---CCcEEEEeecCcccccCCC
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~---~~~vkL~DFGla~~~~~~~ 756 (927)
|+|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 133 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~- 204 (349)
T 2w4o_A 133 GELFDRIVE----KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ- 204 (349)
T ss_dssp CBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCcc-
Confidence 999998843 35689999999999999999999998 9999999999999975 889999999999855332
Q ss_pred CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 757 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .+... +..+... .. ...
T Consensus 205 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~~----i~~~~~~-~~-~~~ 274 (349)
T 2w4o_A 205 -VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ---FMFRR----ILNCEYY-FI-SPW 274 (349)
T ss_dssp ---------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH---HHHHH----HHTTCCC-CC-TTT
T ss_pred -cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH---HHHHH----HHhCCCc-cC-Cch
Confidence 22234568999999999999899999999999999999999999996543111 11111 1111110 00 011
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
. ......+.+++.+|++.||++|||+.|++++
T Consensus 275 ~----~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 275 W----DEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp T----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred h----hhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 1223468899999999999999999999875
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=350.75 Aligned_cols=248 Identities=23% Similarity=0.309 Sum_probs=200.0
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
+.+.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+++|++++||||+++++++.+.+..++||||
T Consensus 17 y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 96 (384)
T 4fr4_A 17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDL 96 (384)
T ss_dssp EEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEec
Confidence 456789999999999999876 57889999987542 22346788999999999999999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
+.+|+|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 97 ~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 168 (384)
T 4fr4_A 97 LLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE- 168 (384)
T ss_dssp CTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCC-
Confidence 999999999853 45689999999999999999999998 9999999999999999999999999999865433
Q ss_pred CceeeeeccCCCccCcccccc---CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccC
Q 002409 757 SHVSSIVRGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 833 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~---~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 833 (927)
.......||+.|+|||++.. ..++.++|||||||++|||++|+.||...... ....+...... ..
T Consensus 169 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~-~~~~~~~~~~~----~~------ 236 (384)
T 4fr4_A 169 -TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST-SSKEIVHTFET----TV------ 236 (384)
T ss_dssp -CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS-CHHHHHHHHHH----CC------
T ss_pred -CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc-cHHHHHHHHhh----cc------
Confidence 22344569999999999974 45899999999999999999999999754321 11122221111 10
Q ss_pred CcccCccCHHHHHHHHHHHhhhcCCCCCCCCc-HHHHHHH
Q 002409 834 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS-ISEVLKD 872 (927)
Q Consensus 834 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-m~eV~~~ 872 (927)
..++......+.+++.+|++.+|++||+ +.+|.++
T Consensus 237 ----~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 237 ----VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp ----CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred ----cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 0111222346889999999999999998 7777653
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=334.77 Aligned_cols=253 Identities=22% Similarity=0.365 Sum_probs=198.9
Q ss_pred HHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
..+.+.+.||+|+||.||+++.. +++.+|+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 35667899999999999999876 68899999987653 33457789999999999999999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEE---CCCCcEEEEeecCccccc
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAV 753 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl---~~~~~vkL~DFGla~~~~ 753 (927)
+++|+|.+++.........+++..++.++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 999999999865544456799999999999999999999998 99999999999999 456789999999997554
Q ss_pred CCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccC
Q 002409 754 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 833 (927)
Q Consensus 754 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 833 (927)
... ......||+.|+|||.+. +.++.++|||||||++|||++|+.||...... .+....... ..... ..
T Consensus 179 ~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~----~~~~~~~~~--~~~~~--~~ 247 (285)
T 3is5_A 179 SDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE----EVQQKATYK--EPNYA--VE 247 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHC--CCCCC--C-
T ss_pred Ccc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH----HHHhhhccC--Ccccc--cc
Confidence 322 223456899999999875 56889999999999999999999999764421 111111111 00000 00
Q ss_pred CcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 834 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 834 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
... ....+.+++.+|++.||++|||+.||+++
T Consensus 248 ---~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 248 ---CRP----LTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp ----CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred ---cCc----CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001 12367899999999999999999999874
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=351.93 Aligned_cols=272 Identities=18% Similarity=0.247 Sum_probs=203.4
Q ss_pred HHHHhcccccc--CceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEE
Q 002409 600 TKMLEKKIGSG--GFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 674 (927)
Q Consensus 600 ~~~~~~~IG~G--~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~ 674 (927)
.|.+.+.||+| +||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 26 ~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 105 (389)
T 3gni_B 26 CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 105 (389)
T ss_dssp GEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEE
Confidence 35567899999 99999999987 68999999997543 333467888999999999999999999999999999999
Q ss_pred EeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccC
Q 002409 675 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 754 (927)
Q Consensus 675 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 754 (927)
||+++|+|.+++... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||.+.....
T Consensus 106 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 106 SFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp ECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 999999999998543 234589999999999999999999998 999999999999999999999999998864322
Q ss_pred CCC------ceeeeeccCCCccCcccccc--CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhh-c-
Q 002409 755 GAS------HVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI-E- 824 (927)
Q Consensus 755 ~~~------~~~~~~~gt~~Y~aPE~~~~--~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~-~- 824 (927)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+........ .
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 260 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence 111 11122468999999999987 6799999999999999999999999976442221111110000000 0
Q ss_pred -----------------cCCcccccCC---c------ccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH--HHHH
Q 002409 825 -----------------SGDIQGIIDP---S------LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD--IQDA 876 (927)
Q Consensus 825 -----------------~~~~~~~~d~---~------l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~--L~~~ 876 (927)
...+.+.+.. . ....+.......+.+++.+|++.||++|||+.|++++ ++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~ 340 (389)
T 3gni_B 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 340 (389)
T ss_dssp ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence 0000000000 0 0000112223468899999999999999999999987 5544
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=337.32 Aligned_cols=257 Identities=16% Similarity=0.243 Sum_probs=197.0
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc---hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
|.+.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 36 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 115 (309)
T 2h34_A 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRL 115 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEe
Confidence 456789999999999999976 688999999875432 2246788999999999999999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
+++++|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 116 ~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 116 INGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp CCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 999999999853 35689999999999999999999998 99999999999999999999999999997654433
Q ss_pred CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 757 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
........||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .+....... .....
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~~---~~~~~------ 255 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS----VMGAHINQA---IPRPS------ 255 (309)
T ss_dssp --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH----HHHHHHHSC---CCCGG------
T ss_pred cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH----HHHHHhccC---CCCcc------
Confidence 33333456899999999999999999999999999999999999999764411 111111110 00000
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCC-cHHHHHHHHHHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRP-SISEVLKDIQDAIVI 879 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-sm~eV~~~L~~~~~~ 879 (927)
.........+.+++.+|++.+|++|| ++.++++.|++++..
T Consensus 256 --~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 256 --TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp --GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred --ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 11112223688999999999999999 999999999987654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=377.02 Aligned_cols=254 Identities=25% Similarity=0.419 Sum_probs=206.3
Q ss_pred HHHHhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
.+.+.+.||+|+||.||+|+++++..||||+++... ...+.|.+|+++|++++||||+++++++.+ +..++||||+++
T Consensus 268 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~ 345 (535)
T 2h8h_A 268 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 345 (535)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred hhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcC
Confidence 345678999999999999999988899999997654 335679999999999999999999999876 678999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
|+|.+++... ....+++..++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 346 gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 420 (535)
T 2h8h_A 346 GSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 420 (535)
T ss_dssp EEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHT
T ss_pred CcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceec
Confidence 9999999542 234588999999999999999999998 99999999999999999999999999998654321111
Q ss_pred eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCcccC
Q 002409 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 838 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 838 (927)
.....++..|+|||.+....++.++|||||||+||||++ |+.||...... .+.+.+ ..+.. .
T Consensus 421 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~----~~~~~i----~~~~~---------~ 483 (535)
T 2h8h_A 421 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLDQV----ERGYR---------M 483 (535)
T ss_dssp TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH----HHHHHH----HTTCC---------C
T ss_pred ccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHH----HcCCC---------C
Confidence 223346789999999999999999999999999999999 99999754311 222221 11110 0
Q ss_pred ccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHH
Q 002409 839 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 877 (927)
Q Consensus 839 ~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~ 877 (927)
..+......+.+++.+|++.+|++|||+.+|++.|+.+.
T Consensus 484 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 484 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 111223346889999999999999999999999999875
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=363.07 Aligned_cols=246 Identities=23% Similarity=0.303 Sum_probs=192.5
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecC---CchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
+.+.+.||+|+||.||+|+.. +++.||||++... .......+.+|+.++++++||||+++++++...+..++||||
T Consensus 150 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 229 (446)
T 4ejn_A 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY 229 (446)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECC
T ss_pred cEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEee
Confidence 455789999999999999876 6889999999753 223345678899999999999999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhh-CCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 755 (927)
+++|+|.+++. ....+++..+..++.|++.||+|||+ + +|+||||||+|||++.++.+||+|||+++.....
T Consensus 230 ~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 230 ANGGELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp CSSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred CCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 99999999884 34568999999999999999999998 7 9999999999999999999999999999754332
Q ss_pred CCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCc
Q 002409 756 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 835 (927)
Q Consensus 756 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 835 (927)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+...+.. ....+
T Consensus 303 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~i~~--~~~~~------- 368 (446)
T 4ejn_A 303 G-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KLFELILM--EEIRF------- 368 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHH--CCCCC-------
T ss_pred C-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH----HHHHHHHh--CCCCC-------
Confidence 2 2233456999999999999999999999999999999999999999765422 12221111 11111
Q ss_pred ccCccCHHHHHHHHHHHhhhcCCCCCCCC-----cHHHHHHH
Q 002409 836 LLDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 872 (927)
Q Consensus 836 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----sm~eV~~~ 872 (927)
+......+.+++.+|++.||++|| ++.|+++|
T Consensus 369 -----p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 369 -----PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp -----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -----CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 111224688999999999999999 99999986
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=340.04 Aligned_cols=263 Identities=22% Similarity=0.284 Sum_probs=195.9
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc--hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
.+.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 6 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (311)
T 4agu_A 6 EKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCD 85 (311)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCC
Confidence 45688999999999999986 589999999865432 234668899999999999999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
+++|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 157 (311)
T 4agu_A 86 HTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD- 157 (311)
T ss_dssp EEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred CchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-
Confidence 9999888742 35688999999999999999999998 999999999999999999999999999986543222
Q ss_pred eeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHh-------hhccCC-cc
Q 002409 759 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL-------HIESGD-IQ 829 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~-------~~~~~~-~~ 829 (927)
......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+...... ...... ..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
T 4agu_A 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence 2234468999999999976 67899999999999999999999999765422211111111000 000000 00
Q ss_pred --cccCCcccCc---cCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 830 --GIIDPSLLDE---YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 830 --~~~d~~l~~~---~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
...++.-... ........+.+++.+|++.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000000000 001223468899999999999999999999986
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=346.36 Aligned_cols=256 Identities=24% Similarity=0.379 Sum_probs=192.6
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc---hhhHhHHHHHHHHhhccCCCccceecceeecCe----EE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR----SV 671 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~----~~ 671 (927)
.|.+.+.||+|+||.||+|+.. +++.||||+++.... .....+.+|++++++++||||+++++++..... .+
T Consensus 13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 92 (311)
T 3ork_A 13 RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 92 (311)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccE
Confidence 3456789999999999999874 688999999976532 234568899999999999999999999876543 49
Q ss_pred EEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccc
Q 002409 672 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 751 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 751 (927)
+||||+++|+|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 93 lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 93 IVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred EEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 99999999999999853 45689999999999999999999998 999999999999999999999999999976
Q ss_pred ccCCCCc--eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcc
Q 002409 752 AVDGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 829 (927)
Q Consensus 752 ~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 829 (927)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ............
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-------~~~~~~~~~~~~ 238 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-------VAYQHVREDPIP 238 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHCCCCC
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-------HHHHHhcCCCCC
Confidence 5433221 2233568999999999999999999999999999999999999997644211 111111111100
Q ss_pred cccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHH-HHHHH
Q 002409 830 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK-DIQDA 876 (927)
Q Consensus 830 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~-~L~~~ 876 (927)
+ ..........+.+++.+|++.||++||++.++++ .|...
T Consensus 239 ----~---~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 239 ----P---SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp ----H---HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ----c---ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 0 0001112346889999999999999997666554 45443
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=334.37 Aligned_cols=262 Identities=21% Similarity=0.313 Sum_probs=203.7
Q ss_pred HHHHHhccccccCceEEEEEEE-CCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecce-eecCeEEEEEEe
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC-QEEGRSVLVYEF 676 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~-~~~~~~~lV~E~ 676 (927)
..|.+.+.||+|+||.||+|+. .+++.||||++.... ....+.+|++++++++|++++..++++ ...+..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence 3456678999999999999987 468899999876443 234688999999999988887777766 566778999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEE---CCCCcEEEEeecCccccc
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAV 753 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl---~~~~~vkL~DFGla~~~~ 753 (927)
+ +++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 87 ~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 87 L-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp C-CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred c-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 9 99999998532 34689999999999999999999998 99999999999999 788999999999998654
Q ss_pred CCCCc------eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCC
Q 002409 754 DGASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 827 (927)
Q Consensus 754 ~~~~~------~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 827 (927)
..... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+.......... .
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~ 238 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-P 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-C
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc-h
Confidence 43221 2234569999999999999999999999999999999999999997654322222222221111110 0
Q ss_pred cccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHH
Q 002409 828 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 879 (927)
Q Consensus 828 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~ 879 (927)
.. .+... ....+.+++.+|++.+|++||++.||++.|++++..
T Consensus 239 ~~-----~~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~ 281 (296)
T 4hgt_A 239 IE-----VLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp HH-----HHTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred hh-----hhhcc----CCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence 00 00011 124688999999999999999999999999998754
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=342.67 Aligned_cols=261 Identities=22% Similarity=0.298 Sum_probs=203.9
Q ss_pred cCHHHHHHHHHHHh-ccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhc-cCCCccceeccee
Q 002409 591 FTLSDIEDATKMLE-KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQ 665 (927)
Q Consensus 591 ~~~~ei~~~~~~~~-~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~ 665 (927)
+...+.....|.+. +.||+|+||.||+|+.. +++.||||++.... ......+.+|+.+++++ +||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 44445555555554 88999999999999877 68999999987542 23356789999999999 5699999999999
Q ss_pred ecCeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECC---CCcEE
Q 002409 666 EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAK 742 (927)
Q Consensus 666 ~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~---~~~vk 742 (927)
..+..++||||+++|+|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+|||++. ++.+|
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEE
T ss_pred eCCeEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEE
Confidence 999999999999999999998542 245689999999999999999999998 9999999999999998 78999
Q ss_pred EEeecCcccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhh
Q 002409 743 VSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH 822 (927)
Q Consensus 743 L~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~ 822 (927)
|+|||+++...... ......||+.|+|||++....++.++|||||||++|||++|+.||......+....+.. .
T Consensus 175 L~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~----~ 248 (327)
T 3lm5_A 175 IVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ----V 248 (327)
T ss_dssp ECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----T
T ss_pred EeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHh----c
Confidence 99999998654322 22335699999999999999999999999999999999999999976542211111111 0
Q ss_pred hccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 823 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 823 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.... ...........+.+++.+|++.+|++|||+.|++++
T Consensus 249 --~~~~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 249 --NVDY--------SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp --CCCC--------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred --cccc--------CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 0000 011111223468899999999999999999999876
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=337.73 Aligned_cols=255 Identities=30% Similarity=0.474 Sum_probs=198.4
Q ss_pred HHHhccccccCceEEEEEEECC----CcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceeccee-ecCeEEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQ-EEGRSVLVY 674 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~~----g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~-~~~~~~lV~ 674 (927)
+.+.+.||+|+||.||+|++.+ ...+|+|.+.... ....+.+.+|+.++++++||||+++++++. ..+..++||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 106 (298)
T 3f66_A 27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 106 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence 3456889999999999998653 2358999987543 334567899999999999999999999864 456789999
Q ss_pred EeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccC
Q 002409 675 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 754 (927)
Q Consensus 675 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 754 (927)
||+++|+|.+++.. ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 107 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 107 PYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp ECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred eCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccc
Confidence 99999999999954 245678999999999999999999998 999999999999999999999999999975543
Q ss_pred CCC---ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCccc
Q 002409 755 GAS---HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQG 830 (927)
Q Consensus 755 ~~~---~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 830 (927)
... .......||+.|+|||.+.+..++.++|||||||++|||++ |..||...... .+...... +..
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~----~~~~~~~~----~~~-- 250 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF----DITVYLLQ----GRR-- 250 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT----THHHHHHT----TCC--
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH----HHHHHHhc----CCC--
Confidence 221 12233457889999999999999999999999999999999 55555543311 11111111 110
Q ss_pred ccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 831 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 831 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
... +......+.+++.+|++.+|++||++.|+++.|++++.
T Consensus 251 ~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 251 LLQ-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp CCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCC-------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 000 11122468899999999999999999999999999875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=336.38 Aligned_cols=254 Identities=24% Similarity=0.354 Sum_probs=200.2
Q ss_pred hccccccCceEEEEEEECC-C---cEEEEEEeecCCc-hhhHhHHHHHHHHhhccCCCccceecceeecCeE-EEEEEec
Q 002409 604 EKKIGSGGFGVVYYGKLKD-G---KEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS-VLVYEFM 677 (927)
Q Consensus 604 ~~~IG~G~fG~Vy~~~~~~-g---~~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~-~lV~E~~ 677 (927)
.+.||+|+||.||+|++.+ + ..+|+|++..... ...+.+.+|++++++++||||+++++++.+.+.. ++||||+
T Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~ 105 (298)
T 3pls_A 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM 105 (298)
T ss_dssp EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCC
T ss_pred CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecc
Confidence 5789999999999998642 2 3699999875433 3456789999999999999999999999876655 9999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC-
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA- 756 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~- 756 (927)
.+|+|.+++.. ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 106 ~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 106 CHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp TTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred cCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 99999999854 245688999999999999999999998 99999999999999999999999999997543321
Q ss_pred --CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCC
Q 002409 757 --SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 834 (927)
Q Consensus 757 --~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 834 (927)
........+|+.|+|||.+.+..++.++|||||||++|||++|..|+...... ..+....... ..
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~---~~~~~~~~~~----~~------ 246 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP---FDLTHFLAQG----RR------ 246 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG---GGHHHHHHTT----CC------
T ss_pred cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH---HHHHHHhhcC----CC------
Confidence 11223345788999999999999999999999999999999966654332211 1222221111 10
Q ss_pred cccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHH
Q 002409 835 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 879 (927)
Q Consensus 835 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~ 879 (927)
...+......+.+++.+|++.+|++|||+.|+++.|++++..
T Consensus 247 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 247 ---LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 001111234688999999999999999999999999998753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=333.21 Aligned_cols=249 Identities=24% Similarity=0.358 Sum_probs=200.3
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 87 (284)
T 3kk8_A 8 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV 87 (284)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred hhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecC
Confidence 345688999999999999876 58899999987543 233467889999999999999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCc---EEEEeecCcccccC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR---AKVSDFGLSKFAVD 754 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~---vkL~DFGla~~~~~ 754 (927)
++++|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||++.....
T Consensus 88 ~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 88 TGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp CSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 99999888843 45689999999999999999999998 9999999999999986655 99999999976543
Q ss_pred CCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCC
Q 002409 755 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 834 (927)
Q Consensus 755 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 834 (927)
... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .+..... .+.... ..+
T Consensus 161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~~~~~----~~~~~~-~~~ 229 (284)
T 3kk8_A 161 SEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH----RLYAQIK----AGAYDY-PSP 229 (284)
T ss_dssp SCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHH----HTCCCC-CTT
T ss_pred Ccc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh----HHHHHHH----hccccC-Cch
Confidence 322 23356899999999999999999999999999999999999999764421 1111111 111100 000
Q ss_pred cccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 835 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 835 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
... .....+.+++.+|++.+|++|||+.|++++
T Consensus 230 -~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 230 -EWD----TVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp -TTT----TSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -hhc----ccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 011 122468899999999999999999999886
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=351.95 Aligned_cols=254 Identities=30% Similarity=0.478 Sum_probs=192.6
Q ss_pred HHhccccccCceEEEEEEEC--CC--cEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceee-cCeEEEEEE
Q 002409 602 MLEKKIGSGGFGVVYYGKLK--DG--KEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE-EGRSVLVYE 675 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~--~g--~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~-~~~~~lV~E 675 (927)
.+.+.||+|+||.||+|++. ++ ..||||.++... ....+.+.+|+.++++++||||+++++++.. .+..++|||
T Consensus 92 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e 171 (373)
T 3c1x_A 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 171 (373)
T ss_dssp EEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEE
T ss_pred ecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEE
Confidence 34678999999999999864 22 358999886543 3445779999999999999999999998754 567899999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCC
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 755 (927)
|+++|+|.+++... ...+++..++.++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 172 ~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 172 YMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp CCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred CCCCCCHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999999532 34578899999999999999999998 9999999999999999999999999999855432
Q ss_pred CCc---eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccc
Q 002409 756 ASH---VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 831 (927)
Q Consensus 756 ~~~---~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 831 (927)
... ......+|+.|+|||.+.+..++.++|||||||++|||++ |..||...... .+..... .+.. .
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~----~~~~~~~----~~~~--~ 315 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF----DITVYLL----QGRR--L 315 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS----CHHHHHH----TTCC--C
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH----HHHHHHH----cCCC--C
Confidence 211 1233457889999999999999999999999999999999 67777654322 1222111 1110 0
Q ss_pred cCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 832 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 832 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
.. +......+.+++.+|++.+|++||++.|++++|++++.
T Consensus 316 ~~-------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~ 355 (373)
T 3c1x_A 316 LQ-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355 (373)
T ss_dssp CC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 00 11223468899999999999999999999999999864
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=344.41 Aligned_cols=256 Identities=28% Similarity=0.446 Sum_probs=202.4
Q ss_pred HHHhccccccCceEEEEEEEC-CCcE--EEEEEeecC-CchhhHhHHHHHHHHhhc-cCCCccceecceeecCeEEEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKE--IAVKVLTSN-SYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE 675 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~--VAVK~l~~~-~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~lV~E 675 (927)
+.+.+.||+|+||.||+|+.. ++.. +|+|.++.. .....+.+.+|+++++++ +||||+++++++...+..++|||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 106 (327)
T 1fvr_A 27 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 106 (327)
T ss_dssp CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEe
Confidence 456789999999999999875 4554 499988754 233456789999999999 99999999999999999999999
Q ss_pred eccCCchhhhccccc------------ccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEE
Q 002409 676 FMHNGTLKEHLYGTL------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV 743 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL 743 (927)
|+++|+|.+++.... .....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||
T Consensus 107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kL 183 (327)
T 1fvr_A 107 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKI 183 (327)
T ss_dssp CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEE
T ss_pred cCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeEEE
Confidence 999999999986542 2234689999999999999999999998 9999999999999999999999
Q ss_pred EeecCcccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhh
Q 002409 744 SDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLH 822 (927)
Q Consensus 744 ~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~ 822 (927)
+|||+++..... .......+++.|+|||.+....++.++|||||||++|||++ |+.||...... .+.+.
T Consensus 184 ~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~----~~~~~---- 253 (327)
T 1fvr_A 184 ADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----ELYEK---- 253 (327)
T ss_dssp CCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHH----
T ss_pred cccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH----HHHHH----
Confidence 999998733211 11223347889999999988889999999999999999998 99999764421 11111
Q ss_pred hccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 823 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 823 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
+..+.. ...+......+.+++.+|++.+|++||++.|++++|++++.
T Consensus 254 ~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 300 (327)
T 1fvr_A 254 LPQGYR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300 (327)
T ss_dssp GGGTCC---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhcCCC---------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 111110 01111223468899999999999999999999999999875
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=354.23 Aligned_cols=248 Identities=23% Similarity=0.322 Sum_probs=193.9
Q ss_pred HHHhccccccCceEEEEEEECCCcEEEEEEeecCC--chhhHhHHHHHHHHhhcc--CCCccceecceeecCeEEEEEEe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIH--HRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~--HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
|.+.+.||+|+||.||++...+++.||||++.... ......+.+|+++|++++ ||||+++++++...+..++|||
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E- 136 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 136 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-
T ss_pred eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-
Confidence 55678999999999999998889999999987543 334567899999999996 5999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
+.+++|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++ ++.+||+|||+++......
T Consensus 137 ~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 137 CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 668899999853 34688889999999999999999998 999999999999995 5899999999998654332
Q ss_pred Cc-eeeeeccCCCccCcccccc-----------CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhc
Q 002409 757 SH-VSSIVRGTVGYLDPEYYIS-----------QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE 824 (927)
Q Consensus 757 ~~-~~~~~~gt~~Y~aPE~~~~-----------~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~ 824 (927)
.. ......||+.|+|||++.. ..++.++|||||||++|||++|+.||..... .........
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~------~~~~~~~~~- 281 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------QISKLHAII- 281 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC------HHHHHHHHH-
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH------HHHHHHHHh-
Confidence 22 2334569999999999865 3688899999999999999999999965321 111111111
Q ss_pred cCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 825 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 825 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
++.....++......+.+++.+|++.+|++||++.|++++
T Consensus 282 --------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 282 --------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp --------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --------CccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1111111111123468899999999999999999999976
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=343.23 Aligned_cols=268 Identities=24% Similarity=0.379 Sum_probs=194.0
Q ss_pred HHHhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHH--HHHHhhccCCCccceeccee-----ecCeEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNE--VTLLSRIHHRNLVQFLGYCQ-----EEGRSVLV 673 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~E--i~iL~~l~HpnIv~l~g~~~-----~~~~~~lV 673 (927)
+.+.+.||+|+||.||+|+.. ++.||||++.... ...+..| +..+..++||||+++++.+. .....++|
T Consensus 15 y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv 90 (336)
T 3g2f_A 15 LKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLV 90 (336)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEE
T ss_pred hheeeecccCCCeEEEEEEEC-CeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEE
Confidence 345689999999999999874 8999999987443 2333444 44455689999999998543 23367899
Q ss_pred EEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCC------CCceecCCCCCCCeEECCCCcEEEEeec
Q 002409 674 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC------VPAIIHRDLKSSNILLDKHMRAKVSDFG 747 (927)
Q Consensus 674 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~------~~~ivHrDLkp~NILl~~~~~vkL~DFG 747 (927)
|||+++|+|.+++.. ...++..++.++.|+++||+|||+.+ .++|+||||||+|||++.++.+||+|||
T Consensus 91 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG 165 (336)
T 3g2f_A 91 MEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165 (336)
T ss_dssp ECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred EecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence 999999999999843 34588899999999999999999862 2389999999999999999999999999
Q ss_pred CcccccCCC-------CceeeeeccCCCccCcccccc-------CcCCCccceeeHHHHHHHHHhCCCcccccccccccc
Q 002409 748 LSKFAVDGA-------SHVSSIVRGTVGYLDPEYYIS-------QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCR 813 (927)
Q Consensus 748 la~~~~~~~-------~~~~~~~~gt~~Y~aPE~~~~-------~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~ 813 (927)
+++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.|+..........
T Consensus 166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~ 245 (336)
T 3g2f_A 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245 (336)
T ss_dssp TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence 998654321 111223469999999999976 456778999999999999999987764332111111
Q ss_pred hhhH----------HHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHH
Q 002409 814 NIVQ----------WAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 879 (927)
Q Consensus 814 ~l~~----------~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~ 879 (927)
.... ..............+..... ........+.+++.+|++.+|++|||+.||++.|++++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWK--ENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCC--CCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HhhhcccCCCchHHHHHhhhcccccCCCCCcccc--cccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 1110 00000001110011111110 1233556799999999999999999999999999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=333.48 Aligned_cols=251 Identities=24% Similarity=0.347 Sum_probs=200.3
Q ss_pred HHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCch------hhHhHHHHHHHHhhccCCCccceecceeecCeEE
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 671 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~------~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~ 671 (927)
..|.+.+.||+|+||.||+++.. +++.||+|++...... ..+.+.+|++++++++||||+++++++...+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 34567789999999999999987 6899999998754221 3567899999999999999999999999999999
Q ss_pred EEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCC----cEEEEeec
Q 002409 672 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM----RAKVSDFG 747 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~----~vkL~DFG 747 (927)
+||||+++++|.+++.. ...+++..++.++.|++.||+|||++ +++||||||+||+++.++ .+||+|||
T Consensus 85 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 99999999999999843 45689999999999999999999998 999999999999999877 89999999
Q ss_pred CcccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCC
Q 002409 748 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 827 (927)
Q Consensus 748 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 827 (927)
+++...... ......||+.|+|||.+....++.++||||||+++|||++|+.||......+ ..... ....
T Consensus 158 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~----~~~~ 227 (283)
T 3bhy_A 158 IAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE----TLTNI----SAVN 227 (283)
T ss_dssp TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHH----HTTC
T ss_pred cceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH----HHHHh----Hhcc
Confidence 997654322 1233458999999999998999999999999999999999999997644211 11111 1110
Q ss_pred cccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 828 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 828 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
. ..++... ......+.+++.+|++.+|++||++.|++++
T Consensus 228 ~--~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 228 Y--DFDEEYF----SNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp C--CCCHHHH----TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred c--CCcchhc----ccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 0 0000111 1123468899999999999999999999985
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=332.35 Aligned_cols=260 Identities=22% Similarity=0.310 Sum_probs=203.6
Q ss_pred HHHhccccccCceEEEEEEE-CCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecce-eecCeEEEEEEecc
Q 002409 601 KMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC-QEEGRSVLVYEFMH 678 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~-~~~~~~~lV~E~~~ 678 (927)
|.+.+.||+|+||.||+|+. .+++.||||++..... ...+.+|+.++++++|++++..+.++ ...+..++||||+
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~- 87 (296)
T 3uzp_A 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 87 (296)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred EEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-
Confidence 34568899999999999987 4789999999875432 35688999999999998877777666 5567789999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEEC---CCCcEEEEeecCcccccCC
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~---~~~~vkL~DFGla~~~~~~ 755 (927)
+++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++ .++.+||+|||+++.....
T Consensus 88 ~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 88 GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 89999998532 34689999999999999999999998 999999999999994 7889999999999865543
Q ss_pred CCc------eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcc
Q 002409 756 ASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 829 (927)
Q Consensus 756 ~~~------~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 829 (927)
... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+......... ....
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~ 240 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-TPIE 240 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH-SCHH
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC-CchH
Confidence 321 123456999999999999999999999999999999999999999864422222222111111111 0000
Q ss_pred cccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHH
Q 002409 830 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 879 (927)
Q Consensus 830 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~ 879 (927)
.+.. .....+.+++.+|++.+|++||++.||++.|+++...
T Consensus 241 -----~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 281 (296)
T 3uzp_A 241 -----VLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp -----HHTT----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred -----HHHh----hCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence 0011 1224688999999999999999999999999998653
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=346.50 Aligned_cols=264 Identities=27% Similarity=0.398 Sum_probs=206.8
Q ss_pred HHHHhccccccCceEEEEEEE-----CCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecC--eEEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKL-----KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG--RSVL 672 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~-----~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~~~l 672 (927)
.+.+.+.||+|+||.||++++ .+++.||||++........+.+.+|++++++++||||+++++++...+ ..++
T Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 121 (326)
T 2w1i_A 42 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 121 (326)
T ss_dssp GEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEE
T ss_pred HceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEE
Confidence 345678999999999999984 368899999998766666778999999999999999999999886644 6799
Q ss_pred EEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccc
Q 002409 673 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 752 (927)
Q Consensus 673 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 752 (927)
||||+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 122 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 122 IMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 99999999999998543 34589999999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCCce--eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccc--------cccchhhHHHHhh
Q 002409 753 VDGASHV--SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG--------ANCRNIVQWAKLH 822 (927)
Q Consensus 753 ~~~~~~~--~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~--------~~~~~l~~~~~~~ 822 (927)
....... .....++..|+|||.+.+..++.++|||||||++|||++|+.|+...... .............
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence 4433221 12334678899999999888999999999999999999999988643200 0000011111111
Q ss_pred hccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 823 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 823 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
...+.. ...+......+.+++.+|++.+|++||++.||++.|+++..
T Consensus 276 ~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 276 LKNNGR---------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HHTTCC---------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhcCCC---------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111110 11112233568899999999999999999999999998864
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=349.51 Aligned_cols=252 Identities=24% Similarity=0.321 Sum_probs=201.1
Q ss_pred HHHhccccccCceEEEEEEE----CCCcEEEEEEeecCC----chhhHhHHHHHHHHhhc-cCCCccceecceeecCeEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKL----KDGKEIAVKVLTSNS----YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSV 671 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~----~~g~~VAVK~l~~~~----~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~ 671 (927)
|.+.+.||+|+||.||+++. .+++.||||+++... ......+.+|+++++++ +||||+++++++...+..+
T Consensus 56 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 135 (355)
T 1vzo_A 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 135 (355)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEE
Confidence 45678999999999999987 368999999986532 22345677899999999 6999999999999999999
Q ss_pred EEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccc
Q 002409 672 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 751 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 751 (927)
+||||+++|+|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 136 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 136 LILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred EEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 99999999999999853 35689999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCCceeeeeccCCCccCcccccc--CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcc
Q 002409 752 AVDGASHVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 829 (927)
Q Consensus 752 ~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 829 (927)
.............||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.+.....
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~------- 281 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS------- 281 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-------
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc-------
Confidence 54433333444579999999999985 457889999999999999999999997544222222222211110
Q ss_pred cccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCC-----cHHHHHHHH
Q 002409 830 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKDI 873 (927)
Q Consensus 830 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----sm~eV~~~L 873 (927)
.+ .++......+.+++.+|++.||++|| ++.|++++.
T Consensus 282 ---~~----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 ---EP----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ---CC----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ---CC----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 01 11122234678999999999999999 999999875
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=334.23 Aligned_cols=244 Identities=25% Similarity=0.403 Sum_probs=197.2
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
|.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (279)
T 3fdn_A 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 90 (279)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEec
Confidence 345688999999999999876 56789999986542 12246688999999999999999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
+++|+|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 91 ~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~- 162 (279)
T 3fdn_A 91 APLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 162 (279)
T ss_dssp CTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCcc-
Confidence 999999998843 35688999999999999999999998 9999999999999999999999999988643322
Q ss_pred CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 757 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....+ .....
T Consensus 163 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~~-------- 224 (279)
T 3fdn_A 163 --RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI--------SRVEF-------- 224 (279)
T ss_dssp -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--------HHTCC--------
T ss_pred --cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHH--------HhCCC--------
Confidence 223346899999999999999999999999999999999999999765422111111 11100
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.++......+.+++.+|++.+|++||++.|++++
T Consensus 225 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 225 --TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp --CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred --CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0111123467899999999999999999999987
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=351.02 Aligned_cols=242 Identities=26% Similarity=0.325 Sum_probs=189.5
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc---hhhHhHHHHHHH-HhhccCCCccceecceeecCeEEEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTL-LSRIHHRNLVQFLGYCQEEGRSVLVYE 675 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~i-L~~l~HpnIv~l~g~~~~~~~~~lV~E 675 (927)
+.+.+.||+|+||.||+++.+ +++.||||+++.... .....+..|..+ ++.++||||+++++++.+.+..++|||
T Consensus 40 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E 119 (373)
T 2r5t_A 40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLD 119 (373)
T ss_dssp EEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEe
Confidence 456789999999999999987 578899999976532 223456667766 577899999999999999999999999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCC
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 755 (927)
|+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++.....
T Consensus 120 ~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 120 YINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp CCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 9999999998843 45688899999999999999999998 9999999999999999999999999999854332
Q ss_pred CCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCc
Q 002409 756 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 835 (927)
Q Consensus 756 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 835 (927)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.. +.+ .
T Consensus 193 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--------~~~------~ 257 (373)
T 2r5t_A 193 N-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN--------KPL------Q 257 (373)
T ss_dssp C-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHH--------SCC------C
T ss_pred C-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh--------ccc------C
Confidence 2 233455799999999999999999999999999999999999999976542222222211 111 0
Q ss_pred ccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHH
Q 002409 836 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISE 868 (927)
Q Consensus 836 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~e 868 (927)
+... ....+.+++.+|++.+|++||++.+
T Consensus 258 ~~~~----~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 258 LKPN----ITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp CCSS----SCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred CCCC----CCHHHHHHHHHHcccCHHhCCCCCC
Confidence 1111 2235789999999999999999853
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=370.66 Aligned_cols=249 Identities=26% Similarity=0.415 Sum_probs=200.0
Q ss_pred cccccCceEEEEEEEC---CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCCc
Q 002409 606 KIGSGGFGVVYYGKLK---DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 681 (927)
Q Consensus 606 ~IG~G~fG~Vy~~~~~---~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gs 681 (927)
.||+|+||.||+|.+. ++..||||+++... ....+.+.+|+++|++++||||+++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 6999999999999874 45679999997653 3346789999999999999999999999976 56899999999999
Q ss_pred hhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCcee-
Q 002409 682 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS- 760 (927)
Q Consensus 682 L~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~- 760 (927)
|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..........
T Consensus 422 L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 495 (613)
T 2ozo_A 422 LHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495 (613)
T ss_dssp HHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred HHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence 99998542 45689999999999999999999998 999999999999999999999999999986543322211
Q ss_pred -eeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCcccC
Q 002409 761 -SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 838 (927)
Q Consensus 761 -~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 838 (927)
....+|+.|+|||++....++.++|||||||++|||++ |+.||...... .+.+.+ ..+.. .
T Consensus 496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~----~~~~~i----~~~~~---------~ 558 (613)
T 2ozo_A 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----EVMAFI----EQGKR---------M 558 (613)
T ss_dssp ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH----HHHHHH----HTTCC---------C
T ss_pred ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH----HHHHHH----HcCCC---------C
Confidence 22335689999999999999999999999999999998 99999765422 222221 11211 1
Q ss_pred ccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 839 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 839 ~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
..+......+.+++.+|++.+|++||++.+|++.|+.+..
T Consensus 559 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 598 (613)
T 2ozo_A 559 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 598 (613)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 1122334578899999999999999999999999998764
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=332.13 Aligned_cols=247 Identities=23% Similarity=0.362 Sum_probs=179.9
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc---hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
+.+.+.||+|+||.||+|+.. +++.||||++..... .....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 13 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 92 (278)
T 3cok_A 13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEM 92 (278)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEec
Confidence 345688999999999999874 789999999865421 2236788999999999999999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
+++++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 93 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 93 CHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp CTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred CCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 9999999998532 35689999999999999999999998 99999999999999999999999999997654322
Q ss_pred CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 757 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+ ... +...
T Consensus 167 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~~~------~~~~ 231 (278)
T 3cok_A 167 E-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV--------VLA------DYEM 231 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C--------CSS------CCCC
T ss_pred C-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH--------hhc------ccCC
Confidence 1 223346899999999999888999999999999999999999999764422111100 000 0011
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
+......+.+++.+|++.+|++||++.|++++
T Consensus 232 ----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 232 ----PSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp ----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ----ccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 11123467899999999999999999999875
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=339.31 Aligned_cols=261 Identities=27% Similarity=0.407 Sum_probs=197.1
Q ss_pred HHHHHhccccccCceEEEEEEEC----CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecC----
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG---- 668 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~----~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~---- 668 (927)
..+.+.+.||+|+||.||+|++. .++.||||+++... ....+.+.+|+.++++++||||+++++++...+
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 113 (313)
T 3brb_A 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGI 113 (313)
T ss_dssp GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC------
T ss_pred HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCC
Confidence 34556788999999999999765 24579999987542 233467899999999999999999999997655
Q ss_pred -eEEEEEEeccCCchhhhccccc--ccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEe
Q 002409 669 -RSVLVYEFMHNGTLKEHLYGTL--THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD 745 (927)
Q Consensus 669 -~~~lV~E~~~~gsL~~~L~~~~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~D 745 (927)
..++||||+++|+|.+++.... .....+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|
T Consensus 114 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~D 190 (313)
T 3brb_A 114 PKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVAD 190 (313)
T ss_dssp -CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEECS
T ss_pred cccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEee
Confidence 3499999999999999984322 2345689999999999999999999998 999999999999999999999999
Q ss_pred ecCcccccCCCC-ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhh
Q 002409 746 FGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHI 823 (927)
Q Consensus 746 FGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~ 823 (927)
||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||...... .+......
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----~~~~~~~~-- 264 (313)
T 3brb_A 191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH----EMYDYLLH-- 264 (313)
T ss_dssp CSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----GHHHHHHT--
T ss_pred cCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH----HHHHHHHc--
Confidence 999976543321 12233457889999999999999999999999999999999 88898765422 12221111
Q ss_pred ccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHH
Q 002409 824 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 879 (927)
Q Consensus 824 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~ 879 (927)
+... ..+......+.+++.+|++.+|++||++.|++++|++++..
T Consensus 265 --~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 265 --GHRL---------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp --TCCC---------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCCC---------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1100 11112234688999999999999999999999999998753
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=337.84 Aligned_cols=256 Identities=23% Similarity=0.322 Sum_probs=194.8
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhc-cCCCccceecceeecCeEEEEEEeccCCc
Q 002409 604 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHNGT 681 (927)
Q Consensus 604 ~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~gs 681 (927)
.+.||+|+||.||+|+.. +++.||||++..........+.+|++++.++ +||||+++++++.+.+..++||||+++|+
T Consensus 18 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 97 (316)
T 2ac3_A 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGS 97 (316)
T ss_dssp CCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred CceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCc
Confidence 367999999999999865 6899999999876555567889999999985 79999999999999999999999999999
Q ss_pred hhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCc---EEEEeecCcccccCCC--
Q 002409 682 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR---AKVSDFGLSKFAVDGA-- 756 (927)
Q Consensus 682 L~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~---vkL~DFGla~~~~~~~-- 756 (927)
|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+++......
T Consensus 98 L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 170 (316)
T 2ac3_A 98 ILSHIHK----RRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC 170 (316)
T ss_dssp HHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--------
T ss_pred HHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcc
Confidence 9999853 35688999999999999999999998 9999999999999998776 9999999987543211
Q ss_pred ----CceeeeeccCCCccCcccccc-----CcCCCccceeeHHHHHHHHHhCCCcccccccccccc-------hhhHHHH
Q 002409 757 ----SHVSSIVRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCR-------NIVQWAK 820 (927)
Q Consensus 757 ----~~~~~~~~gt~~Y~aPE~~~~-----~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~-------~l~~~~~ 820 (927)
........||+.|+|||++.. ..++.++|||||||++|||++|+.||......+... .......
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 250 (316)
T 2ac3_A 171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF 250 (316)
T ss_dssp -----------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHH
T ss_pred ccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHH
Confidence 111223459999999999875 568999999999999999999999997643211000 0000011
Q ss_pred hhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 821 LHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 821 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
..+..+... +..... ......+.+++.+|++.||++|||+.|++++
T Consensus 251 ~~i~~~~~~--~~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 251 ESIQEGKYE--FPDKDW----AHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHCCCC--CCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHhccCcc--cCchhc----ccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 111111110 000000 0123468899999999999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=334.01 Aligned_cols=246 Identities=19% Similarity=0.302 Sum_probs=198.0
Q ss_pred HHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecC--CchhhHhHHHHHHHHhhc-cCCCccceecceeecCeEEEEE
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVY 674 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~lV~ 674 (927)
..|.+.+.||+|+||.||+|+.. +++.||||++... .......+.+|+..+.++ +||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 44566789999999999999887 7899999999754 233456788999999999 9999999999999999999999
Q ss_pred EeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCC----------------
Q 002409 675 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH---------------- 738 (927)
Q Consensus 675 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~---------------- 738 (927)
||+++++|.+++.........+++..++.++.|++.||+|||++ +|+||||||+|||++.+
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC------------------
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 99999999999965433336689999999999999999999998 99999999999999844
Q ss_pred ---CcEEEEeecCcccccCCCCceeeeeccCCCccCccccccC-cCCCccceeeHHHHHHHHHhCCCcccccccccccch
Q 002409 739 ---MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRN 814 (927)
Q Consensus 739 ---~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~ 814 (927)
..+||+|||++....... ...||+.|+|||.+.+. .++.++|||||||++|||++|..++.... .
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------~ 236 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD------Q 236 (289)
T ss_dssp --CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH------H
T ss_pred CCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh------H
Confidence 479999999998654322 23489999999999765 56679999999999999999988764332 1
Q ss_pred hhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 815 IVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 815 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
... ...+... .+... ....+.+++.+|++.+|++|||+.|++++
T Consensus 237 ~~~-----~~~~~~~-----~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 237 WHE-----IRQGRLP-----RIPQV----LSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HHH-----HHTTCCC-----CCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHH-----HHcCCCC-----CCCcc----cCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 111 1112111 11112 22468899999999999999999999875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=331.18 Aligned_cols=252 Identities=28% Similarity=0.435 Sum_probs=204.9
Q ss_pred HHHHHHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceee-------
Q 002409 595 DIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE------- 666 (927)
Q Consensus 595 ei~~~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~------- 666 (927)
+.....+.+.+.||+|+||.||+|+.. +++.||+|++.... ..+.+|++++++++||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 344455667889999999999999987 78999999987543 457789999999999999999998854
Q ss_pred ---------cCeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECC
Q 002409 667 ---------EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK 737 (927)
Q Consensus 667 ---------~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~ 737 (927)
....++||||+++|+|.+++... ....+++..++.++.|++.||.|||++ +|+||||||+|||++.
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~ 157 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVD 157 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEE
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcC
Confidence 44579999999999999999643 235689999999999999999999998 9999999999999999
Q ss_pred CCcEEEEeecCcccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhH
Q 002409 738 HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 817 (927)
Q Consensus 738 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~ 817 (927)
++.+||+|||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|..|+.... ....
T Consensus 158 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------~~~~ 229 (284)
T 2a19_B 158 TKQVKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS------KFFT 229 (284)
T ss_dssp TTEEEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH------HHHH
T ss_pred CCCEEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH------HHHH
Confidence 9999999999998654432 2233458999999999999999999999999999999999998875322 1111
Q ss_pred HHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHH
Q 002409 818 WAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 879 (927)
Q Consensus 818 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~ 879 (927)
....+.+. ..++ ..+.+++.+|++.+|++||++.|++++|+.+...
T Consensus 230 ----~~~~~~~~--------~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 230 ----DLRDGIIS--------DIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp ----HHHTTCCC--------TTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred ----Hhhccccc--------ccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 11112111 1122 3578999999999999999999999999987543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=345.62 Aligned_cols=245 Identities=24% Similarity=0.381 Sum_probs=196.6
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc---hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 675 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E 675 (927)
.+.+.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 134 (348)
T 1u5q_A 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 134 (348)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence 3455678999999999999874 788999999975432 223568899999999999999999999999999999999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCC
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 755 (927)
|+. |+|.+++.. ....+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 135 ~~~-g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 135 YCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp CCS-EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred cCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 997 688877743 235689999999999999999999998 9999999999999999999999999999755332
Q ss_pred CCceeeeeccCCCccCccccc---cCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCccccc
Q 002409 756 ASHVSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 832 (927)
Q Consensus 756 ~~~~~~~~~gt~~Y~aPE~~~---~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 832 (927)
....||+.|+|||++. ...++.++|||||||++|||++|+.||....... .+.. .. .+....
T Consensus 208 -----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~---~~~~----~~-~~~~~~-- 272 (348)
T 1u5q_A 208 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYH----IA-QNESPA-- 272 (348)
T ss_dssp -----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHH----HH-HSCCCC--
T ss_pred -----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHH----HH-hcCCCC--
Confidence 2346899999999985 5678999999999999999999999997543111 1111 11 111111
Q ss_pred CCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 833 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 833 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
... ......+.+++.+|++.+|++|||+.|++++
T Consensus 273 ---~~~---~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 273 ---LQS---GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ---CCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ---CCC---CCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 111 1122357899999999999999999999876
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=337.25 Aligned_cols=250 Identities=23% Similarity=0.380 Sum_probs=200.6
Q ss_pred HHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
..|.+.+.||+|+||.||+++.. +++.||+|+++.........+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 45566789999999999999886 68999999998665445567899999999999999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEE---CCCCcEEEEeecCcccccC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVD 754 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl---~~~~~vkL~DFGla~~~~~ 754 (927)
++++|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||+++....
T Consensus 89 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 89 SGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 99999998843 35688999999999999999999998 99999999999999 7889999999999875432
Q ss_pred CCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCC
Q 002409 755 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 834 (927)
Q Consensus 755 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 834 (927)
. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .+.... .++... ...
T Consensus 162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~i----~~~~~~--~~~ 228 (304)
T 2jam_A 162 G---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES----KLFEKI----KEGYYE--FES 228 (304)
T ss_dssp B---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHHH----HHCCCC--CCT
T ss_pred C---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHH----HcCCCC--CCc
Confidence 2 223345899999999999989999999999999999999999999754421 111111 111110 011
Q ss_pred cccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 835 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 835 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
... ......+.+++.+|++.+|++||++.|++++
T Consensus 229 ~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 229 PFW----DDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp TTT----TTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccc----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111 1223468899999999999999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=342.75 Aligned_cols=260 Identities=23% Similarity=0.403 Sum_probs=207.4
Q ss_pred HHHHhccccccCceEEEEEEEC------CCcEEEEEEeecCCc-hhhHhHHHHHHHHhhccCCCccceecceeecCeEEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 672 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~------~g~~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~l 672 (927)
.+.+.+.||+|+||.||+|++. +++.||||++..... .....+.+|++++++++||||+++++++...+..++
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 105 (322)
T 1p4o_A 26 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 105 (322)
T ss_dssp GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEE
T ss_pred heeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEE
Confidence 4556789999999999999765 367899999875433 334568899999999999999999999999999999
Q ss_pred EEEeccCCchhhhcccccc------cccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEee
Q 002409 673 VYEFMHNGTLKEHLYGTLT------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF 746 (927)
Q Consensus 673 V~E~~~~gsL~~~L~~~~~------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DF 746 (927)
||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 106 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~Df 182 (322)
T 1p4o_A 106 IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDF 182 (322)
T ss_dssp EEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCT
T ss_pred EEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEECcC
Confidence 9999999999999864321 114568899999999999999999998 9999999999999999999999999
Q ss_pred cCcccccCCCCc-eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhc
Q 002409 747 GLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIE 824 (927)
Q Consensus 747 Gla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~ 824 (927)
|+++........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...... .+...+ .
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----~~~~~~----~ 254 (322)
T 1p4o_A 183 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE----QVLRFV----M 254 (322)
T ss_dssp TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH----HHHHHH----H
T ss_pred ccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH----HHHHHH----H
Confidence 999755432221 1223346889999999998899999999999999999999 88998754321 122211 1
Q ss_pred cCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHH
Q 002409 825 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 879 (927)
Q Consensus 825 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~ 879 (927)
.+.... .+......+.+++.+|++.+|++||++.|++++|++++..
T Consensus 255 ~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 255 EGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp TTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred cCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 111111 1112234688999999999999999999999999987653
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=373.14 Aligned_cols=249 Identities=27% Similarity=0.412 Sum_probs=199.0
Q ss_pred ccccccCceEEEEEEEC---CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 605 KKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~---~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
+.||+|+||.||+|.+. .++.||||+++... ....+++.+|+++|++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999653 46789999997643 2335789999999999999999999999964 458899999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc-
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH- 758 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~- 758 (927)
|+|.+++. ....+++..++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 454 g~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 99999994 345689999999999999999999998 9999999999999999999999999999865443221
Q ss_pred -eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 759 -VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 759 -~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
......+|+.|+|||++....++.++|||||||++|||++ |+.||...... .+.+. +..+..
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~----~~~~~----i~~~~~-------- 590 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS----EVTAM----LEKGER-------- 590 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----HHHHH----HHTTCC--------
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHH----HHcCCC--------
Confidence 2233446789999999999999999999999999999998 99999765421 12221 111211
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
...+.....++.+++.+|++.+|++||++.+|++.|+++..
T Consensus 591 -~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 591 -MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11122233578899999999999999999999999998764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=345.12 Aligned_cols=251 Identities=24% Similarity=0.343 Sum_probs=198.9
Q ss_pred HHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhc-cCCCccceecceeecCeEEEEEEe
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
..|.+.+.||+|+||.||+++.+ +++.||||++.... ....+|++++.++ +||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT----CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc----CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 34566789999999999999886 68899999997543 2345788888888 799999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCC----CcEEEEeecCcccc
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH----MRAKVSDFGLSKFA 752 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~----~~vkL~DFGla~~~ 752 (927)
+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+..+ +.+||+|||+++..
T Consensus 98 ~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 98 MKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 999999998843 35689999999999999999999998 99999999999998543 35999999999865
Q ss_pred cCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCccccc
Q 002409 753 VDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 832 (927)
Q Consensus 753 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 832 (927)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ......+... +..+.+.
T Consensus 171 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-~~~~~~~~~~----i~~~~~~--- 241 (342)
T 2qr7_A 171 RAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP-DDTPEEILAR----IGSGKFS--- 241 (342)
T ss_dssp BCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSST-TSCHHHHHHH----HHHCCCC---
T ss_pred cCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCC-cCCHHHHHHH----HccCCcc---
Confidence 44322 2334568999999999988889999999999999999999999997532 1111122221 1222211
Q ss_pred CCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 833 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 833 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
+...+.......+.+++.+|++.||++||++.|+++|
T Consensus 242 ---~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 242 ---LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp ---CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ---cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0111111223468899999999999999999999876
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=336.59 Aligned_cols=254 Identities=24% Similarity=0.332 Sum_probs=202.1
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceeccee--ecCeEEEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQ--EEGRSVLVYE 675 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~~~lV~E 675 (927)
|.+.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|++++++++||||+++++++. .....++|||
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 87 (279)
T 2w5a_A 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 87 (279)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEE
T ss_pred eeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEe
Confidence 345688999999999999886 68899999997543 334567899999999999999999999874 4678899999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCc-----eecCCCCCCCeEECCCCcEEEEeecCcc
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA-----IIHRDLKSSNILLDKHMRAKVSDFGLSK 750 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~-----ivHrDLkp~NILl~~~~~vkL~DFGla~ 750 (927)
|+++++|.+++.........+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||+|||+++
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 88 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp CCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred CCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 9999999999965443445589999999999999999999998 6 9999999999999999999999999997
Q ss_pred cccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCccc
Q 002409 751 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 830 (927)
Q Consensus 751 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 830 (927)
...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .+... +..+....
T Consensus 165 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~----i~~~~~~~ 235 (279)
T 2w5a_A 165 ILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK----ELAGK----IREGKFRR 235 (279)
T ss_dssp HC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHH----HHHTCCCC
T ss_pred eecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH----HHHHH----Hhhccccc
Confidence 654322 1222346899999999999889999999999999999999999999764411 12221 11222111
Q ss_pred ccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHH
Q 002409 831 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 875 (927)
Q Consensus 831 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~ 875 (927)
+ +......+.+++.+|++.+|++||++.||++++..
T Consensus 236 -----~----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 236 -----I----PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp -----C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred -----C----CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 1 11223468899999999999999999999997764
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=345.12 Aligned_cols=263 Identities=19% Similarity=0.213 Sum_probs=196.0
Q ss_pred HHHHHhccccccCceEEEEEEEC----CCcEEEEEEeecCCch-----------hhHhHHHHHHHHhhccCCCccceecc
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNSYQ-----------GKREFTNEVTLLSRIHHRNLVQFLGY 663 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~----~g~~VAVK~l~~~~~~-----------~~~~~~~Ei~iL~~l~HpnIv~l~g~ 663 (927)
..|.+.+.||+|+||.||+|+.. .+..+|||++...... ....+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 34566789999999999999986 4678999998765322 12346678889999999999999999
Q ss_pred eee----cCeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCC
Q 002409 664 CQE----EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM 739 (927)
Q Consensus 664 ~~~----~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~ 739 (927)
+.. ....++||||+ +++|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence 987 67889999999 9999999853 33789999999999999999999998 999999999999999887
Q ss_pred --cEEEEeecCcccccCCCC------ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccc
Q 002409 740 --RAKVSDFGLSKFAVDGAS------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGAN 811 (927)
Q Consensus 740 --~vkL~DFGla~~~~~~~~------~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~ 811 (927)
.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~- 267 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP- 267 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH-
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc-
Confidence 999999999975533211 11134569999999999999899999999999999999999999996432111
Q ss_pred cchhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHH
Q 002409 812 CRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 876 (927)
Q Consensus 812 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~ 876 (927)
......+..... .+...+..... ......++.+++.+|++.+|++||++.||++.|+++
T Consensus 268 --~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 268 --VAVQTAKTNLLD-ELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp --HHHHHHHHHHHH-TTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred --HHHHHHHHhhcc-cccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 111111111110 01110100000 002234688999999999999999999999999975
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=330.02 Aligned_cols=251 Identities=22% Similarity=0.360 Sum_probs=201.5
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
.+.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (276)
T 2yex_A 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 87 (276)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEec
Confidence 4556789999999999999886 68999999987543 334567899999999999999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
++++|.+++.. ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++........
T Consensus 88 ~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 88 SGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp TTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred CCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 99999998843 45689999999999999999999998 999999999999999999999999999975433221
Q ss_pred -ceeeeeccCCCccCccccccCcC-CCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCc
Q 002409 758 -HVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 835 (927)
Q Consensus 758 -~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 835 (927)
.......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||...... ......|.... .. ..
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~---~~----~~-- 229 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS--CQEYSDWKEKK---TY----LN-- 229 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT--SHHHHHHHTTC---TT----ST--
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH--HHHHHHhhhcc---cc----cC--
Confidence 12234568999999999987665 77899999999999999999999764311 11122221111 00 00
Q ss_pred ccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 836 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 836 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.. ......+.+++.+|++.+|++|||+.|++++
T Consensus 230 ~~----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 230 PW----KKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp TG----GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ch----hhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 00 1123467899999999999999999999875
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=357.85 Aligned_cols=245 Identities=24% Similarity=0.397 Sum_probs=201.6
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc---hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
|.+.+.||+|+||.||+|++. +|+.||||++..... .....+.+|++++++++||||+++++++...+..++||||
T Consensus 18 Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~ 97 (476)
T 2y94_A 18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEY 97 (476)
T ss_dssp EEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 456789999999999999986 789999999975421 2245788999999999999999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 98 ~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 98 VSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp CSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 999999999843 45689999999999999999999998 99999999999999999999999999998654432
Q ss_pred CceeeeeccCCCccCccccccCcC-CCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCc
Q 002409 757 SHVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 835 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 835 (927)
......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... .+... +..+...
T Consensus 171 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~----~~~~~----i~~~~~~------ 234 (476)
T 2y94_A 171 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP----TLFKK----ICDGIFY------ 234 (476)
T ss_dssp --CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH----HHHHH----HHTTCCC------
T ss_pred --cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH----HHHHH----HhcCCcC------
Confidence 2334569999999999988765 67999999999999999999999765422 11111 1111110
Q ss_pred ccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 836 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 836 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.+......+.+++.+|++.||++|||+.|++++
T Consensus 235 ----~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 235 ----TPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ----CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 011112358899999999999999999999975
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=334.20 Aligned_cols=249 Identities=30% Similarity=0.452 Sum_probs=196.1
Q ss_pred HHHhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeec-CeEEEEEEeccC
Q 002409 601 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-GRSVLVYEFMHN 679 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~-~~~~lV~E~~~~ 679 (927)
+.+.+.||+|+||.||+++.. ++.||||+++... ..+.+.+|++++++++||||+++++++.+. +..++||||+++
T Consensus 23 y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~ 99 (278)
T 1byg_A 23 LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 99 (278)
T ss_dssp EEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred ceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCC
Confidence 456789999999999999886 8999999987543 356789999999999999999999987554 578999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
++|.+++... ....+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++.....
T Consensus 100 ~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~---- 170 (278)
T 1byg_A 100 GSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 170 (278)
T ss_dssp EEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc----
Confidence 9999998542 223478899999999999999999998 9999999999999999999999999998754332
Q ss_pred eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCcccC
Q 002409 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 838 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 838 (927)
.....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .+... ...+.. .
T Consensus 171 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~----~~~~~----~~~~~~-----~---- 233 (278)
T 1byg_A 171 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----DVVPR----VEKGYK-----M---- 233 (278)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG----GHHHH----HTTTCC-----C----
T ss_pred ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHH----HhcCCC-----C----
Confidence 122357889999999998899999999999999999998 99999765421 12211 111110 1
Q ss_pred ccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 839 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 839 ~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
..+......+.+++.+|++.+|++||++.|+++.|+++..
T Consensus 234 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 234 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 1112233468899999999999999999999999998754
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=343.73 Aligned_cols=264 Identities=19% Similarity=0.209 Sum_probs=190.6
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc--hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
.|.+.+.||+|+||.||+|+.. +++.||||+++.... .....+.+|++++++++||||+++++++...+..++||||
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 114 (329)
T 3gbz_A 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY 114 (329)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEec
Confidence 3556789999999999999866 688999999975432 2245678999999999999999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEE-----CCCCcEEEEeecCccc
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL-----DKHMRAKVSDFGLSKF 751 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl-----~~~~~vkL~DFGla~~ 751 (927)
++ |+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 115 ~~-~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 115 AE-NDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp CS-EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred CC-CCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 97 599988843 34589999999999999999999998 99999999999999 4556699999999986
Q ss_pred ccCCCCceeeeeccCCCccCccccccC-cCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccC----
Q 002409 752 AVDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG---- 826 (927)
Q Consensus 752 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~---- 826 (927)
...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+.+.........
T Consensus 187 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (329)
T 3gbz_A 187 FGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV 265 (329)
T ss_dssp HC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred cCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhh
Confidence 543222 22334589999999999874 589999999999999999999999976542221111111100000000
Q ss_pred --------CcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 827 --------DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 827 --------~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.........+..........++.+++.+|++.||++|||+.|++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp GGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 0000000000000011123567899999999999999999999874
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=342.97 Aligned_cols=241 Identities=23% Similarity=0.342 Sum_probs=198.8
Q ss_pred HHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc--------hhhHhHHHHHHHHhhccCCCccceecceeecCe
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--------QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR 669 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~--------~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~ 669 (927)
..|.+.+.||+|+||.||+|+.. +++.||||++..... .....+.+|++++++++||||+++++++.+.+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 34556789999999999999865 688999999976532 123467889999999999999999999999999
Q ss_pred EEEEEEeccCC-chhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecC
Q 002409 670 SVLVYEFMHNG-TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 748 (927)
Q Consensus 670 ~~lV~E~~~~g-sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGl 748 (927)
.++||||+.+| +|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeeccc
Confidence 99999999777 99988843 45689999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCceeeeeccCCCccCccccccCcC-CCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCC
Q 002409 749 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 827 (927)
Q Consensus 749 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 827 (927)
++....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... ...
T Consensus 177 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~---------- 238 (335)
T 3dls_A 177 AAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVE---------- 238 (335)
T ss_dssp CEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTT----------
T ss_pred ceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHh----------
Confidence 986544322 234569999999999988776 7889999999999999999999964320 000
Q ss_pred cccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 828 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 828 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
..... +......+.+++.+|++.+|++|||+.|++++
T Consensus 239 ------~~~~~--~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 239 ------AAIHP--PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ------TCCCC--SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ------hccCC--CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 01122368899999999999999999999987
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=360.90 Aligned_cols=251 Identities=23% Similarity=0.338 Sum_probs=202.7
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEeecCCc---hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 604 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 604 ~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
.+.||+|+||.||+++.+ +|+.||||++..... .....+..|++++++++||||+++++++...+..++||||+++
T Consensus 190 ~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~g 269 (543)
T 3c4z_A 190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNG 269 (543)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccC
Confidence 467999999999999986 689999999975422 2345688999999999999999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
|+|.+++.........+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 270 g~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~-~ 345 (543)
T 3c4z_A 270 GDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-K 345 (543)
T ss_dssp CBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC-C
T ss_pred CCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCc-c
Confidence 999999866544456799999999999999999999998 999999999999999999999999999986544322 2
Q ss_pred eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCc
Q 002409 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 839 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 839 (927)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.+.+.. +.. .
T Consensus 346 ~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~----~~~----------~ 411 (543)
T 3c4z_A 346 TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE----QAV----------T 411 (543)
T ss_dssp BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH----CCC----------C
T ss_pred cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh----ccc----------C
Confidence 23457999999999999999999999999999999999999999765322111222221111 110 1
Q ss_pred cCHHHHHHHHHHHhhhcCCCCCCCCcH-----HHHHHH
Q 002409 840 YDIQSMWKIEEKALMCVLPHGHMRPSI-----SEVLKD 872 (927)
Q Consensus 840 ~~~~~~~~l~~L~~~Cl~~dP~~RPsm-----~eV~~~ 872 (927)
++......+.+++.+|++.+|++||++ .||.+|
T Consensus 412 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 412 YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 111223467899999999999999975 666654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=342.67 Aligned_cols=252 Identities=18% Similarity=0.161 Sum_probs=202.0
Q ss_pred HHHHhccccccCceEEEEEE------ECCCcEEEEEEeecCCchhhHhHHHHHHHHhhcc---CCCccceecceeecCeE
Q 002409 600 TKMLEKKIGSGGFGVVYYGK------LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH---HRNLVQFLGYCQEEGRS 670 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~------~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~---HpnIv~l~g~~~~~~~~ 670 (927)
.+.+.+.||+|+||.||+|. ..+++.||||+++... ..++..|++++++++ |+||+++++++...+..
T Consensus 66 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~ 142 (365)
T 3e7e_A 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGS 142 (365)
T ss_dssp EEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCE
T ss_pred EEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCc
Confidence 34556889999999999994 3468899999987543 456777888877776 99999999999999999
Q ss_pred EEEEEeccCCchhhhcccccc-cccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECC-----------C
Q 002409 671 VLVYEFMHNGTLKEHLYGTLT-HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-----------H 738 (927)
Q Consensus 671 ~lV~E~~~~gsL~~~L~~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~-----------~ 738 (927)
++||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+|||++. +
T Consensus 143 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~ 219 (365)
T 3e7e_A 143 VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLS 219 (365)
T ss_dssp EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------C
T ss_pred EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccccccc
Confidence 999999999999999964322 345699999999999999999999998 9999999999999998 8
Q ss_pred CcEEEEeecCcccccC-CCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhH
Q 002409 739 MRAKVSDFGLSKFAVD-GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 817 (927)
Q Consensus 739 ~~vkL~DFGla~~~~~-~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~ 817 (927)
+.+||+|||+++.... ..........||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 220 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~----- 294 (365)
T 3e7e_A 220 AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK----- 294 (365)
T ss_dssp TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE-----
T ss_pred CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee-----
Confidence 9999999999975432 2233445567999999999999999999999999999999999999999654311100
Q ss_pred HHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCC-CcHHHHHHHHHHHHHH
Q 002409 818 WAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMR-PSISEVLKDIQDAIVI 879 (927)
Q Consensus 818 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~R-Psm~eV~~~L~~~~~~ 879 (927)
++..+.... ....+.+++..|++.+|.+| |++.++.+.|++.+..
T Consensus 295 --------------~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 295 --------------PEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp --------------ECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred --------------echhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 011111111 12356688899999999988 5889999999988764
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=343.52 Aligned_cols=264 Identities=22% Similarity=0.326 Sum_probs=198.1
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc--hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
|.+.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 27 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 106 (331)
T 4aaa_A 27 YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV 106 (331)
T ss_dssp EEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred heeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecC
Confidence 445689999999999999886 588999999865432 23456889999999999999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
++++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 107 ~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 178 (331)
T 4aaa_A 107 DHTILDDLEL----FPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 178 (331)
T ss_dssp SEEHHHHHHH----STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred CcchHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCc-
Confidence 9999988763 234689999999999999999999998 99999999999999999999999999997554322
Q ss_pred ceeeeeccCCCccCccccccC-cCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHH------------hhh-
Q 002409 758 HVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK------------LHI- 823 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~------------~~~- 823 (927)
.......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+..... ...
T Consensus 179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 222344689999999999775 789999999999999999999999976542222111111100 000
Q ss_pred ccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 824 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 824 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
....+...................+.+++.+|++.||++|||+.|++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0001111111111011111234578999999999999999999999986
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=347.83 Aligned_cols=267 Identities=23% Similarity=0.283 Sum_probs=201.4
Q ss_pred HHHHHHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhcc-----CCCccceecceeecC
Q 002409 595 DIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-----HRNLVQFLGYCQEEG 668 (927)
Q Consensus 595 ei~~~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~-----HpnIv~l~g~~~~~~ 668 (927)
++....|.+.++||+|+||.||+|+.. +++.||||+++.. ....+.+..|++++++++ ||||+++++++...+
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~ 109 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD 109 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC
Confidence 333445667889999999999999885 6889999998743 334566788999999986 999999999999999
Q ss_pred eEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECC-----------
Q 002409 669 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK----------- 737 (927)
Q Consensus 669 ~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~----------- 737 (927)
..++||||+ +++|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+|||++.
T Consensus 110 ~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~ 183 (360)
T 3llt_A 110 HMCLIFEPL-GPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVR 183 (360)
T ss_dssp EEEEEECCC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEE
T ss_pred eeEEEEcCC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchh
Confidence 999999999 89999998543 234588999999999999999999998 9999999999999975
Q ss_pred --------------CCcEEEEeecCcccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcc
Q 002409 738 --------------HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAI 803 (927)
Q Consensus 738 --------------~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~ 803 (927)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 184 ~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf 259 (360)
T 3llt_A 184 RVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLF 259 (360)
T ss_dssp CTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred cccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCC
Confidence 789999999999854332 22346899999999999999999999999999999999999999
Q ss_pred cccccccccchhhHHHHh-------hhccCCcccccC-CcccC--------------------ccCHHHHHHHHHHHhhh
Q 002409 804 SNEKFGANCRNIVQWAKL-------HIESGDIQGIID-PSLLD--------------------EYDIQSMWKIEEKALMC 855 (927)
Q Consensus 804 ~~~~~~~~~~~l~~~~~~-------~~~~~~~~~~~d-~~l~~--------------------~~~~~~~~~l~~L~~~C 855 (927)
......+....+...... ..........++ ..+.. .+.......+.+++.+|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 339 (360)
T 3llt_A 260 RTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSI 339 (360)
T ss_dssp CCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHH
T ss_pred CCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHH
Confidence 754422111111110000 000000000000 00000 00000114677999999
Q ss_pred cCCCCCCCCcHHHHHHH
Q 002409 856 VLPHGHMRPSISEVLKD 872 (927)
Q Consensus 856 l~~dP~~RPsm~eV~~~ 872 (927)
++.||++|||+.|++++
T Consensus 340 L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 340 LQIDPTLRPSPAELLKH 356 (360)
T ss_dssp CCSSGGGSCCHHHHTTS
T ss_pred hcCChhhCCCHHHHhcC
Confidence 99999999999999864
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=345.48 Aligned_cols=247 Identities=21% Similarity=0.253 Sum_probs=188.5
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhh-ccCCCccceecceee----cCeEEEEEEec
Q 002409 604 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSR-IHHRNLVQFLGYCQE----EGRSVLVYEFM 677 (927)
Q Consensus 604 ~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~-l~HpnIv~l~g~~~~----~~~~~lV~E~~ 677 (927)
.+.||+|+||+||+++.. +++.||||++.. ...+.+|++++.+ .+||||+++++++.. ....++||||+
T Consensus 67 ~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~ 141 (400)
T 1nxk_A 67 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 141 (400)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred cceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeC
Confidence 368999999999999876 688999999863 2456788888754 589999999998865 56789999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECC---CCcEEEEeecCcccccC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVD 754 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~---~~~vkL~DFGla~~~~~ 754 (927)
++|+|.+++... ....+++..+..++.|++.||.|||++ +|+||||||+|||++. ++.+||+|||+++....
T Consensus 142 ~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~ 216 (400)
T 1nxk_A 142 DGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216 (400)
T ss_dssp CSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred CCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence 999999999643 234689999999999999999999998 9999999999999998 78999999999985543
Q ss_pred CCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCC
Q 002409 755 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 834 (927)
Q Consensus 755 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 834 (927)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+...+. .+.... -.+
T Consensus 217 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~----~~~~~~-~~~ 289 (400)
T 1nxk_A 217 HN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR----MGQYEF-PNP 289 (400)
T ss_dssp ------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH----HTCCCC-CTT
T ss_pred CC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH----cCcccC-CCc
Confidence 22 22345689999999999999999999999999999999999999976542221111212111 111100 000
Q ss_pred cccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 835 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 835 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.. .....++.+++.+|++.||++|||+.|++++
T Consensus 290 -~~----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 290 -EW----SEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp -TT----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -cc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 1123468899999999999999999999987
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=361.69 Aligned_cols=250 Identities=28% Similarity=0.374 Sum_probs=203.7
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
.+.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+++|++++||||+++++++.+.+..++||||+
T Consensus 187 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~ 266 (576)
T 2acx_A 187 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 266 (576)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcC
Confidence 34678999999999999886 68999999997542 223456889999999999999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
++|+|.+++... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 267 ~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~- 340 (576)
T 2acx_A 267 NGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ- 340 (576)
T ss_dssp CSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC-
T ss_pred CCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccCc-
Confidence 999999998643 234589999999999999999999998 99999999999999999999999999998654432
Q ss_pred ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCccc
Q 002409 758 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 837 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 837 (927)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.+.+.. ..
T Consensus 341 -~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~----~~---------- 405 (576)
T 2acx_A 341 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE----VP---------- 405 (576)
T ss_dssp -CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH----CC----------
T ss_pred -cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc----cc----------
Confidence 223457999999999999999999999999999999999999999765422222222222111 10
Q ss_pred CccCHHHHHHHHHHHhhhcCCCCCCCC-----cHHHHHHH
Q 002409 838 DEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 872 (927)
Q Consensus 838 ~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----sm~eV~~~ 872 (927)
..++......+.+++.+|++.||++|| ++.||++|
T Consensus 406 ~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 406 EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 011112234688999999999999999 88999876
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=355.81 Aligned_cols=260 Identities=22% Similarity=0.288 Sum_probs=192.6
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecC--CchhhHhHHHHHHHHhhccCCCccceecceeec------CeEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRSV 671 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~------~~~~ 671 (927)
|.+.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.+|++++||||+++++++... ...+
T Consensus 64 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 143 (464)
T 3ttj_A 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 143 (464)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred eEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEE
Confidence 455788999999999999876 6889999999754 333456788999999999999999999998654 4579
Q ss_pred EEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccc
Q 002409 672 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 751 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 751 (927)
+||||++++ |.+.+. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 144 lv~E~~~~~-l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 144 LVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp EEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred EEEeCCCCC-HHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 999999764 555552 2378899999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHH-----------
Q 002409 752 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK----------- 820 (927)
Q Consensus 752 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~----------- 820 (927)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.+...
T Consensus 214 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 214 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp ---C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred cCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 5432 223445699999999999999999999999999999999999999976542221111111100
Q ss_pred ----hhhcc------CCcccccCCcccC---ccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 821 ----LHIES------GDIQGIIDPSLLD---EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 821 ----~~~~~------~~~~~~~d~~l~~---~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
..... ..+...+...+.. .........+.+|+.+||+.||++|||+.|+++|
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 0000001000000 0011124568999999999999999999999986
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=352.50 Aligned_cols=263 Identities=24% Similarity=0.374 Sum_probs=188.2
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecC--CchhhHhHHHHHHHHhhcc-CCCccceecceeecC--eEEEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEG--RSVLV 673 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~--~~~lV 673 (927)
.|.+.+.||+|+||.||+|... +++.||||++... .......+.+|+.+++++. ||||+++++++...+ ..++|
T Consensus 10 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 89 (388)
T 3oz6_A 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLV 89 (388)
T ss_dssp TEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEE
T ss_pred ceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEE
Confidence 4456789999999999999875 6899999998643 2334566789999999997 999999999997544 68999
Q ss_pred EEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccccc
Q 002409 674 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 753 (927)
Q Consensus 674 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 753 (927)
||||+ |+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 90 ~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 90 FDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFV 160 (388)
T ss_dssp EECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred ecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence 99997 589888843 4688899999999999999999998 99999999999999999999999999998543
Q ss_pred CC--------------------CCceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCccccccccccc
Q 002409 754 DG--------------------ASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANC 812 (927)
Q Consensus 754 ~~--------------------~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~ 812 (927)
.. .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~ 240 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL 240 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 21 1112233569999999999976 67899999999999999999999999765422222
Q ss_pred chhhHHHHhhhccCCccccc------------------CCcccCcc------------CHHHHHHHHHHHhhhcCCCCCC
Q 002409 813 RNIVQWAKLHIESGDIQGII------------------DPSLLDEY------------DIQSMWKIEEKALMCVLPHGHM 862 (927)
Q Consensus 813 ~~l~~~~~~~~~~~~~~~~~------------------d~~l~~~~------------~~~~~~~l~~L~~~Cl~~dP~~ 862 (927)
..+....... ....+..+- .......+ .......+.+|+.+|++.||++
T Consensus 241 ~~i~~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~ 319 (388)
T 3oz6_A 241 ERIIGVIDFP-SNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK 319 (388)
T ss_dssp HHHHHHHCCC-CHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHHhcCCC-CHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCccc
Confidence 1221110000 000000000 00000000 0012346889999999999999
Q ss_pred CCcHHHHHHH
Q 002409 863 RPSISEVLKD 872 (927)
Q Consensus 863 RPsm~eV~~~ 872 (927)
|||+.|+++|
T Consensus 320 R~t~~e~l~H 329 (388)
T 3oz6_A 320 RISANDALKH 329 (388)
T ss_dssp SCCHHHHTTS
T ss_pred CCCHHHHhCC
Confidence 9999999987
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=349.46 Aligned_cols=267 Identities=20% Similarity=0.244 Sum_probs=199.9
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceee------------
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE------------ 666 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~------------ 666 (927)
.|.+.+.||+|+||.||+|+.. +++.||||++.... ....+|++++++++||||+++++++..
T Consensus 8 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~ 83 (383)
T 3eb0_A 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP 83 (383)
T ss_dssp TEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC-----------
T ss_pred eEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCcccccccccc
Confidence 3456789999999999999875 78999999987542 223479999999999999999999843
Q ss_pred --------------------------cCeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCC
Q 002409 667 --------------------------EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 720 (927)
Q Consensus 667 --------------------------~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~ 720 (927)
....++||||++ |+|.+.+.........+++..+..++.|+++||+|||++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-- 160 (383)
T 3eb0_A 84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL-- 160 (383)
T ss_dssp --------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT--
T ss_pred cccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 334789999998 588888765545567799999999999999999999998
Q ss_pred CceecCCCCCCCeEEC-CCCcEEEEeecCcccccCCCCceeeeeccCCCccCccccccC-cCCCccceeeHHHHHHHHHh
Q 002409 721 PAIIHRDLKSSNILLD-KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELIS 798 (927)
Q Consensus 721 ~~ivHrDLkp~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvL~ellt 798 (927)
+|+||||||+|||++ .++.+||+|||+++....... .....||+.|+|||.+.+. .++.++||||+||++|||++
T Consensus 161 -gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 161 -GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp -TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred -cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence 999999999999998 688999999999986544322 2334589999999998764 58999999999999999999
Q ss_pred CCCcccccccccccchhhHHHHh-----------hhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHH
Q 002409 799 GQEAISNEKFGANCRNIVQWAKL-----------HIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSIS 867 (927)
Q Consensus 799 G~~p~~~~~~~~~~~~l~~~~~~-----------~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~ 867 (927)
|+.||......+....++..... ...+..+...........++......+.+++.+|++.+|++|||+.
T Consensus 238 g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 317 (383)
T 3eb0_A 238 GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPY 317 (383)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHH
Confidence 99999765422222222211100 0000111111111111112223345689999999999999999999
Q ss_pred HHHHH--HHHH
Q 002409 868 EVLKD--IQDA 876 (927)
Q Consensus 868 eV~~~--L~~~ 876 (927)
|+++| ++++
T Consensus 318 e~l~hp~f~~~ 328 (383)
T 3eb0_A 318 EAMAHPFFDHL 328 (383)
T ss_dssp HHHTSGGGHHH
T ss_pred HHhcCHHHHHH
Confidence 99976 5544
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=333.40 Aligned_cols=246 Identities=21% Similarity=0.345 Sum_probs=201.0
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
|.+.+.||+|+||.||+++.. +++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 17 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 96 (294)
T 2rku_A 17 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL 96 (294)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEec
Confidence 345688999999999999987 57889999987542 23456788999999999999999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
+++++|.+++. ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 97 ~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 97 CRRRSLLELHK----RRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp CTTCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 99999999874 245689999999999999999999998 99999999999999999999999999998654322
Q ss_pred CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 757 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+. .. ....+.. .+
T Consensus 170 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~----~~~~~~~------~~ 234 (294)
T 2rku_A 170 -ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET----YL----RIKKNEY------SI 234 (294)
T ss_dssp -CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HH----HHHTTCC------CC
T ss_pred -cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HH----HHhhccC------CC
Confidence 222345689999999999988899999999999999999999999976442111 11 1111111 01
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.. .....+.+++.+|++.+|++||++.|++++
T Consensus 235 ~~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 235 PK----HINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp CT----TSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cc----ccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11 122467899999999999999999999876
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=342.68 Aligned_cols=262 Identities=14% Similarity=0.202 Sum_probs=202.8
Q ss_pred HHHHhccccccCceEEEEEEECC---------CcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccc-----------
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLKD---------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQ----------- 659 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~~---------g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~----------- 659 (927)
.|.+.+.||+|+||.||+|+... ++.||||++... ..+.+|++++++++||||++
T Consensus 43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence 34567899999999999998864 788999998743 46889999999999999998
Q ss_pred ----eecceee-cCeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeE
Q 002409 660 ----FLGYCQE-EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL 734 (927)
Q Consensus 660 ----l~g~~~~-~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIL 734 (927)
+++++.. .+..++||||+ +++|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+|||
T Consensus 118 ~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl 191 (352)
T 2jii_A 118 AIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIF 191 (352)
T ss_dssp SCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEE
T ss_pred CccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEE
Confidence 4556655 67889999999 99999999643 246799999999999999999999998 9999999999999
Q ss_pred ECCCC--cEEEEeecCcccccCCCCc------eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCccccc
Q 002409 735 LDKHM--RAKVSDFGLSKFAVDGASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 806 (927)
Q Consensus 735 l~~~~--~vkL~DFGla~~~~~~~~~------~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~ 806 (927)
++.++ .+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 9999999999755432211 112346999999999999989999999999999999999999999765
Q ss_pred ccccccchhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHH
Q 002409 807 KFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 879 (927)
Q Consensus 807 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~ 879 (927)
... ...+......... ......+..... ......+.+++.+|++.+|++||++.||++.|++++..
T Consensus 272 ~~~--~~~~~~~~~~~~~--~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 337 (352)
T 2jii_A 272 LPN--TEDIMKQKQKFVD--KPGPFVGPCGHW---IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD 337 (352)
T ss_dssp TTC--HHHHHHHHHHHHH--SCCCEECTTSCE---ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CcC--HHHHHHHHHhccC--Chhhhhhhcccc---CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence 311 1122222111111 111111111110 01124688999999999999999999999999998754
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=331.20 Aligned_cols=245 Identities=28% Similarity=0.438 Sum_probs=194.8
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceee----cCeEEEEE
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE----EGRSVLVY 674 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~----~~~~~lV~ 674 (927)
.+.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.++++++||||+++++++.. ....++||
T Consensus 29 ~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~ 108 (290)
T 1t4h_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEE
Confidence 45678999999999999876 57889999987542 3345678999999999999999999998865 35689999
Q ss_pred EeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCc--eecCCCCCCCeEEC-CCCcEEEEeecCccc
Q 002409 675 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA--IIHRDLKSSNILLD-KHMRAKVSDFGLSKF 751 (927)
Q Consensus 675 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivHrDLkp~NILl~-~~~~vkL~DFGla~~ 751 (927)
||+++|+|.+++.. ...+++..++.++.|++.||.|||+. + |+||||||+|||++ .++.+||+|||++..
T Consensus 109 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 109 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 99999999999843 35688999999999999999999998 7 99999999999998 789999999999975
Q ss_pred ccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccc
Q 002409 752 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 831 (927)
Q Consensus 752 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 831 (927)
.... ......||+.|+|||.+. +.++.++|||||||++|||++|+.||...... ..+... ...+....
T Consensus 182 ~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~~~~----~~~~~~~~- 249 (290)
T 1t4h_A 182 KRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA---AQIYRR----VTSGVKPA- 249 (290)
T ss_dssp CCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH---HHHHHH----HTTTCCCG-
T ss_pred cccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH---HHHHHH----HhccCCcc-
Confidence 4332 223456999999999876 56899999999999999999999999754311 111111 11111111
Q ss_pred cCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 832 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 832 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
..+......+.+++.+|++.+|++|||+.|++++
T Consensus 250 -------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 250 -------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1111122468899999999999999999999875
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=351.07 Aligned_cols=240 Identities=13% Similarity=0.127 Sum_probs=185.2
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecC---CchhhHhHHHHH---HHHhhccCCCcccee-------cceeec
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN---SYQGKREFTNEV---TLLSRIHHRNLVQFL-------GYCQEE 667 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei---~iL~~l~HpnIv~l~-------g~~~~~ 667 (927)
.+.+.||+|+||.||+|++. +++.||||++... .....+.+.+|+ +++++++||||++++ +++...
T Consensus 76 ~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~ 155 (377)
T 3byv_A 76 VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP 155 (377)
T ss_dssp EEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECT
T ss_pred EEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhcc
Confidence 34688999999999999864 6899999999743 333457788999 555566899999998 444443
Q ss_pred C-----------------eEEEEEEeccCCchhhhccccc---ccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCC
Q 002409 668 G-----------------RSVLVYEFMHNGTLKEHLYGTL---THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRD 727 (927)
Q Consensus 668 ~-----------------~~~lV~E~~~~gsL~~~L~~~~---~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrD 727 (927)
+ ..++||||+ +|+|.+++.... .....+++..++.|+.|++.||+|||++ +|+|||
T Consensus 156 ~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrD 231 (377)
T 3byv_A 156 QKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTY 231 (377)
T ss_dssp TSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred CCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 3 278999999 689999986421 1123455688889999999999999998 999999
Q ss_pred CCCCCeEECCCCcEEEEeecCcccccCCCCceeeeeccCCCccCccccccC-----------cCCCccceeeHHHHHHHH
Q 002409 728 LKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ-----------QLTDKSDVYSFGVILLEL 796 (927)
Q Consensus 728 Lkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----------~~s~~sDVwSlGvvL~el 796 (927)
|||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||++|||
T Consensus 232 ikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el 306 (377)
T 3byv_A 232 LRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306 (377)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred CCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence 999999999999999999999985322 3334557 999999999887 899999999999999999
Q ss_pred HhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 797 ISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 797 ltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
++|+.||...........+.. . ... ....+.+++.+|++.||++||++.|++++
T Consensus 307 ltg~~Pf~~~~~~~~~~~~~~--------~----------~~~----~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 307 WCADLPITKDAALGGSEWIFR--------S----------CKN----IPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHSSCCC------CCSGGGGS--------S----------CCC----CCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHCCCCCcccccccchhhhhh--------h----------ccC----CCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 999999975442211111100 0 011 12468899999999999999999999975
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=340.16 Aligned_cols=246 Identities=21% Similarity=0.337 Sum_probs=201.3
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
|.+.+.||+|+||.||+++.. +++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 43 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 122 (335)
T 2owb_A 43 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL 122 (335)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEec
Confidence 445789999999999999887 47889999987542 23456788999999999999999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
+++++|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 123 ~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 123 CRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp CTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 999999998742 45689999999999999999999998 99999999999999999999999999998654322
Q ss_pred CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 757 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .... ...+.. .+
T Consensus 196 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~----~~~~~~------~~ 260 (335)
T 2owb_A 196 -ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE----TYLR----IKKNEY------SI 260 (335)
T ss_dssp -CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHH----HHHTCC------CC
T ss_pred -ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH----HHHH----HhcCCC------CC
Confidence 22234568999999999999899999999999999999999999997544211 1111 111111 01
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
... ....+.+++.+|++.||++||++.|++++
T Consensus 261 ~~~----~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 261 PKH----INPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp CTT----SCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred Ccc----CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111 22357899999999999999999999875
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=350.28 Aligned_cols=251 Identities=24% Similarity=0.362 Sum_probs=189.5
Q ss_pred HHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC--------chhhHhHHHHHHHHhhccCCCccceecceeecCe
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--------YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR 669 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--------~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~ 669 (927)
..|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+++|++++||||+++++++.. +.
T Consensus 135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~ 213 (419)
T 3i6u_A 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-ED 213 (419)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SE
T ss_pred ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-Cc
Confidence 34566789999999999999876 57899999987532 1122358899999999999999999999754 55
Q ss_pred EEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCC---CcEEEEee
Q 002409 670 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH---MRAKVSDF 746 (927)
Q Consensus 670 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~---~~vkL~DF 746 (927)
.++||||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+||
T Consensus 214 ~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DF 286 (419)
T 3i6u_A 214 YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDF 286 (419)
T ss_dssp EEEEEECCTTCBGGGGTS----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred eEEEEEcCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeec
Confidence 799999999999999884 345689999999999999999999998 99999999999999754 45999999
Q ss_pred cCcccccCCCCceeeeeccCCCccCcccccc---CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhh
Q 002409 747 GLSKFAVDGASHVSSIVRGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 823 (927)
Q Consensus 747 Gla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~ 823 (927)
|+++..... .......||+.|+|||++.. ..++.++|||||||++|||++|+.||....... .+....
T Consensus 287 G~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~---~~~~~i---- 357 (419)
T 3i6u_A 287 GHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV---SLKDQI---- 357 (419)
T ss_dssp STTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC---CHHHHH----
T ss_pred ccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH---HHHHHH----
Confidence 999865432 22344569999999999863 567889999999999999999999997543221 111111
Q ss_pred ccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 824 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 824 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
..+.... .+... ......+.+++.+|++.+|++||++.|+++|
T Consensus 358 ~~~~~~~--~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 358 TSGKYNF--IPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HTTCCCC--CHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hcCCCCC--Cchhh----cccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 1111100 00000 1123468899999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=340.94 Aligned_cols=263 Identities=25% Similarity=0.393 Sum_probs=204.8
Q ss_pred HHHHHHhccccccCceEEEEEEEC------CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeE
Q 002409 598 DATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS 670 (927)
Q Consensus 598 ~~~~~~~~~IG~G~fG~Vy~~~~~------~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~ 670 (927)
...+.+.+.||+|+||.||+|++. +++.||||++.... ......+.+|+.++++++||||+++++++...+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 344567789999999999999842 56789999997543 34456789999999999999999999999999999
Q ss_pred EEEEEeccCCchhhhcccccc---cccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECC---CCcEEEE
Q 002409 671 VLVYEFMHNGTLKEHLYGTLT---HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVS 744 (927)
Q Consensus 671 ~lV~E~~~~gsL~~~L~~~~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~---~~~vkL~ 744 (927)
++||||+++|+|.+++..... ....+++..++.++.|++.||.|||++ +|+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999965421 224589999999999999999999998 9999999999999994 4569999
Q ss_pred eecCcccccCCCC-ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhh
Q 002409 745 DFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLH 822 (927)
Q Consensus 745 DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~ 822 (927)
|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||++ |+.||...... .+...+..
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~~~~~~~~- 260 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ----EVLEFVTS- 260 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----HHHHHHHT-
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH----HHHHHHhc-
Confidence 9999975433221 12233457899999999998899999999999999999998 99999754311 22222211
Q ss_pred hccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHHH
Q 002409 823 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 880 (927)
Q Consensus 823 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~~ 880 (927)
+... ..+......+.+++.+|++.+|++||++.||+++|+.+....
T Consensus 261 ---~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 261 ---GGRM---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp ---TCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred ---CCCC---------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 1110 011122346889999999999999999999999999886543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=342.41 Aligned_cols=262 Identities=21% Similarity=0.299 Sum_probs=192.7
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCCch-hhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
.+.+.||+|+||.||+|+.. +++.||||++...... ....+.+|++++++++||||+++++++...+..++||||++
T Consensus 5 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 83 (324)
T 3mtl_A 5 IKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD- 83 (324)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-
T ss_pred EEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-
Confidence 45678999999999999986 6889999998754322 22345679999999999999999999999999999999997
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 84 ~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~ 156 (324)
T 3mtl_A 84 KDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KT 156 (324)
T ss_dssp EEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc-cc
Confidence 5888887532 34688999999999999999999998 99999999999999999999999999997543322 22
Q ss_pred eeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCC----
Q 002409 760 SSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP---- 834 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~---- 834 (927)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+.+..... ...........
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTP-TEETWPGILSNEEFK 235 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC-CTTTSTTGGGCHHHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC-ChHhchhhhcchhhc
Confidence 233458999999999876 568999999999999999999999997654222221221111100 00001110000
Q ss_pred -----cccC----ccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 835 -----SLLD----EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 835 -----~l~~----~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.... .........+.+++.+|++.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000 0011223467899999999999999999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=329.49 Aligned_cols=248 Identities=24% Similarity=0.383 Sum_probs=195.5
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCCchh
Q 002409 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK 683 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~ 683 (927)
..||+|+||.||+|+.. +++.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 47999999999999875 67899999998766555678999999999999999999999999999999999999999999
Q ss_pred hhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECC-CCcEEEEeecCcccccCCCCceeee
Q 002409 684 EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLSKFAVDGASHVSSI 762 (927)
Q Consensus 684 ~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~ 762 (927)
+++.... ....+++..+..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+++...... .....
T Consensus 108 ~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 182 (295)
T 2clq_A 108 ALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTET 182 (295)
T ss_dssp HHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------CC
T ss_pred HHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCC-Ccccc
Confidence 9986432 234567888999999999999999998 9999999999999987 8999999999997654322 12234
Q ss_pred eccCCCccCccccccCc--CCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCcc
Q 002409 763 VRGTVGYLDPEYYISQQ--LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 840 (927)
Q Consensus 763 ~~gt~~Y~aPE~~~~~~--~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 840 (927)
..||+.|+|||.+.... ++.++|||||||++|||++|+.||........ .... .... . ..+.+
T Consensus 183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~--~~~~--~-----~~~~~---- 247 (295)
T 2clq_A 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA--AMFK--VGMF--K-----VHPEI---- 247 (295)
T ss_dssp CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH--HHHH--HHHH--C-----CCCCC----
T ss_pred cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH--HHHh--hccc--c-----ccccc----
Confidence 46899999999997643 78899999999999999999999975431110 1111 0000 0 01111
Q ss_pred CHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 841 DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 841 ~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
+......+.+++.+|++.+|++||++.|++++
T Consensus 248 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 248 PESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11223468899999999999999999999875
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=330.31 Aligned_cols=244 Identities=24% Similarity=0.367 Sum_probs=200.1
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
+.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 16 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 95 (284)
T 2vgo_A 16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEF 95 (284)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEe
Confidence 445789999999999999886 57789999986532 22246788999999999999999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
+++|+|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 96 ~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (284)
T 2vgo_A 96 APRGELYKELQK----HGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR 168 (284)
T ss_dssp CTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence 999999998843 34688999999999999999999998 99999999999999999999999999987543321
Q ss_pred CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 757 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+. .. .+..... .+
T Consensus 169 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~----~~~~~~~------~~ 231 (284)
T 2vgo_A 169 ---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET----HR----RIVNVDL------KF 231 (284)
T ss_dssp ---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HH----HHHTTCC------CC
T ss_pred ---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH----HH----HHhcccc------CC
Confidence 2334689999999999999999999999999999999999999975442111 11 1111110 11
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
+......+.+++.+|++.+|++||++.|++++
T Consensus 232 ----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 232 ----PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp ----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred ----CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 11122467899999999999999999999886
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=352.18 Aligned_cols=262 Identities=23% Similarity=0.266 Sum_probs=194.0
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeec------CeEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRSVLV 673 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~------~~~~lV 673 (927)
|.+.+.||+|+||.||+|++. +++.||||++.... +...+|+++|++++||||+++++++... ...++|
T Consensus 56 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv 131 (420)
T 1j1b_A 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131 (420)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred EEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence 345688999999999999986 58999999986542 2345799999999999999999988542 236799
Q ss_pred EEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCC-CcEEEEeecCcccc
Q 002409 674 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFA 752 (927)
Q Consensus 674 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~-~~vkL~DFGla~~~ 752 (927)
|||+++ +|.+.+.........+++..+..++.||++||+|||++ +|+||||||+|||++.+ +.+||+|||+++..
T Consensus 132 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred hhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 999986 66666644333456789999999999999999999998 99999999999999965 67899999999865
Q ss_pred cCCCCceeeeeccCCCccCccccccC-cCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHh----hhc--c
Q 002409 753 VDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL----HIE--S 825 (927)
Q Consensus 753 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~----~~~--~ 825 (927)
..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+....++..... .+. .
T Consensus 208 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~ 285 (420)
T 1j1b_A 208 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 285 (420)
T ss_dssp CTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHC
T ss_pred ccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 44322 2234689999999998764 7899999999999999999999999765422211122211000 000 0
Q ss_pred CCcccccCCccc-----CccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 826 GDIQGIIDPSLL-----DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 826 ~~~~~~~d~~l~-----~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
....+..-+.+. ..+......++.+|+.+|++.||++||++.|+++|
T Consensus 286 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp SCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 011111111111 11122233578999999999999999999999976
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=340.12 Aligned_cols=266 Identities=21% Similarity=0.230 Sum_probs=196.9
Q ss_pred HHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCch-----hhHhHHHHHHHHhhccCCCccceecceeecCeEEE
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-----GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 672 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~-----~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~l 672 (927)
..|.+.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|++++++++||||+++++++...+..++
T Consensus 10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (346)
T 1ua2_A 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL 89 (346)
T ss_dssp ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence 34566789999999999999876 5899999998753221 13468899999999999999999999999999999
Q ss_pred EEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccc
Q 002409 673 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 752 (927)
Q Consensus 673 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 752 (927)
||||+++ +|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 90 v~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 90 VFDFMET-DLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp EEECCSE-EHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred EEEcCCC-CHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 9999986 888877532 34578888999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCCceeeeeccCCCccCccccccC-cCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccC-----
Q 002409 753 VDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG----- 826 (927)
Q Consensus 753 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~----- 826 (927)
.... .......||+.|+|||.+.+. .++.++|||||||++|||++|..||......+....+...........
T Consensus 163 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 241 (346)
T 1ua2_A 163 GSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 241 (346)
T ss_dssp TSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred cCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhc
Confidence 4332 223345689999999998754 588899999999999999999999876542222212221111000000
Q ss_pred CcccccCCcccCccC-----HHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 827 DIQGIIDPSLLDEYD-----IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 827 ~~~~~~d~~l~~~~~-----~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
...+.+........+ ......+.+++.+|++.||++|||+.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000000000000001 1223578999999999999999999999886
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=331.28 Aligned_cols=247 Identities=25% Similarity=0.408 Sum_probs=202.8
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
+.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++......++||||++
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 103 (303)
T 3a7i_A 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 103 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred HHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCC
Confidence 445688999999999999875 68899999997553 3345778999999999999999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
+++|.+++. ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++....... .
T Consensus 104 ~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 174 (303)
T 3a7i_A 104 GGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-I 174 (303)
T ss_dssp TEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-C
T ss_pred CCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccc-c
Confidence 999999884 24689999999999999999999998 99999999999999999999999999997654332 1
Q ss_pred eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccC
Q 002409 759 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 838 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 838 (927)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ...... ..+.. +.+..
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~----~~~~~-----~~~~~ 241 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM----KVLFLI----PKNNP-----PTLEG 241 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHHH----HHSCC-----CCCCS
T ss_pred ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH----HHHHHh----hcCCC-----CCCcc
Confidence 223456899999999999999999999999999999999999999754311 111111 11111 11112
Q ss_pred ccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHH
Q 002409 839 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 873 (927)
Q Consensus 839 ~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L 873 (927)
.+ ...+.+++.+|++.+|++|||+.|++++.
T Consensus 242 ~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 242 NY----SKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp SC----CHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred cc----CHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 22 23588999999999999999999999864
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=354.18 Aligned_cols=250 Identities=26% Similarity=0.387 Sum_probs=197.4
Q ss_pred HHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEE
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 675 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E 675 (927)
..|.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 45667889999999999999986 68899999997653 2335678999999999999999999999999999999999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCC---CcEEEEeecCcccc
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH---MRAKVSDFGLSKFA 752 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~---~~vkL~DFGla~~~ 752 (927)
|+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.. +.+||+|||+++..
T Consensus 117 ~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 117 CYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp CCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 9999999988843 45688999999999999999999998 99999999999999764 55999999999865
Q ss_pred cCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCccccc
Q 002409 753 VDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 832 (927)
Q Consensus 753 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 832 (927)
.... ......||+.|+|||++. +.++.++||||+||++|||++|+.||...... .+...+. .+... .
T Consensus 190 ~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i~----~~~~~--~ 256 (494)
T 3lij_A 190 ENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ----EILRKVE----KGKYT--F 256 (494)
T ss_dssp BTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHH----HTCCC--C
T ss_pred CCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHH----hCCCC--C
Confidence 4332 233456999999999876 57999999999999999999999999765422 1222111 11110 0
Q ss_pred CCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 833 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 833 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
+..... .....+.+++.+|++.+|++|||+.|++++
T Consensus 257 ~~~~~~----~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 257 DSPEWK----NVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp CSGGGT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred Cchhcc----cCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 101111 122468899999999999999999999987
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=353.26 Aligned_cols=251 Identities=27% Similarity=0.365 Sum_probs=200.5
Q ss_pred HHHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecC--CchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEE
Q 002409 598 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 674 (927)
Q Consensus 598 ~~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~ 674 (927)
...|.+.+.||+|+||+||+|+.. +++.||||++... .......+.+|++++++++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 345677899999999999999886 6899999998643 2234567899999999999999999999999999999999
Q ss_pred EeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEEC---CCCcEEEEeecCccc
Q 002409 675 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFGLSKF 751 (927)
Q Consensus 675 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~---~~~~vkL~DFGla~~ 751 (927)
||+.+|+|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++ .++.+||+|||+++.
T Consensus 101 e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 101 ELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp CCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 99999999988843 45689999999999999999999998 999999999999995 456799999999986
Q ss_pred ccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccc
Q 002409 752 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 831 (927)
Q Consensus 752 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 831 (927)
..... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||...... .+...+ ..+....
T Consensus 174 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i----~~~~~~~- 241 (486)
T 3mwu_A 174 FQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY----DILKRV----ETGKYAF- 241 (486)
T ss_dssp BCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHH----HHTCCCS-
T ss_pred CCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHH----HhCCCCC-
Confidence 54322 2234569999999999865 5899999999999999999999999764421 122211 1111110
Q ss_pred cCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 832 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 832 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
+.... ......+.+++.+|++.+|++|||+.|++++
T Consensus 242 -~~~~~----~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 242 -DLPQW----RTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp -CSGGG----GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred -CCccc----CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 1123468899999999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=345.37 Aligned_cols=262 Identities=22% Similarity=0.264 Sum_probs=194.8
Q ss_pred HHHhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecC------eEEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------RSVLVY 674 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~------~~~lV~ 674 (927)
|.+.+.||+|+||.||+|++..+..+|+|++.... ....+|++++++++||||+++++++...+ ..++||
T Consensus 42 Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~ 117 (394)
T 4e7w_A 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL 117 (394)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEE
T ss_pred EEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEe
Confidence 45678999999999999999878889999886442 22347999999999999999999986543 378999
Q ss_pred EeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEEC-CCCcEEEEeecCccccc
Q 002409 675 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD-KHMRAKVSDFGLSKFAV 753 (927)
Q Consensus 675 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~-~~~~vkL~DFGla~~~~ 753 (927)
||++++.+ +.+.........+++..+..++.|+++||+|||++ +|+||||||+|||++ .++.+||+|||+++...
T Consensus 118 e~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 118 EYVPETVY-RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193 (394)
T ss_dssp ECCSEEHH-HHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eccCccHH-HHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence 99987543 33332223356789999999999999999999998 999999999999999 78999999999998654
Q ss_pred CCCCceeeeeccCCCccCccccccC-cCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHH-----------h
Q 002409 754 DGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK-----------L 821 (927)
Q Consensus 754 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~-----------~ 821 (927)
.... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+..... .
T Consensus 194 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 271 (394)
T 4e7w_A 194 AGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNP 271 (394)
T ss_dssp TTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCG
T ss_pred CCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence 4332 2234589999999998764 589999999999999999999999976542222222221110 0
Q ss_pred hhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 822 HIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 822 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
......+...-...+...+......++.+++.+|++.||++|||+.|+++|
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 272 NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp GGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 000111111111111111222234578999999999999999999999987
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=354.54 Aligned_cols=251 Identities=27% Similarity=0.388 Sum_probs=203.3
Q ss_pred HHHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEE
Q 002409 598 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 673 (927)
Q Consensus 598 ~~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV 673 (927)
...|.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 456677899999999999999887 78999999997542 23456789999999999999999999999999999999
Q ss_pred EEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEE---CCCCcEEEEeecCcc
Q 002409 674 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSK 750 (927)
Q Consensus 674 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl---~~~~~vkL~DFGla~ 750 (927)
|||+.+|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||+++
T Consensus 105 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp ECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 999999999998843 45689999999999999999999998 99999999999999 567899999999998
Q ss_pred cccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCccc
Q 002409 751 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 830 (927)
Q Consensus 751 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 830 (927)
...... ......||+.|+|||++.+ .++.++||||+||++|||++|+.||...... .+...+. .+...-
T Consensus 178 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i~----~~~~~~ 246 (484)
T 3nyv_A 178 HFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY----DILKKVE----KGKYTF 246 (484)
T ss_dssp HBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHH----HCCCCC
T ss_pred Eccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHH----cCCCCC
Confidence 654432 2233469999999999865 6899999999999999999999999765421 2222111 111110
Q ss_pred ccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 831 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 831 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
+.... ......+.+++.+|++.+|++|||+.|+++|
T Consensus 247 --~~~~~----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 247 --ELPQW----KKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp --CSGGG----GGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --CCccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 00000 1223468899999999999999999999876
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=326.66 Aligned_cols=245 Identities=24% Similarity=0.413 Sum_probs=192.3
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
|.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 13 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 92 (276)
T 2h6d_A 13 YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEY 92 (276)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEec
Confidence 445788999999999999987 78999999987542 22345788999999999999999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
+++++|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.......
T Consensus 93 ~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 93 VSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp CCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred cCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 999999999843 34688999999999999999999998 99999999999999999999999999997654322
Q ss_pred CceeeeeccCCCccCccccccCcC-CCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCc
Q 002409 757 SHVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 835 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 835 (927)
......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||...... .+.+... .+.. .
T Consensus 166 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~----~~~~------~ 229 (276)
T 2h6d_A 166 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP----TLFKKIR----GGVF------Y 229 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHH----HCCC------C
T ss_pred --ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH----HHHHHhh----cCcc------c
Confidence 2233458999999999987665 67999999999999999999999754321 1111111 1110 0
Q ss_pred ccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 836 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 836 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
+ +......+.+++.+|++.+|++|||+.|++++
T Consensus 230 ~----~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 230 I----PEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred C----chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0 11122468899999999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=336.08 Aligned_cols=250 Identities=24% Similarity=0.361 Sum_probs=199.0
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc--------hhhHhHHHHHHHHhhc-cCCCccceecceeecCe
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--------QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGR 669 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~--------~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~ 669 (927)
.|.+.+.||+|+||.||+|++. +|+.||||+++.... ...+.+.+|+.+++++ +||||+++++++...+.
T Consensus 95 ~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 174 (365)
T 2y7j_A 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF 174 (365)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSE
T ss_pred hcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCE
Confidence 3444689999999999999986 699999999875431 1134678899999999 79999999999999999
Q ss_pred EEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCc
Q 002409 670 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 749 (927)
Q Consensus 670 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla 749 (927)
.++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 175 ~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~~ 247 (365)
T 2y7j_A 175 MFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFS 247 (365)
T ss_dssp EEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCcc
Confidence 9999999999999999843 45689999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeeccCCCccCcccccc------CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhh
Q 002409 750 KFAVDGASHVSSIVRGTVGYLDPEYYIS------QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 823 (927)
Q Consensus 750 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~ 823 (927)
....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+
T Consensus 248 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~----~~~~~i---- 317 (365)
T 2y7j_A 248 CHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI----LMLRMI---- 317 (365)
T ss_dssp EECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHH----
T ss_pred cccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH----HHHHHH----
Confidence 7654332 2234569999999999863 35888999999999999999999999754311 111111
Q ss_pred ccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 824 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 824 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
..+.... ..+ ... .....+.+++.+|++.+|++||++.|++++
T Consensus 318 ~~~~~~~-~~~-~~~----~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 318 MEGQYQF-SSP-EWD----DRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHTCCCC-CHH-HHS----SSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhCCCCC-CCc-ccc----cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1111100 000 001 112358899999999999999999999875
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=331.93 Aligned_cols=256 Identities=26% Similarity=0.369 Sum_probs=194.4
Q ss_pred HHHHhccccccCceEEEEEEEC--CCc--EEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK--DGK--EIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 672 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~--~g~--~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~l 672 (927)
.+.+.+.||+|+||.||+|++. +++ .||||+++... ....+.+.+|++++++++||||+++++++.... .++
T Consensus 19 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 97 (291)
T 1u46_A 19 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKM 97 (291)
T ss_dssp GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEE
T ss_pred HeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-cee
Confidence 3456789999999999999864 233 68999987542 334567899999999999999999999998765 789
Q ss_pred EEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccc
Q 002409 673 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 752 (927)
Q Consensus 673 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 752 (927)
|+||+++++|.+++... ...+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||+++..
T Consensus 98 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 98 VTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccc
Confidence 99999999999998542 35688999999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCCce--eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcc
Q 002409 753 VDGASHV--SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQ 829 (927)
Q Consensus 753 ~~~~~~~--~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 829 (927)
....... .....+|..|+|||.+....++.++||||||+++|||++ |+.||...... .+..... ..+..
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~~~~---~~~~~- 243 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS----QILHKID---KEGER- 243 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHHHH---TSCCC-
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH----HHHHHHH---ccCCC-
Confidence 4433221 223457889999999998889999999999999999999 99999754421 1222111 11100
Q ss_pred cccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 830 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 830 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
..........+.+++.+|++.+|++||++.|++++|+++..
T Consensus 244 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 244 --------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred --------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 00111223468899999999999999999999999998643
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=351.67 Aligned_cols=192 Identities=24% Similarity=0.368 Sum_probs=150.8
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecC--CchhhHhHHHHHHHHhhccCCCccceecceee-----cCeEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE-----EGRSV 671 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~-----~~~~~ 671 (927)
.|.+.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+++|++++||||+++++++.. ....+
T Consensus 54 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 133 (458)
T 3rp9_A 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELY 133 (458)
T ss_dssp TEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEE
Confidence 3556789999999999999876 6889999998654 23345678899999999999999999999843 35789
Q ss_pred EEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccc
Q 002409 672 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 751 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 751 (927)
+||||+ +|+|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 134 lv~e~~-~~~L~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 134 VVLEIA-DSDFKKLFR----TPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEECCC-SEEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEecc-ccchhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchh
Confidence 999998 568988884 345689999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCC--------------------------ceeeeeccCCCccCcccc-ccCcCCCccceeeHHHHHHHHHhC
Q 002409 752 AVDGAS--------------------------HVSSIVRGTVGYLDPEYY-ISQQLTDKSDVYSFGVILLELISG 799 (927)
Q Consensus 752 ~~~~~~--------------------------~~~~~~~gt~~Y~aPE~~-~~~~~s~~sDVwSlGvvL~elltG 799 (927)
...... .......||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 542211 112334689999999986 456799999999999999999993
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=335.13 Aligned_cols=252 Identities=24% Similarity=0.315 Sum_probs=185.9
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc-h-hhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-Q-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~-~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
+.+.+.||+|+||.||+|+.. +++.||||+++.... . ..+.+.++...++.++||||+++++++.+.+..++||||+
T Consensus 9 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 88 (290)
T 3fme_A 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM 88 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECC
T ss_pred hhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehh
Confidence 445789999999999999875 688999999975432 2 2334455566688899999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
+ |+|.+++.........+++..++.++.|++.||+|||++ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 89 ~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 164 (290)
T 3fme_A 89 D-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV- 164 (290)
T ss_dssp S-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC-----------
T ss_pred c-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccccccc-
Confidence 7 588888765444567799999999999999999999985 289999999999999999999999999997654322
Q ss_pred ceeeeeccCCCccCcccc----ccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccC
Q 002409 758 HVSSIVRGTVGYLDPEYY----ISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 833 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~----~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 833 (927)
......||+.|+|||.+ ....++.++|||||||++|||++|+.||...... ...+... ..... ....
T Consensus 165 -~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~----~~~~~-~~~~- 235 (290)
T 3fme_A 165 -AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP--FQQLKQV----VEEPS-PQLP- 235 (290)
T ss_dssp ------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH--HHHHHHH----HHSCC-CCCC-
T ss_pred -cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch--HHHHHHH----hccCC-CCcc-
Confidence 22334589999999996 4567888999999999999999999999753211 1111111 11111 0000
Q ss_pred CcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 834 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 834 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.......+.+++.+|++.+|++|||+.|++++
T Consensus 236 -------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 236 -------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp -------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred -------cccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 11123468899999999999999999999885
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=337.39 Aligned_cols=265 Identities=19% Similarity=0.268 Sum_probs=197.2
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc--hhhHhHHHHHHHHhhccCCCccceecceee--------cC
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQE--------EG 668 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--------~~ 668 (927)
.|.+.+.||+|+||.||+|+.. +++.||||++..... .....+.+|++++++++||||+++++++.. .+
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 97 (351)
T 3mi9_A 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 97 (351)
T ss_dssp GEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------C
T ss_pred ceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCc
Confidence 3556789999999999999985 789999999865432 234568899999999999999999999876 44
Q ss_pred eEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecC
Q 002409 669 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 748 (927)
Q Consensus 669 ~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGl 748 (927)
..++||||+++ +|.+.+... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 98 ~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 98 SIYLVFDFCEH-DLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp EEEEEEECCSE-EHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred eEEEEEeccCC-CHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 68999999975 777766432 34589999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCC---CceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhc
Q 002409 749 SKFAVDGA---SHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE 824 (927)
Q Consensus 749 a~~~~~~~---~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~ 824 (927)
++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.+.... ..
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-~~ 249 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS-IT 249 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC-CC
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC-CC
Confidence 98654221 122234568999999999876 56899999999999999999999999765422222122111110 00
Q ss_pred cCCcccc--------cCCcccCccCH-H------HHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 825 SGDIQGI--------IDPSLLDEYDI-Q------SMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 825 ~~~~~~~--------~d~~l~~~~~~-~------~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
....... +.......... + ....+.+++.+|++.||++|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0000000 00000000000 0 12357899999999999999999999886
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=341.95 Aligned_cols=264 Identities=22% Similarity=0.301 Sum_probs=199.7
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
.+.+.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 34 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 113 (360)
T 3eqc_A 34 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 113 (360)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECC
Confidence 3445678999999999999887 68899999997653 334567899999999999999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
++++|.+++.. ...+++..+..++.|++.||+|||+.+ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 114 ~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 185 (360)
T 3eqc_A 114 DGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 185 (360)
T ss_dssp TTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred CCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence 99999999843 346889999999999999999999841 7999999999999999999999999998754322
Q ss_pred ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHH--------hhhccC---
Q 002409 758 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK--------LHIESG--- 826 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~--------~~~~~~--- 826 (927)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+..... .....+
T Consensus 186 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (360)
T 3eqc_A 186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264 (360)
T ss_dssp -C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred -cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence 12234689999999999999999999999999999999999999975432111000000000 000000
Q ss_pred -----------CcccccC----CcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 827 -----------DIQGIID----PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 827 -----------~~~~~~d----~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
...+.++ ..............+.+++.+|++.+|++|||+.|+++|
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ---------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0000000 000000001123468899999999999999999999987
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=344.71 Aligned_cols=274 Identities=22% Similarity=0.284 Sum_probs=204.7
Q ss_pred cccCHHHHHHHHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhcc--------CCCccc
Q 002409 589 HCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH--------HRNLVQ 659 (927)
Q Consensus 589 ~~~~~~ei~~~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~--------HpnIv~ 659 (927)
+.+..+++....|.+.++||+|+||.||+|+.. +++.||||+++.. ....+.+.+|++++++++ |+||++
T Consensus 27 ~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~ 105 (397)
T 1wak_A 27 HLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQ 105 (397)
T ss_dssp CSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred eEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence 344455555556777899999999999999875 5788999999743 334567889999999995 788999
Q ss_pred eeccee----ecCeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEE
Q 002409 660 FLGYCQ----EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL 735 (927)
Q Consensus 660 l~g~~~----~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl 735 (927)
+++++. .....++||||+ +++|.+++... ....+++..++.++.||+.||+|||+++ +|+||||||+|||+
T Consensus 106 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll 180 (397)
T 1wak_A 106 LLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILL 180 (397)
T ss_dssp EEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEE
T ss_pred eecceeecCCCCceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeE
Confidence 999987 556789999999 55666665432 2356899999999999999999999953 89999999999999
Q ss_pred CCCC-------------------------------------------------cEEEEeecCcccccCCCCceeeeeccC
Q 002409 736 DKHM-------------------------------------------------RAKVSDFGLSKFAVDGASHVSSIVRGT 766 (927)
Q Consensus 736 ~~~~-------------------------------------------------~vkL~DFGla~~~~~~~~~~~~~~~gt 766 (927)
+.++ .+||+|||+++..... .....||
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt 256 (397)
T 1wak_A 181 SVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQT 256 (397)
T ss_dssp CCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSC
T ss_pred eccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCC
Confidence 9775 7999999999865432 2234589
Q ss_pred CCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchh--hHHHHhhhc-------------------c
Q 002409 767 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI--VQWAKLHIE-------------------S 825 (927)
Q Consensus 767 ~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l--~~~~~~~~~-------------------~ 825 (927)
+.|+|||++.+..++.++|||||||++|||++|+.||......+..... ......... .
T Consensus 257 ~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 336 (397)
T 1wak_A 257 RQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKK 336 (397)
T ss_dssp GGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTT
T ss_pred CcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCc
Confidence 9999999999999999999999999999999999999754422211111 110000000 0
Q ss_pred CCcccccCCcc---------cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 826 GDIQGIIDPSL---------LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 826 ~~~~~~~d~~l---------~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
+....+.+..- ....+......+.+|+.+|++.||++|||+.|+++|
T Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 337 GDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp SSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 00101000000 012245566789999999999999999999999875
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=340.26 Aligned_cols=258 Identities=21% Similarity=0.287 Sum_probs=191.3
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecC------eEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------RSV 671 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~------~~~ 671 (927)
|.+.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++...+ ..+
T Consensus 27 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 106 (367)
T 1cm8_A 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY 106 (367)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred EEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEE
Confidence 445688999999999999875 68999999986432 233567889999999999999999999987653 459
Q ss_pred EEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccc
Q 002409 672 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 751 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 751 (927)
+||||+ +++|.+++.. ..+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 107 lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 107 LVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp EEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 999999 7899998843 4688999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCCceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhh-------h
Q 002409 752 AVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH-------I 823 (927)
Q Consensus 752 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~-------~ 823 (927)
.... .....||+.|+|||++.+ ..++.++||||+||+++||++|+.||......+....+....... +
T Consensus 178 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 253 (367)
T 1cm8_A 178 ADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 253 (367)
T ss_dssp CCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred cccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 5332 233468999999999887 689999999999999999999999997644221111111110000 0
Q ss_pred ccC-------CcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 824 ESG-------DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 824 ~~~-------~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
... .+...-...+ ..........+.+++.+|++.||++|||+.|+++|
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 254 QSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp SCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 000 0000000000 01111223468899999999999999999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=345.96 Aligned_cols=197 Identities=24% Similarity=0.360 Sum_probs=163.6
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecC--CchhhHhHHHHHHHHhhccCCCccceecceeec-----CeEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-----GRSV 671 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~-----~~~~ 671 (927)
.|.+.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+++|++++||||+++++++... ...+
T Consensus 27 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 106 (432)
T 3n9x_A 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY 106 (432)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEE
Confidence 3456789999999999999876 5788999999754 223456788999999999999999999999766 5789
Q ss_pred EEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccc
Q 002409 672 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 751 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 751 (927)
+||||+. |+|.+++.. ...+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 107 lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 107 IVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 9999986 599998843 45689999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCC---------------------ceeeeeccCCCccCcccc-ccCcCCCccceeeHHHHHHHHHhCCCccc
Q 002409 752 AVDGAS---------------------HVSSIVRGTVGYLDPEYY-ISQQLTDKSDVYSFGVILLELISGQEAIS 804 (927)
Q Consensus 752 ~~~~~~---------------------~~~~~~~gt~~Y~aPE~~-~~~~~s~~sDVwSlGvvL~elltG~~p~~ 804 (927)
...... .......||+.|+|||++ ....++.++||||+||++|||++|..|+.
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 543221 112445699999999986 45679999999999999999998766654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=332.19 Aligned_cols=261 Identities=24% Similarity=0.384 Sum_probs=183.4
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
+.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++...+..++||||++
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 96 (303)
T 2vwi_A 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLS 96 (303)
T ss_dssp CEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCT
T ss_pred hhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhcc
Confidence 445789999999999999865 68899999886443 2335678899999999999999999999999999999999999
Q ss_pred CCchhhhccccc----ccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccC
Q 002409 679 NGTLKEHLYGTL----THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 754 (927)
Q Consensus 679 ~gsL~~~L~~~~----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 754 (927)
+++|.+++.... .....+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 97 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 173 (303)
T 2vwi_A 97 GGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLAT 173 (303)
T ss_dssp TCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC-
T ss_pred CCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchheecc
Confidence 999999985321 1245589999999999999999999998 999999999999999999999999999875543
Q ss_pred CCC----ceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcc
Q 002409 755 GAS----HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 829 (927)
Q Consensus 755 ~~~----~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 829 (927)
... .......||+.|+|||.+.. ..++.++|||||||++|||++|+.||....... ...............
T Consensus 174 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~ 249 (303)
T 2vwi_A 174 GGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK----VLMLTLQNDPPSLET 249 (303)
T ss_dssp --------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG----HHHHHHTSSCCCTTC
T ss_pred CCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh----HHHHHhccCCCcccc
Confidence 211 11233468999999999876 568999999999999999999999997644211 111111100000001
Q ss_pred cccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 830 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 830 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
...++.....+ ...+.+++.+|++.+|++||++.|++++
T Consensus 250 ~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 250 GVQDKEMLKKY----GKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp -----CCCCCC----CHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccccchhhhhh----hHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 11111122222 2468899999999999999999999975
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=343.47 Aligned_cols=251 Identities=11% Similarity=0.034 Sum_probs=177.6
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc---hhhHhHHHHHHHHhhc--cCCCcccee-------cceeec-
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRI--HHRNLVQFL-------GYCQEE- 667 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~iL~~l--~HpnIv~l~-------g~~~~~- 667 (927)
.+.+.||+|+||.||+|++. +++.||||++..... ...+.+.+|+.+++.+ +||||++++ +++...
T Consensus 65 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~ 144 (371)
T 3q60_A 65 KLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQS 144 (371)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETT
T ss_pred eeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCC
Confidence 45688999999999999976 788999999987543 2345677885555554 699988755 333322
Q ss_pred ----------------CeEEEEEEeccCCchhhhcccccccccccCHHHH------HHHHHHHHhHhHHHhhCCCCceec
Q 002409 668 ----------------GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR------LEIAEDAAKGIEYLHTGCVPAIIH 725 (927)
Q Consensus 668 ----------------~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~------~~i~~qia~gL~yLH~~~~~~ivH 725 (927)
...++||||++ |+|.+++... ...+.+..+ +.++.|++.||+|||++ +|+|
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivH 217 (371)
T 3q60_A 145 QPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVH 217 (371)
T ss_dssp SCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred CCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCcc
Confidence 33799999998 8999999643 223344455 67889999999999998 9999
Q ss_pred CCCCCCCeEECCCCcEEEEeecCcccccCCCCceeeeeccCCCccCcccccc--CcCCCccceeeHHHHHHHHHhCCCcc
Q 002409 726 RDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAI 803 (927)
Q Consensus 726 rDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~sDVwSlGvvL~elltG~~p~ 803 (927)
|||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999985532 1223457799999999987 78999999999999999999999999
Q ss_pred cccccccccchhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 804 SNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 804 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
......... .|.. ......................+.+++.+|++.||++|||+.|++++
T Consensus 294 ~~~~~~~~~----~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 294 GLVTPGIKG----SWKR-----PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp TBCCTTCTT----CCCB-----CCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCcCccccc----chhh-----hhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 765421100 0000 00000000111111111233568899999999999999999999875
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-36 Score=329.72 Aligned_cols=251 Identities=22% Similarity=0.339 Sum_probs=198.0
Q ss_pred HHHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 598 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 598 ~~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
...+.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+|+.++++++||||+++++++...+..++||||
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 334556789999999999999886 58999999997543 346788999999999999999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
+++++|.+++.. ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 106 ~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 106 CGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp CTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred CCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 999999999852 245689999999999999999999998 99999999999999999999999999997654332
Q ss_pred CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 757 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ..... ...........
T Consensus 180 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~----~~~~~~~~~~~--- 247 (314)
T 3com_A 180 A-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM----RAIFM----IPTNPPPTFRK--- 247 (314)
T ss_dssp S-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHH----HHHSCCCCCSS---
T ss_pred c-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH----HHHHH----HhcCCCcccCC---
Confidence 2 223446899999999999989999999999999999999999999754311 11110 01111000000
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
+......+.+++.+|++.+|++||++.|++++
T Consensus 248 ----~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 248 ----PELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp ----GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ----cccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11123468899999999999999999999875
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=366.47 Aligned_cols=246 Identities=24% Similarity=0.305 Sum_probs=201.0
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhc-cCCCccceecceeecCeEEEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE 675 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~lV~E 675 (927)
+.+.+.||+|+||.||+|+.. +++.||||+++... ......+..|..++..+ +||||+++++++.+.+..++|||
T Consensus 343 f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E 422 (674)
T 3pfq_A 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 422 (674)
T ss_dssp EEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEE
T ss_pred eEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEe
Confidence 445689999999999999876 57889999997542 22345678899999887 79999999999999999999999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCC
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 755 (927)
|+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+||||+.++++||+|||+++.....
T Consensus 423 ~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 423 YVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp CCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred CcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence 9999999999853 35689999999999999999999998 9999999999999999999999999999854322
Q ss_pred CCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCc
Q 002409 756 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 835 (927)
Q Consensus 756 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 835 (927)
. .......||+.|+|||++.+..++.++|||||||+||||++|+.||......+....+. .+.+
T Consensus 496 ~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~--------~~~~------- 559 (674)
T 3pfq_A 496 G-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM--------EHNV------- 559 (674)
T ss_dssp T-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--------SSCC-------
T ss_pred C-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHH--------hCCC-------
Confidence 2 23345679999999999999999999999999999999999999997654222111111 1111
Q ss_pred ccCccCHHHHHHHHHHHhhhcCCCCCCCCcH-----HHHHHH
Q 002409 836 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSI-----SEVLKD 872 (927)
Q Consensus 836 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm-----~eV~~~ 872 (927)
.++.....++.+|+.+|++.||++||++ .||.+|
T Consensus 560 ---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 560 ---AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred ---CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 1112223468899999999999999997 777765
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=332.35 Aligned_cols=256 Identities=19% Similarity=0.297 Sum_probs=196.0
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhcc-CCCccceecceee--cCeEEEEEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQE--EGRSVLVYE 675 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~--~~~~~lV~E 675 (927)
.|.+.+.||+|+||.||+|+.. +++.||||+++.. ..+.+.+|++++++++ ||||+++++++.. ....++|||
T Consensus 37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e 113 (330)
T 3nsz_A 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 113 (330)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred ceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence 3456789999999999999874 6889999998743 3467899999999997 9999999999987 667899999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCC-cEEEEeecCcccccC
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVD 754 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-~vkL~DFGla~~~~~ 754 (927)
|+.+++|.+++. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++....
T Consensus 114 ~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 114 HVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp CCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred ccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 999999998873 378889999999999999999998 999999999999999776 899999999986543
Q ss_pred CCCceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHh--------hhcc
Q 002409 755 GASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL--------HIES 825 (927)
Q Consensus 755 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~--------~~~~ 825 (927)
... .....||..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ...+...... .+..
T Consensus 184 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~--~~~l~~~~~~~~~~~~~~~~~~ 259 (330)
T 3nsz_A 184 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN--YDQLVRIAKVLGTEDLYDYIDK 259 (330)
T ss_dssp TCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH--HHHHHHHHHHHCHHHHHHHHHH
T ss_pred CCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch--HHHHHHHHHhcCCchhhhHHHH
Confidence 322 233468999999999977 67899999999999999999999999543211 0111111000 0000
Q ss_pred CC------ccc--------ccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 826 GD------IQG--------IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 826 ~~------~~~--------~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.. +.+ .................+.+++.+|++.||++|||+.|+++|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00 000 000000111111234578999999999999999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-36 Score=326.54 Aligned_cols=249 Identities=27% Similarity=0.304 Sum_probs=198.6
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc---------hhhHhHHHHHHHHhhcc-CCCccceecceeecCe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---------QGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGR 669 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~---------~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~~ 669 (927)
|.+.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+++++++. ||||+++++++...+.
T Consensus 19 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 98 (298)
T 1phk_A 19 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 98 (298)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred cceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCe
Confidence 445688999999999999986 688999999975431 12356789999999995 9999999999999999
Q ss_pred EEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCc
Q 002409 670 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 749 (927)
Q Consensus 670 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla 749 (927)
.++||||+++++|.+++.. ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++
T Consensus 99 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 99 FFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp EEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccch
Confidence 9999999999999999843 45689999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeeccCCCccCccccc------cCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhh
Q 002409 750 KFAVDGASHVSSIVRGTVGYLDPEYYI------SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 823 (927)
Q Consensus 750 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~ 823 (927)
+...... ......||+.|+|||++. ...++.++||||||+++|||++|+.||....... +... +
T Consensus 172 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~----~ 241 (298)
T 1phk_A 172 CQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML----MLRM----I 241 (298)
T ss_dssp EECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH----H
T ss_pred hhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH----HHHH----H
Confidence 7654332 223345899999999985 4568889999999999999999999997543111 1111 1
Q ss_pred ccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 824 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 824 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
..+.... ..+ ........+.+++.+|++.+|++||++.|++++
T Consensus 242 ~~~~~~~-~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 242 MSGNYQF-GSP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp HHTCCCC-CTT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred hcCCccc-Ccc-----cccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 1111100 000 011223468899999999999999999999874
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=341.06 Aligned_cols=262 Identities=19% Similarity=0.226 Sum_probs=191.7
Q ss_pred HHHhccccccCceEEEEEEECCCcEEEEEEeecCCch-----------hhHhHHHHHHHHhhccCCCccceecceee---
Q 002409 601 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ-----------GKREFTNEVTLLSRIHHRNLVQFLGYCQE--- 666 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~-----------~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--- 666 (927)
|.+.+.||+|+||.||+|+..+++.||||++...... ..+.+.+|++++++++||||+++++++..
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 103 (362)
T 3pg1_A 24 YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEE 103 (362)
T ss_dssp CEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCT
T ss_pred eEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccC
Confidence 3456899999999999999888999999998643221 12678999999999999999999999843
Q ss_pred --cCeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEE
Q 002409 667 --EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 744 (927)
Q Consensus 667 --~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~ 744 (927)
....++||||+. |+|.+++.. ....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+
T Consensus 104 ~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~ 176 (362)
T 3pg1_A 104 PAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITIC 176 (362)
T ss_dssp TTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCEEEE
Confidence 346799999998 688887753 245689999999999999999999998 99999999999999999999999
Q ss_pred eecCcccccCCCCceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhh
Q 002409 745 DFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 823 (927)
Q Consensus 745 DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~ 823 (927)
|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+........
T Consensus 177 Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 254 (362)
T 3pg1_A 177 DFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254 (362)
T ss_dssp CTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred ecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 99999744332 22234568999999999876 6789999999999999999999999976542222222222111000
Q ss_pred ---------------ccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 824 ---------------ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 824 ---------------~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
....... ................+.+++.+|++.+|++|||+.|++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 255 IEDVVMFSSPSARDYLRNSLSN-VPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHTSCHHHHHHTTTCCCC-CCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hHHhhhccchhhhHHHHhhccc-CChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 0000000 00000011112223468899999999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=331.57 Aligned_cols=252 Identities=24% Similarity=0.398 Sum_probs=195.4
Q ss_pred HHHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc--------hhhHhHHHHHHHHhhccCCCccceecceeecC
Q 002409 598 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--------QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG 668 (927)
Q Consensus 598 ~~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~--------~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~ 668 (927)
...|.+.+.||+|+||.||+|+.. +++.||||++..... .....+.+|++++++++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 345667899999999999999876 578999999864321 12345889999999999999999999987655
Q ss_pred eEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCc---EEEEe
Q 002409 669 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR---AKVSD 745 (927)
Q Consensus 669 ~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~---vkL~D 745 (927)
.++||||+++++|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++. +||+|
T Consensus 89 -~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp -EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred -eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 8999999999999998843 45689999999999999999999998 9999999999999987654 99999
Q ss_pred ecCcccccCCCCceeeeeccCCCccCccccc---cCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhh
Q 002409 746 FGLSKFAVDGASHVSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH 822 (927)
Q Consensus 746 FGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~ 822 (927)
||+++..... .......||+.|+|||++. ...++.++|||||||++|||++|+.||....... .+.....
T Consensus 161 fg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~-- 233 (322)
T 2ycf_A 161 FGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV---SLKDQIT-- 233 (322)
T ss_dssp CTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS---CHHHHHH--
T ss_pred Cccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH---HHHHHHH--
Confidence 9999865332 2223456899999999974 4678899999999999999999999997544221 1111111
Q ss_pred hccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 823 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 823 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.+... ..+.... .....+.+++.+|++.||++||++.|++++
T Consensus 234 --~~~~~--~~~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 234 --SGKYN--FIPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp --HTCCC--CCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --hCccc--cCchhhh----hcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 11110 0001111 123468899999999999999999999975
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=332.59 Aligned_cols=250 Identities=22% Similarity=0.360 Sum_probs=195.2
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
|.+.+.||+|+||.||+|+.. +++.||+|++..........+.+|++++++++||||+++++++...+..++||||+++
T Consensus 21 y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 100 (302)
T 2j7t_A 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPG 100 (302)
T ss_dssp EEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTT
T ss_pred eeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCC
Confidence 456788999999999999987 5889999999766555667899999999999999999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
++|.+++... ...+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||++....... ..
T Consensus 101 ~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 173 (302)
T 2j7t_A 101 GAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-QK 173 (302)
T ss_dssp EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-HC
T ss_pred CcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc-cc
Confidence 9999988532 35689999999999999999999998 99999999999999999999999999875322110 11
Q ss_pred eeeeccCCCccCccccc-----cCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCC
Q 002409 760 SSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 834 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~-----~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 834 (927)
.....||+.|+|||.+. ...++.++|||||||++|||++|+.||....... .+.... .+.......
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~-----~~~~~~~~~- 244 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR---VLLKIA-----KSDPPTLLT- 244 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHH-----HSCCCCCSS-
T ss_pred cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HHHHHh-----ccCCcccCC-
Confidence 22345899999999984 5678899999999999999999999997543111 111111 111111110
Q ss_pred cccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 835 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 835 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
+......+.+++.+|++.+|++|||+.|++++
T Consensus 245 ------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 245 ------PSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp ------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred ------ccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 11223468899999999999999999999874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=337.24 Aligned_cols=260 Identities=22% Similarity=0.297 Sum_probs=189.2
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecC------eEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------RSV 671 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~------~~~ 671 (927)
|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++...+ ..+
T Consensus 27 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~ 106 (371)
T 2xrw_A 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 106 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEE
T ss_pred eeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceE
Confidence 445688999999999999876 68899999997542 233467889999999999999999999987654 789
Q ss_pred EEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccc
Q 002409 672 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 751 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 751 (927)
+||||+++ +|.+.+. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 107 lv~e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 107 IVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEECCSE-EHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred EEEEcCCC-CHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 99999975 7877773 3478889999999999999999998 999999999999999999999999999975
Q ss_pred ccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhH--------------
Q 002409 752 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ-------------- 817 (927)
Q Consensus 752 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~-------------- 817 (927)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+..
T Consensus 177 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 177 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred cccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 5332 122345689999999999999999999999999999999999999976442111111110
Q ss_pred -HHHhhhccC------CcccccCCcccC---ccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 818 -WAKLHIESG------DIQGIIDPSLLD---EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 818 -~~~~~~~~~------~~~~~~d~~l~~---~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
......... .+...+...... .........+.+++.+|++.||++|||+.|++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000000000 000000000000 0112234578999999999999999999999987
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=347.29 Aligned_cols=260 Identities=20% Similarity=0.321 Sum_probs=203.3
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccC-CCccceecceeecCeEEEEEEecc
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH-RNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~H-pnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
|.+.++||+|+||.||+|++. +++.||||++..... ..++..|+++++.++| +++..+..++...+..++||||+
T Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~- 85 (483)
T 3sv0_A 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (483)
T ss_dssp EECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-
Confidence 445789999999999999874 689999998865432 3468899999999987 55555666667788889999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEE---CCCCcEEEEeecCcccccCC
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl---~~~~~vkL~DFGla~~~~~~ 755 (927)
+++|.+++... ...+++..++.|+.||+.||+|||++ +|+||||||+|||| +.++.+||+|||+++.....
T Consensus 86 g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 86 GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 99999998532 35689999999999999999999998 99999999999999 58899999999999865543
Q ss_pred CCc------eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcc
Q 002409 756 ASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 829 (927)
Q Consensus 756 ~~~------~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 829 (927)
... ......||+.|+|||++.+..++.++|||||||+||||++|+.||...........+......... ..+.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-~~~~ 238 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA-TSIE 238 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH-SCHH
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc-ccHH
Confidence 322 122456999999999999999999999999999999999999999765422222112111111110 1110
Q ss_pred cccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHH
Q 002409 830 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 879 (927)
Q Consensus 830 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~ 879 (927)
. +... ...++.+++..|++.+|++||++.+|++.|++++..
T Consensus 239 ~-----l~~~----~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 239 A-----LCRG----YPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp H-----HHTT----SCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred H-----HhcC----CcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 0 0011 124689999999999999999999999999998764
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-36 Score=352.05 Aligned_cols=249 Identities=28% Similarity=0.408 Sum_probs=197.4
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc-------------hhhHhHHHHHHHHhhccCCCccceeccee
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-------------QGKREFTNEVTLLSRIHHRNLVQFLGYCQ 665 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~-------------~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~ 665 (927)
.|.+.++||+|+||+||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++.
T Consensus 37 ~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 116 (504)
T 3q5i_A 37 SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFE 116 (504)
T ss_dssp TEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 3556789999999999999886 578999999875421 22467889999999999999999999999
Q ss_pred ecCeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCC---cEE
Q 002409 666 EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM---RAK 742 (927)
Q Consensus 666 ~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~---~vk 742 (927)
+.+..++||||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+|
T Consensus 117 ~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 117 DKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEE
T ss_pred cCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEE
Confidence 99999999999999999998843 45689999999999999999999998 999999999999998776 699
Q ss_pred EEeecCcccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhh
Q 002409 743 VSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH 822 (927)
Q Consensus 743 L~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~ 822 (927)
|+|||+++...... ......||+.|+|||++. +.++.++||||+||++|+|++|+.||...... .+...+
T Consensus 190 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i--- 259 (504)
T 3q5i_A 190 IVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ----DIIKKV--- 259 (504)
T ss_dssp ECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHH---
T ss_pred EEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHH---
Confidence 99999998654432 223456999999999986 56899999999999999999999999765422 122211
Q ss_pred hccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 823 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 823 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
..+.... +..... .....+.+++.+|++.+|++|||+.|++++
T Consensus 260 -~~~~~~~--~~~~~~----~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 260 -EKGKYYF--DFNDWK----NISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp -HHCCCCC--CHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -HcCCCCC--CccccC----CCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1111100 000001 122468899999999999999999999875
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=337.17 Aligned_cols=256 Identities=22% Similarity=0.288 Sum_probs=200.8
Q ss_pred HHHhccccccCceEEEEEEECCCcEEEEEEeecCCchh-----------------hHhHHHHHHHHhhccCCCccceecc
Q 002409 601 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-----------------KREFTNEVTLLSRIHHRNLVQFLGY 663 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~-----------------~~~~~~Ei~iL~~l~HpnIv~l~g~ 663 (927)
|.+.+.||+|+||.||+|+. +++.||||++....... ...+.+|++++++++||||++++++
T Consensus 33 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 111 (348)
T 2pml_X 33 YRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI 111 (348)
T ss_dssp EEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEE
T ss_pred eEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 45678999999999999999 79999999987542111 1779999999999999999999999
Q ss_pred eeecCeEEEEEEeccCCchhhh------cccccccccccCHHHHHHHHHHHHhHhHHHhh-CCCCceecCCCCCCCeEEC
Q 002409 664 CQEEGRSVLVYEFMHNGTLKEH------LYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLD 736 (927)
Q Consensus 664 ~~~~~~~~lV~E~~~~gsL~~~------L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDLkp~NILl~ 736 (927)
+...+..++||||+++|+|.++ +.. .....+++..++.++.|++.||+|||+ + +|+||||||+|||++
T Consensus 112 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 112 ITNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILMD 186 (348)
T ss_dssp EESSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEEC
T ss_pred EeeCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEEc
Confidence 9999999999999999999998 432 125678999999999999999999999 7 999999999999999
Q ss_pred CCCcEEEEeecCcccccCCCCceeeeeccCCCccCccccccC-cCCC-ccceeeHHHHHHHHHhCCCcccccccccccch
Q 002409 737 KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ-QLTD-KSDVYSFGVILLELISGQEAISNEKFGANCRN 814 (927)
Q Consensus 737 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~-~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~ 814 (927)
.++.+||+|||+++..... ......||+.|+|||.+.+. .++. ++|||||||++|||++|+.||...... ..
T Consensus 187 ~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~ 260 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL---VE 260 (348)
T ss_dssp TTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS---HH
T ss_pred CCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH---HH
Confidence 9999999999999865432 23345689999999999877 6666 999999999999999999999765421 11
Q ss_pred hhHHHHhhhccCCcccc------cCCcc---cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 815 IVQWAKLHIESGDIQGI------IDPSL---LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 815 l~~~~~~~~~~~~~~~~------~d~~l---~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
+.+... .+..... ..+.. ...........+.+++.+|++.+|++||++.|++++
T Consensus 261 ~~~~i~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 261 LFNNIR----TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHHHT----SCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHHh----ccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 222111 1111000 00000 000012233468899999999999999999999985
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=346.70 Aligned_cols=197 Identities=25% Similarity=0.339 Sum_probs=169.2
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhc------cCCCccceecceeecCeEEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI------HHRNLVQFLGYCQEEGRSVL 672 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l------~HpnIv~l~g~~~~~~~~~l 672 (927)
.|.+.+.||+|+||.||+|+.. +++.||||+++.. ....+.+.+|+++++.+ +|+||+++++++...+..++
T Consensus 98 ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 176 (429)
T 3kvw_A 98 RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICM 176 (429)
T ss_dssp TEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEE
T ss_pred cEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEE
Confidence 3556789999999999999876 5889999999753 23356678888888887 56799999999999999999
Q ss_pred EEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCc--EEEEeecCcc
Q 002409 673 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR--AKVSDFGLSK 750 (927)
Q Consensus 673 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~--vkL~DFGla~ 750 (927)
||||+. ++|.+++... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+|||+++
T Consensus 177 v~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 177 TFELLS-MNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EECCCC-CBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEeccC-CCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 999996 6898888543 234589999999999999999999998 9999999999999999987 9999999997
Q ss_pred cccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccc
Q 002409 751 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 807 (927)
Q Consensus 751 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~ 807 (927)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 251 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 251 YEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp ETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 54322 223468999999999999999999999999999999999999997654
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=363.37 Aligned_cols=258 Identities=21% Similarity=0.333 Sum_probs=203.6
Q ss_pred HHHHHhccccccCceEEEEEEECC----CcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEE
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 673 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~~----g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV 673 (927)
..+.+.+.||+|+||.||+|++.. +..||||+++... ....+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~lv 468 (656)
T 2j0j_A 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWII 468 (656)
T ss_dssp GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEEE
Confidence 445567899999999999998752 4579999987543 3334678999999999999999999999854 568999
Q ss_pred EEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccccc
Q 002409 674 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 753 (927)
Q Consensus 674 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 753 (927)
|||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 469 ~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 469 MELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp EECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred EEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 9999999999998532 34588999999999999999999998 99999999999999999999999999998665
Q ss_pred CCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCccccc
Q 002409 754 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 832 (927)
Q Consensus 754 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 832 (927)
...........+|+.|+|||++....++.++|||||||++|||++ |..||...... .+...+. .+...
T Consensus 543 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~----~~~~~i~----~~~~~--- 611 (656)
T 2j0j_A 543 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN----DVIGRIE----NGERL--- 611 (656)
T ss_dssp C----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHHHH----HTCCC---
T ss_pred CCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHH----cCCCC---
Confidence 443333334557889999999998899999999999999999997 99999764421 2222211 11110
Q ss_pred CCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHHH
Q 002409 833 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 880 (927)
Q Consensus 833 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~~ 880 (927)
..+......+.+++.+|++.+|++||++.||++.|++++..+
T Consensus 612 ------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 612 ------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 011223346889999999999999999999999999987644
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=335.59 Aligned_cols=263 Identities=21% Similarity=0.281 Sum_probs=198.4
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc-hhhHhHHHHHHHHhhccCCCccceecceeec-----CeEEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-----GRSVL 672 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~-----~~~~l 672 (927)
.|.+.+.||+|+||.||+|+.. +++.||||++..... .....+.+|++++++++||||+++++++... ...++
T Consensus 28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i 107 (364)
T 3qyz_A 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 107 (364)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence 3556789999999999999876 678899999975433 3346788999999999999999999998654 46899
Q ss_pred EEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccc
Q 002409 673 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 752 (927)
Q Consensus 673 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 752 (927)
||||+. |+|.+++. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 108 v~e~~~-~~L~~~l~-----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 108 VQDLME-TDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEECCS-EEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEcccC-cCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 999997 58988874 34589999999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCCce--eeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcc
Q 002409 753 VDGASHV--SSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 829 (927)
Q Consensus 753 ~~~~~~~--~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 829 (927)
....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+.........+ .+.
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~~~ 257 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE-DLN 257 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHH-HHH
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHH-HHH
Confidence 4322211 234569999999998765 458999999999999999999999997655333222222111000000 000
Q ss_pred ------------cccCCcc--cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 830 ------------GIIDPSL--LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 830 ------------~~~d~~l--~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
....+.. ...........+.+++.+|++.||++|||+.|++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 000011223468899999999999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=330.12 Aligned_cols=249 Identities=23% Similarity=0.381 Sum_probs=192.1
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhc-cCCCccceecceee------cCeEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQE------EGRSVL 672 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~------~~~~~l 672 (927)
|.+.+.||+|+||.||+|+.. +++.||||++.... .....+.+|+.+++++ +||||+++++++.. .+..++
T Consensus 26 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~l 104 (326)
T 2x7f_A 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL 104 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEE
T ss_pred EEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEE
Confidence 345789999999999999885 68899999987543 3356788999999999 89999999999976 467899
Q ss_pred EEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccc
Q 002409 673 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 752 (927)
Q Consensus 673 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 752 (927)
||||+++|+|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 105 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 179 (326)
T 2x7f_A 105 VMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179 (326)
T ss_dssp EEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred EEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence 99999999999998643 245688999999999999999999998 9999999999999999999999999998754
Q ss_pred cCCCCceeeeeccCCCccCccccc-----cCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCC
Q 002409 753 VDGASHVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 827 (927)
Q Consensus 753 ~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 827 (927)
.... .......||+.|+|||.+. ...++.++|||||||++|||++|+.||...... ...... ....
T Consensus 180 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~----~~~~ 250 (326)
T 2x7f_A 180 DRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM----RALFLI----PRNP 250 (326)
T ss_dssp ------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHHH----HHSC
T ss_pred CcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH----HHHHHh----hcCc
Confidence 3321 1223346899999999987 567889999999999999999999999654311 111111 1111
Q ss_pred cccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 828 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 828 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
..... ... ....+.+++.+|++.+|++||++.|++++
T Consensus 251 ~~~~~----~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 251 APRLK----SKK----WSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp CCCCS----CSC----SCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cccCC----ccc----cCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 11111 111 12468899999999999999999999885
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=326.20 Aligned_cols=248 Identities=22% Similarity=0.313 Sum_probs=194.4
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC----chhhHhHHHHHHHHhhccCCCccceecce--eecCeEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS----YQGKREFTNEVTLLSRIHHRNLVQFLGYC--QEEGRSVLV 673 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~~~lV 673 (927)
|.+.+.||+|+||.||++... +++.||+|++.... ......+.+|++++++++||||+++++++ .+....++|
T Consensus 7 y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (305)
T 2wtk_C 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMV 86 (305)
T ss_dssp BCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEE
T ss_pred eeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEE
Confidence 445788999999999999875 68899999987542 23456789999999999999999999998 445678999
Q ss_pred EEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccccc
Q 002409 674 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 753 (927)
Q Consensus 674 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 753 (927)
|||++++ |.+++... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 87 ~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 87 MEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp EECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred ehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 9999876 66666432 245689999999999999999999998 99999999999999999999999999998654
Q ss_pred CCC-CceeeeeccCCCccCccccccCc--CCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCccc
Q 002409 754 DGA-SHVSSIVRGTVGYLDPEYYISQQ--LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 830 (927)
Q Consensus 754 ~~~-~~~~~~~~gt~~Y~aPE~~~~~~--~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 830 (927)
... ........||+.|+|||++.+.. ++.++|||||||++|||++|+.||...... .+.+. +..+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~----i~~~~~-- 230 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY----KLFEN----IGKGSY-- 230 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHH----HHHCCC--
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH----HHHHH----HhcCCC--
Confidence 322 22233456899999999987643 477999999999999999999999764421 11111 111111
Q ss_pred ccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 831 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 831 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.+.. .....+.+++.+|++.||++||++.|++++
T Consensus 231 ----~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 ----AIPG----DCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ----CCCS----SSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----CCCC----ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111 123467899999999999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-36 Score=336.31 Aligned_cols=266 Identities=20% Similarity=0.259 Sum_probs=187.9
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCe-------EE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR-------SV 671 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~-------~~ 671 (927)
.|.+.+.||+|+||.||+|+.. +++.||||++.... .......+|++.++.++||||+++++++...+. .+
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~ 102 (360)
T 3e3p_A 24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLN 102 (360)
T ss_dssp TEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEE
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEE
Confidence 4455789999999999999986 68999999986543 223456778888999999999999999866443 78
Q ss_pred EEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHh--hCCCCceecCCCCCCCeEECC-CCcEEEEeecC
Q 002409 672 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH--TGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGL 748 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH--~~~~~~ivHrDLkp~NILl~~-~~~vkL~DFGl 748 (927)
+||||+++ +|.+.+.........+++..+..++.|++.||.||| ++ +|+||||||+|||++. ++.+||+|||+
T Consensus 103 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 103 VVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDFGS 178 (360)
T ss_dssp EEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred EEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence 99999986 555555443345667889999999999999999999 76 9999999999999997 89999999999
Q ss_pred cccccCCCCceeeeeccCCCccCccccccC-cCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHh------
Q 002409 749 SKFAVDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL------ 821 (927)
Q Consensus 749 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~------ 821 (927)
++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+.+....
T Consensus 179 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (360)
T 3e3p_A 179 AKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL 256 (360)
T ss_dssp CBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHH
Confidence 986544322 2334589999999998764 4899999999999999999999999765432222222221100
Q ss_pred -hhcc-CCcccccCC------cccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 822 -HIES-GDIQGIIDP------SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 822 -~~~~-~~~~~~~d~------~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.... .......+. .............+.+++.+|++.||++|||+.|+++|
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000 000000000 00111122245678999999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=336.59 Aligned_cols=258 Identities=22% Similarity=0.302 Sum_probs=180.4
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecC--CchhhHhHHHHHHHHhhccCCCccceecceeec------CeEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRSV 671 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~------~~~~ 671 (927)
|.+.+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|++++++++||||+++++++... ...+
T Consensus 31 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~ 110 (367)
T 2fst_X 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 110 (367)
T ss_dssp EEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred eEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEE
Confidence 455688999999999999865 6889999998653 223456788999999999999999999998654 5679
Q ss_pred EEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccc
Q 002409 672 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 751 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 751 (927)
+|+|++ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 111 lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 111 LVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH 181 (367)
T ss_dssp EEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC------
T ss_pred EEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence 999999 6899888742 4689999999999999999999998 999999999999999999999999999985
Q ss_pred ccCCCCceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhh-------h
Q 002409 752 AVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH-------I 823 (927)
Q Consensus 752 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~-------~ 823 (927)
.... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.+..... +
T Consensus 182 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 257 (367)
T 2fst_X 182 TADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257 (367)
T ss_dssp -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred cccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 4322 233468999999999877 678999999999999999999999997654221111111111000 0
Q ss_pred ccC-------CcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 824 ESG-------DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 824 ~~~-------~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
... .+...-...+. .........+.+|+.+|++.||++|||+.|+++|
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 258 SSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CCHHHHHHHHTSCCCCCCCHH-HHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhHHHHHHHhccCCCCCCCHH-HHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000 00000000000 0001123468899999999999999999999886
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=321.27 Aligned_cols=250 Identities=24% Similarity=0.348 Sum_probs=190.1
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceee------------
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE------------ 666 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~------------ 666 (927)
.+.+.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|++++++++||||+++++++.+
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (303)
T 1zy4_A 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK 85 (303)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred cchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence 4456789999999999999975 7899999998643 3345678899999999999999999998754
Q ss_pred -cCeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEe
Q 002409 667 -EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD 745 (927)
Q Consensus 667 -~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~D 745 (927)
.+..++||||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 86 KKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECC
T ss_pred cCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEee
Confidence 45679999999999999999642 34678889999999999999999998 999999999999999999999999
Q ss_pred ecCcccccCCC-------------CceeeeeccCCCccCccccccC-cCCCccceeeHHHHHHHHHhCCCcccccccccc
Q 002409 746 FGLSKFAVDGA-------------SHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGAN 811 (927)
Q Consensus 746 FGla~~~~~~~-------------~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~ 811 (927)
||+++...... ........||+.|+|||.+.+. .++.++|||||||++|||++ ||.... .
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~---~ 233 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM---E 233 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH---H
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch---h
Confidence 99997553221 1122344589999999999754 78999999999999999998 443211 0
Q ss_pred cchhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 812 CRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 812 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
...+..... ... ..+...++......+.+++.+|++.||++|||+.|++++
T Consensus 234 ~~~~~~~~~----~~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 234 RVNILKKLR----SVS------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHHHH----STT------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHHhcc----ccc------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 011111111 110 111122333344568899999999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=329.85 Aligned_cols=264 Identities=21% Similarity=0.285 Sum_probs=197.7
Q ss_pred HHHhccccccCceEEEEEEEC--CCcEEEEEEeecCCc--hhhHhHHHHHHHHhhc---cCCCccceeccee-----ecC
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK--DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRI---HHRNLVQFLGYCQ-----EEG 668 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~--~g~~VAVK~l~~~~~--~~~~~~~~Ei~iL~~l---~HpnIv~l~g~~~-----~~~ 668 (927)
|.+.+.||+|+||.||+|+.. +++.||||+++.... .....+.+|+.+++++ +||||+++++++. ...
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 92 (326)
T 1blx_A 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 92 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred eeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCc
Confidence 456789999999999999983 678899999875432 2234677888888777 8999999999987 556
Q ss_pred eEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecC
Q 002409 669 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 748 (927)
Q Consensus 669 ~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGl 748 (927)
..++||||+. |+|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 93 ~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 93 KLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp EEEEEEECCS-CBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred eEEEEEecCC-CCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCcc
Confidence 7899999998 6999988543 234588999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCc
Q 002409 749 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 828 (927)
Q Consensus 749 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 828 (927)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.............
T Consensus 167 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (326)
T 1blx_A 167 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 244 (326)
T ss_dssp CCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred cccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCc
Confidence 9754322 12234568999999999999999999999999999999999999997654222221222111100000000
Q ss_pred cc------cc---CCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 829 QG------II---DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 829 ~~------~~---d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.. .+ .......+.......+.+++.+|++.+|++||++.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 245 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00 00 0000011112233568899999999999999999999875
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=335.98 Aligned_cols=263 Identities=22% Similarity=0.276 Sum_probs=194.7
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeec-----CeEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-----GRSVLV 673 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~-----~~~~lV 673 (927)
+.+.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|++++++++||||+++++++... ...++|
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 92 (353)
T 2b9h_A 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYII 92 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEE
T ss_pred eEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEE
Confidence 345688999999999999886 68899999997543 23356788999999999999999999988654 678999
Q ss_pred EEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccccc
Q 002409 674 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 753 (927)
Q Consensus 674 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 753 (927)
|||+. |+|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 93 QELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp ECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 99997 589888742 4688999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCc---------eeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhh
Q 002409 754 DGASH---------VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 823 (927)
Q Consensus 754 ~~~~~---------~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~ 823 (927)
..... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||...........+........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence 32111 1123468999999998764 6789999999999999999999999976542111111111000000
Q ss_pred ccCCcccccCC--------------cccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 824 ESGDIQGIIDP--------------SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 824 ~~~~~~~~~d~--------------~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
..........+ .-...........+.+++.+|++.||++|||+.|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000000 00000011223468899999999999999999999885
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=338.68 Aligned_cols=263 Identities=20% Similarity=0.267 Sum_probs=180.3
Q ss_pred hccccccCceEEEEEEEC---CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceee--cCeEEEEEEecc
Q 002409 604 EKKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVLVYEFMH 678 (927)
Q Consensus 604 ~~~IG~G~fG~Vy~~~~~---~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--~~~~~lV~E~~~ 678 (927)
+++||+|+||.||+|+++ +++.||||++.... ....+.+|+++|++++||||+++++++.. ....++||||+.
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~ 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence 468999999999999976 57889999986442 23568899999999999999999999954 678999999997
Q ss_pred CCchhhhccccc-----ccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEE----CCCCcEEEEeecCc
Q 002409 679 NGTLKEHLYGTL-----THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLS 749 (927)
Q Consensus 679 ~gsL~~~L~~~~-----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl----~~~~~vkL~DFGla 749 (927)
|+|.+++.... .....+++..++.++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 104 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 179 (405)
T 3rgf_A 104 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 179 (405)
T ss_dssp -EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred -CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence 47877774221 1223589999999999999999999998 99999999999999 67789999999999
Q ss_pred ccccCCCC--ceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCccccccccc-----ccchhhHHHHh
Q 002409 750 KFAVDGAS--HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGA-----NCRNIVQWAKL 821 (927)
Q Consensus 750 ~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~-----~~~~l~~~~~~ 821 (927)
+....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ...........
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~ 259 (405)
T 3rgf_A 180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 259 (405)
T ss_dssp C----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHH
T ss_pred eecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHH
Confidence 86543221 22234568999999999987 458999999999999999999999996543210 00011111111
Q ss_pred hhccC---Ccccc------------cCCcccCcc---------CHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 822 HIESG---DIQGI------------IDPSLLDEY---------DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 822 ~~~~~---~~~~~------------~d~~l~~~~---------~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.+... ....+ +........ .......+.+|+.+||+.||++|||+.|+++|
T Consensus 260 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 260 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 11000 00000 000000000 00012367899999999999999999999987
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-36 Score=329.27 Aligned_cols=254 Identities=24% Similarity=0.375 Sum_probs=195.5
Q ss_pred HHHhccccccCceEEEEEEECCCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 601 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
+.+.+.||+|+||.||+|+.+. .+|+|+++... ....+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 35 ~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~ 112 (319)
T 2y4i_B 35 LEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCK 112 (319)
T ss_dssp EECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCC
T ss_pred eEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeeccc
Confidence 4467899999999999999863 59999987542 2234567889999999999999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC--
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA-- 756 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-- 756 (927)
+++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++ ++.+||+|||+++......
T Consensus 113 ~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~ 185 (319)
T 2y4i_B 113 GRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG 185 (319)
T ss_dssp SEEHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC--------
T ss_pred CCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccccccccc
Confidence 99999998542 34688999999999999999999998 999999999999998 6799999999987542211
Q ss_pred --CceeeeeccCCCccCcccccc---------CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhcc
Q 002409 757 --SHVSSIVRGTVGYLDPEYYIS---------QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES 825 (927)
Q Consensus 757 --~~~~~~~~gt~~Y~aPE~~~~---------~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 825 (927)
........||+.|+|||.+.. ..++.++|||||||++|||++|+.||...... .+... ...
T Consensus 186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~----~~~ 257 (319)
T 2y4i_B 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE----AIIWQ----MGT 257 (319)
T ss_dssp --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH----HHHHH----HHT
T ss_pred ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHH----hcc
Confidence 112233458999999999864 35788999999999999999999999754421 11111 111
Q ss_pred CCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHH
Q 002409 826 GDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 879 (927)
Q Consensus 826 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~ 879 (927)
+........ . ....+.+++.+|++.+|++|||+.||++.|+++...
T Consensus 258 ~~~~~~~~~----~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 258 GMKPNLSQI----G----MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp TCCCCCCCS----S----CCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred CCCCCCCcC----C----CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 111111111 1 123588999999999999999999999999998654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=326.96 Aligned_cols=262 Identities=21% Similarity=0.260 Sum_probs=190.7
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceeccee--------------
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ-------------- 665 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~-------------- 665 (927)
|.+.+.||+|+||.||+|+.. +++.||||++........+.+.+|++++++++||||+++++++.
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~ 92 (320)
T 2i6l_A 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLT 92 (320)
T ss_dssp EEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CC
T ss_pred eeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccccc
Confidence 345688999999999999987 48899999998766666778999999999999999999998873
Q ss_pred ecCeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEEC-CCCcEEEE
Q 002409 666 EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD-KHMRAKVS 744 (927)
Q Consensus 666 ~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~-~~~~vkL~ 744 (927)
+....++||||++ |+|.+++. ...+++..++.++.|++.||+|||++ +|+||||||+|||++ +++.+||+
T Consensus 93 ~~~~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 93 ELNSVYIVQEYME-TDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp SCSEEEEEEECCS-EEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEEC
T ss_pred ccCceeEEeeccC-CCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEc
Confidence 4467899999997 69999884 24588999999999999999999998 999999999999997 56799999
Q ss_pred eecCcccccCCCC--ceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHH-
Q 002409 745 DFGLSKFAVDGAS--HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK- 820 (927)
Q Consensus 745 DFGla~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~- 820 (927)
|||+++....... .......+|..|+|||.+.. ..++.++|||||||++|||++|+.||......+....+.....
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 243 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV 243 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCC
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999986543211 11233457999999998865 6789999999999999999999999976542211111111000
Q ss_pred ------hhhccCCcccccCCccc------CccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 821 ------LHIESGDIQGIIDPSLL------DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 821 ------~~~~~~~~~~~~d~~l~------~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.... ..+...+..... ..........+.+++.+|++.||++|||+.|++++
T Consensus 244 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 244 VHEEDRQELL-SVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp CCHHHHHHHH-TTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred Cchhhhhhhh-hcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 0000 000000000000 00111223568899999999999999999999875
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=328.52 Aligned_cols=250 Identities=24% Similarity=0.319 Sum_probs=192.6
Q ss_pred HHHHhccccccCceEEEEEEECCCcEEEEEEeecCC--chhhHhHHHHHHHHhhcc--CCCccceecceeecCeEEEEEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIH--HRNLVQFLGYCQEEGRSVLVYE 675 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~--HpnIv~l~g~~~~~~~~~lV~E 675 (927)
.|.+.+.||+|+||.||+++..+++.||||++.... ......+.+|++++++++ |+||+++++++...+..++|||
T Consensus 29 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e 108 (313)
T 3cek_A 29 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 108 (313)
T ss_dssp EEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC
T ss_pred eEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe
Confidence 345678999999999999999889999999997543 334567899999999997 5999999999999999999999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCC
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 755 (927)
+.+++|.+++.. ...+++..++.++.|++.||.|||++ +|+||||||+|||+++ +.+||+|||+++.....
T Consensus 109 -~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 109 -CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPD 179 (313)
T ss_dssp -CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC----
T ss_pred -cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccCc
Confidence 668899999853 35688999999999999999999998 9999999999999964 89999999999865433
Q ss_pred CCc-eeeeeccCCCccCcccccc-----------CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhh
Q 002409 756 ASH-VSSIVRGTVGYLDPEYYIS-----------QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 823 (927)
Q Consensus 756 ~~~-~~~~~~gt~~Y~aPE~~~~-----------~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~ 823 (927)
... ......||+.|+|||.+.. ..++.++|||||||++|||++|+.||..... .. .......
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~-~~~~~~~ 253 (313)
T 3cek_A 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QI-SKLHAII 253 (313)
T ss_dssp ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HH-HHHHHHH
T ss_pred cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-----HH-HHHHHHH
Confidence 221 2234468999999999865 4678899999999999999999999965331 11 1111111
Q ss_pred ccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHH
Q 002409 824 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 873 (927)
Q Consensus 824 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L 873 (927)
. +.....++......+.+++.+|++.+|++||++.|++++-
T Consensus 254 ~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 254 D---------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp C---------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred h---------cccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 1 1111111111234688999999999999999999999863
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=332.73 Aligned_cols=258 Identities=20% Similarity=0.288 Sum_probs=193.3
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecCeE------E
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS------V 671 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~------~ 671 (927)
|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++...+.. +
T Consensus 44 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 123 (371)
T 4exu_A 44 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY 123 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCE
T ss_pred EEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEE
Confidence 445688999999999999876 68899999997542 23356788999999999999999999999877654 9
Q ss_pred EEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccc
Q 002409 672 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 751 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 751 (927)
+||||+. ++|.+++. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 124 lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 124 LVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp EEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred EEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 9999997 68887762 3488999999999999999999998 999999999999999999999999999975
Q ss_pred ccCCCCceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhcc--CCc
Q 002409 752 AVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES--GDI 828 (927)
Q Consensus 752 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~--~~~ 828 (927)
.... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+.........+ ..+
T Consensus 194 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 269 (371)
T 4exu_A 194 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL 269 (371)
T ss_dssp ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred cccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHh
Confidence 4322 233468999999999987 788999999999999999999999997654222222221110000000 000
Q ss_pred c--------cccCCcccC---ccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 829 Q--------GIIDPSLLD---EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 829 ~--------~~~d~~l~~---~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
. ..+...... .........+.+++.+|++.||++|||+.|++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 270 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp SCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0 000000000 0011223568899999999999999999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=326.09 Aligned_cols=262 Identities=20% Similarity=0.261 Sum_probs=199.6
Q ss_pred HHHHhccccccCceEEEEEEE-C-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCC------ccceecceeecCeEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKL-K-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN------LVQFLGYCQEEGRSV 671 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~-~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~Hpn------Iv~l~g~~~~~~~~~ 671 (927)
.|.+.+.||+|+||.||+|.. . +++.||||+++.. ......+.+|++++++++|++ ++++++++...+..+
T Consensus 15 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~ 93 (339)
T 1z57_A 15 RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC 93 (339)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEE
T ss_pred ceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEE
Confidence 456678999999999999987 3 6789999998743 234567889999999997765 999999999999999
Q ss_pred EEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECC--------------
Q 002409 672 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-------------- 737 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~-------------- 737 (927)
+||||+ +++|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+|||++.
T Consensus 94 lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 94 IVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccc
Confidence 999999 88999988543 234688999999999999999999998 9999999999999987
Q ss_pred -----CCcEEEEeecCcccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCccccccccccc
Q 002409 738 -----HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANC 812 (927)
Q Consensus 738 -----~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~ 812 (927)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+..
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 243 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred cccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 668999999999764332 22346899999999999999999999999999999999999999764422111
Q ss_pred chhhHHHH-------hhhccCCc------c------------cccCCcc-cCccCHHHHHHHHHHHhhhcCCCCCCCCcH
Q 002409 813 RNIVQWAK-------LHIESGDI------Q------------GIIDPSL-LDEYDIQSMWKIEEKALMCVLPHGHMRPSI 866 (927)
Q Consensus 813 ~~l~~~~~-------~~~~~~~~------~------------~~~d~~l-~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm 866 (927)
..+..... ........ . ....+.. ...........+.+++.+|++.||++|||+
T Consensus 244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 323 (339)
T 1z57_A 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL 323 (339)
T ss_dssp HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence 11111000 00000000 0 0000000 001123445678999999999999999999
Q ss_pred HHHHHH
Q 002409 867 SEVLKD 872 (927)
Q Consensus 867 ~eV~~~ 872 (927)
.|++++
T Consensus 324 ~ell~h 329 (339)
T 1z57_A 324 REALKH 329 (339)
T ss_dssp HHHTTS
T ss_pred HHHhcC
Confidence 999876
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=319.65 Aligned_cols=254 Identities=26% Similarity=0.362 Sum_probs=201.5
Q ss_pred HHHHHHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecCeEE
Q 002409 595 DIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 671 (927)
Q Consensus 595 ei~~~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~ 671 (927)
......|.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++...+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 334456677899999999999999986 68899999987542 234567899999999999999999999999999999
Q ss_pred EEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCC---CcEEEEeecC
Q 002409 672 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH---MRAKVSDFGL 748 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~---~~vkL~DFGl 748 (927)
+|+||+++++|.+++.. ...+++..++.++.|++.||+|||++ +++||||||+||+++.+ +.+||+|||+
T Consensus 98 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~ 170 (287)
T 2wei_A 98 IVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGL 170 (287)
T ss_dssp EEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred EEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCc
Confidence 99999999999988843 34689999999999999999999998 99999999999999764 4799999999
Q ss_pred cccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCc
Q 002409 749 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 828 (927)
Q Consensus 749 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 828 (927)
++....... .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||...... .+... +..+..
T Consensus 171 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~----~~~~~~ 239 (287)
T 2wei_A 171 STCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY----DILKR----VETGKY 239 (287)
T ss_dssp GGTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHH----HHHCCC
T ss_pred ceeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH----HHHHH----HHcCCC
Confidence 976543221 223458999999998865 5899999999999999999999999764411 11111 111111
Q ss_pred ccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 829 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 829 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.. +...... ....+.+++.+|++.+|++|||+.|++++
T Consensus 240 ~~--~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 240 AF--DLPQWRT----ISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp CC--CSGGGTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred CC--Cchhhhh----cCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 10 0000011 22468899999999999999999999985
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-35 Score=327.21 Aligned_cols=257 Identities=20% Similarity=0.303 Sum_probs=192.7
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecCe------EE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR------SV 671 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~------~~ 671 (927)
|.+.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++...+. .+
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 105 (353)
T 3coi_A 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY 105 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred EEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEE
Confidence 345678999999999999876 68899999997542 2234678899999999999999999999977654 49
Q ss_pred EEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccc
Q 002409 672 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 751 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 751 (927)
+||||+. ++|.+++. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 106 lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 106 LVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp EEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred EEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccC
Confidence 9999997 58888773 3488999999999999999999998 999999999999999999999999999975
Q ss_pred ccCCCCceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHh-------hh
Q 002409 752 AVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL-------HI 823 (927)
Q Consensus 752 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~-------~~ 823 (927)
.... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+...... ..
T Consensus 176 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 251 (353)
T 3coi_A 176 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL 251 (353)
T ss_dssp ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTC
T ss_pred CCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHH
Confidence 4322 223468999999999877 67899999999999999999999999765422111111111000 00
Q ss_pred ccC-------CcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 824 ESG-------DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 824 ~~~-------~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.+. .+.....+.+ ..........+.+++.+|++.||++|||+.|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 252 NDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp SCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 0000000000 01112234578899999999999999999999876
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-35 Score=336.81 Aligned_cols=249 Identities=24% Similarity=0.324 Sum_probs=184.7
Q ss_pred hccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhc-cCCCccceecceeecCeEEEEEEeccCCch
Q 002409 604 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 682 (927)
Q Consensus 604 ~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 682 (927)
.+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++.+.+..++||||+. |+|
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL 95 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNL 95 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCH
Confidence 5789999999998776677999999998643 234678899999886 89999999999999999999999995 699
Q ss_pred hhhcccccccccc---cCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCC-------------CcEEEEee
Q 002409 683 KEHLYGTLTHEQR---INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-------------MRAKVSDF 746 (927)
Q Consensus 683 ~~~L~~~~~~~~~---l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~-------------~~vkL~DF 746 (927)
.+++......... ..+..++.++.|++.||+|||++ +|+||||||+|||++.+ +.+||+||
T Consensus 96 ~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DF 172 (434)
T 2rio_A 96 QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172 (434)
T ss_dssp HHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCC
T ss_pred HHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEccc
Confidence 9998654222111 13334578999999999999998 99999999999999754 48999999
Q ss_pred cCcccccCCCCc---eeeeeccCCCccCcccccc-------CcCCCccceeeHHHHHHHHHh-CCCcccccccccccchh
Q 002409 747 GLSKFAVDGASH---VSSIVRGTVGYLDPEYYIS-------QQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNI 815 (927)
Q Consensus 747 Gla~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~-------~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l 815 (927)
|+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||...... ...+
T Consensus 173 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--~~~i 250 (434)
T 2rio_A 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR--ESNI 250 (434)
T ss_dssp TTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH--HHHH
T ss_pred ccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh--HHHH
Confidence 999866543222 1234569999999999965 678999999999999999999 99999654311 0111
Q ss_pred hHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 816 VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 816 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
. ..... .. ............++.+++.+|++.+|++|||+.||+++
T Consensus 251 ~---~~~~~---~~-----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 251 I---RGIFS---LD-----EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp H---HTCCC---CC-----CCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred h---cCCCC---cc-----cccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 1 11111 00 01111133455678999999999999999999999875
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=328.04 Aligned_cols=199 Identities=25% Similarity=0.299 Sum_probs=166.8
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhcc-CC-----CccceecceeecCeEEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HR-----NLVQFLGYCQEEGRSVL 672 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~-Hp-----nIv~l~g~~~~~~~~~l 672 (927)
.|.+.+.||+|+||.||+|+.. +++.||||+++.. .....++..|+++++.++ |+ +|+++++++...+..++
T Consensus 55 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 133 (382)
T 2vx3_A 55 RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCL 133 (382)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEE
T ss_pred eEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEE
Confidence 4556789999999999999876 6788999999743 233566788999988885 44 49999999999999999
Q ss_pred EEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEEC--CCCcEEEEeecCcc
Q 002409 673 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD--KHMRAKVSDFGLSK 750 (927)
Q Consensus 673 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~--~~~~vkL~DFGla~ 750 (927)
||||+. |+|.+++... ....+++..+..++.|++.||.|||.+ ..+|+||||||+|||++ .++.+||+|||+++
T Consensus 134 v~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~ 209 (382)
T 2vx3_A 134 VFEMLS-YNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 209 (382)
T ss_dssp EEECCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEecCC-CCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence 999996 5999988643 224589999999999999999999952 13899999999999995 47789999999998
Q ss_pred cccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccc
Q 002409 751 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 807 (927)
Q Consensus 751 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~ 807 (927)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 210 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 210 QLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp ETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 65432 223468999999999999999999999999999999999999998654
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=329.79 Aligned_cols=263 Identities=21% Similarity=0.344 Sum_probs=196.6
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhcc-----------CCCccceecceeec
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-----------HRNLVQFLGYCQEE 667 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~-----------HpnIv~l~g~~~~~ 667 (927)
.|.+.+.||+|+||.||+|+.. +++.||||++... ......+.+|+.++++++ |+||+++++++...
T Consensus 20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~ 98 (373)
T 1q8y_A 20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 98 (373)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred eEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence 4566789999999999999875 6889999998743 234567889999999886 89999999998765
Q ss_pred C----eEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEEC------C
Q 002409 668 G----RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD------K 737 (927)
Q Consensus 668 ~----~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~------~ 737 (927)
+ ..++||||+ +++|.+++... ....+++..+..++.||+.||+|||+++ +|+||||||+|||++ .
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 99 GPNGVHVVMVFEVL-GENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp ETTEEEEEEEECCC-CEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTT
T ss_pred CCCCceEEEEEecC-CCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcC
Confidence 4 789999999 88999998543 2345889999999999999999999952 899999999999994 4
Q ss_pred CCcEEEEeecCcccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccc---cch
Q 002409 738 HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGAN---CRN 814 (927)
Q Consensus 738 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~---~~~ 814 (927)
.+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...
T Consensus 174 ~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 249 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249 (373)
T ss_dssp EEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence 458999999999865432 2234689999999999999999999999999999999999999975431111 111
Q ss_pred hhHHHHhh-----------------hcc-CCcccccCCcc---------cCccCHHHHHHHHHHHhhhcCCCCCCCCcHH
Q 002409 815 IVQWAKLH-----------------IES-GDIQGIIDPSL---------LDEYDIQSMWKIEEKALMCVLPHGHMRPSIS 867 (927)
Q Consensus 815 l~~~~~~~-----------------~~~-~~~~~~~d~~l---------~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~ 867 (927)
+.+..... ... +....+..... ...++......+.+++.+|++.||++|||+.
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 329 (373)
T 1q8y_A 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329 (373)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence 11111000 000 00000000000 0123456677899999999999999999999
Q ss_pred HHHHH
Q 002409 868 EVLKD 872 (927)
Q Consensus 868 eV~~~ 872 (927)
|++++
T Consensus 330 ell~h 334 (373)
T 1q8y_A 330 GLVNH 334 (373)
T ss_dssp HHHTC
T ss_pred HHhhC
Confidence 99885
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=325.38 Aligned_cols=245 Identities=24% Similarity=0.397 Sum_probs=190.2
Q ss_pred HHHHHHHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc------hhhHhHHHHHHHHhhc----cCCCccceec
Q 002409 594 SDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY------QGKREFTNEVTLLSRI----HHRNLVQFLG 662 (927)
Q Consensus 594 ~ei~~~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~------~~~~~~~~Ei~iL~~l----~HpnIv~l~g 662 (927)
.+.....|.+.+.||+|+||.||+|+.. +++.||||++..... .....+.+|+.++.++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 3444556777899999999999999875 688999999975432 1234566799999998 8999999999
Q ss_pred ceeecCeEEEEEEe-ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEEC-CCCc
Q 002409 663 YCQEEGRSVLVYEF-MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD-KHMR 740 (927)
Q Consensus 663 ~~~~~~~~~lV~E~-~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~-~~~~ 740 (927)
++...+..++|+|+ +.+++|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+||+++ .++.
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCe
Confidence 99999999999999 789999999853 34689999999999999999999998 999999999999999 8899
Q ss_pred EEEEeecCcccccCCCCceeeeeccCCCccCccccccCcCC-CccceeeHHHHHHHHHhCCCcccccccccccchhhHHH
Q 002409 741 AKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT-DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA 819 (927)
Q Consensus 741 vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~ 819 (927)
+||+|||+++...... .....||..|+|||++.+..+. .++|||||||++|||++|+.||.... .+..
T Consensus 179 ~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~-- 247 (312)
T 2iwi_A 179 AKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILE-- 247 (312)
T ss_dssp EEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH--
T ss_pred EEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhh--
Confidence 9999999998654322 2334589999999999876664 48999999999999999999996532 1111
Q ss_pred HhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 820 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 820 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
... . ++......+.+++.+|++.+|++||++.|++++
T Consensus 248 ------~~~------~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 248 ------AEL------H----FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ------TCC------C----CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ------hcc------C----CcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0 111122467899999999999999999999985
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-35 Score=326.05 Aligned_cols=264 Identities=19% Similarity=0.247 Sum_probs=197.9
Q ss_pred HHHHHHhccccccCceEEEEEEEC-CC-cEEEEEEeecCCchhhHhHHHHHHHHhhccCCC------ccceecceeecCe
Q 002409 598 DATKMLEKKIGSGGFGVVYYGKLK-DG-KEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN------LVQFLGYCQEEGR 669 (927)
Q Consensus 598 ~~~~~~~~~IG~G~fG~Vy~~~~~-~g-~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~Hpn------Iv~l~g~~~~~~~ 669 (927)
...|.+.+.||+|+||.||+|+.. ++ +.||||+++.. ......+.+|++++++++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 345667789999999999999875 34 68999999743 334567888999999998776 8899999999999
Q ss_pred EEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEE--------------
Q 002409 670 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL-------------- 735 (927)
Q Consensus 670 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl-------------- 735 (927)
.++||||+ +++|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred EEEEEecc-CCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccc
Confidence 99999999 56777766432 234689999999999999999999998 99999999999999
Q ss_pred -----CCCCcEEEEeecCcccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCccccccccc
Q 002409 736 -----DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGA 810 (927)
Q Consensus 736 -----~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~ 810 (927)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 56789999999999854332 223468999999999999999999999999999999999999997644221
Q ss_pred ccchhhHHHHh-------hhccCCcc----cccCC-------------cc--cCccCHHHHHHHHHHHhhhcCCCCCCCC
Q 002409 811 NCRNIVQWAKL-------HIESGDIQ----GIIDP-------------SL--LDEYDIQSMWKIEEKALMCVLPHGHMRP 864 (927)
Q Consensus 811 ~~~~l~~~~~~-------~~~~~~~~----~~~d~-------------~l--~~~~~~~~~~~l~~L~~~Cl~~dP~~RP 864 (927)
....+...... ........ ...+. .+ ...........+.+++.+|++.||++||
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 11111110000 00000000 00000 00 0011223345789999999999999999
Q ss_pred cHHHHHHH
Q 002409 865 SISEVLKD 872 (927)
Q Consensus 865 sm~eV~~~ 872 (927)
|+.|++++
T Consensus 327 t~~e~l~h 334 (355)
T 2eu9_A 327 TLAEALLH 334 (355)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999976
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-35 Score=324.33 Aligned_cols=254 Identities=26% Similarity=0.327 Sum_probs=175.8
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc-hhhHhHHHHHH-HHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVT-LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~-iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
.+.+.||+|+||.||+|+.. +++.||||+++.... ....++..|+. +++.++||||+++++++...+..++||||++
T Consensus 25 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (327)
T 3aln_A 25 KDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS 104 (327)
T ss_dssp EC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCS
T ss_pred hehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecC
Confidence 34578999999999999986 688999999976532 33445555665 7778899999999999999999999999998
Q ss_pred CCchhhhccccc-ccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 679 NGTLKEHLYGTL-THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 679 ~gsL~~~L~~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
+ +|.+++.... .....+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||+++......
T Consensus 105 ~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~- 180 (327)
T 3aln_A 105 T-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI- 180 (327)
T ss_dssp E-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC------
T ss_pred C-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceeccccc-
Confidence 5 7777764211 1245688999999999999999999995 389999999999999999999999999997654322
Q ss_pred ceeeeeccCCCccCcccc----ccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccC
Q 002409 758 HVSSIVRGTVGYLDPEYY----ISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 833 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~----~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 833 (927)
......||+.|+|||++ .+..++.++|||||||++|||++|+.||...... .+.... ...+..
T Consensus 181 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~-~~~~~~----- 247 (327)
T 3aln_A 181 -AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV------FDQLTQ-VVKGDP----- 247 (327)
T ss_dssp --------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CC-CCCSCC-----
T ss_pred -ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH------HHHHHH-HhcCCC-----
Confidence 12233589999999998 4567899999999999999999999999753311 000000 011111
Q ss_pred CcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 834 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 834 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
+.+...........+.+++.+|++.+|++||++.||+++
T Consensus 248 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 248 PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 111111111233468899999999999999999999875
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=322.81 Aligned_cols=247 Identities=20% Similarity=0.253 Sum_probs=168.1
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceee----cCeEEEEEEecc
Q 002409 604 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE----EGRSVLVYEFMH 678 (927)
Q Consensus 604 ~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~----~~~~~lV~E~~~ 678 (927)
.+.||+|+||.||+|+.. +++.||||++.... ....+....++.++||||+++++++.. ....++||||++
T Consensus 34 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 109 (336)
T 3fhr_A 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECME 109 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCT
T ss_pred ceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccC
Confidence 456999999999999887 68999999986431 222223334566799999999999876 455899999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECC---CCcEEEEeecCcccccCC
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~---~~~vkL~DFGla~~~~~~ 755 (927)
+|+|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 110 gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~ 184 (336)
T 3fhr_A 110 GGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN 184 (336)
T ss_dssp TEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC---
T ss_pred CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccceecccc
Confidence 99999999643 234689999999999999999999998 9999999999999986 455999999999754332
Q ss_pred CCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCc
Q 002409 756 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 835 (927)
Q Consensus 756 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 835 (927)
......||+.|+|||++....++.++|||||||++|||++|+.||.............. ....+...
T Consensus 185 ---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~----~~~~~~~~------ 251 (336)
T 3fhr_A 185 ---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR----RIRLGQYG------ 251 (336)
T ss_dssp ----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------C------
T ss_pred ---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH----hhhccccc------
Confidence 22344689999999999888999999999999999999999999975442211111111 11111000
Q ss_pred ccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 836 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 836 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
............+.+++.+|++.+|++|||+.|++++
T Consensus 252 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 252 FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000011223468899999999999999999999985
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=325.94 Aligned_cols=240 Identities=22% Similarity=0.369 Sum_probs=195.6
Q ss_pred HHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCch------hhHhHHHHHHHHhhcc--CCCccceecceeecCe
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ------GKREFTNEVTLLSRIH--HRNLVQFLGYCQEEGR 669 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~------~~~~~~~Ei~iL~~l~--HpnIv~l~g~~~~~~~ 669 (927)
..|.+.+.||+|+||.||+|+.. +++.||||++...... ....+.+|+.++++++ |+||+++++++...+.
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~ 122 (320)
T 3a99_A 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122 (320)
T ss_dssp TTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCc
Confidence 34556789999999999999865 6889999999754321 2345778999999996 5999999999999999
Q ss_pred EEEEEEeccC-CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEEC-CCCcEEEEeec
Q 002409 670 SVLVYEFMHN-GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD-KHMRAKVSDFG 747 (927)
Q Consensus 670 ~~lV~E~~~~-gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~-~~~~vkL~DFG 747 (927)
.++|+|++.+ ++|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++ +++.+||+|||
T Consensus 123 ~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 123 FVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp EEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 9999999986 899998843 45688999999999999999999998 999999999999999 78999999999
Q ss_pred CcccccCCCCceeeeeccCCCccCccccccCcC-CCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccC
Q 002409 748 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG 826 (927)
Q Consensus 748 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 826 (927)
+++..... ......||+.|+|||++....+ +.++|||||||++|||++|+.||.... .+.. +
T Consensus 196 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~--------~ 258 (320)
T 3a99_A 196 SGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR--------G 258 (320)
T ss_dssp TCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH--------C
T ss_pred cccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhc--------c
Confidence 99865432 2233458999999999987665 678899999999999999999996532 1110 0
Q ss_pred CcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 827 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 827 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.. ..... ...++.+++.+|++.+|++||++.||+++
T Consensus 259 ~~------~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 259 QV------FFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp CC------CCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cc------ccccc----CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 00111 22468899999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-34 Score=314.06 Aligned_cols=248 Identities=24% Similarity=0.311 Sum_probs=175.3
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCCch-h-hHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-G-KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~-~-~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
.+.+.||+|+||.||+|+.. +++.||||++...... . .+.+.++..+++.++||||+++++++...+..++||||+
T Consensus 28 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 106 (318)
T 2dyl_A 28 ENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM- 106 (318)
T ss_dssp EEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-
T ss_pred cccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-
Confidence 45678999999999999986 6899999999765322 2 234455556788889999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhh-CCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
++.+..+... ....+++..+..++.|++.||.|||+ . +|+||||||+|||++.++.+||+|||+++......
T Consensus 107 ~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~- 179 (318)
T 2dyl_A 107 GTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK- 179 (318)
T ss_dssp SEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred CCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc-
Confidence 4444444321 23568899999999999999999998 4 89999999999999999999999999997554322
Q ss_pred ceeeeeccCCCccCccccc-----cCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCccccc
Q 002409 758 HVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 832 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~~-----~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 832 (927)
......||+.|+|||.+. ...++.++|||||||++|||++|+.||...... ...... ... +...
T Consensus 180 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~---~~~-~~~~--- 248 (318)
T 2dyl_A 180 -AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD---FEVLTK---VLQ-EEPP--- 248 (318)
T ss_dssp --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH---HHHHHH---HHH-SCCC---
T ss_pred -cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc---HHHHHH---Hhc-cCCC---
Confidence 223345899999999994 456888999999999999999999999753311 111111 111 1100
Q ss_pred CCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 833 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 833 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.+.. .......+.+++.+|++.+|++||++.|++++
T Consensus 249 --~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 249 --LLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp --CCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred --CCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0000 01122468899999999999999999999876
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=332.04 Aligned_cols=247 Identities=24% Similarity=0.330 Sum_probs=183.0
Q ss_pred HHHhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhc-cCCCccceecceeecCeEEEEEEeccC
Q 002409 601 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
+.+.+.||+|+||+||.....+++.||||++.... ...+.+|+++|+++ +||||+++++++.+.+..++||||+.
T Consensus 26 y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~- 101 (432)
T 3p23_A 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA- 101 (432)
T ss_dssp EEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred EecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-
Confidence 34467899999999766556679999999986543 23467899999999 89999999999999999999999996
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECC-----CCcEEEEeecCcccccC
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-----HMRAKVSDFGLSKFAVD 754 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~-----~~~vkL~DFGla~~~~~ 754 (927)
|+|.+++.... ..+....++.++.|++.||+|||++ +|+||||||+|||++. ...+||+|||+++....
T Consensus 102 g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 102 ATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp EEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred CCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 69999986432 2234445678999999999999998 9999999999999953 34688999999986543
Q ss_pred CCC--ceeeeeccCCCccCccccc---cCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCc
Q 002409 755 GAS--HVSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDI 828 (927)
Q Consensus 755 ~~~--~~~~~~~gt~~Y~aPE~~~---~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 828 (927)
... .......||+.|+|||++. ...++.++|||||||++|||++ |..||..... .... ........
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~-----~~~~---~~~~~~~~ 247 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ-----RQAN---ILLGACSL 247 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT-----HHHH---HHTTCCCC
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH-----HHHH---HHhccCCc
Confidence 321 2233456999999999997 4567889999999999999999 9999864321 1111 11111111
Q ss_pred ccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 829 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 829 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.... ........+.+++.+|++.||++|||+.||++|
T Consensus 248 -~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 248 -DCLH------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp -TTSC------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -cccC------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 0000 112233457899999999999999999999965
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=343.89 Aligned_cols=240 Identities=19% Similarity=0.290 Sum_probs=192.5
Q ss_pred HHHHHhccccccCceEEEEEEEC--CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCe-----E
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLK--DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR-----S 670 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~--~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~-----~ 670 (927)
..|.+.+.||+|+||.||+|++. +++.||||++.... ......+.+|++++++++||||+++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 34667789999999999999986 58999999986543 3445678899999999999999999999987665 6
Q ss_pred EEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcc
Q 002409 671 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 750 (927)
Q Consensus 671 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 750 (927)
++||||+++++|.+++. ..+++..++.++.||+.||.|||++ +|+||||||+|||++.+ .+||+|||+++
T Consensus 160 ~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccch
Confidence 99999999999988763 2689999999999999999999998 99999999999999986 89999999998
Q ss_pred cccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCccc
Q 002409 751 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 830 (927)
Q Consensus 751 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 830 (927)
..... ....||+.|+|||++.+.. +.++|||||||++|||++|..|+........ .
T Consensus 230 ~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~-----------------~- 285 (681)
T 2pzi_A 230 RINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL-----------------P- 285 (681)
T ss_dssp ETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC-----------------C-
T ss_pred hcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc-----------------c-
Confidence 65432 3346999999999987654 8899999999999999999888764321100 0
Q ss_pred ccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCC-cHHHHHHHHHHHHH
Q 002409 831 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP-SISEVLKDIQDAIV 878 (927)
Q Consensus 831 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-sm~eV~~~L~~~~~ 878 (927)
...........+.+++.+|++.+|++|| ++.++.+.|..++.
T Consensus 286 ------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 286 ------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp ------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred ------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 0000111224688999999999999999 56667777777654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=313.66 Aligned_cols=236 Identities=14% Similarity=0.130 Sum_probs=183.4
Q ss_pred HHHHHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc---hhhHhHHHHHHHHhhccCCCccceecceeecCeEE
Q 002409 596 IEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 671 (927)
Q Consensus 596 i~~~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~ 671 (927)
+....|.+.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++...+..+
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 33345667789999999999999986 489999999976532 23467899999999999999999999999999999
Q ss_pred EEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccc
Q 002409 672 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 751 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 751 (927)
+||||+++++|.+++... ....++..++.|++.||+|||++ +|+||||||+|||++.++.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~---- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA---- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC----
T ss_pred EEEEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc----
Confidence 999999999999998432 34556888999999999999998 99999999999999999999997443
Q ss_pred ccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccc
Q 002409 752 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 831 (927)
Q Consensus 752 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 831 (927)
|++| ++.++|||||||++|||++|+.||......+....... ... +..
T Consensus 175 -----------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~----~~~-~~~--- 222 (286)
T 3uqc_A 175 -----------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER----DTA-GQP--- 222 (286)
T ss_dssp -----------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCB----CTT-SCB---
T ss_pred -----------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHH----Hhc-cCC---
Confidence 3433 67899999999999999999999986542211100000 000 000
Q ss_pred cCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHHH
Q 002409 832 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 880 (927)
Q Consensus 832 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~~ 880 (927)
.............+.+++.+|++.||++| |+.|+++.|+++....
T Consensus 223 ---~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 223 ---IEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp ---CCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred ---CChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 00001112233468899999999999999 9999999999886543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=342.43 Aligned_cols=268 Identities=22% Similarity=0.329 Sum_probs=202.3
Q ss_pred HHHHHhccccccCceEEEEEEEC-CCcEEEEEEeecC-CchhhHhHHHHHHHHhhccCCCccceecceee------cCeE
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE------EGRS 670 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~------~~~~ 670 (927)
..|.+.+.||+|+||.||+|... +|+.||||+++.. .......+.+|++++++++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 45677899999999999999875 6889999998754 33445678999999999999999999998765 6678
Q ss_pred EEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCc---EEEEeec
Q 002409 671 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR---AKVSDFG 747 (927)
Q Consensus 671 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~---vkL~DFG 747 (927)
++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +||+|||
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 99999999999999986532 234588889999999999999999998 9999999999999997664 9999999
Q ss_pred CcccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCC
Q 002409 748 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 827 (927)
Q Consensus 748 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 827 (927)
+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ....|.......+.
T Consensus 170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~------~~~~~~~~i~~~~~ 241 (676)
T 3qa8_A 170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW------QPVQWHGKVREKSN 241 (676)
T ss_dssp CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC------HHHHSSTTCC----
T ss_pred ccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc------chhhhhhhhhcccc
Confidence 998654432 2234569999999999999999999999999999999999999997543 11222111111110
Q ss_pred cccccCC------------cccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHH-----HHHHHHHHHH
Q 002409 828 IQGIIDP------------SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISE-----VLKDIQDAIV 878 (927)
Q Consensus 828 ~~~~~d~------------~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~e-----V~~~L~~~~~ 878 (927)
....... .............+.+++.+|++.||++|||+.| ..+.++.++.
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 0000000 0111233446678999999999999999999988 4455665554
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-34 Score=326.54 Aligned_cols=243 Identities=13% Similarity=0.079 Sum_probs=181.2
Q ss_pred HhccccccCceEEEEEEEC-CCcEEEEEEeecCCc---hhhHhHHHHHHHHhhccC-CCccceecc--------------
Q 002409 603 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHH-RNLVQFLGY-------------- 663 (927)
Q Consensus 603 ~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~iL~~l~H-pnIv~l~g~-------------- 663 (927)
+.+.||+|+||.||+|++. +|+.||||++..... ...+.+.+|+.+++.++| +|......+
T Consensus 82 ~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (413)
T 3dzo_A 82 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 161 (413)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC
T ss_pred EecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCC
Confidence 3578999999999999965 689999999874322 225678999999999977 333222111
Q ss_pred -------eee-----cCeEEEEEEeccCCchhhhcccc---cccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCC
Q 002409 664 -------CQE-----EGRSVLVYEFMHNGTLKEHLYGT---LTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDL 728 (927)
Q Consensus 664 -------~~~-----~~~~~lV~E~~~~gsL~~~L~~~---~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDL 728 (927)
+.. ....+++|+++ +++|.+++... ......+++..++.++.|+++||+|||++ +|+||||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrDi 237 (413)
T 3dzo_A 162 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYL 237 (413)
T ss_dssp ---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred CCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCc
Confidence 111 12356777755 67999887421 22355688899999999999999999998 9999999
Q ss_pred CCCCeEECCCCcEEEEeecCcccccCCCCceeeeeccCCCccCcccc----------ccCcCCCccceeeHHHHHHHHHh
Q 002409 729 KSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY----------ISQQLTDKSDVYSFGVILLELIS 798 (927)
Q Consensus 729 kp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~----------~~~~~s~~sDVwSlGvvL~ellt 798 (927)
||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||++|||++
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt 312 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred ccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence 999999999999999999998754322 334557 999999999 55568889999999999999999
Q ss_pred CCCcccccccccccchhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH--HHHH
Q 002409 799 GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD--IQDA 876 (927)
Q Consensus 799 G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~--L~~~ 876 (927)
|+.||......+....+ +... ... ...+.+++.+|++.+|++||++.|++++ ++++
T Consensus 313 g~~Pf~~~~~~~~~~~~----------------~~~~--~~~----~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 313 ADLPNTDDAALGGSEWI----------------FRSC--KNI----PQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp SSCCCCTTGGGSCSGGG----------------GSSC--CCC----CHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred CCCCCCCcchhhhHHHH----------------Hhhc--ccC----CHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence 99999765422211111 1100 011 2468899999999999999999998765 4444
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.98 E-value=3e-33 Score=312.27 Aligned_cols=245 Identities=18% Similarity=0.180 Sum_probs=184.8
Q ss_pred HHHHHHHhccccccCceEEEEEEECCCcEEEEEEeecCCc--------hhhHhHHHHHHHHhhcc---------------
Q 002409 597 EDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY--------QGKREFTNEVTLLSRIH--------------- 653 (927)
Q Consensus 597 ~~~~~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~--------~~~~~~~~Ei~iL~~l~--------------- 653 (927)
....|.+.+.||+|+||.||+|+. +++.||||++..... ...+.+.+|++++++++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 345677889999999999999998 589999999975531 22367889999999886
Q ss_pred -----------CCCccceecceee-------------cCeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHH
Q 002409 654 -----------HRNLVQFLGYCQE-------------EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA 709 (927)
Q Consensus 654 -----------HpnIv~l~g~~~~-------------~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia 709 (927)
||||+++++++.. .+..++||||+++|++.+.+.. ..+++..+..++.||+
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHH
Confidence 5666666666554 6789999999999987776632 4578999999999999
Q ss_pred hHhHHHh-hCCCCceecCCCCCCCeEECCCC--------------------cEEEEeecCcccccCCCCceeeeeccCCC
Q 002409 710 KGIEYLH-TGCVPAIIHRDLKSSNILLDKHM--------------------RAKVSDFGLSKFAVDGASHVSSIVRGTVG 768 (927)
Q Consensus 710 ~gL~yLH-~~~~~~ivHrDLkp~NILl~~~~--------------------~vkL~DFGla~~~~~~~~~~~~~~~gt~~ 768 (927)
.||+||| ++ +|+||||||+|||++.++ .+||+|||+|+..... ...||+.
T Consensus 172 ~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~ 242 (336)
T 2vuw_A 172 ASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDV 242 (336)
T ss_dssp HHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCC
T ss_pred HHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeec
Confidence 9999999 88 999999999999999887 8999999999865432 3469999
Q ss_pred ccCccccccCcCCCccceeeHHHH-HHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCccCHHHHHH
Q 002409 769 YLDPEYYISQQLTDKSDVYSFGVI-LLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWK 847 (927)
Q Consensus 769 Y~aPE~~~~~~~s~~sDVwSlGvv-L~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 847 (927)
|+|||++.+.. +.++||||++++ .+++++|..||...... ..+.+...... .. ..............+
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~---~~~~~~~~~~~---~~----~~~~~~~~~~~~s~~ 311 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL---HYLTDKMLKQM---TF----KTKCNTPAMKQIKRK 311 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH---HHHHHHHHHTC---CC----SSCCCSHHHHHHHHH
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhh---hHHHHhhhhhh---cc----CcccchhhhhhcCHH
Confidence 99999998665 889999998777 78899999998542100 01111111000 00 011111122345567
Q ss_pred HHHHHhhhcCCCCCCCCcHHHHH-HH
Q 002409 848 IEEKALMCVLPHGHMRPSISEVL-KD 872 (927)
Q Consensus 848 l~~L~~~Cl~~dP~~RPsm~eV~-~~ 872 (927)
+.+++.+|++.+ |+.|++ +|
T Consensus 312 ~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 312 IQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHHHGGGSS-----SHHHHHHHC
T ss_pred HHHHHHHHhccC-----CHHHHHhcC
Confidence 999999999966 888888 54
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-32 Score=297.31 Aligned_cols=226 Identities=21% Similarity=0.270 Sum_probs=173.9
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHH-hhccCCCccceecceee----cCeEEEEEEec
Q 002409 604 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLL-SRIHHRNLVQFLGYCQE----EGRSVLVYEFM 677 (927)
Q Consensus 604 ~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL-~~l~HpnIv~l~g~~~~----~~~~~lV~E~~ 677 (927)
.+.||+|+||.||++... +++.||||+++. ...+.+|++++ +..+||||+++++++.. ....++||||+
T Consensus 23 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~ 97 (299)
T 3m2w_A 23 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 97 (299)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred CcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeec
Confidence 367999999999999875 688999999863 24567888888 55699999999999876 67789999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECC---CCcEEEEeecCcccccC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVD 754 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~---~~~vkL~DFGla~~~~~ 754 (927)
++|+|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+++...
T Consensus 98 ~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~- 171 (299)
T 3m2w_A 98 DGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT- 171 (299)
T ss_dssp CSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-
T ss_pred CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccccc-
Confidence 999999998643 234689999999999999999999998 9999999999999998 7899999999986432
Q ss_pred CCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCC
Q 002409 755 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 834 (927)
Q Consensus 755 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 834 (927)
+..++.++|||||||++|||++|+.||...........+.. ....+..
T Consensus 172 ----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~----~~~~~~~------ 219 (299)
T 3m2w_A 172 ----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT----RIRMGQY------ 219 (299)
T ss_dssp ----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC----SSCTTCC------
T ss_pred ----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH----HHhhccc------
Confidence 23467899999999999999999999975431111000000 0000000
Q ss_pred cccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 835 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 835 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.............+.+++.+|++.+|++|||+.|++++
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 220 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00000001123468899999999999999999999986
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4e-27 Score=280.68 Aligned_cols=186 Identities=16% Similarity=0.115 Sum_probs=130.4
Q ss_pred cccccCceEEEEEE-ECCCcEEEEEEeecCCc----------hhhHhHHHHHHHHhhc-cCCCccceecceeecCeEEEE
Q 002409 606 KIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSY----------QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLV 673 (927)
Q Consensus 606 ~IG~G~fG~Vy~~~-~~~g~~VAVK~l~~~~~----------~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~lV 673 (927)
..+.|++|....++ .--|+.+|||++..... ...++|.+|+++|+++ .|+||+++++++.+++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 45667777666553 23488999999975421 1235699999999999 799999999999999999999
Q ss_pred EEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccccc
Q 002409 674 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 753 (927)
Q Consensus 674 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 753 (927)
|||++|++|.++|.. ...++.. +|+.||+.||+|||++ |||||||||+|||++.++++||+|||+|+...
T Consensus 321 MEyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 999999999999953 3445543 5889999999999999 99999999999999999999999999998654
Q ss_pred CCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcc
Q 002409 754 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAI 803 (927)
Q Consensus 754 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~ 803 (927)
.... ......||++|||||++.+ .+..++|+||+|+++++|.++..++
T Consensus 391 ~~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 391 QDCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp ---C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CCCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 4322 2344679999999999865 5677899999999999888776554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.1e-24 Score=255.75 Aligned_cols=182 Identities=18% Similarity=0.227 Sum_probs=145.0
Q ss_pred hccccccCceEEEEEEECCCcEEEEEEeecCCch--------hhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEE
Q 002409 604 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ--------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 675 (927)
Q Consensus 604 ~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~--------~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E 675 (927)
.+.||+|+||.||+|+.. ++.+++|+....... ..+.+.+|++++++++||||+++..++...+..++|||
T Consensus 341 ~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 568999999999999554 788999987543211 13458899999999999999977777777788899999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCC
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 755 (927)
|+++++|.+++.. +..++.|+++||+|||++ +|+||||||+|||++. ++||+|||+++.....
T Consensus 420 ~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 420 YINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp CCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred CCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 9999999999853 457899999999999998 9999999999999999 9999999999866442
Q ss_pred CCce------eeeeccCCCccCcccccc--CcCCCccceeeHHHHHHHHHhCCCcc
Q 002409 756 ASHV------SSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAI 803 (927)
Q Consensus 756 ~~~~------~~~~~gt~~Y~aPE~~~~--~~~s~~sDVwSlGvvL~elltG~~p~ 803 (927)
.... .....||+.|||||++.. ..|+..+|+||..+-..+.+.++.++
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 2211 134579999999999986 67888899999998888888776654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.7e-21 Score=211.96 Aligned_cols=141 Identities=17% Similarity=0.108 Sum_probs=115.1
Q ss_pred hccccccCceEEEEEEECCCcEEEEEEeecCCc------------------hhhHhHHHHHHHHhhccCCCccceeccee
Q 002409 604 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY------------------QGKREFTNEVTLLSRIHHRNLVQFLGYCQ 665 (927)
Q Consensus 604 ~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~------------------~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~ 665 (927)
.+.||+|+||.||+|+..+|+.||||+++.... .....+.+|++++++++ | +++.+++.
T Consensus 95 ~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~ 171 (282)
T 1zar_A 95 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYA 171 (282)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEE
T ss_pred cCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEe
Confidence 488999999999999997799999999864321 12456889999999999 5 67777554
Q ss_pred ecCeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEe
Q 002409 666 EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD 745 (927)
Q Consensus 666 ~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~D 745 (927)
. +..++||||+++|+|.+ +.. .....++.|++.||.|||+. +|+||||||+|||++ ++.+||+|
T Consensus 172 ~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 172 W-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp E-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEECC
T ss_pred c-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEEE
Confidence 4 55699999999999988 421 12346899999999999998 999999999999999 99999999
Q ss_pred ecCcccccCCCCceeeeeccCCCccCcccccc
Q 002409 746 FGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 777 (927)
Q Consensus 746 FGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 777 (927)
||+++ .+..++|||++.+
T Consensus 236 FG~a~--------------~~~~~~a~e~l~r 253 (282)
T 1zar_A 236 FPQSV--------------EVGEEGWREILER 253 (282)
T ss_dssp CTTCE--------------ETTSTTHHHHHHH
T ss_pred CCCCe--------------ECCCCCHHHHHHH
Confidence 99986 2455789998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=7.6e-18 Score=180.61 Aligned_cols=134 Identities=24% Similarity=0.267 Sum_probs=102.3
Q ss_pred HhccccccCceEEEEEEE-CCCcE--EEEEEeecCCch------------------------hhHhHHHHHHHHhhccCC
Q 002409 603 LEKKIGSGGFGVVYYGKL-KDGKE--IAVKVLTSNSYQ------------------------GKREFTNEVTLLSRIHHR 655 (927)
Q Consensus 603 ~~~~IG~G~fG~Vy~~~~-~~g~~--VAVK~l~~~~~~------------------------~~~~~~~Ei~iL~~l~Hp 655 (927)
+.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+.+|.+++|+
T Consensus 51 i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 130 (258)
T 1zth_A 51 MGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEA 130 (258)
T ss_dssp EEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHT
T ss_pred hCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhC
Confidence 457899999999999988 67888 999997543111 113578899999999988
Q ss_pred Cc--cceecceeecCeEEEEEEeccC-C----chhhhcccccccccccCHHHHHHHHHHHHhHhHHHh-hCCCCceecCC
Q 002409 656 NL--VQFLGYCQEEGRSVLVYEFMHN-G----TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH-TGCVPAIIHRD 727 (927)
Q Consensus 656 nI--v~l~g~~~~~~~~~lV~E~~~~-g----sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH-~~~~~~ivHrD 727 (927)
++ ..++++ +..+|||||+.+ | +|.+.... .++..+..++.|++.+|.||| +. +|+|||
T Consensus 131 ~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givHrD 196 (258)
T 1zth_A 131 GVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVHAD 196 (258)
T ss_dssp TCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEECSS
T ss_pred CCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEeCC
Confidence 65 233322 356899999942 4 45444321 123456789999999999999 87 999999
Q ss_pred CCCCCeEECCCCcEEEEeecCcccc
Q 002409 728 LKSSNILLDKHMRAKVSDFGLSKFA 752 (927)
Q Consensus 728 Lkp~NILl~~~~~vkL~DFGla~~~ 752 (927)
|||+|||++. .++|+|||+|...
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEET
T ss_pred CCHHHEEEcC--cEEEEECcccccC
Confidence 9999999998 9999999999754
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.63 E-value=3e-16 Score=173.01 Aligned_cols=144 Identities=28% Similarity=0.496 Sum_probs=125.6
Q ss_pred CchHHHHHHHHhcC----CCCcCCCCCCCCCCCCcceeecCCCC-CCceEEEEecCCCCCc--cCCchhhcCCCCcEEec
Q 002409 373 GSIDAIVSVISLYS----SADWAQEGGDPCLPVPWSWLQCNSDP-QPSITVIHLSSKNLTG--NIPSDLTKLSSLVELWL 445 (927)
Q Consensus 373 ~~~dal~~~~~~~~----~~~w~~~~~dpC~~~~~~~v~C~~~~-~~~l~~L~L~~n~l~g--~ip~~i~~L~~L~~L~L 445 (927)
.+++|+.++|+.+. ..+|.. +.|||. ..|.||.|+... ..+|+.|+|++|+++| .+|..|+++++|++|+|
T Consensus 6 ~~~~aL~~~k~~~~~~~~l~~W~~-~~~~C~-~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L 83 (313)
T 1ogq_A 6 QDKQALLQIKKDLGNPTTLSSWLP-TTDCCN-RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYI 83 (313)
T ss_dssp HHHHHHHHHHHHTTCCGGGTTCCT-TSCTTT-TCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEE
T ss_pred HHHHHHHHHHHhcCCcccccCCCC-CCCCCc-CCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCeeeC
Confidence 46789999999874 367965 578883 249999997532 3689999999999999 99999999999999999
Q ss_pred cC-CcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCccccccccccccccccccccc--cccccccccCCc
Q 002409 446 DG-NSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL--SKNVVLNYAGNI 518 (927)
Q Consensus 446 s~-N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l~g~iP~~l~--~~~~~l~~~~n~ 518 (927)
++ |.+.+.+|. +.++++|++|+|++|+++|.+|..+.++++|++|+|++|+|+|.+|..+. +.+..+.+.+|.
T Consensus 84 ~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 160 (313)
T 1ogq_A 84 GGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred CCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCc
Confidence 95 999999886 89999999999999999999999999999999999999999999998874 456777888874
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.57 E-value=1.5e-15 Score=170.05 Aligned_cols=135 Identities=15% Similarity=0.156 Sum_probs=95.0
Q ss_pred HHhccccccCceEEEEEEECCCcEEEEEEeecCCc-----h---------hhHhH--------HHHHHHHhhccCCCccc
Q 002409 602 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY-----Q---------GKREF--------TNEVTLLSRIHHRNLVQ 659 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~-----~---------~~~~~--------~~Ei~iL~~l~HpnIv~ 659 (927)
.+.++||+|+||.||+|...+|+.||||+++.... . ..... .+|...|.++.+.++..
T Consensus 98 ~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~v 177 (397)
T 4gyi_A 98 SVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPV 177 (397)
T ss_dssp EEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSC
T ss_pred EecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 34678999999999999999999999999764210 0 01111 23455555554433321
Q ss_pred eecceeecCeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCC
Q 002409 660 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM 739 (927)
Q Consensus 660 l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~ 739 (927)
..-+.. ...+|||||+++++|.++... .....++.|++.+|.+||+. +||||||||.|||+++++
T Consensus 178 p~p~~~--~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 178 PEPIAQ--SRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEK 242 (397)
T ss_dssp CCEEEE--ETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEE
T ss_pred Ceeeec--cCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCC
Confidence 111111 223799999999888765421 12346789999999999998 999999999999998876
Q ss_pred ----------cEEEEeecCccc
Q 002409 740 ----------RAKVSDFGLSKF 751 (927)
Q Consensus 740 ----------~vkL~DFGla~~ 751 (927)
.+.|+||+.+..
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEE
T ss_pred CcccccccccceEEEEeCCccc
Confidence 389999997754
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.55 E-value=3e-15 Score=185.69 Aligned_cols=141 Identities=18% Similarity=0.241 Sum_probs=122.4
Q ss_pred CchHHHHHHHHhcCCCCcCCCC----CCC--CCCCCc------------ceeecCCCCCCceEEEEecCCCCCccCCchh
Q 002409 373 GSIDAIVSVISLYSSADWAQEG----GDP--CLPVPW------------SWLQCNSDPQPSITVIHLSSKNLTGNIPSDL 434 (927)
Q Consensus 373 ~~~dal~~~~~~~~~~~w~~~~----~dp--C~~~~~------------~~v~C~~~~~~~l~~L~L~~n~l~g~ip~~i 434 (927)
.+++||.++++++...+|...+ .+| | .| .||.|+. ..+|+.|+|++|+|.|.+|+.|
T Consensus 269 ~d~~ALl~~k~~l~~~~W~~~~~~~~~~~~~C---~W~~~~~~~~w~~~~GV~C~~--~~~V~~L~Ls~~~L~G~ip~~l 343 (876)
T 4ecn_A 269 KDYKALKAIWEALDGKNWRYYSGTINNTIHSL---NWNFNKELDMWGDQPGVDLDN--NGRVTGLSLAGFGAKGRVPDAI 343 (876)
T ss_dssp HHHHHHHHHHHHTTGGGCCCCCSSCSSCCCCC---SCCCSSCGGGTTCCTTEEECT--TSCEEEEECTTTCCEEEECGGG
T ss_pred HHHHHHHHHHHHcCCCCCCcCCCcccccCCcc---ccccccccccccCcCceEecC--CCCEEEEECccCCCCCcCchHH
Confidence 4678999999999877997644 366 6 79 9999986 3699999999999999999999
Q ss_pred hcCCCCcEEec-cCCcCCCC------------------------------------------------------------
Q 002409 435 TKLSSLVELWL-DGNSLTGP------------------------------------------------------------ 453 (927)
Q Consensus 435 ~~L~~L~~L~L-s~N~l~g~------------------------------------------------------------ 453 (927)
++|++|+.|+| ++|.++|.
T Consensus 344 ~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~~~l 423 (876)
T 4ecn_A 344 GQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRI 423 (876)
T ss_dssp GGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCCCCC
T ss_pred hccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccccccccc
Confidence 99999999999 88866554
Q ss_pred ----------------CCC-CCCCCCccEEEecCCCcCC-----------------CCCcccc--CCCcccccccccccc
Q 002409 454 ----------------IPD-FSGCPDLRIIHLEDNQLTG-----------------PLPSSLM--NLPNLRELYVQNNML 497 (927)
Q Consensus 454 ----------------~p~-~~~l~~L~~L~Ls~N~l~g-----------------~~P~~l~--~l~~L~~L~l~~N~l 497 (927)
||. +.+|++|++|+|++|+|+| .+|+.++ +|++|+.|+|++|++
T Consensus 424 ~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l 503 (876)
T 4ecn_A 424 SLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPN 503 (876)
T ss_dssp CCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTT
T ss_pred chhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCC
Confidence 664 7889999999999999998 4999988 999999999999999
Q ss_pred ccccccccc--cccccccccCCc
Q 002409 498 SGTVPSSLL--SKNVVLNYAGNI 518 (927)
Q Consensus 498 ~g~iP~~l~--~~~~~l~~~~n~ 518 (927)
.|.+|..+. +.+..+++.+|.
T Consensus 504 ~~~iP~~l~~L~~L~~L~Ls~N~ 526 (876)
T 4ecn_A 504 MTQLPDFLYDLPELQSLNIACNR 526 (876)
T ss_dssp CCSCCGGGGGCSSCCEEECTTCT
T ss_pred CccChHHHhCCCCCCEEECcCCC
Confidence 999998874 456778888885
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.52 E-value=5.7e-15 Score=178.78 Aligned_cols=139 Identities=19% Similarity=0.259 Sum_probs=119.4
Q ss_pred CchHHHHHHHHhcCCC-------------CcCCCCCCCCCCCCc---ceeecCCCCCCceEEEEecCCCCCccCCchhhc
Q 002409 373 GSIDAIVSVISLYSSA-------------DWAQEGGDPCLPVPW---SWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTK 436 (927)
Q Consensus 373 ~~~dal~~~~~~~~~~-------------~w~~~~~dpC~~~~~---~~v~C~~~~~~~l~~L~L~~n~l~g~ip~~i~~ 436 (927)
.+++||.+++.++... +|.. +.||| .| .||.|+.. .+|+.|+|++|+|+|.+|+.|++
T Consensus 30 ~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~-~~~~c---~w~~~~GV~C~~~--~~V~~L~L~~~~l~g~lp~~l~~ 103 (636)
T 4eco_A 30 KDYLALKEIWDALNGKNWSQQGFGTQPGANWNF-NKELD---MWGAQPGVSLNSN--GRVTGLSLEGFGASGRVPDAIGQ 103 (636)
T ss_dssp HHHHHHHHHHHHTTGGGCCCCC------CCCCC-SSCGG---GTTCCTTEEECTT--CCEEEEECTTSCCEEEECGGGGG
T ss_pred HHHHHHHHHHHHcCCCCcccCCcCCccCCCCCC-CCCcc---cccCCCCeEEcCC--CCEEEEEecCcccCCcCChHHhc
Confidence 4678999999886543 4654 46788 68 99999764 69999999999999999999999
Q ss_pred CCCCcEEeccCCc-------------------------------------------------------------------
Q 002409 437 LSSLVELWLDGNS------------------------------------------------------------------- 449 (927)
Q Consensus 437 L~~L~~L~Ls~N~------------------------------------------------------------------- 449 (927)
|++|+.|+|++|.
T Consensus 104 L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l 183 (636)
T 4eco_A 104 LTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITL 183 (636)
T ss_dssp CTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCC
T ss_pred CccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccch
Confidence 9999999999984
Q ss_pred -----------CCCCCCC-CCCCCCccEEEecCCCcCCC-----------------CCcccc--CCCccccccccccccc
Q 002409 450 -----------LTGPIPD-FSGCPDLRIIHLEDNQLTGP-----------------LPSSLM--NLPNLRELYVQNNMLS 498 (927)
Q Consensus 450 -----------l~g~~p~-~~~l~~L~~L~Ls~N~l~g~-----------------~P~~l~--~l~~L~~L~l~~N~l~ 498 (927)
|+| ||. ++++++|++|+|++|+|+|. +|+.++ ++++|++|+|++|+++
T Consensus 184 ~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~ 262 (636)
T 4eco_A 184 KDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNL 262 (636)
T ss_dssp CTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTC
T ss_pred hhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCC
Confidence 445 564 88899999999999999986 999999 9999999999999999
Q ss_pred cccccccc--cccccccccCCc
Q 002409 499 GTVPSSLL--SKNVVLNYAGNI 518 (927)
Q Consensus 499 g~iP~~l~--~~~~~l~~~~n~ 518 (927)
|.+|..+. +.+..+++.+|.
T Consensus 263 ~~~p~~l~~l~~L~~L~Ls~n~ 284 (636)
T 4eco_A 263 TKLPTFLKALPEMQLINVACNR 284 (636)
T ss_dssp SSCCTTTTTCSSCCEEECTTCT
T ss_pred ccChHHHhcCCCCCEEECcCCC
Confidence 99998874 456778888885
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=1.3e-14 Score=179.56 Aligned_cols=113 Identities=28% Similarity=0.433 Sum_probs=105.0
Q ss_pred CCCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCccccc
Q 002409 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 490 (927)
Q Consensus 412 ~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L 490 (927)
..+.|+.|||++|+++|.+|..|++|++|+.|+|++|+|+|.+|. ++++++|+.|||++|+++|.+|..+++|++|+.|
T Consensus 630 ~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L 709 (768)
T 3rgz_A 630 NNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEI 709 (768)
T ss_dssp SSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEE
T ss_pred ccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEE
Confidence 356899999999999999999999999999999999999999997 8999999999999999999999999999999999
Q ss_pred ccccccccccccccc-ccccccccccCCcccccCC
Q 002409 491 YVQNNMLSGTVPSSL-LSKNVVLNYAGNINLHEGG 524 (927)
Q Consensus 491 ~l~~N~l~g~iP~~l-~~~~~~l~~~~n~~l~~~~ 524 (927)
+|++|+|+|.||..- +.......+.||+++|+.+
T Consensus 710 ~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~ 744 (768)
T 3rgz_A 710 DLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP 744 (768)
T ss_dssp ECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTT
T ss_pred ECcCCcccccCCCchhhccCCHHHhcCCchhcCCC
Confidence 999999999999763 5555677899999999875
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.39 E-value=6.6e-13 Score=135.37 Aligned_cols=123 Identities=24% Similarity=0.301 Sum_probs=105.7
Q ss_pred CcceeecCCCC--------CCceEEEEecCCCCCccCCc-hhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCC
Q 002409 402 PWSWLQCNSDP--------QPSITVIHLSSKNLTGNIPS-DLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDN 471 (927)
Q Consensus 402 ~~~~v~C~~~~--------~~~l~~L~L~~n~l~g~ip~-~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N 471 (927)
.|..+.|+... ..+++.|+|++|+|++..+. .+.++++|++|+|++|+|++.+|. |.++++|++|+|++|
T Consensus 9 ~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 88 (192)
T 1w8a_A 9 EGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp ETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred CCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCC
Confidence 46778887532 24899999999999976664 489999999999999999999886 899999999999999
Q ss_pred CcCCCCCccccCCCccccccccccccccccccccc--cccccccccCCcccccCC
Q 002409 472 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL--SKNVVLNYAGNINLHEGG 524 (927)
Q Consensus 472 ~l~g~~P~~l~~l~~L~~L~l~~N~l~g~iP~~l~--~~~~~l~~~~n~~l~~~~ 524 (927)
+|++..|..+.++++|+.|+|++|+|++.+|..+. +.+..+.+.+|+-.|...
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred cCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 99998888899999999999999999988787763 456788899998777653
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.37 E-value=1.2e-12 Score=137.40 Aligned_cols=121 Identities=24% Similarity=0.335 Sum_probs=102.0
Q ss_pred CCCCCCCCCcceeecCCCC--------CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCcc
Q 002409 394 GGDPCLPVPWSWLQCNSDP--------QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLR 464 (927)
Q Consensus 394 ~~dpC~~~~~~~v~C~~~~--------~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~ 464 (927)
+.+.| +|.+|.|+... .++|+.|+|++|+|++..|..+.++++|+.|+|++|+|++..+. +.++++|+
T Consensus 15 ~~~~C---s~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~ 91 (229)
T 3e6j_A 15 SQCSC---SGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLT 91 (229)
T ss_dssp TTCEE---ETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred CCCEE---eCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcC
Confidence 57888 69999997632 36799999999999988899999999999999999999877766 68899999
Q ss_pred EEEecCCCcCCCCCccccCCCccccccccccccccccccccc--cccccccccCCc
Q 002409 465 IIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL--SKNVVLNYAGNI 518 (927)
Q Consensus 465 ~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l~g~iP~~l~--~~~~~l~~~~n~ 518 (927)
+|+|++|+|++..+..+..+++|+.|+|++|+|+ .+|..+. ..+..+.+.+|.
T Consensus 92 ~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~ 146 (229)
T 3e6j_A 92 VLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQ 146 (229)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSC
T ss_pred EEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCc
Confidence 9999999999776777889999999999999999 8887763 345666777774
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.37 E-value=2.4e-13 Score=168.17 Aligned_cols=124 Identities=30% Similarity=0.500 Sum_probs=80.5
Q ss_pred CchHHHHHHHHhcC----CCCcCCCCCCCCCCCCcceeecCCCCCCceEEEEecCCCCCcc---CCchhhc---------
Q 002409 373 GSIDAIVSVISLYS----SADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGN---IPSDLTK--------- 436 (927)
Q Consensus 373 ~~~dal~~~~~~~~----~~~w~~~~~dpC~~~~~~~v~C~~~~~~~l~~L~L~~n~l~g~---ip~~i~~--------- 436 (927)
.+++|+.++|+.+. +.+|.. +.||| .|.||+|+ ..+|+.|+|+++++.|. +|+.+++
T Consensus 12 ~~~~all~~k~~~~~~~~l~~W~~-~~~~C---~w~gv~C~---~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~ 84 (768)
T 3rgz_A 12 REIHQLISFKDVLPDKNLLPDWSS-NKNPC---TFDGVTCR---DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFL 84 (768)
T ss_dssp HHHHHHHHHHTTCSCTTSSTTCCT-TSCGG---GSTTEEEE---TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEEC
T ss_pred HHHHHHHHHHhhCCCcccccCCCC-CCCCc---CCcceEEC---CCcEEEEECCCCCcCCccCccChhHhccCcccccCC
Confidence 46779999999874 678974 67899 79999998 36999999999999998 6655544
Q ss_pred --------------CCCCcEEeccCCcCCCCCCC---CCCCCCccEEEecCCCcCCCCCccc-cCCCccccccccccccc
Q 002409 437 --------------LSSLVELWLDGNSLTGPIPD---FSGCPDLRIIHLEDNQLTGPLPSSL-MNLPNLRELYVQNNMLS 498 (927)
Q Consensus 437 --------------L~~L~~L~Ls~N~l~g~~p~---~~~l~~L~~L~Ls~N~l~g~~P~~l-~~l~~L~~L~l~~N~l~ 498 (927)
|++|++|+|++|.++|.+|. ++++++|++|+|++|++++.+|..+ .++++|+.|+|++|+++
T Consensus 85 ~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~ 164 (768)
T 3rgz_A 85 SNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSIS 164 (768)
T ss_dssp TTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCE
T ss_pred cCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccC
Confidence 45555555555555554442 4445555555555555555555443 45555555555555555
Q ss_pred ccccc
Q 002409 499 GTVPS 503 (927)
Q Consensus 499 g~iP~ 503 (927)
|..|.
T Consensus 165 ~~~~~ 169 (768)
T 3rgz_A 165 GANVV 169 (768)
T ss_dssp EETHH
T ss_pred CcCCh
Confidence 44443
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=2.6e-12 Score=128.76 Aligned_cols=139 Identities=17% Similarity=0.207 Sum_probs=96.9
Q ss_pred eEecCCCCCccccCCCeEEccCCccc-cCcceeeec----C---cccccccceeeeecCCCCcceeeecccCCceEEEeE
Q 002409 33 VSLNCGGNENFTDEIGLQWIADDHLI-YGEISNISV----A---NETRKQYMTLRHFPADSRKYCYKLDVITRTRYLIRA 104 (927)
Q Consensus 33 ~~idcG~~~~~~~~~~~~~~~d~~~~-~~~~~~~~~----~---~~~~~~~~tlR~Fp~~~~~~cy~l~~~~~~~ylvr~ 104 (927)
+.||||++.. +|..+++|.+|..|. .|..+.... . ....+.|+|.|.||. +.+|.+|+.++|+|+||+
T Consensus 8 ~~INcGg~~~-~d~~gr~w~~D~~~~~~g~~~~~~~~~~~~~~~~~~~~lY~TaR~~~~---~~tY~f~v~~~G~Y~VrL 83 (174)
T 2jwp_A 8 WAVNAGGESH-VDVHGIHYRKDPLEGRVGRASDYGMKLPILRSNPEDQVLYQTERYNED---SFGYDIPIKEEGEYVLVL 83 (174)
T ss_dssp EEEEETSSSE-EETTTEEECSSCSSTTCCCCCCCCTTSCCSSSCHHHHHTTTCCCCCCS---CEEEEEECCSCEEEEEEE
T ss_pred EEEECCCCCc-cCCCCCEEcCCcCcccCCcccccccceEecccCCCCchhhhhhccCCC---CeEEEEEeCCCeEEEEEE
Confidence 4799998875 567899999998886 343221110 1 112347899999995 579999999999999999
Q ss_pred EeeecCcCCCCCCCeeEEEECCcee-eEEeeC---CCCccEEEEEEEEe-------------cCCCceEEEecCCCCCce
Q 002409 105 TFLYGNFDNNNVYPKFDISLGPTHW-STIVIS---DAATIEVRELIFLA-------------SSPKIDVCLSNATTGQPF 167 (927)
Q Consensus 105 ~f~yg~~d~~~~~p~fd~~~~~~~w-~~v~~~---~~~~~~~~e~~~~~-------------~~~~~~vcl~~~~~~~pf 167 (927)
+|.--.|.. ....+||++|++..- .-.+.. ....+.+.|..+.+ .+..+.|.|.+...+.||
T Consensus 84 hF~ei~~~~-~~~rvFdV~ing~~~l~~fdi~~~ag~~~~~~~~~~~~v~~~~l~i~~~~~~~~g~L~I~f~p~~~~~a~ 162 (174)
T 2jwp_A 84 KFAEVYFAQ-SQQKVFDVRVNGHTVVKDLDIFDRVGHSTAHDEIIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYYDNPK 162 (174)
T ss_dssp EEECCSCCC-SSSSCEEEEETTEEEEEEECHHHHHSSSSCEEEEEEEEEETTEEEETTEEEECCSEEEEEEECSSSCSSS
T ss_pred EEeccccCC-CCCeEeEEEECCEEeecCcCHHHhhCCCeeEEEEEEEEEecCceeeeeeecccCCeEEEEEeccCCCCcE
Confidence 998766654 456799999998532 112211 12335566666543 455688888865466899
Q ss_pred eeeeeeeec
Q 002409 168 ISTLELRQF 176 (927)
Q Consensus 168 is~le~~~l 176 (927)
||+||+++-
T Consensus 163 inaIEI~~~ 171 (174)
T 2jwp_A 163 VCALFIMKG 171 (174)
T ss_dssp EEEEEEESS
T ss_pred EEEEEEEeC
Confidence 999999864
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.35 E-value=2.1e-13 Score=151.22 Aligned_cols=139 Identities=23% Similarity=0.315 Sum_probs=116.4
Q ss_pred CchHHHHHHHHhcC--C----CCcC---CCCCCCCCCCCcceeecCC-------CCCCceEEEEecCCCCCccCCchhhc
Q 002409 373 GSIDAIVSVISLYS--S----ADWA---QEGGDPCLPVPWSWLQCNS-------DPQPSITVIHLSSKNLTGNIPSDLTK 436 (927)
Q Consensus 373 ~~~dal~~~~~~~~--~----~~w~---~~~~dpC~~~~~~~v~C~~-------~~~~~l~~L~L~~n~l~g~ip~~i~~ 436 (927)
.+++|+.++++.+. . .+|. ...+++| .|.|+.|+. ...++|+.|+|++|+++ .+|+.+++
T Consensus 27 ~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~---~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~~ 102 (328)
T 4fcg_A 27 PYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE---TRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFR 102 (328)
T ss_dssp CHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSC---CSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGGG
T ss_pred hHHHHHHHHHHhccCCchhhhhhhccccccccccc---ccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhhh
Confidence 45678999988652 2 4563 2256777 699999952 34578999999999999 89999999
Q ss_pred CCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCcccccccccccccccccccc----------
Q 002409 437 LSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL---------- 505 (927)
Q Consensus 437 L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l~g~iP~~l---------- 505 (927)
|++|++|+|++|.|+ .+|. +.++++|++|+|++|+++ .+|..++++++|+.|+|++|++.|.+|..+
T Consensus 103 l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~ 180 (328)
T 4fcg_A 103 LSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQ 180 (328)
T ss_dssp GTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEE
T ss_pred CCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhc
Confidence 999999999999999 6665 889999999999999999 899999999999999999999999999987
Q ss_pred -ccccccccccCC
Q 002409 506 -LSKNVVLNYAGN 517 (927)
Q Consensus 506 -~~~~~~l~~~~n 517 (927)
+..+..+.+.+|
T Consensus 181 ~l~~L~~L~L~~n 193 (328)
T 4fcg_A 181 GLVNLQSLRLEWT 193 (328)
T ss_dssp ESTTCCEEEEEEE
T ss_pred cCCCCCEEECcCC
Confidence 445566666666
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.34 E-value=2.6e-12 Score=131.19 Aligned_cols=120 Identities=23% Similarity=0.285 Sum_probs=104.5
Q ss_pred cceeecCCCC--------CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCc
Q 002409 403 WSWLQCNSDP--------QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQL 473 (927)
Q Consensus 403 ~~~v~C~~~~--------~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l 473 (927)
+..+.|+... .+.|+.|+|++|+|+ .+|..+.++++|+.|+|++|+|++..+. |.++++|++|+|++|+|
T Consensus 12 ~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l 90 (193)
T 2wfh_A 12 DTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL 90 (193)
T ss_dssp TTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCcc
Confidence 5567786532 357999999999999 8999999999999999999999998886 89999999999999999
Q ss_pred CCCCCccccCCCccccccccccccccccccccc---cccccccccCCcccccCC
Q 002409 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL---SKNVVLNYAGNINLHEGG 524 (927)
Q Consensus 474 ~g~~P~~l~~l~~L~~L~l~~N~l~g~iP~~l~---~~~~~l~~~~n~~l~~~~ 524 (927)
++..|..|..+++|+.|+|++|+|+ .+|...+ ..+..+.+.+|+-.|.+.
T Consensus 91 ~~i~~~~f~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~~~C~c~ 143 (193)
T 2wfh_A 91 RCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPLYCDCN 143 (193)
T ss_dssp CBCCTTTTTTCTTCCEEECCSSCCC-BCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred CEeCHHHhCCCCCCCEEECCCCCCC-eeChhhhhcCccccEEEeCCCCeecCCc
Confidence 9888889999999999999999999 6776543 456778889999888664
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.33 E-value=3.9e-12 Score=127.55 Aligned_cols=121 Identities=24% Similarity=0.271 Sum_probs=103.4
Q ss_pred CcceeecCCCC--------CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCC
Q 002409 402 PWSWLQCNSDP--------QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 472 (927)
Q Consensus 402 ~~~~v~C~~~~--------~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~ 472 (927)
.|.++.|+... .++|+.|+|++|++++..+..+.++++|++|+|++|+|++.++. +.++++|++|+|++|+
T Consensus 8 ~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~ 87 (177)
T 2o6r_A 8 SGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENK 87 (177)
T ss_dssp ETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CCCEEEecCCCCccCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCC
Confidence 68889997533 36899999999999976666789999999999999999988876 6899999999999999
Q ss_pred cCCCCCccccCCCccccccccccccccccccccc---cccccccccCCcccccC
Q 002409 473 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL---SKNVVLNYAGNINLHEG 523 (927)
Q Consensus 473 l~g~~P~~l~~l~~L~~L~l~~N~l~g~iP~~l~---~~~~~l~~~~n~~l~~~ 523 (927)
|++..+..+.++++|+.|+|++|+|+ .+|...+ +.+..+.+.+|+-.|..
T Consensus 88 l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~~~~ 140 (177)
T 2o6r_A 88 LQSLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSC 140 (177)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred ccccCHHHhhCCcccCEEECcCCcce-EeCHHHhcCCcccCEEEecCCCeeccC
Confidence 99877777899999999999999999 6776653 45577888999876654
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.31 E-value=2.5e-12 Score=134.04 Aligned_cols=113 Identities=21% Similarity=0.254 Sum_probs=96.6
Q ss_pred CCCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCccccc
Q 002409 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 490 (927)
Q Consensus 412 ~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L 490 (927)
..++|+.|+|++|.|++..+..|.++++|+.|+|++|+|++.+|. +.++++|++|+|++|+|++..|..+.++++|+.|
T Consensus 55 ~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 134 (220)
T 2v70_A 55 KLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLL 134 (220)
T ss_dssp GCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEE
T ss_pred cCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEE
Confidence 356899999999999987777899999999999999999988886 8889999999999999998889999999999999
Q ss_pred cccccccccccccccc--cccccccccCCcccccCC
Q 002409 491 YVQNNMLSGTVPSSLL--SKNVVLNYAGNINLHEGG 524 (927)
Q Consensus 491 ~l~~N~l~g~iP~~l~--~~~~~l~~~~n~~l~~~~ 524 (927)
+|++|+|++..|..+. ..+..+.+.+|+-.|...
T Consensus 135 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 135 SLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp ECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred ECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 9999999966676663 455778888998777654
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.29 E-value=5.9e-12 Score=131.27 Aligned_cols=113 Identities=24% Similarity=0.297 Sum_probs=94.5
Q ss_pred CCCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCccccc
Q 002409 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 490 (927)
Q Consensus 412 ~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L 490 (927)
..++|+.|+|++|.|++..|..|.+|++|++|+|++|+|++..+. |.++++|++|+|++|+|++..|..+.++++|+.|
T Consensus 54 ~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 133 (220)
T 2v9t_B 54 PYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLL 133 (220)
T ss_dssp TCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEE
Confidence 356899999999999988889999999999999999999977776 6889999999999999998888899999999999
Q ss_pred ccccccccccccccc--ccccccccccCCcccccCC
Q 002409 491 YVQNNMLSGTVPSSL--LSKNVVLNYAGNINLHEGG 524 (927)
Q Consensus 491 ~l~~N~l~g~iP~~l--~~~~~~l~~~~n~~l~~~~ 524 (927)
+|++|+|++..|..+ +..+..+.+.+|+-.|.+.
T Consensus 134 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 169 (220)
T 2v9t_B 134 SLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCH 169 (220)
T ss_dssp ECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred ECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCc
Confidence 999999994444333 2345678889998877653
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.28 E-value=1.4e-12 Score=143.56 Aligned_cols=109 Identities=27% Similarity=0.317 Sum_probs=101.4
Q ss_pred eEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCcccccccccc
Q 002409 416 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 495 (927)
Q Consensus 416 l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N 495 (927)
|+.|+|++|.+++.+|..+.++++|+.|+|++|++++.+|.+..+++|++|+|++|+|+|.+|..+.++++|+.|+|++|
T Consensus 199 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N 278 (313)
T 1ogq_A 199 LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN 278 (313)
T ss_dssp CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSS
T ss_pred ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccccc-ccccccccccCCcccccCC
Q 002409 496 MLSGTVPSSL-LSKNVVLNYAGNINLHEGG 524 (927)
Q Consensus 496 ~l~g~iP~~l-~~~~~~l~~~~n~~l~~~~ 524 (927)
+|+|.+|..- ++.+..+.+.+|+.+|+.+
T Consensus 279 ~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p 308 (313)
T 1ogq_A 279 NLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308 (313)
T ss_dssp EEEEECCCSTTGGGSCGGGTCSSSEEESTT
T ss_pred cccccCCCCccccccChHHhcCCCCccCCC
Confidence 9999999862 3456778899999999864
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.27 E-value=4.4e-12 Score=129.21 Aligned_cols=113 Identities=22% Similarity=0.281 Sum_probs=97.2
Q ss_pred CCCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCccccc
Q 002409 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 490 (927)
Q Consensus 412 ~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L 490 (927)
..++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.+|. +.++++|++|+|++|+|++.+|..+..+++|+.|
T Consensus 52 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 131 (192)
T 1w8a_A 52 RLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSL 131 (192)
T ss_dssp GCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEE
T ss_pred cCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEE
Confidence 357899999999999999999999999999999999999999887 8899999999999999999999999999999999
Q ss_pred ccccccccccccccccc-ccccccccCCcccccCC
Q 002409 491 YVQNNMLSGTVPSSLLS-KNVVLNYAGNINLHEGG 524 (927)
Q Consensus 491 ~l~~N~l~g~iP~~l~~-~~~~l~~~~n~~l~~~~ 524 (927)
+|++|++++..+...+. .+....+.++...|..+
T Consensus 132 ~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P 166 (192)
T 1w8a_A 132 NLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp ECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred EeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCC
Confidence 99999999887754432 22333445565666655
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.25 E-value=1.2e-11 Score=123.37 Aligned_cols=84 Identities=29% Similarity=0.351 Sum_probs=39.2
Q ss_pred ceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCcccccccc
Q 002409 415 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 493 (927)
Q Consensus 415 ~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~ 493 (927)
+|+.|+|++|+|++..|..|.+|++|++|+|++|+|++.+|. |.++++|++|+|++|+|++..|..+.++++|+.|+|+
T Consensus 31 ~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 110 (170)
T 3g39_A 31 TTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLL 110 (170)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEeC
Confidence 344444444444444444444444444444444444444443 3444444444444444443333334444444444444
Q ss_pred ccccc
Q 002409 494 NNMLS 498 (927)
Q Consensus 494 ~N~l~ 498 (927)
+|+++
T Consensus 111 ~N~~~ 115 (170)
T 3g39_A 111 NNPWD 115 (170)
T ss_dssp SSCBC
T ss_pred CCCCC
Confidence 44444
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.25 E-value=2.8e-12 Score=150.11 Aligned_cols=108 Identities=15% Similarity=0.128 Sum_probs=90.5
Q ss_pred CCceEEEEecCCCCCccCCchhh-cCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCcccccc
Q 002409 413 QPSITVIHLSSKNLTGNIPSDLT-KLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 491 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~ip~~i~-~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~ 491 (927)
.++|+.|+|++|.|++.+|..+. +|++|+.|+|++|.|++. |.+..+++|+.|+|++|+|++ +|+.+..+++|+.|+
T Consensus 143 l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~ 220 (487)
T 3oja_A 143 RSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KGQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWIS 220 (487)
T ss_dssp GSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-ECCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEE
T ss_pred CCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cccccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEE
Confidence 46899999999999988888886 799999999999999887 555579999999999999996 555688999999999
Q ss_pred ccccccccccccccc--cccccccccCCcccccC
Q 002409 492 VQNNMLSGTVPSSLL--SKNVVLNYAGNINLHEG 523 (927)
Q Consensus 492 l~~N~l~g~iP~~l~--~~~~~l~~~~n~~l~~~ 523 (927)
|++|+|+ .+|..+. +.+..+++.+|+..|+.
T Consensus 221 Ls~N~l~-~lp~~l~~l~~L~~L~l~~N~l~c~~ 253 (487)
T 3oja_A 221 LRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGT 253 (487)
T ss_dssp CTTSCCC-EECTTCCCCTTCCEEECTTCCBCHHH
T ss_pred ecCCcCc-ccchhhccCCCCCEEEcCCCCCcCcc
Confidence 9999999 5887763 45677888999877654
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.21 E-value=2.1e-11 Score=127.03 Aligned_cols=118 Identities=20% Similarity=0.237 Sum_probs=99.0
Q ss_pred CcceeecCCCC--------CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCC
Q 002409 402 PWSWLQCNSDP--------QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 472 (927)
Q Consensus 402 ~~~~v~C~~~~--------~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~ 472 (927)
.|..+.|+... .++|+.|+|++|+|++..+..+..+++|+.|+|++|+|++..|. |.++++|++|+|++|+
T Consensus 12 ~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~ 91 (220)
T 2v9t_B 12 SNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91 (220)
T ss_dssp ETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred CCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence 46778887533 24799999999999977777899999999999999999998886 8999999999999999
Q ss_pred cCCCCCccccCCCccccccccccccccccccccc--cccccccccCCcc
Q 002409 473 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL--SKNVVLNYAGNIN 519 (927)
Q Consensus 473 l~g~~P~~l~~l~~L~~L~l~~N~l~g~iP~~l~--~~~~~l~~~~n~~ 519 (927)
|++..+..+..+++|+.|+|++|+|++..|..+. ..+..+++.+|..
T Consensus 92 l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 140 (220)
T 2v9t_B 92 ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKL 140 (220)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcC
Confidence 9965555678999999999999999966666553 4567778888853
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.21 E-value=3e-11 Score=126.66 Aligned_cols=111 Identities=24% Similarity=0.219 Sum_probs=96.1
Q ss_pred CCCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCccccc
Q 002409 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 490 (927)
Q Consensus 412 ~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L 490 (927)
..++|+.|+|++|+|++..+..+.+|++|+.|+|++|+|++..+. +..+++|++|+|++|+|+ .+|..+.++++|+.|
T Consensus 62 ~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L 140 (229)
T 3e6j_A 62 SLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHL 140 (229)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEE
T ss_pred CccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEE
Confidence 357899999999999855556679999999999999999998887 688999999999999999 899999999999999
Q ss_pred cccccccccccccccc---cccccccccCCcccccCC
Q 002409 491 YVQNNMLSGTVPSSLL---SKNVVLNYAGNINLHEGG 524 (927)
Q Consensus 491 ~l~~N~l~g~iP~~l~---~~~~~l~~~~n~~l~~~~ 524 (927)
+|++|+|+ .+|...+ +.+..+.+.+|+-.|.+.
T Consensus 141 ~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 141 ALDQNQLK-SIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp ECCSSCCC-CCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred ECCCCcCC-ccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 99999999 5665543 456778889998877663
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.21 E-value=3.5e-11 Score=123.84 Aligned_cols=116 Identities=25% Similarity=0.344 Sum_probs=93.9
Q ss_pred CcceeecCCCC--------CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCC
Q 002409 402 PWSWLQCNSDP--------QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 472 (927)
Q Consensus 402 ~~~~v~C~~~~--------~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~ 472 (927)
.|.++.|+... .++|+.|+|++|++++..+..+.++++|++|+|++|+|++..+. +.++++|++|+|++|+
T Consensus 8 ~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 87 (208)
T 2o6s_A 8 SGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQ 87 (208)
T ss_dssp ETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCc
Confidence 68889997532 35789999999999966666788999999999999999987776 6889999999999999
Q ss_pred cCCCCCccccCCCcccccccccccccccccccc---ccccccccccCCc
Q 002409 473 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGNI 518 (927)
Q Consensus 473 l~g~~P~~l~~l~~L~~L~l~~N~l~g~iP~~l---~~~~~~l~~~~n~ 518 (927)
+++..+..+.++++|+.|+|++|+|+ .+|... +..+..+++.+|.
T Consensus 88 l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~ 135 (208)
T 2o6s_A 88 LQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQ 135 (208)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSC
T ss_pred CCccCHhHhcCccCCCEEEcCCCcCc-ccCHhHhccCCcCCEEECCCCc
Confidence 99766667889999999999999999 455543 3455667777774
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.21 E-value=2.2e-11 Score=121.54 Aligned_cols=105 Identities=24% Similarity=0.299 Sum_probs=90.7
Q ss_pred eEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCccccccccc
Q 002409 416 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 494 (927)
Q Consensus 416 l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~ 494 (927)
.+.|++++|+|+ .+|..+. ++|+.|+|++|+|++..|. |.++++|++|+|++|+|++..|..+.++++|+.|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 468999999999 6888774 8999999999999999886 89999999999999999977777789999999999999
Q ss_pred ccccccccccc---ccccccccccCCcccccCC
Q 002409 495 NMLSGTVPSSL---LSKNVVLNYAGNINLHEGG 524 (927)
Q Consensus 495 N~l~g~iP~~l---~~~~~~l~~~~n~~l~~~~ 524 (927)
|+|+ .+|... +..+..+.+.+|+-.|...
T Consensus 88 N~l~-~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 88 NQLK-SIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp SCCC-CCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred CccC-EeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 9999 566553 3456788899998877763
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.19 E-value=3.5e-11 Score=125.33 Aligned_cols=118 Identities=19% Similarity=0.236 Sum_probs=99.6
Q ss_pred CcceeecCCCC--------CCceEEEEecCCCCCccCCc-hhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCC
Q 002409 402 PWSWLQCNSDP--------QPSITVIHLSSKNLTGNIPS-DLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDN 471 (927)
Q Consensus 402 ~~~~v~C~~~~--------~~~l~~L~L~~n~l~g~ip~-~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N 471 (927)
.|..+.|+... ...++.|+|++|+|++..|. .+.++++|+.|+|++|+|++..+. |.++++|++|+|++|
T Consensus 12 ~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 12 EGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp ETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 46678887543 24678999999999977654 589999999999999999998884 899999999999999
Q ss_pred CcCCCCCccccCCCccccccccccccccccccccc--cccccccccCCcc
Q 002409 472 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL--SKNVVLNYAGNIN 519 (927)
Q Consensus 472 ~l~g~~P~~l~~l~~L~~L~l~~N~l~g~iP~~l~--~~~~~l~~~~n~~ 519 (927)
+|++..|..+.++++|+.|+|++|+|++..|..+. ..+..+++.+|..
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 141 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQI 141 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCC
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcC
Confidence 99988888899999999999999999976676663 4567778888843
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.18 E-value=5.3e-11 Score=126.41 Aligned_cols=111 Identities=23% Similarity=0.279 Sum_probs=94.2
Q ss_pred CCCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCccccc
Q 002409 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 490 (927)
Q Consensus 412 ~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L 490 (927)
..++|+.|+|++|+|++..+..+..+++|++|+|++|+|++..+. +.++++|++|+|++|+|++..|..+.++++|+.|
T Consensus 81 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 160 (251)
T 3m19_A 81 DLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTL 160 (251)
T ss_dssp TCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEE
Confidence 357899999999999977777889999999999999999988877 6889999999999999997777789999999999
Q ss_pred ccccccccccccccc--ccccccccccCCccccc
Q 002409 491 YVQNNMLSGTVPSSL--LSKNVVLNYAGNINLHE 522 (927)
Q Consensus 491 ~l~~N~l~g~iP~~l--~~~~~~l~~~~n~~l~~ 522 (927)
+|++|+|++..|..+ ++.+..+.+.+|+-.|.
T Consensus 161 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 161 SLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp ECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred ECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 999999995444344 34567788899987776
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.17 E-value=1.8e-11 Score=119.03 Aligned_cols=105 Identities=19% Similarity=0.213 Sum_probs=89.0
Q ss_pred CCceEEEEecCCCCC-ccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCcccccc
Q 002409 413 QPSITVIHLSSKNLT-GNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 491 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~-g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~ 491 (927)
.++|+.|+|++|+++ |.+|..+..+++|+.|+|++|.+++. +.+.++++|++|+|++|++++.+|..+.++++|+.|+
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 357999999999998 88999899999999999999999988 7789999999999999999988888888899999999
Q ss_pred ccccccccc-ccccc--ccccccccccCCc
Q 002409 492 VQNNMLSGT-VPSSL--LSKNVVLNYAGNI 518 (927)
Q Consensus 492 l~~N~l~g~-iP~~l--~~~~~~l~~~~n~ 518 (927)
|++|++++. .|..+ ++.+..+.+.+|.
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~ 124 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCE 124 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCG
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCc
Confidence 999999952 23444 3445677777774
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.17 E-value=8.1e-11 Score=121.10 Aligned_cols=112 Identities=24% Similarity=0.227 Sum_probs=93.7
Q ss_pred CCCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCccccc
Q 002409 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 490 (927)
Q Consensus 412 ~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L 490 (927)
..++|+.|+|++|++++..+..+.++++|++|+|++|+|++.++. +.++++|++|+|++|+|++..+..+.++++|+.|
T Consensus 50 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 129 (208)
T 2o6s_A 50 ELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDL 129 (208)
T ss_dssp TCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred ccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEE
Confidence 356899999999999966556678999999999999999988776 6889999999999999997777778999999999
Q ss_pred ccccccccccccccc---ccccccccccCCcccccCC
Q 002409 491 YVQNNMLSGTVPSSL---LSKNVVLNYAGNINLHEGG 524 (927)
Q Consensus 491 ~l~~N~l~g~iP~~l---~~~~~~l~~~~n~~l~~~~ 524 (927)
+|++|+|+ .+|... +..+..+.+.+|+..|..+
T Consensus 130 ~l~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 165 (208)
T 2o6s_A 130 RLYQNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCP 165 (208)
T ss_dssp ECCSSCCS-CCCTTTTTTCTTCCEEECCSCCBCCCTT
T ss_pred ECCCCccc-eeCHHHhccCCCccEEEecCCCeecCCC
Confidence 99999999 555554 3456778888997766543
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.17 E-value=5.1e-11 Score=119.42 Aligned_cols=103 Identities=22% Similarity=0.348 Sum_probs=79.7
Q ss_pred EEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCcccccccccc
Q 002409 417 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 495 (927)
Q Consensus 417 ~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N 495 (927)
+.|++++|+|+ .+|..+. ++|+.|+|++|+|++.+|. |.++++|++|+|++|+|++..+..+.++++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 57888888886 7887664 7888888888888888775 778888888888888888655555688888888888888
Q ss_pred cccccccccc---ccccccccccCCcccccC
Q 002409 496 MLSGTVPSSL---LSKNVVLNYAGNINLHEG 523 (927)
Q Consensus 496 ~l~g~iP~~l---~~~~~~l~~~~n~~l~~~ 523 (927)
+|+ .+|... ++.+..+.+.+|+-.|..
T Consensus 92 ~l~-~l~~~~~~~l~~L~~L~L~~N~~~c~~ 121 (174)
T 2r9u_A 92 HLK-SIPRGAFDNLKSLTHIYLYNNPWDCEC 121 (174)
T ss_dssp CCC-CCCTTTTTTCTTCSEEECCSSCBCTTB
T ss_pred ccc-eeCHHHhccccCCCEEEeCCCCccccc
Confidence 888 566553 344567778888776655
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.16 E-value=5.3e-11 Score=119.29 Aligned_cols=91 Identities=23% Similarity=0.328 Sum_probs=81.9
Q ss_pred CceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCccccccc
Q 002409 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 492 (927)
Q Consensus 414 ~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 492 (927)
++|+.|+|++|+|++..|..|.+|++|+.|+|++|+|++.++. |.++++|++|+|++|+|++..+..+..+++|+.|+|
T Consensus 33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L 112 (174)
T 2r9u_A 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYL 112 (174)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEe
Confidence 5789999999999988899999999999999999999998877 689999999999999999766666999999999999
Q ss_pred ccccccccccccc
Q 002409 493 QNNMLSGTVPSSL 505 (927)
Q Consensus 493 ~~N~l~g~iP~~l 505 (927)
++|++. ..|..+
T Consensus 113 ~~N~~~-c~~~~~ 124 (174)
T 2r9u_A 113 YNNPWD-CECRDI 124 (174)
T ss_dssp CSSCBC-TTBGGG
T ss_pred CCCCcc-cccccH
Confidence 999999 455433
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.16 E-value=3.1e-11 Score=119.80 Aligned_cols=104 Identities=22% Similarity=0.266 Sum_probs=89.6
Q ss_pred CCceEEEEecCCCCC-ccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCcccccc
Q 002409 413 QPSITVIHLSSKNLT-GNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 491 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~-g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~ 491 (927)
.++|+.|+|++|+++ |.+|..+..+++|+.|+|++|.|++. +.+..+++|++|+|++|++++.+|..+.++++|+.|+
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 468999999999998 88999999999999999999999987 7789999999999999999988888888899999999
Q ss_pred ccccccccccc--ccc--ccccccccccCCc
Q 002409 492 VQNNMLSGTVP--SSL--LSKNVVLNYAGNI 518 (927)
Q Consensus 492 l~~N~l~g~iP--~~l--~~~~~~l~~~~n~ 518 (927)
|++|+|++ +| ..+ ++.+..+.+.+|.
T Consensus 102 Ls~N~l~~-~~~~~~l~~l~~L~~L~l~~N~ 131 (168)
T 2ell_A 102 LSGNKLKD-ISTLEPLKKLECLKSLDLFNCE 131 (168)
T ss_dssp CBSSSCCS-SGGGGGGSSCSCCCEEECCSSG
T ss_pred ccCCccCc-chhHHHHhcCCCCCEEEeeCCc
Confidence 99999994 44 344 3455677777774
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.16 E-value=8.1e-11 Score=126.61 Aligned_cols=113 Identities=19% Similarity=0.143 Sum_probs=97.1
Q ss_pred CCCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCccccc
Q 002409 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 490 (927)
Q Consensus 412 ~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L 490 (927)
..++|+.|+|++|++++..+..+.++++|++|+|++|++++.++. +.++++|+.|+|++|++++..|..+.++++|+.|
T Consensus 107 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 186 (272)
T 3rfs_A 107 KLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDL 186 (272)
T ss_dssp TCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEE
Confidence 457899999999999977777789999999999999999988887 6889999999999999998777788999999999
Q ss_pred ccccccccccccccc--ccccccccccCCcccccCC
Q 002409 491 YVQNNMLSGTVPSSL--LSKNVVLNYAGNINLHEGG 524 (927)
Q Consensus 491 ~l~~N~l~g~iP~~l--~~~~~~l~~~~n~~l~~~~ 524 (927)
+|++|+|++..|..+ ++.+..+.+.+|+-.|..+
T Consensus 187 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 222 (272)
T 3rfs_A 187 RLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 222 (272)
T ss_dssp ECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred ECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc
Confidence 999999996555433 3556778889998777664
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.16 E-value=3.2e-11 Score=133.58 Aligned_cols=107 Identities=18% Similarity=0.270 Sum_probs=90.8
Q ss_pred CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCccccccc
Q 002409 413 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 492 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 492 (927)
.++|+.|+|++|+|+ .+|..++++++|+.|+|++|++++.++.+.++++|++|+|++|++.+.+|..++++++|+.|+|
T Consensus 182 l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L 260 (328)
T 4fcg_A 182 LVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLIL 260 (328)
T ss_dssp STTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEEC
T ss_pred CCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEEC
Confidence 567889999999988 8888899999999999999999987777888899999999999998899998999999999999
Q ss_pred cccccccccccccc--cccccccccCCccc
Q 002409 493 QNNMLSGTVPSSLL--SKNVVLNYAGNINL 520 (927)
Q Consensus 493 ~~N~l~g~iP~~l~--~~~~~l~~~~n~~l 520 (927)
++|++.+.+|..+. +.+..+++.+|...
T Consensus 261 ~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~ 290 (328)
T 4fcg_A 261 KDCSNLLTLPLDIHRLTQLEKLDLRGCVNL 290 (328)
T ss_dssp TTCTTCCBCCTTGGGCTTCCEEECTTCTTC
T ss_pred CCCCchhhcchhhhcCCCCCEEeCCCCCch
Confidence 99988888888763 44567777887644
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.14 E-value=9.5e-11 Score=127.49 Aligned_cols=112 Identities=31% Similarity=0.383 Sum_probs=97.0
Q ss_pred CCCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCccccc
Q 002409 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 490 (927)
Q Consensus 412 ~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L 490 (927)
..++|+.|+|++|+|++..|..|.+|++|+.|+|++|+|++.++. +..+++|+.|+|++|+|++..+..+.++++|+.|
T Consensus 98 ~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L 177 (290)
T 1p9a_G 98 TLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177 (290)
T ss_dssp TCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEE
T ss_pred cCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEE
Confidence 356899999999999977677899999999999999999988776 6889999999999999996555567889999999
Q ss_pred cccccccccccccccccc--cccccccCCcccccCC
Q 002409 491 YVQNNMLSGTVPSSLLSK--NVVLNYAGNINLHEGG 524 (927)
Q Consensus 491 ~l~~N~l~g~iP~~l~~~--~~~l~~~~n~~l~~~~ 524 (927)
+|++|+|+ .+|..++.. +..+.+.+|+-.|.+.
T Consensus 178 ~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c~ 212 (290)
T 1p9a_G 178 LLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCE 212 (290)
T ss_dssp ECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred ECCCCcCC-ccChhhcccccCCeEEeCCCCccCcCc
Confidence 99999999 899888654 5677889999888764
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.12 E-value=1.5e-10 Score=122.91 Aligned_cols=105 Identities=24% Similarity=0.284 Sum_probs=66.2
Q ss_pred CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCcccccc
Q 002409 413 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 491 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~ 491 (927)
.++|+.|+|++|.|++..|..+.++++|++|+|++|+|++.++. +.++++|++|+|++|+|++..+..+.++++|+.|+
T Consensus 58 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 137 (251)
T 3m19_A 58 LTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELR 137 (251)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEE
Confidence 35667777777777766666666677777777777777666554 56667777777777777655555566677777777
Q ss_pred cccccccccccc-cc--ccccccccccCCc
Q 002409 492 VQNNMLSGTVPS-SL--LSKNVVLNYAGNI 518 (927)
Q Consensus 492 l~~N~l~g~iP~-~l--~~~~~~l~~~~n~ 518 (927)
|++|+|+ .+|. .+ ++.+..+++.+|.
T Consensus 138 Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~ 166 (251)
T 3m19_A 138 LNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQ 166 (251)
T ss_dssp CCSSCCC-CCCTTTTTTCTTCCEEECCSSC
T ss_pred CcCCcCC-ccCHHHcCcCcCCCEEECCCCc
Confidence 7777776 3433 22 2344555556653
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.11 E-value=1.2e-10 Score=125.22 Aligned_cols=105 Identities=25% Similarity=0.301 Sum_probs=82.6
Q ss_pred CceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCccccccc
Q 002409 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 492 (927)
Q Consensus 414 ~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 492 (927)
+.++.|+|++|++++..+..+.++++|++|+|++|+|++..+. +.++++|++|+|++|++++..+..+.++++|+.|+|
T Consensus 37 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 116 (270)
T 2o6q_A 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRL 116 (270)
T ss_dssp TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEEC
T ss_pred CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEEC
Confidence 4588899999999866666888999999999999999876666 578999999999999998766667888899999999
Q ss_pred ccccccccccccc--ccccccccccCCc
Q 002409 493 QNNMLSGTVPSSL--LSKNVVLNYAGNI 518 (927)
Q Consensus 493 ~~N~l~g~iP~~l--~~~~~~l~~~~n~ 518 (927)
++|++++..|..+ ++.+..+.+.+|.
T Consensus 117 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 144 (270)
T 2o6q_A 117 DRNQLKSLPPRVFDSLTKLTYLSLGYNE 144 (270)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CCCccCeeCHHHhCcCcCCCEEECCCCc
Confidence 9999984443333 3455667777773
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.09 E-value=1e-10 Score=140.55 Aligned_cols=113 Identities=19% Similarity=0.132 Sum_probs=94.8
Q ss_pred eeecCCCC--------CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCC
Q 002409 405 WLQCNSDP--------QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTG 475 (927)
Q Consensus 405 ~v~C~~~~--------~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g 475 (927)
-+.|+..+ ++.++.|||++|+|++..|..|.+|++|++|+|++|+|++..|. |.+|++|++|+|++|+|++
T Consensus 35 ~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~ 114 (635)
T 4g8a_A 35 TYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS 114 (635)
T ss_dssp EEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCE
T ss_pred EEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCC
Confidence 46787532 24789999999999977777899999999999999999998886 8999999999999999997
Q ss_pred CCCccccCCCcccccccccccccccccccc---ccccccccccCCc
Q 002409 476 PLPSSLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGNI 518 (927)
Q Consensus 476 ~~P~~l~~l~~L~~L~l~~N~l~g~iP~~l---~~~~~~l~~~~n~ 518 (927)
..|..|.+|++|++|+|++|+|+ .+|... ++.+..+++.+|.
T Consensus 115 l~~~~f~~L~~L~~L~Ls~N~l~-~l~~~~~~~L~~L~~L~Ls~N~ 159 (635)
T 4g8a_A 115 LALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNL 159 (635)
T ss_dssp ECGGGGTTCTTCCEEECTTSCCC-CSTTCCCTTCTTCCEEECCSSC
T ss_pred CCHHHhcCCCCCCEEECCCCcCC-CCChhhhhcCcccCeeccccCc
Confidence 66678999999999999999999 555543 3455677777774
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.09 E-value=9.8e-11 Score=130.43 Aligned_cols=102 Identities=19% Similarity=0.217 Sum_probs=75.4
Q ss_pred EEecCC-CCCccCCchhhcCCCCcEEeccC-CcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCcccccccccc
Q 002409 419 IHLSSK-NLTGNIPSDLTKLSSLVELWLDG-NSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 495 (927)
Q Consensus 419 L~L~~n-~l~g~ip~~i~~L~~L~~L~Ls~-N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N 495 (927)
++++++ +|+ .||. |..+++|+.|+|++ |+|++.+|. |.+|++|+.|+|++|+|++..|..|.+|++|+.|+|++|
T Consensus 13 v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 13 LRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp EECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 355555 677 4777 88888888888885 888877765 778888888888888888777777888888888888888
Q ss_pred ccccccccccccc--cccccccCCcccccC
Q 002409 496 MLSGTVPSSLLSK--NVVLNYAGNINLHEG 523 (927)
Q Consensus 496 ~l~g~iP~~l~~~--~~~l~~~~n~~l~~~ 523 (927)
+|+ .+|..++.. +..|.+.+|+-.|.+
T Consensus 91 ~l~-~~~~~~~~~~~L~~l~l~~N~~~c~c 119 (347)
T 2ifg_A 91 ALE-SLSWKTVQGLSLQELVLSGNPLHCSC 119 (347)
T ss_dssp CCS-CCCSTTTCSCCCCEEECCSSCCCCCG
T ss_pred ccc-eeCHHHcccCCceEEEeeCCCccCCC
Confidence 888 566655443 456667777766654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.08 E-value=2.8e-10 Score=121.45 Aligned_cols=138 Identities=18% Similarity=0.107 Sum_probs=107.3
Q ss_pred HhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhcc-CCCccceecceeecCeEEEEEEeccCCc
Q 002409 603 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMHNGT 681 (927)
Q Consensus 603 ~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~~~~lV~E~~~~gs 681 (927)
+...++.|+.+.||+.... ++.+++|+...........+.+|+++++.+. |..+.++++++...+..++||||++|.+
T Consensus 18 ~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~ 96 (263)
T 3tm0_A 18 CVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVL 96 (263)
T ss_dssp EEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEE
T ss_pred eEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCee
Confidence 3456788888999999865 7899999987532233456899999999984 6778889999988889999999999999
Q ss_pred hhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCC------------------------------------------
Q 002409 682 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC------------------------------------------ 719 (927)
Q Consensus 682 L~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~------------------------------------------ 719 (927)
|.+.+.. ......++.+++++|+.||+..
T Consensus 97 l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (263)
T 3tm0_A 97 CSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP 167 (263)
T ss_dssp HHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred hhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence 8775311 1122367889999999999810
Q ss_pred --------------CCceecCCCCCCCeEECCCCcEEEEeecCcc
Q 002409 720 --------------VPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 750 (927)
Q Consensus 720 --------------~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 750 (927)
...++|+|++|.|||++++..+.|+||+.+.
T Consensus 168 ~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1369999999999999876566799999764
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.06 E-value=1.7e-10 Score=129.44 Aligned_cols=92 Identities=22% Similarity=0.263 Sum_probs=57.8
Q ss_pred CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCcccccc
Q 002409 413 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 491 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~ 491 (927)
.++|+.|+|++|+|++..|..|.+|++|++|+|++|+|++..+. |.++++|++|+|++|+|++..|..|.++++|+.|+
T Consensus 63 l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 142 (361)
T 2xot_A 63 LTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLY 142 (361)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred ccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEE
Confidence 34566666666666655555566666666666666666665554 56666666666666666655566666666666666
Q ss_pred cccccccccccccc
Q 002409 492 VQNNMLSGTVPSSL 505 (927)
Q Consensus 492 l~~N~l~g~iP~~l 505 (927)
|++|+|+ .+|..+
T Consensus 143 L~~N~l~-~l~~~~ 155 (361)
T 2xot_A 143 LSQNQIS-RFPVEL 155 (361)
T ss_dssp CCSSCCC-SCCGGG
T ss_pred CCCCcCC-eeCHHH
Confidence 6666666 455544
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.06 E-value=4.3e-10 Score=120.75 Aligned_cols=112 Identities=23% Similarity=0.242 Sum_probs=97.7
Q ss_pred CCCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCccccc
Q 002409 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 490 (927)
Q Consensus 412 ~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L 490 (927)
..++|+.|+|++|.+++..+..+.++++|++|+|++|.|++..+. +.++++|+.|+|++|++++..|..+.++++|+.|
T Consensus 107 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 186 (270)
T 2o6q_A 107 QLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTL 186 (270)
T ss_dssp TCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE
T ss_pred cccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEE
Confidence 356899999999999987777899999999999999999988776 7899999999999999998777789999999999
Q ss_pred cccccccccccccccc---cccccccccCCcccccCC
Q 002409 491 YVQNNMLSGTVPSSLL---SKNVVLNYAGNINLHEGG 524 (927)
Q Consensus 491 ~l~~N~l~g~iP~~l~---~~~~~l~~~~n~~l~~~~ 524 (927)
+|++|+|+ .+|...+ ..+..+.+.+|+-.|.+.
T Consensus 187 ~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 187 KLDNNQLK-RVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp ECCSSCCS-CCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred ECCCCcCC-cCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 99999999 5666543 455778899999888764
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.05 E-value=2.9e-10 Score=113.81 Aligned_cols=91 Identities=22% Similarity=0.317 Sum_probs=81.4
Q ss_pred CCCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCccccc
Q 002409 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 490 (927)
Q Consensus 412 ~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L 490 (927)
..++|+.|+|++|.|++..+..+.++++|+.|+|++|+|++.++. +.++++|++|+|++|+|++..+..+..+++|+.|
T Consensus 50 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L 129 (177)
T 2o6r_A 50 KLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKI 129 (177)
T ss_dssp TCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE
T ss_pred CcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEE
Confidence 356899999999999966666789999999999999999998887 6889999999999999996655567899999999
Q ss_pred cccccccccccc
Q 002409 491 YVQNNMLSGTVP 502 (927)
Q Consensus 491 ~l~~N~l~g~iP 502 (927)
+|++|++++..|
T Consensus 130 ~l~~N~~~~~~~ 141 (177)
T 2o6r_A 130 WLHTNPWDCSCP 141 (177)
T ss_dssp ECCSSCBCCCHH
T ss_pred EecCCCeeccCc
Confidence 999999998776
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.05 E-value=1.5e-10 Score=133.73 Aligned_cols=114 Identities=22% Similarity=0.250 Sum_probs=98.3
Q ss_pred eecCCCC-------CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC--CCCCCCccEEEecCCCcCCC
Q 002409 406 LQCNSDP-------QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQLTGP 476 (927)
Q Consensus 406 v~C~~~~-------~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~--~~~l~~L~~L~Ls~N~l~g~ 476 (927)
+.|+... .++|++|+|++|.+++..|..|.+|++|++|+|++|.+.+.++. |.++++|++|+|++|++++.
T Consensus 15 ~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~ 94 (455)
T 3v47_A 15 AICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQL 94 (455)
T ss_dssp EECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEE
T ss_pred cCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCcc
Confidence 7787543 25799999999999988899999999999999999999987753 89999999999999999998
Q ss_pred CCccccCCCccccccccccccccccccc--c--ccccccccccCCcc
Q 002409 477 LPSSLMNLPNLRELYVQNNMLSGTVPSS--L--LSKNVVLNYAGNIN 519 (927)
Q Consensus 477 ~P~~l~~l~~L~~L~l~~N~l~g~iP~~--l--~~~~~~l~~~~n~~ 519 (927)
.|..++++++|+.|+|++|++++.+|.. + +..+..+.+.+|..
T Consensus 95 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l 141 (455)
T 3v47_A 95 ETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNI 141 (455)
T ss_dssp CTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBC
T ss_pred ChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCcc
Confidence 8999999999999999999999877654 3 34566777777753
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.05 E-value=4.3e-10 Score=120.95 Aligned_cols=107 Identities=25% Similarity=0.241 Sum_probs=87.0
Q ss_pred CCCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCccccc
Q 002409 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 490 (927)
Q Consensus 412 ~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L 490 (927)
..++|+.|+|++|.+++..+..+.++++|++|+|++|++++.++. +.++++|++|+|++|++++..|..+.++++|+.|
T Consensus 83 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 162 (272)
T 3rfs_A 83 ELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTEL 162 (272)
T ss_dssp TCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEE
Confidence 356899999999999977777788999999999999999988877 6889999999999999997777778899999999
Q ss_pred ccccccccccccccc--ccccccccccCCc
Q 002409 491 YVQNNMLSGTVPSSL--LSKNVVLNYAGNI 518 (927)
Q Consensus 491 ~l~~N~l~g~iP~~l--~~~~~~l~~~~n~ 518 (927)
+|++|+|++..|..+ ++.+..+.+.+|.
T Consensus 163 ~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 192 (272)
T 3rfs_A 163 DLSYNQLQSLPEGVFDKLTQLKDLRLYQNQ 192 (272)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred ECCCCCcCccCHHHhcCCccCCEEECCCCc
Confidence 999999994444332 3455677777774
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.05 E-value=2.1e-10 Score=123.97 Aligned_cols=113 Identities=22% Similarity=0.286 Sum_probs=96.4
Q ss_pred CCCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCccccc
Q 002409 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 490 (927)
Q Consensus 412 ~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L 490 (927)
..++|+.|+|++|.+++..+..+.++++|+.|+|++|++++..+. +.++++|++|+|++|++++..|..+.++++|+.|
T Consensus 127 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 206 (285)
T 1ozn_A 127 GLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTL 206 (285)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred CCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEe
Confidence 356899999999999976666799999999999999999988776 8889999999999999999889999999999999
Q ss_pred ccccccccccccccc--ccccccccccCCcccccCC
Q 002409 491 YVQNNMLSGTVPSSL--LSKNVVLNYAGNINLHEGG 524 (927)
Q Consensus 491 ~l~~N~l~g~iP~~l--~~~~~~l~~~~n~~l~~~~ 524 (927)
+|++|+|++..|..+ ++.+..+++.+|+-.|...
T Consensus 207 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~ 242 (285)
T 1ozn_A 207 YLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (285)
T ss_dssp ECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred eCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCC
Confidence 999999995433333 3456778889998877664
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.04 E-value=4.2e-10 Score=122.35 Aligned_cols=107 Identities=27% Similarity=0.309 Sum_probs=94.4
Q ss_pred CCCCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCcccc
Q 002409 411 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRE 489 (927)
Q Consensus 411 ~~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~ 489 (927)
...++|+.|+|++|.|+ .+|..+..+++|+.|+|++|+|++.+|. |.++++|++|+|++|+|++..|..+..+++|+.
T Consensus 74 ~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 152 (290)
T 1p9a_G 74 GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEK 152 (290)
T ss_dssp SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE
T ss_pred CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCE
Confidence 35678999999999999 8999999999999999999999998876 899999999999999999777777899999999
Q ss_pred ccccccccccccccccc---cccccccccCCcc
Q 002409 490 LYVQNNMLSGTVPSSLL---SKNVVLNYAGNIN 519 (927)
Q Consensus 490 L~l~~N~l~g~iP~~l~---~~~~~l~~~~n~~ 519 (927)
|+|++|+|+ .+|...+ ..+..+.+.+|.-
T Consensus 153 L~L~~N~l~-~l~~~~~~~l~~L~~L~L~~N~l 184 (290)
T 1p9a_G 153 LSLANNNLT-ELPAGLLNGLENLDTLLLQENSL 184 (290)
T ss_dssp EECTTSCCS-CCCTTTTTTCTTCCEEECCSSCC
T ss_pred EECCCCcCC-ccCHHHhcCcCCCCEEECCCCcC
Confidence 999999999 7887764 3456777788753
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.04 E-value=1.8e-10 Score=138.30 Aligned_cols=113 Identities=19% Similarity=0.189 Sum_probs=100.7
Q ss_pred CCCceEEEEecCCCC-CccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCcccc
Q 002409 412 PQPSITVIHLSSKNL-TGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRE 489 (927)
Q Consensus 412 ~~~~l~~L~L~~n~l-~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~ 489 (927)
..+.++.|+|++|.+ .+.+|..+..|++|+.|+|++|+|++.+|. |.++++|++|+|++|+|++..|..+.++++|+.
T Consensus 467 ~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~ 546 (635)
T 4g8a_A 467 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQV 546 (635)
T ss_dssp TCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCE
T ss_pred cchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCE
Confidence 457899999999975 456788999999999999999999999887 899999999999999999888889999999999
Q ss_pred ccccccccccccccccc---cccccccccCCcccccCC
Q 002409 490 LYVQNNMLSGTVPSSLL---SKNVVLNYAGNINLHEGG 524 (927)
Q Consensus 490 L~l~~N~l~g~iP~~l~---~~~~~l~~~~n~~l~~~~ 524 (927)
|+|++|+|++..|..+. +.+..+++.+|+-.|.+.
T Consensus 547 L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 547 LDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp EECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred EECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 99999999987777764 456778999999998874
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.03 E-value=2.4e-10 Score=131.90 Aligned_cols=112 Identities=21% Similarity=0.235 Sum_probs=94.4
Q ss_pred CCCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCccccc
Q 002409 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 490 (927)
Q Consensus 412 ~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L 490 (927)
..++|+.|+|++|.+++..|..+.++++|+.|+|++|.+++.+|. +.++++|++|+|++|++++..|..+.++++|+.|
T Consensus 297 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 376 (455)
T 3v47_A 297 HFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKEL 376 (455)
T ss_dssp TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred cCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEE
Confidence 356899999999999988888899999999999999999888776 7889999999999999998888899999999999
Q ss_pred cccccccccccccccc---cccccccccCCcccccCC
Q 002409 491 YVQNNMLSGTVPSSLL---SKNVVLNYAGNINLHEGG 524 (927)
Q Consensus 491 ~l~~N~l~g~iP~~l~---~~~~~l~~~~n~~l~~~~ 524 (927)
+|++|+|+ .+|...+ +.+..+.+.+|+-.|..+
T Consensus 377 ~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 377 ALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp ECCSSCCS-CCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred ECCCCccc-cCCHhHhccCCcccEEEccCCCcccCCC
Confidence 99999999 4666543 455778888998877765
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.03 E-value=2.9e-10 Score=126.57 Aligned_cols=98 Identities=27% Similarity=0.277 Sum_probs=84.3
Q ss_pred CcceeecCCC----------CCCceEEEEecC-CCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEec
Q 002409 402 PWSWLQCNSD----------PQPSITVIHLSS-KNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLE 469 (927)
Q Consensus 402 ~~~~v~C~~~----------~~~~l~~L~L~~-n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls 469 (927)
.|..+.|+.. ..++|+.|+|++ |.|++..|..|.+|++|+.|+|++|+|++.+|. |.+|++|++|+|+
T Consensus 9 ~~~~v~~~~~n~l~~ip~l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 9 GSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred cCCEEEcCCCCCCCccCCCCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 5778899765 235699999996 999987778999999999999999999999997 7999999999999
Q ss_pred CCCcCCCCCccccCCCccccccccccccccc
Q 002409 470 DNQLTGPLPSSLMNLPNLRELYVQNNMLSGT 500 (927)
Q Consensus 470 ~N~l~g~~P~~l~~l~~L~~L~l~~N~l~g~ 500 (927)
+|+|++..|..+..++ |+.|+|++|+|...
T Consensus 89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 89 FNALESLSWKTVQGLS-LQELVLSGNPLHCS 118 (347)
T ss_dssp SSCCSCCCSTTTCSCC-CCEEECCSSCCCCC
T ss_pred CCccceeCHHHcccCC-ceEEEeeCCCccCC
Confidence 9999965555555555 99999999999843
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.02 E-value=2.5e-10 Score=124.74 Aligned_cols=113 Identities=19% Similarity=0.179 Sum_probs=97.0
Q ss_pred CCCceEEEEecCCCCCc-cCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCcccc
Q 002409 412 PQPSITVIHLSSKNLTG-NIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRE 489 (927)
Q Consensus 412 ~~~~l~~L~L~~n~l~g-~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~ 489 (927)
..++|+.|+|++|.+++ .+|..+..+++|+.|+|++|++++.+|. +.++++|+.|+|++|++++..+..+..+++|+.
T Consensus 148 ~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 227 (306)
T 2z66_A 148 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQV 227 (306)
T ss_dssp TCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCE
T ss_pred cCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCE
Confidence 35689999999999987 6888999999999999999999998775 788999999999999999777778999999999
Q ss_pred cccccccccccccccccc---ccccccccCCcccccCC
Q 002409 490 LYVQNNMLSGTVPSSLLS---KNVVLNYAGNINLHEGG 524 (927)
Q Consensus 490 L~l~~N~l~g~iP~~l~~---~~~~l~~~~n~~l~~~~ 524 (927)
|+|++|++++..|..+.. .+..+++.+|+-.|.+.
T Consensus 228 L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~ 265 (306)
T 2z66_A 228 LDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 265 (306)
T ss_dssp EECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGG
T ss_pred eECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccC
Confidence 999999999888877643 45778889998777653
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.02 E-value=1.8e-10 Score=136.40 Aligned_cols=105 Identities=23% Similarity=0.197 Sum_probs=90.0
Q ss_pred CceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCccccccc
Q 002409 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 492 (927)
Q Consensus 414 ~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 492 (927)
++|+.|+|++|++++..|..+.++++|++|+|++|++++.+|. +.++++|++|+|++|++++..|..++++++|++|+|
T Consensus 26 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 105 (549)
T 2z81_A 26 AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNL 105 (549)
T ss_dssp TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEEC
T ss_pred CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEEC
Confidence 5799999999999988888999999999999999999998875 899999999999999999877777999999999999
Q ss_pred ccccccc-cccccc--ccccccccccCCc
Q 002409 493 QNNMLSG-TVPSSL--LSKNVVLNYAGNI 518 (927)
Q Consensus 493 ~~N~l~g-~iP~~l--~~~~~~l~~~~n~ 518 (927)
++|++++ .+|..+ ++.+..+.+.+|.
T Consensus 106 s~n~l~~~~~~~~~~~l~~L~~L~L~~n~ 134 (549)
T 2z81_A 106 MGNPYQTLGVTSLFPNLTNLQTLRIGNVE 134 (549)
T ss_dssp TTCCCSSSCSSCSCTTCTTCCEEEEEESS
T ss_pred CCCcccccchhhhhhccCCccEEECCCCc
Confidence 9999986 355544 3445666666664
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=99.01 E-value=2e-10 Score=115.03 Aligned_cols=156 Identities=17% Similarity=0.092 Sum_probs=94.1
Q ss_pred EEeeeccCCCCCCCccCCCCCCCCccccCccccccccccccCcccccccccccCCCCCCCChHHHHhhcccccCCceEEe
Q 002409 193 VSARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGTNGSLTYR 272 (927)
Q Consensus 193 ~~~r~~~g~~~~~~iryp~D~~dR~W~p~~~~~~~~~~~~~~~~~~~st~~~i~~~~~~~pP~~V~qtA~t~~~~~l~~~ 272 (927)
.+.|.|||+.. +. |..+|.|++|......... ..... .+.....+.+|+.|+|||=... .+++|.
T Consensus 6 ~~~~INcGg~~---~~---d~~gr~w~~D~~~~~~g~~------~~~~~--~~~~~~~~~~~~~lY~TaR~~~-~~~tY~ 70 (174)
T 2jwp_A 6 VIWAVNAGGES---HV---DVHGIHYRKDPLEGRVGRA------SDYGM--KLPILRSNPEDQVLYQTERYNE-DSFGYD 70 (174)
T ss_dssp EEEEEEETSSS---EE---ETTTEEECSSCSSTTCCCC------CCCCT--TSCCSSSCHHHHHTTTCCCCCC-SCEEEE
T ss_pred EEEEEECCCCC---cc---CCCCCEEcCCcCcccCCcc------ccccc--ceEecccCCCCchhhhhhccCC-CCeEEE
Confidence 35699999843 22 6789999998532210100 00001 1111223456899999996643 468899
Q ss_pred ecCCCCCCcceeEEeeccccCCCCCcceEEEEEECCccccccceeccccccCcc-eEEecccccc---------ccccce
Q 002409 273 LNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGK-YRVYEPGYTN---------LSLPFV 342 (927)
Q Consensus 273 ~~~~~~~~~~y~~~yFae~~~~~~~~~R~F~i~in~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---------~~~~~~ 342 (927)
++++..- .+.+.|||+|+.. ...+.|+|||+|||+.+.+++++.-....... +.-+....++ ....+.
T Consensus 71 f~v~~~G-~Y~VrLhF~ei~~-~~~~~rvFdV~ing~~~l~~fdi~~~ag~~~~~~~~~~~~v~~~~l~i~~~~~~~~g~ 148 (174)
T 2jwp_A 71 IPIKEEG-EYVLVLKFAEVYF-AQSQQKVFDVRVNGHTVVKDLDIFDRVGHSTAHDEIIPISIKKGKLSVQGEVSTFTGK 148 (174)
T ss_dssp EECCSCE-EEEEEEEEECCSC-CCSSSSCEEEEETTEEEEEEECHHHHHSSSSCEEEEEEEEEETTEEEETTEEEECCSE
T ss_pred EEeCCCe-EEEEEEEEecccc-CCCCCeEeEEEECCEEeecCcCHHHhhCCCeeEEEEEEEEEecCceeeeeeecccCCe
Confidence 9876443 4467999999985 45789999999999998887665422221111 1111111000 012345
Q ss_pred eeeecccccccccCcccchhhhchh
Q 002409 343 LSFKFGKTYDSSRGPLLNAMEINKY 367 (927)
Q Consensus 343 ~~~~~~~t~~s~lpPlina~e~~~~ 367 (927)
+.+.+.+. ..-.|+|||+|+++-
T Consensus 149 L~I~f~p~--~~~~a~inaIEI~~~ 171 (174)
T 2jwp_A 149 LSVEFVKG--YYDNPKVCALFIMKG 171 (174)
T ss_dssp EEEEEECS--SSCSSSEEEEEEESS
T ss_pred EEEEEecc--CCCCcEEEEEEEEeC
Confidence 67777753 356799999999853
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.01 E-value=2.5e-10 Score=116.58 Aligned_cols=105 Identities=19% Similarity=0.193 Sum_probs=82.8
Q ss_pred CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCcccccc
Q 002409 413 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 491 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~ 491 (927)
.++|+.|+|++|.+++..|..+++|++|++|+|++|++++..|. +..+++|++|+|++|++.+.+| .+..+++|+.|+
T Consensus 87 l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~ 165 (197)
T 4ezg_A 87 LSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLN 165 (197)
T ss_dssp CTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEE
T ss_pred CCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEE
Confidence 46788999999999887888899999999999999999886665 7888999999999998444676 688889999999
Q ss_pred ccccccccccccccccccccccccCCc
Q 002409 492 VQNNMLSGTVPSSLLSKNVVLNYAGNI 518 (927)
Q Consensus 492 l~~N~l~g~iP~~l~~~~~~l~~~~n~ 518 (927)
|++|++++..+-.-++.+..+.+.+|+
T Consensus 166 l~~n~i~~~~~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 166 IQFDGVHDYRGIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp CTTBCCCCCTTGGGCSSCCEEEECBC-
T ss_pred CCCCCCcChHHhccCCCCCEEEeeCcc
Confidence 999998853233334556777777775
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.00 E-value=5e-10 Score=114.09 Aligned_cols=91 Identities=23% Similarity=0.322 Sum_probs=82.1
Q ss_pred CCCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCccccc
Q 002409 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 490 (927)
Q Consensus 412 ~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L 490 (927)
..++|+.|+|++|.|++..+..|.+|++|+.|+|++|+|++..|. |.++++|++|+|++|+|++..+..+..+++|+.|
T Consensus 52 ~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 131 (193)
T 2wfh_A 52 NYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHL 131 (193)
T ss_dssp GCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEE
T ss_pred cccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEE
Confidence 356899999999999987778899999999999999999999886 8999999999999999996666679999999999
Q ss_pred cccccccccccc
Q 002409 491 YVQNNMLSGTVP 502 (927)
Q Consensus 491 ~l~~N~l~g~iP 502 (927)
+|++|.+...-.
T Consensus 132 ~L~~N~~~C~c~ 143 (193)
T 2wfh_A 132 AIGANPLYCDCN 143 (193)
T ss_dssp ECCSSCEECSGG
T ss_pred EeCCCCeecCCc
Confidence 999999985443
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.99 E-value=4.3e-10 Score=126.21 Aligned_cols=116 Identities=22% Similarity=0.253 Sum_probs=96.2
Q ss_pred cceeecCCCC--------CCceEEEEecCCCCCccCCchhh-cCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCC
Q 002409 403 WSWLQCNSDP--------QPSITVIHLSSKNLTGNIPSDLT-KLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 472 (927)
Q Consensus 403 ~~~v~C~~~~--------~~~l~~L~L~~n~l~g~ip~~i~-~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~ 472 (927)
+..+.|+... ...++.|+|++|+|++..+..+. ++++|+.|+|++|+|++..|. |.++++|++|+|++|+
T Consensus 20 ~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~ 99 (361)
T 2xot_A 20 SNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNH 99 (361)
T ss_dssp TTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCc
Confidence 4557786533 24588999999999977777777 999999999999999998886 8999999999999999
Q ss_pred cCCCCCccccCCCcccccccccccccccccccc--ccccccccccCCc
Q 002409 473 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNI 518 (927)
Q Consensus 473 l~g~~P~~l~~l~~L~~L~l~~N~l~g~iP~~l--~~~~~~l~~~~n~ 518 (927)
|++..+..|.++++|+.|+|++|+|++..|..+ +..+..|.+.+|.
T Consensus 100 l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~ 147 (361)
T 2xot_A 100 LHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQ 147 (361)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCc
Confidence 997777789999999999999999995555555 3455677777774
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=98.99 E-value=3.8e-10 Score=134.17 Aligned_cols=85 Identities=27% Similarity=0.344 Sum_probs=49.5
Q ss_pred CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCC-CccccCCCcccccc
Q 002409 413 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPL-PSSLMNLPNLRELY 491 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~-P~~l~~l~~L~~L~ 491 (927)
+++|+.|+|++|.|+ .+|..|++|++|+.|+|++|+|++ +|.+++|++|++|+|++|+|++.+ |..++.|++|+.|+
T Consensus 462 l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~ 539 (567)
T 1dce_A 462 LLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLN 539 (567)
T ss_dssp GTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CGGGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEE
T ss_pred cccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-CcccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEE
Confidence 345556666666655 555556666666666666666655 345555566666666666665544 55555666666666
Q ss_pred cccccccc
Q 002409 492 VQNNMLSG 499 (927)
Q Consensus 492 l~~N~l~g 499 (927)
|++|+|++
T Consensus 540 L~~N~l~~ 547 (567)
T 1dce_A 540 LQGNSLCQ 547 (567)
T ss_dssp CTTSGGGG
T ss_pred ecCCcCCC
Confidence 66666653
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=98.99 E-value=3.6e-10 Score=134.42 Aligned_cols=101 Identities=32% Similarity=0.429 Sum_probs=89.1
Q ss_pred ceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCccccccccc
Q 002409 415 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 494 (927)
Q Consensus 415 ~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~ 494 (927)
.|+.|+|++|+|++ +|. |++|++|+.|+|++|+|+..++.+++|++|+.|+|++|+|++ +| .+++|++|+.|+|++
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~ 517 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCN 517 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCS
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCcccccccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCC
Confidence 48899999999996 787 999999999999999999443458999999999999999997 78 899999999999999
Q ss_pred ccccccc-cccc--ccccccccccCCcc
Q 002409 495 NMLSGTV-PSSL--LSKNVVLNYAGNIN 519 (927)
Q Consensus 495 N~l~g~i-P~~l--~~~~~~l~~~~n~~ 519 (927)
|+|++.. |..+ ++.+..+++.+|+-
T Consensus 518 N~l~~~~~p~~l~~l~~L~~L~L~~N~l 545 (567)
T 1dce_A 518 NRLQQSAAIQPLVSCPRLVLLNLQGNSL 545 (567)
T ss_dssp SCCCSSSTTGGGGGCTTCCEEECTTSGG
T ss_pred CCCCCCCCcHHHhcCCCCCEEEecCCcC
Confidence 9999776 8877 45567888888864
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.98 E-value=6.1e-10 Score=133.62 Aligned_cols=88 Identities=20% Similarity=0.290 Sum_probs=41.4
Q ss_pred ceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCcccccccc
Q 002409 415 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 493 (927)
Q Consensus 415 ~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~ 493 (927)
+|+.|+|++|.|++..|..|+++++|+.|+|++|.|++.+|. |+++++|++|+|++|+|++..+..|+++++|+.|+|+
T Consensus 76 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls 155 (597)
T 3oja_B 76 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMS 155 (597)
T ss_dssp CCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEee
Confidence 344444555555444444445555555555555555544443 3445555555555555543222233445555555555
Q ss_pred ccccccccc
Q 002409 494 NNMLSGTVP 502 (927)
Q Consensus 494 ~N~l~g~iP 502 (927)
+|.|++..|
T Consensus 156 ~N~l~~~~~ 164 (597)
T 3oja_B 156 NNNLERIED 164 (597)
T ss_dssp SSCCCBCCT
T ss_pred CCcCCCCCh
Confidence 555543333
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=98.98 E-value=3.7e-10 Score=138.40 Aligned_cols=91 Identities=32% Similarity=0.375 Sum_probs=60.9
Q ss_pred CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCccccccc
Q 002409 413 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 492 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 492 (927)
+++|+.|+|++|.|+ .||..|++|++|+.|+|++|+|+..++.+.+|++|++|+|++|+|+ .+|..|++|++|+.|+|
T Consensus 246 l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L 323 (727)
T 4b8c_D 246 YDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLTSLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGV 323 (727)
T ss_dssp CCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCSSCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEEC
T ss_pred CCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCCccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeC
Confidence 456667777777776 6676677777777777777777633223666777777777777665 66666777777777777
Q ss_pred ccccccccccccc
Q 002409 493 QNNMLSGTVPSSL 505 (927)
Q Consensus 493 ~~N~l~g~iP~~l 505 (927)
++|+|+|.+|..+
T Consensus 324 ~~N~l~~~~p~~~ 336 (727)
T 4b8c_D 324 EGNPLEKQFLKIL 336 (727)
T ss_dssp TTSCCCSHHHHHH
T ss_pred CCCccCCCChHHH
Confidence 7777776666655
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.97 E-value=1.4e-09 Score=115.37 Aligned_cols=130 Identities=19% Similarity=0.127 Sum_probs=97.4
Q ss_pred ccc-ccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCc--cceecceeecCeEEEEEEeccCCch
Q 002409 606 KIG-SGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL--VQFLGYCQEEGRSVLVYEFMHNGTL 682 (927)
Q Consensus 606 ~IG-~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnI--v~l~g~~~~~~~~~lV~E~~~~gsL 682 (927)
.++ .|..+.||+....+|+.+++|+.... ....+..|+++++.+.+.++ .+++++....+..++||||++|.+|
T Consensus 26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l 102 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 102 (264)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCccc
Confidence 344 55569999998777888999997643 23568899999999965554 4588888877788999999999888
Q ss_pred hhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCC-------------------------------------------
Q 002409 683 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC------------------------------------------- 719 (927)
Q Consensus 683 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~------------------------------------------- 719 (927)
. ... .. ...++.++++.|..||+..
T Consensus 103 ~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (264)
T 1nd4_A 103 L--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 170 (264)
T ss_dssp T--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred C--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHH
Confidence 4 211 01 1246677778888888642
Q ss_pred ------------CCceecCCCCCCCeEECCCCcEEEEeecCcc
Q 002409 720 ------------VPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 750 (927)
Q Consensus 720 ------------~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 750 (927)
...++|+|++|.|||++.++.+.|+||+.+.
T Consensus 171 ~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 171 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1139999999999999877667799999875
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=98.97 E-value=7.8e-10 Score=118.90 Aligned_cols=105 Identities=18% Similarity=0.124 Sum_probs=88.3
Q ss_pred CceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCccccccc
Q 002409 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 492 (927)
Q Consensus 414 ~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 492 (927)
++|+.|+|++|++++..+..+.++++|++|+|++|++++..+. +.++++|++|+|++|++++..|..+.++++|+.|++
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 4699999999999977777899999999999999999987774 888999999999999999888888999999999999
Q ss_pred ccccccccccccc--ccccccccccCCc
Q 002409 493 QNNMLSGTVPSSL--LSKNVVLNYAGNI 518 (927)
Q Consensus 493 ~~N~l~g~iP~~l--~~~~~~l~~~~n~ 518 (927)
++|++++..+..+ ++.+..+.+.+|.
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 135 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNL 135 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSC
T ss_pred CCCCccccCchhcccCCCCCEEECcCCc
Confidence 9999995444343 3455667777774
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=98.97 E-value=5.1e-10 Score=135.35 Aligned_cols=108 Identities=22% Similarity=0.246 Sum_probs=98.0
Q ss_pred CceEEEEecCCCCCccCCchhh--cCCCCcEEeccCCcCCCCCCCCCCCCCccEEEe------cCCCcCCCCCccccCCC
Q 002409 414 PSITVIHLSSKNLTGNIPSDLT--KLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHL------EDNQLTGPLPSSLMNLP 485 (927)
Q Consensus 414 ~~l~~L~L~~n~l~g~ip~~i~--~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L------s~N~l~g~~P~~l~~l~ 485 (927)
++|+.|+|++|+|+ .+|..+. .+++|+.|+|++|+|++.++.+.++++|+.|+| ++|++.+.+|..+++++
T Consensus 488 ~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~ 566 (636)
T 4eco_A 488 YLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCP 566 (636)
T ss_dssp GGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSSCCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCS
T ss_pred CCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCCcChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCC
Confidence 48999999999999 8999998 999999999999999994334889999999999 56889999999999999
Q ss_pred ccccccccccccccccccccccccccccccCCcccccC
Q 002409 486 NLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEG 523 (927)
Q Consensus 486 ~L~~L~l~~N~l~g~iP~~l~~~~~~l~~~~n~~l~~~ 523 (927)
+|+.|+|++|+| +.+|..+.+.+..+++++|+..|..
T Consensus 567 ~L~~L~Ls~N~l-~~ip~~~~~~L~~L~Ls~N~l~~~~ 603 (636)
T 4eco_A 567 SLTQLQIGSNDI-RKVNEKITPNISVLDIKDNPNISID 603 (636)
T ss_dssp SCCEEECCSSCC-CBCCSCCCTTCCEEECCSCTTCEEE
T ss_pred CCCEEECCCCcC-CccCHhHhCcCCEEECcCCCCcccc
Confidence 999999999999 6999999988899999999877644
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=98.97 E-value=7.1e-10 Score=110.96 Aligned_cols=102 Identities=19% Similarity=0.158 Sum_probs=83.6
Q ss_pred CceEEEEecCCCCCccCCchhhcCC-CCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCccccccc
Q 002409 414 PSITVIHLSSKNLTGNIPSDLTKLS-SLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 492 (927)
Q Consensus 414 ~~l~~L~L~~n~l~g~ip~~i~~L~-~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 492 (927)
.+|+.|+|++|+++ .+|. +..+. +|+.|+|++|.|++. +.+.++++|++|+|++|+|++..|..+..+++|+.|+|
T Consensus 19 ~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 95 (176)
T 1a9n_A 19 VRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL 95 (176)
T ss_dssp TSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEEC
T ss_pred CCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc-cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEEC
Confidence 47999999999999 5664 66665 999999999999986 78999999999999999999644444589999999999
Q ss_pred ccccccccccc--cc--ccccccccccCCcc
Q 002409 493 QNNMLSGTVPS--SL--LSKNVVLNYAGNIN 519 (927)
Q Consensus 493 ~~N~l~g~iP~--~l--~~~~~~l~~~~n~~ 519 (927)
++|+|+ .+|. .+ ++.+..+.+.+|+.
T Consensus 96 ~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i 125 (176)
T 1a9n_A 96 TNNSLV-ELGDLDPLASLKSLTYLCILRNPV 125 (176)
T ss_dssp CSCCCC-CGGGGGGGGGCTTCCEEECCSSGG
T ss_pred CCCcCC-cchhhHhhhcCCCCCEEEecCCCC
Confidence 999997 7776 44 34456778888864
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=98.97 E-value=9.5e-10 Score=118.82 Aligned_cols=106 Identities=21% Similarity=0.280 Sum_probs=87.3
Q ss_pred CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCcccccc
Q 002409 413 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 491 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~ 491 (927)
.++|+.|+|++|.+++..|..+.++++|++|+|++|.+++..+. +.++++|++|+|++|++++..+..+.++++|+.|+
T Consensus 104 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 183 (285)
T 1ozn_A 104 LGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL 183 (285)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred CcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEE
Confidence 46889999999999987788888899999999999999887776 78899999999999999866666788899999999
Q ss_pred ccccccccccccccc--cccccccccCCc
Q 002409 492 VQNNMLSGTVPSSLL--SKNVVLNYAGNI 518 (927)
Q Consensus 492 l~~N~l~g~iP~~l~--~~~~~l~~~~n~ 518 (927)
|++|++++..|..+. +.+..+++.+|.
T Consensus 184 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 212 (285)
T 1ozn_A 184 LHQNRVAHVHPHAFRDLGRLMTLYLFANN 212 (285)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCCCcccccCHhHccCcccccEeeCCCCc
Confidence 999999876676663 445667777774
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=98.96 E-value=3.9e-10 Score=135.26 Aligned_cols=112 Identities=16% Similarity=0.112 Sum_probs=91.9
Q ss_pred CCCceEEEEecCCCCCc-cCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCcccc
Q 002409 412 PQPSITVIHLSSKNLTG-NIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRE 489 (927)
Q Consensus 412 ~~~~l~~L~L~~n~l~g-~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~ 489 (927)
..++|+.|+|++|.+++ .+|..+..+++|+.|+|++|++++.+|. +.++++|++|+|++|++++.+|..+.++++|+.
T Consensus 446 ~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 525 (606)
T 3vq2_A 446 GLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLST 525 (606)
T ss_dssp TCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCE
T ss_pred CCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCE
Confidence 45678888888888887 3788888888888888888888888776 788888899999999888888888888888999
Q ss_pred cccccccccccccccccc---ccccccccCCcccccCC
Q 002409 490 LYVQNNMLSGTVPSSLLS---KNVVLNYAGNINLHEGG 524 (927)
Q Consensus 490 L~l~~N~l~g~iP~~l~~---~~~~l~~~~n~~l~~~~ 524 (927)
|+|++|+|+ .+|..+.. .+..+.+.+|+-.|.++
T Consensus 526 L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 526 LDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICE 562 (606)
T ss_dssp EECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred EECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCc
Confidence 999999888 78877543 35677888888877664
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=98.96 E-value=2.2e-10 Score=111.14 Aligned_cols=89 Identities=24% Similarity=0.322 Sum_probs=78.7
Q ss_pred CCCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCC-CCccccCCCcccc
Q 002409 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGP-LPSSLMNLPNLRE 489 (927)
Q Consensus 412 ~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~-~P~~l~~l~~L~~ 489 (927)
..++|+.|+|++|.+++. ..++++++|+.|+|++|.+++.+|. +.++++|++|+|++|++++. .|..+..+++|+.
T Consensus 40 ~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~ 117 (149)
T 2je0_A 40 EFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKS 117 (149)
T ss_dssp TCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCE
T ss_pred hcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCE
Confidence 457899999999999965 7899999999999999999998887 45699999999999999973 4588999999999
Q ss_pred ccccccccccccc
Q 002409 490 LYVQNNMLSGTVP 502 (927)
Q Consensus 490 L~l~~N~l~g~iP 502 (927)
|++++|++++..+
T Consensus 118 L~l~~N~l~~~~~ 130 (149)
T 2je0_A 118 LDLFNCEVTNLND 130 (149)
T ss_dssp EECTTCGGGGSTT
T ss_pred EeCcCCcccchHH
Confidence 9999999995433
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=98.95 E-value=9.9e-10 Score=131.71 Aligned_cols=124 Identities=24% Similarity=0.237 Sum_probs=87.8
Q ss_pred CCCCCCC-CcceeecCCCC--------CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCcc
Q 002409 395 GDPCLPV-PWSWLQCNSDP--------QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLR 464 (927)
Q Consensus 395 ~dpC~~~-~~~~v~C~~~~--------~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~ 464 (927)
.+||... .-..+.|+... .++|+.|+|++|.+++..+..|.++++|++|+|++|++++..|. |.++++|+
T Consensus 4 ~~~c~~~~~~~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~ 83 (606)
T 3vq2_A 4 LNPCIEVVPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLS 83 (606)
T ss_dssp --CCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCC
T ss_pred CCCceecCCCCceEccCCCcccCCCCCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcC
Confidence 4667421 11246776422 35688888888888877777888888888888888888887775 77888888
Q ss_pred EEEecCCCcCCCCCccccCCCcccccccccccccccccccc--ccccccccccCCc
Q 002409 465 IIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNI 518 (927)
Q Consensus 465 ~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l~g~iP~~l--~~~~~~l~~~~n~ 518 (927)
+|+|++|++++..|..++++++|++|+|++|++++..|..+ +..+..+++.+|.
T Consensus 84 ~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 139 (606)
T 3vq2_A 84 NLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNF 139 (606)
T ss_dssp EEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSC
T ss_pred EeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCc
Confidence 88888888887778888888888888888888874443444 2344556666664
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.95 E-value=5.9e-10 Score=124.46 Aligned_cols=121 Identities=25% Similarity=0.230 Sum_probs=96.7
Q ss_pred CCCCCCCCCccee-ecCCC--------CCCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCc
Q 002409 394 GGDPCLPVPWSWL-QCNSD--------PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDL 463 (927)
Q Consensus 394 ~~dpC~~~~~~~v-~C~~~--------~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L 463 (927)
...+| .|.++ .|+.. -.++|+.|+|++|++++..+..+.++++|+.|+|++|++++..|. +.++++|
T Consensus 26 ~~~~C---~~~~~c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 102 (353)
T 2z80_A 26 ASLSC---DRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSL 102 (353)
T ss_dssp -CCEE---CTTSEEECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred cCCCC---CCCeEeeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCC
Confidence 35566 57775 33322 135899999999999976666899999999999999999998876 8999999
Q ss_pred cEEEecCCCcCCCCCccccCCCcccccccccccccccccc-cc---ccccccccccCCc
Q 002409 464 RIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPS-SL---LSKNVVLNYAGNI 518 (927)
Q Consensus 464 ~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l~g~iP~-~l---~~~~~~l~~~~n~ 518 (927)
++|+|++|++++..+..+.++++|+.|+|++|+++ .+|. .. ++.+..+.+.+|.
T Consensus 103 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~ 160 (353)
T 2z80_A 103 EHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMD 160 (353)
T ss_dssp CEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESS
T ss_pred CEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCc
Confidence 99999999999654455999999999999999999 6776 33 3445666777763
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=98.95 E-value=1.2e-09 Score=126.21 Aligned_cols=116 Identities=24% Similarity=0.298 Sum_probs=97.5
Q ss_pred CcceeecCCCC--------CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCC
Q 002409 402 PWSWLQCNSDP--------QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 472 (927)
Q Consensus 402 ~~~~v~C~~~~--------~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~ 472 (927)
.+..+.|+... .++++.|+|++|+|++..|..|.+|++|+.|+|++|+|++..|. |.++++|++|+|++|+
T Consensus 55 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~ 134 (452)
T 3zyi_A 55 QFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134 (452)
T ss_dssp SSCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCc
Confidence 35668887533 35799999999999998899999999999999999999998876 8999999999999999
Q ss_pred cCCCCCccccCCCccccccccccccccccccccc---cccccccccCCc
Q 002409 473 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL---SKNVVLNYAGNI 518 (927)
Q Consensus 473 l~g~~P~~l~~l~~L~~L~l~~N~l~g~iP~~l~---~~~~~l~~~~n~ 518 (927)
|++..+..+.++++|+.|+|++|+|+ .+|...+ +.+..+.+.+|.
T Consensus 135 l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~~~ 182 (452)
T 3zyi_A 135 LTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELK 182 (452)
T ss_dssp CSBCCTTTSSSCTTCCEEECCSCCCC-EECTTTTTTCTTCCEEECCCCT
T ss_pred CCccChhhhcccCCCCEEECCCCCcc-eeCHhHHhcCCcccEEeCCCCC
Confidence 99776777999999999999999999 6776544 344556666643
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=98.95 E-value=1.3e-09 Score=117.11 Aligned_cols=105 Identities=24% Similarity=0.323 Sum_probs=57.5
Q ss_pred CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCcccccc
Q 002409 413 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 491 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~ 491 (927)
.++|+.|+|++|.+++..+..+.++++|++|+|++|.+++..+. +.++++|++|+|++|++++..+..+.++++|+.|+
T Consensus 51 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 130 (276)
T 2z62_A 51 FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130 (276)
T ss_dssp CTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEE
T ss_pred ccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEE
Confidence 34556666666666544444555566666666666666555543 55566666666666666554444555566666666
Q ss_pred cccccccc-ccccccc--cccccccccCC
Q 002409 492 VQNNMLSG-TVPSSLL--SKNVVLNYAGN 517 (927)
Q Consensus 492 l~~N~l~g-~iP~~l~--~~~~~l~~~~n 517 (927)
|++|++++ .+|..+. +.+..+++.+|
T Consensus 131 l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N 159 (276)
T 2z62_A 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159 (276)
T ss_dssp CCSSCCCCCCCCGGGGGCTTCCEEECCSS
T ss_pred CcCCccceecCchhhccCCCCCEEECCCC
Confidence 66666553 2444442 23344444444
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.94 E-value=2.9e-10 Score=124.88 Aligned_cols=87 Identities=18% Similarity=0.206 Sum_probs=54.9
Q ss_pred CceEEEEecCCCCCccCCchh--hcCCCCcEEeccCCcCCCCCCCCCCC-----CCccEEEecCCCcCCCCCccccCCCc
Q 002409 414 PSITVIHLSSKNLTGNIPSDL--TKLSSLVELWLDGNSLTGPIPDFSGC-----PDLRIIHLEDNQLTGPLPSSLMNLPN 486 (927)
Q Consensus 414 ~~l~~L~L~~n~l~g~ip~~i--~~L~~L~~L~Ls~N~l~g~~p~~~~l-----~~L~~L~Ls~N~l~g~~P~~l~~l~~ 486 (927)
++|+.|+|++|+++|.+|..+ ..+++|++|+|++|++++.++.+.++ ++|++|+|++|++++..|..++++++
T Consensus 95 ~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~ 174 (312)
T 1wwl_A 95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPA 174 (312)
T ss_dssp SCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSSSSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSS
T ss_pred CCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcchhHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCC
Confidence 456666666666666666655 66666666666666666662223333 66666666666666655566666666
Q ss_pred cccccccccccccc
Q 002409 487 LRELYVQNNMLSGT 500 (927)
Q Consensus 487 L~~L~l~~N~l~g~ 500 (927)
|+.|+|++|+++|.
T Consensus 175 L~~L~Ls~N~l~~~ 188 (312)
T 1wwl_A 175 LSTLDLSDNPELGE 188 (312)
T ss_dssp CCEEECCSCTTCHH
T ss_pred CCEEECCCCCcCcc
Confidence 66666666666654
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.94 E-value=1.2e-09 Score=127.09 Aligned_cols=117 Identities=19% Similarity=0.212 Sum_probs=96.6
Q ss_pred CcceeecCCCC--------CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCC
Q 002409 402 PWSWLQCNSDP--------QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 472 (927)
Q Consensus 402 ~~~~v~C~~~~--------~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~ 472 (927)
.|..|.|+... .+.++.|+|++|+|++..|..|.++++|+.|+|++|.+++..|. |.++++|++|+|++|+
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 91 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence 35678886533 35789999999999988888999999999999999999998775 8899999999999999
Q ss_pred cCCCCCccccCCCcccccccccccccccccccc--ccccccccccCCc
Q 002409 473 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNI 518 (927)
Q Consensus 473 l~g~~P~~l~~l~~L~~L~l~~N~l~g~iP~~l--~~~~~~l~~~~n~ 518 (927)
+++..+..|.++++|+.|+|++|++++..|..+ +..+..+.+.+|.
T Consensus 92 l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~ 139 (477)
T 2id5_A 92 LKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDND 139 (477)
T ss_dssp CCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTT
T ss_pred CCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCc
Confidence 996555678999999999999999996666655 3445667777764
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.94 E-value=1.1e-09 Score=126.20 Aligned_cols=110 Identities=26% Similarity=0.316 Sum_probs=97.7
Q ss_pred CCCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCccccc
Q 002409 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 490 (927)
Q Consensus 412 ~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L 490 (927)
..++|+.|+|++|+|+ .+| .+..+++|+.|+|++|+|++..|. |.++++|+.|+|++|++++..|..|.++++|+.|
T Consensus 183 ~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 260 (440)
T 3zyj_A 183 GLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEI 260 (440)
T ss_dssp TCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEE
T ss_pred cccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEE
Confidence 3578999999999999 677 489999999999999999998886 8999999999999999999999999999999999
Q ss_pred cccccccccccccccc---cccccccccCCcccccCC
Q 002409 491 YVQNNMLSGTVPSSLL---SKNVVLNYAGNINLHEGG 524 (927)
Q Consensus 491 ~l~~N~l~g~iP~~l~---~~~~~l~~~~n~~l~~~~ 524 (927)
+|++|+|+ .+|...+ ..+..+.+.+|+-.|.+.
T Consensus 261 ~L~~N~l~-~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 296 (440)
T 3zyj_A 261 NLAHNNLT-LLPHDLFTPLHHLERIHLHHNPWNCNCD 296 (440)
T ss_dssp ECTTSCCC-CCCTTTTSSCTTCCEEECCSSCEECSST
T ss_pred ECCCCCCC-ccChhHhccccCCCEEEcCCCCccCCCC
Confidence 99999999 6666554 455778899999888874
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=98.93 E-value=9.5e-10 Score=108.95 Aligned_cols=83 Identities=25% Similarity=0.316 Sum_probs=42.1
Q ss_pred CceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCC-CCCCCccEEEecCCCcCCC-CCccccCCCcccccc
Q 002409 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF-SGCPDLRIIHLEDNQLTGP-LPSSLMNLPNLRELY 491 (927)
Q Consensus 414 ~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~-~~l~~L~~L~Ls~N~l~g~-~P~~l~~l~~L~~L~ 491 (927)
++|+.|+|++|.+++. ..+..+++|++|+|++|++++.+|.+ .++++|++|+|++|++++. .+..+..+++|+.|+
T Consensus 49 ~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~ 126 (168)
T 2ell_A 49 VNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLD 126 (168)
T ss_dssp GGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEE
T ss_pred CCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEE
Confidence 3455555555555533 44555555555555555555544442 2355555555555555532 114455555555555
Q ss_pred ccccccc
Q 002409 492 VQNNMLS 498 (927)
Q Consensus 492 l~~N~l~ 498 (927)
|++|+++
T Consensus 127 l~~N~l~ 133 (168)
T 2ell_A 127 LFNCEVT 133 (168)
T ss_dssp CCSSGGG
T ss_pred eeCCcCc
Confidence 5555555
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.92 E-value=9.2e-10 Score=136.60 Aligned_cols=104 Identities=21% Similarity=0.307 Sum_probs=83.8
Q ss_pred ceEEEEecCCCCCccCCchhh--cCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecC------CCcCCCCCccccCCCc
Q 002409 415 SITVIHLSSKNLTGNIPSDLT--KLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLED------NQLTGPLPSSLMNLPN 486 (927)
Q Consensus 415 ~l~~L~L~~n~l~g~ip~~i~--~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~------N~l~g~~P~~l~~l~~ 486 (927)
+|+.|+|++|+|+ .+|..+. .+++|+.|+|++|+|++.++.+.++++|+.|+|++ |++.+.+|..+.+|++
T Consensus 729 ~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~ 807 (876)
T 4ecn_A 729 LLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPS 807 (876)
T ss_dssp GCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSSCCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSS
T ss_pred CccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCccchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCC
Confidence 7888888888888 7888887 88888888888888888433477888888888866 7788888888888888
Q ss_pred cccccccccccccccccccccccccccccCCccc
Q 002409 487 LRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINL 520 (927)
Q Consensus 487 L~~L~l~~N~l~g~iP~~l~~~~~~l~~~~n~~l 520 (927)
|+.|+|++|+| +.+|..+.+.+..+++++|+..
T Consensus 808 L~~L~Ls~N~L-~~Ip~~l~~~L~~LdLs~N~l~ 840 (876)
T 4ecn_A 808 LIQLQIGSNDI-RKVDEKLTPQLYILDIADNPNI 840 (876)
T ss_dssp CCEEECCSSCC-CBCCSCCCSSSCEEECCSCTTC
T ss_pred CCEEECCCCCC-CccCHhhcCCCCEEECCCCCCC
Confidence 88888888888 6888888777777888888643
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=98.91 E-value=5.4e-10 Score=111.83 Aligned_cols=100 Identities=20% Similarity=0.277 Sum_probs=84.7
Q ss_pred CceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCC-CCCCCccEEEecCCCcCCCCCc--cccCCCccccc
Q 002409 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF-SGCPDLRIIHLEDNQLTGPLPS--SLMNLPNLREL 490 (927)
Q Consensus 414 ~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~-~~l~~L~~L~Ls~N~l~g~~P~--~l~~l~~L~~L 490 (927)
++|+.|+|++|.|++. +.+.++++|+.|+|++|+|++.+|.+ .++++|++|+|++|+|+ .+|. .+..+++|+.|
T Consensus 42 ~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L 118 (176)
T 1a9n_A 42 DQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYL 118 (176)
T ss_dssp TCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEE
T ss_pred CCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEE
Confidence 4899999999999964 68999999999999999999887775 88999999999999996 6776 89999999999
Q ss_pred cccccccccccccc----c--ccccccccccCC
Q 002409 491 YVQNNMLSGTVPSS----L--LSKNVVLNYAGN 517 (927)
Q Consensus 491 ~l~~N~l~g~iP~~----l--~~~~~~l~~~~n 517 (927)
+|++|+++ .+|.. + ++.+..++..+|
T Consensus 119 ~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n 150 (176)
T 1a9n_A 119 CILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKV 150 (176)
T ss_dssp ECCSSGGG-GSTTHHHHHHHHCTTCSEETTEEC
T ss_pred EecCCCCC-CcHhHHHHHHHHCCccceeCCCcC
Confidence 99999998 67764 2 334455555555
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=98.91 E-value=5.1e-10 Score=137.15 Aligned_cols=104 Identities=31% Similarity=0.478 Sum_probs=91.8
Q ss_pred CCCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCC-CCCCCCCccEEEecCCCcCCCCCccccCCCccccc
Q 002409 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 490 (927)
Q Consensus 412 ~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L 490 (927)
..+.|+.|+|++|.|. .+|..+++|++|+.|+|++|.|+ .+| .+.+|++|++|+|++|+|+ .+|..|++|++|+.|
T Consensus 222 ~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L 298 (727)
T 4b8c_D 222 DDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYF 298 (727)
T ss_dssp CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEE
T ss_pred cCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEE
Confidence 4578999999999999 89999999999999999999999 555 4889999999999999999 889999999999999
Q ss_pred cccccccccccccccc--cccccccccCCcc
Q 002409 491 YVQNNMLSGTVPSSLL--SKNVVLNYAGNIN 519 (927)
Q Consensus 491 ~l~~N~l~g~iP~~l~--~~~~~l~~~~n~~ 519 (927)
+|++|.|+ .+|.++. ..+..|++.+|.-
T Consensus 299 ~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l 328 (727)
T 4b8c_D 299 YFFDNMVT-TLPWEFGNLCNLQFLGVEGNPL 328 (727)
T ss_dssp ECCSSCCC-CCCSSTTSCTTCCCEECTTSCC
T ss_pred ECCCCCCC-ccChhhhcCCCccEEeCCCCcc
Confidence 99999998 8998863 4567778888853
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.90 E-value=1.3e-09 Score=129.60 Aligned_cols=113 Identities=21% Similarity=0.225 Sum_probs=97.6
Q ss_pred CCCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCC-CCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCcccc
Q 002409 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLT-GPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRE 489 (927)
Q Consensus 412 ~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~-g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~ 489 (927)
..++|+.|+|++|.+.+.+|..+.++++|+.|+|++|.++ +.+|. +.++++|++|+|++|++++..|..+.++++|+.
T Consensus 419 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 498 (570)
T 2z63_A 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 498 (570)
T ss_dssp TCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred cCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCE
Confidence 4578999999999999999999999999999999999998 56775 888999999999999999888999999999999
Q ss_pred cccccccccccccccc--ccccccccccCCcccccCC
Q 002409 490 LYVQNNMLSGTVPSSL--LSKNVVLNYAGNINLHEGG 524 (927)
Q Consensus 490 L~l~~N~l~g~iP~~l--~~~~~~l~~~~n~~l~~~~ 524 (927)
|+|++|+|++..|..+ ++.+..+.+.+|+-.|..+
T Consensus 499 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 535 (570)
T 2z63_A 499 LNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535 (570)
T ss_dssp EECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred EeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCc
Confidence 9999999996555444 3456778889998887765
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.89 E-value=1.5e-09 Score=118.54 Aligned_cols=108 Identities=24% Similarity=0.287 Sum_probs=93.2
Q ss_pred CCCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCC-CCCC-CCCCCCccEEEecCCCcCCCCCccccCCCcccc
Q 002409 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRE 489 (927)
Q Consensus 412 ~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g-~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~ 489 (927)
..++|+.|+|++|.+.+..|..+.++++|+.|+|++|.+++ .+|. +.++++|++|+|++|++++..|..+.++++|+.
T Consensus 124 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 203 (306)
T 2z66_A 124 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 203 (306)
T ss_dssp TCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred hccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCE
Confidence 35689999999999999999999999999999999999998 4565 889999999999999999888999999999999
Q ss_pred cccccccccccccccc--ccccccccccCCcc
Q 002409 490 LYVQNNMLSGTVPSSL--LSKNVVLNYAGNIN 519 (927)
Q Consensus 490 L~l~~N~l~g~iP~~l--~~~~~~l~~~~n~~ 519 (927)
|+|++|++++..+..+ ++.+..+++.+|..
T Consensus 204 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 235 (306)
T 2z66_A 204 LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI 235 (306)
T ss_dssp EECTTSCCSBCCSGGGTTCTTCCEEECTTSCC
T ss_pred EECCCCccCccChhhccCcccCCEeECCCCCC
Confidence 9999999995444344 34567778888854
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.89 E-value=2.7e-09 Score=127.93 Aligned_cols=106 Identities=20% Similarity=0.234 Sum_probs=93.7
Q ss_pred CCCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCccccc
Q 002409 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 490 (927)
Q Consensus 412 ~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L 490 (927)
..++|+.|+|++|.|++..|..|++|++|++|+|++|.|++.++. |.++++|++|+|++|+|++..|..++++++|+.|
T Consensus 97 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 176 (597)
T 3oja_B 97 YAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNL 176 (597)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEE
T ss_pred CCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEE
Confidence 457899999999999988888899999999999999999988777 6899999999999999999888899999999999
Q ss_pred cccccccccccccccccccccccccCCc
Q 002409 491 YVQNNMLSGTVPSSLLSKNVVLNYAGNI 518 (927)
Q Consensus 491 ~l~~N~l~g~iP~~l~~~~~~l~~~~n~ 518 (927)
+|++|.|+ .+|...++.+..+.+.+|.
T Consensus 177 ~L~~N~l~-~~~~~~l~~L~~L~l~~n~ 203 (597)
T 3oja_B 177 QLSSNRLT-HVDLSLIPSLFHANVSYNL 203 (597)
T ss_dssp ECTTSCCS-BCCGGGCTTCSEEECCSSC
T ss_pred ECcCCCCC-CcChhhhhhhhhhhcccCc
Confidence 99999999 4676666777777776663
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=98.89 E-value=1.6e-09 Score=125.27 Aligned_cols=110 Identities=25% Similarity=0.319 Sum_probs=96.6
Q ss_pred CCCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCccccc
Q 002409 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 490 (927)
Q Consensus 412 ~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L 490 (927)
..++|+.|+|++|+|++ +| .+..+++|+.|+|++|.|++..|. +.++++|+.|+|++|++++..|..+.++++|+.|
T Consensus 194 ~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 271 (452)
T 3zyi_A 194 GLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVEL 271 (452)
T ss_dssp TCTTCCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCCEEECCCCcccc-cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEE
Confidence 35689999999999994 55 589999999999999999998886 8999999999999999999989999999999999
Q ss_pred cccccccccccccccc---cccccccccCCcccccCC
Q 002409 491 YVQNNMLSGTVPSSLL---SKNVVLNYAGNINLHEGG 524 (927)
Q Consensus 491 ~l~~N~l~g~iP~~l~---~~~~~l~~~~n~~l~~~~ 524 (927)
+|++|+|+ .+|...+ +.+..+.+.+|+-.|.+.
T Consensus 272 ~L~~N~l~-~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 307 (452)
T 3zyi_A 272 NLAHNNLS-SLPHDLFTPLRYLVELHLHHNPWNCDCD 307 (452)
T ss_dssp ECCSSCCS-CCCTTSSTTCTTCCEEECCSSCEECSTT
T ss_pred ECCCCcCC-ccChHHhccccCCCEEEccCCCcCCCCC
Confidence 99999999 6666553 455778899999888774
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=98.88 E-value=2.1e-09 Score=118.71 Aligned_cols=105 Identities=27% Similarity=0.389 Sum_probs=90.4
Q ss_pred CceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCccccccc
Q 002409 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 492 (927)
Q Consensus 414 ~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 492 (927)
++|+.|+|++|.+++..|..+.++++|+.|+|++|.+++..+. +.++++|++|+|++|+++ .+|..+..+++|+.|+|
T Consensus 192 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l 270 (330)
T 1xku_A 192 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL 270 (330)
T ss_dssp TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEEC
T ss_pred ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEEC
Confidence 5899999999999988899999999999999999999998874 888999999999999999 89999999999999999
Q ss_pred cccccccccccccc---------cccccccccCCccc
Q 002409 493 QNNMLSGTVPSSLL---------SKNVVLNYAGNINL 520 (927)
Q Consensus 493 ~~N~l~g~iP~~l~---------~~~~~l~~~~n~~l 520 (927)
++|+|+ .+|...+ ..+..+.+.+|+..
T Consensus 271 ~~N~i~-~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~ 306 (330)
T 1xku_A 271 HNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 306 (330)
T ss_dssp CSSCCC-CCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred CCCcCC-ccChhhcCCcccccccccccceEeecCccc
Confidence 999999 5655443 22345667777653
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.88 E-value=1.6e-09 Score=135.37 Aligned_cols=90 Identities=24% Similarity=0.214 Sum_probs=52.3
Q ss_pred CceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCC-CC-CCCCCCccEEEecCCCcCCCCCccccCCCcccccc
Q 002409 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPI-PD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 491 (927)
Q Consensus 414 ~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~-p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~ 491 (927)
++|+.|||++|.+++..|..|.+|++|+.|+|++|.+.+.+ |. |.+|++|++|+|++|++++..|..|.++++|+.|+
T Consensus 24 ~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 103 (844)
T 3j0a_A 24 NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELR 103 (844)
T ss_dssp TTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEE
T ss_pred CCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEee
Confidence 45666666666666555556666666666666666554444 22 55556666666666665555555555555666666
Q ss_pred cccccccccccc
Q 002409 492 VQNNMLSGTVPS 503 (927)
Q Consensus 492 l~~N~l~g~iP~ 503 (927)
|++|.+++.+|.
T Consensus 104 Ls~n~l~~~~~~ 115 (844)
T 3j0a_A 104 LYFCGLSDAVLK 115 (844)
T ss_dssp CTTCCCSSCCST
T ss_pred CcCCCCCccccc
Confidence 666655554443
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.87 E-value=1.2e-09 Score=123.61 Aligned_cols=109 Identities=20% Similarity=0.232 Sum_probs=94.4
Q ss_pred CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCccccccc
Q 002409 413 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 492 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 492 (927)
.++|+.|+|++|.+++..|..+.++++|+.|+|++|++++..+.+..+++|++|+|++|+++ .+|..+..+++|+.|+|
T Consensus 247 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L 325 (390)
T 3o6n_A 247 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYL 325 (390)
T ss_dssp CTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCEEECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEEC
T ss_pred CCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcccCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEEC
Confidence 46899999999999988899999999999999999999987666778999999999999998 67888889999999999
Q ss_pred cccccccccccccccccccccccCCcccccC
Q 002409 493 QNNMLSGTVPSSLLSKNVVLNYAGNINLHEG 523 (927)
Q Consensus 493 ~~N~l~g~iP~~l~~~~~~l~~~~n~~l~~~ 523 (927)
++|+|+ .+|...++.+..+++.+|+-.|.+
T Consensus 326 ~~N~i~-~~~~~~~~~L~~L~l~~N~~~~~~ 355 (390)
T 3o6n_A 326 DHNSIV-TLKLSTHHTLKNLTLSHNDWDCNS 355 (390)
T ss_dssp CSSCCC-CCCCCTTCCCSEEECCSSCEEHHH
T ss_pred CCCccc-eeCchhhccCCEEEcCCCCccchh
Confidence 999998 677777777888888999766543
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.87 E-value=1.4e-09 Score=127.85 Aligned_cols=107 Identities=20% Similarity=0.208 Sum_probs=92.5
Q ss_pred CCCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCC--CCCC-CCCCCCccEEEecCCCcCCCCCcc-ccCCCcc
Q 002409 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG--PIPD-FSGCPDLRIIHLEDNQLTGPLPSS-LMNLPNL 487 (927)
Q Consensus 412 ~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g--~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~-l~~l~~L 487 (927)
..++|+.|+|++|.+++.+|..+.++++|+.|+|++|++++ .+|. +.++++|++|+|++|++++.+|.. +..+++|
T Consensus 322 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L 401 (520)
T 2z7x_B 322 KISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSL 401 (520)
T ss_dssp SCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTC
T ss_pred hCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccC
Confidence 45789999999999998899999999999999999999997 4554 788999999999999999877765 7888999
Q ss_pred ccccccccccccccccccccccccccccCCc
Q 002409 488 RELYVQNNMLSGTVPSSLLSKNVVLNYAGNI 518 (927)
Q Consensus 488 ~~L~l~~N~l~g~iP~~l~~~~~~l~~~~n~ 518 (927)
+.|+|++|++++.+|..+...+..+++++|.
T Consensus 402 ~~L~Ls~N~l~~~~~~~l~~~L~~L~Ls~N~ 432 (520)
T 2z7x_B 402 LSLNMSSNILTDTIFRCLPPRIKVLDLHSNK 432 (520)
T ss_dssp CEEECCSSCCCGGGGGSCCTTCCEEECCSSC
T ss_pred CEEECcCCCCCcchhhhhcccCCEEECCCCc
Confidence 9999999999988888887777788888874
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.86 E-value=4.4e-09 Score=118.94 Aligned_cols=106 Identities=20% Similarity=0.234 Sum_probs=91.4
Q ss_pred CCCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCccccc
Q 002409 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 490 (927)
Q Consensus 412 ~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L 490 (927)
..++|+.|+|++|.+++..|..+.++++|++|+|++|+++..++. +.++++|++|+|++|++++..|..+.++++|+.|
T Consensus 91 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 170 (390)
T 3o6n_A 91 YAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNL 170 (390)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEE
T ss_pred CCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEE
Confidence 457899999999999987788899999999999999999977666 5889999999999999998888889999999999
Q ss_pred cccccccccccccccccccccccccCCc
Q 002409 491 YVQNNMLSGTVPSSLLSKNVVLNYAGNI 518 (927)
Q Consensus 491 ~l~~N~l~g~iP~~l~~~~~~l~~~~n~ 518 (927)
+|++|+++ .++...++.+..+.+.+|.
T Consensus 171 ~l~~n~l~-~~~~~~l~~L~~L~l~~n~ 197 (390)
T 3o6n_A 171 QLSSNRLT-HVDLSLIPSLFHANVSYNL 197 (390)
T ss_dssp ECCSSCCS-BCCGGGCTTCSEEECCSSC
T ss_pred ECCCCcCC-ccccccccccceeeccccc
Confidence 99999999 4666666777777777663
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=98.86 E-value=2.5e-09 Score=128.25 Aligned_cols=116 Identities=18% Similarity=0.096 Sum_probs=95.8
Q ss_pred ceeecCCCC--------CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcC
Q 002409 404 SWLQCNSDP--------QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLT 474 (927)
Q Consensus 404 ~~v~C~~~~--------~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~ 474 (927)
.-+.|+... ...++.|+|++|.+++..|..|+++++|++|+|++|++++..|. |.++++|++|+|++|+++
T Consensus 15 ~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~ 94 (606)
T 3t6q_A 15 KTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94 (606)
T ss_dssp TEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCS
T ss_pred ceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCccc
Confidence 347786532 35789999999999988888999999999999999999998886 899999999999999999
Q ss_pred CCCCccccCCCcccccccccccccccccccc--ccccccccccCCcc
Q 002409 475 GPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNIN 519 (927)
Q Consensus 475 g~~P~~l~~l~~L~~L~l~~N~l~g~iP~~l--~~~~~~l~~~~n~~ 519 (927)
+..|..++++++|+.|+|++|++++..|..+ ++.+..+.+.+|..
T Consensus 95 ~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l 141 (606)
T 3t6q_A 95 FMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHI 141 (606)
T ss_dssp EECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCC
T ss_pred ccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcc
Confidence 8889999999999999999999995434444 34556677777743
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.86 E-value=3.5e-09 Score=121.95 Aligned_cols=117 Identities=21% Similarity=0.292 Sum_probs=96.6
Q ss_pred CcceeecCCCC--------CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCC
Q 002409 402 PWSWLQCNSDP--------QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 472 (927)
Q Consensus 402 ~~~~v~C~~~~--------~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~ 472 (927)
.+..|.|.... .+.++.|+|++|++++..+..|.+|++|+.|+|++|+|++..+. |.++++|++|+|++|+
T Consensus 44 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~ 123 (440)
T 3zyj_A 44 QFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123 (440)
T ss_dssp TSCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCc
Confidence 35568887533 35689999999999988889999999999999999999988775 8999999999999999
Q ss_pred cCCCCCccccCCCccccccccccccccccccccc---cccccccccCCcc
Q 002409 473 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL---SKNVVLNYAGNIN 519 (927)
Q Consensus 473 l~g~~P~~l~~l~~L~~L~l~~N~l~g~iP~~l~---~~~~~l~~~~n~~ 519 (927)
|++..+..+..+++|+.|+|++|+|+ .+|...+ +.+..+.+.+|..
T Consensus 124 l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~~~l~~L~~L~l~~~~~ 172 (440)
T 3zyj_A 124 LTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKR 172 (440)
T ss_dssp CSSCCTTTSCSCSSCCEEECCSCCCC-EECTTTTTTCTTCCEEECCCCTT
T ss_pred CCeeCHhHhhccccCceeeCCCCccc-ccCHHHhhhCcccCEeCCCCCCC
Confidence 99766668999999999999999999 6666443 3445666666543
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.85 E-value=7.4e-09 Score=115.89 Aligned_cols=140 Identities=16% Similarity=0.304 Sum_probs=104.8
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEee--cCC-chhhHhHHHHHHHHhhcc--CCCccceecceeec---CeEEEEEEe
Q 002409 605 KKIGSGGFGVVYYGKLKDGKEIAVKVLT--SNS-YQGKREFTNEVTLLSRIH--HRNLVQFLGYCQEE---GRSVLVYEF 676 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~~g~~VAVK~l~--~~~-~~~~~~~~~Ei~iL~~l~--HpnIv~l~g~~~~~---~~~~lV~E~ 676 (927)
+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+++++.+. +..+.+++.++.+. +..++||||
T Consensus 44 ~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 46889999999999876 4678888765 322 123457889999999997 45577888888766 457999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCC-------------------------------------
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC------------------------------------- 719 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~------------------------------------- 719 (927)
++|..+.+.. ...++...+..++.++++.|+.||+..
T Consensus 123 v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 123 VSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp CCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred cCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 9998875422 123567778889999999999999721
Q ss_pred ------------------CCceecCCCCCCCeEECCCCc--EEEEeecCccc
Q 002409 720 ------------------VPAIIHRDLKSSNILLDKHMR--AKVSDFGLSKF 751 (927)
Q Consensus 720 ------------------~~~ivHrDLkp~NILl~~~~~--vkL~DFGla~~ 751 (927)
...++|||+++.|||++.++. +.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999997753 68999998863
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.85 E-value=2.8e-09 Score=123.95 Aligned_cols=105 Identities=21% Similarity=0.220 Sum_probs=69.2
Q ss_pred CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCcccccc
Q 002409 413 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 491 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~ 491 (927)
.++|+.|+|++|.+++..|..|.+|++|++|+|++|+|++..+. |.++++|++|+|++|++++..|..+.++++|+.|+
T Consensus 55 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 134 (477)
T 2id5_A 55 FPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLE 134 (477)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEE
Confidence 45677777777777766666777777777777777777766554 56677777777777777766666777777777777
Q ss_pred ccccccccccccccc--cccccccccCC
Q 002409 492 VQNNMLSGTVPSSLL--SKNVVLNYAGN 517 (927)
Q Consensus 492 l~~N~l~g~iP~~l~--~~~~~l~~~~n 517 (927)
|++|++++..|..+. ..+..+.+.+|
T Consensus 135 l~~n~l~~~~~~~~~~l~~L~~L~l~~n 162 (477)
T 2id5_A 135 VGDNDLVYISHRAFSGLNSLEQLTLEKC 162 (477)
T ss_dssp ECCTTCCEECTTSSTTCTTCCEEEEESC
T ss_pred CCCCccceeChhhccCCCCCCEEECCCC
Confidence 777777644444442 23444555555
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.85 E-value=9.6e-10 Score=120.67 Aligned_cols=106 Identities=23% Similarity=0.261 Sum_probs=83.2
Q ss_pred CCCceEEEEecCCCCCccCCchhhcC-----CCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCC--CCccc--
Q 002409 412 PQPSITVIHLSSKNLTGNIPSDLTKL-----SSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGP--LPSSL-- 481 (927)
Q Consensus 412 ~~~~l~~L~L~~n~l~g~ip~~i~~L-----~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~--~P~~l-- 481 (927)
..++|+.|+|++|.+++. |..++.+ ++|++|+|++|++++.+|. +.++++|++|+|++|+++|. +|..+
T Consensus 119 ~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~ 197 (312)
T 1wwl_A 119 TGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCP 197 (312)
T ss_dssp CSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCT
T ss_pred cCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHh
Confidence 456889999999999876 8888887 8899999999999888864 78899999999999998776 34455
Q ss_pred cCCCcccccccccccccc--ccccccc---cccccccccCCc
Q 002409 482 MNLPNLRELYVQNNMLSG--TVPSSLL---SKNVVLNYAGNI 518 (927)
Q Consensus 482 ~~l~~L~~L~l~~N~l~g--~iP~~l~---~~~~~l~~~~n~ 518 (927)
.++++|+.|+|++|+|++ .+|..++ +.+..+++++|.
T Consensus 198 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~ 239 (312)
T 1wwl_A 198 LKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNS 239 (312)
T ss_dssp TSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSC
T ss_pred ccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCc
Confidence 788899999999999883 4444443 456677777774
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.85 E-value=3e-09 Score=108.42 Aligned_cols=103 Identities=17% Similarity=0.223 Sum_probs=71.2
Q ss_pred CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCC-CCCCCCCccEEEecCCCcCCCCCccccCCCcccccc
Q 002409 413 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 491 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~ 491 (927)
.++|+.|+|++|.++ .++.+..+++|++|+|++|++++..| .+.++++|++|+|++|++++..|..+.++++|+.|+
T Consensus 65 l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~ 142 (197)
T 4ezg_A 65 AHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSID 142 (197)
T ss_dssp CTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEE
T ss_pred CCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEE
Confidence 356778888877554 33467778888888888888877444 477788888888888888777777777888888888
Q ss_pred cccccccccccccc--ccccccccccCCc
Q 002409 492 VQNNMLSGTVPSSL--LSKNVVLNYAGNI 518 (927)
Q Consensus 492 l~~N~l~g~iP~~l--~~~~~~l~~~~n~ 518 (927)
|++|++.+.+| .+ ++.+..+.+.+|.
T Consensus 143 L~~n~~i~~~~-~l~~l~~L~~L~l~~n~ 170 (197)
T 4ezg_A 143 LSYNGAITDIM-PLKTLPELKSLNIQFDG 170 (197)
T ss_dssp CCSCTBCCCCG-GGGGCSSCCEEECTTBC
T ss_pred ccCCCCccccH-hhcCCCCCCEEECCCCC
Confidence 88887333565 23 3344556666653
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=98.85 E-value=2.4e-09 Score=128.43 Aligned_cols=111 Identities=23% Similarity=0.240 Sum_probs=74.5
Q ss_pred CCceEEEEecCCCCCcc---CCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCccc
Q 002409 413 QPSITVIHLSSKNLTGN---IPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 488 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~---ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~ 488 (927)
.++|+.|+|++|.+++. .+..+..+++|+.|+|++|++++.+|. +.++++|+.|+|++|++++..|..+.++++|
T Consensus 448 l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L- 526 (606)
T 3t6q_A 448 LPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI- 526 (606)
T ss_dssp CTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-
T ss_pred CCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-
Confidence 45677777777777652 234566777777777777777776664 6667777777777777777777777777777
Q ss_pred ccccccccccccccccc--ccccccccccCCcccccCC
Q 002409 489 ELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINLHEGG 524 (927)
Q Consensus 489 ~L~l~~N~l~g~iP~~l--~~~~~~l~~~~n~~l~~~~ 524 (927)
.|+|++|++++..|..+ ++.+..+++.+|+-.|.+.
T Consensus 527 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 527 YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence 77777777775545433 3445667777777766553
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=98.83 E-value=1.5e-09 Score=128.76 Aligned_cols=114 Identities=27% Similarity=0.397 Sum_probs=75.7
Q ss_pred CcCCCCCCCCCC--CCccee-ecCCCCCCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccE
Q 002409 389 DWAQEGGDPCLP--VPWSWL-QCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRI 465 (927)
Q Consensus 389 ~w~~~~~dpC~~--~~~~~v-~C~~~~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~ 465 (927)
+|.. +++||.. ..|.++ .|.. .+|+.|+|++|+|++ +|..+. ++|+.|+|++|+|+ .+| ..+++|++
T Consensus 35 ~W~~-~~~~~~~~~~~~~~l~~C~~---~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip--~~l~~L~~ 104 (571)
T 3cvr_A 35 KWEK-QALPGENRNEAVSLLKECLI---NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP--ELPASLEY 104 (571)
T ss_dssp HHHT-TCCTTCCHHHHHHHHHHHHH---TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC--CCCTTCCE
T ss_pred HHhc-cCCccccccchhhhcccccc---CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc--cccCCCCE
Confidence 4654 5778842 247777 5754 267788888888875 776663 67777777777777 455 45677777
Q ss_pred EEecCCCcCCCCCccccCCCccccccccccccccccccccccccccccccCCc
Q 002409 466 IHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNI 518 (927)
Q Consensus 466 L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l~g~iP~~l~~~~~~l~~~~n~ 518 (927)
|+|++|+|++ +|. +.+ +|+.|+|++|+|++ +|. .++.+..+++++|.
T Consensus 105 L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~-~l~~L~~L~Ls~N~ 151 (571)
T 3cvr_A 105 LDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE-LPALLEYINADNNQ 151 (571)
T ss_dssp EECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC-CCTTCCEEECCSSC
T ss_pred EEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC-cCccccEEeCCCCc
Confidence 7777777775 666 554 67777777777774 666 45555556665553
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.82 E-value=4.8e-09 Score=124.75 Aligned_cols=102 Identities=22% Similarity=0.224 Sum_probs=85.9
Q ss_pred CceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCccccccc
Q 002409 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 492 (927)
Q Consensus 414 ~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 492 (927)
++|+.|+|++|.+++..|..|.++++|++|+|++|+|++..|. |.++++|++|+|++|+|+ .+|.. .+++|+.|+|
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 128 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDL 128 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEEC
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEEC
Confidence 6799999999999977778999999999999999999998776 888999999999999998 68876 8999999999
Q ss_pred ccccccc-ccccccc--cccccccccCCc
Q 002409 493 QNNMLSG-TVPSSLL--SKNVVLNYAGNI 518 (927)
Q Consensus 493 ~~N~l~g-~iP~~l~--~~~~~l~~~~n~ 518 (927)
++|++++ .+|..+. +.+..+++.+|.
T Consensus 129 s~N~l~~l~~p~~~~~l~~L~~L~L~~n~ 157 (562)
T 3a79_B 129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAK 157 (562)
T ss_dssp CSSCCSBCCCCGGGGGCTTCCEEEEECSB
T ss_pred CCCCccccCchHhhcccCcccEEecCCCc
Confidence 9999985 3455553 455667777764
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.82 E-value=3.4e-09 Score=126.11 Aligned_cols=107 Identities=21% Similarity=0.224 Sum_probs=93.7
Q ss_pred CCCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCC--C-CCCCCCCccEEEecCCCcCCCCCcc-ccCCCcc
Q 002409 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPI--P-DFSGCPDLRIIHLEDNQLTGPLPSS-LMNLPNL 487 (927)
Q Consensus 412 ~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~--p-~~~~l~~L~~L~Ls~N~l~g~~P~~-l~~l~~L 487 (927)
..++|+.|+|++|.+++.+|..+.++++|+.|+|++|++++.. | .+.++++|++|+|++|++++.+|.. +..+++|
T Consensus 351 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L 430 (562)
T 3a79_B 351 SPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESI 430 (562)
T ss_dssp SCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTC
T ss_pred CCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccC
Confidence 4578999999999999989999999999999999999999843 4 3788999999999999999877764 7889999
Q ss_pred ccccccccccccccccccccccccccccCCc
Q 002409 488 RELYVQNNMLSGTVPSSLLSKNVVLNYAGNI 518 (927)
Q Consensus 488 ~~L~l~~N~l~g~iP~~l~~~~~~l~~~~n~ 518 (927)
+.|+|++|+|+|.+|..+...+..+++++|.
T Consensus 431 ~~L~l~~n~l~~~~~~~l~~~L~~L~L~~N~ 461 (562)
T 3a79_B 431 LVLNLSSNMLTGSVFRCLPPKVKVLDLHNNR 461 (562)
T ss_dssp CEEECCSSCCCGGGGSSCCTTCSEEECCSSC
T ss_pred CEEECCCCCCCcchhhhhcCcCCEEECCCCc
Confidence 9999999999999988877777888888874
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.82 E-value=3e-09 Score=117.02 Aligned_cols=108 Identities=15% Similarity=0.128 Sum_probs=91.0
Q ss_pred CCceEEEEecCCCCCccCCchhh-cCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCcccccc
Q 002409 413 QPSITVIHLSSKNLTGNIPSDLT-KLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 491 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~ip~~i~-~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~ 491 (927)
.++|+.|+|++|.+++..|..+. .+++|+.|+|++|.|++. |....+++|++|+|++|++++ +|..+..+++|+.|+
T Consensus 143 l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~ 220 (317)
T 3o53_A 143 RSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KGQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWIS 220 (317)
T ss_dssp GSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-ECCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEE
T ss_pred cCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-ccccccccCCEEECCCCcCCc-chhhhcccCcccEEE
Confidence 46899999999999987777774 799999999999999877 555569999999999999995 666699999999999
Q ss_pred ccccccccccccccc--cccccccccCCcccccC
Q 002409 492 VQNNMLSGTVPSSLL--SKNVVLNYAGNINLHEG 523 (927)
Q Consensus 492 l~~N~l~g~iP~~l~--~~~~~l~~~~n~~l~~~ 523 (927)
|++|+|+ .+|..+. +.+..+.+.+|+..|..
T Consensus 221 L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~ 253 (317)
T 3o53_A 221 LRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGT 253 (317)
T ss_dssp CTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHH
T ss_pred CcCCccc-chhhHhhcCCCCCEEEccCCCccCcC
Confidence 9999999 7887763 45677888999876643
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.81 E-value=4.4e-09 Score=115.18 Aligned_cols=105 Identities=16% Similarity=0.136 Sum_probs=59.0
Q ss_pred CCceEEEEecCCCCCccCC----chhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCC--CC--ccccC
Q 002409 413 QPSITVIHLSSKNLTGNIP----SDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGP--LP--SSLMN 483 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~ip----~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~--~P--~~l~~ 483 (927)
.++|+.|+|++|.+++..+ ..+..+++|++|+|++|++++.+|. +.++++|++|+|++|++++. ++ ..+++
T Consensus 116 ~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~ 195 (310)
T 4glp_A 116 GLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHK 195 (310)
T ss_dssp CBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTS
T ss_pred CCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhc
Confidence 4556666666666665544 2334566666666666666665554 55666666666666665542 21 22355
Q ss_pred CCcccccccccccccccccc---cc---ccccccccccCCc
Q 002409 484 LPNLRELYVQNNMLSGTVPS---SL---LSKNVVLNYAGNI 518 (927)
Q Consensus 484 l~~L~~L~l~~N~l~g~iP~---~l---~~~~~~l~~~~n~ 518 (927)
+++|+.|+|++|+|+ .+|. .+ +..+..+++++|.
T Consensus 196 l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~ 235 (310)
T 4glp_A 196 FPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNS 235 (310)
T ss_dssp SCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSC
T ss_pred CCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCC
Confidence 666666666666665 3332 12 2344555555553
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.80 E-value=1.1e-09 Score=120.08 Aligned_cols=105 Identities=22% Similarity=0.239 Sum_probs=68.7
Q ss_pred CCceEEEEecCCCCCcc--C--CchhhcCCCCcEEeccCCcCCCCCCC----CCCCCCccEEEecCCCcCCCCCccccCC
Q 002409 413 QPSITVIHLSSKNLTGN--I--PSDLTKLSSLVELWLDGNSLTGPIPD----FSGCPDLRIIHLEDNQLTGPLPSSLMNL 484 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~--i--p~~i~~L~~L~~L~Ls~N~l~g~~p~----~~~l~~L~~L~Ls~N~l~g~~P~~l~~l 484 (927)
.++|+.|+|++|++.+. + +..+.++++|++|+|++|+++...+. +.++++|++|+|++|+|++.+|+.++.+
T Consensus 168 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 247 (310)
T 4glp_A 168 FPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRC 247 (310)
T ss_dssp CTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSC
T ss_pred CCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhc
Confidence 45677777777776642 2 22235677777777777777533221 3456777777777777777667666666
Q ss_pred ---CccccccccccccccccccccccccccccccCCc
Q 002409 485 ---PNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNI 518 (927)
Q Consensus 485 ---~~L~~L~l~~N~l~g~iP~~l~~~~~~l~~~~n~ 518 (927)
++|+.|+|++|+|+ .+|..+.+.+..+++++|.
T Consensus 248 ~~~~~L~~L~Ls~N~l~-~lp~~~~~~L~~L~Ls~N~ 283 (310)
T 4glp_A 248 MWSSALNSLNLSFAGLE-QVPKGLPAKLRVLDLSSNR 283 (310)
T ss_dssp CCCTTCCCEECCSSCCC-SCCSCCCSCCSCEECCSCC
T ss_pred cCcCcCCEEECCCCCCC-chhhhhcCCCCEEECCCCc
Confidence 57777777777777 6777776666666666663
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.80 E-value=2.3e-09 Score=126.03 Aligned_cols=101 Identities=20% Similarity=0.219 Sum_probs=59.5
Q ss_pred CceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCccccccc
Q 002409 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 492 (927)
Q Consensus 414 ~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 492 (927)
++|+.|+|++|.+++..|..|.++++|++|+|++|++++..|. +.++++|++|+|++|+|+ .+|.. .+++|++|+|
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEEC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEec
Confidence 4566666666666655555666666666666666666665553 566666666666666666 45554 5666666666
Q ss_pred ccccccc-ccccccc--cccccccccCC
Q 002409 493 QNNMLSG-TVPSSLL--SKNVVLNYAGN 517 (927)
Q Consensus 493 ~~N~l~g-~iP~~l~--~~~~~l~~~~n 517 (927)
++|++++ .+|..+. +.+..+++.+|
T Consensus 98 ~~N~l~~~~~p~~~~~l~~L~~L~L~~n 125 (520)
T 2z7x_B 98 SFNAFDALPICKEFGNMSQLKFLGLSTT 125 (520)
T ss_dssp CSSCCSSCCCCGGGGGCTTCCEEEEEES
T ss_pred cCCccccccchhhhccCCcceEEEecCc
Confidence 6666664 3455442 33344444444
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=98.79 E-value=7.3e-09 Score=125.97 Aligned_cols=106 Identities=25% Similarity=0.286 Sum_probs=77.7
Q ss_pred CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCcccccc
Q 002409 413 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 491 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~ 491 (927)
.++|+.|+|++|++++..+..|+++++|++|+|++|++++..|. +.++++|++|+|++|++++..|..++++++|+.|+
T Consensus 72 l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 151 (680)
T 1ziw_A 72 LPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELL 151 (680)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEE
T ss_pred ccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEE
Confidence 45788888888888843334688888888888888888777664 77788888888888888877777788888888888
Q ss_pred ccccccccccccccc----cccccccccCCc
Q 002409 492 VQNNMLSGTVPSSLL----SKNVVLNYAGNI 518 (927)
Q Consensus 492 l~~N~l~g~iP~~l~----~~~~~l~~~~n~ 518 (927)
|++|++++..|..+. ..+..+++.+|.
T Consensus 152 L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~ 182 (680)
T 1ziw_A 152 LSNNKIQALKSEELDIFANSSLKKLELSSNQ 182 (680)
T ss_dssp CCSSCCCCBCHHHHGGGTTCEESEEECTTCC
T ss_pred ccCCcccccCHHHhhccccccccEEECCCCc
Confidence 888888865554431 345566666663
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=98.79 E-value=8.1e-09 Score=114.12 Aligned_cols=113 Identities=24% Similarity=0.376 Sum_probs=90.3
Q ss_pred CcceeecCCCC--------CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCC
Q 002409 402 PWSWLQCNSDP--------QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 472 (927)
Q Consensus 402 ~~~~v~C~~~~--------~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~ 472 (927)
.|..+.|+... .++|+.|+|++|++++..|..+.++++|+.|+|++|++++..|. +.++++|++|+|++|+
T Consensus 34 ~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 113 (332)
T 2ft3_A 34 HLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH 113 (332)
T ss_dssp ETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSC
T ss_pred cCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCc
Confidence 47778886432 35789999999999977777899999999999999999988775 8889999999999999
Q ss_pred cCCCCCccccCCCcccccccccccccccccccc---ccccccccccCCc
Q 002409 473 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGNI 518 (927)
Q Consensus 473 l~g~~P~~l~~l~~L~~L~l~~N~l~g~iP~~l---~~~~~~l~~~~n~ 518 (927)
++ .+|..+. ++|+.|+|++|+++ .+|... ++.+..+.+.+|.
T Consensus 114 l~-~l~~~~~--~~L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~l~~n~ 158 (332)
T 2ft3_A 114 LV-EIPPNLP--SSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNP 158 (332)
T ss_dssp CC-SCCSSCC--TTCCEEECCSSCCC-CCCSGGGSSCSSCCEEECCSCC
T ss_pred CC-ccCcccc--ccCCEEECCCCccC-ccCHhHhCCCccCCEEECCCCc
Confidence 98 7787766 78999999999998 566543 3445666777774
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.79 E-value=8.1e-09 Score=122.58 Aligned_cols=94 Identities=19% Similarity=0.245 Sum_probs=63.3
Q ss_pred CCCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCC-CCCCCCCccEEEecCCCcCC-CCCccccCCCcccc
Q 002409 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTG-PLPSSLMNLPNLRE 489 (927)
Q Consensus 412 ~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~Ls~N~l~g-~~P~~l~~l~~L~~ 489 (927)
..++|+.|+|++|.+++..|..|.++++|++|+|++|++++..+ .++++++|++|+|++|++++ .+|..++++++|+.
T Consensus 74 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~ 153 (570)
T 2z63_A 74 SLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEH 153 (570)
T ss_dssp TCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCE
T ss_pred CchhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCE
Confidence 34567777777777776566667777777777777777766555 36677777777777777765 46777777777777
Q ss_pred cccccccccccccccc
Q 002409 490 LYVQNNMLSGTVPSSL 505 (927)
Q Consensus 490 L~l~~N~l~g~iP~~l 505 (927)
|++++|++++..|..+
T Consensus 154 L~l~~n~l~~~~~~~~ 169 (570)
T 2z63_A 154 LDLSSNKIQSIYCTDL 169 (570)
T ss_dssp EECTTSCCCEECGGGG
T ss_pred EeCcCCccceecHHHc
Confidence 7777777774444433
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.79 E-value=6.8e-09 Score=129.65 Aligned_cols=106 Identities=21% Similarity=0.230 Sum_probs=77.1
Q ss_pred CCCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC---CCCCCCccEEEecCCCcCCCCC-ccccCCCcc
Q 002409 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD---FSGCPDLRIIHLEDNQLTGPLP-SSLMNLPNL 487 (927)
Q Consensus 412 ~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~---~~~l~~L~~L~Ls~N~l~g~~P-~~l~~l~~L 487 (927)
..++|+.|+|++|.+++..|..|.+|++|++|+|++|.+++.+|. +.++++|++|+|++|++++..| ..+++|++|
T Consensus 71 ~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L 150 (844)
T 3j0a_A 71 NLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSL 150 (844)
T ss_dssp SCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSC
T ss_pred CCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCC
Confidence 345788888888888877788888888888888888888876553 6778888888888888876654 467888888
Q ss_pred ccccccccccccccccccc----cccccccccCC
Q 002409 488 RELYVQNNMLSGTVPSSLL----SKNVVLNYAGN 517 (927)
Q Consensus 488 ~~L~l~~N~l~g~iP~~l~----~~~~~l~~~~n 517 (927)
+.|+|++|++++..|..+. ..+..+.+.+|
T Consensus 151 ~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n 184 (844)
T 3j0a_A 151 KSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAAN 184 (844)
T ss_dssp CEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCS
T ss_pred CEEECCCCcCCeeCHHHcccccCCccceEECCCC
Confidence 8888888888776666553 23344444444
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.78 E-value=3.4e-09 Score=123.90 Aligned_cols=105 Identities=22% Similarity=0.149 Sum_probs=80.7
Q ss_pred CCCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-----------------CCCCCCccEEEecCCCcC
Q 002409 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-----------------FSGCPDLRIIHLEDNQLT 474 (927)
Q Consensus 412 ~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-----------------~~~l~~L~~L~Ls~N~l~ 474 (927)
..++|+.|+|++|.+++.+| +..+++|++|+|++|.|++..+. ...+++|+.|+|++|+|+
T Consensus 56 ~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N~l~~~~~~~l~~L~~L~L~~N~l~ 133 (487)
T 3oja_A 56 PFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKIT 133 (487)
T ss_dssp TCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCCCEEECCCSSCEEEECCSSCCC
T ss_pred CCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCCCCcCEEECcCCcCCCCCccccCCCCEEECCCCCCC
Confidence 45688888999888887655 88888888888888877764321 123567888888888888
Q ss_pred CCCCccccCCCccccccccccccccccccccc---cccccccccCCc
Q 002409 475 GPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL---SKNVVLNYAGNI 518 (927)
Q Consensus 475 g~~P~~l~~l~~L~~L~l~~N~l~g~iP~~l~---~~~~~l~~~~n~ 518 (927)
+..|..++++++|+.|+|++|+|+|.+|..+. +.+..+++++|.
T Consensus 134 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~ 180 (487)
T 3oja_A 134 MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180 (487)
T ss_dssp SGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSC
T ss_pred CCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCc
Confidence 88888888899999999999999988887764 455667777774
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=98.77 E-value=4.3e-09 Score=124.47 Aligned_cols=90 Identities=23% Similarity=0.254 Sum_probs=49.7
Q ss_pred CceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCC-CCCccccCCCcccccc
Q 002409 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTG-PLPSSLMNLPNLRELY 491 (927)
Q Consensus 414 ~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g-~~P~~l~~l~~L~~L~ 491 (927)
++|++|+|++|++++..|..|.+|++|++|+|++|++++.+|. +.++++|++|+|++|++++ .+|..++++++|+.|+
T Consensus 50 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~ 129 (549)
T 2z81_A 50 ANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLR 129 (549)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEE
T ss_pred CcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEE
Confidence 4555555555555555555555555555555555555555554 5555555555555555554 2444555555555555
Q ss_pred cccccccccccc
Q 002409 492 VQNNMLSGTVPS 503 (927)
Q Consensus 492 l~~N~l~g~iP~ 503 (927)
|++|++.+.+|.
T Consensus 130 L~~n~~~~~~~~ 141 (549)
T 2z81_A 130 IGNVETFSEIRR 141 (549)
T ss_dssp EEESSSCCEECT
T ss_pred CCCCccccccCH
Confidence 555554444543
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=98.77 E-value=4.9e-09 Score=114.89 Aligned_cols=102 Identities=24% Similarity=0.382 Sum_probs=63.6
Q ss_pred CCCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCcccccc
Q 002409 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 491 (927)
Q Consensus 412 ~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~ 491 (927)
..++|+.|+|++|.+++ ++. +.++++|+.|+|++|++++..+ +.++++|+.|+|++|++++..| +..+++|+.|+
T Consensus 127 ~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~ 201 (308)
T 1h6u_A 127 GLSNLQVLYLDLNQITN-ISP-LAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKISDISP--LASLPNLIEVH 201 (308)
T ss_dssp TCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEE
T ss_pred CCCCCCEEECCCCccCc-Ccc-ccCCCCccEEEccCCcCCCChh-hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEE
Confidence 34567777777777764 333 6677777777777777766444 6667777777777777764332 66677777777
Q ss_pred ccccccccccccccccccccccccCCc
Q 002409 492 VQNNMLSGTVPSSLLSKNVVLNYAGNI 518 (927)
Q Consensus 492 l~~N~l~g~iP~~l~~~~~~l~~~~n~ 518 (927)
|++|++++..|-.-++.+..+.+.+|+
T Consensus 202 L~~N~l~~~~~l~~l~~L~~L~l~~N~ 228 (308)
T 1h6u_A 202 LKNNQISDVSPLANTSNLFIVTLTNQT 228 (308)
T ss_dssp CTTSCCCBCGGGTTCTTCCEEEEEEEE
T ss_pred ccCCccCccccccCCCCCCEEEccCCe
Confidence 777777744432223444555556664
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=98.77 E-value=9.1e-09 Score=125.14 Aligned_cols=104 Identities=24% Similarity=0.246 Sum_probs=56.7
Q ss_pred CceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCccccccc
Q 002409 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 492 (927)
Q Consensus 414 ~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 492 (927)
++|+.|+|++|.+++..|..+++|++|++|+|++|++++.++. |.++++|++|+|++|++++..|..++++++|+.|+|
T Consensus 49 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 128 (680)
T 1ziw_A 49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDL 128 (680)
T ss_dssp TTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEEC
T ss_pred CcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEEC
Confidence 3455555555555555555555555555555555555554443 555666666666666665544455666666666666
Q ss_pred ccccccccccccc--ccccccccccCC
Q 002409 493 QNNMLSGTVPSSL--LSKNVVLNYAGN 517 (927)
Q Consensus 493 ~~N~l~g~iP~~l--~~~~~~l~~~~n 517 (927)
++|++++..|..+ ++.+..+.+.+|
T Consensus 129 s~n~l~~~~~~~~~~l~~L~~L~L~~n 155 (680)
T 1ziw_A 129 SHNGLSSTKLGTQVQLENLQELLLSNN 155 (680)
T ss_dssp CSSCCSCCCCCSSSCCTTCCEEECCSS
T ss_pred CCCcccccCchhhcccccCCEEEccCC
Confidence 6666655444433 223344444544
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=98.76 E-value=9.6e-09 Score=113.37 Aligned_cols=114 Identities=25% Similarity=0.362 Sum_probs=77.9
Q ss_pred CcceeecCCCC--------CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCC
Q 002409 402 PWSWLQCNSDP--------QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 472 (927)
Q Consensus 402 ~~~~v~C~~~~--------~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~ 472 (927)
.+..+.|+... .+.++.|+|++|++++..+..|.++++|++|+|++|++++..|. +.++++|++|+|++|+
T Consensus 32 ~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 111 (330)
T 1xku_A 32 HLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 111 (330)
T ss_dssp ETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSC
T ss_pred CCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCc
Confidence 45667775422 34677788888888866666778888888888888888877664 7778888888888888
Q ss_pred cCCCCCccccCCCcccccccccccccccccccc--ccccccccccCCc
Q 002409 473 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNI 518 (927)
Q Consensus 473 l~g~~P~~l~~l~~L~~L~l~~N~l~g~iP~~l--~~~~~~l~~~~n~ 518 (927)
++ .+|..+. ++|+.|++++|++++..+..+ ++.+..+.+.+|.
T Consensus 112 l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 156 (330)
T 1xku_A 112 LK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNP 156 (330)
T ss_dssp CS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSC
T ss_pred CC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCc
Confidence 77 6676654 678888888888874333322 2334555556553
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=98.75 E-value=7e-09 Score=108.95 Aligned_cols=104 Identities=23% Similarity=0.217 Sum_probs=80.4
Q ss_pred CCceEEEEecC-CCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCcc---EEEecCC-CcCCCCCccccCCCcc
Q 002409 413 QPSITVIHLSS-KNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLR---IIHLEDN-QLTGPLPSSLMNLPNL 487 (927)
Q Consensus 413 ~~~l~~L~L~~-n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~---~L~Ls~N-~l~g~~P~~l~~l~~L 487 (927)
.++|+.|+|++ |.|++..+..+.++++|+.|+|++|.+++ +|.+.++++|+ +|+|++| ++++..+..+.++++|
T Consensus 79 l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L 157 (239)
T 2xwt_C 79 LSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNE 157 (239)
T ss_dssp CTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCCCTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSS
T ss_pred CcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccccccccccccccEEECCCCcchhhcCcccccchhcc
Confidence 45788888888 88886556678888888888888888887 56677777777 8888888 8886666678888888
Q ss_pred c-cccccccccccccccccccc--cccccccCCc
Q 002409 488 R-ELYVQNNMLSGTVPSSLLSK--NVVLNYAGNI 518 (927)
Q Consensus 488 ~-~L~l~~N~l~g~iP~~l~~~--~~~l~~~~n~ 518 (927)
+ .|+|++|+++ .+|...+.. +..+.+.+|.
T Consensus 158 ~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~ 190 (239)
T 2xwt_C 158 TLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNK 190 (239)
T ss_dssp EEEEECCSCCCC-EECTTTTTTCEEEEEECTTCT
T ss_pred eeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCC
Confidence 8 8888888888 788765543 4556667774
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.74 E-value=1.7e-08 Score=107.99 Aligned_cols=99 Identities=30% Similarity=0.446 Sum_probs=69.5
Q ss_pred CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCccccccc
Q 002409 413 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 492 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 492 (927)
.++|+.|+|++|.|++ +|+ +.+|++|+.|+|++|++++ +|.+.. ++|++|+|++|++++ +| .+.++++|+.|+|
T Consensus 62 l~~L~~L~L~~N~i~~-~~~-l~~l~~L~~L~L~~N~l~~-l~~~~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~L 135 (263)
T 1xeu_A 62 FTNLKELHLSHNQISD-LSP-LKDLTKLEELSVNRNRLKN-LNGIPS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSI 135 (263)
T ss_dssp CTTCCEEECCSSCCCC-CGG-GTTCSSCCEEECCSSCCSC-CTTCCC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEEC
T ss_pred CCCCCEEECCCCccCC-Chh-hccCCCCCEEECCCCccCC-cCcccc-CcccEEEccCCccCC-Ch-hhcCcccccEEEC
Confidence 4678888888888884 444 8888888888888888877 344444 778888888888875 33 5778888888888
Q ss_pred ccccccccccc-ccccccccccccCCc
Q 002409 493 QNNMLSGTVPS-SLLSKNVVLNYAGNI 518 (927)
Q Consensus 493 ~~N~l~g~iP~-~l~~~~~~l~~~~n~ 518 (927)
++|+|++ +|. .-++.+..+++.+|.
T Consensus 136 s~N~i~~-~~~l~~l~~L~~L~L~~N~ 161 (263)
T 1xeu_A 136 RNNKLKS-IVMLGFLSKLEVLDLHGNE 161 (263)
T ss_dssp TTSCCCB-CGGGGGCTTCCEEECTTSC
T ss_pred CCCcCCC-ChHHccCCCCCEEECCCCc
Confidence 8888874 341 223445566666664
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=98.73 E-value=8.5e-09 Score=114.45 Aligned_cols=104 Identities=20% Similarity=0.318 Sum_probs=83.8
Q ss_pred CCCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCcccccc
Q 002409 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 491 (927)
Q Consensus 412 ~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~ 491 (927)
..++|+.|+|++|.+++ + +.+..+++|+.|+|++|.+++. |.+..+++|+.|+|++|++++..|..+..+++|+.|+
T Consensus 241 ~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 317 (347)
T 4fmz_A 241 NLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISDI-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLF 317 (347)
T ss_dssp TCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEE
T ss_pred cCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCCC-hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEE
Confidence 35678888999888885 3 4688888899999999988875 6678888899999999998888888888888999999
Q ss_pred ccccccccccccccccccccccccCCc
Q 002409 492 VQNNMLSGTVPSSLLSKNVVLNYAGNI 518 (927)
Q Consensus 492 l~~N~l~g~iP~~l~~~~~~l~~~~n~ 518 (927)
|++|++++..|..-++.+..+++.+|+
T Consensus 318 L~~n~l~~~~~~~~l~~L~~L~l~~N~ 344 (347)
T 4fmz_A 318 LSQNHITDIRPLASLSKMDSADFANQV 344 (347)
T ss_dssp CCSSSCCCCGGGGGCTTCSEESSSCC-
T ss_pred ccCCccccccChhhhhccceeehhhhc
Confidence 999998876664556666777777775
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=98.72 E-value=1.4e-08 Score=110.18 Aligned_cols=81 Identities=30% Similarity=0.495 Sum_probs=47.4
Q ss_pred CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCccccccc
Q 002409 413 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 492 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 492 (927)
.++|+.|+|++|++++ + +.+..+++|+.|+|++|++++. +.+..+++|+.|+|++|++++..| +..+++|+.|+|
T Consensus 111 l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L 185 (291)
T 1h6t_A 111 LKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYL 185 (291)
T ss_dssp CTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred CCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCCccccchh--hcCCCccCEEEC
Confidence 3456666666666653 2 3455666666666666666554 445556666666666666654333 556666666666
Q ss_pred cccccc
Q 002409 493 QNNMLS 498 (927)
Q Consensus 493 ~~N~l~ 498 (927)
++|+|+
T Consensus 186 ~~N~i~ 191 (291)
T 1h6t_A 186 SKNHIS 191 (291)
T ss_dssp CSSCCC
T ss_pred CCCcCC
Confidence 666665
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=98.72 E-value=9.5e-09 Score=113.56 Aligned_cols=101 Identities=25% Similarity=0.366 Sum_probs=92.2
Q ss_pred ceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCcccccccc
Q 002409 415 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 493 (927)
Q Consensus 415 ~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~ 493 (927)
+++.|++++++++ .+|..+. ++|+.|+|++|.+++..|. +.++++|++|+|++|++++..|..+.++++|+.|+|+
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 6789999999999 8898774 7999999999999998874 8999999999999999998889999999999999999
Q ss_pred ccccccccccccccccccccccCCcc
Q 002409 494 NNMLSGTVPSSLLSKNVVLNYAGNIN 519 (927)
Q Consensus 494 ~N~l~g~iP~~l~~~~~~l~~~~n~~ 519 (927)
+|+++ .+|..+...+..+.+.+|..
T Consensus 111 ~n~l~-~l~~~~~~~L~~L~l~~n~i 135 (332)
T 2ft3_A 111 KNHLV-EIPPNLPSSLVELRIHDNRI 135 (332)
T ss_dssp SSCCC-SCCSSCCTTCCEEECCSSCC
T ss_pred CCcCC-ccCccccccCCEEECCCCcc
Confidence 99999 89999888888888888853
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.72 E-value=9.2e-09 Score=114.74 Aligned_cols=105 Identities=27% Similarity=0.181 Sum_probs=69.6
Q ss_pred CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCC--CCCCCCCccEEEecCCC-cCCCCCccccCCCcccc
Q 002409 413 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP--DFSGCPDLRIIHLEDNQ-LTGPLPSSLMNLPNLRE 489 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p--~~~~l~~L~~L~Ls~N~-l~g~~P~~l~~l~~L~~ 489 (927)
.++|+.|+|++|++++..+..+.++++|++|+|++|++++..+ .+.++++|++|+|++|+ +++..|..+.++++|+.
T Consensus 99 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~ 178 (353)
T 2z80_A 99 LGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEE 178 (353)
T ss_dssp CTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEE
T ss_pred CCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCE
Confidence 4567777777777774333337777777777777777776554 36677777777777774 55445566777777777
Q ss_pred cccccccccccccccccc--ccccccccCC
Q 002409 490 LYVQNNMLSGTVPSSLLS--KNVVLNYAGN 517 (927)
Q Consensus 490 L~l~~N~l~g~iP~~l~~--~~~~l~~~~n 517 (927)
|++++|++++..|..+.. .+..+.+.+|
T Consensus 179 L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n 208 (353)
T 2z80_A 179 LEIDASDLQSYEPKSLKSIQNVSHLILHMK 208 (353)
T ss_dssp EEEEETTCCEECTTTTTTCSEEEEEEEECS
T ss_pred EECCCCCcCccCHHHHhccccCCeecCCCC
Confidence 777777777665665532 3345555555
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=98.72 E-value=1.3e-08 Score=110.63 Aligned_cols=81 Identities=25% Similarity=0.392 Sum_probs=54.0
Q ss_pred CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCccccccc
Q 002409 413 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 492 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 492 (927)
.++|+.|+|++|++++. +.+.++++|+.|+|++|++++..| +..+++|+.|+|++|++++ +| .+..+++|+.|+|
T Consensus 133 l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l 207 (291)
T 1h6t_A 133 LPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLEL 207 (291)
T ss_dssp CTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEE
T ss_pred CCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh-hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEEC
Confidence 45677777777777643 456667777777777777766555 6667777777777777763 44 3666777777777
Q ss_pred cccccc
Q 002409 493 QNNMLS 498 (927)
Q Consensus 493 ~~N~l~ 498 (927)
++|+++
T Consensus 208 ~~n~i~ 213 (291)
T 1h6t_A 208 FSQECL 213 (291)
T ss_dssp EEEEEE
T ss_pred cCCccc
Confidence 777766
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=98.70 E-value=1.9e-08 Score=110.22 Aligned_cols=103 Identities=28% Similarity=0.420 Sum_probs=83.5
Q ss_pred CCCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCcccccc
Q 002409 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 491 (927)
Q Consensus 412 ~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~ 491 (927)
..++|+.|+|++|++++ +|. +..+++|+.|+|++|.+++..+ +.++++|++|+|++|++++ +|. +.++++|+.|+
T Consensus 105 ~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~ 179 (308)
T 1h6u_A 105 GLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP-LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLK 179 (308)
T ss_dssp TCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEE
T ss_pred CCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc-ccCCCCccEEEccCCcCCC-Chh-hcCCCCCCEEE
Confidence 35689999999999985 554 8999999999999999988665 8889999999999999985 444 89999999999
Q ss_pred ccccccccccccccccccccccccCCcc
Q 002409 492 VQNNMLSGTVPSSLLSKNVVLNYAGNIN 519 (927)
Q Consensus 492 l~~N~l~g~iP~~l~~~~~~l~~~~n~~ 519 (927)
|++|++++..|-.-++.+..+.+.+|.-
T Consensus 180 l~~n~l~~~~~l~~l~~L~~L~L~~N~l 207 (308)
T 1h6u_A 180 ADDNKISDISPLASLPNLIEVHLKNNQI 207 (308)
T ss_dssp CCSSCCCCCGGGGGCTTCCEEECTTSCC
T ss_pred CCCCccCcChhhcCCCCCCEEEccCCcc
Confidence 9999999544433345567777777743
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=98.69 E-value=2.3e-08 Score=118.57 Aligned_cols=91 Identities=29% Similarity=0.417 Sum_probs=57.1
Q ss_pred ceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCccccccccc
Q 002409 415 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 494 (927)
Q Consensus 415 ~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~ 494 (927)
+|+.|+|++|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|++|+|++|+|++ +|. +. ++|+.|+|++
T Consensus 121 ~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~--~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~ 189 (571)
T 3cvr_A 121 SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE--LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVST 189 (571)
T ss_dssp TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC--CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCS
T ss_pred CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC--cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcC
Confidence 56677777777765 555 56667777777777766 443 46667777777777765 665 54 6677777777
Q ss_pred ccccccccccccccc-------ccccccCCc
Q 002409 495 NMLSGTVPSSLLSKN-------VVLNYAGNI 518 (927)
Q Consensus 495 N~l~g~iP~~l~~~~-------~~l~~~~n~ 518 (927)
|+|+ .+|. +...+ ..+.+.+|.
T Consensus 190 N~L~-~lp~-~~~~L~~~~~~L~~L~Ls~N~ 218 (571)
T 3cvr_A 190 NLLE-SLPA-VPVRNHHSEETEIFFRCRENR 218 (571)
T ss_dssp SCCS-SCCC-CC--------CCEEEECCSSC
T ss_pred CCCC-chhh-HHHhhhcccccceEEecCCCc
Confidence 7777 6666 44444 555566653
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=98.68 E-value=1.9e-08 Score=120.37 Aligned_cols=103 Identities=27% Similarity=0.402 Sum_probs=82.0
Q ss_pred CCCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCcccccc
Q 002409 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 491 (927)
Q Consensus 412 ~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~ 491 (927)
.+++|+.|+|++|.|++ + +.+..|++|+.|+|++|.|++. +.+..|++|+.|+|++|+|++..| +..|++|+.|+
T Consensus 107 ~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~ 181 (605)
T 1m9s_A 107 DLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLY 181 (605)
T ss_dssp TCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC-GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred cCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc-hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEE
Confidence 46789999999999985 4 4688899999999999999886 778889999999999999987666 88899999999
Q ss_pred cccccccccccc-ccccccccccccCCccc
Q 002409 492 VQNNMLSGTVPS-SLLSKNVVLNYAGNINL 520 (927)
Q Consensus 492 l~~N~l~g~iP~-~l~~~~~~l~~~~n~~l 520 (927)
|++|+|++ +|. .-++.+..|.+.+|+..
T Consensus 182 Ls~N~i~~-l~~l~~l~~L~~L~L~~N~l~ 210 (605)
T 1m9s_A 182 LSKNHISD-LRALAGLKNLDVLELFSQECL 210 (605)
T ss_dssp CCSSCCCB-CGGGTTCTTCSEEECCSEEEE
T ss_pred CcCCCCCC-ChHHccCCCCCEEEccCCcCc
Confidence 99999985 442 22445667777777543
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=98.68 E-value=2.7e-08 Score=119.10 Aligned_cols=89 Identities=24% Similarity=0.360 Sum_probs=71.7
Q ss_pred CCCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCcccccc
Q 002409 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 491 (927)
Q Consensus 412 ~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~ 491 (927)
.+++|+.|+|++|.|++. +.+..|++|+.|+|++|.|++.+| +..|++|+.|+|++|+|++ +| .+..|++|+.|+
T Consensus 129 ~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~ 203 (605)
T 1m9s_A 129 HLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLE 203 (605)
T ss_dssp GCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEE
T ss_pred CCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh-hccCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEE
Confidence 356888899999988854 678888899999999998888777 8888889999999998885 44 588888899999
Q ss_pred ccccccccccccccc
Q 002409 492 VQNNMLSGTVPSSLL 506 (927)
Q Consensus 492 l~~N~l~g~iP~~l~ 506 (927)
|++|+|++ .|....
T Consensus 204 L~~N~l~~-~p~~~~ 217 (605)
T 1m9s_A 204 LFSQECLN-KPINHQ 217 (605)
T ss_dssp CCSEEEEC-CCCCCC
T ss_pred ccCCcCcC-Cccccc
Confidence 99998883 454443
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.67 E-value=8e-09 Score=112.85 Aligned_cols=184 Identities=21% Similarity=0.247 Sum_probs=119.2
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhcc-CCCc--cceecceeecC---eEEEEEEecc
Q 002409 605 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNL--VQFLGYCQEEG---RSVLVYEFMH 678 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~-HpnI--v~l~g~~~~~~---~~~lV~E~~~ 678 (927)
+.++.|....||+.. +.+++|+-... .....+.+|+++|+.+. +..+ .+.+......+ ..++|||+++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 457899999999863 56888885422 34567889999998883 3332 33444433332 3478999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhC----------------------------------------
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG---------------------------------------- 718 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~---------------------------------------- 718 (927)
|.+|.+... ..++..++..++.++++.|+.||+.
T Consensus 100 G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 100 GVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 988865331 2355666677788888888888851
Q ss_pred ---------------CCCceecCCCCCCCeEECC--CCcEEEEeecCcccccCCCCceeeeeccCCCc---cCcccccc-
Q 002409 719 ---------------CVPAIIHRDLKSSNILLDK--HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY---LDPEYYIS- 777 (927)
Q Consensus 719 ---------------~~~~ivHrDLkp~NILl~~--~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y---~aPE~~~~- 777 (927)
..+.++|+|++|.||+++. ...+.|+||+.+..... ..... ....+ ..|+....
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~-~~Dl~----~~~~~~~~~~~~~~~~~ 248 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDP-DNDFI----SLMEDDEEYGMEFVSKI 248 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECT-THHHH----TTCCTTTSCCHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCCh-HHHHH----HHHhhccccCHHHHHHH
Confidence 1146899999999999998 45688999998864321 11110 01111 22222111
Q ss_pred ----C---------cCCCccceeeHHHHHHHHHhCCCcccc
Q 002409 778 ----Q---------QLTDKSDVYSFGVILLELISGQEAISN 805 (927)
Q Consensus 778 ----~---------~~s~~sDVwSlGvvL~elltG~~p~~~ 805 (927)
+ ......+.|+++.++|++.+|+.++..
T Consensus 249 l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~~ 289 (304)
T 3sg8_A 249 LNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWYE 289 (304)
T ss_dssp HHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHH
T ss_pred HHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHHH
Confidence 0 011225889999999999999988743
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.66 E-value=3.7e-08 Score=105.34 Aligned_cols=99 Identities=20% Similarity=0.293 Sum_probs=83.0
Q ss_pred CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCccccccc
Q 002409 413 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 492 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 492 (927)
.++|+.|+|++|+++ .+| .+..+++|+.|+|++|+|++..| +.++++|++|+|++|++++ +|.. .. ++|+.|+|
T Consensus 40 l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~-l~~l~~L~~L~L~~N~l~~-l~~~-~~-~~L~~L~L 113 (263)
T 1xeu_A 40 LSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP-LKDLTKLEELSVNRNRLKN-LNGI-PS-ACLSRLFL 113 (263)
T ss_dssp HTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG-GTTCSSCCEEECCSSCCSC-CTTC-CC-SSCCEEEC
T ss_pred cCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh-hccCCCCCEEECCCCccCC-cCcc-cc-CcccEEEc
Confidence 468999999999999 677 79999999999999999999877 9999999999999999996 5543 33 89999999
Q ss_pred ccccccccccc-ccccccccccccCCc
Q 002409 493 QNNMLSGTVPS-SLLSKNVVLNYAGNI 518 (927)
Q Consensus 493 ~~N~l~g~iP~-~l~~~~~~l~~~~n~ 518 (927)
++|+|++ +|. .-++.+..+++++|.
T Consensus 114 ~~N~l~~-~~~l~~l~~L~~L~Ls~N~ 139 (263)
T 1xeu_A 114 DNNELRD-TDSLIHLKNLEILSIRNNK 139 (263)
T ss_dssp CSSCCSB-SGGGTTCTTCCEEECTTSC
T ss_pred cCCccCC-ChhhcCcccccEEECCCCc
Confidence 9999995 542 224456677777774
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=98.64 E-value=2.9e-08 Score=104.17 Aligned_cols=102 Identities=17% Similarity=0.094 Sum_probs=72.2
Q ss_pred eEEEEecCC-CCCccCCchhhcCCCCc-EEeccCCcCCCCCCCCCCCCCccEEEecCCC-cCCCCCccccCC-Ccccccc
Q 002409 416 ITVIHLSSK-NLTGNIPSDLTKLSSLV-ELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQ-LTGPLPSSLMNL-PNLRELY 491 (927)
Q Consensus 416 l~~L~L~~n-~l~g~ip~~i~~L~~L~-~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~-l~g~~P~~l~~l-~~L~~L~ 491 (927)
|+.|+|++| ++++..+..+.++++|+ .|+|++|+++...+.....++|+.|+|++|+ +++..+..+..+ ++|+.|+
T Consensus 132 L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~ 211 (239)
T 2xwt_C 132 FFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLD 211 (239)
T ss_dssp EEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEE
T ss_pred ccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEE
Confidence 448888888 78765555678888888 8888888887443333333788888888884 775555667777 8888888
Q ss_pred ccccccccccccccccccccccccCCc
Q 002409 492 VQNNMLSGTVPSSLLSKNVVLNYAGNI 518 (927)
Q Consensus 492 l~~N~l~g~iP~~l~~~~~~l~~~~n~ 518 (927)
|++|+|+ .+|...+..+..+.+.++.
T Consensus 212 l~~N~l~-~l~~~~~~~L~~L~l~~~~ 237 (239)
T 2xwt_C 212 VSQTSVT-ALPSKGLEHLKELIARNTW 237 (239)
T ss_dssp CTTCCCC-CCCCTTCTTCSEEECTTC-
T ss_pred CCCCccc-cCChhHhccCceeeccCcc
Confidence 8888888 6777666666666655543
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.62 E-value=2.7e-08 Score=110.91 Aligned_cols=103 Identities=19% Similarity=0.228 Sum_probs=84.3
Q ss_pred CcceeecCCCC--------CCceEEEEecCCCCCccCCc-hhhcCCCCcEEeccCCcCCCCCCC--CCCCCCccE-EEec
Q 002409 402 PWSWLQCNSDP--------QPSITVIHLSSKNLTGNIPS-DLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRI-IHLE 469 (927)
Q Consensus 402 ~~~~v~C~~~~--------~~~l~~L~L~~n~l~g~ip~-~i~~L~~L~~L~Ls~N~l~g~~p~--~~~l~~L~~-L~Ls 469 (927)
.+..|.|+... .++++.|+|++|+|+ .||+ .|.+|++|++|+|++|++.+.+|. |.++++|+. +.++
T Consensus 10 ~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 10 SNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp ETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred eCCEEEecCCCCCccCcCcCCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 45668896532 257899999999999 5654 689999999999999999988875 788988765 7778
Q ss_pred CCCcCCCCCccccCCCcccccccccccccccccccc
Q 002409 470 DNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 505 (927)
Q Consensus 470 ~N~l~g~~P~~l~~l~~L~~L~l~~N~l~g~iP~~l 505 (927)
.|++++..|..|.++++|+.|++++|+|++..+...
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~ 124 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHK 124 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTT
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhh
Confidence 899998778899999999999999999994433333
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.61 E-value=1.1e-08 Score=112.49 Aligned_cols=98 Identities=24% Similarity=0.252 Sum_probs=77.9
Q ss_pred CceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCcccccccc
Q 002409 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 493 (927)
Q Consensus 414 ~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~ 493 (927)
++|+.|+|++|++++..|..+.++++|+.|+|++|.+++.+| +..+++|++|+|++|++++ +| .+++|+.|+++
T Consensus 34 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~-~~~l~~L~~L~Ls~n~l~~-l~----~~~~L~~L~l~ 107 (317)
T 3o53_A 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD-LESLSTLRTLDLNNNYVQE-LL----VGPSIETLHAA 107 (317)
T ss_dssp GGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE-ETTCTTCCEEECCSSEEEE-EE----ECTTCCEEECC
T ss_pred CCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh-hhhcCCCCEEECcCCcccc-cc----CCCCcCEEECC
Confidence 478899999999997777788999999999999999988776 8888999999999998884 22 34788888888
Q ss_pred ccccccccccccccccccccccCCc
Q 002409 494 NNMLSGTVPSSLLSKNVVLNYAGNI 518 (927)
Q Consensus 494 ~N~l~g~iP~~l~~~~~~l~~~~n~ 518 (927)
+|++++ +|...+..+..+.+.+|.
T Consensus 108 ~n~l~~-~~~~~~~~L~~L~l~~N~ 131 (317)
T 3o53_A 108 NNNISR-VSCSRGQGKKNIYLANNK 131 (317)
T ss_dssp SSCCSE-EEECCCSSCEEEECCSSC
T ss_pred CCccCC-cCccccCCCCEEECCCCC
Confidence 888884 444456667777777774
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=98.59 E-value=4.6e-08 Score=113.43 Aligned_cols=102 Identities=25% Similarity=0.299 Sum_probs=75.5
Q ss_pred CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCccccccc
Q 002409 413 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 492 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 492 (927)
.++|+.|+|++|.+++..| +..+++|+.|+|++|++++..| +..+++|+.|+|++|++++. ..+.++++|+.|++
T Consensus 286 l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l 360 (466)
T 1o6v_A 286 LTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSA 360 (466)
T ss_dssp CTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEEC
T ss_pred CCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh-hccCccCCEeECCCCccCCc--hhhccCCCCCEEeC
Confidence 4678888888888875433 7778888888888888887766 67788888888888888764 46778888888888
Q ss_pred cccccccccccccccccccccccCCcc
Q 002409 493 QNNMLSGTVPSSLLSKNVVLNYAGNIN 519 (927)
Q Consensus 493 ~~N~l~g~iP~~l~~~~~~l~~~~n~~ 519 (927)
++|+++|..|..-++.+..+.+.+|.-
T Consensus 361 ~~n~l~~~~~~~~l~~L~~L~l~~n~~ 387 (466)
T 1o6v_A 361 GHNQISDLTPLANLTRITQLGLNDQAW 387 (466)
T ss_dssp CSSCCCBCGGGTTCTTCCEEECCCEEE
T ss_pred CCCccCccchhhcCCCCCEEeccCCcc
Confidence 888888777744455566666666643
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.58 E-value=9.4e-08 Score=110.65 Aligned_cols=78 Identities=22% Similarity=0.253 Sum_probs=41.5
Q ss_pred CceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCcccccccc
Q 002409 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 493 (927)
Q Consensus 414 ~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~ 493 (927)
++|+.|+|++|++++ +| ++.+++|+.|+|++|++++. ++..+++|++|+|++|++++ +| ++.+++|+.|+++
T Consensus 170 ~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~--~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~ 241 (457)
T 3bz5_A 170 TQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL--DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCS 241 (457)
T ss_dssp TTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC--CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECC
T ss_pred CcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee--ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEee
Confidence 455555555555553 33 55555555555555555553 24555555555555555554 44 4555555555555
Q ss_pred cccccc
Q 002409 494 NNMLSG 499 (927)
Q Consensus 494 ~N~l~g 499 (927)
+|+|+|
T Consensus 242 ~N~l~~ 247 (457)
T 3bz5_A 242 VNPLTE 247 (457)
T ss_dssp SSCCSC
T ss_pred CCcCCC
Confidence 555553
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=98.58 E-value=9.4e-10 Score=112.30 Aligned_cols=101 Identities=29% Similarity=0.320 Sum_probs=72.7
Q ss_pred CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCcccccc
Q 002409 413 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 491 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~ 491 (927)
.++|+.|+|++|.+++ +| .+.++++|+.|+|++|.|+. +|. +..+++|++|+|++|++++ +| .+.++++|+.|+
T Consensus 47 l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~-l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~ 121 (198)
T 1ds9_A 47 LKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLY 121 (198)
T ss_dssp TTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECS-CSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEE
T ss_pred CCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCccc-ccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEE
Confidence 4578888888888885 67 78888888888888888874 444 4556788888888888875 55 577788888888
Q ss_pred cccccccccccc--cc--ccccccccccCCcc
Q 002409 492 VQNNMLSGTVPS--SL--LSKNVVLNYAGNIN 519 (927)
Q Consensus 492 l~~N~l~g~iP~--~l--~~~~~~l~~~~n~~ 519 (927)
|++|+++ .+|. .+ ++.+..+.+.+|+.
T Consensus 122 l~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~l 152 (198)
T 1ds9_A 122 MSNNKIT-NWGEIDKLAALDKLEDLLLAGNPL 152 (198)
T ss_dssp ESEEECC-CHHHHHHHTTTTTCSEEEECSCHH
T ss_pred CCCCcCC-chhHHHHHhcCCCCCEEEecCCcc
Confidence 8888887 3433 22 33455666677753
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=98.57 E-value=6e-08 Score=112.48 Aligned_cols=99 Identities=31% Similarity=0.422 Sum_probs=57.5
Q ss_pred CceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCcccccccc
Q 002409 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 493 (927)
Q Consensus 414 ~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~ 493 (927)
++|+.|+|++|.+++..| +..+++|+.|+|++|.+++..+ +..+++|+.|+|++|++++..| +..+++|+.|+|+
T Consensus 243 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~ 317 (466)
T 1o6v_A 243 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLY 317 (466)
T ss_dssp TTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECC
T ss_pred CCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc-ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECc
Confidence 456666666666664333 5666666666666666665444 5556666666666666664333 5566666666666
Q ss_pred ccccccccccccccccccccccCC
Q 002409 494 NNMLSGTVPSSLLSKNVVLNYAGN 517 (927)
Q Consensus 494 ~N~l~g~iP~~l~~~~~~l~~~~n 517 (927)
+|++++..|..-++.+..+.+.+|
T Consensus 318 ~n~l~~~~~~~~l~~L~~L~l~~n 341 (466)
T 1o6v_A 318 FNNISDISPVSSLTKLQRLFFYNN 341 (466)
T ss_dssp SSCCSCCGGGGGCTTCCEEECCSS
T ss_pred CCcCCCchhhccCccCCEeECCCC
Confidence 666665555443444455555555
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=98.57 E-value=1e-09 Score=112.05 Aligned_cols=99 Identities=26% Similarity=0.385 Sum_probs=58.7
Q ss_pred ceEEEEecCCCCCccCCc------hhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCccc
Q 002409 415 SITVIHLSSKNLTGNIPS------DLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 488 (927)
Q Consensus 415 ~l~~L~L~~n~l~g~ip~------~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~ 488 (927)
+++.++|+.+.+.|.+|. .+.++++|+.|+|++|.+++ +|.+.++++|++|+|++|+++ .+|..+..+++|+
T Consensus 19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~ 96 (198)
T 1ds9_A 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-ISSLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96 (198)
T ss_dssp CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CCCHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCS
T ss_pred cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-ccccccCCCCCEEECCCCCcc-cccchhhcCCcCC
Confidence 344455555555555554 66666666666666666666 445566666666666666666 5666666666666
Q ss_pred ccccccccccccccccc--ccccccccccCC
Q 002409 489 ELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 517 (927)
Q Consensus 489 ~L~l~~N~l~g~iP~~l--~~~~~~l~~~~n 517 (927)
.|+|++|+|++ +| .+ ++.+..+++.+|
T Consensus 97 ~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N 125 (198)
T 1ds9_A 97 ELWISYNQIAS-LS-GIEKLVNLRVLYMSNN 125 (198)
T ss_dssp EEEEEEEECCC-HH-HHHHHHHSSEEEESEE
T ss_pred EEECcCCcCCc-CC-ccccCCCCCEEECCCC
Confidence 66666666663 44 22 223344455554
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.54 E-value=1.4e-07 Score=109.30 Aligned_cols=96 Identities=25% Similarity=0.254 Sum_probs=55.4
Q ss_pred CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCccccccc
Q 002409 413 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 492 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 492 (927)
.++|+.|+|++|++++ +| ++++++|++|+|++|.|++. | ++++++|++|+|++|++++ +| ++++++|+.|++
T Consensus 63 l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~-~-~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l 134 (457)
T 3bz5_A 63 LTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNL-D-VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNC 134 (457)
T ss_dssp CTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC-C-CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEEC
T ss_pred cCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCcee-e-cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEEC
Confidence 3456666666666664 33 56666666666666666653 2 5566666666666666664 33 566666666666
Q ss_pred cccccccccccccccccccccccCC
Q 002409 493 QNNMLSGTVPSSLLSKNVVLNYAGN 517 (927)
Q Consensus 493 ~~N~l~g~iP~~l~~~~~~l~~~~n 517 (927)
++|+|++ +|.+-++.+..+.+.+|
T Consensus 135 ~~N~l~~-l~l~~l~~L~~L~l~~n 158 (457)
T 3bz5_A 135 ARNTLTE-IDVSHNTQLTELDCHLN 158 (457)
T ss_dssp TTSCCSC-CCCTTCTTCCEEECTTC
T ss_pred CCCccce-eccccCCcCCEEECCCC
Confidence 6666664 44333444455555555
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=98.50 E-value=1.2e-07 Score=105.07 Aligned_cols=102 Identities=22% Similarity=0.323 Sum_probs=82.9
Q ss_pred CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCccccccc
Q 002409 413 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 492 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 492 (927)
.++|+.|+|++|++++ ++. +..+++|+.|+|++|.+++. +.+..+++|++|+|++|++++. +.+..+++|+.|+|
T Consensus 220 ~~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L 294 (347)
T 4fmz_A 220 MTRLNSLKIGNNKITD-LSP-LANLSQLTWLEIGTNQISDI-NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFL 294 (347)
T ss_dssp CTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEEC
T ss_pred CCcCCEEEccCCccCC-Ccc-hhcCCCCCEEECCCCccCCC-hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEEC
Confidence 4689999999999984 444 88899999999999998874 6788899999999999999863 45888999999999
Q ss_pred ccccccccccccc--ccccccccccCCcc
Q 002409 493 QNNMLSGTVPSSL--LSKNVVLNYAGNIN 519 (927)
Q Consensus 493 ~~N~l~g~iP~~l--~~~~~~l~~~~n~~ 519 (927)
++|++++..|..+ ++.+..+.+.+|.-
T Consensus 295 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l 323 (347)
T 4fmz_A 295 NNNQLGNEDMEVIGGLTNLTTLFLSQNHI 323 (347)
T ss_dssp CSSCCCGGGHHHHHTCTTCSEEECCSSSC
T ss_pred cCCcCCCcChhHhhccccCCEEEccCCcc
Confidence 9999987776655 34567777888853
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=98.47 E-value=2.2e-07 Score=107.39 Aligned_cols=96 Identities=34% Similarity=0.497 Sum_probs=75.3
Q ss_pred CceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCcccccccc
Q 002409 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 493 (927)
Q Consensus 414 ~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~ 493 (927)
++|+.|+|++|.+++ +| .++++++|++|+|++|++++ +|.. ..+|++|+|++|++++ +| .++++++|+.|+++
T Consensus 131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~--~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~ 203 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDL--PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYAD 203 (454)
T ss_dssp TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCC--CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECC
T ss_pred CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCC--cccccEEECcCCcCCc-Cc-cccCCCCCCEEECC
Confidence 578899999999986 77 58899999999999999887 5543 3588999999999886 66 58889999999999
Q ss_pred ccccccccccccccccccccccCCc
Q 002409 494 NNMLSGTVPSSLLSKNVVLNYAGNI 518 (927)
Q Consensus 494 ~N~l~g~iP~~l~~~~~~l~~~~n~ 518 (927)
+|++++ +|... ..+..+.+.+|.
T Consensus 204 ~N~l~~-l~~~~-~~L~~L~l~~n~ 226 (454)
T 1jl5_A 204 NNSLKK-LPDLP-LSLESIVAGNNI 226 (454)
T ss_dssp SSCCSS-CCCCC-TTCCEEECCSSC
T ss_pred CCcCCc-CCCCc-CcccEEECcCCc
Confidence 999884 66533 455666666663
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.45 E-value=2e-08 Score=113.48 Aligned_cols=105 Identities=20% Similarity=0.301 Sum_probs=63.6
Q ss_pred CceEEEEecCCCCC--c---cCCchhhcCCCCcEEeccCCcCC----CCCCC-CCCCCCccEEEecCCCcCCC----CCc
Q 002409 414 PSITVIHLSSKNLT--G---NIPSDLTKLSSLVELWLDGNSLT----GPIPD-FSGCPDLRIIHLEDNQLTGP----LPS 479 (927)
Q Consensus 414 ~~l~~L~L~~n~l~--g---~ip~~i~~L~~L~~L~Ls~N~l~----g~~p~-~~~l~~L~~L~Ls~N~l~g~----~P~ 479 (927)
++|+.|+|++|+++ | .+|..+.++++|+.|+|++|.|+ +.+|. +..+++|++|+|++|+|++. +|.
T Consensus 187 ~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~ 266 (386)
T 2ca6_A 187 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVD 266 (386)
T ss_dssp TTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHH
T ss_pred CCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHH
Confidence 45666777766666 2 23335666666777777777664 44443 55666677777777766654 455
Q ss_pred cc--cCCCcccccccccccccc----cccccc---ccccccccccCCc
Q 002409 480 SL--MNLPNLRELYVQNNMLSG----TVPSSL---LSKNVVLNYAGNI 518 (927)
Q Consensus 480 ~l--~~l~~L~~L~l~~N~l~g----~iP~~l---~~~~~~l~~~~n~ 518 (927)
.+ +++++|+.|+|++|+|++ .+|..+ ++.+..+.+.+|.
T Consensus 267 ~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~ 314 (386)
T 2ca6_A 267 AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNR 314 (386)
T ss_dssp HHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSB
T ss_pred HHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCc
Confidence 55 336667777777777665 366655 3445556666664
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=98.44 E-value=1.2e-07 Score=113.85 Aligned_cols=85 Identities=32% Similarity=0.397 Sum_probs=71.8
Q ss_pred CceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCcccccccc
Q 002409 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 493 (927)
Q Consensus 414 ~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~ 493 (927)
++|+.|+|++|+|++ +| ..+++|+.|+|++|+|++ +|. .+++|+.|+|++|+|+ .+|..+.++++|+.|+|+
T Consensus 221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~--~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~ 292 (622)
T 3g06_A 221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPM--LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE 292 (622)
T ss_dssp TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC--CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECC
T ss_pred CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCc--ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEec
Confidence 578999999999985 77 456889999999999985 444 6788999999999998 788889999999999999
Q ss_pred ccccccccccccc
Q 002409 494 NNMLSGTVPSSLL 506 (927)
Q Consensus 494 ~N~l~g~iP~~l~ 506 (927)
+|+|+|.+|..+.
T Consensus 293 ~N~l~~~~~~~l~ 305 (622)
T 3g06_A 293 GNPLSERTLQALR 305 (622)
T ss_dssp SCCCCHHHHHHHH
T ss_pred CCCCCCcCHHHHH
Confidence 9999988887664
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=98.43 E-value=1.5e-07 Score=108.84 Aligned_cols=85 Identities=31% Similarity=0.482 Sum_probs=41.8
Q ss_pred CceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCC--CCCccccCC-------
Q 002409 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTG--PLPSSLMNL------- 484 (927)
Q Consensus 414 ~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g--~~P~~l~~l------- 484 (927)
++|+.|+|++|++++ +|.. +++|+.|+|++|++++ +|. .+++|++|+|++|++++ .+|.++.+|
T Consensus 317 ~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~--~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~ 389 (454)
T 1jl5_A 317 PSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE-VPE--LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLA 389 (454)
T ss_dssp TTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC--CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC---
T ss_pred CcCCEEECCCCcccc-cccc---CCcCCEEECCCCcccc-ccc--hhhhccEEECCCCCCCcCCCChHHHHhhhhccccc
Confidence 366677777777764 5543 4667777777777764 444 46677777777777776 666666666
Q ss_pred ------Ccccccccccccccc--cccccc
Q 002409 485 ------PNLRELYVQNNMLSG--TVPSSL 505 (927)
Q Consensus 485 ------~~L~~L~l~~N~l~g--~iP~~l 505 (927)
++|+.|++++|+++| .+|.++
T Consensus 390 ~i~~~~~~L~~L~ls~N~l~~~~~iP~sl 418 (454)
T 1jl5_A 390 EVPELPQNLKQLHVETNPLREFPDIPESV 418 (454)
T ss_dssp -----------------------------
T ss_pred ccccccCcCCEEECCCCcCCccccchhhH
Confidence 666777777777665 566554
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.43 E-value=1.9e-08 Score=113.56 Aligned_cols=105 Identities=25% Similarity=0.373 Sum_probs=83.1
Q ss_pred CceEEEEecCCCCC-ccCC---chhhcCCCCcEEeccCCcCC--C---CCC-CCCCCCCccEEEecCCCcC----CCCCc
Q 002409 414 PSITVIHLSSKNLT-GNIP---SDLTKLSSLVELWLDGNSLT--G---PIP-DFSGCPDLRIIHLEDNQLT----GPLPS 479 (927)
Q Consensus 414 ~~l~~L~L~~n~l~-g~ip---~~i~~L~~L~~L~Ls~N~l~--g---~~p-~~~~l~~L~~L~Ls~N~l~----g~~P~ 479 (927)
++|+.|+|++|.++ +.+| ..+.++++|+.|+|++|+|+ | .+| .+..+++|+.|+|++|+++ +.+|.
T Consensus 159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~ 238 (386)
T 2ca6_A 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 238 (386)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHH
Confidence 57889999999887 5556 46778889999999999888 4 456 5778889999999999986 67888
Q ss_pred cccCCCccccccccccccccc----ccccc----ccccccccccCCc
Q 002409 480 SLMNLPNLRELYVQNNMLSGT----VPSSL----LSKNVVLNYAGNI 518 (927)
Q Consensus 480 ~l~~l~~L~~L~l~~N~l~g~----iP~~l----~~~~~~l~~~~n~ 518 (927)
.+..+++|+.|+|++|+|++. +|..+ .+.+..+++.+|.
T Consensus 239 ~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~ 285 (386)
T 2ca6_A 239 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNE 285 (386)
T ss_dssp HGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSC
T ss_pred HHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCc
Confidence 888888999999999998865 56655 4556777777774
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=98.38 E-value=5.6e-08 Score=107.18 Aligned_cols=103 Identities=17% Similarity=0.182 Sum_probs=68.7
Q ss_pred CceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCC-CCC-CCCCCCccEEEecCCCcCCCCCccccCCCcccccc
Q 002409 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGP-IPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 491 (927)
Q Consensus 414 ~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~-~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~ 491 (927)
++++.|+|++|.+.+.++. +.++++|+.|+|++|.+++. +|. +.++++|++|+|++|++++..|..++++++|+.|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 5677777777777765544 55677777777777777664 554 56677777777777777777777777777777777
Q ss_pred cccc-ccccc-ccccc--ccccccccccCC
Q 002409 492 VQNN-MLSGT-VPSSL--LSKNVVLNYAGN 517 (927)
Q Consensus 492 l~~N-~l~g~-iP~~l--~~~~~~l~~~~n 517 (927)
|++| .+++. +|..+ ++.+..+++.+|
T Consensus 149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~ 178 (336)
T 2ast_B 149 LSGCSGFSEFALQTLLSSCSRLDELNLSWC 178 (336)
T ss_dssp CTTCBSCCHHHHHHHHHHCTTCCEEECCCC
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCEEcCCCC
Confidence 7777 56652 44433 334455566655
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=98.29 E-value=1.1e-06 Score=105.34 Aligned_cols=73 Identities=34% Similarity=0.524 Sum_probs=31.5
Q ss_pred eEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCcccccccccc
Q 002409 416 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 495 (927)
Q Consensus 416 l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N 495 (927)
++.|+|++|+|+ .+|..+. ++|+.|+|++|+|++ +|. .+++|++|+|++|+|+ .+|. .+++|+.|+|++|
T Consensus 42 l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~-lp~--~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N 111 (622)
T 3g06_A 42 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA--LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFSN 111 (622)
T ss_dssp CCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSC-CCC--CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECSC
T ss_pred CcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCCC-CCC--cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCC
Confidence 444444444444 4444333 444444444444442 222 3344444444444444 2333 3344444444444
Q ss_pred ccc
Q 002409 496 MLS 498 (927)
Q Consensus 496 ~l~ 498 (927)
+|+
T Consensus 112 ~l~ 114 (622)
T 3g06_A 112 PLT 114 (622)
T ss_dssp CCC
T ss_pred cCC
Confidence 444
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=98.27 E-value=8.2e-08 Score=105.84 Aligned_cols=112 Identities=20% Similarity=0.289 Sum_probs=95.5
Q ss_pred CcceeecCCCCCCceEEEEecCCCCCccCCchhhcC--CCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCC-CC
Q 002409 402 PWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKL--SSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGP-LP 478 (927)
Q Consensus 402 ~~~~v~C~~~~~~~l~~L~L~~n~l~g~ip~~i~~L--~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~-~P 478 (927)
.|..+.|+. ..++.|+|+++.+. |..+..+ ++|+.|+|++|.+++.++.+.++++|++|+|++|++++. +|
T Consensus 38 ~W~~~~~~~---~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~ 111 (336)
T 2ast_B 38 RWYRLASDE---SLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLH 111 (336)
T ss_dssp HHHHHHTCS---TTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHH
T ss_pred HHHHHhcCc---hhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHH
Confidence 466666642 35789999999887 5778888 999999999999999999988999999999999999876 88
Q ss_pred ccccCCCccccccccccccccccccccc--cccccccccCCcc
Q 002409 479 SSLMNLPNLRELYVQNNMLSGTVPSSLL--SKNVVLNYAGNIN 519 (927)
Q Consensus 479 ~~l~~l~~L~~L~l~~N~l~g~iP~~l~--~~~~~l~~~~n~~ 519 (927)
..+..+++|+.|+|++|++++.+|..+. +.+..+++.+|..
T Consensus 112 ~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~ 154 (336)
T 2ast_B 112 GILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSG 154 (336)
T ss_dssp HHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBS
T ss_pred HHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCC
Confidence 8999999999999999999988887663 4557777777743
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.27 E-value=1e-07 Score=106.77 Aligned_cols=88 Identities=23% Similarity=0.225 Sum_probs=52.1
Q ss_pred ceEEEEecCCCCCccCC----chhhcCC-CCcEEeccCCcCCCCCCC-CCCC-----CCccEEEecCCCcCCCCCccccC
Q 002409 415 SITVIHLSSKNLTGNIP----SDLTKLS-SLVELWLDGNSLTGPIPD-FSGC-----PDLRIIHLEDNQLTGPLPSSLMN 483 (927)
Q Consensus 415 ~l~~L~L~~n~l~g~ip----~~i~~L~-~L~~L~Ls~N~l~g~~p~-~~~l-----~~L~~L~Ls~N~l~g~~P~~l~~ 483 (927)
+|+.|||++|.+++..+ ..+.+++ +|+.|+|++|.|++..+. +..+ ++|++|+|++|++++..+..+..
T Consensus 23 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~ 102 (362)
T 3goz_A 23 GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVK 102 (362)
T ss_dssp TCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred CceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHH
Confidence 46666666666665444 4555666 666666666666665443 3322 66666666666666555553333
Q ss_pred ----C-Cccccccccccccccccc
Q 002409 484 ----L-PNLRELYVQNNMLSGTVP 502 (927)
Q Consensus 484 ----l-~~L~~L~l~~N~l~g~iP 502 (927)
+ ++|+.|+|++|+|++..+
T Consensus 103 ~l~~~~~~L~~L~Ls~N~l~~~~~ 126 (362)
T 3goz_A 103 TLAAIPFTITVLDLGWNDFSSKSS 126 (362)
T ss_dssp HHHTSCTTCCEEECCSSCGGGSCH
T ss_pred HHHhCCCCccEEECcCCcCCcHHH
Confidence 2 566666666666664433
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.27 E-value=3.3e-07 Score=97.67 Aligned_cols=78 Identities=26% Similarity=0.363 Sum_probs=42.4
Q ss_pred CCceEEEEecCCCCCc--cCCchhhcCCCCcEEeccCCcCCCC--CCCCCCCCCccEEEecCCCcCCCCCc-------cc
Q 002409 413 QPSITVIHLSSKNLTG--NIPSDLTKLSSLVELWLDGNSLTGP--IPDFSGCPDLRIIHLEDNQLTGPLPS-------SL 481 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g--~ip~~i~~L~~L~~L~Ls~N~l~g~--~p~~~~l~~L~~L~Ls~N~l~g~~P~-------~l 481 (927)
.++|+.|+|++|+|++ .+|..+..|++|+.|+|++|+|++. +..+..+ +|++|+|++|.+.+.+|+ .+
T Consensus 169 l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l~~l~~l-~L~~L~L~~Npl~~~~~~~~~y~~~il 247 (267)
T 3rw6_A 169 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGL-KLEELWLDGNSLCDTFRDQSTYISAIR 247 (267)
T ss_dssp CTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGGGGGTTS-CCSEEECTTSTTGGGCSSHHHHHHHHH
T ss_pred CCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhhhhcccC-CcceEEccCCcCccccCcchhHHHHHH
Confidence 3456666666666665 4445555666666666666666653 1123333 566666666666655552 24
Q ss_pred cCCCcccccc
Q 002409 482 MNLPNLRELY 491 (927)
Q Consensus 482 ~~l~~L~~L~ 491 (927)
..+++|+.||
T Consensus 248 ~~~P~L~~LD 257 (267)
T 3rw6_A 248 ERFPKLLRLD 257 (267)
T ss_dssp HHCTTCCEES
T ss_pred HHCcccCeEC
Confidence 4555555543
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.10 E-value=4.4e-07 Score=101.48 Aligned_cols=101 Identities=20% Similarity=0.180 Sum_probs=85.9
Q ss_pred EEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCC----C-CCCCC-CccEEEecCCCcCCCCCccccCC-----Cc
Q 002409 418 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP----D-FSGCP-DLRIIHLEDNQLTGPLPSSLMNL-----PN 486 (927)
Q Consensus 418 ~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p----~-~~~l~-~L~~L~Ls~N~l~g~~P~~l~~l-----~~ 486 (927)
.++|+.|+++|.+|..+...++|+.|+|++|.|++..+ . +.+++ +|++|+|++|++++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 46899999999999888888889999999999998876 3 67788 99999999999998888888776 99
Q ss_pred cccccccccccccccccccc-------cccccccccCCc
Q 002409 487 LRELYVQNNMLSGTVPSSLL-------SKNVVLNYAGNI 518 (927)
Q Consensus 487 L~~L~l~~N~l~g~iP~~l~-------~~~~~l~~~~n~ 518 (927)
|+.|+|++|+|++..+..+. +.+..+++++|.
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~ 120 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWND 120 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSC
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCc
Confidence 99999999999977766442 355677777775
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.08 E-value=1.5e-05 Score=86.93 Aligned_cols=134 Identities=20% Similarity=0.244 Sum_probs=88.3
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCC---Cccceeccee-ecCeEEEEEEeccCC
Q 002409 605 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR---NLVQFLGYCQ-EEGRSVLVYEFMHNG 680 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~Hp---nIv~l~g~~~-~~~~~~lV~E~~~~g 680 (927)
+.++.|....||+. ++.+++|+-. .......+..|.++|+.+.+. .+.+.+.++. ..+..++|||+++|.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 45788888899987 5678888742 223456788999999999653 2445555553 345678999999998
Q ss_pred chhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhC------------------------------------------
Q 002409 681 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG------------------------------------------ 718 (927)
Q Consensus 681 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~------------------------------------------ 718 (927)
++.+.... .++...+..++.++++.|+.||+.
T Consensus 99 ~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 99 ILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp ECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred ECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 87653211 112223333344444444444331
Q ss_pred ---------------CCCceecCCCCCCCeEECC---CCc-EEEEeecCcc
Q 002409 719 ---------------CVPAIIHRDLKSSNILLDK---HMR-AKVSDFGLSK 750 (927)
Q Consensus 719 ---------------~~~~ivHrDLkp~NILl~~---~~~-vkL~DFGla~ 750 (927)
..+.++|+|+++.|||++. ++. +.|+||+.+.
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 2236799999999999997 455 5899999775
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.06 E-value=4.6e-07 Score=96.52 Aligned_cols=67 Identities=27% Similarity=0.467 Sum_probs=57.1
Q ss_pred hcCCCCcEEeccCCcCCC--CCCC-CCCCCCccEEEecCCCcCCCCCccccCCC--cccccccccccccccccc
Q 002409 435 TKLSSLVELWLDGNSLTG--PIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLP--NLRELYVQNNMLSGTVPS 503 (927)
Q Consensus 435 ~~L~~L~~L~Ls~N~l~g--~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~--~L~~L~l~~N~l~g~iP~ 503 (927)
.+|++|+.|+|++|+|++ .+|. +..+++|+.|+|++|+|++. ..+..+. +|+.|+|++|.+++.+|.
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~ 238 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRD 238 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSS
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCc
Confidence 568999999999999999 5565 56799999999999999965 4455555 899999999999988873
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.00 E-value=1.4e-05 Score=88.97 Aligned_cols=80 Identities=4% Similarity=0.057 Sum_probs=55.8
Q ss_pred ccc-cccCceEEEEEEEC-------CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccC---CCccceecceeec---
Q 002409 605 KKI-GSGGFGVVYYGKLK-------DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHH---RNLVQFLGYCQEE--- 667 (927)
Q Consensus 605 ~~I-G~G~fG~Vy~~~~~-------~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~H---pnIv~l~g~~~~~--- 667 (927)
+.| +.|....+|+.... +++.+++|+-.... ......+..|+.+++.+.. -.+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 78888999988764 26778888764322 1123568889999998853 2456677777654
Q ss_pred CeEEEEEEeccCCchhh
Q 002409 668 GRSVLVYEFMHNGTLKE 684 (927)
Q Consensus 668 ~~~~lV~E~~~~gsL~~ 684 (927)
+..++|||+++|..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999877654
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=97.99 E-value=6.5e-06 Score=91.54 Aligned_cols=105 Identities=19% Similarity=0.199 Sum_probs=66.5
Q ss_pred CceEEEEecC-CCCCccCCchhhcCC-CCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCc-cccCCCccccc
Q 002409 414 PSITVIHLSS-KNLTGNIPSDLTKLS-SLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPS-SLMNLPNLREL 490 (927)
Q Consensus 414 ~~l~~L~L~~-n~l~g~ip~~i~~L~-~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~-~l~~l~~L~~L 490 (927)
.++..|++.+ +++....+..+..+. .|+.|+|++|+|+...+......+|+.|+|++|+..+.+|. .|..+++|+.|
T Consensus 128 ~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~L 207 (350)
T 4ay9_X 128 LQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVIL 207 (350)
T ss_dssp SSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEE
T ss_pred chhhhhhhccccccccccccchhhcchhhhhhccccccccCCChhhccccchhHHhhccCCcccCCCHHHhccCcccchh
Confidence 3566677755 445533333455554 57777888887776666655566777777775433335554 56777778888
Q ss_pred cccccccccccccccccccccccccCCcc
Q 002409 491 YVQNNMLSGTVPSSLLSKNVVLNYAGNIN 519 (927)
Q Consensus 491 ~l~~N~l~g~iP~~l~~~~~~l~~~~n~~ 519 (927)
+|++|+|+ .+|...+..+..+....+.+
T Consensus 208 dLs~N~l~-~lp~~~~~~L~~L~~l~~~~ 235 (350)
T 4ay9_X 208 DISRTRIH-SLPSYGLENLKKLRARSTYN 235 (350)
T ss_dssp ECTTSCCC-CCCSSSCTTCCEEECTTCTT
T ss_pred hcCCCCcC-ccChhhhccchHhhhccCCC
Confidence 88888877 77777666666555554443
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.98 E-value=2.7e-05 Score=82.88 Aligned_cols=134 Identities=17% Similarity=0.118 Sum_probs=92.9
Q ss_pred cccccCce-EEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhcc-CCCccceecceeecCeEEEEEEeccCCch
Q 002409 606 KIGSGGFG-VVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMHNGTL 682 (927)
Q Consensus 606 ~IG~G~fG-~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 682 (927)
.+..|..| .||+.... ++..+++|+-.. .....+.+|...|+.+. +--+-++++++.+.+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34555555 68987765 456789998653 23567888999998884 33356788888888999999999999877
Q ss_pred hhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCC-------------------------------------------
Q 002409 683 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC------------------------------------------- 719 (927)
Q Consensus 683 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~------------------------------------------- 719 (927)
.+..... ......++.+++..|+.||+..
T Consensus 108 ~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 108 FQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred cccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 6543211 0112234455555555555421
Q ss_pred ------------CCceecCCCCCCCeEECCCCcEEEEeecCcc
Q 002409 720 ------------VPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 750 (927)
Q Consensus 720 ------------~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 750 (927)
.+.++|+|+.+.|||++.++.+-|+||+.+.
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1248999999999999987777799999765
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=97.90 E-value=9.8e-07 Score=101.62 Aligned_cols=105 Identities=24% Similarity=0.180 Sum_probs=77.2
Q ss_pred CCceEEEEecCCCCCcc----CCchhhcCCCCcEEeccCCcCCCCCCC------CCCCCCccEEEecCCCcCCC----CC
Q 002409 413 QPSITVIHLSSKNLTGN----IPSDLTKLSSLVELWLDGNSLTGPIPD------FSGCPDLRIIHLEDNQLTGP----LP 478 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~----ip~~i~~L~~L~~L~Ls~N~l~g~~p~------~~~l~~L~~L~Ls~N~l~g~----~P 478 (927)
.++|+.|+|++|.+++. ++..+.++++|+.|+|++|.+++..+. ....++|++|+|++|++++. +|
T Consensus 255 ~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~ 334 (461)
T 1z7x_W 255 SSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFS 334 (461)
T ss_dssp TCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHH
Confidence 46788888888888854 677788888899999998888754332 12346888889988888865 56
Q ss_pred ccccCCCccccccccccccccccccccc-------cccccccccCC
Q 002409 479 SSLMNLPNLRELYVQNNMLSGTVPSSLL-------SKNVVLNYAGN 517 (927)
Q Consensus 479 ~~l~~l~~L~~L~l~~N~l~g~iP~~l~-------~~~~~l~~~~n 517 (927)
..+..+++|+.|+|++|++++..+..+. +.+..+++.+|
T Consensus 335 ~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n 380 (461)
T 1z7x_W 335 SVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADC 380 (461)
T ss_dssp HHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred HHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCC
Confidence 6777788888999998888865554443 24556666666
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=97.87 E-value=8.6e-07 Score=102.11 Aligned_cols=89 Identities=31% Similarity=0.393 Sum_probs=52.1
Q ss_pred CceEEEEecCCCCCc----cCCchhhcCCCCcEEeccCCcCCCCCCC-C-CCCC----CccEEEecCCCcCC----CCCc
Q 002409 414 PSITVIHLSSKNLTG----NIPSDLTKLSSLVELWLDGNSLTGPIPD-F-SGCP----DLRIIHLEDNQLTG----PLPS 479 (927)
Q Consensus 414 ~~l~~L~L~~n~l~g----~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~-~~l~----~L~~L~Ls~N~l~g----~~P~ 479 (927)
++|+.|+|++|++++ .++..+..+++|++|+|++|.++...+. + ..++ +|++|+|++|+++. .+|.
T Consensus 28 ~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~ 107 (461)
T 1z7x_W 28 QQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSS 107 (461)
T ss_dssp TTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred CCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHH
Confidence 356666666666663 3455566666666666666666553221 1 1232 56666666666662 4566
Q ss_pred cccCCCccccccccccccccccc
Q 002409 480 SLMNLPNLRELYVQNNMLSGTVP 502 (927)
Q Consensus 480 ~l~~l~~L~~L~l~~N~l~g~iP 502 (927)
.+.++++|+.|+|++|.+++..+
T Consensus 108 ~l~~~~~L~~L~Ls~n~i~~~~~ 130 (461)
T 1z7x_W 108 TLRTLPTLQELHLSDNLLGDAGL 130 (461)
T ss_dssp HTTSCTTCCEEECCSSBCHHHHH
T ss_pred HHccCCceeEEECCCCcCchHHH
Confidence 66666666666666666664333
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00013 Score=80.16 Aligned_cols=140 Identities=15% Similarity=0.224 Sum_probs=79.8
Q ss_pred cccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCC--Cccceec------ceeecCeEEEEEEec
Q 002409 606 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR--NLVQFLG------YCQEEGRSVLVYEFM 677 (927)
Q Consensus 606 ~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~Hp--nIv~l~g------~~~~~~~~~lV~E~~ 677 (927)
.|+.|..+.||+....++ .+++|+.... ...+..|..+++.+... .+.+++. +....+..+++|||+
T Consensus 39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp ECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 455577889999987644 5889988642 23445566666666321 2233332 123456789999999
Q ss_pred cCCchhh--------------hcccccc----c-c-----cccCHHHH-------------------------------H
Q 002409 678 HNGTLKE--------------HLYGTLT----H-E-----QRINWIKR-------------------------------L 702 (927)
Q Consensus 678 ~~gsL~~--------------~L~~~~~----~-~-----~~l~~~~~-------------------------------~ 702 (927)
+|..+.. .+|.... . . ..-.|... .
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 9865530 1111100 0 0 00122111 0
Q ss_pred HHHHHHHhHhHHHhh----------CCCCceecCCCCCCCeEECCCCcEEEEeecCcc
Q 002409 703 EIAEDAAKGIEYLHT----------GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 750 (927)
Q Consensus 703 ~i~~qia~gL~yLH~----------~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 750 (927)
.+..++..++++|++ .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111223445666653 012489999999999999888899999999764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00015 Score=81.77 Aligned_cols=74 Identities=18% Similarity=0.152 Sum_probs=48.5
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeecCCc-------hhhHhHHHHHHHHhhccC--CCcc-ceecceeecCeEEEE
Q 002409 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-------QGKREFTNEVTLLSRIHH--RNLV-QFLGYCQEEGRSVLV 673 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~-------~~~~~~~~Ei~iL~~l~H--pnIv-~l~g~~~~~~~~~lV 673 (927)
+.||.|..+.||+++.. +++.++||....... .....+..|.++|+.+.. +..+ +++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 46899999999999764 468899998653211 123456789999888743 3333 44433 34456899
Q ss_pred EEeccCC
Q 002409 674 YEFMHNG 680 (927)
Q Consensus 674 ~E~~~~g 680 (927)
||++++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999764
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=97.63 E-value=5.3e-05 Score=83.26 Aligned_cols=92 Identities=22% Similarity=0.289 Sum_probs=76.8
Q ss_pred CceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCcc-EEEecCCCcCCCCCccccCCCcccccc
Q 002409 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLR-IIHLEDNQLTGPLPSSLMNLPNLRELY 491 (927)
Q Consensus 414 ~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~-~L~Ls~N~l~g~~P~~l~~l~~L~~L~ 491 (927)
++|+.|+|++|+++..-+..|.++++|+.|+|++| ++...+. |.+|++|+ .|+|++ +++..-+..|.+|++|+.|+
T Consensus 226 ~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~ 303 (329)
T 3sb4_A 226 PNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVL 303 (329)
T ss_dssp TTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEE
T ss_pred CCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEE
Confidence 57999999999999444457889999999999998 6654444 89999999 999999 77755567899999999999
Q ss_pred ccccccccccccccccc
Q 002409 492 VQNNMLSGTVPSSLLSK 508 (927)
Q Consensus 492 l~~N~l~g~iP~~l~~~ 508 (927)
|++|+++ .|+...+..
T Consensus 304 l~~n~i~-~I~~~aF~~ 319 (329)
T 3sb4_A 304 ATGDKIT-TLGDELFGN 319 (329)
T ss_dssp ECSSCCC-EECTTTTCT
T ss_pred eCCCccC-ccchhhhcC
Confidence 9999999 787766543
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00024 Score=76.38 Aligned_cols=74 Identities=20% Similarity=0.244 Sum_probs=54.2
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCC-C--ccceecceeecCeEEEEEEeccCCc
Q 002409 605 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR-N--LVQFLGYCQEEGRSVLVYEFMHNGT 681 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~Hp-n--Iv~l~g~~~~~~~~~lV~E~~~~gs 681 (927)
+.+|.|..+.||+.+..||+.+++|+-..........|..|++.|+.+... . +.+.+++ + ..++||||++.+.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEEeecccC
Confidence 468999999999999999999999987655444456688999999988432 2 2333433 2 2478999988764
Q ss_pred h
Q 002409 682 L 682 (927)
Q Consensus 682 L 682 (927)
.
T Consensus 97 ~ 97 (288)
T 3f7w_A 97 P 97 (288)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.57 E-value=4.8e-06 Score=93.50 Aligned_cols=84 Identities=24% Similarity=0.207 Sum_probs=38.4
Q ss_pred ceEEEEecCCCCCc----cCCchhhcCCCCcEEeccCCcCCCCC----CC-CCCCCCccEEEecCCCcCC----CCCccc
Q 002409 415 SITVIHLSSKNLTG----NIPSDLTKLSSLVELWLDGNSLTGPI----PD-FSGCPDLRIIHLEDNQLTG----PLPSSL 481 (927)
Q Consensus 415 ~l~~L~L~~n~l~g----~ip~~i~~L~~L~~L~Ls~N~l~g~~----p~-~~~l~~L~~L~Ls~N~l~g----~~P~~l 481 (927)
.|+.|+|++|.|+. .++..+..+++|++|+|++|.|+..- +. +..+++|+.|+|++|+|+. .++..+
T Consensus 156 ~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L 235 (372)
T 3un9_A 156 QITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAA 235 (372)
T ss_dssp CCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHH
T ss_pred ccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHH
Confidence 45555555555542 13333344555555555555554311 11 3334455555555555542 122333
Q ss_pred cCCCccccccccccccc
Q 002409 482 MNLPNLRELYVQNNMLS 498 (927)
Q Consensus 482 ~~l~~L~~L~l~~N~l~ 498 (927)
...++|+.|+|++|.|+
T Consensus 236 ~~~~~L~~L~Ls~N~i~ 252 (372)
T 3un9_A 236 REHPSLELLHLYFNELS 252 (372)
T ss_dssp HHCSSCCEEECTTSSCC
T ss_pred HhCCCCCEEeccCCCCC
Confidence 33445555555555554
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.55 E-value=6.1e-06 Score=92.70 Aligned_cols=84 Identities=23% Similarity=0.248 Sum_probs=45.8
Q ss_pred ceEEEEecCCCCCccCCchhh-----cCCCCcEEeccCCcCCCC----CCC-CCCCCCccEEEecCCCcCC----CCCcc
Q 002409 415 SITVIHLSSKNLTGNIPSDLT-----KLSSLVELWLDGNSLTGP----IPD-FSGCPDLRIIHLEDNQLTG----PLPSS 480 (927)
Q Consensus 415 ~l~~L~L~~n~l~g~ip~~i~-----~L~~L~~L~Ls~N~l~g~----~p~-~~~l~~L~~L~Ls~N~l~g----~~P~~ 480 (927)
+|+.|+|++|+|+..-...+. ..++|+.|+|++|.|+.. ++. +..+++|++|+|++|+|+. .++..
T Consensus 127 ~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~ 206 (372)
T 3un9_A 127 RARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQ 206 (372)
T ss_dssp TEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHH
T ss_pred hccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHH
Confidence 466666666666533222222 245566666666666431 111 3445666666666666653 22344
Q ss_pred ccCCCccccccccccccc
Q 002409 481 LMNLPNLRELYVQNNMLS 498 (927)
Q Consensus 481 l~~l~~L~~L~l~~N~l~ 498 (927)
+..+++|+.|+|++|+|+
T Consensus 207 L~~~~~L~~L~Ls~N~i~ 224 (372)
T 3un9_A 207 LDRNRQLQELNVAYNGAG 224 (372)
T ss_dssp GGGCSCCCEEECCSSCCC
T ss_pred HhcCCCcCeEECCCCCCC
Confidence 555566666666666665
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.44 E-value=0.00052 Score=74.82 Aligned_cols=74 Identities=19% Similarity=0.242 Sum_probs=58.7
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhcc---CCCccceecceeecCeEEEEEEeccCCc
Q 002409 605 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH---HRNLVQFLGYCQEEGRSVLVYEFMHNGT 681 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~---HpnIv~l~g~~~~~~~~~lV~E~~~~gs 681 (927)
+.|+.|....+|+.... ++.+++|+.... ....+..|.+.|+.+. ...+.+++.++...+..++|||++++..
T Consensus 42 ~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 42 EKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred EEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 35788999999998864 778899987532 3566889999998884 2557788888887788999999999876
Q ss_pred h
Q 002409 682 L 682 (927)
Q Consensus 682 L 682 (927)
+
T Consensus 118 ~ 118 (312)
T 3jr1_A 118 N 118 (312)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.34 E-value=1.8e-05 Score=79.64 Aligned_cols=86 Identities=20% Similarity=0.327 Sum_probs=55.8
Q ss_pred CceEEEEecCC-CCCcc----CCchhhcCCCCcEEeccCCcCCCC----CCC-CCCCCCccEEEecCCCcCCC----CCc
Q 002409 414 PSITVIHLSSK-NLTGN----IPSDLTKLSSLVELWLDGNSLTGP----IPD-FSGCPDLRIIHLEDNQLTGP----LPS 479 (927)
Q Consensus 414 ~~l~~L~L~~n-~l~g~----ip~~i~~L~~L~~L~Ls~N~l~g~----~p~-~~~l~~L~~L~Ls~N~l~g~----~P~ 479 (927)
+.|+.|+|++| .+... +...+...++|++|+|++|.|... +.. +...+.|++|+|++|+|... +..
T Consensus 36 ~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~ 115 (185)
T 1io0_A 36 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 115 (185)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHH
Confidence 46777777777 76532 344555567777888888777542 111 34456777788888777642 455
Q ss_pred cccCCCccccccc--ccccccc
Q 002409 480 SLMNLPNLRELYV--QNNMLSG 499 (927)
Q Consensus 480 ~l~~l~~L~~L~l--~~N~l~g 499 (927)
.+...++|+.|+| ++|.|+.
T Consensus 116 ~L~~n~~L~~L~L~~~~N~i~~ 137 (185)
T 1io0_A 116 ALQSNTSLIELRIDNQSQPLGN 137 (185)
T ss_dssp GGGGCSSCCEEECCCCSSCCCH
T ss_pred HHHhCCCceEEEecCCCCCCCH
Confidence 6666677777887 6777763
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=97.30 E-value=2.7e-05 Score=92.61 Aligned_cols=105 Identities=18% Similarity=0.089 Sum_probs=56.4
Q ss_pred CceEEEEec----CCCCCcc-----CCchhhcCCCCcEEeccCC--cCCCCCCC-C-CCCCCccEEEecCCCcCC-CCCc
Q 002409 414 PSITVIHLS----SKNLTGN-----IPSDLTKLSSLVELWLDGN--SLTGPIPD-F-SGCPDLRIIHLEDNQLTG-PLPS 479 (927)
Q Consensus 414 ~~l~~L~L~----~n~l~g~-----ip~~i~~L~~L~~L~Ls~N--~l~g~~p~-~-~~l~~L~~L~Ls~N~l~g-~~P~ 479 (927)
++|+.|+|+ .|.+++. ++..+.++++|+.|+|+.| .+++..+. + ..+++|++|+|++|++++ .++.
T Consensus 403 ~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~ 482 (592)
T 3ogk_B 403 KNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLME 482 (592)
T ss_dssp CSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHH
T ss_pred CCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHH
Confidence 456666664 5555542 3333555666666666532 24443322 2 235666666666666664 2344
Q ss_pred cccCCCcccccccccccccccccccc---ccccccccccCCc
Q 002409 480 SLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGNI 518 (927)
Q Consensus 480 ~l~~l~~L~~L~l~~N~l~g~iP~~l---~~~~~~l~~~~n~ 518 (927)
.+..+++|+.|+|++|+|++.....+ ++.+..+.+++|.
T Consensus 483 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~ 524 (592)
T 3ogk_B 483 FSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYR 524 (592)
T ss_dssp HHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCB
T ss_pred HHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCc
Confidence 44566666666666666654433222 3344555555554
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.12 E-value=3.7e-05 Score=77.27 Aligned_cols=86 Identities=10% Similarity=0.144 Sum_probs=68.7
Q ss_pred CCceEEEEecCCCCCcc----CCchhhcCCCCcEEeccCCcCCCC----C-CCCCCCCCccEEEe--cCCCcCCC----C
Q 002409 413 QPSITVIHLSSKNLTGN----IPSDLTKLSSLVELWLDGNSLTGP----I-PDFSGCPDLRIIHL--EDNQLTGP----L 477 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~----ip~~i~~L~~L~~L~Ls~N~l~g~----~-p~~~~l~~L~~L~L--s~N~l~g~----~ 477 (927)
.+.|+.|+|++|.|... +...+...+.|++|+|++|.|+.. + ..+...+.|++|+| ++|.|... +
T Consensus 64 ~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l 143 (185)
T 1io0_A 64 NTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEI 143 (185)
T ss_dssp CCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHH
T ss_pred CCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHH
Confidence 35799999999999742 455566778999999999999863 2 23677889999999 88999843 4
Q ss_pred CccccCCCccccccccccccc
Q 002409 478 PSSLMNLPNLRELYVQNNMLS 498 (927)
Q Consensus 478 P~~l~~l~~L~~L~l~~N~l~ 498 (927)
...+...++|+.|+|++|.+.
T Consensus 144 ~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 144 ANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHhCCCcCEEeccCCCCC
Confidence 455666789999999999986
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0019 Score=73.47 Aligned_cols=78 Identities=15% Similarity=0.202 Sum_probs=45.6
Q ss_pred CceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCceeeee-ccCCCccCccccccCc---CCCccceeeHHHHHHHH
Q 002409 721 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV-RGTVGYLDPEYYISQQ---LTDKSDVYSFGVILLEL 796 (927)
Q Consensus 721 ~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~-~gt~~Y~aPE~~~~~~---~s~~sDVwSlGvvL~el 796 (927)
..++|||+++.|||++.++ ++|+||+.+....... ...... .-...|++|+...... -....++......+|+.
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~-Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF-DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH-HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH-HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 4899999999999998876 9999999886432110 110000 0012455555443111 11123455777777777
Q ss_pred HhCC
Q 002409 797 ISGQ 800 (927)
Q Consensus 797 ltG~ 800 (927)
+.+.
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0025 Score=69.26 Aligned_cols=143 Identities=16% Similarity=0.201 Sum_probs=79.7
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCc--cceecc------eeecCeEEEEEEe
Q 002409 605 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL--VQFLGY------CQEEGRSVLVYEF 676 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnI--v~l~g~------~~~~~~~~lV~E~ 676 (927)
+.|+.|....+|+....++ .+++|+.... .....+..|+.+++.+....+ .+++.. ....+..+++++|
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 3466788889999987755 6788987642 123456678888877743232 233321 1224567899999
Q ss_pred ccCCchhhh--------------ccccc---ccc-----cccCHHHHHH------------HHHHHHhHhHHHhhC----
Q 002409 677 MHNGTLKEH--------------LYGTL---THE-----QRINWIKRLE------------IAEDAAKGIEYLHTG---- 718 (927)
Q Consensus 677 ~~~gsL~~~--------------L~~~~---~~~-----~~l~~~~~~~------------i~~qia~gL~yLH~~---- 718 (927)
++|..+... ++... ... ....|..... +...+...++++++.
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 988654220 11100 000 0011222110 011133445555432
Q ss_pred CCCceecCCCCCCCeEECCCCcEEEEeecCcc
Q 002409 719 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 750 (927)
Q Consensus 719 ~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 750 (927)
....++|+|+++.|||++.+..+.|+||+.+.
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 12479999999999999987666899998764
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.82 E-value=0.00015 Score=71.80 Aligned_cols=85 Identities=12% Similarity=0.086 Sum_probs=65.5
Q ss_pred CceEEEEecCCCCCccCCchhhcCCCCcEEeccCCc-CCC-CCCCCCCC----CCccEEEecCCC-cCCCCCccccCCCc
Q 002409 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNS-LTG-PIPDFSGC----PDLRIIHLEDNQ-LTGPLPSSLMNLPN 486 (927)
Q Consensus 414 ~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~-l~g-~~p~~~~l----~~L~~L~Ls~N~-l~g~~P~~l~~l~~ 486 (927)
.+|+.|||+++.++..--..+.++++|+.|+|++|. ++. .+..++.+ ++|++|+|+++. +|..=-..+.++++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 479999999999875444567889999999999995 654 23334443 479999999984 77433346788999
Q ss_pred cccccccccc-cc
Q 002409 487 LRELYVQNNM-LS 498 (927)
Q Consensus 487 L~~L~l~~N~-l~ 498 (927)
|+.|+|+++. ++
T Consensus 141 L~~L~L~~c~~It 153 (176)
T 3e4g_A 141 LKYLFLSDLPGVK 153 (176)
T ss_dssp CCEEEEESCTTCC
T ss_pred CCEEECCCCCCCC
Confidence 9999999986 55
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=96.80 E-value=0.00018 Score=85.46 Aligned_cols=83 Identities=13% Similarity=0.185 Sum_probs=49.9
Q ss_pred CceEEEEecCCCCCccCCchhh-cCCCCcEEeccCC-cCCCC-CCCC-CCCCCccEEEecCCCcCCCCCcccc----CCC
Q 002409 414 PSITVIHLSSKNLTGNIPSDLT-KLSSLVELWLDGN-SLTGP-IPDF-SGCPDLRIIHLEDNQLTGPLPSSLM----NLP 485 (927)
Q Consensus 414 ~~l~~L~L~~n~l~g~ip~~i~-~L~~L~~L~Ls~N-~l~g~-~p~~-~~l~~L~~L~Ls~N~l~g~~P~~l~----~l~ 485 (927)
++|+.|+|++|.+++..+..+. .+++|+.|+|++| .++.. ++.+ .++++|++|+|++|.+++..+..+. .++
T Consensus 105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~ 184 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT 184 (594)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence 4566777777766665555555 5667777777766 44331 3333 3566777777777766654444333 445
Q ss_pred ccccccccccc
Q 002409 486 NLRELYVQNNM 496 (927)
Q Consensus 486 ~L~~L~l~~N~ 496 (927)
+|+.|+|++|.
T Consensus 185 ~L~~L~l~~~~ 195 (594)
T 2p1m_B 185 SLVSLNISCLA 195 (594)
T ss_dssp CCCEEECTTCC
T ss_pred cCcEEEecccC
Confidence 67777776665
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0048 Score=67.23 Aligned_cols=141 Identities=13% Similarity=0.150 Sum_probs=80.6
Q ss_pred cccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCC--ccceecc-----eeecCeEEEEEEecc
Q 002409 606 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN--LVQFLGY-----CQEEGRSVLVYEFMH 678 (927)
Q Consensus 606 ~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~g~-----~~~~~~~~lV~E~~~ 678 (927)
.++ |....||+....+|+.+++|+..... .....+..|..+++.+.... +.+++.. ....+..+++||+++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 355 77789999877777789999986332 23456777888888875322 3334432 122456688999998
Q ss_pred CCchhh----h----------cccccc-----cccccCHHHH----------------------HHHHHHHHhHhHHHhh
Q 002409 679 NGTLKE----H----------LYGTLT-----HEQRINWIKR----------------------LEIAEDAAKGIEYLHT 717 (927)
Q Consensus 679 ~gsL~~----~----------L~~~~~-----~~~~l~~~~~----------------------~~i~~qia~gL~yLH~ 717 (927)
|..+.. . ++.... ....+++... ...+.+++..+.-+..
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 865431 0 111000 0111221110 0111122222221111
Q ss_pred -CCCCceecCCCCCCCeEECCCCcEEEEeecCcc
Q 002409 718 -GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 750 (927)
Q Consensus 718 -~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 750 (927)
.....++|+|+++.|||++ + .+.|+||+.+.
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 1224789999999999999 4 89999998765
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=96.76 E-value=0.00049 Score=81.57 Aligned_cols=56 Identities=13% Similarity=0.138 Sum_probs=29.1
Q ss_pred CceEEEEecCCCCC----ccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEec
Q 002409 414 PSITVIHLSSKNLT----GNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLE 469 (927)
Q Consensus 414 ~~l~~L~L~~n~l~----g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls 469 (927)
++|+.|+|++|.++ +.++..+.++++|+.|+|++|.+.+....+.++++|+.|+++
T Consensus 192 ~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~l~~~~~~~~~L~~L~l~ 251 (592)
T 3ogk_B 192 TSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGG 251 (592)
T ss_dssp CCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGGGHHHHHHCTTCCEEEEC
T ss_pred CCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHHHHHHHhhhhHHHhhccc
Confidence 45666666666655 233444455566666666666555422223444444444444
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0032 Score=68.93 Aligned_cols=141 Identities=13% Similarity=0.110 Sum_probs=71.8
Q ss_pred cccccCceE-EEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCC--ccceecceeecCeEEEEEEeccCCch
Q 002409 606 KIGSGGFGV-VYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN--LVQFLGYCQEEGRSVLVYEFMHNGTL 682 (927)
Q Consensus 606 ~IG~G~fG~-Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~g~~~~~~~~~lV~E~~~~gsL 682 (927)
.|+.|+... +|+....+++.+++|...... ...+..|+.+++.+.... +.+++.+..+.+ +++||++.+..+
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l 99 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALF 99 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBH
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcch
Confidence 455554444 667765446777777643221 134566788877774323 345565543333 789999876665
Q ss_pred hhhccccc---------------------cc-ccccCHHHHH--------------------HHHHHHHhHhHHHh---h
Q 002409 683 KEHLYGTL---------------------TH-EQRINWIKRL--------------------EIAEDAAKGIEYLH---T 717 (927)
Q Consensus 683 ~~~L~~~~---------------------~~-~~~l~~~~~~--------------------~i~~qia~gL~yLH---~ 717 (927)
.+.+.... .. ...++..... .....+...++.+. .
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~ 179 (333)
T 3csv_A 100 TEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQL 179 (333)
T ss_dssp HHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHC
T ss_pred HHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcc
Confidence 44331100 00 0011110000 00011111222221 1
Q ss_pred CCCCceecCCCCCCCeEECCC----CcEEEEeecCccc
Q 002409 718 GCVPAIIHRDLKSSNILLDKH----MRAKVSDFGLSKF 751 (927)
Q Consensus 718 ~~~~~ivHrDLkp~NILl~~~----~~vkL~DFGla~~ 751 (927)
.....++|||+.+.|||++.+ +.+.|+||+.+..
T Consensus 180 ~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 180 EGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred cCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 112489999999999999875 6899999998763
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=96.72 E-value=0.00012 Score=86.99 Aligned_cols=105 Identities=14% Similarity=0.091 Sum_probs=62.3
Q ss_pred CCceEEEEec--C----CCCCc-----cCCchhhcCCCCcEEeccCCcCCCCCC-CCCC-CCCccEEEecCCCcCCCCCc
Q 002409 413 QPSITVIHLS--S----KNLTG-----NIPSDLTKLSSLVELWLDGNSLTGPIP-DFSG-CPDLRIIHLEDNQLTGPLPS 479 (927)
Q Consensus 413 ~~~l~~L~L~--~----n~l~g-----~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~-l~~L~~L~Ls~N~l~g~~P~ 479 (927)
.++|+.|+|+ + +++++ .++..+.++++|+.|+|++ .+++..+ .+.. +++|++|+|++|++++..+.
T Consensus 396 ~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~ 474 (594)
T 2p1m_B 396 RPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMH 474 (594)
T ss_dssp CTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHH
T ss_pred CCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHH
Confidence 3567777777 3 44542 1122256677777777766 4544322 2433 67777777777777655444
Q ss_pred cc-cCCCccccccccccccccccccccc---cccccccccCCc
Q 002409 480 SL-MNLPNLRELYVQNNMLSGTVPSSLL---SKNVVLNYAGNI 518 (927)
Q Consensus 480 ~l-~~l~~L~~L~l~~N~l~g~iP~~l~---~~~~~l~~~~n~ 518 (927)
.+ ..+++|+.|+|++|.+++..+..+. +.+..+.+.+|+
T Consensus 475 ~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~ 517 (594)
T 2p1m_B 475 HVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCS 517 (594)
T ss_dssp HHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSC
T ss_pred HHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCC
Confidence 44 5577777777777777644443332 344556666664
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0041 Score=67.12 Aligned_cols=70 Identities=11% Similarity=0.131 Sum_probs=44.5
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCcc-ceecceeecCeEEEEEEec-cCCch
Q 002409 605 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV-QFLGYCQEEGRSVLVYEFM-HNGTL 682 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv-~l~g~~~~~~~~~lV~E~~-~~gsL 682 (927)
+.|+.|....+|+. +.+++|+-..... .......|+.+++.+....+. ++++++ .+..++++||+ ++.++
T Consensus 24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----GDLCLRIPGKGTE-EYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQTM 95 (301)
T ss_dssp EEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEEC
T ss_pred eEcCCcccccccee-----eeEEEECCCCCcc-ceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCccC
Confidence 56888999999998 5688888754321 122345788888887544443 445443 33346899999 65544
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.58 E-value=0.0057 Score=69.70 Aligned_cols=72 Identities=14% Similarity=0.316 Sum_probs=49.2
Q ss_pred ccccccCceEEEEEEECC--------CcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCc-cceecceeecCeEEEEEE
Q 002409 605 KKIGSGGFGVVYYGKLKD--------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL-VQFLGYCQEEGRSVLVYE 675 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~~--------g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~g~~~~~~~~~lV~E 675 (927)
+.|+.|-...+|+....+ ++.+++|+.... .....+..|..+++.+...++ .++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 457788889999998763 578999987432 111455679999988854444 456655432 28999
Q ss_pred eccCCch
Q 002409 676 FMHNGTL 682 (927)
Q Consensus 676 ~~~~gsL 682 (927)
|++|.+|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986554
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=96.41 E-value=0.0006 Score=76.00 Aligned_cols=105 Identities=18% Similarity=0.313 Sum_probs=61.2
Q ss_pred CCceEEEEecCCCCCccCCchhh--cCCCCcEEeccC--CcCCCC--C----CCC--CCCCCccEEEecCCCcCCCCCcc
Q 002409 413 QPSITVIHLSSKNLTGNIPSDLT--KLSSLVELWLDG--NSLTGP--I----PDF--SGCPDLRIIHLEDNQLTGPLPSS 480 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~ip~~i~--~L~~L~~L~Ls~--N~l~g~--~----p~~--~~l~~L~~L~Ls~N~l~g~~P~~ 480 (927)
.++|+.|+|..+++.......+. .|++|+.|+|+. |...|. + +.+ ..+++|++|+|++|.+.+..+..
T Consensus 192 ~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~ 271 (362)
T 2ra8_A 192 RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEM 271 (362)
T ss_dssp CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHH
T ss_pred CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHH
Confidence 35677777777766543333444 677888888753 222221 1 122 24778888888888876544333
Q ss_pred cc---CCCccccccccccccccc----ccccc--ccccccccccCC
Q 002409 481 LM---NLPNLRELYVQNNMLSGT----VPSSL--LSKNVVLNYAGN 517 (927)
Q Consensus 481 l~---~l~~L~~L~l~~N~l~g~----iP~~l--~~~~~~l~~~~n 517 (927)
+. .+++|+.|+|+.|.|++. ++..+ ++.+..+++..|
T Consensus 272 la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n 317 (362)
T 2ra8_A 272 FLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYN 317 (362)
T ss_dssp HHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSB
T ss_pred HHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCC
Confidence 32 467788888888888753 23222 233455555555
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=96.32 E-value=0.0038 Score=68.25 Aligned_cols=77 Identities=21% Similarity=0.182 Sum_probs=65.2
Q ss_pred CceEEEEecCCCCCccCCchhhcCCCCc-EEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCcccccc
Q 002409 414 PSITVIHLSSKNLTGNIPSDLTKLSSLV-ELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 491 (927)
Q Consensus 414 ~~l~~L~L~~n~l~g~ip~~i~~L~~L~-~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~ 491 (927)
.+|+.|+|.+| ++..-+..|.++++|+ .|+|++ +++...+. |.+|++|+.|+|++|+++..-+..|.++++|+.|+
T Consensus 250 ~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 250 KYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp TTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred CCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence 57999999998 7744455789999999 999999 77765554 99999999999999999966666899999999886
Q ss_pred c
Q 002409 492 V 492 (927)
Q Consensus 492 l 492 (927)
.
T Consensus 328 ~ 328 (329)
T 3sb4_A 328 K 328 (329)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.29 E-value=0.012 Score=65.85 Aligned_cols=141 Identities=18% Similarity=0.249 Sum_probs=79.9
Q ss_pred ccccccCceEEEEEEEC--------CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCc-cceecceeecCeEEEEEE
Q 002409 605 KKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL-VQFLGYCQEEGRSVLVYE 675 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~--------~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~g~~~~~~~~~lV~E 675 (927)
+.|..|-...+|+.... +++.+++|+.... ......+.+|.++++.+...++ .++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 34666777889998875 2478999985321 2234566789999988853333 455655543 28999
Q ss_pred eccCCchhhh-c----------------ccccc-cccccC--HHHHHHHHHHHHh-------------------HhHHHh
Q 002409 676 FMHNGTLKEH-L----------------YGTLT-HEQRIN--WIKRLEIAEDAAK-------------------GIEYLH 716 (927)
Q Consensus 676 ~~~~gsL~~~-L----------------~~~~~-~~~~l~--~~~~~~i~~qia~-------------------gL~yLH 716 (927)
|++|..|..- + |.... ...... |.+..++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998665421 1 11100 011111 2333333333221 122222
Q ss_pred ----hC-CCCceecCCCCCCCeEECCC----CcEEEEeecCcc
Q 002409 717 ----TG-CVPAIIHRDLKSSNILLDKH----MRAKVSDFGLSK 750 (927)
Q Consensus 717 ----~~-~~~~ivHrDLkp~NILl~~~----~~vkL~DFGla~ 750 (927)
.. ....++|+|+.+.|||++.+ +.+.++||..+.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 21 12479999999999999876 789999998775
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.12 E-value=0.026 Score=64.69 Aligned_cols=74 Identities=12% Similarity=0.133 Sum_probs=48.1
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCcc-ceecceeecCeEEEEEEeccCCch
Q 002409 605 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV-QFLGYCQEEGRSVLVYEFMHNGTL 682 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~~-g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv-~l~g~~~~~~~~~lV~E~~~~gsL 682 (927)
+.|+.|-...+|+....+ ++.+++|+..... ........|..+++.+...++. ++++.+. + .+||||+++.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 467888889999998875 4788899864322 1112236889999988655553 5666552 2 259999987655
Q ss_pred h
Q 002409 683 K 683 (927)
Q Consensus 683 ~ 683 (927)
.
T Consensus 189 ~ 189 (458)
T 2qg7_A 189 S 189 (458)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.12 E-value=0.0062 Score=57.20 Aligned_cols=37 Identities=32% Similarity=0.328 Sum_probs=18.6
Q ss_pred CccEEEecCCCcCCCCCccccCCCccccccccccccc
Q 002409 462 DLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLS 498 (927)
Q Consensus 462 ~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l~ 498 (927)
+|+.|+|++|+|+..-+..|..+++|+.|+|++|.+.
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 3455555555555332334455555555555555543
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=96.10 E-value=0.00065 Score=75.68 Aligned_cols=86 Identities=15% Similarity=0.183 Sum_probs=60.7
Q ss_pred CCceEEEEecC--CCCCcc-----CCchh--hcCCCCcEEeccCCcCCCCCCC----CCCCCCccEEEecCCCcCCC---
Q 002409 413 QPSITVIHLSS--KNLTGN-----IPSDL--TKLSSLVELWLDGNSLTGPIPD----FSGCPDLRIIHLEDNQLTGP--- 476 (927)
Q Consensus 413 ~~~l~~L~L~~--n~l~g~-----ip~~i--~~L~~L~~L~Ls~N~l~g~~p~----~~~l~~L~~L~Ls~N~l~g~--- 476 (927)
.++|+.|+|+. |...|. +...+ ..+++|+.|+|++|.+....+. ...+++|++|+|+.|+|++.
T Consensus 218 lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~ 297 (362)
T 2ra8_A 218 LPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGAR 297 (362)
T ss_dssp CTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHH
T ss_pred CCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHH
Confidence 56788888853 222111 11222 3478999999999998754332 23578999999999998863
Q ss_pred -CCccccCCCccccccccccccc
Q 002409 477 -LPSSLMNLPNLRELYVQNNMLS 498 (927)
Q Consensus 477 -~P~~l~~l~~L~~L~l~~N~l~ 498 (927)
++..+.++++|+.|+|++|.|+
T Consensus 298 ~L~~~L~~l~~L~~L~L~~n~i~ 320 (362)
T 2ra8_A 298 LLLDHVDKIKHLKFINMKYNYLS 320 (362)
T ss_dssp HHHTTHHHHTTCSEEECCSBBCC
T ss_pred HHHhhcccCCcceEEECCCCcCC
Confidence 4555667899999999999988
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.03 E-value=0.014 Score=64.87 Aligned_cols=73 Identities=15% Similarity=0.193 Sum_probs=44.5
Q ss_pred ccccccCceEEEEEEECC---------CcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCcc-ceecceeecCeEEEEE
Q 002409 605 KKIGSGGFGVVYYGKLKD---------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV-QFLGYCQEEGRSVLVY 674 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~~---------g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv-~l~g~~~~~~~~~lV~ 674 (927)
+.|+.|....+|+....+ ++.+++|+..... ........|.++++.+...+++ ++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 457778888999998764 2688888865332 1122346788888888544443 555433 2 26899
Q ss_pred EeccCCch
Q 002409 675 EFMHNGTL 682 (927)
Q Consensus 675 E~~~~gsL 682 (927)
||++|..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987554
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=95.90 E-value=0.0081 Score=56.35 Aligned_cols=55 Identities=31% Similarity=0.514 Sum_probs=45.9
Q ss_pred EEEecCCCCC-ccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcC
Q 002409 418 VIHLSSKNLT-GNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLT 474 (927)
Q Consensus 418 ~L~L~~n~l~-g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~ 474 (927)
.++.++++|+ ..+|..|. .+|+.|+|++|+|+...+. |..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 7888899987 46775432 4799999999999987776 688999999999999875
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.61 E-value=0.075 Score=58.29 Aligned_cols=68 Identities=12% Similarity=0.201 Sum_probs=43.8
Q ss_pred cccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccC---CCccceecc------eeecCeEEEEEEecc
Q 002409 608 GSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH---RNLVQFLGY------CQEEGRSVLVYEFMH 678 (927)
Q Consensus 608 G~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~H---pnIv~l~g~------~~~~~~~~lV~E~~~ 678 (927)
|.|....||+....+| .+++|+...... ..|+.+++.+.. |.+.+.+.. ....+..+++|+|++
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 3333679999987766 899998765432 356666666532 224444432 233567799999999
Q ss_pred CCch
Q 002409 679 NGTL 682 (927)
Q Consensus 679 ~gsL 682 (927)
|..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 8766
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=94.87 E-value=0.04 Score=62.05 Aligned_cols=59 Identities=17% Similarity=0.228 Sum_probs=24.8
Q ss_pred hhhcCCCCcEEeccCCcCCC----CCCC--CCCCCCccEEEecCCCcCCCCCccccCCCccccccc
Q 002409 433 DLTKLSSLVELWLDGNSLTG----PIPD--FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 492 (927)
Q Consensus 433 ~i~~L~~L~~L~Ls~N~l~g----~~p~--~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 492 (927)
.|.++++|+.|+|.+|.+.. .|+. |.+|++|+.|+|. |+++-.-...|.++++|+.|.|
T Consensus 266 aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~l 330 (401)
T 4fdw_A 266 AFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTI 330 (401)
T ss_dssp TTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEE
T ss_pred HhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEE
Confidence 44444455555554444431 1221 4444445554444 2233222223444444444444
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=94.15 E-value=0.05 Score=61.25 Aligned_cols=89 Identities=15% Similarity=0.120 Sum_probs=65.1
Q ss_pred CCceEEEEecCCCCC-----ccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCc
Q 002409 413 QPSITVIHLSSKNLT-----GNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPN 486 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~-----g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~ 486 (927)
.++|+.|+|.+|.+. -.-+..|..+++|+.|+|.+ +++..-.. |.+|++|+.|+|..| ++..-+..|.++ +
T Consensus 270 c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~ 346 (401)
T 4fdw_A 270 CPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-G 346 (401)
T ss_dssp CTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-C
T ss_pred CCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-C
Confidence 357889999887765 23345688899999999984 46554443 888999999999655 664445678888 9
Q ss_pred ccccccccccccccccccc
Q 002409 487 LRELYVQNNMLSGTVPSSL 505 (927)
Q Consensus 487 L~~L~l~~N~l~g~iP~~l 505 (927)
|+.|++++|.+. .++...
T Consensus 347 L~~l~l~~n~~~-~l~~~~ 364 (401)
T 4fdw_A 347 IKEVKVEGTTPP-QVFEKV 364 (401)
T ss_dssp CCEEEECCSSCC-BCCCSS
T ss_pred CCEEEEcCCCCc-cccccc
Confidence 999999999877 454443
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=93.96 E-value=0.19 Score=51.08 Aligned_cols=103 Identities=14% Similarity=0.063 Sum_probs=65.3
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
-+|.+.|.. .+..+++.++|.++.|.+.+|.-+-.+.. . ..+=+.|..|++..+|.+...+ +.+.
T Consensus 33 vSL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc---------
Confidence 478888753 36789999999999999999877622110 1 1233456899999999888753 1110
Q ss_pred eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCc
Q 002409 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEA 802 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p 802 (927)
.....+.+||... ...+.+.=|||+|+++|.-+-=..|
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0123466888763 3456778899999999998864443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.95 E-value=0.14 Score=58.05 Aligned_cols=73 Identities=14% Similarity=0.157 Sum_probs=47.8
Q ss_pred ccccccCceEEEEEEECC--------CcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCc-cceecceeecCeEEEEEE
Q 002409 605 KKIGSGGFGVVYYGKLKD--------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL-VQFLGYCQEEGRSVLVYE 675 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~~--------g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~g~~~~~~~~~lV~E 675 (927)
+.+..|-...+|+....+ ++.+++|+..... .......+|.++++.+...++ .++++.+ . -++|+|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEE
Confidence 456667778999998763 5788998854322 222345678888888854344 3445432 2 268999
Q ss_pred eccCCch
Q 002409 676 FMHNGTL 682 (927)
Q Consensus 676 ~~~~gsL 682 (927)
|++|..|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998664
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=92.75 E-value=0.022 Score=56.18 Aligned_cols=82 Identities=10% Similarity=0.035 Sum_probs=55.5
Q ss_pred CCCcEEeccCCcCCCC-CCCCCCCCCccEEEecCCC-cCCCCCccccCC----Cccccccccccc-ccccccccc--ccc
Q 002409 438 SSLVELWLDGNSLTGP-IPDFSGCPDLRIIHLEDNQ-LTGPLPSSLMNL----PNLRELYVQNNM-LSGTVPSSL--LSK 508 (927)
Q Consensus 438 ~~L~~L~Ls~N~l~g~-~p~~~~l~~L~~L~Ls~N~-l~g~~P~~l~~l----~~L~~L~l~~N~-l~g~iP~~l--~~~ 508 (927)
-.|+.|||+++.++.. +..+.+|++|+.|+|+++. ++..--..+..+ ++|+.|+|++|. +|..==..+ ++.
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 4799999999998763 4457899999999999995 764333445654 379999999985 772110111 234
Q ss_pred cccccccCCcc
Q 002409 509 NVVLNYAGNIN 519 (927)
Q Consensus 509 ~~~l~~~~n~~ 519 (927)
+..|.+.+.+.
T Consensus 141 L~~L~L~~c~~ 151 (176)
T 3e4g_A 141 LKYLFLSDLPG 151 (176)
T ss_dssp CCEEEEESCTT
T ss_pred CCEEECCCCCC
Confidence 45555555443
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=92.74 E-value=0.015 Score=58.46 Aligned_cols=82 Identities=15% Similarity=0.270 Sum_probs=51.8
Q ss_pred CceEEEEecCC-CCCc----cCCchhhcCCCCcEEeccCCcCCCCC----CC-CCCCCCccEEEecCCCcCCC----CCc
Q 002409 414 PSITVIHLSSK-NLTG----NIPSDLTKLSSLVELWLDGNSLTGPI----PD-FSGCPDLRIIHLEDNQLTGP----LPS 479 (927)
Q Consensus 414 ~~l~~L~L~~n-~l~g----~ip~~i~~L~~L~~L~Ls~N~l~g~~----p~-~~~l~~L~~L~Ls~N~l~g~----~P~ 479 (927)
+.|+.|+|++| +|.. .|-..+..-+.|+.|+|++|.|...- -+ +..-+.|+.|+|+.|+|... +-+
T Consensus 41 ~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~ 120 (197)
T 1pgv_A 41 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 120 (197)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHH
Confidence 35778888875 5542 13344555677888888888886421 11 33446788888888887632 223
Q ss_pred cccCCCcccccccccc
Q 002409 480 SLMNLPNLRELYVQNN 495 (927)
Q Consensus 480 ~l~~l~~L~~L~l~~N 495 (927)
.|..-+.|+.|+|++|
T Consensus 121 aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 121 STLVTQSIVEFKADNQ 136 (197)
T ss_dssp HTTTTCCCSEEECCCC
T ss_pred HHhhCCceeEEECCCC
Confidence 4444566888888765
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=88.83 E-value=0.061 Score=54.05 Aligned_cols=86 Identities=12% Similarity=0.105 Sum_probs=60.6
Q ss_pred CCceEEEEecCCCCCcc----CCchhhcCCCCcEEeccCCcCCCCCC-----CCCCCCCccEEEecCCCc--CC-----C
Q 002409 413 QPSITVIHLSSKNLTGN----IPSDLTKLSSLVELWLDGNSLTGPIP-----DFSGCPDLRIIHLEDNQL--TG-----P 476 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~----ip~~i~~L~~L~~L~Ls~N~l~g~~p-----~~~~l~~L~~L~Ls~N~l--~g-----~ 476 (927)
.+.|+.|+|++|.|... |...+..=+.|+.|+|++|.|+..-- .+..-+.|+.|+|++|.. .| .
T Consensus 69 N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ 148 (197)
T 1pgv_A 69 SKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMD 148 (197)
T ss_dssp CSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHH
T ss_pred CCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHH
Confidence 35799999999999732 34445566899999999999985322 255566799999997632 12 2
Q ss_pred CCccccCCCccccccccccccc
Q 002409 477 LPSSLMNLPNLRELYVQNNMLS 498 (927)
Q Consensus 477 ~P~~l~~l~~L~~L~l~~N~l~ 498 (927)
|-+.+..-+.|+.|+|+.|.+.
T Consensus 149 ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 149 MMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHHHhCCCcCeEeccCCCcc
Confidence 3344555577888888777654
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=87.26 E-value=0.53 Score=52.42 Aligned_cols=79 Identities=19% Similarity=0.164 Sum_probs=49.2
Q ss_pred CceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCccccccc
Q 002409 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 492 (927)
Q Consensus 414 ~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 492 (927)
.+|+.+.+.++ ++-.-...+.++++|+.++|.++ ++..-.. |.+|++|+.++|..| ++..-...|.++++|+.++|
T Consensus 297 ~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~l 373 (394)
T 4fs7_A 297 SSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVEL 373 (394)
T ss_dssp TTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEE
T ss_pred ccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEE
Confidence 35667777654 55222345667788888888644 4433332 777888888888766 55333346777788887776
Q ss_pred ccc
Q 002409 493 QNN 495 (927)
Q Consensus 493 ~~N 495 (927)
..+
T Consensus 374 p~~ 376 (394)
T 4fs7_A 374 PKR 376 (394)
T ss_dssp EGG
T ss_pred CCC
Confidence 543
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=87.07 E-value=0.93 Score=49.92 Aligned_cols=77 Identities=16% Similarity=0.235 Sum_probs=45.7
Q ss_pred ceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCC-ccccCCCccccccc
Q 002409 415 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLP-SSLMNLPNLRELYV 492 (927)
Q Consensus 415 ~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P-~~l~~l~~L~~L~l 492 (927)
.|+.+++.++ +.-.-...+..+++|+.+.|.+|.++..-+. |.+|.+|+.+.|..| ++ .|. .+|.++.+|+.+.+
T Consensus 264 ~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~~i~i 340 (379)
T 4h09_A 264 ALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LK-TIQVYAFKNCKALSTISY 340 (379)
T ss_dssp TCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCCCCC
T ss_pred hhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-cc-EEHHHHhhCCCCCCEEEE
Confidence 4556666433 4422223456677777777777766654443 677777777777644 44 333 35667777777766
Q ss_pred cc
Q 002409 493 QN 494 (927)
Q Consensus 493 ~~ 494 (927)
..
T Consensus 341 p~ 342 (379)
T 4h09_A 341 PK 342 (379)
T ss_dssp CT
T ss_pred CC
Confidence 43
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=86.20 E-value=1.5 Score=48.96 Aligned_cols=29 Identities=31% Similarity=0.484 Sum_probs=24.6
Q ss_pred ceecCCCCCCCeEE------CCCCcEEEEeecCcc
Q 002409 722 AIIHRDLKSSNILL------DKHMRAKVSDFGLSK 750 (927)
Q Consensus 722 ~ivHrDLkp~NILl------~~~~~vkL~DFGla~ 750 (927)
.++|+|+.+.|||+ +++..++++||..|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 46799999999999 456779999998875
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=85.37 E-value=1.1 Score=49.61 Aligned_cols=81 Identities=23% Similarity=0.346 Sum_probs=52.2
Q ss_pred CceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCC-ccccCCCcccccc
Q 002409 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLP-SSLMNLPNLRELY 491 (927)
Q Consensus 414 ~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P-~~l~~l~~L~~L~ 491 (927)
..|+.+.+. ++++..-...|.++++|+.++|..| ++..-.. |.+|++|+.+.|..| ++ .|. ..|.++++|+.++
T Consensus 288 ~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~-~I~~~aF~~C~~L~~i~ 363 (394)
T 4gt6_A 288 PALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VT-KIPESAFSNCTALNNIE 363 (394)
T ss_dssp TTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CC-BCCGGGGTTCTTCCEEE
T ss_pred cccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cC-EEhHhHhhCCCCCCEEE
Confidence 356777775 3455222345667888888888754 4433232 778888888888654 55 344 4677888888888
Q ss_pred ccccccc
Q 002409 492 VQNNMLS 498 (927)
Q Consensus 492 l~~N~l~ 498 (927)
+.+|...
T Consensus 364 ~~~~~~~ 370 (394)
T 4gt6_A 364 YSGSRSQ 370 (394)
T ss_dssp ESSCHHH
T ss_pred ECCceee
Confidence 8776543
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=83.47 E-value=1.7 Score=48.30 Aligned_cols=99 Identities=15% Similarity=0.334 Sum_probs=66.7
Q ss_pred CceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCccccccc
Q 002409 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 492 (927)
Q Consensus 414 ~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 492 (927)
..|+.++|.++..+ .-...+.++++|+.+.+. +.++..... |.+|.+|+.++|..| ++..-..+|.++.+|+.+.|
T Consensus 265 ~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~i 341 (394)
T 4gt6_A 265 AYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAI 341 (394)
T ss_dssp SSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEE
T ss_pred ccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEE
Confidence 35777888765443 334467789999999996 445543333 899999999999865 55333457889999999988
Q ss_pred ccccccccccccccc---ccccccccCC
Q 002409 493 QNNMLSGTVPSSLLS---KNVVLNYAGN 517 (927)
Q Consensus 493 ~~N~l~g~iP~~l~~---~~~~l~~~~n 517 (927)
..+ ++ .|....+. .+..+.+.+|
T Consensus 342 p~s-v~-~I~~~aF~~C~~L~~i~~~~~ 367 (394)
T 4gt6_A 342 PSS-VT-KIPESAFSNCTALNNIEYSGS 367 (394)
T ss_dssp CTT-CC-BCCGGGGTTCTTCCEEEESSC
T ss_pred Ccc-cC-EEhHhHhhCCCCCCEEEECCc
Confidence 644 66 66665543 2344455554
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=82.66 E-value=2.1 Score=47.05 Aligned_cols=89 Identities=16% Similarity=0.201 Sum_probs=63.8
Q ss_pred CceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCC-CCCCCCCccEEEecCCCcCCCCCccccCCCccccccc
Q 002409 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 492 (927)
Q Consensus 414 ~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 492 (927)
..|+.+.+..+ ++..-...+.++.+|+.+.+..+ +..... .|.+|++|+.+.|.+|.++..-...|.++.+|+.+.|
T Consensus 240 ~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~l 317 (379)
T 4h09_A 240 KALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTL 317 (379)
T ss_dssp SSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEEC
T ss_pred ccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEc
Confidence 36778888765 55333446778899999999765 443333 2889999999999999888444457889999999988
Q ss_pred cccccccccccccc
Q 002409 493 QNNMLSGTVPSSLL 506 (927)
Q Consensus 493 ~~N~l~g~iP~~l~ 506 (927)
..+ ++ .|+...+
T Consensus 318 p~~-l~-~I~~~aF 329 (379)
T 4h09_A 318 PTA-LK-TIQVYAF 329 (379)
T ss_dssp CTT-CC-EECTTTT
T ss_pred Ccc-cc-EEHHHHh
Confidence 654 66 5655543
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 927 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-65 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-63 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-62 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-61 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-60 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-56 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-56 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-56 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-56 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-56 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-56 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-55 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-55 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-54 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-54 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-54 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-53 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-53 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-53 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-53 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-53 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-52 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-51 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-50 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-49 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-48 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-48 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-47 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-47 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-45 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-42 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-41 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-40 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-38 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-36 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-05 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-11 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-06 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 9e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 0.001 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-10 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 9e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.002 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 4e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 7e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.003 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 3e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.003 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.004 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 3e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 6e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.002 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.001 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 4e-65
Identities = 80/276 (28%), Positives = 134/276 (48%), Gaps = 23/276 (8%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 662
+ ++IGSG FG VY GK + + +T+ + Q + F NEV +L + H N++ F+G
Sbjct: 12 VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 663 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 722
Y +V ++ +L HL+ E + IK ++IA A+G++YLH +
Sbjct: 72 YSTAPQL-AIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHA---KS 124
Query: 723 IIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYISQQ-- 779
IIHRDLKS+NI L + + K+ DFGL+ + SH + G++ ++ PE Q
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 780 -LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 838
+ +SDVY+FG++L EL++GQ SN N + +G + P L
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNI-------NNRDQIIFMVG----RGYLSPD-LS 232
Query: 839 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 874
+ ++ C+ RP ++L I+
Sbjct: 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 5e-63
Identities = 75/274 (27%), Positives = 126/274 (45%), Gaps = 25/274 (9%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 662
K++G+G FGVV YGK + ++A+K++ + EF E ++ + H LVQ G
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 66
Query: 663 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 722
C ++ ++ E+M NG L +L R + LE+ +D + +EYL +
Sbjct: 67 VCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLESKQ--- 120
Query: 723 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 782
+HRDL + N L++ KVSDFGLS++ +D S + V + PE + + +
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 783 KSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD 841
KSD+++FGV++ E+ S G+ +I Q +L+ P L E
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY----------RPHLASE-- 228
Query: 842 IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 875
K+ C RP+ +L +I D
Sbjct: 229 -----KVYTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 4e-62
Identities = 69/273 (25%), Positives = 123/273 (45%), Gaps = 23/273 (8%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 662
++IGSG FG+V+ G + ++A+K + + +F E ++ ++ H LVQ G
Sbjct: 9 FVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYG 67
Query: 663 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 722
C E+ LV+EFM +G L ++ T L + D +G+ YL C
Sbjct: 68 VCLEQAPICLVFEFMEHGCLSDY---LRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--- 121
Query: 723 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 782
+IHRDL + N L+ ++ KVSDFG+++F +D S+ + V + PE + + +
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 783 KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 842
KSDV+SFGV++ E+ S + + + + + P L
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR---------LYKPRLAST--- 229
Query: 843 QSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 875
+ + C RP+ S +L+ + +
Sbjct: 230 ----HVYQIMNHCWKERPEDRPAFSRLLRQLAE 258
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 3e-61
Identities = 65/273 (23%), Positives = 123/273 (45%), Gaps = 23/273 (8%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 662
L +++G+G FG V+ G ++AVK L F E L+ ++ H+ LV+
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 663 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 722
+E ++ E+M NG+L + L ++ K L++A A+G+ ++
Sbjct: 76 VVTQEPI-YIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN--- 129
Query: 723 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 782
IHRDL+++NIL+ + K++DFGL++ D + + + PE T
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 783 KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 842
KSDV+SFG++L E+++ G ++Q ++E G ++ P E
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYP---GMTNPEVIQ----NLERG--YRMVRPDNCPE--- 237
Query: 843 QSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 875
++ + +C RP+ + ++D
Sbjct: 238 ----ELYQLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 4e-60
Identities = 62/295 (21%), Positives = 126/295 (42%), Gaps = 29/295 (9%)
Query: 602 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 661
+L++ IG G FG V+ GK + G+E+AVK+ +S + E+ + H N++ F+
Sbjct: 6 VLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFI 63
Query: 662 GYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 717
++ + LV ++ +G+L ++L + + +++A A G+ +LH
Sbjct: 64 AADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHM 118
Query: 718 GCV-----PAIIHRDLKSSNILLDKHMRAKVSDFGLSKF---AVDGASHVSSIVRGTVGY 769
V PAI HRDLKS NIL+ K+ ++D GL+ A D + GT Y
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178
Query: 770 LDPEYYISQ------QLTDKSDVYSFGVILLELISGQEAISNEKFGANC---RNIVQWAK 820
+ PE + ++D+Y+ G++ E+ + +
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238
Query: 821 LHIESGDIQGIIDPSLLDEYD-IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 874
+ + + P++ + + +++ + + C +G R + + K +
Sbjct: 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 1e-56
Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 11/200 (5%)
Query: 603 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 660
++G+G GVV+ K G +A K++ R E+ +L + +V F
Sbjct: 10 KISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGF 69
Query: 661 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 720
G +G + E M G+L + L RI +++ KG+ YL
Sbjct: 70 YGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLREKH- 124
Query: 721 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 780
I+HRD+K SNIL++ K+ DFG+S +D +++ GT Y+ PE
Sbjct: 125 -KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMSPERLQGTHY 180
Query: 781 TDKSDVYSFGVILLELISGQ 800
+ +SD++S G+ L+E+ G+
Sbjct: 181 SVQSDIWSMGLSLVEMAVGR 200
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 1e-56
Identities = 62/273 (22%), Positives = 114/273 (41%), Gaps = 23/273 (8%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 662
LE K+G G FG V+ G +A+K L F E ++ ++ H LVQ
Sbjct: 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 79
Query: 663 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 722
EE +V E+M G+L + L G + + + +++A A G+ Y+
Sbjct: 80 VVSEEPI-YIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN--- 133
Query: 723 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 782
+HRDL+++NIL+ +++ KV+DFGL++ D + + + PE + + T
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 193
Query: 783 KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 842
KSDV+SFG++L EL + + ++ ++
Sbjct: 194 KSDVWSFGILLTELTTKGRVPYPGM----------------VNREVLDQVERGYRMPCPP 237
Query: 843 QSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 875
+ + + C RP+ + ++D
Sbjct: 238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 270
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 5e-56
Identities = 63/277 (22%), Positives = 109/277 (39%), Gaps = 25/277 (9%)
Query: 603 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 659
+ IG+G +G + K DGK + K L S + K+ +EV LL + H N+V+
Sbjct: 8 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR 67
Query: 660 FLGYCQEE--GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH- 716
+ + +V E+ G L + Q ++ L + ++ H
Sbjct: 68 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 127
Query: 717 -TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY 775
+ ++HRDLK +N+ LD K+ DFGL++ S + GT Y+ PE
Sbjct: 128 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMSPEQM 186
Query: 776 ISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 835
+KSD++S G +L EL + + I + I
Sbjct: 187 NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR-----YSDE 241
Query: 836 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872
L + I M +++ RPS+ E+L++
Sbjct: 242 LNE--IITRMLNLKDY----------HRPSVEEILEN 266
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 7e-56
Identities = 67/278 (24%), Positives = 115/278 (41%), Gaps = 32/278 (11%)
Query: 603 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 659
+ +IG G F VY G + E+A L + ++ F E +L + H N+V+
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 660 FLGYCQEEGRS----VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 715
F + + VLV E M +GTLK +L + + KG+++L
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFL 128
Query: 716 HTGCVPAIIHRDLKSSNILL-DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 774
HT P IIHRDLK NI + K+ D GL+ + + V GT ++ PE
Sbjct: 129 HTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEM 184
Query: 775 YISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 834
++ + DVY+FG+ +LE+ + + S + N I + ++ + P
Sbjct: 185 -YEEKYDESVDVYAFGMCMLEMATSEYPYSECQ---NAAQIYRRVTSGVKPASFDKVAIP 240
Query: 835 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872
+ + I+ + + R SI ++L
Sbjct: 241 EVKEI--IEGCIRQNKDE----------RYSIKDLLNH 266
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 193 bits (490), Expect = 8e-56
Identities = 72/307 (23%), Positives = 137/307 (44%), Gaps = 42/307 (13%)
Query: 591 FTLSDIEDATK-----------MLEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTSN- 634
FT D +A + +E+ IG+G FG V G LK + +A+K L S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 635 SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQ 694
+ + +R+F +E +++ + H N++ G + +++ EFM NG+L L ++
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR---QNDG 123
Query: 695 RINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 754
+ I+ + + A G++YL +HRDL + NIL++ ++ KVSDFGLS+F D
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 755 GASHVSSI----VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGA 810
S + + + + PE ++ T SDV+S+G+++ E++S E +
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD---- 236
Query: 811 NCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVL 870
+ + D+ I+ + + + L C + RP +++
Sbjct: 237 ------------MTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284
Query: 871 KDIQDAI 877
+ I
Sbjct: 285 NTLDKMI 291
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 192 bits (489), Expect = 8e-56
Identities = 70/274 (25%), Positives = 120/274 (43%), Gaps = 23/274 (8%)
Query: 603 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 661
++ K+G G +G VY G K +AVK L ++ + EF E ++ I H NLVQ L
Sbjct: 21 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 79
Query: 662 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 721
G C E ++ EFM G L ++L + Q ++ + L +A + +EYL
Sbjct: 80 GVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK---K 134
Query: 722 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 781
IHRDL + N L+ ++ KV+DFGLS+ + + + + PE + +
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 194
Query: 782 DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD 841
KSDV++FGV+L E+ + + + + +++ E
Sbjct: 195 IKSDVWAFGVLLWEIATYGMSPYPGI----------------DLSQVYELLEKDYRMERP 238
Query: 842 IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 875
K+ E C + RPS +E+ + +
Sbjct: 239 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (488), Expect = 2e-55
Identities = 66/285 (23%), Positives = 123/285 (43%), Gaps = 37/285 (12%)
Query: 597 EDATKMLE--KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGK---REFTNEVTLLS 650
+D K+ ++IG G FG VY+ + +++ + +A+K ++ + Q ++ EV L
Sbjct: 11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 651 RIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK 710
++ H N +Q+ G E + LV E+ H++ + ++ + A +
Sbjct: 71 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQ 126
Query: 711 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 770
G+ YLH+ +IHRD+K+ NILL + K+ DFG + S V GT ++
Sbjct: 127 GLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWM 178
Query: 771 DPEYYISQ---QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 827
PE ++ Q K DV+S G+ +EL + + N + +I Q ++SG
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH 238
Query: 828 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872
+ + S + + RP+ +LK
Sbjct: 239 ----WSEYFRNF--VDSCLQKIPQD----------RPTSEVLLKH 267
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 5e-55
Identities = 61/284 (21%), Positives = 114/284 (40%), Gaps = 29/284 (10%)
Query: 595 DIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIH 653
+ ED +++ ++G G FG VY + K+ A KV+ + S + ++ E+ +L+
Sbjct: 9 NPEDFWEII-GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD 67
Query: 654 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 713
H N+V+ L E ++ EF G + + E+ + + + + +
Sbjct: 68 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALN 124
Query: 714 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 773
YLH IIHRDLK+ NIL K++DFG+S S + GT ++ PE
Sbjct: 125 YLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPE 180
Query: 774 YYISQQLTD-----KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 828
+ + D K+DV+S G+ L+E+ + I + +
Sbjct: 181 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPS- 239
Query: 829 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872
+ D ++ + A R + S++L+
Sbjct: 240 --RWSSNFKDF--LKKCLEKNVDA----------RWTTSQLLQH 269
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 9e-55
Identities = 60/271 (22%), Positives = 115/271 (42%), Gaps = 25/271 (9%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 661
+KIG G G VY + G+E+A++ + K NE+ ++ + N+V +L
Sbjct: 24 RFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 662 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 721
+V E++ G+L + + E ++ + + + + +E+LH+
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSNQ-- 136
Query: 722 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 781
+IHRD+KS NILL K++DFG S S++V GT ++ PE +
Sbjct: 137 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 194
Query: 782 DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD 841
K D++S G++ +E+I G+ NE I +++ + + D
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE---KLSAIFRDF-- 249
Query: 842 IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872
+ ++ + R S E+L+
Sbjct: 250 LNRCLDMDVE----------KRGSAKELLQH 270
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 4e-54
Identities = 66/286 (23%), Positives = 111/286 (38%), Gaps = 37/286 (12%)
Query: 591 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGK---REFTNEV 646
+ L D E + + +G G FG VY + K +A+KVL + + EV
Sbjct: 3 WALEDFE-----IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 57
Query: 647 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE 706
+ S + H N+++ GY + R L+ E+ GT+ L + + +
Sbjct: 58 EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYIT 113
Query: 707 DAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT 766
+ A + Y H+ +IHRD+K N+LL K++DFG S A + GT
Sbjct: 114 ELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT---LCGT 167
Query: 767 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG 826
+ YL PE + +K D++S GV+ E + G+ + + I +
Sbjct: 168 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR------VEF 221
Query: 827 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872
+ D I + K RP + EVL+
Sbjct: 222 TFPDFVTEGARDL--ISRLLKHNPSQ----------RPMLREVLEH 255
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 4e-54
Identities = 74/286 (25%), Positives = 131/286 (45%), Gaps = 34/286 (11%)
Query: 591 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLS 650
+ +++ L + IG G FG V G + G ++AVK + +++ + F E ++++
Sbjct: 4 LNMKELK-----LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMT 55
Query: 651 RIHHRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA 709
++ H NLVQ LG +E+G +V E+M G+L ++L + L+ + D
Sbjct: 56 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVC 113
Query: 710 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 769
+ +EYL +HRDL + N+L+ + AKVSDFGL+K A S + V +
Sbjct: 114 EAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKW 166
Query: 770 LDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 829
PE ++ + KSDV+SFG++L E+ S +++V +E G
Sbjct: 167 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP---YPRIPLKDVVP----RVEKGYKM 219
Query: 830 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 875
D Y++ C MRPS ++ + ++
Sbjct: 220 DAPDGCPPAVYEV---------MKNCWHLDAAMRPSFLQLREQLEH 256
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 8e-54
Identities = 79/308 (25%), Positives = 127/308 (41%), Gaps = 32/308 (10%)
Query: 577 VSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGK----EIAVKVLT 632
+S+LN +A + + IG G FG VY+G L D AVK L
Sbjct: 6 LSALNPELVQAVQHVVI-GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 64
Query: 633 SNSYQGK-REFTNEVTLLSRIHHRNLVQFLGYCQE-EGRSVLVYEFMHNGTLKEHLYGTL 690
+ G+ +F E ++ H N++ LG C EG ++V +M +G L+ +
Sbjct: 65 RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR--- 121
Query: 691 THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 750
+ AKG + +HRDL + N +LD+ KV+DFGL++
Sbjct: 122 NETHNPTVKDLIGFGLQVAKG---MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178
Query: 751 FAVDG---ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 807
D + H + + V ++ E +Q+ T KSDV+SFGV+L EL++ +
Sbjct: 179 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 238
Query: 808 FGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSIS 867
N ++ L EY ++++ L C P MRPS S
Sbjct: 239 ------NTFDITVYLLQG-------RRLLQPEYCPDPLYEV---MLKCWHPKAEMRPSFS 282
Query: 868 EVLKDIQD 875
E++ I
Sbjct: 283 ELVSRISA 290
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 1e-53
Identities = 69/280 (24%), Positives = 123/280 (43%), Gaps = 33/280 (11%)
Query: 604 EKKIGSGGFGVVYYGKLKD---GKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLV 658
+K++GSG FG V G + K +AVK+L +N K E E ++ ++ + +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 659 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 718
+ +G C+ E +LV E G L ++L + + +E+ + G++YL
Sbjct: 72 RMIGICEAESW-MLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES 126
Query: 719 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS--IVRGTVGYLDPEYYI 776
+HRDL + N+LL AK+SDFGLSK ++ + + V + PE
Sbjct: 127 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 777 SQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 835
+ + KSDV+SFGV++ E S GQ+ K + + ++ +G
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAG-----CPRE 238
Query: 836 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 875
+ D + W + + RP + V +++
Sbjct: 239 MYDL--MNLCWTYDVE----------NRPGFAAVELRLRN 266
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 186 bits (473), Expect = 1e-53
Identities = 67/300 (22%), Positives = 120/300 (40%), Gaps = 47/300 (15%)
Query: 603 LEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHR 655
+ IG G FG V+ + +AVK+L + + +F E L++ +
Sbjct: 17 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 76
Query: 656 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH--------------------EQR 695
N+V+ LG C L++E+M G L E L H
Sbjct: 77 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 136
Query: 696 INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755
++ ++L IA A G+ YL +HRDL + N L+ ++M K++DFGLS+
Sbjct: 137 LSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 193
Query: 756 -ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRN 814
+ ++ PE + T +SDV+++GV+L E+ S +G
Sbjct: 194 DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY---YGMAHEE 250
Query: 815 IVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 874
++ + + G+I + L+ Y++ +C RPS + + +Q
Sbjct: 251 VIYY----VRDGNILACPENCPLELYNL---------MRLCWSKLPADRPSFCSIHRILQ 297
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 2e-53
Identities = 59/274 (21%), Positives = 113/274 (41%), Gaps = 26/274 (9%)
Query: 603 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQF 660
L + +G G +G V + + +AVK++ + E+ + ++H N+V+F
Sbjct: 9 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 68
Query: 661 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 720
G+ +E L E+ G L + + + + G+ YLH
Sbjct: 69 YGHRREGNIQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHG--- 121
Query: 721 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 779
I HRD+K N+LLD+ K+SDFGL+ F + + + + GT+ Y+ PE ++
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 780 L-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 838
+ DV+S G++L +++G+ + + K ++ ID + L
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK---KIDSAPLA 238
Query: 839 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872
+ + A R +I ++ KD
Sbjct: 239 --LLHKILVENPSA----------RITIPDIKKD 260
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 3e-53
Identities = 66/283 (23%), Positives = 129/283 (45%), Gaps = 30/283 (10%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKE-----IAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRN 656
+K IG+G FG VY G LK +A+K L + + +R +F E ++ + H N
Sbjct: 11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 70
Query: 657 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 716
+++ G + +++ E+M NG L + L + + ++ + + A G++YL
Sbjct: 71 IIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLA 127
Query: 717 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG--ASHVSSIVRGTVGYLDPEY 774
+HRDL + NIL++ ++ KVSDFGLS+ D A++ +S + + + PE
Sbjct: 128 N---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184
Query: 775 YISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 834
++ T SDV+SFG+++ E+++ E E + + ++ I+
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWE----------------LSNHEVMKAIND 228
Query: 835 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 877
+ I + + C RP ++++ + I
Sbjct: 229 GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 4e-53
Identities = 70/282 (24%), Positives = 118/282 (41%), Gaps = 31/282 (10%)
Query: 601 KMLEKKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRN 656
+ + ++G G FG V G + ++A+KVL + + E E ++ ++ +
Sbjct: 11 LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPY 70
Query: 657 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 716
+V+ +G CQ E +LV E G L + L G + I E+ + G++YL
Sbjct: 71 IVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLE 126
Query: 717 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF--AVDGASHVSSIVRGTVGYLDPEY 774
+HRDL + N+LL AK+SDFGLSK A D S + + + PE
Sbjct: 127 E---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 183
Query: 775 YISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 833
++ + +SDV+S+GV + E +S GQ+ K I Q ++
Sbjct: 184 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPE-----CP 238
Query: 834 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 875
P L Y + C + RP V + ++
Sbjct: 239 PEL---YAL---------MSDCWIYKWEDRPDFLTVEQRMRA 268
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 7e-52
Identities = 67/298 (22%), Positives = 119/298 (39%), Gaps = 41/298 (13%)
Query: 603 LEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRI-HH 654
K +G+G FG V +AVK+L +++ +RE +E+ +LS + +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 655 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG--------------TLTHEQRINWIK 700
N+V LG C G ++++ E+ G L L E ++
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 701 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH-V 759
L + AKG+ +L + IHRDL + NILL K+ DFGL++ + +++ V
Sbjct: 147 LLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA 819
R V ++ PE + T +SDV+S+G+ L EL S +
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS---------------PY 248
Query: 820 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 877
+I + ++ + C RP+ ++++ I+ I
Sbjct: 249 PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 5e-51
Identities = 65/297 (21%), Positives = 117/297 (39%), Gaps = 46/297 (15%)
Query: 603 LEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRI-HH 654
K +GSG FG V ++AVK+L + +RE +E+ +++++ H
Sbjct: 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100
Query: 655 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH-------------------EQR 695
N+V LG C G L++E+ G L +L
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 696 INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755
+ + L A AKG+E+L + +HRDL + N+L+ K+ DFGL++ +
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217
Query: 756 ASHVS-SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRN 814
+++V R V ++ PE T KSDV+S+G++L E+ S
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP----------- 266
Query: 815 IVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 871
+ + +++ + +I + + +I C RPS +
Sbjct: 267 ---YPGIPVDA-NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 2e-50
Identities = 59/285 (20%), Positives = 114/285 (40%), Gaps = 30/285 (10%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNL 657
L + IG G FG V+ G + +A+K + + RE F E + + H ++
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 658 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 717
V+ +G E ++ E G L+ L + ++ + A + + YL +
Sbjct: 71 VKLIGVI-TENPVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLES 126
Query: 718 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 777
+HRD+ + N+L+ + K+ DFGLS++ D + +S + + ++ PE
Sbjct: 127 ---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183
Query: 778 QQLTDKSDVYSFGVILLELI-SGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836
++ T SDV+ FGV + E++ G + K I +L + P+L
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN-----CPPTL 238
Query: 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIER 881
+ W + RP +E+ + + E+
Sbjct: 239 YSL--MTKCWAYDPS----------RRPRFTELKAQLSTILEEEK 271
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 177 bits (451), Expect = 7e-50
Identities = 60/273 (21%), Positives = 108/273 (39%), Gaps = 25/273 (9%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 661
+ +++G+G FGVV+ G A K + + K E+ +S + H LV
Sbjct: 30 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH 89
Query: 662 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 721
+++ V++YEFM G L E + +++ + +E KG+ ++H
Sbjct: 90 DAFEDDNEMVMIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHENN-- 144
Query: 722 AIIHRDLKSSNILL--DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 779
+H DLK NI+ + K+ DFGL+ S GT + PE +
Sbjct: 145 -YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV--TTGTAEFAAPEVAEGKP 201
Query: 780 LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 839
+ +D++S GV+ L+SG E RN+ +++ G I D
Sbjct: 202 VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC-DWNMDDSAFSG-ISEDGKDF 259
Query: 840 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872
I+ + + R +I + L+
Sbjct: 260 --IRKLLLADPNT----------RMTIHQALEH 280
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 1e-49
Identities = 70/292 (23%), Positives = 121/292 (41%), Gaps = 38/292 (13%)
Query: 603 LEKKIGSGGFGVVYYGKLKDG---KEIAVKVL-TSNSYQGKREFTNEVTLLSRI-HHRNL 657
+ IG G FG V ++K + A+K + S R+F E+ +L ++ HH N+
Sbjct: 14 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 73
Query: 658 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE------------QRINWIKRLEIA 705
+ LG C+ G L E+ +G L + L + E ++ + L A
Sbjct: 74 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 133
Query: 706 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG 765
D A+G++YL IHRDL + NIL+ ++ AK++DFGLS+ R
Sbjct: 134 ADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM--GRL 188
Query: 766 TVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES 825
V ++ E T SDV+S+GV+L E++S G C + +
Sbjct: 189 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC---GMTCAELYEK------- 238
Query: 826 GDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 877
+ E + ++ + C + RPS +++L + +
Sbjct: 239 ------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 2e-48
Identities = 64/283 (22%), Positives = 106/283 (37%), Gaps = 31/283 (10%)
Query: 603 LEKKIGSGGFGVVYYGKLK----DGKEIAVKVL---TSNSYQGKREFTNEVTLLSRIHHR 655
L +K+G G FGVV G+ +AVK L + + +F EV + + HR
Sbjct: 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 656 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 715
NL++ G +V E G+L + L H+ A A+G+ YL
Sbjct: 72 NLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 716 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH--VSSIVRGTVGYLDPE 773
+ IHRDL + N+LL K+ DFGL + H + + + PE
Sbjct: 128 ESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 774 YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 833
++ + SD + FGV L E+ + + N Q + G+ +
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG------LNGSQILHKIDKEGERLPRPE 238
Query: 834 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 876
D Y++ + C RP+ + + +A
Sbjct: 239 DCPQDIYNV---------MVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 173 bits (440), Expect = 2e-48
Identities = 55/273 (20%), Positives = 121/273 (44%), Gaps = 25/273 (9%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 661
+ +++GSG FGVV+ G+ K + + K NE+++++++HH L+
Sbjct: 33 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH 92
Query: 662 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 721
+++ VL+ EF+ G L + + + +++ + + A +G++++H
Sbjct: 93 DAFEDKYEMVLILEFLSGGELFDRI---AAEDYKMSEAEVINYMRQACEGLKHMHE---H 146
Query: 722 AIIHRDLKSSNILLD--KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 779
+I+H D+K NI+ + K K+ DFGL+ + + T + PE +
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVDREP 204
Query: 780 LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 839
+ +D+++ GV+ L+SG + E +N+ + E D + P D
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE--DAFSSVSPEAKDF 262
Query: 840 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872
I+++ + E + R ++ + L+
Sbjct: 263 --IKNLLQKEPRK----------RLTVHDALEH 283
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 6e-48
Identities = 57/279 (20%), Positives = 116/279 (41%), Gaps = 30/279 (10%)
Query: 603 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVL-----TSNSYQGKREFTNEVTLLSRIHHRN 656
K +GSG FG VY G +G+++ + V + S + +E +E +++ + + +
Sbjct: 13 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 72
Query: 657 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 716
+ + LG C L+ + M G L +++ H+ I L AKG+ YL
Sbjct: 73 VCRLLGICLTSTV-QLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYL- 127
Query: 717 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYY 775
++HRDL + N+L+ K++DFGL+K + + + + + ++ E
Sbjct: 128 --EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 776 ISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 835
+ + T +SDV+S+GV + EL++ + + +I I++
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI----------------PASEISSILEKG 229
Query: 836 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 874
+ + C + RP E++ +
Sbjct: 230 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 2e-47
Identities = 57/274 (20%), Positives = 104/274 (37%), Gaps = 30/274 (10%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL---TSNSYQGKREFTNEVTLLSRIHHRNLV 658
K +G G F V + L +E A+K+L T E ++SR+ H V
Sbjct: 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71
Query: 659 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 718
+ Q++ + + NG L +++ + + +EYLH
Sbjct: 72 KLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHG- 126
Query: 719 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYIS 777
IIHRDLK NILL++ M +++DFG +K + + ++ GT Y+ PE
Sbjct: 127 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 778 QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 837
+ SD+++ G I+ +L++G + I++ D P
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK------LEYDFPEKFFPKAR 238
Query: 838 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 871
D ++ + ++ R E+
Sbjct: 239 DL--VEKLLVLDATK----------RLGCEEMEG 260
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 3e-47
Identities = 63/289 (21%), Positives = 122/289 (42%), Gaps = 33/289 (11%)
Query: 603 LEKKIGSGGFGVVYYGKLK------DGKEIAVKVLT-SNSYQGKREFTNEVTLLSRIHHR 655
+ +++G G FG+VY G K +A+K + + S + + EF NE +++ +
Sbjct: 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83
Query: 656 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY------GTLTHEQRINWIKRLEIAEDAA 709
++V+ LG + ++++ E M G LK +L + K +++A + A
Sbjct: 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143
Query: 710 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG-ASHVSSIVRGTVG 768
G+ YL+ +HRDL + N ++ + K+ DFG+++ + V
Sbjct: 144 DGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 769 YLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 828
++ PE T SDV+SFGV+L E+ + E + + G +
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-------NEQVLRFVMEGGL 253
Query: 829 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 877
D +++ MC + MRPS E++ I++ +
Sbjct: 254 LDKPDNCPDMLFEL---------MRMCWQYNPKMRPSFLEIISSIKEEM 293
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 6e-47
Identities = 72/297 (24%), Positives = 121/297 (40%), Gaps = 40/297 (13%)
Query: 603 LEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQG-KREFTNEVTLLSRI-HH 654
L K +G G FG V + +AVK+L + R +E+ +L I HH
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 655 RNLVQFLGYCQEEGRSV-LVYEFMHNGTLKEHLYG------------TLTHEQRINWIKR 701
N+V LG C + G + ++ EF G L +L ++ +
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 702 LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-S 760
+ + AKG+E+L + IHRDL + NILL + K+ DFGL++ +V
Sbjct: 137 ICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 761 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK 820
R + ++ PE + T +SDV+SFGV+L E+ S + I +
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV------KIDEEFC 247
Query: 821 LHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 877
++ G D + + Y L C RP+ SE+++ + + +
Sbjct: 248 RRLKEGTRMRAPDYTTPEMYQT---------MLDCWHGEPSQRPTFSELVEHLGNLL 295
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 3e-45
Identities = 50/273 (18%), Positives = 107/273 (39%), Gaps = 26/273 (9%)
Query: 603 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 661
+ + +G G FG+V+ K K + + E+++L+ HRN++
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLH 67
Query: 662 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 721
+ V+++EF+ + E + T +N + + + +++LH+
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHS---H 121
Query: 722 AIIHRDLKSSNILLD--KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 779
I H D++ NI+ + K+ +FG ++ G + ++ Y PE +
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEVHQHDV 179
Query: 780 LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 839
++ +D++S G ++ L+SG E NI+ A+ + + I +D
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN-AEYTFDEEAFKE-ISIEAMDF 237
Query: 840 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872
+ + E K R + SE L+
Sbjct: 238 --VDRLLVKERK----------SRMTASEALQH 258
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (412), Expect = 4e-45
Identities = 68/283 (24%), Positives = 114/283 (40%), Gaps = 29/283 (10%)
Query: 595 DIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRI 652
DI D +G+G F V + + K +A+K + + +GK NE+ +L +I
Sbjct: 6 DIRDIYD-FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI 64
Query: 653 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 712
H N+V + G L+ + + G L + + + + +
Sbjct: 65 KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQVLDAV 120
Query: 713 EYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 769
+YLH I+HRDLK N+L D+ + +SDFGLSK G V S GT GY
Sbjct: 121 KYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--SVLSTACGTPGY 175
Query: 770 LDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 829
+ PE + + D +S GVI L+ G +E I++ A+ +S
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK-AEYEFDSPYWD 234
Query: 830 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872
I S D I+ + + + + R + + L+
Sbjct: 235 D-ISDSAKDF--IRHLMEKDPEK----------RFTCEQALQH 264
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 8e-45
Identities = 62/298 (20%), Positives = 127/298 (42%), Gaps = 42/298 (14%)
Query: 603 LEKKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRI- 652
L K +G G FG V + ++AVK+L S++ + + +E+ ++ I
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 653 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY------------GTLTHEQRINWIK 700
H+N++ LG C ++G ++ E+ G L+E+L + E++++
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 701 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 760
+ A A+G+EYL + IHRDL + N+L+ + K++DFGL++ +
Sbjct: 137 LVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 761 SIV-RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA 819
+ R V ++ PE + T +SDV+SFGV+L E+ + +
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV------------ 241
Query: 820 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 877
++ ++ + ++ C RP+ ++++D+ +
Sbjct: 242 ----PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 160 bits (405), Expect = 4e-44
Identities = 58/285 (20%), Positives = 118/285 (41%), Gaps = 33/285 (11%)
Query: 591 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVL---TSNSYQGKREFTNEV 646
++L D + + + +G+G FG V+ + + +G+ A+KVL + +E
Sbjct: 1 YSLQDFQ-----ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDER 55
Query: 647 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE 706
+LS + H +++ G Q+ + ++ +++ G L L + + E+
Sbjct: 56 LMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL 115
Query: 707 DAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT 766
L II+RDLK NILLDK+ K++DFG +K+ D + GT
Sbjct: 116 -------ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT----LCGT 164
Query: 767 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG 826
Y+ PE ++ D +SFG+++ E+++G + I+ A+L
Sbjct: 165 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN-AELRFPPF 223
Query: 827 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 871
+ + D + + + + G+++ +V
Sbjct: 224 -----FNEDVKDL--LSRLITRDLSQRL-----GNLQNGTEDVKN 256
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 156 bits (394), Expect = 4e-43
Identities = 57/225 (25%), Positives = 108/225 (48%), Gaps = 17/225 (7%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGK---REFTNEVTLLSRIHHRNLV 658
L + +G GG V+ + L+ +++AVKVL ++ + F E + ++H +V
Sbjct: 11 LGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 70
Query: 659 QFLGYCQEE----GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 714
+ E +V E++ TL++ ++ E + + +E+ DA + + +
Sbjct: 71 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNF 126
Query: 715 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV--SSIVRGTVGYLDP 772
H IIHRD+K +NI++ KV DFG+++ D + V ++ V GT YL P
Sbjct: 127 SHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 773 EYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 817
E + +SDVYS G +L E+++G+ + + + V+
Sbjct: 184 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR 228
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 154 bits (390), Expect = 1e-42
Identities = 66/287 (22%), Positives = 108/287 (37%), Gaps = 40/287 (13%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL---------TSNSYQGKREFTNEVTLLSRI 652
++ +G G VV KE AVK++ + + EV +L ++
Sbjct: 7 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 66
Query: 653 H-HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 711
H N++Q + LV++ M G L ++L T + ++ + +I +
Sbjct: 67 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRALLEV 122
Query: 712 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 771
I LH I+HRDLK NILLD M K++DFG S G V GT YL
Sbjct: 123 ICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTPSYLA 177
Query: 772 PEYYISQQL------TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES 825
PE + D++S GVI+ L++G + K R I+ S
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG-NYQFGS 236
Query: 826 GDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872
+ ++ D + ++ + R + E L
Sbjct: 237 PEWDD-YSDTVKDL--VSRFLVVQPQK----------RYTAEEALAH 270
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 2e-41
Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 13/203 (6%)
Query: 603 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNL 657
L K +G G FG V+ + K + A+K L + + + L H L
Sbjct: 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65
Query: 658 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 717
Q + V E+++ G L H+ + + + A + G+++LH+
Sbjct: 66 THMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 718 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 777
I++RDLK NILLDK K++DFG+ K + G + ++ GT Y+ PE +
Sbjct: 122 KG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLG 177
Query: 778 QQLTDKSDVYSFGVILLELISGQ 800
Q+ D +SFGV+L E++ GQ
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQ 200
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 153 bits (388), Expect = 2e-41
Identities = 65/277 (23%), Positives = 108/277 (38%), Gaps = 28/277 (10%)
Query: 603 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSY---QGKREFTNEV---TLLSRIHHR 655
+ + IG GGFG VY + D GK A+K L QG+ NE +L+S
Sbjct: 8 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 67
Query: 656 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 715
+V + + + M+ G L HL + + A + G+E++
Sbjct: 68 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILGLEHM 123
Query: 716 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY 775
H +++RDLK +NILLD+H ++SD GL+ H GT GY+ PE
Sbjct: 124 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPEVL 177
Query: 776 ISQQLTD-KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 834
D +D +S G +L +L+ G K + +E + P
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE---LPDSFSP 234
Query: 835 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 871
L ++ + + + + G + EV +
Sbjct: 235 ELRSL--LEGLLQRDVNRRL-----GCLGRGAQEVKE 264
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 149 bits (378), Expect = 1e-40
Identities = 54/288 (18%), Positives = 104/288 (36%), Gaps = 34/288 (11%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 661
L +KIGSG FG +Y G + G+E+A+K+ + + E + + + +
Sbjct: 11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTI 68
Query: 662 GYCQEEGRS-VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 720
+C EG V+V E + + ++ + L +A+ IEY+H+
Sbjct: 69 RWCGAEGDYNVMVMELLGPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHSKN- 123
Query: 721 PAIIHRDLKSSNIL---LDKHMRAKVSDFGLSKFAVDGASHV------SSIVRGTVGYLD 771
IHRD+K N L K + DFGL+K D +H + + GT Y
Sbjct: 124 --FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 772 PEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA--KLHIESGDIQ 829
++ + + + D+ S G +L+ G K + + + K+ +
Sbjct: 182 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241
Query: 830 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 877
+ + +P S + + ++
Sbjct: 242 KGYPSEFATY--LNFCRSLRFDD----------KPDYSYLRQLFRNLF 277
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 1e-40
Identities = 58/276 (21%), Positives = 104/276 (37%), Gaps = 27/276 (9%)
Query: 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE-----FTNEVTLLSRIHHRNLV 658
+G G F VY + K + +A+K + ++ E+ LL + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 659 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 718
L + LV++FM + + +G+EYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 719 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 778
I+HRDLK +N+LLD++ K++DFGL+K + V T Y PE
Sbjct: 120 W---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGA 175
Query: 779 QLTD-KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 837
++ D+++ G IL EL+ + + I + + P+
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI------------FETLGTPTEE 223
Query: 838 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 873
D+ S+ +P H+ + + L D+
Sbjct: 224 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDL 259
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 148 bits (375), Expect = 2e-40
Identities = 52/283 (18%), Positives = 97/283 (34%), Gaps = 20/283 (7%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQF 660
+KIG G +GVVY + G+ A+K + E+++L + H N+V+
Sbjct: 6 GLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 661 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 720
+ R VLV+E + K E + + GI Y H
Sbjct: 66 YDVIHTKKRLVLVFEHLDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDRR- 120
Query: 721 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 780
++HRDLK N+L+++ K++DFGL++ + + S++
Sbjct: 121 --VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 781 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ---------WAKLHIESGDIQGI 831
+ D++S G I E+++G I + W +
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 832 IDPSLLDEYDIQSMWKIEEKALM--CVLPHGHMRPSISEVLKD 872
L L+ + + R + + L+
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 2e-40
Identities = 65/293 (22%), Positives = 115/293 (39%), Gaps = 35/293 (11%)
Query: 591 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVL------TSNSYQGKREFT 643
F +++D +++GSG F VV + K G + A K + +S + +
Sbjct: 3 FRQENVDDYYDTG-EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 61
Query: 644 NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLE 703
EV++L I H N++ + + +L+ E + G L + L ++ + + E
Sbjct: 62 REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA----EKESLTEEEATE 117
Query: 704 IAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH----MRAKVSDFGLSKFAVDGASHV 759
+ G+ YLH+ I H DLK NI+L R K+ DFGL+ G
Sbjct: 118 FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF- 173
Query: 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA 819
+ GT ++ PE + L ++D++S GVI L+SG + N+
Sbjct: 174 -KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV- 231
Query: 820 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872
E + D I+ + + K R +I + L+
Sbjct: 232 NYEFED-EYFSNTSALAKDF--IRRLLVKDPK----------KRMTIQDSLQH 271
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 5e-40
Identities = 57/291 (19%), Positives = 104/291 (35%), Gaps = 29/291 (9%)
Query: 603 LEKKIGSGGFGVVYYGKLK--DGKEIAVKVLTSNSYQGK--REFTNEVTLLSRI---HHR 655
+IG G +G V+ + G+ +A+K + + + EV +L + H
Sbjct: 11 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHP 70
Query: 656 NLVQFLGYC-----QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK 710
N+V+ C E + LV+E + E + ++ +
Sbjct: 71 NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLR 127
Query: 711 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 770
G+++LH+ ++HRDLK NIL+ + K++DFGL++ + S V T+ Y
Sbjct: 128 GLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--VVVTLWYR 182
Query: 771 DPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 830
PE + D++S G I E+ + I+ L E +
Sbjct: 183 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242
Query: 831 IIDPSLLDEYDIQSMWKI-------EEKALM--CVLPHGHMRPSISEVLKD 872
+ P + K L+ C+ + R S L
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 6e-40
Identities = 54/284 (19%), Positives = 106/284 (37%), Gaps = 20/284 (7%)
Query: 603 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 659
+KIG G +GVVY + K G+ +A+K + + + E++LL ++H N+V+
Sbjct: 6 KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 65
Query: 660 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 719
L E + LV+EF+H K + I +G+ + H+
Sbjct: 66 LLDVIHTENKLYLVFEFLHQDLKKFMD---ASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 720 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 779
++HRDLK N+L++ K++DFGL++ + V +
Sbjct: 123 ---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 780 LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ---------WAKLHIESGDIQG 830
+ D++S G I E+++ + + I + W +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 831 IIDPSLLDEYDIQSMWKIEEKALM--CVLPHGHMRPSISEVLKD 872
+ D + + ++L+ + + R S L
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 6e-40
Identities = 55/288 (19%), Positives = 107/288 (37%), Gaps = 22/288 (7%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 660
IG G +G+V + +A+K ++ +Q + E+ +L R H N++
Sbjct: 12 NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI 71
Query: 661 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 720
+ + ++ L L Q ++ +G++Y+H+
Sbjct: 72 NDIIRAPTIEQMKDVYLVTH-LMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN- 129
Query: 721 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI--VRGTVGYLDPEYYISQ 778
++HRDLK SN+LL+ K+ DFGL++ A H + T Y PE ++
Sbjct: 130 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 187
Query: 779 QLTDKS-DVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 837
+ KS D++S G IL E++S + + + +I+ + I +
Sbjct: 188 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 247
Query: 838 DEYDIQSMWKIEEKALM-------------CVLPHGHMRPSISEVLKD 872
+ K+ L + + H R + + L
Sbjct: 248 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 7e-39
Identities = 55/284 (19%), Positives = 107/284 (37%), Gaps = 37/284 (13%)
Query: 601 KMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLV 658
K+ + +G G G V + ++ A+K+L Q + EV L R ++V
Sbjct: 14 KVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIV 68
Query: 659 QFLGYCQ----EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 714
+ + + ++V E + G L + +Q + EI + + I+Y
Sbjct: 69 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQY 126
Query: 715 LHTGCVPAIIHRDLKSSNILLDKHM---RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 771
LH+ I HRD+K N+L K++DFG +K S + T Y+
Sbjct: 127 LHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVA 181
Query: 772 PEYYISQQLTDKSDVYSFGVILLELISGQ---EAISNEKFGANCRNIVQWAKLHIESGDI 828
PE ++ D++S GVI+ L+ G + + ++ + + +
Sbjct: 182 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 241
Query: 829 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872
+ + I+++ K E R +I+E +
Sbjct: 242 SE-VSEEVKML--IRNLLKTEPT----------QRMTITEFMNH 272
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 1e-38
Identities = 62/289 (21%), Positives = 108/289 (37%), Gaps = 28/289 (9%)
Query: 603 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 661
K IG+G FGVVY KL D G+ +A+K + Q KR E+ ++ ++ H N+V+
Sbjct: 24 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLR 79
Query: 662 GYCQEEGRS------VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 715
+ G LV +++ + + +Q + I + + Y+
Sbjct: 80 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 716 HTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 774
H+ I HRD+K N+LLD K+ DFG +K V G S +
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELI 194
Query: 775 YISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ---------WAKLHIES 825
+ + T DV+S G +L EL+ GQ + I++ +++
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254
Query: 826 GDIQGIIDPSLLDEYDIQSMWKIEEKALM--CVLPHGHMRPSISEVLKD 872
+ + + + E AL + R + E
Sbjct: 255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 143 bits (361), Expect = 1e-38
Identities = 44/289 (15%), Positives = 105/289 (36%), Gaps = 34/289 (11%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 661
+ ++IG G FGV++ G L + +++A+K S + +E + + +
Sbjct: 9 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNV 66
Query: 662 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 721
Y +EG ++ + +L++ L ++ + A+ ++ +H
Sbjct: 67 YYFGQEGLHNVLVIDLLGPSLEDLL---DLCGRKFSVKTVAMAAKQMLARVQSIHEKS-- 121
Query: 722 AIIHRDLKSSNILLDKHMR-----AKVSDFGLSKFAVDGASHVSSI------VRGTVGYL 770
+++RD+K N L+ + V DFG+ KF D + + GT Y+
Sbjct: 122 -LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 771 DPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 830
++ ++ + + D+ + G + + + G K A + + +S ++
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK-AATNKQKYERIGEKKQSTPLRE 239
Query: 831 IID--PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 877
+ P +Y + + A P + +
Sbjct: 240 LCAGFPEEFYKY-MHYARNLAFDA----------TPDYDYLQGLFSKVL 277
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 1e-38
Identities = 52/281 (18%), Positives = 98/281 (34%), Gaps = 44/281 (15%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE------FTNEVTLLSRIH-- 653
+ +GSGGFG VY G + D +A+K + + E EV LL ++
Sbjct: 8 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 654 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 713
+++ L + + VL+ E +T + + +
Sbjct: 68 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDF---ITERGALQEELARSFFWQVLEAVR 124
Query: 714 YLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 772
+ H ++HRD+K NIL+D + K+ DFG D V + GT Y P
Sbjct: 125 HCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFDGTRVYSPP 178
Query: 773 EYYISQQLTDKS-DVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 831
E+ + +S V+S G++L +++ G ++ + ++
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-------EEIIRGQVFFRQR----- 226
Query: 832 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872
+ I+ + RP+ E+
Sbjct: 227 VSSECQHL--IRWCLALRPSD----------RPTFEEIQNH 255
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 2e-38
Identities = 50/285 (17%), Positives = 104/285 (36%), Gaps = 22/285 (7%)
Query: 603 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 659
+KIG G +G V+ K + + +A+K + + E+ LL + H+N+V+
Sbjct: 6 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVR 65
Query: 660 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 719
+ + LV+EF K ++ KG+ + H+
Sbjct: 66 LHDVLHSDKKLTLVFEFCDQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 720 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 779
++HRDLK N+L++++ K+++FGL++ S+ V + ++
Sbjct: 122 ---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 780 LTDKSDVYSFGVILLELISG----------QEAISNEKFGANCRNIVQWAKLHIESGDIQ 829
+ D++S G I EL + + + QW +
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 830 GIIDPSLLDEYDIQSMWKIEEKALM--CVLPHGHMRPSISEVLKD 872
+ P+ ++ + L+ + + R S E L+
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 3e-37
Identities = 54/213 (25%), Positives = 85/213 (39%), Gaps = 17/213 (7%)
Query: 592 TLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE---FTNEVT 647
T++D + K +G G FG V + K G+ A+K+L K E E
Sbjct: 3 TMNDFD-----YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 648 LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED 707
+L H L Q R V E+ + G L HL R
Sbjct: 58 VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-------SRERVFTEERARFY 110
Query: 708 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 767
A+ + L +++RD+K N++LDK K++DFGL K + + + + GT
Sbjct: 111 GAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTP 169
Query: 768 GYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 800
YL PE D + GV++ E++ G+
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 6e-36
Identities = 55/286 (19%), Positives = 103/286 (36%), Gaps = 22/286 (7%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 659
+ +GSG +G V + G ++A+K L S + E+ LL + H N++
Sbjct: 22 DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIG 81
Query: 660 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 719
L + +F G L +++ + + KG+ Y+H
Sbjct: 82 LLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG 141
Query: 720 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 779
IIHRDLK N+ +++ K+ DFGL++ A S ++ V +
Sbjct: 142 ---IIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTGYVVTRWYRAPEVILNWMR 195
Query: 780 LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ---------WAKLHIESGDIQG 830
T D++S G I+ E+I+G+ + I++ +L +
Sbjct: 196 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 255
Query: 831 IIDPSLLDEYDIQSMWKIEEKAL----MCVLPHGHMRPSISEVLKD 872
P L + + A+ ++ R + E L
Sbjct: 256 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 9e-36
Identities = 53/300 (17%), Positives = 110/300 (36%), Gaps = 38/300 (12%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQ 659
KIG G FG V+ + K G+++A+K + + + E+ +L + H N+V
Sbjct: 14 KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVN 73
Query: 660 FLGYCQE--------EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 711
+ C+ +G LV++F + + EI
Sbjct: 74 LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS-------NVLVKFTLSEIKRVMQML 126
Query: 712 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF---AVDGASHVSSIVRGTVG 768
+ L+ I+HRD+K++N+L+ + K++DFGL++ A + + + T+
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 769 YLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 827
Y PE + ++ D++ G I+ E+ + + I Q I
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ-LCGSITPEV 245
Query: 828 IQGIIDPSLLDEYDIQSMWKIEEKALM---------------CVLPHGHMRPSISEVLKD 872
+ + L ++ ++ K + K + ++ R + L
Sbjct: 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 135 bits (341), Expect = 3e-35
Identities = 58/290 (20%), Positives = 113/290 (38%), Gaps = 33/290 (11%)
Query: 605 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 660
K +G+G FG V K + G A+K+L ++ NE +L ++ LV+
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 661 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 720
++ +V E++ G + HL R + A EYLH+
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD- 161
Query: 721 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 780
+I+RDLK N+L+D+ +V+DFG +K + GT L PE +S+
Sbjct: 162 --LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT----LCGTPEALAPEIILSKGY 215
Query: 781 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 840
D ++ GV++ E+ +G ++ IV L D
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG------KVRFPSHFSSDLKD-- 267
Query: 841 DIQSMWKIEEKALMCVLPHGHMRPSISEVL-----KDIQDAIVIEREAAA 885
++++ +++ G+++ ++++ + +R+ A
Sbjct: 268 LLRNLLQVDLTKRF-----GNLKNGVNDIKNHKWFATTDWIAIYQRKVEA 312
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 129 bits (326), Expect = 2e-33
Identities = 52/277 (18%), Positives = 114/277 (41%), Gaps = 23/277 (8%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQF 660
L +K+G G + V+ + + +++ VK+L K++ E+ +L + N++
Sbjct: 39 LVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITL 95
Query: 661 LGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 718
++ LV+E ++N K+ Q + + K ++Y H+
Sbjct: 96 ADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM 148
Query: 719 CVPAIIHRDLKSSNILLD-KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 777
I+HRD+K N+++D +H + ++ D+GL++F G + + + + PE +
Sbjct: 149 G---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV--ASRYFKGPELLVD 203
Query: 778 QQLTD-KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836
Q+ D D++S G +L +I +E + N +V+ AK+ I ++
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGH--DNYDQLVRIAKVLGTEDLYDYIDKYNI 261
Query: 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 873
+ + + H + +S D
Sbjct: 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF 298
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 1e-31
Identities = 56/209 (26%), Positives = 86/209 (41%), Gaps = 18/209 (8%)
Query: 603 LEKKIGSGGFGVVYYGKL----KDGKEIAVKVL----TSNSYQGKREFTNEVTLLSRI-H 653
L K +G+G +G V+ + GK A+KVL + E +L I
Sbjct: 28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 87
Query: 654 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 713
LV Q E + L+ ++++ G L HL + I EI
Sbjct: 88 SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL------- 140
Query: 714 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 773
L II+RD+K NILLD + ++DFGLSK V + + GT+ Y+ P+
Sbjct: 141 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200
Query: 774 YYISQQ--LTDKSDVYSFGVILLELISGQ 800
D +S GV++ EL++G
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 4e-30
Identities = 56/276 (20%), Positives = 104/276 (37%), Gaps = 22/276 (7%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 659
+GSG +G V K G +AVK L S + E+ LL + H N++
Sbjct: 22 NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 81
Query: 660 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 719
L + L + Q++ + +G++Y+H+
Sbjct: 82 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 720 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 779
IIHRDLK SN+ +++ K+ DFGL++ + T Y PE ++
Sbjct: 142 ---IIHRDLKPSNLAVNEDCELKILDFGLARH----TDDEMTGYVATRWYRAPEIMLNWM 194
Query: 780 LTD-KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 838
+ D++S G I+ EL++G+ + I++ + G LL
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR----------LVGTPGAELLK 244
Query: 839 EYDIQSMWK-IEEKALMCVLPHGHMRPSISEVLKDI 873
+ +S I+ M + ++ + + D+
Sbjct: 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDL 280
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (300), Expect = 7e-30
Identities = 50/225 (22%), Positives = 92/225 (40%), Gaps = 21/225 (9%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 659
K IGSG G+V + +A+K L + + E+ L+ ++H+N++
Sbjct: 21 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 80
Query: 660 FLGYC------QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 713
L +E LV E M + + ++ + + GI+
Sbjct: 81 LLNVFTPQKTLEEFQDVYLVMELMDANLCQ-------VIQMELDHERMSYLLYQMLCGIK 133
Query: 714 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 773
+LH+ IIHRDLK SNI++ K+ DFGL++ G S + + T Y PE
Sbjct: 134 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPE 188
Query: 774 YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQW 818
+ + D++S G I+ E++ + + +++
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 115 bits (288), Expect = 3e-28
Identities = 42/241 (17%), Positives = 97/241 (40%), Gaps = 18/241 (7%)
Query: 603 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL---- 657
L +K+G G F V+ K + + +A+K++ +E+ LL R++ +
Sbjct: 17 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKED 75
Query: 658 -------VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL-EIAEDAA 709
++ L + +G + + + + L +E R + + +I++
Sbjct: 76 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135
Query: 710 KGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGASHVS-SIVRGTV 767
G++Y+H C IIH D+K N+L++ + ++ + T
Sbjct: 136 LGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193
Query: 768 GYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 827
Y PE + +D++S ++ ELI+G ++ + ++ A++ G+
Sbjct: 194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE 253
Query: 828 I 828
+
Sbjct: 254 L 254
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 93.3 bits (231), Expect = 3e-22
Identities = 29/158 (18%), Positives = 48/158 (30%), Gaps = 21/158 (13%)
Query: 603 LEKKIGSGGFGVVYYGKLKDGKEIAVKVL----------TSNSYQGKREFTNEVTLLSRI 652
+ K +G G V+ + E VK G F+ +R
Sbjct: 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 653 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 712
R L + G VY + N L E R+ E+ + + +
Sbjct: 64 EFRALQKLQGLAV-----PKVYAWEGNAVLME--LIDAKELYRVRVENPDEVLDMILEEV 116
Query: 713 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 750
+ I+H DL N+L+ + + DF S
Sbjct: 117 AKFYHRG---IVHGDLSQYNVLVSEEG-IWIIDFPQSV 150
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 73.1 bits (178), Expect = 4e-14
Identities = 15/93 (16%), Positives = 36/93 (38%), Gaps = 5/93 (5%)
Query: 403 WSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPD 462
++T + L N++ P ++ L+ L L+ N ++ + +
Sbjct: 296 QLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV-SSLANLTN 352
Query: 463 LRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 495
+ + NQ++ P L NL + +L + +
Sbjct: 353 INWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 66.6 bits (161), Expect = 4e-12
Identities = 21/81 (25%), Positives = 37/81 (45%), Gaps = 3/81 (3%)
Query: 437 LSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 496
L +L L L N+++ P S L+ + +N+++ SSL NL N+ L +N
Sbjct: 306 LKNLTYLTLYFNNISDISP-VSSLTKLQRLFFANNKVSDV--SSLANLTNINWLSAGHNQ 362
Query: 497 LSGTVPSSLLSKNVVLNYAGN 517
+S P + L++ L
Sbjct: 363 ISDLTPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 50.0 bits (118), Expect = 8e-07
Identities = 36/131 (27%), Positives = 52/131 (39%), Gaps = 24/131 (18%)
Query: 410 SDPQPSITVIHLSSKNLTGNI---PSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRII 466
SD P + +L +L GN L L++L +L L N ++ P SG L +
Sbjct: 210 SDITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP-LSGLTKLTEL 268
Query: 467 HLEDNQLTGPLP--------------------SSLMNLPNLRELYVQNNMLSGTVPSSLL 506
L NQ++ P S + NL NL L + N +S P S L
Sbjct: 269 KLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSL 328
Query: 507 SKNVVLNYAGN 517
+K L +A N
Sbjct: 329 TKLQRLFFANN 339
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 46.5 bits (109), Expect = 1e-05
Identities = 13/78 (16%), Positives = 30/78 (38%), Gaps = 3/78 (3%)
Query: 437 LSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 496
L+ ++ L ++T + + + + + + + L NL ++ NN
Sbjct: 21 LAEKMKTVLGKTNVTDTVS-QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQ 77
Query: 497 LSGTVPSSLLSKNVVLNY 514
L+ P L+K V +
Sbjct: 78 LTDITPLKNLTKLVDILM 95
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 45.8 bits (107), Expect = 2e-05
Identities = 24/78 (30%), Positives = 36/78 (46%), Gaps = 3/78 (3%)
Query: 436 KLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 495
KL++L L N ++ P +L + L NQL +L +L NL +L + NN
Sbjct: 195 KLTNLESLIATNNQISDITPLGI-LTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANN 251
Query: 496 MLSGTVPSSLLSKNVVLN 513
+S P S L+K L
Sbjct: 252 QISNLAPLSGLTKLTELK 269
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 69.8 bits (169), Expect = 2e-13
Identities = 19/79 (24%), Positives = 34/79 (43%), Gaps = 2/79 (2%)
Query: 403 WSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPD 462
++ ++ + L + + G +P LT+L L L + N+L G IP
Sbjct: 233 LAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQR 292
Query: 463 LRIIHLEDNQ-LTG-PLPS 479
+ +N+ L G PLP+
Sbjct: 293 FDVSAYANNKCLCGSPLPA 311
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 60.5 bits (145), Expect = 2e-10
Identities = 21/62 (33%), Positives = 28/62 (45%), Gaps = 1/62 (1%)
Query: 460 CPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL-LSKNVVLNYAGNI 518
+L + L +N++ G LP L L L L V N L G +P L + V YA N
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302
Query: 519 NL 520
L
Sbjct: 303 CL 304
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 56.3 bits (134), Expect = 5e-09
Identities = 15/58 (25%), Positives = 22/58 (37%), Gaps = 3/58 (5%)
Query: 444 WLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN-MLSG 499
L N + G +P + L +++ N L G +P NL NN L G
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCG 306
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 63.1 bits (152), Expect = 4e-11
Identities = 25/104 (24%), Positives = 39/104 (37%), Gaps = 5/104 (4%)
Query: 415 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQL 473
+ V+ S L +P DL L L N +T DF +L + L +N++
Sbjct: 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 474 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 517
+ P + L L LY+ N L +P + L N
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHEN 110
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 54.3 bits (129), Expect = 2e-08
Identities = 24/93 (25%), Positives = 38/93 (40%), Gaps = 4/93 (4%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 472
P ++ L + +T D L +L L L N ++ P F+ L ++L NQ
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 473 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 505
L LP + L+EL V N ++ S
Sbjct: 91 LKE-LPEKMPK--TLQELRVHENEITKVRKSVF 120
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 46.6 bits (109), Expect = 7e-06
Identities = 16/128 (12%), Positives = 38/128 (29%), Gaps = 25/128 (19%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG--------------------- 452
++ + L + ++ P L L L+L N L
Sbjct: 55 KNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITK 114
Query: 453 ---PIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN 509
+ + + + + +G + + L + + + ++ T+P L
Sbjct: 115 VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSL 173
Query: 510 VVLNYAGN 517
L+ GN
Sbjct: 174 TELHLDGN 181
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 40.0 bits (92), Expect = 9e-04
Identities = 17/115 (14%), Positives = 38/115 (33%), Gaps = 30/115 (26%)
Query: 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLD------------------------GNS 449
PS+T +HL +T + L L++L +L L N
Sbjct: 171 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK 230
Query: 450 LTGPIPDFSGCPDLRIIHLEDNQLTG------PLPSSLMNLPNLRELYVQNNMLS 498
L + +++++L +N ++ P + + + +N +
Sbjct: 231 LVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 39.6 bits (91), Expect = 0.001
Identities = 19/71 (26%), Positives = 31/71 (43%), Gaps = 4/71 (5%)
Query: 436 KLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 494
+VEL + +G F G L I + D +T +P L P+L EL++
Sbjct: 124 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDG 180
Query: 495 NMLSGTVPSSL 505
N ++ +SL
Sbjct: 181 NKITKVDAASL 191
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 55.5 bits (133), Expect = 7e-10
Identities = 24/105 (22%), Positives = 38/105 (36%), Gaps = 25/105 (23%)
Query: 418 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDL-------------- 463
V+HL+ K+LT + L +L + L L N L P + L
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD 59
Query: 464 --------RIIHLEDNQLTG-PLPSSLMNLPNLRELYVQNNMLSG 499
+ + L +N+L L++ P L L +Q N L
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.2 bits (88), Expect = 9e-04
Identities = 11/40 (27%), Positives = 17/40 (42%), Gaps = 2/40 (5%)
Query: 464 RIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPS 503
R++HL LT L L + L + +N L P+
Sbjct: 1 RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPA 38
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 52.3 bits (124), Expect = 6e-08
Identities = 25/97 (25%), Positives = 43/97 (44%), Gaps = 3/97 (3%)
Query: 398 CLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF 457
L + + + S + +LS N + + L LS L L D N ++ I
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD-ISPL 191
Query: 458 SGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 494
+ P+L +HL++NQ++ P L N NL + + N
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 44.6 bits (104), Expect = 2e-05
Identities = 15/59 (25%), Positives = 30/59 (50%), Gaps = 2/59 (3%)
Query: 455 PDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLN 513
+ L + +DN+++ P L +LPNL E++++NN +S P + S ++
Sbjct: 167 TPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLANTSNLFIVT 223
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 6e-04
Identities = 8/61 (13%), Positives = 26/61 (42%), Gaps = 3/61 (4%)
Query: 437 LSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 496
L++ +++ +++T + + + + +T + L NL L +++N
Sbjct: 18 LANAIKIAAGKSNVTDTVT-QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQ 74
Query: 497 L 497
+
Sbjct: 75 I 75
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.7 bits (122), Expect = 2e-07
Identities = 23/118 (19%), Positives = 37/118 (31%), Gaps = 9/118 (7%)
Query: 390 WAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNS 449
P + + + I S SL EL + N
Sbjct: 236 LTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNK 295
Query: 450 LTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSG--TVPSSL 505
L +P + P L + N L +P NL++L+V+ N L +P S+
Sbjct: 296 LIE-LP--ALPPRLERLIASFNHLAE-VPEL---PQNLKQLHVEYNPLREFPDIPESV 346
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.6 bits (116), Expect = 1e-06
Identities = 15/75 (20%), Positives = 28/75 (37%), Gaps = 6/75 (8%)
Query: 439 SLVELWLDGNSLT--GPIPDFSGCPDLRIIHLEDNQLTG----PLPSSLMNLPNLRELYV 492
+ L + L+ +++ L+D LT + S+L P L EL +
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 493 QNNMLSGTVPSSLLS 507
++N L +L
Sbjct: 63 RSNELGDVGVHCVLQ 77
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 7e-06
Identities = 20/103 (19%), Positives = 34/103 (33%), Gaps = 14/103 (13%)
Query: 402 PWSWLQCNSDPQPSITVIHLSSKNLTGN----IPSDLTKLSSLVELWLDGNSLTGPIPD- 456
Q P + V+ L+ +++ + + + L SL EL L N L
Sbjct: 357 VRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQ 416
Query: 457 -----FSGCPDLRIIHLEDNQLTGPLPSSLMNL----PNLREL 490
L + L D + + L L P+LR +
Sbjct: 417 LVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 7e-04
Identities = 14/55 (25%), Positives = 24/55 (43%), Gaps = 4/55 (7%)
Query: 457 FSGCPDLRIIHLEDNQLTG----PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 507
LR++ L D ++ L ++L+ +LREL + NN L L+
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE 419
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.2 bits (108), Expect = 8e-06
Identities = 18/64 (28%), Positives = 32/64 (50%), Gaps = 2/64 (3%)
Query: 433 DLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 492
+++K++S +E+ D +LT PD D I+HL +N L ++LM L +L +
Sbjct: 5 EVSKVASHLEVNCDKRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 493 QNNM 496
Sbjct: 63 DRAE 66
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.5 bits (88), Expect = 0.002
Identities = 16/100 (16%), Positives = 30/100 (30%), Gaps = 3/100 (3%)
Query: 398 CLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDG-NSLTGPIPD 456
+ L + N +P L + +E N+LT
Sbjct: 107 VSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAG 166
Query: 457 -FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 495
+G +L + L++N L +P L ++ N
Sbjct: 167 LLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.8 bits (104), Expect = 3e-05
Identities = 22/107 (20%), Positives = 40/107 (37%), Gaps = 8/107 (7%)
Query: 400 PVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FS 458
P + L + +HL L P L++L L+L N+L D F
Sbjct: 98 PATFHGLGR-------LHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFR 150
Query: 459 GCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 505
+L + L N+++ + L +L L + N ++ P +
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAF 197
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.9 bits (102), Expect = 4e-05
Identities = 12/76 (15%), Positives = 28/76 (36%), Gaps = 2/76 (2%)
Query: 423 SKNLTGNIPSDLTKLSSLVELWLDGNSLT--GPIPDFSGCPDLRIIHLEDNQLTGPLPSS 480
++ ++ + + L + + S C L+ + LE +L+ P+ ++
Sbjct: 31 PRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNT 90
Query: 481 LMNLPNLRELYVQNNM 496
L NL L +
Sbjct: 91 LAKNSNLVRLNLSGCS 106
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 4e-05
Identities = 12/73 (16%), Positives = 29/73 (39%), Gaps = 3/73 (4%)
Query: 435 TKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 494
+ ++ L S+T + + + I ++ + + LPN+ +L++
Sbjct: 21 DAFAETIKDNLKKKSVTDAVTQ-NELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 495 NMLSGTVPSSLLS 507
N L+ P + L
Sbjct: 78 NKLTDIKPLANLK 90
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 7e-04
Identities = 10/41 (24%), Positives = 19/41 (46%), Gaps = 2/41 (4%)
Query: 454 IPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 494
I +G L+ ++L N ++ +L L NL L + +
Sbjct: 171 IVPLAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.003
Identities = 11/66 (16%), Positives = 25/66 (37%), Gaps = 3/66 (4%)
Query: 403 WSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPD 462
+ + L ++ +P L L+ L L+L N ++ + +G +
Sbjct: 145 KITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LRALAGLKN 201
Query: 463 LRIIHL 468
L ++ L
Sbjct: 202 LDVLEL 207
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.2 bits (93), Expect = 3e-04
Identities = 16/72 (22%), Positives = 27/72 (37%), Gaps = 2/72 (2%)
Query: 429 NIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTG--PLPSSLMNLPN 486
DL + V L + P+L ++L +N+L + S + PN
Sbjct: 33 RSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPN 92
Query: 487 LRELYVQNNMLS 498
L+ L + N L
Sbjct: 93 LKILNLSGNELK 104
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.1 bits (85), Expect = 0.003
Identities = 16/90 (17%), Positives = 30/90 (33%), Gaps = 3/90 (3%)
Query: 420 HLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPS 479
L + + + ++K + LD L PD +++ + L
Sbjct: 3 ELKPEQVE-QLKLIMSKRYDGSQQALDLKGLRS-DPDLVAQNIDVVLNRRSSMAAT-LRI 59
Query: 480 SLMNLPNLRELYVQNNMLSGTVPSSLLSKN 509
N+P L L + NN L S + +
Sbjct: 60 IEENIPELLSLNLSNNRLYRLDDMSSIVQK 89
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (94), Expect = 3e-04
Identities = 10/43 (23%), Positives = 14/43 (32%)
Query: 453 PIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 495
P F G I+ + ++ L NL LR N
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (85), Expect = 0.004
Identities = 14/88 (15%), Positives = 24/88 (27%), Gaps = 12/88 (13%)
Query: 402 PWSWLQCNSDPQPSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD-FSG 459
+ + + ++LS N +P+D S V L + +
Sbjct: 164 GIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLEN 223
Query: 460 CPDLRIIHLEDNQLTGPLPSSLMNLPNL 487
LR +L LP L
Sbjct: 224 LKKLRARST----------YNLKKLPTL 241
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.2 bits (92), Expect = 3e-04
Identities = 16/109 (14%), Positives = 35/109 (32%), Gaps = 3/109 (2%)
Query: 415 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQ 472
+ + + + L +L EL+++ + G +LR + + +
Sbjct: 9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67
Query: 473 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 521
L P + P L L + N L ++ ++ LH
Sbjct: 68 LRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 6e-04
Identities = 10/65 (15%), Positives = 25/65 (38%), Gaps = 3/65 (4%)
Query: 435 TKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 494
T L+ ++ L ++T + + + + + + + L NL ++ N
Sbjct: 15 TALAEKMKTVLGKTNVTDTVS-QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 71
Query: 495 NMLSG 499
N L+
Sbjct: 72 NQLTD 76
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.002
Identities = 11/47 (23%), Positives = 18/47 (38%), Gaps = 3/47 (6%)
Query: 444 WLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 490
N +T P + L + + N+++ S L L NL L
Sbjct: 156 NFSSNQVTDLKP-LANLTTLERLDISSNKVSDI--SVLAKLTNLESL 199
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (88), Expect = 0.001
Identities = 6/55 (10%), Positives = 17/55 (30%), Gaps = 1/55 (1%)
Query: 454 IPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 508
++ R + L ++ + + L + +N + LL +
Sbjct: 11 AAQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKLDGFPLLRR 64
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 927 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.83 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.68 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.32 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.26 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.12 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.09 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.04 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.03 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.01 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 98.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 98.9 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 98.81 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 98.8 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 98.75 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 98.65 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 98.63 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.52 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.44 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 98.43 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.41 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.37 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.37 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.36 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.32 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.26 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.22 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.19 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.1 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.0 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 97.86 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.74 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 97.64 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 97.56 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.53 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.2 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.08 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.05 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.98 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.7 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 96.49 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 96.45 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 96.19 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 96.15 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 95.89 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.43 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 94.9 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.35 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 91.79 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 88.26 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-48 Score=414.22 Aligned_cols=253 Identities=28% Similarity=0.470 Sum_probs=198.4
Q ss_pred HHhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCCc
Q 002409 602 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 681 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gs 681 (927)
.+.+.||+|+||+||+|++.+++.||||+++... ...++|.+|++++++++||||++++|+|...+..++||||+++|+
T Consensus 8 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~ 86 (263)
T d1sm2a_ 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 86 (263)
T ss_dssp EEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred EEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCc
Confidence 3567899999999999999988999999997543 345789999999999999999999999999999999999999999
Q ss_pred hhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCceee
Q 002409 682 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 761 (927)
Q Consensus 682 L~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 761 (927)
|.+++... ...+++..++.++.|+|+||+|||++ +|+||||||+|||+++++.+||+|||+++...........
T Consensus 87 L~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 160 (263)
T d1sm2a_ 87 LSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160 (263)
T ss_dssp HHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred HHHHhhcc---ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence 99988543 45688999999999999999999998 9999999999999999999999999999876554444444
Q ss_pred eeccCCCccCccccccCcCCCccceeeHHHHHHHHHhC-CCcccccccccccchhhHHHHhhhccCCcccccCCcccCcc
Q 002409 762 IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG-QEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 840 (927)
Q Consensus 762 ~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG-~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 840 (927)
...||+.|+|||++.+..++.++|||||||++|||+++ +.|+.... ...+.+.+.. +.. ...+
T Consensus 161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~----~~~~~~~i~~----~~~--~~~p------ 224 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS----NSEVVEDIST----GFR--LYKP------ 224 (263)
T ss_dssp ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC----HHHHHHHHHH----TCC--CCCC------
T ss_pred ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC----HHHHHHHHHh----cCC--CCCc------
Confidence 56799999999999999999999999999999999995 45554332 1122222221 110 0111
Q ss_pred CHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 841 DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 841 ~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
.....++.+++.+|++.+|++||||+||+++|+++.+
T Consensus 225 -~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 225 -RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp -TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 1223468899999999999999999999999998854
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-48 Score=416.13 Aligned_cols=256 Identities=24% Similarity=0.390 Sum_probs=208.2
Q ss_pred HHHHhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
.+.+.+.||+|+||+||+|++++++.||||+++... ...+.|.+|+++|++++||||++++|++.+ +..++||||+++
T Consensus 14 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~ 91 (272)
T d1qpca_ 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN 91 (272)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred HeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCC
Confidence 345678899999999999999988999999997543 345679999999999999999999998865 457899999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
|+|.+++... ....+++..++.|+.||++||.|||++ +|+||||||+||||++++.+||+|||+|+.........
T Consensus 92 g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 92 GSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp CBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcccc
Confidence 9999987543 345689999999999999999999998 99999999999999999999999999998766544444
Q ss_pred eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCc
Q 002409 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 839 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 839 (927)
.....||+.|+|||++.++.++.++|||||||++|||+||..|+..... ...+.+.+. .+. .+ .
T Consensus 167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~---~~~~~~~i~----~~~-----~~----~ 230 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT---NPEVIQNLE----RGY-----RM----V 230 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHHHHHH----TTC-----CC----C
T ss_pred ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC---HHHHHHHHH----hcC-----CC----C
Confidence 4556789999999999999999999999999999999996655533221 112222221 111 00 1
Q ss_pred cCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 840 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 840 ~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
.+.....++.+|+.+|++.+|++||||.||++.|++...
T Consensus 231 ~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 111223468899999999999999999999999998764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.9e-47 Score=416.29 Aligned_cols=252 Identities=27% Similarity=0.453 Sum_probs=196.8
Q ss_pred hccccccCceEEEEEEECC-C---cEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 604 EKKIGSGGFGVVYYGKLKD-G---KEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 604 ~~~IG~G~fG~Vy~~~~~~-g---~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
.+.||+|+||+||+|+++. + ..||||++.... ....+.|.+|+++|++++|||||+++|+|...+..++|||||+
T Consensus 31 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~ 110 (299)
T d1jpaa_ 31 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFME 110 (299)
T ss_dssp EEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecC
Confidence 4689999999999998763 3 258899886543 3445679999999999999999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
+|+|.+++... ...+++.+++.++.|+++||+|||++ +|+||||||+||||+.++++||+|||+++........
T Consensus 111 ~g~L~~~~~~~---~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 184 (299)
T d1jpaa_ 111 NGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184 (299)
T ss_dssp TEEHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred CCcceeeeccc---cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccCCCCc
Confidence 99999988532 45689999999999999999999998 9999999999999999999999999999865443222
Q ss_pred e----eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccC
Q 002409 759 V----SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 833 (927)
Q Consensus 759 ~----~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 833 (927)
. .....||+.|||||.+.++.++.++|||||||++|||+| |+.||..... ..+...+.. +.
T Consensus 185 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~----~~~~~~i~~----~~------ 250 (299)
T d1jpaa_ 185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN----QDVINAIEQ----DY------ 250 (299)
T ss_dssp -----------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHHHHHT----TC------
T ss_pred ceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH----HHHHHHHHc----CC------
Confidence 1 122457899999999999999999999999999999998 8999976542 123332221 11
Q ss_pred CcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 834 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 834 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
+...+.+....+.+|+.+|++.+|++||||.||++.|+++++
T Consensus 251 ---~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 251 ---RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 011122334568899999999999999999999999998875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-47 Score=417.52 Aligned_cols=256 Identities=27% Similarity=0.382 Sum_probs=211.5
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
.+.+.+.||+|+||+||+|+++ +++.||||+++... ...++|.+|+++|++++||||++++++|.+.+..++|||||+
T Consensus 18 ~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~ 96 (287)
T d1opja_ 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 96 (287)
T ss_dssp GEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeeccc
Confidence 3456789999999999999986 58899999987554 345679999999999999999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
+|+|.+++... ....+++..++.++.|+++||+|||++ +|+||||||+|||+++++++||+|||+|+........
T Consensus 97 ~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~ 171 (287)
T d1opja_ 97 YGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 171 (287)
T ss_dssp TCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE
T ss_pred CcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCce
Confidence 99999998543 345789999999999999999999998 9999999999999999999999999999876555444
Q ss_pred eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccC
Q 002409 759 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 838 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 838 (927)
......||+.|+|||++.+..++.++|||||||++|||++|..|+..... ...+.+.+.. +. ..
T Consensus 172 ~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~---~~~~~~~i~~----~~---------~~ 235 (287)
T d1opja_ 172 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEK----DY---------RM 235 (287)
T ss_dssp EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHHHHHHHT----TC---------CC
T ss_pred eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch---HHHHHHHHhc----CC---------CC
Confidence 44556689999999999999999999999999999999997776643221 1122222211 11 11
Q ss_pred ccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHH
Q 002409 839 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 877 (927)
Q Consensus 839 ~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~ 877 (927)
..+.....++.+|+.+|++.||++||||.||++.|+.+.
T Consensus 236 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 112223346889999999999999999999999998764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=411.85 Aligned_cols=255 Identities=32% Similarity=0.540 Sum_probs=199.4
Q ss_pred HHhccccccCceEEEEEEECCCcEEEEEEeecC--CchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 602 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
.+.+.||+|+||+||+|+++ ..||||+++.. .....+.|.+|+++|++++||||+++++++.+ +..++|||||++
T Consensus 11 ~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~ 87 (276)
T d1uwha_ 11 TVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEG 87 (276)
T ss_dssp CCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCE
T ss_pred EEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCC
Confidence 45688999999999999875 36999998754 33446789999999999999999999998865 467999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC-Cc
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA-SH 758 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~ 758 (927)
|+|.+++... ...+++..++.++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+|+...... ..
T Consensus 88 g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 88 SSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp EEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred CCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence 9999998643 35689999999999999999999998 99999999999999999999999999998654432 22
Q ss_pred eeeeeccCCCccCcccccc---CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCc
Q 002409 759 VSSIVRGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 835 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~---~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 835 (927)
......||+.|||||++.. ..++.++|||||||+||||++|+.||....... .+...+. .+.. .+.
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~---~~~~~~~----~~~~----~p~ 230 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---QIIFMVG----RGYL----SPD 230 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---HHHHHHH----HTSC----CCC
T ss_pred cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH---HHHHHHh----cCCC----CCc
Confidence 3345679999999999864 357889999999999999999999997643111 1111111 1111 111
Q ss_pred ccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHH
Q 002409 836 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 877 (927)
Q Consensus 836 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~ 877 (927)
+ ...+......+.+++.+|++.+|++||||.||+++|+.+.
T Consensus 231 ~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 231 L-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp G-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred c-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1 1112233457889999999999999999999999999875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=401.81 Aligned_cols=249 Identities=29% Similarity=0.492 Sum_probs=209.4
Q ss_pred HhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCCch
Q 002409 603 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 682 (927)
Q Consensus 603 ~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 682 (927)
+.++||+|+||+||+|++++++.||||+++.... ..++|.+|+.++++++||||++++|+|.+++..++||||+++|+|
T Consensus 8 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l 86 (258)
T d1k2pa_ 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 86 (258)
T ss_dssp CCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEH
T ss_pred EeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcH
Confidence 5688999999999999999888999999986543 467899999999999999999999999999999999999999999
Q ss_pred hhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCceeee
Q 002409 683 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 762 (927)
Q Consensus 683 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 762 (927)
.+++... ...+++..+++++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++............
T Consensus 87 ~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 160 (258)
T d1k2pa_ 87 LNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 160 (258)
T ss_dssp HHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCC
T ss_pred HHhhhcc---ccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceeecc
Confidence 9987533 45688999999999999999999998 99999999999999999999999999998665544444444
Q ss_pred eccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCcccCccC
Q 002409 763 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD 841 (927)
Q Consensus 763 ~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 841 (927)
..||+.|+|||.+....++.++|||||||++|||+| |+.||...... .+... +.++.. .. .+
T Consensus 161 ~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~----~~~~~----i~~~~~--~~-------~p 223 (258)
T d1k2pa_ 161 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS----ETAEH----IAQGLR--LY-------RP 223 (258)
T ss_dssp SCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH----HHHHH----HHTTCC--CC-------CC
T ss_pred cCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH----HHHHH----HHhCCC--CC-------Cc
Confidence 568999999999999999999999999999999998 89999765422 22221 112210 01 11
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHH
Q 002409 842 IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 875 (927)
Q Consensus 842 ~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~ 875 (927)
.....++.+++.+|++.+|++|||+.||+++|.+
T Consensus 224 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 1223468899999999999999999999999865
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-46 Score=403.19 Aligned_cols=250 Identities=22% Similarity=0.342 Sum_probs=199.5
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
|.+.+.||+|+||+||+|+++ +|+.||||++.... .+..+.+.+|+++|++++||||+++++++.+++..++||||++
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 86 (271)
T d1nvra_ 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 86 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccC
Confidence 345689999999999999986 68999999997543 3345678999999999999999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC-C
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA-S 757 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~ 757 (927)
+|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||+++++++||+|||+|+...... .
T Consensus 87 gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 87 GGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp TEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred CCcHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 999999984 345799999999999999999999998 99999999999999999999999999998654332 2
Q ss_pred ceeeeeccCCCccCccccccCcC-CCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 758 HVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
.......||+.|||||++.+..+ +.++|||||||++|||++|+.||....... .....+. ......
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~~~~~~~----~~~~~~------- 226 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QEYSDWK----EKKTYL------- 226 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS--HHHHHHH----TTCTTS-------
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH--HHHHHHh----cCCCCC-------
Confidence 23345679999999999988776 578999999999999999999997543111 1111111 100000
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
........++.+|+.+|++.||++|||+.|+++|
T Consensus 227 --~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 227 --NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp --TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0001122457789999999999999999998764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-46 Score=405.54 Aligned_cols=248 Identities=24% Similarity=0.346 Sum_probs=204.6
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
|.+.+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|+++|++++||||+++++++.+.+..++|||||++
T Consensus 22 Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g 101 (293)
T d1yhwa1 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (293)
T ss_dssp BCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCC
Confidence 455688999999999999875 6899999999866555567799999999999999999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
|+|.+++. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++....... .
T Consensus 102 g~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~ 172 (293)
T d1yhwa1 102 GSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (293)
T ss_dssp CBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred CcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc-c
Confidence 99998774 34689999999999999999999998 999999999999999999999999999986644332 2
Q ss_pred eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCc
Q 002409 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 839 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 839 (927)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..... ....+.. . + .
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~----~~~~~---~~~~~~~-~-----~--~ 237 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL----RALYL---IATNGTP-E-----L--Q 237 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHH---HHHHCSC-C-----C--S
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH----HHHHH---HHhCCCC-C-----C--C
Confidence 34456999999999999999999999999999999999999999754411 11111 1111110 0 0 0
Q ss_pred cCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 840 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 840 ~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.+......+.+++.+|++.||++|||+.|+++|
T Consensus 238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111223468899999999999999999999875
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=401.50 Aligned_cols=244 Identities=25% Similarity=0.407 Sum_probs=203.3
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
|.+.+.||+|+||+||+|+.+ +++.||||++.... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy 87 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 87 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEee
Confidence 456789999999999999986 68899999987432 23356788999999999999999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
|++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 88 ~~~g~L~~~l~----~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~- 159 (263)
T d2j4za1 88 APLGTVYRELQ----KLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 159 (263)
T ss_dssp CTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred cCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC-
Confidence 99999999984 345689999999999999999999998 9999999999999999999999999999765432
Q ss_pred CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 757 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
......||+.|||||++.+..++.++|||||||++|||++|+.||...... .+... +..+.. .
T Consensus 160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~----~~~~~----i~~~~~------~- 222 (263)
T d2j4za1 160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ----ETYKR----ISRVEF------T- 222 (263)
T ss_dssp --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHH----HHTTCC------C-
T ss_pred --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH----HHHHH----HHcCCC------C-
Confidence 233456999999999999999999999999999999999999999765422 12111 111111 0
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
++.....++.+++.+|++.||++|||+.|+++|
T Consensus 223 ---~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 223 ---FPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ---CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 111122467899999999999999999999875
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=405.51 Aligned_cols=254 Identities=24% Similarity=0.346 Sum_probs=194.1
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceee--cCeEEEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVLVYE 675 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--~~~~~lV~E 675 (927)
|.+.+.||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|+++|++++||||+++++++.+ .+..++|||
T Consensus 6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmE 85 (269)
T d2java1 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 85 (269)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEE
T ss_pred CEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEe
Confidence 445689999999999999876 68899999987553 2334668899999999999999999999865 456899999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCC--CCceecCCCCCCCeEECCCCcEEEEeecCccccc
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC--VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 753 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 753 (927)
||++|+|.+++.........+++..++.++.|++.||+|||++. ..+|+||||||+|||++.++.+||+|||+++...
T Consensus 86 y~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 165 (269)
T d2java1 86 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 165 (269)
T ss_dssp CCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-
T ss_pred cCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecc
Confidence 99999999998665445677999999999999999999999862 1249999999999999999999999999998664
Q ss_pred CCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccC
Q 002409 754 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 833 (927)
Q Consensus 754 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 833 (927)
... .......||+.|||||++.+..++.++|||||||++|||++|+.||...... .+... +.++....
T Consensus 166 ~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~----~~~~~----i~~~~~~~--- 233 (269)
T d2java1 166 HDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK----ELAGK----IREGKFRR--- 233 (269)
T ss_dssp -----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHH----HHHTCCCC---
T ss_pred cCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH----HHHHH----HHcCCCCC---
Confidence 432 2234467999999999999999999999999999999999999999764421 22221 12222211
Q ss_pred CcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 834 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 834 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
+...+ ..++.+++.+|++.||++|||+.|+++|
T Consensus 234 --~~~~~----s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 234 --IPYRY----SDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp --CCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --CCccc----CHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 11122 2368899999999999999999999864
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-46 Score=401.07 Aligned_cols=249 Identities=27% Similarity=0.402 Sum_probs=200.3
Q ss_pred ccccccCceEEEEEEECC---CcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 605 KKIGSGGFGVVYYGKLKD---GKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~~---g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
++||+|+||+||+|.+++ ++.||||+++... ....+.|.+|+++|++++||||++++|+|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999998653 4679999996542 3345679999999999999999999999965 457899999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
|+|.+++.. ...+++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 999999853 45689999999999999999999998 99999999999999999999999999998665443332
Q ss_pred --eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 760 --SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 760 --~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
.....||+.|||||.+.+..++.++|||||||++|||++ |+.||...... .+...+ ..+..
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~----~~~~~i----~~~~~-------- 228 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS----EVTAML----EKGER-------- 228 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----HHHHHH----HTTCC--------
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH----HHHHHH----HcCCC--------
Confidence 233568999999999999999999999999999999998 89999764421 222221 12211
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
...+.....++.+|+.+|++.+|++|||+.||++.|+....
T Consensus 229 -~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 229 -MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 11122233568899999999999999999999999987653
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=407.00 Aligned_cols=256 Identities=25% Similarity=0.403 Sum_probs=199.7
Q ss_pred HHhccccccCceEEEEEEECCC-----cEEEEEEeecCCc-hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEE
Q 002409 602 MLEKKIGSGGFGVVYYGKLKDG-----KEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 675 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~~g-----~~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E 675 (927)
.+.+.||+|+||.||+|.++.. ..||||+++.... ....+|.+|++++++++|||||+++|++.+.+..++|||
T Consensus 10 ~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e 89 (283)
T d1mqba_ 10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITE 89 (283)
T ss_dssp EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEE
Confidence 3467899999999999987632 3699999975533 335578999999999999999999999999999999999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCC
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 755 (927)
|+.+|++.+++... ...+++..++.++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 90 ~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 90 YMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp CCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred ecccCcchhhhhcc---cccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 99999998877532 45689999999999999999999998 9999999999999999999999999999865443
Q ss_pred CC--ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccC
Q 002409 756 AS--HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 833 (927)
Q Consensus 756 ~~--~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 833 (927)
.. .......||+.|||||++..+.++.++|||||||++|||++|..|+..... ...+.+.+. ++.
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~---~~~~~~~i~----~~~------ 230 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS---NHEVMKAIN----DGF------ 230 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHHH----TTC------
T ss_pred CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC---HHHHHHHHh----ccC------
Confidence 22 222345689999999999999999999999999999999997666543221 112222222 111
Q ss_pred CcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHH
Q 002409 834 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 879 (927)
Q Consensus 834 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~ 879 (927)
+...+.....++.+|+.+|++.+|++||||.||++.|++++..
T Consensus 231 ---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 231 ---RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp ---CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ---CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 1112223345688999999999999999999999999988753
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-46 Score=404.26 Aligned_cols=250 Identities=22% Similarity=0.314 Sum_probs=203.7
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
|.+.+.||+|+||+||+|++. +++.||||+++.......+.+.+|+++|++++||||+++++++.+++..++|||||++
T Consensus 14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~ 93 (288)
T d2jfla1 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCC
Confidence 445688999999999999876 6889999999877666678899999999999999999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
|+|.+++... ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++++||+|||+|+...... ..
T Consensus 94 g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~ 166 (288)
T d2jfla1 94 GAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 166 (288)
T ss_dssp EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HH
T ss_pred CcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc-cc
Confidence 9999987532 35689999999999999999999998 99999999999999999999999999997543221 12
Q ss_pred eeeeccCCCccCccccc-----cCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCC
Q 002409 760 SSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 834 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~-----~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 834 (927)
.....||+.|+|||++. ...|+.++|||||||++|||++|+.||......+ +...+. .+......
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~----~~~~i~----~~~~~~~~-- 236 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR----VLLKIA----KSEPPTLA-- 236 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG----HHHHHH----HSCCCCCS--
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH----HHHHHH----cCCCCCCC--
Confidence 23456999999999984 4568899999999999999999999997654222 111111 11111110
Q ss_pred cccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 835 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 835 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.+.....++.+++.+|++.||++|||+.|+++|
T Consensus 237 -----~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 237 -----QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp -----SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -----ccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111223468899999999999999999999875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=400.61 Aligned_cols=249 Identities=27% Similarity=0.426 Sum_probs=203.6
Q ss_pred cccccCceEEEEEEEC---CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccCCc
Q 002409 606 KIGSGGFGVVYYGKLK---DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 681 (927)
Q Consensus 606 ~IG~G~fG~Vy~~~~~---~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gs 681 (927)
+||+|+||+||+|.++ ++..||||+++... ....+.|.+|+++|++++|||||+++|++.. +..++|||||++|+
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~ 94 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 94 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence 4999999999999865 34579999997653 3345779999999999999999999999865 46789999999999
Q ss_pred hhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce--
Q 002409 682 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-- 759 (927)
Q Consensus 682 L~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~-- 759 (927)
|.+++.. ....+++..++.++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 95 L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 168 (285)
T d1u59a_ 95 LHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 168 (285)
T ss_dssp HHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECC
T ss_pred HHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccccccccccc
Confidence 9998753 245689999999999999999999998 99999999999999999999999999998665433222
Q ss_pred eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCcccC
Q 002409 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 838 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 838 (927)
.....||+.|+|||++..+.++.++|||||||++|||+| |+.||...... .+... +.++...
T Consensus 169 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~----~~~~~----i~~~~~~--------- 231 (285)
T d1u59a_ 169 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----EVMAF----IEQGKRM--------- 231 (285)
T ss_dssp CCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH----HHHHH----HHTTCCC---------
T ss_pred ccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH----HHHHH----HHcCCCC---------
Confidence 233458999999999999999999999999999999998 99999765422 22222 1222211
Q ss_pred ccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 839 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 839 ~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
..+.....++.+|+.+|++.+|++||||.+|++.|+.+..
T Consensus 232 ~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 232 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1122233568899999999999999999999999997754
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-46 Score=409.49 Aligned_cols=257 Identities=26% Similarity=0.390 Sum_probs=204.5
Q ss_pred HHHHhccccccCceEEEEEEECC-C-----cEEEEEEeecCC-chhhHhHHHHHHHHhhc-cCCCccceecceeecCeEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLKD-G-----KEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSV 671 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~~-g-----~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~ 671 (927)
.+.+.+.||+|+||+||+|++.. + ..||||++.... ......+.+|+.+|.++ +|||||++++++.+.+..+
T Consensus 38 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~ 117 (325)
T d1rjba_ 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIY 117 (325)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEE
Confidence 44567899999999999998752 2 369999986543 33456789999999998 8999999999999999999
Q ss_pred EEEEeccCCchhhhcccccc-------------------cccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCC
Q 002409 672 LVYEFMHNGTLKEHLYGTLT-------------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSN 732 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~~-------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~N 732 (927)
+|||||++|+|.++|+.... ....+++..++.++.|+++||+|||++ +|+||||||+|
T Consensus 118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~N 194 (325)
T d1rjba_ 118 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARN 194 (325)
T ss_dssp EEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGG
T ss_pred EEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchhc
Confidence 99999999999999965321 124589999999999999999999998 99999999999
Q ss_pred eEECCCCcEEEEeecCcccccCCCCc-eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCccccccccc
Q 002409 733 ILLDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGA 810 (927)
Q Consensus 733 ILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~ 810 (927)
||++.++.+||+|||+|+........ ......||+.|||||++.++.++.++|||||||++|||++ |+.||......+
T Consensus 195 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~ 274 (325)
T d1rjba_ 195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274 (325)
T ss_dssp EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred cccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999999865544333 2344568999999999999999999999999999999998 899997654222
Q ss_pred ccchhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHH
Q 002409 811 NCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 875 (927)
Q Consensus 811 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~ 875 (927)
. +...+. .+. ....+.....++.+|+.+|++.+|++|||++||+++|..
T Consensus 275 ~---~~~~~~----~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 275 N---FYKLIQ----NGF---------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp H---HHHHHH----TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred H---HHHHHh----cCC---------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 1 112111 111 111122233568899999999999999999999999974
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-45 Score=390.75 Aligned_cols=247 Identities=28% Similarity=0.446 Sum_probs=195.3
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceee----cCeEEEEE
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE----EGRSVLVY 674 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~----~~~~~lV~ 674 (927)
.+.++||+|+||+||+|++. +++.||+|++.... ....+.+.+|+++|++++||||+++++++.. ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 35678999999999999876 68899999987542 3345678999999999999999999999865 34579999
Q ss_pred EeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEEC-CCCcEEEEeecCccccc
Q 002409 675 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD-KHMRAKVSDFGLSKFAV 753 (927)
Q Consensus 675 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~-~~~~vkL~DFGla~~~~ 753 (927)
||+++|+|.+++. ....+++..+..++.||++||+|||++. ++|+||||||+|||++ +++.+||+|||+|+...
T Consensus 92 E~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHh----ccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 9999999999984 3457899999999999999999999971 1399999999999996 57899999999998543
Q ss_pred CCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccC
Q 002409 754 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 833 (927)
Q Consensus 754 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 833 (927)
. .......||+.|||||++.+ .++.++|||||||++|||++|+.||...... ..+.+ .+..+....
T Consensus 167 ~---~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~---~~~~~----~i~~~~~~~--- 232 (270)
T d1t4ha_ 167 A---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA---AQIYR----RVTSGVKPA--- 232 (270)
T ss_dssp T---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH---HHHHH----HHTTTCCCG---
T ss_pred C---CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH---HHHHH----HHHcCCCCc---
Confidence 2 22345679999999998864 6999999999999999999999999654311 11211 111111111
Q ss_pred CcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 834 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 834 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.++.....++.+++.+|++.||++|||+.|+++|
T Consensus 233 -----~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 233 -----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp -----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -----ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 1111122357899999999999999999999874
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-46 Score=410.28 Aligned_cols=260 Identities=23% Similarity=0.318 Sum_probs=200.5
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
|.+.++||+|+||+||+|+.. +|+.||+|+++... ......+.+|+.+|++++||||+++++++.+.+..++|||||+
T Consensus 8 y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~ 87 (322)
T d1s9ja_ 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 87 (322)
T ss_dssp EEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred CEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 445688999999999999976 68899999997553 3345678999999999999999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
+|+|.+++.. ...+++..+..++.|++.||.|||+++ +|+||||||+|||++.++++||+|||+|+...+.
T Consensus 88 gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--- 158 (322)
T d1s9ja_ 88 GGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 158 (322)
T ss_dssp TEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred CCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCCC---
Confidence 9999999853 456899999999999999999999731 7999999999999999999999999999865432
Q ss_pred eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhc--------cC----
Q 002409 759 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE--------SG---- 826 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~--------~~---- 826 (927)
......||+.|+|||++.+..|+.++||||+||++|||++|+.||......+.............. .+
T Consensus 159 ~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (322)
T d1s9ja_ 159 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238 (322)
T ss_dssp TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccc
Confidence 223457999999999999999999999999999999999999999754311110000000000000 00
Q ss_pred ----------Ccccc-------cCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 827 ----------DIQGI-------IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 827 ----------~~~~~-------~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
...+. ..+.+.. .....++.+++.+|++.||++|||+.|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPS---GVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp -------CCCCHHHHHHHHHTSCCCCCCB---TTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccchhHHHHHhhhhccCCccCcc---ccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00000 0000000 0112468899999999999999999999987
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-46 Score=403.52 Aligned_cols=255 Identities=24% Similarity=0.400 Sum_probs=201.7
Q ss_pred HHHHhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
.+.+.+.||+|+||.||+|++++++.||||+++... ...+.|.+|+.++++++|||||+++|+|.+ +..++||||+++
T Consensus 18 ~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~ 95 (285)
T d1fmka3 18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 95 (285)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred HEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCC
Confidence 355788999999999999999988899999997543 346779999999999999999999999865 567899999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
|+|.+++... ....++|..++.++.||+.||+|||++ +|+||||||+||||+.++++||+|||+++.........
T Consensus 96 g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 96 GSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp CBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred Cchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 9999888643 245689999999999999999999998 99999999999999999999999999998765544444
Q ss_pred eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcccCc
Q 002409 760 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 839 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 839 (927)
.....||+.|+|||++..+.++.++|||||||++|||++|..|+..... ...+...+.... . ..
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~---~~~~~~~i~~~~---~----------~~ 234 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---NREVLDQVERGY---R----------MP 234 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHHHHHHTTC---C----------CC
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC---HHHHHHHHHhcC---C----------CC
Confidence 4556799999999999999999999999999999999997666544321 122333322111 0 11
Q ss_pred cCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHH
Q 002409 840 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 877 (927)
Q Consensus 840 ~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~ 877 (927)
.+.....++.+++.+|++.+|++||+|.||++.|++..
T Consensus 235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 12223346889999999999999999999999998764
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=396.04 Aligned_cols=257 Identities=21% Similarity=0.336 Sum_probs=197.3
Q ss_pred HHHHhccccccCceEEEEEEECC----CcEEEEEEeecCCc-hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 674 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~~----g~~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~ 674 (927)
.+.+.+.||+|+||.||+|++.. +..||||+++.... ...+.+.+|+++|++++||||+++++++.+ +..++||
T Consensus 8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv~ 86 (273)
T d1mp8a_ 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIM 86 (273)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEEE
Confidence 45567899999999999998753 34688998865433 335679999999999999999999999964 6789999
Q ss_pred EeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccC
Q 002409 675 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 754 (927)
Q Consensus 675 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 754 (927)
||+++|+|.+++.. ....+++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 87 E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 87 ELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp ECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccC
Confidence 99999999988753 245689999999999999999999998 999999999999999999999999999987655
Q ss_pred CCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccC
Q 002409 755 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 833 (927)
Q Consensus 755 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 833 (927)
..........||+.|+|||++....++.++|||||||++|||++ |+.||...... .+...+. .+...
T Consensus 161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~----~~~~~i~----~~~~~---- 228 (273)
T d1mp8a_ 161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN----DVIGRIE----NGERL---- 228 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----GHHHHHH----TTCCC----
T ss_pred CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH----HHHHHHH----cCCCC----
Confidence 44444555678999999999999999999999999999999998 89999765522 2222221 12111
Q ss_pred CcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHHHH
Q 002409 834 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 880 (927)
Q Consensus 834 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~~~ 880 (927)
..+.....++.+|+.+|++.||++|||+.||+++|+.+++.+
T Consensus 229 -----~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 229 -----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 111223346889999999999999999999999999987654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=399.92 Aligned_cols=247 Identities=23% Similarity=0.313 Sum_probs=201.0
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
|.+.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+++|++++||||+++++++.+++..++||||
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy 89 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 89 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEc
Confidence 457789999999999999885 68999999997532 22346789999999999999999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+......
T Consensus 90 ~~gg~L~~~~~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 90 AKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCCHHHhhh----ccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 99999999874 346789999999999999999999998 99999999999999999999999999998664332
Q ss_pred -CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCc
Q 002409 757 -SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 835 (927)
Q Consensus 757 -~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 835 (927)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......+ +.+. +..+.+ .
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~----~~~~----i~~~~~------~ 228 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL----IFQK----IIKLEY------D 228 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH----HHTTCC------C
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH----HHHH----HHcCCC------C
Confidence 223344579999999999999999999999999999999999999997654221 1111 111111 0
Q ss_pred ccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 836 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 836 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
++.....++.+|+.+|++.||++|||+.|++++
T Consensus 229 ----~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 229 ----FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp ----CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred ----CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 111122457899999999999999999998654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.9e-45 Score=400.58 Aligned_cols=249 Identities=23% Similarity=0.339 Sum_probs=188.5
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc-hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
|.+.+.||+|+||+||+|+.+ +++.||||++..... .....+.+|+.+|++++||||+++++++.+++..++|||||+
T Consensus 11 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~ 90 (307)
T d1a06a_ 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVS 90 (307)
T ss_dssp EEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred eEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 566789999999999999886 688999999975532 234568899999999999999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEEC---CCCcEEEEeecCcccccCC
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~---~~~~vkL~DFGla~~~~~~ 755 (927)
+|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||+. +++.+||+|||+++.....
T Consensus 91 gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 91 GGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp SCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred CCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 9999999843 45799999999999999999999998 999999999999995 5789999999999865433
Q ss_pred CCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCc
Q 002409 756 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 835 (927)
Q Consensus 756 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 835 (927)
. ......||+.|||||++.+..++.++|||||||++|||++|+.||......+ +...+.. +... .+..
T Consensus 164 ~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~----~~~~i~~----~~~~--~~~~ 231 (307)
T d1a06a_ 164 S--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK----LFEQILK----AEYE--FDSP 231 (307)
T ss_dssp -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHT----TCCC--CCTT
T ss_pred C--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH----HHHHHhc----cCCC--CCCc
Confidence 2 2334569999999999999999999999999999999999999997654221 2221111 1110 1111
Q ss_pred ccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 836 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 836 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.. ......+.+++.+|++.||++|||+.|+++|
T Consensus 232 ~~----~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 232 YW----DDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp TT----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cc----cCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 11 1223468899999999999999999999986
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.3e-44 Score=403.27 Aligned_cols=251 Identities=23% Similarity=0.353 Sum_probs=206.8
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
.|.+.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++||||+++++++.+.+..++|||||+
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 106 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 106 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 3567789999999999999876 689999999987665666789999999999999999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECC--CCcEEEEeecCcccccCCC
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK--HMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~--~~~vkL~DFGla~~~~~~~ 756 (927)
+|+|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 107 gg~L~~~l~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~- 179 (350)
T d1koaa2 107 GGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 179 (350)
T ss_dssp SCBHHHHHTCT---TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-
T ss_pred CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccc-
Confidence 99999988532 45699999999999999999999998 9999999999999964 578999999999866443
Q ss_pred CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 757 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
.......||+.|||||++.+..++.++|||||||++|||++|+.||......+....+.. . ...+ +...
T Consensus 180 -~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~----~--~~~~----~~~~ 248 (350)
T d1koaa2 180 -QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS----C--DWNM----DDSA 248 (350)
T ss_dssp -SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----T--CCCS----CCGG
T ss_pred -cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHh----C--CCCC----Cccc
Confidence 233456799999999999999999999999999999999999999976542222212111 0 0111 1111
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
. ......+.+++.+|++.||++|||+.|+++|
T Consensus 249 ~----~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 249 F----SGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp G----GGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred c----cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 1122467899999999999999999999986
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.6e-45 Score=399.50 Aligned_cols=245 Identities=24% Similarity=0.372 Sum_probs=198.8
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCch---hhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 675 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~---~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E 675 (927)
.|...+.||+|+||+||+|+.. +++.||||+++..... ..+.+.+|+++|++++||||+++++++.+++..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 3555788999999999999875 6888999999765432 23568899999999999999999999999999999999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCC
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 755 (927)
||.+|+|..++. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 96 ~~~~g~l~~~~~----~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 96 YCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp CCSEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 999999876653 345789999999999999999999998 9999999999999999999999999999854332
Q ss_pred CCceeeeeccCCCccCcccccc---CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCccccc
Q 002409 756 ASHVSSIVRGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 832 (927)
Q Consensus 756 ~~~~~~~~~gt~~Y~aPE~~~~---~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 832 (927)
....||+.|||||++.+ +.|+.++|||||||++|||++|+.||......+ .... ...+......
T Consensus 169 -----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~----~~~~----i~~~~~~~~~ 235 (309)
T d1u5ra_ 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----ALYH----IAQNESPALQ 235 (309)
T ss_dssp -----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHHH----HHHSCCCCCS
T ss_pred -----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH----HHHH----HHhCCCCCCC
Confidence 23469999999999864 468999999999999999999999997543111 1111 1111111111
Q ss_pred CCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 833 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 833 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
. . .....+.+++.+|++.||++|||+.|+++|
T Consensus 236 ~----~----~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 236 S----G----HWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp C----T----TSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred C----C----CCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 1 1 122368899999999999999999999874
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.4e-44 Score=401.42 Aligned_cols=250 Identities=21% Similarity=0.340 Sum_probs=206.8
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
|.+.+.||+|+||.||+|+.. +|+.||||+++.........+.+|+++|++++||||+++++++.+++..++|||||++
T Consensus 31 Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g 110 (352)
T d1koba_ 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 110 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence 567789999999999999875 6899999999876656667789999999999999999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEEC--CCCcEEEEeecCcccccCCCC
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD--KHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~--~~~~vkL~DFGla~~~~~~~~ 757 (927)
|+|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+|+.....
T Consensus 111 g~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-- 182 (352)
T d1koba_ 111 GELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-- 182 (352)
T ss_dssp CBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--
T ss_pred ChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCC--
Confidence 999887743 245699999999999999999999998 999999999999998 5789999999999866543
Q ss_pred ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCccc
Q 002409 758 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 837 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 837 (927)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+...+. .+... ......
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~----~~~~~i~----~~~~~--~~~~~~ 252 (352)
T d1koba_ 183 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL----ETLQNVK----RCDWE--FDEDAF 252 (352)
T ss_dssp SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH----HHHHHHH----HCCCC--CCSSTT
T ss_pred CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHH----hCCCC--CCcccc
Confidence 2344567999999999999999999999999999999999999999765421 1222111 11110 111111
Q ss_pred CccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 838 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 838 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.....++.+|+.+||+.||++|||+.|+++|
T Consensus 253 ----~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 253 ----SSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp ----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ----cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1223467899999999999999999999886
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-44 Score=391.88 Aligned_cols=250 Identities=24% Similarity=0.326 Sum_probs=203.2
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc------hhhHhHHHHHHHHhhccCCCccceecceeecCeEEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY------QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 672 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~------~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~l 672 (927)
.|.+.+.||+|+||+||+|+.+ +|+.||||++..... ...+.+.+|+++|++++||||+++++++.+.+..++
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 90 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 4566789999999999999985 689999999975422 224678999999999999999999999999999999
Q ss_pred EEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCC----cEEEEeecC
Q 002409 673 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM----RAKVSDFGL 748 (927)
Q Consensus 673 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~----~vkL~DFGl 748 (927)
|||||++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+
T Consensus 91 v~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 91 ILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhh
Confidence 9999999999999843 45799999999999999999999998 999999999999998776 599999999
Q ss_pred cccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCc
Q 002409 749 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 828 (927)
Q Consensus 749 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 828 (927)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ +...+ ..+..
T Consensus 164 a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~----~~~~i----~~~~~ 233 (293)
T d1jksa_ 164 AHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE----TLANV----SAVNY 233 (293)
T ss_dssp CEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHH----HTTCC
T ss_pred hhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH----HHHHH----HhcCC
Confidence 98654332 2334568999999999999999999999999999999999999997654221 11111 11110
Q ss_pred ccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 829 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 829 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.............+.+++.+|++.||++|||+.|+++|
T Consensus 234 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 234 ------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp ------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00011111223467899999999999999999999875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-44 Score=384.16 Aligned_cols=248 Identities=29% Similarity=0.446 Sum_probs=197.2
Q ss_pred HHhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceee-cCeEEEEEEeccCC
Q 002409 602 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE-EGRSVLVYEFMHNG 680 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~-~~~~~lV~E~~~~g 680 (927)
.+.+.||+|+||.||+|+++ |+.||||+++.. ...+.+.+|++++++++||||++++|+|.+ .+..++||||+++|
T Consensus 10 ~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g 86 (262)
T d1byga_ 10 KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 86 (262)
T ss_dssp EEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred EEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCC
Confidence 35688999999999999996 889999999654 335679999999999999999999999865 45689999999999
Q ss_pred chhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCcee
Q 002409 681 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 760 (927)
Q Consensus 681 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 760 (927)
+|.+++... ....+++..+++++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 87 ~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----~ 157 (262)
T d1byga_ 87 SLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----Q 157 (262)
T ss_dssp EHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred CHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC----C
Confidence 999999643 234589999999999999999999998 9999999999999999999999999999864332 2
Q ss_pred eeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCcccccCCcccCc
Q 002409 761 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 839 (927)
Q Consensus 761 ~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 839 (927)
....+|+.|+|||++.++.++.++|||||||++|||++ |+.||..... .++..++.. +. +..
T Consensus 158 ~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~----~~~~~~i~~----~~---------~~~ 220 (262)
T d1byga_ 158 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVVPRVEK----GY---------KMD 220 (262)
T ss_dssp ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG----GGHHHHHTT----TC---------CCC
T ss_pred ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH----HHHHHHHHc----CC---------CCC
Confidence 23458899999999999999999999999999999998 6777765432 233333322 11 111
Q ss_pred cCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 840 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 840 ~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
.+.....++.+|+.+|++.||++||||.||+++|+++..
T Consensus 221 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 221 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 222233468899999999999999999999999998753
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=394.38 Aligned_cols=261 Identities=26% Similarity=0.397 Sum_probs=197.0
Q ss_pred HHHHHhccccccCceEEEEEEEC------CCcEEEEEEeecCC-chhhHhHHHHHHHHhhc-cCCCccceecceeec-Ce
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE-GR 669 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~------~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~-~~ 669 (927)
..+.+.+.||+|+||.||+|++. +++.||||+++... ....+.+.+|..++.++ +|+||+.+++++... ..
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 34566789999999999999864 34689999987543 33456678888888777 789999999988654 46
Q ss_pred EEEEEEeccCCchhhhcccccc------------cccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECC
Q 002409 670 SVLVYEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK 737 (927)
Q Consensus 670 ~~lV~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~ 737 (927)
.++|||||++|+|.++++.... ....+++..++.++.|+++||+|||++ +|+||||||+|||++.
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECC
Confidence 8999999999999999964321 234589999999999999999999998 9999999999999999
Q ss_pred CCcEEEEeecCcccccCCCCc-eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCC-Ccccccccccccchh
Q 002409 738 HMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ-EAISNEKFGANCRNI 815 (927)
Q Consensus 738 ~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~-~p~~~~~~~~~~~~l 815 (927)
++++||+|||+|+........ ......||+.|+|||++.++.++.++|||||||++|||++|. .||......+ .+
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~---~~ 246 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---EF 246 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH---HH
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH---HH
Confidence 999999999999865443332 334456999999999999999999999999999999999975 5676543221 11
Q ss_pred hHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 816 VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 816 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
.. .+.++.... .+.....++.+++.+|++.||++|||+.||+++|+++++
T Consensus 247 ~~----~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 247 CR----RLKEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HH----HHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH----HHhcCCCCC---------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11 112221111 111223468899999999999999999999999999875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-44 Score=396.13 Aligned_cols=254 Identities=24% Similarity=0.387 Sum_probs=200.4
Q ss_pred HHHhccccccCceEEEEEEEC-CCc----EEEEEEeecC-CchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGK----EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 674 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~----~VAVK~l~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~ 674 (927)
|.+.+.||+|+||+||+|++. +|+ +||+|+++.. ..+..++|.+|++++++++||||++++|+|.++ ..++++
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~ 89 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 89 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence 445689999999999999875 343 5899988654 344567899999999999999999999999875 567889
Q ss_pred EeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccC
Q 002409 675 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 754 (927)
Q Consensus 675 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 754 (927)
||+.+|+|.+++.. ....+++..++.++.||++||+|||++ +|+||||||+|||++.++++||+|||+|+....
T Consensus 90 e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 90 QLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp ECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 99999999988754 346789999999999999999999998 999999999999999999999999999986654
Q ss_pred CCCc-eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCccccc
Q 002409 755 GASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 832 (927)
Q Consensus 755 ~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 832 (927)
.... ......||+.|+|||++.++.++.++|||||||++|||+| |+.||...... .+...+. .+..
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~----~~~~~i~----~~~~---- 231 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----EISSILE----KGER---- 231 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG----GHHHHHH----HTCC----
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH----HHHHHHH----cCCC----
Confidence 3332 2334568999999999999999999999999999999998 78888765422 2222211 1110
Q ss_pred CCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 833 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 833 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
...+......+.+|+.+|++.+|++|||+.||+++|+.+..
T Consensus 232 -----~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 232 -----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp -----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 11122233468899999999999999999999999998754
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=389.71 Aligned_cols=254 Identities=29% Similarity=0.447 Sum_probs=202.6
Q ss_pred HhccccccCceEEEEEEECCC----cEEEEEEeecC-CchhhHhHHHHHHHHhhccCCCccceecceee-cCeEEEEEEe
Q 002409 603 LEKKIGSGGFGVVYYGKLKDG----KEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE-EGRSVLVYEF 676 (927)
Q Consensus 603 ~~~~IG~G~fG~Vy~~~~~~g----~~VAVK~l~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~-~~~~~lV~E~ 676 (927)
+.++||+|+||+||+|++.++ ..||||+++.. .....++|.+|+++|++++||||++++|++.+ ++..++||||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 457899999999999987642 25899998754 34445779999999999999999999999876 4688999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
|++|+|.+++... ...+++..++.++.|+++||.|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 111 ~~~g~l~~~~~~~---~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 111 MKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp CTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred eecCchhhhhccc---cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 9999999988643 45577888999999999999999998 99999999999999999999999999998654432
Q ss_pred Cc---eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccC
Q 002409 757 SH---VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 833 (927)
Q Consensus 757 ~~---~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 833 (927)
.. ......||+.|+|||.+.++.++.++|||||||++|||++|+.||...... ..+..++. .+... ..
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~---~~~~~~i~----~g~~~--~~ 255 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDITVYLL----QGRRL--LQ 255 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---------CHHHHH----TTCCC--CC
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH---HHHHHHHH----cCCCC--CC
Confidence 22 223356899999999999999999999999999999999988887643311 12223222 12111 11
Q ss_pred CcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 834 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 834 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
+.....++.+|+.+|++.||++||+|.||+++|++++.
T Consensus 256 -------p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 256 -------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp -------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11223468899999999999999999999999998864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-44 Score=394.63 Aligned_cols=257 Identities=25% Similarity=0.410 Sum_probs=206.2
Q ss_pred HHHhccccccCceEEEEEEEC------CCcEEEEEEeecCCc-hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 673 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~------~g~~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV 673 (927)
+.+.+.||+|+||+||+|+++ +++.||||+++.... +..++|.+|+++|++++||||++++++|...+..+++
T Consensus 15 ~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v 94 (301)
T d1lufa_ 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL 94 (301)
T ss_dssp CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred cEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEE
Confidence 345788999999999999864 357899999975533 3356799999999999999999999999999999999
Q ss_pred EEeccCCchhhhccccc--------------------ccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCe
Q 002409 674 YEFMHNGTLKEHLYGTL--------------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI 733 (927)
Q Consensus 674 ~E~~~~gsL~~~L~~~~--------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NI 733 (927)
|||+++|+|.++++... .....+++..++.|+.|++.||+|||++ +|+||||||+||
T Consensus 95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~NI 171 (301)
T d1lufa_ 95 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNC 171 (301)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred EEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccce
Confidence 99999999999985421 1233488999999999999999999998 999999999999
Q ss_pred EECCCCcEEEEeecCcccccCCC-CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCC-Ccccccccccc
Q 002409 734 LLDKHMRAKVSDFGLSKFAVDGA-SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ-EAISNEKFGAN 811 (927)
Q Consensus 734 Ll~~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~-~p~~~~~~~~~ 811 (927)
|++.++.+||+|||+|+...... ........||+.|+|||.+.+..++.++|||||||++|||++|. .||......
T Consensus 172 Lld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~-- 249 (301)
T d1lufa_ 172 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE-- 249 (301)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--
T ss_pred EECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHH--
Confidence 99999999999999998554332 22334456899999999999999999999999999999999986 567654321
Q ss_pred cchhhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHH
Q 002409 812 CRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 877 (927)
Q Consensus 812 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~ 877 (927)
.+...+ .++.... .+.....++.+|+.+|++.+|++||||.||++.|+++.
T Consensus 250 --e~~~~v----~~~~~~~---------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 250 --EVIYYV----RDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp --HHHHHH----HTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred --HHHHHH----HcCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 222222 2222211 11223346889999999999999999999999999874
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=387.80 Aligned_cols=265 Identities=23% Similarity=0.349 Sum_probs=200.1
Q ss_pred HhccccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecC----eEEEEEEecc
Q 002409 603 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG----RSVLVYEFMH 678 (927)
Q Consensus 603 ~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~----~~~lV~E~~~ 678 (927)
+.+.||+|+||.||+|+++ |+.||||+++... ......+.|+..+.+++||||++++++|.+.+ ..++|||||+
T Consensus 7 l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~ 84 (303)
T d1vjya_ 7 LQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 84 (303)
T ss_dssp EEEEEECCSSSEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred EEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEeccc
Confidence 4678999999999999975 8999999986432 21222344566667789999999999998654 5799999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCC-----CCceecCCCCCCCeEECCCCcEEEEeecCccccc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC-----VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 753 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 753 (927)
+|+|.++|+. ..++|..++.++.|+|.||+|||+.+ .++|+||||||+||||+.++++||+|||+++...
T Consensus 85 ~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~ 159 (303)
T d1vjya_ 85 HGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp TCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccccc
Confidence 9999999953 35899999999999999999999731 2499999999999999999999999999998765
Q ss_pred CCCCc---eeeeeccCCCccCccccccC------cCCCccceeeHHHHHHHHHhCCCcccccccccc-cch------hhH
Q 002409 754 DGASH---VSSIVRGTVGYLDPEYYISQ------QLTDKSDVYSFGVILLELISGQEAISNEKFGAN-CRN------IVQ 817 (927)
Q Consensus 754 ~~~~~---~~~~~~gt~~Y~aPE~~~~~------~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~-~~~------l~~ 817 (927)
..... ......||+.|+|||++... .++.++|||||||+||||++|..|+........ ... ...
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T d1vjya_ 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239 (303)
T ss_dssp TTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred CCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHH
Confidence 54332 22345699999999998654 367789999999999999999988754321111 000 111
Q ss_pred HHHhhhccCCcccccCCcccCcc-CHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 818 WAKLHIESGDIQGIIDPSLLDEY-DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 818 ~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
....... ...+++.+.... ..+....+.+|+.+|++.||++||||.||+++|+++..
T Consensus 240 ~~~~~~~----~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 240 EMRKVVC----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHHT----TSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHh----ccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 1111111 112233332222 33566779999999999999999999999999998764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=391.54 Aligned_cols=246 Identities=24% Similarity=0.319 Sum_probs=203.5
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
|.+.+.||+|+||.||+|+.+ +|+.||||++++.. ....+.+.+|+.+|++++||||+++++++.+.+..++||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey 86 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceec
Confidence 445789999999999999875 78999999997542 22356788999999999999999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
|++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.+|.+||+|||+|+......
T Consensus 87 ~~gg~L~~~~~----~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 87 ANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp CTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred cCCCchhhhhh----cccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 99999999884 356788999999999999999999998 99999999999999999999999999998654322
Q ss_pred CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 757 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
......+||+.|+|||++.+..|+.++||||+||++|||++|+.||......+ +.+. ...+.+ .
T Consensus 160 -~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~----~~~~----i~~~~~------~- 223 (337)
T d1o6la_ 160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----LFEL----ILMEEI------R- 223 (337)
T ss_dssp -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH----HHHCCC------C-
T ss_pred -cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH----HHHH----HhcCCC------C-
Confidence 23345679999999999999999999999999999999999999998655222 2221 111111 0
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCCc-----HHHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 872 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----m~eV~~~ 872 (927)
++.....++.+|+.+||+.||++||+ +.|+++|
T Consensus 224 ---~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 224 ---FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 11112235789999999999999995 8888876
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2e-43 Score=381.87 Aligned_cols=256 Identities=24% Similarity=0.353 Sum_probs=198.5
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc---hhhHhHHHHHHHHhhccCCCccceecceeecC----eEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG----RSVL 672 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~----~~~l 672 (927)
|.+.+.||+|+||+||+|+.. +|+.||||+++.... .....+.+|++++++++||||+++++++...+ ..++
T Consensus 9 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~l 88 (277)
T d1o6ya_ 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 88 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred eEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEE
Confidence 456789999999999999875 789999999976532 23456899999999999999999999987654 3789
Q ss_pred EEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccc
Q 002409 673 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 752 (927)
Q Consensus 673 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 752 (927)
||||+++|+|.+++. ....+++.+++.++.||+.||+|||++ +|+||||||+|||++.++..+|+|||.++..
T Consensus 89 vmE~~~g~~L~~~~~----~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 89 VMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEECCCEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred EEECCCCCEehhhhc----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhh
Confidence 999999999998874 345789999999999999999999998 9999999999999999999999999998754
Q ss_pred cCCCC--ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCccc
Q 002409 753 VDGAS--HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 830 (927)
Q Consensus 753 ~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 830 (927)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ........+....
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-------~~~~~~~~~~~~~ 234 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-------VAYQHVREDPIPP 234 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHCCCCCG
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH-------HHHHHHhcCCCCC
Confidence 33222 23344579999999999999999999999999999999999999997644211 1111222211110
Q ss_pred ccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCC-cHHHHHHHHHHHH
Q 002409 831 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP-SISEVLKDIQDAI 877 (927)
Q Consensus 831 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-sm~eV~~~L~~~~ 877 (927)
.........++.+++.+|++.||++|| |++|+.+.|.++.
T Consensus 235 -------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 235 -------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp -------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 011111224688999999999999999 8999999888763
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.9e-43 Score=388.73 Aligned_cols=243 Identities=24% Similarity=0.384 Sum_probs=201.5
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
|.+.+.||+|+||+||+|+.+ +|+.||||+++... ....+.+.+|+.+|++++||||+++++++.+.+..++||||
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 85 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 85 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeee
Confidence 346789999999999999985 68999999997542 23356788999999999999999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
|++|+|..++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 86 ~~gg~l~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 86 IEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp CCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred cCCcccccccc----ccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence 99999998874 345678888899999999999999998 9999999999999999999999999999865432
Q ss_pred CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 757 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
.....||+.|||||++.+..++.++|||||||++|||++|+.||......+....+. .+.. .
T Consensus 158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~--------~~~~------~- 219 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL--------NAEL------R- 219 (316)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--------HCCC------C-
T ss_pred ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHH--------cCCC------C-
Confidence 234579999999999999999999999999999999999999997654222111111 1111 0
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCC-----cHHHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 872 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----sm~eV~~~ 872 (927)
++......+.+++.+|++.+|++|| |+.|+++|
T Consensus 220 ---~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 220 ---FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 1111224578999999999999996 89999886
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-44 Score=391.73 Aligned_cols=261 Identities=25% Similarity=0.370 Sum_probs=209.1
Q ss_pred HHHHHhccccccCceEEEEEEEC------CCcEEEEEEeecCCc-hhhHhHHHHHHHHhhc-cCCCccceecceeecCeE
Q 002409 599 ATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRS 670 (927)
Q Consensus 599 ~~~~~~~~IG~G~fG~Vy~~~~~------~g~~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~ 670 (927)
..+.+.++||+|+||.||+|++. +++.||||+++.... .....+.+|+.+++++ +||||++++++|.+.+..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 34556789999999999999863 456899999976543 3455789999999999 699999999999999999
Q ss_pred EEEEEeccCCchhhhccccc--------------ccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEEC
Q 002409 671 VLVYEFMHNGTLKEHLYGTL--------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD 736 (927)
Q Consensus 671 ~lV~E~~~~gsL~~~L~~~~--------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~ 736 (927)
++|||||++|+|.++++... .....+++..+..++.||++||+|||++ +++||||||+|||++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccccc
Confidence 99999999999999986532 1234689999999999999999999998 999999999999999
Q ss_pred CCCcEEEEeecCcccccCCCCc-eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhC-CCcccccccccccch
Q 002409 737 KHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG-QEAISNEKFGANCRN 814 (927)
Q Consensus 737 ~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG-~~p~~~~~~~~~~~~ 814 (927)
.++.+|++|||+++........ ......||+.|+|||++.++.++.++|||||||++|||+++ ++|+......+....
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~ 259 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 9999999999999876554333 33456799999999999999999999999999999999994 555544332211111
Q ss_pred hhHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 815 IVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 815 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
++ .. +. ....+......+.+|+.+|++.||++||||.||++.|++++.
T Consensus 260 ~i---~~----~~---------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 260 MI---KE----GF---------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp HH---HH----TC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH---hc----CC---------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 21 11 11 111112223468899999999999999999999999998764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=381.58 Aligned_cols=253 Identities=26% Similarity=0.378 Sum_probs=193.9
Q ss_pred HHHhccccccCceEEEEEEEC--CC--cEEEEEEeecC---CchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK--DG--KEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 673 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~--~g--~~VAVK~l~~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV 673 (927)
+.+.+.||+|+||.||+|++. ++ ..||||++... ..+..++|.+|+.+|++++||||++++|+|.+. ..++|
T Consensus 10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~lv 88 (273)
T d1u46a_ 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMV 88 (273)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEEE
T ss_pred eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chhee
Confidence 345688999999999999864 22 36899998654 233456799999999999999999999999764 67899
Q ss_pred EEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccccc
Q 002409 674 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 753 (927)
Q Consensus 674 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 753 (927)
|||+++|+|.+++.. ....+++..++.++.|+++||.|||++ +|+||||||+|||++.++++||+|||+++...
T Consensus 89 ~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 89 TELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 999999999988753 245699999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCce--eeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchhhHHHHhhhccCCccc
Q 002409 754 DGASHV--SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQG 830 (927)
Q Consensus 754 ~~~~~~--~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 830 (927)
...... .....||..|+|||.+.+..++.++|||||||++|||++ |+.||...... .+..++.. .+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~----~~~~~i~~---~~~~-- 233 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS----QILHKIDK---EGER-- 233 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHHHHT---SCCC--
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH----HHHHHHHh---CCCC--
Confidence 443332 233457889999999999999999999999999999998 89999755422 22222221 1111
Q ss_pred ccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHH
Q 002409 831 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 876 (927)
Q Consensus 831 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~ 876 (927)
...+......+.+|+.+|++.||++||||.||.+.|+++
T Consensus 234 -------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 234 -------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 011112234688999999999999999999999988864
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=388.45 Aligned_cols=255 Identities=27% Similarity=0.430 Sum_probs=202.3
Q ss_pred HHhccccccCceEEEEEEECC-Cc--EEEEEEeecC-CchhhHhHHHHHHHHhhc-cCCCccceecceeecCeEEEEEEe
Q 002409 602 MLEKKIGSGGFGVVYYGKLKD-GK--EIAVKVLTSN-SYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~~-g~--~VAVK~l~~~-~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
.+.++||+|+||+||+|++++ +. .||||+++.. .....+.+.+|+++|+++ +||||++++|+|.+.+..++||||
T Consensus 13 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey 92 (309)
T d1fvra_ 13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 92 (309)
T ss_dssp EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred EEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEe
Confidence 356889999999999998763 44 4788887644 334456799999999998 799999999999999999999999
Q ss_pred ccCCchhhhccccc------------ccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEE
Q 002409 677 MHNGTLKEHLYGTL------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 744 (927)
Q Consensus 677 ~~~gsL~~~L~~~~------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~ 744 (927)
+++|+|.++|+... .....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+
T Consensus 93 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl~ 169 (309)
T d1fvra_ 93 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIA 169 (309)
T ss_dssp CTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEEC
T ss_pred cCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceEEc
Confidence 99999999986531 2346789999999999999999999998 99999999999999999999999
Q ss_pred eecCcccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCC-cccccccccccchhhHHHHhhh
Q 002409 745 DFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE-AISNEKFGANCRNIVQWAKLHI 823 (927)
Q Consensus 745 DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~-p~~~~~~~~~~~~l~~~~~~~~ 823 (927)
|||+++...... ......||..|+|||.+....++.++|||||||++|||++|.. ||...... .+.+.+.
T Consensus 170 DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~----~~~~~i~--- 240 (309)
T d1fvra_ 170 DFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----ELYEKLP--- 240 (309)
T ss_dssp CTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHHGG---
T ss_pred cccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH----HHHHHHH---
Confidence 999997543221 1233458999999999999999999999999999999999765 56544322 2222221
Q ss_pred ccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 824 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 824 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
++.. ...+.....++.+|+.+|++.+|++||||.||+++|+++++
T Consensus 241 -~~~~---------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 241 -QGYR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp -GTCC---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -hcCC---------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1110 11122233468899999999999999999999999999864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-44 Score=388.72 Aligned_cols=259 Identities=25% Similarity=0.436 Sum_probs=204.9
Q ss_pred HHHHhccccccCceEEEEEEECC--------CcEEEEEEeecCCc-hhhHhHHHHHHHHhhc-cCCCccceecceeecCe
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLKD--------GKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGR 669 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~~--------g~~VAVK~l~~~~~-~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~~ 669 (927)
.+.+.+.||+|+||.||+|+... +..||||+++.... ....++.+|+..+.++ +||||++++++|.+++.
T Consensus 14 ~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~ 93 (299)
T d1fgka_ 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP 93 (299)
T ss_dssp GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCe
Confidence 44567899999999999998642 34799999976543 3356788899999888 89999999999999999
Q ss_pred EEEEEEeccCCchhhhccccc------------ccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECC
Q 002409 670 SVLVYEFMHNGTLKEHLYGTL------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK 737 (927)
Q Consensus 670 ~~lV~E~~~~gsL~~~L~~~~------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~ 737 (927)
.++||||+++|+|.+++.... .....+++..++.++.|++.||+|||++ +|+||||||+|||++.
T Consensus 94 ~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~~ 170 (299)
T d1fgka_ 94 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTE 170 (299)
T ss_dssp CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECT
T ss_pred EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeecC
Confidence 999999999999999996442 1235689999999999999999999998 9999999999999999
Q ss_pred CCcEEEEeecCcccccCCCC-ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHh-CCCcccccccccccchh
Q 002409 738 HMRAKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNI 815 (927)
Q Consensus 738 ~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~ellt-G~~p~~~~~~~~~~~~l 815 (927)
++.+||+|||+++....... .......||+.|+|||.+.++.++.++|||||||++|||++ |+.||...... .+
T Consensus 171 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~----~~ 246 (299)
T d1fgka_ 171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE----EL 246 (299)
T ss_dssp TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----HH
T ss_pred CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH----HH
Confidence 99999999999986654332 23344568999999999999999999999999999999998 68888654421 22
Q ss_pred hHHHHhhhccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 816 VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 816 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
.+. +..+... ..+.....++.+|+.+|++.+|++|||+.||++.|++++.
T Consensus 247 ~~~----i~~~~~~---------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 247 FKL----LKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHH----HHTTCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHH----HHcCCCC---------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 222 2222111 1111223468899999999999999999999999999875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.2e-43 Score=376.86 Aligned_cols=249 Identities=27% Similarity=0.292 Sum_probs=200.9
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCch---------hhHhHHHHHHHHhhcc-CCCccceecceeecCe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---------GKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGR 669 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~---------~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~~ 669 (927)
|.+.+.||+|+||+||+|+.. +++.||||+++..... ..+.+.+|+.++++++ ||||+++++++.+++.
T Consensus 5 y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~ 84 (277)
T d1phka_ 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 84 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcc
Confidence 345789999999999999875 6889999999754321 1235889999999997 9999999999999999
Q ss_pred EEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCc
Q 002409 670 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 749 (927)
Q Consensus 670 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla 749 (927)
.++|||||++|+|.+++. ....+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 85 ~~ivmE~~~~g~L~~~l~----~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 85 FFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp EEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEcCCCchHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchhe
Confidence 999999999999999995 345799999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeeccCCCccCcccccc------CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhh
Q 002409 750 KFAVDGASHVSSIVRGTVGYLDPEYYIS------QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 823 (927)
Q Consensus 750 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~ 823 (927)
+...... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...........+
T Consensus 158 ~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i-------- 227 (277)
T d1phka_ 158 CQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI-------- 227 (277)
T ss_dssp EECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------
T ss_pred eEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHH--------
Confidence 8665432 2334569999999999863 35688999999999999999999999865422111111
Q ss_pred ccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 824 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 824 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
..+... . ..........++.+++.+|++.+|++|||+.||++|
T Consensus 228 ~~~~~~--~----~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 228 MSGNYQ--F----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHTCCC--C----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HhCCCC--C----CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 111110 0 010111223468899999999999999999999875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-42 Score=378.65 Aligned_cols=260 Identities=22% Similarity=0.224 Sum_probs=194.5
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeecCCch-----hhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 605 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-----GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~-----~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
++||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|+++|++++||||+++++++..++..++||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 67999999999999975 6899999998654221 13468899999999999999999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
++++..+.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 84 ~~~~~~~~~----~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 84 TDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp EEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred chHHhhhhh----cccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 887776652 345688889999999999999999998 9999999999999999999999999999865443322
Q ss_pred eeeeeccCCCccCccccccC-cCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccC-----Cccccc
Q 002409 759 VSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG-----DIQGII 832 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~-----~~~~~~ 832 (927)
.....||+.|+|||++... .++.++|||||||++|||++|+.||......+....+.+.......+. ......
T Consensus 157 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ua2a_ 157 -YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235 (299)
T ss_dssp -CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred -ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhh
Confidence 2334699999999998754 578999999999999999999999976442222112221110000000 000000
Q ss_pred CCcccCccC-----HHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 833 DPSLLDEYD-----IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 833 d~~l~~~~~-----~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.-......+ ......+.+|+.+|++.||++|||+.|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 000000001 1123468899999999999999999999875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-42 Score=386.99 Aligned_cols=243 Identities=23% Similarity=0.295 Sum_probs=201.3
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEe
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 676 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~ 676 (927)
|.+.+.||+|+||.||+|+++ +|+.||||++.... ....+.+.+|+++|++++||||+++++++.+....++||||
T Consensus 43 y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~ 122 (350)
T d1rdqe_ 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccccc
Confidence 455689999999999999886 68999999987432 22345688999999999999999999999999999999999
Q ss_pred ccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCC
Q 002409 677 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 756 (927)
Q Consensus 677 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 756 (927)
+.+|+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++++||+|||+|+.....
T Consensus 123 ~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 123 VAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp CTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred ccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 999999998843 45689999999999999999999998 9999999999999999999999999999865432
Q ss_pred CceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCcc
Q 002409 757 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 836 (927)
Q Consensus 757 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 836 (927)
.....||+.|||||++.+..++.++|||||||++|||++|+.||...... .+...+ ..+.. ..
T Consensus 195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~----~~~~~i----~~~~~------~~ 257 (350)
T d1rdqe_ 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI----QIYEKI----VSGKV------RF 257 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHH----HHCCC------CC
T ss_pred ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH----HHHHHH----hcCCC------CC
Confidence 23456999999999999999999999999999999999999999764421 111111 11111 01
Q ss_pred cCccCHHHHHHHHHHHhhhcCCCCCCCC-----cHHHHHHH
Q 002409 837 LDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 872 (927)
Q Consensus 837 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----sm~eV~~~ 872 (927)
+.....++.+++.+|++.||++|+ |+.|+++|
T Consensus 258 ----p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 258 ----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ----CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 111224688999999999999994 89999875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-42 Score=382.29 Aligned_cols=249 Identities=19% Similarity=0.307 Sum_probs=202.3
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
|.+.+.||+|+||+||+|+.. +++.||||+++... .....+.+|+++|++++||||+++++++.+.+..++|||||++
T Consensus 7 Y~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~g 85 (321)
T d1tkia_ 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG 85 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCC
Confidence 456789999999999999886 68899999997653 3345688999999999999999999999999999999999999
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCC--CcEEEEeecCcccccCCCC
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH--MRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~--~~vkL~DFGla~~~~~~~~ 757 (927)
|+|.+++... ...+++.++..++.||+.||+|||++ +|+||||||+|||++.+ ..+||+|||+++.....
T Consensus 86 g~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~-- 157 (321)
T d1tkia_ 86 LDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-- 157 (321)
T ss_dssp CBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--
T ss_pred CcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccC--
Confidence 9999998532 34689999999999999999999998 99999999999999854 58999999999865432
Q ss_pred ceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCccc
Q 002409 758 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 837 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 837 (927)
.......||+.|+|||.+.+..++.++||||+||++|||++|+.||......+....+.. +... ++....
T Consensus 158 ~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~--------~~~~--~~~~~~ 227 (321)
T d1tkia_ 158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN--------AEYT--FDEEAF 227 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--------TCCC--CCHHHH
T ss_pred CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------CCCC--CChhhc
Confidence 333445689999999999999999999999999999999999999976542221111111 1100 010001
Q ss_pred CccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 838 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 838 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.. ...++.+++.+|++.||++|||+.|+++|
T Consensus 228 ~~----~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 228 KE----ISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp TT----SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cC----CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 12357899999999999999999999985
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-43 Score=386.17 Aligned_cols=259 Identities=24% Similarity=0.401 Sum_probs=207.4
Q ss_pred HHHHhccccccCceEEEEEEEC------CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecCeEEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 672 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~------~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~l 672 (927)
.+.+.+.||+|+||+||+|.+. +++.||||+++... .+....|.+|++++++++||||++++++|...+..++
T Consensus 21 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 100 (308)
T d1p4oa_ 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 100 (308)
T ss_dssp GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEE
T ss_pred HeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeE
Confidence 3456789999999999999864 35789999997553 3334568999999999999999999999999999999
Q ss_pred EEEeccCCchhhhccccc------ccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEee
Q 002409 673 VYEFMHNGTLKEHLYGTL------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF 746 (927)
Q Consensus 673 V~E~~~~gsL~~~L~~~~------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DF 746 (927)
||||+++|+|.+++.... .....+++..+..++.|+++||.|||++ +|+||||||+|||++.++++||+||
T Consensus 101 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DF 177 (308)
T d1p4oa_ 101 IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDF 177 (308)
T ss_dssp EEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCT
T ss_pred EEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEeec
Confidence 999999999999985431 1223468999999999999999999998 9999999999999999999999999
Q ss_pred cCcccccCCCCc-eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCC-CcccccccccccchhhHHHHhhhc
Q 002409 747 GLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ-EAISNEKFGANCRNIVQWAKLHIE 824 (927)
Q Consensus 747 Gla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~-~p~~~~~~~~~~~~l~~~~~~~~~ 824 (927)
|+++........ ......||+.|+|||.+.+..++.++|||||||++|||++|+ .||...... .+.+.+ .
T Consensus 178 Gla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~----~~~~~i----~ 249 (308)
T d1p4oa_ 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE----QVLRFV----M 249 (308)
T ss_dssp TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH----HHHHHH----H
T ss_pred ccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH----HHHHHH----H
Confidence 999865443322 223345899999999999999999999999999999999985 666544311 222221 1
Q ss_pred cCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 825 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 825 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
++.... .+......+.+++.+|++.+|++||||.||+++|++.++
T Consensus 250 ~~~~~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 250 EGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp TTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred hCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 222111 111223468999999999999999999999999998754
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-42 Score=383.54 Aligned_cols=246 Identities=24% Similarity=0.378 Sum_probs=199.0
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHHHHHHHh-hccCCCccceecceeecCeEEEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLS-RIHHRNLVQFLGYCQEEGRSVLVYE 675 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~iL~-~l~HpnIv~l~g~~~~~~~~~lV~E 675 (927)
|.+.+.||+|+||+||+|+.. +++.||||++++.. ....+.+..|..++. .++||||+++++++.+++..++|||
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE 83 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 83 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEe
Confidence 346789999999999999886 68899999997542 222345666766665 6899999999999999999999999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCC
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 755 (927)
||++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++.....
T Consensus 84 y~~~g~L~~~i~----~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 84 YLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp CCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred ecCCCcHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 999999999984 345688999999999999999999998 9999999999999999999999999999855433
Q ss_pred CCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCCc
Q 002409 756 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 835 (927)
Q Consensus 756 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 835 (927)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+...+ ..+.. .
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~----~~~~~i----~~~~~------~ 221 (320)
T d1xjda_ 157 D-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE----ELFHSI----RMDNP------F 221 (320)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHH----HHCCC------C
T ss_pred c-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH----HHHHHH----HcCCC------C
Confidence 2 2334456999999999999999999999999999999999999999765421 222211 11111 1
Q ss_pred ccCccCHHHHHHHHHHHhhhcCCCCCCCCcHH-HHHHH
Q 002409 836 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSIS-EVLKD 872 (927)
Q Consensus 836 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~-eV~~~ 872 (927)
++.....++.+|+.+|++.||++||++. |+++|
T Consensus 222 ----~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 222 ----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp ----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred ----CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 1111224588999999999999999995 78654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-42 Score=378.23 Aligned_cols=247 Identities=22% Similarity=0.263 Sum_probs=193.7
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhc-cCCCccceecceee----cCeEEEEEEec
Q 002409 604 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQE----EGRSVLVYEFM 677 (927)
Q Consensus 604 ~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~----~~~~~lV~E~~ 677 (927)
.+.||+|+||+||+|+.. +++.||||+++. ...+.+|++++.++ +||||+++++++.+ ....++|||||
T Consensus 17 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~ 91 (335)
T d2ozaa1 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 91 (335)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred eEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECC
Confidence 356999999999999875 689999999863 34577899987655 89999999999865 46789999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECC---CCcEEEEeecCcccccC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVD 754 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~---~~~vkL~DFGla~~~~~ 754 (927)
++|+|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+++....
T Consensus 92 ~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~ 166 (335)
T d2ozaa1 92 DGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 166 (335)
T ss_dssp CSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCC
T ss_pred CCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeeeccC
Confidence 999999999642 235699999999999999999999998 9999999999999985 56799999999986554
Q ss_pred CCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcccccCC
Q 002409 755 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 834 (927)
Q Consensus 755 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 834 (927)
... .....||+.|||||++.+..|+.++|||||||++|||++|+.||...........+ ......+...
T Consensus 167 ~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~----~~~i~~~~~~----- 235 (335)
T d2ozaa1 167 HNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM----KTRIRMGQYE----- 235 (335)
T ss_dssp CCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------CCCSCSSS-----
T ss_pred CCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH----HHHHhcCCCC-----
Confidence 322 33456999999999999999999999999999999999999999765422111111 1111111110
Q ss_pred cccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 835 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 835 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
...........++.+|+.+|++.||++|||+.|+++|
T Consensus 236 -~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 236 -FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp -CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0000011233468899999999999999999999875
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.8e-42 Score=384.72 Aligned_cols=247 Identities=25% Similarity=0.307 Sum_probs=195.8
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC---chhhHhHHH---HHHHHhhccCCCccceecceeecCeEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTN---EVTLLSRIHHRNLVQFLGYCQEEGRSVLV 673 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~---~~~~~~~~~---Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV 673 (927)
|.+.+.||+|+||.||+|+.. +|+.||||++.... ......+.+ |+++++.++||||+++++++.+.+..++|
T Consensus 6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv 85 (364)
T d1omwa3 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 85 (364)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred CeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEE
Confidence 345789999999999999976 68999999986432 112233444 46777788899999999999999999999
Q ss_pred EEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccccc
Q 002409 674 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 753 (927)
Q Consensus 674 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~ 753 (927)
||||++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 86 mE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 86 LDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp ECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 999999999999843 45688999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCccccc
Q 002409 754 DGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 832 (927)
Q Consensus 754 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 832 (927)
... .....||+.|+|||++.. ..++.++|||||||++|||++|+.||........ ..+.. . .....
T Consensus 159 ~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~~~---~-~~~~~----- 225 (364)
T d1omwa3 159 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDR---M-TLTMA----- 225 (364)
T ss_dssp SSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH-HHHHH---H-SSSCC-----
T ss_pred CCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH---h-cccCC-----
Confidence 432 234569999999999975 5689999999999999999999999976542211 11111 1 11110
Q ss_pred CCcccCccCHHHHHHHHHHHhhhcCCCCCCCCc-----HHHHHHH
Q 002409 833 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 872 (927)
Q Consensus 833 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----m~eV~~~ 872 (927)
...... ...++.+++.+||+.||++||| +.|+++|
T Consensus 226 -~~~~~~----~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 226 -VELPDS----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp -CCCCSS----SCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred -CCCCCC----CCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 111111 2235889999999999999999 6888876
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=371.10 Aligned_cols=263 Identities=21% Similarity=0.257 Sum_probs=195.6
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEecc
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
.+.+.||+|+||+||+|++. +++.||||+++... ......+.+|+++|++++||||+++++++.+++..++||||+.
T Consensus 5 ~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~ 84 (298)
T d1gz8a_ 5 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH 84 (298)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecC
Confidence 34678999999999999875 68999999996543 2235678999999999999999999999999999999999997
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 758 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 758 (927)
++ +.+++.. .....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+...... .
T Consensus 85 ~~-~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-~ 157 (298)
T d1gz8a_ 85 QD-LKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-R 157 (298)
T ss_dssp EE-HHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-B
T ss_pred Cc-hhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCc-c
Confidence 65 4444422 2345689999999999999999999998 99999999999999999999999999998654432 2
Q ss_pred eeeeeccCCCccCccccccCc-CCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcc--------
Q 002409 759 VSSIVRGTVGYLDPEYYISQQ-LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ-------- 829 (927)
Q Consensus 759 ~~~~~~gt~~Y~aPE~~~~~~-~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~-------- 829 (927)
......||+.|+|||.+.... ++.++||||+||++|||++|+.||......+....+...... ..+....
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT-PDEVVWPGVTSMPDY 236 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC-CCTTTSTTGGGSTTC
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCC-Cchhhcccccccccc
Confidence 333456999999999987655 578999999999999999999999754321111111110000 0000000
Q ss_pred -cccCCcccCc---cCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 830 -GIIDPSLLDE---YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 830 -~~~d~~l~~~---~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.......... ........+.+++.+|++.||++|||+.|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0000000000 001122467899999999999999999999986
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.7e-41 Score=368.36 Aligned_cols=263 Identities=20% Similarity=0.258 Sum_probs=197.9
Q ss_pred HHhccccccCceEEEEEEECCCcEEEEEEeecCCc--hhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEeccC
Q 002409 602 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 679 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 679 (927)
.+.++||+|+||+||+|++++|+.||||+++.... ...+.+.+|+.+|++++||||+++++++...+..++++|++.+
T Consensus 5 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~ 84 (286)
T d1ob3a_ 5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ 84 (286)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE
T ss_pred eeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehh
Confidence 45678999999999999999999999999975532 2356789999999999999999999999999999999999988
Q ss_pred CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCCce
Q 002409 680 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 759 (927)
Q Consensus 680 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 759 (927)
+.+..+. .....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 85 ~~~~~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-~~ 156 (286)
T d1ob3a_ 85 DLKKLLD----VCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RK 156 (286)
T ss_dssp EHHHHHH----TSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred hhHHHHH----hhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc-cc
Confidence 7776665 2356799999999999999999999998 99999999999999999999999999998654432 22
Q ss_pred eeeeccCCCccCccccccC-cCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhh--------ccCCccc
Q 002409 760 SSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI--------ESGDIQG 830 (927)
Q Consensus 760 ~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~--------~~~~~~~ 830 (927)
.....|++.|+|||.+... .++.++||||+||++|||++|+.||......+...++..-..... .......
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence 3344589999999998754 568999999999999999999999975442221111111000000 0000000
Q ss_pred cc---CCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 831 II---DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 831 ~~---d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.. .+.-...........+.+++.+|++.||++|||++|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0000011111223467899999999999999999999865
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-42 Score=368.15 Aligned_cols=242 Identities=22% Similarity=0.379 Sum_probs=195.6
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCc------hhhHhHHHHHHHHhhcc--CCCccceecceeecCeEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY------QGKREFTNEVTLLSRIH--HRNLVQFLGYCQEEGRSV 671 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~------~~~~~~~~Ei~iL~~l~--HpnIv~l~g~~~~~~~~~ 671 (927)
|.+.+.||+|+||+||+|+.. +|+.||||++..... .....+.+|+.+|++++ ||||+++++++.+.+..+
T Consensus 6 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~ 85 (273)
T d1xwsa_ 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV 85 (273)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred EEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEE
Confidence 556789999999999999875 689999999875421 12244778999999996 899999999999999999
Q ss_pred EEEEeccC-CchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECC-CCcEEEEeecCc
Q 002409 672 LVYEFMHN-GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLS 749 (927)
Q Consensus 672 lV~E~~~~-gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~-~~~vkL~DFGla 749 (927)
+||||+.+ +++.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+|
T Consensus 86 lv~e~~~~~~~l~~~~~----~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 86 LILERPEPVQDLFDFIT----ERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEECCSSEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEeccCcchHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccc
Confidence 99999976 57777763 346789999999999999999999998 9999999999999985 479999999999
Q ss_pred ccccCCCCceeeeeccCCCccCccccccCcC-CCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCc
Q 002409 750 KFAVDGASHVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 828 (927)
Q Consensus 750 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 828 (927)
+..... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.... .+.. +..
T Consensus 159 ~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~--------~~~ 221 (273)
T d1xwsa_ 159 ALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR--------GQV 221 (273)
T ss_dssp EECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH--------CCC
T ss_pred eecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhh--------ccc
Confidence 865332 2334569999999999987765 567899999999999999999997532 1111 110
Q ss_pred ccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH--HHHH
Q 002409 829 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD--IQDA 876 (927)
Q Consensus 829 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~--L~~~ 876 (927)
.+ .... ..++.+++.+|++.||++|||+.|+++| ++++
T Consensus 222 --~~----~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 222 --FF----RQRV----SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp --CC----SSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred --CC----CCCC----CHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 01 1112 2357899999999999999999999986 5543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-41 Score=368.20 Aligned_cols=265 Identities=20% Similarity=0.273 Sum_probs=196.0
Q ss_pred HHHHhccccccCceEEEEEEEC-C-CcEEEEEEeecCCc--hhhHhHHHHHHHHhhc---cCCCccceecceee-----c
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-D-GKEIAVKVLTSNSY--QGKREFTNEVTLLSRI---HHRNLVQFLGYCQE-----E 667 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~-g~~VAVK~l~~~~~--~~~~~~~~Ei~iL~~l---~HpnIv~l~g~~~~-----~ 667 (927)
.|.+.+.||+|+||+||+|++. + ++.||||+++.... .....+.+|+.+|+.+ +||||+++++++.. .
T Consensus 8 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~ 87 (305)
T d1blxa_ 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 87 (305)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred CEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccC
Confidence 3456789999999999999874 4 56799999875422 2244577888887776 79999999999853 3
Q ss_pred CeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeec
Q 002409 668 GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG 747 (927)
Q Consensus 668 ~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFG 747 (927)
...+++|||+.++.+..... .....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 88 ~~~~~~~e~~~~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 88 TKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp EEEEEEEECCSCBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred ceEEEEEEeccCCchhhhhh---ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchh
Confidence 46799999999887654432 2345688999999999999999999998 99999999999999999999999999
Q ss_pred CcccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccC-
Q 002409 748 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG- 826 (927)
Q Consensus 748 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~- 826 (927)
+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+.+.........
T Consensus 162 ~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 162 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp SCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 98754322 233456699999999999999999999999999999999999999976542222222222111100000
Q ss_pred ----Cccccc----CCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 827 ----DIQGII----DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 827 ----~~~~~~----d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
...... ...-...+.......+.+|+.+|++.||++|||+.|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000 0000011112223467899999999999999999999876
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=364.37 Aligned_cols=265 Identities=22% Similarity=0.244 Sum_probs=194.6
Q ss_pred HHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCccceecceeec------CeEEEEE
Q 002409 602 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRSVLVY 674 (927)
Q Consensus 602 ~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~------~~~~lV~ 674 (927)
...++||+|+||+||+|++. +|+.||||++..... ...+|+++|++++||||+++++++... .+.++||
T Consensus 23 ~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 98 (350)
T d1q5ka_ 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 98 (350)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred EeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEE
Confidence 34578999999999999986 689999999975432 234799999999999999999998543 3578999
Q ss_pred EeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCC-cEEEEeecCccccc
Q 002409 675 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAV 753 (927)
Q Consensus 675 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-~vkL~DFGla~~~~ 753 (927)
|||+++.+. .+.........+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++...
T Consensus 99 Ey~~~~~~~-~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 99 DYVPETVYR-VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp ECCSEEHHH-HHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred eccCCccHH-HHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 999876443 3332223456799999999999999999999998 999999999999999775 89999999998654
Q ss_pred CCCCceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHH--------HHhh--
Q 002409 754 DGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQW--------AKLH-- 822 (927)
Q Consensus 754 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~--------~~~~-- 822 (927)
.... .....||+.|+|||.+.. ..++.++||||+||++|||++|+.||......+....+... ....
T Consensus 175 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 252 (350)
T d1q5ka_ 175 RGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252 (350)
T ss_dssp TTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC
T ss_pred CCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhcc
Confidence 4322 233569999999998875 57899999999999999999999999755422211111110 0000
Q ss_pred -hccCCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH--HHHH
Q 002409 823 -IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD--IQDA 876 (927)
Q Consensus 823 -~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~--L~~~ 876 (927)
.....+...................+.+|+.+|++.||++|||+.|+++| ++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 00011111111111111112233468899999999999999999999986 5543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-39 Score=358.12 Aligned_cols=265 Identities=18% Similarity=0.247 Sum_probs=193.0
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceee--------cC
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--------EG 668 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--------~~ 668 (927)
.|.+.+.||+|+||+||+|++. +|+.||||++.... ......+.+|+++|++++||||+++++++.. .+
T Consensus 11 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~ 90 (318)
T d3blha1 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 90 (318)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------
T ss_pred CEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCc
Confidence 3456789999999999999975 78999999986442 2335678899999999999999999998754 34
Q ss_pred eEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecC
Q 002409 669 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 748 (927)
Q Consensus 669 ~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGl 748 (927)
..++||||+.++.+.... .....++...+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 91 ~~~iv~e~~~~~~~~~~~----~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 91 SIYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp CEEEEEECCCEEHHHHHT----CTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred eEEEEEeccCCCccchhh----hcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecce
Confidence 679999999887776554 2345688889999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCC---ceeeeeccCCCccCccccccC-cCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhc
Q 002409 749 SKFAVDGAS---HVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE 824 (927)
Q Consensus 749 a~~~~~~~~---~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~ 824 (927)
++....... .......||+.|+|||++... .++.++||||+||++|||++|+.||...........+.+.... ..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~-~~ 242 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS-IT 242 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC-CC
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCC-CC
Confidence 975543221 122334699999999998764 6899999999999999999999999754422111112111110 00
Q ss_pred cCCcccc--------cCCcccCccCH-------HHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 825 SGDIQGI--------IDPSLLDEYDI-------QSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 825 ~~~~~~~--------~d~~l~~~~~~-------~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
....... +.......... .....+.+|+.+|++.||++|||++|+++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0000000 00000000111 112356789999999999999999999876
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-39 Score=354.39 Aligned_cols=259 Identities=21% Similarity=0.277 Sum_probs=196.9
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCcccee-cceeecCeEEEEEEecc
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL-GYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~-g~~~~~~~~~lV~E~~~ 678 (927)
|.+.+.||+|+||+||+|++. +|+.||||++.... ...++..|++++++++|+|++..+ ++..+.+..++||||+.
T Consensus 9 Y~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~ 86 (299)
T d1ckia_ 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG 86 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC
T ss_pred EEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC
Confidence 556789999999999999875 68899999987543 235688999999999877765554 55567788899999995
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECC---CCcEEEEeecCcccccCC
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVDG 755 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~---~~~vkL~DFGla~~~~~~ 755 (927)
++|.+.+.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++. +..+||+|||+|+.....
T Consensus 87 -~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 87 -PSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp -CBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred -Cchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 566555532 345789999999999999999999998 9999999999999864 457999999999866543
Q ss_pred CCc------eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcc
Q 002409 756 ASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 829 (927)
Q Consensus 756 ~~~------~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 829 (927)
... ......||+.|||||.+.+..++.++|||||||++|||++|+.||...........+..+....... ..
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~-~~- 237 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-PI- 237 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS-CH-
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC-Ch-
Confidence 322 2234569999999999999999999999999999999999999997654332222222222211110 00
Q ss_pred cccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 830 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 830 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
+.+.. ....++.+++..|++.+|++||++.++.+.|+.+..
T Consensus 238 ----~~~~~----~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 238 ----EVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp ----HHHTT----TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred ----hHhcc----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 00111 122468899999999999999999999999988764
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-39 Score=348.99 Aligned_cols=263 Identities=19% Similarity=0.221 Sum_probs=199.4
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecCeEEEEEEec
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 677 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 677 (927)
|++.+.||+|+||+||+|++. +++.||||+++... ......+.+|+.+|++++||||+++++++......++|+|++
T Consensus 4 y~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~ 83 (292)
T d1unla_ 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeec
Confidence 345689999999999999975 68899999997543 233577899999999999999999999999999999999999
Q ss_pred cCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccCCCC
Q 002409 678 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 757 (927)
Q Consensus 678 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 757 (927)
.+++|..++. ..+.+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++.......
T Consensus 84 ~~~~l~~~~~----~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 84 DQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp SEEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred cccccccccc----cccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 9998887763 346788999999999999999999998 999999999999999999999999999986544332
Q ss_pred ceeeeeccCCCccCccccccCc-CCCccceeeHHHHHHHHHhCCCccccccc-ccccchhhHHHHhhhccCCc---cccc
Q 002409 758 HVSSIVRGTVGYLDPEYYISQQ-LTDKSDVYSFGVILLELISGQEAISNEKF-GANCRNIVQWAKLHIESGDI---QGII 832 (927)
Q Consensus 758 ~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDVwSlGvvL~elltG~~p~~~~~~-~~~~~~l~~~~~~~~~~~~~---~~~~ 832 (927)
......+++.|+|||.+.... ++.++||||+||++|||++|+.||..... .+....+....... .+... ....
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 234 (292)
T d1unla_ 157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP-TEEQWPSMTKLP 234 (292)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCC-CTTTCTTGGGST
T ss_pred -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCC-Chhhhhhhhhcc
Confidence 223345788999999987655 68999999999999999999999743321 11111111111100 00000 0000
Q ss_pred C---------CcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 833 D---------PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 833 d---------~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
+ ..-...........+.+|+.+|++.||++|||++||++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 000001112223467899999999999999999999875
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=8.3e-39 Score=348.15 Aligned_cols=259 Identities=17% Similarity=0.233 Sum_probs=203.7
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhccC-CCccceecceeecCeEEEEEEecc
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH-RNLVQFLGYCQEEGRSVLVYEFMH 678 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~H-pnIv~l~g~~~~~~~~~lV~E~~~ 678 (927)
|.+.+.||+|+||+||+|++. +|+.||||++.... ....+.+|++.++.+.| +|++.+++++......++||||+
T Consensus 7 Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~- 83 (293)
T d1csna_ 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL- 83 (293)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-
Confidence 456789999999999999976 68899999986542 23567889999999965 89999999999999999999999
Q ss_pred CCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECC-----CCcEEEEeecCccccc
Q 002409 679 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-----HMRAKVSDFGLSKFAV 753 (927)
Q Consensus 679 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~-----~~~vkL~DFGla~~~~ 753 (927)
+++|.+++.. ....+++.++..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+|+...
T Consensus 84 ~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 84 GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 6899888753 245689999999999999999999998 9999999999999974 5789999999998654
Q ss_pred CCCCc------eeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCC
Q 002409 754 DGASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 827 (927)
Q Consensus 754 ~~~~~------~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 827 (927)
..... ......||+.|||||.+.+..++.++|||||||++|||++|+.||............ ..+........
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~-~~i~~~~~~~~ 236 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY-ERIGEKKQSTP 236 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH-HHHHHHHHHSC
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHH-HHHHhccCCCC
Confidence 43211 223456999999999999999999999999999999999999999765432222111 11111111011
Q ss_pred cccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHHHHHHHH
Q 002409 828 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 878 (927)
Q Consensus 828 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~L~~~~~ 878 (927)
..+ +.. ..+.++.+++..|++.+|++||++..+.+.|++++.
T Consensus 237 ~~~-----l~~----~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 237 LRE-----LCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp HHH-----HTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred hHH-----hcC----CCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence 111 111 123468889999999999999999999999998865
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-39 Score=358.69 Aligned_cols=251 Identities=24% Similarity=0.318 Sum_probs=201.2
Q ss_pred HHHhccccccCceEEEEEEEC----CCcEEEEEEeecCC----chhhHhHHHHHHHHhhccC-CCccceecceeecCeEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS----YQGKREFTNEVTLLSRIHH-RNLVQFLGYCQEEGRSV 671 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~----~g~~VAVK~l~~~~----~~~~~~~~~Ei~iL~~l~H-pnIv~l~g~~~~~~~~~ 671 (927)
|.+.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++| |||+++++++.+....+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence 566789999999999999763 47899999986432 2234668899999999976 89999999999999999
Q ss_pred EEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccc
Q 002409 672 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 751 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 751 (927)
++|||+.+|+|.+++. ....+....+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~v~e~~~~~~L~~~i~----~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 106 LILDYINGGELFTHLS----QRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEECCCCSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeecccccHHHHHHH----hcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhh
Confidence 9999999999999884 345677888899999999999999998 999999999999999999999999999986
Q ss_pred ccCCCCceeeeeccCCCccCccccccC--cCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccCCcc
Q 002409 752 AVDGASHVSSIVRGTVGYLDPEYYISQ--QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 829 (927)
Q Consensus 752 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 829 (927)
.............|++.|++||.+... .++.++|||||||+||||++|+.||......+....+...... ..
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~----~~-- 252 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK----SE-- 252 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH----CC--
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc----CC--
Confidence 654444444556799999999999754 4688999999999999999999999766533333333321111 10
Q ss_pred cccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCc-----HHHHHHH
Q 002409 830 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 872 (927)
Q Consensus 830 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----m~eV~~~ 872 (927)
+ .++.....++.+++.+|++.+|++||| ++|+++|
T Consensus 253 ----~----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 253 ----P----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp ----C----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ----C----CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 0 111123346889999999999999994 7888875
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-39 Score=356.33 Aligned_cols=262 Identities=21% Similarity=0.284 Sum_probs=190.4
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceeecC------eEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------RSV 671 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~------~~~ 671 (927)
|.+.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++||||+++++++...+ ..+
T Consensus 20 Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 99 (346)
T d1cm8a_ 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY 99 (346)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEE
Confidence 445688999999999999875 68999999997542 233567889999999999999999999997654 569
Q ss_pred EEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccc
Q 002409 672 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 751 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 751 (927)
+||||+ +.+|..++. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+|++|||+++.
T Consensus 100 lv~e~~-~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 100 LVMPFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp EEEECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecc-cccHHHHHH-----hccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceec
Confidence 999999 556766552 45699999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCCceeeeeccCCCccCccccccC-cCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHh-------hh
Q 002409 752 AVDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL-------HI 823 (927)
Q Consensus 752 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~-------~~ 823 (927)
.... .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||...........+...... ..
T Consensus 171 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (346)
T d1cm8a_ 171 ADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 246 (346)
T ss_dssp CCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred cCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence 5432 2345699999999998764 5689999999999999999999999754311111111100000 00
Q ss_pred cc-------CCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH--HHHH
Q 002409 824 ES-------GDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD--IQDA 876 (927)
Q Consensus 824 ~~-------~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~--L~~~ 876 (927)
.. ..+.+.....+. .........+.+|+.+||..||++|||+.|+++| |+.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 247 QSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp SCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred cchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 00 000000000000 0111122357899999999999999999999987 6654
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-39 Score=356.80 Aligned_cols=263 Identities=19% Similarity=0.240 Sum_probs=191.3
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC-chhhHhHHHHHHHHhhccCCCccceecceeecC----eEEEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG----RSVLVY 674 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~----~~~lV~ 674 (927)
|.+.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++||||+++++++.... ..++++
T Consensus 10 Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~ 89 (345)
T d1pmea_ 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV 89 (345)
T ss_dssp EEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred eEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE
Confidence 445689999999999999875 79999999997543 333567889999999999999999999986543 234555
Q ss_pred EeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccccC
Q 002409 675 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 754 (927)
Q Consensus 675 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 754 (927)
+++.+|+|.+++. ...+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 90 ~~~~~g~L~~~l~-----~~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 90 THLMGADLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EECCCEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EeecCCchhhhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 6677999999984 34689999999999999999999998 999999999999999999999999999975543
Q ss_pred CCC--ceeeeeccCCCccCcccccc-CcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhhccC-----
Q 002409 755 GAS--HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG----- 826 (927)
Q Consensus 755 ~~~--~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~----- 826 (927)
... .......||+.|+|||++.. ..++.++||||+||++|||++|+.||......+....... ........
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG-ILGSPSQEDLNCI 240 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-HHCSCCHHHHHTC
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhh-hccCCChhhhhhh
Confidence 222 12344569999999999854 5678899999999999999999999975442111111000 00000000
Q ss_pred ------CcccccCCcccC---ccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 827 ------DIQGIIDPSLLD---EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 827 ------~~~~~~d~~l~~---~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
............ ........++.+++.+|++.||++|||+.|+++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000000 0001112357899999999999999999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.1e-38 Score=349.33 Aligned_cols=258 Identities=18% Similarity=0.283 Sum_probs=193.3
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhcc-CCCccceecceee--cCeEEEEEE
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQE--EGRSVLVYE 675 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~--~~~~~lV~E 675 (927)
.|.+.++||+|+||+||+|+.. +++.||||+++... .+.+.+|+++|++++ ||||+++++++.. ....++|||
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 4567789999999999999985 68899999987432 467889999999995 9999999999874 456899999
Q ss_pred eccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCC-cEEEEeecCcccccC
Q 002409 676 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVD 754 (927)
Q Consensus 676 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-~vkL~DFGla~~~~~ 754 (927)
|+.+++|.... +.+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+|+....
T Consensus 113 ~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 113 HVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp CCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred ecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccC
Confidence 99999987654 3588999999999999999999998 999999999999998655 699999999986544
Q ss_pred CCCceeeeeccCCCccCccccccC-cCCCccceeeHHHHHHHHHhCCCcccccccccc-cchhhH---------HHHhhh
Q 002409 755 GASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGAN-CRNIVQ---------WAKLHI 823 (927)
Q Consensus 755 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~-~~~l~~---------~~~~~~ 823 (927)
... .....||+.|+|||.+.+. .++.++||||+||+++||++|+.||........ ...+.. |.....
T Consensus 183 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 183 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp TCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred CCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 322 2345689999999998765 479999999999999999999999965431110 001110 100000
Q ss_pred cc--CCcccccCCc--------ccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 824 ES--GDIQGIIDPS--------LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 824 ~~--~~~~~~~d~~--------l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
.. .......... ...........++.+|+.+||+.||++|||++|+++|
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0000000000 0000111222467899999999999999999999875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-38 Score=352.16 Aligned_cols=260 Identities=21% Similarity=0.285 Sum_probs=187.4
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceee------cCeEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE------EGRSV 671 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~------~~~~~ 671 (927)
|.+.++||+|+||+||+|++. +|+.||||++.... ......+.+|+.+|++++||||+++++++.. ....+
T Consensus 19 Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~ 98 (355)
T d2b1pa1 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 98 (355)
T ss_dssp EEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred eEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeE
Confidence 445689999999999999976 68999999997543 2334568899999999999999999999853 36789
Q ss_pred EEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCccc
Q 002409 672 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 751 (927)
Q Consensus 672 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~ 751 (927)
+||||+.++.+. .+ ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+|++|||+++.
T Consensus 99 iv~Ey~~~~l~~-~~------~~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 99 LVMELMDANLCQ-VI------QMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEECCSEEHHH-HH------TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEeccchHHHH-hh------hcCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhc
Confidence 999999765544 33 23578899999999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccchhhH--------------
Q 002409 752 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ-------------- 817 (927)
Q Consensus 752 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~-------------- 817 (927)
.... .......||+.|+|||++.+..++.++||||+||+++||++|+.||...........+..
T Consensus 169 ~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 169 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred cccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 4432 233445689999999999999999999999999999999999999965431111111110
Q ss_pred -HHHhhhccC------CcccccCCcccC---ccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 818 -WAKLHIESG------DIQGIIDPSLLD---EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 818 -~~~~~~~~~------~~~~~~d~~l~~---~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
......... .....+...... .........+.+|+.+|++.||++|||++|+++|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000000 000011111111 1122344578899999999999999999999987
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-37 Score=347.68 Aligned_cols=259 Identities=20% Similarity=0.261 Sum_probs=190.5
Q ss_pred HHHhccccccCceEEEEEEEC-CCcEEEEEEeecCC--chhhHhHHHHHHHHhhccCCCccceecceee-----cCeEEE
Q 002409 601 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE-----EGRSVL 672 (927)
Q Consensus 601 ~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~-----~~~~~l 672 (927)
|.+.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++||||+++++++.. ....++
T Consensus 20 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 99 (348)
T d2gfsa1 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 99 (348)
T ss_dssp EEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCE
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEE
Confidence 456789999999999999875 68999999997543 2334578899999999999999999998853 234466
Q ss_pred EEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEEeecCcccc
Q 002409 673 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 752 (927)
Q Consensus 673 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGla~~~ 752 (927)
+++|+.+|+|.+++. .+.+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++...
T Consensus 100 i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 100 LVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp EEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred EEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhccc
Confidence 778888999999884 34689999999999999999999998 9999999999999999999999999998744
Q ss_pred cCCCCceeeeeccCCCccCccccccC-cCCCccceeeHHHHHHHHHhCCCcccccccccccchhhHHHHhhh---cc---
Q 002409 753 VDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI---ES--- 825 (927)
Q Consensus 753 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~~l~~~~~~~~---~~--- 825 (927)
.. ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||...........+........ ..
T Consensus 172 ~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (348)
T d2gfsa1 172 DD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247 (348)
T ss_dssp TG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred Cc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhcc
Confidence 22 22345689999999987765 468899999999999999999999975442211111111100000 00
Q ss_pred --------CCcccccCCcccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHHHHH
Q 002409 826 --------GDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 872 (927)
Q Consensus 826 --------~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV~~~ 872 (927)
..+...-...+... .......+.+|+.+||+.||++|||+.|+++|
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 248 SESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHH-STTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred chhhhhhhhhcccCCCcchhhh-cCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 00000000000000 01122457899999999999999999999886
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.1e-34 Score=321.13 Aligned_cols=269 Identities=19% Similarity=0.273 Sum_probs=191.3
Q ss_pred HHHHhccccccCceEEEEEEEC-CCcEEEEEEeecCCchhhHhHHHHHHHHhhcc-----------CCCccceecceee-
Q 002409 600 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-----------HRNLVQFLGYCQE- 666 (927)
Q Consensus 600 ~~~~~~~IG~G~fG~Vy~~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~-----------HpnIv~l~g~~~~- 666 (927)
+|.+.++||+|+||+||+|+.. +|+.||||+++... ...+.+.+|+.++++++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 4677899999999999999975 68999999997543 23456788999988875 5778889888754
Q ss_pred -cCeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCC------
Q 002409 667 -EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM------ 739 (927)
Q Consensus 667 -~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~------ 739 (927)
....+++++++..+........ ......+++..+..++.|++.||+|||+. .+|+||||||+|||++.++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIK-KYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHH-HTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEE
T ss_pred cccceeeeeeecccccccccccc-cccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCcccccc
Confidence 3566777777665543333221 23456678889999999999999999983 2899999999999998654
Q ss_pred cEEEEeecCcccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHHHHHHHHhCCCcccccccccccc---hhh
Q 002409 740 RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCR---NIV 816 (927)
Q Consensus 740 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvL~elltG~~p~~~~~~~~~~~---~l~ 816 (927)
.+|++|||.+...... .....||+.|+|||++....++.++||||+||+++||++|+.||.......... .+.
T Consensus 170 ~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 3999999998754322 234569999999999999999999999999999999999999997543211111 111
Q ss_pred HHHHhh-----------------hccCCcccccCCc----------ccCccCHHHHHHHHHHHhhhcCCCCCCCCcHHHH
Q 002409 817 QWAKLH-----------------IESGDIQGIIDPS----------LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEV 869 (927)
Q Consensus 817 ~~~~~~-----------------~~~~~~~~~~d~~----------l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPsm~eV 869 (927)
...... .........+... ...........++.+|+.+|+..||++|||++|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 111100 0000000000000 0112334566789999999999999999999999
Q ss_pred HHH--HHHH
Q 002409 870 LKD--IQDA 876 (927)
Q Consensus 870 ~~~--L~~~ 876 (927)
++| +++.
T Consensus 326 L~Hp~f~~~ 334 (362)
T d1q8ya_ 326 VNHPWLKDT 334 (362)
T ss_dssp HTCGGGTTC
T ss_pred hcCcccCCC
Confidence 887 6644
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.83 E-value=1.9e-21 Score=196.48 Aligned_cols=166 Identities=17% Similarity=0.161 Sum_probs=118.0
Q ss_pred HhccccccCceEEEEEEECCCcEEEEEEeecCCc------------------hhhHhHHHHHHHHhhccCCCccceecce
Q 002409 603 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY------------------QGKREFTNEVTLLSRIHHRNLVQFLGYC 664 (927)
Q Consensus 603 ~~~~IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~------------------~~~~~~~~Ei~iL~~l~HpnIv~l~g~~ 664 (927)
+.++||+|+||+||+|+..+|++||||+++.... ........|...+.++.|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 4678999999999999998999999998763211 0112345688899999999998877653
Q ss_pred eecCeEEEEEEeccCCchhhhcccccccccccCHHHHHHHHHHHHhHhHHHhhCCCCceecCCCCCCCeEECCCCcEEEE
Q 002409 665 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 744 (927)
Q Consensus 665 ~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~vkL~ 744 (927)
..+++|||+++..+.++ +......++.|++++|+|||++ +|+||||||+|||++++ .++|+
T Consensus 84 ----~~~lvme~~~~~~~~~l-----------~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 84 ----GNAVLMELIDAKELYRV-----------RVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp ----TTEEEEECCCCEEGGGC-----------CCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEEC
T ss_pred ----CCEEEEEeeccccccch-----------hhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEE
Confidence 23799999988655432 2233457899999999999998 99999999999999865 58999
Q ss_pred eecCcccccCCCCceeeeeccCCCccCccccccCcCCCccceeeHHH
Q 002409 745 DFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGV 791 (927)
Q Consensus 745 DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGv 791 (927)
|||+|+...+...... .......+ .| +..+.|+.++|+||..-
T Consensus 145 DFG~a~~~~~~~~~~~--l~rd~~~~-~~-~f~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 145 DFPQSVEVGEEGWREI--LERDVRNI-IT-YFSRTYRTEKDINSAID 187 (191)
T ss_dssp CCTTCEETTSTTHHHH--HHHHHHHH-HH-HHHHHHCCCCCHHHHHH
T ss_pred ECCCcccCCCCCcHHH--HHHHHHHH-HH-HHcCCCCCcccHHHHHH
Confidence 9999975543221100 00000000 01 12467888999999654
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.68 E-value=2e-17 Score=179.56 Aligned_cols=146 Identities=29% Similarity=0.500 Sum_probs=126.2
Q ss_pred CCCchHHHHHHHHhcC----CCCcCCCCCCCCCCCCcceeecCCC-CCCceEEEEecCCCCCc--cCCchhhcCCCCcEE
Q 002409 371 NDGSIDAIVSVISLYS----SADWAQEGGDPCLPVPWSWLQCNSD-PQPSITVIHLSSKNLTG--NIPSDLTKLSSLVEL 443 (927)
Q Consensus 371 ~~~~~dal~~~~~~~~----~~~w~~~~~dpC~~~~~~~v~C~~~-~~~~l~~L~L~~n~l~g--~ip~~i~~L~~L~~L 443 (927)
...+++|+.++|+.+. +.+|.. ++|||. ..|.||.|+.+ ...+|+.|||++|+++| .+|++|++|++|++|
T Consensus 4 ~~~e~~aLl~~k~~~~~~~~l~sW~~-~~d~C~-~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L 81 (313)
T d1ogqa_ 4 NPQDKQALLQIKKDLGNPTTLSSWLP-TTDCCN-RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFL 81 (313)
T ss_dssp CHHHHHHHHHHHHHTTCCGGGTTCCT-TSCTTT-TCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEE
T ss_pred CHHHHHHHHHHHHHCCCCCcCCCCCC-CCCCCC-CcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcccccc
Confidence 3456889999999875 578976 689993 25999999864 34589999999999998 589999999999999
Q ss_pred eccC-CcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCcccccccccccccccccccccc--ccccccccCCc
Q 002409 444 WLDG-NSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS--KNVVLNYAGNI 518 (927)
Q Consensus 444 ~Ls~-N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l~g~iP~~l~~--~~~~l~~~~n~ 518 (927)
+|++ |+++|.+|. +++|++|++|+|++|+|+|..|..+.++.+|+.+++++|++.+.+|.++.. .+..+.+.+|.
T Consensus 82 ~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~ 160 (313)
T d1ogqa_ 82 YIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred ccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeeccccc
Confidence 9997 899999986 899999999999999999999999999999999999999999999988843 44566667664
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.32 E-value=1.4e-12 Score=130.59 Aligned_cols=122 Identities=23% Similarity=0.279 Sum_probs=102.6
Q ss_pred CcceeecCCCC--------CCceEEEEecCCCCCccC-CchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCC
Q 002409 402 PWSWLQCNSDP--------QPSITVIHLSSKNLTGNI-PSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDN 471 (927)
Q Consensus 402 ~~~~v~C~~~~--------~~~l~~L~L~~n~l~g~i-p~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N 471 (927)
.+..|.|+... ++.++.|+|++|.|++.+ +..+.++++|+.|+|++|.+.+.++. +.++++|++|+|++|
T Consensus 9 ~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 9 EGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp ETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred cCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 46678897533 257899999999998766 45678999999999999999998887 788999999999999
Q ss_pred CcCCCCCccccCCCccccccccccccccccccccc---cccccccccCCcccccCC
Q 002409 472 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL---SKNVVLNYAGNINLHEGG 524 (927)
Q Consensus 472 ~l~g~~P~~l~~l~~L~~L~l~~N~l~g~iP~~l~---~~~~~l~~~~n~~l~~~~ 524 (927)
+|++..|..|.++++|+.|+|++|+|+ .+|...+ ..+..+.+.+|+-.|...
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~-~i~~~~f~~l~~L~~l~L~~N~~~~~~~ 143 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCC-EECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred cccccCHHHHhCCCcccccccCCcccc-ccCHHHhcCCcccccccccccccccccc
Confidence 999877888999999999999999999 6666554 345678889998776553
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.26 E-value=1.1e-12 Score=141.49 Aligned_cols=110 Identities=26% Similarity=0.317 Sum_probs=101.3
Q ss_pred ceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCccccccccc
Q 002409 415 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 494 (927)
Q Consensus 415 ~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~ 494 (927)
....++++++.+.|.+|..+..+++|+.|++++|.+++.+|.+..+++|++|+|++|+|+|.+|++|++|++|+.|+|++
T Consensus 198 ~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~ 277 (313)
T d1ogqa_ 198 NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF 277 (313)
T ss_dssp CCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccCccCeecccCChHHhCCCCCCEEECcC
Confidence 34579999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccc-ccccccccccCCcccccCC
Q 002409 495 NMLSGTVPSSL-LSKNVVLNYAGNINLHEGG 524 (927)
Q Consensus 495 N~l~g~iP~~l-~~~~~~l~~~~n~~l~~~~ 524 (927)
|+|+|.+|..- ++.+..+.+.+|+.+|+.+
T Consensus 278 N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~p 308 (313)
T d1ogqa_ 278 NNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308 (313)
T ss_dssp SEEEEECCCSTTGGGSCGGGTCSSSEEESTT
T ss_pred CcccccCCCcccCCCCCHHHhCCCccccCCC
Confidence 99999999642 4566778899999999875
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.12 E-value=5.2e-11 Score=110.08 Aligned_cols=97 Identities=33% Similarity=0.449 Sum_probs=66.5
Q ss_pred EEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCcccccccccccc
Q 002409 418 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNML 497 (927)
Q Consensus 418 ~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l 497 (927)
+|||++|+|+ .++ .+.+|++|++|+|++|+|+...+.++.+++|+.|+|++|+|++ +| .+.++++|+.|++++|+|
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~i 77 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRL 77 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccCcchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCcc
Confidence 5777788777 555 3777777888888888777654457777778888888887773 44 477777788888888877
Q ss_pred cccccc--cc--ccccccccccCCcc
Q 002409 498 SGTVPS--SL--LSKNVVLNYAGNIN 519 (927)
Q Consensus 498 ~g~iP~--~l--~~~~~~l~~~~n~~ 519 (927)
+ .+|. .+ ++.+..+.+.+|+-
T Consensus 78 ~-~~~~~~~l~~~~~L~~L~l~~N~i 102 (124)
T d1dcea3 78 Q-QSAAIQPLVSCPRLVLLNLQGNSL 102 (124)
T ss_dssp C-SSSTTGGGGGCTTCCEEECTTSGG
T ss_pred C-CCCCchhhcCCCCCCEEECCCCcC
Confidence 7 4442 22 23345666677753
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.09 E-value=4.9e-11 Score=119.01 Aligned_cols=113 Identities=22% Similarity=0.279 Sum_probs=94.2
Q ss_pred CCCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCccccc
Q 002409 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 490 (927)
Q Consensus 412 ~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L 490 (927)
..++|+.|+|++|++.+..+..+..+++|++|+|++|+|++..|. |.++++|++|+|++|+|++..|..|..+++|++|
T Consensus 52 ~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l 131 (192)
T d1w8aa_ 52 RLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSL 131 (192)
T ss_dssp GCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEE
T ss_pred CCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccc
Confidence 357899999999999999999999999999999999999998887 8999999999999999998888889999999999
Q ss_pred cccccccccccccccc-cccccccccCCcccccCC
Q 002409 491 YVQNNMLSGTVPSSLL-SKNVVLNYAGNINLHEGG 524 (927)
Q Consensus 491 ~l~~N~l~g~iP~~l~-~~~~~l~~~~n~~l~~~~ 524 (927)
+|++|.+.+..+...+ ..+......+|...|..+
T Consensus 132 ~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p 166 (192)
T d1w8aa_ 132 NLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp ECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred cccccccccccchHHHhhhhhhhcccCCCeEeCCC
Confidence 9999999865544332 223334445555555544
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.04 E-value=1.3e-10 Score=107.37 Aligned_cols=85 Identities=27% Similarity=0.328 Sum_probs=76.6
Q ss_pred CCCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCC-CccccCCCccccc
Q 002409 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPL-PSSLMNLPNLREL 490 (927)
Q Consensus 412 ~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~-P~~l~~l~~L~~L 490 (927)
..+.|++|+|++|.|+ .+|+.++.+++|+.|+|++|.|++. |.+.++++|++|++++|+|+... +..+..+++|+.|
T Consensus 18 ~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~L 95 (124)
T d1dcea3 18 QLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLL 95 (124)
T ss_dssp GGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-GGGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEE
T ss_pred cCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-CccccccccCeEECCCCccCCCCCchhhcCCCCCCEE
Confidence 3568999999999999 7899999999999999999999964 67999999999999999998432 2578999999999
Q ss_pred cccccccc
Q 002409 491 YVQNNMLS 498 (927)
Q Consensus 491 ~l~~N~l~ 498 (927)
++++|+++
T Consensus 96 ~l~~N~i~ 103 (124)
T d1dcea3 96 NLQGNSLC 103 (124)
T ss_dssp ECTTSGGG
T ss_pred ECCCCcCC
Confidence 99999998
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.03 E-value=1.5e-10 Score=112.22 Aligned_cols=104 Identities=18% Similarity=0.163 Sum_probs=86.6
Q ss_pred CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCccccccc
Q 002409 413 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 492 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 492 (927)
..++++|||++|+|+ .||..+..+++|+.|+|++|.|+. ++.+..+++|++|+|++|+++...+..+..+++|+.|+|
T Consensus 17 ~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~-l~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L 94 (162)
T d1a9na_ 17 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-LDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL 94 (162)
T ss_dssp TTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCE-ECCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEEC
T ss_pred cCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCc-cCCcccCcchhhhhcccccccCCCcccccccccccccee
Confidence 347899999999999 678777889999999999999985 477999999999999999999544445678999999999
Q ss_pred ccccccccccc--cc--ccccccccccCCcc
Q 002409 493 QNNMLSGTVPS--SL--LSKNVVLNYAGNIN 519 (927)
Q Consensus 493 ~~N~l~g~iP~--~l--~~~~~~l~~~~n~~ 519 (927)
++|+|+ .++. .+ ++.+..+.+.+|+-
T Consensus 95 ~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i 124 (162)
T d1a9na_ 95 TNNSLV-ELGDLDPLASLKSLTYLCILRNPV 124 (162)
T ss_dssp CSCCCC-CGGGGGGGGGCTTCCEEECCSSGG
T ss_pred cccccc-ccccccccccccccchhhcCCCcc
Confidence 999998 5554 22 34567778888863
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.01 E-value=2.9e-10 Score=109.45 Aligned_cols=103 Identities=17% Similarity=0.184 Sum_probs=77.9
Q ss_pred EEecCCCCCccCCchhhcCCCCcEEeccCCc-CCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCccccccccccc
Q 002409 419 IHLSSKNLTGNIPSDLTKLSSLVELWLDGNS-LTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 496 (927)
Q Consensus 419 L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~-l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~ 496 (927)
++++++++. .+|..+..+++|+.|+|++|+ |+...+. |.++++|+.|+|++|+|+...|..|..+++|+.|+|++|+
T Consensus 13 l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~ 91 (156)
T d2ifga3 13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91 (156)
T ss_dssp EECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred EEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCC
Confidence 344455555 567778888888888887664 7765554 8888888888888888887667778888888888888888
Q ss_pred cccccccccccc--cccccccCCcccccC
Q 002409 497 LSGTVPSSLLSK--NVVLNYAGNINLHEG 523 (927)
Q Consensus 497 l~g~iP~~l~~~--~~~l~~~~n~~l~~~ 523 (927)
|+ .+|..++.. +..+.+.+|+-.|..
T Consensus 92 l~-~l~~~~~~~~~l~~L~L~~Np~~C~C 119 (156)
T d2ifga3 92 LE-SLSWKTVQGLSLQELVLSGNPLHCSC 119 (156)
T ss_dssp CS-CCCSTTTCSCCCCEEECCSSCCCCCG
T ss_pred Cc-ccChhhhccccccccccCCCcccCCc
Confidence 88 788777653 356777888877665
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.92 E-value=1.3e-09 Score=114.20 Aligned_cols=112 Identities=31% Similarity=0.376 Sum_probs=99.6
Q ss_pred CCCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCccccc
Q 002409 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 490 (927)
Q Consensus 412 ~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L 490 (927)
..++|+.|+|++|.+.+..+..+..+.+|+.|++++|.+++..+. +..+++|+.|++++|+|++..|..+..+++|+.|
T Consensus 98 ~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L 177 (266)
T d1p9ag_ 98 TLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177 (266)
T ss_dssp TCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEE
T ss_pred cccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCcccccccccccee
Confidence 457899999999999977778888999999999999999988777 6779999999999999998888889999999999
Q ss_pred ccccccccccccccccc--ccccccccCCcccccCC
Q 002409 491 YVQNNMLSGTVPSSLLS--KNVVLNYAGNINLHEGG 524 (927)
Q Consensus 491 ~l~~N~l~g~iP~~l~~--~~~~l~~~~n~~l~~~~ 524 (927)
+|++|+|+ .+|.+++. .+..+.+.||+-.|.+.
T Consensus 178 ~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~ 212 (266)
T d1p9ag_ 178 LLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCE 212 (266)
T ss_dssp ECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred ecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCcc
Confidence 99999999 99998864 45778899999888763
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.90 E-value=8e-10 Score=116.94 Aligned_cols=112 Identities=22% Similarity=0.293 Sum_probs=96.8
Q ss_pred CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCcccccc
Q 002409 413 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 491 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~ 491 (927)
...|+.+++++|.|++..+..+..+++|+.|+|++|+|++..+. +.++++|++|+|++|++++..|..|.++++|+.|+
T Consensus 128 ~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~ 207 (284)
T d1ozna_ 128 LAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY 207 (284)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred hcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccccc
Confidence 46799999999999966667788999999999999999988776 78999999999999999999999999999999999
Q ss_pred cccccccccccccc--ccccccccccCCcccccCC
Q 002409 492 VQNNMLSGTVPSSL--LSKNVVLNYAGNINLHEGG 524 (927)
Q Consensus 492 l~~N~l~g~iP~~l--~~~~~~l~~~~n~~l~~~~ 524 (927)
+++|.+++..|..+ ...+..+.+.+|+-.|.+.
T Consensus 208 l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~ 242 (284)
T d1ozna_ 208 LFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (284)
T ss_dssp CCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred ccccccccccccccccccccCEEEecCCCCCCCcc
Confidence 99999996555444 2345778889998777653
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.81 E-value=3e-09 Score=111.41 Aligned_cols=101 Identities=32% Similarity=0.328 Sum_probs=81.8
Q ss_pred CceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCcccccccc
Q 002409 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 493 (927)
Q Consensus 414 ~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~ 493 (927)
+.++.|+|++|.|++..+..|.+|++|++|+|++|+|+. +|.++.+++|++|+|++|+++ .+|..+.++++|+.|+++
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~ 108 (266)
T d1p9ag_ 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVS 108 (266)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EECCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECC
T ss_pred cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-ccccccccccccccccccccc-cccccccccccccccccc
Confidence 469999999999996555779999999999999999984 566788999999999999998 467788999999999999
Q ss_pred cccccccccccccc---ccccccccCC
Q 002409 494 NNMLSGTVPSSLLS---KNVVLNYAGN 517 (927)
Q Consensus 494 ~N~l~g~iP~~l~~---~~~~l~~~~n 517 (927)
+|.+. .++...+. .+..+.+.+|
T Consensus 109 ~~~~~-~~~~~~~~~l~~l~~L~l~~n 134 (266)
T d1p9ag_ 109 FNRLT-SLPLGALRGLGELQELYLKGN 134 (266)
T ss_dssp SSCCC-CCCSSTTTTCTTCCEEECTTS
T ss_pred ccccc-eeecccccccccccccccccc
Confidence 99998 45544433 2344555555
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.80 E-value=2.8e-09 Score=113.67 Aligned_cols=105 Identities=27% Similarity=0.390 Sum_probs=91.5
Q ss_pred CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCcccccc
Q 002409 413 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 491 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~ 491 (927)
.++|+.|+|++|.+.+..+..+.+++.++.|++++|.+++..+. +.++++|++|+|++|+|+ .+|.++.++++|+.|+
T Consensus 170 ~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~ 248 (305)
T d1xkua_ 170 PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVY 248 (305)
T ss_dssp CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEE
T ss_pred CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEE
Confidence 46899999999999999999999999999999999999998776 788999999999999998 7899999999999999
Q ss_pred cccccccccccccccc---------ccccccccCCcc
Q 002409 492 VQNNMLSGTVPSSLLS---------KNVVLNYAGNIN 519 (927)
Q Consensus 492 l~~N~l~g~iP~~l~~---------~~~~l~~~~n~~ 519 (927)
|++|+|+ .|+...+. .+..+.+.+|+-
T Consensus 249 Ls~N~i~-~i~~~~f~~~~~~~~~~~L~~L~L~~N~~ 284 (305)
T d1xkua_ 249 LHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPV 284 (305)
T ss_dssp CCSSCCC-CCCTTSSSCSSCCTTSCCCSEEECCSSSS
T ss_pred CCCCccC-ccChhhccCcchhcccCCCCEEECCCCcC
Confidence 9999999 77765432 235567788864
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.75 E-value=3.9e-09 Score=101.29 Aligned_cols=102 Identities=28% Similarity=0.329 Sum_probs=84.7
Q ss_pred CCCCCCCcceeecCCC----------CCCceEEEEecCCC-CCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCc
Q 002409 396 DPCLPVPWSWLQCNSD----------PQPSITVIHLSSKN-LTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDL 463 (927)
Q Consensus 396 dpC~~~~~~~v~C~~~----------~~~~l~~L~L~~n~-l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L 463 (927)
+.|.+..++++.|+.. ..++|+.|+|++|+ |+..-+..|.+|++|+.|+|++|+|+...|. |.++++|
T Consensus 3 ~~C~c~~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L 82 (156)
T d2ifga3 3 DACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82 (156)
T ss_dssp SSSCCSSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCC
T ss_pred CCCCcCCCCeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccc
Confidence 3466667788999752 24688999998765 8854456799999999999999999998887 8999999
Q ss_pred cEEEecCCCcCCCCCccccCCCccccccccccccc
Q 002409 464 RIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLS 498 (927)
Q Consensus 464 ~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l~ 498 (927)
++|+|++|+|+ .+|..+....+|+.|+|++|.+.
T Consensus 83 ~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 83 SRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp CEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred cceeccCCCCc-ccChhhhccccccccccCCCccc
Confidence 99999999999 67776666668999999999985
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.65 E-value=5.4e-09 Score=100.96 Aligned_cols=86 Identities=21% Similarity=0.272 Sum_probs=75.2
Q ss_pred CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCC--ccccCCCcccc
Q 002409 413 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLP--SSLMNLPNLRE 489 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P--~~l~~l~~L~~ 489 (927)
.+.|+.|||++|.|+ .++ .+..|++|++|+|++|+++...+. +..+++|+.|+|++|+++ .++ ..+..+++|+.
T Consensus 40 l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~-~~~~l~~l~~l~~L~~ 116 (162)
T d1a9na_ 40 LDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTY 116 (162)
T ss_dssp TTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCE
T ss_pred cccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccceecccccc-ccccccccccccccch
Confidence 457999999999999 665 589999999999999999988777 467999999999999998 444 46889999999
Q ss_pred ccccccccccccc
Q 002409 490 LYVQNNMLSGTVP 502 (927)
Q Consensus 490 L~l~~N~l~g~iP 502 (927)
|++++|+++ ..|
T Consensus 117 L~l~~N~i~-~~~ 128 (162)
T d1a9na_ 117 LCILRNPVT-NKK 128 (162)
T ss_dssp EECCSSGGG-GST
T ss_pred hhcCCCccc-ccc
Confidence 999999998 555
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.63 E-value=2.7e-08 Score=104.87 Aligned_cols=108 Identities=20% Similarity=0.261 Sum_probs=93.4
Q ss_pred CCCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCccccc
Q 002409 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 490 (927)
Q Consensus 412 ~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L 490 (927)
..++|+.|+|++|++.+..+..+..+++|+.+++++|+|++.++. |.++++|+.|+|++|+|++..|..+.++++|+.|
T Consensus 103 ~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l 182 (284)
T d1ozna_ 103 GLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRL 182 (284)
T ss_dssp TCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred ccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchh
Confidence 346899999999999977777888899999999999999988776 7889999999999999998888899999999999
Q ss_pred cccccccccccccccc--cccccccccCCcc
Q 002409 491 YVQNNMLSGTVPSSLL--SKNVVLNYAGNIN 519 (927)
Q Consensus 491 ~l~~N~l~g~iP~~l~--~~~~~l~~~~n~~ 519 (927)
++++|++++..|..+. +.+..+++..|..
T Consensus 183 ~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i 213 (284)
T d1ozna_ 183 LLHQNRVAHVHPHAFRDLGRLMTLYLFANNL 213 (284)
T ss_dssp ECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred hhhhccccccChhHhhhhhhccccccccccc
Confidence 9999999977777664 4456777777743
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.52 E-value=8.6e-08 Score=95.42 Aligned_cols=99 Identities=24% Similarity=0.341 Sum_probs=55.9
Q ss_pred CceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCcccccccc
Q 002409 414 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 493 (927)
Q Consensus 414 ~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~ 493 (927)
.+++.|+|++|+++ .++ .+..|++|++|+|++|+|++..| +.++++|++|++++|.+. .+| .+.++++|+.|+++
T Consensus 40 ~~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~~~~-l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~ 114 (199)
T d2omxa2 40 DQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLF 114 (199)
T ss_dssp TTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECC
T ss_pred cCCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccCccc-ccCCcccccccccccccc-ccc-cccccccccccccc
Confidence 35666666666665 343 36666666666666666665433 566666666666666665 333 25666666666666
Q ss_pred ccccccccccccccccccccccCC
Q 002409 494 NNMLSGTVPSSLLSKNVVLNYAGN 517 (927)
Q Consensus 494 ~N~l~g~iP~~l~~~~~~l~~~~n 517 (927)
+|.+....+..-++.+..+.+++|
T Consensus 115 ~~~~~~~~~~~~l~~L~~L~l~~n 138 (199)
T d2omxa2 115 NNQITDIDPLKNLTNLNRLELSSN 138 (199)
T ss_dssp SSCCCCCGGGTTCTTCSEEECCSS
T ss_pred ccccccccccchhhhhHHhhhhhh
Confidence 666653322222344444555554
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.44 E-value=5.5e-08 Score=106.22 Aligned_cols=76 Identities=20% Similarity=0.419 Sum_probs=35.9
Q ss_pred ceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCccccccccc
Q 002409 415 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 494 (927)
Q Consensus 415 ~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~ 494 (927)
+++.|+|++|++++ ++ .+..+++|+.|+|++|+|++ ++.+.+|++|++|+|++|+|++..| +.+|++|+.|+|++
T Consensus 308 ~l~~L~ls~n~l~~-l~-~l~~l~~L~~L~L~~n~l~~-l~~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~ 382 (384)
T d2omza2 308 NLTYLTLYFNNISD-IS-PVSSLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLND 382 (384)
T ss_dssp TCSEEECCSSCCSC-CG-GGGGCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCC
T ss_pred ccCeEECCCCCCCC-Cc-ccccCCCCCEEECCCCCCCC-ChhHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCC
Confidence 44455555555543 22 14445555555555555543 2334445555555555555543322 44455555555554
Q ss_pred c
Q 002409 495 N 495 (927)
Q Consensus 495 N 495 (927)
|
T Consensus 383 N 383 (384)
T d2omza2 383 Q 383 (384)
T ss_dssp E
T ss_pred C
Confidence 4
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.43 E-value=1.4e-07 Score=99.99 Aligned_cols=88 Identities=24% Similarity=0.352 Sum_probs=42.9
Q ss_pred CCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCcccccccccccccccc
Q 002409 423 SKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTV 501 (927)
Q Consensus 423 ~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l~g~i 501 (927)
+++|+ ++|..|. ++|++|+|++|+|+...+. |.++++|++|++++|.++...|..|.++++|+.|++++|+|+ .+
T Consensus 19 ~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~-~l 94 (305)
T d1xkua_ 19 DLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-EL 94 (305)
T ss_dssp TSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BC
T ss_pred CCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccC-cC
Confidence 33444 4444442 3455555555555544442 455555555555555555444445555555555555555555 44
Q ss_pred ccccccccccccc
Q 002409 502 PSSLLSKNVVLNY 514 (927)
Q Consensus 502 P~~l~~~~~~l~~ 514 (927)
|..+...+..+..
T Consensus 95 ~~~~~~~l~~L~~ 107 (305)
T d1xkua_ 95 PEKMPKTLQELRV 107 (305)
T ss_dssp CSSCCTTCCEEEC
T ss_pred ccchhhhhhhhhc
Confidence 5444443333333
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.41 E-value=2e-07 Score=93.56 Aligned_cols=79 Identities=27% Similarity=0.467 Sum_probs=36.7
Q ss_pred ceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCccccccccc
Q 002409 415 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 494 (927)
Q Consensus 415 ~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~ 494 (927)
+|+.|++++|.++. ++ .|..|++|++|+|++|+|++. +.++++++|++|+|++|++++ +| .+.++++|+.|++++
T Consensus 47 ~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~l-~~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~ 121 (210)
T d1h6ta2 47 SIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDI-KPLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEH 121 (210)
T ss_dssp TCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTT
T ss_pred CccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccCc-cccccCccccccccccccccc-cc-ccccccccccccccc
Confidence 34445555554442 22 244455555555555555442 224445555555555555442 33 244455555555555
Q ss_pred cccc
Q 002409 495 NMLS 498 (927)
Q Consensus 495 N~l~ 498 (927)
|.++
T Consensus 122 ~~~~ 125 (210)
T d1h6ta2 122 NGIS 125 (210)
T ss_dssp SCCC
T ss_pred cccc
Confidence 5444
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.37 E-value=2e-07 Score=101.65 Aligned_cols=100 Identities=23% Similarity=0.293 Sum_probs=81.6
Q ss_pred CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCccccccc
Q 002409 413 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 492 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 492 (927)
.+.+..+++..|.+++ ...+..+++|+.|+|++|++++.. .+..+++|+.|+|++|+|++ +| .+.+|++|++|+|
T Consensus 284 ~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~-~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l 358 (384)
T d2omza2 284 LTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS-PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSA 358 (384)
T ss_dssp CTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG-GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEEC
T ss_pred cccccccccccccccc--ccccchhcccCeEECCCCCCCCCc-ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEEC
Confidence 4567888899999885 345889999999999999999864 48889999999999999984 55 6999999999999
Q ss_pred cccccccccccccccccccccccCC
Q 002409 493 QNNMLSGTVPSSLLSKNVVLNYAGN 517 (927)
Q Consensus 493 ~~N~l~g~iP~~l~~~~~~l~~~~n 517 (927)
++|+|++..|-.-++.+..+.+..|
T Consensus 359 ~~N~l~~l~~l~~l~~L~~L~L~~N 383 (384)
T d2omza2 359 GHNQISDLTPLANLTRITQLGLNDQ 383 (384)
T ss_dssp CSSCCCBCGGGTTCTTCSEEECCCE
T ss_pred CCCcCCCChhhccCCCCCEeeCCCC
Confidence 9999996655333455666666655
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.37 E-value=3.9e-09 Score=105.56 Aligned_cols=103 Identities=29% Similarity=0.326 Sum_probs=82.8
Q ss_pred CCCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC-CCCCCCccEEEecCCCcCCCCCccccCCCccccc
Q 002409 412 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 490 (927)
Q Consensus 412 ~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L 490 (927)
.+++|+.|+|++|+|+ .++ .+..|++|+.|+|++|.|+. +|. ...+++|++|+|++|+++. + +.+.++++|+.|
T Consensus 46 ~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~~-i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l~~L~~L 120 (198)
T d1m9la_ 46 TLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIAS-L-SGIEKLVNLRVL 120 (198)
T ss_dssp HTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEECS-CSSHHHHHHHCCEEECSEEECCC-H-HHHHHHHHSSEE
T ss_pred cccccceeECcccCCC-Ccc-cccCCccccChhhccccccc-ccccccccccccccccccccccc-c-cccccccccccc
Confidence 3678999999999999 676 59999999999999999985 454 3446789999999999984 4 358889999999
Q ss_pred ccccccccccccc--cc--ccccccccccCCccc
Q 002409 491 YVQNNMLSGTVPS--SL--LSKNVVLNYAGNINL 520 (927)
Q Consensus 491 ~l~~N~l~g~iP~--~l--~~~~~~l~~~~n~~l 520 (927)
+|++|+|+ .++. .+ ++.+..+.+.+|+..
T Consensus 121 ~L~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 121 YMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp EESEEECC-CHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred ccccchhc-cccccccccCCCccceeecCCCccc
Confidence 99999998 5543 22 455677888898643
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.36 E-value=3.1e-07 Score=92.09 Aligned_cols=100 Identities=30% Similarity=0.475 Sum_probs=76.2
Q ss_pred CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCccccccc
Q 002409 413 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 492 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 492 (927)
.++|+.|+|++|++++ ++ .+++|++|+.|+|++|+|++ +|.+.++++|+.|++++|.+. .+ ..+..+++|+.+++
T Consensus 67 l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~-l~~l~~l~~L~~L~l~~~~~~-~~-~~l~~l~~l~~l~~ 141 (210)
T d1h6ta2 67 LPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYL 141 (210)
T ss_dssp CTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-GGGGTTCTTCCEEECTTSCCC-CC-GGGGGCTTCCEEEC
T ss_pred CCCCCEEeCCCccccC-cc-ccccCccccccccccccccc-ccccccccccccccccccccc-cc-cccccccccccccc
Confidence 5689999999999985 54 37889999999999999886 556888889999999998886 33 35778888888888
Q ss_pred cccccccccccccccccccccccCC
Q 002409 493 QNNMLSGTVPSSLLSKNVVLNYAGN 517 (927)
Q Consensus 493 ~~N~l~g~iP~~l~~~~~~l~~~~n 517 (927)
++|.+++..+..-++.+..+.+.+|
T Consensus 142 ~~n~l~~~~~~~~l~~L~~l~l~~n 166 (210)
T d1h6ta2 142 GNNKITDITVLSRLTKLDTLSLEDN 166 (210)
T ss_dssp CSSCCCCCGGGGGCTTCSEEECCSS
T ss_pred ccccccccccccccccccccccccc
Confidence 8888875444444455566666666
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.32 E-value=4.3e-07 Score=90.14 Aligned_cols=99 Identities=30% Similarity=0.453 Sum_probs=69.0
Q ss_pred CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCccccccc
Q 002409 413 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 492 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 492 (927)
.++|+.|+|++|.+++ +++ +++|++|++|++++|.+.. ++.+.+++.|+.|++++|.+... ..+..+++|+.|++
T Consensus 61 l~nL~~L~Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~~~-~~~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l 135 (199)
T d2omxa2 61 LNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIAD-ITPLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLEL 135 (199)
T ss_dssp CTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CGGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEEC
T ss_pred CCCcCcCccccccccC-ccc-ccCCccccccccccccccc-ccccccccccccccccccccccc--cccchhhhhHHhhh
Confidence 4678888888888885 443 7888888888888888765 34577788888888888877643 34777888888888
Q ss_pred ccccccccccc-ccccccccccccCC
Q 002409 493 QNNMLSGTVPS-SLLSKNVVLNYAGN 517 (927)
Q Consensus 493 ~~N~l~g~iP~-~l~~~~~~l~~~~n 517 (927)
++|+++ .+|. .-...+..+...+|
T Consensus 136 ~~n~l~-~~~~l~~~~~L~~L~l~~n 160 (199)
T d2omxa2 136 SSNTIS-DISALSGLTSLQQLNFSSN 160 (199)
T ss_dssp CSSCCC-CCGGGTTCTTCSEEECCSS
T ss_pred hhhhhc-ccccccccccccccccccc
Confidence 888877 4442 22333445555555
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.26 E-value=2.4e-07 Score=93.92 Aligned_cols=79 Identities=27% Similarity=0.448 Sum_probs=40.3
Q ss_pred ceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCccccccccc
Q 002409 415 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 494 (927)
Q Consensus 415 ~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~ 494 (927)
.+..+.++++.+... ..+.++++|+.|++++|.+++..+ +.++++|+.|+|++|++++ +|. +.++++|++|+|++
T Consensus 130 ~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~~-l~~l~~L~~L~Ls~n~l~~-l~~-l~~l~~L~~L~Ls~ 204 (227)
T d1h6ua2 130 NLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKN 204 (227)
T ss_dssp TCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECTT
T ss_pred chhhhhchhhhhchh--hhhccccccccccccccccccchh-hcccccceecccCCCccCC-Chh-hcCCCCCCEEECcC
Confidence 444555555555422 124455555555555555543322 4555555555555555553 322 55555555555555
Q ss_pred cccc
Q 002409 495 NMLS 498 (927)
Q Consensus 495 N~l~ 498 (927)
|+|+
T Consensus 205 N~lt 208 (227)
T d1h6ua2 205 NQIS 208 (227)
T ss_dssp SCCC
T ss_pred CcCC
Confidence 5555
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.22 E-value=5.4e-07 Score=91.95 Aligned_cols=97 Identities=22% Similarity=0.293 Sum_probs=77.1
Q ss_pred cceeecCCCC--------CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCC--CCCCCCccEEEecC-C
Q 002409 403 WSWLQCNSDP--------QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED-N 471 (927)
Q Consensus 403 ~~~v~C~~~~--------~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~--~~~l~~L~~L~Ls~-N 471 (927)
...+.|+..+ +++++.|+|++|.|+...+..|.+|++|++|+|++|.+...+|. |.+++++++|.+.. |
T Consensus 10 ~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n 89 (242)
T d1xwdc1 10 NRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 89 (242)
T ss_dssp SSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCT
T ss_pred CCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccc
Confidence 3457775422 24789999999999844444688999999999999999887664 67899999998764 6
Q ss_pred CcCCCCCccccCCCcccccccccccccc
Q 002409 472 QLTGPLPSSLMNLPNLRELYVQNNMLSG 499 (927)
Q Consensus 472 ~l~g~~P~~l~~l~~L~~L~l~~N~l~g 499 (927)
+++...+..+.++++|+.|++++|.++.
T Consensus 90 ~l~~~~~~~~~~l~~L~~l~l~~~~l~~ 117 (242)
T d1xwdc1 90 NLLYINPEAFQNLPNLQYLLISNTGIKH 117 (242)
T ss_dssp TCCEECTTSEECCTTCCEEEEESCCCCS
T ss_pred cccccccccccccccccccccchhhhcc
Confidence 7887777888999999999999999883
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.19 E-value=9.1e-07 Score=89.50 Aligned_cols=77 Identities=25% Similarity=0.408 Sum_probs=66.8
Q ss_pred CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCccccccc
Q 002409 413 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 492 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 492 (927)
.++|+.|++++|.+.+. + .+.++++|+.|+|++|++++ +|.++++++|++|+|++|++++ +|+ +.++++|+.|+|
T Consensus 150 ~~~L~~L~l~~n~~~~~-~-~l~~l~~L~~L~Ls~n~l~~-l~~l~~l~~L~~L~Ls~N~lt~-i~~-l~~l~~L~~L~l 224 (227)
T d1h6ua2 150 LTNLQYLSIGNAQVSDL-T-PLANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQISD-VSP-LANTSNLFIVTL 224 (227)
T ss_dssp CTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECTTSCCCB-CGG-GTTCTTCCEEEE
T ss_pred ccccccccccccccccc-h-hhcccccceecccCCCccCC-ChhhcCCCCCCEEECcCCcCCC-Ccc-cccCCCCCEEEe
Confidence 46799999999999843 3 38999999999999999987 5668999999999999999994 553 899999999999
Q ss_pred cc
Q 002409 493 QN 494 (927)
Q Consensus 493 ~~ 494 (927)
++
T Consensus 225 sn 226 (227)
T d1h6ua2 225 TN 226 (227)
T ss_dssp EE
T ss_pred eC
Confidence 74
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.10 E-value=5.8e-08 Score=96.75 Aligned_cols=97 Identities=23% Similarity=0.328 Sum_probs=75.6
Q ss_pred EEEecCC--CCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCcccccccccc
Q 002409 418 VIHLSSK--NLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 495 (927)
Q Consensus 418 ~L~L~~n--~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N 495 (927)
.++|.++ .+. .+|..+..|++|++|+|++|+|+. ++.+.+|++|+.|+|++|+|+ .+|.....+++|+.|++++|
T Consensus 27 ~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~-i~~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N 103 (198)
T d1m9la_ 27 KVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEK-ISSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYN 103 (198)
T ss_dssp CEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESC-CCCHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEE
T ss_pred eeeeecccCchh-hhhhHHhcccccceeECcccCCCC-cccccCCccccChhhcccccc-cccccccccccccccccccc
Confidence 3444433 344 567789999999999999999985 577889999999999999998 67876666788999999999
Q ss_pred cccccccc-ccccccccccccCCc
Q 002409 496 MLSGTVPS-SLLSKNVVLNYAGNI 518 (927)
Q Consensus 496 ~l~g~iP~-~l~~~~~~l~~~~n~ 518 (927)
+|+ .++. .-+..+..+++.+|.
T Consensus 104 ~i~-~l~~~~~l~~L~~L~L~~N~ 126 (198)
T d1m9la_ 104 QIA-SLSGIEKLVNLRVLYMSNNK 126 (198)
T ss_dssp ECC-CHHHHHHHHHSSEEEESEEE
T ss_pred ccc-ccccccccccccccccccch
Confidence 999 5543 223455667777774
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.00 E-value=1e-05 Score=83.20 Aligned_cols=130 Identities=18% Similarity=0.136 Sum_probs=89.1
Q ss_pred CceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhcc-CCCccceecceeecCeEEEEEEeccCCchhhhcccc
Q 002409 611 GFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGT 689 (927)
Q Consensus 611 ~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~ 689 (927)
..+.||+...+ ++.+++|+...........+.+|...++.+. +--+.+++.+....+..++||+++++.++.+.....
T Consensus 26 s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~ 104 (263)
T d1j7la_ 26 SPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE 104 (263)
T ss_dssp SSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC
T ss_pred CCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc
Confidence 34689988654 6778889876554444556788998888774 333566778888888899999999998776543211
Q ss_pred cccccccCHHHHHHHHHHHHhHhHHHhhCC--------------------------------------------------
Q 002409 690 LTHEQRINWIKRLEIAEDAAKGIEYLHTGC-------------------------------------------------- 719 (927)
Q Consensus 690 ~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-------------------------------------------------- 719 (927)
. ....++.++++.++.||+..
T Consensus 105 ~---------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (263)
T d1j7la_ 105 Q---------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLK 175 (263)
T ss_dssp S---------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHH
T ss_pred c---------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHH
Confidence 0 11223444455555555311
Q ss_pred ------CCceecCCCCCCCeEECCCCcEEEEeecCcc
Q 002409 720 ------VPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 750 (927)
Q Consensus 720 ------~~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 750 (927)
...++|+|+.|.|||+++++..-|+||+.+.
T Consensus 176 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 176 TEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1248999999999999987666799999765
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=97.86 E-value=1.2e-05 Score=85.78 Aligned_cols=91 Identities=27% Similarity=0.362 Sum_probs=57.7
Q ss_pred ceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCccccccccc
Q 002409 415 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 494 (927)
Q Consensus 415 ~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~ 494 (927)
+++.|||++++|+ .+|+. +++|++|+|++|+|+ .+|+. +.+|+.|++++|+++ .++. + .+.|++|++++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~--~~~L~~L~l~~n~l~-~l~~-l--p~~L~~L~L~~ 107 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL--PQSLKSLLVDNNNLK-ALSD-L--PPLLEYLGVSN 107 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC--CTTCCEEECCSSCCS-CCCS-C--CTTCCEEECCS
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccc--hhhhhhhhhhhcccc-hhhh-h--ccccccccccc
Confidence 4677888888887 57753 457788888888887 44542 456777788888776 4442 1 13577788888
Q ss_pred ccccccccccc-ccccccccccCC
Q 002409 495 NMLSGTVPSSL-LSKNVVLNYAGN 517 (927)
Q Consensus 495 N~l~g~iP~~l-~~~~~~l~~~~n 517 (927)
|+++ .+|..- +..+..+...+|
T Consensus 108 n~l~-~lp~~~~l~~L~~L~l~~~ 130 (353)
T d1jl5a_ 108 NQLE-KLPELQNSSFLKIIDVDNN 130 (353)
T ss_dssp SCCS-SCCCCTTCTTCCEEECCSS
T ss_pred cccc-cccchhhhccceeeccccc
Confidence 8877 565421 233444454444
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.74 E-value=4.3e-05 Score=77.85 Aligned_cols=76 Identities=20% Similarity=0.157 Sum_probs=55.0
Q ss_pred cccccCc-eEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCC--ccceecceeecCeEEEEEEeccCCch
Q 002409 606 KIGSGGF-GVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN--LVQFLGYCQEEGRSVLVYEFMHNGTL 682 (927)
Q Consensus 606 ~IG~G~f-G~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~g~~~~~~~~~lV~E~~~~gsL 682 (927)
.+..|.. +.||+...+++..+++|.-... ....+..|.+.++.+.... +.++++++.+.+..++||+++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3445553 6899998887888899976533 2345778888888775433 45677777888889999999988766
Q ss_pred hh
Q 002409 683 KE 684 (927)
Q Consensus 683 ~~ 684 (927)
.+
T Consensus 94 ~~ 95 (255)
T d1nd4a_ 94 LS 95 (255)
T ss_dssp TT
T ss_pred cc
Confidence 44
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=97.64 E-value=3.6e-05 Score=81.73 Aligned_cols=81 Identities=33% Similarity=0.511 Sum_probs=66.8
Q ss_pred CCceEEEEecCCCCCccCCchhhcCCCCcEEeccCCcCCCCCCCCCCCCCccEEEecCCCcCCCCCccccCCCccccccc
Q 002409 413 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 492 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 492 (927)
.++|+.|+|++|+|+ .+|..+ .+|+.|++++|+++. ++++. +.|++|+|++|+++ .+|. ++++++|+.|++
T Consensus 57 ~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~-l~~lp--~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l 127 (353)
T d1jl5a_ 57 PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKA-LSDLP--PLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDV 127 (353)
T ss_dssp CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSC-CCSCC--TTCCEEECCSSCCS-SCCC-CTTCTTCCEEEC
T ss_pred CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccch-hhhhc--cccccccccccccc-cccc-hhhhccceeecc
Confidence 468999999999999 888764 578999999999874 34332 46999999999998 6775 688999999999
Q ss_pred ccccccccccc
Q 002409 493 QNNMLSGTVPS 503 (927)
Q Consensus 493 ~~N~l~g~iP~ 503 (927)
++|.++ ..|.
T Consensus 128 ~~~~~~-~~~~ 137 (353)
T d1jl5a_ 128 DNNSLK-KLPD 137 (353)
T ss_dssp CSSCCS-CCCC
T ss_pred cccccc-cccc
Confidence 999998 4444
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.56 E-value=7.6e-05 Score=75.31 Aligned_cols=93 Identities=18% Similarity=0.178 Sum_probs=45.1
Q ss_pred ceEEEEecCCCCCccCCchhhcCC-CCcEEeccCCcCCCCCCCCCCCCCccEE-EecCCCcCCCCCc-cccCCCcccccc
Q 002409 415 SITVIHLSSKNLTGNIPSDLTKLS-SLVELWLDGNSLTGPIPDFSGCPDLRII-HLEDNQLTGPLPS-SLMNLPNLRELY 491 (927)
Q Consensus 415 ~l~~L~L~~n~l~g~ip~~i~~L~-~L~~L~Ls~N~l~g~~p~~~~l~~L~~L-~Ls~N~l~g~~P~-~l~~l~~L~~L~ 491 (927)
.+..+...++.+...-+..+..+. .++.|++++|+++...+...+..+++.+ ++++|+++ .+|. .|.++++|+.|+
T Consensus 129 ~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~-~l~~~~f~~l~~L~~L~ 207 (242)
T d1xwdc1 129 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILD 207 (242)
T ss_dssp CEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCC-CCCTTTTTTSCCCSEEE
T ss_pred ccccccccccccccccccccccccccceeeecccccccccccccccchhhhccccccccccc-cccHHHhcCCCCCCEEE
Confidence 444445555555433333344443 4555566655555544443333443333 34445555 3332 355555666666
Q ss_pred cccccccccccccccccc
Q 002409 492 VQNNMLSGTVPSSLLSKN 509 (927)
Q Consensus 492 l~~N~l~g~iP~~l~~~~ 509 (927)
|++|+|+ .+|...+..+
T Consensus 208 Ls~N~l~-~l~~~~~~~l 224 (242)
T d1xwdc1 208 ISRTRIH-SLPSYGLENL 224 (242)
T ss_dssp CTTSCCC-CCCSSSCTTC
T ss_pred CCCCcCC-ccCHHHHcCC
Confidence 6666655 5555444443
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.53 E-value=6.2e-06 Score=78.78 Aligned_cols=68 Identities=26% Similarity=0.343 Sum_probs=39.2
Q ss_pred hhhcCCCCcEEeccCCcCCCCC--CC-CCCCCCccEEEecCCCcCCCCCc-cccCCCcccccccccccccccc
Q 002409 433 DLTKLSSLVELWLDGNSLTGPI--PD-FSGCPDLRIIHLEDNQLTGPLPS-SLMNLPNLRELYVQNNMLSGTV 501 (927)
Q Consensus 433 ~i~~L~~L~~L~Ls~N~l~g~~--p~-~~~l~~L~~L~Ls~N~l~g~~P~-~l~~l~~L~~L~l~~N~l~g~i 501 (927)
...++++|++|+|++|+|+..- +. +..+++|+.|+|++|+++. +++ ......+|+.|+|++|++++..
T Consensus 60 ~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~-l~~l~~l~~~~L~~L~L~~Npl~~~~ 131 (162)
T d1koha1 60 IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS-ERELDKIKGLKLEELWLDGNSLSDTF 131 (162)
T ss_dssp HHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCC-GGGHHHHTTCCCSSCCCTTSTTSSSS
T ss_pred HHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCcccc-chhhhhhhccccceeecCCCCcCcCc
Confidence 3345666777777777766532 22 3456667777777777663 332 2223345667777777766443
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.20 E-value=2.7e-05 Score=74.16 Aligned_cols=84 Identities=25% Similarity=0.279 Sum_probs=52.7
Q ss_pred CCceEEEEecCCCCCcc--CCchhhcCCCCcEEeccCCcCCCCCC-CCCCCCCccEEEecCCCcCCCCCcc-------cc
Q 002409 413 QPSITVIHLSSKNLTGN--IPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSS-------LM 482 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~--ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~Ls~N~l~g~~P~~-------l~ 482 (927)
.+.|+.|+|++|+|+.. ++..+..|++|+.|+|++|.|+...+ ......+|+.|+|++|.+++..... +.
T Consensus 64 ~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~ 143 (162)
T d1koha1 64 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRE 143 (162)
T ss_dssp CTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHT
T ss_pred CCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHH
Confidence 35677778888877732 23456677778888888887776443 1223346777778888777554432 45
Q ss_pred CCCccccccccccccc
Q 002409 483 NLPNLRELYVQNNMLS 498 (927)
Q Consensus 483 ~l~~L~~L~l~~N~l~ 498 (927)
.+|+|+.|| ++++.
T Consensus 144 ~~P~L~~LD--g~~v~ 157 (162)
T d1koha1 144 RFPKLLRLD--GHELP 157 (162)
T ss_dssp TSTTCCEET--TEECC
T ss_pred HCCCCCEEC--cCCCc
Confidence 667777654 44443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.08 E-value=4.2e-05 Score=84.18 Aligned_cols=84 Identities=32% Similarity=0.440 Sum_probs=39.0
Q ss_pred ceEEEEecCCCCC----ccCCchhhcCCCCcEEeccCCcCCCC----CC-CCC-CCCCccEEEecCCCcCCC----CCcc
Q 002409 415 SITVIHLSSKNLT----GNIPSDLTKLSSLVELWLDGNSLTGP----IP-DFS-GCPDLRIIHLEDNQLTGP----LPSS 480 (927)
Q Consensus 415 ~l~~L~L~~n~l~----g~ip~~i~~L~~L~~L~Ls~N~l~g~----~p-~~~-~l~~L~~L~Ls~N~l~g~----~P~~ 480 (927)
+++.|+|++|+++ ..|+..+..+++|+.|||++|.|+.. +. .+. ...+|+.|+|++|+++.. ++..
T Consensus 28 ~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~ 107 (460)
T d1z7xw1 28 QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSST 107 (460)
T ss_dssp TCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred CCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccccccch
Confidence 3445555555544 12333344555555555555555310 11 111 123455555555555422 3344
Q ss_pred ccCCCccccccccccccc
Q 002409 481 LMNLPNLRELYVQNNMLS 498 (927)
Q Consensus 481 l~~l~~L~~L~l~~N~l~ 498 (927)
+..+++|+.|+|++|.++
T Consensus 108 l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 108 LRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp TTSCTTCCEEECCSSBCH
T ss_pred hhccccccccccccccch
Confidence 445555555555555554
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.05 E-value=2.9e-05 Score=85.60 Aligned_cols=105 Identities=24% Similarity=0.295 Sum_probs=75.5
Q ss_pred CceEEEEecCCCCCcc-CCchhhcCCCCcEEeccCCcCCC----CCCC-CCCCCCccEEEecCCCcCC----CCCcccc-
Q 002409 414 PSITVIHLSSKNLTGN-IPSDLTKLSSLVELWLDGNSLTG----PIPD-FSGCPDLRIIHLEDNQLTG----PLPSSLM- 482 (927)
Q Consensus 414 ~~l~~L~L~~n~l~g~-ip~~i~~L~~L~~L~Ls~N~l~g----~~p~-~~~l~~L~~L~Ls~N~l~g----~~P~~l~- 482 (927)
++|+.|||+.|++++. +..-+..+++|+.|+|++|.|+- .+.. +..+++|++|||++|+|+. .+...+.
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 4799999999999853 24457778999999999999873 2333 5678999999999999862 1223332
Q ss_pred CCCccccccccccccccc----ccccc--ccccccccccCCc
Q 002409 483 NLPNLRELYVQNNMLSGT----VPSSL--LSKNVVLNYAGNI 518 (927)
Q Consensus 483 ~l~~L~~L~l~~N~l~g~----iP~~l--~~~~~~l~~~~n~ 518 (927)
...+|+.|+|++|+++.. ++..+ .+.+..+.+.+|.
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~ 123 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 123 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSB
T ss_pred CCCCCCEEECCCCCccccccccccchhhcccccccccccccc
Confidence 234799999999999843 23333 2345666777774
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.98 E-value=0.0012 Score=71.70 Aligned_cols=76 Identities=16% Similarity=0.141 Sum_probs=47.1
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeecCC-------chhhHhHHHHHHHHhhcc-C-C-CccceecceeecCeEEEE
Q 002409 605 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNS-------YQGKREFTNEVTLLSRIH-H-R-NLVQFLGYCQEEGRSVLV 673 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~~-g~~VAVK~l~~~~-------~~~~~~~~~Ei~iL~~l~-H-p-nIv~l~g~~~~~~~~~lV 673 (927)
+.||.|....||+.+..+ ++.++||.-.... .........|.+.|+.+. + | .+.+++.+ ++...++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 468999999999998764 6789999654210 112234556888887663 2 2 33444443 44556899
Q ss_pred EEeccCCch
Q 002409 674 YEFMHNGTL 682 (927)
Q Consensus 674 ~E~~~~gsL 682 (927)
||++.+..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999976543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.70 E-value=0.0016 Score=68.65 Aligned_cols=69 Identities=12% Similarity=0.119 Sum_probs=47.8
Q ss_pred eEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCcc--ceec-----ceeecCeEEEEEEeccCCch
Q 002409 613 GVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV--QFLG-----YCQEEGRSVLVYEFMHNGTL 682 (927)
Q Consensus 613 G~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv--~l~g-----~~~~~~~~~lV~E~~~~gsL 682 (927)
-.||+.+.++|+.+++|+.+.. ....+++.+|...+..+....+. ..+. .....+..+.++++++|..+
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence 4899999999999999997643 33467788899988888533321 1111 22445677889999877543
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=96.49 E-value=0.00014 Score=77.63 Aligned_cols=106 Identities=18% Similarity=0.207 Sum_probs=63.6
Q ss_pred CceEEEEecCCCCCcc-----CCchhhcCCCCcEEeccCCcCCCC----C-CCCCCCCCccEEEecCCCcCCCCC----c
Q 002409 414 PSITVIHLSSKNLTGN-----IPSDLTKLSSLVELWLDGNSLTGP----I-PDFSGCPDLRIIHLEDNQLTGPLP----S 479 (927)
Q Consensus 414 ~~l~~L~L~~n~l~g~-----ip~~i~~L~~L~~L~Ls~N~l~g~----~-p~~~~l~~L~~L~Ls~N~l~g~~P----~ 479 (927)
+.++.|+|++|.+... +...+..+++|+.|+|++|.++.. + ..+..+++|++|+|++|+|++.-. +
T Consensus 186 ~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~ 265 (344)
T d2ca6a1 186 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVD 265 (344)
T ss_dssp TTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHH
T ss_pred hhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHH
Confidence 4577788888877631 334466677788888888877542 1 225667778888888887764322 2
Q ss_pred cccC--CCccccccccccccccc----cccccc---cccccccccCCcc
Q 002409 480 SLMN--LPNLRELYVQNNMLSGT----VPSSLL---SKNVVLNYAGNIN 519 (927)
Q Consensus 480 ~l~~--l~~L~~L~l~~N~l~g~----iP~~l~---~~~~~l~~~~n~~ 519 (927)
.+.. .+.|+.|+|++|+|+.. +...+. +.+..+++.||..
T Consensus 266 ~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~ 314 (344)
T d2ca6a1 266 AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 314 (344)
T ss_dssp HHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBS
T ss_pred HhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcC
Confidence 2222 34677888888887632 222221 2345566666643
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=96.45 E-value=0.00021 Score=76.27 Aligned_cols=106 Identities=22% Similarity=0.313 Sum_probs=78.4
Q ss_pred CCceEEEEecCCCCCc----cCCchhhcCCCCcEEeccCCcCCCC-----C-CCCCCCCCccEEEecCCCcCCC----CC
Q 002409 413 QPSITVIHLSSKNLTG----NIPSDLTKLSSLVELWLDGNSLTGP-----I-PDFSGCPDLRIIHLEDNQLTGP----LP 478 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g----~ip~~i~~L~~L~~L~Ls~N~l~g~-----~-p~~~~l~~L~~L~Ls~N~l~g~----~P 478 (927)
.+.|+.|++++|.+.- .+...+..++.|+.|+|++|+++.. + ..+..+++|+.|+|++|.|+.. +.
T Consensus 157 ~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~ 236 (344)
T d2ca6a1 157 APPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA 236 (344)
T ss_dssp CCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHH
T ss_pred Ccccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccc
Confidence 3578899999998862 2444567789999999999998752 2 2367789999999999998632 45
Q ss_pred ccccCCCccccccccccccccccccccc--------cccccccccCCc
Q 002409 479 SSLMNLPNLRELYVQNNMLSGTVPSSLL--------SKNVVLNYAGNI 518 (927)
Q Consensus 479 ~~l~~l~~L~~L~l~~N~l~g~iP~~l~--------~~~~~l~~~~n~ 518 (927)
..+..+++|+.|+|++|+|++.-...+. ..+..+++++|.
T Consensus 237 ~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~ 284 (344)
T d2ca6a1 237 IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNE 284 (344)
T ss_dssp HHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSC
T ss_pred ccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCc
Confidence 6678899999999999999854222221 234566777763
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.19 E-value=0.0012 Score=68.41 Aligned_cols=82 Identities=23% Similarity=0.268 Sum_probs=60.1
Q ss_pred CceEEEEecCC--CCCc-cCCchhhcCCCCcEEeccCC-cCCCCC-CCCCCCCCccEEEecC-CCcCCCCCccccCCCcc
Q 002409 414 PSITVIHLSSK--NLTG-NIPSDLTKLSSLVELWLDGN-SLTGPI-PDFSGCPDLRIIHLED-NQLTGPLPSSLMNLPNL 487 (927)
Q Consensus 414 ~~l~~L~L~~n--~l~g-~ip~~i~~L~~L~~L~Ls~N-~l~g~~-p~~~~l~~L~~L~Ls~-N~l~g~~P~~l~~l~~L 487 (927)
+.|+.|+|+++ +++. .+...+.++++|++|+|++| .+++.. ..+.++++|++|+|++ +++++.....++++++|
T Consensus 148 ~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L 227 (284)
T d2astb2 148 ETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTL 227 (284)
T ss_dssp TTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTC
T ss_pred cccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCC
Confidence 47888888864 3442 23334456888999999886 466543 4577888999999988 46777767778888899
Q ss_pred cccccccc
Q 002409 488 RELYVQNN 495 (927)
Q Consensus 488 ~~L~l~~N 495 (927)
+.|+++++
T Consensus 228 ~~L~l~~~ 235 (284)
T d2astb2 228 KTLQVFGI 235 (284)
T ss_dssp CEEECTTS
T ss_pred CEEeeeCC
Confidence 99988877
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.15 E-value=0.00068 Score=70.24 Aligned_cols=104 Identities=18% Similarity=0.262 Sum_probs=69.5
Q ss_pred CceEEEEecCC-CCCc-cCCchhhcC-CCCcEEeccCC--cCCC-CCCCC-CCCCCccEEEecCC-CcCCCCCccccCCC
Q 002409 414 PSITVIHLSSK-NLTG-NIPSDLTKL-SSLVELWLDGN--SLTG-PIPDF-SGCPDLRIIHLEDN-QLTGPLPSSLMNLP 485 (927)
Q Consensus 414 ~~l~~L~L~~n-~l~g-~ip~~i~~L-~~L~~L~Ls~N--~l~g-~~p~~-~~l~~L~~L~Ls~N-~l~g~~P~~l~~l~ 485 (927)
++|++|+|+++ +++. .+...+.++ ++|+.|+|+++ .++. .+..+ .++++|++|+|++| .+++..+..+.+++
T Consensus 121 ~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~ 200 (284)
T d2astb2 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN 200 (284)
T ss_dssp TTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCT
T ss_pred HhccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccC
Confidence 57899999885 4442 233344444 68999999875 3443 23333 45889999999886 57877888888999
Q ss_pred cccccccccc-ccccccccccc--cccccccccCC
Q 002409 486 NLRELYVQNN-MLSGTVPSSLL--SKNVVLNYAGN 517 (927)
Q Consensus 486 ~L~~L~l~~N-~l~g~iP~~l~--~~~~~l~~~~n 517 (927)
+|++|+|++| ++++.....+. +.+..+++.|+
T Consensus 201 ~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 201 YLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp TCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred cCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 9999999984 57755444443 23455555554
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=95.89 E-value=0.00051 Score=65.27 Aligned_cols=86 Identities=15% Similarity=0.253 Sum_probs=60.6
Q ss_pred CCceEEEEecCC-CCCcc----CCchhhcCCCCcEEeccCCcCCCCC-CC----CCCCCCccEEEecCCCcCCC----CC
Q 002409 413 QPSITVIHLSSK-NLTGN----IPSDLTKLSSLVELWLDGNSLTGPI-PD----FSGCPDLRIIHLEDNQLTGP----LP 478 (927)
Q Consensus 413 ~~~l~~L~L~~n-~l~g~----ip~~i~~L~~L~~L~Ls~N~l~g~~-p~----~~~l~~L~~L~Ls~N~l~g~----~P 478 (927)
.+.|++|+|+++ .++.. +-..+...+.|+.|+|++|.+...- .. +...+.|+.|+|++|.|+.. +-
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~ 93 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 93 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence 357999999874 45422 3335666788999999999886421 11 44567899999999988742 22
Q ss_pred ccccCCCccccccccccccc
Q 002409 479 SSLMNLPNLRELYVQNNMLS 498 (927)
Q Consensus 479 ~~l~~l~~L~~L~l~~N~l~ 498 (927)
..+...+.|+.|+|++|.+.
T Consensus 94 ~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 94 RSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHTTTTCCCSEEECCCCSSC
T ss_pred HHHHhCCcCCEEECCCCcCC
Confidence 35666788999999888765
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.43 E-value=0.022 Score=61.29 Aligned_cols=73 Identities=14% Similarity=0.288 Sum_probs=49.1
Q ss_pred ccccccCceEEEEEEECCC--------cEEEEEEeecCCchhhHhHHHHHHHHhhccCCCcc-ceecceeecCeEEEEEE
Q 002409 605 KKIGSGGFGVVYYGKLKDG--------KEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV-QFLGYCQEEGRSVLVYE 675 (927)
Q Consensus 605 ~~IG~G~fG~Vy~~~~~~g--------~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv-~l~g~~~~~~~~~lV~E 675 (927)
+.|+.|-.-.+|+....++ +.|.+++.-. ........+|..+++.+.-.++. ++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 4577788889999987643 4577776542 22344567899999888544554 66666642 58999
Q ss_pred eccCCchh
Q 002409 676 FMHNGTLK 683 (927)
Q Consensus 676 ~~~~gsL~ 683 (927)
|+++..|.
T Consensus 122 fi~g~~l~ 129 (395)
T d1nw1a_ 122 YIPSRPLS 129 (395)
T ss_dssp CCCEEECC
T ss_pred EeccccCC
Confidence 99875543
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=94.90 E-value=0.0027 Score=59.99 Aligned_cols=85 Identities=11% Similarity=0.069 Sum_probs=62.8
Q ss_pred CceEEEEecCCCCCc----cCCchhhcCCCCcEEeccCCcCCCCCC-----CCCCCCCccEEEecCCCcCCC-------C
Q 002409 414 PSITVIHLSSKNLTG----NIPSDLTKLSSLVELWLDGNSLTGPIP-----DFSGCPDLRIIHLEDNQLTGP-------L 477 (927)
Q Consensus 414 ~~l~~L~L~~n~l~g----~ip~~i~~L~~L~~L~Ls~N~l~g~~p-----~~~~l~~L~~L~Ls~N~l~g~-------~ 477 (927)
+.|+.|+|++|.+.. .+...+...+.|+.|+|++|.|+..-- .+...+.|++|+|++|++... +
T Consensus 44 ~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l 123 (167)
T d1pgva_ 44 KHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDM 123 (167)
T ss_dssp SCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHH
T ss_pred CccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHH
Confidence 468999999999873 233456667899999999999986321 267788999999999976621 3
Q ss_pred CccccCCCccccccccccccc
Q 002409 478 PSSLMNLPNLRELYVQNNMLS 498 (927)
Q Consensus 478 P~~l~~l~~L~~L~l~~N~l~ 498 (927)
...+...+.|+.|+++.+...
T Consensus 124 ~~~L~~n~sL~~l~l~~~~~~ 144 (167)
T d1pgva_ 124 MMAIEENESLLRVGISFASME 144 (167)
T ss_dssp HHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHHhCCCccEeeCcCCCch
Confidence 344555678888888766543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.35 E-value=0.09 Score=54.11 Aligned_cols=141 Identities=12% Similarity=0.065 Sum_probs=72.7
Q ss_pred ccccCceEEEEEEECCCcEEEEEEeecCCchhhHhHHHHHHHHhhccCCCc-----cceec---ceeecCeEEEEEEecc
Q 002409 607 IGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL-----VQFLG---YCQEEGRSVLVYEFMH 678 (927)
Q Consensus 607 IG~G~fG~Vy~~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~iL~~l~HpnI-----v~l~g---~~~~~~~~~lV~E~~~ 678 (927)
|..|---+.|+.+..+| .+++|+.... ....++..|++++..+.+.++ +...+ +....+....++.+..
T Consensus 26 i~~G~~N~ny~v~t~~g-~yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~ 102 (316)
T d2ppqa1 26 IAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE 102 (316)
T ss_dssp ECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred CCCCcccCeEEEEECCC-cEEEEEcCCC--CCHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeecc
Confidence 44555578899888755 4888987543 223456667777777753332 21111 1223445566777766
Q ss_pred CCchhhhc--------------cc---c---cccccc-----------------cCHHHHHHHHHHHHhHhHHHhh-CCC
Q 002409 679 NGTLKEHL--------------YG---T---LTHEQR-----------------INWIKRLEIAEDAAKGIEYLHT-GCV 720 (927)
Q Consensus 679 ~gsL~~~L--------------~~---~---~~~~~~-----------------l~~~~~~~i~~qia~gL~yLH~-~~~ 720 (927)
+......- +. . ...... .........+......+...+. ...
T Consensus 103 g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~ 182 (316)
T d2ppqa1 103 GMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLP 182 (316)
T ss_dssp CBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSC
T ss_pred cccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCccccc
Confidence 54332110 00 0 000000 0000111222222222222222 223
Q ss_pred CceecCCCCCCCeEECCCCcEEEEeecCcc
Q 002409 721 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK 750 (927)
Q Consensus 721 ~~ivHrDLkp~NILl~~~~~vkL~DFGla~ 750 (927)
.++||+|+.+.||+++.+...-|.||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 489999999999999988777899999775
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=91.79 E-value=0.01 Score=55.60 Aligned_cols=85 Identities=20% Similarity=0.308 Sum_probs=53.7
Q ss_pred CceEEEEecC-CCCCcc----CCchhhcCCCCcEEeccCCcCCCCCC----C-CCCCCCccEEEecCCCcCCC----CCc
Q 002409 414 PSITVIHLSS-KNLTGN----IPSDLTKLSSLVELWLDGNSLTGPIP----D-FSGCPDLRIIHLEDNQLTGP----LPS 479 (927)
Q Consensus 414 ~~l~~L~L~~-n~l~g~----ip~~i~~L~~L~~L~Ls~N~l~g~~p----~-~~~l~~L~~L~Ls~N~l~g~----~P~ 479 (927)
+.|+.|+|++ +.++.. +-..+...++|+.|+|++|.++..-- + +...+.|+.|++++|.++.. +-.
T Consensus 17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~ 96 (166)
T d1io0a_ 17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 96 (166)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHH
Confidence 5788888887 445421 23345567788888888888765321 1 44567888888888887632 224
Q ss_pred cccCCCccccc--cccccccc
Q 002409 480 SLMNLPNLREL--YVQNNMLS 498 (927)
Q Consensus 480 ~l~~l~~L~~L--~l~~N~l~ 498 (927)
.+...++|+.+ ++++|.+.
T Consensus 97 ~l~~~~~L~~l~L~l~~n~i~ 117 (166)
T d1io0a_ 97 ALQSNTSLIELRIDNQSQPLG 117 (166)
T ss_dssp GGGGCSSCCEEECCCCSSCCC
T ss_pred HHHhCccccEEeeccCCCcCc
Confidence 55666777764 44556665
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=88.26 E-value=0.017 Score=53.93 Aligned_cols=86 Identities=10% Similarity=0.117 Sum_probs=63.4
Q ss_pred CCceEEEEecCCCCCcc----CCchhhcCCCCcEEeccCCcCCCCC-----CCCCCCCCccEEEe--cCCCcCC----CC
Q 002409 413 QPSITVIHLSSKNLTGN----IPSDLTKLSSLVELWLDGNSLTGPI-----PDFSGCPDLRIIHL--EDNQLTG----PL 477 (927)
Q Consensus 413 ~~~l~~L~L~~n~l~g~----ip~~i~~L~~L~~L~Ls~N~l~g~~-----p~~~~l~~L~~L~L--s~N~l~g----~~ 477 (927)
.+.|+.|+|++|.++.. +-..+...++|+.|++++|.++... ..+...+.|+.++| ++|.+.. .+
T Consensus 45 n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~L 124 (166)
T d1io0a_ 45 NTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEI 124 (166)
T ss_dssp CCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHH
T ss_pred CCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHH
Confidence 35799999999998754 3345667899999999999987532 23667888987666 5677753 35
Q ss_pred CccccCCCccccccccccccc
Q 002409 478 PSSLMNLPNLRELYVQNNMLS 498 (927)
Q Consensus 478 P~~l~~l~~L~~L~l~~N~l~ 498 (927)
.+.+...++|+.|+++.|+..
T Consensus 125 a~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 125 ANMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp HHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHhCCCcCEEeCcCCCCc
Confidence 556667889999999877654
|